{"_default": {"1": {"Abstract": " Long noncoding RNA (lncRNA) short nucleolar RNA host gene 15 () has been found to have an oncogenic function in numerous malignancies. Nevertheless, the biological function and regulatory mechanisms of  in breast cancer have not been fully elucidated. Quantitative real-time polymerase chain reaction (qRT-PCR) was used to detect the expression of  and in MDA-MB-231 breast cancer cells. The expression of  was silenced using small interfering RNA (siRNA) technology. The proliferation and migration of the cells were examined by colony formation assays, cell counting kit 8 (CCK-8) assays, and transwell assays. For the zebrafish xenograft injection experiments, cultured cells labelled with the fluorescent dye CM-DiI were injected into the perivitelline space of the larvae. This present study revealed that the expression of lncRNA  () was significantly upregulated in breast cancer cells, and its overexpression was associated with the tumor. The relative expression of  could be downregulated using siRNAs, and silencing  inhibited the proliferation and the migration of MDA-MB-231 cells.  experiments using the zebrafish xenograft model showed similar results. Mechanistically, the knockdown effect of  could be restored by inhibiting the expression of the , confirming the negative regulation between  and . Interestingly, cisplatin treatment combined with  knockdown effectively inhibited MDA-MB-231 cell proliferation and migration in the zebrafish xenograft compared to negative controls. In conclusion,  knockdown increased  expression and negated cisplatin resistance in breast cancer cells, and thus,  may be a potential novel target for breast cancer therapy.", "Authors": null, "CiteCrawlerDeep": 1, "CitedBy": null, "DOI": "10.21037/atm-22-5275", "InsertType": null, "Journal": "Annals of translational medicine", "Keywords": [{"IS_Major": false, "IS_Mesh": false, "Text": "Cisplatin"}, {"IS_Major": false, "IS_Mesh": false, "Text": "SNHG15"}, {"IS_Major": false, "IS_Mesh": false, "Text": "human breast cancer"}, {"IS_Major": false, "IS_Mesh": false, "Text": "long noncoding RNA (lncRNA)"}, {"IS_Major": false, "IS_Mesh": false, "Text": "miR-345-5p"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "PubMed-not-MEDLINE", "Article": {"@PubModel": "Print", "Abstract": {"AbstractText": [{"#text": "Long noncoding RNA (lncRNA) short nucleolar RNA host gene 15 () has been found to have an oncogenic function in numerous malignancies. Nevertheless, the biological function and regulatory mechanisms of  in breast cancer have not been fully elucidated.", "@Label": "BACKGROUND", "@NlmCategory": "UNASSIGNED", "i": ["SNHG15", "SNHG15"]}, {"#text": "Quantitative real-time polymerase chain reaction (qRT-PCR) was used to detect the expression of  and in MDA-MB-231 breast cancer cells. The expression of  was silenced using small interfering RNA (siRNA) technology. The proliferation and migration of the cells were examined by colony formation assays, cell counting kit 8 (CCK-8) assays, and transwell assays. For the zebrafish xenograft injection experiments, cultured cells labelled with the fluorescent dye CM-DiI were injected into the perivitelline space of the larvae.", "@Label": "METHODS", "@NlmCategory": "UNASSIGNED", "i": ["SNHG15", "SNHG15"]}, {"#text": "This present study revealed that the expression of lncRNA  () was significantly upregulated in breast cancer cells, and its overexpression was associated with the tumor. The relative expression of  could be downregulated using siRNAs, and silencing  inhibited the proliferation and the migration of MDA-MB-231 cells.  experiments using the zebrafish xenograft model showed similar results. Mechanistically, the knockdown effect of  could be restored by inhibiting the expression of the , confirming the negative regulation between  and . Interestingly, cisplatin treatment combined with  knockdown effectively inhibited MDA-MB-231 cell proliferation and migration in the zebrafish xenograft compared to negative controls.", "@Label": "RESULTS", "@NlmCategory": "UNASSIGNED", "i": ["SNHG15", "lnc-SNHG15", "lnc-SNHG15", "lnc-SNHG15", "In vivo", "lnc-SNHG15", "miR-345-5p", "lnc-SNHG15", "miR-345-5p", "SNHG15"]}, {"#text": "In conclusion,  knockdown increased  expression and negated cisplatin resistance in breast cancer cells, and thus,  may be a potential novel target for breast cancer therapy.", "@Label": "CONCLUSIONS", "@NlmCategory": "UNASSIGNED", "i": ["lnc-SNHG15", "miR-345-5p", "lnc-SNHG15"]}], "CopyrightInformation": "2022 Annals of Translational Medicine. All rights reserved."}, "ArticleTitle": {"#text": "Silencing the expression of lncRNA  may be a novel therapeutic approach in human breast cancer through regulating .", "i": ["SNHG15", "miR-345-5p"]}, "AuthorList": {"@CompleteYN": "Y", "Author": [{"@EqualContrib": "Y", "@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of Anesthesiology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China."}, {"Affiliation": "Department of Surgical Oncology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China."}, {"Affiliation": "Key Laboratory of Minimally Invasive Techniques & Rapid Rehabilitation of Digestive System Tumor of Zhejiang Province, Linhai, China."}], "ForeName": "Minshu", "Initials": "M", "LastName": "Zhu"}, {"@EqualContrib": "Y", "@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of Anesthesiology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China."}, {"Affiliation": "Department of Surgical Oncology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China."}, {"Affiliation": "Key Laboratory of Minimally Invasive Techniques & Rapid Rehabilitation of Digestive System Tumor of Zhejiang Province, Linhai, China."}], "ForeName": "Haifei", "Initials": "H", "LastName": "Xiang"}, {"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of Anesthesiology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China."}, {"Affiliation": "Department of Surgical Oncology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China."}], "ForeName": "Zheng", "Initials": "Z", "LastName": "Peng"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Key Laboratory of Minimally Invasive Techniques & Rapid Rehabilitation of Digestive System Tumor of Zhejiang Province, Linhai, China."}, "ForeName": "Zhaosheng", "Initials": "Z", "LastName": "Ma"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Surgical Oncology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China."}, "ForeName": "Jianfei", "Initials": "J", "LastName": "Shen"}, {"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of Anesthesiology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China."}, {"Affiliation": "Department of Surgical Oncology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China."}], "ForeName": "Tingting", "Initials": "T", "LastName": "Wang"}, {"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of Anesthesiology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China."}, {"Affiliation": "Department of Surgical Oncology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China."}], "ForeName": "Lingyang", "Initials": "L", "LastName": "Chen"}, {"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of Anesthesiology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China."}, {"Affiliation": "Department of Surgical Oncology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China."}], "ForeName": "Donghang", "Initials": "D", "LastName": "Cao"}, {"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of Anesthesiology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China."}, {"Affiliation": "Department of Surgical Oncology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China."}], "ForeName": "Shanye", "Initials": "S", "LastName": "Gu"}, {"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of Anesthesiology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China."}, {"Affiliation": "Department of Surgical Oncology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China."}, {"Affiliation": "Key Laboratory of Minimally Invasive Techniques & Rapid Rehabilitation of Digestive System Tumor of Zhejiang Province, Linhai, China."}], "ForeName": "Mingcang", "Initials": "M", "LastName": "Wang"}, {"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of Anesthesiology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China."}, {"Affiliation": "Department of Surgical Oncology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China."}, {"Affiliation": "Key Laboratory of Minimally Invasive Techniques & Rapid Rehabilitation of Digestive System Tumor of Zhejiang Province, Linhai, China."}], "ForeName": "Jianbin", "Initials": "J", "LastName": "Cao"}]}, "ELocationID": [{"#text": "1173", "@EIdType": "pii", "@ValidYN": "Y"}, {"#text": "10.21037/atm-22-5275", "@EIdType": "doi", "@ValidYN": "Y"}], "Journal": {"ISOAbbreviation": "Ann Transl Med", "ISSN": {"#text": "2305-5839", "@IssnType": "Print"}, "JournalIssue": {"@CitedMedium": "Print", "Issue": "21", "PubDate": {"Month": "Nov", "Year": "2022"}, "Volume": "10"}, "Title": "Annals of translational medicine"}, "Language": "eng", "Pagination": {"MedlinePgn": "1173", "StartPage": "1173"}, "PublicationTypeList": {"PublicationType": {"#text": "Journal Article", "@UI": "D016428"}}}, "CoiStatement": "Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://atm.amegroups.com/article/view/10.21037/atm-22-5275/coif). The authors have no conflicts of interest to declare.", "DateRevised": {"Day": "06", "Month": "12", "Year": "2022"}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"#text": "Cisplatin", "@MajorTopicYN": "N"}, {"#text": "SNHG15", "@MajorTopicYN": "N"}, {"#text": "human breast cancer", "@MajorTopicYN": "N"}, {"#text": "long noncoding RNA (lncRNA)", "@MajorTopicYN": "N"}, {"#text": "miR-345-5p", "@MajorTopicYN": "N"}]}, "MedlineJournalInfo": {"Country": "China", "ISSNLinking": "2305-5839", "MedlineTA": "Ann Transl Med", "NlmUniqueID": "101617978"}, "PMID": {"#text": "36467335", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "36467335", "@IdType": "pubmed"}, {"#text": "PMC9708471", "@IdType": "pmc"}, {"#text": "10.21037/atm-22-5275", "@IdType": "doi"}, {"#text": "atm-10-21-1173", "@IdType": "pii"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "received", "Day": "19", "Month": "9", "Year": "2022"}, {"@PubStatus": "accepted", "Day": "7", "Month": "11", "Year": "2022"}, {"@PubStatus": "entrez", "Day": "5", "Hour": "4", "Minute": "23", "Month": "12", "Year": "2022"}, {"@PubStatus": "pubmed", "Day": "6", "Hour": "6", "Minute": "0", "Month": "12", "Year": "2022"}, {"@PubStatus": "medline", "Day": "6", "Hour": "6", "Minute": "1", "Month": "12", "Year": "2022"}]}, "PublicationStatus": "ppublish", "ReferenceList": {"Reference": [{"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12935-021-01885-0", "@IdType": "doi"}, {"#text": "PMC8097789", "@IdType": "pmc"}, {"#text": "33952250", "@IdType": "pubmed"}]}, "Citation": "Du J, Zhong H, Ma B. Targeting a novel LncRNA SNHG15/miR-451/c-Myc signaling cascade is effective to hamper the pathogenesis of breast cancer (BC) in vitro and in vivo. Cancer Cell Int 2021;21:186. 10.1186/s12935-021-01885-0"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1080/15384047.2018.1456599", "@IdType": "doi"}, {"#text": "PMC6300341", "@IdType": "pmc"}, {"#text": "29580128", "@IdType": "pubmed"}]}, "Citation": "Jin L, Han B, Siegel E, et al. Breast cancer lung metastasis: Molecular biology and therapeutic implications. Cancer Biol Ther 2018;19:858-68. 10.1080/15384047.2018.1456599"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12885-019-6311-z", "@IdType": "doi"}, {"#text": "PMC6852913", "@IdType": "pmc"}, {"#text": "31718602", "@IdType": "pubmed"}]}, "Citation": "Wang R, Zhu Y, Liu X, et al. The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer. BMC Cancer 2019;19:1091. 10.1186/s12885-019-6311-z"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.molonc.2010.04.002", "@IdType": "doi"}, {"#text": "PMC5527941", "@IdType": "pmc"}, {"#text": "20627830", "@IdType": "pubmed"}]}, "Citation": "Jovanovic J, R\u00f8nneberg JA, Tost J, et al. The epigenetics of breast cancer. Mol Oncol 2010;4:242-54. 10.1016/j.molonc.2010.04.002"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s13148-022-01239-1", "@IdType": "doi"}, {"#text": "PMC8830042", "@IdType": "pmc"}, {"#text": "35139887", "@IdType": "pubmed"}]}, "Citation": "Marino N, German R, Podicheti R, et al. Aberrant epigenetic and transcriptional events associated with breast cancer risk. Clin Epigenetics 2022;14:21. 10.1186/s13148-022-01239-1"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41419-020-02954-4", "@IdType": "doi"}, {"#text": "PMC7490374", "@IdType": "pmc"}, {"#text": "32929060", "@IdType": "pubmed"}]}, "Citation": "Liu L, Zhang Y, Lu J. The roles of long noncoding RNAs in breast cancer metastasis. Cell Death Dis 2020;11:749. 10.1038/s41419-020-02954-4"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2147/OTT.S158104", "@IdType": "doi"}, {"#text": "PMC5983019", "@IdType": "pmc"}, {"#text": "29881292", "@IdType": "pubmed"}]}, "Citation": "Hu Y, Zhu QN, Deng JL, et al. Emerging role of long non-coding RNAs in cisplatin resistance. Onco Targets Ther 2018;11:3185-94. 10.2147/OTT.S158104"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1097/IGC.0000000000000828", "@IdType": "doi"}, {"#text": "PMC5084630", "@IdType": "pmc"}, {"#text": "27603915", "@IdType": "pubmed"}]}, "Citation": "Zhong Y, Gao D, He S, et al. Dysregulated Expression of Long Noncoding RNAs in Ovarian Cancer. Int J Gynecol Cancer 2016;26:1564-70. 10.1097/IGC.0000000000000828"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ygeno.2019.07.007", "@IdType": "doi"}, {"#text": "31302201", "@IdType": "pubmed"}]}, "Citation": "Zhu Y, Zhao Y, Dong S, et al. Systematic identification of dysregulated lncRNAs associated with platinum-based chemotherapy response across 11 cancer types. Genomics 2020;112:1214-22. 10.1016/j.ygeno.2019.07.007"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1515/jib-2019-0027", "@IdType": "doi"}, {"#text": "PMC6798851", "@IdType": "pmc"}, {"#text": "31301674", "@IdType": "pubmed"}]}, "Citation": "Zhang P, Wu W, Chen Q, et al. Non-Coding RNAs and their Integrated Networks. J Integr Bioinform 2019;16:20190027. 10.1515/jib-2019-0027"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/ijms20225573", "@IdType": "doi"}, {"#text": "PMC6888083", "@IdType": "pmc"}, {"#text": "31717266", "@IdType": "pubmed"}]}, "Citation": "Zhang X, Wang W, Zhu W, et al. Mechanisms and Functions of Long Non-Coding RNAs at Multiple Regulatory Levels. Int J Mol Sci 2019;20:5573. 10.3390/ijms20225573"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1111/cpr.12716", "@IdType": "doi"}, {"#text": "PMC6985667", "@IdType": "pmc"}, {"#text": "31774607", "@IdType": "pubmed"}]}, "Citation": "Shuai Y, Ma Z, Lu J, et al. LncRNA SNHG15: A new budding star in human cancers. Cell Prolif 2020;53:e12716. 10.1111/cpr.12716"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1155/2020/3417036", "@IdType": "doi"}, {"#text": "PMC7378602", "@IdType": "pmc"}, {"#text": "32733556", "@IdType": "pubmed"}]}, "Citation": "Zhang C, Ke Y, Liu X, et al. High Expression of the Long Noncoding RNA SNHG15 in Cancer Tissue Samples Predicts an Unfavorable Prognosis of Cancer Patients: A Meta-Analysis. J Oncol 2020;2020:3417036. 10.1155/2020/3417036"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3389/fonc.2020.00389", "@IdType": "doi"}, {"#text": "PMC7154078", "@IdType": "pmc"}, {"#text": "32318335", "@IdType": "pubmed"}]}, "Citation": "Zimta AA, Tigu AB, Braicu C, et al. An Emerging Class of Long Non-coding RNA With Oncogenic Role Arises From the snoRNA Host Genes. Front Oncol 2020;10:389. 10.3389/fonc.2020.00389"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12929-017-0353-9", "@IdType": "doi"}, {"#text": "PMC5516387", "@IdType": "pmc"}, {"#text": "28720111", "@IdType": "pubmed"}]}, "Citation": "Liu K, Hou Y, Liu Y, et al. LncRNA SNHG15 contributes to proliferation, invasion and autophagy in osteosarcoma cells by sponging miR-141. J Biomed Sci 2017;24:46. 10.1186/s12929-017-0353-9"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3389/fendo.2018.00402", "@IdType": "doi"}, {"#text": "PMC6085463", "@IdType": "pmc"}, {"#text": "30123182", "@IdType": "pubmed"}]}, "Citation": "O'Brien J, Hayder H, Zayed Y, et al. Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation. Front Endocrinol (Lausanne) 2018;9:402. 10.3389/fendo.2018.00402"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bbamcr.2010.06.013", "@IdType": "doi"}, {"#text": "20619301", "@IdType": "pubmed"}]}, "Citation": "Wahid F, Shehzad A, Khan T, et al. MicroRNAs: synthesis, mechanism, function, and recent clinical trials. Biochim Biophys Acta 2010;1803:1231-43. 10.1016/j.bbamcr.2010.06.013"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3389/fonc.2021.708765", "@IdType": "doi"}, {"#text": "PMC8554338", "@IdType": "pmc"}, {"#text": "34722255", "@IdType": "pubmed"}]}, "Citation": "Otmani K, Lewalle P. Tumor Suppressor miRNA in Cancer Cells and the Tumor Microenvironment: Mechanism of Deregulation and Clinical Implications. Front Oncol 2021;11:708765. 10.3389/fonc.2021.708765"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/abbs/gmz166", "@IdType": "doi"}, {"#text": "32147678", "@IdType": "pubmed"}]}, "Citation": "Zhang J, Wang C, Yan S, et al. miR-345 inhibits migration and stem-like cell phenotype in gastric cancer via inactivation of Rac1 by targeting EPS8. Acta Biochim Biophys Sin (Shanghai) 2020;52:259-67. 10.1093/abbs/gmz166"}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4723872", "@IdType": "pmc"}, {"#text": "26885027", "@IdType": "pubmed"}]}, "Citation": "Chen L, Li X, Chen X. Prognostic significance of tissue miR-345 downregulation in non-small cell lung cancer. Int J Clin Exp Med 2015;8:20971-6."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1631/jzus.B1900312", "@IdType": "doi"}, {"#text": "PMC7086013", "@IdType": "pmc"}, {"#text": "32133796", "@IdType": "pubmed"}]}, "Citation": "Yu H, Li SB. Role of LINC00152 in non-small cell lung cancer. J Zhejiang Univ Sci B 2020;21:179-91. 10.1631/jzus.B1900312"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cell.2017.11.040", "@IdType": "doi"}, {"#text": "PMC5734106", "@IdType": "pmc"}, {"#text": "29245011", "@IdType": "pubmed"}]}, "Citation": "Hosono Y, Niknafs YS, Prensner JR, et al. Oncogenic Role of THOR, a Conserved Cancer/Testis Long Non-coding RNA. Cell 2017;171:1559-1572.e20. 10.1016/j.cell.2017.11.040"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.21037/jgo-21-832", "@IdType": "doi"}, {"#text": "PMC8899727", "@IdType": "pmc"}, {"#text": "35284103", "@IdType": "pubmed"}]}, "Citation": "Wang J, Zhang XY, Xu DY. Zebrafish xenograft model for studying the function of lncRNA SNHG4 in the proliferation and migration of colorectal cancer. J Gastrointest Oncol 2022;13:210-20. 10.21037/jgo-21-832"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1089/nat.2012.0412", "@IdType": "doi"}, {"#text": "PMC3569965", "@IdType": "pmc"}, {"#text": "23391414", "@IdType": "pubmed"}]}, "Citation": "Weinberg MS, Morris KV. Long non-coding RNA targeting and transcriptional de-repression. Nucleic Acid Ther 2013;23:9-14. 10.1089/nat.2012.0412"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ydbio.2009.11.014", "@IdType": "doi"}, {"#text": "19914236", "@IdType": "pubmed"}]}, "Citation": "Aman A, Piotrowski T. Cell migration during morphogenesis. Dev Biol 2010;341:20-33. 10.1016/j.ydbio.2009.11.014"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/1471-2407-9-128", "@IdType": "doi"}, {"#text": "PMC2697170", "@IdType": "pmc"}, {"#text": "19400945", "@IdType": "pubmed"}]}, "Citation": "Marques IJ, Weiss FU, Vlecken DH, et al. Metastatic behaviour of primary human tumours in a zebrafish xenotransplantation model. BMC Cancer 2009;9:128. 10.1186/1471-2407-9-128"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12943-019-1079-y", "@IdType": "doi"}, {"#text": "PMC6794841", "@IdType": "pmc"}, {"#text": "31619268", "@IdType": "pubmed"}]}, "Citation": "Ni W, Yao S, Zhou Y, et al. Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m6A reader YTHDF3. Mol Cancer 2019;18:143. 10.1186/s12943-019-1079-y"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3389/fmolb.2021.691795", "@IdType": "doi"}, {"#text": "PMC8261055", "@IdType": "pmc"}, {"#text": "34250022", "@IdType": "pubmed"}]}, "Citation": "Wang L, Zhao X, Fu J, et al. The Role of Tumour Metabolism in Cisplatin Resistance. Front Mol Biosci 2021;8:691795. 10.3389/fmolb.2021.691795"}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3255438", "@IdType": "pmc"}, {"#text": "22247839", "@IdType": "pubmed"}]}, "Citation": "Sharma GN, Dave R, Sanadya J, et al. Various types and management of breast cancer: an overview. J Adv Pharm Technol Res 2010;1:109-26."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.21037/jtd.2017.02.75", "@IdType": "doi"}, {"#text": "PMC5394024", "@IdType": "pmc"}, {"#text": "28449441", "@IdType": "pubmed"}]}, "Citation": "Nagai H, Kim YH. Cancer prevention from the perspective of global cancer burden patterns. J Thorac Dis 2017;9:448-51. 10.21037/jtd.2017.02.75"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12935-020-01608-x", "@IdType": "doi"}, {"#text": "PMC7640707", "@IdType": "pmc"}, {"#text": "33292213", "@IdType": "pubmed"}]}, "Citation": "Xu B, Mei J, Ji W, et al. LncRNA SNHG3, a potential oncogene in human cancers. Cancer Cell Int 2020;20:536. 10.1186/s12935-020-01608-x"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/0008-5472.CAN-16-2634", "@IdType": "doi"}, {"#text": "PMC8330958", "@IdType": "pmc"}, {"#text": "28701486", "@IdType": "pubmed"}]}, "Citation": "Bhan A, Soleimani M, Mandal SS. Long Noncoding RNA and Cancer: A New Paradigm. Cancer Res 2017;77:3965-81. 10.1158/0008-5472.CAN-16-2634"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41573-021-00219-z", "@IdType": "doi"}, {"#text": "PMC8212082", "@IdType": "pmc"}, {"#text": "34145432", "@IdType": "pubmed"}]}, "Citation": "Winkle M, El-Daly SM, Fabbri M, et al. Noncoding RNA therapeutics - challenges and potential solutions. Nat Rev Drug Discov 2021;20:629-51. 10.1038/s41573-021-00219-z"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/ijc.25257", "@IdType": "doi"}, {"#text": "PMC2946420", "@IdType": "pmc"}, {"#text": "20162579", "@IdType": "pubmed"}]}, "Citation": "Yin D, Chen W, O'Kelly J, et al. Connective tissue growth factor associated with oncogenic activities and drug resistance in glioblastoma multiforme. Int J Cancer 2010;127:2257-67. 10.1002/ijc.25257"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s13046-019-1169-0", "@IdType": "doi"}, {"#text": "PMC6480895", "@IdType": "pmc"}, {"#text": "31014355", "@IdType": "pubmed"}]}, "Citation": "Saeinasab M, Bahrami AR, Gonz\u00e1lez J, et al. SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF. J Exp Clin Cancer Res 2019;38:172. 10.1186/s13046-019-1169-0"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/978-1-4614-8289-5_1", "@IdType": "doi"}, {"#text": "24104470", "@IdType": "pubmed"}]}, "Citation": "Salvador JM, Brown-Clay JD, Fornace AJ, Jr. Gadd45 in stress signaling, cell cycle control, and apoptosis. Adv Exp Med Biol 2013;793:1-19. 10.1007/978-1-4614-8289-5_1"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/sj.onc.1206044", "@IdType": "doi"}, {"#text": "12483536", "@IdType": "pubmed"}]}, "Citation": "Devarajan E, Sahin AA, Chen JS, et al. Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance. Oncogene 2002;21:8843-51. 10.1038/sj.onc.1206044"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2147/OTT.S108929", "@IdType": "doi"}, {"#text": "PMC5138041", "@IdType": "pmc"}, {"#text": "27942222", "@IdType": "pubmed"}]}, "Citation": "Yang K, Gao K, Hu G, et al. CTGF enhances resistance to 5-FU-mediating cell apoptosis through FAK/MEK/ERK signal pathway in colorectal cancer. Onco Targets Ther 2016;9:7285-95. 10.2147/OTT.S108929"}, {"ArticleIdList": {"ArticleId": {"#text": "8950993", "@IdType": "pubmed"}}, "Citation": "Smith ML, Kontny HU, Zhan Q, et al. Antisense GADD45 expression results in decreased DNA repair and sensitizes cells to u.v.-irradiation or cisplatin. Oncogene 1996;13:2255-63."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s13277-015-4404-0", "@IdType": "doi"}, {"#text": "26662309", "@IdType": "pubmed"}]}, "Citation": "Chen SX, Yin JF, Lin BC, et al. Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC. Tumour Biol 2016;37:6801-12. 10.1007/s13277-015-4404-0"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3389/fonc.2019.01370", "@IdType": "doi"}, {"#text": "PMC6915110", "@IdType": "pmc"}, {"#text": "31921634", "@IdType": "pubmed"}]}, "Citation": "Quintero-Fabi\u00e1n S, Arreola R, Becerril-Villanueva E, et al. Role of Matrix Metalloproteinases in Angiogenesis and Cancer. Front Oncol 2019;9:1370. 10.3389/fonc.2019.01370"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bbrc.2017.12.013", "@IdType": "doi"}, {"#text": "29217194", "@IdType": "pubmed"}]}, "Citation": "Kong Q, Qiu M. Long noncoding RNA SNHG15 promotes human breast cancer proliferation, migration and invasion by sponging miR-211-3p. Biochem Biophys Res Commun 2018;495:1594-600. 10.1016/j.bbrc.2017.12.013"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ejphar.2014.07.025", "@IdType": "doi"}, {"#text": "PMC4146684", "@IdType": "pmc"}, {"#text": "25058905", "@IdType": "pubmed"}]}, "Citation": "Dasari S, Tchounwou PB. Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol 2014;740:364-78. 10.1016/j.ejphar.2014.07.025"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s13045-021-01223-x", "@IdType": "doi"}, {"#text": "PMC8740349", "@IdType": "pmc"}, {"#text": "34991659", "@IdType": "pubmed"}]}, "Citation": "Li H, Yang P, Wang J, et al. HLF regulates ferroptosis, development and chemoresistance of triple-negative breast cancer by activating tumor cell-macrophage crosstalk. J Hematol Oncol 2022;15:2. 10.1186/s13045-021-01223-x"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2147/OTT.S223321", "@IdType": "doi"}, {"#text": "PMC6983676", "@IdType": "pmc"}, {"#text": "32021307", "@IdType": "pubmed"}]}, "Citation": "Mi H, Wang X, Wang F, et al. SNHG15 Contributes To Cisplatin Resistance In Breast Cancer Through Sponging miR-381. Onco Targets Ther 2020;13:657-66. 10.2147/OTT.S223321"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/pharmaceutics13121987", "@IdType": "doi"}, {"#text": "PMC8707074", "@IdType": "pmc"}, {"#text": "34959269", "@IdType": "pubmed"}]}, "Citation": "Natesh NS, White BM, Bennett MMC, et al. Emerging Role of miR-345 and Its Effective Delivery as a Potential Therapeutic Candidate in Pancreatic Cancer and Other Cancers. Pharmaceutics 2021;13:1987. 10.3390/pharmaceutics13121987"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/ijc.25191", "@IdType": "doi"}, {"#text": "20099276", "@IdType": "pubmed"}]}, "Citation": "Pogribny IP, Filkowski JN, Tryndyak VP, et al. Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin. Int J Cancer 2010;127:1785-94. 10.1002/ijc.25191"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2147/OTT.S152462", "@IdType": "doi"}, {"#text": "PMC5865556", "@IdType": "pmc"}, {"#text": "29593419", "@IdType": "pubmed"}]}, "Citation": "Hu W, Tan C, He Y, et al. Functional miRNAs in breast cancer drug resistance. Onco Targets Ther 2018;11:1529-41. 10.2147/OTT.S152462"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.canlet.2020.03.025", "@IdType": "doi"}, {"#text": "32246957", "@IdType": "pubmed"}]}, "Citation": "Ulasov I, Borovjagin A, Fares J, et al. MicroRNA 345 (miR345) regulates KISS1-E-cadherin functional interaction in breast cancer brain metastases. Cancer Lett 2020;481:24-31. 10.1016/j.canlet.2020.03.025"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.1918167117", "@IdType": "doi"}, {"#text": "PMC7084067", "@IdType": "pmc"}, {"#text": "32127478", "@IdType": "pubmed"}]}, "Citation": "Na TY, Schecterson L, Mendonsa AM, et al. The functional activity of E-cadherin controls tumor cell metastasis at multiple steps. Proc Natl Acad Sci U S A 2020;117:5931-7. 10.1073/pnas.1918167117"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.biopha.2018.12.121", "@IdType": "doi"}, {"#text": "30841468", "@IdType": "pubmed"}]}, "Citation": "Mou T, Xie F, Zhong P, et al. MiR-345-5p functions as a tumor suppressor in pancreatic cancer by directly targeting CCL8. Biomed Pharmacother 2019;111:891-900. 10.1016/j.biopha.2018.12.121"}]}}}}}, "PMC": "PMC9708471", "PMID": "36467335", "QueryTranslation": "36467335[UID]", "ReferenceCrawlerDeep": 1, "References": ["33952250", "29580128", "31718602", "20627830", "35139887", "32929060", "29881292", "27603915", "31302201", "31301674", "31717266", "31774607", "32733556", "32318335", "28720111", "30123182", "20619301", "34722255", "32147678", "26885027", "32133796", "29245011", "35284103", "23391414", "19914236", "19400945", "31619268", "34250022", "22247839", "28449441", "33292213", "28701486", "34145432", "20162579", "31014355", "24104470", "12483536", "27942222", "8950993", "26662309", "31921634", "29217194", "25058905", "34991659", "32021307", "34959269", "20099276", "29593419", "32246957", "32127478", "30841468"], "State": -1, "Title": "Silencing the expression of lncRNA  may be a novel therapeutic approach in human breast cancer through regulating .", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "2": {"Abstract": " To our knowledge, LncRNA SNHG15 exerted its tumor-promoting effects to facilitate the development of breast cancer (BC), but there still needed more data to elucidate the potential underlying mechanisms. We examined genes expression status by performing Real-Time qPCR and Western Blot analysis, and cellular functions, including cell proliferation, viability, apoptosis, mobility, were measured by using the CCK-8 assay, colony formation assay, trypan blue staining assay, flow cytometer (FCM), transwell assay and wound scratch assay, respectively. The predicted targeting sites in LncRNA SNHG15, miR-451 and c-Myc 3'UTR were validated by dual-luciferase reporter gene system assay. Finally, we established the tumor-bearing mice models, and the expression status, including its enrichment and cellular localization were examined by immunohistochemistry (IHC) assay. Our data indicated LncRNA SNHG15 upregulated c-Myc to facilitate BC progression by sponging miR-451 in a competing endogenous RNA (ceRNA)-dependent manner in vitro and in vivo. Specifically, LncRNA SNHG15 and c-Myc were upregulated, while miR-451 was downregulated in BC cells and clinical tissues, compared to their normal counterparts. In addition, miR-451 negatively correlated with LncRNA SNHG15 and c-Myc, and LncRNA SNHG15 was positively relevant to c-Myc in BC tissues. Next, we validated that LncRNA SNHG15 sponged miR-451 to upregulate c-Myc in BC cells. Further gain- and loss-of-function experiments evidenced that LncRNA SNHG15 promoted, while miR-451 inhibited malignant phenotypes, including cell proliferation, viability, migration, invasion and epithelial-mesenchymal transition (EMT) in BC cells. Interestingly, the inhibiting effects of LncRNA SNHG15 ablation on BC progression were abrogated by both silencing miR-451 and overexpressing c-Myc. We concluded that targeting the LncRNA SNHG15/miR-451/c-Myc signaling cascade was novel to hamper BC progression, which broadened our knowledge in this field, and provided potential biomarkers for BC diagnosis and treatment.", "Authors": [{"Affiliations": [{"Has_Extra": true, "HashID": "3457519787206047432", "Part1": "Department of Breast and Thyroid Surgery", "Part2": "The 3rd Affiliated Teaching Hospital of Xinjiang Medical University (Affiliated Cancer Hospital)", "Part3": "Suzhou East Street No. 789", "Part4": "Xinshi District", "Part5": "Urumqi", "Part6": "830011", "Text": "Department of Breast and Thyroid Surgery, The 3rd Affiliated Teaching Hospital of Xinjiang Medical University (Affiliated Cancer Hospital), Suzhou East Street No. 789, Xinshi District, Urumqi, 830011, Xinjiang, China."}], "ForeName": "Jiang", "FullName": "Jiang Du", "HashID": "-5351736859627955793", "LastName": "Du", "ORCID": null}, {"Affiliations": [{"Has_Extra": true, "HashID": "3457519787206047432", "Part1": "Department of Breast and Thyroid Surgery", "Part2": "The 3rd Affiliated Teaching Hospital of Xinjiang Medical University (Affiliated Cancer Hospital)", "Part3": "Suzhou East Street No. 789", "Part4": "Xinshi District", "Part5": "Urumqi", "Part6": "830011", "Text": "Department of Breast and Thyroid Surgery, The 3rd Affiliated Teaching Hospital of Xinjiang Medical University (Affiliated Cancer Hospital), Suzhou East Street No. 789, Xinshi District, Urumqi, 830011, Xinjiang, China."}], "ForeName": "Hong", "FullName": "Hong Zhong", "HashID": "-2071474677282533878", "LastName": "Zhong", "ORCID": null}, {"Affiliations": [{"Has_Extra": true, "HashID": "3457519787206047432", "Part1": "Department of Breast and Thyroid Surgery", "Part2": "The 3rd Affiliated Teaching Hospital of Xinjiang Medical University (Affiliated Cancer Hospital)", "Part3": "Suzhou East Street No. 789", "Part4": "Xinshi District", "Part5": "Urumqi", "Part6": "830011", "Text": "Department of Breast and Thyroid Surgery, The 3rd Affiliated Teaching Hospital of Xinjiang Medical University (Affiliated Cancer Hospital), Suzhou East Street No. 789, Xinshi District, Urumqi, 830011, Xinjiang, China. madoctor7886@163.com."}], "ForeName": "Binlin", "FullName": "Binlin Ma", "HashID": "1914083698495008680", "LastName": "Ma", "ORCID": "0000-0001-9269-4422"}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.1186/s12935-021-01885-0", "InsertType": null, "Journal": "Cancer cell international", "Keywords": [{"IS_Major": false, "IS_Mesh": false, "Text": "Breast cancer"}, {"IS_Major": false, "IS_Mesh": false, "Text": "C-Myc"}, {"IS_Major": false, "IS_Mesh": false, "Text": "LncRNA SNHG15"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Malignant phenotypes"}, {"IS_Major": false, "IS_Mesh": false, "Text": "MiR-451"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "PubMed-not-MEDLINE", "Article": {"@PubModel": "Electronic", "Abstract": {"AbstractText": [{"#text": "To our knowledge, LncRNA SNHG15 exerted its tumor-promoting effects to facilitate the development of breast cancer (BC), but there still needed more data to elucidate the potential underlying mechanisms.", "@Label": "BACKGROUND", "@NlmCategory": "BACKGROUND"}, {"#text": "We examined genes expression status by performing Real-Time qPCR and Western Blot analysis, and cellular functions, including cell proliferation, viability, apoptosis, mobility, were measured by using the CCK-8 assay, colony formation assay, trypan blue staining assay, flow cytometer (FCM), transwell assay and wound scratch assay, respectively. The predicted targeting sites in LncRNA SNHG15, miR-451 and c-Myc 3'UTR were validated by dual-luciferase reporter gene system assay. Finally, we established the tumor-bearing mice models, and the expression status, including its enrichment and cellular localization were examined by immunohistochemistry (IHC) assay.", "@Label": "METHODS", "@NlmCategory": "METHODS"}, {"#text": "Our data indicated LncRNA SNHG15 upregulated c-Myc to facilitate BC progression by sponging miR-451 in a competing endogenous RNA (ceRNA)-dependent manner in vitro and in vivo. Specifically, LncRNA SNHG15 and c-Myc were upregulated, while miR-451 was downregulated in BC cells and clinical tissues, compared to their normal counterparts. In addition, miR-451 negatively correlated with LncRNA SNHG15 and c-Myc, and LncRNA SNHG15 was positively relevant to c-Myc in BC tissues. Next, we validated that LncRNA SNHG15 sponged miR-451 to upregulate c-Myc in BC cells. Further gain- and loss-of-function experiments evidenced that LncRNA SNHG15 promoted, while miR-451 inhibited malignant phenotypes, including cell proliferation, viability, migration, invasion and epithelial-mesenchymal transition (EMT) in BC cells. Interestingly, the inhibiting effects of LncRNA SNHG15 ablation on BC progression were abrogated by both silencing miR-451 and overexpressing c-Myc.", "@Label": "RESULTS", "@NlmCategory": "RESULTS"}, {"#text": "We concluded that targeting the LncRNA SNHG15/miR-451/c-Myc signaling cascade was novel to hamper BC progression, which broadened our knowledge in this field, and provided potential biomarkers for BC diagnosis and treatment.", "@Label": "CONCLUSIONS", "@NlmCategory": "CONCLUSIONS"}]}, "ArticleDate": {"@DateType": "Electronic", "Day": "31", "Month": "03", "Year": "2021"}, "ArticleTitle": "Targeting a novel LncRNA SNHG15/miR-451/c-Myc signaling cascade is effective to hamper the pathogenesis of breast cancer (BC) in vitro and in vivo.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Breast and Thyroid Surgery, The 3rd Affiliated Teaching Hospital of Xinjiang Medical University (Affiliated Cancer Hospital), Suzhou East Street No. 789, Xinshi District, Urumqi, 830011, Xinjiang, China."}, "ForeName": "Jiang", "Initials": "J", "LastName": "Du"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Breast and Thyroid Surgery, The 3rd Affiliated Teaching Hospital of Xinjiang Medical University (Affiliated Cancer Hospital), Suzhou East Street No. 789, Xinshi District, Urumqi, 830011, Xinjiang, China."}, "ForeName": "Hong", "Initials": "H", "LastName": "Zhong"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Breast and Thyroid Surgery, The 3rd Affiliated Teaching Hospital of Xinjiang Medical University (Affiliated Cancer Hospital), Suzhou East Street No. 789, Xinshi District, Urumqi, 830011, Xinjiang, China. madoctor7886@163.com."}, "ForeName": "Binlin", "Identifier": {"#text": "0000-0001-9269-4422", "@Source": "ORCID"}, "Initials": "B", "LastName": "Ma"}]}, "ELocationID": [{"#text": "186", "@EIdType": "pii", "@ValidYN": "Y"}, {"#text": "10.1186/s12935-021-01885-0", "@EIdType": "doi", "@ValidYN": "Y"}], "Journal": {"ISOAbbreviation": "Cancer Cell Int", "ISSN": {"#text": "1475-2867", "@IssnType": "Print"}, "JournalIssue": {"@CitedMedium": "Print", "Issue": "1", "PubDate": {"Day": "31", "Month": "Mar", "Year": "2021"}, "Volume": "21"}, "Title": "Cancer cell international"}, "Language": "eng", "Pagination": {"MedlinePgn": "186", "StartPage": "186"}, "PublicationTypeList": {"PublicationType": {"#text": "Journal Article", "@UI": "D016428"}}}, "CoiStatement": "None.", "DateRevised": {"Day": "09", "Month": "05", "Year": "2021"}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"#text": "Breast cancer", "@MajorTopicYN": "N"}, {"#text": "C-Myc", "@MajorTopicYN": "N"}, {"#text": "LncRNA SNHG15", "@MajorTopicYN": "N"}, {"#text": "Malignant phenotypes", "@MajorTopicYN": "N"}, {"#text": "MiR-451", "@MajorTopicYN": "N"}]}, "MedlineJournalInfo": {"Country": "England", "ISSNLinking": "1475-2867", "MedlineTA": "Cancer Cell Int", "NlmUniqueID": "101139795"}, "PMID": {"#text": "33952250", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "33952250", "@IdType": "pubmed"}, {"#text": "PMC8097789", "@IdType": "pmc"}, {"#text": "10.1186/s12935-021-01885-0", "@IdType": "doi"}, {"#text": "10.1186/s12935-021-01885-0", "@IdType": "pii"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "received", "Day": "10", "Month": "12", "Year": "2020"}, {"@PubStatus": "accepted", "Day": "16", "Month": "3", "Year": "2021"}, {"@PubStatus": "entrez", "Day": "6", "Hour": "5", "Minute": "44", "Month": "5", "Year": "2021"}, {"@PubStatus": "pubmed", "Day": "7", "Hour": "6", "Minute": "0", "Month": "5", "Year": "2021"}, {"@PubStatus": "medline", "Day": "7", "Hour": "6", "Minute": "1", "Month": "5", "Year": "2021"}]}, "PublicationStatus": "epublish", "ReferenceList": {"Reference": [{"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s10549-018-05125-4", "@IdType": "doi"}, {"#text": "PMC6438948", "@IdType": "pmc"}, {"#text": "30632023", "@IdType": "pubmed"}]}, "Citation": "Rugo HS, Finn RS, Di\u00e9ras V, Ettl J, Lipatov O, Joy AA, Harbeck N, Castrellon A, Iyer S, Lu DR, Mori A, Gauthier ER, Bartlett CH, Gelmon KA, Slamon DJ. Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up. Breast Cancer Res Treat. 2019;174(3):719\u2013729. doi: 10.1007/s10549-018-05125-4."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12885-019-5951-3", "@IdType": "doi"}, {"#text": "PMC6661096", "@IdType": "pmc"}, {"#text": "31351450", "@IdType": "pubmed"}]}, "Citation": "Wang H, Tan Z, Hu H, Liu H, Wu T, Zheng C, Wang X, Luo Z, Wang J, Liu S, Lu Z, Tu J. microRNA-21 promotes breast cancer proliferation and metastasis by targeting LZTFL1. BMC Cancer. 2019;19(1):738. doi: 10.1186/s12885-019-5951-3."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/jcp.26379", "@IdType": "doi"}, {"#text": "29219189", "@IdType": "pubmed"}]}, "Citation": "Jafari SH, Saadatpour Z, Salmaninejad A, Momeni F, Mokhtari M, Nahand JS, Rahmati M, Mirzaei H, Kianmehr M. Breast cancer diagnosis: Imaging techniques and biochemical markers. J Cell Physiol. 2018;233(7):5200\u20135213. doi: 10.1002/jcp.26379."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1080/15384047.2018.1456599", "@IdType": "doi"}, {"#text": "PMC6300341", "@IdType": "pmc"}, {"#text": "29580128", "@IdType": "pubmed"}]}, "Citation": "Jin L, Han B, Siegel E, Cui Y, Giuliano A, Cui X. Breast cancer lung metastasis: Molecular biology and therapeutic implications. Cancer Biol Ther. 2018;19(10):858\u2013868. doi: 10.1080/15384047.2018.1456599."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1001/jama.2018.19323", "@IdType": "doi"}, {"#text": "30667505", "@IdType": "pubmed"}]}, "Citation": "Waks AG, Winer EP. Breast cancer treatment: a review. JAMA. 2019;321(3):288\u2013300. doi: 10.1001/jama.2018.19323."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/1878-0261.12489", "@IdType": "doi"}, {"#text": "PMC6547626", "@IdType": "pmc"}, {"#text": "30959550", "@IdType": "pubmed"}]}, "Citation": "Deva Magendhra Rao AK, Patel K, Korivi Jyothiraj S, Meenakumari B, Sundersingh S, Sridevi V, Rajkumar T, Pandey A, Chatterjee A, Gowda H, Mani S. Identification of lncRNAs associated with early-stage breast cancer and their prognostic implications. Mol Oncol. 2019;13(6):1342\u20131355. doi: 10.1002/1878-0261.12489."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3389/fonc.2019.00407", "@IdType": "doi"}, {"#text": "PMC6555305", "@IdType": "pmc"}, {"#text": "31214490", "@IdType": "pubmed"}]}, "Citation": "Wu Y, Shao A, Wang L, Hu K, Yu C, Pan C, Zhang S. The Role of lncRNAs in the distant metastasis of breast cancer. Front Oncol. 2019;9:407. doi: 10.3389/fonc.2019.00407."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12943-019-1115-y", "@IdType": "doi"}, {"#text": "PMC6921600", "@IdType": "pmc"}, {"#text": "31856843", "@IdType": "pubmed"}]}, "Citation": "Xiu B, Chi Y, Liu L, Chi W, Zhang Q, Chen J, Guo R, Si J, Li L, Xue J, Shao ZM, Wu ZH, Huang S, Wu J. LINC02273 drives breast cancer metastasis by epigenetically increasing AGR2 transcription. Mol Cancer. 2019;18(1):187. doi: 10.1186/s12943-019-1115-y."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41419-019-1741-8", "@IdType": "doi"}, {"#text": "PMC6594972", "@IdType": "pmc"}, {"#text": "31243265", "@IdType": "pubmed"}]}, "Citation": "Ai B, Kong X, Wang X, Zhang K, Yang X, Zhai J, Gao R, Qi Y, Wang J, Wang Z, Fang Y. LINC01355 suppresses breast cancer growth through FOXO3-mediated transcriptional repression of CCND1. Cell Death Dis. 2019;10(7):502. doi: 10.1038/s41419-019-1741-8."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s13046-019-1315-8", "@IdType": "doi"}, {"#text": "PMC6626338", "@IdType": "pmc"}, {"#text": "31300015", "@IdType": "pubmed"}]}, "Citation": "Zheng A, Song X, Zhang L, Zhao L, Mao X, Wei M, Jin F. Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/\u03b2-catenin pathway. J Exp Clin Cancer Res. 2019;38(1):305. doi: 10.1186/s13046-019-1315-8."}, {"ArticleIdList": {"ArticleId": {"#text": "30402848", "@IdType": "pubmed"}}, "Citation": "Cui HX, Zhang MY, Liu K, Liu J, Zhang ZL, Fu L. LncRNA SNHG15 promotes proliferation and migration of lung cancer via targeting microRNA-211-3p. Eur Rev Med Pharmacol Sci. 2018;22(20):6838\u20136844."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.gene.2019.04.033", "@IdType": "doi"}, {"#text": "30981837", "@IdType": "pubmed"}]}, "Citation": "Zhang Y, Zhang D, Lv J, Wang S, Zhang Q. LncRNA SNHG15 acts as an oncogene in prostate cancer by regulating miR-338-3p/FKBP1A axis. Gene. 2019;705:44\u201350. doi: 10.1016/j.gene.2019.04.033."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/cam4.2105", "@IdType": "doi"}, {"#text": "PMC6536931", "@IdType": "pmc"}, {"#text": "30945457", "@IdType": "pubmed"}]}, "Citation": "Li M, Bian Z, Jin G, Zhang J, Yao S, Feng Y, Wang X, Yin Y, Fei B, You Q, Huang Z. LncRNA-SNHG15 enhances cell proliferation in colorectal cancer by inhibiting miR-338-3p. Cancer Med. 2019;8(5):2404\u20132413. doi: 10.1002/cam4.2105."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bbrc.2017.12.013", "@IdType": "doi"}, {"#text": "29217194", "@IdType": "pubmed"}]}, "Citation": "Kong Q, Qiu M. Long noncoding RNA SNHG15 promotes human breast cancer proliferation, migration and invasion by sponging miR-211-3p. Biochem Biophys Res Commun. 2018;495(2):1594\u20131600. doi: 10.1016/j.bbrc.2017.12.013."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/cells8080840", "@IdType": "doi"}, {"#text": "PMC6721829", "@IdType": "pmc"}, {"#text": "31530793", "@IdType": "pubmed"}]}, "Citation": "Khan AQ, Ahmed EI, Elareer NR, Junejo K, Steinhoff M, Uddin S. Role of miRNA-regulated cancer stem cells in the pathogenesis of human malignancies. Cells. 2019;8(8):840. doi: 10.3390/cells8080840."}, {"ArticleIdList": {"ArticleId": {"#text": "31115208", "@IdType": "pubmed"}}, "Citation": "Yang B, Xiong WY, Hou HJ, Xu Q, Cai XL, Zeng TX, Ha XQ. Exosomal miRNAs as biomarkers of cancer: a meta-analysis. Clin Lab. 2019;65(5):17."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41419-018-1287-1", "@IdType": "doi"}, {"#text": "PMC6343010", "@IdType": "pmc"}, {"#text": "30670688", "@IdType": "pubmed"}]}, "Citation": "Liu Z, Zhou Y, Liang G, Ling Y, Tan W, Tan L, Andrews R, Zhong W, Zhang X, Song E, Gong C. Circular RNA hsa_circ_001783 regulates breast cancer progression via sponging miR-200c-3p. Cell Death Dis. 2019;10(2):55. doi: 10.1038/s41419-018-1287-1."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41419-019-1382-y", "@IdType": "doi"}, {"#text": "PMC6382814", "@IdType": "pmc"}, {"#text": "30787278", "@IdType": "pubmed"}]}, "Citation": "Xu JZ, Shao CC, Wang XJ, Zhao X, Chen JQ, Ouyang YX, Feng J, Zhang F, Huang WH, Ying Q, Chen CF, Wei XL, Dong HY, Zhang GJ, Chen M. circTADA2As suppress breast cancer progression and metastasis via targeting miR-203a-3p/SOCS3 axis. Cell Death Dis. 2019;10(3):175. doi: 10.1038/s41419-019-1382-y."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6818541", "@IdType": "pmc"}, {"#text": "31749630", "@IdType": "pubmed"}]}, "Citation": "Motamedi M, Hashemzadeh Chaleshtori M, Ghasemi S, Mokarian F. Plasma level of miR-21 And miR-451 in primary and recurrent breast cancer patients. Breast Cancer. 2019;11:293\u2013301."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/cddis.2017.460", "@IdType": "doi"}, {"#text": "PMC5680582", "@IdType": "pmc"}, {"#text": "28981108", "@IdType": "pubmed"}]}, "Citation": "Wang W, Zhang L, Wang Y, Ding Y, Chen T, Wang Y, Wang H, Li Y, Duan K, Chen S, Yang Q, Chen C. Involvement of miR-451 in resistance to paclitaxel by regulating YWHAZ in breast cancer. Cell Death Dis. 2017;8(10):e3071. doi: 10.1038/cddis.2017.460."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41419-020-2683-x", "@IdType": "doi"}, {"#text": "PMC7354989", "@IdType": "pmc"}, {"#text": "32655137", "@IdType": "pubmed"}]}, "Citation": "Huang J, Pan B, Xia G, Zhu J, Li C, Feng J. LncRNA SNHG15 regulates EGFR-TKI acquired resistance in lung adenocarcinoma through sponging miR-451 to upregulate MDR-1. Cell Death Dis. 2020;11(7):525. doi: 10.1038/s41419-020-2683-x."}, {"ArticleIdList": {"ArticleId": {"#text": "31389598", "@IdType": "pubmed"}}, "Citation": "Liu Y, Li H, Li LH, Tang JB, Sheng YL. Mir-451 inhibits proliferation and migration of non-small cell lung cancer cells via targeting LKB1/AMPK. Eur Rev Med Pharmacol Sci. 2019;23(3 Suppl):274\u2013280."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.gene.2019.02.046", "@IdType": "doi"}, {"#text": "30802541", "@IdType": "pubmed"}]}, "Citation": "Mamoori A, Wahab R, Vider J, Gopalan V, Lam AK. The tumour suppressor effects and regulation of cancer stem cells by macrophage migration inhibitory factor targeted miR-451 in colon cancer. Gene. 2019;697:165\u2013174. doi: 10.1016/j.gene.2019.02.046."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1080/21691401.2019.1626404", "@IdType": "doi"}, {"#text": "31213092", "@IdType": "pubmed"}]}, "Citation": "Liu B, Cao W, Ma H. Knockdown of lncRNA LSINCT5 suppresses growth and metastasis of human glioma cells via up-regulating miR-451. Artif Cells Nanomed Biotechnol. 2019;47(1):2507\u20132515. doi: 10.1080/21691401.2019.1626404."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/aging.101934", "@IdType": "doi"}, {"#text": "PMC6535055", "@IdType": "pmc"}, {"#text": "31058608", "@IdType": "pubmed"}]}, "Citation": "Lou W, Liu J, Ding B, Jin L, Xu L, Li X, Chen J, Fan W. Five miRNAs-mediated PIEZO2 downregulation, accompanied with activation of Hedgehog signaling pathway, predicts poor prognosis of breast cancer. Aging. 2019;11(9):2628\u20132652. doi: 10.18632/aging.101934."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/aging.101933", "@IdType": "doi"}, {"#text": "PMC6535056", "@IdType": "pmc"}, {"#text": "31061236", "@IdType": "pubmed"}]}, "Citation": "Wang W, Lou W, Ding B, Yang B, Lu H, Kong Q, Fan W. A novel mRNA-miRNA-lncRNA competing endogenous RNA triple sub-network associated with prognosis of pancreatic cancer. Aging. 2019;11(9):2610\u20132627. doi: 10.18632/aging.101933."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/or.2016.5040", "@IdType": "doi"}, {"#text": "27571748", "@IdType": "pubmed"}]}, "Citation": "Wang J, Zhao X, Shi J, Pan Y, Chen Q, Leng P, Wang Y. miR-451 suppresses bladder cancer cell migration and invasion via directly targeting c-Myc. Oncol Rep. 2016;36(4):2049\u20132058. doi: 10.3892/or.2016.5040."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ejca.2014.09.008", "@IdType": "doi"}, {"#text": "25310895", "@IdType": "pubmed"}]}, "Citation": "Chen D, Huang J, Zhang K, Pan B, Chen J, De W, Wang R, Chen L. MicroRNA-451 induces epithelial-mesenchymal transition in docetaxel-resistant lung adenocarcinoma cells by targeting proto-oncogene c-Myc. Eur J Cancer. 2014;50(17):3050\u20133067. doi: 10.1016/j.ejca.2014.09.008."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/1541-7786.MCR-18-0630", "@IdType": "doi"}, {"#text": "30266755", "@IdType": "pubmed"}]}, "Citation": "Lee HY, Cha J, Kim SK, Park JH, Song KH, Kim P, Kim MY. c-MYC drives breast cancer metastasis to the brain, but promotes synthetic lethality with TRAIL. Mol Cancer Res. 2019;17(2):544\u2013554. doi: 10.1158/1541-7786.MCR-18-0630."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2217/bmm-2019-0073", "@IdType": "doi"}, {"#text": "31144531", "@IdType": "pubmed"}]}, "Citation": "Shi W, Xu X, Huang R, Yu Q, Zhang P, Xie S, Zheng H, Lu R. Plasma C-MYC level manifesting as an indicator in progression of breast cancer. Biomark Med. 2019;13(11):917\u2013929. doi: 10.2217/bmm-2019-0073."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.amjms.2019.05.014", "@IdType": "doi"}, {"#text": "31324362", "@IdType": "pubmed"}]}, "Citation": "Wang T, Cai B, Ding M, Su Z, Liu Y, Shen L. c-Myc overexpression promotes oral cancer cell proliferation and migration by enhancing Glutaminase and Glutamine Synthetase activity. Am J Med Sci. 2019;358(3):235\u2013242. doi: 10.1016/j.amjms.2019.05.014."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/pros.23754", "@IdType": "doi"}, {"#text": "30609075", "@IdType": "pubmed"}]}, "Citation": "Zhao M, Qi M, Li X, Hu J, Zhang J, Jiao M, Bai X, Peng X, Han B. CUL4B/miR-33b/C-MYC axis promotes prostate cancer progression. Prostate. 2019;79(5):480\u2013488. doi: 10.1002/pros.23754."}]}}}}}, "PMC": "PMC8097789", "PMID": "33952250", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "Targeting a novel LncRNA SNHG15/miR-451/c-Myc signaling cascade is effective to hamper the pathogenesis of breast cancer (BC) in vitro and in vivo.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "3": {"Abstract": "Distant metastasis accounts for the vast majority of deaths in patients with cancer. Breast cancer exhibits a distinct metastatic pattern commonly involving bone, liver, lung, and brain. Breast cancer can be divided into different subtypes based on gene expression profiles, and different breast cancer subtypes show preference to distinct organ sites of metastasis. Luminal breast tumors tend to metastasize to bone while basal-like breast cancer (BLBC) displays a lung tropism of metastasis. However, the mechanisms underlying this organ-specific pattern of metastasis still remain to be elucidated. In this review, we will summarize the recent advances regarding the molecular signaling pathways as well as the therapeutic strategies for treating breast cancer lung metastasis.", "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "-3284345383911842462", "Part1": "a Department of Breast Surgery ", "Part2": "Hubei Cancer Hospital", "Part3": "Wuhan", "Part4": "China.", "Part5": null, "Part6": null, "Text": "a Department of Breast Surgery , Hubei Cancer Hospital , Wuhan , China."}], "ForeName": "Liting", "FullName": "Liting Jin", "HashID": "3409506950178210222", "LastName": "Jin", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "8326066151566562999", "Part1": "b Department of Surgery ", "Part2": "Samuel Oschin Comprehensive Cancer Institute", "Part3": "Cedars-Sinai Medical Center", "Part4": "Los Angeles", "Part5": "CA", "Part6": "USA.", "Text": "b Department of Surgery , Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center , Los Angeles , CA , USA."}], "ForeName": "Bingchen", "FullName": "Bingchen Han", "HashID": "-8418517964738196547", "LastName": "Han", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "8326066151566562999", "Part1": "b Department of Surgery ", "Part2": "Samuel Oschin Comprehensive Cancer Institute", "Part3": "Cedars-Sinai Medical Center", "Part4": "Los Angeles", "Part5": "CA", "Part6": "USA.", "Text": "b Department of Surgery , Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center , Los Angeles , CA , USA."}], "ForeName": "Emily", "FullName": "Emily Siegel", "HashID": "4940732608166227467", "LastName": "Siegel", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "4858148204373681366", "Part1": "c Laboratory for Breast Cancer Diagnosis and Treatment ", "Part2": "Cancer Hospital of Shantou University Medical College", "Part3": "Shantou", "Part4": "China.", "Part5": null, "Part6": null, "Text": "c Laboratory for Breast Cancer Diagnosis and Treatment , Cancer Hospital of Shantou University Medical College , Shantou , China."}], "ForeName": "Yukun", "FullName": "Yukun Cui", "HashID": "-8235657228493063204", "LastName": "Cui", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "8326066151566562999", "Part1": "b Department of Surgery ", "Part2": "Samuel Oschin Comprehensive Cancer Institute", "Part3": "Cedars-Sinai Medical Center", "Part4": "Los Angeles", "Part5": "CA", "Part6": "USA.", "Text": "b Department of Surgery , Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center , Los Angeles , CA , USA."}], "ForeName": "Armando", "FullName": "Armando Giuliano", "HashID": "-4015260558138041256", "LastName": "Giuliano", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "8326066151566562999", "Part1": "b Department of Surgery ", "Part2": "Samuel Oschin Comprehensive Cancer Institute", "Part3": "Cedars-Sinai Medical Center", "Part4": "Los Angeles", "Part5": "CA", "Part6": "USA.", "Text": "b Department of Surgery , Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center , Los Angeles , CA , USA."}], "ForeName": "Xiaojiang", "FullName": "Xiaojiang Cui", "HashID": "-8773103317074563263", "LastName": "Cui", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.1080/15384047.2018.1456599", "InsertType": null, "Journal": "Cancer biology & therapy", "Keywords": [{"IS_Major": false, "IS_Mesh": true, "Text": "Biomarkers"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Breast Neoplasms"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Cytokines"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Female"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Humans"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Lung Neoplasms"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Neoplasm Grading"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Neoplasm Staging"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Neoplastic Stem Cells"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Signal Transduction"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Tumor Microenvironment"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Breast cancer"}, {"IS_Major": false, "IS_Mesh": false, "Text": "cancer stem cell"}, {"IS_Major": false, "IS_Mesh": false, "Text": "chemokine"}, {"IS_Major": false, "IS_Mesh": false, "Text": "lung metastasis"}, {"IS_Major": false, "IS_Mesh": false, "Text": "microenvironment"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "MEDLINE", "Article": {"@PubModel": "Print-Electronic", "Abstract": {"AbstractText": "Distant metastasis accounts for the vast majority of deaths in patients with cancer. Breast cancer exhibits a distinct metastatic pattern commonly involving bone, liver, lung, and brain. Breast cancer can be divided into different subtypes based on gene expression profiles, and different breast cancer subtypes show preference to distinct organ sites of metastasis. Luminal breast tumors tend to metastasize to bone while basal-like breast cancer (BLBC) displays a lung tropism of metastasis. However, the mechanisms underlying this organ-specific pattern of metastasis still remain to be elucidated. In this review, we will summarize the recent advances regarding the molecular signaling pathways as well as the therapeutic strategies for treating breast cancer lung metastasis."}, "ArticleDate": {"@DateType": "Electronic", "Day": "30", "Month": "04", "Year": "2018"}, "ArticleTitle": "Breast cancer lung metastasis: Molecular biology and therapeutic implications.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "a Department of Breast Surgery , Hubei Cancer Hospital , Wuhan , China."}, "ForeName": "Liting", "Initials": "L", "LastName": "Jin"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "b Department of Surgery , Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center , Los Angeles , CA , USA."}, "ForeName": "Bingchen", "Initials": "B", "LastName": "Han"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "b Department of Surgery , Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center , Los Angeles , CA , USA."}, "ForeName": "Emily", "Initials": "E", "LastName": "Siegel"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "c Laboratory for Breast Cancer Diagnosis and Treatment , Cancer Hospital of Shantou University Medical College , Shantou , China."}, "ForeName": "Yukun", "Initials": "Y", "LastName": "Cui"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "b Department of Surgery , Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center , Los Angeles , CA , USA."}, "ForeName": "Armando", "Initials": "A", "LastName": "Giuliano"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "b Department of Surgery , Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center , Los Angeles , CA , USA."}, "ForeName": "Xiaojiang", "Initials": "X", "LastName": "Cui"}]}, "ELocationID": {"#text": "10.1080/15384047.2018.1456599", "@EIdType": "doi", "@ValidYN": "Y"}, "GrantList": {"@CompleteYN": "Y", "Grant": {"Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States", "GrantID": "R01 CA151610"}}, "Journal": {"ISOAbbreviation": "Cancer Biol Ther", "ISSN": {"#text": "1555-8576", "@IssnType": "Electronic"}, "JournalIssue": {"@CitedMedium": "Internet", "Issue": "10", "PubDate": {"Year": "2018"}, "Volume": "19"}, "Title": "Cancer biology & therapy"}, "Language": "eng", "Pagination": {"EndPage": "868", "MedlinePgn": "858-868", "StartPage": "858"}, "PublicationTypeList": {"PublicationType": [{"#text": "Journal Article", "@UI": "D016428"}, {"#text": "Research Support, N.I.H., Extramural", "@UI": "D052061"}, {"#text": "Research Support, Non-U.S. Gov't", "@UI": "D013485"}, {"#text": "Review", "@UI": "D016454"}]}}, "ChemicalList": {"Chemical": [{"NameOfSubstance": {"#text": "Biomarkers", "@UI": "D015415"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "Cytokines", "@UI": "D016207"}, "RegistryNumber": "0"}]}, "CitationSubset": "IM", "DateCompleted": {"Day": "16", "Month": "09", "Year": "2019"}, "DateRevised": {"Day": "09", "Month": "11", "Year": "2022"}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"#text": "Breast cancer", "@MajorTopicYN": "N"}, {"#text": "cancer stem cell", "@MajorTopicYN": "N"}, {"#text": "chemokine", "@MajorTopicYN": "N"}, {"#text": "lung metastasis", "@MajorTopicYN": "N"}, {"#text": "microenvironment", "@MajorTopicYN": "N"}]}, "MedlineJournalInfo": {"Country": "United States", "ISSNLinking": "1538-4047", "MedlineTA": "Cancer Biol Ther", "NlmUniqueID": "101137842"}, "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"#text": "Biomarkers", "@MajorTopicYN": "N", "@UI": "D015415"}}, {"DescriptorName": {"#text": "Breast Neoplasms", "@MajorTopicYN": "N", "@UI": "D001943"}, "QualifierName": [{"#text": "etiology", "@MajorTopicYN": "N", "@UI": "Q000209"}, {"#text": "metabolism", "@MajorTopicYN": "N", "@UI": "Q000378"}, {"#text": "pathology", "@MajorTopicYN": "Y", "@UI": "Q000473"}]}, {"DescriptorName": {"#text": "Cytokines", "@MajorTopicYN": "N", "@UI": "D016207"}, "QualifierName": {"#text": "metabolism", "@MajorTopicYN": "N", "@UI": "Q000378"}}, {"DescriptorName": {"#text": "Female", "@MajorTopicYN": "N", "@UI": "D005260"}}, {"DescriptorName": {"#text": "Humans", "@MajorTopicYN": "N", "@UI": "D006801"}}, {"DescriptorName": {"#text": "Lung Neoplasms", "@MajorTopicYN": "N", "@UI": "D008175"}, "QualifierName": [{"#text": "diagnosis", "@MajorTopicYN": "N", "@UI": "Q000175"}, {"#text": "secondary", "@MajorTopicYN": "Y", "@UI": "Q000556"}, {"#text": "therapy", "@MajorTopicYN": "N", "@UI": "Q000628"}]}, {"DescriptorName": {"#text": "Neoplasm Grading", "@MajorTopicYN": "N", "@UI": "D060787"}}, {"DescriptorName": {"#text": "Neoplasm Staging", "@MajorTopicYN": "N", "@UI": "D009367"}}, {"DescriptorName": {"#text": "Neoplastic Stem Cells", "@MajorTopicYN": "N", "@UI": "D014411"}, "QualifierName": [{"#text": "metabolism", "@MajorTopicYN": "N", "@UI": "Q000378"}, {"#text": "pathology", "@MajorTopicYN": "N", "@UI": "Q000473"}]}, {"DescriptorName": {"#text": "Signal Transduction", "@MajorTopicYN": "N", "@UI": "D015398"}}, {"DescriptorName": {"#text": "Tumor Microenvironment", "@MajorTopicYN": "N", "@UI": "D059016"}}]}, "PMID": {"#text": "29580128", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "29580128", "@IdType": "pubmed"}, {"#text": "PMC6300341", "@IdType": "pmc"}, {"#text": "10.1080/15384047.2018.1456599", "@IdType": "doi"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "pubmed", "Day": "28", "Hour": "6", "Minute": "0", "Month": "3", "Year": "2018"}, {"@PubStatus": "medline", "Day": "17", "Hour": "6", "Minute": "0", "Month": "9", "Year": "2019"}, {"@PubStatus": "entrez", "Day": "28", "Hour": "6", "Minute": "0", "Month": "3", "Year": "2018"}]}, "PublicationStatus": "ppublish", "ReferenceList": {"Reference": [{"ArticleIdList": {"ArticleId": [{"#text": "10.3322/caac.21203", "@IdType": "doi"}, {"#text": "24114568", "@IdType": "pubmed"}]}, "Citation": "DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA Cancer J Clin. 2014;64(1):52\u201362. doi:10.3322/caac.21203. PMID:24114568."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cell.2011.09.024", "@IdType": "doi"}, {"#text": "PMC3261217", "@IdType": "pmc"}, {"#text": "22000009", "@IdType": "pubmed"}]}, "Citation": "Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell. 2011;147(2):275\u201392. doi:10.1016/j.cell.2011.09.024. PMID:22000009."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrd2372", "@IdType": "doi"}, {"#text": "22653217", "@IdType": "pubmed"}]}, "Citation": "Eckhardt BL, Francis PA, Parker BS, Anderson RL. Strategies for the discovery and development of therapies for metastatic breast cancer. Nat Rev Drug Discov. 2012;11(6):479\u201397. doi:10.1038/nrd2372. PMID:22653217."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.jconrel.2015.01.015", "@IdType": "doi"}, {"#text": "25598420", "@IdType": "pubmed"}]}, "Citation": "Cao H, Zhang Z, Zhao S, He X, Yu H, Yin Q, Zhang Z, Gu W, Chen L, Li Y. Hydrophobic interaction mediating self-assembled nanoparticles of succinobucol suppress lung metastasis of breast cancer by inhibition of VCAM-1 expression. J Control Release. 2015;205:162\u201371. doi:10.1016/j.jconrel.2015.01.015. PMID:25598420."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12885-015-1960-z", "@IdType": "doi"}, {"#text": "PMC4682252", "@IdType": "pmc"}, {"#text": "26674531", "@IdType": "pubmed"}]}, "Citation": "Pei S, Yang X, Wang H, Zhang H, Zhou B, Zhang D, Lin D. Plantamajoside, a potential anti-tumor herbal medicine inhibits breast cancer growth and pulmonary metastasis by decreasing the activity of matrix metalloproteinase-9 and -2. BMC Cancer. 2015;15:965. doi:10.1186/s12885-015-1960-z. PMID:26674531."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1200/JCO.2005.02.6617", "@IdType": "doi"}, {"#text": "16622269", "@IdType": "pubmed"}]}, "Citation": "Gaffan J, Dacre J, Jones A. Educating undergraduate medical students about oncology: a literature review. J Clin Oncol. 2006;24(12):1932\u20139. doi:10.1200/JCO.2005.02.6617. PMID:16622269."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/cncr.21359", "@IdType": "doi"}, {"#text": "16149088", "@IdType": "pubmed"}]}, "Citation": "Gennari A, Conte P, Rosso R, Orlandini C, Bruzzi P. Survival of metastatic breast carcinoma patients over a 20-y period: a retrospective analysis based on individual patient data from six consecutive studies. Cancer. 2005;104(8):1742\u201350. doi:10.1002/cncr.21359. PMID:16149088."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s10549-008-0232-x", "@IdType": "doi"}, {"#text": "19101794", "@IdType": "pubmed"}]}, "Citation": "Gligorov J, Lotz JP. Optimal treatment strategies in postmenopausal women with hormone-receptor-positive and HER2-negative metastatic breast cancer. Breast Cancer Res Treat. 2008;112 Suppl 1:53\u201366. doi:10.1007/s10549-008-0232-x. PMID:19101794."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/0008-5472.CAN-07-5644", "@IdType": "doi"}, {"#text": "18451135", "@IdType": "pubmed"}]}, "Citation": "Smid M, Zhang Y, Sieuwerts AM, Yu J, Klijn JG, Foekens JA, Martens JW. Subtypes of breast cancer show preferential site of relapse. Cancer Res. 2008;68(9):3108\u201314. doi:10.1158/0008-5472.CAN-07-5644. PMID:18451135."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.7150/thno.13896", "@IdType": "doi"}, {"#text": "PMC4737729", "@IdType": "pmc"}, {"#text": "26909117", "@IdType": "pubmed"}]}, "Citation": "Dan Z, Cao H, He X, Zhang Z, Zou L, Zeng L, Xu Y, Yin Q, Xu M, Zhong D, et\u00a0al.. A pH-responsive host-guest nanosystem loading succinobucol suppresses lung metastasis of breast cancer. Theranostics. 2016;6(3):435\u201345. doi:10.7150/thno.13896. PMID:26909117."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/cddis.2017.325", "@IdType": "doi"}, {"#text": "PMC5550870", "@IdType": "pmc"}, {"#text": "28703807", "@IdType": "pubmed"}]}, "Citation": "Liang Y, Xu X, Wang T, Li Y, You W, Fu J, Liu Y, Jin S, Ji Q, Zhao W, et\u00a0al.. The EGFR/miR-338-3p/EYA2 axis controls breast tumor growth and lung metastasis. Cell Death Dis. 2017;8(7):e2928. doi:10.1038/cddis.2017.325. PMID:28703807."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/jnci/djv148.", "@IdType": "doi"}, {"#text": "PMC4554196", "@IdType": "pmc"}, {"#text": "26041837", "@IdType": "pubmed"}]}, "Citation": "Jensen TW, Ray T, Wang J, Li X, Naritoku WY, Han B, Bellafiore F, Bagaria SP, Qu A, Cui X, et\u00a0al.. Diagnosis of Basal-Like Breast Cancer Using a FOXC1-Based Assay. J Natl Cancer Inst. 2015;107(8). doi:10.1093/jnci/djv148.."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/0008-5472.CAN-09-4120", "@IdType": "doi"}, {"#text": "20406990", "@IdType": "pubmed"}]}, "Citation": "Ray PS, Wang J, Qu Y, Sim MS, Shamonki J, Bagaria SP, Ye X, Liu B, Elashoff D, Hoon DS, et\u00a0al.. FOXC1 is a potential prognostic biomarker with functional significance in basal-like breast cancer. Cancer Res. 2010;70(10):3870\u20136. doi:10.1158/0008-5472.CAN-09-4120. PMID:20406990."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.breast.2012.03.003", "@IdType": "doi"}, {"#text": "22425534", "@IdType": "pubmed"}]}, "Citation": "Cardoso F, Costa A, Norton L, Cameron D, Cufer T, Fallowfield L, Francis P, Gligorov J, Kyriakides S, Lin N, et\u00a0al.. 1st International consensus guidelines for advanced breast cancer (ABC 1). Breast. 2012;21(3):242\u201352. doi:10.1016/j.breast.2012.03.003. PMID:22425534."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cell.2006.11.001", "@IdType": "doi"}, {"#text": "17110329", "@IdType": "pubmed"}]}, "Citation": "Gupta GP, Massague J. Cancer metastasis: building a framework. Cell. 2006;127(4):679\u201395. doi:10.1016/j.cell.2006.11.001. PMID:17110329."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/S0140-6736(05)66544-0", "@IdType": "doi"}, {"#text": "15894097", "@IdType": "pubmed"}]}, "Citation": "Early Breast Cancer Trialists' Collaborative G. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-y survival: an overview of the randomised trials. Lancet. 2005;365(9472):1687\u2013717. doi:10.1016/S0140-6736(05)66544-0. PMID:15894097."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1309/AJCPYO5FSV3UPEXS", "@IdType": "doi"}, {"#text": "25779997", "@IdType": "pubmed"}]}, "Citation": "Soni A, Ren Z, Hameed O, Chanda D, Morgan CJ, Siegal GP, Wei S. Breast cancer subtypes predispose the site of distant metastases. Am J Clin Pathol. 2015;143(4):471\u20138. doi:10.1309/AJCPYO5FSV3UPEXS. PMID:25779997."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/annonc/mdn424", "@IdType": "doi"}, {"#text": "PMC2733115", "@IdType": "pmc"}, {"#text": "18641006", "@IdType": "pubmed"}]}, "Citation": "Largillier R, Ferrero JM, Doyen J, Barriere J, Namer M, Mari V, Courdi A, Hannoun-Levi JM, Ettore F, Birtwisle-Peyrottes I, et\u00a0al.. Prognostic factors in 1,038 women with metastatic breast cancer. Ann Oncol. 2008;19(12):2012\u20139. doi:10.1093/annonc/mdn424. PMID:18641006."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/cncr.11083", "@IdType": "doi"}, {"#text": "12548595", "@IdType": "pubmed"}]}, "Citation": "Chang J, Clark GM, Allred DC, Mohsin S, Chamness G, Elledge RM. Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor. Cancer. 2003;97(3):545\u201353. doi:10.1002/cncr.11083. PMID:12548595."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1200/JCO.2009.25.9820", "@IdType": "doi"}, {"#text": "20498394", "@IdType": "pubmed"}]}, "Citation": "Kennecke H, Yerushalmi R, Woods R, Cheang MC, Voduc D, Speers CH, Nielsen TO, Gelmon K. Metastatic behavior of breast cancer subtypes. J Clin Oncol. 2010;28(20):3271\u20137. doi:10.1200/JCO.2009.25.9820. PMID:20498394."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s00404-016-4225-4", "@IdType": "doi"}, {"#text": "27832352", "@IdType": "pubmed"}]}, "Citation": "Bartmann C, Wischnewsky M, St\u00fcber T, Stein R, Krockenberger M, H\u00e4usler S, Janni W, Kreienberg R, Blettner M, Schwentner L, et\u00a0al.. Pattern of metastatic spread and subcategories of breast cancer. Arch Gynecol Obstet. 2017;295(1):211\u201323. doi:10.1007/s00404-016-4225-4. PMID:27832352."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1056/NEJMra1001389", "@IdType": "doi"}, {"#text": "21067385", "@IdType": "pubmed"}]}, "Citation": "Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med. 2010;363(20):1938\u201348. doi:10.1056/NEJMra1001389. PMID:21067385."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/cncr.25054", "@IdType": "doi"}, {"#text": "20564396", "@IdType": "pubmed"}]}, "Citation": "Yhim HY, Han SW, Oh DY, Han W, Im SA, Kim TY, Kim YT, Noh DY, Chie EK, Ha SW, et\u00a0al.. Prognostic factors for recurrent breast cancer patients with an isolated, limited number of lung metastases and implications for pulmonary metastasectomy. Cancer. 2010;116(12):2890\u2013901. doi:10.1002/cncr.25054. PMID:20564396."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s10585-015-9697-2", "@IdType": "doi"}, {"#text": "25630269", "@IdType": "pubmed"}]}, "Citation": "Gerratana L, Fanotto V, Bonotto M, Bolzonello S, Minisini AM, Fasola G, Puglisi F. Pattern of metastasis and outcome in patients with breast cancer. Clin Exp Metastasis. 2015;32(2):125\u201333. doi:10.1007/s10585-015-9697-2. PMID:25630269."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.15856", "@IdType": "doi"}, {"#text": "PMC5438624", "@IdType": "pmc"}, {"#text": "28427196", "@IdType": "pubmed"}]}, "Citation": "Wu Q, Li J, Zhu S, Wu J, Chen C, Liu Q, Wei W, Zhang Y, Sun S. Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study. Oncotarget. 2017. 8(17):27990\u20136. doi:10.18632/oncotarget.15856. PMID:28427196."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.0530291100", "@IdType": "doi"}, {"#text": "PMC153034", "@IdType": "pmc"}, {"#text": "12629218", "@IdType": "pubmed"}]}, "Citation": "Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003;100(7):3983\u20138. doi:10.1073/pnas.0530291100. PMID:12629218."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/sj.cdd.4402283", "@IdType": "doi"}, {"#text": "18049477", "@IdType": "pubmed"}]}, "Citation": "Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C, De Maria R, et\u00a0al.. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ. 2008;15(3):504\u201314. doi:10.1038/sj.cdd.4402283. PMID:18049477."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4322524", "@IdType": "pmc"}, {"#text": "25691826", "@IdType": "pubmed"}]}, "Citation": "Czerwinska P, Kaminska B. Regulation of breast cancer stem cell features. Contemp Oncol (Pozn). 2015;19(1A):A7\u2013A15. PMID:25691826."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1371/journal.pone.0002888", "@IdType": "doi"}, {"#text": "PMC2492808", "@IdType": "pmc"}, {"#text": "18682804", "@IdType": "pubmed"}]}, "Citation": "Morel AP, Li\u00e8vre M, Thomas C, Hinkal G, Ansieau S, Puisieux A. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One. 2008;3(8):e2888. doi:10.1371/journal.pone.0002888. PMID:18682804."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bbrc.2014.09.069", "@IdType": "doi"}, {"#text": "25261721", "@IdType": "pubmed"}]}, "Citation": "Kotiyal S, Bhattacharya S. Breast cancer stem cells, EMT and therapeutic targets. Biochem Biophys Res Commun. 2014;453(1):112\u20136. doi:10.1016/j.bbrc.2014.09.069. PMID:25261721."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/bcr1675", "@IdType": "doi"}, {"#text": "PMC1929092", "@IdType": "pmc"}, {"#text": "17504517", "@IdType": "pubmed"}]}, "Citation": "Langerod A, Zhao H, \u00d8 Borgan, Nesland JM, Bukholm IR, Ikdahl T, K\u00e5resen R, B\u00f8rresen-Dale AL, Jeffrey SS. TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer. Breast Cancer Res. 2007;9(3):R30. doi:10.1186/bcr1675. PMID:17504517."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s00428-012-1237-8", "@IdType": "doi"}, {"#text": "22562130", "@IdType": "pubmed"}]}, "Citation": "Schmitt F, Ricardo S, Vieira AF, Dion\u00edsio MR, Paredes J. Cancer stem cell markers in breast neoplasias: their relevance and distribution in distinct molecular subtypes. Virchows Arch. 2012;460(6):545\u201353. doi:10.1007/s00428-012-1237-8. PMID:22562130."}, {"ArticleIdList": {"ArticleId": {"#text": "25804234", "@IdType": "pubmed"}}, "Citation": "Chekhun SV, Zadvorny TV, Tymovska YO, Anikusko MF, Novak OE, Polishchuk LZ. capital ES, CyrillicD44+/CD24- markers of cancer stem cells in patients with breast cancer of different molecular subtypes. Exp Oncol. 2015;37(1):58\u201363. PMID:25804234."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/bcr2108", "@IdType": "doi"}, {"#text": "PMC2481503", "@IdType": "pmc"}, {"#text": "18559090", "@IdType": "pubmed"}]}, "Citation": "Honeth G, Bendahl PO, Ringn\u00e9r M, Saal LH, Gruvberger-Saal SK, L\u00f6vgren K, Grabau D, Fern\u00f6 M, Borg A, Hegardt C. The CD44+/CD24- phenotype is enriched in basal-like breast tumors. Breast Cancer Res. 2008. 10(3):R53. doi:10.1186/bcr2108. PMID:18559090."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.1006732107", "@IdType": "doi"}, {"#text": "PMC2964232", "@IdType": "pmc"}, {"#text": "20921380", "@IdType": "pubmed"}]}, "Citation": "Liu H, Patel MR, Prescher JA, Patsialou A, Qian D, Lin J, Wen S, Chang YF, Bachmann MH, Shimono Y, et\u00a0al.. Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models. Proc Natl Acad Sci U S A. 2010;107(42):18115\u201320. doi:10.1073/pnas.1006732107. PMID:20921380."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1111/j.1582-4934.2008.00455.x", "@IdType": "doi"}, {"#text": "PMC6512388", "@IdType": "pmc"}, {"#text": "18681906", "@IdType": "pubmed"}]}, "Citation": "Croker AK, Goodale D, Chu J, Postenka C, Hedley BD, Hess DA, Allan AL. High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability. J Cell Mol Med. 2009;13(8B):2236\u201352. doi:10.1111/j.1582-4934.2008.00455.x. PMID:18681906."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/ncomms1892", "@IdType": "doi"}, {"#text": "22673910", "@IdType": "pubmed"}]}, "Citation": "Yae T, Tsuchihashi K, Ishimoto T, Motohara T, Yoshikawa M, Yoshida GJ, Wada T, Masuko T, Mogushi K, Tanaka H, et\u00a0al.. Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell. Nat Commun. 2012;3:883. doi:10.1038/ncomms1892. PMID:22673910."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/cddis.2017.72", "@IdType": "doi"}, {"#text": "PMC5386565", "@IdType": "pmc"}, {"#text": "28300837", "@IdType": "pubmed"}]}, "Citation": "Hu J, Li G, Zhang P, Zhuang X, Hu G. A CD44v+ subpopulation of breast cancer stem-like cells with enhanced lung metastasis capacity. Cell Death Dis. 2017;8(3):e2679. doi:10.1038/cddis.2017.72. PMID:28300837."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ceb.2005.08.001", "@IdType": "doi"}, {"#text": "16098727", "@IdType": "pubmed"}]}, "Citation": "Huber MA, Kraut N, Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol. 2005;17(5):548\u201358. doi:10.1016/j.ceb.2005.08.001. PMID:16098727."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s12262-012-0616-3", "@IdType": "doi"}, {"#text": "PMC3689383", "@IdType": "pmc"}, {"#text": "24426422", "@IdType": "pubmed"}]}, "Citation": "Nigam A. Breast cancer stem cells, pathways and therapeutic perspectives 2011. Indian J Surg. 2013;75(3):170\u201380. doi:10.1007/s12262-012-0616-3. PMID:24426422."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1101/gad.976502", "@IdType": "doi"}, {"#text": "12023297", "@IdType": "pubmed"}]}, "Citation": "Barolo S, Posakony JW. Three habits of highly effective signaling pathways: principles of transcriptional control by developmental cell signaling. Genes Dev. 2002;16(10):1167\u201381. doi:10.1101/gad.976502. PMID:12023297."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3272301", "@IdType": "pmc"}, {"#text": "22207549", "@IdType": "pubmed"}]}, "Citation": "Garcia A, Kandel JJ. Notch: a key regulator of tumor angiogenesis and metastasis. Histol Histopathol. 2012;27(2):151\u20136. PMID:22207549."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/0008-5472.CAN-09-1681", "@IdType": "doi"}, {"#text": "PMC3442245", "@IdType": "pmc"}, {"#text": "20068161", "@IdType": "pubmed"}]}, "Citation": "Harrison H, Farnie G, Howell SJ, Rock RE, Stylianou S, Brennan KR, Bundred NJ, Clarke RB. Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor. Cancer Res. 2010;70(2):709\u201318. doi:10.1158/0008-5472.CAN-09-1681. PMID:20068161."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/bcr920", "@IdType": "doi"}, {"#text": "PMC1064073", "@IdType": "pmc"}, {"#text": "15535842", "@IdType": "pubmed"}]}, "Citation": "Dontu G, Jackson KW, McNicholas E, Kawamura MJ, Abdallah WM, Wicha MS. Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res. 2004;6(6):R605\u201315. doi:10.1186/bcr920. PMID:15535842."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1634/stemcells.2006-0442", "@IdType": "doi"}, {"#text": "17158237", "@IdType": "pubmed"}]}, "Citation": "Sansone P, Storci G, Giovannini C, Pandolfi S, Pianetti S, Taffurelli M, Santini D, Ceccarelli C, Chieco P, Bonaf\u00e9 M. p66Shc/Notch-3 interplay controls self-renewal and hypoxia survival in human stem/progenitor cells of the mammary gland expanded in vitro as mammospheres. Stem Cells. 2007;25(3):807\u201315. doi:10.1634/stemcells.2006-0442. PMID:17158237."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC7552110", "@IdType": "pmc"}, {"#text": "27753148", "@IdType": "pubmed"}]}, "Citation": "Pal D, Kolluru V, Chandrasekaran B, Baby BV, Aman M, Suman S, Sirimulla S, Sanders MA, Alatassi H, Ankem MK, et al. Targeting aberrant expression of Notch-1 in ALDH+ cancer stem cells in breast cancer. Mol Carcinog. 2017;56(3):1127\u20131136."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/bjc.2013.642", "@IdType": "doi"}, {"#text": "PMC3833225", "@IdType": "pmc"}, {"#text": "24129237", "@IdType": "pubmed"}]}, "Citation": "Suman S, Das TP, Damodaran C. Silencing NOTCH signaling causes growth arrest in both breast cancer stem cells and breast cancer cells. Br J Cancer. 2013;109(10):2587\u201396. doi:10.1038/bjc.2013.642. PMID:24129237."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.0903768106", "@IdType": "doi"}, {"#text": "PMC2710656", "@IdType": "pmc"}, {"#text": "19564624", "@IdType": "pubmed"}]}, "Citation": "McGovern M, Voutev R, Maciejowski J, Corsi AK, Hubbard EJ. A \u201clatent niche\u201d mechanism for tumor initiation. Proc Natl Acad Sci U S A. 2009;106(28):11617\u201322. doi:10.1073/pnas.0903768106. PMID:19564624."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12967-015-0520-2", "@IdType": "doi"}, {"#text": "PMC4445799", "@IdType": "pmc"}, {"#text": "25990317", "@IdType": "pubmed"}]}, "Citation": "Chen W, Cao G, Yuan X, Zhang X, Zhang Q, Zhu Y, Dong Z, Zhang S. Notch-1 knockdown suppresses proliferation, migration and metastasis of salivary adenoid cystic carcinoma cells. J Transl Med. 2015;13:167. doi:10.1186/s12967-015-0520-2. PMID:25990317."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.gde.2006.12.007", "@IdType": "doi"}, {"#text": "17208432", "@IdType": "pubmed"}]}, "Citation": "Polakis P. The many ways of Wnt in cancer. Curr Opin Genet Dev. 2007;17(1):45\u201351. doi:10.1016/j.gde.2006.12.007. PMID:17208432."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.devcel.2009.06.016", "@IdType": "doi"}, {"#text": "PMC2861485", "@IdType": "pmc"}, {"#text": "19619488", "@IdType": "pubmed"}]}, "Citation": "MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009;17(1):9\u201326. doi:10.1016/j.devcel.2009.06.016. PMID:19619488."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2353/ajpath.2010.091125", "@IdType": "doi"}, {"#text": "PMC2877852", "@IdType": "pmc"}, {"#text": "20395444", "@IdType": "pubmed"}]}, "Citation": "Khramtsov AI, Khramtsova GF, Tretiakova M, Huo D, Olopade OI, Goss KH. Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome. Am J Pathol. 2010;176(6):2911\u201320. doi:10.2353/ajpath.2010.091125. PMID:20395444."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/1055-9965.EPI-09-0741", "@IdType": "doi"}, {"#text": "20056651", "@IdType": "pubmed"}]}, "Citation": "Lopez-Knowles E, Zardawi SJ, McNeil CM, Millar EK, Crea P, Musgrove EA, Sutherland RL, O'Toole SA, et\u00a0al.. Cytoplasmic localization of beta-catenin is a marker of poor outcome in breast cancer patients. Cancer Epidemiol Biomarkers Prev. 2010;19(1):301\u20139. doi:10.1158/1055-9965.EPI-09-0741. PMID:20056651."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/modpathol.2010.205", "@IdType": "doi"}, {"#text": "21076461", "@IdType": "pubmed"}]}, "Citation": "Geyer FC, et\u00a0al.. beta-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation. Mod Pathol. 2011;24(2):209\u201331. doi:10.1038/modpathol.2010.205. PMID:21076461."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1371/journal.pone.0005813", "@IdType": "doi"}, {"#text": "PMC2686096", "@IdType": "pmc"}, {"#text": "19503830", "@IdType": "pubmed"}]}, "Citation": "Lindvall C, Zylstra CR, Evans N, West RA, Dykema K, Furge KA, Williams BO. The Wnt co-receptor Lrp6 is required for normal mouse mammary gland development. PLoS One. 2009;4(6):e5813. doi:10.1371/journal.pone.0005813. PMID:19503830."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.0911220107", "@IdType": "doi"}, {"#text": "PMC2841938", "@IdType": "pmc"}, {"#text": "20194742", "@IdType": "pubmed"}]}, "Citation": "Liu CC, Prior J, Piwnica-Worms D, Bu G. LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy. Proc Natl Acad Sci U S A. 2010;107(11):5136\u201341. doi:10.1073/pnas.0911220107. PMID:20194742."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/cr.2008.47", "@IdType": "doi"}, {"#text": "18392048", "@IdType": "pubmed"}]}, "Citation": "Nusse R. Wnt signaling and stem cell control. Cell Res. 2008;18(5):523\u20137. doi:10.1038/cr.2008.47. PMID:18392048."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.21873/anticanres.11151", "@IdType": "doi"}, {"#text": "27793889", "@IdType": "pubmed"}]}, "Citation": "Pires BR, Amorim \u00cdS DE, Souza LD, Rodrigues JA, Mencalha AL. Targeting cellular signaling pathways in breast cancer stem cells and its implication for cancer treatment. Anticancer Res. 2016. 36(11):5681\u201391. doi:10.21873/anticanres.11151. PMID:27793889."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/1471-2407-13-537", "@IdType": "doi"}, {"#text": "PMC4226307", "@IdType": "pmc"}, {"#text": "24209998", "@IdType": "pubmed"}]}, "Citation": "Dey N, Barwick BG, Moreno CS, Ordanic-Kodani M, Chen Z, Oprea-Ilies G, Tang W, Catzavelos C, Kerstann KF, Sledge GW Jr, et\u00a0al.. Wnt signaling in triple negative breast cancer is associated with metastasis. BMC Cancer. 2013;13:537. doi:10.1186/1471-2407-13-537. PMID:24209998."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/0008-5472.CAN-08-4135", "@IdType": "doi"}, {"#text": "PMC2782448", "@IdType": "pmc"}, {"#text": "19549913", "@IdType": "pubmed"}]}, "Citation": "DiMeo TA, Anderson K, Phadke P, Fan C, Perou CM, Naber S, Kuperwasser C. A novel lung metastasis signature links Wnt signaling with cancer cell self-renewal and epithelial-mesenchymal transition in basal-like breast cancer. Cancer Res. 2009;69(13):5364\u201373. doi:10.1158/0008-5472.CAN-08-4135. PMID:19549913."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/jcp.22924", "@IdType": "doi"}, {"#text": "PMC6957254", "@IdType": "pmc"}, {"#text": "21732367", "@IdType": "pubmed"}]}, "Citation": "Klauzinska M, Baljinnyam B, Raafat A, Rodriguez-Canales J, Strizzi L, Greer YE, Rubin JS, Callahan R. Rspo2/Int7 regulates invasiveness and tumorigenic properties of mammary epithelial cells. J Cell Physiol. 2012;227(5):1960\u201371. doi:10.1002/jcp.22924. PMID:21732367."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/aps.2009.200", "@IdType": "doi"}, {"#text": "PMC4002845", "@IdType": "pmc"}, {"#text": "20139903", "@IdType": "pubmed"}]}, "Citation": "Zhou XL, Qin XR, Zhang XD, Ye LH. Downregulation of Dickkopf-1 is responsible for high proliferation of breast cancer cells via losing control of Wnt/beta-catenin signaling. Acta Pharmacol Sin. 2010;31(2):202\u201310. doi:10.1038/aps.2009.200. PMID:20139903."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1023/B:JOMG.0000037157.94207.33", "@IdType": "doi"}, {"#text": "15300008", "@IdType": "pubmed"}]}, "Citation": "Brennan KR, Brown AM. Wnt proteins in mammary development and cancer. J Mammary Gland Biol Neoplasia. 2004;9(2):119\u201331. doi:10.1023/B:JOMG.0000037157.94207.33. PMID:15300008."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s11481-012-9359-y", "@IdType": "doi"}, {"#text": "22454041", "@IdType": "pubmed"}]}, "Citation": "Zhang K, Zhang J, Han L, Pu P, Kang C. Wnt/beta-catenin signaling in glioma. J Neuroimmune Pharmacol. 2012;7(4):740\u20139. doi:10.1007/s11481-012-9359-y. PMID:22454041."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/ncb3613", "@IdType": "doi"}, {"#text": "28892080", "@IdType": "pubmed"}]}, "Citation": "Zhuang X, Zhang H, Li X, Li X, Cong M, Peng F, Yu J, Zhang X, Yang Q, Hu G. Differential effects on lung and bone metastasis of breast cancer by Wnt signalling inhibitor DKK1. Nat Cell Biol. 2017;19(10):1274\u201385. doi:10.1038/ncb3613. PMID:28892080."}, {"ArticleIdList": {"ArticleId": {"#text": "16465433", "@IdType": "pubmed"}}, "Citation": "Benhaj K, Akcali KC, Ozturk M. Redundant expression of canonical Wnt ligands in human breast cancer cell lines. Oncol Rep. 2006;15(3):701\u20137. PMID:16465433."}, {"ArticleIdList": {"ArticleId": {"#text": "15868903", "@IdType": "pubmed"}}, "Citation": "Leris AC, Roberts TR, Jiang WG, Newbold RF, Mokbel K. WNT5A expression in human breast cancer. Anticancer Res. 2005;25(2A):731\u20134. PMID:15868903."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1371/journal.pone.0058329", "@IdType": "doi"}, {"#text": "PMC3590134", "@IdType": "pmc"}, {"#text": "23484019", "@IdType": "pubmed"}]}, "Citation": "Jiang W, Crossman DK, Mitchell EH, Sohn P, Crowley MR, Serra R. WNT5A inhibits metastasis and alters splicing of Cd44 in breast cancer cells. PLoS One. 2013;8(3):e58329. doi:10.1371/journal.pone.0058329. PMID:23484019."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s13277-013-0694-2", "@IdType": "doi"}, {"#text": "23417837", "@IdType": "pubmed"}]}, "Citation": "Trifa F, Karray-Chouayekh S, Jmal E, Jmaa ZB, Khabir A, Sellami-Boudawara T, Frikha M, Daoud J, Mokdad-Gargouri R. Loss of WIF-1 and Wnt5a expression is related to aggressiveness of sporadic breast cancer in Tunisian patients. Tumour Biol. 2013;34(3):1625\u201333. doi:10.1007/s13277-013-0694-2. PMID:23417837."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.12659/MSM.894821", "@IdType": "doi"}, {"#text": "PMC4700863", "@IdType": "pmc"}, {"#text": "26721633", "@IdType": "pubmed"}]}, "Citation": "Zhong Z, Shan M, Wang J, Liu T, Shi Q, Pang D. Decreased Wnt5a expression is a poor prognostic factor in triple-negative breast cancer. Med Sci Monit. 2016;22:1\u20137. doi:10.12659/MSM.894821. PMID:26721633."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/0008-5472.CAN-14-2761", "@IdType": "doi"}, {"#text": "PMC4433621", "@IdType": "pmc"}, {"#text": "25769722", "@IdType": "pubmed"}]}, "Citation": "Borcherding N, Kusner D, Kolb R, Xie Q, Li W, Yuan F, Velez G, Askeland R, Weigel RJ, Zhang W. Paracrine WNT5A signaling inhibits expansion of tumor-initiating cells. Cancer Res. 2015;75(10):1972\u201382. doi:10.1158/0008-5472.CAN-14-2761. PMID:25769722."}, {"ArticleIdList": {"ArticleId": {"#text": "11493640", "@IdType": "pubmed"}}, "Citation": "Jonsson M, Andersson T. Repression of Wnt-5a impairs DDR1 phosphorylation and modifies adhesion and migration of mammary cells. J Cell Sci. 2001;114(Pt 11):2043\u201353. PMID:11493640."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1074/jbc.M804923200", "@IdType": "doi"}, {"#text": "PMC2667782", "@IdType": "pmc"}, {"#text": "19244247", "@IdType": "pubmed"}]}, "Citation": "Medrek C, Landberg G, Andersson T, Leandersson K. Wnt-5a-CKI{alpha} signaling promotes {beta}-catenin/E-cadherin complex formation and intercellular adhesion in human breast epithelial cells. J Biol Chem. 2009;284(16):10968\u201379. doi:10.1074/jbc.M804923200. PMID:19244247."}, {"ArticleIdList": {"ArticleId": {"#text": "11809689", "@IdType": "pubmed"}}, "Citation": "Jonsson M, Dejmek J, Bendahl PO, Andersson T. Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas. Cancer Res. 2002;62(2):409\u201316. PMID:11809689."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ccr.2014.01.028", "@IdType": "doi"}, {"#text": "PMC4004960", "@IdType": "pmc"}, {"#text": "24525235", "@IdType": "pubmed"}]}, "Citation": "Shi J, Wang Y, Zeng L, Wu Y, Deng J, Zhang Q, Lin Y, Li J, Kang T, Tao M, et\u00a0al.. Disrupting the interaction of BRD4 with diacetylated Twist suppresses tumorigenesis in basal-like breast cancer. Cancer Cell. 2014;25(2):210\u201325. doi:10.1016/j.ccr.2014.01.028. PMID:24525235."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cellsig.2013.01.015", "@IdType": "doi"}, {"#text": "23353182", "@IdType": "pubmed"}]}, "Citation": "Zhu Y, Shen T, Liu J, Zheng J, Zhang Y, Xu R, Sun C, Du J, Chen Y, Gu L. Rab35 is required for Wnt5a/Dvl2-induced Rac1 activation and cell migration in MCF-7 breast cancer cells. Cell Signal. 2013;25(5):1075\u201385. doi:10.1016/j.cellsig.2013.01.015. PMID:23353182."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5844802", "@IdType": "pmc"}, {"#text": "29249801", "@IdType": "pubmed"}]}, "Citation": "Han B, et\u00a0al.. FOXC1-induced non-canonical WNT5A-MMP7 signaling regulates invasiveness in triple-negative breast cancer. Oncogene. 2017."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/cancers7030866", "@IdType": "doi"}, {"#text": "PMC4586799", "@IdType": "pmc"}, {"#text": "26389956", "@IdType": "pubmed"}]}, "Citation": "Flemban A, Qualtrough D. The potential role of hedgehog signaling in the Luminal/Basal Phenotype of breast epithelia and in breast cancer invasion and metastasis. Cancers (Basel). 2015;7(3):1863\u201384. doi:10.3390/cancers7030866. PMID:26389956."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature07737", "@IdType": "doi"}, {"#text": "PMC2946231", "@IdType": "pmc"}, {"#text": "19169242", "@IdType": "pubmed"}]}, "Citation": "Zhao C, Chen A, Jamieson CH, Fereshteh M, Abrahamsson A, Blum J, Kwon HY, Kim J, Chute JP, Rizzieri D, et\u00a0al.. Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature. 2009;458(7239):776\u20139. doi:10.1038/nature07737. PMID:19169242."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/stem.1160", "@IdType": "doi"}, {"#text": "22730244", "@IdType": "pubmed"}]}, "Citation": "Santini R, Vinci MC, Pandolfi S, Penachioni JY, Montagnani V, Olivito B, Gattai R, Pimpinelli N, Gerlini G, Borgognoni L, et\u00a0al.. Hedgehog-GLI signaling drives self-renewal and tumorigenicity of human melanoma-initiating cells. Stem Cells. 2012;30(9):1808\u201318. doi:10.1002/stem.1160. PMID:22730244."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/emmm.200900039", "@IdType": "doi"}, {"#text": "PMC3378144", "@IdType": "pmc"}, {"#text": "20049737", "@IdType": "pubmed"}]}, "Citation": "Varnat F, Duquet A, Malerba M, Zbinden M, Mas C, Gervaz P, Ruiz i Altaba A. Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion. EMBO Mol Med. 2009;1(6\u20137):338\u201351. doi:10.1002/emmm.200900039. PMID:20049737."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/bcr3401", "@IdType": "doi"}, {"#text": "PMC3672663", "@IdType": "pmc"}, {"#text": "23547970", "@IdType": "pubmed"}]}, "Citation": "Hui M, Cazet A, Nair R, Watkins DN, O'Toole SA, Swarbrick A. The Hedgehog signalling pathway in breast development, carcinogenesis and cancer therapy. Breast Cancer Res. 2013;15(2):203. doi:10.1186/bcr3401. PMID:23547970."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.4161/cbt.5.6.2906", "@IdType": "doi"}, {"#text": "PMC1557635", "@IdType": "pmc"}, {"#text": "16855373", "@IdType": "pubmed"}]}, "Citation": "Mukherjee S, Frolova N, Sadlonova A, Novak Z, Steg A, Page GP, Welch DR, Lobo-Ruppert SM, Ruppert JM, Johnson MR, et\u00a0al.. Hedgehog signaling and response to cyclopamine differ in epithelial and stromal cells in benign breast and breast cancer. Cancer Biol Ther. 2006;5(6):674\u201383. doi:10.4161/cbt.5.6.2906. PMID:16855373."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/bjc.2011.133", "@IdType": "doi"}, {"#text": "PMC3101910", "@IdType": "pmc"}, {"#text": "21505458", "@IdType": "pubmed"}]}, "Citation": "Thomas ZI, Gibson W, Sexton JZ, Aird KM, Ingram SM, Aldrich A, Lyerly HK, Devi GR, Williams KP. Targeting GLI1 expression in human inflammatory breast cancer cells enhances apoptosis and attenuates migration. Br J Cancer. 2011;104(10):1575\u201386. doi:10.1038/bjc.2011.133. PMID:21505458."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/0008-5472.CAN-10-3738", "@IdType": "doi"}, {"#text": "21632555", "@IdType": "pubmed"}]}, "Citation": "O'Toole SA, Machalek DA, Shearer RF, Millar EK, Nair R, Schofield P, McLeod D, Cooper CL, McNeil CM, McFarland A, et\u00a0al.. Hedgehog overexpression is associated with stromal interactions and predicts for poor outcome in breast cancer. Cancer Res. 2011;71(11):4002\u201314. doi:10.1158/0008-5472.CAN-10-3738. PMID:21632555."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.5203", "@IdType": "doi"}, {"#text": "PMC4741792", "@IdType": "pmc"}, {"#text": "26413813", "@IdType": "pubmed"}]}, "Citation": "Inaguma S, Riku M, Ito H, Tsunoda T, Ikeda H, Kasai K. GLI1 orchestrates CXCR4/CXCR7 signaling to enhance migration and metastasis of breast cancer cells. Oncotarget. 2015;6(32):33648\u201357. doi:10.18632/oncotarget.5203. PMID:26413813."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bbrc.2007.12.183", "@IdType": "doi"}, {"#text": "PMC2265419", "@IdType": "pmc"}, {"#text": "18187037", "@IdType": "pubmed"}]}, "Citation": "Hayashi H, Kume T. Forkhead transcription factors regulate expression of the chemokine receptor CXCR4 in endothelial cells and CXCL12-induced cell migration. Biochem Biophys Res Commun. 2008;367(3):584\u20139. doi:10.1016/j.bbrc.2007.12.183. PMID:18187037."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.celrep.2015.09.063", "@IdType": "doi"}, {"#text": "PMC4806384", "@IdType": "pmc"}, {"#text": "26565916", "@IdType": "pubmed"}]}, "Citation": "Han B, Qu Y, Jin Y, Yu Y, Deng N, Wawrowsky K, Zhang X, Li N, Bose S, Wang Q, et\u00a0al.. FOXC1 activates smoothened-independent hedgehog signaling in basal-like breast cancer. Cell Rep. 2015;13(5):1046\u201358. doi:10.1016/j.celrep.2015.09.063. PMID:26565916."}, {"ArticleIdList": {"ArticleId": {"#text": "27685901", "@IdType": "pubmed"}}, "Citation": "Zuo HD, Wu Yao W. The role and the potential regulatory pathways of high expression of forkhead box C1 in promoting tumor growth and metastasis of basal-like breast cancer. J BUON. 2016;21(4):818\u201325. PMID:27685901."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.canlet.2016.05.022", "@IdType": "doi"}, {"#text": "27216982", "@IdType": "pubmed"}]}, "Citation": "Liu J, Chen S, Wang W, Ning BF, Chen F, Shen W, Ding J, Chen W, Xie WF, Zhang X. Cancer-associated fibroblasts promote hepatocellular carcinoma metastasis through chemokine-activated hedgehog and TGF-beta pathways. Cancer Lett. 2016;379(1):49\u201359. doi:10.1016/j.canlet.2016.05.022. PMID:27216982."}, {"ArticleIdList": {"ArticleId": {"#text": "19130408", "@IdType": "pubmed"}}, "Citation": "Zardawi SJ, O'Toole SA, Sutherland RL, Musgrove EA. Dysregulation of Hedgehog, Wnt and Notch signalling pathways in breast cancer. Histol Histopathol. 2009;24(3):385\u201398. PMID:19130408."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s10616-014-9830-0", "@IdType": "doi"}, {"#text": "PMC4545436", "@IdType": "pmc"}, {"#text": "25516358", "@IdType": "pubmed"}]}, "Citation": "Salem ML, El-Badawy AS, Li Z. Immunobiology and signaling pathways of cancer stem cells: implication for cancer therapy. Cytotechnology. 2015;67(5):749\u201359. doi:10.1007/s10616-014-9830-0. PMID:25516358."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5666657", "@IdType": "pmc"}, {"#text": "29142600", "@IdType": "pubmed"}]}, "Citation": "Arnold KM, Pohlig RT, Sims-Mourtada J. Co-activation of Hedgehog and Wnt signaling pathways is associated with poor outcomes in triple negative breast cancer. Oncol Lett. 2017;14(5):5285\u201392. PMID:29142600."}, {"ArticleIdList": {"ArticleId": {"#text": "28870926", "@IdType": "pubmed"}}, "Citation": "Okuhashi Y, Itoh M, Tohda S. Hedgehog stimulation suppresses clonogenicity and activates NOTCH signalling in T-lymphoblastic Leukaemia Jurkat cells. Anticancer Res. 2017;37(9):5005\u20139. PMID:28870926."}, {"ArticleIdList": {"ArticleId": {"#text": "16786128", "@IdType": "pubmed"}}, "Citation": "Maeda O, Kondo M, Fujita T, Usami N, Fukui T, Shimokata K, Ando T, Goto H, Sekido Y. Enhancement of GLI1-transcriptional activity by beta-catenin in human cancer cells. Oncol Rep. 2006;16(1):91\u20136. PMID:16786128."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/ncomms12887", "@IdType": "doi"}, {"#text": "PMC5036006", "@IdType": "pmc"}, {"#text": "27650679", "@IdType": "pubmed"}]}, "Citation": "Kikuchi I, Takahashi-Kanemitsu A, Sakiyama N, Tang C, Tang PJ, Noda S, Nakao K, Kassai H, Sato T, Aiba A, et\u00a0al.. Dephosphorylated parafibromin is a transcriptional coactivator of the Wnt/Hedgehog/Notch pathways. Nat Commun. 2016;7:12887. doi:10.1038/ncomms12887. PMID:27650679."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1146/annurev.immunol.18.1.217", "@IdType": "doi"}, {"#text": "10837058", "@IdType": "pubmed"}]}, "Citation": "Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol. 2000;18:217\u201342. doi:10.1146/annurev.immunol.18.1.217. PMID:10837058."}, {"ArticleIdList": {"ArticleId": {"#text": "10699158", "@IdType": "pubmed"}}, "Citation": "Murphy PM, Baggiolini M, Charo IF, H\u00e9bert CA, Horuk R, Matsushima K, Miller LH, Oppenheim JJ, Power CA. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev. 2000;52(1):145\u201376. PMID:10699158."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/S1074-7613(00)80165-X", "@IdType": "doi"}, {"#text": "10714678", "@IdType": "pubmed"}]}, "Citation": "Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity. 2000;12(2):121\u20137. doi:10.1016/S1074-7613(00)80165-X. PMID:10714678."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1034/j.1398-9995.2002.02166.x", "@IdType": "doi"}, {"#text": "12358993", "@IdType": "pubmed"}]}, "Citation": "Locati M, Otero K, Schioppa T, Signorelli P, Perrier P, Baviera S, Sozzani S, Mantovani A. The chemokine system: tuning and shaping by regulation of receptor expression and coupling in polarized responses. Allergy. 2002. 57(11):972\u201382. doi:10.1034/j.1398-9995.2002.02166.x. PMID:12358993."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1146/annurev.immunol.22.012703.104543", "@IdType": "doi"}, {"#text": "15032599", "@IdType": "pubmed"}]}, "Citation": "Rot A, von Andrian UH. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol. 2004;22:891\u2013928. doi:10.1146/annurev.immunol.22.012703.104543. PMID:15032599."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1146/annurev.immunol.24.021605.090529", "@IdType": "doi"}, {"#text": "17291188", "@IdType": "pubmed"}]}, "Citation": "Allen SJ, Crown SE, Handel TM. Chemokine: receptor structure, interactions, and antagonism. Annu Rev Immunol 2007;25:787\u2013820. doi:10.1146/annurev.immunol.24.021605.090529. PMID:17291188."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/S0140-6736(00)04046-0", "@IdType": "doi"}, {"#text": "11229684", "@IdType": "pubmed"}]}, "Citation": "Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357(9255):539\u201345. doi:10.1016/S0140-6736(00)04046-0. PMID:11229684."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrc1388", "@IdType": "doi"}, {"#text": "15229479", "@IdType": "pubmed"}]}, "Citation": "Balkwill F. Cancer and the chemokine network. Nat Rev Cancer. 2004;4(7):540\u201350. doi:10.1038/nrc1388. PMID:15229479."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1089/jir.2008.0027", "@IdType": "doi"}, {"#text": "PMC2755091", "@IdType": "pmc"}, {"#text": "19441883", "@IdType": "pubmed"}]}, "Citation": "Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res. 2009;29(6):313\u201326. doi:10.1089/jir.2008.0027. PMID:19441883."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s00109-015-1355-2", "@IdType": "doi"}, {"#text": "26489606", "@IdType": "pubmed"}]}, "Citation": "Maru Y. The lung metastatic niche. J Mol Med (Berl). 2015;93(11):1185\u201392. doi:10.1007/s00109-015-1355-2. PMID:26489606."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cell.2012.04.042", "@IdType": "doi"}, {"#text": "PMC3528019", "@IdType": "pmc"}, {"#text": "22770218", "@IdType": "pubmed"}]}, "Citation": "Acharyya S, Oskarsson T, Vanharanta S, Malladi S, Kim J, Morris PG, Manova-Todorova K, Leversha M, Hogg N, Seshan VE, et\u00a0al.. A CXCL1 paracrine network links cancer chemoresistance and metastasis. Cell. 2012;150(1):165\u201378. doi:10.1016/j.cell.2012.04.042. PMID:22770218."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/35065016", "@IdType": "doi"}, {"#text": "11242036", "@IdType": "pubmed"}]}, "Citation": "Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, et\u00a0al.. Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001;410(6824):50\u20136. doi:10.1038/35065016. PMID:11242036."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3555200", "@IdType": "pmc"}, {"#text": "23359227", "@IdType": "pubmed"}]}, "Citation": "Mukherjee D, Zhao J. The Role of chemokine receptor CXCR4 in breast cancer metastasis. Am J Cancer Res. 2013;3(1):46\u201357. PMID:23359227."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1634/stemcells.2004-0342", "@IdType": "doi"}, {"#text": "15888687", "@IdType": "pubmed"}]}, "Citation": "Kucia M, Reca R, Miekus K, Wanzeck J, Wojakowski W, Janowska-Wieczorek A, Ratajczak J, Ratajczak MZ. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells. 2005;23(7):879\u201394. doi:10.1634/stemcells.2004-0342. PMID:15888687."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.pharmthera.2016.09.011", "@IdType": "doi"}, {"#text": "27613100", "@IdType": "pubmed"}]}, "Citation": "Atretkhany KN, et\u00a0al.. Chemokines, cytokines and exosomes help tumors to shape inflammatory microenvironment. Pharmacol Ther. 2016;168:98\u2013112. doi:10.1016/j.pharmthera.2016.09.011. PMID:27613100."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/ol.2015.3810", "@IdType": "doi"}, {"#text": "PMC4665726", "@IdType": "pmc"}, {"#text": "26788178", "@IdType": "pubmed"}]}, "Citation": "Gong HY, Hu WG, Hu QY, Li XP, Song QB. Radiation-induced pulmonary injury accelerated pulmonary metastasis in a mouse model of breast cancer. Oncol Lett. 2015. 10(6):3613\u20138. doi:10.3892/ol.2015.3810. PMID:26788178."}, {"ArticleIdList": {"ArticleId": {"#text": "23331013", "@IdType": "pubmed"}}, "Citation": "Chen HW, Du CW, Wei XL, Khoo US, Zhang GJ. Cytoplasmic CXCR4 high-expression exhibits distinct poor clinicopathological characteristics and predicts poor prognosis in triple-negative breast cancer. Curr Mol Med. 2013;13(3):410\u20136. PMID:23331013."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/bcr3108", "@IdType": "doi"}, {"#text": "PMC3496141", "@IdType": "pmc"}, {"#text": "22314082", "@IdType": "pubmed"}]}, "Citation": "Boimel PJ, Smirnova T, Zhou ZN, Wyckoff J, Park H, Coniglio SJ, Qian BZ, Stanley ER, Cox D, Pollard JW, et\u00a0al.. Contribution of CXCL12 secretion to invasion of breast cancer cells. Breast Cancer Res. 2012;14(1):R23. doi:10.1186/bcr3108. PMID:22314082."}, {"ArticleIdList": {"ArticleId": {"#text": "12499259", "@IdType": "pubmed"}}, "Citation": "Bachelder RE, Wendt MA, Mercurio AM. Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res. 2002;62(24):7203\u20136. PMID:12499259."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1210/me.2002-0438", "@IdType": "doi"}, {"#text": "12586845", "@IdType": "pubmed"}]}, "Citation": "Hall JM, Korach KS. Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells. Mol Endocrinol. 2003;17(5):792\u2013803. doi:10.1210/me.2002-0438. PMID:12586845."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1074/jbc.M300609200", "@IdType": "doi"}, {"#text": "12690099", "@IdType": "pubmed"}]}, "Citation": "Helbig G, Christopherson KW 2nd, Bhat-Nakshatri P, Kumar S, Kishimoto H, Miller KD, Broxmeyer HE, Nakshatri H. NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J Biol Chem. 2003;278(24):21631\u20138. doi:10.1074/jbc.M300609200. PMID:12690099."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nri1964", "@IdType": "doi"}, {"#text": "17124512", "@IdType": "pubmed"}]}, "Citation": "Mantovani A, Bonecchi R, Locati M. Tuning inflammation and immunity by chemokine sequestration: decoys and more. Nat Rev Immunol. 2006;6(12):907\u201318. doi:10.1038/nri1964. PMID:17124512."}, {"ArticleIdList": {"ArticleId": {"#text": "16313795", "@IdType": "pubmed"}}, "Citation": "Wang J, Ou ZL, Hou YF, Luo JM, Chen Y, Zhou J, Shen ZZ, Ding J, Shao ZM. Duffy antigen receptor for chemokines attenuates breast cancer growth and metastasis: an experiment with nude mice. Zhonghua Yi Xue Za Zhi. 2005;85(29):2033\u20137. PMID:16313795."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.pharmthera.2009.12.003", "@IdType": "doi"}, {"#text": "PMC7112609", "@IdType": "pmc"}, {"#text": "20117133", "@IdType": "pubmed"}]}, "Citation": "Galzi JL, Hachet-Haas M, Bonnet D, Daubeuf F, Lecat S, Hibert M, Haiech J, Frossard N. Neutralizing endogenous chemokines with small molecules. Principles and potential therapeutic applications. Pharmacol Ther. 2010;126(1):39\u201355. doi:10.1016/j.pharmthera.2009.12.003. PMID:20117133."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/1541-7786.MCR-07-2108", "@IdType": "doi"}, {"#text": "18708360", "@IdType": "pubmed"}]}, "Citation": "Wu FY, Ou ZL, Feng LY, Luo JM, Wang LP, Shen ZZ, Shao ZM. Chemokine decoy receptor d6 plays a negative role in human breast cancer. Mol Cancer Res. 2008;6(8):1276\u201388. doi:10.1158/1541-7786.MCR-07-2108. PMID:18708360."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cytogfr.2009.11.007", "@IdType": "doi"}, {"#text": "20004131", "@IdType": "pubmed"}]}, "Citation": "Mantovani A, Savino B, Locati M, Zammataro L, Allavena P, Bonecchi R. The chemokine system in cancer biology and therapy. Cytokine Growth Factor Rev. 2010;21(1):27\u201339. doi:10.1016/j.cytogfr.2009.11.007. PMID:20004131."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.devcel.2010.05.012", "@IdType": "doi"}, {"#text": "PMC2905377", "@IdType": "pmc"}, {"#text": "20627072", "@IdType": "pubmed"}]}, "Citation": "Egeblad M, Nakasone ES, Werb Z. Tumors as organs: complex tissues that interface with the entire organism. Dev Cell. 2010;18(6):884\u2013901. doi:10.1016/j.devcel.2010.05.012. PMID:20627072."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1101/cshperspect.a003244", "@IdType": "doi"}, {"#text": "PMC2964182", "@IdType": "pmc"}, {"#text": "20591988", "@IdType": "pubmed"}]}, "Citation": "Polyak K, Kalluri R. The role of the microenvironment in mammary gland development and cancer. Cold Spring Harb Perspect Biol. 2010;2(11):a003244. doi:10.1101/cshperspect.a003244. PMID:20591988."}, {"ArticleIdList": {"ArticleId": {"#text": "26577808", "@IdType": "pubmed"}}, "Citation": "Ursini-Siegel J, Siegel PM. The influence of the pre-metastatic niche on breast cancer metastasis. Cancer Lett. 2016;380(1):281\u20138."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2353/ajpath.2010.090748", "@IdType": "doi"}, {"#text": "PMC2893681", "@IdType": "pmc"}, {"#text": "20489157", "@IdType": "pubmed"}]}, "Citation": "Soikkeli J, Podlasz P, Yin M, Nummela P, Jahkola T, Virolainen S, Krogerus L, Heikkil\u00e4 P, von Smitten K, Saksela O, et\u00a0al.. Metastatic outgrowth encompasses COL-I, FN1, and POSTN up-regulation and assembly to fibrillar networks regulating cell adhesion, migration, and growth. Am J Pathol. 2010;177(1):387\u2013403. doi:10.2353/ajpath.2010.090748. PMID:20489157."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nm.2379", "@IdType": "doi"}, {"#text": "PMC4020577", "@IdType": "pmc"}, {"#text": "21706029", "@IdType": "pubmed"}]}, "Citation": "Oskarsson T, Acharyya S, Zhang XH, Vanharanta S, Tavazoie SF, Morris PG, Downey RJ, Manova-Todorova K, Brogi E, Massagu\u00e9 J. Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat Med. 2011;17(7):867\u201374. doi:10.1038/nm.2379. PMID:21706029."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.1109493108", "@IdType": "doi"}, {"#text": "PMC3179047", "@IdType": "pmc"}, {"#text": "21911392", "@IdType": "pubmed"}]}, "Citation": "O'Connell JT, Sugimoto H, Cooke VG, MacDonald BA, Mehta AI, LeBleu VS, Dewar R, Rocha RM, Brentani RR, Resnick MB, et\u00a0al.. VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization. Proc Natl Acad Sci U S A. 2011;108(38):16002\u20137. doi:10.1073/pnas.1109493108. PMID:21911392."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature10694", "@IdType": "doi"}, {"#text": "22158103", "@IdType": "pubmed"}]}, "Citation": "Malanchi I, Santamaria-Martine A, Susanto E, Peng H, Lehr HA, Delaloye JF, Huelsken J. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature. 2012;481(7379):85\u20139. doi:10.1038/nature10694."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/0008-5472.CAN-11-2905", "@IdType": "doi"}, {"#text": "22282653", "@IdType": "pubmed"}]}, "Citation": "Gao D, Joshi N, Choi H, Ryu S, Hahn M, Catena R, Sadik H, Argani P, Wagner P, Vahdat LT, et\u00a0al.. Myeloid progenitor cells in the premetastatic lung promote metastases by inducing mesenchymal to epithelial transition. Cancer Res. 2012;72(6):1384\u201394. doi:10.1158/0008-5472.CAN-11-2905. PMID:22282653."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s13402-017-0324-x", "@IdType": "doi"}, {"#text": "28534212", "@IdType": "pubmed"}]}, "Citation": "Sharma R, Sharma R, Khaket TP, Dutta C, Chakraborty B, Mukherjee TK. Breast cancer metastasis: Putative therapeutic role of vascular cell adhesion molecule-1. Cell Oncol (Dordr). 2017;40(3):199\u2013208. doi:10.1007/s13402-017-0324-x. PMID:28534212."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature03799", "@IdType": "doi"}, {"#text": "PMC1283098", "@IdType": "pmc"}, {"#text": "16049480", "@IdType": "pubmed"}]}, "Citation": "Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, Viale A, Olshen AB, Gerald WL, Massagu\u00e9 J. Genes that mediate breast cancer metastasis to lung. Nature. 2005;436(7050):518\u201324. doi:10.1038/nature03799. PMID:16049480."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cell.2008.01.046", "@IdType": "doi"}, {"#text": "PMC2390892", "@IdType": "pmc"}, {"#text": "18394990", "@IdType": "pubmed"}]}, "Citation": "Padua D, Zhang XH, Wang Q, Nadal C, Gerald WL, Gomis RR, Massagu\u00e9 J. TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell. 2008;133(1):66\u201377. doi:10.1016/j.cell.2008.01.046. PMID:18394990."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1593/neo.10200", "@IdType": "doi"}, {"#text": "PMC2864480", "@IdType": "pmc"}, {"#text": "20454514", "@IdType": "pubmed"}]}, "Citation": "Hembruff SL, Jokar I, Yang L, Cheng N. Loss of transforming growth factor-beta signaling in mammary fibroblasts enhances CCL2 secretion to promote mammary tumor progression through macrophage-dependent and -independent mechanisms. Neoplasia. 2010;12(5):425\u201333. doi:10.1593/neo.10200. PMID:20454514."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s10911-011-9217-1", "@IdType": "doi"}, {"#text": "PMC3095797", "@IdType": "pmc"}, {"#text": "21494783", "@IdType": "pubmed"}]}, "Citation": "Drabsch Y, ten Dijke P. TGF-beta signaling in breast cancer cell invasion and bone metastasis. J Mammary Gland Biol Neoplasia. 2011;16(2):97\u2013108. doi:10.1007/s10911-011-9217-1. PMID:21494783."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s13277-013-0831-y", "@IdType": "doi"}, {"#text": "23686802", "@IdType": "pubmed"}]}, "Citation": "Fazilaty H, Gardaneh M, Bahrami T, Salmaninejad A, Behnam B. Crosstalk between breast cancer stem cells and metastatic niche: emerging molecular metastasis pathway? Tumour Biol. 2013;34(4):2019\u201330. doi:10.1007/s13277-013-0831-y. PMID:23686802."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s10735-015-9633-4", "@IdType": "doi"}, {"#text": "26208571", "@IdType": "pubmed"}]}, "Citation": "Ye Y, Liu S, Wu C, Sun Z. TGFbeta modulates inflammatory cytokines and growth factors to create premetastatic microenvironment and stimulate lung metastasis. J Mol Histol. 2015;46(4\u20135):365\u201375. doi:10.1007/s10735-015-9633-4. PMID:26208571."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.canlet.2014.05.006", "@IdType": "doi"}, {"#text": "24887560", "@IdType": "pubmed"}]}, "Citation": "Park CY, Min KN, Son JY, Park SY, Nam JS, Kim DK, Sheen YY. An novel inhibitor of TGF-beta type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition. Cancer Lett. 2014;351(1):72\u201380. doi:10.1016/j.canlet.2014.05.006. PMID:24887560."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/1535-7163.MCT-13-0903", "@IdType": "doi"}, {"#text": "24817629", "@IdType": "pubmed"}]}, "Citation": "Son JY, Park SY, Kim SJ, Lee SJ, Park SA, Kim MJ, Kim SW, Kim DK, Nam JS, Sheen YY. EW-7197, a novel ALK-5 kinase inhibitor, potently inhibits breast to lung metastasis. Mol Cancer Ther. 2014;13(7):1704\u201316. doi:10.1158/1535-7163.MCT-13-0903. PMID:24817629."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/0008-5472.CAN-10-0706", "@IdType": "doi"}, {"#text": "PMC4675145", "@IdType": "pmc"}, {"#text": "20631080", "@IdType": "pubmed"}]}, "Citation": "Yan HH, Pickup M, Pang Y, Gorska AE, Li Z, Chytil A, Geng Y, Gray JW, Moses HL, Yang L. Gr-1+CD11b+ myeloid cells tip the balance of immune protection to tumor promotion in the premetastatic lung. Cancer Res. 2010;70(15):6139\u201349. doi:10.1158/0008-5472.CAN-10-0706. PMID:20631080."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1084/jem.181.1.435", "@IdType": "doi"}, {"#text": "PMC2191807", "@IdType": "pmc"}, {"#text": "7807024", "@IdType": "pubmed"}]}, "Citation": "Pekarek LA, Starr BA, Toledano AY, Schreiber H. Inhibition of tumor growth by elimination of granulocytes. J Exp Med. 1995;181(1):435\u201340. doi:10.1084/jem.181.1.435. PMID:7807024."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature14282", "@IdType": "doi"}, {"#text": "PMC4475637", "@IdType": "pmc"}, {"#text": "25822788", "@IdType": "pubmed"}]}, "Citation": "Coffelt SB, Kersten K, Doornebal CW, Weiden J, Vrijland K, Hau CS, Verstegen NJM, Ciampricotti M, Hawinkels LJAC, Jonkers J, et\u00a0al.. IL-17-producing gammadelta T cells and neutrophils conspire to promote breast cancer metastasis. Nature. 2015;522(7556):345\u20138. doi:10.1038/nature14282. PMID:25822788."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/ncb1507", "@IdType": "doi"}, {"#text": "17128264", "@IdType": "pubmed"}]}, "Citation": "Hiratsuka S, Watanabe A, Aburatani H, Maru Y. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol. 2006;8(12):1369\u201375. doi:10.1038/ncb1507. PMID:17128264."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ccr.2008.11.012", "@IdType": "doi"}, {"#text": "PMC3050620", "@IdType": "pmc"}, {"#text": "19111879", "@IdType": "pubmed"}]}, "Citation": "Erler JT, Bennewith KL, Cox TR, Lang G, Bird D, Koong A, Le QT, Giaccia AJ. Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell. 2009;15(1):35\u201344. doi:10.1016/j.ccr.2008.11.012. PMID:19111879."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature04186", "@IdType": "doi"}, {"#text": "PMC2945882", "@IdType": "pmc"}, {"#text": "16341007", "@IdType": "pubmed"}]}, "Citation": "Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, MacDonald DD, Jin DK, Shido K, Kerns SA, et\u00a0al.. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature. 2005;438(7069):820\u20137. doi:10.1038/nature04186. PMID:16341007."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5290040", "@IdType": "pmc"}, {"#text": "27375023", "@IdType": "pubmed"}]}, "Citation": "Yu PF, Huang Y, Han YY, Lin LY, Sun WH, Rabson AB, Wang Y, Shi YF. TNFalpha-activated mesenchymal stromal cells promote breast cancer metastasis by recruiting CXCR2+ neutrophils. Oncogene. 2016;36(4):482\u2013490."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/cr.2016.17", "@IdType": "doi"}, {"#text": "PMC4783468", "@IdType": "pmc"}, {"#text": "26823207", "@IdType": "pubmed"}]}, "Citation": "Acharyya S, Massague J. Arresting supporters: targeting neutrophils in metastasis. Cell Res. 2016;26(3):273\u20134. doi:10.1038/cr.2016.17. PMID:26823207."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature16140", "@IdType": "doi"}, {"#text": "PMC4700594", "@IdType": "pmc"}, {"#text": "26649828", "@IdType": "pubmed"}]}, "Citation": "Wculek SK, Malanchi I. Neutrophils support lung colonization of metastasis-initiating breast cancer cells. Nature. 2015;528(7582):413\u20137. doi:10.1038/nature16140. PMID:26649828."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrc1256", "@IdType": "doi"}, {"#text": "14708027", "@IdType": "pubmed"}]}, "Citation": "Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer. 2004;4(1):71\u20138. doi:10.1038/nrc1256. PMID:14708027."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature10138", "@IdType": "doi"}, {"#text": "PMC3208506", "@IdType": "pmc"}, {"#text": "21654748", "@IdType": "pubmed"}]}, "Citation": "Qian BZ, Li J, Zhang H, Kitamura T, Zhang J, Campion LR, Kaiser EA, Snyder LA, Pollard JW. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature. 2011;475(7355):222\u20135. doi:10.1038/nature10138. PMID:21654748."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ccr.2011.02.006", "@IdType": "doi"}, {"#text": "PMC3107500", "@IdType": "pmc"}, {"#text": "21481794", "@IdType": "pubmed"}]}, "Citation": "Chen J, Yao Y, Gong C, Yu F, Su S, Chen J, Liu B, Deng H, Wang F, Lin L, et\u00a0al.. CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3. Cancer Cell. 2011;19(4):541\u201355. doi:10.1016/j.ccr.2011.02.006. PMID:21481794."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.4107", "@IdType": "doi"}, {"#text": "PMC4653020", "@IdType": "pmc"}, {"#text": "26244871", "@IdType": "pubmed"}]}, "Citation": "Lin X, Chen L, Yao Y, Zhao R, Cui X, Chen J, Hou K, Zhang M, Su F, Chen J, et\u00a0al.. CCL18-mediated down-regulation of miR98 and miR27b promotes breast cancer metastasis. Oncotarget. 2015;6(24):20485\u201399. doi:10.18632/oncotarget.4107. PMID:26244871."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ccr.2011.08.025", "@IdType": "doi"}, {"#text": "PMC3293160", "@IdType": "pmc"}, {"#text": "22014578", "@IdType": "pubmed"}]}, "Citation": "Chen Q, Zhang XH, Massague J. Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs. Cancer Cell. 2011;20(4):538\u201349. doi:10.1016/j.ccr.2011.08.025. PMID:22014578."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/ijc.30387", "@IdType": "doi"}, {"#text": "27537102", "@IdType": "pubmed"}]}, "Citation": "Li XJ, Gangadaran P, Kalimuthu S, Oh JM, Zhu L, Jeong SY, Lee SW, Lee J, Ahn BC. Role of pulmonary macrophages in initiation of lung metastasis in anaplastic thyroid cancer. Int J Cancer. 2016;139(11):2583\u201392. doi:10.1002/ijc.30387. PMID:27537102."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1021/acsnano.6b03148", "@IdType": "doi"}, {"#text": "27454827", "@IdType": "pubmed"}]}, "Citation": "Cao H, Dan Z, He X, Zhang Z, Yu H, Yin Q, Li Y. Liposomes coated with isolated macrophage membrane can target lung metastasis of breast cancer. ACS Nano. 2016;10(8):7738\u201348. doi:10.1021/acsnano.6b03148. PMID:27454827."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3791/54306", "@IdType": "doi"}, {"#text": "PMC4993250", "@IdType": "pmc"}, {"#text": "27403530", "@IdType": "pubmed"}]}, "Citation": "Vadrevu SK, Sharma S, Chintala N, Patel J, Karbowniczek M, Markiewski M. Studying the role of alveolar macrophages in breast cancer metastasis. J Vis Exp. 2016;(112). doi:10.3791/54306. PMID:27403530."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s13058-016-0674-8", "@IdType": "doi"}, {"#text": "PMC4730665", "@IdType": "pmc"}, {"#text": "26821678", "@IdType": "pubmed"}]}, "Citation": "Xu K, Tian X, Oh SY, Movassaghi M, Naber SP, Kuperwasser C, Buchsbaum RJ. The fibroblast Tiam1-osteopontin pathway modulates breast cancer invasion and metastasis. Breast Cancer Res. 2016;18(1):14. doi:10.1186/s13058-016-0674-8. PMID:26821678."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12967-015-0587-9", "@IdType": "doi"}, {"#text": "PMC4702422", "@IdType": "pmc"}, {"#text": "26163388", "@IdType": "pubmed"}]}, "Citation": "Kim HM, Jung WH, Koo JS. Expression of cancer-associated fibroblast related proteins in metastatic breast cancer: an immunohistochemical analysis. J Transl Med. 2015;13:222. doi:10.1186/s12967-015-0587-9. PMID:26163388."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1517/14728222.2013.757305", "@IdType": "doi"}, {"#text": "23297753", "@IdType": "pubmed"}]}, "Citation": "Hasebe T. Tumor-stromal interactions in breast tumor progression\u2013significance of histological heterogeneity of tumor-stromal fibroblasts. Expert Opin Ther Targets. 2013;17(4):449\u201360. doi:10.1517/14728222.2013.757305. PMID:23297753."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.12658", "@IdType": "doi"}, {"#text": "PMC5341254", "@IdType": "pmc"}, {"#text": "27756881", "@IdType": "pubmed"}]}, "Citation": "Takai K, Le A, Weaver VM, Werb Z. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer. Oncotarget. 2016;7(50):82889\u2013901. doi:10.18632/oncotarget.12658. PMID:27756881."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/molecules21121634", "@IdType": "doi"}, {"#text": "PMC6273039", "@IdType": "pmc"}, {"#text": "27999314", "@IdType": "pubmed"}]}, "Citation": "Ci Y, Qiao J, Han M. Molecular mechanisms and metabolomics of natural polyphenols interfering with breast cancer metastasis. Molecules. 2016;21(12):E1634. doi:10.3390/molecules21121634. PMID:27999314."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/978-0-387-74039-3_1", "@IdType": "doi"}, {"#text": "17993229", "@IdType": "pubmed"}]}, "Citation": "Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN. Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol. 2007;608:1\u201322. doi:10.1007/978-0-387-74039-3_1. PMID:17993229."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/0008-5472.CAN-14-2041", "@IdType": "doi"}, {"#text": "25660951", "@IdType": "pubmed"}]}, "Citation": "Jang GB, Hong IS, Kim RJ, Lee SY, Park SJ, Lee ES, Park JH, Yun CH, Chung JU, Lee KJ, et\u00a0al.. Wnt/beta-Catenin small-molecule inhibitor CWP232228 preferentially inhibits the growth of breast cancer stem-like cells. Cancer Res. 2015;75(8):1691\u2013702. doi:10.1158/0008-5472.CAN-14-2041. PMID:25660951."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1111/cas.13205", "@IdType": "doi"}, {"#text": "PMC5448645", "@IdType": "pmc"}, {"#text": "28211214", "@IdType": "pubmed"}]}, "Citation": "Kurebayashi J, Koike Y, Ohta Y, Saitoh W, Yamashita T, Kanomata N, Moriya T. Anti-cancer stem cell activity of a hedgehog inhibitor GANT61 in estrogen receptor-positive breast cancer cells. Cancer Sci. 2017;108(5):918\u201330. doi:10.1111/cas.13205. PMID:28211214."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s12282-017-0757-0", "@IdType": "doi"}, {"#text": "28144905", "@IdType": "pubmed"}]}, "Citation": "Koike Y, Ohta Y, Saitoh W, Yamashita T, Kanomata N, Moriya T, Kurebayashi J. Anti-cell growth and anti-cancer stem cell activities of the non-canonical hedgehog inhibitor GANT61 in triple-negative breast cancer cells. Breast Cancer. 2017;24(5):683\u201393. doi:10.1007/s12282-017-0757-0. PMID:28144905."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4540115", "@IdType": "pmc"}, {"#text": "26316815", "@IdType": "pubmed"}]}, "Citation": "Huebschman ML, Lane NL, Liu H, Sarode VR, Devlin JL, Frenkel EP. Molecular heterogeneity in adjacent cells in triple-negative breast cancer. Breast Cancer (Dove Med Press). 2015;7:231\u20137. PMID:26316815."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/bcr1771", "@IdType": "doi"}, {"#text": "PMC2242660", "@IdType": "pmc"}, {"#text": "17910759", "@IdType": "pubmed"}]}, "Citation": "Kreike B, van Kouwenhove M, Horlings H, Weigelt B, Peterse H, Bartelink H, van de Vijver MJ. Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas. Breast Cancer Res. 2007;9(5):R65. doi:10.1186/bcr1771. PMID:17910759."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1172/JCI45014", "@IdType": "doi"}, {"#text": "PMC3127435", "@IdType": "pmc"}, {"#text": "21633166", "@IdType": "pubmed"}]}, "Citation": "Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, Pietenpol JA. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest. 2011;121(7):2750\u201367. doi:10.1172/JCI45014. PMID:21633166."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/onc.2009.489", "@IdType": "doi"}, {"#text": "PMC2852518", "@IdType": "pmc"}, {"#text": "20101236", "@IdType": "pubmed"}]}, "Citation": "Turner N, Lambros MB, Horlings HM, Pearson A, Sharpe R, Natrajan R, Geyer FC, van Kouwenhove M, Kreike B, Mackay A, et\u00a0al.. Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets. Oncogene. 2010;29(14):2013\u201323. doi:10.1038/onc.2009.489. PMID:20101236."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/1535-7163.MCT-15-0243", "@IdType": "doi"}, {"#text": "PMC4674314", "@IdType": "pmc"}, {"#text": "26384399", "@IdType": "pubmed"}]}, "Citation": "Bartholomeusz C, Xie X, Pitner MK, Kondo K, Dadbin A, Lee J, Saso H, Smith PD, Dalby KN, Ueno NT. MEK inhibitor Selumetinib (AZD6244; ARRY-142886) Prevents lung metastasis in a triple-negative breast cancer xenograft model. Mol Cancer Ther. 2015. 14(12):2773\u201381. doi:10.1158/1535-7163.MCT-15-0243. PMID:26384399."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1126/scisignal.2002962", "@IdType": "doi"}, {"#text": "23033540", "@IdType": "pubmed"}]}, "Citation": "Citterio C, Menacho-M\u00e1rquez M, Garc\u00eda-Escudero R, Larive RM, Barreiro O, S\u00e1nchez-Madrid F, Paramio JM, Bustelo XR. The rho exchange factors vav2 and vav3 control a lung metastasis-specific transcriptional program in breast cancer cells. Sci Signal. 2012;5(244):ra71. doi:10.1126/scisignal.2002962. PMID:23033540."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2741/2675", "@IdType": "doi"}, {"#text": "PMC3086378", "@IdType": "pmc"}, {"#text": "17981543", "@IdType": "pubmed"}]}, "Citation": "Emens LA. Chemotherapy and tumor immunity: an unexpected collaboration. Front Biosci. 2008;13:249\u201357. doi:10.2741/2675. PMID:17981543."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/0008-5472.CAN-05-1797", "@IdType": "doi"}, {"#text": "16166275", "@IdType": "pubmed"}]}, "Citation": "Emens LA, Jaffee EM. Leveraging the activity of tumor vaccines with cytotoxic chemotherapy. Cancer Res. 2005. 65(18):8059\u201364. doi:10.1158/0008-5472.CAN-05-1797. PMID:16166275."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1056/NEJMra072739", "@IdType": "doi"}, {"#text": "18565863", "@IdType": "pubmed"}]}, "Citation": "Finn OJ. Cancer immunology. N Engl J Med. 2008;358(25):2704\u201315. doi:10.1056/NEJMra072739. PMID:18565863."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5341497", "@IdType": "pmc"}, {"#text": "27564847", "@IdType": "pubmed"}]}, "Citation": "Varn FS, Mullins DW, Arias-Pulido H, Fiering S, Cheng C. Adaptive immunity programmes in breast cancer. Immunology. 2016;150(1):25\u201334. PMID:27564847."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s13058-016-0708-2", "@IdType": "doi"}, {"#text": "PMC4864933", "@IdType": "pmc"}, {"#text": "27169467", "@IdType": "pubmed"}]}, "Citation": "Gray MJ, Gong J, Hatch MM, Nguyen V, Hughes CC, Hutchins JT, Freimark BD. Phosphatidylserine-targeting antibodies augment the anti-tumorigenic activity of anti-PD-1 therapy by enhancing immune activation and downregulating pro-oncogenic factors induced by T-cell checkpoint inhibition in murine triple-negative breast cancers. Breast Cancer Res. 2016;18(1):50. doi:10.1186/s13058-016-0708-2. PMID:27169467."}]}}}}}, "PMC": "PMC6300341", "PMID": "29580128", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "Breast cancer lung metastasis: Molecular biology and therapeutic implications.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "4": {"Abstract": " The features and survival of stage IV breast cancer patients with different metastatic sites are poorly understood. This study aims to examine the clinicopathological features and survival of stage IV breast cancer patients according to different metastatic sites. Using the Surveillance, Epidemiology, and End Results database, we restricted our study population to stage IV breast cancer patients diagnosed between 2010 to 2015. The clinicopathological features were examined by chi-square tests. Breast cancer-specific survival (BCSS) and overall survival (OS) were compared among patients with different metastatic sites by the Kaplan-Meier method with log-rank test. Univariable and multivariable analyses were also performed using the Cox proportional hazard model to identify statistically significant prognostic factors. A total of 18,322 patients were identified for survival analysis. Bone-only metastasis accounted for 39.80% of patients, followed by multiple metastasis (33.07%), lung metastasis (10.94%), liver metastasis (7.34%), other metastasis (7.34%), and brain metastasis (1.51%). The Kaplan-Meier plots showed that patients with bone metastasis had the best survival, while patients with brain metastasis had the worst survival in both BCSS and OS (p\u2009<\u20090.001, for both). Multivariable analyses showed that age, race, marital status, grade, tumor subtype, tumor size, surgery of primary cancer, and a history of radiotherapy or chemotherapy were independent prognostic factors. Stage IV breast cancer patients have different clinicopathological characteristics and survival outcomes according to different metastatic sites. Patients with bone metastasis have the best prognosis, and brain metastasis is the most aggressive subgroup.", "Authors": [{"Affiliations": [{"Has_Extra": true, "HashID": "-4120123633604556599", "Part1": "Department of Breast Surgery", "Part2": "The First Affiliated Hospital of Xi'an Jiaotong University", "Part3": "277 West Yanta Road", "Part4": "Xi'an", "Part5": "710061", "Part6": "Shaanxi", "Text": "Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, 710061, Shaanxi, China."}, {"Has_Extra": false, "HashID": "-3892326238709431618", "Part1": "Institute for Cell Engineering", "Part2": "The Johns Hopkins University School of Medicine", "Part3": "Baltimore", "Part4": "MD", "Part5": "21205", "Part6": "USA.", "Text": "Institute for Cell Engineering, The Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA."}], "ForeName": "Ru", "FullName": "Ru Wang", "HashID": "-639076095137272728", "LastName": "Wang", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-3892326238709431618", "Part1": "Institute for Cell Engineering", "Part2": "The Johns Hopkins University School of Medicine", "Part3": "Baltimore", "Part4": "MD", "Part5": "21205", "Part6": "USA.", "Text": "Institute for Cell Engineering, The Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA."}, {"Has_Extra": true, "HashID": "-7128954065801483516", "Part1": "Liver Cancer Institute", "Part2": "Zhongshan Hospital", "Part3": "and Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education)", "Part4": "Fudan University", "Part5": "180 Fenglin Road", "Part6": "Shanghai", "Text": "Liver Cancer Institute, Zhongshan Hospital, and Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University, 180 Fenglin Road, Shanghai, 200032, China."}], "ForeName": "Yayun", "FullName": "Yayun Zhu", "HashID": "-6575310783980602007", "LastName": "Zhu", "ORCID": null}, {"Affiliations": [{"Has_Extra": true, "HashID": "-4120123633604556599", "Part1": "Department of Breast Surgery", "Part2": "The First Affiliated Hospital of Xi'an Jiaotong University", "Part3": "277 West Yanta Road", "Part4": "Xi'an", "Part5": "710061", "Part6": "Shaanxi", "Text": "Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, 710061, Shaanxi, China."}], "ForeName": "Xiaoxu", "FullName": "Xiaoxu Liu", "HashID": "-7856373407242149746", "LastName": "Liu", "ORCID": null}, {"Affiliations": [{"Has_Extra": true, "HashID": "-4120123633604556599", "Part1": "Department of Breast Surgery", "Part2": "The First Affiliated Hospital of Xi'an Jiaotong University", "Part3": "277 West Yanta Road", "Part4": "Xi'an", "Part5": "710061", "Part6": "Shaanxi", "Text": "Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, 710061, Shaanxi, China."}], "ForeName": "Xiaoqin", "FullName": "Xiaoqin Liao", "HashID": "-2634615171640348498", "LastName": "Liao", "ORCID": null}, {"Affiliations": [{"Has_Extra": true, "HashID": "-4120123633604556599", "Part1": "Department of Breast Surgery", "Part2": "The First Affiliated Hospital of Xi'an Jiaotong University", "Part3": "277 West Yanta Road", "Part4": "Xi'an", "Part5": "710061", "Part6": "Shaanxi", "Text": "Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, 710061, Shaanxi, China."}], "ForeName": "Jianjun", "FullName": "Jianjun He", "HashID": "-2506924522576498688", "LastName": "He", "ORCID": null}, {"Affiliations": [{"Has_Extra": true, "HashID": "-4120123633604556599", "Part1": "Department of Breast Surgery", "Part2": "The First Affiliated Hospital of Xi'an Jiaotong University", "Part3": "277 West Yanta Road", "Part4": "Xi'an", "Part5": "710061", "Part6": "Shaanxi", "Text": "Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, 710061, Shaanxi, China. chinanlg@163.com."}], "ForeName": "Ligang", "FullName": "Ligang Niu", "HashID": "6409775861736982115", "LastName": "Niu", "ORCID": "0000-0003-3612-928X"}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.1186/s12885-019-6311-z", "InsertType": null, "Journal": "BMC cancer", "Keywords": [{"IS_Major": false, "IS_Mesh": true, "Text": "Adult"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Aged"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Aged, 80 and over"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Breast Neoplasms"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Female"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Humans"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Kaplan-Meier Estimate"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Middle Aged"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Neoplasm Metastasis"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Neoplasm Staging"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Patient Outcome Assessment"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Prognosis"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Proportional Hazards Models"}, {"IS_Major": false, "IS_Mesh": true, "Text": "SEER Program"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Survival Analysis"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Young Adult"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Breast cancer"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Metastatic sites"}, {"IS_Major": false, "IS_Mesh": false, "Text": "SEER"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Survival outcomes"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "MEDLINE", "Article": {"@PubModel": "Electronic", "Abstract": {"AbstractText": [{"#text": "The features and survival of stage IV breast cancer patients with different metastatic sites are poorly understood. This study aims to examine the clinicopathological features and survival of stage IV breast cancer patients according to different metastatic sites.", "@Label": "BACKGROUND", "@NlmCategory": "BACKGROUND"}, {"#text": "Using the Surveillance, Epidemiology, and End Results database, we restricted our study population to stage IV breast cancer patients diagnosed between 2010 to 2015. The clinicopathological features were examined by chi-square tests. Breast cancer-specific survival (BCSS) and overall survival (OS) were compared among patients with different metastatic sites by the Kaplan-Meier method with log-rank test. Univariable and multivariable analyses were also performed using the Cox proportional hazard model to identify statistically significant prognostic factors.", "@Label": "METHODS", "@NlmCategory": "METHODS"}, {"#text": "A total of 18,322 patients were identified for survival analysis. Bone-only metastasis accounted for 39.80% of patients, followed by multiple metastasis (33.07%), lung metastasis (10.94%), liver metastasis (7.34%), other metastasis (7.34%), and brain metastasis (1.51%). The Kaplan-Meier plots showed that patients with bone metastasis had the best survival, while patients with brain metastasis had the worst survival in both BCSS and OS (p\u2009<\u20090.001, for both). Multivariable analyses showed that age, race, marital status, grade, tumor subtype, tumor size, surgery of primary cancer, and a history of radiotherapy or chemotherapy were independent prognostic factors.", "@Label": "RESULTS", "@NlmCategory": "RESULTS"}, {"#text": "Stage IV breast cancer patients have different clinicopathological characteristics and survival outcomes according to different metastatic sites. Patients with bone metastasis have the best prognosis, and brain metastasis is the most aggressive subgroup.", "@Label": "CONCLUSION", "@NlmCategory": "CONCLUSIONS"}]}, "ArticleDate": {"@DateType": "Electronic", "Day": "12", "Month": "11", "Year": "2019"}, "ArticleTitle": "The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, 710061, Shaanxi, China."}, {"Affiliation": "Institute for Cell Engineering, The Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA."}], "ForeName": "Ru", "Initials": "R", "LastName": "Wang"}, {"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Institute for Cell Engineering, The Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA."}, {"Affiliation": "Liver Cancer Institute, Zhongshan Hospital, and Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University, 180 Fenglin Road, Shanghai, 200032, China."}], "ForeName": "Yayun", "Initials": "Y", "LastName": "Zhu"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, 710061, Shaanxi, China."}, "ForeName": "Xiaoxu", "Initials": "X", "LastName": "Liu"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, 710061, Shaanxi, China."}, "ForeName": "Xiaoqin", "Initials": "X", "LastName": "Liao"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, 710061, Shaanxi, China."}, "ForeName": "Jianjun", "Initials": "J", "LastName": "He"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, 710061, Shaanxi, China. chinanlg@163.com."}, "ForeName": "Ligang", "Identifier": {"#text": "0000-0003-3612-928X", "@Source": "ORCID"}, "Initials": "L", "LastName": "Niu"}]}, "ELocationID": [{"#text": "1091", "@EIdType": "pii", "@ValidYN": "Y"}, {"#text": "10.1186/s12885-019-6311-z", "@EIdType": "doi", "@ValidYN": "Y"}], "Journal": {"ISOAbbreviation": "BMC Cancer", "ISSN": {"#text": "1471-2407", "@IssnType": "Electronic"}, "JournalIssue": {"@CitedMedium": "Internet", "Issue": "1", "PubDate": {"Day": "12", "Month": "Nov", "Year": "2019"}, "Volume": "19"}, "Title": "BMC cancer"}, "Language": "eng", "Pagination": {"MedlinePgn": "1091", "StartPage": "1091"}, "PublicationTypeList": {"PublicationType": {"#text": "Journal Article", "@UI": "D016428"}}}, "CitationSubset": "IM", "CoiStatement": "The authors declare that they have no competing interests.", "DateCompleted": {"Day": "30", "Month": "03", "Year": "2020"}, "DateRevised": {"Day": "30", "Month": "03", "Year": "2020"}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"#text": "Breast cancer", "@MajorTopicYN": "N"}, {"#text": "Metastatic sites", "@MajorTopicYN": "N"}, {"#text": "SEER", "@MajorTopicYN": "N"}, {"#text": "Survival outcomes", "@MajorTopicYN": "N"}]}, "MedlineJournalInfo": {"Country": "England", "ISSNLinking": "1471-2407", "MedlineTA": "BMC Cancer", "NlmUniqueID": "100967800"}, "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"#text": "Adult", "@MajorTopicYN": "N", "@UI": "D000328"}}, {"DescriptorName": {"#text": "Aged", "@MajorTopicYN": "N", "@UI": "D000368"}}, {"DescriptorName": {"#text": "Aged, 80 and over", "@MajorTopicYN": "N", "@UI": "D000369"}}, {"DescriptorName": {"#text": "Breast Neoplasms", "@MajorTopicYN": "N", "@UI": "D001943"}, "QualifierName": [{"#text": "epidemiology", "@MajorTopicYN": "N", "@UI": "Q000453"}, {"#text": "mortality", "@MajorTopicYN": "Y", "@UI": "Q000401"}, {"#text": "pathology", "@MajorTopicYN": "Y", "@UI": "Q000473"}, {"#text": "therapy", "@MajorTopicYN": "N", "@UI": "Q000628"}]}, {"DescriptorName": {"#text": "Female", "@MajorTopicYN": "N", "@UI": "D005260"}}, {"DescriptorName": {"#text": "Humans", "@MajorTopicYN": "N", "@UI": "D006801"}}, {"DescriptorName": {"#text": "Kaplan-Meier Estimate", "@MajorTopicYN": "N", "@UI": "D053208"}}, {"DescriptorName": {"#text": "Middle Aged", "@MajorTopicYN": "N", "@UI": "D008875"}}, {"DescriptorName": {"#text": "Neoplasm Metastasis", "@MajorTopicYN": "N", "@UI": "D009362"}}, {"DescriptorName": {"#text": "Neoplasm Staging", "@MajorTopicYN": "N", "@UI": "D009367"}}, {"DescriptorName": {"#text": "Patient Outcome Assessment", "@MajorTopicYN": "N", "@UI": "D063868"}}, {"DescriptorName": {"#text": "Prognosis", "@MajorTopicYN": "N", "@UI": "D011379"}}, {"DescriptorName": {"#text": "Proportional Hazards Models", "@MajorTopicYN": "N", "@UI": "D016016"}}, {"DescriptorName": {"#text": "SEER Program", "@MajorTopicYN": "N", "@UI": "D018426"}}, {"DescriptorName": {"#text": "Survival Analysis", "@MajorTopicYN": "N", "@UI": "D016019"}}, {"DescriptorName": {"#text": "Young Adult", "@MajorTopicYN": "N", "@UI": "D055815"}}]}, "PMID": {"#text": "31718602", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "31718602", "@IdType": "pubmed"}, {"#text": "PMC6852913", "@IdType": "pmc"}, {"#text": "10.1186/s12885-019-6311-z", "@IdType": "doi"}, {"#text": "10.1186/s12885-019-6311-z", "@IdType": "pii"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "received", "Day": "7", "Month": "7", "Year": "2019"}, {"@PubStatus": "accepted", "Day": "30", "Month": "10", "Year": "2019"}, {"@PubStatus": "entrez", "Day": "14", "Hour": "6", "Minute": "0", "Month": "11", "Year": "2019"}, {"@PubStatus": "pubmed", "Day": "14", "Hour": "6", "Minute": "0", "Month": "11", "Year": "2019"}, {"@PubStatus": "medline", "Day": "31", "Hour": "6", "Minute": "0", "Month": "3", "Year": "2020"}]}, "PublicationStatus": "epublish", "ReferenceList": {"Reference": [{"ArticleIdList": {"ArticleId": [{"#text": "10.3322/caac.21492", "@IdType": "doi"}, {"#text": "30207593", "@IdType": "pubmed"}]}, "Citation": "Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424. doi: 10.3322/caac.21492."}, {"ArticleIdList": {"ArticleId": {"#text": "31577379", "@IdType": "pubmed"}}, "Citation": "DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Goding Sauer A, Jemal A, Siegel RL. Breast cancer statistics, 2019. CA Cancer J Clin:2019."}, {"Citation": "Noone AMHN, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA, editors. SEER Cancer statistics review, 1975\u20132015: National Cancer Institute; 2018."}, {"Citation": "Howlader NNA, Krapcho M. SEER Fast Stats, 1975-2014. Stage Distrib. 2018:2005\u201314."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/1055-9965.EPI-16-0889", "@IdType": "doi"}, {"#text": "PMC5833304", "@IdType": "pmc"}, {"#text": "28522448", "@IdType": "pubmed"}]}, "Citation": "Mariotto AB, Etzioni R, Hurlbert M, Penberthy L, Mayer M. Estimation of the number of women living with metastatic breast Cancer in the United States. Cancer Epidemiol Biomarkers Prev. 2017;26(6):809\u2013815. doi: 10.1158/1055-9965.EPI-16-0889."}, {"ArticleIdList": {"ArticleId": {"#text": "28500107", "@IdType": "pubmed"}}, "Citation": "Peart O. Metastatic breast Cancer. Radiol Technol. 2017;88(5):519M\u2013539M."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1200/JCO.2009.25.9820", "@IdType": "doi"}, {"#text": "20498394", "@IdType": "pubmed"}]}, "Citation": "Kennecke H, Yerushalmi R, Woods R, Cheang MCU, Voduc D, Speers CH, Nielsen TO, Gelmon K. Metastatic behavior of breast Cancer subtypes. J Clin Oncol. 2010;28(20):3271\u20133277. doi: 10.1200/JCO.2009.25.9820."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s10549-013-2711-y", "@IdType": "doi"}, {"#text": "24104881", "@IdType": "pubmed"}]}, "Citation": "Lobbezoo DJ, van Kampen RJ, Voogd AC, Dercksen MW, van den Berkmortel F, Smilde TJ, van de Wouw AJ, Peters FP, van Riel JM, Peters NA, et al. Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome. Breast Cancer Res Treat. 2013;141(3):507\u2013514. doi: 10.1007/s10549-013-2711-y."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/annonc/mdn424", "@IdType": "doi"}, {"#text": "PMC2733115", "@IdType": "pmc"}, {"#text": "18641006", "@IdType": "pubmed"}]}, "Citation": "Largillier R, Ferrero JM, Doyen J, Barriere J, Namer M, Mari V, Courdi A, Hannoun-Levi JM, Ettore F, Birtwisle-Peyrottes I, et al. Prognostic factors in 1,038 women with metastatic breast cancer. Ann Oncol. 2008;19(12):2012\u20132019. doi: 10.1093/annonc/mdn424."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/S1470-2045(14)71116-7", "@IdType": "doi"}, {"#text": "PMC4465353", "@IdType": "pmc"}, {"#text": "25846097", "@IdType": "pubmed"}]}, "Citation": "Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173\u2013e180. doi: 10.1016/S1470-2045(14)71116-7."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1023/A:1023002322935", "@IdType": "doi"}, {"#text": "12749723", "@IdType": "pubmed"}]}, "Citation": "Wingo PAJP, Hiatt RA. Building the infrastructure for nationwide cancer surveillance and control\u2013a comparison between the National Program of Cancer registries (NPCR) and the surveillance, epidemiology, and end results (SEER) program (United States) Cancer Causes Control. 2003;14:175\u2013193. doi: 10.1023/A:1023002322935."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s10585-015-9697-2", "@IdType": "doi"}, {"#text": "25630269", "@IdType": "pubmed"}]}, "Citation": "Gerratana L, Fanotto V, Bonotto M, Bolzonello S, Minisini AM, Fasola G, Puglisi F. Pattern of metastasis and outcome in patients with breast cancer. Clin Exp Metastasis. 2015;32(2):125\u2013133. doi: 10.1007/s10585-015-9697-2."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5216993", "@IdType": "pmc"}, {"#text": "27322074", "@IdType": "pubmed"}]}, "Citation": "Wu SG, Sun JY, Yang LC, Tang LY, Wang X, Chen XT, Liu GH, Lin HX, Lin Q, He ZY. Patterns of distant metastasis in Chinese women according to breast cancer subtypes. Oncotarget. 2016;7(30):47975\u201347984."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s10549-016-3782-3", "@IdType": "doi"}, {"#text": "27083181", "@IdType": "pubmed"}]}, "Citation": "Liede A, Jerzak KJ, Hernandez RK, Wade SW, Sun P, Narod SA. The incidence of bone metastasis after early-stage breast cancer in Canada. Breast Cancer Res Treat. 2016;156(3):587\u2013595. doi: 10.1007/s10549-016-3782-3."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.clbc.2014.06.007", "@IdType": "doi"}, {"#text": "25258308", "@IdType": "pubmed"}]}, "Citation": "Kai M, Kogawa T, Liu DD, Fouad TM, Kai K, Niikura N, Hsu L, Willey JS, Theriault RL, Valero V, et al. Clinical characteristics and outcome of bone-only metastasis in inflammatory and noninflammatory breast cancers. Clin Breast Cancer. 2015;15(1):37\u201342. doi: 10.1016/j.clbc.2014.06.007."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/1477-7819-10-4", "@IdType": "doi"}, {"#text": "PMC3286379", "@IdType": "pmc"}, {"#text": "22226178", "@IdType": "pubmed"}]}, "Citation": "Park HS, Kim S, Kim K, Yoo H, Chae BJ, Bae JS, Song BJ, Jung SS. Pattern of distant recurrence according to the molecular subtypes in Korean women with breast cancer. World J Surg Oncol. 2012;10:4. doi: 10.1186/1477-7819-10-4."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1001/jamaoncol.2017.0001", "@IdType": "doi"}, {"#text": "PMC5824221", "@IdType": "pmc"}, {"#text": "28301662", "@IdType": "pubmed"}]}, "Citation": "Martin AM, Cagney DN, Catalano PJ, Warren LE, Bellon JR, Punglia RS, Claus EB, Lee EQ, Wen PY, Haas-Kogan DA, et al. Brain metastases in newly diagnosed breast Cancer: a population-based study. JAMA Oncol. 2017;3(8):1069\u20131077. doi: 10.1001/jamaoncol.2017.0001."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/modpathol.3800830", "@IdType": "doi"}, {"#text": "17541441", "@IdType": "pubmed"}]}, "Citation": "Gaedcke J, Traub F, Milde S, Wilkens L, Stan A, Ostertag H, Christgen M, von Wasielewski R, Kreipe HH. Predominance of the basal type and HER-2/neu type in brain metastasis from breast cancer. Mod Pathol. 2007;20(8):864\u2013870. doi: 10.1038/modpathol.3800830."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s10549-015-3341-3", "@IdType": "doi"}, {"#text": "25783184", "@IdType": "pubmed"}]}, "Citation": "Kast K, Link T, Friedrich K, Petzold A, Niedostatek A, Schoffer O, Werner C, Klug SJ, Werner A, Gatzweiler A, et al. Impact of breast cancer subtypes and patterns of metastasis on outcome. Breast Cancer Res Treat. 2015;150(3):621\u2013629. doi: 10.1007/s10549-015-3341-3."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s10585-016-9824-8", "@IdType": "doi"}, {"#text": "27718076", "@IdType": "pubmed"}]}, "Citation": "Ording AG, Heide-Jorgensen U, Christiansen CF, Norgaard M, Acquavella J, Sorensen HT. Site of metastasis and breast cancer mortality: a Danish nationwide registry-based cohort study. Clin Exp Metastasis. 2017;34(1):93\u2013101. doi: 10.1007/s10585-016-9824-8."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.clineuro.2013.07.030", "@IdType": "doi"}, {"#text": "23954201", "@IdType": "pubmed"}]}, "Citation": "Gerdan L, Segedin B, Nagy V, Khoa MT, Trang NT, Schild SE, Rades D. The number of involved extracranial organs: a new predictor of survival in breast cancer patients with brain metastasis. Clin Neurol Neurosurg. 2013;115(10):2108\u20132110. doi: 10.1016/j.clineuro.2013.07.030."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41586-019-1007-8", "@IdType": "doi"}, {"#text": "PMC6647838", "@IdType": "pmc"}, {"#text": "30867590", "@IdType": "pubmed"}]}, "Citation": "Rueda OM, Sammut SJ, Seoane JA, Chin SF, Caswell-Jin JL, Callari M, Batra R, Pereira B, Bruna A, Ali HR, et al. Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups. Nature. 2019;567(7748):399\u2013404. doi: 10.1038/s41586-019-1007-8."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5905205", "@IdType": "pmc"}, {"#text": "29475920", "@IdType": "pubmed"}]}, "Citation": "Yamamura J, Kamigaki S, Fujita J, Osato H, Komoike Y. The difference in prognostic outcomes between De novo stage IV and recurrent metastatic patients with hormone receptor-positive, HER2-negative breast Cancer. In Vivo. 2018;32(2):353\u2013358."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1067/msy.2002.127544", "@IdType": "doi"}, {"#text": "12407345", "@IdType": "pubmed"}]}, "Citation": "Khan SA, Stewart AK, Morrow M. Does aggressive local therapy improve survival in metastatic breast cancer? Surgery. 2002;132(4):620\u2013626. doi: 10.1067/msy.2002.127544."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.eururo.2014.05.034", "@IdType": "doi"}, {"#text": "24931622", "@IdType": "pubmed"}]}, "Citation": "Heng DY, Wells JC, Rini BI, Beuselinck B, Lee JL, Knox JJ, Bjarnason GA, Pal SK, Kollmannsberger CK, Yuasa T, et al. Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the international metastatic renal cell carcinoma database consortium. Eur Urol. 2014;66(4):704\u2013710. doi: 10.1016/j.eururo.2014.05.034."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.surg.2015.05.042", "@IdType": "doi"}, {"#text": "PMC4688058", "@IdType": "pmc"}, {"#text": "26453135", "@IdType": "pubmed"}]}, "Citation": "Keutgen XM, Nilubol N, Glanville J, Sadowski SM, Liewehr DJ, Venzon DJ, Steinberg SM, Kebebew E. Resection of primary tumor site is associated with prolonged survival in metastatic nonfunctioning pancreatic neuroendocrine tumors. Surgery. 2016;159(1):311\u2013318. doi: 10.1016/j.surg.2015.05.042."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1080/17474124.2017.1259563", "@IdType": "doi"}, {"#text": "27830958", "@IdType": "pubmed"}]}, "Citation": "Abdel-Rahman O. Role of liver-directed local tumor therapy in the management of hepatocellular carcinoma with extrahepatic metastases: a SEER database analysis. Expert Rev Gastroenterol Hepatol. 2017;11(2):183\u2013189. doi: 10.1080/17474124.2017.1259563."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/1471-2482-12-5", "@IdType": "doi"}, {"#text": "PMC3348008", "@IdType": "pmc"}, {"#text": "22469291", "@IdType": "pubmed"}]}, "Citation": "Ruiterkamp J, Voogd AC, Tjan-Heijnen VC, Bosscha K, van der Linden YM, Rutgers EJ, Boven E, van der Sangen MJ, Ernst MF, Dutch breast Cancer Trialists G SUBMIT: systemic therapy with or without up front surgery of the primary tumor in breast cancer patients with distant metastases at initial presentation. BMC Surg. 2012;12:5. doi: 10.1186/1471-2482-12-5."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/S1470-2045(15)00135-7", "@IdType": "doi"}, {"#text": "26363985", "@IdType": "pubmed"}]}, "Citation": "Badwe R, Hawaldar R, Nair N, Kaushik R, Parmar V, Siddique S, Budrukkar A, Mittra I, Gupta S. Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial. Lancet Oncol. 2015;16(13):1380\u20131388. doi: 10.1016/S1470-2045(15)00135-7."}, {"ArticleIdList": {"ArticleId": {"#text": "10.1200/JCO.2016.34.15_suppl.1005", "@IdType": "doi"}}, "Citation": "Soran A, Ozmen V, Ozbas S, Karanlik H, Muslumanoglu M, Igci A, Canturk Z, Utkan Z, Ozaslan C, Evrensel T, et al. A randomized controlled trial evaluating resection of the primary breast tumor in women presenting with de novo stage IV breast cancer: Turkish Study (Protocol MF07\u201301) J Clin Oncol. 2016;34(15_suppl):1005. doi: 10.1200/JCO.2016.34.15_suppl.1005."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/bjc.2015.127", "@IdType": "doi"}, {"#text": "PMC4453676", "@IdType": "pmc"}, {"#text": "25880008", "@IdType": "pubmed"}]}, "Citation": "Lobbezoo DJ, van Kampen RJ, Voogd AC, Dercksen MW, van den Berkmortel F, Smilde TJ, van de Wouw AJ, Peters FP, van Riel JM, Peters NA, et al. Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer? Br J Cancer. 2015;112(9):1445\u20131451. doi: 10.1038/bjc.2015.127."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/S0140-6736(02)09454-0", "@IdType": "doi"}, {"#text": "12133652", "@IdType": "pubmed"}]}, "Citation": "Cancer CGoHFiB Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50\u2008302 women with breast cancer and 96\u2008973 women without the disease. Lancet. 2002;360(9328):187\u2013195. doi: 10.1016/S0140-6736(02)09454-0."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/bcr2212", "@IdType": "doi"}, {"#text": "PMC2656904", "@IdType": "pmc"}, {"#text": "19087323", "@IdType": "pubmed"}]}, "Citation": "Orgeas CC, Hall P, Rosenberg LU, Czene K. The influence of menstrual risk factors on tumor characteristics and survival in postmenopausal breast cancer. Breast Cancer Res. 2008;10(6):R107. doi: 10.1186/bcr2212."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s10549-006-9346-1", "@IdType": "doi"}, {"#text": "17004111", "@IdType": "pubmed"}]}, "Citation": "Trivers KF, Gammon MD, Abrahamson PE, Lund MJ, Flagg EW, Kaufman JS, Moorman PG, Cai J, Olshan AF, Porter PL, et al. Association between reproductive factors and breast cancer survival in younger women. Breast Cancer Res Treat. 2007;103(1):93\u2013102. doi: 10.1007/s10549-006-9346-1."}]}}}}}, "PMC": "PMC6852913", "PMID": "31718602", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "5": {"Abstract": "Epigenetic changes can be defined as stable molecular alterations of a cellular phenotype such as the gene expression profile of a cell that are heritable during somatic cell divisions (and sometimes germ line transmissions) but do not involve changes of the DNA sequence itself. Epigenetic phenomena are mediated by several molecular mechanisms comprising histone modifications, polycomb/trithorax protein complexes, small non-coding or antisense RNAs and DNA methylation. These different modifications are closely interconnected. Epigenetic regulation is critical in normal growth and development and closely conditions the transcriptional potential of genes. Epigenetic mechanisms convey genomic adaption to an environment thereby ultimately contributing towards given phenotype. In this review we will describe the various aspects of epigenetics and in particular DNA methylation in breast carcinogenesis and their potential application for diagnosis, prognosis and treatment decision.", "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "6962879241719379452", "Part1": "Department for Clinical Molecular Biology (EpiGen)", "Part2": "Institute for Clinical Medicine", "Part3": "Akershus University Hospital", "Part4": "University of Oslo", "Part5": "Norway.", "Part6": null, "Text": "Department for Clinical Molecular Biology (EpiGen), Institute for Clinical Medicine, Akershus University Hospital, University of Oslo, Norway."}], "ForeName": "Jovana", "FullName": "Jovana Jovanovic", "HashID": "1908411844861672727", "LastName": "Jovanovic", "ORCID": null}, {"Affiliations": null, "ForeName": "Jo Anders", "FullName": "Jo Anders R\u00f8nneberg", "HashID": "-9057785195478677204", "LastName": "R\u00f8nneberg", "ORCID": null}, {"Affiliations": null, "ForeName": "J\u00f6rg", "FullName": "J\u00f6rg Tost", "HashID": "-2285866463497458192", "LastName": "Tost", "ORCID": null}, {"Affiliations": null, "ForeName": "Vessela", "FullName": "Vessela Kristensen", "HashID": "-4121958819356710202", "LastName": "Kristensen", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.1016/j.molonc.2010.04.002", "InsertType": null, "Journal": "Molecular oncology", "Keywords": [{"IS_Major": false, "IS_Mesh": true, "Text": "Biomarkers, Tumor"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Breast Neoplasms"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Chromatin"}, {"IS_Major": false, "IS_Mesh": true, "Text": "DNA"}, {"IS_Major": false, "IS_Mesh": true, "Text": "DNA Methylation"}, {"IS_Major": false, "IS_Mesh": true, "Text": "DNA Modification Methylases"}, {"IS_Major": true, "IS_Mesh": true, "Text": "Epigenesis, Genetic"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Female"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Gene Expression Regulation, Neoplastic"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Histones"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Humans"}, {"IS_Major": false, "IS_Mesh": true, "Text": "MicroRNAs"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Molecular Structure"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Prognosis"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Receptors, Estrogen"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "MEDLINE", "Article": {"@PubModel": "Print-Electronic", "Abstract": {"AbstractText": "Epigenetic changes can be defined as stable molecular alterations of a cellular phenotype such as the gene expression profile of a cell that are heritable during somatic cell divisions (and sometimes germ line transmissions) but do not involve changes of the DNA sequence itself. Epigenetic phenomena are mediated by several molecular mechanisms comprising histone modifications, polycomb/trithorax protein complexes, small non-coding or antisense RNAs and DNA methylation. These different modifications are closely interconnected. Epigenetic regulation is critical in normal growth and development and closely conditions the transcriptional potential of genes. Epigenetic mechanisms convey genomic adaption to an environment thereby ultimately contributing towards given phenotype. In this review we will describe the various aspects of epigenetics and in particular DNA methylation in breast carcinogenesis and their potential application for diagnosis, prognosis and treatment decision.", "CopyrightInformation": "(c) 2010. Published by Elsevier B.V."}, "ArticleDate": {"@DateType": "Electronic", "Day": "29", "Month": "04", "Year": "2010"}, "ArticleTitle": "The epigenetics of breast cancer.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department for Clinical Molecular Biology (EpiGen), Institute for Clinical Medicine, Akershus University Hospital, University of Oslo, Norway."}, "ForeName": "Jovana", "Initials": "J", "LastName": "Jovanovic"}, {"@ValidYN": "Y", "ForeName": "Jo Anders", "Initials": "JA", "LastName": "R\u00f8nneberg"}, {"@ValidYN": "Y", "ForeName": "J\u00f6rg", "Initials": "J", "LastName": "Tost"}, {"@ValidYN": "Y", "ForeName": "Vessela", "Initials": "V", "LastName": "Kristensen"}]}, "ELocationID": {"#text": "10.1016/j.molonc.2010.04.002", "@EIdType": "doi", "@ValidYN": "Y"}, "Journal": {"ISOAbbreviation": "Mol Oncol", "ISSN": {"#text": "1878-0261", "@IssnType": "Electronic"}, "JournalIssue": {"@CitedMedium": "Internet", "Issue": "3", "PubDate": {"Month": "Jun", "Year": "2010"}, "Volume": "4"}, "Title": "Molecular oncology"}, "Language": "eng", "Pagination": {"EndPage": "254", "MedlinePgn": "242-54", "StartPage": "242"}, "PublicationTypeList": {"PublicationType": [{"#text": "Journal Article", "@UI": "D016428"}, {"#text": "Research Support, Non-U.S. Gov't", "@UI": "D013485"}, {"#text": "Review", "@UI": "D016454"}]}}, "ChemicalList": {"Chemical": [{"NameOfSubstance": {"#text": "Biomarkers, Tumor", "@UI": "D014408"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "Chromatin", "@UI": "D002843"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "Histones", "@UI": "D006657"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "MicroRNAs", "@UI": "D035683"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "Receptors, Estrogen", "@UI": "D011960"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "DNA", "@UI": "D004247"}, "RegistryNumber": "9007-49-2"}, {"NameOfSubstance": {"#text": "DNA Modification Methylases", "@UI": "D015254"}, "RegistryNumber": "EC 2.1.1.-"}]}, "CitationSubset": "IM", "DateCompleted": {"Day": "08", "Month": "10", "Year": "2010"}, "DateRevised": {"Day": "30", "Month": "03", "Year": "2022"}, "MedlineJournalInfo": {"Country": "United States", "ISSNLinking": "1574-7891", "MedlineTA": "Mol Oncol", "NlmUniqueID": "101308230"}, "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"#text": "Biomarkers, Tumor", "@MajorTopicYN": "N", "@UI": "D014408"}, "QualifierName": {"#text": "metabolism", "@MajorTopicYN": "N", "@UI": "Q000378"}}, {"DescriptorName": {"#text": "Breast Neoplasms", "@MajorTopicYN": "N", "@UI": "D001943"}, "QualifierName": [{"#text": "diagnosis", "@MajorTopicYN": "N", "@UI": "Q000175"}, {"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}, {"#text": "pathology", "@MajorTopicYN": "N", "@UI": "Q000473"}, {"#text": "therapy", "@MajorTopicYN": "N", "@UI": "Q000628"}]}, {"DescriptorName": {"#text": "Chromatin", "@MajorTopicYN": "N", "@UI": "D002843"}, "QualifierName": [{"#text": "chemistry", "@MajorTopicYN": "N", "@UI": "Q000737"}, {"#text": "metabolism", "@MajorTopicYN": "N", "@UI": "Q000378"}]}, {"DescriptorName": {"#text": "DNA", "@MajorTopicYN": "N", "@UI": "D004247"}, "QualifierName": [{"#text": "chemistry", "@MajorTopicYN": "N", "@UI": "Q000737"}, {"#text": "metabolism", "@MajorTopicYN": "N", "@UI": "Q000378"}]}, {"DescriptorName": {"#text": "DNA Methylation", "@MajorTopicYN": "N", "@UI": "D019175"}}, {"DescriptorName": {"#text": "DNA Modification Methylases", "@MajorTopicYN": "N", "@UI": "D015254"}, "QualifierName": {"#text": "metabolism", "@MajorTopicYN": "N", "@UI": "Q000378"}}, {"DescriptorName": {"#text": "Epigenesis, Genetic", "@MajorTopicYN": "Y", "@UI": "D044127"}}, {"DescriptorName": {"#text": "Female", "@MajorTopicYN": "N", "@UI": "D005260"}}, {"DescriptorName": {"#text": "Gene Expression Regulation, Neoplastic", "@MajorTopicYN": "N", "@UI": "D015972"}}, {"DescriptorName": {"#text": "Histones", "@MajorTopicYN": "N", "@UI": "D006657"}, "QualifierName": {"#text": "metabolism", "@MajorTopicYN": "N", "@UI": "Q000378"}}, {"DescriptorName": {"#text": "Humans", "@MajorTopicYN": "N", "@UI": "D006801"}}, {"DescriptorName": {"#text": "MicroRNAs", "@MajorTopicYN": "N", "@UI": "D035683"}, "QualifierName": [{"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}, {"#text": "metabolism", "@MajorTopicYN": "N", "@UI": "Q000378"}]}, {"DescriptorName": {"#text": "Molecular Structure", "@MajorTopicYN": "N", "@UI": "D015394"}}, {"DescriptorName": {"#text": "Prognosis", "@MajorTopicYN": "N", "@UI": "D011379"}}, {"DescriptorName": {"#text": "Receptors, Estrogen", "@MajorTopicYN": "N", "@UI": "D011960"}, "QualifierName": [{"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}, {"#text": "metabolism", "@MajorTopicYN": "N", "@UI": "Q000378"}]}]}, "PMID": {"#text": "20627830", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "20627830", "@IdType": "pubmed"}, {"#text": "PMC5527941", "@IdType": "pmc"}, {"#text": "10.1016/j.molonc.2010.04.002", "@IdType": "doi"}, {"#text": "S1574-7891(10)00024-4", "@IdType": "pii"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "received", "Day": "14", "Month": "3", "Year": "2010"}, {"@PubStatus": "revised", "Day": "23", "Month": "3", "Year": "2010"}, {"@PubStatus": "accepted", "Day": "2", "Month": "4", "Year": "2010"}, {"@PubStatus": "entrez", "Day": "15", "Hour": "6", "Minute": "0", "Month": "7", "Year": "2010"}, {"@PubStatus": "pubmed", "Day": "16", "Hour": "6", "Minute": "0", "Month": "7", "Year": "2010"}, {"@PubStatus": "medline", "Day": "12", "Hour": "6", "Minute": "0", "Month": "10", "Year": "2010"}]}, "PublicationStatus": "ppublish", "ReferenceList": {"Reference": [{"ArticleIdList": {"ArticleId": [{"#text": "PMC2880427", "@IdType": "pmc"}, {"#text": "20078854", "@IdType": "pubmed"}]}, "Citation": "Aaroe, J. , Lindahl, T. , Dumeaux, V. , Saebo, S. , Tobin, D. , Hagen, N. , 2010. Gene expression profiling of peripheral blood cells for early detection of breast cancer. Breast Cancer Res. 12, R7"}, {"ArticleIdList": {"ArticleId": {"#text": "11427539", "@IdType": "pubmed"}}, "Citation": "Bachman, K.E. , Rountree, M.R. , Baylin, S.B. , 2001. Dnmt3a and Dnmt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin. J. Biol. Chem. 276, 32282\u201332287."}, {"ArticleIdList": {"ArticleId": {"#text": "15447983", "@IdType": "pubmed"}}, "Citation": "Bae, Y.K. , Brown, A. , Garrett, E. , Bornman, D. , Fackler, M.J. , Sukumar, S. , 2004. Hypermethylation in histologically distinct classes of breast cancer. Clin. Cancer Res. 10, 5998\u20136005."}, {"ArticleIdList": {"ArticleId": {"#text": "16491070", "@IdType": "pubmed"}}, "Citation": "Baylin, S.B. , Ohm, J.E. , 2006. Epigenetic gene silencing in cancer-mechanism for early oncogenic pathway addiction?. Nat. Rev. Cancer. 6, 107\u2013116."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3901992", "@IdType": "pmc"}, {"#text": "19459041", "@IdType": "pubmed"}]}, "Citation": "Billam, M. , Sobolewski, M.D. , Davidson, N.E. , 2009. Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells. Breast Cancer Res. Treat. 120, 581\u2013592."}, {"ArticleIdList": {"ArticleId": {"#text": "11782440", "@IdType": "pubmed"}}, "Citation": "Bird, A. , 2002. DNA methylation patterns and epigenetic memory. Genes Dev. 16, 6\u201321."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2532972", "@IdType": "pmc"}, {"#text": "18780791", "@IdType": "pubmed"}]}, "Citation": "Bloushtain-Qimron, N. , Yao, J. , Snyder, E.L. , Shipitsin, M. , Campbell, L.L. , Mani, S.A. , Hu, M. , Chen, H. , Ustyansky, V. , Antosiewicz, J.E. , Argani, P. , Halushka, M.K. , Thomson, J.A. , Pharoah, P. , Porgador, A. , Sukumar, S. , Parsons, R. , Richardson, A.L. , Stampfer, M.R. , Gelman, R.S. , Nikolskaya, T. , Nikolsky, Y. , Polyak, K. , 2008. Cell type-specific DNA methylation patterns in the human breast. Proc. Natl. Acad. Sci. U.S.A. 105, 14076\u201314081."}, {"ArticleIdList": {"ArticleId": {"#text": "16955068", "@IdType": "pubmed"}}, "Citation": "Bolden, J.E. , Peart, M.J. , Johnstone, R.W. , 2006. Anticancer activities of histone deacetylase inhibitors. Nat. Rev. Drug Discov. 5, 769\u2013784."}, {"ArticleIdList": {"ArticleId": {"#text": "15491775", "@IdType": "pubmed"}}, "Citation": "Brueckner, B. , Lyko, F. , 2004. DNA methyltransferase inhibitors: old and new drugs for epigenetic cancer therapy. Trends Pharmacol. Sci. 25, 551\u2013554."}, {"ArticleIdList": {"ArticleId": {"#text": "16356834", "@IdType": "pubmed"}}, "Citation": "Chekhun, V.F. , Kulik, G.I. , Yurchenko, O.V. , Tryndyak, V.P. , Todor, I.N. , Luniv, L.S. , 2006. Role of DNA hypomethylation in the development of the resistance to doxorubicin in human MCF-7 breast adenocarcinoma cells. Cancer Lett. 231, 87\u201393."}, {"ArticleIdList": {"ArticleId": {"#text": "17363502", "@IdType": "pubmed"}}, "Citation": "Chekhun, V.F. , Lukyanova, N.Y. , Kovalchuk, O. , Tryndyak, V.P. , Pogribny, I.P. , 2007. Epigenetic profiling of multidrug-resistant human MCF-7 breast adenocarcinoma cells reveals novel hyper- and hypomethylated targets. Mol. Cancer Ther. 6, 1089\u20131098."}, {"ArticleIdList": {"ArticleId": {"#text": "15867352", "@IdType": "pubmed"}}, "Citation": "Cicek, M. , Fukuyama, R. , Welch, D.R. , Sizemore, N. , Casey, G. , 2005. Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity. Cancer Res. 65, 3586\u20133595."}, {"ArticleIdList": {"ArticleId": {"#text": "10888881", "@IdType": "pubmed"}}, "Citation": "Dammann, R. , Li, C. , Yoon, J.H. , Chin, P.L. , Bates, S. , Pfeifer, G.P. , 2000. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat. Genet. 25, 315\u2013319."}, {"ArticleIdList": {"ArticleId": {"#text": "11306494", "@IdType": "pubmed"}}, "Citation": "Dammann, R. , Yang, G. , Pfeifer, G.P. , 2001. Hypermethylation of the cpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers. Cancer Res. 61, 3105\u20133109."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC1220459", "@IdType": "pmc"}, {"#text": "10455009", "@IdType": "pubmed"}]}, "Citation": "D'Amours, D. , Desnoyers, S. , D'Silva, I. , 1999. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem. J. 342, 242\u2013268."}, {"Citation": "De Murcia, G. , Shall, S. , 2000. From DNA Damage and Stress Signaling to Cell Death: Poly ADP-ribosylation Reactions Oxford University Press;"}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC416434", "@IdType": "pmc"}, {"#text": "15143172", "@IdType": "pubmed"}]}, "Citation": "De Smet, C. , Loriot, A. , Boon, T. , 2004. Promoter-dependent mechanism leading to selective hypomethylation within the 5\u2032 region of gene MAGE-A1 in tumor cells. Mol. Cell. Biol. 24, 4781\u20134790."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2861056", "@IdType": "pmc"}, {"#text": "20338046", "@IdType": "pubmed"}]}, "Citation": "Dejeux, E. , R\u00f8nneberg, J.A. , Solvang, H. , Bukholm, I. , Geisler, S. , Aas, T. , Gut, I.G. , B\u00f8rresen-Dale, A.L. , L\u00f8nning, P.E. , Kristensen, V.N. , Tost, J. , 2010. DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response. Mol. Cancer. 9, 68"}, {"ArticleIdList": {"ArticleId": {"#text": "15705865", "@IdType": "pubmed"}}, "Citation": "DeWald, D.B. , Torabinejad, J. , Samant, R.S. , Johnston, D. , Erin, N. , Shope, J.C. , 2005. Metastasis suppression by breast cancer metastasis suppressor 1 involves reduction of phosphoinositide signaling in MDA-MB-435 breast carcinoma cells. Cancer Res. 65, 713\u2013717."}, {"ArticleIdList": {"ArticleId": {"#text": "9269993", "@IdType": "pubmed"}}, "Citation": "Dobrovic, A. , Simpfendorfer, D. , 1997. Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res. 57, 3347\u20133350."}, {"ArticleIdList": {"ArticleId": {"#text": "19138839", "@IdType": "pubmed"}}, "Citation": "Duffy, M.J. , Napieralski, R. , Martens, J.W. , Span, P.N. , Spyratos, F. , Sweep, F.C. , 2009. Methylated genes as new cancer biomarkers. Eur. J. Cancer. 45, 335\u2013346."}, {"ArticleIdList": {"ArticleId": {"#text": "10749912", "@IdType": "pubmed"}}, "Citation": "Esteller, M. , Silva, J.M. , Dominguez, G. , Bonilla, F. , Matias-Guiu, X. , Lerma, E. , 2000. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J. Natl. Cancer Inst. 92, 564\u2013569."}, {"ArticleIdList": {"ArticleId": {"#text": "11751682", "@IdType": "pubmed"}}, "Citation": "Esteller, M., Fraga, M.F., Guo, M., Garcia-Foncillas, J., Hedenfalk, I., Godwin, A.K., et\u00a0al., 2001. DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. 10, 3001\u20133007."}, {"ArticleIdList": {"ArticleId": {"#text": "17339880", "@IdType": "pubmed"}}, "Citation": "Esteller, M. , 2007. Cancer epigenomics: DNA methylomes and histone modification maps. Nat. Rev. Genet. 8, 286\u2013298."}, {"ArticleIdList": {"ArticleId": {"#text": "11343741", "@IdType": "pubmed"}}, "Citation": "Evron, E. , Dooley, W.C. , Umbricht, C.B. , Rosenthal, D. , Sacchi, N. , Gabrielson, E. , 2001. Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR. Lancet. 357, 1335\u20131336."}, {"ArticleIdList": {"ArticleId": {"#text": "11289162", "@IdType": "pubmed"}}, "Citation": "Evron, E. , Umbricht, C.B. , Korz, D. , Raman, V. , Loeb, D.M. , Niranjan, B. , 2001. Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation. Cancer Res. 61, 2782\u20132787."}, {"ArticleIdList": {"ArticleId": {"#text": "14601057", "@IdType": "pubmed"}}, "Citation": "Fackler, M.J. , McVeigh, M. , Evron, E. , Garrett, E. , Mehrotra, J. , Polyak, K. , 2003. DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma. Cancer. 107, 970\u2013975."}, {"ArticleIdList": {"ArticleId": {"#text": "16740751", "@IdType": "pubmed"}}, "Citation": "Fackler, M.J. , Malone, K. , Zhang, Z. , Schilling, E. , Garrett-Mayer, E. , Swift-Scanlan, T. , 2006. Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluid. Clin. Cancer Res. 12, 3306\u20133310."}, {"ArticleIdList": {"ArticleId": {"#text": "17178894", "@IdType": "pubmed"}}, "Citation": "Fan, M. , Yan, P.S. , Hartman-Frey, C. , Chen, L. , Paik, H. , Oyer, S.L. , 2006. Diverse gene expression and DNA methylation profiles correlate with differential adaptation of breast cancer cells to the antiestrogens tamoxifen and fulvestrant. Cancer Res. 66, 11954\u201311966."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2206733", "@IdType": "pmc"}, {"#text": "17764565", "@IdType": "pubmed"}]}, "Citation": "Feng, W. , Shen, L. , Wen, S. , Rosen, D.G. , Jelinek, J. , Hu, X. , 2007. Correlation between CpG methylation profiles and hormone receptor status in breast cancers. Breast Cancer Res. 9, R57"}, {"ArticleIdList": {"ArticleId": {"#text": "7538900", "@IdType": "pubmed"}}, "Citation": "Ferguson, A.T. , Lapidus, R.G. , Baylin, S.B. , Davidson, N.E. , 1995. Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression. Cancer Res. 55, 2279\u20132283."}, {"ArticleIdList": {"ArticleId": {"#text": "15734995", "@IdType": "pubmed"}}, "Citation": "Fiegl, H. , Millinger, S. , Mueller-Holzner, E. , Marth, C. , Ensinger, C. , Berger, A. , 2005. Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patients. Cancer Res. 65, 1141\u20131145."}, {"ArticleIdList": {"ArticleId": {"#text": "18519782", "@IdType": "pubmed"}}, "Citation": "Fiegl, H. , Jones, A. , Hauser-Kronberger, C. , Hutarew, G. , Reitsamer, R. , Jones, R.L. , 2008. Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancer. Clin. Cancer Res. 14, 3494\u20133502."}, {"ArticleIdList": {"ArticleId": {"#text": "11536294", "@IdType": "pubmed"}}, "Citation": "Forsberg, E.C. , Bresnick, E.H. , 2001. Histone acetylation beyond promoters: long-range acetylation patterns in the chromatin world. Bioessays. 23, 820\u2013830."}, {"ArticleIdList": {"ArticleId": {"#text": "16642018", "@IdType": "pubmed"}}, "Citation": "Frigola, J. , Song, J. , Stirzaker, C. , Hinshelwood, R.A. , Peinado, M.A. , Clark, S.J. , 2006. Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across entire chromosome band. Nat. Genet. 38, 540\u2013549."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2783691", "@IdType": "pmc"}, {"#text": "19861523", "@IdType": "pubmed"}]}, "Citation": "Gaudet, M.M. , Campan, M. , Figueroa, J.D. , Yang, X.R. , Lissowska, J. , Peplonska, B. , 2009. DNA hypermethylation of ESR1 and PGR in breast cancer: pathologic and epidemiologic associations. Cancer Epidemiol. Biomarkers Prev. 18, 3036\u20133043."}, {"ArticleIdList": {"ArticleId": {"#text": "7585573", "@IdType": "pubmed"}}, "Citation": "Graff, J.R. , Herman, J.G. , Lapidus, R.G. , Chopra, H. , Xu, R. , Jarrard, D.F. , 1995. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res. 55, 5195\u20135199."}, {"ArticleIdList": {"ArticleId": {"#text": "12566312", "@IdType": "pubmed"}}, "Citation": "Gupta, A. , Godwin, A.K. , Vanderveer, L. , Lu, A. , Liu, J. , 2003. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma. Cancer Res. 63, 664\u2013673."}, {"ArticleIdList": {"ArticleId": {"#text": "19118060", "@IdType": "pubmed"}}, "Citation": "Hartmann, O. , Spyratos, F. , Harbeck, N. , Dietrich, D. , Fassbender, A. , Schmitt, M. , 2009. DNA methylation markers predict outcome in node-positive, estrogen receptor-positive breast cancer with adjuvant anthracycline-based chemotherapy. Clin. Cancer Res. 15, 315\u2013323."}, {"ArticleIdList": {"ArticleId": {"#text": "7553621", "@IdType": "pubmed"}}, "Citation": "Herman, J.G. , Merlo, A. , Mao, L. , Lapidus, R.G. , Issa, J.P. , Davidson, N.E. , 1995. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 55, 4525\u20134530."}, {"ArticleIdList": {"ArticleId": {"#text": "18716754", "@IdType": "pubmed"}}, "Citation": "Hinshelwood, R.A. , Clark, S.J. , 2008. Breast cancer epigenetics: normal human mammary epithelial cells as a model system. J. Mol. Med. 86, 1315\u20131328."}, {"ArticleIdList": {"ArticleId": {"#text": "12670910", "@IdType": "pubmed"}}, "Citation": "Holst, C.R. , Nuovo, G.J. , Esteller, M. , Chew, K. , Baylin, S.B. , Herman, J.G. , 2003. Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia. Cancer Res. 63, 1596\u20131601."}, {"ArticleIdList": {"ArticleId": {"#text": "16908936", "@IdType": "pubmed"}}, "Citation": "Hoque, M.O. , Feng, Q. , Toure, P. , Dem, A. , Critchlow, C.W. , Hawes, S.E. , 2006. Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer. J. Clin. Oncol. 24, 4262\u20134269."}, {"ArticleIdList": {"ArticleId": {"#text": "11091697", "@IdType": "pubmed"}}, "Citation": "Hori, M. , 1999. Hypermethylation of the estrogen receptor alpha gene is not related to lack of receptor protein in human breast cancer. Breast Cancer. 6, 79\u201386."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC1557677", "@IdType": "pmc"}, {"#text": "16919237", "@IdType": "pubmed"}]}, "Citation": "Hurst, D.R. , Mehta, A. , Moore, B.P. , Phadke, P.A. , Meehan, W.J. , Accavitti, M.A. , 2006. Breast cancer metastasis suppressor 1 (BRMS1) is stabilized by the Hsp90 chaperone. Biochem. Biophys. Res. Commun. 348, 1429\u20131435."}, {"ArticleIdList": {"ArticleId": {"#text": "16783580", "@IdType": "pubmed"}}, "Citation": "Hurtubise, A. , Momparler, R.L. , 2006. Effect of histone deacetylase inhibitor LAQ824 on antineoplastic action of 5-Aza-2\u2032 deoxycytidine (decitabine) on human breast carcinoma cells. Cancer Chemother. Pharmacol. 58, 618\u2013625."}, {"ArticleIdList": {"ArticleId": {"#text": "9721850", "@IdType": "pubmed"}}, "Citation": "Huschtscha, L.I. , Noble, J.R. , Neumann, A.A. , Moy, E.L. , Barry, P. , Melki, J.R. , 1998. Loss of p16INK4 expression by methylation is associated with lifespan extension of human mammary epithelial cells. Cancer Res. 58, 3508\u20133512."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC88765", "@IdType": "pmc"}, {"#text": "10958685", "@IdType": "pubmed"}]}, "Citation": "Ito, K. , Barnes, P.J. , Adcock, I.M. , 2002. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol. Cell. Biol. 20, 6891\u20136903."}, {"ArticleIdList": {"ArticleId": {"#text": "12960130", "@IdType": "pubmed"}}, "Citation": "Jeronimo, C. , Costa, I. , Martins, M.C. , Monteiro, P. , Lisboa, S. , Palmeira, C. , 2003. Detection of gene promoter hypermethylation in fine needle washings from breast lesions. Clin. Cancer Res. 9, 3413\u20133417."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3894624", "@IdType": "pmc"}, {"#text": "17320506", "@IdType": "pubmed"}]}, "Citation": "Jones, P.A. , Baylin, S.B. , 2007. The epigenomics of cancer. Cell. 128, 683\u2013692."}, {"ArticleIdList": {"ArticleId": {"#text": "9620779", "@IdType": "pubmed"}}, "Citation": "Jones, P.L. , Veenstra, G.J.C. , Wade, P.A. , 1998. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet. 19, 187\u2013191."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2848990", "@IdType": "pmc"}, {"#text": "18772397", "@IdType": "pubmed"}]}, "Citation": "Jones, S. , Zhang, X. , Parsons, D.W. , Lin, J.C. , Leary, R.J. , Angenendt, P. , Mankoo, P. , Carter, H. , Kamiyama, H. , Jimeno, A. , Hong, S.M. , Fu, B. , Lin, M.T. , Calhoun, E.S. , Kamiyama, M. , Walter, K. , Nikolskaya, T. , Nikolsky, Y. , Hartigan, J. , Smith, D.R. , Hidalgo, M. , Leach, S.D. , Klein, A.P. , Jaffee, E.M. , Goggins, M. , Maitra, A. , Iacobuzio-Donahue, C. , Eshleman, J.R. , Kern, S.E. , Hruban, R.H. , Karchin, R. , Papadopoulos, N. , Parmigiani, G. , Vogelstein, B. , Velculescu, V.E. , Kinzler, K.W. , 2008. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science. 321, 1801\u20131806."}, {"ArticleIdList": {"ArticleId": {"#text": "9816032", "@IdType": "pubmed"}}, "Citation": "Ki Hong, W. , Lippman, S.M. , Hittelmann, W.N. , Lotan, R. , 1993. Retinoid chemoprevention of aerodigestive cancer: from basic research to the clinic. Clin. Oncol. 11, 1216\u20131222."}, {"ArticleIdList": {"ArticleId": {"#text": "17998811", "@IdType": "pubmed"}}, "Citation": "Kim, T.Y. , Bang, Y.J. , Robertson, K.D. , 2006. Histone deacetylase inhibitors for cancer therapy. Epigenetics. 1, 14\u201323."}, {"ArticleIdList": {"ArticleId": {"#text": "18288399", "@IdType": "pubmed"}}, "Citation": "Kim, S.J. , Kang, H.S. , Chang, H.L. , Jung, Y.C. , Sim, H.B. , Lee, K.S. , 2008. Promoter hypomethylation of the N-acetyltransferase 1 gene in breast cancer. Oncol. Rep. 19, 663\u2013668."}, {"ArticleIdList": {"ArticleId": {"#text": "11893494", "@IdType": "pubmed"}}, "Citation": "Kouzarides, T. , 2002. Histone methylation in transcriptional control. Curr. Opin. Genet. Dev. 12, 198\u2013209."}, {"ArticleIdList": {"ArticleId": {"#text": "14734448", "@IdType": "pubmed"}}, "Citation": "Krassenstein, R. , Sauter, E. , Dulaimi, E. , Battagli, C. , Ehya, H. , Klein-Szanto, A. , 2004. Detection of breast cancer in nipple aspirate fluid by CpG island hypermethylation. Clin. Cancer Res. 10, 28\u201332."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC55532", "@IdType": "pmc"}, {"#text": "11481438", "@IdType": "pubmed"}]}, "Citation": "Krop, I.E. , Sgroi, D. , Porter, D.A. , Lunetta, K.L. , LeVangie, R. , Seth, P. , 2001. HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 98, 9796\u20139801."}, {"ArticleIdList": {"ArticleId": {"#text": "16266985", "@IdType": "pubmed"}}, "Citation": "Krop, I. , Parker, M.T. , Bloushtain-Qimron, N. , Porter, D. , Gelman, R. , Sasaki, H. , 2005. HIN-1, an inhibitor of cell growth, invasion, and AKT activation. Cancer Res. 65, 9659\u20139669."}, {"ArticleIdList": {"ArticleId": {"#text": "12730288", "@IdType": "pubmed"}}, "Citation": "Lachner, M. , Roderick, J. , O'Sullivan, 2003. An epigenetic road map for histone lysine methylation. J. Cell. Sci. 116, 2117\u20132124."}, {"ArticleIdList": {"ArticleId": {"#text": "9816234", "@IdType": "pubmed"}}, "Citation": "Lapidus, R. , 1996. Methylation of estrogen and progesterone receptor gene 5\u2032 CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors. Clin. Cancer Res. 2, 805\u2013810."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC1850646", "@IdType": "pmc"}, {"#text": "11839581", "@IdType": "pubmed"}]}, "Citation": "Lehmann, U. , Langer, F. , Feist, H. , Glockner, S. , Hasemeier, B. , Kreipe, H. , 2002. Quantitative assessment of promoter hypermethylation during breast cancer development. Am. J. Pathol. 160, 605\u2013612."}, {"ArticleIdList": {"ArticleId": {"#text": "17368950", "@IdType": "pubmed"}}, "Citation": "Levenson, V.V. , 2007. Biomarkers for early detection of breast cancer: what, when, and where?. Biochim. Biophys. Acta. 1770, 847\u2013856."}, {"ArticleIdList": {"ArticleId": {"#text": "11498546", "@IdType": "pubmed"}}, "Citation": "Litt, M.D. , Simpson, M. , Gaszner, M. , Allis, C.D. , Felsenfeld, G. , 2001. Correlation between histone lysine 9 methylation and developmental changes at the chicken beta-globin locus. Science. 293, 2453\u20132455."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC1636810", "@IdType": "pmc"}, {"#text": "17000776", "@IdType": "pubmed"}]}, "Citation": "Liu, Y. , Smith, P.W. , Jones, D.R. , 2006. Breast cancer metastasis suppressor 1 functions as a corepressor by enhancing histone deacetylase 1-mediated deacetylation of RelA/p65 and promoting apoptosis. 26, 8683\u20138696."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2633440", "@IdType": "pmc"}, {"#text": "19072646", "@IdType": "pubmed"}]}, "Citation": "Lo, P.K. , Sukumar, S. , 2008. Epigenomics and breast cancer. Pharmacogenomics. 12, 1879\u20131902."}, {"ArticleIdList": {"ArticleId": {"#text": "17601725", "@IdType": "pubmed"}}, "Citation": "Maier, S. , Nimmrich, I. , Koenig, T. , Eppenberger-Castori, S. , Bohlmann, I. , Paradiso, A. , 2007. DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients \u2013 technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group. Eur. J. Cancer. 43, 1679\u20131686."}, {"ArticleIdList": {"ArticleId": {"#text": "9528858", "@IdType": "pubmed"}}, "Citation": "Mancini, D.N. , Rodenhiser, D.I. , Ainsworth, P.J. , O'Malley, F.P. , Singh, S.M. , Xing, W. , 1998. CpG methylation within the 5\u2032 regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site. Oncogene. 16, 1161\u20131169."}, {"ArticleIdList": {"ArticleId": {"#text": "15899800", "@IdType": "pubmed"}}, "Citation": "Martens, J.W. , Nimmrich, I. , Koenig, T. , Look, M.P. , Harbeck, N. , Model, F. , 2005. Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancer. Cancer Res. 65, 4101\u20134117."}, {"ArticleIdList": {"ArticleId": {"#text": "16261189", "@IdType": "pubmed"}}, "Citation": "Martin, C. , Zhang, Y. , 2005. The diverse functions of histone lysine methylation. Nat. Rev. Mol. Cell. Biol. 6, 838\u2013849."}, {"ArticleIdList": {"ArticleId": {"#text": "14581478", "@IdType": "pubmed"}}, "Citation": "Meehan, W.J. , Samant, R.S. , Hopper, J.E. , Carrozza, M.J. , Shevde, L.A. , Workman, J.L. , 2004. Breast cancer metastasis suppressor 1 (BRMS1) forms complexes with retinoblastoma-binding protein 1 (RBP1) and the mSin3 histone deacetylase complex and represses transcription. J. Biol. Chem. 279, 1562\u20131569."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2175548", "@IdType": "pmc"}, {"#text": "18165279", "@IdType": "pubmed"}]}, "Citation": "Melnikov, A.A. , Scholtens, D.M. , Wiley, E.L. , Khan, S.A. , Levenson, V.V. , 2008. Array-based multiplex analysis of DNA methylation in breast cancer tissues. J. Mol. Diagn. 10, 93\u2013101."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2763604", "@IdType": "pmc"}, {"#text": "18566899", "@IdType": "pubmed"}]}, "Citation": "Metge, B.J. , Frost, A.R. , King, J.A. , Dyess, D.L. , Welch, D.R. , Samant, R.S. , Shevde, L.A. , 2008. Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer. Clin. Exp. Metastasis. 25, 753\u2013763."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2880421", "@IdType": "pmc"}, {"#text": "20056007", "@IdType": "pubmed"}]}, "Citation": "Muggerud, A.A. , Ronneberg, J.A. , Warnberg, F. , Botling, J. , Busato, F. , Jovanovic, J. , Solvang, H. , Bukholm, I. , Borresen-Dale, A.L. , Kristensen, V.N. , Sorlie, T. , Tost, J. , 2010. Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Res. 12, R3"}, {"ArticleIdList": {"ArticleId": {"#text": "14633683", "@IdType": "pubmed"}}, "Citation": "Muller, H.M. , Widschwendter, A. , Fiegl, H. , Ivarsson, L. , Goebel, G. , Perkmann, E. , 2003. DNA methylation in serum of breast cancer patients: an independent prognostic marker. Cancer Res. 63, 7641\u20137645."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2768109", "@IdType": "pmc"}, {"#text": "19738609", "@IdType": "pubmed"}]}, "Citation": "Munster, P.N. , Marchion, D. , Thomas, S. , Egorin, M. , Minton, S. , Springett, G. , Lee, J.H. , Simon, G. , Chiappori, A. , Sullivan, D. , Daud, A. , 2009. 2.Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker. Br. J. Cancer. 101, 1044\u20131050."}, {"ArticleIdList": {"ArticleId": {"#text": "9620804", "@IdType": "pubmed"}}, "Citation": "Nan, X. , Ng, H.H. , Johnson, C.A. , 1998. Transcriptional repression by the methyl-CpG binding protein MeCP2 involves a histone deacetylase complex. Nature. 393, 386\u2013389."}, {"ArticleIdList": {"ArticleId": {"#text": "17965955", "@IdType": "pubmed"}}, "Citation": "Nimmrich, I. , Sieuwerts, A.M. , Meijer-van Gelder, M.E. , Schwope, I. , Bolt-de, V.J. , Harbeck, N. , 2008. DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients. Breast Cancer Res. Treat. 111, 429\u2013437."}, {"ArticleIdList": {"ArticleId": {"#text": "17090521", "@IdType": "pubmed"}}, "Citation": "Novak, P. , Jensen, T. , Oshiro, M.M. , Wozniak, R.J. , Nouzova, M. , Watts, G.S. , Klimecki, W.T. , Kim, C. , Futscher, B.W. , 2006. Epigenetic inactivation of the HOX gene cluster in breast cancer. Cancer Res. 66, 10664\u201310670."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2680223", "@IdType": "pmc"}, {"#text": "18922938", "@IdType": "pubmed"}]}, "Citation": "Novak, P. , Jensen, T. , Oshiro, M.M. , Watts, G.S. , Kim, C.J. , Futscher, B.W. , 2008. Agglomerative epigenetic aberrations are a common event in human breast cancer. Cancer Res. 68, 8616\u20138625."}, {"ArticleIdList": {"ArticleId": {"#text": "15150277", "@IdType": "pubmed"}}, "Citation": "Pakneshan, P. , Szyf, M. , Farias-Eisner, R. , Rabbani, S.A. , 2004. Reversal of the hypomethylation status of urokinase (uPA) promoter blocks breast cancer growth and metastasis. J. Biol. Chem. 279, 31735\u201331744."}, {"ArticleIdList": {"ArticleId": {"#text": "16115928", "@IdType": "pubmed"}}, "Citation": "Paredes, J. , Albergaria, A. , Oliveira, J.T. , Jeronimo, C. , Milanezi, F. , Schmitt, F.C. , 2005. P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation. Clin. Cancer Res. 11, 5869\u20135877."}, {"ArticleIdList": {"ArticleId": {"#text": "10963602", "@IdType": "pubmed"}}, "Citation": "Perou, C.M. , Sorlie, T. , Eisen, M.B. , van de Rijn, M. , Jeffrey, S.S. , Rees, C.A. , Pollack, J.R. , Ross, D.T. , Johnsen, H. , Akslen, L.A. , 2000. Molecular portraits of human breast tumours. Nature. 406, 747\u2013752."}, {"ArticleIdList": {"ArticleId": {"#text": "11740497", "@IdType": "pubmed"}}, "Citation": "Peters, A.H. , Mermoud, J.E. , Carroll, D.O. , 2002. Histone H3 lysine 9 methylation is an epigenetic imprint of facultative heterochromatin. Nat. Genet. 30, 77\u201380."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2824590", "@IdType": "pmc"}, {"#text": "19308457", "@IdType": "pubmed"}]}, "Citation": "Pfeifer, G.P. , Besaratinia, A. , 2009. Mutational spectra of human cancer. Hum. Genet. 125, 493\u2013506."}, {"ArticleIdList": {"ArticleId": {"#text": "10949293", "@IdType": "pubmed"}}, "Citation": "Rea, S. , Eisenhaber, F. , O'Carroll, D. , 2000. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature. 406, 579\u2013580."}, {"ArticleIdList": {"ArticleId": {"#text": "10888886", "@IdType": "pubmed"}}, "Citation": "Robertson, K.D. , Ait-Si-Ali, S. , Yokochi, T. , 2000. DNMT1 forms a complex with Rb, E2F1, and HDAC1 and represses transcription from E2F-responsive promoters. Nat. Genet. 25, 338\u2013342."}, {"ArticleIdList": {"ArticleId": {"#text": "11214324", "@IdType": "pubmed"}}, "Citation": "Romanov, S.R. , Kozakiewicz, B.K. , Holst, C.R. , Stampfer, M.R. , Haupt, L.M. , Tlsty, T.D. , 2001. Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature. 409, 633\u2013637."}, {"ArticleIdList": {"ArticleId": {"#text": "11395403", "@IdType": "pubmed"}}, "Citation": "Roth, S.Y. , Denu, J.M. , Allis, C.D. , 2001. Histone acetyltransferases. Annu. Rev. Biochem. 70, 81\u2013120."}, {"ArticleIdList": {"ArticleId": {"#text": "11827072", "@IdType": "pubmed"}}, "Citation": "Samant, R.S. , Seraj, M.J. , Saunders, M.M. , Sakamaki, T.S. , Shevde, L.A. , Harms, J.F. , 2000. Analysis of mechanisms underlying BRMS1 suppression of metastasis. Clin. Exp. Metastasis. 18, 683\u2013693."}, {"ArticleIdList": {"ArticleId": {"#text": "11774238", "@IdType": "pubmed"}}, "Citation": "Samant, R.S. , Debies, M.T. , Shevde, L.A. , Verderame, M.F. , Welch, D.R. , 2002. Identification and characterization of the murine ortholog (brms1) of breast-cancer metastasis suppressor 1 (BRMS1). Int. J. Cancer. 97, 15\u201320."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC1796551", "@IdType": "pmc"}, {"#text": "17227585", "@IdType": "pubmed"}]}, "Citation": "Samant, R.S. , Clark, D.W. , Fillmore, R.A. , Cicek, M. , Metge, B.J. , Chandramouli, K.H. , 2007. Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NFkappaB activation. Mol. Cancer. 6, 6"}, {"ArticleIdList": {"ArticleId": {"#text": "11280719", "@IdType": "pubmed"}}, "Citation": "Saunders, M.M. , Seraj, M.J. , Li, Z. , Zhou, Z. , Winter, C.R. , Welch, D.R. , 2001. Breast cancer metastatic potential correlates with a breakdown in homospecific and heterospecific gap junctional intercellular communication. Cancer Res. 61, 1765\u20131767."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC420352", "@IdType": "pmc"}, {"#text": "15175259", "@IdType": "pubmed"}]}, "Citation": "Schubeler, D. , macAlpine, D.M. , Scalzo, D. , 2004. The histone modification pattern of active genes revealed through genome-wide chromatin analysis of higher eukaryote. Genes Dev. 18, 1263\u20131271."}, {"ArticleIdList": {"ArticleId": {"#text": "10850410", "@IdType": "pubmed"}}, "Citation": "Seraj, M.J. , Samant, R.S. , Verderame, M.F. , Welch, D.R. , 2000. Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13. Cancer Res. 60, 2764\u20132769."}, {"ArticleIdList": {"ArticleId": {"#text": "19923318", "@IdType": "pubmed"}}, "Citation": "Serena, T. , 2009. Emerging treatment combinations: integrating therapy into clinical practice. Am. J. Health Syst. Pharm. 66, 9\u201314."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2696763", "@IdType": "pmc"}, {"#text": "19436308", "@IdType": "pubmed"}]}, "Citation": "Shah, R. , Smith, P. , Quinlan, C. , Baker, L. , Aman, P. , Thompson, A.M. , Crook, T. , 2009. The prolyl 3-hydroxylases P3H2 and P3H3 are novel targets for epigenetic silencing in breast cancer. Br. J. Cancer. 100, 1687\u20131696."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2336806", "@IdType": "pmc"}, {"#text": "18256232", "@IdType": "pubmed"}]}, "Citation": "Shann, Y.J. , Cheng, C. , Chiao, C.H. , Chen, D.T. , Li, P.H. , Hsu, M.T. , 2008. Genome-wide mapping and characterization of hypomethylated sites in human tissues and breast cancer cell lines. Genome Res. 18, 791\u2013801."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC1242124", "@IdType": "pmc"}, {"#text": "16168108", "@IdType": "pubmed"}]}, "Citation": "Sharma, P. , Sahni, N.S. , Tibshirani, R. , Skaane, P. , Urdal, P. , Berghagen, H. , 2005. Early detection of breast cancer based on gene-expression patterns in peripheral blood cells. Breast Cancer Res. 7, R634\u2013R644."}, {"ArticleIdList": {"ArticleId": {"#text": "11822878", "@IdType": "pubmed"}}, "Citation": "Shevde, L.A. , Samant, R.S. , Goldberg, S.F. , Sikaneta, T. , Alessandrini, A. , Donahue, H.J. , 2002. Suppression of human melanoma metastasis by the metastasis suppressor gene, BRMS1. Exp. Cell Res. 273, 229\u2013239."}, {"ArticleIdList": {"ArticleId": {"#text": "16756492", "@IdType": "pubmed"}}, "Citation": "Shilatifard, A. , 2006. Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression. Annu. Rev. Biochem. 75, 243\u2013269."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2948671", "@IdType": "pmc"}, {"#text": "19010819", "@IdType": "pubmed"}]}, "Citation": "Singh, P. , Yang, M. , Dai, H. , Yu, D. , Huang, Q. , Tan, W. , 2008. Overexpression and hypomethylation of flap endonuclease 1 gene in breast and other cancers. Mol. Cancer Res. 6, 1710\u20131717."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC58566", "@IdType": "pmc"}, {"#text": "11553815", "@IdType": "pubmed"}]}, "Citation": "Sorlie, T. , Perou, C.M. , Tibshirani, R. , Aas, T. , Geisler, S. , Johnsen, H. , Hastie, T. , Eisen, M.B. , van de Rijn, M. , Jeffrey, S.S. , 2001. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. U.S.A. 98, 10869\u201310874."}, {"ArticleIdList": {"ArticleId": {"#text": "15592684", "@IdType": "pubmed"}}, "Citation": "Stark, A.M. , Tongers, K. , Maass, N. , Mehdorn, H.M. , Held-Feindt, J. , 2005. Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases. J. Cancer Res. Clin. Oncol. 131, 191\u2013198."}, {"ArticleIdList": {"ArticleId": {"#text": "18058459", "@IdType": "pubmed"}}, "Citation": "Stearns, V. , Zhou, Q. , Davidson, N.E. , 2007. Epigenetic regulation as a new target for breast cancer therapy. Cancer Invest. 25, 659\u2013665."}, {"ArticleIdList": {"ArticleId": {"#text": "10638745", "@IdType": "pubmed"}}, "Citation": "Strahl, B.D. , Allis, C.D. , 2000. The language of covalent histone modifications. Nature. 403, 41\u201345."}, {"ArticleIdList": {"ArticleId": {"#text": "17099711", "@IdType": "pubmed"}}, "Citation": "Stransky, N. , Vallot, C. , Reyal, F. , Bernard-Pierrot, I. , de Medina, S.G. , Segraves, R. , de Rycke, Y. , Elvin, P. , Cassidy, A. , Spraggon, C. , Graham, A. , Southgate, J. , Asselain, B. , Allory, Y. , Abbou, C.C. , Albertson, D.G. , Thiery, J.P. , Chopin, D.K. , Pinkel, D. , Radvanyi, F. , 2006. Regional copy number-independent deregulation of transcription in cancer. Nat. Genet. 38, 1386\u20131396."}, {"ArticleIdList": {"ArticleId": {"#text": "19185986", "@IdType": "pubmed"}}, "Citation": "Thomas, S. , Munster, P.N. , 2009. Histone deacetylase inhibitor induced modulation of anti-estrogen therapy. Cancer Lett. 280, 184\u2013191."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC15395", "@IdType": "pmc"}, {"#text": "10639144", "@IdType": "pubmed"}]}, "Citation": "Toyota, M. , Ohe-Toyota, M. , Ahuja, N. , Issa, J.P. , 2000. Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype. Proc. Natl. Acad. Sci. U.S.A. 97, 7"}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC14549", "@IdType": "pmc"}, {"#text": "11134513", "@IdType": "pubmed"}]}, "Citation": "Furumai, R. , Komatsu, Y. , Nishino, N. , Khochbin, S. , Yoshida, M. , Horinouchi, S. , 2001. Potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxin. Proc. Natl. Acad. Sci. U.S.A. 98, 710\u2013715."}, {"ArticleIdList": {"ArticleId": {"#text": "17016441", "@IdType": "pubmed"}}, "Citation": "Turner, N.C. , Reis-Filho, J.S. , Russell, A.M. , Springall, R.J. , Ryder, K. , Steele, D. , 2007. BRCA1 dysfunction in sporadic basal-like breast cancer. Oncogene. 26, 2126\u20132132."}, {"ArticleIdList": {"ArticleId": {"#text": "10944586", "@IdType": "pubmed"}}, "Citation": "Turner, B.M. , 2000. Histone acetylation and an epigenetic code. Bioessays. 22, 836\u2013845."}, {"ArticleIdList": {"ArticleId": {"#text": "11257101", "@IdType": "pubmed"}}, "Citation": "Wade, P.A. , 2001. Transcriptional control at regulatory checkpoints by histone deacetylases: molecular connections between cancer and chromatin. Hum. Mol. Genet. 10, 693\u2013698."}, {"ArticleIdList": {"ArticleId": {"#text": "8339250", "@IdType": "pubmed"}}, "Citation": "Weigel, R.J. , deConinck, E.C. , 1993. Transcriptional control of estrogen receptor in estrogen receptor-negative breast carcinoma. Cancer Res. 53, 3472\u20133474."}, {"ArticleIdList": {"ArticleId": {"#text": "12154408", "@IdType": "pubmed"}}, "Citation": "Widschwendter, M. , Jones, P.A. , 2002. DNA methylation and breast carcinogenesis. Oncogene. 21, 5462\u20135482."}, {"ArticleIdList": {"ArticleId": {"#text": "10814678", "@IdType": "pubmed"}}, "Citation": "Widschwendter, M. , Berger, J. , Hermann, M. , Muller, H.M. , Amberger, A. , Zeschnigk, M. , 2000. Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer. J. Natl. Cancer Inst. 92, 826\u2013832."}, {"ArticleIdList": {"ArticleId": {"#text": "15172987", "@IdType": "pubmed"}}, "Citation": "Widschwendter, M. , Siegmund, K.D. , Muller, H.M. , Fiegl, H. , Marth, C. , Muller-Holzner, E. , 2004. Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen. Cancer Res. 64, 3807\u20133813."}, {"ArticleIdList": {"ArticleId": {"#text": "19855177", "@IdType": "pubmed"}}, "Citation": "Xu, D. , Bai, J. , Duan, Q. , Costa, M. , Dai, W. , 2009. Covalent modifications of histones during mitosis and meiosis. Cell Cycle. 8, 3688\u20133694."}, {"ArticleIdList": {"ArticleId": {"#text": "12874023", "@IdType": "pubmed"}}, "Citation": "Yuan, J. , Luo, R.Z. , Fujii, S. , Wang, L. , Hu, W. , Andreeff, M. , 2003. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers. Cancer Res. 63, 4174\u20134180."}, {"ArticleIdList": {"ArticleId": {"#text": "12897854", "@IdType": "pubmed"}}, "Citation": "Zardo, G. , Reale, A. , De Matteis, G. , 2003. A role for poly(ADP-ribosyl)ation in DNA methylation. Biochem. Cell. Biol. 81, 197\u2013208."}, {"ArticleIdList": {"ArticleId": {"#text": "17085653", "@IdType": "pubmed"}}, "Citation": "Zhang, Z. , Yamashita, H. , Toyama, T. , Yamamoto, Y. , Kawasoe, T. , Iwase, H. , 2006. Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer. Clin. Cancer Res. 12, 6410\u20136414."}]}}}}}, "PMC": "PMC5527941", "PMID": "20627830", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "The epigenetics of breast cancer.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "6": {"Abstract": " Genome-wide association studies have identified several breast cancer susceptibility loci.\u00a0However, biomarkers for risk assessment are still missing. Here, we investigated cancer-related molecular changes detected in tissues from women at high risk for breast cancer prior to disease manifestation. Disease-free breast tissue cores donated by healthy women (N\u2009=\u2009146, median age\u2009=\u200939\u00a0years) were processed for both methylome (MethylCap) and transcriptome (Illumina's HiSeq4000) sequencing. Analysis of tissue microarray and primary breast epithelial cells was used to confirm gene expression dysregulation. Transcriptomic analysis identified 69 differentially expressed genes between women at high and those at average risk of breast cancer (Tyrer-Cuzick model) at FDR\u2009<\u20090.05 and fold change\u2009\u2265\u20092. Majority of the identified genes were involved in DNA damage checkpoint, cell cycle, and cell adhesion. Two genes, FAM83A and NEK2, were overexpressed in tissue sections (FDR\u2009<\u20090.01) and primary epithelial cells (p\u2009<\u20090.05) from high-risk breasts. Moreover, 1698 DNA methylation changes were identified in high-risk breast tissues (FDR\u2009<\u20090.05), partially overlapped with cancer-related signatures, and correlated with transcriptional changes (p\u2009<\u20090.05, r\u2009\u2264\u20090.5). Finally, among the participants, 35 women donated breast biopsies at two time points, and age-related molecular alterations enhanced in high-risk subjects were identified. Normal breast tissue from women at high risk of breast cancer bears molecular aberrations that may contribute to breast cancer susceptibility. This study is the first molecular characterization of the true normal breast tissues, and provides an opportunity to investigate molecular markers of breast cancer risk, which may lead to new preventive approaches.", "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "-8955784754426379682", "Part1": "Susan G. Komen Tissue Bank at the IU Simon Comprehensive Cancer Center", "Part2": "Indianapolis", "Part3": "IN", "Part4": "46202", "Part5": "USA. marinon@iu.edu.", "Part6": null, "Text": "Susan G. Komen Tissue Bank at the IU Simon Comprehensive Cancer Center, Indianapolis, IN, 46202, USA. marinon@iu.edu."}, {"Has_Extra": true, "HashID": "8813279383243298027", "Part1": "Department of Medicine", "Part2": "Hematology/Oncology Division", "Part3": "Indiana University School of Medicine", "Part4": "Indianapolis", "Part5": "IN", "Part6": "46202", "Text": "Department of Medicine, Hematology/Oncology Division, Indiana University School of Medicine, Indianapolis, IN, 46202, USA. marinon@iu.edu."}], "ForeName": "Natascia", "FullName": "Natascia Marino", "HashID": "-7692090612121009855", "LastName": "Marino", "ORCID": "0000-0001-6771-8963"}, {"Affiliations": [{"Has_Extra": false, "HashID": "-8955784754426379682", "Part1": "Susan G. Komen Tissue Bank at the IU Simon Comprehensive Cancer Center", "Part2": "Indianapolis", "Part3": "IN", "Part4": "46202", "Part5": "USA.", "Part6": null, "Text": "Susan G. Komen Tissue Bank at the IU Simon Comprehensive Cancer Center, Indianapolis, IN, 46202, USA."}], "ForeName": "Rana", "FullName": "Rana German", "HashID": "3238754318729719905", "LastName": "German", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "4409458560529122129", "Part1": "Center for Genomics and Bioinformatics", "Part2": "Indiana University", "Part3": "Bloomington", "Part4": "IN", "Part5": "47405", "Part6": "USA.", "Text": "Center for Genomics and Bioinformatics, Indiana University, Bloomington, IN, 47405, USA."}], "ForeName": "Ram", "FullName": "Ram Podicheti", "HashID": "6114436471641590404", "LastName": "Podicheti", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "4409458560529122129", "Part1": "Center for Genomics and Bioinformatics", "Part2": "Indiana University", "Part3": "Bloomington", "Part4": "IN", "Part5": "47405", "Part6": "USA.", "Text": "Center for Genomics and Bioinformatics, Indiana University, Bloomington, IN, 47405, USA."}], "ForeName": "Douglas B", "FullName": "Douglas B Rusch", "HashID": "8076995516990621085", "LastName": "Rusch", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-8955784754426379682", "Part1": "Susan G. Komen Tissue Bank at the IU Simon Comprehensive Cancer Center", "Part2": "Indianapolis", "Part3": "IN", "Part4": "46202", "Part5": "USA.", "Part6": null, "Text": "Susan G. Komen Tissue Bank at the IU Simon Comprehensive Cancer Center, Indianapolis, IN, 46202, USA."}], "ForeName": "Pam", "FullName": "Pam Rockey", "HashID": "-4118888687263618484", "LastName": "Rockey", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "4409458560529122129", "Part1": "Center for Genomics and Bioinformatics", "Part2": "Indiana University", "Part3": "Bloomington", "Part4": "IN", "Part5": "47405", "Part6": "USA.", "Text": "Center for Genomics and Bioinformatics, Indiana University, Bloomington, IN, 47405, USA."}], "ForeName": "Jie", "FullName": "Jie Huang", "HashID": "-2991450835591540527", "LastName": "Huang", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "8635311428365911016", "Part1": "Pathology and Laboratory Medicine", "Part2": "Indiana University School of Medicine", "Part3": "Indianapolis", "Part4": "IN", "Part5": "46202", "Part6": "USA.", "Text": "Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, 46202, USA."}], "ForeName": "George E", "FullName": "George E Sandusky", "HashID": "1034875370533939827", "LastName": "Sandusky", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "8635311428365911016", "Part1": "Pathology and Laboratory Medicine", "Part2": "Indiana University School of Medicine", "Part3": "Indianapolis", "Part4": "IN", "Part5": "46202", "Part6": "USA.", "Text": "Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, 46202, USA."}], "ForeName": "Constance J", "FullName": "Constance J Temm", "HashID": "-5350500002871509520", "LastName": "Temm", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-2825901431845965839", "Part1": "Department of Biostatistics and Health Data Science", "Part2": "Indiana University School of Medicine", "Part3": "Indianapolis", "Part4": "IN", "Part5": "46202", "Part6": "USA.", "Text": "Department of Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis, IN, 46202, USA."}], "ForeName": "Sandra", "FullName": "Sandra Althouse", "HashID": "-7525587516290903465", "LastName": "Althouse", "ORCID": null}, {"Affiliations": [{"Has_Extra": true, "HashID": "6867294357793599851", "Part1": "Department of Anatomy", "Part2": "Cell Biology", "Part3": "& Physiology", "Part4": "Indiana University", "Part5": "Bloomington", "Part6": "IN", "Text": "Department of Anatomy, Cell Biology, & Physiology, Indiana University, Bloomington, IN, 47405, USA."}], "ForeName": "Kenneth P", "FullName": "Kenneth P Nephew", "HashID": "4056637850104325375", "LastName": "Nephew", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "917090873416154743", "Part1": "Department of Surgery", "Part2": "Indiana University School of Medicine", "Part3": "Indianapolis", "Part4": "IN", "Part5": "46202", "Part6": "USA.", "Text": "Department of Surgery, Indiana University School of Medicine, Indianapolis, IN, 46202, USA."}], "ForeName": "Harikrishna", "FullName": "Harikrishna Nakshatri", "HashID": "-6385933136862896800", "LastName": "Nakshatri", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "4409458560529122129", "Part1": "Center for Genomics and Bioinformatics", "Part2": "Indiana University", "Part3": "Bloomington", "Part4": "IN", "Part5": "47405", "Part6": "USA.", "Text": "Center for Genomics and Bioinformatics, Indiana University, Bloomington, IN, 47405, USA."}], "ForeName": "Jun", "FullName": "Jun Liu", "HashID": "-4869093894842400941", "LastName": "Liu", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-8955784754426379682", "Part1": "Susan G. Komen Tissue Bank at the IU Simon Comprehensive Cancer Center", "Part2": "Indianapolis", "Part3": "IN", "Part4": "46202", "Part5": "USA.", "Part6": null, "Text": "Susan G. Komen Tissue Bank at the IU Simon Comprehensive Cancer Center, Indianapolis, IN, 46202, USA."}], "ForeName": "Ashley", "FullName": "Ashley Vode", "HashID": "7967903646190794076", "LastName": "Vode", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-2825901431845965839", "Part1": "Department of Biostatistics and Health Data Science", "Part2": "Indiana University School of Medicine", "Part3": "Indianapolis", "Part4": "IN", "Part5": "46202", "Part6": "USA.", "Text": "Department of Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis, IN, 46202, USA."}], "ForeName": "Sha", "FullName": "Sha Cao", "HashID": "5822077548593765597", "LastName": "Cao", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-8955784754426379682", "Part1": "Susan G. Komen Tissue Bank at the IU Simon Comprehensive Cancer Center", "Part2": "Indianapolis", "Part3": "IN", "Part4": "46202", "Part5": "USA.", "Part6": null, "Text": "Susan G. Komen Tissue Bank at the IU Simon Comprehensive Cancer Center, Indianapolis, IN, 46202, USA."}, {"Has_Extra": true, "HashID": "8813279383243298027", "Part1": "Department of Medicine", "Part2": "Hematology/Oncology Division", "Part3": "Indiana University School of Medicine", "Part4": "Indianapolis", "Part5": "IN", "Part6": "46202", "Text": "Department of Medicine, Hematology/Oncology Division, Indiana University School of Medicine, Indianapolis, IN, 46202, USA."}], "ForeName": "Anna Maria V", "FullName": "Anna Maria V Storniolo", "HashID": "-2644058121900604905", "LastName": "Storniolo", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.1186/s13148-022-01239-1", "InsertType": null, "Journal": "Clinical epigenetics", "Keywords": [{"IS_Major": false, "IS_Mesh": true, "Text": "Adult"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Biomarkers, Tumor"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Breast Neoplasms"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Cohort Studies"}, {"IS_Major": false, "IS_Mesh": true, "Text": "DNA Methylation"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Epigenesis, Genetic"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Female"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Genome-Wide Association Study"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Humans"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Middle Aged"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Risk Assessment"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Transcriptional Activation"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Cancer risk"}, {"IS_Major": false, "IS_Mesh": false, "Text": "DNA methylation"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Normal breast"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Transcriptome"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "MEDLINE", "Article": {"@PubModel": "Electronic", "Abstract": {"AbstractText": [{"#text": "Genome-wide association studies have identified several breast cancer susceptibility loci.\u00a0However, biomarkers for risk assessment are still missing. Here, we investigated cancer-related molecular changes detected in tissues from women at high risk for breast cancer prior to disease manifestation. Disease-free breast tissue cores donated by healthy women (N\u2009=\u2009146, median age\u2009=\u200939\u00a0years) were processed for both methylome (MethylCap) and transcriptome (Illumina's HiSeq4000) sequencing. Analysis of tissue microarray and primary breast epithelial cells was used to confirm gene expression dysregulation.", "@Label": "BACKGROUND"}, {"#text": "Transcriptomic analysis identified 69 differentially expressed genes between women at high and those at average risk of breast cancer (Tyrer-Cuzick model) at FDR\u2009<\u20090.05 and fold change\u2009\u2265\u20092. Majority of the identified genes were involved in DNA damage checkpoint, cell cycle, and cell adhesion. Two genes, FAM83A and NEK2, were overexpressed in tissue sections (FDR\u2009<\u20090.01) and primary epithelial cells (p\u2009<\u20090.05) from high-risk breasts. Moreover, 1698 DNA methylation changes were identified in high-risk breast tissues (FDR\u2009<\u20090.05), partially overlapped with cancer-related signatures, and correlated with transcriptional changes (p\u2009<\u20090.05, r\u2009\u2264\u20090.5). Finally, among the participants, 35 women donated breast biopsies at two time points, and age-related molecular alterations enhanced in high-risk subjects were identified.", "@Label": "RESULTS"}, {"#text": "Normal breast tissue from women at high risk of breast cancer bears molecular aberrations that may contribute to breast cancer susceptibility. This study is the first molecular characterization of the true normal breast tissues, and provides an opportunity to investigate molecular markers of breast cancer risk, which may lead to new preventive approaches.", "@Label": "CONCLUSIONS"}], "CopyrightInformation": "\u00a9 2022. The Author(s)."}, "ArticleDate": {"@DateType": "Electronic", "Day": "09", "Month": "02", "Year": "2022"}, "ArticleTitle": "Aberrant epigenetic and transcriptional events associated with breast cancer risk.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Susan G. Komen Tissue Bank at the IU Simon Comprehensive Cancer Center, Indianapolis, IN, 46202, USA. marinon@iu.edu."}, {"Affiliation": "Department of Medicine, Hematology/Oncology Division, Indiana University School of Medicine, Indianapolis, IN, 46202, USA. marinon@iu.edu."}], "ForeName": "Natascia", "Identifier": {"#text": "0000-0001-6771-8963", "@Source": "ORCID"}, "Initials": "N", "LastName": "Marino"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Susan G. Komen Tissue Bank at the IU Simon Comprehensive Cancer Center, Indianapolis, IN, 46202, USA."}, "ForeName": "Rana", "Initials": "R", "LastName": "German"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Center for Genomics and Bioinformatics, Indiana University, Bloomington, IN, 47405, USA."}, "ForeName": "Ram", "Initials": "R", "LastName": "Podicheti"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Center for Genomics and Bioinformatics, Indiana University, Bloomington, IN, 47405, USA."}, "ForeName": "Douglas B", "Initials": "DB", "LastName": "Rusch"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Susan G. Komen Tissue Bank at the IU Simon Comprehensive Cancer Center, Indianapolis, IN, 46202, USA."}, "ForeName": "Pam", "Initials": "P", "LastName": "Rockey"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Center for Genomics and Bioinformatics, Indiana University, Bloomington, IN, 47405, USA."}, "ForeName": "Jie", "Initials": "J", "LastName": "Huang"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, 46202, USA."}, "ForeName": "George E", "Initials": "GE", "LastName": "Sandusky"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, 46202, USA."}, "ForeName": "Constance J", "Initials": "CJ", "LastName": "Temm"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis, IN, 46202, USA."}, "ForeName": "Sandra", "Initials": "S", "LastName": "Althouse"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Anatomy, Cell Biology, & Physiology, Indiana University, Bloomington, IN, 47405, USA."}, "ForeName": "Kenneth P", "Initials": "KP", "LastName": "Nephew"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Surgery, Indiana University School of Medicine, Indianapolis, IN, 46202, USA."}, "ForeName": "Harikrishna", "Initials": "H", "LastName": "Nakshatri"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Center for Genomics and Bioinformatics, Indiana University, Bloomington, IN, 47405, USA."}, "ForeName": "Jun", "Initials": "J", "LastName": "Liu"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Susan G. Komen Tissue Bank at the IU Simon Comprehensive Cancer Center, Indianapolis, IN, 46202, USA."}, "ForeName": "Ashley", "Initials": "A", "LastName": "Vode"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis, IN, 46202, USA."}, "ForeName": "Sha", "Initials": "S", "LastName": "Cao"}, {"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Susan G. Komen Tissue Bank at the IU Simon Comprehensive Cancer Center, Indianapolis, IN, 46202, USA."}, {"Affiliation": "Department of Medicine, Hematology/Oncology Division, Indiana University School of Medicine, Indianapolis, IN, 46202, USA."}], "ForeName": "Anna Maria V", "Initials": "AMV", "LastName": "Storniolo"}]}, "ELocationID": [{"#text": "21", "@EIdType": "pii", "@ValidYN": "Y"}, {"#text": "10.1186/s13148-022-01239-1", "@EIdType": "doi", "@ValidYN": "Y"}], "Journal": {"ISOAbbreviation": "Clin Epigenetics", "ISSN": {"#text": "1868-7083", "@IssnType": "Electronic"}, "JournalIssue": {"@CitedMedium": "Internet", "Issue": "1", "PubDate": {"Day": "09", "Month": "Feb", "Year": "2022"}, "Volume": "14"}, "Title": "Clinical epigenetics"}, "Language": "eng", "Pagination": {"MedlinePgn": "21", "StartPage": "21"}, "PublicationTypeList": {"PublicationType": [{"#text": "Journal Article", "@UI": "D016428"}, {"#text": "Research Support, Non-U.S. Gov't", "@UI": "D013485"}]}}, "ChemicalList": {"Chemical": {"NameOfSubstance": {"#text": "Biomarkers, Tumor", "@UI": "D014408"}, "RegistryNumber": "0"}}, "CitationSubset": "IM", "CoiStatement": "The authors have no conflicts of interest to disclose.", "DateCompleted": {"Day": "23", "Month": "02", "Year": "2022"}, "DateRevised": {"Day": "23", "Month": "02", "Year": "2022"}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"#text": "Cancer risk", "@MajorTopicYN": "N"}, {"#text": "DNA methylation", "@MajorTopicYN": "N"}, {"#text": "Normal breast", "@MajorTopicYN": "N"}, {"#text": "Transcriptome", "@MajorTopicYN": "N"}]}, "MedlineJournalInfo": {"Country": "Germany", "ISSNLinking": "1868-7075", "MedlineTA": "Clin Epigenetics", "NlmUniqueID": "101516977"}, "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"#text": "Adult", "@MajorTopicYN": "N", "@UI": "D000328"}}, {"DescriptorName": {"#text": "Biomarkers, Tumor", "@MajorTopicYN": "N", "@UI": "D014408"}, "QualifierName": [{"#text": "analysis", "@MajorTopicYN": "N", "@UI": "Q000032"}, {"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}]}, {"DescriptorName": {"#text": "Breast Neoplasms", "@MajorTopicYN": "N", "@UI": "D001943"}, "QualifierName": [{"#text": "diagnosis", "@MajorTopicYN": "Y", "@UI": "Q000175"}, {"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}, {"#text": "physiopathology", "@MajorTopicYN": "N", "@UI": "Q000503"}]}, {"DescriptorName": {"#text": "Cohort Studies", "@MajorTopicYN": "N", "@UI": "D015331"}}, {"DescriptorName": {"#text": "DNA Methylation", "@MajorTopicYN": "N", "@UI": "D019175"}, "QualifierName": [{"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}, {"#text": "physiology", "@MajorTopicYN": "N", "@UI": "Q000502"}]}, {"DescriptorName": {"#text": "Epigenesis, Genetic", "@MajorTopicYN": "N", "@UI": "D044127"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Female", "@MajorTopicYN": "N", "@UI": "D005260"}}, {"DescriptorName": {"#text": "Genome-Wide Association Study", "@MajorTopicYN": "N", "@UI": "D055106"}, "QualifierName": [{"#text": "methods", "@MajorTopicYN": "N", "@UI": "Q000379"}, {"#text": "statistics & numerical data", "@MajorTopicYN": "N", "@UI": "Q000706"}]}, {"DescriptorName": {"#text": "Humans", "@MajorTopicYN": "N", "@UI": "D006801"}}, {"DescriptorName": {"#text": "Middle Aged", "@MajorTopicYN": "N", "@UI": "D008875"}}, {"DescriptorName": {"#text": "Risk Assessment", "@MajorTopicYN": "N", "@UI": "D018570"}, "QualifierName": [{"#text": "methods", "@MajorTopicYN": "Y", "@UI": "Q000379"}, {"#text": "statistics & numerical data", "@MajorTopicYN": "N", "@UI": "Q000706"}]}, {"DescriptorName": {"#text": "Transcriptional Activation", "@MajorTopicYN": "N", "@UI": "D015533"}, "QualifierName": [{"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}, {"#text": "physiology", "@MajorTopicYN": "N", "@UI": "Q000502"}]}]}, "PMID": {"#text": "35139887", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "35139887", "@IdType": "pubmed"}, {"#text": "PMC8830042", "@IdType": "pmc"}, {"#text": "10.1186/s13148-022-01239-1", "@IdType": "doi"}, {"#text": "10.1186/s13148-022-01239-1", "@IdType": "pii"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "received", "Day": "10", "Month": "9", "Year": "2021"}, {"@PubStatus": "accepted", "Day": "25", "Month": "1", "Year": "2022"}, {"@PubStatus": "entrez", "Day": "10", "Hour": "5", "Minute": "29", "Month": "2", "Year": "2022"}, {"@PubStatus": "pubmed", "Day": "11", "Hour": "6", "Minute": "0", "Month": "2", "Year": "2022"}, {"@PubStatus": "medline", "Day": "24", "Hour": "6", "Minute": "0", "Month": "2", "Year": "2022"}]}, "PublicationStatus": "epublish", "ReferenceList": {"Reference": [{"ArticleIdList": {"ArticleId": [{"#text": "PMC5798588", "@IdType": "pmc"}, {"#text": "29059683", "@IdType": "pubmed"}]}, "Citation": "Michailidou K, Lindstrom S, Dennis J, Beesley J, Hui S, Kar S, et al. Association analysis identifies 65 new breast cancer risk loci. Nature. 2017;551(7678):92\u201394."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5808456", "@IdType": "pmc"}, {"#text": "29058716", "@IdType": "pubmed"}]}, "Citation": "Milne RL, Kuchenbaecker KB, Michailidou K, Beesley J, Kar S, Lindstrom S, et al. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. Nat Genet. 2017;49(12):1767\u20131778."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC8127622", "@IdType": "pmc"}, {"#text": "33471974", "@IdType": "pubmed"}]}, "Citation": "Hu C, Hart SN, Gnanaolivu R, Huang H, Lee KY, Na J, et al. A population-based study of genes previously implicated in breast cancer. N Engl J Med. 2021."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC7611105", "@IdType": "pmc"}, {"#text": "33471991", "@IdType": "pubmed"}]}, "Citation": "Breast Cancer Association C, Dorling L, Carvalho S, Allen J, Gonzalez-Neira A, Luccarini C, et al. Breast Cancer Risk Genes\u2014Association Analysis in More than 113,000 Women. N Engl J Med. 2021;384(5):428\u201339."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC7987299", "@IdType": "pmc"}, {"#text": "32115800", "@IdType": "pubmed"}]}, "Citation": "Feng H, Gusev A, Pasaniuc B, Wu L, Long J, Abu-Full Z, et al. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status. Genet Epidemiol. 2020;44(5):442\u2013468."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6465407", "@IdType": "pmc"}, {"#text": "30988301", "@IdType": "pubmed"}]}, "Citation": "Ferreira MA, Gamazon ER, Al-Ejeh F, Aittomaki K, Andrulis IL, Anton-Culver H, et al. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer. Nat Commun. 2019;10(1):1741."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5619687", "@IdType": "pmc"}, {"#text": "28957356", "@IdType": "pubmed"}]}, "Citation": "Gao G, Pierce BL, Olopade OI, Im HK, Huo D. Trans-ethnic predicted expression genome-wide association analysis identifies a gene for estrogen receptor-negative breast cancer. PLoS Genet. 2017;13(9):e1006727."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5391966", "@IdType": "pmc"}, {"#text": "28362817", "@IdType": "pubmed"}]}, "Citation": "Hoffman JD, Graff RE, Emami NC, Tai CG, Passarelli MN, Hu D, et al. Cis-eQTL-based trans-ethnic meta-analysis reveals novel genes associated with breast cancer risk. PLoS Genet. 2017;13(3):e1006690."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6314198", "@IdType": "pmc"}, {"#text": "29915430", "@IdType": "pubmed"}]}, "Citation": "Wu L, Shi W, Long J, Guo X, Michailidou K, Beesley J, et al. A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer. Nat Genet. 2018;50(7):968\u2013978."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6324778", "@IdType": "pmc"}, {"#text": "30647841", "@IdType": "pubmed"}]}, "Citation": "Kothari C, Ouellette G, Labrie Y, Jacob S, Diorio C, Durocher F. Identification of a gene signature for different stages of breast cancer development that could be used for early diagnosis and specific therapy. Oncotarget. 2018;9(100):37407\u201337420."}, {"ArticleIdList": {"ArticleId": {"#text": "23463313", "@IdType": "pubmed"}}, "Citation": "Cantone I, Fisher AG. Epigenetic programming and reprogramming during development. Nat Struct Mol Biol. 2013;20(3):282\u2013289."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3471399", "@IdType": "pmc"}, {"#text": "22843497", "@IdType": "pubmed"}]}, "Citation": "Hansmann T, Pliushch G, Leubner M, Kroll P, Endt D, Gehrig A, et al. Constitutive promoter methylation of BRCA1 and RAD51C in patients with familial ovarian cancer and early-onset sporadic breast cancer. Hum Mol Genet. 2012;21(21):4669\u20134679."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3894624", "@IdType": "pmc"}, {"#text": "17320506", "@IdType": "pubmed"}]}, "Citation": "Jones PA, Baylin SB. The epigenomics of cancer. Cell. 2007;128(4):683\u2013692."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC7538898", "@IdType": "pmc"}, {"#text": "33083529", "@IdType": "pubmed"}]}, "Citation": "Marino N, German R, Rao X, Simpson E, Liu S, Wan J, et al. Upregulation of lipid metabolism genes in the breast prior to cancer diagnosis. NPJ Breast Cancer. 2020;6:50."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3003008", "@IdType": "pmc"}, {"#text": "21118987", "@IdType": "pubmed"}]}, "Citation": "Latimer JJ, Johnson JM, Kelly CM, Miles TD, Beaudry-Rodgers KA, Lalanne NA, et al. Nucleotide excision repair deficiency is intrinsic in sporadic stage I breast cancer. Proc Natl Acad Sci USA. 2010;107(50):21725\u201321730."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6884575", "@IdType": "pmc"}, {"#text": "31815181", "@IdType": "pubmed"}]}, "Citation": "Ziegler Y, Laws MJ, Sanabria Guillen V, Kim SH, Dey P, Smith BP, et al. Suppression of FOXM1 activities and breast cancer growth in vitro and in vivo by a new class of compounds. NPJ Breast Cancer. 2019;5:45."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3440846", "@IdType": "pmc"}, {"#text": "22522925", "@IdType": "pubmed"}]}, "Citation": "Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 2012;486(7403):346\u2013352."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4866047", "@IdType": "pmc"}, {"#text": "27161491", "@IdType": "pubmed"}]}, "Citation": "Pereira B, Chin SF, Rueda OM, Vollan HK, Provenzano E, Bardwell HA, et al. The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes. Nat Commun. 2016;7:11479."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5384236", "@IdType": "pmc"}, {"#text": "28387367", "@IdType": "pubmed"}]}, "Citation": "Piazza R, Ramazzotti D, Spinelli R, Pirola A, De Sano L, Ferrari P, et al. OncoScore: a novel, Internet-based tool to assess the oncogenic potential of genes. Sci Rep. 2017;7:46290."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6125218", "@IdType": "pmc"}, {"#text": "29997232", "@IdType": "pubmed"}]}, "Citation": "Kumar B, Prasad M, Bhat-Nakshatri P, Anjanappa M, Kalra M, Marino N, et al. Normal breast-derived epithelial cells with luminal and intrinsic subtype-enriched gene expression document interindividual differences in their differentiation cascade. Cancer Res. 2018;78(17):5107\u20135123."}, {"ArticleIdList": {"ArticleId": {"#text": "28225755", "@IdType": "pubmed"}}, "Citation": "Neri F, Rapelli S, Krepelova A, Incarnato D, Parlato C, Basile G, et al. Intragenic DNA methylation prevents spurious transcription initiation. Nature. 2017;543(7643):72\u201377."}, {"ArticleIdList": {"ArticleId": {"#text": "23064414", "@IdType": "pubmed"}}, "Citation": "Kulis M, Heath S, Bibikova M, Queiros AC, Navarro A, Clot G, et al. Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia. Nat Genet. 2012;44(11):1236\u20131242."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3621754", "@IdType": "pmc"}, {"#text": "22580612", "@IdType": "pubmed"}]}, "Citation": "Kufe DW. MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches. Oncogene. 2013;32(9):1073\u20131081."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6313072", "@IdType": "pmc"}, {"#text": "30483806", "@IdType": "pubmed"}]}, "Citation": "Jing X, Liang H, Hao C, Yang X, Cui X. Overexpression of MUC1 predicts poor prognosis in patients with breast cancer. Oncol Rep. 2019;41(2):801\u2013810."}, {"ArticleIdList": {"ArticleId": {"#text": "30355485", "@IdType": "pubmed"}}, "Citation": "Saghafinia S, Mina M, Riggi N, Hanahan D, Ciriello G. Pan-cancer landscape of aberrant DNA methylation across human tumors. Cell Rep. 2018;25(4):1066\u201380 e8."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6839140", "@IdType": "pmc"}, {"#text": "31699026", "@IdType": "pubmed"}]}, "Citation": "Chen X, Zhang J, Dai X. DNA methylation profiles capturing breast cancer heterogeneity. BMC Genomics. 2019;20(1):823."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6416975", "@IdType": "pmc"}, {"#text": "30866861", "@IdType": "pubmed"}]}, "Citation": "de Almeida BP, Apolonio JD, Binnie A, Castelo-Branco P. Roadmap of DNA methylation in breast cancer identifies novel prognostic biomarkers. BMC Cancer. 2019;19(1):219."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC7489106", "@IdType": "pmc"}, {"#text": "30989176", "@IdType": "pubmed"}]}, "Citation": "Xu Z, Sandler DP, Taylor JA. Blood DNA methylation and breast cancer: a prospective case-cohort analysis in the sister study. J Natl Cancer Inst. 2020;112(1):87\u201394."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5504720", "@IdType": "pmc"}, {"#text": "28693600", "@IdType": "pubmed"}]}, "Citation": "Johnson KC, Houseman EA, King JE, Christensen BC. Normal breast tissue DNA methylation differences at regulatory elements are associated with the cancer risk factor age. Breast Cancer Res. 2017;19(1):81."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5487725", "@IdType": "pmc"}, {"#text": "28364215", "@IdType": "pubmed"}]}, "Citation": "Sehl ME, Henry JE, Storniolo AM, Ganz PA, Horvath S. DNA methylation age is elevated in breast tissue of healthy women. Breast Cancer Res Treat. 2017;164(1):209\u2013219."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4015143", "@IdType": "pmc"}, {"#text": "24138928", "@IdType": "pubmed"}]}, "Citation": "Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013;14(10):R115."}, {"ArticleIdList": {"ArticleId": {"#text": "15057881", "@IdType": "pubmed"}}, "Citation": "Tyrer J, Duffy SW, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med. 2004;23(7):1111\u20131130."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC7970065", "@IdType": "pmc"}, {"#text": "33657372", "@IdType": "pubmed"}]}, "Citation": "Branigan TB, Kozono D, Schade AE, Deraska P, Rivas HG, Sambel L, et al. MMB-FOXM1-driven premature mitosis is required for CHK1 inhibitor sensitivity. Cell Rep. 2021;34(9):108808."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6025793", "@IdType": "pmc"}, {"#text": "29789297", "@IdType": "pubmed"}]}, "Citation": "Fulcher LJ, Bozatzi P, Tachie-Menson T, Wu KZL, Cummins TD, Bufton JC, et al. The DUF1669 domain of FAM83 family proteins anchor casein kinase 1 isoforms. Sci Signal. 2018;11:531."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3428078", "@IdType": "pmc"}, {"#text": "22886302", "@IdType": "pubmed"}]}, "Citation": "Cipriano R, Graham J, Miskimen KL, Bryson BL, Bruntz RC, Scott SA, et al. FAM83B mediates EGFR- and RAS-driven oncogenic transformation. J Clin Invest. 2012;122(9):3197\u20133210."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4135001", "@IdType": "pmc"}, {"#text": "24736947", "@IdType": "pubmed"}]}, "Citation": "Cipriano R, Miskimen KL, Bryson BL, Foy CR, Bartel CA, Jackson MW. Conserved oncogenic behavior of the FAM83 family regulates MAPK signaling in human cancer. Mol Cancer Res. 2014;12(8):1156\u20131165."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6746704", "@IdType": "pmc"}, {"#text": "31527715", "@IdType": "pubmed"}]}, "Citation": "Parameswaran N, Bartel CA, Hernandez-Sanchez W, Miskimen KL, Smigiel JM, Khalil AM, et al. A FAM83A positive feed-back loop drives survival and tumorigenicity of pancreatic ductal adenocarcinomas. Sci Rep. 2019;9(1):13396."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5413028", "@IdType": "pmc"}, {"#text": "28463969", "@IdType": "pubmed"}]}, "Citation": "Bartel CA, Jackson MW. HER2-positive breast cancer cells expressing elevated FAM83A are sensitive to FAM83A loss. PLoS ONE. 2017;12(5):e0176778."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6562954", "@IdType": "pmc"}, {"#text": "31083571", "@IdType": "pubmed"}]}, "Citation": "Richtmann S, Wilkens D, Warth A, Lasitschka F, Winter H, Christopoulos P, et al. FAM83A and FAM83B as prognostic biomarkers and potential new therapeutic targets in NSCLC. Cancers (Basel). 2019;11(5)."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC7066079", "@IdType": "pmc"}, {"#text": "32195172", "@IdType": "pubmed"}]}, "Citation": "Zheng YW, Li ZH, Lei L, Liu CC, Wang Z, Fei LR, et al. FAM83A promotes lung cancer progression by regulating the wnt and hippo signaling pathways and indicates poor prognosis. Front Oncol. 2020;10:180."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5527452", "@IdType": "pmc"}, {"#text": "28078827", "@IdType": "pubmed"}]}, "Citation": "Snijders AM, Lee SY, Hang B, Hao W, Bissell MJ, Mao JH. FAM83 family oncogenes are broadly involved in human cancers: an integrative multi-omics approach. Mol Oncol. 2017;11(2):167\u2013179."}, {"ArticleIdList": {"ArticleId": {"#text": "31594212", "@IdType": "pubmed"}}, "Citation": "Zhang J, Sun G, Mei X. Elevated FAM83A expression predicts poorer clincal outcome in lung adenocarcinoma. Cancer Biomark. 2019;26(3):367\u2013373."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC7746878", "@IdType": "pmc"}, {"#text": "33344485", "@IdType": "pubmed"}]}, "Citation": "Rong L, Li H, Li Z, Ouyang J, Ma Y, Song F, et al. FAM83A as a potential biological marker is regulated by miR-206 to promote cervical cancer progression through PI3K/AKT/mTOR pathway. Front Med (Lausanne) 2020;7:608441."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC1410752", "@IdType": "pmc"}, {"#text": "16280042", "@IdType": "pubmed"}]}, "Citation": "Pawitan Y, Bjohle J, Amler L, Borg AL, Egyhazi S, Hall P, et al. Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts. Breast Cancer Res. 2005;7(6):R953\u2013R964."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3428077", "@IdType": "pmc"}, {"#text": "22886303", "@IdType": "pubmed"}]}, "Citation": "Lee SY, Meier R, Furuta S, Lenburg ME, Kenny PA, Xu R, et al. FAM83A confers EGFR-TKI resistance in breast cancer cells and in mice. J Clin Invest. 2012;122(9):3211\u20133220."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3428099", "@IdType": "pmc"}, {"#text": "22886299", "@IdType": "pubmed"}]}, "Citation": "Grant S. FAM83A and FAM83B: candidate oncogenes and TKI resistance mediators. J Clin Invest. 2012;122(9):3048\u20133051."}, {"ArticleIdList": {"ArticleId": {"#text": "16084011", "@IdType": "pubmed"}}, "Citation": "Hayward DG, Fry AM. Nek2 kinase in chromosome instability and cancer. Cancer Lett. 2006;237(2):155\u2013166."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5533946", "@IdType": "pmc"}, {"#text": "28287611", "@IdType": "pubmed"}]}, "Citation": "Chen S, Huang J, Liu Z, Liang Q, Zhang N, Jin Y. FAM83A is amplified and promotes cancer stem cell-like traits and chemoresistance in pancreatic cancer. Oncogenesis. 2017;6(3):e300."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3500863", "@IdType": "pmc"}, {"#text": "23132929", "@IdType": "pubmed"}]}, "Citation": "Fry AM, O'Regan L, Sabir SR, Bayliss R. Cell cycle regulation by the NEK family of protein kinases. J Cell Sci. 2012;125(Pt 19):4423\u20134433."}, {"ArticleIdList": {"ArticleId": {"#text": "15492258", "@IdType": "pubmed"}}, "Citation": "Hayward DG, Clarke RB, Faragher AJ, Pillai MR, Hagan IM, Fry AM. The centrosomal kinase Nek2 displays elevated levels of protein expression in human breast cancer. Cancer Res. 2004;64(20):7370\u20137376."}, {"ArticleIdList": {"ArticleId": {"#text": "31092416", "@IdType": "pubmed"}}, "Citation": "Kokuryo T, Yokoyama Y, Yamaguchi J, Tsunoda N, Ebata T, Nagino M. NEK2 Is an effective target for cancer therapy with potential to induce regression of multiple human malignancies. Anticancer Res. 2019;39(5):2251\u20132258."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4889274", "@IdType": "pmc"}, {"#text": "27019372", "@IdType": "pubmed"}]}, "Citation": "Fang Y, Zhang X. Targeting NEK2 as a promising therapeutic approach for cancer treatment. Cell Cycle. 2016;15(7):895\u2013907."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4258842", "@IdType": "pmc"}, {"#text": "25387393", "@IdType": "pubmed"}]}, "Citation": "Gormally MV, Dexheimer TS, Marsico G, Sanders DA, Lowe C, Matak-Vinkovic D, et al. Suppression of the FOXM1 transcriptional programme via novel small molecule inhibition. Nat Commun. 2014;5:5165."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3568974", "@IdType": "pmc"}, {"#text": "20682973", "@IdType": "pubmed"}]}, "Citation": "Cho YH, Yazici H, Wu HC, Terry MB, Gonzalez K, Qu M, et al. Aberrant promoter hypermethylation and genomic hypomethylation in tumor, adjacent normal tissues and blood from breast cancer patients. Anticancer Res. 2010;30(7):2489\u20132496."}, {"ArticleIdList": {"ArticleId": {"#text": "10749912", "@IdType": "pubmed"}}, "Citation": "Esteller M, Silva JM, Dominguez G, Bonilla F, Matias-Guiu X, Lerma E, et al. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst. 2000;92(7):564\u2013569."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2655767", "@IdType": "pmc"}, {"#text": "19153073", "@IdType": "pubmed"}]}, "Citation": "Flanagan JM, Munoz-Alegre M, Henderson S, Tang T, Sun P, Johnson N, et al. Gene-body hypermethylation of ATM in peripheral blood DNA of bilateral breast cancer patients. Hum Mol Genet. 2009;18(7):1332\u20131342."}, {"ArticleIdList": {"ArticleId": {"#text": "18281473", "@IdType": "pubmed"}}, "Citation": "Potapova A, Hoffman AM, Godwin AK, Al-Saleem T, Cairns P. Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer. Cancer Res. 2008;68(4):998\u20131002."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2777956", "@IdType": "pmc"}, {"#text": "19918057", "@IdType": "pubmed"}]}, "Citation": "Eswaran J, Patnaik D, Filippakopoulos P, Wang F, Stein RL, Murray JW, et al. Structure and functional characterization of the atypical human kinase haspin. Proc Natl Acad Sci U S A. 2009;106(48):20198\u201320203."}, {"ArticleIdList": {"ArticleId": {"#text": "31912902", "@IdType": "pubmed"}}, "Citation": "Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7\u201330."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC7650528", "@IdType": "pmc"}, {"#text": "32883324", "@IdType": "pubmed"}]}, "Citation": "Teschendorff AE, Zhu T, Breeze CE, Beck S. EPISCORE: cell type deconvolution of bulk tissue DNA methylomes from single-cell RNA-Seq data. Genome Biol. 2020;21(1):221."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6610714", "@IdType": "pmc"}, {"#text": "31061481", "@IdType": "pubmed"}]}, "Citation": "Newman AM, Steen CB, Liu CL, Gentles AJ, Chaudhuri AA, Scherer F, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019;37(7):773\u2013782."}, {"ArticleIdList": {"ArticleId": {"#text": "32498779", "@IdType": "pubmed"}}, "Citation": "McClintock AH, Golob AL, Laya MB. Breast cancer risk assessment: a step-wise approach for primary care providers on the front lines of shared decision Making. Mayo Clin Proc. 2020;95(6):1268\u20131275."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3530905", "@IdType": "pmc"}, {"#text": "23104886", "@IdType": "pubmed"}]}, "Citation": "Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15\u201321."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2705234", "@IdType": "pmc"}, {"#text": "19451168", "@IdType": "pubmed"}]}, "Citation": "Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25(14):1754\u20131760."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5516887", "@IdType": "pmc"}, {"#text": "28522752", "@IdType": "pubmed"}]}, "Citation": "Maiuri AR, Peng M, Podicheti R, Sriramkumar S, Kamplain CM, Rusch DB, et al. Mismatch repair proteins initiate epigenetic alterations during inflammation-driven tumorigenesis. Cancer Res. 2017;77(13):3467\u20133478."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6791707", "@IdType": "pmc"}, {"#text": "31240997", "@IdType": "pubmed"}]}, "Citation": "Maiuri AR, Savant SS, Podicheti R, Rusch DB, O'Hagan HM. DNA methyltransferase inhibition reduces inflammation-induced colon tumorigenesis. Epigenetics. 2019;14(12):1209\u20131223."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC1907322", "@IdType": "pmc"}, {"#text": "12707371", "@IdType": "pubmed"}]}, "Citation": "Cheadle C, Vawter MP, Freed WJ, Becker KG. Analysis of microarray data using Z score transformation. J Mol Diagn. 2003;5(2):73\u201381."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3928520", "@IdType": "pmc"}, {"#text": "24336805", "@IdType": "pubmed"}]}, "Citation": "Kramer A, Green J, Pollard J, Jr, Tugendreich S. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics. 2014;30(4):523\u2013530."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5516091", "@IdType": "pmc"}, {"#text": "28732212", "@IdType": "pubmed"}]}, "Citation": "Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi B, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19(8):649\u2013658."}, {"ArticleIdList": {"ArticleId": {"#text": "30718355", "@IdType": "pubmed"}}, "Citation": "Nakshatri H, Kumar B, Burney HN, Cox ML, Jacobsen M, Sandusky GE, et al. Genetic ancestry-dependent differences in breast cancer-induced field defects in the tumor-adjacent normal breast. Clin Cancer Res. 2019;25(9):2848\u20132859."}, {"ArticleIdList": {"ArticleId": {"#text": "12121239", "@IdType": "pubmed"}}, "Citation": "Sandusky GE, Mintze KS, Pratt SE, Dantzig AH. Expression of multidrug resistance-associated protein 2 (MRP2) in normal human tissues and carcinomas using tissue microarrays. Histopathology. 2002;41(1):65\u201374."}]}}}}}, "PMC": "PMC8830042", "PMID": "35139887", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "Aberrant epigenetic and transcriptional events associated with breast cancer risk.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "7": {"Abstract": "Breast cancer is the most significant threat to female health. Breast cancer metastasis is the major cause of mortality in breast cancer patients. To fully unravel the molecular mechanisms that underlie the breast cancer cell metastasis is critical for developing strategies to improve survival and prognosis in breast cancer patients. Recent studies have revealed that the long noncoding RNAs (lncRNAs) are involved in breast cancer metastasis through a variety of molecule mechanisms, though the precise functional details of these lncRNAs are yet to be clarified. In the present review, we focus on the functions of lncRNAs in breast cancer invasion and metastasis, with particular emphasis on the functional properties, the regulatory factors, the therapeutic promise, as well as the future challenges in studying these lncRNA.", "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "-6475567956146669644", "Part1": "The Key Laboratory of Molecular Epigenetics of Ministry of Education (MOE)", "Part2": "Northeast Normal University", "Part3": "Changchun", "Part4": "China.", "Part5": null, "Part6": null, "Text": "The Key Laboratory of Molecular Epigenetics of Ministry of Education (MOE), Northeast Normal University, Changchun, China."}], "ForeName": "Lingxia", "FullName": "Lingxia Liu", "HashID": "-1375937533520717604", "LastName": "Liu", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "8881670954277129211", "Part1": "The Institute of Genetics and Cytology", "Part2": "Northeast Normal University", "Part3": "Changchun", "Part4": "China. zhangy288@nenu.edu.cn.", "Part5": null, "Part6": null, "Text": "The Institute of Genetics and Cytology, Northeast Normal University, Changchun, China. zhangy288@nenu.edu.cn."}], "ForeName": "Yu", "FullName": "Yu Zhang", "HashID": "-1596817536831927300", "LastName": "Zhang", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "5248111168196474073", "Part1": "The Key Laboratory of Molecular Epigenetics of Ministry of Education (MOE)", "Part2": "Northeast Normal University", "Part3": "Changchun", "Part4": "China. luj809@nenu.edu.cn.", "Part5": null, "Part6": null, "Text": "The Key Laboratory of Molecular Epigenetics of Ministry of Education (MOE), Northeast Normal University, Changchun, China. luj809@nenu.edu.cn."}], "ForeName": "Jun", "FullName": "Jun Lu", "HashID": "-1810085091259892543", "LastName": "Lu", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.1038/s41419-020-02954-4", "InsertType": null, "Journal": "Cell death & disease", "Keywords": [{"IS_Major": false, "IS_Mesh": true, "Text": "Breast Neoplasms"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Cell Movement"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Female"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Humans"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Neoplasm Metastasis"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Prognosis"}, {"IS_Major": false, "IS_Mesh": true, "Text": "RNA, Long Noncoding"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "MEDLINE", "Article": {"@PubModel": "Electronic", "Abstract": {"AbstractText": "Breast cancer is the most significant threat to female health. Breast cancer metastasis is the major cause of mortality in breast cancer patients. To fully unravel the molecular mechanisms that underlie the breast cancer cell metastasis is critical for developing strategies to improve survival and prognosis in breast cancer patients. Recent studies have revealed that the long noncoding RNAs (lncRNAs) are involved in breast cancer metastasis through a variety of molecule mechanisms, though the precise functional details of these lncRNAs are yet to be clarified. In the present review, we focus on the functions of lncRNAs in breast cancer invasion and metastasis, with particular emphasis on the functional properties, the regulatory factors, the therapeutic promise, as well as the future challenges in studying these lncRNA."}, "ArticleDate": {"@DateType": "Electronic", "Day": "14", "Month": "09", "Year": "2020"}, "ArticleTitle": "The roles of long noncoding RNAs in breast cancer metastasis.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "The Key Laboratory of Molecular Epigenetics of Ministry of Education (MOE), Northeast Normal University, Changchun, China."}, "ForeName": "Lingxia", "Initials": "L", "LastName": "Liu"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "The Institute of Genetics and Cytology, Northeast Normal University, Changchun, China. zhangy288@nenu.edu.cn."}, "ForeName": "Yu", "Initials": "Y", "LastName": "Zhang"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "The Key Laboratory of Molecular Epigenetics of Ministry of Education (MOE), Northeast Normal University, Changchun, China. luj809@nenu.edu.cn."}, "ForeName": "Jun", "Initials": "J", "LastName": "Lu"}]}, "ELocationID": [{"#text": "749", "@EIdType": "pii", "@ValidYN": "Y"}, {"#text": "10.1038/s41419-020-02954-4", "@EIdType": "doi", "@ValidYN": "Y"}], "Journal": {"ISOAbbreviation": "Cell Death Dis", "ISSN": {"#text": "2041-4889", "@IssnType": "Electronic"}, "JournalIssue": {"@CitedMedium": "Internet", "Issue": "9", "PubDate": {"Day": "14", "Month": "Sep", "Year": "2020"}, "Volume": "11"}, "Title": "Cell death & disease"}, "Language": "eng", "Pagination": {"MedlinePgn": "749", "StartPage": "749"}, "PublicationTypeList": {"PublicationType": [{"#text": "Journal Article", "@UI": "D016428"}, {"#text": "Research Support, Non-U.S. Gov't", "@UI": "D013485"}, {"#text": "Review", "@UI": "D016454"}]}}, "ChemicalList": {"Chemical": {"NameOfSubstance": {"#text": "RNA, Long Noncoding", "@UI": "D062085"}, "RegistryNumber": "0"}}, "CitationSubset": "IM", "CoiStatement": "The authors declare that they have no conflict of interest.", "DateCompleted": {"Day": "20", "Month": "04", "Year": "2021"}, "DateRevised": {"Day": "14", "Month": "09", "Year": "2021"}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Cell Death Dis", "NlmUniqueID": "101524092"}, "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"#text": "Breast Neoplasms", "@MajorTopicYN": "N", "@UI": "D001943"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Cell Movement", "@MajorTopicYN": "N", "@UI": "D002465"}}, {"DescriptorName": {"#text": "Female", "@MajorTopicYN": "N", "@UI": "D005260"}}, {"DescriptorName": {"#text": "Humans", "@MajorTopicYN": "N", "@UI": "D006801"}}, {"DescriptorName": {"#text": "Neoplasm Metastasis", "@MajorTopicYN": "N", "@UI": "D009362"}}, {"DescriptorName": {"#text": "Prognosis", "@MajorTopicYN": "N", "@UI": "D011379"}}, {"DescriptorName": {"#text": "RNA, Long Noncoding", "@MajorTopicYN": "N", "@UI": "D062085"}, "QualifierName": {"#text": "metabolism", "@MajorTopicYN": "Y", "@UI": "Q000378"}}]}, "PMID": {"#text": "32929060", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "32929060", "@IdType": "pubmed"}, {"#text": "PMC7490374", "@IdType": "pmc"}, {"#text": "10.1038/s41419-020-02954-4", "@IdType": "doi"}, {"#text": "10.1038/s41419-020-02954-4", "@IdType": "pii"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "received", "Day": "12", "Month": "5", "Year": "2020"}, {"@PubStatus": "accepted", "Day": "27", "Month": "8", "Year": "2020"}, {"@PubStatus": "revised", "Day": "19", "Month": "8", "Year": "2020"}, {"@PubStatus": "entrez", "Day": "15", "Hour": "5", "Minute": "42", "Month": "9", "Year": "2020"}, {"@PubStatus": "pubmed", "Day": "16", "Hour": "6", "Minute": "0", "Month": "9", "Year": "2020"}, {"@PubStatus": "medline", "Day": "21", "Hour": "6", "Minute": "0", "Month": "4", "Year": "2021"}]}, "PublicationStatus": "epublish", "ReferenceList": {"Reference": [{"ArticleIdList": {"ArticleId": {"#text": "26808342", "@IdType": "pubmed"}}, "Citation": "Chen W, et al. Cancer statistics in China, 2015. CA Cancer J. Clin. 2016;66:115\u2013132."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC1064079", "@IdType": "pmc"}, {"#text": "15535852", "@IdType": "pubmed"}]}, "Citation": "Bray F, McCarron P, Parkin DM. The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res. 2004;6:229\u2013239.."}, {"ArticleIdList": {"ArticleId": {"#text": "17110329", "@IdType": "pubmed"}}, "Citation": "Gupta GP, Massague J. Cancer metastasis: building a framework. Cell. 2006;127:679\u2013695.."}, {"ArticleIdList": {"ArticleId": {"#text": "21376230", "@IdType": "pubmed"}}, "Citation": "Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u2013674.."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6316884", "@IdType": "pmc"}, {"#text": "30545127", "@IdType": "pubmed"}]}, "Citation": "Klinge, C. M. Non-voding RNAs in breast cancer: intracellular and intercellular communication. Noncoding RNA4, 40 (2018)."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6165837", "@IdType": "pmc"}, {"#text": "30217944", "@IdType": "pubmed"}]}, "Citation": "Zhou, S. et al. The regulatory roles of lncRNAs in the process of breast cancer invasion and metastasis. Biosci. Rep. 38, BSR20180772 (2018)."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6546402", "@IdType": "pmc"}, {"#text": "30874469", "@IdType": "pubmed"}]}, "Citation": "Arun G, Spector DL. MALAT1 long non-coding RNA and breast cancer. RNA Biol. 2019;16:860\u2013863."}, {"ArticleIdList": {"ArticleId": {"#text": "31048026", "@IdType": "pubmed"}}, "Citation": "Tomar D, et al. Non-coding RNAs as potential therapeutic targets in breast cancer. Biochim Biophys. Acta Gene Regul. Mech. 2020;1863:194378."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6233376", "@IdType": "pmc"}, {"#text": "30459529", "@IdType": "pubmed"}]}, "Citation": "Bin X, et al. Research progresses in roles of LncRNA and its relationships with breast cancer. Cancer Cell Int. 2018;18:179."}, {"ArticleIdList": {"ArticleId": {"#text": "28701486", "@IdType": "pubmed"}}, "Citation": "Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: a new paradigm. Cancer Res. 2017;77:3965\u20133981."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4417758", "@IdType": "pmc"}, {"#text": "25599403", "@IdType": "pubmed"}]}, "Citation": "Iyer MK, et al. The landscape of long noncoding RNAs in the human transcriptome. Nat. Genet. 2015;47:199\u2013208."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3199020", "@IdType": "pmc"}, {"#text": "21925379", "@IdType": "pubmed"}]}, "Citation": "Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol. Cell. 2011;43:904\u2013914.."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6466467", "@IdType": "pmc"}, {"#text": "30983509", "@IdType": "pubmed"}]}, "Citation": "Zhang T, et al. Long non-coding RNA and breast cancer. Technol. Cancer Res Treat. 2019;18:1533033819843889."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3040650", "@IdType": "pmc"}, {"#text": "21057500", "@IdType": "pubmed"}]}, "Citation": "Loewer S, et al. Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells. Nat. Genet. 2010;42:1113\u20131117."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3289881", "@IdType": "pmc"}, {"#text": "22302877", "@IdType": "pubmed"}]}, "Citation": "Kretz M, et al. Suppression of progenitor differentiation requires the long noncoding RNA ANCR. Genes Dev. 2012;26:338\u2013343."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4500257", "@IdType": "pmc"}, {"#text": "26080435", "@IdType": "pubmed"}]}, "Citation": "Salameh A, et al. PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3. Proc. Natl Acad. Sci. USA. 2015;112:8403\u20138408."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6859920", "@IdType": "pmc"}, {"#text": "31762940", "@IdType": "pubmed"}]}, "Citation": "Lemos AEG, et al. The long non-coding RNA PCA3: an update of its functions and clinical applications as a biomarker in prostate cancer. Oncotarget. 2019;10:6589\u20136603."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5303624", "@IdType": "pmc"}, {"#text": "28132848", "@IdType": "pubmed"}]}, "Citation": "Kim DH, Sung S. Vernalization-triggered intragenic chromatin loop formation by long noncoding RNAs. Dev. Cell. 2017;40:302\u2013312.e4."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6196504", "@IdType": "pmc"}, {"#text": "30279181", "@IdType": "pubmed"}]}, "Citation": "Jin JJ, et al. Long noncoding RNA SYISL regulates myogenesis by interacting with polycomb repressive complex 2. Proc. Natl Acad. Sci. USA. 2018;115:E9802\u2013e9811."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3945889", "@IdType": "pmc"}, {"#text": "24481530", "@IdType": "pubmed"}]}, "Citation": "Lai F, Shiekhattar R. Where long noncoding RNAs meet DNA methylation. Cell Res. 2014;24:263\u2013264."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6683341", "@IdType": "pmc"}, {"#text": "31382922", "@IdType": "pubmed"}]}, "Citation": "Gomes CP, et al. An antisense transcript mediates MALAT1 response in human breast cancer. BMC Cancer. 2019;19:771."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6289468", "@IdType": "pmc"}, {"#text": "30496290", "@IdType": "pubmed"}]}, "Citation": "Jadaliha M, et al. A natural antisense lncRNA controls breast cancer progression by promoting tumor suppressor gene mRNA stability. PLoS Genet. 2018;14:e1007802."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6131976", "@IdType": "pmc"}, {"#text": "30175821", "@IdType": "pubmed"}]}, "Citation": "Zhu Y, et al. Oncogenic activity of Wrap53 in human colorectal cancer in vitro and in nude mouse xenografts. Med. Sci. Monit. 2018;24:6129\u20136136."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5773557", "@IdType": "pmc"}, {"#text": "29348663", "@IdType": "pubmed"}]}, "Citation": "Miao Y, et al. Enhancer-associated long non-coding RNA LEENE regulates endothelial nitric oxide synthase and endothelial function. Nat. Commun. 2018;9:292."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6306333", "@IdType": "pmc"}, {"#text": "30448228", "@IdType": "pubmed"}]}, "Citation": "Huang Z, et al. The enhancer RNA lnc-SLC4A1-1 epigenetically regulates unexplained recurrent pregnancy loss (URPL) by activating CXCL8 and NF-kB pathway. EBioMedicine. 2018;38:162\u2013170."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5386573", "@IdType": "pmc"}, {"#text": "28300839", "@IdType": "pubmed"}]}, "Citation": "Tang J, et al. Bidirectional transcription of Linc00441 and RB1 via H3K27 modification-dependent way promotes hepatocellular carcinoma. Cell Death Dis. 2017;8:e2675."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5645346", "@IdType": "pmc"}, {"#text": "29042633", "@IdType": "pubmed"}]}, "Citation": "Jim\u00e9nez-Badillo SE, et al. Catsper1 promoter is bidirectional and regulates the expression of a novel lncRNA. Sci. Rep. 2017;7:13351."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6450570", "@IdType": "pmc"}, {"#text": "28604750", "@IdType": "pubmed"}]}, "Citation": "Peng WX, Koirala P, Mo YY. LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 2017;36:5661\u20135667."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5260507", "@IdType": "pmc"}, {"#text": "27716745", "@IdType": "pubmed"}]}, "Citation": "Li Z, et al. The degradation of EZH2 mediated by lncRNA ANCR attenuated the invasion and metastasis of breast cancer. Cell Death Differ. 2017;24:59\u201371."}, {"ArticleIdList": {"ArticleId": {"#text": "29565494", "@IdType": "pubmed"}}, "Citation": "Lou KX, et al. Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion. Eur. Rev. Med. Pharm. Sci. 2018;22:1358\u20131365."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5521048", "@IdType": "pmc"}, {"#text": "28701685", "@IdType": "pubmed"}]}, "Citation": "Li W, et al. Long non-coding RNA (LncRNA) HOXA11-AS promotes breast cancer invasion and metastasis by regulating epithelial-mesenchymal transition. Med. Sci. Monit. 2017;23:3393\u20133403."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5420816", "@IdType": "pmc"}, {"#text": "28446530", "@IdType": "pubmed"}]}, "Citation": "Weidle UH, et al. Long non-coding RNAs and their role in metastasis. Cancer Genomics Proteom. 2017;14:143\u2013160."}, {"ArticleIdList": {"ArticleId": {"#text": "30071765", "@IdType": "pubmed"}}, "Citation": "Rafiee A, et al. Long noncoding RNAs: regulation, function and cancer. Biotechnol. Genet. Eng. Rev. 2018;34:153\u2013180."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3049919", "@IdType": "pmc"}, {"#text": "20393566", "@IdType": "pubmed"}]}, "Citation": "Gupta RA, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010;464:1071\u20131076."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6548158", "@IdType": "pmc"}, {"#text": "31205562", "@IdType": "pubmed"}]}, "Citation": "Collina F, et al. LncRNA HOTAIR up-regulation is strongly related with lymph nodes metastasis and LAR subtype of triple negative breast cancer. J. Cancer. 2019;10:2018\u20132024."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4611722", "@IdType": "pmc"}, {"#text": "24922071", "@IdType": "pubmed"}]}, "Citation": "Hou P, et al. LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis. Cell Death Dis. 2014;5:e1287."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4499915", "@IdType": "pmc"}, {"#text": "26169368", "@IdType": "pubmed"}]}, "Citation": "Fan J, et al. Long non-coding RNA ROR decoys gene-specific histone methylation to promote tumorigenesis. Genome Biol. 2015;16:139."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3587705", "@IdType": "pmc"}, {"#text": "23208419", "@IdType": "pubmed"}]}, "Citation": "Zhang A, et al. The human long non-coding RNA-RoR is a p53 repressor in response to DNA damage. Cell Res. 2013;23:340\u2013350."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4266991", "@IdType": "pmc"}, {"#text": "25416949", "@IdType": "pubmed"}]}, "Citation": "Xing Z, et al. lncRNA directs cooperative epigenetic regulation downstream of chemokine signals. Cell. 2014;159:1110\u20131125."}, {"ArticleIdList": {"ArticleId": {"#text": "31556319", "@IdType": "pubmed"}}, "Citation": "Yi T, et al. Activation of lncRNA lnc-SLC4A1-1 induced by H3K27 acetylation promotes the development of breast cancer via activating CXCL8 and NF-kB pathway. Artif. Cells Nanomed. Biotechnol. 2019;47:3765\u20133773."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6323810", "@IdType": "pmc"}, {"#text": "30621694", "@IdType": "pubmed"}]}, "Citation": "Dong H, et al. Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer. Mol. Cancer. 2019;18:3."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5707156", "@IdType": "pmc"}, {"#text": "29130936", "@IdType": "pubmed"}]}, "Citation": "Wang S, et al. JAK2-binding long noncoding RNA promotes breast cancer brain metastasis. J. Clin. Investig. 2017;127:4498\u20134515."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6354401", "@IdType": "pmc"}, {"#text": "30733855", "@IdType": "pubmed"}]}, "Citation": "Hu X, et al. Long non-coding RNA BLACAT1 promotes breast cancer cell proliferation and metastasis by miR-150-5p/CCR2. Cell Biosci. 2019;9:14."}, {"ArticleIdList": {"ArticleId": {"#text": "28611183", "@IdType": "pubmed"}}, "Citation": "Zhou, W. et al. The lncRNA H19 mediates breast cancer cell plasticity during EMT and MET plasticity by differentially sponging miR-200b/c and let-7b. Sci. Signal.10, eaak9557 (2017)."}, {"ArticleIdList": {"ArticleId": {"#text": "24703882", "@IdType": "pubmed"}}, "Citation": "Matouk IJ, et al. Oncofetal H19 RNA promotes tumor metastasis. Biochim. Biophys. Acta. 2014;1843:1414\u20131426."}, {"ArticleIdList": {"ArticleId": {"#text": "29317255", "@IdType": "pubmed"}}, "Citation": "Camacho CV, Choudhari R, Gadad SS. Long noncoding RNAs and cancer, an overview. Steroids. 2018;133:93\u201395."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5340452", "@IdType": "pmc"}, {"#text": "28248879", "@IdType": "pubmed"}]}, "Citation": "Liu M, Xing LQ, Liu YJ. A three-long noncoding RNA signature as a diagnostic biomarker for differentiating between triple-negative and non-triple-negative breast cancers. Medicine. 2017;96:e6222."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3408587", "@IdType": "pmc"}, {"#text": "22840402", "@IdType": "pubmed"}]}, "Citation": "Zhang B, et al. The lncRNA Malat1 is dispensable for mouse development but its transcription plays a cis-regulatory role in the adult. Cell Rep. 2012;2:111\u2013123."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2722846", "@IdType": "pmc"}, {"#text": "19041754", "@IdType": "pubmed"}]}, "Citation": "Wilusz JE, Freier SM, Spector DL. 3\u2032 end processing of a long nuclear-retained noncoding RNA yields a tRNA-like cytoplasmic RNA. Cell. 2008;135:919\u2013932.."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC1800850", "@IdType": "pmc"}, {"#text": "17270048", "@IdType": "pubmed"}]}, "Citation": "Hutchinson JN, et al. A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains. BMC Genomics. 2007;8:39."}, {"ArticleIdList": {"ArticleId": {"#text": "12970751", "@IdType": "pubmed"}}, "Citation": "Ji P, et al. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene. 2003;22:8031\u20138041."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6265076", "@IdType": "pmc"}, {"#text": "30349115", "@IdType": "pubmed"}]}, "Citation": "Kim J, et al. Long noncoding RNA MALAT1 suppresses breast cancer metastasis. Nat. Genet. 2018;50:1705\u20131715."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4701977", "@IdType": "pmc"}, {"#text": "26701265", "@IdType": "pubmed"}]}, "Citation": "Arun G, et al. Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss. Genes Dev. 2016;30:34\u201351."}, {"ArticleIdList": {"ArticleId": {"#text": "25759022", "@IdType": "pubmed"}}, "Citation": "Liu B, et al. A cytoplasmic NF-kappaB interacting long noncoding RNA blocks IkappaB phosphorylation and suppresses breast cancer metastasis. Cancer Cell. 2015;27:370\u2013381."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5620176", "@IdType": "pmc"}, {"#text": "28978036", "@IdType": "pubmed"}]}, "Citation": "Li Z, et al. LncRNA ANCR down-regulation promotes TGF-beta-induced EMT and metastasis in breast cancer. Oncotarget. 2017;8:67329\u201367343."}, {"ArticleIdList": {"ArticleId": {"#text": "23764001", "@IdType": "pubmed"}}, "Citation": "Tiwari N, et al. Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming. Cancer Cell. 2013;23:768\u2013783."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6815803", "@IdType": "pmc"}, {"#text": "31557401", "@IdType": "pubmed"}]}, "Citation": "Song Z, et al. LINC01133 inhibits breast cancer invasion and metastasis by negatively regulating SOX4 expression through EZH2. J. Cell Mol. Med. 2019;23:7554\u20137565."}, {"ArticleIdList": {"ArticleId": {"#text": "30967631", "@IdType": "pubmed"}}, "Citation": "Tan BS, et al. LncRNA NORAD is repressed by the YAP pathway and suppresses lung and breast cancer metastasis by sequestering S100P. Oncogene. 2019;38:5612\u20135626."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6203274", "@IdType": "pmc"}, {"#text": "30386180", "@IdType": "pubmed"}]}, "Citation": "Wang XX, et al. miR-506 attenuates methylation of lncRNA MEG3 to inhibit migration and invasion of breast cancer cell lines via targeting SP1 and SP3. Cancer Cell Int. 2018;18:171."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5859407", "@IdType": "pmc"}, {"#text": "29559853", "@IdType": "pubmed"}]}, "Citation": "Xu R, et al. LncRNA XIST/miR-200c regulates the stemness properties and tumourigenicity of human bladder cancer stem cell-like cells. Cancer Cell Int. 2018;18:41."}, {"ArticleIdList": {"ArticleId": {"#text": "29550489", "@IdType": "pubmed"}}, "Citation": "Zheng R, et al. Long non-coding RNA XIST inhibited breast cancer cell growth, migration, and invasion via miR-155/CDX1 axis. Biochem. Biophys. Res. Commun. 2018;498:1002\u20131008."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6072593", "@IdType": "pmc"}, {"#text": "30026327", "@IdType": "pubmed"}]}, "Citation": "Xing F, et al. Loss of XIST in breast cancer activates MSN-c-Met and reprograms microglia via exosomal miRNA to promote brain metastasis. Cancer Res. 2018;78:4316\u20134330."}, {"ArticleIdList": {"ArticleId": {"#text": "28656261", "@IdType": "pubmed"}}, "Citation": "Tang Y, et al. lncRNA XIST interacts with miR-140 to modulate lung cancer growth by targeting iASPP. Oncol. Rep. 2017;38:941\u2013948."}, {"ArticleIdList": {"ArticleId": {"#text": "26875870", "@IdType": "pubmed"}}, "Citation": "Dhamija S, Diederichs S. From junk to master regulators of invasion: lncRNA functions in migration, EMT and metastasis. Int. J. Cancer. 2016;139:269\u201380.."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3721235", "@IdType": "pmc"}, {"#text": "23898399", "@IdType": "pubmed"}]}, "Citation": "Rapicavoli NA, et al. A mammalian pseudogene lncRNA at the interface of inflammation and anti-inflammatory therapeutics. Elife. 2013;2:e00762."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3652667", "@IdType": "pmc"}, {"#text": "21642992", "@IdType": "pubmed"}]}, "Citation": "Hung T, et al. Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat. Genet. 2011;43:621\u2013629."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3235919", "@IdType": "pmc"}, {"#text": "21802130", "@IdType": "pubmed"}]}, "Citation": "Salmena L, et al. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell. 2011;146:353\u2013358."}, {"ArticleIdList": {"ArticleId": {"#text": "18951091", "@IdType": "pubmed"}}, "Citation": "Pandey RR, et al. Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation. Mol. Cell. 2008;32:232\u2013246."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2956184", "@IdType": "pmc"}, {"#text": "20673990", "@IdType": "pubmed"}]}, "Citation": "Huarte M, et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell. 2010;142:409\u2013419."}, {"ArticleIdList": {"ArticleId": {"#text": "25159663", "@IdType": "pubmed"}}, "Citation": "Yang G, Lu X, Yuan L. LncRNA: a link between RNA and cancer. Biochim. Biophys. Acta. 2014;1839:1097\u20131109.."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3924787", "@IdType": "pmc"}, {"#text": "23827673", "@IdType": "pubmed"}]}, "Citation": "Ulitsky I, Bartel DP. lincRNAs: genomics, evolution, and mechanisms. Cell. 2013;154:26\u201346."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4428586", "@IdType": "pmc"}, {"#text": "25155612", "@IdType": "pubmed"}]}, "Citation": "West JA, et al. The long noncoding RNAs NEAT1 and MALAT1 bind active chromatin sites. Mol. Cell. 2014;55:791\u2013802."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3249421", "@IdType": "pmc"}, {"#text": "21963238", "@IdType": "pubmed"}]}, "Citation": "Chu C, et al. Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions. Mol. Cell. 2011;44:667\u2013678."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4927085", "@IdType": "pmc"}, {"#text": "27111890", "@IdType": "pubmed"}]}, "Citation": "Zhang Y, et al. Long noncoding RNA LINP1 regulates repair of DNA double-strand breaks in triple-negative breast cancer. Nat. Struct. Mol. Biol. 2016;23:522\u2013530."}, {"ArticleIdList": {"ArticleId": {"#text": "26715267", "@IdType": "pubmed"}}, "Citation": "Peng L, et al. LncRNAs: key players and novel insights into cervical cancer. Tumour Biol. 2016;37:2779\u20132788."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4158944", "@IdType": "pmc"}, {"#text": "20797886", "@IdType": "pubmed"}]}, "Citation": "Tripathi V, et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol. Cell. 2010;39:925\u2013938."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2944070", "@IdType": "pmc"}, {"#text": "20729808", "@IdType": "pubmed"}]}, "Citation": "Bernard D, et al. A long nuclear-retained non-coding RNA regulates synaptogenesis by modulating gene expression. EMBO J. 2010;29:3082\u20133093."}, {"ArticleIdList": {"ArticleId": {"#text": "19250907", "@IdType": "pubmed"}}, "Citation": "Mahmoudi S, et al. Wrap53, a natural p53 antisense transcript required for p53 induction upon DNA damage. Mol. Cell. 2009;33:462\u2013471."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3324542", "@IdType": "pmc"}, {"#text": "22509368", "@IdType": "pubmed"}]}, "Citation": "Wang Y, et al. Regulation of p53 stability and apoptosis by a ROR agonist. PLoS ONE. 2012;7:e34921."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5450112", "@IdType": "pmc"}, {"#text": "28558830", "@IdType": "pubmed"}]}, "Citation": "Jiang Z, et al. LincIN, a novel NF90-binding long non-coding RNA, is overexpressed in advanced breast tumors and involved in metastasis. Breast Cancer Res. 2017;19:62."}, {"ArticleIdList": {"ArticleId": {"#text": "23395002", "@IdType": "pubmed"}}, "Citation": "Yang F, et al. Repression of the long noncoding RNA-LET by histone deacetylase 3 contributes to hypoxia-mediated metastasis. Mol. Cell. 2013;49:1083\u20131096."}, {"ArticleIdList": {"ArticleId": {"#text": "24316222", "@IdType": "pubmed"}}, "Citation": "Yang F, et al. Reciprocal regulation of HIF-1alpha and lincRNA-p21 modulates the Warburg effect. Mol. Cell. 2014;53:88\u2013100."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2084369", "@IdType": "pmc"}, {"#text": "17604720", "@IdType": "pubmed"}]}, "Citation": "Rinn JL, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell. 2007;129:1311\u20131323."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5651513", "@IdType": "pmc"}, {"#text": "25961689", "@IdType": "pubmed"}]}, "Citation": "Liu Y, Sharma S, Watabe K. Roles of lncRNA in breast cancer. Front. Biosci. 2015;7:94\u2013108."}, {"ArticleIdList": {"ArticleId": {"#text": "25168368", "@IdType": "pubmed"}}, "Citation": "Wu Y, et al. Long noncoding RNA HOTAIR involvement in cancer. Tumour Biol. 2014;35:9531\u20139538."}, {"ArticleIdList": {"ArticleId": {"#text": "27780718", "@IdType": "pubmed"}}, "Citation": "Vennin C, et al. The long non-coding RNA 91H increases aggressive phenotype of breast cancer cells and up-regulates H19/IGF2 expression through epigenetic modifications. Cancer Lett. 2017;385:198\u2013206."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5713286", "@IdType": "pmc"}, {"#text": "29469819", "@IdType": "pubmed"}]}, "Citation": "Paw\u0142owska, E., Szczepanska, J. & Blasiak, J. The long noncoding RNA HOTAIR in breast cancer: does autophagy play a role? Int. J. Mol. Sci.18, 2317 (2017)."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5386479", "@IdType": "pmc"}, {"#text": "28182000", "@IdType": "pubmed"}]}, "Citation": "Bao X, et al. Knockdown of long non-coding RNA HOTAIR increases miR-454-3p by targeting Stat3 and Atg12 to inhibit chondrosarcoma growth. Cell Death Dis. 2017;8:e2605."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3485022", "@IdType": "pmc"}, {"#text": "23133536", "@IdType": "pubmed"}]}, "Citation": "Chisholm KM, et al. Detection of long non-coding RNA in archival tissue: correlation with polycomb protein expression in primary and metastatic breast carcinoma. PLoS One. 2012;7:e47998."}, {"ArticleIdList": {"ArticleId": {"#text": "25070049", "@IdType": "pubmed"}}, "Citation": "Zhang H, et al. MiR-7, inhibited indirectly by lincRNA HOTAIR, directly inhibits SETDB1 and reverses the EMT of breast cancer stem cells by downregulating the STAT3 pathway. Stem Cells. 2014;32:2858\u20132868."}, {"ArticleIdList": {"ArticleId": {"#text": "21529719", "@IdType": "pubmed"}}, "Citation": "Badouel C, McNeill H. SnapShot: the hippo signaling pathway. Cell. 2011;145:484\u2013484.e1."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5336186", "@IdType": "pmc"}, {"#text": "28114269", "@IdType": "pubmed"}]}, "Citation": "Li C, et al. A ROR1-HER3-lncRNA signalling axis modulates the Hippo-YAP pathway to regulate bone metastasis. Nat. Cell Biol. 2017;19:106\u2013119."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5009810", "@IdType": "pmc"}, {"#text": "27485121", "@IdType": "pubmed"}]}, "Citation": "Sas-Chen A, et al. LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer. EMBO Mol. Med. 2016;8:1052\u20131064."}, {"ArticleIdList": {"ArticleId": {"#text": "27424981", "@IdType": "pubmed"}}, "Citation": "Xiao C, Wu CH, Hu HZ. LncRNA UCA1 promotes epithelial-mesenchymal transition (EMT) of breast cancer cells via enhancing Wnt/beta-catenin signaling pathway. Eur. Rev. Med. Pharm. Sci. 2016;20:2819\u20132824."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4503053", "@IdType": "pmc"}, {"#text": "26191181", "@IdType": "pubmed"}]}, "Citation": "Xu S, et al. Downregulation of long noncoding RNA MALAT1 induces epithelial-to-mesenchymal transition via the PI3K-AKT pathway in breast cancer. Int. J. Clin. Exp. Pathol. 2015;8:4881\u20134891."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3792431", "@IdType": "pmc"}, {"#text": "23933812", "@IdType": "pubmed"}]}, "Citation": "Zhang Z, et al. Negative regulation of lncRNA GAS5 by miR-21. Cell Death Differ. 2013;20:1558\u20131568."}, {"ArticleIdList": {"ArticleId": {"#text": "28407576", "@IdType": "pubmed"}}, "Citation": "Yu Y, et al. HOTAIR may regulate proliferation, apoptosis, migration and invasion of MCF-7 cells through regulating the P53/Akt/JNK signaling pathway. Biomed. Pharmacother. 2017;90:555\u2013561."}, {"ArticleIdList": {"ArticleId": {"#text": "27848085", "@IdType": "pubmed"}}, "Citation": "Li T, et al. Long non-coding RNA TUG1 promotes cell proliferation and metastasis in human breast cancer. Breast Cancer. 2017;24:535\u2013543."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4358111", "@IdType": "pmc"}, {"#text": "25605728", "@IdType": "pubmed"}]}, "Citation": "Richards EJ, et al. Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF) beta: LncRNA-hit-mediated TGFbeta-induced epithelial to mesenchymal transition in mammary epithelia. J. Biol. Chem. 2015;290:6857\u20136867."}, {"ArticleIdList": {"ArticleId": {"#text": "17072321", "@IdType": "pubmed"}}, "Citation": "Gilmore TD. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene. 2006;25:6680\u20136684."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5811242", "@IdType": "pmc"}, {"#text": "29348395", "@IdType": "pubmed"}]}, "Citation": "Ke S, et al. NKILA inhibits NF-kappaB signaling and suppresses tumor metastasis. Aging. 2018;10:56\u201371."}, {"ArticleIdList": {"ArticleId": {"#text": "29761481", "@IdType": "pubmed"}}, "Citation": "Wu W, et al. LncRNA NKILA suppresses TGF-beta-induced epithelial-mesenchymal transition by blocking NF-kappaB signaling in breast cancer. Int. J. Cancer. 2018;143:2213\u20132224."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2033751", "@IdType": "pmc"}, {"#text": "7710952", "@IdType": "pubmed"}]}, "Citation": "Watson CJ, Miller WR. Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts. Br. J. Cancer. 1995;71:840\u2013844."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2754849", "@IdType": "pmc"}, {"#text": "19182780", "@IdType": "pubmed"}]}, "Citation": "Guttman M, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature. 2009;458:223\u2013227."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3082894", "@IdType": "pmc"}, {"#text": "21177654", "@IdType": "pubmed"}]}, "Citation": "Anno YN, et al. Genome-wide evidence for an essential role of the human Staf/ZNF143 transcription factor in bidirectional transcription. Nucleic Acids Res. 2011;39:3116\u20133127."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6509113", "@IdType": "pmc"}, {"#text": "31073122", "@IdType": "pubmed"}]}, "Citation": "Jia X, et al. KLF5 regulated lncRNA RP1 promotes the growth and metastasis of breast cancer via repressing p27kip1 translation. Cell Death Dis. 2019;10:373."}, {"ArticleIdList": {"ArticleId": {"#text": "16707459", "@IdType": "pubmed"}}, "Citation": "Barsyte-Lovejoy D, et al. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. Cancer Res. 2006;66:5330\u20135337."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6114182", "@IdType": "pmc"}, {"#text": "30157918", "@IdType": "pubmed"}]}, "Citation": "Dong H, et al. SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88. J. Exp. Clin. Cancer Res. 2018;37:202."}, {"ArticleIdList": {"ArticleId": {"#text": "30266755", "@IdType": "pubmed"}}, "Citation": "Ho, et al., c-MYC drives breast cancer metastasis to the brain, but promotes synthetic lethality with TRAIL. Mol. Cancer Res. 17, 544\u2013554 (2019)."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2840447", "@IdType": "pmc"}, {"#text": "20133671", "@IdType": "pubmed"}]}, "Citation": "Wolfer A, et al. MYC regulation of a \u201cpoor-prognosis\u201d metastatic cancer cell state. Proc. Natl Acad. Sci. USA. 2010;107:3698\u20133703."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3089000", "@IdType": "pmc"}, {"#text": "21406394", "@IdType": "pubmed"}]}, "Citation": "Wolfer A, Ramaswamy S. MYC and metastasis. Cancer Res. 2011;71:2034\u20132037."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5340688", "@IdType": "pmc"}, {"#text": "28337281", "@IdType": "pubmed"}]}, "Citation": "Wang O, et al. C-MYC-induced upregulation of lncRNA SNHG12 regulates cell proliferation, apoptosis and migration in triple-negative breast cancer. Am. J. Transl. Res. 2017;9:533\u2013545."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4240923", "@IdType": "pmc"}, {"#text": "25425964", "@IdType": "pubmed"}]}, "Citation": "Prensner JR, et al. The long non-coding RNA PCAT-1 promotes prostate cancer cell proliferation through cMyc. Neoplasia. 2014;16:900\u2013908."}, {"ArticleIdList": {"ArticleId": {"#text": "25385164", "@IdType": "pubmed"}}, "Citation": "Zhou X, Chen J, Tang W. The molecular mechanism of HOTAIR in tumorigenesis, metastasis, and drug resistance. Acta Biochim. Biophys. Sin. 2014;46:1011\u20131015."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4085645", "@IdType": "pmc"}, {"#text": "24953832", "@IdType": "pubmed"}]}, "Citation": "Ma MZ, et al. Long non-coding RNA HOTAIR, a c-Myc activated driver of malignancy, negatively regulates miRNA-130a in gallbladder cancer. Mol. Cancer. 2014;13:156."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4284533", "@IdType": "pmc"}, {"#text": "25512540", "@IdType": "pubmed"}]}, "Citation": "Hung CL, et al. A long noncoding RNA connects c-Myc to tumor metabolism. Proc. Natl Acad. Sci. USA. 2014;111:18697\u201318702."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4350361", "@IdType": "pmc"}, {"#text": "25587025", "@IdType": "pubmed"}]}, "Citation": "Hart JR, et al. MYC regulates the non-coding transcriptome. Oncotarget. 2014;5:12543\u201312554."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6888833", "@IdType": "pmc"}, {"#text": "30770877", "@IdType": "pubmed"}]}, "Citation": "Xu TP, et al. KLF5 and MYC modulated LINC00346 contributes to gastric cancer progression through acting as a competing endogeous RNA and indicates poor outcome. Cell Death Differ. 2019;26:2179\u20132193."}, {"ArticleIdList": {"ArticleId": {"#text": "25960131", "@IdType": "pubmed"}}, "Citation": "Vizca\u00edno C, Mansilla S, Portugal J. Sp1 transcription factor: a long-standing target in cancer chemotherapy. Pharm. Ther. 2015;152:111\u2013124."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5383578", "@IdType": "pmc"}, {"#text": "28214253", "@IdType": "pubmed"}]}, "Citation": "Huang M, et al. Long noncoding RNA LINC00673 is activated by SP1 and exerts oncogenic properties by interacting with LSD1 and EZH2 in gastric cancer. Mol. Ther. 2017;25:1014\u20131026."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5896100", "@IdType": "pmc"}, {"#text": "29642935", "@IdType": "pubmed"}]}, "Citation": "Xu Y, et al. SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinoma. J. Exp. Clin. Cancer Res. 2018;37:81."}, {"ArticleIdList": {"ArticleId": {"#text": "30831032", "@IdType": "pubmed"}}, "Citation": "Zhang L, et al. SP1-induced up-regulation of lncRNA LUCAT1 promotes proliferation, migration and invasion of cervical cancer by sponging miR-181a. Artif. Cells Nanomed. Biotechnol. 2019;47:556\u2013564."}, {"ArticleIdList": {"ArticleId": {"#text": "30119232", "@IdType": "pubmed"}}, "Citation": "Yang L, et al. Long non-coding RNA FTH1P3 regulated metastasis and invasion of esophageal squamous cell carcinoma through SP1/NF-kB pathway. Biomed. Pharmacother. 2018;106:1570\u20131577."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3298503", "@IdType": "pmc"}, {"#text": "22289355", "@IdType": "pubmed"}]}, "Citation": "Augoff K, et al. miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer. Mol. Cancer. 2012;11:5."}, {"ArticleIdList": {"ArticleId": {"#text": "21400503", "@IdType": "pubmed"}}, "Citation": "Benetatos L, Vartholomatos G, Hatzimichael E. MEG3 imprinted gene contribution in tumorigenesis. Int. J. Cancer. 2011;129:773\u2013779."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5525547", "@IdType": "pmc"}, {"#text": "28263966", "@IdType": "pubmed"}]}, "Citation": "Zhou C, et al. LncRNA MEG3 downregulation mediated by DNMT3b contributes to nickel malignant transformation of human bronchial epithelial cells via modulating PHLPP1 transcription and HIF-1alpha translation. Oncogene. 2017;36:3878\u20133889."}, {"ArticleIdList": {"ArticleId": {"#text": "28635399", "@IdType": "pubmed"}}, "Citation": "Zhang CY, et al. Overexpression of long non-coding RNA MEG3 suppresses breast cancer cell proliferation, invasion, and angiogenesis through AKT pathway. Tumour Biol. 2017;39:1010428317701311."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3431493", "@IdType": "pmc"}, {"#text": "22955988", "@IdType": "pubmed"}]}, "Citation": "Derrien T, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012;22:1775\u20131789."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3439153", "@IdType": "pmc"}, {"#text": "22955616", "@IdType": "pubmed"}]}, "Citation": "The ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature, 489, 57\u201374 (2012)."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2704441", "@IdType": "pmc"}, {"#text": "19458021", "@IdType": "pubmed"}]}, "Citation": "Hiller M, et al. Conserved introns reveal novel transcripts in Drosophila melanogaster. Genome Res. 2009;19:1289\u20131300."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5578890", "@IdType": "pmc"}, {"#text": "28825698", "@IdType": "pubmed"}]}, "Citation": "Grelet S, et al. A regulated PNUTS mRNA to lncRNA splice switch mediates EMT and tumour progression. Nat. Cell Biol. 2017;19:1105\u20131115."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2593745", "@IdType": "pmc"}, {"#text": "18978772", "@IdType": "pubmed"}]}, "Citation": "Wang ET, et al. Alternative isoform regulation in human tissue transcriptomes. Nature. 2008;456:470\u2013476."}, {"ArticleIdList": {"ArticleId": {"#text": "24258260", "@IdType": "pubmed"}}, "Citation": "Sorensen KP, et al. Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer. Breast Cancer Res. Treat. 2013;142:529\u2013536."}, {"ArticleIdList": {"ArticleId": {"#text": "26033707", "@IdType": "pubmed"}}, "Citation": "Zhang L, et al. Circulating DNA of HOTAIR in serum is a novel biomarker for breast cancer. Breast Cancer Res. Treat. 2015;152:199\u2013208."}, {"ArticleIdList": {"ArticleId": {"#text": "30220561", "@IdType": "pubmed"}}, "Citation": "Sang LJ, et al. LncRNA CamK-A regulates Ca(2+)-signaling-mediated tumor microenvironment remodeling. Mol. Cell. 2018;72:71\u201383.e7."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5852357", "@IdType": "pmc"}, {"#text": "29473328", "@IdType": "pubmed"}]}, "Citation": "Zhao W, et al. LncRNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR-20a-5p/HMGA2 axis in breast cancer. Cancer Med. 2018;7:842\u2013855."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6643429", "@IdType": "pmc"}, {"#text": "31367244", "@IdType": "pubmed"}]}, "Citation": "Li Y, et al. A compound AC1Q3QWB selectively disrupts HOTAIR-mediated recruitment of PRC2 and enhances cancer therapy of DZNep. Theranostics. 2019;9:4608\u20134623."}, {"ArticleIdList": {"ArticleId": {"#text": "23748105", "@IdType": "pubmed"}}, "Citation": "Li CH, Chen Y. Targeting long non-coding RNAs in cancers: progress and prospects. Int. J. Biochem. Cell Biol. 2013;45:1895\u20131910."}, {"ArticleIdList": {"ArticleId": {"#text": "31601996", "@IdType": "pubmed"}}, "Citation": "Yousefi H, et al. Long noncoding RNAs and exosomal lncRNAs: classification, and mechanisms in breast cancer metastasis and drug resistance. Oncogene. 2020;39:953\u2013974."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3589741", "@IdType": "pmc"}, {"#text": "23243023", "@IdType": "pubmed"}]}, "Citation": "Gutschner T, et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res. 2013;73:1180\u20131189."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4221572", "@IdType": "pmc"}, {"#text": "22859208", "@IdType": "pubmed"}]}, "Citation": "Wheeler TM, et al. Targeting nuclear RNA for in vivo correction of myotonic dystrophy. Nature. 2012;488:111\u2013115."}, {"ArticleIdList": {"ArticleId": {"#text": "25408407", "@IdType": "pubmed"}}, "Citation": "Cong L, Zhang F. Genome engineering using CRISPR-Cas9 system. Methods Mol. Biol. 2015;1239:197\u2013217."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4265475", "@IdType": "pmc"}, {"#text": "25263330", "@IdType": "pubmed"}]}, "Citation": "Platt RJ, et al. CRISPR-Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014;159:440\u2013455."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4179957", "@IdType": "pmc"}, {"#text": "25137067", "@IdType": "pubmed"}]}, "Citation": "Han J, et al. Efficient in vivo deletion of a large imprinted lncRNA by CRISPR/Cas9. RNA Biol. 2014;11:829\u2013835."}, {"ArticleIdList": {"ArticleId": {"#text": "24486104", "@IdType": "pubmed"}}, "Citation": "Niu Y, et al. Generation of gene-modified cynomolgus monkey via Cas9/RNA-mediated gene targeting in one-cell embryos. Cell. 2014;156:836\u2013843."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4821475", "@IdType": "pmc"}, {"#text": "26030444", "@IdType": "pubmed"}]}, "Citation": "Shechner DM, et al. Multiplexable, locus-specific targeting of long RNAs with CRISPR-Display. Nat. Methods. 2015;12:664\u2013670."}, {"ArticleIdList": {"ArticleId": {"#text": "17277804", "@IdType": "pubmed"}}, "Citation": "Struhl K. Transcriptional noise and the fidelity of initiation by RNA polymerase II. Nat. Struct. Mol. Biol. 2007;14:103\u2013105."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6555305", "@IdType": "pmc"}, {"#text": "31214490", "@IdType": "pubmed"}]}, "Citation": "Wu Y, et al. The role of lncRNAs in the distant metastasis of breast cancer. Front. Oncol. 2019;9:407."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6220217", "@IdType": "pmc"}, {"#text": "30416660", "@IdType": "pubmed"}]}, "Citation": "Li Z, et al. LncRNA MALAT1 promotes relapse of breast cancer patients with postoperative fever. Am. J. Transl. Res. 2018;10:3186\u20133197."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6020372", "@IdType": "pmc"}, {"#text": "29983835", "@IdType": "pubmed"}]}, "Citation": "Rodriguez Bautista R, et al. Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer. Clin. Epigenetics. 2018;10:88."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4356254", "@IdType": "pmc"}, {"#text": "25640239", "@IdType": "pubmed"}]}, "Citation": "Anderson DM, et al. A micropeptide encoded by a putative long noncoding RNA regulates muscle performance. Cell. 2015;160:595\u2013606."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2967777", "@IdType": "pmc"}, {"#text": "20616235", "@IdType": "pubmed"}]}, "Citation": "Tsai MC, et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science. 2010;329:689\u2013693."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4336811", "@IdType": "pmc"}, {"#text": "25253741", "@IdType": "pubmed"}]}, "Citation": "Eades G, et al. lincRNA-RoR and miR-145 Regulate Invasion in Triple-Negative Breast Cancer via Targeting ARF6. Mol. Cancer Res. 2014;13:330."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6695844", "@IdType": "pmc"}, {"#text": "31344855", "@IdType": "pubmed"}]}, "Citation": "Li, X., et al. LncRNA NEAT1 silenced miR-133b promotes migration and invasion of breast cancer cells. Int. J. Mol. Sci.20, 3616 (2019)."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5629202", "@IdType": "pmc"}, {"#text": "28983112", "@IdType": "pubmed"}]}, "Citation": "Gooding AJ, et al. The lncRNA BORG drives breast cancer metastasis and disease recurrence. Sci. Rep. 2017;7:12698."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5752909", "@IdType": "pmc"}, {"#text": "29312511", "@IdType": "pubmed"}]}, "Citation": "Liu J, et al. The long non-coding RNA SUMO1P3 facilitates breast cancer progression by negatively regulating miR-320a. Am. J. Transl. Res. 2017;9:5594\u20135602."}, {"ArticleIdList": {"ArticleId": {"#text": "30042416", "@IdType": "pubmed"}}, "Citation": "Huang X, et al. Adam12 and lnc015192 act as ceRNAs in breast cancer by regulating miR-34a. Oncogene. 2018;37:6316\u20136326."}, {"ArticleIdList": {"ArticleId": {"#text": "30002443", "@IdType": "pubmed"}}, "Citation": "Luo L, et al. LINC01638 lncRNA activates MTDH-Twist1 signaling by preventing SPOP-mediated c-Myc degradation in triple-negative breast cancer. Oncogene. 2018;37:6166\u20136179."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6261952", "@IdType": "pmc"}, {"#text": "29844570", "@IdType": "pubmed"}]}, "Citation": "Yang F, et al. An androgen receptor negatively induced long non-coding RNA ARNILA binding to miR-204 promotes the invasion and metastasis of triple-negative breast cancer. Cell Death Differ. 2018;25:2209\u20132220."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4484483", "@IdType": "pmc"}, {"#text": "25871474", "@IdType": "pubmed"}]}, "Citation": "Shi SJ, et al. LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer. Oncotarget. 2015;6:11652\u201311663."}, {"ArticleIdList": {"ArticleId": {"#text": "28272713", "@IdType": "pubmed"}}, "Citation": "Wu ZJ, et al. Long non-coding RNA CCAT2 promotes the breast cancer growth and metastasis by regulating TGF-beta signaling pathway. Eur. Rev. Med. Pharm. Sci. 2017;21:706\u2013714."}, {"ArticleIdList": {"ArticleId": {"#text": "26926567", "@IdType": "pubmed"}}, "Citation": "Chou J, et al. MALAT1 induced migration and invasion of human breast cancer cells by competitively binding miR-1 with cdc42. Biochem. Biophys. Res. Commun. 2016;472:262\u2013269."}, {"ArticleIdList": {"ArticleId": {"#text": "29236319", "@IdType": "pubmed"}}, "Citation": "Lu PW, et al. Effects of long non-coding RNA HOST2 on cell migration and invasion by regulating MicroRNA let-7b in breast cancer. J. Cell Biochem. 2018;119:4570\u20134580."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5790352", "@IdType": "pmc"}, {"#text": "29293402", "@IdType": "pubmed"}]}, "Citation": "Liang Y, et al. Long noncoding RNA LINP1 acts as an oncogene and promotes chemoresistance in breast cancer. Cancer Biol. Ther. 2018;19:120\u2013131."}, {"ArticleIdList": {"ArticleId": {"#text": "32521278", "@IdType": "pubmed"}}, "Citation": "Lin X, et al. Enhancer-driven lncRNA BDNF-AS induces endocrine resistance and malignant progression of breast cancer through the RNH1/TRIM21/mTOR Cascade. Cell Rep. 2020;31:107753."}, {"ArticleIdList": {"ArticleId": {"#text": "30106139", "@IdType": "pubmed"}}, "Citation": "Gao Z, et al. Long non-coding RNA CASC2 inhibits breast cancer cell growth and metastasis through the regulation of the miR-96-5p/SYVN1 pathway. Int. J. Oncol. 2018;53:2081\u20132090."}]}}}}}, "PMC": "PMC7490374", "PMID": "32929060", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "The roles of long noncoding RNAs in breast cancer metastasis.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "8": {"Abstract": "Cisplatin (CDDP) is one of the most commonly used chemotherapy drugs for the treatment of various cancers. Although platinum-based therapies are highly efficacious against rapidly proliferating malignant tumors, the development of CDDP resistance results in significant relapse as well as decreased overall survival rates, which is a significant obstacle in CDDP-based cancer therapy. Long non-coding RNAs (lncRNAs) are involved in cancer development and progression by the regulation of processes related to chromatin remodeling, transcription, and posttranscriptional processing. Emerging evidence has recently highlighted the roles of lncRNAs in the development of CDDP resistance. In this review, we discuss the roles and mechanisms of lncRNAs in CDDP chemoresistance, including changes in cellular uptake or efflux of a drug, intracellular detoxification, DNA repair, apoptosis, autophagy, cell stemness, and the related signaling pathways, aiming to provide potential lncRNA-targeted strategies for overcoming drug resistance in cancer therapy.", "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "7774965541547322707", "Part1": "Department of Clinical Pharmacology", "Part2": "Xiangya Hospital", "Part3": "Central South University", "Part4": "Changsha", "Part5": "Hunan", "Part6": "People's Republic of China.", "Text": "Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China."}, {"Has_Extra": false, "HashID": "8994319722828694906", "Part1": "Institute of Clinical Pharmacology", "Part2": "Central South University", "Part3": "Hunan Key Laboratory of Pharmacogenetics", "Part4": "Changsha", "Part5": "Hunan", "Part6": "People's Republic of China.", "Text": "Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan, People's Republic of China."}], "ForeName": "Yang", "FullName": "Yang Hu", "HashID": "7388940010203559354", "LastName": "Hu", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "7774965541547322707", "Part1": "Department of Clinical Pharmacology", "Part2": "Xiangya Hospital", "Part3": "Central South University", "Part4": "Changsha", "Part5": "Hunan", "Part6": "People's Republic of China.", "Text": "Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China."}, {"Has_Extra": false, "HashID": "8994319722828694906", "Part1": "Institute of Clinical Pharmacology", "Part2": "Central South University", "Part3": "Hunan Key Laboratory of Pharmacogenetics", "Part4": "Changsha", "Part5": "Hunan", "Part6": "People's Republic of China.", "Text": "Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan, People's Republic of China."}], "ForeName": "Qiong-Ni", "FullName": "Qiong-Ni Zhu", "HashID": "9199238191277677540", "LastName": "Zhu", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "7774965541547322707", "Part1": "Department of Clinical Pharmacology", "Part2": "Xiangya Hospital", "Part3": "Central South University", "Part4": "Changsha", "Part5": "Hunan", "Part6": "People's Republic of China.", "Text": "Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China."}, {"Has_Extra": false, "HashID": "8994319722828694906", "Part1": "Institute of Clinical Pharmacology", "Part2": "Central South University", "Part3": "Hunan Key Laboratory of Pharmacogenetics", "Part4": "Changsha", "Part5": "Hunan", "Part6": "People's Republic of China.", "Text": "Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan, People's Republic of China."}], "ForeName": "Jun-Li", "FullName": "Jun-Li Deng", "HashID": "-1638651916262557960", "LastName": "Deng", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "7774965541547322707", "Part1": "Department of Clinical Pharmacology", "Part2": "Xiangya Hospital", "Part3": "Central South University", "Part4": "Changsha", "Part5": "Hunan", "Part6": "People's Republic of China.", "Text": "Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China."}, {"Has_Extra": false, "HashID": "8994319722828694906", "Part1": "Institute of Clinical Pharmacology", "Part2": "Central South University", "Part3": "Hunan Key Laboratory of Pharmacogenetics", "Part4": "Changsha", "Part5": "Hunan", "Part6": "People's Republic of China.", "Text": "Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan, People's Republic of China."}], "ForeName": "Zhi-Xing", "FullName": "Zhi-Xing Li", "HashID": "3034767125621703177", "LastName": "Li", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "7774965541547322707", "Part1": "Department of Clinical Pharmacology", "Part2": "Xiangya Hospital", "Part3": "Central South University", "Part4": "Changsha", "Part5": "Hunan", "Part6": "People's Republic of China.", "Text": "Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China."}, {"Has_Extra": false, "HashID": "8994319722828694906", "Part1": "Institute of Clinical Pharmacology", "Part2": "Central South University", "Part3": "Hunan Key Laboratory of Pharmacogenetics", "Part4": "Changsha", "Part5": "Hunan", "Part6": "People's Republic of China.", "Text": "Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan, People's Republic of China."}], "ForeName": "Guo", "FullName": "Guo Wang", "HashID": "-5527242689654794691", "LastName": "Wang", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-772523163274046143", "Part1": "Department of Medicine", "Part2": "Weill Cornell Medicine", "Part3": "New York", "Part4": "NY", "Part5": "USA.", "Part6": null, "Text": "Department of Medicine, Weill Cornell Medicine, New York, NY, USA."}], "ForeName": "Yuan-Shan", "FullName": "Yuan-Shan Zhu", "HashID": "-8629849587678193723", "LastName": "Zhu", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.2147/OTT.S158104", "InsertType": null, "Journal": "OncoTargets and therapy", "Keywords": [{"IS_Major": false, "IS_Mesh": false, "Text": "cancer"}, {"IS_Major": false, "IS_Mesh": false, "Text": "chemoresistance"}, {"IS_Major": false, "IS_Mesh": false, "Text": "cisplatin"}, {"IS_Major": false, "IS_Mesh": false, "Text": "lncRNAs"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "PubMed-not-MEDLINE", "Article": {"@PubModel": "Electronic-eCollection", "Abstract": {"AbstractText": "Cisplatin (CDDP) is one of the most commonly used chemotherapy drugs for the treatment of various cancers. Although platinum-based therapies are highly efficacious against rapidly proliferating malignant tumors, the development of CDDP resistance results in significant relapse as well as decreased overall survival rates, which is a significant obstacle in CDDP-based cancer therapy. Long non-coding RNAs (lncRNAs) are involved in cancer development and progression by the regulation of processes related to chromatin remodeling, transcription, and posttranscriptional processing. Emerging evidence has recently highlighted the roles of lncRNAs in the development of CDDP resistance. In this review, we discuss the roles and mechanisms of lncRNAs in CDDP chemoresistance, including changes in cellular uptake or efflux of a drug, intracellular detoxification, DNA repair, apoptosis, autophagy, cell stemness, and the related signaling pathways, aiming to provide potential lncRNA-targeted strategies for overcoming drug resistance in cancer therapy."}, "ArticleDate": {"@DateType": "Electronic", "Day": "28", "Month": "05", "Year": "2018"}, "ArticleTitle": "Emerging role of long non-coding RNAs in cisplatin resistance.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China."}, {"Affiliation": "Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan, People's Republic of China."}], "ForeName": "Yang", "Initials": "Y", "LastName": "Hu"}, {"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China."}, {"Affiliation": "Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan, People's Republic of China."}], "ForeName": "Qiong-Ni", "Initials": "QN", "LastName": "Zhu"}, {"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China."}, {"Affiliation": "Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan, People's Republic of China."}], "ForeName": "Jun-Li", "Initials": "JL", "LastName": "Deng"}, {"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China."}, {"Affiliation": "Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan, People's Republic of China."}], "ForeName": "Zhi-Xing", "Initials": "ZX", "LastName": "Li"}, {"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China."}, {"Affiliation": "Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan, People's Republic of China."}], "ForeName": "Guo", "Initials": "G", "LastName": "Wang"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Medicine, Weill Cornell Medicine, New York, NY, USA."}, "ForeName": "Yuan-Shan", "Initials": "YS", "LastName": "Zhu"}]}, "ELocationID": {"#text": "10.2147/OTT.S158104", "@EIdType": "doi", "@ValidYN": "Y"}, "Journal": {"ISOAbbreviation": "Onco Targets Ther", "ISSN": {"#text": "1178-6930", "@IssnType": "Print"}, "JournalIssue": {"@CitedMedium": "Print", "PubDate": {"Year": "2018"}, "Volume": "11"}, "Title": "OncoTargets and therapy"}, "Language": "eng", "Pagination": {"EndPage": "3194", "MedlinePgn": "3185-3194", "StartPage": "3185"}, "PublicationTypeList": {"PublicationType": [{"#text": "Journal Article", "@UI": "D016428"}, {"#text": "Review", "@UI": "D016454"}]}}, "CoiStatement": "Disclosure The authors report no conflicts of interest in this work.", "DateRevised": {"Day": "30", "Month": "09", "Year": "2020"}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"#text": "cancer", "@MajorTopicYN": "N"}, {"#text": "chemoresistance", "@MajorTopicYN": "N"}, {"#text": "cisplatin", "@MajorTopicYN": "N"}, {"#text": "lncRNAs", "@MajorTopicYN": "N"}]}, "MedlineJournalInfo": {"Country": "New Zealand", "ISSNLinking": "1178-6930", "MedlineTA": "Onco Targets Ther", "NlmUniqueID": "101514322"}, "PMID": {"#text": "29881292", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "29881292", "@IdType": "pubmed"}, {"#text": "PMC5983019", "@IdType": "pmc"}, {"#text": "10.2147/OTT.S158104", "@IdType": "doi"}, {"#text": "ott-11-3185", "@IdType": "pii"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "entrez", "Day": "9", "Hour": "6", "Minute": "0", "Month": "6", "Year": "2018"}, {"@PubStatus": "pubmed", "Day": "9", "Hour": "6", "Minute": "0", "Month": "6", "Year": "2018"}, {"@PubStatus": "medline", "Day": "9", "Hour": "6", "Minute": "1", "Month": "6", "Year": "2018"}]}, "PublicationStatus": "epublish", "ReferenceList": {"Reference": [{"ArticleIdList": {"ArticleId": {"#text": "25651787", "@IdType": "pubmed"}}, "Citation": "Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87\u2013108."}, {"ArticleIdList": {"ArticleId": {"#text": "29313949", "@IdType": "pubmed"}}, "Citation": "Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7\u201330."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5352108", "@IdType": "pmc"}, {"#text": "27713133", "@IdType": "pubmed"}]}, "Citation": "Chen QN, Wei CC, Wang ZX, Sun M. Long non-coding RNAs in anti-cancer drug resistance. Oncotarget. 2017;8(1):1925\u20131936."}, {"ArticleIdList": {"ArticleId": {"#text": "17625587", "@IdType": "pubmed"}}, "Citation": "Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer. 2007;7(8):573\u2013584."}, {"ArticleIdList": {"ArticleId": {"#text": "15757445", "@IdType": "pubmed"}}, "Citation": "Huddart RA, Birtle AJ. Recent advances in the treatment of testicular cancer. Expert Rev Anticancer Ther. 2005;5(1):123\u2013138."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4384209", "@IdType": "pmc"}, {"#text": "25870801", "@IdType": "pubmed"}]}, "Citation": "Artal Cortes A, Calera Urquizu L, Hernando Cubero J. Adjuvant chemotherapy in non-small cell lung cancer: state-of-the-art. Transl Lung Cancer Res. 2015;4(2):191\u2013197."}, {"ArticleIdList": {"ArticleId": {"#text": "20647037", "@IdType": "pubmed"}}, "Citation": "Koberle B, Tomicic MT, Usanova S, Kaina B. Cisplatin resistance: preclinical findings and clinical implications. Biochim Biophys Acta. 2010;1806(2):172\u2013182."}, {"ArticleIdList": {"ArticleId": {"#text": "14576837", "@IdType": "pubmed"}}, "Citation": "Siddik ZH. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene. 2003;22(47):7265\u20137279."}, {"ArticleIdList": {"ArticleId": {"#text": "23435357", "@IdType": "pubmed"}}, "Citation": "Rebucci M, Michiels C. Molecular aspects of cancer cell resistance to chemotherapy. Biochem Pharmacol. 2013;85(9):1219\u20131226."}, {"ArticleIdList": {"ArticleId": {"#text": "27180308", "@IdType": "pubmed"}}, "Citation": "Xiong XD, Ren X, Cai MY, Yang JW, Liu X, Yang JM. Long non-coding RNAs: an emerging powerhouse in the battle between life and death of tumor cells. Drug Resist Updat. 2016;26:28\u201342."}, {"ArticleIdList": {"ArticleId": {"#text": "27427176", "@IdType": "pubmed"}}, "Citation": "Majidinia M, Yousefi B. Long non-coding RNAs in cancer drug resistance development. DNA Repair (Amst) 2016;45:25\u201333."}, {"ArticleIdList": {"ArticleId": {"#text": "11749487", "@IdType": "pubmed"}}, "Citation": "Jamieson ER, Lippard SJ. Structure, recognition, and processing of cisplatin-DNA adducts. Chem Rev. 1999;99(9):2467\u20132498."}, {"ArticleIdList": {"ArticleId": {"#text": "5782119", "@IdType": "pubmed"}}, "Citation": "Rosenberg B, VanCamp L, Trosko JE, Mansour VH. Platinum compounds: a new class of potent antitumour agents. Nature. 1969;222(5191):385\u2013386."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2929606", "@IdType": "pmc"}, {"#text": "20811617", "@IdType": "pubmed"}]}, "Citation": "Basu A, Krishnamurthy S. Cellular responses to cisplatin-induced DNA damage. J Nucleic Acids. 2010;2010:201367."}, {"ArticleIdList": {"ArticleId": {"#text": "28032148", "@IdType": "pubmed"}}, "Citation": "Brozovic A. The relationship between platinum drug resistance and epithelial-mesenchymal transition. Arch Toxicol. 2017;91(2):605\u2013619."}, {"ArticleIdList": {"ArticleId": {"#text": "26830314", "@IdType": "pubmed"}}, "Citation": "Ferreira JA, Peixoto A, Neves M, et al. Mechanisms of cisplatin resistance and targeting of cancer stem cells: adding glycosylation to the equation. Drug Resist Updat. 2016;24:34\u201354."}, {"ArticleIdList": {"ArticleId": {"#text": "1700077", "@IdType": "pubmed"}}, "Citation": "Einhorn LH. Treatment of testicular cancer: a new and improved model. J Clin Oncol. 1990;8(11):1777\u20131781."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3202487", "@IdType": "pmc"}, {"#text": "20159940", "@IdType": "pubmed"}]}, "Citation": "Howell SB, Safaei R, Larson CA, Sailor MJ. Copper transporters and the cellular pharmacology of the platinum-containing cancer drugs. Mol Pharmacol. 2010;77(6):887\u2013894."}, {"ArticleIdList": {"ArticleId": {"#text": "16213010", "@IdType": "pubmed"}}, "Citation": "Guminski AD, Balleine RL, Chiew YE, et al. MRP2 (ABCC2) and cisplatin sensitivity in hepatocytes and human ovarian carcinoma. Gynecol Oncol. 2006;100(2):239\u2013246."}, {"ArticleIdList": {"ArticleId": {"#text": "21892204", "@IdType": "pubmed"}}, "Citation": "Galluzzi L, Senovilla L, Vitale I, et al. Molecular mechanisms of cisplatin resistance. Oncogene. 2012;31(15):1869\u20131883."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4331052", "@IdType": "pmc"}, {"#text": "20418188", "@IdType": "pubmed"}]}, "Citation": "Arora S, Kothandapani A, Tillison K, Kalman-Maltese V, Patrick SM. Downregulation of XPF-ERCC1 enhances cisplatin efficacy in cancer cells. DNA Repair (Amst) 2010;9(7):745\u2013753."}, {"ArticleIdList": {"ArticleId": {"#text": "8895738", "@IdType": "pubmed"}}, "Citation": "Fink D, Nebel S, Aebi S, et al. The role of DNA mismatch repair in platinum drug resistance. Cancer Res. 1996;56(21):4881\u20134886."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4053124", "@IdType": "pmc"}, {"#text": "23146216", "@IdType": "pubmed"}]}, "Citation": "Turner NC, Tutt AN. Platinum chemotherapy for BRCA1-related breast cancer: do we need more evidence? Breast Cancer Res. 2012;14(6):115."}, {"ArticleIdList": {"ArticleId": {"#text": "10697522", "@IdType": "pubmed"}}, "Citation": "Asada N, Tsuchiya H, Tomita K. De novo deletions of p53 gene and wild-type p53 correlate with acquired cisplatin-resistance in human osteosarcoma OST cell line. Anticancer Res. 1999;19(6B):5131\u20135137."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC1849987", "@IdType": "pmc"}, {"#text": "17446929", "@IdType": "pubmed"}]}, "Citation": "Leong CO, Vidnovic N, DeYoung MP, Sgroi D, Ellisen LW. The p63/p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancers. J Clin Invest. 2007;117(5):1370\u20131380."}, {"ArticleIdList": {"ArticleId": {"#text": "22112972", "@IdType": "pubmed"}}, "Citation": "van Oosterwijk JG, Herpers B, Meijer D, et al. Restoration of chemo-sensitivity for doxorubicin and cisplatin in chondrosarcoma in vitro: BCL-2 family members cause chemoresistance. Ann Oncol. 2012;23(6):1617\u20131626."}, {"ArticleIdList": {"ArticleId": {"#text": "10397248", "@IdType": "pubmed"}}, "Citation": "Henkels KM, Turchi JJ. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines. Cancer Res. 1999;59(13):3077\u20133083."}, {"ArticleIdList": {"ArticleId": {"#text": "11912244", "@IdType": "pubmed"}}, "Citation": "Park MS, De Leon M, Devarajan P. Cisplatin induces apoptosis in LLC-PK1 cells via activation of mitochondrial pathways. J Am Soc Nephrol. 2002;13(4):858\u2013865."}, {"ArticleIdList": {"ArticleId": {"#text": "20187799", "@IdType": "pubmed"}}, "Citation": "Ren JH, He WS, Nong L, et al. Acquired cisplatin resistance in human lung adenocarcinoma cells is associated with enhanced autophagy. Cancer Biother Radiopharm. 2010;25(1):75\u201380."}, {"ArticleIdList": {"ArticleId": {"#text": "11034077", "@IdType": "pubmed"}}, "Citation": "Mitsuuchi Y, Johnson SW, Selvakumaran M, Williams SJ, Hamilton TC, Testa JR. The phosphatidylinositol 3-kinase/AKT signal transduction pathway plays a critical role in the expression of p21WAF1/CIP1/SDI1 induced by cisplatin and paclitaxel. Cancer Res. 2000;60(19):5390\u20135394."}, {"ArticleIdList": {"ArticleId": {"#text": "20628352", "@IdType": "pubmed"}}, "Citation": "Alexander RP, Fang G, Rozowsky J, Snyder M, Gerstein MB. Annotating non-coding regions of the genome. Nat Rev Genet. 2010;11(8):559\u2013571."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4111732", "@IdType": "pmc"}, {"#text": "23696037", "@IdType": "pubmed"}]}, "Citation": "Ma L, Bajic VB, Zhang Z. On the classification of long non-coding RNAs. RNA Biol. 2013;10(6):925\u2013933."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5316185", "@IdType": "pmc"}, {"#text": "28212646", "@IdType": "pubmed"}]}, "Citation": "Tang Y, Wang J, Lian Y, et al. Linking long non-coding RNAs and SWI/SNF complexes to chromatin remodeling in cancer. Mol Cancer. 2017;16(1):42."}, {"ArticleIdList": {"ArticleId": {"#text": "26885843", "@IdType": "pubmed"}}, "Citation": "Wu R, Su Y, Wu H, Dai Y, Zhao M, Lu Q. Characters, functions and clinical perspectives of long non-coding RNAs. Mol Genet Genomics. 2016;291(3):1013\u20131033."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3098824", "@IdType": "pmc"}, {"#text": "21489289", "@IdType": "pubmed"}]}, "Citation": "Gibb EA, Brown CJ, Lam WL. The functional role of long non-coding RNA in human carcinomas. Mol Cancer. 2011;10:38."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5696158", "@IdType": "pmc"}, {"#text": "29190892", "@IdType": "pubmed"}]}, "Citation": "Zhu QN, Wang G, Guo Y, et al. LncRNA H19 is a major mediator of doxorubicin chemoresistance in breast cancer cells through a cullin4A-MDR1 pathway. Oncotarget. 2017;8(54):91990\u201392003."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5587918", "@IdType": "pmc"}, {"#text": "28831025", "@IdType": "pubmed"}]}, "Citation": "Du P, Zhao H, Peng R, et al. LncRNA-XIST interacts with miR-29c to modulate the chemoresistance of glioma cell to TMZ through DNA mismatch repair pathway. Biosci Rep. 2017;37(5):BSR20170696."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4820696", "@IdType": "pmc"}, {"#text": "27046651", "@IdType": "pubmed"}]}, "Citation": "Bian Z, Jin L, Zhang J, et al. LncRNA-UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p. Sci Rep. 2016;6:23892."}, {"ArticleIdList": {"ArticleId": {"#text": "25763542", "@IdType": "pubmed"}}, "Citation": "Hang Q, Sun R, Jiang C, Li Y. Notch 1 promotes cisplatin-resistant gastric cancer formation by upregulating lncRNA AK022798 expression. Anticancer Drugs. 2015;26(6):632\u2013640."}, {"ArticleIdList": {"ArticleId": {"#text": "25956062", "@IdType": "pubmed"}}, "Citation": "Zhang XW, Bu P, Liu L, Zhang XZ, Li J. Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance. Biochem Biophys Res Commun. 2015;462(3):227\u2013232."}, {"ArticleIdList": {"ArticleId": {"#text": "27121324", "@IdType": "pubmed"}}, "Citation": "Lan WG, Xu DH, Xu C, et al. Silencing of long non-coding RNA ANRIL inhibits the development of multidrug resistance in gastric cancer cells. Oncol Rep. 2016;36(1):263\u2013270."}, {"ArticleIdList": {"ArticleId": {"#text": "22516052", "@IdType": "pubmed"}}, "Citation": "Xu X, Ren H, Zhou B, et al. Prediction of copper transport protein 1 (CTR1) genotype on severe cisplatin induced toxicity in non-small cell lung cancer (NSCLC) patients. Lung Cancer. 2012;77(2):438\u2013442."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5190027", "@IdType": "pmc"}, {"#text": "27270317", "@IdType": "pubmed"}]}, "Citation": "Jiang P, Wu X, Wang X, Huang W, Feng Q. NEAT1 upregulates EGCG-induced CTR1 to enhance cisplatin sensitivity in lung cancer cells. Oncotarget. 2016;7(28):43337\u201343351."}, {"ArticleIdList": {"ArticleId": {"#text": "12433807", "@IdType": "pubmed"}}, "Citation": "Dabrowiak JC, Goodisman J, Souid AK. Kinetic study of the reaction of cisplatin with thiols. Drug Metab Dispos. 2002;30(12):1378\u20131384."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4403068", "@IdType": "pmc"}, {"#text": "25901159", "@IdType": "pubmed"}]}, "Citation": "Jamali B, Nakhjavani M, Hosseinzadeh L, Amidi S, Nikounezhad N, H Shirazi F. Intracellular GSH alterations and its relationship to level of resistance following exposure to cisplatin in cancer cells. Iran J Pharm Res. 2015;14(2):513\u2013519."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4872133", "@IdType": "pmc"}, {"#text": "27193186", "@IdType": "pubmed"}]}, "Citation": "Zheng ZG, Xu H, Suo SS, et al. The essential role of H19 contributing to cisplatin resistance by regulating glutathione metabolism in high-grade serous ovarian cancer. Sci Rep. 2016;6:26093."}, {"ArticleIdList": {"ArticleId": {"#text": "16360037", "@IdType": "pubmed"}}, "Citation": "Janssens S, Tinel A, Lippens S, Tschopp J. PIDD mediates NF-kappaB activation in response to DNA damage. Cell. 2005;123(6):1079\u20131092."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5050052", "@IdType": "pmc"}, {"#text": "27041570", "@IdType": "pubmed"}]}, "Citation": "Ozes AR, Miller DF, Ozes ON, et al. NF-kappaB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer. Oncogene. 2016;35(41):5350\u20135361."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3796503", "@IdType": "pmc"}, {"#text": "24155936", "@IdType": "pubmed"}]}, "Citation": "Liu Z, Sun M, Lu K, et al. The long noncoding RNA HOTAIR contributes to cisplatin resistance of human lung adenocarcinoma cells via downregualtion of p21(WAF1/CIP1) expression. PLoS One. 2013;8(10):e77293."}, {"ArticleIdList": {"ArticleId": {"#text": "28117929", "@IdType": "pubmed"}}, "Citation": "Wang Y, Cheng N, Luo J. Downregulation of lncRNA ANRIL represses tumorigenicity and enhances cisplatin-induced cytotoxicity via regulating microRNA let-7a in nasopharyngeal carcinoma. J Biochem Mol Toxicol. 2017;31(7):e21904."}, {"ArticleIdList": {"ArticleId": {"#text": "20477830", "@IdType": "pubmed"}}, "Citation": "Pang JC, Li KK, Lau KM, et al. KIAA0495/PDAM is frequently downregulated in oligodendroglial tumors and its knockdown by siRNA induces cisplatin resistance in glioma cells. Brain Pathol. 2010;20(6):1021\u20131032."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5021023", "@IdType": "pmc"}, {"#text": "27311700", "@IdType": "pubmed"}]}, "Citation": "Li L, Gu M, You B, et al. Long non-coding RNA ROR promotes proliferation, migration and chemoresistance of nasopharyngeal carcinoma. Cancer Sci. 2016;107(9):1215\u20131222."}, {"ArticleIdList": {"ArticleId": {"#text": "26059239", "@IdType": "pubmed"}}, "Citation": "Xia Y, He Z, Liu B, Wang P, Chen Y. Downregulation of Meg3 enhances cisplatin resistance of lung cancer cells through activation of the WNT/beta-catenin signaling pathway. Mol Med Rep. 2015;12(3):4530\u20134537."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4439130", "@IdType": "pmc"}, {"#text": "25992654", "@IdType": "pubmed"}]}, "Citation": "Liu J, Wan L, Lu K, et al. The long noncoding RNA MEG3 contributes to cisplatin resistance of human lung adenocarcinoma. PLoS One. 2015;10(5):e0114586."}, {"ArticleIdList": {"ArticleId": {"#text": "26768586", "@IdType": "pubmed"}}, "Citation": "Ma W, Li J, Hu J, et al. miR214-regulated p53-NOX4/p66shc pathway plays a crucial role in the protective effect of Ginkgolide B against cisplatin-induced cytotoxicity in HEI-OC1 cells. Chem Biol Interact. 2016;245:72\u201381."}, {"ArticleIdList": {"ArticleId": {"#text": "28678322", "@IdType": "pubmed"}}, "Citation": "Ma LY, Xie XW, Ma L, et al. Downregulated long non-coding RNA TRPM2-AS inhibits cisplatin resistance of non-small cell lung cancer cells via activation of p53-p66shc pathway. Eur Rev Med Pharmacol Sci. 2017;21(11):2626\u20132634."}, {"ArticleIdList": {"ArticleId": {"#text": "18097445", "@IdType": "pubmed"}}, "Citation": "Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol. 2008;9(1):47\u201359."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5356823", "@IdType": "pmc"}, {"#text": "27911863", "@IdType": "pubmed"}]}, "Citation": "Wang Q, Cheng N, Li X, et al. Correlation of long non-coding RNA H19 expression with cisplatin-resistance and clinical outcome in lung adenocarcinoma. Oncotarget. 2017;8(2):2558\u20132567."}, {"ArticleIdList": {"ArticleId": {"#text": "28128423", "@IdType": "pubmed"}}, "Citation": "Yan H, Xia JY, Feng FZ. Long non-coding RNA ENST00000457645 reverses cisplatin resistance in CP70 ovarian cancer cells. Genet Mol Res. 2017;16(1):gmr16019411."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4723819", "@IdType": "pmc"}, {"#text": "26884974", "@IdType": "pubmed"}]}, "Citation": "Liu E, Liu Z, Zhou Y, Mi R, Wang D. Overexpression of long non-coding RNA PVT1 in ovarian cancer cells promotes cisplatin resistance by regulating apoptotic pathways. Int J Clin Exp Med. 2015;8(11):20565\u201320572."}, {"ArticleIdList": {"ArticleId": {"#text": "27591936", "@IdType": "pubmed"}}, "Citation": "Pan J, Li X, Wu W, et al. Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells. Cancer Lett. 2016;382(1):64\u201376."}, {"ArticleIdList": {"ArticleId": {"#text": "28414550", "@IdType": "pubmed"}}, "Citation": "Wang B, Huang Z, Gao R, et al. Expression of long noncoding RNA urothelial cancer associated 1 promotes cisplatin resistance in cervical cancer. Cancer Biother Radiopharm. 2017;32(3):101\u2013110."}, {"ArticleIdList": {"ArticleId": {"#text": "28175963", "@IdType": "pubmed"}}, "Citation": "Zhang J, Liu J, Xu X, Li L. Curcumin suppresses cisplatin resistance development partly via modulating extracellular vesicle-mediated transfer of MEG3 and miR-214 in ovarian cancer. Cancer Chemother Pharmacol. 2017;79(3):479\u2013487."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5722577", "@IdType": "pmc"}, {"#text": "29228625", "@IdType": "pubmed"}]}, "Citation": "Li L, Yin JY, He FZ, et al. Long noncoding RNA SFTA1P promoted apoptosis and increased cisplatin chemosensitivity via regulating the hnRNP-U-GADD45A axis in lung squamous cell carcinoma. Oncotarget. 2017;8(57):97476\u201397489."}, {"ArticleIdList": {"ArticleId": {"#text": "22576688", "@IdType": "pubmed"}}, "Citation": "Wang Y, Chen W, Yang C, et al. Long non-coding RNA UCA1a(CUDR) promotes proliferation and tumorigenesis of bladder cancer. Int J Oncol. 2012;41(1):276\u2013284."}, {"ArticleIdList": {"ArticleId": {"#text": "25824616", "@IdType": "pubmed"}}, "Citation": "Wang Y, Wang H, Song T, et al. HOTAIR is a potential target for the treatment of cisplatinresistant ovarian cancer. Mol Med Rep. 2015;12(2):2211\u20132216."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5346790", "@IdType": "pmc"}, {"#text": "28356873", "@IdType": "pubmed"}]}, "Citation": "Zhang Y, Song X, Wang X, Hu J, Jiang L. Silencing of LncRNA HULC enhances chemotherapy induced apoptosis in human gastric cancer. J Med Biochem. 2016;35(2):137\u2013143."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4674781", "@IdType": "pmc"}, {"#text": "26603103", "@IdType": "pubmed"}]}, "Citation": "Wickstrom M, Dyberg C, Milosevic J, et al. Wnt/beta-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance. Nat Commun. 2015;6:8904."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3669360", "@IdType": "pmc"}, {"#text": "23741487", "@IdType": "pubmed"}]}, "Citation": "Yang Y, Li H, Hou S, Hu B, Liu J, Wang J. The noncoding RNA expression profile and the effect of lncRNA AK126698 on cisplatin resistance in non-small-cell lung cancer cell. PLoS One. 2013;8(5):e65309."}, {"ArticleIdList": {"ArticleId": {"#text": "24495014", "@IdType": "pubmed"}}, "Citation": "Fan Y, Shen B, Tan M, et al. Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling. FEBS J. 2014;281(7):1750\u20131758."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4891451", "@IdType": "pmc"}, {"#text": "27347346", "@IdType": "pubmed"}]}, "Citation": "Li Z, Zhao L, Wang Q. Overexpression of long non-coding RNA HOTTIP increases chemoresistance of osteosarcoma cell by activating the Wnt/beta-catenin pathway. Am J Transl Res. 2016;8(5):2385\u20132393."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2696814", "@IdType": "pmc"}, {"#text": "18191218", "@IdType": "pubmed"}]}, "Citation": "Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008;132(1):27\u201342."}, {"ArticleIdList": {"ArticleId": {"#text": "27338051", "@IdType": "pubmed"}}, "Citation": "Zhang N, Yang GQ, Shao XM, Wei L. GAS5 modulated autophagy is a mechanism modulating cisplatin sensitivity in NSCLC cells. Eur Rev Med Pharmacol Sci. 2016;20(11):2271\u20132277."}, {"ArticleIdList": {"ArticleId": {"#text": "28721581", "@IdType": "pubmed"}}, "Citation": "Sun MY, Zhu JY, Zhang CY, et al. Autophagy regulated by lncRNA HOTAIR contributes to the cisplatin-induced resistance in endometrial cancer cells. Biotechnol Lett. 2017;39(10):1477\u20131484."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5783579", "@IdType": "pmc"}, {"#text": "29130102", "@IdType": "pubmed"}]}, "Citation": "Sun W, Zu Y, Fu X, Deng Y. Knockdown of lncRNA-XIST enhances the chemosensitivity of NSCLC cells via suppression of autophagy. Oncol Rep. 2017;38(6):3347\u20133354."}, {"ArticleIdList": {"ArticleId": {"#text": "28499919", "@IdType": "pubmed"}}, "Citation": "Ma B, Yuan Z, Zhang L, et al. Long non-coding RNA AC023115.3 suppresses chemoresistance of glioblastoma by reducing autophagy. Biochim Biophys Acta. 2017;1864(8):1393\u20131404."}, {"ArticleIdList": {"ArticleId": {"#text": "29331418", "@IdType": "pubmed"}}, "Citation": "Yan H, Bu P. Non-coding RNAs in cancer stem cells. Cancer Lett. 2018;421:121\u2013126."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5179381", "@IdType": "pmc"}, {"#text": "28066612", "@IdType": "pubmed"}]}, "Citation": "Liu MY, Li XQ, Gao TH, et al. Elevated HOTAIR expression associated with cisplatin resistance in non-small cell lung cancer patients. J Thorac Dis. 2016;8(11):3314\u20133322."}, {"ArticleIdList": {"ArticleId": {"#text": "27609068", "@IdType": "pubmed"}}, "Citation": "Wang Y, Zhang L, Zheng X, et al. Long non-coding RNA LINC00161 sensitises osteosarcoma cells to cisplatin-induced apoptosis by regulating the miR-645-IFIT2 axis. Cancer Lett. 2016;382(2):137\u2013146."}, {"ArticleIdList": {"ArticleId": {"#text": "28495512", "@IdType": "pubmed"}}, "Citation": "Feng Y, Zou W, Hu C, et al. Modulation of CASC2/miR-21/PTEN pathway sensitizes cervical cancer to cisplatin. Arch Biochem Biophys. 2017:623\u2013624. 20\u201330."}, {"ArticleIdList": {"ArticleId": {"#text": "28686971", "@IdType": "pubmed"}}, "Citation": "Cao L, Chen J, Ou B, Liu C, Zou Y, Chen Q. GAS5 knockdown reduces the chemo-sensitivity of non-small cell lung cancer (NSCLC) cell to cisplatin (DDP) through regulating miR-21/PTEN axis. Biomed Pharmacother. 2017;93:570\u2013579."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5661845", "@IdType": "pmc"}, {"#text": "29123412", "@IdType": "pubmed"}]}, "Citation": "Wang P, Chen D, Ma H, Li Y. LncRNA MEG3 enhances cisplatin sensitivity in non-small cell lung cancer by regulating miR-21-5p/SOX7 axis. Onco Targets Ther. 2017;10:5137\u20135149."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5499972", "@IdType": "pmc"}, {"#text": "28472815", "@IdType": "pubmed"}]}, "Citation": "Wen Q, Liu Y, Lyu H, et al. Long noncoding RNA GAS5, which acts as a tumor suppressor via microRNA 21, regulates cisplatin resistance expression in cervical cancer. Int J Gynecol Cancer. 2017;27(6):1096\u20131108."}, {"ArticleIdList": {"ArticleId": {"#text": "22498722", "@IdType": "pubmed"}}, "Citation": "Hanna N, Ohana P, Konikoff FM, et al. Phase 1/2a, dose-escalation, safety, pharmacokinetic and preliminary efficacy study of intratumoral administration of BC-819 in patients with unresectable pancreatic cancer. Cancer Gene Ther. 2012;19(6):374\u2013381."}, {"ArticleIdList": {"ArticleId": {"#text": "24342146", "@IdType": "pubmed"}}, "Citation": "Gofrit ON, Benjamin S, Halachmi S, et al. DNA based therapy with diphtheria toxin-A BC-819: a phase 2b marker lesion trial in patients with intermediate risk nonmuscle invasive bladder cancer. J Urol. 2014;191(6):1697\u20131702."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5315703", "@IdType": "pmc"}, {"#text": "28154921", "@IdType": "pubmed"}]}, "Citation": "Lavie O, Edelman D, Levy T, et al. A phase 1/2a, dose-escalation, safety, pharmacokinetic, and preliminary efficacy study of intraperitoneal administration of BC-819 (H19-DTA) in subjects with recurrent ovarian/peritoneal cancer. Arch Gynecol Obstet. 2017;295(3):751\u2013761."}]}}}}}, "PMC": "PMC5983019", "PMID": "29881292", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "Emerging role of long non-coding RNAs in cisplatin resistance.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "9": {"Abstract": "Ovarian cancer is the leading cause of death among women with gynecologic malignancies. The development and progression of ovarian cancer are complex and a multiple-step process. New biomarker molecules for diagnostic and prognostic are essential for novel therapeutic targets and to extend the survival time of patients with ovarian cancer. Long noncoding RNAs (lncRNAs) are non-protein-coding transcripts longer than 200 nucleotides that have recently been found as key regulators of various biological processes and to be involved in the development and progression of many diseases including cancers. In this review, we summarized the expression pattern of several dysregulated lncRNAs (HOTAIR, H19, XIST, and HOST2) and the functional molecular mechanism of these lncRNAs on the initiation and progression of ovarian cancer. The lncRNAs as biomarkers may be used for current and future clinical diagnosis, therapeutics, and prognosis.", "Authors": [{"Affiliations": [{"Has_Extra": true, "HashID": "1236925916747440909", "Part1": "*The Key Laboratory of Carcinogenesis of the Chinese Ministry of Health", "Part2": "Xiangya Hospital", "Part3": "\u2020The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education", "Part4": "Cancer Research Institute", "Part5": "\u2021Hunan Key Laboratory of Nonresolving Inflammation and Cancer", "Part6": "the Third Xiangya Hospital", "Text": "*The Key Laboratory of Carcinogenesis of the Chinese Ministry of Health, Xiangya Hospital, \u2020The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute, \u2021Hunan Key Laboratory of Nonresolving Inflammation and Cancer, the Third Xiangya Hospital, Central South University, Changsha, Hunan, China, and \u00a7State Key Laboratory of High Performance Complex Manufacturing, Central South University, Changsha, China."}], "ForeName": "Yancheng", "FullName": "Yancheng Zhong", "HashID": "-999845693031427094", "LastName": "Zhong", "ORCID": null}, {"Affiliations": null, "ForeName": "Dan", "FullName": "Dan Gao", "HashID": "8408544647996988760", "LastName": "Gao", "ORCID": null}, {"Affiliations": null, "ForeName": "Shiwei", "FullName": "Shiwei He", "HashID": "8596141438574455110", "LastName": "He", "ORCID": null}, {"Affiliations": null, "ForeName": "Cijun", "FullName": "Cijun Shuai", "HashID": "-4522100303390426062", "LastName": "Shuai", "ORCID": null}, {"Affiliations": null, "ForeName": "Shuping", "FullName": "Shuping Peng", "HashID": "8005775701093373105", "LastName": "Peng", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.1097/IGC.0000000000000828", "InsertType": null, "Journal": "International journal of gynecological cancer : official journal of the International Gynecological Cancer Society", "Keywords": [{"IS_Major": false, "IS_Mesh": true, "Text": "Carcinoma"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Female"}, {"IS_Major": true, "IS_Mesh": true, "Text": "Gene Expression Regulation, Neoplastic"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Humans"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Ovarian Neoplasms"}, {"IS_Major": false, "IS_Mesh": true, "Text": "RNA, Long Noncoding"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "MEDLINE", "Article": {"@PubModel": "Print", "Abstract": {"AbstractText": "Ovarian cancer is the leading cause of death among women with gynecologic malignancies. The development and progression of ovarian cancer are complex and a multiple-step process. New biomarker molecules for diagnostic and prognostic are essential for novel therapeutic targets and to extend the survival time of patients with ovarian cancer. Long noncoding RNAs (lncRNAs) are non-protein-coding transcripts longer than 200 nucleotides that have recently been found as key regulators of various biological processes and to be involved in the development and progression of many diseases including cancers. In this review, we summarized the expression pattern of several dysregulated lncRNAs (HOTAIR, H19, XIST, and HOST2) and the functional molecular mechanism of these lncRNAs on the initiation and progression of ovarian cancer. The lncRNAs as biomarkers may be used for current and future clinical diagnosis, therapeutics, and prognosis."}, "ArticleTitle": "Dysregulated Expression of Long Noncoding RNAs in Ovarian Cancer.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "*The Key Laboratory of Carcinogenesis of the Chinese Ministry of Health, Xiangya Hospital, \u2020The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute, \u2021Hunan Key Laboratory of Nonresolving Inflammation and Cancer, the Third Xiangya Hospital, Central South University, Changsha, Hunan, China, and \u00a7State Key Laboratory of High Performance Complex Manufacturing, Central South University, Changsha, China."}, "ForeName": "Yancheng", "Initials": "Y", "LastName": "Zhong"}, {"@ValidYN": "Y", "ForeName": "Dan", "Initials": "D", "LastName": "Gao"}, {"@ValidYN": "Y", "ForeName": "Shiwei", "Initials": "S", "LastName": "He"}, {"@ValidYN": "Y", "ForeName": "Cijun", "Initials": "C", "LastName": "Shuai"}, {"@ValidYN": "Y", "ForeName": "Shuping", "Initials": "S", "LastName": "Peng"}]}, "Journal": {"ISOAbbreviation": "Int J Gynecol Cancer", "ISSN": {"#text": "1525-1438", "@IssnType": "Electronic"}, "JournalIssue": {"@CitedMedium": "Internet", "Issue": "9", "PubDate": {"Month": "Nov", "Year": "2016"}, "Volume": "26"}, "Title": "International journal of gynecological cancer : official journal of the International Gynecological Cancer Society"}, "Language": "eng", "Pagination": {"EndPage": "1570", "MedlinePgn": "1564-1570", "StartPage": "1564"}, "PublicationTypeList": {"PublicationType": [{"#text": "Journal Article", "@UI": "D016428"}, {"#text": "Review", "@UI": "D016454"}, {"#text": "Research Support, Non-U.S. Gov't", "@UI": "D013485"}]}}, "ChemicalList": {"Chemical": {"NameOfSubstance": {"#text": "RNA, Long Noncoding", "@UI": "D062085"}, "RegistryNumber": "0"}}, "CitationSubset": "IM", "CoiStatement": "The authors declare no conflicts of interest.", "DateCompleted": {"Day": "24", "Month": "01", "Year": "2018"}, "DateRevised": {"Day": "13", "Month": "11", "Year": "2018"}, "MedlineJournalInfo": {"Country": "England", "ISSNLinking": "1048-891X", "MedlineTA": "Int J Gynecol Cancer", "NlmUniqueID": "9111626"}, "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"#text": "Carcinoma", "@MajorTopicYN": "N", "@UI": "D002277"}, "QualifierName": {"#text": "metabolism", "@MajorTopicYN": "Y", "@UI": "Q000378"}}, {"DescriptorName": {"#text": "Female", "@MajorTopicYN": "N", "@UI": "D005260"}}, {"DescriptorName": {"#text": "Gene Expression Regulation, Neoplastic", "@MajorTopicYN": "Y", "@UI": "D015972"}}, {"DescriptorName": {"#text": "Humans", "@MajorTopicYN": "N", "@UI": "D006801"}}, {"DescriptorName": {"#text": "Ovarian Neoplasms", "@MajorTopicYN": "N", "@UI": "D010051"}, "QualifierName": {"#text": "metabolism", "@MajorTopicYN": "Y", "@UI": "Q000378"}}, {"DescriptorName": {"#text": "RNA, Long Noncoding", "@MajorTopicYN": "N", "@UI": "D062085"}, "QualifierName": {"#text": "metabolism", "@MajorTopicYN": "Y", "@UI": "Q000378"}}]}, "PMID": {"#text": "27603915", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "27603915", "@IdType": "pubmed"}, {"#text": "PMC5084630", "@IdType": "pmc"}, {"#text": "10.1097/IGC.0000000000000828", "@IdType": "doi"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "pubmed", "Day": "26", "Hour": "6", "Minute": "0", "Month": "10", "Year": "2016"}, {"@PubStatus": "medline", "Day": "25", "Hour": "6", "Minute": "0", "Month": "1", "Year": "2018"}, {"@PubStatus": "entrez", "Day": "8", "Hour": "6", "Minute": "0", "Month": "9", "Year": "2016"}]}, "PublicationStatus": "ppublish", "ReferenceList": {"Reference": [{"ArticleIdList": {"ArticleId": {"#text": "26080288", "@IdType": "pubmed"}}, "Citation": "Sopik V, Iqbal J, Rosen B, et al. Why have ovarian cancer mortality rates declined? Part II. Case-fatality. Gynecol Oncol. 2015;138:750\u2013756."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3576854", "@IdType": "pmc"}, {"#text": "21521830", "@IdType": "pubmed"}]}, "Citation": "Jelovac D, Armstrong DK. Recent progress in the diagnosis and treatment of ovarian cancer. CA Cancer J Clin. 2011;61:183\u2013203."}, {"ArticleIdList": {"ArticleId": {"#text": "17550756", "@IdType": "pubmed"}}, "Citation": "Aletti GD, Gallenberg MM, Cliby WA, et al. Current management strategies for ovarian cancer. Mayo Clin Proc. 2007;82:751\u2013770."}, {"ArticleIdList": {"ArticleId": {"#text": "17607916", "@IdType": "pubmed"}}, "Citation": "Lage H, Denkert C. Resistance to chemotherapy in ovarian carcinoma. Recent Results Cancer Res. 2007;176:51\u201360."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4669740", "@IdType": "pmc"}, {"#text": "25569100", "@IdType": "pubmed"}]}, "Citation": "Ma MZ, Chu BF, Zhang Y, et al. Long non-coding RNA CCAT1 promotes gallbladder cancer development via negative modulation of miRNA-218-5p. Cell Death Dis. 2015;6:e1583."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3439153", "@IdType": "pmc"}, {"#text": "22955616", "@IdType": "pubmed"}]}, "Citation": "ENCODE Project Consortium An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489:57\u201374."}, {"ArticleIdList": {"ArticleId": {"#text": "24091687", "@IdType": "pubmed"}}, "Citation": "Zhao Y, Wang J, Chen X, et al. Large-scale study of long non-coding RNA functions based on structure and expression features. Sci China Life Sci. 2013;56:953\u2013959."}, {"ArticleIdList": {"ArticleId": {"#text": "22070123", "@IdType": "pubmed"}}, "Citation": "Ip JY, Nakagawa S. Long non-coding RNAs in nuclear bodies. Dev Growth Differ. 2012;54:44\u201354."}, {"ArticleIdList": {"ArticleId": {"#text": "25124562", "@IdType": "pubmed"}}, "Citation": "Ye N, Wang B, Quan ZF, et al. Functional roles of long non-coding RNA in human breast cancer. Asian Pac J Cancer Prev. 2014;15:5993\u20135997."}, {"ArticleIdList": {"ArticleId": {"#text": "19188922", "@IdType": "pubmed"}}, "Citation": "Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10:155\u2013159."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4294373", "@IdType": "pmc"}, {"#text": "25428918", "@IdType": "pubmed"}]}, "Citation": "Di Gesualdo F, Capaccioli S, Lulli M. A pathophysiological view of the long non-coding RNA world. Oncotarget. 2014;5:10976\u201310996."}, {"ArticleIdList": {"ArticleId": {"#text": "23504273", "@IdType": "pubmed"}}, "Citation": "Sun L, Luo H, Liao Q, et al. Systematic study of human long intergenic non-coding RNAs and their impact on cancer. Sci China Life Sci. 2013;56:324\u2013334."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4552604", "@IdType": "pmc"}, {"#text": "25619839", "@IdType": "pubmed"}]}, "Citation": "Ling H, Vincent K, Pichler M, et al. Junk DNA and the long non-coding RNA twist in cancer genetics. Oncogene. 2015;34:5003\u20135011."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2667263", "@IdType": "pmc"}, {"#text": "19390609", "@IdType": "pubmed"}]}, "Citation": "Mattick JS. The genetic signatures of noncoding RNAs. PLoS Genet. 2009;5:e1000459."}, {"ArticleIdList": {"ArticleId": {"#text": "22996375", "@IdType": "pubmed"}}, "Citation": "Qi P, Du X. The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. Mod Pathol. 2013;26:155\u2013165."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3413108", "@IdType": "pmc"}, {"#text": "22492512", "@IdType": "pubmed"}]}, "Citation": "Moran VA, Perera RJ, Khalil AM. Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs. Nucleic Acids Res. 2012;40:6391\u20136400."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4851900", "@IdType": "pmc"}, {"#text": "27013343", "@IdType": "pubmed"}]}, "Citation": "Parasramka MA, Maji S, Matsuda A, et al. Long non-coding RNAs as novel targets for therapy in hepatocellular carcinoma. Pharmacol Ther. 2016;161:67\u201378."}, {"ArticleIdList": {"ArticleId": {"#text": "21256239", "@IdType": "pubmed"}}, "Citation": "Clark MB, Mattick JS. Long noncoding RNAs in cell biology. Semin Cell Dev Biol. 2011;22:366\u2013376."}, {"ArticleIdList": {"ArticleId": {"#text": "25444905", "@IdType": "pubmed"}}, "Citation": "Fang XY, Pan HF, Leng RX, et al. Long noncoding RNAs: novel insights into gastric cancer. Cancer Lett. 2015;356:357\u2013366."}, {"ArticleIdList": {"ArticleId": {"#text": "24006224", "@IdType": "pubmed"}}, "Citation": "Sun M, Xia R, Jin F, et al. Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer. Tumour Biol. 2014;35:1065\u20131073."}, {"ArticleIdList": {"ArticleId": {"#text": "14562052", "@IdType": "pubmed"}}, "Citation": "Rangel LB, Sherman-Baust CA, Wernyj RP, et al. Characterization of novel human ovarian cancer-specific transcripts (HOSTs) identified by serial analysis of gene expression. Oncogene. 2003;22:7225\u20137232."}, {"ArticleIdList": {"ArticleId": {"#text": "25292198", "@IdType": "pubmed"}}, "Citation": "Gao Y, Meng H, Liu S, et al. LncRNA-HOST2 regulates cell biological behaviors in epithelial ovarian cancer through a mechanism involving microRNA let-7b. Hum Mol Genet. 2015;24:841\u2013852."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3103462", "@IdType": "pmc"}, {"#text": "21496275", "@IdType": "pubmed"}]}, "Citation": "He S, Liu S, Zhu H. The sequence, structure and evolutionary features of HOTAIR in mammals. BMC Evol Biol. 2011;11:102."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3066151", "@IdType": "pmc"}, {"#text": "20864820", "@IdType": "pubmed"}]}, "Citation": "Wan Y, Chang HY. HOTAIR: flight of noncoding RNAs in cancer metastasis. Cell Cycle. 2010;9:3391\u20133392."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2084369", "@IdType": "pmc"}, {"#text": "17604720", "@IdType": "pubmed"}]}, "Citation": "Rinn JL, Kertesz M, Wang JK, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell. 2007;129:1311\u20131323."}, {"ArticleIdList": {"ArticleId": {"#text": "15643670", "@IdType": "pubmed"}}, "Citation": "Grier DG, Thompson A, Kwasniewska A, et al. The pathophysiology of HOX genes and their role in cancer. J Pathol. 2005;205:154\u2013171."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2967777", "@IdType": "pmc"}, {"#text": "20616235", "@IdType": "pubmed"}]}, "Citation": "Tsai MC, Manor O, Wan Y, et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science. 2010;329:689\u2013693."}, {"ArticleIdList": {"ArticleId": {"#text": "25796453", "@IdType": "pubmed"}}, "Citation": "Jun-jun Qiu YJH, Gong Yang K. The long non-coding RNA HOTAIR promotes the proliferation of serous ovarian cancer cells through the regulation of cell cycle arrest and apoptosis. Exp Cell Res. 2015:238\u2013248."}, {"ArticleIdList": {"ArticleId": {"#text": "7536897", "@IdType": "pubmed"}}, "Citation": "Leighton PA, Ingram RS, Eggenschwiler J, et al. Disruption of imprinting caused by deletion of the H19 gene region in mice. Nature. 1995;375:34\u201339."}, {"ArticleIdList": {"ArticleId": {"#text": "8564957", "@IdType": "pubmed"}}, "Citation": "Hibi K, Nakamura H, Hirai A, et al. Loss of H19 imprinting in esophageal cancer. Cancer Res. 1996;56:480\u2013482."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4233163", "@IdType": "pmc"}, {"#text": "25205099", "@IdType": "pubmed"}]}, "Citation": "Medrzycki M, Zhang Y, Zhang W, et al. Histone h1.3 suppresses h19 noncoding RNA expression and cell growth of ovarian cancer cells. Cancer Res. 2014;74:6463\u20136473."}, {"ArticleIdList": {"ArticleId": {"#text": "15195139", "@IdType": "pubmed"}}, "Citation": "Kawakami T, Zhang C, Taniguchi T, et al. Characterization of loss-of-inactive X in Klinefelter syndrome and female-derived cancer cells. Oncogene. 2004;23:6163\u20136169."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2734756", "@IdType": "pmc"}, {"#text": "19656414", "@IdType": "pubmed"}]}, "Citation": "Mizrahi A, Czerniak A, Levy T, et al. Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences. J Transl Med. 2009;7:69."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3275083", "@IdType": "pmc"}, {"#text": "21212949", "@IdType": "pubmed"}]}, "Citation": "Weakley SM, Wang H, Yao Q, et al. Expression and function of a large non-coding RNA gene XIST in human cancer. World J Surg. 2011;35:1751\u20131756."}, {"ArticleIdList": {"ArticleId": {"#text": "24937141", "@IdType": "pubmed"}}, "Citation": "Chaligne R, Heard E. X-chromosome inactivation in development and cancer. FEBS Lett. 2014;588:2514\u20132522."}, {"ArticleIdList": {"ArticleId": {"#text": "17143508", "@IdType": "pubmed"}}, "Citation": "Benoit MH, Hudson TJ, Maire G, et al. Global analysis of chromosome X gene expression in primary cultures of normal ovarian surface epithelial cells and epithelial ovarian cancer cell lines. Int J Oncol. 2007;30:5\u201317."}, {"ArticleIdList": {"ArticleId": {"#text": "12492109", "@IdType": "pubmed"}}, "Citation": "Huang KC, Rao PH, Lau CC, et al. Relationship of XIST expression and responses of ovarian cancer to chemotherapy. Mol Cancer Ther. 2002;1:769\u2013776."}, {"ArticleIdList": {"ArticleId": {"#text": "18501714", "@IdType": "pubmed"}}, "Citation": "Wang F, Li X, Xie X, et al. UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion. FEBS Lett. 2008;582:1919\u20131927."}, {"Citation": "Wang Fan ZJXX. Invasion and migration effect and mechanism of long non -coding RNA UCA1 in ovarian cancer cells. Modern Oncology. 2015."}, {"ArticleIdList": {"ArticleId": {"#text": "26867765", "@IdType": "pubmed"}}, "Citation": "Yang Y, Jiang Y, Wan Y, et al. UCA1 functions as a competing endogenous RNA to suppress epithelial ovarian cancer metastasis. Tumour Biol. 2016. [Epub ahead of print]."}, {"ArticleIdList": {"ArticleId": {"#text": "10027795", "@IdType": "pubmed"}}, "Citation": "Hecht SS, Hatsukami DK, Bonilla LE, et al. Quantitation of 4-oxo-4-(3-pyridyl)butanoic acid and enantiomers of 4-hydroxy-4-(3-pyridyl)butanoic acid in human urine: a substantial pathway of nicotine metabolism. Chem Res Toxicol. 1999;12:172\u2013179."}, {"ArticleIdList": {"ArticleId": {"#text": "22817756", "@IdType": "pubmed"}}, "Citation": "Harries LW. Long non-coding RNAs and human disease. Biochem Soc Trans. 2012;40:902\u2013906."}, {"ArticleIdList": {"ArticleId": {"#text": "21532345", "@IdType": "pubmed"}}, "Citation": "Silva JM, Boczek NJ, Berres MW, et al. LSINCT5 is over expressed in breast and ovarian cancer and affects cellular proliferation. RNA Biol. 2011;8:496\u2013505."}, {"ArticleIdList": {"ArticleId": {"#text": "10759892", "@IdType": "pubmed"}}, "Citation": "Miyoshi N, Wagatsuma H, Wakana S, et al. Identification of an imprinted gene, Meg3/Gtl2 and its human homologue MEG3, first mapped on mouse distal chromosome 12 and human chromosome 14q. Genes Cells. 2000;5:211\u2013220."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3738193", "@IdType": "pmc"}, {"#text": "22393162", "@IdType": "pubmed"}]}, "Citation": "Zhou Y. MEG3 noncoding RNA: a tumor suppressor. J Mol Endocrinol. 2012;83:R45\u2013R53."}, {"ArticleIdList": {"ArticleId": {"#text": "14602737", "@IdType": "pubmed"}}, "Citation": "Zhang X, Zhou Y, Mehta KR, et al. A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells. J Clin Endocrinol Metab. 2003;88:5119\u20135126."}, {"ArticleIdList": {"ArticleId": {"#text": "17569660", "@IdType": "pubmed"}}, "Citation": "Zhou Y, Zhong Y, Wang Y, et al. Activation of p53 by MEG3 non-coding RNA. J Biol Chem. 2007;282:24731\u201324742."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4292930", "@IdType": "pmc"}, {"#text": "21625215", "@IdType": "pubmed"}]}, "Citation": "Braconi C, Kogure T, Valeri N, et al. microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene. 2011;30:4750\u20134756."}, {"ArticleIdList": {"ArticleId": {"#text": "24859196", "@IdType": "pubmed"}}, "Citation": "Sheng X, Li J, Yang L, et al. Promoter hypermethylation influences the suppressive role of maternally expressed 3, a long non-coding RNA, in the development of epithelial ovarian cancer. Oncol Rep. 2014;32:277\u2013285."}, {"ArticleIdList": {"ArticleId": {"#text": "21400503", "@IdType": "pubmed"}}, "Citation": "Benetatos L, Vartholomatos G, Hatzimichael E. MEG3 imprinted gene contribution in tumorigenesis. Int J Cancer. 2011;129:773\u2013779."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6576500", "@IdType": "pmc"}, {"#text": "7684772", "@IdType": "pubmed"}]}, "Citation": "Tiedge H, Chen W, Brosius J. Primary structure, neural-specific expression, and dendritic location of human BC200 RNA. J Neurosci. 1993;13:2382\u20132390."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4734031", "@IdType": "pmc"}, {"#text": "26893717", "@IdType": "pubmed"}]}, "Citation": "Wu DI, Wang T, Ren C, et al. Downregulation of BC200 in ovarian cancer contributes to cancer cell proliferation and chemoresistance to carboplatin. Oncol Lett. 2016;11:1189\u20131194."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2257975", "@IdType": "pmc"}, {"#text": "18194563", "@IdType": "pubmed"}]}, "Citation": "Beck-Engeser GB, Lum AM, Huppi K, et al. Pvt1-encoded microRNAs in oncogenesis. Retrovirology. 2008;5:4."}, {"ArticleIdList": {"ArticleId": {"#text": "17908964", "@IdType": "pubmed"}}, "Citation": "Guan Y, Kuo WL, Stilwell JL, et al. Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer. Clin Cancer Res. 2007;13:5745\u20135755."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4723819", "@IdType": "pmc"}, {"#text": "26884974", "@IdType": "pubmed"}]}, "Citation": "Liu E, Liu Z, Zhou Y, et al. Overexpression of long non-coding RNA PVT1 in ovarian cancer cells promotes cisplatin resistance by regulating apoptotic pathways. Int J Clin Exp Med. 2015;8:20565\u201320572."}, {"ArticleIdList": {"ArticleId": {"#text": "27180308", "@IdType": "pubmed"}}, "Citation": "Xiong XD, Ren X, Cai MY, et al. Long non-coding RNAs: An emerging powerhouse in the battle between life and death of tumor cells. Drug Resist Updat. 2016;26:28\u201342."}]}}}}}, "PMC": "PMC5084630", "PMID": "27603915", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "Dysregulated Expression of Long Noncoding RNAs in Ovarian Cancer.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "10": {"Abstract": "Aberrant expression of long non-coding RNAs (lncRNAs) leads to the development of chemoresistance by regulating a series of biological processes, which is one of the major obstacles in the cancer treatment. This study aimed to identify some key lncRNAs that are associated with platinum-based chemoresistance in multiple cancers. Regulating the expression levels of these lncRNAs can enhance the sensitivity of patients to chemotherapy drugs and improve the therapeutic effect of cancer. By systematically analyzing 648 samples regarding platinum drug response from the Cancer Genome Atlas (TCGA), we have identified 32 dysregulated lncRNAs across 11 cancer types that could affect platinum-based chemotherapy response, of which 78.125% (25/32) were significantly down-regulated in drug-resistant samples. Drug response prediction model that had been constructed based on the expression pattern of these dysregulated lncRNAs could accurately predict the chemotherapy response of tumor patients, and the area under the curve (AUC) was between 0.8034 and 0.9984. In particular, all of these dysregulated lncRNAs that we identified were cancer-specific. They were significantly associated with the survival of tumor patients and could serve as cancer-specific biomarkers for prognosis. In conclusion, this study will contribute to improving the drug resistance of tumor patients during chemotherapy, and it is of real significance for selecting effective chemotherapy drugs and achieving precision medicine.", "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "-4439793558998245952", "Part1": "College of Bioinformatics Science and Technology", "Part2": "Harbin Medical University", "Part3": "Harbin", "Part4": "China.", "Part5": null, "Part6": null, "Text": "College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China."}], "ForeName": "Yanjiao", "FullName": "Yanjiao Zhu", "HashID": "5108462666275413197", "LastName": "Zhu", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-4439793558998245952", "Part1": "College of Bioinformatics Science and Technology", "Part2": "Harbin Medical University", "Part3": "Harbin", "Part4": "China.", "Part5": null, "Part6": null, "Text": "College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China."}], "ForeName": "Yichuan", "FullName": "Yichuan Zhao", "HashID": "645568550620397", "LastName": "Zhao", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-4439793558998245952", "Part1": "College of Bioinformatics Science and Technology", "Part2": "Harbin Medical University", "Part3": "Harbin", "Part4": "China.", "Part5": null, "Part6": null, "Text": "College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China."}], "ForeName": "Siyao", "FullName": "Siyao Dong", "HashID": "6866384856662410237", "LastName": "Dong", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-4439793558998245952", "Part1": "College of Bioinformatics Science and Technology", "Part2": "Harbin Medical University", "Part3": "Harbin", "Part4": "China.", "Part5": null, "Part6": null, "Text": "College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China."}], "ForeName": "Lu", "FullName": "Lu Liu", "HashID": "1036231591583274860", "LastName": "Liu", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-4439793558998245952", "Part1": "College of Bioinformatics Science and Technology", "Part2": "Harbin Medical University", "Part3": "Harbin", "Part4": "China.", "Part5": null, "Part6": null, "Text": "College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China."}], "ForeName": "Lin", "FullName": "Lin Tai", "HashID": "-3323795789780109459", "LastName": "Tai", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "3212208149624775806", "Part1": "College of Bioinformatics Science and Technology", "Part2": "Harbin Medical University", "Part3": "Harbin", "Part4": "China. Electronic address: xuyan@ems.hrbmu.edu.cn.", "Part5": null, "Part6": null, "Text": "College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China. Electronic address: xuyan@ems.hrbmu.edu.cn."}], "ForeName": "Yan", "FullName": "Yan Xu", "HashID": "7206241845874316141", "LastName": "Xu", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.1016/j.ygeno.2019.07.007", "InsertType": null, "Journal": "Genomics", "Keywords": [{"IS_Major": false, "IS_Mesh": true, "Text": "Antineoplastic Agents"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Drug Resistance, Neoplasm"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Humans"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Neoplasms"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Platinum Compounds"}, {"IS_Major": false, "IS_Mesh": true, "Text": "RNA, Long Noncoding"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Aberrant expression"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Cancer"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Chemoresistance"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Platinum"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Prognosis"}, {"IS_Major": false, "IS_Mesh": false, "Text": "lncRNAs"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "MEDLINE", "Article": {"@PubModel": "Print-Electronic", "Abstract": {"AbstractText": "Aberrant expression of long non-coding RNAs (lncRNAs) leads to the development of chemoresistance by regulating a series of biological processes, which is one of the major obstacles in the cancer treatment. This study aimed to identify some key lncRNAs that are associated with platinum-based chemoresistance in multiple cancers. Regulating the expression levels of these lncRNAs can enhance the sensitivity of patients to chemotherapy drugs and improve the therapeutic effect of cancer. By systematically analyzing 648 samples regarding platinum drug response from the Cancer Genome Atlas (TCGA), we have identified 32 dysregulated lncRNAs across 11 cancer types that could affect platinum-based chemotherapy response, of which 78.125% (25/32) were significantly down-regulated in drug-resistant samples. Drug response prediction model that had been constructed based on the expression pattern of these dysregulated lncRNAs could accurately predict the chemotherapy response of tumor patients, and the area under the curve (AUC) was between 0.8034 and 0.9984. In particular, all of these dysregulated lncRNAs that we identified were cancer-specific. They were significantly associated with the survival of tumor patients and could serve as cancer-specific biomarkers for prognosis. In conclusion, this study will contribute to improving the drug resistance of tumor patients during chemotherapy, and it is of real significance for selecting effective chemotherapy drugs and achieving precision medicine.", "CopyrightInformation": "Copyright \u00a9 2019 Elsevier Inc. All rights reserved."}, "ArticleDate": {"@DateType": "Electronic", "Day": "11", "Month": "07", "Year": "2019"}, "ArticleTitle": "Systematic identification of dysregulated lncRNAs associated with platinum-based chemotherapy response across 11 cancer types.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China."}, "ForeName": "Yanjiao", "Initials": "Y", "LastName": "Zhu"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China."}, "ForeName": "Yichuan", "Initials": "Y", "LastName": "Zhao"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China."}, "ForeName": "Siyao", "Initials": "S", "LastName": "Dong"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China."}, "ForeName": "Lu", "Initials": "L", "LastName": "Liu"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China."}, "ForeName": "Lin", "Initials": "L", "LastName": "Tai"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China. Electronic address: xuyan@ems.hrbmu.edu.cn."}, "ForeName": "Yan", "Initials": "Y", "LastName": "Xu"}]}, "ELocationID": [{"#text": "10.1016/j.ygeno.2019.07.007", "@EIdType": "doi", "@ValidYN": "Y"}, {"#text": "S0888-7543(19)30315-5", "@EIdType": "pii", "@ValidYN": "Y"}], "Journal": {"ISOAbbreviation": "Genomics", "ISSN": {"#text": "1089-8646", "@IssnType": "Electronic"}, "JournalIssue": {"@CitedMedium": "Internet", "Issue": "2", "PubDate": {"Month": "Mar", "Year": "2020"}, "Volume": "112"}, "Title": "Genomics"}, "Language": "eng", "Pagination": {"EndPage": "1222", "MedlinePgn": "1214-1222", "StartPage": "1214"}, "PublicationTypeList": {"PublicationType": [{"#text": "Journal Article", "@UI": "D016428"}, {"#text": "Research Support, Non-U.S. Gov't", "@UI": "D013485"}]}}, "ChemicalList": {"Chemical": [{"NameOfSubstance": {"#text": "Antineoplastic Agents", "@UI": "D000970"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "Platinum Compounds", "@UI": "D017671"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "RNA, Long Noncoding", "@UI": "D062085"}, "RegistryNumber": "0"}]}, "CitationSubset": "IM", "CoiStatement": "Declaration of Competing Interest The authors declare that they have no competing interests.", "DateCompleted": {"Day": "04", "Month": "01", "Year": "2021"}, "DateRevised": {"Day": "04", "Month": "01", "Year": "2021"}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"#text": "Aberrant expression", "@MajorTopicYN": "N"}, {"#text": "Cancer", "@MajorTopicYN": "N"}, {"#text": "Chemoresistance", "@MajorTopicYN": "N"}, {"#text": "Platinum", "@MajorTopicYN": "N"}, {"#text": "Prognosis", "@MajorTopicYN": "N"}, {"#text": "lncRNAs", "@MajorTopicYN": "N"}]}, "MedlineJournalInfo": {"Country": "United States", "ISSNLinking": "0888-7543", "MedlineTA": "Genomics", "NlmUniqueID": "8800135"}, "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"#text": "Antineoplastic Agents", "@MajorTopicYN": "N", "@UI": "D000970"}, "QualifierName": {"#text": "therapeutic use", "@MajorTopicYN": "N", "@UI": "Q000627"}}, {"DescriptorName": {"#text": "Drug Resistance, Neoplasm", "@MajorTopicYN": "N", "@UI": "D019008"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Humans", "@MajorTopicYN": "N", "@UI": "D006801"}}, {"DescriptorName": {"#text": "Neoplasms", "@MajorTopicYN": "N", "@UI": "D009369"}, "QualifierName": [{"#text": "drug therapy", "@MajorTopicYN": "N", "@UI": "Q000188"}, {"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}]}, {"DescriptorName": {"#text": "Platinum Compounds", "@MajorTopicYN": "N", "@UI": "D017671"}, "QualifierName": {"#text": "therapeutic use", "@MajorTopicYN": "N", "@UI": "Q000627"}}, {"DescriptorName": {"#text": "RNA, Long Noncoding", "@MajorTopicYN": "N", "@UI": "D062085"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}}]}, "PMID": {"#text": "31302201", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "31302201", "@IdType": "pubmed"}, {"#text": "10.1016/j.ygeno.2019.07.007", "@IdType": "doi"}, {"#text": "S0888-7543(19)30315-5", "@IdType": "pii"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "received", "Day": "28", "Month": "5", "Year": "2019"}, {"@PubStatus": "revised", "Day": "26", "Month": "6", "Year": "2019"}, {"@PubStatus": "accepted", "Day": "10", "Month": "7", "Year": "2019"}, {"@PubStatus": "pubmed", "Day": "16", "Hour": "6", "Minute": "0", "Month": "7", "Year": "2019"}, {"@PubStatus": "medline", "Day": "5", "Hour": "6", "Minute": "0", "Month": "1", "Year": "2021"}, {"@PubStatus": "entrez", "Day": "15", "Hour": "6", "Minute": "0", "Month": "7", "Year": "2019"}]}, "PublicationStatus": "ppublish"}}}}, "PMC": null, "PMID": "31302201", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "Systematic identification of dysregulated lncRNAs associated with platinum-based chemotherapy response across 11 cancer types.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "11": {"Abstract": "Eukaryotic genomes are pervasively transcribed. Besides protein-coding RNAs, there are different types of non-coding RNAs that modulate complex molecular and cellular processes. RNA sequencing technologies and bioinformatics methods greatly promoted the study of ncRNAs, which revealed ncRNAs' essential roles in diverse aspects of biological functions. As important key players in gene regulatory networks, ncRNAs work with other biomolecules, including coding and non-coding RNAs, DNAs and proteins. In this review, we discuss the distinct types of ncRNAs, including housekeeping ncRNAs and regulatory ncRNAs, their versatile functions and interactions, transcription, translation, and modification. Moreover, we summarize the integrated networks of ncRNA interactions, providing a comprehensive landscape of ncRNAs regulatory roles.", "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "791633630788245427", "Part1": "Department of Bioinformatics", "Part2": "State Key Laboratory of Plant Physiology and Biochemistry", "Part3": "College of Life Sciences", "Part4": "Zhejiang University", "Part5": "Hangzhou 310058", "Part6": "China.", "Text": "Department of Bioinformatics, State Key Laboratory of Plant Physiology and Biochemistry, College of Life Sciences, Zhejiang University, Hangzhou 310058, China."}], "ForeName": "Peijing", "FullName": "Peijing Zhang", "HashID": "8133831866724187488", "LastName": "Zhang", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "791633630788245427", "Part1": "Department of Bioinformatics", "Part2": "State Key Laboratory of Plant Physiology and Biochemistry", "Part3": "College of Life Sciences", "Part4": "Zhejiang University", "Part5": "Hangzhou 310058", "Part6": "China.", "Text": "Department of Bioinformatics, State Key Laboratory of Plant Physiology and Biochemistry, College of Life Sciences, Zhejiang University, Hangzhou 310058, China."}], "ForeName": "Wenyi", "FullName": "Wenyi Wu", "HashID": "1862889175876167624", "LastName": "Wu", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "791633630788245427", "Part1": "Department of Bioinformatics", "Part2": "State Key Laboratory of Plant Physiology and Biochemistry", "Part3": "College of Life Sciences", "Part4": "Zhejiang University", "Part5": "Hangzhou 310058", "Part6": "China.", "Text": "Department of Bioinformatics, State Key Laboratory of Plant Physiology and Biochemistry, College of Life Sciences, Zhejiang University, Hangzhou 310058, China."}], "ForeName": "Qi", "FullName": "Qi Chen", "HashID": "3024818579845659928", "LastName": "Chen", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "791633630788245427", "Part1": "Department of Bioinformatics", "Part2": "State Key Laboratory of Plant Physiology and Biochemistry", "Part3": "College of Life Sciences", "Part4": "Zhejiang University", "Part5": "Hangzhou 310058", "Part6": "China.", "Text": "Department of Bioinformatics, State Key Laboratory of Plant Physiology and Biochemistry, College of Life Sciences, Zhejiang University, Hangzhou 310058, China."}, {"Has_Extra": false, "HashID": "2316754440076333925", "Part1": "James D. Watson Institute of Genome Sciences", "Part2": "Zhejiang University", "Part3": "Hangzhou 310058", "Part4": "China.", "Part5": null, "Part6": null, "Text": "James D. Watson Institute of Genome Sciences, Zhejiang University, Hangzhou 310058, China."}], "ForeName": "Ming", "FullName": "Ming Chen", "HashID": "431138453870170389", "LastName": "Chen", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.1515/jib-2019-0027", "InsertType": null, "Journal": "Journal of integrative bioinformatics", "Keywords": [{"IS_Major": true, "IS_Mesh": true, "Text": "Computational Biology"}, {"IS_Major": true, "IS_Mesh": true, "Text": "Gene Regulatory Networks"}, {"IS_Major": true, "IS_Mesh": true, "Text": "RNA, Untranslated"}, {"IS_Major": true, "IS_Mesh": true, "Text": "Sequence Analysis, RNA"}, {"IS_Major": false, "IS_Mesh": false, "Text": "ceRNA network"}, {"IS_Major": false, "IS_Mesh": false, "Text": "integrated network"}, {"IS_Major": false, "IS_Mesh": false, "Text": "ncRNA interaction"}, {"IS_Major": false, "IS_Mesh": false, "Text": "non-coding RNA"}, {"IS_Major": false, "IS_Mesh": false, "Text": "regulatory ncRNA"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "MEDLINE", "Article": {"@PubModel": "Electronic", "Abstract": {"AbstractText": "Eukaryotic genomes are pervasively transcribed. Besides protein-coding RNAs, there are different types of non-coding RNAs that modulate complex molecular and cellular processes. RNA sequencing technologies and bioinformatics methods greatly promoted the study of ncRNAs, which revealed ncRNAs' essential roles in diverse aspects of biological functions. As important key players in gene regulatory networks, ncRNAs work with other biomolecules, including coding and non-coding RNAs, DNAs and proteins. In this review, we discuss the distinct types of ncRNAs, including housekeeping ncRNAs and regulatory ncRNAs, their versatile functions and interactions, transcription, translation, and modification. Moreover, we summarize the integrated networks of ncRNA interactions, providing a comprehensive landscape of ncRNAs regulatory roles."}, "ArticleDate": {"@DateType": "Electronic", "Day": "13", "Month": "07", "Year": "2019"}, "ArticleTitle": "Non-Coding RNAs and their Integrated Networks.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Bioinformatics, State Key Laboratory of Plant Physiology and Biochemistry, College of Life Sciences, Zhejiang University, Hangzhou 310058, China."}, "ForeName": "Peijing", "Initials": "P", "LastName": "Zhang"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Bioinformatics, State Key Laboratory of Plant Physiology and Biochemistry, College of Life Sciences, Zhejiang University, Hangzhou 310058, China."}, "ForeName": "Wenyi", "Initials": "W", "LastName": "Wu"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Bioinformatics, State Key Laboratory of Plant Physiology and Biochemistry, College of Life Sciences, Zhejiang University, Hangzhou 310058, China."}, "ForeName": "Qi", "Initials": "Q", "LastName": "Chen"}, {"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of Bioinformatics, State Key Laboratory of Plant Physiology and Biochemistry, College of Life Sciences, Zhejiang University, Hangzhou 310058, China."}, {"Affiliation": "James D. Watson Institute of Genome Sciences, Zhejiang University, Hangzhou 310058, China."}], "ForeName": "Ming", "Initials": "M", "LastName": "Chen"}]}, "ELocationID": [{"#text": "20190027", "@EIdType": "pii", "@ValidYN": "Y"}, {"#text": "10.1515/jib-2019-0027", "@EIdType": "doi", "@ValidYN": "Y"}], "Journal": {"ISOAbbreviation": "J Integr Bioinform", "ISSN": {"#text": "1613-4516", "@IssnType": "Electronic"}, "JournalIssue": {"@CitedMedium": "Internet", "Issue": "3", "PubDate": {"Day": "13", "Month": "Jul", "Year": "2019"}, "Volume": "16"}, "Title": "Journal of integrative bioinformatics"}, "Language": "eng", "PublicationTypeList": {"PublicationType": [{"#text": "Journal Article", "@UI": "D016428"}, {"#text": "Review", "@UI": "D016454"}]}}, "ChemicalList": {"Chemical": {"NameOfSubstance": {"#text": "RNA, Untranslated", "@UI": "D022661"}, "RegistryNumber": "0"}}, "CitationSubset": "IM", "CoiStatement": "Authors state no conflict of interest. All authors have read the journal\u2019s publication ethics and publication malpractice statement available at the journal\u2019s website and hereby confirm that they comply with all its parts applicable to the present scientific work.", "DateCompleted": {"Day": "13", "Month": "02", "Year": "2020"}, "DateRevised": {"Day": "13", "Month": "02", "Year": "2020"}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"#text": "ceRNA network", "@MajorTopicYN": "N"}, {"#text": "integrated network", "@MajorTopicYN": "N"}, {"#text": "ncRNA interaction", "@MajorTopicYN": "N"}, {"#text": "non-coding RNA", "@MajorTopicYN": "N"}, {"#text": "regulatory ncRNA", "@MajorTopicYN": "N"}]}, "MedlineJournalInfo": {"Country": "Germany", "ISSNLinking": "1613-4516", "MedlineTA": "J Integr Bioinform", "NlmUniqueID": "101503361"}, "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"#text": "Computational Biology", "@MajorTopicYN": "Y", "@UI": "D019295"}}, {"DescriptorName": {"#text": "Gene Regulatory Networks", "@MajorTopicYN": "Y", "@UI": "D053263"}}, {"DescriptorName": {"#text": "RNA, Untranslated", "@MajorTopicYN": "Y", "@UI": "D022661"}, "QualifierName": [{"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}, {"#text": "metabolism", "@MajorTopicYN": "N", "@UI": "Q000378"}]}, {"DescriptorName": {"#text": "Sequence Analysis, RNA", "@MajorTopicYN": "Y", "@UI": "D017423"}}]}, "PMID": {"#text": "31301674", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "31301674", "@IdType": "pubmed"}, {"#text": "PMC6798851", "@IdType": "pmc"}, {"#text": "10.1515/jib-2019-0027", "@IdType": "doi"}, {"#text": "/j/jib.ahead-of-print/jib-2019-0027/jib-2019-0027.xml", "@IdType": "pii"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "received", "Day": "7", "Month": "4", "Year": "2019"}, {"@PubStatus": "accepted", "Day": "21", "Month": "5", "Year": "2019"}, {"@PubStatus": "pubmed", "Day": "14", "Hour": "6", "Minute": "0", "Month": "7", "Year": "2019"}, {"@PubStatus": "medline", "Day": "14", "Hour": "6", "Minute": "0", "Month": "2", "Year": "2020"}, {"@PubStatus": "entrez", "Day": "14", "Hour": "6", "Minute": "0", "Month": "7", "Year": "2019"}]}, "PublicationStatus": "epublish", "ReferenceList": {"Reference": [{"ArticleIdList": {"ArticleId": {"#text": "11237011", "@IdType": "pubmed"}}, "Citation": "Consortium IHGS. Initial sequencing and analysis of the human genome. Nature 2001;409:860\u2013921."}, {"ArticleIdList": {"ArticleId": {"#text": "11237011", "@IdType": "pubmed"}}, "Citation": "Consortium IHGS. Initial sequencing and analysis of the human genome. Nature. 2001;409:860\u2013921."}, {"ArticleIdList": {"ArticleId": {"#text": "12466850", "@IdType": "pubmed"}}, "Citation": "Consortium MGS. Initial sequencing and comparative analysis of the mouse genome. Nature 2002;420:520\u201362."}, {"ArticleIdList": {"ArticleId": {"#text": "12466850", "@IdType": "pubmed"}}, "Citation": "Consortium MGS. Initial sequencing and comparative analysis of the mouse genome. Nature. 2002;420:520\u201362."}, {"ArticleIdList": {"ArticleId": {"#text": "11733745", "@IdType": "pubmed"}}, "Citation": "Eddy SR. Non\u2013coding RNA genes and the modern RNA world. Nat Rev Genet 2001;2:919\u201329."}, {"ArticleIdList": {"ArticleId": {"#text": "11733745", "@IdType": "pubmed"}}, "Citation": "Eddy SR. Non\u2013coding RNA genes and the modern RNA world. Nat Rev Genet. 2001;2:919\u201329."}, {"ArticleIdList": {"ArticleId": {"#text": "2181665", "@IdType": "pubmed"}}, "Citation": "Watson JD. The human genome project: past, present, and future. Science 1990;248:44\u20139."}, {"ArticleIdList": {"ArticleId": {"#text": "2181665", "@IdType": "pubmed"}}, "Citation": "Watson JD. The human genome project: past, present, and future. Science. 1990;248:44\u20139."}, {"ArticleIdList": {"ArticleId": {"#text": "16141072", "@IdType": "pubmed"}}, "Citation": "Carninci P, Kasukawa T, Katayama S, Gough J, Frith M, Maeda N, et al. The transcriptional landscape of the mammalian genome. Science 2005;309:1559\u201363."}, {"ArticleIdList": {"ArticleId": {"#text": "16141072", "@IdType": "pubmed"}}, "Citation": "Carninci P, Kasukawa T, Katayama S, Gough J, Frith M, Maeda N. et al. The transcriptional landscape of the mammalian genome. Science. 2005;309:1559\u201363."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC1880871", "@IdType": "pmc"}, {"#text": "16255080", "@IdType": "pubmed"}]}, "Citation": "Consortium I. A haplotype map of the human genome. Nature 2005;437:1299\u2013320."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC1880871", "@IdType": "pmc"}, {"#text": "16255080", "@IdType": "pubmed"}]}, "Citation": "Consortium I. A haplotype map of the human genome. Nature. 2005;437:1299\u2013320."}, {"ArticleIdList": {"ArticleId": {"#text": "18218868", "@IdType": "pubmed"}}, "Citation": "Kaiser J. A plan to capture human diversity in 1000 genomes. Science 2008;319:1336."}, {"ArticleIdList": {"ArticleId": {"#text": "18218868", "@IdType": "pubmed"}}, "Citation": "Kaiser J. A plan to capture human diversity in 1000 genomes. Science. 2008;319:1336."}, {"ArticleIdList": {"ArticleId": {"#text": "19997069", "@IdType": "pubmed"}}, "Citation": "Metzker ML. Sequencing technologies \u2013 the next generation. Nat Rev Genet 2010;11:31\u201346."}, {"ArticleIdList": {"ArticleId": {"#text": "19997069", "@IdType": "pubmed"}}, "Citation": "Metzker ML. Sequencing technologies \u2013 the next generation. Nat Rev Genet. 2010;11:31\u201346."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3439153", "@IdType": "pmc"}, {"#text": "22955616", "@IdType": "pubmed"}]}, "Citation": "Consortium EP. An integrated encyclopedia of DNA elements in the human genome. Nature 2012;489:57\u201374."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3439153", "@IdType": "pmc"}, {"#text": "22955616", "@IdType": "pubmed"}]}, "Citation": "Consortium EP. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489:57\u201374."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3684276", "@IdType": "pmc"}, {"#text": "22955620", "@IdType": "pubmed"}]}, "Citation": "Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A, et al. Landscape of transcription in human cells. Nature 2012;489:101\u20138."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3684276", "@IdType": "pmc"}, {"#text": "22955620", "@IdType": "pubmed"}]}, "Citation": "Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A. et al. Landscape of transcription in human cells. Nature. 2012;489:101\u20138."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC165453", "@IdType": "pmc"}, {"#text": "12520045", "@IdType": "pubmed"}]}, "Citation": "Griffiths-Jones S, Bateman A, Marshall M, Khanna A, Eddy SR. Rfam: an RNA family database. Nucleic Acids Res 2003;31:439\u201341."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC165453", "@IdType": "pmc"}, {"#text": "12520045", "@IdType": "pubmed"}]}, "Citation": "Griffiths-Jones S, Bateman A, Marshall M, Khanna A, Eddy SR. Rfam: an RNA family database. Nucleic Acids Res. 2003;31:439\u201341."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC539995", "@IdType": "pmc"}, {"#text": "15608158", "@IdType": "pubmed"}]}, "Citation": "Liu C, Bai B, Skogerbo G, Cai L, Deng W, Zhang Y, et al. NONCODE: an integrated knowledge database of non-coding RNAs. Nucleic Acids Res 2005;33(Database issue):D112\u20135."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC539995", "@IdType": "pmc"}, {"#text": "15608158", "@IdType": "pubmed"}]}, "Citation": "Liu C, Bai B, Skogerbo G, Cai L, Deng W, Zhang Y. et al. NONCODE: an integrated knowledge database of non-coding RNAs. Nucleic Acids Res. 2005;33(Database issue):D112\u20135."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC1347474", "@IdType": "pmc"}, {"#text": "16381832", "@IdType": "pubmed"}]}, "Citation": "Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006;34(Database issue):D140\u20134."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC1347474", "@IdType": "pmc"}, {"#text": "16381832", "@IdType": "pubmed"}]}, "Citation": "Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 2006;34(Database issue):D140\u20134."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4201819", "@IdType": "pmc"}, {"#text": "25234927", "@IdType": "pubmed"}]}, "Citation": "Glazar P, Papavasileiou P, Rajewsky N. circBase: a database for circular RNAs. RNA 2014;20:1666\u201370."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4201819", "@IdType": "pmc"}, {"#text": "25234927", "@IdType": "pubmed"}]}, "Citation": "Glazar P, Papavasileiou P, Rajewsky N. circBase: a database for circular RNAs. RNA. 2014;20:1666\u201370."}, {"ArticleIdList": {"ArticleId": {"#text": "20935674", "@IdType": "pubmed"}}, "Citation": "Pavet V, Portal MM, Moulin JC, Herbrecht R, Gronemeyer H. Towards novel paradigms for cancer therapy. Oncogene 2011;30:1\u201320."}, {"ArticleIdList": {"ArticleId": {"#text": "20935674", "@IdType": "pubmed"}}, "Citation": "Pavet V, Portal MM, Moulin JC, Herbrecht R, Gronemeyer H. Towards novel paradigms for cancer therapy. Oncogene. 2011;30:1\u201320."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5673675", "@IdType": "pmc"}, {"#text": "29017967", "@IdType": "pubmed"}]}, "Citation": "Wang J, Meng X, Dobrovolskaya OB, Orlov YL, Chen M. Non-coding RNAs and their roles in stress response in plants. Genomics Proteomics Bioinformatics 2017;15:301\u201312."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5673675", "@IdType": "pmc"}, {"#text": "29017967", "@IdType": "pubmed"}]}, "Citation": "Wang J, Meng X, Dobrovolskaya OB, Orlov YL, Chen M. Non-coding RNAs and their roles in stress response in plants. Genomics Proteomics Bioinformatics. 2017;15:301\u201312."}, {"ArticleIdList": {"ArticleId": {"#text": "24679528", "@IdType": "pubmed"}}, "Citation": "Cech TR, Steitz JA. The noncoding RNA revolution \u2013 trashing old rules to forge new ones. Cell 2014;157:77\u201394."}, {"ArticleIdList": {"ArticleId": {"#text": "24679528", "@IdType": "pubmed"}}, "Citation": "Cech TR, Steitz JA. The noncoding RNA revolution \u2013 trashing old rules to forge new ones. Cell. 2014;157:77\u201394."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3928183", "@IdType": "pmc"}, {"#text": "24739571", "@IdType": "pubmed"}]}, "Citation": "Peschansky VJ, Wahlestedt C. Non-coding RNAs as direct and indirect modulators of epigenetic regulation. Epigenetics 2014;9:3\u201312."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3928183", "@IdType": "pmc"}, {"#text": "24739571", "@IdType": "pubmed"}]}, "Citation": "Peschansky VJ, Wahlestedt C. Non-coding RNAs as direct and indirect modulators of epigenetic regulation. Epigenetics. 2014;9:3\u201312."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC1855172", "@IdType": "pmc"}, {"#text": "17387145", "@IdType": "pubmed"}]}, "Citation": "Ponjavic J, Ponting CP, Lunter G. Functionality or transcriptional noise? Evidence for selection within long noncoding RNAs. Genome Res 2007;17:556\u201365."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC1855172", "@IdType": "pmc"}, {"#text": "17387145", "@IdType": "pubmed"}]}, "Citation": "Ponjavic J, Ponting CP, Lunter G. Functionality or transcriptional noise? Evidence for selection within long noncoding RNAs. Genome Res. 2007;17:556\u201365."}, {"ArticleIdList": {"ArticleId": {"#text": "4999725", "@IdType": "pubmed"}}, "Citation": "Cerutti P, Holt JW, Miller N. Detection and determination of 5, 6-dihydrouridine and 4-thiouridine in transfer ribonucleic acid from different sources. J Mol Biol 1968;34:505\u201318."}, {"ArticleIdList": {"ArticleId": {"#text": "4999725", "@IdType": "pubmed"}}, "Citation": "Cerutti P, Holt JW, Miller N. Detection and determination of 5, 6-dihydrouridine and 4-thiouridine in transfer ribonucleic acid from different sources. J Mol Biol. 1968;34:505\u201318."}, {"ArticleIdList": {"ArticleId": {"#text": "954090", "@IdType": "pubmed"}}, "Citation": "Zieve G, Penman S. Small RNA species of the HeLa cell: metabolism and subcellular localization. Cell 1976;8:19\u201331."}, {"ArticleIdList": {"ArticleId": {"#text": "954090", "@IdType": "pubmed"}}, "Citation": "Zieve G, Penman S. Small RNA species of the HeLa cell: metabolism and subcellular localization. Cell. 1976;8:19\u201331."}, {"ArticleIdList": {"ArticleId": {"#text": "29939215", "@IdType": "pubmed"}}, "Citation": "Chen Q, Meng X, Liao Q, Chen M. Versatile interactions and bioinformatics analysis of noncoding RNAs. Brief Bioinform 2018."}, {"ArticleIdList": {"ArticleId": {"#text": "29939215", "@IdType": "pubmed"}}, "Citation": "Chen Q, Meng X, Liao Q, Chen M. Versatile interactions and bioinformatics analysis of noncoding RNAs. Brief Bioinform. 2018"}, {"ArticleIdList": {"ArticleId": {"#text": "28875994", "@IdType": "pubmed"}}, "Citation": "Schimmel P. The emerging complexity of the tRNA world: mammalian tRNAs beyond protein synthesis. Nat Rev Mol Cell Biol 2018;19:45\u201358."}, {"ArticleIdList": {"ArticleId": {"#text": "28875994", "@IdType": "pubmed"}}, "Citation": "Schimmel P. The emerging complexity of the tRNA world: mammalian tRNAs beyond protein synthesis. Nat Rev Mol Cell Biol. 2018;19:45\u201358."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2912555", "@IdType": "pmc"}, {"#text": "20679393", "@IdType": "pubmed"}]}, "Citation": "Schaefer M, Pollex T, Hanna K, Tuorto F, Meusburger M, Helm M, et al. RNA methylation by Dnmt2 protects transfer RNAs against stress-induced cleavage. Genes Dev 2010;24:1590\u20135."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2912555", "@IdType": "pmc"}, {"#text": "20679393", "@IdType": "pubmed"}]}, "Citation": "Schaefer M, Pollex T, Hanna K, Tuorto F, Meusburger M, Helm M. et al. RNA methylation by Dnmt2 protects transfer RNAs against stress-induced cleavage. Genes Dev. 2010;24:1590\u20135."}, {"ArticleIdList": {"ArticleId": {"#text": "26743126", "@IdType": "pubmed"}}, "Citation": "Venkatesh T, Suresh PS, Tsutsumi R. tRFs: miRNAs in disguise. Gene 2016;579:133\u20138."}, {"ArticleIdList": {"ArticleId": {"#text": "26743126", "@IdType": "pubmed"}}, "Citation": "Venkatesh T, Suresh PS, Tsutsumi R. tRFs: miRNAs in disguise. Gene. 2016;579:133\u20138."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2704076", "@IdType": "pmc"}, {"#text": "19474147", "@IdType": "pubmed"}]}, "Citation": "Taft RJ, Glazov EA, Lassmann T, Hayashizaki Y, Carninci P, Mattick JS. Small RNAs derived from snoRNAs. RNA 2009;15:1233\u201340."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2704076", "@IdType": "pmc"}, {"#text": "19474147", "@IdType": "pubmed"}]}, "Citation": "Taft RJ, Glazov EA, Lassmann T, Hayashizaki Y, Carninci P, Mattick JS. Small RNAs derived from snoRNAs. RNA. 2009;15:1233\u201340."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3089480", "@IdType": "pmc"}, {"#text": "21247878", "@IdType": "pubmed"}]}, "Citation": "Ono M, Scott MS, Yamada K, Avolio F, Barton GJ, Lamond AI. Identification of human miRNA precursors that resemble box C/D snoRNAs. Nucleic Acids Res 2011;39:3879\u201391."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3089480", "@IdType": "pmc"}, {"#text": "21247878", "@IdType": "pubmed"}]}, "Citation": "Ono M, Scott MS, Yamada K, Avolio F, Barton GJ, Lamond AI. Identification of human miRNA precursors that resemble box C/D snoRNAs. Nucleic Acids Res. 2011;39:3879\u201391."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4402533", "@IdType": "pmc"}, {"#text": "25779046", "@IdType": "pubmed"}]}, "Citation": "He X, Chen X, Zhang X, Duan X, Pan T, Hu Q, et al. An Lnc RNA (GAS5)/SnoRNA-derived piRNA induces activation of TRAIL gene by site-specifically recruiting MLL/COMPASS-like complexes. Nucleic Acids Res 2015;43:3712\u201325."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4402533", "@IdType": "pmc"}, {"#text": "25779046", "@IdType": "pubmed"}]}, "Citation": "He X, Chen X, Zhang X, Duan X, Pan T, Hu Q. et al. An Lnc RNA (GAS5)/SnoRNA-derived piRNA induces activation of TRAIL gene by site-specifically recruiting MLL/COMPASS-like complexes. Nucleic Acids Res. 2015;43:3712\u201325."}, {"ArticleIdList": {"ArticleId": {"#text": "11679670", "@IdType": "pubmed"}}, "Citation": "Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001;294:853\u20138."}, {"ArticleIdList": {"ArticleId": {"#text": "11679670", "@IdType": "pubmed"}}, "Citation": "Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science. 2001;294:853\u20138."}, {"ArticleIdList": {"ArticleId": {"#text": "8252621", "@IdType": "pubmed"}}, "Citation": "Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993;75:843\u201354."}, {"ArticleIdList": {"ArticleId": {"#text": "8252621", "@IdType": "pubmed"}}, "Citation": "Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75:843\u201354."}, {"ArticleIdList": {"ArticleId": {"#text": "10706289", "@IdType": "pubmed"}}, "Citation": "Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000;403:901\u20136."}, {"ArticleIdList": {"ArticleId": {"#text": "10706289", "@IdType": "pubmed"}}, "Citation": "Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE. et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature. 2000;403:901\u20136."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6323917", "@IdType": "pmc"}, {"#text": "30423142", "@IdType": "pubmed"}]}, "Citation": "Kozomara A, Birgaoanu M, Griffiths-Jones S. miRBase: from microRNA sequences to function. Nucleic Acids Res 2019;47(D1):D155\u201362."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6323917", "@IdType": "pmc"}, {"#text": "30423142", "@IdType": "pubmed"}]}, "Citation": "Kozomara A, Birgaoanu M, Griffiths-Jones S. miRBase: from microRNA sequences to function. Nucleic Acids Res. 2019;47(D1):D155\u201362."}, {"ArticleIdList": {"ArticleId": {"#text": "10542148", "@IdType": "pubmed"}}, "Citation": "Hamilton AJ, Baulcombe DC. A species of small antisense RNA in posttranscriptional gene silencing in plants. Science 1999;286:950\u20132."}, {"ArticleIdList": {"ArticleId": {"#text": "10542148", "@IdType": "pubmed"}}, "Citation": "Hamilton AJ, Baulcombe DC. A species of small antisense RNA in posttranscriptional gene silencing in plants. Science. 1999;286:950\u20132."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC24986", "@IdType": "pmc"}, {"#text": "9811908", "@IdType": "pubmed"}]}, "Citation": "Waterhouse PM, Graham MW, Wang MB. Virus resistance and gene silencing in plants can be induced by simultaneous expression of sense and antisense RNA. Proc Natl Acad Sci USA 1998;95:13959\u201364."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC24986", "@IdType": "pmc"}, {"#text": "9811908", "@IdType": "pubmed"}]}, "Citation": "Waterhouse PM, Graham MW, Wang MB. Virus resistance and gene silencing in plants can be induced by simultaneous expression of sense and antisense RNA. Proc Natl Acad Sci USA. 1998;95:13959\u201364."}, {"ArticleIdList": {"ArticleId": {"#text": "23040327", "@IdType": "pubmed"}}, "Citation": "McCue AD, Slotkin RK. Transposable element small RNAs as regulators of gene expression. Trends Genet 2012;28:616\u201323."}, {"ArticleIdList": {"ArticleId": {"#text": "23040327", "@IdType": "pubmed"}}, "Citation": "McCue AD, Slotkin RK. Transposable element small RNAs as regulators of gene expression. Trends Genet. 2012;28:616\u201323."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2081978", "@IdType": "pmc"}, {"#text": "18003861", "@IdType": "pubmed"}]}, "Citation": "Katiyar-Agarwal S, Gao S, Vivian-Smith A, Jin H. A novel class of bacteria-induced small RNAs in Arabidopsis. Genes Dev 2007;21:3123\u201334."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2081978", "@IdType": "pmc"}, {"#text": "18003861", "@IdType": "pubmed"}]}, "Citation": "Katiyar-Agarwal S, Gao S, Vivian-Smith A, Jin H. A novel class of bacteria-induced small RNAs in Arabidopsis. Genes Dev. 2007;21:3123\u201334."}, {"ArticleIdList": {"ArticleId": {"#text": "16893673", "@IdType": "pubmed"}}, "Citation": "Vazquez F. Arabidopsis endogenous small RNAs: highways and byways. Trends Plant Sci 2006;11:460\u20138."}, {"ArticleIdList": {"ArticleId": {"#text": "16893673", "@IdType": "pubmed"}}, "Citation": "Vazquez F. Arabidopsis endogenous small RNAs: highways and byways. Trends Plant Sci. 2006;11:460\u20138."}, {"ArticleIdList": {"ArticleId": {"#text": "17975059", "@IdType": "pubmed"}}, "Citation": "Aravin AA, Hannon GJ, Brennecke J. The Piwi-piRNA pathway provides an adaptive defense in the transposon arms race. Science 2007;318:761\u20134."}, {"ArticleIdList": {"ArticleId": {"#text": "17975059", "@IdType": "pubmed"}}, "Citation": "Aravin AA, Hannon GJ, Brennecke J. The Piwi-piRNA pathway provides an adaptive defense in the transposon arms race. Science. 2007;318:761\u20134."}, {"ArticleIdList": {"ArticleId": {"#text": "15790806", "@IdType": "pubmed"}}, "Citation": "Kim JK, Gabel HW, Kamath RS, Tewari M, Pasquinelli A, Rual J-F, et al. Functional genomic analysis of RNA interference in C. elegans. Science 2005;308:1164\u20137."}, {"ArticleIdList": {"ArticleId": {"#text": "15790806", "@IdType": "pubmed"}}, "Citation": "Kim JK, Gabel HW, Kamath RS, Tewari M, Pasquinelli A, Rual J-F. et al. Functional genomic analysis of RNA interference in C. elegans. Science. 2005;308:1164\u20137."}, {"ArticleIdList": {"ArticleId": {"#text": "16809489", "@IdType": "pubmed"}}, "Citation": "Vagin VV, Sigova A, Li C, Seitz H, Gvozdev V, Zamore PD. A distinct small RNA pathway silences selfish genetic elements in the germline. Science 2006;313:320\u20134."}, {"ArticleIdList": {"ArticleId": {"#text": "16809489", "@IdType": "pubmed"}}, "Citation": "Vagin VV, Sigova A, Li C, Seitz H, Gvozdev V, Zamore PD. A distinct small RNA pathway silences selfish genetic elements in the germline. Science. 2006;313:320\u20134."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4444957", "@IdType": "pmc"}, {"#text": "26013764", "@IdType": "pubmed"}]}, "Citation": "Martinez VD, Vucic EA, Thu KL, Hubaux R, Enfield KS, Pikor LA, et al. Unique somatic and malignant expression patterns implicate PIWI-interacting RNAs in cancer-type specific biology. Sci Rep 2015;5:10423."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4444957", "@IdType": "pmc"}, {"#text": "26013764", "@IdType": "pubmed"}]}, "Citation": "Martinez VD, Vucic EA, Thu KL, Hubaux R, Enfield KS, Pikor LA. et al. Unique somatic and malignant expression patterns implicate PIWI-interacting RNAs in cancer-type specific biology. Sci Rep. 2015;5:10423."}, {"ArticleIdList": {"ArticleId": {"#text": "21427766", "@IdType": "pubmed"}}, "Citation": "Siomi MC, Sato K, Pezic D, Aravin AA. PIWI-interacting small RNAs: the vanguard of genome defence. Nat Rev Mol Cell Biol 2011;12:246\u201358."}, {"ArticleIdList": {"ArticleId": {"#text": "21427766", "@IdType": "pubmed"}}, "Citation": "Siomi MC, Sato K, Pezic D, Aravin AA. PIWI-interacting small RNAs: the vanguard of genome defence. Nat Rev Mol Cell Biol. 2011;12:246\u201358."}, {"ArticleIdList": {"ArticleId": {"#text": "21074719", "@IdType": "pubmed"}}, "Citation": "Saito K, Siomi MC. Small RNA-mediated quiescence of transposable elements in animals. Dev Cell 2010;19:687\u201397."}, {"ArticleIdList": {"ArticleId": {"#text": "21074719", "@IdType": "pubmed"}}, "Citation": "Saito K, Siomi MC. Small RNA-mediated quiescence of transposable elements in animals. Dev Cell. 2010;19:687\u201397."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4111732", "@IdType": "pmc"}, {"#text": "23696037", "@IdType": "pubmed"}]}, "Citation": "Ma L, Bajic VB, Zhang Z. On the classification of long non-coding RNAs. RNA Biol 2013;10:924\u201333."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4111732", "@IdType": "pmc"}, {"#text": "23696037", "@IdType": "pubmed"}]}, "Citation": "Ma L, Bajic VB, Zhang Z. On the classification of long non-coding RNAs. RNA Biol. 2013;10:924\u201333."}, {"ArticleIdList": {"ArticleId": {"#text": "24677606", "@IdType": "pubmed"}}, "Citation": "Bhan A, Mandal SS. Long noncoding RNAs: emerging stars in gene regulation, epigenetics and human disease. ChemMedChem 2014;9:1932\u201356."}, {"ArticleIdList": {"ArticleId": {"#text": "24677606", "@IdType": "pubmed"}}, "Citation": "Bhan A, Mandal SS. Long noncoding RNAs: emerging stars in gene regulation, epigenetics and human disease. ChemMedChem. 2014;9:1932\u201356."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3668284", "@IdType": "pmc"}, {"#text": "23721193", "@IdType": "pubmed"}]}, "Citation": "Kornienko AE, Guenzl PM, Barlow DP, Pauler FM. Gene regulation by the act of long non-coding RNA transcription. BMC Biol 2013;11:59."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3668284", "@IdType": "pmc"}, {"#text": "23721193", "@IdType": "pubmed"}]}, "Citation": "Kornienko AE, Guenzl PM, Barlow DP, Pauler FM. Gene regulation by the act of long non-coding RNA transcription. BMC Biol. 2013;11:59."}, {"ArticleIdList": {"ArticleId": {"#text": "21843590", "@IdType": "pubmed"}}, "Citation": "R\u00f6ther S, Meister G. Small RNAs derived from longer non-coding RNAs. Biochimie 2011;93:1905\u201315."}, {"ArticleIdList": {"ArticleId": {"#text": "21843590", "@IdType": "pubmed"}}, "Citation": "R\u00f6ther S, Meister G. Small RNAs derived from longer non-coding RNAs. Biochimie. 2011;93:1905\u201315."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3020079", "@IdType": "pmc"}, {"#text": "20393465", "@IdType": "pubmed"}]}, "Citation": "Kim T-K, Hemberg M, Gray JM, Costa AM, Bear DM, Wu J, et al. Widespread transcription at neuronal activity-regulated enhancers. Nature 2010;465:182."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3020079", "@IdType": "pmc"}, {"#text": "20393465", "@IdType": "pubmed"}]}, "Citation": "Kim T-K, Hemberg M, Gray JM, Costa AM, Bear DM, Wu J. et al. Widespread transcription at neuronal activity-regulated enhancers. Nature. 2010;465:182."}, {"ArticleIdList": {"ArticleId": {"#text": "25565028", "@IdType": "pubmed"}}, "Citation": "Lafontaine DL. Noncoding RNAs in eukaryotic ribosome biogenesis and function. Nat Struct Mol Biol 2015;22:11\u20139."}, {"ArticleIdList": {"ArticleId": {"#text": "25565028", "@IdType": "pubmed"}}, "Citation": "Lafontaine DL. Noncoding RNAs in eukaryotic ribosome biogenesis and function. Nat Struct Mol Biol. 2015;22:11\u20139."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3532253", "@IdType": "pmc"}, {"#text": "23132786", "@IdType": "pubmed"}]}, "Citation": "Moghe GD, Lehti-Shiu MD, Seddon AE, Yin S, Chen Y, Juntawong P, et al. Characteristics and significance of intergenic polyadenylated RNA transcription in Arabidopsis. Plant Physiol 2013;161:210\u201324."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3532253", "@IdType": "pmc"}, {"#text": "23132786", "@IdType": "pubmed"}]}, "Citation": "Moghe GD, Lehti-Shiu MD, Seddon AE, Yin S, Chen Y, Juntawong P. et al. Characteristics and significance of intergenic polyadenylated RNA transcription in Arabidopsis. Plant Physiol. 2013;161:210\u201324."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3919156", "@IdType": "pmc"}, {"#text": "24440503", "@IdType": "pubmed"}]}, "Citation": "Legnini I, Morlando M, Mangiavacchi A, Fatica A, Bozzoni I. A feedforward regulatory loop between HuR and the long noncoding RNA linc-MD1 controls early phases of myogenesis. Mol Cell 2014;53:506\u201314."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3919156", "@IdType": "pmc"}, {"#text": "24440503", "@IdType": "pubmed"}]}, "Citation": "Legnini I, Morlando M, Mangiavacchi A, Fatica A, Bozzoni I. A feedforward regulatory loop between HuR and the long noncoding RNA linc-MD1 controls early phases of myogenesis. Mol Cell. 2014;53:506\u201314."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3668042", "@IdType": "pmc"}, {"#text": "23590974", "@IdType": "pubmed"}]}, "Citation": "Loraine AE, McCormick S, Estrada A, Patel K, Qin P. RNA-seq of Arabidopsis pollen uncovers novel transcription and alternative splicing. Plant Physiol 2013;162:1092\u2013109."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3668042", "@IdType": "pmc"}, {"#text": "23590974", "@IdType": "pubmed"}]}, "Citation": "Loraine AE, McCormick S, Estrada A, Patel K, Qin P. RNA-seq of Arabidopsis pollen uncovers novel transcription and alternative splicing. Plant Physiol. 2013;162:1092\u2013109."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3531837", "@IdType": "pmc"}, {"#text": "23136377", "@IdType": "pubmed"}]}, "Citation": "Liu J, Jung C, Xu J, Wang H, Deng S, Bernad L, et al. Genome-wide analysis uncovers regulation of long intergenic noncoding RNAs in Arabidopsis. Plant Cell 2012;24:4333\u201345."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3531837", "@IdType": "pmc"}, {"#text": "23136377", "@IdType": "pubmed"}]}, "Citation": "Liu J, Jung C, Xu J, Wang H, Deng S, Bernad L. et al. Genome-wide analysis uncovers regulation of long intergenic noncoding RNAs in Arabidopsis. Plant Cell. 2012;24:4333\u201345."}, {"ArticleIdList": {"ArticleId": {"#text": "15935759", "@IdType": "pubmed"}}, "Citation": "Wyers F, Rougemaille M, Badis G, Rousselle J-C, Dufour M-E, Boulay J, et al. Cryptic pol II transcripts are degraded by a nuclear quality control pathway involving a new poly (A) polymerase. Cell 2005;121:725\u201337."}, {"ArticleIdList": {"ArticleId": {"#text": "15935759", "@IdType": "pubmed"}}, "Citation": "Wyers F, Rougemaille M, Badis G, Rousselle J-C, Dufour M-E, Boulay J. et al. Cryptic pol II transcripts are degraded by a nuclear quality control pathway involving a new poly (A) polymerase. Cell. 2005;121:725\u201337."}, {"ArticleIdList": {"ArticleId": {"#text": "22905871", "@IdType": "pubmed"}}, "Citation": "Natoli G, Andrau J-C. Noncoding transcription at enhancers: general principles and functional models. Annu Rev Genet 2012;46:1\u201319."}, {"ArticleIdList": {"ArticleId": {"#text": "22905871", "@IdType": "pubmed"}}, "Citation": "Natoli G, Andrau J-C. Noncoding transcription at enhancers: general principles and functional models. Annu Rev Genet. 2012;46:1\u201319."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3730096", "@IdType": "pmc"}, {"#text": "23636943", "@IdType": "pubmed"}]}, "Citation": "Hah N, Murakami S, Nagari A, Danko CG, Kraus WL. Enhancer transcripts mark active estrogen receptor binding sites. Genome Res 2013;23:1210\u201323."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3730096", "@IdType": "pmc"}, {"#text": "23636943", "@IdType": "pubmed"}]}, "Citation": "Hah N, Murakami S, Nagari A, Danko CG, Kraus WL. Enhancer transcripts mark active estrogen receptor binding sites. Genome Res. 2013;23:1210\u201323."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3839578", "@IdType": "pmc"}, {"#text": "23728303", "@IdType": "pubmed"}]}, "Citation": "Lam MT, Cho H, Lesch HP, Gosselin D, Heinz S, Tanaka-Oishi Y, et al. Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription. Nature 2013;498:511\u20135."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3839578", "@IdType": "pmc"}, {"#text": "23728303", "@IdType": "pubmed"}]}, "Citation": "Lam MT, Cho H, Lesch HP, Gosselin D, Heinz S, Tanaka-Oishi Y. et al. Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription. Nature. 2013;498:511\u20135."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5215096", "@IdType": "pmc"}, {"#text": "24670763", "@IdType": "pubmed"}]}, "Citation": "Andersson R, Gebhard C, Miguel-Escalada I, Hoof I, Bornholdt J, Boyd M, et al. An atlas of active enhancers across human cell types and tissues. Nature 2014;507:455\u201361."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5215096", "@IdType": "pmc"}, {"#text": "24670763", "@IdType": "pubmed"}]}, "Citation": "Andersson R, Gebhard C, Miguel-Escalada I, Hoof I, Bornholdt J, Boyd M. et al. An atlas of active enhancers across human cell types and tissues. Nature. 2014;507:455\u201361."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3718886", "@IdType": "pmc"}, {"#text": "23728302", "@IdType": "pubmed"}]}, "Citation": "Li W, Notani D, Ma Q, Tanasa B, Nunez E, Chen AY, et al. Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation. Nature 2013;498:516\u201320."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3718886", "@IdType": "pmc"}, {"#text": "23728302", "@IdType": "pubmed"}]}, "Citation": "Li W, Notani D, Ma Q, Tanasa B, Nunez E, Chen AY. et al. Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation. Nature. 2013;498:516\u201320."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3270023", "@IdType": "pmc"}, {"#text": "22319583", "@IdType": "pubmed"}]}, "Citation": "Salzman J, Gawad C, Wang PL, Lacayo N, Brown PO. Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types. PloS One 2012;7:e30733."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3270023", "@IdType": "pmc"}, {"#text": "22319583", "@IdType": "pubmed"}]}, "Citation": "Salzman J, Gawad C, Wang PL, Lacayo N, Brown PO. Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types. PloS One. 2012;7:e30733."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3543092", "@IdType": "pmc"}, {"#text": "23249747", "@IdType": "pubmed"}]}, "Citation": "Jeck WR, Sorrentino JA, Wang K, Slevin MK, Burd CE, Liu J, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA 2013;19:141\u201357."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3543092", "@IdType": "pmc"}, {"#text": "23249747", "@IdType": "pubmed"}]}, "Citation": "Jeck WR, Sorrentino JA, Wang K, Slevin MK, Burd CE, Liu J. et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA. 2013;19:141\u201357."}, {"ArticleIdList": {"ArticleId": {"#text": "26204923", "@IdType": "pubmed"}}, "Citation": "Ye CY, Chen L, Liu C, Zhu QH, Fan L. Widespread noncoding circular RNAs in plants. New Phytol 2015;208:88\u201395."}, {"ArticleIdList": {"ArticleId": {"#text": "26204923", "@IdType": "pubmed"}}, "Citation": "Ye CY, Chen L, Liu C, Zhu QH, Fan L. Widespread noncoding circular RNAs in plants. New Phytol. 2015;208:88\u201395."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5680671", "@IdType": "pmc"}, {"#text": "28402213", "@IdType": "pubmed"}]}, "Citation": "Noto JJ, Schmidt CA, Matera AG. Engineering and expressing circular RNAs via tRNA splicing. RNA Biol 2017;14:978\u201384."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5680671", "@IdType": "pmc"}, {"#text": "28402213", "@IdType": "pubmed"}]}, "Citation": "Noto JJ, Schmidt CA, Matera AG. Engineering and expressing circular RNAs via tRNA splicing. RNA Biol. 2017;14:978\u201384."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4948998", "@IdType": "pmc"}, {"#text": "27050930", "@IdType": "pubmed"}]}, "Citation": "Salzman J. Circular RNA expression: its potential regulation and function. Trends Genet 2016;32:309\u201316."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4948998", "@IdType": "pmc"}, {"#text": "27050930", "@IdType": "pubmed"}]}, "Citation": "Salzman J. Circular RNA expression: its potential regulation and function. Trends Genet. 2016;32:309\u201316."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5216934", "@IdType": "pmc"}, {"#text": "27363013", "@IdType": "pubmed"}]}, "Citation": "Huang M, Zhong Z, Lv M, Shu J, Tian Q, Chen J. Comprehensive analysis of differentially expressed profiles of lncRNAs and circRNAs with associated co-expression and ceRNA networks in bladder carcinoma. Oncotarget 2016;7:47186\u2013200."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5216934", "@IdType": "pmc"}, {"#text": "27363013", "@IdType": "pubmed"}]}, "Citation": "Huang M, Zhong Z, Lv M, Shu J, Tian Q, Chen J. Comprehensive analysis of differentially expressed profiles of lncRNAs and circRNAs with associated co-expression and ceRNA networks in bladder carcinoma. Oncotarget. 2016;7:47186\u2013200."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4988292", "@IdType": "pmc"}, {"#text": "27097729", "@IdType": "pubmed"}]}, "Citation": "Sun X, Liu J, Xu C, Tang SC, Ren H. The insights of Let-7 miRNAs in oncogenesis and stem cell potency. J Cell Mol Med 2016;20:1779\u201388."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4988292", "@IdType": "pmc"}, {"#text": "27097729", "@IdType": "pubmed"}]}, "Citation": "Sun X, Liu J, Xu C, Tang SC, Ren H. The insights of Let-7 miRNAs in oncogenesis and stem cell potency. J Cell Mol Med. 2016;20:1779\u201388."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2861495", "@IdType": "pmc"}, {"#text": "20371350", "@IdType": "pubmed"}]}, "Citation": "Hafner M, Landthaler M, Burger L, Khorshid M, Hausser J, Berninger P, et al. Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 2010;141:129\u201341."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2861495", "@IdType": "pmc"}, {"#text": "20371350", "@IdType": "pubmed"}]}, "Citation": "Hafner M, Landthaler M, Burger L, Khorshid M, Hausser J, Berninger P. et al. Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell. 2010;141:129\u201341."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2733940", "@IdType": "pmc"}, {"#text": "19536157", "@IdType": "pubmed"}]}, "Citation": "Chi SW, Zang JB, Mele A, Darnell RB. Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 2009;460:479\u201386."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2733940", "@IdType": "pmc"}, {"#text": "19536157", "@IdType": "pubmed"}]}, "Citation": "Chi SW, Zang JB, Mele A, Darnell RB. Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature. 2009;460:479\u201386."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3650559", "@IdType": "pmc"}, {"#text": "23622248", "@IdType": "pubmed"}]}, "Citation": "Helwak A, Kudla G, Dudnakova T, Tollervey D. Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell 2013;153:654\u201365."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3650559", "@IdType": "pmc"}, {"#text": "23622248", "@IdType": "pubmed"}]}, "Citation": "Helwak A, Kudla G, Dudnakova T, Tollervey D. Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell. 2013;153:654\u201365."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5743474", "@IdType": "pmc"}, {"#text": "29290807", "@IdType": "pubmed"}]}, "Citation": "Koo J, Zhang J, Chaterji S. Tiresias: Context-sensitive approach to decipher the presence and strength of MicroRNA regulatory interactions. Theranostics 2018;8:277\u201391."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5743474", "@IdType": "pmc"}, {"#text": "29290807", "@IdType": "pubmed"}]}, "Citation": "Koo J, Zhang J, Chaterji S. Tiresias: Context-sensitive approach to decipher the presence and Strength of MicroRNA regulatory interactions. Theranostics. 2018;8:277\u201391."}, {"ArticleIdList": {"ArticleId": {"#text": "30635894", "@IdType": "pubmed"}}, "Citation": "Sacar Demirci MD, Yousef M, Allmer J. Computational Prediction of Functional MicroRNA-mRNA Interactions. Methods in molecular biology 2019;1912:175\u201396."}, {"ArticleIdList": {"ArticleId": {"#text": "30635894", "@IdType": "pubmed"}}, "Citation": "Sacar Demirci MD, Yousef M, Allmer J. Computational Prediction of Functional MicroRNA-mRNA Interactions. Methods in molecular biology. 2019;1912:175\u201396."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3167600", "@IdType": "pmc"}, {"#text": "21652644", "@IdType": "pubmed"}]}, "Citation": "Thomson DW, Bracken CP, Goodall GJ. Experimental strategies for microRNA target identification. Nucleic Acids Res 2011;39:6845\u201353."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3167600", "@IdType": "pmc"}, {"#text": "21652644", "@IdType": "pubmed"}]}, "Citation": "Thomson DW, Bracken CP, Goodall GJ. Experimental strategies for microRNA target identification. Nucleic Acids Res. 2011;39:6845\u201353."}, {"ArticleIdList": {"ArticleId": {"#text": "27184080", "@IdType": "pubmed"}}, "Citation": "Sharma E, Sterne-Weiler T, O\u2018Hanlon D, Blencowe BJ. Global mapping of human RNA-RNA interactions. Mol Cell 2016;62:618\u201326."}, {"ArticleIdList": {"ArticleId": {"#text": "27184080", "@IdType": "pubmed"}}, "Citation": "Sharma E, Sterne-Weiler T, O\u2018Hanlon D, Blencowe BJ. Global mapping of human RNA-RNA interactions. Mol Cell. 2016;62:618\u201326."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6387700", "@IdType": "pmc"}, {"#text": "30881525", "@IdType": "pubmed"}]}, "Citation": "Wang QS, Shi LL, Sun F, Zhang YF, Chen RW, Yang SL, et al. High Expression of ANXA2 pseudogene ANXA2P2 promotes an aggressive phenotype in hepatocellular carcinoma. Dis Markers 2019;2019:9267046."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6387700", "@IdType": "pmc"}, {"#text": "30881525", "@IdType": "pubmed"}]}, "Citation": "Wang QS, Shi LL, Sun F, Zhang YF, Chen RW, Yang SL. et al. High Expression of ANXA2 pseudogene ANXA2P2 promotes an aggressive phenotype in hepatocellular carcinoma. Dis Markers. 2019;2019:9267046."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4930690", "@IdType": "pmc"}, {"#text": "27325641", "@IdType": "pubmed"}]}, "Citation": "Svoronos AA, Engelman DM, Slack FJ. OncomiR or tumor suppressor? The duplicity of microRNAs in cancer. Cancer Res 2016;76:3666\u201370."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4930690", "@IdType": "pmc"}, {"#text": "27325641", "@IdType": "pubmed"}]}, "Citation": "Svoronos AA, Engelman DM, Slack FJ. OncomiR or tumor suppressor? The duplicity of microRNAs in cancer. Cancer Res. 2016;76:3666\u201370."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6112665", "@IdType": "pmc"}, {"#text": "30153287", "@IdType": "pubmed"}]}, "Citation": "Chen G, Wang Q, Yang Q, Li Z, Du Z, Ren M, et al. Circular RNAs hsa_circ_0032462, hsa_circ_0028173, hsa_circ_0005909 are predicted to promote CADM1 expression by functioning as miRNAs sponge in human osteosarcoma. PLoS One 2018;13:e0202896."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6112665", "@IdType": "pmc"}, {"#text": "30153287", "@IdType": "pubmed"}]}, "Citation": "Chen G, Wang Q, Yang Q, Li Z, Du Z, Ren M. et al. Circular RNAs hsa_circ_0032462, hsa_circ_0028173, hsa_circ_0005909 are predicted to promote CADM1 expression by functioning as miRNAs sponge in human osteosarcoma. PLoS One. 2018;13:e0202896."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6155266", "@IdType": "pmc"}, {"#text": "28272374", "@IdType": "pubmed"}]}, "Citation": "Palmini G, Marini F, Brandi M. What is new in the miRNA world regarding osteosarcoma and chondrosarcoma? Molecules 2017;22:417."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6155266", "@IdType": "pmc"}, {"#text": "28272374", "@IdType": "pubmed"}]}, "Citation": "Palmini G, Marini F, Brandi M. What is new in the miRNA world regarding osteosarcoma and chondrosarcoma? Molecules. 2017;22:417."}, {"ArticleIdList": {"ArticleId": {"#text": "30853185", "@IdType": "pubmed"}}, "Citation": "Lu J, Zhang P-Y, Li P, Xie J-W, Wang J-B, Lin J-X, et al. Circular RNA hsa_circ_0001368 suppresses the progression of gastric cancer by regulating miR-6506\u20135p/FOXO3 axis. Biochem Biophys Res Commun 2019;512:29\u201333."}, {"ArticleIdList": {"ArticleId": {"#text": "30853185", "@IdType": "pubmed"}}, "Citation": "Lu J, Zhang P-Y, Li P, Xie J-W, Wang J-B, Lin J-X. et al. Circular RNA hsa_circ_0001368 suppresses the progression of gastric cancer by regulating miR-6506\u20135p/FOXO3 axis. Biochem Biophys Res Commun. 2019;512:29\u201333."}, {"ArticleIdList": {"ArticleId": {"#text": "27551063", "@IdType": "pubmed"}}, "Citation": "Xu J, Shao T, Ding N, Li Y, Li X. miRNA\u2013miRNA crosstalk: from genomics to phenomics. Brief Bioinform 2016;18:1002\u201311."}, {"ArticleIdList": {"ArticleId": {"#text": "27551063", "@IdType": "pubmed"}}, "Citation": "Xu J, Shao T, Ding N, Li Y, Li X. miRNA\u2013miRNA crosstalk: from genomics to phenomics. Brief Bioinform. 2016;18:1002\u201311."}, {"ArticleIdList": {"ArticleId": {"#text": "15806104", "@IdType": "pubmed"}}, "Citation": "Krek A, Gr\u00fcn D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, et al. Combinatorial microRNA target predictions. Nat Genet 2005;37:495\u2013500."}, {"ArticleIdList": {"ArticleId": {"#text": "15806104", "@IdType": "pubmed"}}, "Citation": "Krek A, Gr\u00fcn D, Poy MN, Wolf R, Rosenberg L, Epstein EJ. et al. Combinatorial microRNA target predictions. Nat Genet. 2005;37:495\u2013500."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3615747", "@IdType": "pmc"}, {"#text": "23519125", "@IdType": "pubmed"}]}, "Citation": "Wang S, Huang J, Lyu H, Lee C, Tan J, Wang J, et al. Functional cooperation of miR-125a, miR-125b, and miR-205 in entinostat-induced downregulation of erbB2/erbB3 and apoptosis in breast cancer cells. Cell Death Dis 2013;4:e556."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3615747", "@IdType": "pmc"}, {"#text": "23519125", "@IdType": "pubmed"}]}, "Citation": "Wang S, Huang J, Lyu H, Lee C, Tan J, Wang J. et al. Functional cooperation of miR-125a, miR-125b, and miR-205 in entinostat-induced downregulation of erbB2/erbB3 and apoptosis in breast cancer cells. Cell Death Dis. 2013;4:e556."}, {"ArticleIdList": {"ArticleId": {"#text": "26196323", "@IdType": "pubmed"}}, "Citation": "Grossi E, Sanchez Y, Huarte M. Expanding the p53 regulatory network: LncRNAs take up the challenge. Biochim Biophys Acta Gene Regul Mech 2016;1859:200\u20138."}, {"ArticleIdList": {"ArticleId": {"#text": "26196323", "@IdType": "pubmed"}}, "Citation": "Grossi E, Sanchez Y, Huarte M. Expanding the p53 regulatory network: LncRNAs take up the challenge. Biochim Biophys Acta Gene Regul Mech. 2016;1859:200\u20138."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4694810", "@IdType": "pmc"}, {"#text": "26305674", "@IdType": "pubmed"}]}, "Citation": "Li Y, Chen J, Zhang J, Wang Z, Shao T, Jiang C, et al. Construction and analysis of lncRNA-lncRNA synergistic networks to reveal clinically relevant lncRNAs in cancer. Oncotarget 2015;6:25003\u201316."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4694810", "@IdType": "pmc"}, {"#text": "26305674", "@IdType": "pubmed"}]}, "Citation": "Li Y, Chen J, Zhang J, Wang Z, Shao T, Jiang C. et al. Construction and analysis of lncRNA-lncRNA synergistic networks to reveal clinically relevant lncRNAs in cancer. Oncotarget. 2015;6:25003\u201316."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2719882", "@IdType": "pmc"}, {"#text": "19169241", "@IdType": "pubmed"}]}, "Citation": "Fejes-Toth K, Sotirova V, Sachidanandam R, Assaf G, Hannon GJ, Kapranov P, et al. Post-transcriptional processing generates a diversity of 5\u2032-modified long and short RNAs: Affymetrix/Cold Spring Harbor Laboratory ENCODE Transcriptome Project. Nature 2009;457:1028\u201332."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2719882", "@IdType": "pmc"}, {"#text": "19169241", "@IdType": "pubmed"}]}, "Citation": "Fejes-Toth K, Sotirova V, Sachidanandam R, Assaf G, Hannon GJ, Kapranov P. et al. Post-transcriptional processing generates a diversity of 5\u2032-modified long and short RNAs: Affymetrix/Cold Spring Harbor Laboratory ENCODE Transcriptome Project. Nature. 2009;457:1028\u201332."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4726728", "@IdType": "pmc"}, {"#text": "26159929", "@IdType": "pubmed"}]}, "Citation": "Kowalski MP, Krude T. Functional roles of non-coding Y RNAs. Int J Biochem Cell Biol 2015;66:20\u20139."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4726728", "@IdType": "pmc"}, {"#text": "26159929", "@IdType": "pubmed"}]}, "Citation": "Kowalski MP, Krude T. Functional roles of non-coding Y RNAs. Int J Biochem Cell Biol. 2015;66:20\u20139."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5953555", "@IdType": "pmc"}, {"#text": "28922346", "@IdType": "pubmed"}]}, "Citation": "Li X, Zhou B, Chen L, Gou L-T, Li H, Fu X-D. GRID-seq reveals the global RNA\u2013chromatin interactome. Nat Biotechnol 2017;35:940\u201350."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5953555", "@IdType": "pmc"}, {"#text": "28922346", "@IdType": "pubmed"}]}, "Citation": "Li X, Zhou B, Chen L, Gou L-T, Li H, Fu X-D. GRID-seq reveals the global RNA\u2013chromatin interactome. Nat Biotechnol. 2017;35:940\u201350."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4428586", "@IdType": "pmc"}, {"#text": "25155612", "@IdType": "pubmed"}]}, "Citation": "West JA, Davis CP, Sunwoo H, Simon MD, Sadreyev RI, Wang PI, et al. The long noncoding RNAs NEAT1 and MALAT1 bind active chromatin sites. Mol Cell 2014;55:791\u2013802."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4428586", "@IdType": "pmc"}, {"#text": "25155612", "@IdType": "pubmed"}]}, "Citation": "West JA, Davis CP, Sunwoo H, Simon MD, Sadreyev RI, Wang PI. et al. The long noncoding RNAs NEAT1 and MALAT1 bind active chromatin sites. Mol Cell. 2014;55:791\u2013802."}, {"ArticleIdList": {"ArticleId": {"#text": "30865882", "@IdType": "pubmed"}}, "Citation": "Blank-Giwojna A, Postepska-Igielska A, Grummt I. lncRNA KHPS1 activates a poised enhancer by triplex-dependent recruitment of epigenomic regulators. Cell Rep 2019;26:2904\u201315. e4."}, {"ArticleIdList": {"ArticleId": {"#text": "30865882", "@IdType": "pubmed"}}, "Citation": "Blank-Giwojna A, Postepska-Igielska A, Grummt I. lncRNA KHPS1 activates a poised enhancer by triplex-dependent recruitment of epigenomic regulators. Cell Rep. 2019;26:2904\u201315. e4."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2266855", "@IdType": "pmc"}, {"#text": "18283318", "@IdType": "pubmed"}]}, "Citation": "Christov C, Trivier E, Krude T. Noncoding human Y RNAs are overexpressed in tumours and required for cell proliferation. Br J Cancer 2008;98:981\u20138."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2266855", "@IdType": "pmc"}, {"#text": "18283318", "@IdType": "pubmed"}]}, "Citation": "Christov C, Trivier E, Krude T. Noncoding human Y RNAs are overexpressed in tumours and required for cell proliferation. Br J Cancer. 2008;98:981\u20138."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2597294", "@IdType": "pmc"}, {"#text": "18978773", "@IdType": "pubmed"}]}, "Citation": "Licatalosi DD, Mele A, Fak JJ, Ule J, Kayikci M, Chi SW, et al. HITS-CLIP yields genome-wide insights into brain alternative RNA processing. Nature 2008;456:464\u20139."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2597294", "@IdType": "pmc"}, {"#text": "18978773", "@IdType": "pubmed"}]}, "Citation": "Licatalosi DD, Mele A, Fak JJ, Ule J, Kayikci M, Chi SW. et al. HITS-CLIP yields genome-wide insights into brain alternative RNA processing. Nature. 2008;456:464\u20139."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5617379", "@IdType": "pmc"}, {"#text": "28959731", "@IdType": "pubmed"}]}, "Citation": "Long Y, Wang X, Youmans DT, Cech TR. How do lncRNAs regulate transcription? Sci Adv 2017;3:eaao2110."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5617379", "@IdType": "pmc"}, {"#text": "28959731", "@IdType": "pubmed"}]}, "Citation": "Long Y, Wang X, Youmans DT, Cech TR. How do lncRNAs regulate transcription? Sci Adv. 2017;3:eaao2110."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4516396", "@IdType": "pmc"}, {"#text": "25915022", "@IdType": "pubmed"}]}, "Citation": "McHugh CA, Chen C-K, Chow A, Surka CF, Tran C, McDonel P, et al. The Xist lncRNA interacts directly with SHARP to silence transcription through HDAC3. Nature 2015;521:232\u20136."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4516396", "@IdType": "pmc"}, {"#text": "25915022", "@IdType": "pubmed"}]}, "Citation": "McHugh CA, Chen C-K, Chow A, Surka CF, Tran C, McDonel P. et al. The Xist lncRNA interacts directly with SHARP to silence transcription through HDAC3. Nature. 2015;521:232\u20136."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5299715", "@IdType": "pmc"}, {"#text": "27886165", "@IdType": "pubmed"}]}, "Citation": "Du WW, Fang L, Yang W, Wu N, Awan FM, Yang Z, et al. Induction of tumor apoptosis through a circular RNA enhancing Foxo3 activity. Cell Death Differ 2017;24:357\u201370."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5299715", "@IdType": "pmc"}, {"#text": "27886165", "@IdType": "pubmed"}]}, "Citation": "Du WW, Fang L, Yang W, Wu N, Awan FM, Yang Z. et al. Induction of tumor apoptosis through a circular RNA enhancing Foxo3 activity. Cell Death Differ. 2017;24:357\u201370."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4374487", "@IdType": "pmc"}, {"#text": "25821635", "@IdType": "pubmed"}]}, "Citation": "Fu X-D. Non-coding RNA: a new frontier in regulatory biology. Natl Sci Rev 2014;1:190\u2013204."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4374487", "@IdType": "pmc"}, {"#text": "25821635", "@IdType": "pubmed"}]}, "Citation": "Fu X-D. Non-coding RNA: a new frontier in regulatory biology. Natl Sci Rev. 2014;1:190\u2013204."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3235919", "@IdType": "pmc"}, {"#text": "21802130", "@IdType": "pubmed"}]}, "Citation": "Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 2011;146:353\u20138."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3235919", "@IdType": "pmc"}, {"#text": "21802130", "@IdType": "pubmed"}]}, "Citation": "Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell. 2011;146:353\u20138."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3206313", "@IdType": "pmc"}, {"#text": "20577206", "@IdType": "pubmed"}]}, "Citation": "Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, Pandolfi PP. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 2010;465:1033\u20138."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3206313", "@IdType": "pmc"}, {"#text": "20577206", "@IdType": "pubmed"}]}, "Citation": "Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, Pandolfi PP. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature. 2010;465:1033\u20138."}, {"ArticleIdList": {"ArticleId": {"#text": "15143321", "@IdType": "pubmed"}}, "Citation": "Bartel DP, Chen C-Z. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat Rev Genet 2004;5:396\u2013400."}, {"ArticleIdList": {"ArticleId": {"#text": "15143321", "@IdType": "pubmed"}}, "Citation": "Bartel DP, Chen C-Z. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat Rev Genet. 2004;5:396\u2013400."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3236086", "@IdType": "pmc"}, {"#text": "22000016", "@IdType": "pubmed"}]}, "Citation": "Karreth FA, Tay Y, Perna D, Ala U, Tan SM, Rust AG, et al. In vivo identification of tumor-suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma. Cell 2011;147:382\u201395."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3236086", "@IdType": "pmc"}, {"#text": "22000016", "@IdType": "pubmed"}]}, "Citation": "Karreth FA, Tay Y, Perna D, Ala U, Tan SM, Rust AG. et al. In vivo identification of tumor-suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma. Cell. 2011;147:382\u201395."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2963607", "@IdType": "pmc"}, {"#text": "21049042", "@IdType": "pubmed"}]}, "Citation": "Lee DY, Jeyapalan Z, Fang L, Yang J, Zhang Y, Yee AY, et al. Expression of versican 3\u2032-untranslated region modulates endogenous microRNA functions. PloS One 2010;5:e13599."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2963607", "@IdType": "pmc"}, {"#text": "21049042", "@IdType": "pubmed"}]}, "Citation": "Lee DY, Jeyapalan Z, Fang L, Yang J, Zhang Y, Yee AY. et al. Expression of versican 3\u2032-untranslated region modulates endogenous microRNA functions. PloS One. 2010;5:e13599."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2638016", "@IdType": "pmc"}, {"#text": "19223980", "@IdType": "pubmed"}]}, "Citation": "Lee DY, Shatseva T, Jeyapalan Z, Du WW, Deng Z, Yang BB. A 3\u2032-untranslated region (3\u2032 UTR) induces organ adhesion by regulating miR-199a* functions. PloS One 2009;4:e4527."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2638016", "@IdType": "pmc"}, {"#text": "19223980", "@IdType": "pubmed"}]}, "Citation": "Lee DY, Shatseva T, Jeyapalan Z, Du WW, Deng Z, Yang BB. A 3\u2032-untranslated region (3\u2032 UTR) induces organ adhesion by regulating miR-199a* functions. PloS One. 2009;4:e4527."}, {"ArticleIdList": {"ArticleId": {"#text": "23180826", "@IdType": "pubmed"}}, "Citation": "Fang L, Du WW, Yang X, Chen K, Ghanekar A, Levy G, et al. Versican 3\u2032-untranslated region (3\u2032-UTR) functions as a ceRNA in inducing the development of hepatocellular carcinoma by regulating miRNA activity. FASEB J 2013;27:907\u201319."}, {"ArticleIdList": {"ArticleId": {"#text": "23180826", "@IdType": "pubmed"}}, "Citation": "Fang L, Du WW, Yang X, Chen K, Ghanekar A, Levy G. et al. Versican 3\u2032-untranslated region (3\u2032-UTR) functions as a ceRNA in inducing the development of hepatocellular carcinoma by regulating miRNA activity. FASEB J. 2013;27:907\u201319."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3843377", "@IdType": "pmc"}, {"#text": "24055342", "@IdType": "pubmed"}]}, "Citation": "Kallen AN, Zhou X-B, Xu J, Qiao C, Ma J, Yan L, et al. The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol Cell 2013;52:101\u201312."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3843377", "@IdType": "pmc"}, {"#text": "24055342", "@IdType": "pubmed"}]}, "Citation": "Kallen AN, Zhou X-B, Xu J, Qiao C, Ma J, Yan L. et al. The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol Cell. 2013;52:101\u201312."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3580494", "@IdType": "pmc"}, {"#text": "23153069", "@IdType": "pubmed"}]}, "Citation": "Marques AC, Tan J, Lee S, Kong L, Heger A, Ponting CP. Evidence for conserved post-transcriptional roles of unitary pseudogenes and for frequent bifunctionality of mRNAs. Genome Biol 2012;13:R102."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3580494", "@IdType": "pmc"}, {"#text": "23153069", "@IdType": "pubmed"}]}, "Citation": "Marques AC, Tan J, Lee S, Kong L, Heger A, Ponting CP. Evidence for conserved post-transcriptional roles of unitary pseudogenes and for frequent bifunctionality of mRNAs. Genome Biol. 2012;13:R102."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4109059", "@IdType": "pmc"}, {"#text": "23417068", "@IdType": "pubmed"}]}, "Citation": "Lai F, Orom UA, Cesaroni M, Beringer M, Taatjes DJ, Blobel GA, et al. Activating RNAs associate with Mediator to enhance chromatin architecture and transcription. Nature 2013;494:497\u2013501."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4109059", "@IdType": "pmc"}, {"#text": "23417068", "@IdType": "pubmed"}]}, "Citation": "Lai F, Orom UA, Cesaroni M, Beringer M, Taatjes DJ, Blobel GA. et al. Activating RNAs associate with Mediator to enhance chromatin architecture and transcription. Nature. 2013;494:497\u2013501."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3924898", "@IdType": "pmc"}, {"#text": "24388749", "@IdType": "pubmed"}]}, "Citation": "Halley P, Kadakkuzha BM, Faghihi MA, Magistri M, Zeier Z, Khorkova O, et al. Regulation of the apolipoprotein gene cluster by a long noncoding RNA. Cell Rep 2014;6:222\u201330."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3924898", "@IdType": "pmc"}, {"#text": "24388749", "@IdType": "pubmed"}]}, "Citation": "Halley P, Kadakkuzha BM, Faghihi MA, Magistri M, Zeier Z, Khorkova O. et al. Regulation of the apolipoprotein gene cluster by a long noncoding RNA. Cell Rep. 2014;6:222\u201330."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3904790", "@IdType": "pmc"}, {"#text": "24162848", "@IdType": "pubmed"}]}, "Citation": "Simon MD, Pinter SF, Fang R, Sarma K, Rutenberg-Schoenberg M, Bowman SK, et al. High-resolution Xist binding maps reveal two-step spreading during X-chromosome inactivation. Nature 2013;504:465\u20139."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3904790", "@IdType": "pmc"}, {"#text": "24162848", "@IdType": "pubmed"}]}, "Citation": "Simon MD, Pinter SF, Fang R, Sarma K, Rutenberg-Schoenberg M, Bowman SK. et al. High-resolution Xist binding maps reveal two-step spreading during X-chromosome inactivation. Nature. 2013;504:465\u20139."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3778663", "@IdType": "pmc"}, {"#text": "23828888", "@IdType": "pubmed"}]}, "Citation": "Engreitz JM, Pandya-Jones A, McDonel P, Shishkin A, Sirokman K, Surka C, et al. The Xist lncRNA exploits three-dimensional genome architecture to spread across the X chromosome. Science 2013;341:1237973."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3778663", "@IdType": "pmc"}, {"#text": "23828888", "@IdType": "pubmed"}]}, "Citation": "Engreitz JM, Pandya-Jones A, McDonel P, Shishkin A, Sirokman K, Surka C. et al. The Xist lncRNA exploits three-dimensional genome architecture to spread across the X chromosome. Science. 2013;341:1237973."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2593616", "@IdType": "pmc"}, {"#text": "19052240", "@IdType": "pubmed"}]}, "Citation": "Hu Q, Kwon YS, Nunez E, Cardamone MD, Hutt KR, Ohgi KA, et al. Enhancing nuclear receptor-induced transcription requires nuclear motor and LSD1-dependent gene networking in interchromatin granules. Proc Natl Acad Sci USA 2008;105:19199\u2013204."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2593616", "@IdType": "pmc"}, {"#text": "19052240", "@IdType": "pubmed"}]}, "Citation": "Hu Q, Kwon YS, Nunez E, Cardamone MD, Hutt KR, Ohgi KA. et al. Enhancing nuclear receptor-induced transcription requires nuclear motor and LSD1-dependent gene networking in interchromatin granules. Proc Natl Acad Sci USA. 2008;105:19199\u2013204."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2796509", "@IdType": "pmc"}, {"#text": "19846290", "@IdType": "pubmed"}]}, "Citation": "Nunez E, Fu XD, Rosenfeld MG. Nuclear organization in the 3D space of the nucleus \u2013 cause or consequence? Curr Opin Genet Dev 2009;19:424\u201336."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2796509", "@IdType": "pmc"}, {"#text": "19846290", "@IdType": "pubmed"}]}, "Citation": "Nunez E, Fu XD, Rosenfeld MG. Nuclear organization in the 3D space of the nucleus \u2013 cause or consequence? Curr Opin Genet Dev. 2009;19:424\u201336."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3509343", "@IdType": "pmc"}, {"#text": "22841487", "@IdType": "pubmed"}]}, "Citation": "Yoon JH, Abdelmohsen K, Srikantan S, Yang X, Martindale JL, De S, et al. LincRNA-p21 suppresses target mRNA translation. Mol Cell 2012;47:648\u201355."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3509343", "@IdType": "pmc"}, {"#text": "22841487", "@IdType": "pubmed"}]}, "Citation": "Yoon JH, Abdelmohsen K, Srikantan S, Yang X, Martindale JL, De S. et al. LincRNA-p21 suppresses target mRNA translation. Mol Cell. 2012;47:648\u201355."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4376664", "@IdType": "pmc"}, {"#text": "25714049", "@IdType": "pubmed"}]}, "Citation": "You X, Vlatkovic I, Babic A, Will T, Epstein I, Tushev G, et al. Neural circular RNAs are derived from synaptic genes and regulated by development and plasticity. Nat Neurosci 2015;18:603\u201310."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4376664", "@IdType": "pmc"}, {"#text": "25714049", "@IdType": "pubmed"}]}, "Citation": "You X, Vlatkovic I, Babic A, Will T, Epstein I, Tushev G. et al. Neural circular RNAs are derived from synaptic genes and regulated by development and plasticity. Nat Neurosci. 2015;18:603\u201310."}, {"ArticleIdList": {"ArticleId": {"#text": "19335997", "@IdType": "pubmed"}}, "Citation": "Kim MY, Hur J, Jeong S. Emerging roles of RNA and RNA-binding protein network in cancer cells. BMB Rep 2009;42:125\u201330."}, {"ArticleIdList": {"ArticleId": {"#text": "19335997", "@IdType": "pubmed"}}, "Citation": "Kim MY, Hur J, Jeong S. Emerging roles of RNA and RNA-binding protein network in cancer cells. BMB Rep. 2009;42:125\u201330."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4540328", "@IdType": "pmc"}, {"#text": "22201738", "@IdType": "pubmed"}]}, "Citation": "Srikantan S, Gorospe M. HuR function in disease. Front Biosci (Landmark Ed) 2012;17:189\u2013205."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4540328", "@IdType": "pmc"}, {"#text": "22201738", "@IdType": "pubmed"}]}, "Citation": "Srikantan S, Gorospe M. HuR function in disease. Front Biosci (Landmark Ed) 2012;17:189\u2013205."}]}}}}}, "PMC": "PMC6798851", "PMID": "31301674", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "Non-Coding RNAs and their Integrated Networks.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "12": {"Abstract": "Long non-coding (lnc) RNAs are non-coding RNAs longer than 200 nt. lncRNAs primarily interact with mRNA, DNA, protein, and miRNA and consequently regulate gene expression at the epigenetic, transcriptional, post-transcriptional, translational, and post-translational levels in a variety of ways. They play important roles in biological processes such as chromatin remodeling, transcriptional activation, transcriptional interference, RNA processing, and mRNA translation. lncRNAs have important functions in plant growth and development; biotic and abiotic stress responses; and in regulation of cell differentiation, the cell cycle, and the occurrence of many diseases in humans and animals. In this review, we summarize the functions and mechanisms of lncRNAs in plants, humans, and animals at different regulatory levels.", "Authors": [{"Affiliations": [{"Has_Extra": true, "HashID": "4896289833654431699", "Part1": "State Key Laboratory of Crop Biology", "Part2": "College of Agronomy", "Part3": "Shandong Agricultural University", "Part4": "NO. 61 Daizong Street", "Part5": "Tai'an 271018", "Part6": "Shandong", "Text": "State Key Laboratory of Crop Biology, College of Agronomy, Shandong Agricultural University, NO. 61 Daizong Street, Tai'an 271018, Shandong, China."}], "ForeName": "Xiaopei", "FullName": "Xiaopei Zhang", "HashID": "-6471828034267380293", "LastName": "Zhang", "ORCID": null}, {"Affiliations": [{"Has_Extra": true, "HashID": "4896289833654431699", "Part1": "State Key Laboratory of Crop Biology", "Part2": "College of Agronomy", "Part3": "Shandong Agricultural University", "Part4": "NO. 61 Daizong Street", "Part5": "Tai'an 271018", "Part6": "Shandong", "Text": "State Key Laboratory of Crop Biology, College of Agronomy, Shandong Agricultural University, NO. 61 Daizong Street, Tai'an 271018, Shandong, China."}], "ForeName": "Wei", "FullName": "Wei Wang", "HashID": "-8534075993070402255", "LastName": "Wang", "ORCID": "0000-0002-5705-8591"}, {"Affiliations": [{"Has_Extra": false, "HashID": "8176565454929990540", "Part1": "State Key Laboratory of Cotton Biology", "Part2": "Chinese Academy of Agricultural Sciences Cotton Research Institute", "Part3": "Key Laboratory for Cotton Genetic Improvement", "Part4": "Anyang 45500", "Part5": "Henan", "Part6": "China.", "Text": "State Key Laboratory of Cotton Biology, Chinese Academy of Agricultural Sciences Cotton Research Institute, Key Laboratory for Cotton Genetic Improvement, Anyang 45500, Henan, China."}], "ForeName": "Weidong", "FullName": "Weidong Zhu", "HashID": "-4433959699463815126", "LastName": "Zhu", "ORCID": null}, {"Affiliations": [{"Has_Extra": true, "HashID": "4896289833654431699", "Part1": "State Key Laboratory of Crop Biology", "Part2": "College of Agronomy", "Part3": "Shandong Agricultural University", "Part4": "NO. 61 Daizong Street", "Part5": "Tai'an 271018", "Part6": "Shandong", "Text": "State Key Laboratory of Crop Biology, College of Agronomy, Shandong Agricultural University, NO. 61 Daizong Street, Tai'an 271018, Shandong, China."}], "ForeName": "Jie", "FullName": "Jie Dong", "HashID": "3495824780508240095", "LastName": "Dong", "ORCID": null}, {"Affiliations": [{"Has_Extra": true, "HashID": "4896289833654431699", "Part1": "State Key Laboratory of Crop Biology", "Part2": "College of Agronomy", "Part3": "Shandong Agricultural University", "Part4": "NO. 61 Daizong Street", "Part5": "Tai'an 271018", "Part6": "Shandong", "Text": "State Key Laboratory of Crop Biology, College of Agronomy, Shandong Agricultural University, NO. 61 Daizong Street, Tai'an 271018, Shandong, China."}], "ForeName": "Yingying", "FullName": "Yingying Cheng", "HashID": "3432672813809775176", "LastName": "Cheng", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "8176565454929990540", "Part1": "State Key Laboratory of Cotton Biology", "Part2": "Chinese Academy of Agricultural Sciences Cotton Research Institute", "Part3": "Key Laboratory for Cotton Genetic Improvement", "Part4": "Anyang 45500", "Part5": "Henan", "Part6": "China.", "Text": "State Key Laboratory of Cotton Biology, Chinese Academy of Agricultural Sciences Cotton Research Institute, Key Laboratory for Cotton Genetic Improvement, Anyang 45500, Henan, China."}], "ForeName": "Zujun", "FullName": "Zujun Yin", "HashID": "8176158258659579655", "LastName": "Yin", "ORCID": null}, {"Affiliations": [{"Has_Extra": true, "HashID": "4896289833654431699", "Part1": "State Key Laboratory of Crop Biology", "Part2": "College of Agronomy", "Part3": "Shandong Agricultural University", "Part4": "NO. 61 Daizong Street", "Part5": "Tai'an 271018", "Part6": "Shandong", "Text": "State Key Laboratory of Crop Biology, College of Agronomy, Shandong Agricultural University, NO. 61 Daizong Street, Tai'an 271018, Shandong, China."}], "ForeName": "Fafu", "FullName": "Fafu Shen", "HashID": "1774081959563652728", "LastName": "Shen", "ORCID": "0000-0003-1977-8712"}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.3390/ijms20225573", "InsertType": null, "Journal": "International journal of molecular sciences", "Keywords": [{"IS_Major": false, "IS_Mesh": true, "Text": "Animals"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Chromatin"}, {"IS_Major": false, "IS_Mesh": true, "Text": "DNA Methylation"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Genome"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Histones"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Humans"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Protein Processing, Post-Translational"}, {"IS_Major": false, "IS_Mesh": true, "Text": "RNA, Long Noncoding"}, {"IS_Major": false, "IS_Mesh": false, "Text": "epigenetic"}, {"IS_Major": false, "IS_Mesh": false, "Text": "lncRNA"}, {"IS_Major": false, "IS_Mesh": false, "Text": "post-transcriptional"}, {"IS_Major": false, "IS_Mesh": false, "Text": "post-translational modification"}, {"IS_Major": false, "IS_Mesh": false, "Text": "transcriptional"}, {"IS_Major": false, "IS_Mesh": false, "Text": "translation"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "MEDLINE", "Article": {"@PubModel": "Electronic", "Abstract": {"AbstractText": "Long non-coding (lnc) RNAs are non-coding RNAs longer than 200 nt. lncRNAs primarily interact with mRNA, DNA, protein, and miRNA and consequently regulate gene expression at the epigenetic, transcriptional, post-transcriptional, translational, and post-translational levels in a variety of ways. They play important roles in biological processes such as chromatin remodeling, transcriptional activation, transcriptional interference, RNA processing, and mRNA translation. lncRNAs have important functions in plant growth and development; biotic and abiotic stress responses; and in regulation of cell differentiation, the cell cycle, and the occurrence of many diseases in humans and animals. In this review, we summarize the functions and mechanisms of lncRNAs in plants, humans, and animals at different regulatory levels."}, "ArticleDate": {"@DateType": "Electronic", "Day": "08", "Month": "11", "Year": "2019"}, "ArticleTitle": "Mechanisms and Functions of Long Non-Coding RNAs at Multiple Regulatory Levels.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "State Key Laboratory of Crop Biology, College of Agronomy, Shandong Agricultural University, NO. 61 Daizong Street, Tai'an 271018, Shandong, China."}, "ForeName": "Xiaopei", "Initials": "X", "LastName": "Zhang"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "State Key Laboratory of Crop Biology, College of Agronomy, Shandong Agricultural University, NO. 61 Daizong Street, Tai'an 271018, Shandong, China."}, "ForeName": "Wei", "Identifier": {"#text": "0000-0002-5705-8591", "@Source": "ORCID"}, "Initials": "W", "LastName": "Wang"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "State Key Laboratory of Cotton Biology, Chinese Academy of Agricultural Sciences Cotton Research Institute, Key Laboratory for Cotton Genetic Improvement, Anyang 45500, Henan, China."}, "ForeName": "Weidong", "Initials": "W", "LastName": "Zhu"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "State Key Laboratory of Crop Biology, College of Agronomy, Shandong Agricultural University, NO. 61 Daizong Street, Tai'an 271018, Shandong, China."}, "ForeName": "Jie", "Initials": "J", "LastName": "Dong"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "State Key Laboratory of Crop Biology, College of Agronomy, Shandong Agricultural University, NO. 61 Daizong Street, Tai'an 271018, Shandong, China."}, "ForeName": "Yingying", "Initials": "Y", "LastName": "Cheng"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "State Key Laboratory of Cotton Biology, Chinese Academy of Agricultural Sciences Cotton Research Institute, Key Laboratory for Cotton Genetic Improvement, Anyang 45500, Henan, China."}, "ForeName": "Zujun", "Initials": "Z", "LastName": "Yin"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "State Key Laboratory of Crop Biology, College of Agronomy, Shandong Agricultural University, NO. 61 Daizong Street, Tai'an 271018, Shandong, China."}, "ForeName": "Fafu", "Identifier": {"#text": "0000-0003-1977-8712", "@Source": "ORCID"}, "Initials": "F", "LastName": "Shen"}]}, "ELocationID": [{"#text": "5573", "@EIdType": "pii", "@ValidYN": "Y"}, {"#text": "10.3390/ijms20225573", "@EIdType": "doi", "@ValidYN": "Y"}], "Journal": {"ISOAbbreviation": "Int J Mol Sci", "ISSN": {"#text": "1422-0067", "@IssnType": "Electronic"}, "JournalIssue": {"@CitedMedium": "Internet", "Issue": "22", "PubDate": {"Day": "08", "Month": "Nov", "Year": "2019"}, "Volume": "20"}, "Title": "International journal of molecular sciences"}, "Language": "eng", "PublicationTypeList": {"PublicationType": [{"#text": "Journal Article", "@UI": "D016428"}, {"#text": "Review", "@UI": "D016454"}]}}, "ChemicalList": {"Chemical": [{"NameOfSubstance": {"#text": "Chromatin", "@UI": "D002843"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "Histones", "@UI": "D006657"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "RNA, Long Noncoding", "@UI": "D062085"}, "RegistryNumber": "0"}]}, "CitationSubset": "IM", "CoiStatement": "The authors declare no conflict of interest.", "DateCompleted": {"Day": "13", "Month": "04", "Year": "2020"}, "DateRevised": {"Day": "13", "Month": "04", "Year": "2020"}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"#text": "epigenetic", "@MajorTopicYN": "N"}, {"#text": "lncRNA", "@MajorTopicYN": "N"}, {"#text": "post-transcriptional", "@MajorTopicYN": "N"}, {"#text": "post-translational modification", "@MajorTopicYN": "N"}, {"#text": "transcriptional", "@MajorTopicYN": "N"}, {"#text": "translation", "@MajorTopicYN": "N"}]}, "MedlineJournalInfo": {"Country": "Switzerland", "ISSNLinking": "1422-0067", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791"}, "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"#text": "Animals", "@MajorTopicYN": "N", "@UI": "D000818"}}, {"DescriptorName": {"#text": "Chromatin", "@MajorTopicYN": "N", "@UI": "D002843"}, "QualifierName": {"#text": "metabolism", "@MajorTopicYN": "N", "@UI": "Q000378"}}, {"DescriptorName": {"#text": "DNA Methylation", "@MajorTopicYN": "N", "@UI": "D019175"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Genome", "@MajorTopicYN": "N", "@UI": "D016678"}}, {"DescriptorName": {"#text": "Histones", "@MajorTopicYN": "N", "@UI": "D006657"}, "QualifierName": {"#text": "metabolism", "@MajorTopicYN": "N", "@UI": "Q000378"}}, {"DescriptorName": {"#text": "Humans", "@MajorTopicYN": "N", "@UI": "D006801"}}, {"DescriptorName": {"#text": "Protein Processing, Post-Translational", "@MajorTopicYN": "N", "@UI": "D011499"}}, {"DescriptorName": {"#text": "RNA, Long Noncoding", "@MajorTopicYN": "N", "@UI": "D062085"}, "QualifierName": [{"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}, {"#text": "metabolism", "@MajorTopicYN": "N", "@UI": "Q000378"}]}]}, "PMID": {"#text": "31717266", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "31717266", "@IdType": "pubmed"}, {"#text": "PMC6888083", "@IdType": "pmc"}, {"#text": "10.3390/ijms20225573", "@IdType": "doi"}, {"#text": "ijms20225573", "@IdType": "pii"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "received", "Day": "20", "Month": "9", "Year": "2019"}, {"@PubStatus": "revised", "Day": "5", "Month": "11", "Year": "2019"}, {"@PubStatus": "accepted", "Day": "6", "Month": "11", "Year": "2019"}, {"@PubStatus": "entrez", "Day": "14", "Hour": "6", "Minute": "0", "Month": "11", "Year": "2019"}, {"@PubStatus": "pubmed", "Day": "14", "Hour": "6", "Minute": "0", "Month": "11", "Year": "2019"}, {"@PubStatus": "medline", "Day": "14", "Hour": "6", "Minute": "0", "Month": "4", "Year": "2020"}]}, "PublicationStatus": "epublish", "ReferenceList": {"Reference": [{"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrg3683", "@IdType": "doi"}, {"#text": "24805120", "@IdType": "pubmed"}]}, "Citation": "Matzke M.A., Mosher R.A. RNA-directed DNA methylation: An epigenetic pathway of increasing complexity. Nat. Rev. Genet. 2014;15:394\u2013408. doi: 10.1038/nrg3683."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cell.2008.09.035", "@IdType": "doi"}, {"#text": "PMC2602798", "@IdType": "pmc"}, {"#text": "19013275", "@IdType": "pubmed"}]}, "Citation": "Wierzbicki A.T., Haag J.R., Pikaard C.S. Noncoding transcription by RNA polymerase pol IVb/Pol V mediates transcriptional silencing of overlapping and adjacent genes. Cell. 2008;135:635\u2013648. doi: 10.1016/j.cell.2008.09.035."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1101/gr.132159.111", "@IdType": "doi"}, {"#text": "PMC3431493", "@IdType": "pmc"}, {"#text": "22955988", "@IdType": "pubmed"}]}, "Citation": "Derrien T., Johnson R., Bussotti G., Tanzer A., Djebali S., Tilgner H., Guernec G., Martin D., Merkel A., Knowles D.G., et al. The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression. Genome Res. 2012;22:1775\u20131789. doi: 10.1101/gr.132159.111."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bbagrm.2015.06.009", "@IdType": "doi"}, {"#text": "26112461", "@IdType": "pubmed"}]}, "Citation": "Shafiq S., Li J., Sun Q. Functions of plants long non-coding RNAs. Biochim. Biophys. Acta Gene Regul. Mech. 2016;1859:155\u2013162. doi: 10.1016/j.bbagrm.2015.06.009."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cell.2018.01.011", "@IdType": "doi"}, {"#text": "PMC5978744", "@IdType": "pmc"}, {"#text": "29373828", "@IdType": "pubmed"}]}, "Citation": "Kopp F., Mendell J.T. Functional classification and experimental dissection of long noncoding RNAs. Cell. :2018. doi: 10.1016/j.cell.2018.01.011."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s10577-013-9392-6", "@IdType": "doi"}, {"#text": "PMC4049567", "@IdType": "pmc"}, {"#text": "24233054", "@IdType": "pubmed"}]}, "Citation": "Heo J.B., Lee Y.S., Sung S. Epigenetic regulation by long noncoding RNAs in plants. Chromosom. Res. 2013;338:1435\u20131439. doi: 10.1007/s10577-013-9392-6."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.tig.2014.06.001", "@IdType": "doi"}, {"#text": "PMC4115187", "@IdType": "pmc"}, {"#text": "24974018", "@IdType": "pubmed"}]}, "Citation": "Vance K.W., Ponting C.P. Transcriptional regulatory functions of nuclear long noncoding RNAs. Trends Genet. 2014;30:348\u2013355. doi: 10.1016/j.tig.2014.06.001."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.gpb.2016.12.005", "@IdType": "doi"}, {"#text": "PMC5487525", "@IdType": "pmc"}, {"#text": "28529100", "@IdType": "pubmed"}]}, "Citation": "Dykes I.M., Emanueli C. Transcriptional and post-transcriptional gene regulation by long non-coding RNA. Genom. Proteom. Bioinform. 2017;15:177\u2013186. doi: 10.1016/j.gpb.2016.12.005."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature08975", "@IdType": "doi"}, {"#text": "PMC3049919", "@IdType": "pmc"}, {"#text": "20393566", "@IdType": "pubmed"}]}, "Citation": "Gupta R.A., Shah N., Wang K.C., Kim J., Horlings H.M., Wong D.J., Tsai M.C., Hung T., Argani P., Rinn J.L., et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010;464:1071. doi: 10.1038/nature08975."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.molcel.2013.07.001", "@IdType": "doi"}, {"#text": "PMC3804161", "@IdType": "pmc"}, {"#text": "23870142", "@IdType": "pubmed"}]}, "Citation": "Ilik I.A., Quinn J.J., Georgiev P., Tavares-Cadete F., Maticzka D., Toscano S., Wan Y., Spitale R.C., Luscombe N., Backofen R., et al. Tandem stem-loops in roX RNAs act together to mediate X Chromosome dosage compensation in Drosophila. Mol. Cell. 2013;51:156\u2013173. doi: 10.1016/j.molcel.2013.07.001."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bbagrm.2015.05.006", "@IdType": "doi"}, {"#text": "26004516", "@IdType": "pubmed"}]}, "Citation": "Kanduri C. Long noncoding RNAs: Lessons from genomic imprinting. Biochim. Biophys. Acta Gene Regul. Mech. 2016;1859:102\u2013111. doi: 10.1016/j.bbagrm.2015.05.006."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.molcel.2010.08.011", "@IdType": "doi"}, {"#text": "PMC4158944", "@IdType": "pmc"}, {"#text": "20797886", "@IdType": "pubmed"}]}, "Citation": "Tripathi V., Ellis J.D., Shen Z., Song D.Y., Pan Q., Watt A.T., Freier S.M., Bennett C.F., Sharma A., Bubulya P.A., et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol. Cell. 2010;39:925\u2013938. doi: 10.1016/j.molcel.2010.08.011."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrg3606", "@IdType": "doi"}, {"#text": "24296535", "@IdType": "pubmed"}]}, "Citation": "Fatica A., Bozzoni I. Long non-coding RNAs: New players in cell differentiation and development. Nat. Rev. Genet. 2014;15:7\u201321. doi: 10.1038/nrg3606."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s00018-013-1423-0", "@IdType": "doi"}, {"#text": "PMC3830198", "@IdType": "pmc"}, {"#text": "23880895", "@IdType": "pubmed"}]}, "Citation": "Kitagawa M., Kitagawa K., Kotake Y., Niida H., Ohhata T. Cell cycle regulation by long non-coding RNAs. Cell. Mol. Life Sci. 2013;70:4785\u20134794. doi: 10.1007/s00018-013-1423-0."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bbagrm.2014.08.012", "@IdType": "doi"}, {"#text": "25159663", "@IdType": "pubmed"}]}, "Citation": "Yang G., Lu X., Yuan L. LncRNA: A link between RNA and cancer. Biochim. Biophys. Acta Gene Regul. Mech. 2014;1839:1097\u20131109. doi: 10.1016/j.bbagrm.2014.08.012."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1111/tpj.12869", "@IdType": "doi"}, {"#text": "PMC4691321", "@IdType": "pmc"}, {"#text": "25929799", "@IdType": "pubmed"}]}, "Citation": "Berry S., Dean C. Environmental perception and epigenetic memory: Mechanistic insight through FLC. Plant J. 2015;83:133\u2013148. doi: 10.1111/tpj.12869."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.1409457111", "@IdType": "doi"}, {"#text": "PMC4104870", "@IdType": "pmc"}, {"#text": "24982146", "@IdType": "pubmed"}]}, "Citation": "Wang Y., Fan X., Lin F., He G., Terzaghi W., Zhu D., Deng X.W. Arabidopsis noncoding RNA mediates control of photomorphogenesis by red light. Proc. Natl. Acad. Sci. USA. 2014;111:10359\u201310364. doi: 10.1073/pnas.1409457111."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s13059-014-0512-1", "@IdType": "doi"}, {"#text": "PMC4253996", "@IdType": "pmc"}, {"#text": "25517485", "@IdType": "pubmed"}]}, "Citation": "Zhang Y.C., Liao J.Y., Li Z.Y., Yu Y., Zhang J.P., Li Q.F., Qu L.H., Shu W.S., Chen Y.Q. Genome-wide screening and functional analysis identify a large number of long noncoding RNAs involved in the sexual reproduction of rice. Genome Biol. 2014;15:512. doi: 10.1186/s13059-014-0512-1."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41467-018-05829-7", "@IdType": "doi"}, {"#text": "PMC6115402", "@IdType": "pmc"}, {"#text": "30158538", "@IdType": "pubmed"}]}, "Citation": "Wang Y., Luo X., Sun F., Hu J., Zha X., Su W., Yang J. Overexpressing lncRNA LAIR increases grain yield and regulates neighbouring gene cluster expression in rice. Nat. Commun. 2018;9:1\u20139. doi: 10.1038/s41467-018-05829-7."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/S0959-437X(02)00287-3", "@IdType": "doi"}, {"#text": "11893494", "@IdType": "pubmed"}]}, "Citation": "Kouzarides T. Histone methylation in transcriptional control. Curr. Opin. Genet. Dev. 2002;12:198\u2013209. doi: 10.1016/S0959-437X(02)00287-3."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nbt.1685", "@IdType": "doi"}, {"#text": "20944598", "@IdType": "pubmed"}]}, "Citation": "Portela A., Esteller M. Epigenetic modifications and human disease. Nat. Biotechnol. 2010;28:1057\u20131068. doi: 10.1038/nbt.1685."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1126/science.1197349", "@IdType": "doi"}, {"#text": "21127216", "@IdType": "pubmed"}]}, "Citation": "Heo J.B., Sung S. Vernalization-mediated epigenetic silencing by a long intronic noncoding RNA. Science. 2011;331:76\u201379. doi: 10.1126/science.1197349."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.molcel.2016.10.039", "@IdType": "doi"}, {"#text": "PMC5137794", "@IdType": "pmc"}, {"#text": "27912097", "@IdType": "pubmed"}]}, "Citation": "Jain A.K., Xi Y., McCarthy R., Allton K., Akdemir K.C., Patel L.R., Aronow B., Lin C., Li W., Yang L., et al. LncPRESS1 Is a p53-Regulated LncRNA that Safeguards Pluripotency by Disrupting SIRT6-Mediated De-acetylation of Histone H3K56. Mol. Cell. 2016;64:967\u2013981. doi: 10.1016/j.molcel.2016.10.039."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/2159-8290.CD-15-0921", "@IdType": "doi"}, {"#text": "27147598", "@IdType": "pubmed"}]}, "Citation": "Sun T.-T., He J., Liang Q., Ren L.-L., Yan T.-T., Yu T.-C., Tang J.-Y., Bao Y.-J., Hu Y., Lin Y., et al. LncRNA GClnc1 Promotes gastric carcinogenesis and may act as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern. Cancer Discov. 2016;6:784\u2013801. doi: 10.1158/2159-8290.CD-15-0921."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.tig.2003.09.007", "@IdType": "doi"}, {"#text": "14585615", "@IdType": "pubmed"}]}, "Citation": "Sims R.J., Nishioka K., Reinberg D. Histone lysine methylation: A signature for chromatin function. Trends Genet. 2003;19:629\u2013639. doi: 10.1016/j.tig.2003.09.007."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cell.2006.04.003", "@IdType": "doi"}, {"#text": "16630806", "@IdType": "pubmed"}]}, "Citation": "Trojer P., Reinberg D. Histone lysine demethylases and their impact on epigenetics. Cell. 2006;125:213\u2013217. doi: 10.1016/j.cell.2006.04.003."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature09784", "@IdType": "doi"}, {"#text": "PMC3760771", "@IdType": "pmc"}, {"#text": "21248841", "@IdType": "pubmed"}]}, "Citation": "Margueron R., Reinberg D. The Polycomb complex PRC2 and its mark in life. Nature. 2011;469:343. doi: 10.1038/nature09784."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1371/journal.pgen.1001330", "@IdType": "doi"}, {"#text": "PMC3053346", "@IdType": "pmc"}, {"#text": "21423667", "@IdType": "pubmed"}]}, "Citation": "Jiang D., Kong N.C., Gu X., Li Z., He Y. Arabidopsis COMPASS-like complexes mediate histone H3 lysine-4 trimethylation to control floral transition and plant development. PLoS Genet. 2011;7:e1001330. doi: 10.1371/journal.pgen.1001330."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1371/journal.pgen.1006939", "@IdType": "doi"}, {"#text": "PMC5552341", "@IdType": "pmc"}, {"#text": "28759577", "@IdType": "pubmed"}]}, "Citation": "Kim D.H., Xi Y., Sung S. Modular function of long noncoding RNA, COLDAIR, in the vernalization response. PLoS Genet. 2017;13:e1006939. doi: 10.1371/journal.pgen.1006939."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41467-018-07500-7", "@IdType": "doi"}, {"#text": "PMC6265284", "@IdType": "pmc"}, {"#text": "30498193", "@IdType": "pubmed"}]}, "Citation": "Zhao X., Li J., Lian B., Gu H., Li Y., Qi Y. Global identification of Arabidopsis lncRNAs reveals the regulation of MAF4 by a natural antisense RNA. Nat. Commun. 2018;9:5056. doi: 10.1038/s41467-018-07500-7."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/ijc.32103", "@IdType": "doi"}, {"#text": "30613961", "@IdType": "pubmed"}]}, "Citation": "Hu J., Shan Y., Ma J., Pan Y., Zhou H., Jiang L., Jia L. LncRNA ST3Gal6-AS1/ST3Gal6 axis mediates colorectal cancer progression by regulating \u03b1-2,3 sialylation via PI3K/Akt signaling. Int. J. Cancer. 2019;145:450\u2013460. doi: 10.1002/ijc.32103."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12943-017-0588-9", "@IdType": "doi"}, {"#text": "PMC5314465", "@IdType": "pmc"}, {"#text": "28209170", "@IdType": "pubmed"}]}, "Citation": "Liu Y., Xia R., Lu K., Xie M., Yang F., Sun M., De W., Wang C., Ji G. LincRNAFEZF1-AS1 represses p21 expression to promote gastric cancer proliferation through LSD1-Mediated H3K4me2 demethylation. Mol. Cancer. 2017;16:39. doi: 10.1186/s12943-017-0588-9."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrendo.2015.181", "@IdType": "doi"}, {"#text": "26503676", "@IdType": "pubmed"}]}, "Citation": "Menzies K.J., Zhang H., Katsyuba E., Auwerx J. Protein acetylation in metabolism-metabolites and cofactors. Nat. Rev. Endocrinol. 2016;12:43. doi: 10.1038/nrendo.2015.181."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature06736", "@IdType": "doi"}, {"#text": "PMC2646112", "@IdType": "pmc"}, {"#text": "18337721", "@IdType": "pubmed"}]}, "Citation": "Michishita E., McCord R.A., Berber E., Kioi M., Padilla-Nash H., Damian M., Cheung P., Kusumoto R., Kawahara T.L.A., Barrett J.C., et al. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature. 2008;452:492. doi: 10.1038/nature06736."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrg2521", "@IdType": "doi"}, {"#text": "19188922", "@IdType": "pubmed"}]}, "Citation": "Mercer T.R., Dinger M.E., Mattick J.S. Long non-coding RNAs: Insights into functions. Nat. Rev. Genet. 2009;10:155\u2013159. doi: 10.1038/nrg2521."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1111/tpj.12563", "@IdType": "doi"}, {"#text": "PMC4321213", "@IdType": "pmc"}, {"#text": "24862207", "@IdType": "pubmed"}]}, "Citation": "B\u00f6hmdorfer G., Rowley M.J., Kuci\u0144ski J., Zhu Y., Amies I., Wierzbicki A.T. RNA-directed DNA methylation requires stepwise binding of silencing factors to long non-coding RNA. Plant. J. 2014;79:181\u2013191. doi: 10.1111/tpj.12563."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/emboj.2008.260", "@IdType": "doi"}, {"#text": "PMC2633084", "@IdType": "pmc"}, {"#text": "19078964", "@IdType": "pubmed"}]}, "Citation": "Daxinger L., Kanno T., Bucher E., van der Winden J., Naumann U., Matzke A.J.M., Matzke M. A stepwise pathway for biogenesis of 24-nt secondary siRNAs and spreading of DNA methylation. EMBO J. 2009;28:48\u201357. doi: 10.1038/emboj.2008.260."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1371/journal.pbio.0020104", "@IdType": "doi"}, {"#text": "PMC350667", "@IdType": "pmc"}, {"#text": "15024409", "@IdType": "pubmed"}]}, "Citation": "Xie Z., Johansen L.K., Gustafson A.M., Kasschau K.D., Lellis A.D., Zilberman D., Jacobsen S.E., Carrington J.C. Genetic and Functional Diversification of Small RNA Pathways in Plants. PLoS Biol. 2004;2:e104. doi: 10.1371/journal.pbio.0020104."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.pbi.2011.02.003", "@IdType": "doi"}, {"#text": "PMC3096526", "@IdType": "pmc"}, {"#text": "21420348", "@IdType": "pubmed"}]}, "Citation": "Zhang H., Zhu J.-K. RNA-directed DNA methylation. Curr. Opin. Plant. Biol. 2011;14:142\u2013147. doi: 10.1016/j.pbi.2011.02.003."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.pbi.2012.08.008", "@IdType": "doi"}, {"#text": "22960034", "@IdType": "pubmed"}]}, "Citation": "Wierzbicki A.T. The role of long non-coding RNA in transcriptional gene silencing. Curr. Opin. Plant. Biol. 2012;15:517\u2013522. doi: 10.1016/j.pbi.2012.08.008."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1101/gr.080275.108", "@IdType": "doi"}, {"#text": "PMC2612962", "@IdType": "pmc"}, {"#text": "18997003", "@IdType": "pubmed"}]}, "Citation": "Ben Amor B., Wirth S., Merchan F., Laporte P., d\u2019Aubenton-Carafa Y., Hirsch J., Maizel A., Mallory A., Lucas A., Deragon J.M., et al. Novel long non-protein coding RNAs involved in Arabidopsis differentiation and stress responses. Genome Res. 2009;19:57\u201369. doi: 10.1101/gr.080275.108."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.molcel.2014.06.011", "@IdType": "doi"}, {"#text": "25018019", "@IdType": "pubmed"}]}, "Citation": "Ariel F., Jegu T., Latrasse D., Romero-Barrios N., Christ A., Benhamed M., Crespi M. Noncoding transcription by alternative RNA polymerases dynamically regulates an auxin-driven chromatin loop. Mol. Cell. 2014;55:383\u2013396. doi: 10.1016/j.molcel.2014.06.011."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1101/gad.207001.112", "@IdType": "doi"}, {"#text": "PMC3589554", "@IdType": "pmc"}, {"#text": "23431054", "@IdType": "pubmed"}]}, "Citation": "Georgia S., Kanji M., Bhushan A. DNMT1 represses p53 to maintain progenitor cell survival during pancreatic organogenesis. Genes Dev. 2013;27:372. doi: 10.1101/gad.207001.112."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/jcp.27957", "@IdType": "doi"}, {"#text": "30536843", "@IdType": "pubmed"}]}, "Citation": "Song C., Xiong Y., Liao W., Meng L., Yang S. Long noncoding RNA ATB participates in the development of renal cell carcinoma by downregulating p53 via binding to DNMT1. J. Cell. Physiol. 2019;234:12910\u201312917. doi: 10.1002/jcp.27957."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/jcp.28703", "@IdType": "doi"}, {"#text": "31093972", "@IdType": "pubmed"}]}, "Citation": "Zhao X., Hu X. Downregulated long noncoding RNA LINC00313 inhibits the epithelial\u2013mesenchymal transition, invasion, and migration of thyroid cancer cells through inhibiting the methylation of ALX4. J. Cell. Physiol. 2019;234:20992\u201321004. doi: 10.1002/jcp.28703."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1101/gad.1416106", "@IdType": "doi"}, {"#text": "PMC1475760", "@IdType": "pmc"}, {"#text": "16705037", "@IdType": "pubmed"}]}, "Citation": "Feng J., Bi C., Clark B.S., Mady R., Shah P., Kohtz J.D. The Evf-2 noncoding RNA is transcribed from the Dlx-5/6 ultraconserved region and functions as a Dlx-2 transcriptional coactivator. Genes Dev. 2006;20:1470\u20131484. doi: 10.1101/gad.1416106."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4200285", "@IdType": "pmc"}, {"#text": "25187517", "@IdType": "pubmed"}]}, "Citation": "Zhuang W., Li B., Chen P., Qu J., Shi L., Zhuang W., Fu J., Li J., Zhang X., Sun Y. Activation of LTBP3 gene by a long noncoding RNA (IncRNA) MALAT1 transcript in mesenchymal stem cells from multiple myeloma. J. Biol. Chem. 2014;289:29365\u201329375."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1105/tpc.16.00886", "@IdType": "doi"}, {"#text": "PMC5466027", "@IdType": "pmc"}, {"#text": "28400491", "@IdType": "pubmed"}]}, "Citation": "Seo J.S., Sun H.-X., Park B.S., Huang C.-H., Yeh S.-D., Jung C., Chua N.-H. ELF18-induced long-noncoding RNA associates with mediator to enhance expression of innate immune response genes in arabidopsis. Plant. Cell. 2017;29:1024\u20131038. doi: 10.1105/tpc.16.00886."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1111/nph.15530", "@IdType": "doi"}, {"#text": "30307032", "@IdType": "pubmed"}]}, "Citation": "Seo J.S., Diloknawarit P., Park B.S., Chua N. ELF18-induced long noncoding RNA 1 evicts fibrillarin from mediator subunit to enhance pathogenesis-related gene 1 (PR1) expression. New Phytol. 2019;221:2067\u20132079. doi: 10.1111/nph.15530."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s13046-018-0827-y", "@IdType": "doi"}, {"#text": "PMC6069867", "@IdType": "pmc"}, {"#text": "30064475", "@IdType": "pubmed"}]}, "Citation": "Liu L., Yan X., Wu D., Yang Y., Li M., Su Y., Yang W., Shan Z., Gao Y., Jin Z. High expression of Ras-related protein 1A promotes an aggressive phenotype in colorectal cancer via PTEN/FOXO3/CCND1 pathway. J. Exp. Clin. Cancer Res. 2018;1:178. doi: 10.1186/s13046-018-0827-y."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41419-019-1741-8", "@IdType": "doi"}, {"#text": "PMC6594972", "@IdType": "pmc"}, {"#text": "31243265", "@IdType": "pubmed"}]}, "Citation": "Ai B., Kong X., Wang X., Zhang K., Yang X., Zhai J., Gao R., Qi Y., Wang J., Wang Z., et al. LINC01355 suppresses breast cancer growth through FOXO3-mediated transcriptional repression of CCND1. Cell Death Dis. 2019;10:502. doi: 10.1038/s41419-019-1741-8."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.plantsci.2010.06.019", "@IdType": "doi"}, {"#text": "21421341", "@IdType": "pubmed"}]}, "Citation": "Medina J., Catal\u00e1 R., Salinas J. The CBFs: Three arabidopsis transcription factors to cold acclimate. Plant. Sci. 2011;180:3\u201311. doi: 10.1016/j.plantsci.2010.06.019."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41467-018-07010-6", "@IdType": "doi"}, {"#text": "PMC6212407", "@IdType": "pmc"}, {"#text": "30385760", "@IdType": "pubmed"}]}, "Citation": "Kindgren P., Ard R., Ivanov M., Marquardt S. Transcriptional read-through of the long non-coding RNA SVALKA governs plant cold acclimation. Nat. Commun. 2018;9:4561. doi: 10.1038/s41467-018-07010-6."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrg2776", "@IdType": "doi"}, {"#text": "20376054", "@IdType": "pubmed"}]}, "Citation": "Keren H., Lev-Maor G., Ast G. Alternative splicing and evolution: Diversification, exon definition and function. Nat. Rev. Genet. 2010;11:345\u2013355. doi: 10.1038/nrg2776."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1261/rna.037044.112", "@IdType": "doi"}, {"#text": "PMC3527730", "@IdType": "pmc"}, {"#text": "23175589", "@IdType": "pubmed"}]}, "Citation": "Erkelenz S., Mueller W.F., Evans M.S., Busch A., Sch\u00f6neweis K., Hertel K.J., Schaal H. Position-dependent splicing activation and repression by SR and hnRNP proteins rely on common mechanisms. RNA. 2013;19:96\u2013102. doi: 10.1261/rna.037044.112."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ccr.2014.07.010", "@IdType": "doi"}, {"#text": "PMC4159621", "@IdType": "pmc"}, {"#text": "25203323", "@IdType": "pubmed"}]}, "Citation": "Wang Y., Chen D., Qian H., Tsai Y.S., Shao S., Liu Q., Dominguez D., Wang Z. The splicing factor RBM4 controls apoptosis, proliferation, and migration to suppress tumor progression. Cancer Cell. 2014;26:374\u2013389. doi: 10.1016/j.ccr.2014.07.010."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.devcel.2014.06.017", "@IdType": "doi"}, {"#text": "25073154", "@IdType": "pubmed"}]}, "Citation": "Bardou F., Ariel F., Simpson C.G., Romero-Barrios N., Laporte P., Balzergue S., Brown J.W.S., Crespi M. Long noncoding RNA modulates alternative splicing regulators in arabidopsis. Dev. Cell. 2014;30:166\u2013176. doi: 10.1016/j.devcel.2014.06.017."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/ncb3538", "@IdType": "doi"}, {"#text": "28553938", "@IdType": "pubmed"}]}, "Citation": "Yuan J.H., Liu X.N., Wang T.T., Pan W., Tao Q.F., Zhou W.P., Wang F., Sun S.H. The MBNL3 splicing factor promotes hepatocellular carcinoma by increasing PXN expression through the alternative splicing of lncRNA-PXN-AS1. Nat. Cell Biol. 2017;19:820\u2013832. doi: 10.1038/ncb3538."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1210/me.2007-0038", "@IdType": "doi"}, {"#text": "17622584", "@IdType": "pubmed"}]}, "Citation": "Akker S.A., Misra S., Aslam S., Morgan E.L., Smith P.J., Khoo B., Chew S.L. Pre-Spliceosomal Binding of U1 Small Nuclear Ribonucleoprotein (RNP) and Heterogenous Nuclear RNP E1 Is Associated with Suppression of a Growth Hormone Receptor Pseudoexon. Mol. Endocrinol. 2007;21:2529\u20132540. doi: 10.1210/me.2007-0038."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/ncb3595", "@IdType": "doi"}, {"#text": "PMC5578890", "@IdType": "pmc"}, {"#text": "28825698", "@IdType": "pubmed"}]}, "Citation": "Grelet S., Link L.A., Howley B., Obellianne C., Palanisamy V., Gangaraju V.K., Diehl J.A., Howe P.H. A regulated PNUTS mRNA to lncRNA splice switch mediates EMT and tumour progression. Nat. Cell Biol. 2017;19:1105\u20131115. doi: 10.1038/ncb3595."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/S0092-8674(04)00045-5", "@IdType": "doi"}, {"#text": "14744438", "@IdType": "pubmed"}]}, "Citation": "Bartel D.P. MicroRNAs: Genomics, Biogenesis, Mechanism, and Function. Cell. 2004;116:281\u2013297. doi: 10.1016/S0092-8674(04)00045-5."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrg.2016.20", "@IdType": "doi"}, {"#text": "27040487", "@IdType": "pubmed"}]}, "Citation": "Thomson D.W., Dinger M.E. Endogenous microRNA sponges: Evidence and controversy. Nat. Rev. Genet. 2016;17:272\u2013283. doi: 10.1038/nrg.2016.20."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/nar/gkt1248", "@IdType": "doi"}, {"#text": "PMC3964941", "@IdType": "pmc"}, {"#text": "24297251", "@IdType": "pubmed"}]}, "Citation": "Li J.-H., Liu S., Zhou H., Qu L.-H., Yang J.-H. starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein\u2013RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42:D92\u2013D97. doi: 10.1093/nar/gkt1248."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/database/bav098", "@IdType": "doi"}, {"#text": "PMC4589693", "@IdType": "pmc"}, {"#text": "26424084", "@IdType": "pubmed"}]}, "Citation": "Wang P., Zhi H., Zhang Y., Liu Y., Zhang J., Gao Y., Guo M., Ning S., Li X. miRSponge: A manually curated database for experimentally supported miRNA sponges and ceRNAs. Database J. Biol. Databases Curation. 2015;2015:bav098. doi: 10.1093/database/bav098."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1371/journal.pone.0167698", "@IdType": "doi"}, {"#text": "PMC5148581", "@IdType": "pmc"}, {"#text": "27936097", "@IdType": "pubmed"}]}, "Citation": "Karak\u00fclah G., Y\u00fccebilgili Kurto\u011flu K., Unver T. PeTMbase: A Database of Plant Endogenous Target Mimics (eTMs) PLoS ONE. 2016;11:e0167698. doi: 10.1371/journal.pone.0167698."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.molcel.2014.03.045", "@IdType": "doi"}, {"#text": "PMC4267251", "@IdType": "pmc"}, {"#text": "24793693", "@IdType": "pubmed"}]}, "Citation": "Denzler R., Agarwal V., Stefano J., Bartel D.P., Stoffel M. Assessing the ceRNA hypothesis with quantitative measurements of miRNA and target abundance. Mol. Cell. 2014;54:766\u2013776. doi: 10.1016/j.molcel.2014.03.045."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.molcel.2016.09.027", "@IdType": "doi"}, {"#text": "PMC5101187", "@IdType": "pmc"}, {"#text": "27871486", "@IdType": "pubmed"}]}, "Citation": "Denzler R., McGeary S.E., Title A.C., Agarwal V., Bartel D.P., Stoffel M. Impact of MicroRNA levels, target-site complementarity, and cooperativity on competing endogenous RNA-regulated gene expression. Mol. Cell. 2016;64:565\u2013579. doi: 10.1016/j.molcel.2016.09.027."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/ng2079", "@IdType": "doi"}, {"#text": "17643101", "@IdType": "pubmed"}]}, "Citation": "Franco-Zorrilla J.M., Valli A., Todesco M., Mateos I., Puga M.I., Rubio-Somoza I., Leyva A., Weigel D., Garc\u00eda J.A., Paz-Ares J. Target mimicry provides a new mechanism for regulation of microRNA activity. Nat. Genet. 2007;39:1033\u20131037. doi: 10.1038/ng2079."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1104/pp.18.00034", "@IdType": "doi"}, {"#text": "PMC6084674", "@IdType": "pmc"}, {"#text": "29967097", "@IdType": "pubmed"}]}, "Citation": "Du Q., Wang K., Zou C., Xu C., Li W.-X. The PILNCR1-miR399 regulatory module is important for low-phosphate tolerance in maize. Plant. Physiol. 2018;177:1743\u20131753. doi: 10.1104/pp.18.00034."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/jxb/erx384", "@IdType": "doi"}, {"#text": "PMC5854128", "@IdType": "pmc"}, {"#text": "29165588", "@IdType": "pubmed"}]}, "Citation": "Wang T., Zhao M., Zhang X., Liu M., Yang C., Chen Y., Chen R., Wen J., Mysore K.S., Zhang W.H. Novel phosphate deficiency-responsive long non-coding RNAs in the legume model plant Medicago truncatula. J. Exp. Bot. 2017;68:5937\u20135948. doi: 10.1093/jxb/erx384."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41438-018-0096-0", "@IdType": "doi"}, {"#text": "PMC6355781", "@IdType": "pmc"}, {"#text": "30729018", "@IdType": "pubmed"}]}, "Citation": "Jiang N., Cui J., Shi Y., Yang G., Zhou X., Hou X., Meng J., Luan Y. Tomato lncRNA23468 functions as a competing endogenous RNA to modulate NBS-LRR genes by decoying miR482b in the tomato-Phytophthora infestans interaction. Hortic. Res. 2019;6:28. doi: 10.1038/s41438-018-0096-0."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bbrc.2017.02.094", "@IdType": "doi"}, {"#text": "28232182", "@IdType": "pubmed"}]}, "Citation": "Cai C., Huo Q., Wang X., Chen B., Yang Q. SNHG16 contributes to breast cancer cell migration by competitively binding miR-98 with E2F5. Biochem. Biophys. Res. Commun. 2017;485:272\u2013278. doi: 10.1016/j.bbrc.2017.02.094."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.abb.2017.11.003", "@IdType": "doi"}, {"#text": "29126969", "@IdType": "pubmed"}]}, "Citation": "Zhu H., Zeng Y., Zhou C., Ye W. SNHG16/miR-216-5p/ZEB1 signal pathway contributes to the tumorigenesis of cervical cancer cells. Arch. Biochem. Biophys. 2018;637:1\u20138. doi: 10.1016/j.abb.2017.11.003."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.4149/neo_2018_180720N504", "@IdType": "doi"}, {"#text": "30784284", "@IdType": "pubmed"}]}, "Citation": "Li W., Xu W., Song J.S., Wu T., Wang W.X. LncRNA SNHG16 promotes cell proliferation through miR-302a-3p/FGF19 axis in hepatocellular carcinoma. Neoplasma. 2019;66:397\u2013404. doi: 10.4149/neo_2018_180720N504."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.yexcr.2019.111501", "@IdType": "doi"}, {"#text": "31306653", "@IdType": "pubmed"}]}, "Citation": "Xie X., Xu X., Sun C., Yu Z. Long intergenic noncoding RNA SNHG16 interacts with miR-195 to promote proliferation, invasion and tumorigenesis in hepatocellular carcinoma. Exp. Cell Res. 2019;383:111501. doi: 10.1016/j.yexcr.2019.111501."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2147/OTT.S186923", "@IdType": "doi"}, {"#text": "PMC6343509", "@IdType": "pmc"}, {"#text": "30705598", "@IdType": "pubmed"}]}, "Citation": "Wen Q., Zhao L., Wang T., Lv N., Cheng X., Zhang G., Bai L. LncRNA SNHG16 drives proliferation and invasion of papillary thyroid cancer through modulation of miR-497. Onco. Targets. 2019;12:699\u2013708. doi: 10.2147/OTT.S186923."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.biopha.2019.109153", "@IdType": "doi"}, {"#text": "31234025", "@IdType": "pubmed"}]}, "Citation": "Xu C., Hu C., Wang Y., Liu S. Long noncoding RNA SNHG16 promotes human retinoblastoma progression via sponging miR-140-5p. Biomed. Pharm. 2019;117:109153. doi: 10.1016/j.biopha.2019.109153."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/jcb.27257", "@IdType": "doi"}, {"#text": "30132983", "@IdType": "pubmed"}]}, "Citation": "Feng F., Chen A., Huang J., Xia Q., Chen Y., Jin X. Long noncoding RNA SNHG16 contributes to the development of bladder cancer via regulating miR-98/STAT3/Wnt/\u03b2-catenin pathway axis. J. Cell. Biochem. 2018;119:9408\u20139418. doi: 10.1002/jcb.27257."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.biopha.2019.108798", "@IdType": "doi"}, {"#text": "30909141", "@IdType": "pubmed"}]}, "Citation": "Wang X., Hu K., Chao Y., Wang L. LncRNA SNHG16 promotes proliferation, migration and invasion of osteosarcoma cells by targeting miR-1301/BCL9 axis. Biomed. Pharm. 2019;114:108798. doi: 10.1016/j.biopha.2019.108798."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.biopha.2019.108862", "@IdType": "doi"}, {"#text": "30981105", "@IdType": "pubmed"}]}, "Citation": "Liu S., Zhang W., Liu K., Liu Y. LncRNA SNHG16 promotes tumor growth of pancreatic cancer by targeting miR-218-5p. Biomed. Pharm. 2019;114:108862. doi: 10.1016/j.biopha.2019.108862."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.7150/jca.29527", "@IdType": "doi"}, {"#text": "PMC6400807", "@IdType": "pmc"}, {"#text": "30854107", "@IdType": "pubmed"}]}, "Citation": "Wang X., Kan J., Han J., Zhang W., Bai L., Wu H. LncRNA SNHG16 Functions as an Oncogene by Sponging MiR-135a and Promotes JAK2/STAT3 Signal Pathway in Gastric Cancer. J. Cancer. 2019;10:1013\u20131022. doi: 10.7150/jca.29527."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3389/fgene.2019.00042", "@IdType": "doi"}, {"#text": "PMC6378276", "@IdType": "pmc"}, {"#text": "30804984", "@IdType": "pubmed"}]}, "Citation": "Zhang M., Li F., Sun J., Li D., Li W., Jiang R., Li Z., Liu X., Han R., Li G., et al. LncRNA IMFNCR Promotes Intramuscular Adipocyte Differentiation by Sponging miR-128-3p and miR-27b-3p. Front. Genet. 2019;10:1\u201311. doi: 10.3389/fgene.2019.00042."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ejphar.2019.172407", "@IdType": "doi"}, {"#text": "31132353", "@IdType": "pubmed"}]}, "Citation": "Sun X., Huang T., Liu Z., Sun M., Luo S. LncRNA SNHG7 contributes to tumorigenesis and progression in breast cancer by interacting with miR-34a through EMT initiation and the Notch-1 pathway. Eur. J. Pharm. 2019;856:172407. doi: 10.1016/j.ejphar.2019.172407."}, {"ArticleIdList": {"ArticleId": {"#text": "31114993", "@IdType": "pubmed"}}, "Citation": "Li N., Zhang L., Qiao Y., Song R. Long noncoding RNA LINC00662 functions as miRNA sponge to promote the prostate cancer tumorigenesis through targeting miR-34a. Eur. Rev. Med. Pharm. Sci. 2019;23:3688\u20133698."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/jcb.28692", "@IdType": "doi"}, {"#text": "30983015", "@IdType": "pubmed"}]}, "Citation": "Zhu A., Sun Y., Ma Q., Xu F. lncRNA-ATB promotes viability, migration, and angiogenesis in human microvascular endothelial cells by sponging microRNA-195. J. Cell. Biochem. 2019;120:14360\u201314371. doi: 10.1002/jcb.28692."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.lfs.2019.03.040", "@IdType": "doi"}, {"#text": "30898647", "@IdType": "pubmed"}]}, "Citation": "Wang Q.-M., Lian G.-Y., Song Y., Huang Y.-F., Gong Y. LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195. Life Sci. 2019;231:116335. doi: 10.1016/j.lfs.2019.03.040."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1261/rna.351707", "@IdType": "doi"}, {"#text": "PMC1800509", "@IdType": "pmc"}, {"#text": "17237358", "@IdType": "pubmed"}]}, "Citation": "Cai X., Cullen B.R. The imprinted H19 noncoding RNA is a primary microRNA precursor. RNA. 2007;13:313\u2013316. doi: 10.1261/rna.351707."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/ncb2521", "@IdType": "doi"}, {"#text": "PMC3389517", "@IdType": "pmc"}, {"#text": "22684254", "@IdType": "pubmed"}]}, "Citation": "Keniry A., Oxley D., Monnier P., Kyba M., Dandolo L., Smits G., Reik W. The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r. Nat. Cell Biol. 2012;14:659\u2013665. doi: 10.1038/ncb2521."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nm.4424", "@IdType": "doi"}, {"#text": "PMC5961502", "@IdType": "pmc"}, {"#text": "29035371", "@IdType": "pubmed"}]}, "Citation": "Lu Y., Zhao X., Liu Q., Li C., Graves-Deal R., Cao Z., Singh B., Franklin J.L., Wang J., Hu H., et al. lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/\u03b2-catenin signaling. Nat. Med. 2017;23:1331\u20131341. doi: 10.1038/nm.4424."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1101/gr.089854.108", "@IdType": "doi"}, {"#text": "PMC2720183", "@IdType": "pmc"}, {"#text": "19584097", "@IdType": "pubmed"}]}, "Citation": "Johnson C., Kasprzewska A., Tennessen K., Fernandes J., Nan G.-L., Walbot V., Sundaresan V., Vance V., Bowman L.H. Clusters and superclusters of phased small RNAs in the developing inflorescence of rice. Genome Res. 2009;19:1429\u20131440. doi: 10.1101/gr.089854.108."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3389/fpls.2018.00669", "@IdType": "doi"}, {"#text": "PMC5987159", "@IdType": "pmc"}, {"#text": "29896205", "@IdType": "pubmed"}]}, "Citation": "Gai Y.-P., Yuan S.-S., Zhao Y.-N., Zhao H.-N., Zhang H.-L., Ji X.-L. A Novel LncRNA, MuLnc1, Associated With Environmental Stress in Mulberry (Morus multicaulis) Front. Plant. Sci. 2018;9:1\u201313. doi: 10.3389/fpls.2018.00669."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1111/tpj.13650", "@IdType": "doi"}, {"#text": "28749585", "@IdType": "pubmed"}]}, "Citation": "Liu Y., Ke L., Wu G., Xu Y., Wu X., Xia R., Deng X., Xu Q. miR3954 is a trigger of phasiRNAs that affects flowering time in citrus. Plant. J. 2017;92:263\u2013275. doi: 10.1111/tpj.13650."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature09701", "@IdType": "doi"}, {"#text": "PMC3073508", "@IdType": "pmc"}, {"#text": "21307942", "@IdType": "pubmed"}]}, "Citation": "Gong C., Maquat L.E. lncRNAs transactivate STAU1-mediated mRNA decay by duplexing with 3\u2032 UTRs via Alu elements. Nature. 2011;470:284\u2013288. doi: 10.1038/nature09701."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1101/gad.212639.112", "@IdType": "doi"}, {"#text": "PMC3639419", "@IdType": "pmc"}, {"#text": "23558772", "@IdType": "pubmed"}]}, "Citation": "Wang J., Gong C., Maquat L.E. Control of myogenesis by rodent SINE-containing lncRNAs. Genes Dev. 2013;27:793\u2013804. doi: 10.1101/gad.212639.112."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1530/JME-12-0008", "@IdType": "doi"}, {"#text": "PMC3738193", "@IdType": "pmc"}, {"#text": "22393162", "@IdType": "pubmed"}]}, "Citation": "Zhou Y., Zhang X., Klibanski A. MEG3 noncoding RNA: A tumor suppressor. J. Mol. Endocrinol. 2012;48:R45\u2013R53. doi: 10.1530/JME-12-0008."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1042/BST0360641", "@IdType": "doi"}, {"#text": "18631133", "@IdType": "pubmed"}]}, "Citation": "Sawicka K., Bushell M., Spriggs K.A., Willis A.E. Polypyrimidine-tract-binding protein: A multifunctional RNA-binding protein. Biochem. Soc. Trans. 2008;36:641\u2013647. doi: 10.1042/BST0360641."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/hep.28882", "@IdType": "doi"}, {"#text": "PMC5258819", "@IdType": "pmc"}, {"#text": "27770549", "@IdType": "pubmed"}]}, "Citation": "Zhang L., Yang Z., Trottier J., Barbier O., Wang L. Long noncoding RNA MEG3 induces cholestatic liver injury by interaction with PTBP1 to facilitate shp mRNA decay. Hepatology. 2017;65:604\u2013615. doi: 10.1002/hep.28882."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12943-017-0648-1", "@IdType": "doi"}, {"#text": "PMC5390360", "@IdType": "pmc"}, {"#text": "28407774", "@IdType": "pubmed"}]}, "Citation": "Zhao Y., Hu X., Liu Y., Dong S., Wen Z., He W., Zhang S., Huang Q., Shi M. ROS signaling under metabolic stress: Cross-talk between AMPK and AKT pathway. Mol. Cancer. 2017;16:79. doi: 10.1186/s12943-017-0648-1."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12943-018-0820-2", "@IdType": "doi"}, {"#text": "PMC5838949", "@IdType": "pmc"}, {"#text": "29510730", "@IdType": "pubmed"}]}, "Citation": "Zhao Y., Liu Y., Lin L., Huang Q., He W., Zhang S., Dong S., Wen Z., Rao J., Liao W., et al. The lncRNA MACC1-AS1 promotes gastric cancer cell metabolic plasticity via AMPK/Lin28 mediated mRNA stability of MACC1. Mol. Cancer. 2018;17:69. doi: 10.1186/s12943-018-0820-2."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/srep21865", "@IdType": "doi"}, {"#text": "PMC4763196", "@IdType": "pmc"}, {"#text": "26902620", "@IdType": "pubmed"}]}, "Citation": "Wang G., Wang Y., Xiong Y., Chen X.-C., Ma M., Cai R., Gao Y., Sun Y., Yang G.-S., Pang W.-J. Sirt1 AS lncRNA interacts with its mRNA to inhibit muscle formation by attenuating function of miR-34a. Sci. Rep. 2016;6:21865. doi: 10.1038/srep21865."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cell.2015.01.009", "@IdType": "doi"}, {"#text": "PMC4356254", "@IdType": "pmc"}, {"#text": "25640239", "@IdType": "pubmed"}]}, "Citation": "Anderson D.M., Anderson K.M., Chang C.-L., Makarewich C.A., Nelson B.R., McAnally J.R., Kasaragod P., Shelton J.M., Liou J., Bassel-Duby R., et al. A micropeptide encoded by a putative long noncoding RNA regulates muscle performance. Cell. 2015;160:595\u2013606. doi: 10.1016/j.cell.2015.01.009."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1126/science.1207056", "@IdType": "doi"}, {"#text": "PMC3211112", "@IdType": "pmc"}, {"#text": "22053050", "@IdType": "pubmed"}]}, "Citation": "Zoncu R., Bar-Peled L., Efeyan A., Wang S., Sancak Y., Sabatini D.M. mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H+-ATPase. Science. 2011;334:678\u2013683. doi: 10.1126/science.1207056."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature21034", "@IdType": "doi"}, {"#text": "28024296", "@IdType": "pubmed"}]}, "Citation": "Matsumoto A., Pasut A., Matsumoto M., Yamashita R., Fung J., Monteleone E., Saghatelian A., Nakayama K.I., Clohessy J.G., Pandolfi P.P. MTORC1 and muscle regeneration are regulated by the LINC00961-encoded SPAR polypeptide. Nature. 2017;541:228\u2013232. doi: 10.1038/nature21034."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1046/j.1365-313X.1993.03040573.x", "@IdType": "doi"}, {"#text": "8220464", "@IdType": "pubmed"}]}, "Citation": "Yang W.-C., Katinakis P., Hendriks P., Smolders A., de Vries F., Spee J., van Kammen A., Bisseling T., Franssen H. Characterization of GmENOD40, a gene showing novel patterns of cell-specific expression during soybean nodule development. Plant. J. 1993;3:573\u2013585. doi: 10.1046/j.1365-313X.1993.03040573.x."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.022664799", "@IdType": "doi"}, {"#text": "PMC122294", "@IdType": "pmc"}, {"#text": "11842184", "@IdType": "pubmed"}]}, "Citation": "Rohrig H., Schmidt J., Miklashevichs E., Schell J., John M. Soybean ENOD40 encodes two peptides that bind to sucrose synthase. Proc. Natl. Acad. Sci. USA. 2002;99:1915\u20131920. doi: 10.1073/pnas.022664799."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/j.1460-2075.1994.tb06839.x", "@IdType": "doi"}, {"#text": "PMC395456", "@IdType": "pmc"}, {"#text": "7957074", "@IdType": "pubmed"}]}, "Citation": "Crespi M.D., Jurkevitch E., Poiret M., D\u2019Aubenton-Carafa Y., Petrovics G., Kondorosi E., Kondorosi A. enod40, a gene expressed during nodule organogenesis, codes for a non-translatable RNA involved in plant growth. Embo J. 1994;13:5099\u20135112. doi: 10.1002/j.1460-2075.1994.tb06839.x."}, {"ArticleIdList": {"ArticleId": {"#text": "10.1023/A:1004687822174", "@IdType": "doi"}}, "Citation": "Compaan B., Yang W.C., Bisseling T., Franssen H. ENOD40 expression in the pericycle precedes cortical cell division in rhizobium-legume interaction and the highly conserved internal region of the gene does not encode a peptide. Proc. Plant Soil. 2001;230:1\u20138. doi: 10.1023/A:1004687822174."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1105/tpc.019406", "@IdType": "doi"}, {"#text": "PMC412876", "@IdType": "pmc"}, {"#text": "15037734", "@IdType": "pubmed"}]}, "Citation": "Campalans A. Enod40, a short open reading frame-containing mRNA, induces cytoplasmic localization of a nuclear RNA binding protein in medicago truncatula. Plant. Cell Online. 2004;16:1047\u20131059. doi: 10.1105/tpc.019406."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1261/rna.041178.113", "@IdType": "doi"}, {"#text": "PMC3884656", "@IdType": "pmc"}, {"#text": "24141618", "@IdType": "pubmed"}]}, "Citation": "Liu N., Parisien M., Dai Q., Zheng G., He C., Pan T. Probing N6-methyladenosine RNA modification status at single nucleotide resolution in mRNA and long noncoding RNA. RNA. 2013;19:1848\u20131856. doi: 10.1261/rna.041178.113."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1101/gad.262766.115", "@IdType": "doi"}, {"#text": "PMC4511210", "@IdType": "pmc"}, {"#text": "26159994", "@IdType": "pubmed"}]}, "Citation": "Yue Y., Liu J., He C. RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation. Genes Dev. 2015;29:1343\u20131355. doi: 10.1101/gad.262766.115."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ccell.2017.02.013", "@IdType": "doi"}, {"#text": "PMC5427719", "@IdType": "pmc"}, {"#text": "28344040", "@IdType": "pubmed"}]}, "Citation": "Zhang S., Zhao B.S., Zhou A., Lin K., Zheng S., Lu Z., Chen Y., Sulman E.P., Xie K., B\u00f6gler O., et al. The m6A demethylase ALKBH5 maintains tumorigenicity of glioblastoma stem-like cells by sustaining FOXM1 expression and Cell proliferation program. Cancer Cell. 2017;31:591. doi: 10.1016/j.ccell.2017.02.013."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cell.2010.06.040", "@IdType": "doi"}, {"#text": "PMC2956184", "@IdType": "pmc"}, {"#text": "20673990", "@IdType": "pubmed"}]}, "Citation": "Huarte M., Guttman M., Feldser D., Garber M., Koziol M.J., Kenzelmann-Broz D., Khalil A.M., Zuk O., Amit I., Rabani M., et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell. 2010;142:409\u2013419. doi: 10.1016/j.cell.2010.06.040."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.molcel.2012.06.027", "@IdType": "doi"}, {"#text": "PMC3509343", "@IdType": "pmc"}, {"#text": "22841487", "@IdType": "pubmed"}]}, "Citation": "Yoon J.-H., Abdelmohsen K., Srikantan S., Yang X., Martindale J.L., De S., Huarte M., Zhan M., Becker K.G., Gorospe M. LincRNA-p21 suppresses target mRNA translation. Mol. Cell. 2012;47:648\u2013655. doi: 10.1016/j.molcel.2012.06.027."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1371/journal.pone.0107016", "@IdType": "doi"}, {"#text": "PMC4157848", "@IdType": "pmc"}, {"#text": "25197831", "@IdType": "pubmed"}]}, "Citation": "Hu G., Lou Z., Gupta M. The long non-coding RNA GAS5 cooperates with the eukaryotic translation initiation factor 4E to regulate c-Myc translation. Plos ONE. 2014;9:e107016. doi: 10.1371/journal.pone.0107016."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.phytochem.2011.01.029", "@IdType": "doi"}, {"#text": "21353264", "@IdType": "pubmed"}]}, "Citation": "Bond A.E., Row P.E., Dudley E. Post-translation modification of proteins; methodologies and applications in plant sciences. Phytochemistry. 2011;72:975\u2013996. doi: 10.1016/j.phytochem.2011.01.029."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1126/science.1251456", "@IdType": "doi"}, {"#text": "24744378", "@IdType": "pubmed"}]}, "Citation": "Wang P., Xue Y., Han Y., Lin L., Wu C., Xu S., Jiang Z., Xu J., Liu Q., Cao X. The STAT3-binding long noncoding RNA lnc-DC controls human dendritic cell differentiation. Science. 2014;344:310\u2013313. doi: 10.1126/science.1251456."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s13059-016-0892-5", "@IdType": "doi"}, {"#text": "PMC4762163", "@IdType": "pmc"}, {"#text": "26898989", "@IdType": "pubmed"}]}, "Citation": "Guo H., Liu J., Ben Q., Qu Y., Li M., Wang Y., Chen W., Zhang J. The aspirin-induced long non-coding RNA OLA1P2 blocks phosphorylated STAT3 homodimer formation. Genome Biol. 2016;17:24. doi: 10.1186/s13059-016-0892-5."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/hep.29010", "@IdType": "doi"}, {"#text": "28027578", "@IdType": "pubmed"}]}, "Citation": "Li D., Liu X., Zhou J., Hu J., Zhang D., Liu J., Qiao Y., Zhan Q. Long noncoding RNA HULC modulates the phosphorylation of YB-1 through serving as a scaffold of extracellular signal\u2013regulated kinase and YB-1 to enhance hepatocarcinogenesis. Hepatology. 2017;65:1612\u20131627. doi: 10.1002/hep.29010."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/ncomms3939", "@IdType": "doi"}, {"#text": "PMC4556280", "@IdType": "pmc"}, {"#text": "24326307", "@IdType": "pubmed"}]}, "Citation": "Yoon J.-H., Abdelmohsen K., Kim J., Yang X., Martindale J.L., Tominaga-Yamanaka K., White E.J., Orjalo A.V., Rinn J.L., Kreft S.G., et al. Scaffold function of long non-coding RNA HOTAIR in protein ubiquitination. Nat. Commun. 2013;4:2939. doi: 10.1038/ncomms3939."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ccr.2014.05.001", "@IdType": "doi"}, {"#text": "PMC4126592", "@IdType": "pmc"}, {"#text": "25026211", "@IdType": "pubmed"}]}, "Citation": "Li W., Cooper J., Zhou L., Yang C., Erdjument-Bromage H., Zagzag D., Snuderl M., Ladanyi M., Hanemann C.O., Zhou P., et al. Merlin/NF2 loss-driven tumorigenesis linked to CRL4DCAF1-mediated inhibition of the hippo pathway kinases lats1 and 2 in the nucleus. Cancer Cell. 2014;26:48\u201360. doi: 10.1016/j.ccr.2014.05.001."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s13045-017-0449-4", "@IdType": "doi"}, {"#text": "PMC5395742", "@IdType": "pmc"}, {"#text": "28420424", "@IdType": "pubmed"}]}, "Citation": "Ni W., Zhang Y., Zhan Z., Ye F., Liang Y., Huang J., Chen K., Chen L., Ding Y. A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1. J. Hematol. Oncol. 2017;10:91. doi: 10.1186/s13045-017-0449-4."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41580-018-0081-3", "@IdType": "doi"}, {"#text": "30467427", "@IdType": "pubmed"}]}, "Citation": "Narita T., Weinert B.T., Choudhary C. Functions and mechanisms of non-histone protein acetylation. Nat. Rev. Mol. Cell Biol. 2019;20:156\u2013174. doi: 10.1038/s41580-018-0081-3."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature06500", "@IdType": "doi"}, {"#text": "18235501", "@IdType": "pubmed"}]}, "Citation": "Kim J.E., Chen J., Lou Z. DBC1 is a negative regulator of SIRT1. Nature. 2008;451:583. doi: 10.1038/nature06500."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature06515", "@IdType": "doi"}, {"#text": "PMC2866287", "@IdType": "pmc"}, {"#text": "18235502", "@IdType": "pubmed"}]}, "Citation": "Zhao W., Kruse J.P., Tang Y., Jung S.Y., Qin J., Gu W. Negative regulation of the deacetylase SIRT1 by DBC1. Nature. 2008;451:587. doi: 10.1038/nature06515."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/nar/gkx600", "@IdType": "doi"}, {"#text": "PMC5622371", "@IdType": "pmc"}, {"#text": "28973437", "@IdType": "pubmed"}]}, "Citation": "Chen R., Liu Y., Zhuang H., Yang B., Hei K., Xiao M., Hou C., Gao H., Zhang X., Jia C., et al. Quantitative proteomics reveals that long non-coding RNA MALAT1 interacts with DBC1 to regulate p53 acetylation. Nucleic Acids Res. 2017;45:9947\u20139959. doi: 10.1093/nar/gkx600."}]}}}}}, "PMC": "PMC6888083", "PMID": "31717266", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "Mechanisms and Functions of Long Non-Coding RNAs at Multiple Regulatory Levels.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "13": {"Abstract": " Long non-coding RNAs (lncRNAs) represent an important group of non-coding RNAs (ncRNAs) with more than 200 nucleotides in length that are transcribed from the so-called genomic \"dark matter.\" Mounting evidence has shown that lncRNAs have manifested a paramount function in the pathophysiology of human diseases, especially in the pathogenesis and progression of cancers. Despite the exponential growth in lncRNA publications, our understanding of regulatory mechanism of lncRNAs is still limited, and a lot of controversies remain in the current lncRNA knowledge.The purpose of this article is to explore the clinical significance and molecular mechanism of SNHG15 in tumors. We have systematically searched the Pubmed, Web of Science, Embase and Cochrane databases. We provide an overview of current evidence concerning the functional role, mechanistic models and clinical utilities of SNHG15 in human cancers in this review. Small nucleolar RNA host gene 15 (SNHG15), a novel lncRNA, is identified as a key regulator in tumorigenesis and progression of various human cancers, including colorectal cancer (CRC), gastric cancer (GC), pancreatic cancer (PC) and hepatocellular carcinoma (HCC). Dysregulation of SNHG15 has been revealed to be dramatically correlated with advanced clinicopathological factors and predicts poor prognosis, suggesting its potential clinical value as a promising biomarker and therapeutic target for cancer patients. LncRNA SNHG15 may serve as a prospective and novel biomarker for molecular diagnosis and therapeutics in patients with cancer.", "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "3383676006369712676", "Part1": "Department of Medical Oncology", "Part2": "Jiangsu Cancer Hospital", "Part3": "Jiangsu Institute of Cancer Research", "Part4": "The Affiliated Cancer Hospital of Nanjing Medical University", "Part5": "Nanjing", "Part6": "China.", "Text": "Department of Medical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China."}], "ForeName": "You", "FullName": "You Shuai", "HashID": "-6816869618972747811", "LastName": "Shuai", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "9157567758637119021", "Part1": "Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education)", "Part2": "Division of Gastrointestinal Cancer Translational Research Laboratory", "Part3": "Peking University Cancer Hospital and Institute", "Part4": "Beijing", "Part5": "China.", "Part6": null, "Text": "Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Division of Gastrointestinal Cancer Translational Research Laboratory, Peking University Cancer Hospital and Institute, Beijing, China."}, {"Has_Extra": false, "HashID": "-8490301421540662615", "Part1": "Department of Gastrointestinal Surgery", "Part2": "Peking University Cancer Hospital and Institute", "Part3": "Beijing", "Part4": "China.", "Part5": null, "Part6": null, "Text": "Department of Gastrointestinal Surgery, Peking University Cancer Hospital and Institute, Beijing, China."}], "ForeName": "Zhonghua", "FullName": "Zhonghua Ma", "HashID": "-7647539837032980221", "LastName": "Ma", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "3383676006369712676", "Part1": "Department of Medical Oncology", "Part2": "Jiangsu Cancer Hospital", "Part3": "Jiangsu Institute of Cancer Research", "Part4": "The Affiliated Cancer Hospital of Nanjing Medical University", "Part5": "Nanjing", "Part6": "China.", "Text": "Department of Medical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China."}], "ForeName": "Jianwei", "FullName": "Jianwei Lu", "HashID": "2425080484670189083", "LastName": "Lu", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "3383676006369712676", "Part1": "Department of Medical Oncology", "Part2": "Jiangsu Cancer Hospital", "Part3": "Jiangsu Institute of Cancer Research", "Part4": "The Affiliated Cancer Hospital of Nanjing Medical University", "Part5": "Nanjing", "Part6": "China.", "Text": "Department of Medical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China."}], "ForeName": "Jifeng", "FullName": "Jifeng Feng", "HashID": "3309769518890615231", "LastName": "Feng", "ORCID": "0000-0003-4574-3206"}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.1111/cpr.12716", "InsertType": null, "Journal": "Cell proliferation", "Keywords": [{"IS_Major": false, "IS_Mesh": true, "Text": "Biomarkers, Tumor"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Carcinogenesis"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Humans"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Neoplasms"}, {"IS_Major": false, "IS_Mesh": true, "Text": "RNA, Long Noncoding"}, {"IS_Major": false, "IS_Mesh": true, "Text": "RNA, Neoplasm"}, {"IS_Major": false, "IS_Mesh": false, "Text": "LncRNA"}, {"IS_Major": false, "IS_Mesh": false, "Text": "SNHG15"}, {"IS_Major": false, "IS_Mesh": false, "Text": "biomarker"}, {"IS_Major": false, "IS_Mesh": false, "Text": "cancer"}, {"IS_Major": false, "IS_Mesh": false, "Text": "molecular mechanism"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "MEDLINE", "Article": {"@PubModel": "Print-Electronic", "Abstract": {"AbstractText": [{"#text": "Long non-coding RNAs (lncRNAs) represent an important group of non-coding RNAs (ncRNAs) with more than 200 nucleotides in length that are transcribed from the so-called genomic \"dark matter.\" Mounting evidence has shown that lncRNAs have manifested a paramount function in the pathophysiology of human diseases, especially in the pathogenesis and progression of cancers. Despite the exponential growth in lncRNA publications, our understanding of regulatory mechanism of lncRNAs is still limited, and a lot of controversies remain in the current lncRNA knowledge.The purpose of this article is to explore the clinical significance and molecular mechanism of SNHG15 in tumors.", "@Label": "OBJECTIVES", "@NlmCategory": "OBJECTIVE"}, {"#text": "We have systematically searched the Pubmed, Web of Science, Embase and Cochrane databases. We provide an overview of current evidence concerning the functional role, mechanistic models and clinical utilities of SNHG15 in human cancers in this review.", "@Label": "MATERIALS & METHODS", "@NlmCategory": "METHODS"}, {"#text": "Small nucleolar RNA host gene 15 (SNHG15), a novel lncRNA, is identified as a key regulator in tumorigenesis and progression of various human cancers, including colorectal cancer (CRC), gastric cancer (GC), pancreatic cancer (PC) and hepatocellular carcinoma (HCC). Dysregulation of SNHG15 has been revealed to be dramatically correlated with advanced clinicopathological factors and predicts poor prognosis, suggesting its potential clinical value as a promising biomarker and therapeutic target for cancer patients.", "@Label": "RESULTS", "@NlmCategory": "RESULTS"}, {"#text": "LncRNA SNHG15 may serve as a prospective and novel biomarker for molecular diagnosis and therapeutics in patients with cancer.", "@Label": "CONCLUSIONS", "@NlmCategory": "CONCLUSIONS"}], "CopyrightInformation": "\u00a9 2019 The Authors. Cell Proliferation Published by John Wiley & Sons Ltd."}, "ArticleDate": {"@DateType": "Electronic", "Day": "27", "Month": "11", "Year": "2019"}, "ArticleTitle": "LncRNA SNHG15: A new budding star in human cancers.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Medical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China."}, "ForeName": "You", "Initials": "Y", "LastName": "Shuai"}, {"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Division of Gastrointestinal Cancer Translational Research Laboratory, Peking University Cancer Hospital and Institute, Beijing, China."}, {"Affiliation": "Department of Gastrointestinal Surgery, Peking University Cancer Hospital and Institute, Beijing, China."}], "ForeName": "Zhonghua", "Initials": "Z", "LastName": "Ma"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Medical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China."}, "ForeName": "Jianwei", "Initials": "J", "LastName": "Lu"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Medical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China."}, "ForeName": "Jifeng", "Identifier": {"#text": "0000-0003-4574-3206", "@Source": "ORCID"}, "Initials": "J", "LastName": "Feng"}]}, "ELocationID": [{"#text": "e12716", "@EIdType": "pii", "@ValidYN": "Y"}, {"#text": "10.1111/cpr.12716", "@EIdType": "doi", "@ValidYN": "Y"}], "Journal": {"ISOAbbreviation": "Cell Prolif", "ISSN": {"#text": "1365-2184", "@IssnType": "Electronic"}, "JournalIssue": {"@CitedMedium": "Internet", "Issue": "1", "PubDate": {"Month": "Jan", "Year": "2020"}, "Volume": "53"}, "Title": "Cell proliferation"}, "Language": "eng", "Pagination": {"MedlinePgn": "e12716", "StartPage": "e12716"}, "PublicationTypeList": {"PublicationType": [{"#text": "Journal Article", "@UI": "D016428"}, {"#text": "Systematic Review", "@UI": "D000078182"}]}}, "ChemicalList": {"Chemical": [{"NameOfSubstance": {"#text": "Biomarkers, Tumor", "@UI": "D014408"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "RNA, Long Noncoding", "@UI": "D062085"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "RNA, Neoplasm", "@UI": "D012334"}, "RegistryNumber": "0"}]}, "CitationSubset": "IM", "CoiStatement": "The authors declare that they have no competing interests.", "DateCompleted": {"Day": "25", "Month": "02", "Year": "2020"}, "DateRevised": {"Day": "10", "Month": "01", "Year": "2021"}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"#text": "LncRNA", "@MajorTopicYN": "N"}, {"#text": "SNHG15", "@MajorTopicYN": "N"}, {"#text": "biomarker", "@MajorTopicYN": "N"}, {"#text": "cancer", "@MajorTopicYN": "N"}, {"#text": "molecular mechanism", "@MajorTopicYN": "N"}]}, "MedlineJournalInfo": {"Country": "England", "ISSNLinking": "0960-7722", "MedlineTA": "Cell Prolif", "NlmUniqueID": "9105195"}, "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"#text": "Biomarkers, Tumor", "@MajorTopicYN": "N", "@UI": "D014408"}, "QualifierName": {"#text": "metabolism", "@MajorTopicYN": "Y", "@UI": "Q000378"}}, {"DescriptorName": {"#text": "Carcinogenesis", "@MajorTopicYN": "N", "@UI": "D063646"}, "QualifierName": {"#text": "metabolism", "@MajorTopicYN": "Y", "@UI": "Q000378"}}, {"DescriptorName": {"#text": "Humans", "@MajorTopicYN": "N", "@UI": "D006801"}}, {"DescriptorName": {"#text": "Neoplasms", "@MajorTopicYN": "N", "@UI": "D009369"}, "QualifierName": [{"#text": "diagnosis", "@MajorTopicYN": "N", "@UI": "Q000175"}, {"#text": "metabolism", "@MajorTopicYN": "Y", "@UI": "Q000378"}, {"#text": "therapy", "@MajorTopicYN": "N", "@UI": "Q000628"}]}, {"DescriptorName": {"#text": "RNA, Long Noncoding", "@MajorTopicYN": "N", "@UI": "D062085"}, "QualifierName": {"#text": "metabolism", "@MajorTopicYN": "Y", "@UI": "Q000378"}}, {"DescriptorName": {"#text": "RNA, Neoplasm", "@MajorTopicYN": "N", "@UI": "D012334"}, "QualifierName": {"#text": "metabolism", "@MajorTopicYN": "Y", "@UI": "Q000378"}}]}, "PMID": {"#text": "31774607", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "31774607", "@IdType": "pubmed"}, {"#text": "PMC6985667", "@IdType": "pmc"}, {"#text": "10.1111/cpr.12716", "@IdType": "doi"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "received", "Day": "10", "Month": "8", "Year": "2019"}, {"@PubStatus": "revised", "Day": "16", "Month": "9", "Year": "2019"}, {"@PubStatus": "accepted", "Day": "7", "Month": "10", "Year": "2019"}, {"@PubStatus": "pubmed", "Day": "28", "Hour": "6", "Minute": "0", "Month": "11", "Year": "2019"}, {"@PubStatus": "medline", "Day": "26", "Hour": "6", "Minute": "0", "Month": "2", "Year": "2020"}, {"@PubStatus": "entrez", "Day": "28", "Hour": "6", "Minute": "0", "Month": "11", "Year": "2019"}]}, "PublicationStatus": "ppublish", "ReferenceList": {"Reference": [{"ArticleIdList": {"ArticleId": [{"#text": "PMC4702836", "@IdType": "pmc"}, {"#text": "26527727", "@IdType": "pubmed"}]}, "Citation": "Sloan CA, Chan ET, Davidson JM, et al. ENCODE data at the ENCODE portal. Nucleic Acids Res. 2016;44(D1):D726\u2010D732."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3013645", "@IdType": "pmc"}, {"#text": "21037257", "@IdType": "pubmed"}]}, "Citation": "Raney BJ, Cline MS, Rosenbloom KR, et al. ENCODE whole\u2010genome data in the UCSC genome browser (2011 update). Nucleic Acids Res. 2011;39(suppl_1):D871\u2010D875."}, {"ArticleIdList": {"ArticleId": {"#text": "28701486", "@IdType": "pubmed"}}, "Citation": "Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: a new paradigm. Cancer Res. 2017;77(15):3965\u20103981."}, {"ArticleIdList": {"ArticleId": {"#text": "26631517", "@IdType": "pubmed"}}, "Citation": "Meller VH, Joshi SS, Deshpande N. Modulation of Chromatin by Noncoding RNA. Annu Rev Genet. 2015;49:673\u2010695."}, {"ArticleIdList": {"ArticleId": {"#text": "22104407", "@IdType": "pubmed"}}, "Citation": "Kim ED, Sung S. Long noncoding RNA: unveiling hidden layer of gene regulatory networks. Trends Plant Sci. 2012;17(1):16\u201021."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2754849", "@IdType": "pmc"}, {"#text": "19182780", "@IdType": "pubmed"}]}, "Citation": "Guttman M, Amit I, Garber M, et al. Chromatin signature reveals over a thousand highly conserved large non\u2010coding RNAs in mammals. Nature. 2009;458(7235):223\u2010227."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3234495", "@IdType": "pmc"}, {"#text": "22000014", "@IdType": "pubmed"}]}, "Citation": "Cesana M, Cacchiarelli D, Legnini I, et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell. 2011;147(2):358\u2010369."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6609402", "@IdType": "pmc"}, {"#text": "31272462", "@IdType": "pubmed"}]}, "Citation": "Wang CJ, Zhu CC, Xu J, et al. The lncRNA UCA1 promotes proliferation, migration, immune escape and inhibits apoptosis in gastric cancer by sponging anti\u2010tumor miRNAs. Mol Cancer. 2019;18(1):115."}, {"ArticleIdList": {"ArticleId": {"#text": "31220795", "@IdType": "pubmed"}}, "Citation": "Huang Y, Xu Y, Lu Y, et al. lncRNA Gm10451 regulates PTIP to facilitate iPSCs\u2010derived beta\u2010like cell differentiation by targeting miR\u2010338\u20103p as a ceRNA. Biomaterials. 2019;216:119266."}, {"ArticleIdList": {"ArticleId": {"#text": "27651312", "@IdType": "pubmed"}}, "Citation": "Sun M, Nie F, Wang Y, et al. LncRNA HOXA11\u2010AS Promotes Proliferation and Invasion of Gastric Cancer by Scaffolding the Chromatin Modification Factors PRC2, LSD1, and DNMT1. Cancer Res. 2016;76(21):6299\u20106310."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6599657", "@IdType": "pmc"}, {"#text": "31285770", "@IdType": "pubmed"}]}, "Citation": "Kang CL, Qi B, Cai QQ, et al. LncRNA AY promotes hepatocellular carcinoma metastasis by stimulating ITGAV transcription. Theranostics. 2019;9(15):4421\u20104436."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6609685", "@IdType": "pmc"}, {"#text": "31273190", "@IdType": "pubmed"}]}, "Citation": "Di W, Weinan X, Xin L, et al. Long noncoding RNA SNHG14 facilitates colorectal cancer metastasis through targeting EZH2\u2010regulated EPHA7. Cell Death Dis. 2019;10(7):514."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6402854", "@IdType": "pmc"}, {"#text": "30854423", "@IdType": "pubmed"}]}, "Citation": "Jin X, Xu XE, Jiang YZ, et al. The endogenous retrovirus\u2010derived long noncoding RNA TROJAN promotes triple\u2010negative breast cancer progression via ZMYND8 degradation. Science Advances. 2019;5(3):eaat9820."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6594972", "@IdType": "pmc"}, {"#text": "31243265", "@IdType": "pubmed"}]}, "Citation": "Ai B, Kong X, Wang X, et al. LINC01355 suppresses breast cancer growth through FOXO3\u2010mediated transcriptional repression of CCND1. Cell Death Dis. 2019;10(7):502."}, {"ArticleIdList": {"ArticleId": {"#text": "31183590", "@IdType": "pubmed"}}, "Citation": "Huang J, Chen YX, Zhang B. IGF2\u2010AS affects the prognosis and metastasis of gastric adenocarcinoma via acting as a ceRNA of miR\u2010503 to regulate SHOX2. Gastric Cancer. 2019. Epub ahead of print."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6525996", "@IdType": "pmc"}, {"#text": "31131047", "@IdType": "pubmed"}]}, "Citation": "Jiang L, Wang R, Fang L, et al. HCP5 is a SMAD3\u2010responsive long non\u2010coding RNA that promotes lung adenocarcinoma metastasis via miR\u2010203/SNAI axis. Theranostics. 2019;9(9):2460\u20102474."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5336186", "@IdType": "pmc"}, {"#text": "28114269", "@IdType": "pubmed"}]}, "Citation": "Li C, Wang S, Xing Z, et al. A ROR1\u2010HER3\u2010lncRNA signalling axis modulates the Hippo\u2010YAP pathway to regulate bone metastasis. Nat Cell Biol. 2017;19(2):106\u2010119."}, {"ArticleIdList": {"ArticleId": {"#text": "29750422", "@IdType": "pubmed"}}, "Citation": "Du Y, Kong C, Zhu Y, et al. Knockdown of SNHG15 suppresses renal cell carcinoma proliferation and EMT by regulating the NF\u2010kappaB signaling pathway. Int J Oncol. 2018;53(1):384\u2010394."}, {"ArticleIdList": {"ArticleId": {"#text": "31213086", "@IdType": "pubmed"}}, "Citation": "Sun X, Bai Y, Yang C, et al. Long noncoding RNA SNHG15 enhances the development of colorectal carcinoma via functioning as a ceRNA through miR\u2010141/SIRT1/Wnt/beta\u2010catenin axis. Artif Cells Nanomed Biotechnol. 2019;47(1):2536\u20102544."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4644376", "@IdType": "pmc"}, {"#text": "26417066", "@IdType": "pubmed"}]}, "Citation": "He C, Mao D, Hua G, et al. The Hippo/YAP pathway interacts with EGFR signaling and HPV oncoproteins to regulate cervical cancer progression. Embo Mol Med. 2015;7(11):1426\u20101449."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6628810", "@IdType": "pmc"}, {"#text": "31235588", "@IdType": "pubmed"}]}, "Citation": "Guan H, Zhu T, Wu S, et al. Long noncoding RNA LINC00673\u2010v4 promotes aggressiveness of lung adenocarcinoma via activating WNT/beta\u2010catenin signaling. Proc Natl Acad Sci U S A. 2019;116(28):14019\u201014028."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3057914", "@IdType": "pmc"}, {"#text": "21199792", "@IdType": "pubmed"}]}, "Citation": "Tsai MC, Spitale RC, Chang HY. Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res. 2011;71(1):3\u20107."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6265076", "@IdType": "pmc"}, {"#text": "30349115", "@IdType": "pubmed"}]}, "Citation": "Kim J, Piao HL, Kim BJ, et al. Long noncoding RNA MALAT1 suppresses breast cancer metastasis. Nat Genet. 2018;50(12):1705\u20101715."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5699172", "@IdType": "pmc"}, {"#text": "29162158", "@IdType": "pubmed"}]}, "Citation": "YiRen H, YingCong Y, Sunwu Y, et al. Long noncoding RNA MALAT1 regulates autophagy associated chemoresistance via miR\u201023b\u20103p sequestration in gastric cancer. Mol Cancer. 2017;16(1):174."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4134507", "@IdType": "pmc"}, {"#text": "25025966", "@IdType": "pubmed"}]}, "Citation": "Ji Q, Zhang L, Liu X, et al. Long non\u2010coding RNA MALAT1 promotes tumour growth and metastasis in colorectal cancer through binding to SFPQ and releasing oncogene PTBP2 from SFPQ/PTBP2 complex. Br J Cancer. 2014;111(4):736\u2010748."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4823926", "@IdType": "pmc"}, {"#text": "26938295", "@IdType": "pubmed"}]}, "Citation": "Han Y, Wu Z, Wu T, et al. Tumor\u2010suppressive function of long noncoding RNA MALAT1 in glioma cells by downregulation of MMP2 and inactivation of ERK/MAPK signaling. Cell Death Dis. 2016;7:e2123."}, {"ArticleIdList": {"ArticleId": {"#text": "28069878", "@IdType": "pubmed"}}, "Citation": "Li P, Zhang X, Wang H, et al. MALAT1 Is Associated with Poor Response to Oxaliplatin\u2010Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance through EZH2. Mol Cancer Ther. 2017;16(4):739\u2010751."}, {"ArticleIdList": {"ArticleId": {"#text": "27197265", "@IdType": "pubmed"}}, "Citation": "Latorre E, Carelli S, Raimondi I, et al. The ribonucleic complex HuR\u2010MALAT1 represses cd133 expression and suppresses epithelial\u2010mesenchymal transition in breast cancer. Cancer Res. 2016;76(9):2626\u20102636."}, {"ArticleIdList": {"ArticleId": {"#text": "30280769", "@IdType": "pubmed"}}, "Citation": "Guo XB, Yin HS, Wang JY. Evaluating the diagnostic and prognostic value of long non\u2010coding RNA SNHG15 in pancreatic ductal adenocarcinoma. Eur Rev Med Pharmacol Sci. 2018;22(18):5892\u20105898."}, {"ArticleIdList": {"ArticleId": {"#text": "30981837", "@IdType": "pubmed"}}, "Citation": "Zhang Y, Zhang D, Lv J, Wang S, Zhang Q. LncRNA SNHG15 acts as an oncogene in prostate cancer by regulating miR\u2010338\u20103p/FKBP1A axis. Gene. 2019;705:44\u201050."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5516387", "@IdType": "pmc"}, {"#text": "28720111", "@IdType": "pubmed"}]}, "Citation": "Liu K, Hou Y, Liu Y, Zheng J. LncRNA SNHG15 contributes to proliferation, invasion and autophagy in osteosarcoma cells by sponging miR\u2010141. J Biomed Sci. 2017;24(1):46."}, {"ArticleIdList": {"ArticleId": {"#text": "30623483", "@IdType": "pubmed"}}, "Citation": "Liu Y, Li J, Li F, et al. SNHG15 functions as a tumor suppressor in thyroid cancer. J Cell Biochem. 2019;120(4):6120\u20106126."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6148237", "@IdType": "pmc"}, {"#text": "30237435", "@IdType": "pubmed"}]}, "Citation": "Wu DM, Wang S, Wen X, et al. LncRNA SNHG15 acts as a ceRNA to regulate YAP1\u2010Hippo signaling pathway by sponging miR\u2010200a\u20103p in papillary thyroid carcinoma. Cell Death Dis. 2018;9(10):947."}, {"ArticleIdList": {"ArticleId": {"#text": "27212162", "@IdType": "pubmed"}}, "Citation": "Zhang JH, Wei HW, Yang HG. Long noncoding RNA SNHG15, a potential prognostic biomarker for hepatocellular carcinoma. Eur Rev Med Pharmacol Sci. 2016;20(9):1720\u20101724."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6304080", "@IdType": "pmc"}, {"#text": "30588034", "@IdType": "pubmed"}]}, "Citation": "Qu C, Dai C, Guo Y, Qin R, Liu J. Long noncoding RNA SNHG15 serves as an oncogene and predicts poor prognosis in epithelial ovarian cancer. Onco Targets Ther. 2019;12:101\u2010111."}, {"ArticleIdList": {"ArticleId": {"#text": "29771418", "@IdType": "pubmed"}}, "Citation": "Dong YZ, Meng XM, Li GS. Long non\u2010coding RNA SNHG15 indicates poor prognosis of non\u2010small cell lung cancer and promotes cell proliferation and invasion. Eur Rev Med Pharmacol Sci. 2018;22(9):2671\u20102679."}, {"ArticleIdList": {"ArticleId": {"#text": "22053740", "@IdType": "pubmed"}}, "Citation": "Alix\u2010Panabieres C, Schwarzenbach H, Pantel K. Circulating tumor cells and circulating tumor DNA. Annu Rev Med. 2012;63:199\u2010215."}, {"ArticleIdList": {"ArticleId": {"#text": "30260024", "@IdType": "pubmed"}}, "Citation": "Cai J, Huang L, Huang J, et al. Associations between the cyclooxygenase\u20102 expression in circulating tumor cells and the clinicopathological features of patients with colorectal cancer. J Cell Biochem. 2019;120(4):4935\u20104941."}, {"ArticleIdList": {"ArticleId": {"#text": "24036268", "@IdType": "pubmed"}}, "Citation": "Tani H, Torimura M. Identification of short\u2010lived long non\u2010coding RNAs as surrogate indicators for chemical stress response. Biochem Biophys Res Commun. 2013;439(4):547\u2010551."}, {"ArticleIdList": {"ArticleId": {"#text": "26662309", "@IdType": "pubmed"}}, "Citation": "Chen SX, Yin JF, Lin BC, et al. Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC. Tumour Biol. 2016;37(5):6801\u20106812."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5663584", "@IdType": "pmc"}, {"#text": "29137412", "@IdType": "pubmed"}]}, "Citation": "Ma Z, Huang H, Wang J, et al. Long non\u2010coding RNA SNHG15 inhibits P15 and KLF2 expression to promote pancreatic cancer proliferation through EZH2\u2010mediated H3K27me3. Oncotarget. 2017;8(48):84153\u201084167."}, {"ArticleIdList": {"ArticleId": {"#text": "30317592", "@IdType": "pubmed"}}, "Citation": "Huang L, Lin H, Kang L, et al. Aberrant expression of long noncoding RNA SNHG15 correlates with liver metastasis and poor survival in colorectal cancer. J Cell Physiol. 2019;234(5):7032\u20107039."}, {"ArticleIdList": {"ArticleId": {"#text": "30840276", "@IdType": "pubmed"}}, "Citation": "Ma XR, Xu YL, Qian J, Wang Y. Long non\u2010coding RNA SNHG15 accelerates the progression of non\u2010small cell lung cancer by absorbing miR\u2010211\u20103p. Eur Rev Med Pharmacol Sci. 2019;23(4):1536\u20101544."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6001572", "@IdType": "pmc"}, {"#text": "29630731", "@IdType": "pubmed"}]}, "Citation": "Jin B, Jin H, Wu HB, Xu JJ, Li B. Long non\u2010coding RNA SNHG15 promotes CDK14 expression via miR\u2010486 to accelerate non\u2010small cell lung cancer cells progression and metastasis. J Cell Physiol. 2018;233(9):7164\u20107172."}, {"ArticleIdList": {"ArticleId": {"#text": "25651787", "@IdType": "pubmed"}}, "Citation": "Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87\u2010108."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4744531", "@IdType": "pmc"}, {"#text": "26541320", "@IdType": "pubmed"}]}, "Citation": "Goldstein DA, Zeichner SB, Bartnik CM, Neustadter E, Flowers CR. Metastatic colorectal cancer: a systematic review of the value of current therapies. Clin Colorectal Cancer. 2016;15(1):1\u20106."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6774854", "@IdType": "pmc"}, {"#text": "31221662", "@IdType": "pubmed"}]}, "Citation": "Kawaguchi Y, Kopetz S, Newhook TE, et al. Mutation status of RAS, TP53, and SMAD4 is superior to mutation status of ras alone for predicting prognosis after resection of colorectal liver metastases. Clin Cancer Res. 2019;25(19):5843-5851."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6982526", "@IdType": "pmc"}, {"#text": "31209394", "@IdType": "pubmed"}]}, "Citation": "Hu Z, Ding J, Ma Z, et al. Quantitative evidence for early metastatic seeding in colorectal cancer. Nat Genet. 2019;51(7):1113\u20101122."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6480895", "@IdType": "pmc"}, {"#text": "31014355", "@IdType": "pubmed"}]}, "Citation": "Saeinasab M, Bahrami AR, Gonzalez J, et al. SNHG15 is a bifunctional MYC\u2010regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF. J Exp Clin Cancer Res. 2019;38(1):172."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6536931", "@IdType": "pmc"}, {"#text": "30945457", "@IdType": "pubmed"}]}, "Citation": "Li M, Bian Z, Jin G, et al. LncRNA\u2010SNHG15 enhances cell proliferation in colorectal cancer by inhibiting miR\u2010338\u20103p. Cancer Med. 2019;8(5):2404\u20102413."}, {"ArticleIdList": {"ArticleId": {"#text": "29604394", "@IdType": "pubmed"}}, "Citation": "Jiang H, Li T, Qu Y, et al. Long non\u2010coding RNA SNHG15 interacts with and stabilizes transcription factor Slug and promotes colon cancer progression. Cancer Lett. 2018;425:78\u201087."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6786377", "@IdType": "pmc"}, {"#text": "31235819", "@IdType": "pubmed"}]}, "Citation": "Wang WD, Shang Y, Li Y, Chen SZ. Honokiol inhibits breast cancer cell metastasis by blocking EMT through modulation of Snail/Slug protein translation. Acta Pharmacol Sin. 2019;40(9):1219\u20101227."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6533465", "@IdType": "pmc"}, {"#text": "31020809", "@IdType": "pubmed"}]}, "Citation": "Chen D, Cao G, Liu Q. A\u2010kinase\u2010interacting protein 1 facilitates growth and metastasis of gastric cancer cells via Slug\u2010induced epithelial\u2010mesenchymal transition. J Cell Mol Med. 2019;23(6):4434\u20104442."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2361350", "@IdType": "pmc"}, {"#text": "16773075", "@IdType": "pubmed"}]}, "Citation": "Shioiri M, Shida T, Koda K, et al. Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients. Br J Cancer. 2006;94(12):1816\u20101822."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5957013", "@IdType": "pmc"}, {"#text": "29774079", "@IdType": "pubmed"}]}, "Citation": "Li GY, Wang W, Sun JY, et al. Long non\u2010coding RNAs AC026904.1 and UCA1: a \"one\u2010two punch\" for TGF\u2010beta\u2010induced SNAI2 activation and epithelial\u2010mesenchymal transition in breast cancer. Theranostics. 2018;8(10):2846\u20102861."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5387161", "@IdType": "pmc"}, {"#text": "27878953", "@IdType": "pubmed"}]}, "Citation": "Yu Y, Li L, Zheng Z, et al. Long non\u2010coding RNA linc00261 suppresses gastric cancer progression via promoting Slug degradation. J Cell Mol Med. 2017;21(5):955\u2010967."}, {"ArticleIdList": {"ArticleId": {"#text": "31291576", "@IdType": "pubmed"}}, "Citation": "Gross KM, Zhou W, Breindel JL, et al. Loss of slug compromises DNA damage repair and accelerates stem cell aging in mammary epithelium. Cell Rep. 2019;28(2):394\u2010407.e6."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4867661", "@IdType": "pmc"}, {"#text": "27165481", "@IdType": "pubmed"}]}, "Citation": "Chen D, Sun Q, Cheng X, et al. Genome\u2010wide analysis of long noncoding RNA (lncRNA) expression in colorectal cancer tissues from patients with liver metastasis. Cancer Med. 2016;5(7):1629\u20101639."}, {"ArticleIdList": {"ArticleId": {"#text": "30613961", "@IdType": "pubmed"}}, "Citation": "Hu J, Shan Y, Ma J, et al. LncRNA ST3Gal6\u2010AS1/ST3Gal6 axis mediates colorectal cancer progression by regulating alpha\u20102,3 sialylation via PI3K/Akt signaling. Int J Cancer. 2019;145(2):450\u2010460."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6006356", "@IdType": "pmc"}, {"#text": "29915311", "@IdType": "pubmed"}]}, "Citation": "Shan Y, Ma J, Pan Y, et al. LncRNA SNHG7 sponges miR\u2010216b to promote proliferation and liver metastasis of colorectal cancer through upregulating GALNT1. Cell Death Dis. 2018;9(7):722."}, {"ArticleIdList": {"ArticleId": {"#text": "30207593", "@IdType": "pubmed"}}, "Citation": "Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2010424."}, {"ArticleIdList": {"ArticleId": {"#text": "25444905", "@IdType": "pubmed"}}, "Citation": "Fang XY, Pan HF, Leng RX, Ye DQ. Long noncoding RNAs: Novel insights into gastric cancer. Cancer Lett. 2015;356(2):357\u2010366."}, {"ArticleIdList": {"ArticleId": {"#text": "26260039", "@IdType": "pubmed"}}, "Citation": "Thrumurthy SG, Chaudry MA, Chau I, Allum W. Does surgery have a role in managing incurable gastric cancer? Nat Rev Clin Oncol. 2015;12(11):676\u2010682."}, {"ArticleIdList": {"ArticleId": {"#text": "27317852", "@IdType": "pubmed"}}, "Citation": "Reddy KM, Chang JI, Shi JM, Wu BU. Risk of gastric cancer among patients with intestinal metaplasia of the stomach in a US integrated health care system. Clin Gastroenterol Hepatol. 2016;14(10):1420\u20101425."}, {"ArticleIdList": {"ArticleId": {"#text": "26742998", "@IdType": "pubmed"}}, "Citation": "Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7\u201030."}, {"ArticleIdList": {"ArticleId": {"#text": "29957372", "@IdType": "pubmed"}}, "Citation": "Sabater L, Munoz E, Rosello S, et al. Borderline resectable pancreatic cancer. Challenges and controversies. Cancer Treat Rev. 2018;68:124\u2010135."}, {"ArticleIdList": {"ArticleId": {"#text": "24840647", "@IdType": "pubmed"}}, "Citation": "Rahib L, Smith BD, Aizenberg R, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913\u20102921."}, {"ArticleIdList": {"ArticleId": {"#text": "28254409", "@IdType": "pubmed"}}, "Citation": "Xiong G, Feng M, Yang G, et al. The underlying mechanisms of non\u2010coding RNAs in the chemoresistance of pancreatic cancer. Cancer Lett. 2017;397:94\u2010102."}, {"ArticleIdList": {"ArticleId": {"#text": "26830752", "@IdType": "pubmed"}}, "Citation": "Kamisawa T, Wood LD, Itoi T, Takaori K. Pancreatic cancer. Lancet. 2016;388(10039):73\u201085."}, {"ArticleIdList": {"ArticleId": {"#text": "29550809", "@IdType": "pubmed"}}, "Citation": "Basuroy R, Bouvier C, Ramage JK, et al. Presenting symptoms and delay in diagnosis of gastrointestinal and pancreatic neuroendocrine tumours. Neuroendocrinology. 2018;107(1):42\u201049."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4334572", "@IdType": "pmc"}, {"#text": "25557080", "@IdType": "pubmed"}]}, "Citation": "Boj SF, Hwang CI, Baker LA, et al. Organoid models of human and mouse ductal pancreatic cancer. Cell. 2015;160(1\u20132):324\u2010338."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5491694", "@IdType": "pmc"}, {"#text": "28620797", "@IdType": "pubmed"}]}, "Citation": "Omata M, Cheng AL, Kokudo N, et al. Asia\u2010Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int. 2017;11(4):317\u2010370."}, {"ArticleIdList": {"ArticleId": {"#text": "25646890", "@IdType": "pubmed"}}, "Citation": "Vigano L, Conci S, Cescon M, et al. Liver resection for hepatocellular carcinoma in patients with metabolic syndrome: A multicenter matched analysis with HCV\u2010related HCC. J Hepatol. 2015;63(1):93\u2010101."}, {"ArticleIdList": {"ArticleId": {"#text": "31310393", "@IdType": "pubmed"}}, "Citation": "Ye J, Tan L, Fu Y, et al. LncRNA SNHG15 promotes hepatocellular carcinoma progression by sponging miR\u2010141\u20103p. J Cell Biochem. 2019;120(12):19775\u201019783."}, {"ArticleIdList": {"ArticleId": {"#text": "30600321", "@IdType": "pubmed"}}, "Citation": "Brainard J, Farver C. The diagnosis of non\u2010small cell lung cancer in the molecular era. Mod Pathol. 2019;32(S1):16\u201026."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4539082", "@IdType": "pmc"}, {"#text": "26309397", "@IdType": "pubmed"}]}, "Citation": "Herbertz S, Sawyer JS, Stauber AJ, et al. Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor\u2010beta signaling pathway. Drug Des Devel Ther. 2015;9:4479\u20104499."}, {"ArticleIdList": {"ArticleId": {"#text": "21783417", "@IdType": "pubmed"}}, "Citation": "Zhou C, Wu YL, Chen G, et al. Erlotinib versus chemotherapy as first\u2010line treatment for patients with advanced EGFR mutation\u2010positive non\u2010small\u2010cell lung cancer (OPTIMAL, CTONG\u20100802): a multicentre, open\u2010label, randomised, phase 3 study. Lancet Oncol. 2011;12(8):735\u2010742."}, {"ArticleIdList": {"ArticleId": {"#text": "30402848", "@IdType": "pubmed"}}, "Citation": "Cui HX, Zhang MY, Liu K, et al. LncRNA SNHG15 promotes proliferation and migration of lung cancer via targeting microRNA\u2010211\u20103p. Eur Rev Med Pharmacol Sci. 2018;22(20):6838\u20106844."}, {"ArticleIdList": {"ArticleId": {"#text": "23358352", "@IdType": "pubmed"}}, "Citation": "Ito Y, Nikiforov YE, Schlumberger M, Vigneri R. Increasing incidence of thyroid cancer: controversies explored. Nat Rev Endocrinol. 2013;9(3):178\u2010184."}, {"ArticleIdList": {"ArticleId": {"#text": "25310641", "@IdType": "pubmed"}}, "Citation": "Vigneri R, Malandrino P, Vigneri P. The changing epidemiology of thyroid cancer: why is incidence increasing? Curr Opin Oncol. 2015;27(1):1\u20107."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4329176", "@IdType": "pmc"}, {"#text": "25717220", "@IdType": "pubmed"}]}, "Citation": "Chen W, Zheng R, Zeng H, Zhang S, He J. Annual report on status of cancer in China, 2011. Chin J Cancer Res. 2015;27(1):2\u201012."}, {"ArticleIdList": {"ArticleId": {"#text": "29146581", "@IdType": "pubmed"}}, "Citation": "Murugan AK, Munirajan AK, Alzahrani AS. Long noncoding RNAs: emerging players in thyroid cancer pathogenesis. Endocr Relat Cancer. 2018;25(2):R59\u2010R82."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5512163", "@IdType": "pmc"}, {"#text": "27626519", "@IdType": "pubmed"}]}, "Citation": "Fagin JA, Wells SJ. Biologic and clinical perspectives on thyroid cancer. N Engl J Med. 2016;375(11):1054\u20101067."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5255605", "@IdType": "pmc"}, {"#text": "28049826", "@IdType": "pubmed"}]}, "Citation": "Wang Y, He H, Li W, et al. MYH9 binds to lncRNA gene PTCSC2 and regulates FOXE1 in the 9q22 thyroid cancer risk locus. Proc Natl Acad Sci U S A. 2017;114(3):474\u2010479."}, {"ArticleIdList": {"ArticleId": {"#text": "27758138", "@IdType": "pubmed"}}, "Citation": "Wang Q, Yang H, Wu L, et al. Identification of specific long non\u2010coding RNA expression: profile and analysis of association with clinicopathologic characteristics and BRAF mutation in papillary thyroid cancer. Thyroid. 2016;26(12):1719\u20101732."}, {"ArticleIdList": {"ArticleId": {"#text": "30790329", "@IdType": "pubmed"}}, "Citation": "Liu Y, Li J, Li M, et al. microRNA\u2010510\u20105p promotes thyroid cancer cell proliferation, migration, and invasion through suppressing SNHG15. J Cell Biochem. 2019;120(7):11738\u201011744."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4191828", "@IdType": "pmc"}, {"#text": "24818853", "@IdType": "pubmed"}]}, "Citation": "Salinas CA, Tsodikov A, Ishak\u2010Howard M, Cooney KA. Prostate cancer in young men: an important clinical entity. Nat Rev Urol. 2014;11(6):317\u2010323."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5885905", "@IdType": "pmc"}, {"#text": "29509864", "@IdType": "pubmed"}]}, "Citation": "Martin RM, Donovan JL, Turner EL, et al. Effect of a low\u2010intensity PSA\u2010based screening intervention on prostate cancer mortality: The CAP randomized clinical trial. JAMA. 2018;319(9):883\u2010895."}, {"ArticleIdList": {"ArticleId": {"#text": "28694142", "@IdType": "pubmed"}}, "Citation": "Logozzi M, Angelini DF, Iessi E, et al. Increased PSA expression on prostate cancer exosomes in in vitro condition and in cancer patients. Cancer Lett. 2017;403:318\u2010329."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4979196", "@IdType": "pmc"}, {"#text": "26304877", "@IdType": "pubmed"}]}, "Citation": "Isakoff MS, Bielack SS, Meltzer P, Gorlick R. Osteosarcoma: current treatment and a collaborative pathway to success. J Clin Oncol. 2015;33(27):3029\u20103035."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5862135", "@IdType": "pmc"}, {"#text": "29499942", "@IdType": "pubmed"}]}, "Citation": "Lu Y, Lu D, Hu Y. GLP2 promotes directed differentiation from osteosarcoma cells to osteoblasts and inhibits growth of osteosarcoma cells. Mol Ther Nucleic Acids. 2018;10:292\u2010303."}, {"ArticleIdList": {"ArticleId": {"#text": "20213383", "@IdType": "pubmed"}}, "Citation": "Ottaviani G, Jaffe N. The epidemiology of osteosarcoma. Cancer Treat Res. 2009;152:3\u201013."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5788494", "@IdType": "pmc"}, {"#text": "28837411", "@IdType": "pubmed"}]}, "Citation": "Dodson M, Wani WY, Redmann M, et al. Regulation of autophagy, mitochondrial dynamics, and cellular bioenergetics by 4\u2010hydroxynonenal in primary neurons. Autophagy. 2017;13(11):1828\u20101840."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4590631", "@IdType": "pmc"}, {"#text": "26090585", "@IdType": "pubmed"}]}, "Citation": "Alirezaei M, Flynn CT, Wood MR, Harkins S, Whitton JL. Coxsackievirus can exploit LC3 in both autophagy\u2010dependent and \u2010independent manners in vivo. Autophagy. 2015;11(8):1389\u20101407."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5388218", "@IdType": "pmc"}, {"#text": "28121484", "@IdType": "pubmed"}]}, "Citation": "Feng L, Zhang J, Zhu N, et al. Ubiquitin ligase SYVN1/HRD1 facilitates degradation of the SERPINA1 Z variant/alpha\u20101\u2010antitrypsin Z variant via SQSTM1/p62\u2010dependent selective autophagy. Autophagy. 2017;13(4):686\u2010702."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6098011", "@IdType": "pmc"}, {"#text": "30120248", "@IdType": "pubmed"}]}, "Citation": "Kwon DH, Park OH, Kim L, et al. Insights into degradation mechanism of N\u2010end rule substrates by p62/SQSTM1 autophagy adapter. Nat Commun. 2018;9(1):3291."}, {"ArticleIdList": {"ArticleId": {"#text": "21041768", "@IdType": "pubmed"}}, "Citation": "Taylor LP. Diagnosis, treatment, and prognosis of glioma: five new things. Neurology. 2010;75(18 Suppl 1):S28\u201032."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4201071", "@IdType": "pmc"}, {"#text": "24891448", "@IdType": "pubmed"}]}, "Citation": "Jarry M, Lecointre C, Malleval C, et al. Impact of meriolins, a new class of cyclin\u2010dependent kinase inhibitors, on malignant glioma proliferation and neo\u2010angiogenesis. Neuro Oncol. 2014;16(11):1484\u20101498."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6217061", "@IdType": "pmc"}, {"#text": "30429891", "@IdType": "pubmed"}]}, "Citation": "Tan Z, Chen K, Wu W, et al. Overexpression of HOXC10 promotes angiogenesis in human glioma via interaction with PRMT5 and upregulation of VEGFA expression. Theranostics. 2018;8(18):5143\u20105158."}, {"ArticleIdList": {"ArticleId": {"#text": "30091464", "@IdType": "pubmed"}}, "Citation": "Seliger C, Luber C, Gerken M, et al. Use of metformin and survival of patients with high\u2010grade glioma. Int J Cancer. 2019;144(2):273\u2010280."}, {"ArticleIdList": {"ArticleId": {"#text": "29175980", "@IdType": "pubmed"}}, "Citation": "Papp L, Potsch N, Grahovac M, et al. Glioma survival prediction with combined analysis of in vivo (11)C\u2010MET PET features, ex vivo features, and patient features by supervised machine learning. J Nucl Med. 2018;59(6):892\u2010899."}, {"ArticleIdList": {"ArticleId": {"#text": "27706852", "@IdType": "pubmed"}}, "Citation": "Su SC, Hsieh MJ, Yang WE, et al. Cancer metastasis: Mechanisms of inhibition by melatonin. J Pineal Res. 2017;62(1):e12370."}, {"ArticleIdList": {"ArticleId": {"#text": "21481637", "@IdType": "pubmed"}}, "Citation": "Saharinen P, Eklund L, Pulkki K, Bono P, Alitalo K. VEGF and angiopoietin signaling in tumor angiogenesis and metastasis. Trends Mol Med. 2011;17(7):347\u2010362."}, {"ArticleIdList": {"ArticleId": {"#text": "27995658", "@IdType": "pubmed"}}, "Citation": "Gi T, Sato Y, Tokumitsu T, et al. Microvascular proliferation of brain metastases mimics glioblastomas in squash cytology. Cytopathology. 2017;28(3):228\u2010234."}, {"ArticleIdList": {"ArticleId": {"#text": "8625246", "@IdType": "pubmed"}}, "Citation": "Leon SP, Folkerth RD, Black PM. Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer\u2010Am Cancer Soc. 1996;77(2):362\u2010372."}, {"ArticleIdList": {"ArticleId": {"#text": "29048682", "@IdType": "pubmed"}}, "Citation": "Ma Y, Xue Y, Liu X, et al. SNHG15 affects the growth of glioma microvascular endothelial cells by negatively regulating miR\u2010153. Oncol Rep. 2017;38(5):3265\u20103277."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5858164", "@IdType": "pmc"}, {"#text": "29556338", "@IdType": "pubmed"}]}, "Citation": "Pi J, Liu J, Zhuang T, et al. Elevated expression of miR302\u2010367 in endothelial cells inhibits developmental angiogenesis via CDC42/CCND1 mediated signaling pathways. Theranostics. 2018;8(6):1511\u20101526."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5642684", "@IdType": "pmc"}, {"#text": "28973878", "@IdType": "pubmed"}]}, "Citation": "Sakabe M, Fan J, Odaka Y, et al. YAP/TAZ\u2010CDC42 signaling regulates vascular tip cell migration. Proc Natl Acad Sci U S A. 2017;114(41):10918\u201010923."}, {"ArticleIdList": {"ArticleId": {"#text": "27253694", "@IdType": "pubmed"}}, "Citation": "Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66(4):271\u2010289."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6714301", "@IdType": "pmc"}, {"#text": "31462285", "@IdType": "pubmed"}]}, "Citation": "Li Z, Zhang J, Zheng H, et al. Modulating lncRNA SNHG15/CDK6/miR\u2010627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2\u2010polarization of glioma associated microglia in glioblastoma multiforme. J Exp Clin Cancer Res. 2019;38(1):380."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4154213", "@IdType": "pmc"}, {"#text": "24818537", "@IdType": "pubmed"}]}, "Citation": "Rudel RA, Ackerman JM, Attfield KR, Brody JG. New exposure biomarkers as tools for breast cancer epidemiology, biomonitoring, and prevention: a systematic approach based on animal evidence. Environ Health Perspect. 2014;122(9):881\u2010895."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5070302", "@IdType": "pmc"}, {"#text": "27843622", "@IdType": "pubmed"}]}, "Citation": "Kumler I, Knoop AS, Jessing CA, Ejlertsen B, Nielsen DL. Review of hormone\u2010based treatments in postmenopausal patients with advanced breast cancer focusing on aromatase inhibitors and fulvestrant. ESMO Open. 2016;1(4):e000062."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4794996", "@IdType": "pmc"}, {"#text": "26977878", "@IdType": "pubmed"}]}, "Citation": "Goel S, Wang Q, Watt AC, et al. Overcoming therapeutic resistance in HER2\u2010positive breast cancers with CDK4/6 inhibitors. Cancer Cell. 2016;29(3):255\u2010269."}, {"ArticleIdList": {"ArticleId": {"#text": "29217194", "@IdType": "pubmed"}}, "Citation": "Kong Q, Qiu M. Long noncoding RNA SNHG15 promotes human breast cancer proliferation, migration and invasion by sponging miR\u2010211\u20103p. Biochem Biophys Res Commun. 2018;495(2):1594\u20101600."}, {"ArticleIdList": {"ArticleId": {"#text": "25616710", "@IdType": "pubmed"}}, "Citation": "Ljungberg B, Bensalah K, Canfield S, et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol. 2015;67(5):913\u2010924."}, {"ArticleIdList": {"ArticleId": {"#text": "27649770", "@IdType": "pubmed"}}, "Citation": "Ellinger J, Gevensleben H, Muller SC, Dietrich D. The emerging role of non\u2010coding circulating RNA as a biomarker in renal cell carcinoma. Expert Rev Mol Diagn. 2016;16(10):1059\u20101065."}, {"ArticleIdList": {"ArticleId": {"#text": "28410865", "@IdType": "pubmed"}}, "Citation": "Escudier B, Motzer RJ, Sharma P, et al. Treatment beyond progression in patients with advanced renal cell carcinoma treated with Nivolumab in CheckMate 025. Eur Urol. 2017;72(3):368\u2010376."}, {"ArticleIdList": {"ArticleId": {"#text": "23335087", "@IdType": "pubmed"}}, "Citation": "Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11\u201030."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3576854", "@IdType": "pmc"}, {"#text": "21521830", "@IdType": "pubmed"}]}, "Citation": "Jelovac D, Armstrong DK. Recent progress in the diagnosis and treatment of ovarian cancer. CA Cancer J Clin. 2011;61(3):183\u2010203."}, {"ArticleIdList": {"ArticleId": {"#text": "12569573", "@IdType": "pubmed"}}, "Citation": "Ng A, Tang JP, Goh CH, Hui KM. Regulation of the H19 imprinting gene expression in human nasopharyngeal carcinoma by methylation. Int J Cancer. 2003;104(2):179\u2010187."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4244030", "@IdType": "pmc"}, {"#text": "25422887", "@IdType": "pubmed"}]}, "Citation": "Gong Z, Zhang S, Zeng Z, et al. LOC401317, a p53\u2010regulated long non\u2010coding RNA, inhibits cell proliferation and induces apoptosis in the nasopharyngeal carcinoma cell line HNE2. PLoS ONE. 2014;9(11):e110674."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4427524", "@IdType": "pmc"}, {"#text": "25818646", "@IdType": "pubmed"}]}, "Citation": "Thomas LR, Wang Q, Grieb BC, et al. Interaction with WDR5 promotes target gene recognition and tumorigenesis by MYC. Mol Cell. 2015;58(3):440\u2010452."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6091663", "@IdType": "pmc"}, {"#text": "29570994", "@IdType": "pubmed"}]}, "Citation": "Bartel DP. Metazoan MicroRNAs. Cell. 2018;173(1):20\u201051."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3235919", "@IdType": "pmc"}, {"#text": "21802130", "@IdType": "pubmed"}]}, "Citation": "Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language? Cell. 2011;146(3):353\u2010358."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3616710", "@IdType": "pmc"}, {"#text": "23376929", "@IdType": "pubmed"}]}, "Citation": "Chan WL, Yuo CY, Yang WK, et al. Transcribed pseudogene psiPPM1K generates endogenous siRNA to suppress oncogenic cell growth in hepatocellular carcinoma. Nucleic Acids Res. 2013;41(6):3734\u20103747."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4021402", "@IdType": "pmc"}, {"#text": "24775712", "@IdType": "pubmed"}]}, "Citation": "Liu XH, Sun M, Nie FQ, et al. Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR\u2010331\u20103p in gastric cancer. Mol Cancer. 2014;13:92."}, {"ArticleIdList": {"ArticleId": {"#text": "24014594", "@IdType": "pubmed"}}, "Citation": "Hansen TB, Kjems J, Damgaard CK. Circular RNA and miR\u20107 in cancer. Cancer Res. 2013;73(18):5609\u20105612."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3214599", "@IdType": "pmc"}, {"#text": "22000015", "@IdType": "pubmed"}]}, "Citation": "Sumazin P, Yang X, Chiu HS, et al. An extensive microRNA\u2010mediated network of RNA\u2010RNA interactions regulates established oncogenic pathways in glioblastoma. Cell. 2011;147(2):370\u2010381."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4052263", "@IdType": "pmc"}, {"#text": "24853754", "@IdType": "pubmed"}]}, "Citation": "Nitzan M, Steiman\u2010Shimony A, Altuvia Y, Biham O, Margalit H. Interactions between distant ceRNAs in regulatory networks. Biophys J. 2014;106(10):2254\u20102266."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3801300", "@IdType": "pmc"}, {"#text": "24072616", "@IdType": "pubmed"}]}, "Citation": "Karreth FA, Pandolfi PP. ceRNA Cross\u2010Talk in Cancer: When ce\u2010bling Rivalries Go Awry. Cancer Discov. 2013;3(10):1113\u20101121."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5561086", "@IdType": "pmc"}, {"#text": "28819095", "@IdType": "pubmed"}]}, "Citation": "Song YX, Sun JX, Zhao JH, et al. Non\u2010coding RNAs participate in the regulatory network of CLDN4 via ceRNA mediated miRNA evasion. Nat Commun. 2017;8(1):289."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4026005", "@IdType": "pmc"}, {"#text": "24374312", "@IdType": "pubmed"}]}, "Citation": "Kaneko S, Bonasio R, Saldana\u2010Meyer R, et al. Interactions between JARID2 and noncoding RNAs regulate PRC2 recruitment to chromatin. Mol Cell. 2014;53(2):290\u2010300."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4824075", "@IdType": "pmc"}, {"#text": "26615201", "@IdType": "pubmed"}]}, "Citation": "Liu GY, Zhao GN, Chen XF, et al. The long noncoding RNA Gm15055 represses Hoxa gene expression by recruiting PRC2 to the gene cluster. Nucleic Acids Res. 2016;44(6):2613\u20102627."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6260658", "@IdType": "pmc"}, {"#text": "30470227", "@IdType": "pubmed"}]}, "Citation": "Peng Z, Wang J, Shan B, et al. The long noncoding RNA LINC00312 induces lung adenocarcinoma migration and vasculogenic mimicry through directly binding YBX1. Mol Cancer. 2018;17(1):167."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6452890", "@IdType": "pmc"}, {"#text": "30951652", "@IdType": "pubmed"}]}, "Citation": "Laugesen A, Hojfeldt JW, Helin K. Molecular Mechanisms Directing PRC2 Recruitment and H3K27 Methylation. Mol Cell. 2019;74(1):8\u201018."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5542640", "@IdType": "pmc"}, {"#text": "28487115", "@IdType": "pubmed"}]}, "Citation": "Gu P, Chen X, Xie R, et al. lncRNA HOXD\u2010AS1 Regulates Proliferation and Chemo\u2010Resistance of Castration\u2010Resistant Prostate Cancer via Recruiting WDR5. Mol Ther. 2017;25(8):1959\u20101973."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4918227", "@IdType": "pmc"}, {"#text": "26845405", "@IdType": "pubmed"}]}, "Citation": "Kim KH, Roberts CW. Targeting EZH2 in cancer. Nat Med. 2016;22(2):128\u2010134."}, {"ArticleIdList": {"ArticleId": {"#text": "27179746", "@IdType": "pubmed"}}, "Citation": "Italiano A. Role of the EZH2 histone methyltransferase as a therapeutic target in cancer. Pharmacol Ther. 2016;165:26\u201031."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6393474", "@IdType": "pmc"}, {"#text": "30814490", "@IdType": "pubmed"}]}, "Citation": "Hui B, Ji H, Xu Y, et al. RREB1\u2010induced upregulation of the lncRNA AGAP2\u2010AS1 regulates the proliferation and migration of pancreatic cancer partly through suppressing ANKRD1 and ANGPTL4. Cell Death Dis. 2019;10(3):207."}, {"ArticleIdList": {"ArticleId": {"#text": "29247823", "@IdType": "pubmed"}}, "Citation": "Yoon JH, You BH, Park CH, et al. The long noncoding RNA LUCAT1 promotes tumorigenesis by controlling ubiquitination and stability of DNA methyltransferase 1 in esophageal squamous cell carcinoma. Cancer Lett. 2018;417:47\u201057."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4776244", "@IdType": "pmc"}, {"#text": "26935028", "@IdType": "pubmed"}]}, "Citation": "Yan C, Chen J, Chen N. Long noncoding RNA MALAT1 promotes hepatic steatosis and insulin resistance by increasing nuclear SREBP\u20101c protein stability. Sci Rep. 2016;6:22640."}, {"ArticleIdList": {"ArticleId": {"#text": "23536580", "@IdType": "pubmed"}}, "Citation": "Chen PC, Cheng HC, Tang CH. CCN3 promotes prostate cancer bone metastasis by modulating the tumor\u2010bone microenvironment through RANKL\u2010dependent pathway. Carcinogenesis. 2013;34(7):1669\u20101679."}, {"ArticleIdList": {"ArticleId": {"#text": "25305448", "@IdType": "pubmed"}}, "Citation": "Xu W, Wang Z, Zhang W, et al. Mutated K\u2010ras activates CDK8 to stimulate the epithelial\u2010to\u2010mesenchymal transition in pancreatic cancer in part via the Wnt/beta\u2010catenin signaling pathway. Cancer Lett. 2015;356(2 Pt B):613\u2010627."}, {"ArticleIdList": {"ArticleId": {"#text": "27012187", "@IdType": "pubmed"}}, "Citation": "Zhang Z, Zhou C, Chang Y, et al. Long non\u2010coding RNA CASC11 interacts with hnRNP\u2010K and activates the WNT/beta\u2010catenin pathway to promote growth and metastasis in colorectal cancer. Cancer Lett. 2016;376(1):62\u201073."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5742819", "@IdType": "pmc"}, {"#text": "29258163", "@IdType": "pubmed"}]}, "Citation": "Vu T, Datta PK. Regulation of EMT in colorectal cancer: a culprit in metastasis. Cancers. 2017;9(12):171."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5504657", "@IdType": "pmc"}, {"#text": "28693582", "@IdType": "pubmed"}]}, "Citation": "Ren D, Yang Q, Dai Y, et al. Oncogenic miR\u2010210\u20103p promotes prostate cancer cell EMT and bone metastasis via NF\u2010kappaB signaling pathway. Mol Cancer. 2017;16(1):117."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2662269", "@IdType": "pmc"}, {"#text": "18832382", "@IdType": "pubmed"}]}, "Citation": "Thuault S, Tan EJ, Peinado H, et al. HMGA2 and Smads co\u2010regulate SNAIL1 expression during induction of epithelial\u2010to\u2010mesenchymal transition. J Biol Chem. 2008;283(48):33437\u201033446."}, {"ArticleIdList": {"ArticleId": {"#text": "30737231", "@IdType": "pubmed"}}, "Citation": "Fukuda K, Takeuchi S, Arai S, et al. Epithelial\u2010to\u2010mesenchymal transition is a mechanism of alk inhibitor resistance in lung cancer independent of ALK mutation status. Cancer Res. 2019;79(7):1658\u20101670."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2359811", "@IdType": "pmc"}, {"#text": "18427106", "@IdType": "pubmed"}]}, "Citation": "Sahlgren C, Gustafsson MV, Jin S, Poellinger L, Lendahl U. Notch signaling mediates hypoxia\u2010induced tumor cell migration and invasion. Proc Natl Acad Sci U S A. 2008;105(17):6392\u20106397."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4197875", "@IdType": "pmc"}, {"#text": "24825474", "@IdType": "pubmed"}]}, "Citation": "Mo JS, Park HW, Guan KL. The Hippo signaling pathway in stem cell biology and cancer. Embo Rep. 2014;15(6):642\u2010656."}, {"ArticleIdList": {"ArticleId": {"#text": "31101763", "@IdType": "pubmed"}}, "Citation": "Lan T, Yuan K, Yan X, et al. LncRNA SNHG10 facilitates hepatocarcinogenesis and metastasis by modulating its homolog SCARNA13 via a positive feedback loop. Cancer Res. 2019;79(13):3220-3234."}, {"ArticleIdList": {"ArticleId": {"#text": "30042416", "@IdType": "pubmed"}}, "Citation": "Huang X, Xie X, Liu P, et al. Adam12 and lnc015192 act as ceRNAs in breast cancer by regulating miR\u201034a. Oncogene. 2018;37(49):6316\u20106326."}]}}}}}, "PMC": "PMC6985667", "PMID": "31774607", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "LncRNA SNHG15: A new budding star in human cancers.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "14": {"Abstract": " Although the prognostic value of lncRNA small nucleolar RNA host gene 15 (SNHG15) expression in cancers has been evaluated in many studies, the results remain controversial. This meta-analysis aimed to clarify the role of SNHG15 in the prognosis of different cancer patients. Eligible studies were selected from PubMed, PMC, EMBASE, Web of Science, and Cochrane Library according to the inclusion and exclusion criteria (up to December 20, 2019). The primary outcome was overall survival (OS) and recurrence-free survival (RFS). The secondary outcome was other clinicopathological parameters (including advanced TNM stage, lymph node metastasis, distant metastases, and gender). The Cancer Genome Atlas (TCGA) dataset was used to verify the analysis results. Eleven eligible studies were eventually included, involving 9 different types of cancer and 1,079 patients. The high expression of SNHG15 was indicative of a significantly poor OS of cancer patients (HR\u2009=\u20091.96, 95% CI\u2009=\u20091.55-2.47,  < 0.00001). Subgroup analysis showed that the high expression of SNHG15 was associated with a significantly poor OS of patients with digestive cancer (HR\u2009=\u20091.91, 95% CI\u2009=\u20091.38-2.66, =0.0001), but not lung cancer (HR\u2009=\u20091.83, 95% CI\u2009=\u20090.89-3.76, =0.010). The RFS of patients with high expression of SNHG15 was shorter than that of patients with low expression of SNHG15 (HR\u2009=\u20092.03, 95% CI\u2009=\u20091.46-2.83,  < 0.00001). In addition, high SNHG15 expression level was significantly correlated with later TNM stage (OR\u2009=\u20093.05, 95% CI\u2009=\u20092.31-4.02,  < 0.00001), lymphatic metastasis (OR\u2009=\u20093.20, 95% CI\u2009=\u20092.30-4.45,  < 0.00001), and distant metastasis (OR\u2009=\u20095.05, 95% CI\u2009=\u20092.15-11.85, =0.0002). The TCGA verification results were consistent with those observed in our meta-analysis. High expression of the long noncoding RNA SNHG15 in cancer tissue samples predicts an unfavorable prognosis for cancer patients. LncRNA SNHG15 can be used as an adverse prognostic biomarker for cancer patients.", "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "-3864713261926356229", "Part1": "Department of Hepatobiliary Surgery", "Part2": "The Second Affiliated Hospital of Kunming Medical University", "Part3": "Kunming 650101", "Part4": "China.", "Part5": null, "Part6": null, "Text": "Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Kunming Medical University, Kunming 650101, China."}, {"Has_Extra": false, "HashID": "2350220237693753726", "Part1": "Department of Hepatobiliary Surgery", "Part2": "The Sixth People's Hospital of Chengdu", "Part3": "Chengdu 610041", "Part4": "China.", "Part5": null, "Part6": null, "Text": "Department of Hepatobiliary Surgery, The Sixth People's Hospital of Chengdu, Chengdu 610041, China."}], "ForeName": "Cheng", "FullName": "Cheng Zhang", "HashID": "9171265740783638769", "LastName": "Zhang", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-3864713261926356229", "Part1": "Department of Hepatobiliary Surgery", "Part2": "The Second Affiliated Hospital of Kunming Medical University", "Part3": "Kunming 650101", "Part4": "China.", "Part5": null, "Part6": null, "Text": "Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Kunming Medical University, Kunming 650101, China."}], "ForeName": "Yang", "FullName": "Yang Ke", "HashID": "1282834453577503318", "LastName": "Ke", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-2694592000516946981", "Part1": "Department of Dermatology", "Part2": "The Second Affiliated Hospital of Chengdu Medical College", "Part3": "Chengdu 610051", "Part4": "China.", "Part5": null, "Part6": null, "Text": "Department of Dermatology, The Second Affiliated Hospital of Chengdu Medical College, Chengdu 610051, China."}], "ForeName": "Xin", "FullName": "Xin Liu", "HashID": "5215587628761660052", "LastName": "Liu", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "3936824145059666015", "Part1": "Department of Hepatobiliary Surgery", "Part2": "The First People's Hospital of Yunnan Province", "Part3": "Kunming 650032", "Part4": "China.", "Part5": null, "Part6": null, "Text": "Department of Hepatobiliary Surgery, The First People's Hospital of Yunnan Province, Kunming 650032, China."}], "ForeName": "Xinghong", "FullName": "Xinghong Wang", "HashID": "4211658993814498477", "LastName": "Wang", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-3864713261926356229", "Part1": "Department of Hepatobiliary Surgery", "Part2": "The Second Affiliated Hospital of Kunming Medical University", "Part3": "Kunming 650101", "Part4": "China.", "Part5": null, "Part6": null, "Text": "Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Kunming Medical University, Kunming 650101, China."}], "ForeName": "Yuehua", "FullName": "Yuehua Li", "HashID": "-6692598859574253522", "LastName": "Li", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-3864713261926356229", "Part1": "Department of Hepatobiliary Surgery", "Part2": "The Second Affiliated Hospital of Kunming Medical University", "Part3": "Kunming 650101", "Part4": "China.", "Part5": null, "Part6": null, "Text": "Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Kunming Medical University, Kunming 650101, China."}], "ForeName": "Jian", "FullName": "Jian Zhou", "HashID": "-1798211966912560793", "LastName": "Zhou", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-3864713261926356229", "Part1": "Department of Hepatobiliary Surgery", "Part2": "The Second Affiliated Hospital of Kunming Medical University", "Part3": "Kunming 650101", "Part4": "China.", "Part5": null, "Part6": null, "Text": "Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Kunming Medical University, Kunming 650101, China."}], "ForeName": "Heng", "FullName": "Heng Zhang", "HashID": "-1892967457146364083", "LastName": "Zhang", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-3864713261926356229", "Part1": "Department of Hepatobiliary Surgery", "Part2": "The Second Affiliated Hospital of Kunming Medical University", "Part3": "Kunming 650101", "Part4": "China.", "Part5": null, "Part6": null, "Text": "Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Kunming Medical University, Kunming 650101, China."}], "ForeName": "Lin", "FullName": "Lin Wang", "HashID": "8834809376003602234", "LastName": "Wang", "ORCID": "0000-0001-7383-934X"}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.1155/2020/3417036", "InsertType": null, "Journal": "Journal of oncology", "Keywords": [], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "PubMed-not-MEDLINE", "Article": {"@PubModel": "Electronic-eCollection", "Abstract": {"AbstractText": [{"#text": "Although the prognostic value of lncRNA small nucleolar RNA host gene 15 (SNHG15) expression in cancers has been evaluated in many studies, the results remain controversial. This meta-analysis aimed to clarify the role of SNHG15 in the prognosis of different cancer patients.", "@Label": "BACKGROUND", "@NlmCategory": "BACKGROUND"}, {"#text": "Eligible studies were selected from PubMed, PMC, EMBASE, Web of Science, and Cochrane Library according to the inclusion and exclusion criteria (up to December 20, 2019). The primary outcome was overall survival (OS) and recurrence-free survival (RFS). The secondary outcome was other clinicopathological parameters (including advanced TNM stage, lymph node metastasis, distant metastases, and gender). The Cancer Genome Atlas (TCGA) dataset was used to verify the analysis results.", "@Label": "MATERIALS AND METHODS", "@NlmCategory": "METHODS"}, {"#text": "Eleven eligible studies were eventually included, involving 9 different types of cancer and 1,079 patients. The high expression of SNHG15 was indicative of a significantly poor OS of cancer patients (HR\u2009=\u20091.96, 95% CI\u2009=\u20091.55-2.47,  < 0.00001). Subgroup analysis showed that the high expression of SNHG15 was associated with a significantly poor OS of patients with digestive cancer (HR\u2009=\u20091.91, 95% CI\u2009=\u20091.38-2.66, =0.0001), but not lung cancer (HR\u2009=\u20091.83, 95% CI\u2009=\u20090.89-3.76, =0.010). The RFS of patients with high expression of SNHG15 was shorter than that of patients with low expression of SNHG15 (HR\u2009=\u20092.03, 95% CI\u2009=\u20091.46-2.83,  < 0.00001). In addition, high SNHG15 expression level was significantly correlated with later TNM stage (OR\u2009=\u20093.05, 95% CI\u2009=\u20092.31-4.02,  < 0.00001), lymphatic metastasis (OR\u2009=\u20093.20, 95% CI\u2009=\u20092.30-4.45,  < 0.00001), and distant metastasis (OR\u2009=\u20095.05, 95% CI\u2009=\u20092.15-11.85, =0.0002). The TCGA verification results were consistent with those observed in our meta-analysis.", "@Label": "RESULTS", "@NlmCategory": "RESULTS", "i": ["P", "P", "P", "P", "P", "P", "P"]}, {"#text": "High expression of the long noncoding RNA SNHG15 in cancer tissue samples predicts an unfavorable prognosis for cancer patients. LncRNA SNHG15 can be used as an adverse prognostic biomarker for cancer patients.", "@Label": "CONCLUSION", "@NlmCategory": "CONCLUSIONS"}], "CopyrightInformation": "Copyright \u00a9 2020 Cheng Zhang et al."}, "ArticleDate": {"@DateType": "Electronic", "Day": "15", "Month": "07", "Year": "2020"}, "ArticleTitle": "High Expression of the Long Noncoding RNA SNHG15 in Cancer Tissue Samples Predicts an Unfavorable Prognosis of Cancer Patients: A Meta-Analysis.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Kunming Medical University, Kunming 650101, China."}, {"Affiliation": "Department of Hepatobiliary Surgery, The Sixth People's Hospital of Chengdu, Chengdu 610041, China."}], "ForeName": "Cheng", "Initials": "C", "LastName": "Zhang"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Kunming Medical University, Kunming 650101, China."}, "ForeName": "Yang", "Initials": "Y", "LastName": "Ke"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Dermatology, The Second Affiliated Hospital of Chengdu Medical College, Chengdu 610051, China."}, "ForeName": "Xin", "Initials": "X", "LastName": "Liu"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Hepatobiliary Surgery, The First People's Hospital of Yunnan Province, Kunming 650032, China."}, "ForeName": "Xinghong", "Initials": "X", "LastName": "Wang"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Kunming Medical University, Kunming 650101, China."}, "ForeName": "Yuehua", "Initials": "Y", "LastName": "Li"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Kunming Medical University, Kunming 650101, China."}, "ForeName": "Jian", "Initials": "J", "LastName": "Zhou"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Kunming Medical University, Kunming 650101, China."}, "ForeName": "Heng", "Initials": "H", "LastName": "Zhang"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Kunming Medical University, Kunming 650101, China."}, "ForeName": "Lin", "Identifier": {"#text": "0000-0001-7383-934X", "@Source": "ORCID"}, "Initials": "L", "LastName": "Wang"}]}, "ELocationID": [{"#text": "3417036", "@EIdType": "pii", "@ValidYN": "Y"}, {"#text": "10.1155/2020/3417036", "@EIdType": "doi", "@ValidYN": "Y"}], "Journal": {"ISOAbbreviation": "J Oncol", "ISSN": {"#text": "1687-8450", "@IssnType": "Print"}, "JournalIssue": {"@CitedMedium": "Print", "PubDate": {"Year": "2020"}, "Volume": "2020"}, "Title": "Journal of oncology"}, "Language": "eng", "Pagination": {"MedlinePgn": "3417036", "StartPage": "3417036"}, "PublicationTypeList": {"PublicationType": {"#text": "Journal Article", "@UI": "D016428"}}}, "CoiStatement": "The authors declare that there are no conflicts of interest regarding the publication of this paper.", "DateRevised": {"Day": "15", "Month": "04", "Year": "2022"}, "MedlineJournalInfo": {"Country": "Egypt", "ISSNLinking": "1687-8450", "MedlineTA": "J Oncol", "NlmUniqueID": "101496537"}, "PMID": {"#text": "32733556", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "32733556", "@IdType": "pubmed"}, {"#text": "PMC7378602", "@IdType": "pmc"}, {"#text": "10.1155/2020/3417036", "@IdType": "doi"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "received", "Day": "23", "Month": "12", "Year": "2019"}, {"@PubStatus": "revised", "Day": "23", "Month": "5", "Year": "2020"}, {"@PubStatus": "accepted", "Day": "8", "Month": "6", "Year": "2020"}, {"@PubStatus": "entrez", "Day": "1", "Hour": "6", "Minute": "0", "Month": "8", "Year": "2020"}, {"@PubStatus": "pubmed", "Day": "1", "Hour": "6", "Minute": "0", "Month": "8", "Year": "2020"}, {"@PubStatus": "medline", "Day": "1", "Hour": "6", "Minute": "1", "Month": "8", "Year": "2020"}]}, "PublicationStatus": "epublish", "ReferenceList": {"Reference": [{"ArticleIdList": {"ArticleId": [{"#text": "PMC6248091", "@IdType": "pmc"}, {"#text": "29860482", "@IdType": "pubmed"}]}, "Citation": "Fitzmaurice C., Fitzmaurice C., Akinyemiju T. F., et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: a systematic analysis for the global burden of disease study. JAMA Oncology. 2018;4(11):1553\u20131568."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/s0140-6736(12)60919-2", "@IdType": "doi"}, {"#text": "23079588", "@IdType": "pubmed"}]}, "Citation": "Soerjomataram I., Lortet-Tieulent J., Parkin D. M., et al. Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. The Lancet. 2012;380(9856):1840\u20131850. doi: 10.1016/s0140-6736(12)60919-2."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1634/theoncologist.2017-0040", "@IdType": "doi"}, {"#text": "PMC5553950", "@IdType": "pmc"}, {"#text": "28550030", "@IdType": "pubmed"}]}, "Citation": "Subbiah V., Kurzrock R. Debunking the delusion that precision oncology is an illusion. The Oncologist. 2017;22(8):881\u2013882. doi: 10.1634/theoncologist.2017-0040."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/537s63a", "@IdType": "doi"}, {"#text": "27602743", "@IdType": "pubmed"}]}, "Citation": "Prasad V. Perspective: the precision-oncology illusion. Nature. 2016;537(7619):p. S63. doi: 10.1038/537s63a."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.21037/tcr.2017.10.46", "@IdType": "doi"}, {"#text": "PMC6107076", "@IdType": "pmc"}, {"#text": "30148073", "@IdType": "pubmed"}]}, "Citation": "Dragomir M., Chen B., Calin G. A. Exosomal lncRNAs as new players in cell-to-cell communication. Translational Cancer Research. 2018;7(2):S243\u2013S252. doi: 10.21037/tcr.2017.10.46."}, {"ArticleIdList": {"ArticleId": {"#text": "12466851", "@IdType": "pubmed"}}, "Citation": "Okazaki Y., Furuno M., Kasukawa T., et al. Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature. 2002;420(6915):563\u2013573."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cub.2018.09.026", "@IdType": "doi"}, {"#text": "PMC6264527", "@IdType": "pmc"}, {"#text": "30393032", "@IdType": "pubmed"}]}, "Citation": "Schor I. E., Bussotti G., Male\u0161 M., et al. Non-coding RNA expression, function, and variation during drosophila embryogenesis. Current Biology. 2018;28(22):3547\u20133561.e9. doi: 10.1016/j.cub.2018.09.026."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41590-019-0542-7", "@IdType": "doi"}, {"#text": "31740800", "@IdType": "pubmed"}]}, "Citation": "Xu H., Jiang Y., Xu X., et al. Inducible degradation of lncRNA sros1 promotes IFN-\u03b3-mediated activation of innate immune responses by stabilizing stat1 mRNA. Nature Immunology. 2019;20(12):1621\u20131630. doi: 10.1038/s41590-019-0542-7."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1182/blood-2013-10-530683", "@IdType": "doi"}, {"#text": "PMC3901070", "@IdType": "pmc"}, {"#text": "24200680", "@IdType": "pubmed"}]}, "Citation": "Alvarez-Dominguez J. R., Hu W., Yuan B., et al. Global discovery of erythroid long noncoding RNAs reveals novel regulators of red cell maturation. Blood. 2014;123(4):570\u2013581. doi: 10.1182/blood-2013-10-530683."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.canlet.2019.11.001", "@IdType": "doi"}, {"#text": "31705929", "@IdType": "pubmed"}]}, "Citation": "Ye Y., Guo J., Xiao P., et al. Macrophages-induced long noncoding RNA H19 up-regulation triggers and activates the miR-193b/MAPK1 axis and promotes cell aggressiveness in hepatocellular carcinoma. Cancer Letters. 2020;469:310\u2013322. doi: 10.1016/j.canlet.2019.11.001."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41588-018-0252-3", "@IdType": "doi"}, {"#text": "PMC6265076", "@IdType": "pmc"}, {"#text": "30349115", "@IdType": "pubmed"}]}, "Citation": "Kim J., Piao H.-L., Kim B.-J., et al. Long noncoding RNA MALAT1 suppresses breast cancer metastasis. Nature Genetics. 2018;50(12):1705\u20131715. doi: 10.1038/s41588-018-0252-3."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/cancers11081170", "@IdType": "doi"}, {"#text": "PMC6721601", "@IdType": "pmc"}, {"#text": "31416190", "@IdType": "pubmed"}]}, "Citation": "Pardini B., Sabo A. A., Birolo G., Calin G. A. Noncoding RNAs in extracellular fluids as cancer biomarkers: the new frontier of liquid biopsies. Cancers. 2019;11(8):p. 1170. doi: 10.3390/cancers11081170."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1136/gutjnl-2019-318279", "@IdType": "doi"}, {"#text": "32034004", "@IdType": "pubmed"}]}, "Citation": "Dragomir M. P., Kopetz S., Ajani J. A., Calin G. A. Non-coding RNAs in GI cancers: from cancer hallmarks to clinical utility. Gut. 2020;69(4):748\u2013763. doi: 10.1136/gutjnl-2019-318279."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.93.25.14480", "@IdType": "doi"}, {"#text": "PMC26158", "@IdType": "pmc"}, {"#text": "8962077", "@IdType": "pubmed"}]}, "Citation": "Tycowski K. T., Smith C. M., Shu M.-D., Steitz J. A. A small nucleolar RNA requirement for site-specific ribose methylation of rRNA in xenopus. Proceedings of the National Academy of Sciences. 1996;93(25):14480\u201314485. doi: 10.1073/pnas.93.25.14480."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bbrc.2017.12.013", "@IdType": "doi"}, {"#text": "29217194", "@IdType": "pubmed"}]}, "Citation": "Kong Q., Qiu M. Long noncoding RNA SNHG15 promotes human breast cancer proliferation, migration and invasion by sponging miR-211-3p. Biochemical and Biophysical Research Communications. 2018;495(2):1594\u20131600. doi: 10.1016/j.bbrc.2017.12.013."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1080/21691401.2019.1621328", "@IdType": "doi"}, {"#text": "31213086", "@IdType": "pubmed"}]}, "Citation": "Sun X., Bai Y., Yang C., Hu S., Hou Z., Wang G. Long noncoding RNA SNHG15 enhances the development of colorectal carcinoma via functioning as a ceRNA through miR-141/SIRT1/Wnt/\u03b2-catenin axis. Artificial Cells, Nanomedicine, and Biotechnology. 2019;47(1):2536\u20132544. doi: 10.1080/21691401.2019.1621328."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.gene.2019.04.033", "@IdType": "doi"}, {"#text": "30981837", "@IdType": "pubmed"}]}, "Citation": "Zhang Y., Zhang D., Lv J., Wang S., Zhang Q. LncRNA SNHG15 acts as an oncogene in prostate cancer by regulating miR-338-3p/FKBP1A axis. Gene. 2019;705:44\u201350. doi: 10.1016/j.gene.2019.04.033."}, {"ArticleIdList": {"ArticleId": {"#text": "27212162", "@IdType": "pubmed"}}, "Citation": "Zhang J.-H., Wei H.-W., Yang H.-G. Long noncoding RNA SNHG15, a potential prognostic biomarker for hepatocellular carcinoma. European Review for Medical and Pharmacological Sciences. 2016;20(9):1720\u20131724."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s13277-015-4404-0", "@IdType": "doi"}, {"#text": "26662309", "@IdType": "pubmed"}]}, "Citation": "Chen S.-X., Yin J.-F., Lin B.-C., et al. Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC. Tumour Biology. 2016;37(5):6801\u20136812. doi: 10.1007/s13277-015-4404-0."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.20359", "@IdType": "doi"}, {"#text": "PMC5663584", "@IdType": "pmc"}, {"#text": "29137412", "@IdType": "pubmed"}]}, "Citation": "Ma Z., Huang H., Wang J., et al. Long non-coding RNA SNHG15 inhibits P15 and KLF2 expression to promote pancreatic cancer proliferation through EZH2-mediated H3K27me3. Oncotarget. 2017;8(48):84153\u201384167. doi: 10.18632/oncotarget.20359."}, {"ArticleIdList": {"ArticleId": {"#text": "30280769", "@IdType": "pubmed"}}, "Citation": "Guo X.-B., Yin H.-S., Wang J.-Y. Evaluating the diagnostic and prognostic value of long non-coding RNA SNHG15 in pancreatic ductal adenocarcinoma. European Review for Medical and Pharmacological Sciences. 2018;22(18):5892\u20135898."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/ijo.2018.4395", "@IdType": "doi"}, {"#text": "29750422", "@IdType": "pubmed"}]}, "Citation": "Du Y., Kong C., Zhu Y., et al. Knockdown of SNHG15 suppresses renal cell carcinoma proliferation and EMT by regulating the NF-\u03baB signaling pathway. International Journal of Oncology. 2018;53(1):384\u2013394. doi: 10.3892/ijo.2018.4395."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41419-018-0975-1", "@IdType": "doi"}, {"#text": "PMC6148237", "@IdType": "pmc"}, {"#text": "30237435", "@IdType": "pubmed"}]}, "Citation": "Wu D.-M., Wang S., Wen X., et al. LncRNA SNHG15 acts as a ceRNA to regulate YAP1-hippo signaling pathway by sponging miR-200a-3p in papillary thyroid carcinoma. Cell Death & Disease. 2018;9(10):p. 947. doi: 10.1038/s41419-018-0975-1."}, {"ArticleIdList": {"ArticleId": {"#text": "30402848", "@IdType": "pubmed"}}, "Citation": "Cui H.-X., Zhang M.-Y., Liu K., Liu J., Zhang Z.-L., Fu L. LncRNA SNHG15 promotes proliferation and migration of lung cancer via targeting microRNA-211-3p. European Review for Medical and Pharmacological Sciences. 2018;22(20):6838\u20136844."}, {"ArticleIdList": {"ArticleId": {"#text": "29771418", "@IdType": "pubmed"}}, "Citation": "Dong Y.-Z., Meng X.-M., Li G.-S. Long non-coding RNA SNHG15 indicates poor prognosis of non-small cell lung cancer and promotes cell proliferation and invasion. European Review for Medical and Pharmacological Sciences. 2018;22(9):2671\u20132679."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/jcp.26543", "@IdType": "doi"}, {"#text": "PMC6001572", "@IdType": "pmc"}, {"#text": "29630731", "@IdType": "pubmed"}]}, "Citation": "Jin B., Jin H., Wu H.-B., Xu J.-J., Li B. Long non-coding RNA SNHG15 promotes CDK14 expression via miR-486 to accelerate non-small cell lung cancer cells progression and metastasis. Journal of Cellular Physiology. 2018;233(9):7164\u20137172. doi: 10.1002/jcp.26543."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/jcp.27456", "@IdType": "doi"}, {"#text": "30317592", "@IdType": "pubmed"}]}, "Citation": "Huang L., Lin H., Kang L., et al. Aberrant expression of long noncoding RNA SNHG15 correlates with liver metastasis and poor survival in colorectal cancer. Journal of Cellular Physiology. 2019;234(5):7032\u20137039. doi: 10.1002/jcp.27456."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2147/ott.s182657", "@IdType": "doi"}, {"#text": "PMC6304080", "@IdType": "pmc"}, {"#text": "30588034", "@IdType": "pubmed"}]}, "Citation": "Qu C., Dai C., Guo Y., Qin R., Liu J. Long noncoding RNA SNHG15 serves as an oncogene and predicts poor prognosis in epithelial ovarian cancer. OncoTargets and Therapy. 2019;12:101\u2013111. doi: 10.2147/ott.s182657."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/jcb.27899", "@IdType": "doi"}, {"#text": "30623483", "@IdType": "pubmed"}]}, "Citation": "Liu Y., Li J., Li F., Li M., Shao Y., Wu L. SNHG15 functions as a tumor suppressor in thyroid cancer. Journal of Cellular Biochemistry. 2019;120(4):6120\u20136126. doi: 10.1002/jcb.27899."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/or.2017.5985", "@IdType": "doi"}, {"#text": "29048682", "@IdType": "pubmed"}]}, "Citation": "Ma Y., Xue Y., Liu X., et al. SNHG15 affects the growth of glioma microvascular endothelial cells by negatively regulating miR-153. Oncology Reports. 2017;38(5):3265\u20133277. doi: 10.3892/or.2017.5985."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2147/ott.s107188", "@IdType": "doi"}, {"#text": "PMC4948684", "@IdType": "pmc"}, {"#text": "27471399", "@IdType": "pubmed"}]}, "Citation": "Liu F.-T., Xue Q.-Z., Zhu P.-Q., Luo H.-L., Zhang Y., Hao T. Long noncoding RNA AFAP1-AS1, a potential novel biomarker to predict the clinical outcome of cancer patients: a meta-analysis. OncoTargets and Therapy. 2016;9:4247\u20134254. doi: 10.2147/ott.s107188."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/1745-6215-8-16", "@IdType": "doi"}, {"#text": "PMC1920534", "@IdType": "pmc"}, {"#text": "17555582", "@IdType": "pubmed"}]}, "Citation": "Tierney J. F., Stewart L. A., Ghersi D., Burdett S., Sydes M. R. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:p. 16. doi: 10.1186/1745-6215-8-16."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bbrc.2013.09.006", "@IdType": "doi"}, {"#text": "24036268", "@IdType": "pubmed"}]}, "Citation": "Tani H., Torimura M. Identification of short-lived long non-coding RNAs as surrogate indicators for chemical stress response. Biochemical and Biophysical Research Communications. 2013;439(4):547\u2013551. doi: 10.1016/j.bbrc.2013.09.006."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.canlet.2018.03.038", "@IdType": "doi"}, {"#text": "29604394", "@IdType": "pubmed"}]}, "Citation": "Jiang H., Li T., Qu Y., et al. Long non-coding RNA SNHG15 interacts with and stabilizes transcription factor slug and promotes colon cancer progression. Cancer Letters. 2018;425:78\u201387. doi: 10.1016/j.canlet.2018.03.038."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2147/cmar.s208054", "@IdType": "doi"}, {"#text": "PMC6613027", "@IdType": "pmc"}, {"#text": "31308739", "@IdType": "pubmed"}]}, "Citation": "Tong J., Ma X., Yu H., Yang J. SNHG15: a promising cancer-related long noncoding RNA. Cancer Management and Research. 2019;11:5961\u20135969. doi: 10.2147/cmar.s208054."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12929-017-0353-9", "@IdType": "doi"}, {"#text": "PMC5516387", "@IdType": "pmc"}, {"#text": "28720111", "@IdType": "pubmed"}]}, "Citation": "Liu K., Hou Y., Liu Y., Zheng J. LncRNA SNHG15 contributes to proliferation, invasion and autophagy in osteosarcoma cells by sponging miR-141. Journal of Biomedical Science. 2017;24(1):p. 46. doi: 10.1186/s12929-017-0353-9."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2147/ott.s223321", "@IdType": "doi"}, {"#text": "PMC6983676", "@IdType": "pmc"}, {"#text": "32021307", "@IdType": "pubmed"}]}, "Citation": "Mi H., Wang X., Wang F., et al. SNHG15 contributes to cisplatin resistance in breast cancer through sponging miR-381. OncoTargets and Therapy. 2020;13:657\u2013666. doi: 10.2147/ott.s223321."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s13046-019-1371-0", "@IdType": "doi"}, {"#text": "PMC6714301", "@IdType": "pmc"}, {"#text": "31462285", "@IdType": "pubmed"}]}, "Citation": "Li Z., Zhang J., Zheng H., et al. Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme. Journal of Experimental & Clinical Cancer Research. 2019;38(1):p. 380. doi: 10.1186/s13046-019-1371-0."}]}}}}}, "PMC": "PMC7378602", "PMID": "32733556", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "High Expression of the Long Noncoding RNA SNHG15 in Cancer Tissue Samples Predicts an Unfavorable Prognosis of Cancer Patients: A Meta-Analysis.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "15": {"Abstract": "The small nucleolar RNA host genes (SNHGs) are a group of long non-coding RNAs, which are reported in many studies as being overexpressed in various cancers. With very few exceptions, the SNHGs (SNHG1, SNHG3, SNHG5, SNHG6, SNHG7, SNHG12, SNHG15, SNHG16, SNHG20) are recognized as inducing increased proliferation, cell cycle progression, invasion, and metastasis of cancer cells, which makes this class of transcripts a viable biomarker for cancer development and aggressiveness. Through our literature research, we also found that silencing of SNHGs through small interfering RNAs or short hairpin RNAs is very effective in both  and  experiments by lowering the aggressiveness of solid cancers. The knockdown of SNHG as a new cancer therapeutic option should be investigated more in the future.", "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "-9140326774848524080", "Part1": "Medfuture Research Center for Advanced Medicine", "Part2": "Iuliu Hatieganu University of Medicine and Pharmacy", "Part3": "Cluj-Napoca", "Part4": "Romania.", "Part5": null, "Part6": null, "Text": "Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania."}], "ForeName": "Alina-Andreea", "FullName": "Alina-Andreea Zimta", "HashID": "-743511230986197366", "LastName": "Zimta", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-9140326774848524080", "Part1": "Medfuture Research Center for Advanced Medicine", "Part2": "Iuliu Hatieganu University of Medicine and Pharmacy", "Part3": "Cluj-Napoca", "Part4": "Romania.", "Part5": null, "Part6": null, "Text": "Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania."}], "ForeName": "Adrian Bogdan", "FullName": "Adrian Bogdan Tigu", "HashID": "5191385764862684450", "LastName": "Tigu", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-396930039600889800", "Part1": "Research Center for Functional Genomics", "Part2": "Biomedicine and Translational Medicine", "Part3": "Iuliu Hatieganu University of Medicine and Pharmacy", "Part4": "Cluj-Napoca", "Part5": "Romania.", "Part6": null, "Text": "Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania."}], "ForeName": "Cornelia", "FullName": "Cornelia Braicu", "HashID": "-4341004694409543206", "LastName": "Braicu", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "3115190260715231078", "Part1": "African Organisation for Research and Training in Cancer", "Part2": "Cape Town", "Part3": "South Africa.", "Part4": null, "Part5": null, "Part6": null, "Text": "African Organisation for Research and Training in Cancer, Cape Town, South Africa."}], "ForeName": "Cristina", "FullName": "Cristina Stefan", "HashID": "7107542053735042824", "LastName": "Stefan", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-2225155074559849942", "Part1": "Surgical Department", "Part2": "Municipal Hospital", "Part3": "Cluj-Napoca", "Part4": "Romania.", "Part5": null, "Part6": null, "Text": "Surgical Department, Municipal Hospital, Cluj-Napoca, Romania."}, {"Has_Extra": false, "HashID": "8849507293266041336", "Part1": "Department of Surgery", "Part2": "Iuliu Hatieganu University of Medicine and Pharmacy", "Part3": "Cluj-Napoca", "Part4": "Romania.", "Part5": null, "Part6": null, "Text": "Department of Surgery, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania."}], "ForeName": "Calin", "FullName": "Calin Ionescu", "HashID": "770706752784179692", "LastName": "Ionescu", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-9140326774848524080", "Part1": "Medfuture Research Center for Advanced Medicine", "Part2": "Iuliu Hatieganu University of Medicine and Pharmacy", "Part3": "Cluj-Napoca", "Part4": "Romania.", "Part5": null, "Part6": null, "Text": "Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania."}, {"Has_Extra": false, "HashID": "-396930039600889800", "Part1": "Research Center for Functional Genomics", "Part2": "Biomedicine and Translational Medicine", "Part3": "Iuliu Hatieganu University of Medicine and Pharmacy", "Part4": "Cluj-Napoca", "Part5": "Romania.", "Part6": null, "Text": "Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania."}, {"Has_Extra": false, "HashID": "3713684907331353555", "Part1": "Department of Functional Genomics and Experimental Pathology", "Part2": "The Oncology Institute \"Prof. Dr. I. Chiricuta\"", "Part3": "Cluj-Napoca", "Part4": "Romania.", "Part5": null, "Part6": null, "Text": "Department of Functional Genomics and Experimental Pathology, The Oncology Institute \"Prof. Dr. I. Chiricuta\", Cluj-Napoca, Romania."}], "ForeName": "Ioana", "FullName": "Ioana Berindan-Neagoe", "HashID": "3288437426203935321", "LastName": "Berindan-Neagoe", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.3389/fonc.2020.00389", "InsertType": null, "Journal": "Frontiers in oncology", "Keywords": [{"IS_Major": false, "IS_Mesh": false, "Text": "SNHG"}, {"IS_Major": false, "IS_Mesh": false, "Text": "cancer"}, {"IS_Major": false, "IS_Mesh": false, "Text": "invasion"}, {"IS_Major": false, "IS_Mesh": false, "Text": "lncRNAs"}, {"IS_Major": false, "IS_Mesh": false, "Text": "malignant disease"}, {"IS_Major": false, "IS_Mesh": false, "Text": "proliferation"}, {"IS_Major": false, "IS_Mesh": false, "Text": "snoRNA"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "PubMed-not-MEDLINE", "Article": {"@PubModel": "Electronic-eCollection", "Abstract": {"AbstractText": {"#text": "The small nucleolar RNA host genes (SNHGs) are a group of long non-coding RNAs, which are reported in many studies as being overexpressed in various cancers. With very few exceptions, the SNHGs (SNHG1, SNHG3, SNHG5, SNHG6, SNHG7, SNHG12, SNHG15, SNHG16, SNHG20) are recognized as inducing increased proliferation, cell cycle progression, invasion, and metastasis of cancer cells, which makes this class of transcripts a viable biomarker for cancer development and aggressiveness. Through our literature research, we also found that silencing of SNHGs through small interfering RNAs or short hairpin RNAs is very effective in both  and  experiments by lowering the aggressiveness of solid cancers. The knockdown of SNHG as a new cancer therapeutic option should be investigated more in the future.", "i": ["in vitro", "in vivo"]}, "CopyrightInformation": "Copyright \u00a9 2020 Zimta, Tigu, Braicu, Stefan, Ionescu and Berindan-Neagoe."}, "ArticleDate": {"@DateType": "Electronic", "Day": "07", "Month": "04", "Year": "2020"}, "ArticleTitle": "An Emerging Class of Long Non-coding RNA With Oncogenic Role Arises From the snoRNA Host Genes.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania."}, "ForeName": "Alina-Andreea", "Initials": "AA", "LastName": "Zimta"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania."}, "ForeName": "Adrian Bogdan", "Initials": "AB", "LastName": "Tigu"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania."}, "ForeName": "Cornelia", "Initials": "C", "LastName": "Braicu"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "African Organisation for Research and Training in Cancer, Cape Town, South Africa."}, "ForeName": "Cristina", "Initials": "C", "LastName": "Stefan"}, {"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Surgical Department, Municipal Hospital, Cluj-Napoca, Romania."}, {"Affiliation": "Department of Surgery, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania."}], "ForeName": "Calin", "Initials": "C", "LastName": "Ionescu"}, {"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania."}, {"Affiliation": "Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania."}, {"Affiliation": "Department of Functional Genomics and Experimental Pathology, The Oncology Institute \"Prof. Dr. I. Chiricuta\", Cluj-Napoca, Romania."}], "ForeName": "Ioana", "Initials": "I", "LastName": "Berindan-Neagoe"}]}, "ELocationID": [{"#text": "389", "@EIdType": "pii", "@ValidYN": "Y"}, {"#text": "10.3389/fonc.2020.00389", "@EIdType": "doi", "@ValidYN": "Y"}], "Journal": {"ISOAbbreviation": "Front Oncol", "ISSN": {"#text": "2234-943X", "@IssnType": "Print"}, "JournalIssue": {"@CitedMedium": "Print", "PubDate": {"Year": "2020"}, "Volume": "10"}, "Title": "Frontiers in oncology"}, "Language": "eng", "Pagination": {"MedlinePgn": "389", "StartPage": "389"}, "PublicationTypeList": {"PublicationType": [{"#text": "Journal Article", "@UI": "D016428"}, {"#text": "Review", "@UI": "D016454"}]}}, "DateRevised": {"Day": "28", "Month": "09", "Year": "2020"}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"#text": "SNHG", "@MajorTopicYN": "N"}, {"#text": "cancer", "@MajorTopicYN": "N"}, {"#text": "invasion", "@MajorTopicYN": "N"}, {"#text": "lncRNAs", "@MajorTopicYN": "N"}, {"#text": "malignant disease", "@MajorTopicYN": "N"}, {"#text": "proliferation", "@MajorTopicYN": "N"}, {"#text": "snoRNA", "@MajorTopicYN": "N"}]}, "MedlineJournalInfo": {"Country": "Switzerland", "ISSNLinking": "2234-943X", "MedlineTA": "Front Oncol", "NlmUniqueID": "101568867"}, "PMID": {"#text": "32318335", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "32318335", "@IdType": "pubmed"}, {"#text": "PMC7154078", "@IdType": "pmc"}, {"#text": "10.3389/fonc.2020.00389", "@IdType": "doi"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "received", "Day": "2", "Month": "12", "Year": "2019"}, {"@PubStatus": "accepted", "Day": "4", "Month": "3", "Year": "2020"}, {"@PubStatus": "entrez", "Day": "23", "Hour": "6", "Minute": "0", "Month": "4", "Year": "2020"}, {"@PubStatus": "pubmed", "Day": "23", "Hour": "6", "Minute": "0", "Month": "4", "Year": "2020"}, {"@PubStatus": "medline", "Day": "23", "Hour": "6", "Minute": "1", "Month": "4", "Year": "2020"}]}, "PublicationStatus": "epublish", "ReferenceList": {"Reference": [{"ArticleIdList": {"ArticleId": [{"#text": "10.3322/caac.21492", "@IdType": "doi"}, {"#text": "30207593", "@IdType": "pubmed"}]}, "Citation": "Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. (2018) 68:394\u2013424. 10.3322/caac.21492"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3322/caac.21442", "@IdType": "doi"}, {"#text": "29313949", "@IdType": "pubmed"}]}, "Citation": "Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. (2018) 68:7\u201330. 10.3322/caac.21442"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s11010-013-1688-5", "@IdType": "doi"}, {"#text": "23881244", "@IdType": "pubmed"}]}, "Citation": "Braicu C, Pileczki V, Irimie A, Berindan-Neagoe I. p53siRNA therapy reduces cell proliferation, migration and induces apoptosis in triple negative breast cancer cells. Mol Cell Biochem. (2013) 381:61\u20138. 10.1007/s11010-013-1688-5"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/ijms18071514", "@IdType": "doi"}, {"#text": "PMC5536004", "@IdType": "pmc"}, {"#text": "28703782", "@IdType": "pubmed"}]}, "Citation": "Pop-Bica C, Gulei D, Cojocneanu-Petric R, Braicu C, Petrut B, Berindan-Neagoe I. Understanding the role of non-coding RNAs in bladder cancer: from dark matter to valuable therapeutic targets. Int J Mol Sci. (2017) 18:E1514. 10.3390/ijms18071514"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s13059-017-1224-0", "@IdType": "doi"}, {"#text": "PMC5442648", "@IdType": "pmc"}, {"#text": "28535802", "@IdType": "pubmed"}]}, "Citation": "Rigoutsos I, Lee SK, Nam SY, Anfossi S, Pasculli B, Pichler M, et al. . N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration. Genome Biol. (2017) 18:98. 10.1186/s13059-017-1224-0"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2174/1381612820666140826153529", "@IdType": "doi"}, {"#text": "25341933", "@IdType": "pubmed"}]}, "Citation": "Braicu C, Catana C, Calin GA, Berindan-Neagoe I. NCRNA combined therapy as future treatment option for cancer. Curr Pharm Des. (2014) 20:6565\u201374. 10.2174/1381612820666140826153529"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3389/fmed.2015.00085", "@IdType": "doi"}, {"#text": "PMC4678211", "@IdType": "pmc"}, {"#text": "26697428", "@IdType": "pubmed"}]}, "Citation": "Catana CS, Calin GA, Berindan-Neagoe I. Inflamma-miRs in aging and breast cancer: are they reliable players? Front Med. (2015) 2:85. 10.3389/fmed.2015.00085"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.molmed.2018.01.001", "@IdType": "doi"}, {"#text": "PMC5840027", "@IdType": "pmc"}, {"#text": "29449148", "@IdType": "pubmed"}]}, "Citation": "Arun G, Diermeier SD, Spector DL. Therapeutic targeting of long non-coding RNAs in cancer. Trends Mol Med. (2018) 24:257\u201377. 10.1016/j.molmed.2018.01.001"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.canlet.2018.01.053", "@IdType": "doi"}, {"#text": "29414303", "@IdType": "pubmed"}]}, "Citation": "Bach DH, Lee SK. Long noncoding RNAs in cancer cells. Cancer Lett. (2018) 419:152\u201366. 10.1016/j.canlet.2018.01.053"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/genes9030134", "@IdType": "doi"}, {"#text": "PMC5867855", "@IdType": "pmc"}, {"#text": "29494516", "@IdType": "pubmed"}]}, "Citation": "Irimie AI, Zimta AA, Ciocan C, Mehterov N, Dudea D, Braicu C, et al. . The unforeseen non-coding RNAs in head and neck cancer. Genes. (2018) 9:134. 10.3390/genes9030134"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3389/fonc.2019.00739", "@IdType": "doi"}, {"#text": "PMC6691164", "@IdType": "pmc"}, {"#text": "31448238", "@IdType": "pubmed"}]}, "Citation": "Chen D, Lu T, Tan J, Li H, Wang Q, Wei L. Long non-coding RNAs as communicators and mediators between the tumor microenvironment and cancer cells. Front Oncol. (2019) 9:739. 10.3389/fonc.2019.00739"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/hmg/ddl046", "@IdType": "doi"}, {"#text": "16651366", "@IdType": "pubmed"}]}, "Citation": "Mattick JS, Makunin IV. Non-coding RNA. Hum Mol Genet. (2006) 15 Spec No 1:R17\u201329. 10.1093/hmg/ddl046"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.15706", "@IdType": "doi"}, {"#text": "PMC5438748", "@IdType": "pmc"}, {"#text": "28392501", "@IdType": "pubmed"}]}, "Citation": "Catana CS, Pichler M, Giannelli G, Mader RM, Berindan-Neagoe I. Non-coding RNAs, the Trojan horse in two-way communication between tumor and stroma in colorectal and hepatocellular carcinoma. Oncotarget. (2017) 8:29519\u201334. 10.18632/oncotarget.15706"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ceb.2009.04.001", "@IdType": "doi"}, {"#text": "19447594", "@IdType": "pubmed"}]}, "Citation": "Brosnan CA, Voinnet O. The long and the short of noncoding RNAs. Curr Opin Cell Biol. (2009) 21:416\u201325. 10.1016/j.ceb.2009.04.001"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2174/0929867311320290002", "@IdType": "doi"}, {"#text": "23834177", "@IdType": "pubmed"}]}, "Citation": "Braicu C, Calin GA, Berindan-Neagoe I. MicroRNAs and cancer therapy - from bystanders to major players. Curr Med Chem. (2013) 20:3561\u201373. 10.2174/0929867311320290002"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2147/DDDT.S142337", "@IdType": "doi"}, {"#text": "PMC5628667", "@IdType": "pmc"}, {"#text": "29033548", "@IdType": "pubmed"}]}, "Citation": "Jurj A, Braicu C, Pop LA, Tomuleasa C, Gherman CD, Berindan-Neagoe I. The new era of nanotechnology, an alternative to change cancer treatment. Drug Des Devel Ther. (2017) 11:2871\u201390. 10.2147/DDDT.S142337"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2174/1389202918666171005100124", "@IdType": "doi"}, {"#text": "PMC5930448", "@IdType": "pmc"}, {"#text": "29755289", "@IdType": "pubmed"}]}, "Citation": "Sonea L, Buse M, Gulei D, Onaciu A, Simon I, Braicu C, et al. . Decoding the emerging patterns exhibited in non-coding RNAs characteristic of lung cancer with regard to their clinical significance. Curr Genomics. (2018) 19:258\u201378. 10.2174/1389202918666171005100124"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/ijms140816010", "@IdType": "doi"}, {"#text": "PMC3759897", "@IdType": "pmc"}, {"#text": "23912238", "@IdType": "pubmed"}]}, "Citation": "Gomes AQ, Nolasco S, Soares H. Non-coding RNAs: multi-tasking molecules in the cell. Int J Mol Sci. (2013) 14:16010\u201339. 10.3390/ijms140816010"}, {"Citation": "Berindan-Neagoe I, Braicu C, Gulei D, Tomuleasa C, Calin GA. Noncoding RNAs in lung cancer angiogenesis. In: Simionescu D, Simionescu A. editors. Physiologic and Pathologic Angiogenesis - Signaling Mechanisms and Targeted Therapy. Rijeka: InTech; (2017). p. 14."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.tig.2017.05.004", "@IdType": "doi"}, {"#text": "28629949", "@IdType": "pubmed"}]}, "Citation": "Wu H, Yang L, Chen LL. The diversity of long noncoding RNAs and their generation. Trends Genet. (2017) 33:540\u201352. 10.1016/j.tig.2017.05.004"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.biochi.2011.05.026", "@IdType": "doi"}, {"#text": "PMC3476530", "@IdType": "pmc"}, {"#text": "21664409", "@IdType": "pubmed"}]}, "Citation": "Scott MS, Ono M. From snoRNA to miRNA: dual function regulatory non-coding RNAs. Biochimie. (2011) 93:1987\u201392. 10.1016/j.biochi.2011.05.026"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bbcan.2012.03.005", "@IdType": "doi"}, {"#text": "PMC3842010", "@IdType": "pmc"}, {"#text": "22498252", "@IdType": "pubmed"}]}, "Citation": "Mannoor K, Liao J, Jiang F. Small nucleolar RNAs in cancer. Biochim Biophys Acta. (2012) 1826:121\u20138. 10.1016/j.bbcan.2012.03.005"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.tig.2018.11.005", "@IdType": "doi"}, {"#text": "30563726", "@IdType": "pubmed"}]}, "Citation": "Kufel J, Grzechnik P. Small nucleolar RNAs tell a different tale. Trends Genet. (2019) 35:104\u201317. 10.1016/j.tig.2018.11.005"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/bies.201200117", "@IdType": "doi"}, {"#text": "PMC3732821", "@IdType": "pmc"}, {"#text": "23180440", "@IdType": "pubmed"}]}, "Citation": "Falaleeva M, Stamm S. Processing of snoRNAs as a new source of regulatory non-coding RNAs: snoRNA fragments form a new class of functional RNAs. Bioessays. (2013) 35:46\u201354. 10.1002/bies.201200117"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cell.2009.08.030", "@IdType": "doi"}, {"#text": "PMC3244755", "@IdType": "pmc"}, {"#text": "19766558", "@IdType": "pubmed"}]}, "Citation": "Halic M, Moazed D. Transposon silencing by piRNAs. Cell. (2009) 138:1058\u201360. 10.1016/j.cell.2009.08.030"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/gbe/evp045", "@IdType": "doi"}, {"#text": "PMC2817437", "@IdType": "pmc"}, {"#text": "20333211", "@IdType": "pubmed"}]}, "Citation": "Hoeppner MP, White S, Jeffares DC, Poole AM. Evolutionarily stable association of intronic snoRNAs and microRNAs with their host genes. Genome Biol Evol. (2009) 1:420\u20138. 10.1093/gbe/evp045"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1261/rna.209707", "@IdType": "doi"}, {"#text": "PMC1869039", "@IdType": "pmc"}, {"#text": "17468437", "@IdType": "pubmed"}]}, "Citation": "Tanaka-Fujita R, Soeno Y, Satoh H, Nakamura Y, Mori S. Human and mouse protein-noncoding snoRNA host genes with dissimilar nucleotide sequences show chromosomal synteny. RNA. (2007) 13:811\u20136. 10.1261/rna.209707"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.semcdb.2017.08.016", "@IdType": "doi"}, {"#text": "28811264", "@IdType": "pubmed"}]}, "Citation": "Boivin V, Deschamps-Francoeur G, Scott MS. Protein coding genes as hosts for noncoding RNA expression. Semin Cell Dev Biol. (2018) 75:3\u201312. 10.1016/j.semcdb.2017.08.016"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrc3195", "@IdType": "doi"}, {"#text": "22257949", "@IdType": "pubmed"}]}, "Citation": "Williams GT, Farzaneh F. Are snoRNAs and snoRNA host genes new players in cancer? Nat Rev Cancer. (2012) 12:84\u20138. 10.1038/nrc3195"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.celrep.2017.10.070", "@IdType": "doi"}, {"#text": "29141226", "@IdType": "pubmed"}]}, "Citation": "Gong J, Li Y, Liu C-J, Xiang Y, Li C, Ye Y, et al. . A pan-cancer analysis of the expression and clinical relevance of small nucleolar RNAs in human cancer. Cell Rep. (2017) 21:1968\u201381. 10.1016/j.celrep.2017.10.070"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1261/rna.2528811", "@IdType": "doi"}, {"#text": "PMC3078737", "@IdType": "pmc"}, {"#text": "21460236", "@IdType": "pubmed"}]}, "Citation": "Askarian-Amiri ME, Crawford J, French JD, Smart CE, Smith MA, Clark MB, et al. . SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer. RNA. (2011) 17:878\u201391. 10.1261/rna.2528811"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s13046-016-0486-9", "@IdType": "doi"}, {"#text": "PMC5223416", "@IdType": "pmc"}, {"#text": "28073380", "@IdType": "pubmed"}]}, "Citation": "Lan T, Ma W, Hong Z, Wu L, Chen X, Yuan Y. Long non-coding RNA small nucleolar RNA host gene 12 (SNHG12) promotes tumorigenesis and metastasis by targeting miR-199a/b-5p in hepatocellular carcinoma. J Exp Clin Cancer Res. (2017) 36:11. 10.1186/s13046-016-0486-9"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.omtn.2019.06.008", "@IdType": "doi"}, {"#text": "PMC6630039", "@IdType": "pmc"}, {"#text": "31310946", "@IdType": "pubmed"}]}, "Citation": "Xu T, Yan S, Jiang L, Yu S, Lei T, Yang D, et al. . Gene amplification-driven long noncoding RNA SNHG17 regulates cell proliferation and migration in human non-small-cell lung cancer. Mol Ther Nucleic Acids. (2019) 17:405\u201313. 10.1016/j.omtn.2019.06.008"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1371/journal.pone.0129190", "@IdType": "doi"}, {"#text": "PMC4465335", "@IdType": "pmc"}, {"#text": "26061048", "@IdType": "pubmed"}]}, "Citation": "Yu F, Bracken CP, Pillman KA, Lawrence DM, Goodall GJ, Callen DF, et al. . p53 represses the oncogenic Sno-MiR-28 derived from a SnoRNA. PLoS ONE. (2015) 10:e0129190. 10.1371/journal.pone.0129190"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1017/S1355838201001625", "@IdType": "doi"}, {"#text": "PMC1370079", "@IdType": "pmc"}, {"#text": "11233978", "@IdType": "pubmed"}]}, "Citation": "Peculis BA. snoRNA nuclear import and potential for cotranscriptional function in pre-rRNA processing. RNA. (2001) 7:207\u201319. 10.1017/S1355838201001625"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/onc.2017.286", "@IdType": "doi"}, {"#text": "28825722", "@IdType": "pubmed"}]}, "Citation": "Sun Y, Wei G, Luo H, Wu W, Skogerbo G, Luo J, et al. . The long noncoding RNA SNHG1 promotes tumor growth through regulating transcription of both local and distal genes. Oncogene. (2017) 36:6774\u201383. 10.1038/onc.2017.286"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1021/pr300555y", "@IdType": "doi"}, {"#text": "PMC3749780", "@IdType": "pmc"}, {"#text": "23116296", "@IdType": "pubmed"}]}, "Citation": "Yang Y, Toy W, Choong LY, Hou P, Ashktorab H, Smoot DT, et al. . Discovery of SLC3A2 cell membrane protein as a potential gastric cancer biomarker: implications in molecular imaging. J Proteome Res. (2012) 11:5736\u201347. 10.1021/pr300555y"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/or.2017.5530", "@IdType": "doi"}, {"#text": "PMC5428444", "@IdType": "pmc"}, {"#text": "28350098", "@IdType": "pubmed"}]}, "Citation": "Zhu B, Cheng D, Hou L, Zhou S, Ying T, Yang Q. SLC3A2 is upregulated in human osteosarcoma and promotes tumor growth through the PI3K/Akt signaling pathway. Oncol Rep. (2017) 37:2575\u201382. 10.3892/or.2017.5530"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3109/10409238.2013.840259", "@IdType": "doi"}, {"#text": "PMC3852498", "@IdType": "pmc"}, {"#text": "24088064", "@IdType": "pubmed"}]}, "Citation": "Poss ZC, Ebmeier CC, Taatjes DJ. The mediator complex and transcription regulation. Crit Rev Biochem Mol Biol. (2013) 48:575\u2013608. 10.3109/10409238.2013.840259"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1042/BSR20180420", "@IdType": "doi"}, {"#text": "PMC6127675", "@IdType": "pmc"}, {"#text": "30042166", "@IdType": "pubmed"}]}, "Citation": "Fei F, He Y, He S, He Z, Wang Y, Wu G, et al. . LncRNA SNHG3 enhances the malignant progress of glioma through silencing KLF2 and p21. Biosci Rep. (2018) 38:BSR20180420. 10.1042/BSR20180420"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41419-019-1940-3", "@IdType": "doi"}, {"#text": "PMC6751301", "@IdType": "pmc"}, {"#text": "31534128", "@IdType": "pubmed"}]}, "Citation": "Xuan Y, Wang Y. Long non-coding RNA SNHG3 promotes progression of gastric cancer by regulating neighboring MED18 gene methylation. Cell Death dis. (2019) 10:694. 10.1038/s41419-019-1940-3"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.16189", "@IdType": "doi"}, {"#text": "PMC5482614", "@IdType": "pmc"}, {"#text": "28423738", "@IdType": "pubmed"}]}, "Citation": "Yan Y, Fan Q, Wang L, Zhou Y, Li J, Zhou K. LncRNA Snhg1, a non-degradable sponge for miR-338, promotes expression of proto-oncogene CST3 in primary esophageal cancer cells. Oncotarget. (2017) 8:35750\u201360. 10.18632/oncotarget.16189"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrg.2016.20", "@IdType": "doi"}, {"#text": "27040487", "@IdType": "pubmed"}]}, "Citation": "Thomson DW, Dinger ME. Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet. (2016) 17:272\u201383. 10.1038/nrg.2016.20"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.26355/eurrev_201802_14379", "@IdType": "doi"}, {"#text": "29509245", "@IdType": "pubmed"}]}, "Citation": "Zhao Y, Qin ZS, Feng Y, Tang XJ, Zhang T, Yang L. Long non-coding RNA (lncRNA) small nucleolar RNA host gene 1 (SNHG1) promote cell proliferation in colorectal cancer by affecting P53. Eur Rev Med Pharmacol Sci. (2018) 22:976\u201384. 10.26355/eurrev_201802_14379"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.canlet.2018.03.038", "@IdType": "doi"}, {"#text": "29604394", "@IdType": "pubmed"}]}, "Citation": "Jiang H, Li T, Qu Y, Wang X, Li B, Song J, et al. . Long non-coding RNA SNHG15 interacts with and stabilizes transcription factor Slug and promotes colon cancer progression. Cancer Letters. 425:78\u201387 10.1016/j.canlet.2018.03.038"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s004180050177", "@IdType": "doi"}, {"#text": "9387929", "@IdType": "pubmed"}]}, "Citation": "Frey MR, Wu W, Dunn JM, Matera AG. The U22 host gene (UHG): chromosomal localization of UHG and distribution of U22 small nucleolar RNA. Histochem Cell Biol. (1997) 108:365\u201370. 10.1007/s004180050177"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/379464a0", "@IdType": "doi"}, {"#text": "8559254", "@IdType": "pubmed"}]}, "Citation": "Tycowski KT, Shu MD, Steitz JA. A mammalian gene with introns instead of exons generating stable RNA products. Nature. (1996) 379:464\u20136. 10.1038/379464a0"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.22903", "@IdType": "doi"}, {"#text": "PMC5762354", "@IdType": "pmc"}, {"#text": "29340086", "@IdType": "pubmed"}]}, "Citation": "Zhu Y, Li B, Liu Z, Jiang L, Wang G, Lv M, et al. . Up-regulation of lncRNA SNHG1 indicates poor prognosis and promotes cell proliferation and metastasis of colorectal cancer by activation of the Wnt/beta-catenin signaling pathway. Oncotarget. (2017) 8:111715\u201327. 10.18632/oncotarget.22903"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.23255", "@IdType": "doi"}, {"#text": "PMC5788627", "@IdType": "pmc"}, {"#text": "29416759", "@IdType": "pubmed"}]}, "Citation": "Tian T, Qiu R, Qiu X. SNHG1 promotes cell proliferation by acting as a sponge of miR-145 in colorectal cancer. Oncotarget. (2018) 9:2128\u201339. 10.18632/oncotarget.23255"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1691/ph.2017.7463", "@IdType": "doi"}, {"#text": "29441936", "@IdType": "pubmed"}]}, "Citation": "Qi H, Wang J, Wang F, Ma H. Long non-coding RNA SNHG1 promotes cell proliferation and tumorigenesis in colorectal cancer via Wnt/beta-catenin signaling. Pharmazie. (2017) 72:395\u2013401. 10.1691/ph.2017.7463"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/or.2016.5042", "@IdType": "doi"}, {"#text": "27572146", "@IdType": "pubmed"}]}, "Citation": "Li S, Wu X, Xu Y, Wu S, Li Z, Chen R, et al. . miR-145 suppresses colorectal cancer cell migration and invasion by targeting an ETS-related gene. Oncol Rep. (2016) 36:1917\u201326. 10.3892/or.2016.5042"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.26355/eurrev_201801_14176", "@IdType": "doi"}, {"#text": "29424921", "@IdType": "pubmed"}]}, "Citation": "Ge J, Wu XM, Yang XT, Gao JM, Wang F, Ye KF. Role of long non-coding RNA SNHG1 in occurrence and progression of ovarian carcinoma. Eur Rev Med Pharmacol Sci. (2018) 22:329\u201335. 10.26355/eurrev_201801_14176"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bbrc.2017.03.169", "@IdType": "doi"}, {"#text": "28400279", "@IdType": "pubmed"}]}, "Citation": "Li J, Zhang Z, Xiong L, Guo C, Jiang T, Zeng L, et al. . SNHG1 lncRNA negatively regulates miR-199a-3p to enhance CDK7 expression and promote cell proliferation in prostate cancer. Biochem Biophys Res Commun. (2017) 487:146\u201352. 10.1016/j.bbrc.2017.03.169"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.18315", "@IdType": "doi"}, {"#text": "PMC5663533", "@IdType": "pmc"}, {"#text": "29137361", "@IdType": "pubmed"}]}, "Citation": "Zhong J, Huang R, Su Z, Zhang M, Xu M, Gong J, et al. . Downregulation of miR-199a-5p promotes prostate adeno-carcinoma progression through loss of its inhibition of HIF-1alpha. Oncotarget. (2017) 8:83523\u201338. 10.18632/oncotarget.18315"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3748/wjg.v10.i8.1082", "@IdType": "doi"}, {"#text": "PMC4656338", "@IdType": "pmc"}, {"#text": "15069703", "@IdType": "pubmed"}]}, "Citation": "Shi Y-H, Fang W-G. Hypoxia-inducible factor-1 in tumour angiogenesis. World J Gastroenterol. (2004) 10:1082\u20137. 10.3748/wjg.v10.i8.1082"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41598-017-10977-9", "@IdType": "doi"}, {"#text": "PMC5589838", "@IdType": "pmc"}, {"#text": "28883406", "@IdType": "pubmed"}]}, "Citation": "Park M, Yoon HJ, Kang MC, Kwon J, Lee HW. MiR-338-5p enhances the radiosensitivity of esophageal squamous cell carcinoma by inducing apoptosis through targeting survivin. Sci Rep. (2017) 7:10932. 10.1038/s41598-017-10977-9"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3233/CBM-170286", "@IdType": "doi"}, {"#text": "29081407", "@IdType": "pubmed"}]}, "Citation": "Zhang Y, Jin X, Wang Z, Zhang X, Liu S, Liu G. Downregulation of SNHG1 suppresses cell proliferation and invasion by regulating Notch signaling pathway in esophageal squamous cell cancer. Cancer Biomarkers. (2017) 21:1\u20138. 10.3233/CBM-170286"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1172/JCI39104", "@IdType": "doi"}, {"#text": "PMC2689101", "@IdType": "pmc"}, {"#text": "19487818", "@IdType": "pubmed"}]}, "Citation": "Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Investig. (2009) 119:1420\u20138. 10.1172/JCI39104"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s00018-008-8281-1", "@IdType": "doi"}, {"#text": "18726070", "@IdType": "pubmed"}]}, "Citation": "Van Roy F, Berx G. The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci. (2008) 65:3756\u201388. 10.1007/s00018-008-8281-1"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1387/ijdb.041793ld", "@IdType": "doi"}, {"#text": "15349821", "@IdType": "pubmed"}]}, "Citation": "Derycke LD, Bracke ME. N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling. Int J Dev Biol. (2004) 48:463\u201376. 10.1387/ijdb.041793ld"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1165/rcmb.2013-0314TR", "@IdType": "doi"}, {"#text": "PMC3930939", "@IdType": "pmc"}, {"#text": "23980547", "@IdType": "pubmed"}]}, "Citation": "Kidd ME, Shumaker DK, Ridge KM. The role of vimentin intermediate filaments in the progression of lung cancer. Am J Respir Cell Mol Biol. (2014) 50:1\u20136. 10.1165/rcmb.2013-0314TR"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.biopha.2016.02.036", "@IdType": "doi"}, {"#text": "27133041", "@IdType": "pubmed"}]}, "Citation": "Zhang M, Wang W, Li T, Yu X, Zhu Y, Ding F, et al. . Long noncoding RNA SNHG1 predicts a poor prognosis and promotes hepatocellular carcinoma tumorigenesis. Biomed Pharmacother. (2016) 80:73\u20139. 10.1016/j.biopha.2016.02.036"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.12659/MSM.898574", "@IdType": "doi"}, {"#text": "PMC5167104", "@IdType": "pmc"}, {"#text": "27932778", "@IdType": "pubmed"}]}, "Citation": "Zhang H, Zhou D, Ying M, Chen M, Chen P, Chen Z, et al. . Expression of long non-coding RNA (lncRNA) small nucleolar RNA host gene 1 (SNHG1) exacerbates hepatocellular carcinoma through suppressing miR-195. Med Sci Monit. (2016) 22:4820\u20139. 10.12659/MSM.898574"}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4713510", "@IdType": "pmc"}, {"#text": "26823724", "@IdType": "pubmed"}]}, "Citation": "Wang M, Zhang J, Tong L, Ma X, Qiu X. MiR-195 is a key negative regulator of hepatocellular carcinoma metastasis by targeting FGF2 and VEGFA. Int J Clin Exp Pathol. (2015) 8:14110\u201320."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.biopha.2017.05.014", "@IdType": "doi"}, {"#text": "28501778", "@IdType": "pubmed"}]}, "Citation": "Wang Q, Li Q, Zhou P, Deng D, Xue L, Shao N, et al. . Upregulation of the long non-coding RNA SNHG1 predicts poor prognosis, promotes cell proliferation and invasion, and reduces apoptosis in glioma. Biomed Pharmacother. (2017) 91:906\u201311. 10.1016/j.biopha.2017.05.014"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1096/fj.201701237RR", "@IdType": "doi"}, {"#text": "29466052", "@IdType": "pubmed"}]}, "Citation": "Lu Q, Shan S, Li Y, Zhu D, Jin W, Ren T. Long noncoding RNA SNHG1 promotes non-small cell lung cancer progression by up-regulating MTDH via sponging miR-145-5p. FASEB J. (2018) 32:3957\u201367. 10.1096/fj.201701237RR"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.14854", "@IdType": "doi"}, {"#text": "PMC5392286", "@IdType": "pmc"}, {"#text": "28147312", "@IdType": "pubmed"}]}, "Citation": "Cui Y, Zhang F, Zhu C, Geng L, Tian T, Liu H. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/beta-catenin signaling pathway. Oncotarget. (2017) 8:17785\u201394. 10.18632/oncotarget.14854"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s13073-016-0284-1", "@IdType": "doi"}, {"#text": "PMC4797185", "@IdType": "pmc"}, {"#text": "26988859", "@IdType": "pubmed"}]}, "Citation": "Almeida MI, Calin GA. The miR-143/miR-145 cluster and the tumor microenvironment: unexpected roles. Genome Med. (2016) 8:29. 10.1186/s13073-016-0284-1"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1080/15384047.2016.1139242", "@IdType": "doi"}, {"#text": "PMC4847994", "@IdType": "pmc"}, {"#text": "26909466", "@IdType": "pubmed"}]}, "Citation": "Li Y, Li Y, Liu J, Fan Y, Li X, Dong M, et al. . Expression levels of microRNA-145 and microRNA-10b are associated with metastasis in non-small cell lung cancer. Cancer Biol Ther. (2016) 17:272\u20139. 10.1080/15384047.2016.1139242"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s12032-011-0085-8", "@IdType": "doi"}, {"#text": "21993632", "@IdType": "pubmed"}]}, "Citation": "Luo L, Zhang T, Liu H, Lv T, Yuan D, Yao Y, et al. . MiR-101 and Mcl-1 in non-small-cell lung cancer: expression profile and clinical significance. Med Oncol. (2012) 29:1681\u20136. 10.1007/s12032-011-0085-8"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.biopha.2016.10.008", "@IdType": "doi"}, {"#text": "27723574", "@IdType": "pubmed"}]}, "Citation": "Cao L, Wang J, Wang PQ. MiR-326 is a diagnostic biomarker and regulates cell survival and apoptosis by targeting Bcl-2 in osteosarcoma. Biomed Pharmacother. (2016) 84:828\u201335. 10.1016/j.biopha.2016.10.008"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1126/science.275.5303.1129", "@IdType": "doi"}, {"#text": "9027314", "@IdType": "pubmed"}]}, "Citation": "Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, et al. . Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. (1997) 275:1129\u201332. 10.1126/science.275.5303.1129"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bbrc.2017.11.012", "@IdType": "doi"}, {"#text": "29108989", "@IdType": "pubmed"}]}, "Citation": "Jiang Z, Jiang C, Fang J. Up-regulated lnc-SNHG1 contributes to osteosarcoma progression through sequestration of miR-577 and activation of WNT2B/Wnt/beta-catenin pathway. Biochem Biophys Res Commun. (2018) 495:238\u201345. 10.1016/j.bbrc.2017.11.012"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1128/MCB.18.8.4509", "@IdType": "doi"}, {"#text": "PMC109036", "@IdType": "pmc"}, {"#text": "9671460", "@IdType": "pubmed"}]}, "Citation": "Pelczar P, Filipowicz W. The host gene for intronic U17 small nucleolar RNAs in mammals has no protein-coding potential and is a member of the 5'-terminal oligopyrimidine gene family. Mol Cell Biol. (1998) 18:4509\u201318. 10.1128/MCB.18.8.4509"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.biopha.2019.108695", "@IdType": "doi"}, {"#text": "30797154", "@IdType": "pubmed"}]}, "Citation": "Zheng S, Jiang F, Ge D, Tang J, Chen H, Yang J, et al. . LncRNA SNHG3/miRNA-151a-3p/RAB22A axis regulates invasion and migration of osteosarcoma. Biomed Pharmacother. (2019) 112:108695. 10.1016/j.biopha.2019.108695"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1177/2058738418820743", "@IdType": "doi"}, {"#text": "PMC6329016", "@IdType": "pmc"}, {"#text": "30791797", "@IdType": "pubmed"}]}, "Citation": "Chen J, Wu Z, Zhang Y. LncRNA SNHG3 promotes cell growth by sponging miR-196a-5p and indicates the poor survival in osteosarcoma. Int J Immunopathol Pharmacol. (2019) 33:2058738418820743. 10.1177/2058738418820743"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.4049/jimmunol.175.5.3060", "@IdType": "doi"}, {"#text": "16116194", "@IdType": "pubmed"}]}, "Citation": "Wu J, Lingrel JB. Kruppel-like factor 2, a novel immediate-early transcriptional factor, regulates IL-2 expression in T lymphocyte activation. J Immunol. (2005) 175:3060\u20136. 10.4049/jimmunol.175.5.3060"}, {"ArticleIdList": {"ArticleId": {"#text": "27655487", "@IdType": "pubmed"}}, "Citation": "Mao QQ, Chen JJ, Dong L, Zhong L, Sun X. Kruppel-like factor 2 suppresses growth and invasion of gastric cancer cells in vitro and in vivo. J Biol Regul Homeost Agents. (2016) 30:703\u201312."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrc2657", "@IdType": "doi"}, {"#text": "PMC2722839", "@IdType": "pmc"}, {"#text": "19440234", "@IdType": "pubmed"}]}, "Citation": "Abbas T, Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer. (2009) 9:400\u201314. 10.1038/nrc2657"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/or.2017.5837", "@IdType": "doi"}, {"#text": "PMC5549033", "@IdType": "pmc"}, {"#text": "28731158", "@IdType": "pubmed"}]}, "Citation": "Huang W, Tian Y, Dong S, Cha Y, Li J, Guo X, et al. . The long non-coding RNA SNHG3 functions as a competing endogenous RNA to promote malignant development of colorectal cancer. Oncol Rep. (2017) 38:1402\u201310. 10.3892/or.2017.5837"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s13277-015-4052-4", "@IdType": "doi"}, {"#text": "26373735", "@IdType": "pubmed"}]}, "Citation": "Zhang T, Cao C, Wu D, Liu L. SNHG3 correlates with malignant status and poor prognosis in hepatocellular carcinoma. Tumour Biol. (2016) 37:2379\u201385. 10.1007/s13277-015-4052-4"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/ncomms13875", "@IdType": "doi"}, {"#text": "PMC5192221", "@IdType": "pmc"}, {"#text": "28004750", "@IdType": "pubmed"}]}, "Citation": "Damas ND, Marcatti M, Come C, Christensen LL, Nielsen MM, Baumgartner R, et al. . SNHG5 promotes colorectal cancer cell survival by counteracting STAU1-mediated mRNA destabilization. Nat Commun. (2016) 7:13875. 10.1038/ncomms13875"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.omtn.2019.05.013", "@IdType": "doi"}, {"#text": "PMC6606894", "@IdType": "pmc"}, {"#text": "31255976", "@IdType": "pubmed"}]}, "Citation": "Chi JR, Yu ZH, Liu BW, Zhang D, Ge J, Yu Y, et al. . SNHG5 promotes breast cancer proliferation by sponging the miR-154-5p/PCNA axis. Mol Ther Nucleic Acids. (2019) 17:138\u201349. 10.1016/j.omtn.2019.05.013"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3389/fonc.2018.00015", "@IdType": "doi"}, {"#text": "PMC5807667", "@IdType": "pmc"}, {"#text": "29459886", "@IdType": "pubmed"}]}, "Citation": "Turgeon M-O, Perry NJS, Poulogiannis G. DNA damage, repair, and cancer metabolism. Front Oncol. (2018) 8:15. 10.3389/fonc.2018.00015"}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5574942", "@IdType": "pmc"}, {"#text": "28861326", "@IdType": "pubmed"}]}, "Citation": "He B, Bai Y, Kang W, Zhang X, Jiang X. LncRNA SNHG5 regulates imatinib resistance in chronic myeloid leukemia via acting as a CeRNA against MiR-205-5p. Am J Cancer Res. (2017) 7:1704\u201313."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.4149/neo_2015_115", "@IdType": "doi"}, {"#text": "26458312", "@IdType": "pubmed"}]}, "Citation": "Jurkovicova D, Lukackova R, Magyerkova M, Kulcsar L, Krivjanska M, Krivjansky V, et al. . microRNA expression profiling as supportive diagnostic and therapy prediction tool in chronic myeloid leukemia. Neoplasma. (2015) 62:949\u201358. 10.4149/neo_2015_115"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1096/fj.201600994R", "@IdType": "doi"}, {"#text": "27871067", "@IdType": "pubmed"}]}, "Citation": "Zhao L, Han T, Li Y, Sun J, Zhang S, Liu Y, et al. . The lncRNA SNHG5/miR-32 axis regulates gastric cancer cell proliferation and migration by targeting KLF4. FASEB J. (2017) 31:893\u2013903. 10.1096/fj.201600994R"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/onc.2016.110", "@IdType": "doi"}, {"#text": "27065326", "@IdType": "pubmed"}]}, "Citation": "Zhao L, Guo H, Zhou B, Feng J, Li Y, Han T, et al. . Long non-coding RNA SNHG5 suppresses gastric cancer progression by trapping MTA2 in the cytosol. Oncogene. (2016) 35:5770\u201380. 10.1038/onc.2016.110"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/jjco/hyv062", "@IdType": "doi"}, {"#text": "25969565", "@IdType": "pubmed"}]}, "Citation": "Zhang B, Zhang H, Shen G. Metastasis-associated protein 2 (MTA2) promotes the metastasis of non-small-cell lung cancer through the inhibition of the cell adhesion molecule Ep-CAM and E-cadherin. Jpn J Clin Oncol. (2015) 45:755\u201366. 10.1093/jjco/hyv062"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3109/14756366.2016.1161620", "@IdType": "doi"}, {"#text": "27028474", "@IdType": "pubmed"}]}, "Citation": "Jab\u0142onska-Trypu\u0107 A, Matejczyk M, Rosochacki S. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs. J Enzyme Inhibition Med Chem. (2016) 31:177\u201383. 10.3109/14756366.2016.1161620"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2147/OTT.S184078", "@IdType": "doi"}, {"#text": "PMC6309782", "@IdType": "pmc"}, {"#text": "30636880", "@IdType": "pubmed"}]}, "Citation": "Gao J, Zeng K, Liu Y, Gao L, Liu L. LncRNA SNHG5 promotes growth and invasion in melanoma by regulating the miR-26a-5p/TRPC3 pathway. Onco Targets Ther. (2019) 12:169\u201379. 10.2147/OTT.S184078"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ygeno.2009.02.003", "@IdType": "doi"}, {"#text": "19272437", "@IdType": "pubmed"}]}, "Citation": "Makarova JA, Kramerov DA. Analysis of C/D box snoRNA genes in vertebrates: the number of copies decreases in placental mammals. Genomics. (2009) 94:11\u20139. 10.1016/j.ygeno.2009.02.003"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/ijms14059099", "@IdType": "doi"}, {"#text": "PMC3676775", "@IdType": "pmc"}, {"#text": "23698766", "@IdType": "pubmed"}]}, "Citation": "Chaudhry MA. Expression pattern of small nucleolar RNA host genes and long non-coding RNA in X-rays-treated lymphoblastoid cells. Int J Mol Sci. (2013) 14:9099\u2013110. 10.3390/ijms14059099"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1159/000478682", "@IdType": "doi"}, {"#text": "28683446", "@IdType": "pubmed"}]}, "Citation": "Yan K, Tian J, Shi W, Xia H, Zhu Y. LncRNA SNHG6 is associated with poor prognosis of gastric cancer and promotes cell proliferation and EMT through Epigenetically Silencing p27 and sponging miR-101-3p. Cell Physiol Biochem. (2017) 42:999\u20131012. 10.1159/000478682"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2147/OTT.S197433", "@IdType": "doi"}, {"#text": "PMC6504670", "@IdType": "pmc"}, {"#text": "31118686", "@IdType": "pubmed"}]}, "Citation": "Zhang M, Duan W, Sun W. LncRNA SNHG6 promotes the migration, invasion, and epithelial-mesenchymal transition of colorectal cancer cells by miR-26a/EZH2 axis. Onco Targets Ther. (2019) 12:3349\u201360. 10.2147/OTT.S197433"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2147/CMAR.S182719", "@IdType": "doi"}, {"#text": "PMC6331078", "@IdType": "pmc"}, {"#text": "30666158", "@IdType": "pubmed"}]}, "Citation": "Yu C, Sun J, Leng X, Yang J. Long noncoding RNA SNHG6 functions as a competing endogenous RNA by sponging miR-181a-5p to regulate E2F5 expression in colorectal cancer. Cancer Manag Res. (2019) 11:611\u201324. 10.2147/CMAR.S182719"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s13045-018-0690-5", "@IdType": "doi"}, {"#text": "PMC6327409", "@IdType": "pmc"}, {"#text": "30626446", "@IdType": "pubmed"}]}, "Citation": "Xu M, Chen X, Lin K, Zeng K, Liu X, Xu X, et al. . lncRNA SNHG6 regulates EZH2 expression by sponging miR-26a/b and miR-214 in colorectal cancer. J Hematol Oncol. (2019) 12:3. 10.1186/s13045-018-0690-5"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.4161/15384047.2014.987523", "@IdType": "doi"}, {"#text": "PMC4622743", "@IdType": "pmc"}, {"#text": "25561270", "@IdType": "pubmed"}]}, "Citation": "Zhou X, Xia Y, Li L, Zhang G. MiR-101 inhibits cell growth and tumorigenesis of Helicobacter pylori related gastric cancer by repression of SOCS2. Cancer Biol Ther. (2015) 16:160\u20139. 10.4161/15384047.2014.987523"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1111/febs.12013", "@IdType": "doi"}, {"#text": "23013439", "@IdType": "pubmed"}]}, "Citation": "He XP, Shao Y, Li XL, Xu W, Chen GS, Sun HH, et al. . Downregulation of miR-101 in gastric cancer correlates with cyclooxygenase-2 overexpression and tumor growth. FEBS J. (2012) 279:4201\u201312. 10.1111/febs.12013"}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6413246", "@IdType": "pmc"}, {"#text": "30899408", "@IdType": "pubmed"}]}, "Citation": "Zhang Y, Li R, Ding X, Zhang K, Qin W. Upregulation of long non-coding RNA SNHG6 promote esophageal squamous cell carcinoma cell malignancy and its diagnostic value. Am J Transl Res. (2019) 11:1084\u201391."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.canlet.2016.09.034", "@IdType": "doi"}, {"#text": "27702662", "@IdType": "pubmed"}]}, "Citation": "Chang L, Yuan Y, Li C, Guo T, Qi H, Xiao Y, et al. . Upregulation of SNHG6 regulates ZEB1 expression by competitively binding miR-101-3p and interacting with UPF1 in hepatocellular carcinoma. Cancer Lett. (2016) 383:183\u201394. 10.1016/j.canlet.2016.09.034"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12935-019-0794-1", "@IdType": "doi"}, {"#text": "PMC6448242", "@IdType": "pmc"}, {"#text": "30988663", "@IdType": "pubmed"}]}, "Citation": "Zhu X, Yang G, Xu J, Zhang C. Silencing of SNHG6 induced cell autophagy by targeting miR-26a-5p/ULK1 signaling pathway in human osteosarcoma. Cancer Cell Int. (2019) 19:82. 10.1186/s12935-019-0794-1"}, {"ArticleIdList": {"ArticleId": {"#text": "10.1101/709352", "@IdType": "doi"}}, "Citation": "Boone D, Warburton A, Som S, Lee A. A negative feedback loop between Insulin-like Growth Factor signaling and the lncRNA SNHG7 tightly regulates transcript levels and proliferation. (2019). 10.1101/709352"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.7150/jca.25507", "@IdType": "doi"}, {"#text": "PMC6360294", "@IdType": "pmc"}, {"#text": "30719150", "@IdType": "pubmed"}]}, "Citation": "Xu C, Zhou J, Wang Y, Wang A, Su L, Liu S, et al. . Inhibition of malignant human bladder cancer phenotypes through the down-regulation of the long non-coding RNA SNHG7. J Cancer. (2019) 10:539\u201346. 10.7150/jca.25507"}, {"ArticleIdList": {"ArticleId": {"#text": "30003751", "@IdType": "pubmed"}}, "Citation": "Zhong X, Long Z, Wu S, Xiao M, Hu W. LncRNA-SNHG7 regulates proliferation, apoptosis and invasion of bladder cancer cells assurance guidelines. J Buon. (2018) 23:776\u201381."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.prp.2018.11.015", "@IdType": "doi"}, {"#text": "30527358", "@IdType": "pubmed"}]}, "Citation": "Chen Y, Peng Y, Xu Z, Ge B, Xiang X, Zhang T, et al. . Knockdown of lncRNA SNHG7 inhibited cell proliferation and migration in bladder cancer through activating Wnt/beta-catenin pathway. Pathol Res Pract. (2019) 215:302\u20137. 10.1016/j.prp.2018.11.015"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.tcb.2008.01.007", "@IdType": "doi"}, {"#text": "PMC3242477", "@IdType": "pmc"}, {"#text": "18314333", "@IdType": "pubmed"}]}, "Citation": "Chipuk JE, Green DR. How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol. (2008) 18:157\u201364. 10.1016/j.tcb.2008.01.007"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.devcel.2009.06.016", "@IdType": "doi"}, {"#text": "PMC2861485", "@IdType": "pmc"}, {"#text": "19619488", "@IdType": "pubmed"}]}, "Citation": "Macdonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. (2009) 17:9\u201326. 10.1016/j.devcel.2009.06.016"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ejphar.2019.172407", "@IdType": "doi"}, {"#text": "31132353", "@IdType": "pubmed"}]}, "Citation": "Sun X, Huang T, Liu Z, Sun M, Luo S. LncRNA SNHG7 contributes to tumorigenesis and progression in breast cancer by interacting with miR-34a through EMT initiation and the Notch-1 pathway. Eur J Pharmacol. (2019) 856:172407. 10.1016/j.ejphar.2019.172407"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.26355/eurrev_201811_16403", "@IdType": "doi"}, {"#text": "30536320", "@IdType": "pubmed"}]}, "Citation": "Luo X, Song Y, Tang L, Sun DH, Ji DG. LncRNA SNHG7 promotes development of breast cancer by regulating microRNA-186. Eur Rev Med Pharmacol Sci. (2018) 22:7788\u201397. 10.26355/eurrev_201811_16403"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.26355/eurrev_201908_18545", "@IdType": "doi"}, {"#text": "31378900", "@IdType": "pubmed"}]}, "Citation": "Gao YT, Zhou YC. Long non-coding RNA (lncRNA) small nucleolar RNA host gene 7 (SNHG7) promotes breast cancer progression by sponging miRNA-381. Eur Rev Med Pharmacol Sci. (2019) 23:6588\u201395. 10.26355/eurrev_201908_18545"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s13045-018-0632-2", "@IdType": "doi"}, {"#text": "PMC6029165", "@IdType": "pmc"}, {"#text": "29970122", "@IdType": "pubmed"}]}, "Citation": "Li Y, Zeng C, Hu J, Pan Y, Shan Y, Liu B, et al. . Long non-coding RNA-SNHG7 acts as a target of miR-34a to increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in colorectal cancer progression. J Hematol Oncol. (2018) 11:89. 10.1186/s13045-018-0632-2"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41419-018-0759-7", "@IdType": "doi"}, {"#text": "PMC6006356", "@IdType": "pmc"}, {"#text": "29915311", "@IdType": "pubmed"}]}, "Citation": "Shan Y, Ma J, Pan Y, Hu J, Liu B, Jia L. LncRNA SNHG7 sponges miR-216b to promote proliferation and liver metastasis of colorectal cancer through upregulating GALNT1. Cell Death Dis. (2018) 9:1\u201313. 10.1038/s41419-018-0759-7"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.26355/eurrev_201805_14961", "@IdType": "doi"}, {"#text": "29771415", "@IdType": "pubmed"}]}, "Citation": "Xu LJ, Yu XJ, Wei B, Hui HX, Sun Y, Dai J, et al. . LncRNA SNHG7 promotes the proliferation of esophageal cancer cells and inhibits its apoptosis. Eur Rev Med Pharmacol Sci. (2018) 22:2653\u201361. 10.26355/eurrev_201805_14961"}, {"ArticleIdList": {"ArticleId": {"#text": "29131253", "@IdType": "pubmed"}}, "Citation": "Wang MW, Liu J, Liu Q, Xu QH, Li TF, Jin S, et al. . LncRNA SNHG7 promotes the proliferation and inhibits apoptosis of gastric cancer cells by repressing the P15 and P16 expression. Eur Rev Med Pharmacol Sci. (2017) 21:4613\u201322."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bbrc.2018.01.109", "@IdType": "doi"}, {"#text": "29360452", "@IdType": "pubmed"}]}, "Citation": "Ren J, Yang Y, Xue J, Xi Z, Hu L, Pan SJ, et al. . Long noncoding RNA SNHG7 promotes the progression and growth of glioblastoma via inhibition of miR-5095. Biochem Biophys Res Commun. (2018) 496:712\u20138. 10.1016/j.bbrc.2018.01.109"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.26355/eurrev_201907_18307", "@IdType": "doi"}, {"#text": "31298322", "@IdType": "pubmed"}]}, "Citation": "Sun BZ, Ji DG, Feng ZX, Wang Y. Long noncoding RNA SNHG7 represses the expression of RBM5 to strengthen metastasis of hepatocellular carcinoma. Eur Rev Med Pharmacol Sci. (2019) 23:5699\u2013704. 10.26355/eurrev_201907_18307"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.26355/eurrev_201906_18069", "@IdType": "doi"}, {"#text": "31210315", "@IdType": "pubmed"}]}, "Citation": "Zhang C, Zhu B, Li XB, Cao YQ, Yang JC, Li X, et al. . Long non-coding RNA SNHG7 promotes migration and invasion of melanoma via upregulating SOX4. Eur Rev Med Pharmacol Sci. (2019) 23:4828\u201334. 10.26355/eurrev_201906_18069"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bbrc.2015.07.127", "@IdType": "doi"}, {"#text": "26231797", "@IdType": "pubmed"}]}, "Citation": "Guo J, Liu X, Wang M. miR-503 suppresses tumor cell proliferation and metastasis by directly targeting RNF31 in prostate cancer. Biochem Biophys Res Commun. (2015) 464:1302\u20138. 10.1016/j.bbrc.2015.07.127"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.biopha.2018.03.011", "@IdType": "doi"}, {"#text": "29571017", "@IdType": "pubmed"}]}, "Citation": "Qi H, Wen B, Wu Q, Cheng W, Lou J, Wei J, et al. . Long noncoding RNA SNHG7 accelerates prostate cancer proliferation and cycle progression through cyclin D1 by sponging miR-503. Biomed Pharmacother. (2018) 102:326\u201332. 10.1016/j.biopha.2018.03.011"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/or.2016.5105", "@IdType": "doi"}, {"#text": "27666964", "@IdType": "pubmed"}]}, "Citation": "She K, Huang J, Zhou H, Huang T, Chen G, He J. lncRNA-SNHG7 promotes the proliferation, migration and invasion and inhibits apoptosis of lung cancer cells by enhancing the FAIM2 expression. Oncol Rep. (2016) 36:2673\u201380. 10.3892/or.2016.5105"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1111/cpr.12406", "@IdType": "doi"}, {"#text": "PMC6528931", "@IdType": "pmc"}, {"#text": "29131440", "@IdType": "pubmed"}]}, "Citation": "She K, Yan H, Huang J, Zhou H, He J. miR-193b availability is antagonized by LncRNA-SNHG7 for FAIM2-induced tumour progression in non-small cell lung cancer. Cell Prolif. (2018) 51:e12406. 10.1111/cpr.12406"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/jcp.28017", "@IdType": "doi"}, {"#text": "30623419", "@IdType": "pubmed"}]}, "Citation": "Chi R, Chen X, Liu M, Zhang H, Li F, Fan X, et al. . Role of SNHG7-miR-653-5p-STAT2 feedback loop in regulating neuroblastoma progression. J Cell Physiol. (2019) 234:13403\u201312. 10.1002/jcp.28017"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1159/000488045", "@IdType": "doi"}, {"#text": "29533945", "@IdType": "pubmed"}]}, "Citation": "Dong J, Wang Q, Li L, Xiao-Jin Z. Upregulation of long non-coding RNA small nucleolar RNA host gene 12 contributes to cell growth and invasion in cervical cancer by acting as a sponge for MiR-424-5p. Cell Physiol Biochem. (2018) 45:2086\u201394. 10.1159/000488045"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/mmr.2017.8143", "@IdType": "doi"}, {"#text": "29207106", "@IdType": "pubmed"}]}, "Citation": "Zhang H, Lu W. LncRNA SNHG12 regulates gastric cancer progression by acting as a molecular sponge of miR320. Mol Med Rep. (2018) 17:2743\u20139. 10.3892/mmr.2017.8143"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12935-019-0782-5", "@IdType": "doi"}, {"#text": "PMC6518781", "@IdType": "pmc"}, {"#text": "31114448", "@IdType": "pubmed"}]}, "Citation": "Chen Q, Zhou W, Du SQ, Gong DX, Li J, Bi JB, et al. . Overexpression of SNHG12 regulates the viability and invasion of renal cell carcinoma cells through modulation of HIF1alpha. Cancer Cell Int. (2019) 19:128. 10.1186/s12935-019-0782-5"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.26355/eurrev_201803_14471", "@IdType": "doi"}, {"#text": "29565487", "@IdType": "pubmed"}]}, "Citation": "Yang BF, Cai W, Chen B. LncRNA SNHG12 regulated the proliferation of gastric carcinoma cell BGC-823 by targeting microRNA-199a/b-5p. Eur Rev Med Pharmacol Sci. (2018) 22:1297\u2013306. 10.26355/eurrev_201803_14471"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.20475", "@IdType": "doi"}, {"#text": "PMC5663579", "@IdType": "pmc"}, {"#text": "29137407", "@IdType": "pubmed"}]}, "Citation": "Wang P, Chen D, Ma H, Li Y. LncRNA SNHG12 contributes to multidrug resistance through activating the MAPK/Slug pathway by sponging miR-181a in non-small cell lung cancer. Oncotarget. (2017) 8:84086\u2013101. 10.18632/oncotarget.20475"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.14670/HH-18-155", "@IdType": "doi"}, {"#text": "31355416", "@IdType": "pubmed"}]}, "Citation": "Feng X, Dong X, Wu D, Zhao H, Xu C, Li H. Long noncoding RNA small nucleolar RNA host gene 12 promotes papillary thyroid carcinoma cell growth and invasion by targeting miR-16-5p. Histol Histopathol. (2019) 35:217\u201324. 10.14670/HH-18-155"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.12659/MSM.917088", "@IdType": "doi"}, {"#text": "PMC6681687", "@IdType": "pmc"}, {"#text": "31348766", "@IdType": "pubmed"}]}, "Citation": "Li J, Sun S, Chen W, Yuan K. Small nucleolar RNA host gene 12 (SNHG12) promotes proliferation and invasion of laryngeal cancer cells via sponging miR-129-5p and potentiating WW domain-containing E3 ubiquitin protein ligase 1 (WWP1) expression. Med Sci Monit. (2019) 25:5552\u201360. 10.12659/MSM.917088"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bbrc.2017.12.047", "@IdType": "doi"}, {"#text": "29229388", "@IdType": "pubmed"}]}, "Citation": "Zhou S, Yu L, Xiong M, Dai G. LncRNA SNHG12 promotes tumorigenesis and metastasis in osteosarcoma by upregulating Notch2 by sponging miR-195-5p. Biochem Biophys Res Commun. (2018) 495:1822\u201332. 10.1016/j.bbrc.2017.12.047"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/ol.2018.9880", "@IdType": "doi"}, {"#text": "PMC6351734", "@IdType": "pmc"}, {"#text": "30719111", "@IdType": "pubmed"}]}, "Citation": "Wang Y, Liang S, Yu Y, Shi Y, Zheng H. Knockdown of SNHG12 suppresses tumor metastasis and epithelial-mesenchymal transition via the Slug/ZEB2 signaling pathway by targeting miR-218 in NSCLC. Oncol Lett. (2019) 17:2356\u201364. 10.3892/ol.2018.9880"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.biopha.2018.07.003", "@IdType": "doi"}, {"#text": "30119255", "@IdType": "pubmed"}]}, "Citation": "Zhou B, Li L, Li Y, Sun H, Zeng C. Long noncoding RNA SNHG12 mediates doxorubicin resistance of osteosarcoma via miR-320a/MCL1 axis. Biomed Pharmacother. (2018) 106:850\u20137. 10.1016/j.biopha.2018.07.003"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.gene.2018.08.034", "@IdType": "doi"}, {"#text": "30098431", "@IdType": "pubmed"}]}, "Citation": "Sun Y, Liu J, Chu L, Yang W, Liu H, Li C, et al. . Long noncoding RNA SNHG12 facilitates the tumorigenesis of glioma through miR-101-3p/FOXP1 axis. Gene. (2018) 676:315\u201321. 10.1016/j.gene.2018.08.034"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.omtn.2017.12.001", "@IdType": "doi"}, {"#text": "PMC5751968", "@IdType": "pmc"}, {"#text": "29499929", "@IdType": "pubmed"}]}, "Citation": "Liu X, Zheng J, Xue Y, Qu C, Chen J, Wang Z, et al. . Inhibition of TDP43-mediated SNHG12-miR-195-SOX5 feedback loop impeded malignant biological behaviors of glioma cells. Mol Ther Nucleic Acids. (2018) 10:142\u201358. 10.1016/j.omtn.2017.12.001"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/ijo.2018.4478", "@IdType": "doi"}, {"#text": "30015836", "@IdType": "pubmed"}]}, "Citation": "Lei W, Wang ZL, Feng HJ, Lin XD, Li CZ, Fan D. Long non-coding RNA SNHG12promotes the proliferation and migration of glioma cells by binding to HuR. Int J Oncol. (2018) 53:1374\u201384. 10.3892/ijo.2018.4478"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/onc.2012.121", "@IdType": "doi"}, {"#text": "22469983", "@IdType": "pubmed"}]}, "Citation": "Xu J, Li Y, Wang F, Wang X, Cheng B, Ye F, et al. . Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer. Oncogene. (2013) 32:976\u201387. 10.1038/onc.2012.121"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.12716", "@IdType": "doi"}, {"#text": "PMC5363600", "@IdType": "pmc"}, {"#text": "27769049", "@IdType": "pubmed"}]}, "Citation": "Wang X, Li Q, Jin H, Zou H, Xia W, Dai N, et al. . miR-424 acts as a tumor radiosensitizer by targeting aprataxin in cervical cancer. Oncotarget. (2016) 7:77508\u201315. 10.18632/oncotarget.12716"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1590/1414-431x20176079", "@IdType": "doi"}, {"#text": "PMC5333723", "@IdType": "pmc"}, {"#text": "28225893", "@IdType": "pubmed"}]}, "Citation": "Wang JZ, Xu CL, Wu H, Shen SJ. LncRNA SNHG12 promotes cell growth and inhibits cell apoptosis in colorectal cancer cells. Braz J Med Biol Res. (2017) 50:e6079. 10.1590/1414-431x20176079"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bbcan.2014.09.008", "@IdType": "doi"}, {"#text": "25450577", "@IdType": "pubmed"}]}, "Citation": "Danielsen SA, Eide PW, Nesbakken A, Guren T, Leithe E, Lothe RA. Portrait of the PI3K/AKT pathway in colorectal cancer. Biochim Biophys Acta. (2015) 1855:104\u201321. 10.1016/j.bbcan.2014.09.008"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/S0968-0004(01)01958-2", "@IdType": "doi"}, {"#text": "11701324", "@IdType": "pubmed"}]}, "Citation": "Brazil DP, Hemmings BA. Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem Sci. (2001) 26:657\u201364. 10.1016/S0968-0004(01)01958-2"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1074/jbc.M109745200", "@IdType": "doi"}, {"#text": "11923280", "@IdType": "pubmed"}]}, "Citation": "Ogawara Y, Kishishita S, Obata T, Isazawa Y, Suzuki T, Tanaka K, et al. . Akt enhances Mdm2-mediated ubiquitination and degradation of p53. J Biol Chem. (2002) 277:21843\u201350. 10.1074/jbc.M109745200"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.8676", "@IdType": "doi"}, {"#text": "PMC5045395", "@IdType": "pmc"}, {"#text": "27086911", "@IdType": "pubmed"}]}, "Citation": "Wang Y, Zeng J, Pan J, Geng X, Li L, Wu J, et al. . MiR-320a inhibits gastric carcinoma by targeting activity in the FoxM1-P27KIP1 axis. Oncotarget. (2016) 7:29275\u201386. 10.18632/oncotarget.8676"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1089/dna.2017.3830", "@IdType": "doi"}, {"#text": "28872894", "@IdType": "pubmed"}]}, "Citation": "Wang X, Qi G, Zhang J, Wu J, Zhou N, Li L, et al. . Knockdown of long noncoding RNA small nucleolar RNA host gene 12 inhibits cell growth and induces apoptosis by upregulating miR-138 in nonsmall cell lung cancer. DNA Cell Biol. (2017) 36:892\u2013900. 10.1089/dna.2017.3830"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/or.2017.5619", "@IdType": "doi"}, {"#text": "PMC5442395", "@IdType": "pmc"}, {"#text": "28498463", "@IdType": "pubmed"}]}, "Citation": "Ye Z, Fang B, Pan J, Zhang N, Huang J, Xie C, et al. . miR-138 suppresses the proliferation, metastasis and autophagy of non-small cell lung cancer by targeting Sirt1. Oncol Rep. (2017) 37:3244\u201352. 10.3892/or.2017.5619"}, {"ArticleIdList": {"ArticleId": {"#text": "27049260", "@IdType": "pubmed"}}, "Citation": "Jin Z, Guan L, Song Y, Xiang GM, Chen SX, Gao B. MicroRNA-138 regulates chemoresistance in human non-small cell lung cancer via epithelial mesenchymal transition. Eur Rev Med Pharmacol Sci. (2016) 20:1080\u20136."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/genes8040106", "@IdType": "doi"}, {"#text": "PMC5406853", "@IdType": "pmc"}, {"#text": "28333122", "@IdType": "pubmed"}]}, "Citation": "Al-Hebshi NN, Alharbi FA, Mahri M, Chen T. Differences in the bacteriome of smokeless tobacco products with different oral carcinogenicity: compositional and predicted functional analysis. Genes. (2017) 8:106. 10.3390/genes8040106"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/abbs/gmv054", "@IdType": "doi"}, {"#text": "26124189", "@IdType": "pubmed"}]}, "Citation": "Ma Z, Qiu X, Wang D, Li Y, Zhang B, Yuan T, et al. . MiR-181a-5p inhibits cell proliferation and migration by targeting Kras in non-small cell lung cancer A549 cells. Acta Biochim Biophys Sin. (2015) 47:630\u20138. 10.1093/abbs/gmv054"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s10555-017-9714-9", "@IdType": "doi"}, {"#text": "29327093", "@IdType": "pubmed"}]}, "Citation": "Pop-Bica C, Pintea S, Cojocneanu-Petric R, Del Sal G, Piazza S, Wu ZH, et al. . MiR-181 family-specific behavior in different cancers: a meta-analysis view. Cancer Metastasis Rev. (2018) 37:17\u201332. 10.1007/s10555-017-9714-9"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s13277-015-4256-7", "@IdType": "doi"}, {"#text": "26486328", "@IdType": "pubmed"}]}, "Citation": "Ruan W, Wang P, Feng S, Xue Y, Li Y. Long non-coding RNA small nucleolar RNA host gene 12 (SNHG12) promotes cell proliferation and migration by upregulating angiomotin gene expression in human osteosarcoma cells. Tumour Biol. (2016) 37:4065\u201373. 10.1007/s13277-015-4256-7"}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5340688", "@IdType": "pmc"}, {"#text": "28337281", "@IdType": "pubmed"}]}, "Citation": "Wang O, Yang F, Liu Y, Lv L, Ma R, Chen C, et al. . C-MYC-induced upregulation of lncRNA SNHG12 regulates cell proliferation, apoptosis and migration in triple-negative breast cancer. Am J Transl Res. (2017) 9:533\u201345."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s13046-019-1169-0", "@IdType": "doi"}, {"#text": "PMC6480895", "@IdType": "pmc"}, {"#text": "31014355", "@IdType": "pubmed"}]}, "Citation": "Saeinasab M, Bahrami AR, Gonz\u00e1lez J, Marchese FP, Martinez D, Mowla SJ, et al. . SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF. J Exp Clin Cancer Res. (2019) 38:172. 10.1186/s13046-019-1169-0"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/jcb.29283", "@IdType": "doi"}, {"#text": "31310393", "@IdType": "pubmed"}]}, "Citation": "Ye J, Tan L, Fu Y, Xu H, Wen L, Deng Y, et al. . LncRNA SNHG15 promotes hepatocellular carcinoma progression by sponging miR-141-3p. J Cell Biochem. (2019) 120:19775\u201383. 10.1002/jcb.29283"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.gene.2019.04.033", "@IdType": "doi"}, {"#text": "30981837", "@IdType": "pubmed"}]}, "Citation": "Zhang Y, Zhang D, Lv J, Wang S, Zhang Q. LncRNA SNHG15 acts as an oncogene in prostate cancer by regulating miR-338-3p/FKBP1A axis. Gene. (2019) 705:44\u201350. 10.1016/j.gene.2019.04.033"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.26355/eurrev_201810_16152", "@IdType": "doi"}, {"#text": "30402848", "@IdType": "pubmed"}]}, "Citation": "Cui HX, Zhang MY, Liu K, Liu J, Zhang ZL, Fu L. LncRNA SNHG15 promotes proliferation and migration of lung cancer via targeting microRNA-211-3p. Eur Rev Med Pharmacol Sci. (2018) 22:6838\u201344. 10.26355/eurrev_201810_16152"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.26355/eurrev_201902_17112", "@IdType": "doi"}, {"#text": "30840276", "@IdType": "pubmed"}]}, "Citation": "Ma XR, Xu YL, Qian J, Wang Y. Long non-coding RNA SNHG15 accelerates the progression of non-small cell lung cancer by absorbing miR-211-3p. Eur Rev Med Pharmacol Sci. (2019) 23:1536\u201344. 10.26355/eurrev_201902_17112"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bbrc.2017.12.013", "@IdType": "doi"}, {"#text": "29217194", "@IdType": "pubmed"}]}, "Citation": "Kong Q, Qiu M. Long noncoding RNA SNHG15 promotes human breast cancer proliferation, migration and invasion by sponging miR-211-3p. Biochem Biophys Res Commun. (2018) 495:1594\u2013600. 10.1016/j.bbrc.2017.12.013"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/ijo.2018.4395", "@IdType": "doi"}, {"#text": "29750422", "@IdType": "pubmed"}]}, "Citation": "Du Y, Kong C, Zhu Y, Yu M, Li Z, Bi J, et al. . Knockdown of SNHG15 suppresses renal cell carcinoma proliferation and EMT by regulating the NF-kappaB signaling pathway. Int J Oncol. (2018) 53:384\u201394. 10.3892/ijo.2018.4395"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1080/21691401.2019.1621328", "@IdType": "doi"}, {"#text": "31213086", "@IdType": "pubmed"}]}, "Citation": "Sun X, Bai Y, Yang C, Hu S, Hou Z, Wang G. Long noncoding RNA SNHG15 enhances the development of colorectal carcinoma via functioning as a ceRNA through miR-141/SIRT1/Wnt/beta-catenin axis. Artif Cells Nanomed Biotechnol. (2019) 47:2536\u201344. 10.1080/21691401.2019.1621328"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/cam4.2105", "@IdType": "doi"}, {"#text": "PMC6536931", "@IdType": "pmc"}, {"#text": "30945457", "@IdType": "pubmed"}]}, "Citation": "Li M, Bian Z, Jin G, Zhang J, Yao S, Feng Y, et al. . LncRNA-SNHG15 enhances cell proliferation in colorectal cancer by inhibiting miR-338-3p. Cancer Med. (2019) 8:2404\u201313. 10.1002/cam4.2105"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/jcb.28454", "@IdType": "doi"}, {"#text": "30790329", "@IdType": "pubmed"}]}, "Citation": "Liu Y, Li J, Li M, Li F, Shao Y, Wu L. microRNA-510-5p promotes thyroid cancer cell proliferation, migration, and invasion through suppressing SNHG15. J Cell Biochem. (2019). [Epub ahead of print]. 10.1002/jcb.28454"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41419-018-0975-1", "@IdType": "doi"}, {"#text": "PMC6148237", "@IdType": "pmc"}, {"#text": "30237435", "@IdType": "pubmed"}]}, "Citation": "Wu DM, Wang S, Wen X, Han XR, Wang YJ, Shen M, et al. . LncRNA SNHG15 acts as a ceRNA to regulate YAP1-Hippo signaling pathway by sponging miR-200a-3p in papillary thyroid carcinoma. Cell Death Dis. (2018) 9:947. 10.1038/s41419-018-0975-1"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12929-017-0353-9", "@IdType": "doi"}, {"#text": "PMC5516387", "@IdType": "pmc"}, {"#text": "28720111", "@IdType": "pubmed"}]}, "Citation": "Liu K, Hou Y, Liu Y, Zheng J. LncRNA SNHG15 contributes to proliferation, invasion and autophagy in osteosarcoma cells by sponging miR-141. J Biomed Sci. (2017) 24:46. 10.1186/s12929-017-0353-9"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s12013-013-9801-7", "@IdType": "doi"}, {"#text": "24307282", "@IdType": "pubmed"}]}, "Citation": "Xu H, Mei Q, Xiong C, Zhao J. Tumor-suppressing effects of miR-141 in human osteosarcoma. Cell Biochem Biophys. (2014) 69:319\u201325. 10.1007/s12013-013-9801-7"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.20359", "@IdType": "doi"}, {"#text": "PMC5663584", "@IdType": "pmc"}, {"#text": "29137412", "@IdType": "pubmed"}]}, "Citation": "Ma Z, Huang H, Wang J, Zhou Y, Pu F, Zhao Q, et al. . Long non-coding RNA SNHG15 inhibits P15 and KLF2 expression to promote pancreatic cancer proliferation through EZH2-mediated H3K27me3. Oncotarget. (2017) 8:84153\u201367. 10.18632/oncotarget.20359"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/or.2017.5985", "@IdType": "doi"}, {"#text": "29048682", "@IdType": "pubmed"}]}, "Citation": "Ma Y, Xue Y, Liu X, Qu C, Cai H, Wang P, et al. . SNHG15 affects the growth of glioma microvascular endothelial cells by negatively regulating miR-153. Oncol Rep. (2017) 38:3265\u201377. 10.3892/or.2017.5985"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s13277-015-4404-0", "@IdType": "doi"}, {"#text": "26662309", "@IdType": "pubmed"}]}, "Citation": "Chen SX, Yin JF, Lin BC, Su HF, Zheng Z, Xie CY, et al. . Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC. Tumour Biol. (2016) 37:6801\u201312. 10.1007/s13277-015-4404-0"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.molonc.2016.06.003", "@IdType": "doi"}, {"#text": "PMC5423192", "@IdType": "pmc"}, {"#text": "27396952", "@IdType": "pubmed"}]}, "Citation": "Christensen LL, True K, Hamilton MP, Nielsen MM, Damas ND, Damgaard CK, et al. . SNHG16 is regulated by the Wnt pathway in colorectal cancer and affects genes involved in lipid metabolism. Mol Oncol. (2016) 10:1266\u201382. 10.1016/j.molonc.2016.06.003"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1159/000487974", "@IdType": "doi"}, {"#text": "29529599", "@IdType": "pubmed"}]}, "Citation": "Lu YF, Cai XL, Li ZZ, Lv J, Xiang YA, Chen JJ, et al. . LncRNA SNHG16 functions as an oncogene by sponging MiR-4518 and up-regulating PRMT5 expression in glioma. Cell Physiol Biochem. (2018) 45:1975\u201385. 10.1159/000487974"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.23178", "@IdType": "doi"}, {"#text": "PMC5787416", "@IdType": "pmc"}, {"#text": "29416674", "@IdType": "pubmed"}]}, "Citation": "Zhang K, Chen J, Song H, Chen LB. SNHG16/miR-140-5p axis promotes esophagus cancer cell proliferation, migration and EMT formation through regulating ZEB1. Oncotarget. (2018) 9:1028\u201340. 10.18632/oncotarget.23178"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.abb.2017.11.003", "@IdType": "doi"}, {"#text": "29126969", "@IdType": "pubmed"}]}, "Citation": "Zhu H, Zeng Y, Zhou CC, Ye W. SNHG16/miR-216-5p/ZEB1 signal pathway contributes to the tumorigenesis of cervical cancer cells. Arch Biochem Biophys. (2018) 637:1\u20138. 10.1016/j.abb.2017.11.003"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bbrc.2017.02.094", "@IdType": "doi"}, {"#text": "28232182", "@IdType": "pubmed"}]}, "Citation": "Cai C, Huo Q, Wang X, Chen B, Yang Q. SNHG16 contributes to breast cancer cell migration by competitively binding miR-98 with E2F5. Biochem Biophys Res Commun. (2017) 485:272\u20138. 10.1016/j.bbrc.2017.02.094"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.13980", "@IdType": "doi"}, {"#text": "PMC5352366", "@IdType": "pmc"}, {"#text": "27999202", "@IdType": "pubmed"}]}, "Citation": "Zhu H, Zhang L, Yan S, Li W, Cui J, Zhu M, et al. . LncRNA16 is a potential biomarker for diagnosis of early-stage lung cancer that promotes cell proliferation by regulating the cell cycle. Oncotarget. (2017) 8:7867\u201377. 10.18632/oncotarget.13980"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.26355/eurrev_201802_14284", "@IdType": "doi"}, {"#text": "29461589", "@IdType": "pubmed"}]}, "Citation": "Yang XS, Wang GX, Luo L. Long non-coding RNA SNHG16 promotes cell growth and metastasis in ovarian cancer. Eur Rev Med Pharmacol Sci. (2018) 22:616\u201322. 10.26355/eurrev_201802_14284"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/cddis.2017.484", "@IdType": "doi"}, {"#text": "PMC5682652", "@IdType": "pmc"}, {"#text": "28981099", "@IdType": "pubmed"}]}, "Citation": "Chen Z, Chen X, Chen P, Yu S, Nie F, Lu B, et al. . Long non-coding RNA SNHG20 promotes non-small cell lung cancer cell proliferation and migration by epigenetically silencing of P21 expression. Cell Death Dis. (2017) 8:e3092. 10.1038/cddis.2017.484"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s00018-017-2626-6", "@IdType": "doi"}, {"#text": "PMC5765200", "@IdType": "pmc"}, {"#text": "28840253", "@IdType": "pubmed"}]}, "Citation": "Yamamura S, Imai-Sumida M, Tanaka Y, Dahiya R. Interaction and cross-talk between non-coding RNAs. Cell Mol Life Sci. (2018) 75:467\u201384. 10.1007/s00018-017-2626-6"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1042/BSR20182186", "@IdType": "doi"}, {"#text": "PMC6443951", "@IdType": "pmc"}, {"#text": "30846486", "@IdType": "pubmed"}]}, "Citation": "Wang D, Dai J, Hou S, Qian Y. LncRNA SNHG20 predicts a poor prognosis and promotes cell progression in epithelial ovarian cancer. Biosci Rep. (2019) 39:BSR20182186. 10.1042/BSR20182186"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/iub.2137", "@IdType": "doi"}, {"#text": "31408278", "@IdType": "pubmed"}]}, "Citation": "Wang B, Li X, Hu W, Zhou Y, Din Y. Silencing of lncRNA SNHG20 delays the progression of nonalcoholic fatty liver disease to hepatocellular carcinoma via regulating liver Kupffer cells polarization. IUBMB Life. (2019) 71:1952\u201361. 10.1002/iub.2137"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.26355/eurrev_201904_17704", "@IdType": "doi"}, {"#text": "31081112", "@IdType": "pubmed"}]}, "Citation": "Li Y, Xu J, Guo YN, Yang BB. LncRNA SNHG20 promotes the development of laryngeal squamous cell carcinoma by regulating miR-140. Eur Rev Med Pharmacol Sci. (2019) 23:3401\u20139. 10.26355/eurrev_201904_17704"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/jcb.28444", "@IdType": "doi"}, {"#text": "30767270", "@IdType": "pubmed"}]}, "Citation": "Zhang C, Jiang F, Su C, Xie P, Xu L. Upregulation of long noncoding RNA SNHG20 promotes cell growth and metastasis in esophageal squamous cell carcinoma via modulating ATM-JAK-PD-L1 pathway. J Cell Biochem. (2019) 120. 10.1002/jcb.28444"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/etm.2018.6849", "@IdType": "doi"}, {"#text": "PMC6257038", "@IdType": "pmc"}, {"#text": "30546404", "@IdType": "pubmed"}]}, "Citation": "Sun C, Sun Y, Zhang E. Long non-coding RNA SNHG20 promotes nasopharyngeal carcinoma cell migration and invasion by upregulating TGF-beta1. Exp Ther Med. (2018) 16:4967\u201374. 10.3892/etm.2018.6849"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bbrc.2018.07.137", "@IdType": "doi"}, {"#text": "30072099", "@IdType": "pubmed"}]}, "Citation": "Wang W, Luo P, Guo W, Shi Y, Xu D, Zheng H, et al. . LncRNA SNHG20 knockdown suppresses the osteosarcoma tumorigenesis through the mitochondrial apoptosis pathway by miR-139/RUNX2 axis. Biochem Biophys Res Commun. (2018) 503:1927\u201333. 10.1016/j.bbrc.2018.07.137"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/iub.1922", "@IdType": "doi"}, {"#text": "30120876", "@IdType": "pubmed"}]}, "Citation": "Zhang J, Ju C, Zhang W, Xie L. LncRNA SNHG20 is associated with clinical progression and enhances cell migration and invasion in osteosarcoma. IUBMB Life. (2018) 70:1115\u201321. 10.1002/iub.1922"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/jcb.26588", "@IdType": "doi"}, {"#text": "29236315", "@IdType": "pubmed"}]}, "Citation": "Guan YX, Zhang MZ, Chen XZ, Zhang Q, Liu SZ, Zhang YL. Lnc RNA SNHG20 participated in proliferation, invasion, and migration of breast cancer cells via miR-495. J Cell Biochem. (2018) 119:7971\u201381. 10.1002/jcb.26588"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/ol.2018.9709", "@IdType": "doi"}, {"#text": "PMC6312994", "@IdType": "pmc"}, {"#text": "30655853", "@IdType": "pubmed"}]}, "Citation": "Gao P, Fan R, Ge T. SNHG20 serves as a predictor for prognosis and promotes cell growth in oral squamous cell carcinoma. Oncol Lett. (2019) 17:951\u20137. 10.3892/ol.2018.9709"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1111/jcmm.13987", "@IdType": "doi"}, {"#text": "PMC6307847", "@IdType": "pmc"}, {"#text": "30394668", "@IdType": "pubmed"}]}, "Citation": "Wu J, Zhao W, Wang Z, Xiang X, Zhang S, Liu L. Long non-coding RNA SNHG20 promotes the tumorigenesis of oral squamous cell carcinoma via targeting miR-197/LIN28 axis. J Cell Mol Med. (2019) 23:680\u20138. 10.1111/jcmm.13987"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.20959", "@IdType": "doi"}, {"#text": "PMC5655232", "@IdType": "pmc"}, {"#text": "29113337", "@IdType": "pubmed"}]}, "Citation": "Liu J, Liu L, Wan JX, Song Y. Long noncoding RNA SNHG20 promotes gastric cancer progression by inhibiting p21 expression and regulating the GSK-3beta/ beta-catenin signaling pathway. Oncotarget. (2017) 8:80700\u20138. 10.18632/oncotarget.20959"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/ol.2019.10439", "@IdType": "doi"}, {"#text": "PMC6607387", "@IdType": "pmc"}, {"#text": "31423195", "@IdType": "pubmed"}]}, "Citation": "Yu J, Shen J, Qiao X, Cao L, Yang Z, Ye H, et al. . SNHG20/miR-140-5p/NDRG3 axis contributes to 5-fluorouracil resistance in gastric cancer. Oncol Lett. (2019) 18:1337\u201343. 10.3892/ol.2019.10439"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/jcb.27539", "@IdType": "doi"}, {"#text": "30520073", "@IdType": "pubmed"}]}, "Citation": "Cui N, Liu J, Xia H, Xu D. LncRNA SNHG20 contributes to cell proliferation and invasion by upregulating ZFX expression sponging miR-495-3p in gastric cancer. J Cell Biochem. (2019) 120:3114\u201323. 10.1002/jcb.27539"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/ijmm.2018.3819", "@IdType": "doi"}, {"#text": "30106094", "@IdType": "pubmed"}]}, "Citation": "Zhao Q, Gao S, Du Q, Liu Y. Long non-coding RNA SNHG20 promotes bladder cancer via activating the Wnt/beta-catenin signalling pathway. Int J Mol Med. (2018) 42:2839\u201348. 10.3892/ijmm.2018.3819"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.26355/eurrev_201906_18199", "@IdType": "doi"}, {"#text": "31298384", "@IdType": "pubmed"}]}, "Citation": "Liu J, Cheng LG, Li HG. LncRNA SNHG20 promoted the proliferation of glioma cells via sponging miR-4486 to regulate the MDM2-p53 pathway. Eur Rev Med Pharmacol Sci. (2019) 23:5323\u201331. 10.26355/eurrev_201906_18199"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2147/OTT.S192641", "@IdType": "doi"}, {"#text": "PMC6352861", "@IdType": "pmc"}, {"#text": "30774368", "@IdType": "pubmed"}]}, "Citation": "Li XS, Shen FZ, Huang LY, Hui L, Liu RH, Ma YJ, et al. . lncRNA small nucleolar RNA host gene 20 predicts poor prognosis in glioma and promotes cell proliferation by silencing P21. Onco Targets Ther. (2019) 12:805\u201314. 10.2147/OTT.S192641"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s13046-019-1073-7", "@IdType": "doi"}, {"#text": "PMC6371528", "@IdType": "pmc"}, {"#text": "30744670", "@IdType": "pubmed"}]}, "Citation": "Li X, Xue Y, Liu X, Zheng J, Shen S, Yang C, et al. . ZRANB2/SNHG20/FOXK1 Axis regulates Vasculogenic mimicry formation in glioma. J Exp Clin Cancer Res. (2019) 38:68. 10.1186/s13046-019-1073-7"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1042/BSR20170681", "@IdType": "doi"}, {"#text": "PMC5754315", "@IdType": "pmc"}, {"#text": "29101241", "@IdType": "pubmed"}]}, "Citation": "He S, Zhao Y, Wang X, Deng Y, Wan Z, Yao S, et al. . Up-regulation of long non-coding RNA SNHG20 promotes ovarian cancer progression via Wnt/beta-catenin signaling. Biosci Rep. (2018) 38:BSR20170681. 10.1042/BSR20170681"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.biopha.2017.01.011", "@IdType": "doi"}, {"#text": "28282787", "@IdType": "pubmed"}]}, "Citation": "Liu J, Lu C, Xiao M, Jiang F, Qu L, Ni R. Long non-coding RNA SNHG20 predicts a poor prognosis for HCC and promotes cell invasion by regulating the epithelial-to-mesenchymal transition. Biomed Pharmacother. (2017) 89:857\u201363. 10.1016/j.biopha.2017.01.011"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12885-016-2719-x", "@IdType": "doi"}, {"#text": "PMC4992210", "@IdType": "pmc"}, {"#text": "27543107", "@IdType": "pubmed"}]}, "Citation": "Li C, Zhou L, He J, Fang XQ, Zhu SW, Xiong MM. Increased long noncoding RNA SNHG20 predicts poor prognosis in colorectal cancer. BMC Cancer. (2016) 16:655. 10.1186/s12885-016-2719-x"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/1535-7163.MCT-06-0163", "@IdType": "doi"}, {"#text": "16818495", "@IdType": "pubmed"}]}, "Citation": "Gartel AL. Is p21 an oncogene? Mol Cancer Ther. (2006) 5:1385\u20136. 10.1158/1535-7163.MCT-06-0163"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/jcb.29421", "@IdType": "doi"}, {"#text": "31762107", "@IdType": "pubmed"}]}, "Citation": "Liu Z, Tao H. Small nucleolar RNA host gene 3 facilitates cell proliferation and migration in oral squamous cell carcinoma via targeting nuclear transcription factor Y subunit gamma. J Cell Biochem. (2020) 121:2150\u20138. 10.1002/jcb.29421"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.7150/jca.26207", "@IdType": "doi"}, {"#text": "PMC6072808", "@IdType": "pmc"}, {"#text": "30087712", "@IdType": "pubmed"}]}, "Citation": "Zhang Y, Zhang R, Luo G, Ai K. Long noncoding RNA SNHG1 promotes cell proliferation through PI3K/AKT signaling pathway in pancreatic ductal adenocarcinoma. J Cancer. (2018) 9:2713\u201322. 10.7150/jca.26207"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s13046-019-1177-0", "@IdType": "doi"}, {"#text": "PMC6499991", "@IdType": "pmc"}, {"#text": "31053148", "@IdType": "pubmed"}]}, "Citation": "Li W, Dong X, He C, Tan G, Li Z, Zhai B, et al. . LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells. J Exp Clin Cancer Res. (2019) 38:183. 10.1186/s13046-019-1177-0"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/aging.102493", "@IdType": "doi"}, {"#text": "PMC6932881", "@IdType": "pmc"}, {"#text": "31808752", "@IdType": "pubmed"}]}, "Citation": "Zhang R, Liu Y, Liu H, Chen W, Fan H-N, Zhang J, et al. . The long non-coding RNA SNHG12 promotes gastric cancer by activating the phosphatidylinositol 3-kinase/AKT pathway. Aging. (2019) 11:10902\u201322. 10.18632/aging.102493"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3727/096504018X15420741307616", "@IdType": "doi"}, {"#text": "PMC7848332", "@IdType": "pmc"}, {"#text": "30764893", "@IdType": "pubmed"}]}, "Citation": "Li Z, Li X, Du X, Zhang H, Wu Z, Ren K, et al. . The interaction between lncRNA SNHG1 and miR-140 in regulating growth and tumorigenesis via the TLR4/NF-kappaB pathway in cholangiocarcinoma. Oncol Res. (2019) 27:663\u201372. 10.3727/096504018X15420741307616"}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6176179", "@IdType": "pmc"}, {"#text": "30323965", "@IdType": "pubmed"}]}, "Citation": "Gao L, Cao H, Cheng X. A positive feedback regulation between long noncoding RNA SNHG1 and YAP1 modulates growth and metastasis in laryngeal squamous cell carcinoma. Am J Cancer Res. (2018) 8:1712\u201324."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12935-019-0971-2", "@IdType": "doi"}, {"#text": "PMC6788067", "@IdType": "pmc"}, {"#text": "31632195", "@IdType": "pubmed"}]}, "Citation": "Zhang C, Ren X, He J, Wang W, Tu C, Li Z. The prognostic value of long noncoding RNA SNHG16 on clinical outcomes in human cancers: a systematic review and meta-analysis. Cancer Cell Int. (2019) 19:261. 10.1186/s12935-019-0971-2"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12885-019-5987-4", "@IdType": "doi"}, {"#text": "PMC6686246", "@IdType": "pmc"}, {"#text": "31391030", "@IdType": "pubmed"}]}, "Citation": "Dong B, Chen X, Zhang Y, Zhu C, Dong Q. The prognostic value of lncRNA SNHG1 in cancer patients: a meta-analysis. BMC Cancer. (2019) 19:780. 10.1186/s12885-019-5987-4"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1097/MD.0000000000015196", "@IdType": "doi"}, {"#text": "PMC6494252", "@IdType": "pmc"}, {"#text": "31008944", "@IdType": "pubmed"}]}, "Citation": "Yu J, Yan Y, Hua C, Ming L. Upregulation of lncRNA SNHG1 is associated with metastasis and poor prognosis in cancers: a meta-analysis. Medicine. (2019) 98:e15196. 10.1097/MD.0000000000015196"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2147/OTT.S184803", "@IdType": "doi"}, {"#text": "PMC6497895", "@IdType": "pmc"}, {"#text": "31114252", "@IdType": "pubmed"}]}, "Citation": "Yu Y, Yang J, Yang S, Li Q, Zhang M, Wang L, et al. . Expression level and clinical significance of SNHG1 in human cancers: a meta-analysis. Onco Targets Ther. (2019) 12:3119\u201327. 10.2147/OTT.S184803"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.7754/Clin.Lab.2019.190346", "@IdType": "doi"}, {"#text": "31710436", "@IdType": "pubmed"}]}, "Citation": "Wu Y, Zhang Y, Zhu X, Liu H. The association of long non-coding RNA SNHG6 expression with clinicopathological features and prognosis in cancer. Clin Lab. (2019) 65. 10.7754/Clin.Lab.2019.190346"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ijbiomac.2018.06.033", "@IdType": "doi"}, {"#text": "29886172", "@IdType": "pubmed"}]}, "Citation": "Pei X, Wang X, Li H. LncRNA SNHG1 regulates the differentiation of Treg cells and affects the immune escape of breast cancer via regulating miR-448/IDO. Int J Biol Macromol. (2018) 118:24\u201330. 10.1016/j.ijbiomac.2018.06.033"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1089/hum.2018.063", "@IdType": "doi"}, {"#text": "30045635", "@IdType": "pubmed"}]}, "Citation": "Zhen S, Li X. Application of CRISPR/Cas9 for long non-coding RNA genes in cancer research. Hum Gene Ther. (2018) 30:3\u20139. 10.1089/hum.2018.063"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3389/fphar.2019.01246", "@IdType": "doi"}, {"#text": "PMC6856654", "@IdType": "pmc"}, {"#text": "31780925", "@IdType": "pubmed"}]}, "Citation": "Filippova JA, Matveeva AM, Zhuravlev ES, Balakhonova EA, Prokhorova DV, Malanin SJ, et al. . Are small nucleolar RNAs \u201cCRISPRable\u201d? A report on box C/D small nucleolar RNA editing in human cells. Front Pharmacol. (2019) 10:1246. 10.3389/fphar.2019.01246"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/or.2018.6412", "@IdType": "doi"}, {"#text": "PMC6059747", "@IdType": "pmc"}, {"#text": "29749530", "@IdType": "pubmed"}]}, "Citation": "Yang H, Wang S, Kang YJ, Wang C, Xu Y, Zhang Y, et al. . Long non-coding RNA SNHG1 predicts a poor prognosis and promotes colon cancer tumorigenesis. Oncol Rep. (2018) 40:261\u201371. 10.3892/or.2018.6412"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.biopha.2018.03.083", "@IdType": "doi"}, {"#text": "29579705", "@IdType": "pubmed"}]}, "Citation": "Cai G, Zhu Q, Yuan L, Lan Q. LncRNA SNHG6 acts as a prognostic factor to regulate cell proliferation in glioma through targeting p21. Biomed Pharmacother. (2018) 102:452\u20137. 10.1016/j.biopha.2018.03.083"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.addr.2014.05.010", "@IdType": "doi"}, {"#text": "24859534", "@IdType": "pubmed"}]}, "Citation": "Tay FC, Lim JK, Zhu H, Hin LC, Wang S. Using artificial microRNA sponges to achieve microRNA loss-of-function in cancer cells. Adv Drug Deliv Rev. (2015) 81:117\u201327. 10.1016/j.addr.2014.05.010"}]}}}}}, "PMC": "PMC7154078", "PMID": "32318335", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "An Emerging Class of Long Non-coding RNA With Oncogenic Role Arises From the snoRNA Host Genes.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "16": {"Abstract": " LncRNA small nucleolar RNA host gene 15 (SNHG15) was reported to play an oncogenic role in tumors. However, the role of SNHG15 and its molecular mechanism in osteosarcoma (OS) cells are largely unknown. qRT-PCR was performed to evaluate the expression levels of SNHG15 and miR-141 in OS tissues and cells. Cell transfection with different siRNAs, miRNAs or pcDNAs into U2OS and MG63 cells were carried out by Lipofectamine 2000. The effects of SNHG15 and miR-141 on OS cell proliferation, invasion and the levels of autophagy-related proteins were analyzed by MTT assay, Transwell invasion/migration assay and western blot, respectively. Luciferase reporter assay was used to confirm whether SNHG15 could directly interact with miR-141. We found that up-regulation of SNHG15 was inversely correlated with miR-141 expression in OS tissues. SNHG15 knockdown and miR-141 overexpression significantly suppressed cell proliferation, invasion, migration and autophagy while SNHG15 overexpression and miR-141 repression exhibited the opposite effects on OS cells. Besides, SNHG15 could directly interact with miR-141 and regulate its expression. Furthermore, miR-141 suppressing significantly overturned the inhibition on proliferation, invasion, migration and autophagy mediated by SNHG15 knockdown while miR-141 overexpression remarkably attenuated SNHG15 overexpression-induced proliferation, invasion, migration and autophagy in OS cells. Our data showed that SNHG15 contributes to proliferation, invasion, migration and autophagy in OS by negatively regulating miR-141, providing a new potential target and prognostic biomarker for the treatment of OS.", "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "-602828013973978803", "Part1": "Department of Orthopaedics", "Part2": "Henan Provincial People's Hospital", "Part3": "No. 7 Weiwu Road", "Part4": "Zhengzhou", "Part5": "450003", "Part6": "China.", "Text": "Department of Orthopaedics, Henan Provincial People's Hospital, No. 7 Weiwu Road, Zhengzhou, 450003, China."}], "ForeName": "Ke", "FullName": "Ke Liu", "HashID": "-8049484977932200688", "LastName": "Liu", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-602828013973978803", "Part1": "Department of Orthopaedics", "Part2": "Henan Provincial People's Hospital", "Part3": "No. 7 Weiwu Road", "Part4": "Zhengzhou", "Part5": "450003", "Part6": "China.", "Text": "Department of Orthopaedics, Henan Provincial People's Hospital, No. 7 Weiwu Road, Zhengzhou, 450003, China."}], "ForeName": "Yi", "FullName": "Yi Hou", "HashID": "-4847453695067808168", "LastName": "Hou", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-602828013973978803", "Part1": "Department of Orthopaedics", "Part2": "Henan Provincial People's Hospital", "Part3": "No. 7 Weiwu Road", "Part4": "Zhengzhou", "Part5": "450003", "Part6": "China.", "Text": "Department of Orthopaedics, Henan Provincial People's Hospital, No. 7 Weiwu Road, Zhengzhou, 450003, China."}], "ForeName": "Yunke", "FullName": "Yunke Liu", "HashID": "-5074825824107714268", "LastName": "Liu", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-602828013973978803", "Part1": "Department of Orthopaedics", "Part2": "Henan Provincial People's Hospital", "Part3": "No. 7 Weiwu Road", "Part4": "Zhengzhou", "Part5": "450003", "Part6": "China. zhengjiaguke@163.com.", "Text": "Department of Orthopaedics, Henan Provincial People's Hospital, No. 7 Weiwu Road, Zhengzhou, 450003, China. zhengjiaguke@163.com."}], "ForeName": "Jia", "FullName": "Jia Zheng", "HashID": "2038594647521464769", "LastName": "Zheng", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.1186/s12929-017-0353-9", "InsertType": null, "Journal": "Journal of biomedical science", "Keywords": [{"IS_Major": false, "IS_Mesh": true, "Text": "Autophagy"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Bone Neoplasms"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Cell Line, Tumor"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Cell Proliferation"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Humans"}, {"IS_Major": false, "IS_Mesh": true, "Text": "MicroRNAs"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Neoplasm Invasiveness"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Osteosarcoma"}, {"IS_Major": false, "IS_Mesh": true, "Text": "RNA, Long Noncoding"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Osteosarcoma"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Sponge"}, {"IS_Major": false, "IS_Mesh": false, "Text": "lncRNA SNHG15"}, {"IS_Major": false, "IS_Mesh": false, "Text": "miR-141"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "MEDLINE", "Article": {"@PubModel": "Electronic", "Abstract": {"AbstractText": [{"#text": "LncRNA small nucleolar RNA host gene 15 (SNHG15) was reported to play an oncogenic role in tumors. However, the role of SNHG15 and its molecular mechanism in osteosarcoma (OS) cells are largely unknown.", "@Label": "BACKGROUND", "@NlmCategory": "BACKGROUND"}, {"#text": "qRT-PCR was performed to evaluate the expression levels of SNHG15 and miR-141 in OS tissues and cells. Cell transfection with different siRNAs, miRNAs or pcDNAs into U2OS and MG63 cells were carried out by Lipofectamine 2000. The effects of SNHG15 and miR-141 on OS cell proliferation, invasion and the levels of autophagy-related proteins were analyzed by MTT assay, Transwell invasion/migration assay and western blot, respectively. Luciferase reporter assay was used to confirm whether SNHG15 could directly interact with miR-141.", "@Label": "METHODS", "@NlmCategory": "METHODS"}, {"#text": "We found that up-regulation of SNHG15 was inversely correlated with miR-141 expression in OS tissues. SNHG15 knockdown and miR-141 overexpression significantly suppressed cell proliferation, invasion, migration and autophagy while SNHG15 overexpression and miR-141 repression exhibited the opposite effects on OS cells. Besides, SNHG15 could directly interact with miR-141 and regulate its expression. Furthermore, miR-141 suppressing significantly overturned the inhibition on proliferation, invasion, migration and autophagy mediated by SNHG15 knockdown while miR-141 overexpression remarkably attenuated SNHG15 overexpression-induced proliferation, invasion, migration and autophagy in OS cells.", "@Label": "RESULTS", "@NlmCategory": "RESULTS"}, {"#text": "Our data showed that SNHG15 contributes to proliferation, invasion, migration and autophagy in OS by negatively regulating miR-141, providing a new potential target and prognostic biomarker for the treatment of OS.", "@Label": "CONCLUSION", "@NlmCategory": "CONCLUSIONS"}]}, "ArticleDate": {"@DateType": "Electronic", "Day": "18", "Month": "07", "Year": "2017"}, "ArticleTitle": "LncRNA SNHG15 contributes to proliferation, invasion and autophagy in osteosarcoma cells by sponging miR-141.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Orthopaedics, Henan Provincial People's Hospital, No. 7 Weiwu Road, Zhengzhou, 450003, China."}, "ForeName": "Ke", "Initials": "K", "LastName": "Liu"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Orthopaedics, Henan Provincial People's Hospital, No. 7 Weiwu Road, Zhengzhou, 450003, China."}, "ForeName": "Yi", "Initials": "Y", "LastName": "Hou"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Orthopaedics, Henan Provincial People's Hospital, No. 7 Weiwu Road, Zhengzhou, 450003, China."}, "ForeName": "Yunke", "Initials": "Y", "LastName": "Liu"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Orthopaedics, Henan Provincial People's Hospital, No. 7 Weiwu Road, Zhengzhou, 450003, China. zhengjiaguke@163.com."}, "ForeName": "Jia", "Initials": "J", "LastName": "Zheng"}]}, "ELocationID": [{"#text": "46", "@EIdType": "pii", "@ValidYN": "Y"}, {"#text": "10.1186/s12929-017-0353-9", "@EIdType": "doi", "@ValidYN": "Y"}], "Journal": {"ISOAbbreviation": "J Biomed Sci", "ISSN": {"#text": "1423-0127", "@IssnType": "Electronic"}, "JournalIssue": {"@CitedMedium": "Internet", "Issue": "1", "PubDate": {"Day": "18", "Month": "Jul", "Year": "2017"}, "Volume": "24"}, "Title": "Journal of biomedical science"}, "Language": "eng", "Pagination": {"MedlinePgn": "46", "StartPage": "46"}, "PublicationTypeList": {"PublicationType": {"#text": "Journal Article", "@UI": "D016428"}}}, "ChemicalList": {"Chemical": [{"NameOfSubstance": {"#text": "MIRN141 microRNA, human", "@UI": "C533895"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "MicroRNAs", "@UI": "D035683"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "RNA, Long Noncoding", "@UI": "D062085"}, "RegistryNumber": "0"}]}, "CitationSubset": "IM", "CoiStatement": "AUTHORS\u2019 INFORMATION: Ke Liu, the first author. Jia Zheng, the corresponding author. ETHICS APPROVAL AND CONSENT TO PARTICIPATE: Not applicable. CONSENT FOR PUBLICATION: All the authors have consented for publication. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER\u2019S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.", "DateCompleted": {"Day": "01", "Month": "05", "Year": "2018"}, "DateRevised": {"Day": "30", "Month": "03", "Year": "2022"}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"#text": "Osteosarcoma", "@MajorTopicYN": "N"}, {"#text": "Sponge", "@MajorTopicYN": "N"}, {"#text": "lncRNA SNHG15", "@MajorTopicYN": "N"}, {"#text": "miR-141", "@MajorTopicYN": "N"}]}, "MedlineJournalInfo": {"Country": "England", "ISSNLinking": "1021-7770", "MedlineTA": "J Biomed Sci", "NlmUniqueID": "9421567"}, "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"#text": "Autophagy", "@MajorTopicYN": "N", "@UI": "D001343"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Bone Neoplasms", "@MajorTopicYN": "N", "@UI": "D001859"}, "QualifierName": {"#text": "metabolism", "@MajorTopicYN": "Y", "@UI": "Q000378"}}, {"DescriptorName": {"#text": "Cell Line, Tumor", "@MajorTopicYN": "N", "@UI": "D045744"}}, {"DescriptorName": {"#text": "Cell Proliferation", "@MajorTopicYN": "N", "@UI": "D049109"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Humans", "@MajorTopicYN": "N", "@UI": "D006801"}}, {"DescriptorName": {"#text": "MicroRNAs", "@MajorTopicYN": "N", "@UI": "D035683"}, "QualifierName": [{"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}, {"#text": "metabolism", "@MajorTopicYN": "Y", "@UI": "Q000378"}]}, {"DescriptorName": {"#text": "Neoplasm Invasiveness", "@MajorTopicYN": "N", "@UI": "D009361"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Osteosarcoma", "@MajorTopicYN": "N", "@UI": "D012516"}, "QualifierName": [{"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}, {"#text": "physiopathology", "@MajorTopicYN": "Y", "@UI": "Q000503"}]}, {"DescriptorName": {"#text": "RNA, Long Noncoding", "@MajorTopicYN": "N", "@UI": "D062085"}, "QualifierName": [{"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}, {"#text": "metabolism", "@MajorTopicYN": "N", "@UI": "Q000378"}]}]}, "PMID": {"#text": "28720111", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "28720111", "@IdType": "pubmed"}, {"#text": "PMC5516387", "@IdType": "pmc"}, {"#text": "10.1186/s12929-017-0353-9", "@IdType": "doi"}, {"#text": "10.1186/s12929-017-0353-9", "@IdType": "pii"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "received", "Day": "19", "Month": "12", "Year": "2016"}, {"@PubStatus": "accepted", "Day": "12", "Month": "7", "Year": "2017"}, {"@PubStatus": "entrez", "Day": "20", "Hour": "6", "Minute": "0", "Month": "7", "Year": "2017"}, {"@PubStatus": "pubmed", "Day": "20", "Hour": "6", "Minute": "0", "Month": "7", "Year": "2017"}, {"@PubStatus": "medline", "Day": "2", "Hour": "6", "Minute": "0", "Month": "5", "Year": "2018"}]}, "PublicationStatus": "epublish", "ReferenceList": {"Reference": [{"ArticleIdList": {"ArticleId": [{"#text": "10.3322/caac.21254", "@IdType": "doi"}, {"#text": "25559415", "@IdType": "pubmed"}]}, "Citation": "Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5\u201329. doi: 10.3322/caac.21254."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.4055/cios.2011.3.1.48", "@IdType": "doi"}, {"#text": "PMC3042169", "@IdType": "pmc"}, {"#text": "21369478", "@IdType": "pubmed"}]}, "Citation": "Cho Y, Jung GH, Chung SH, Kim JY, Choi Y, Kim JD. Long-term survivals of stage IIb osteosarcoma: a 20-year experience in a single institution. Clin Orthop Surg. 2011;3:48\u201354. doi: 10.4055/cios.2011.3.1.48."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1155/2011/548151", "@IdType": "doi"}, {"#text": "PMC3061299", "@IdType": "pmc"}, {"#text": "21437228", "@IdType": "pubmed"}]}, "Citation": "Savage SA, Mirabello L. Using epidemiology and genomics to understand osteosarcoma etiology. Sarcoma. 2011;2011:548151. doi: 10.1155/2011/548151."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1155/2011/959248", "@IdType": "doi"}, {"#text": "PMC3087974", "@IdType": "pmc"}, {"#text": "21559216", "@IdType": "pubmed"}]}, "Citation": "Broadhead ML, Clark JC, Myers DE, Dass CR, Choong PF. The molecular pathogenesis of osteosarcoma: a review. Sarcoma. 2011;2011:959248. doi: 10.1155/2011/959248."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature11233", "@IdType": "doi"}, {"#text": "PMC3684276", "@IdType": "pmc"}, {"#text": "22955620", "@IdType": "pubmed"}]}, "Citation": "Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A, et al. Landscape of transcription in human cells. Nature. 2012;489:101\u2013108. doi: 10.1038/nature11233."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1097/PPO.0b013e318250c001", "@IdType": "doi"}, {"#text": "PMC3528102", "@IdType": "pmc"}, {"#text": "22647357", "@IdType": "pubmed"}]}, "Citation": "Iorio MV, Croce CM. Causes and consequences of microRNA dysregulation. Cancer J. 2012;18:215\u2013222. doi: 10.1097/PPO.0b013e318250c001."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.4252/wjsc.v6.i5.591", "@IdType": "doi"}, {"#text": "PMC4178258", "@IdType": "pmc"}, {"#text": "25426255", "@IdType": "pubmed"}]}, "Citation": "Wolfson B, Eades G, Zhou Q. Roles of microRNA-140 in stem cell-associated early stage breast cancer. World J Stem Cells. 2014;6:591\u2013597. doi: 10.4252/wjsc.v6.i5.591."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.molonc.2016.04.004", "@IdType": "doi"}, {"#text": "PMC5423177", "@IdType": "pmc"}, {"#text": "27155790", "@IdType": "pubmed"}]}, "Citation": "Berlanga P, Munoz L, Piqueras M, Sirerol JA, Sanchez-Izquierdo MD, Hervas D, et al. miR-200c and phospho-AKT as prognostic factors and mediators of osteosarcoma progression and lung metastasis. Mol Oncol. 2016;10:1043\u20131053. doi: 10.1016/j.molonc.2016.04.004."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s12013-013-9801-7", "@IdType": "doi"}, {"#text": "24307282", "@IdType": "pubmed"}]}, "Citation": "Xu H, Mei Q, Xiong C, Zhao J. Tumor-suppressing effects of miR-141 in human osteosarcoma. Cell Biochem Biophys. 2014;69:319\u2013325. doi: 10.1007/s12013-013-9801-7."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s13277-015-3396-0", "@IdType": "doi"}, {"#text": "25854173", "@IdType": "pubmed"}]}, "Citation": "Cui SQ, Wang H. MicroRNA-144 inhibits the proliferation, apoptosis, invasion, and migration of osteosarcoma cell line F5M2. Tumour Biol. 2015;36:6949\u20136958. doi: 10.1007/s13277-015-3396-0."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1111/cas.12436", "@IdType": "doi"}, {"#text": "PMC4317920", "@IdType": "pmc"}, {"#text": "24815002", "@IdType": "pubmed"}]}, "Citation": "Mei Q, Li F, Quan H, Liu Y, Xu H. Busulfan inhibits growth of human osteosarcoma through miR-200 family microRNAs in vitro and in vivo. Cancer Sci. 2014;105:755\u2013762. doi: 10.1111/cas.12436."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4859907", "@IdType": "pmc"}, {"#text": "27186302", "@IdType": "pubmed"}]}, "Citation": "He P, Zhang Z, Huang G, Wang H, Xu D, Liao W, et al. miR-141 modulates osteoblastic cell proliferation by regulating the target gene of lncRNA H19 and lncRNA H19-derived miR-675. Am J Transl Res. 2016;8:1780\u20131788."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/cddis.2016.64", "@IdType": "doi"}, {"#text": "PMC4823963", "@IdType": "pmc"}, {"#text": "27010857", "@IdType": "pubmed"}]}, "Citation": "Liu Y, Zhao R, Wang H, Luo Y, Wang X, Niu W, et al. miR-141 is involved in BRD7-mediated cell proliferation and tumor formation through suppression of the PTEN/AKT pathway in nasopharyngeal carcinoma. Cell Death Dis. 2016;7:e2156. doi: 10.1038/cddis.2016.64."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s13046-016-0289-z", "@IdType": "doi"}, {"#text": "PMC4721207", "@IdType": "pmc"}, {"#text": "26790956", "@IdType": "pubmed"}]}, "Citation": "Lou G, Dong X, Xia C, Ye B, Yan Q, Wu S, et al. Direct targeting sperm-associated antigen 9 by miR-141 influences hepatocellular carcinoma cell growth and metastasis via JNK pathway. J Exp Clin Cancer Res. 2016;35:14. doi: 10.1186/s13046-016-0289-z."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.4238/2015.December.16.31", "@IdType": "doi"}, {"#text": "26681225", "@IdType": "pubmed"}]}, "Citation": "Lu YB, Hu JJ, Sun WJ, Duan XH, Chen X. Prognostic value of miR-141 downregulation in gastric cancer. Genet Mol Res. 2015;14:17305\u201317311. doi: 10.4238/2015.December.16.31."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1042/BST20120020", "@IdType": "doi"}, {"#text": "22817756", "@IdType": "pubmed"}]}, "Citation": "Harries LW. Long non-coding RNAs and human disease. Biochem Soc Trans. 2012;40:902\u2013906. doi: 10.1042/BST20120020."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ccell.2016.03.010", "@IdType": "doi"}, {"#text": "PMC4831138", "@IdType": "pmc"}, {"#text": "27070700", "@IdType": "pubmed"}]}, "Citation": "Schmitt AM, Chang HY. Long noncoding RNAs in cancer pathways. Cancer Cell. 2016;29:452\u2013463. doi: 10.1016/j.ccell.2016.03.010."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.2469", "@IdType": "doi"}, {"#text": "PMC4226665", "@IdType": "pmc"}, {"#text": "25275300", "@IdType": "pubmed"}]}, "Citation": "Malek E, Jagannathan S, Driscoll JJ. Correlation of long non-coding RNA expression with metastasis, drug resistance and clinical outcome in cancer. Oncotarget. 2014;5:8027\u20138038. doi: 10.18632/oncotarget.2469."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4544839", "@IdType": "pmc"}, {"#text": "26208723", "@IdType": "pubmed"}]}, "Citation": "Bhan A, Mandal SS. LncRNA HOTAIR: a master regulator of chromatin dynamics and cancer. Biochim Biophys Acta. 1856;2015:151\u2013164."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s13277-016-4927-z", "@IdType": "doi"}, {"#text": "26861560", "@IdType": "pubmed"}]}, "Citation": "Sand M, Bechara FG, Sand D, Gambichler T, Hahn SA, Bromba M, et al. Long-noncoding RNAs in basal cell carcinoma. Tumour Biol. 2016;37:10595\u201310608. doi: 10.1007/s13277-016-4927-z."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s13277-016-5012-3", "@IdType": "doi"}, {"#text": "26960690", "@IdType": "pubmed"}]}, "Citation": "Lemos AE, Ferreira LB, Batoreu NM, de Freitas PP, Bonamino MH, Gimba ER. PCA3 long noncoding RNA modulates the expression of key cancer-related genes in LNCaP prostate cancer cells. Tumour Biol. 2016;37:11339\u201311348. doi: 10.1007/s13277-016-5012-3."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s11033-016-3975-1", "@IdType": "doi"}, {"#text": "27022737", "@IdType": "pubmed"}]}, "Citation": "Sun J, Wang X, Fu C, Wang X, Zou J, Hua H, et al. Long noncoding RNA FGFR3-AS1 promotes osteosarcoma growth through regulating its natural antisense transcript FGFR3. Mol Biol Rep. 2016;43:427\u2013436. doi: 10.1007/s11033-016-3975-1."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5021870", "@IdType": "pmc"}, {"#text": "27660759", "@IdType": "pubmed"}]}, "Citation": "Zheng H and Min J. Role of Long Noncoding RNA HOTAIR in the Growth and Apoptosis of Osteosarcoma Cell MG-63. Biomed Res Int.\u00a02016;2016:5757641."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5009402", "@IdType": "pmc"}, {"#text": "27648140", "@IdType": "pubmed"}]}, "Citation": "Zhao H, Hou W, Tao J, Zhao Y, Wan G, Ma C, et al. Upregulation of lncRNA HNF1A-AS1 promotes cell proliferation and metastasis in osteosarcoma through activation of the Wnt/beta-catenin signaling pathway. Am J Transl Res. 2016;8:3503\u20133512."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.jbo.2016.05.003", "@IdType": "doi"}, {"#text": "PMC4908186", "@IdType": "pmc"}, {"#text": "27335776", "@IdType": "pubmed"}]}, "Citation": "Li W, Xie P, Ruan WH. Overexpression of lncRNA UCA1 promotes osteosarcoma progression and correlates with poor prognosis. J Bone Oncol. 2016;5:80\u201385. doi: 10.1016/j.jbo.2016.05.003."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.jbiosc.2014.10.012", "@IdType": "doi"}, {"#text": "25468426", "@IdType": "pubmed"}]}, "Citation": "Tani H, Torimura M. Development of cytotoxicity-sensitive human cells using overexpression of long non-coding RNAs. J Biosci Bioeng. 2015;119:604\u2013608. doi: 10.1016/j.jbiosc.2014.10.012."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bbrc.2013.09.006", "@IdType": "doi"}, {"#text": "24036268", "@IdType": "pubmed"}]}, "Citation": "Tani H, Torimura M. Identification of short-lived long non-coding RNAs as surrogate indicators for chemical stress response. Biochem Biophys Res Commun. 2013;439:547\u2013551. doi: 10.1016/j.bbrc.2013.09.006."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrc1692", "@IdType": "doi"}, {"#text": "16148885", "@IdType": "pubmed"}]}, "Citation": "Kondo Y, Kanzawa T, Sawaya R, Kondo S. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer. 2005;5:726\u2013734. doi: 10.1038/nrc1692."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5190133", "@IdType": "pmc"}, {"#text": "27007056", "@IdType": "pubmed"}]}, "Citation": "Li J, Yang Z, Li Y, Xia J, Li D, Li H, et al. Cell apoptosis, autophagy and necroptosis in osteosarcoma treatment. Oncotarget. 2016;7:44763\u201344778."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12929-016-0297-5", "@IdType": "doi"}, {"#text": "PMC5116184", "@IdType": "pmc"}, {"#text": "27863492", "@IdType": "pubmed"}]}, "Citation": "Zhang D, Zhao Q, Sun H, Yin L, Wu J, Xu J, et al. Defective autophagy leads to the suppression of stem-like features of CD271+ osteosarcoma cells. J Biomed Sci. 2016;23:82. doi: 10.1186/s12929-016-0297-5."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s13277-014-1797-0", "@IdType": "doi"}, {"#text": "24609901", "@IdType": "pubmed"}]}, "Citation": "Li X, Wang S, Chen Y, Liu G, Yang X. miR-22 targets the 3\u2032 UTR of HMGB1 and inhibits the HMGB1-associated autophagy in osteosarcoma cells during chemotherapy. Tumour Biol. 2014;35:6021\u20136028. doi: 10.1007/s13277-014-1797-0."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.pan.2016.03.004", "@IdType": "doi"}, {"#text": "27017485", "@IdType": "pubmed"}]}, "Citation": "Zhu H, Huang L, Zhu S, Li X, Li Z, Yu C, et al. Regulation of autophagy by systemic admission of microRNA-141 to target HMGB1 in l-arginine-induced acute pancreatitis in vivo. Pancreatology. 2016;16:337\u2013346. doi: 10.1016/j.pan.2016.03.004."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1159/000456162", "@IdType": "doi"}, {"#text": "28135713", "@IdType": "pubmed"}]}, "Citation": "Yang Y, Liu Y, Xue J, Yang Z, Shi Y, Shi Y, et al. MicroRNA-141 targets Sirt1 and inhibits Autophagy to reduce HBV replication. Cell Physiol Biochem. 2017;41:310\u2013322. doi: 10.1159/000456162."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5122351", "@IdType": "pmc"}, {"#text": "27192121", "@IdType": "pubmed"}]}, "Citation": "Shao Y, Ye M, Li Q, Sun W, Ye G, Zhang X, et al. LncRNA-RMRP promotes carcinogenesis by acting as a miR-206 sponge and is used as a novel biomarker for gastric cancer. Oncotarget. 2016;7:37812\u201337824."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1042/BCJ20160540", "@IdType": "doi"}, {"#text": "27520307", "@IdType": "pubmed"}]}, "Citation": "Zhou Y, Dai QS, Zhu SC, Han YH, Han HL, Zhao B, et al. AK048794 maintains the mouse embryonic stem cell pluripotency by functioning as an miRNA sponge for miR-592. Biochem J. 2016;473:3639\u20133654. doi: 10.1042/BCJ20160540."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/ijc.30039", "@IdType": "doi"}, {"#text": "26875870", "@IdType": "pubmed"}]}, "Citation": "Dhamija S, Diederichs S. From junk to master regulators of invasion: lncRNA functions in migration. EMT and metastasis Int J Cancer. 2016;139:269\u2013280. doi: 10.1002/ijc.30039."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.tcb.2011.04.001", "@IdType": "doi"}, {"#text": "21550244", "@IdType": "pubmed"}]}, "Citation": "Wapinski O, Chang HY. Long noncoding RNAs and human disease. Trends Cell Biol. 2011;21:354\u2013361. doi: 10.1016/j.tcb.2011.04.001."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s13277-015-4404-0", "@IdType": "doi"}, {"#text": "26662309", "@IdType": "pubmed"}]}, "Citation": "Chen SX, Yin JF, Lin BC, Su HF, Zheng Z, Xie CY, et al. Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC. Tumour Biol. 2016;37:6801\u20136812. doi: 10.1007/s13277-015-4404-0."}, {"ArticleIdList": {"ArticleId": {"#text": "27212162", "@IdType": "pubmed"}}, "Citation": "Zhang JH, Wei HW, Yang HG. Long noncoding RNA SNHG15, a potential prognostic biomarker for hepatocellular carcinoma. Eur Rev Med Pharmacol Sci. 2016;20:1720\u20131724."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5009407", "@IdType": "pmc"}, {"#text": "27648145", "@IdType": "pubmed"}]}, "Citation": "Huang M, Wu L, Qin Y, Li Z, Luo S, Qin H, et al. Anti-proliferative role and prognostic implication of miR-141 in gastric cancer. Am J Transl Res. 2016;8:3549\u20133557."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4811401", "@IdType": "pmc"}, {"#text": "26936280", "@IdType": "pubmed"}]}, "Citation": "Wang Z, Lei H, Sun Q. MicroRNA-141 and its associated gene FUS modulate proliferation, migration and cisplatin chemosensitivity in neuroblastoma cell lines. Oncol Rep. 2016;35:2943\u20132951."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5009403", "@IdType": "pmc"}, {"#text": "27648141", "@IdType": "pubmed"}]}, "Citation": "Peng T, Zhang S, Li W, Fu S, Luan Y, Zuo L. MicroRNA-141 inhibits glioma cells growth and metastasis by targeting TGF-beta2. Am J Transl Res. 2016;8:3513\u20133521."}, {"ArticleIdList": {"ArticleId": {"#text": "27412940", "@IdType": "pubmed"}}, "Citation": "Yao B, Xue Y, Liu Z, Xu M, Tu K, Wang J. Over-expression of miR-141 inhibits the proliferation, invasion and migration of hepatocellular carcinoma MHCC-97H cells. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016;32:1083\u20131087."}, {"ArticleIdList": {"ArticleId": {"#text": "27658774", "@IdType": "pubmed"}}, "Citation": "Xie CH, Cao YM, Huang Y, Shi QW, Guo JH, Fan ZW, et al. Long non-coding RNA TUG1 contributes to tumorigenesis of human osteosarcoma by sponging miR-9-5p and regulating POU2F1 expression. Tumour Biol. 2016;37:15031-41."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.6395", "@IdType": "doi"}, {"#text": "PMC5342377", "@IdType": "pmc"}, {"#text": "27458156", "@IdType": "pubmed"}]}, "Citation": "Luo W, He H, Xiao W, Liu Q, Deng Z, Lu Y, et al. MALAT1 promotes osteosarcoma development by targeting TGFA via MIR376A. Oncotarget. 2016;7:54733\u201354743. doi: 10.18632/oncotarget.6395."}]}}}}}, "PMC": "PMC5516387", "PMID": "28720111", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "LncRNA SNHG15 contributes to proliferation, invasion and autophagy in osteosarcoma cells by sponging miR-141.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "17": {"Abstract": "MicroRNAs (miRNAs) are a class of non-coding RNAs that play important roles in regulating gene expression. The majority of miRNAs are transcribed from DNA sequences into primary miRNAs and processed into precursor miRNAs, and finally mature miRNAs. In most cases, miRNAs interact with the 3' untranslated region (3' UTR) of target mRNAs to induce mRNA degradation and translational repression. However, interaction of miRNAs with other regions, including the 5' UTR, coding sequence, and gene promoters, have also been reported. Under certain conditions, miRNAs can also activate translation or regulate transcription. The interaction of miRNAs with their target genes is dynamic and dependent on many factors, such as subcellular location of miRNAs, the abundancy of miRNAs and target mRNAs, and the affinity of miRNA-mRNA interactions. miRNAs can be secreted into extracellular fluids and transported to target cells via vesicles, such as exosomes, or by binding to proteins, including Argonautes. Extracellular miRNAs function as chemical messengers to mediate cell-cell communication. In this review, we provide an update on canonical and non-canonical miRNA biogenesis pathways and various mechanisms underlying miRNA-mediated gene regulations. We also summarize the current knowledge of the dynamics of miRNA action and of the secretion, transfer, and uptake of extracellular miRNAs.", "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "6914367442474211623", "Part1": "Department of Biology", "Part2": "York University", "Part3": "Toronto", "Part4": "ON", "Part5": "Canada.", "Part6": null, "Text": "Department of Biology, York University, Toronto, ON, Canada."}], "ForeName": "Jacob", "FullName": "Jacob O'Brien", "HashID": "-5658714027249265563", "LastName": "O'Brien", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "6914367442474211623", "Part1": "Department of Biology", "Part2": "York University", "Part3": "Toronto", "Part4": "ON", "Part5": "Canada.", "Part6": null, "Text": "Department of Biology, York University, Toronto, ON, Canada."}], "ForeName": "Heyam", "FullName": "Heyam Hayder", "HashID": "8569576514324356652", "LastName": "Hayder", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "6914367442474211623", "Part1": "Department of Biology", "Part2": "York University", "Part3": "Toronto", "Part4": "ON", "Part5": "Canada.", "Part6": null, "Text": "Department of Biology, York University, Toronto, ON, Canada."}], "ForeName": "Yara", "FullName": "Yara Zayed", "HashID": "-1749359772914325368", "LastName": "Zayed", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "6914367442474211623", "Part1": "Department of Biology", "Part2": "York University", "Part3": "Toronto", "Part4": "ON", "Part5": "Canada.", "Part6": null, "Text": "Department of Biology, York University, Toronto, ON, Canada."}], "ForeName": "Chun", "FullName": "Chun Peng", "HashID": "224291747332885189", "LastName": "Peng", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.3389/fendo.2018.00402", "InsertType": null, "Journal": "Frontiers in endocrinology", "Keywords": [{"IS_Major": false, "IS_Mesh": false, "Text": "cell-cell communication"}, {"IS_Major": false, "IS_Mesh": false, "Text": "extracellular microRNA"}, {"IS_Major": false, "IS_Mesh": false, "Text": "gene regulation"}, {"IS_Major": false, "IS_Mesh": false, "Text": "microRNA biogenesis"}, {"IS_Major": false, "IS_Mesh": false, "Text": "microRNA dynamics"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "PubMed-not-MEDLINE", "Article": {"@PubModel": "Electronic-eCollection", "Abstract": {"AbstractText": "MicroRNAs (miRNAs) are a class of non-coding RNAs that play important roles in regulating gene expression. The majority of miRNAs are transcribed from DNA sequences into primary miRNAs and processed into precursor miRNAs, and finally mature miRNAs. In most cases, miRNAs interact with the 3' untranslated region (3' UTR) of target mRNAs to induce mRNA degradation and translational repression. However, interaction of miRNAs with other regions, including the 5' UTR, coding sequence, and gene promoters, have also been reported. Under certain conditions, miRNAs can also activate translation or regulate transcription. The interaction of miRNAs with their target genes is dynamic and dependent on many factors, such as subcellular location of miRNAs, the abundancy of miRNAs and target mRNAs, and the affinity of miRNA-mRNA interactions. miRNAs can be secreted into extracellular fluids and transported to target cells via vesicles, such as exosomes, or by binding to proteins, including Argonautes. Extracellular miRNAs function as chemical messengers to mediate cell-cell communication. In this review, we provide an update on canonical and non-canonical miRNA biogenesis pathways and various mechanisms underlying miRNA-mediated gene regulations. We also summarize the current knowledge of the dynamics of miRNA action and of the secretion, transfer, and uptake of extracellular miRNAs."}, "ArticleDate": {"@DateType": "Electronic", "Day": "03", "Month": "08", "Year": "2018"}, "ArticleTitle": "Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Biology, York University, Toronto, ON, Canada."}, "ForeName": "Jacob", "Initials": "J", "LastName": "O'Brien"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Biology, York University, Toronto, ON, Canada."}, "ForeName": "Heyam", "Initials": "H", "LastName": "Hayder"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Biology, York University, Toronto, ON, Canada."}, "ForeName": "Yara", "Initials": "Y", "LastName": "Zayed"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Biology, York University, Toronto, ON, Canada."}, "ForeName": "Chun", "Initials": "C", "LastName": "Peng"}]}, "ELocationID": [{"#text": "402", "@EIdType": "pii", "@ValidYN": "Y"}, {"#text": "10.3389/fendo.2018.00402", "@EIdType": "doi", "@ValidYN": "Y"}], "Journal": {"ISOAbbreviation": "Front Endocrinol (Lausanne)", "ISSN": {"#text": "1664-2392", "@IssnType": "Print"}, "JournalIssue": {"@CitedMedium": "Print", "PubDate": {"Year": "2018"}, "Volume": "9"}, "Title": "Frontiers in endocrinology"}, "Language": "eng", "Pagination": {"MedlinePgn": "402", "StartPage": "402"}, "PublicationTypeList": {"PublicationType": [{"#text": "Journal Article", "@UI": "D016428"}, {"#text": "Review", "@UI": "D016454"}]}}, "DateRevised": {"Day": "09", "Month": "04", "Year": "2022"}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"#text": "cell-cell communication", "@MajorTopicYN": "N"}, {"#text": "extracellular microRNA", "@MajorTopicYN": "N"}, {"#text": "gene regulation", "@MajorTopicYN": "N"}, {"#text": "microRNA biogenesis", "@MajorTopicYN": "N"}, {"#text": "microRNA dynamics", "@MajorTopicYN": "N"}]}, "MedlineJournalInfo": {"Country": "Switzerland", "ISSNLinking": "1664-2392", "MedlineTA": "Front Endocrinol (Lausanne)", "NlmUniqueID": "101555782"}, "PMID": {"#text": "30123182", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "30123182", "@IdType": "pubmed"}, {"#text": "PMC6085463", "@IdType": "pmc"}, {"#text": "10.3389/fendo.2018.00402", "@IdType": "doi"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "received", "Day": "23", "Month": "4", "Year": "2018"}, {"@PubStatus": "accepted", "Day": "28", "Month": "6", "Year": "2018"}, {"@PubStatus": "entrez", "Day": "21", "Hour": "6", "Minute": "0", "Month": "8", "Year": "2018"}, {"@PubStatus": "pubmed", "Day": "21", "Hour": "6", "Minute": "0", "Month": "8", "Year": "2018"}, {"@PubStatus": "medline", "Day": "21", "Hour": "6", "Minute": "1", "Month": "8", "Year": "2018"}]}, "PublicationStatus": "epublish", "ReferenceList": {"Reference": [{"ArticleIdList": {"ArticleId": [{"#text": "10.1016/0092-8674(93)90529-Y", "@IdType": "doi"}, {"#text": "8252621", "@IdType": "pubmed"}]}, "Citation": "Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell (1993) 75:843\u201354. 10.1016/0092-8674(93)90529-Y"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/0092-8674(93)90530-4", "@IdType": "doi"}, {"#text": "8252622", "@IdType": "pubmed"}]}, "Citation": "Wightman B, Ha I, Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell (1993) 75:855\u201362. 10.1016/0092-8674(93)90530-4"}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC1214309", "@IdType": "pmc"}, {"#text": "7262539", "@IdType": "pubmed"}]}, "Citation": "Horvitz HR, Sulston JE. Isolation and genetic characterization of cell-lineage mutants of the nematode Caenorhabditis elegans. Genetics (1980) 96:435\u201354."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/0092-8674(81)90501-8", "@IdType": "doi"}, {"#text": "7237544", "@IdType": "pubmed"}]}, "Citation": "Chalfie M, Horvitz HR, Sulston JE. Mutations that lead to reiterations in the cell lineages of C. Elegans. Cell (1981) 24:59\u201369. 10.1016/0092-8674(81)90501-8"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1101/gad.1.4.398", "@IdType": "doi"}, {"#text": "3678829", "@IdType": "pubmed"}]}, "Citation": "Ambros V, Horvitz HR. The lin-14 locus of Caenorhabditis elegans controls the time of expression of specific postembryonic developmental events. Genes Dev. (1987) 1:398\u2013414. 10.1101/gad.1.4.398"}, {"ArticleIdList": {"ArticleId": {"#text": "2881214", "@IdType": "pubmed"}}, "Citation": "Ferguson EL, Sternberg PW, Horvitz HR. A genetic pathway for the specification of the vulval cell lineages of Caenorhabditis elegans. Nature (1987) 326:259\u201367."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/S0092-8674(04)00035-2", "@IdType": "doi"}, {"#text": "15055592", "@IdType": "pubmed"}]}, "Citation": "Lee R, Feinbaum R, Ambros V. A short history of a short RNA. Cell (2004) 116(2 Suppl.), S89\u201392. 10.1016/S0092-8674(04)00035-2"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.mrfmmm.2011.03.009", "@IdType": "doi"}, {"#text": "21458467", "@IdType": "pubmed"}]}, "Citation": "Almeida MI, Reis RM, Calin GA. MicroRNA history: discovery, recent applications, and next frontiers. Mutat Res. (2011) 717:1\u20138. 10.1016/j.mrfmmm.2011.03.009"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/35040556", "@IdType": "doi"}, {"#text": "11081512", "@IdType": "pubmed"}]}, "Citation": "Pasquinelli AE, Reinhart BJ, Slack F, Martindale MQ, Kuroda MI, Maller B, et al. . Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature (2000) 408:86\u20139. 10.1038/35040556"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/jb/mvq096", "@IdType": "doi"}, {"#text": "PMC2981492", "@IdType": "pmc"}, {"#text": "20833630", "@IdType": "pubmed"}]}, "Citation": "Davis-Dusenbery BN, Hata A. Mechanisms of control of microRNA biogenesis. J Biochem. (2010) 148:381\u201392. 10.1093/jb/mvq096"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ygeno.2010.03.009", "@IdType": "doi"}, {"#text": "20347954", "@IdType": "pubmed"}]}, "Citation": "Li SC, Chan WC, Hu LY, Lai CH, Hsu CN, Lin WC. Identification of homologous microRNAs in 56 animal genomes. Genomics (2010) 96:1\u20139. 10.1016/j.ygeno.2010.03.009"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/gb-2014-15-4-r57", "@IdType": "doi"}, {"#text": "PMC4054668", "@IdType": "pmc"}, {"#text": "24708865", "@IdType": "pubmed"}]}, "Citation": "Friedlander MR, Lizano E, Houben AJ, Bezdan D, Banez-Coronel M, Kudla G, et al. . Evidence for the biogenesis of more than 1,000 novel human microRNAs. Genome Biol. (2014) 15:R57. 10.1186/gb-2014-15-4-r57"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nbt.3947", "@IdType": "doi"}, {"#text": "PMC5767576", "@IdType": "pmc"}, {"#text": "28829439", "@IdType": "pubmed"}]}, "Citation": "de Rie D, Abugessaisa I, Alam T, Arner E, Arner P, Ashoor H, et al. . An integrated expression atlas of miRNAs and their promoters in human and mouse. Nat Biotechnol. (2017) 35:872\u20138. 10.1038/nbt.3947"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrm3838", "@IdType": "doi"}, {"#text": "25027649", "@IdType": "pubmed"}]}, "Citation": "Ha M, Kim VN. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol. (2014) 15:509\u201324. 10.1038/nrm3838"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.molcel.2016.09.004", "@IdType": "doi"}, {"#text": "PMC5074850", "@IdType": "pmc"}, {"#text": "27720646", "@IdType": "pubmed"}]}, "Citation": "Broughton JP, Lovci MT, Huang JL, Yeo GW, Pasquinelli AE. Pairing beyond the Seed Supports MicroRNA Targeting Specificity. Mol Cell. (2016) 64:320\u201333. 10.1016/j.molcel.2016.09.004"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/wrna.121", "@IdType": "doi"}, {"#text": "22072587", "@IdType": "pubmed"}]}, "Citation": "Vasudevan S. Posttranscriptional upregulation by microRNAs. Wiley Interdiscip Rev RNA (2012) 3:311\u201330. 10.1002/wrna.121"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.proghi.2016.06.001", "@IdType": "doi"}, {"#text": "27396686", "@IdType": "pubmed"}]}, "Citation": "Makarova JA, Shkurnikov MU, Wicklein D, Lange T, Samatov TR, Turchinovich AA, et al. . Intracellular and extracellular microRNA: an update on localization and biological role. Prog Histochem Cytochem. (2016) 51:33\u201349. 10.1016/j.proghi.2016.06.001"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/ijms14035519", "@IdType": "doi"}, {"#text": "PMC3634453", "@IdType": "pmc"}, {"#text": "23528856", "@IdType": "pubmed"}]}, "Citation": "Fu G, Brkic J, Hayder H, Peng C. MicroRNAs in human placental development and pregnancy complications. Int J Mol Sci. (2013) 14:5519\u201344. 10.3390/ijms14035519"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/978-1-62703-748-8_3", "@IdType": "doi"}, {"#text": "24272430", "@IdType": "pubmed"}]}, "Citation": "Tufekci KU, Oner MG, Meuwissen RL, Genc S. The role of microRNAs in human diseases. Methods Mol Biol. (2014) 1107:33\u201350. 10.1007/978-1-62703-748-8_3"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/jcp.25854", "@IdType": "doi"}, {"#text": "28181241", "@IdType": "pubmed"}]}, "Citation": "Paul P, Chakraborty A, Sarkar D, Langthasa M, Rahman M, Bari M, et al. . Interplay between miRNAs and human diseases. J Cell Physiol. (2018) 233:2007\u201318. 10.1002/jcp.25854"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.molmed.2014.06.005", "@IdType": "doi"}, {"#text": "25027972", "@IdType": "pubmed"}]}, "Citation": "Hayes J, Peruzzi PP, Lawler S. MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol Med. (2014) 20:460\u20139. 10.1016/j.molmed.2014.06.005"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/jcp.25056", "@IdType": "doi"}, {"#text": "26031493", "@IdType": "pubmed"}]}, "Citation": "Wang J, Chen J, Sen S. MicroRNA as Biomarkers and Diagnostics. J Cell Physiol. (2016) 231:25\u201330. 10.1002/jcp.25056"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/978-1-4939-7046-9_4", "@IdType": "doi"}, {"#text": "28540676", "@IdType": "pubmed"}]}, "Citation": "Huang W. MicroRNAs: biomarkers, diagnostics, and therapeutics. Methods Mol Biol. (2017) 1617:57\u201367. 10.1007/978-1-4939-7046-9_4"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/sj.emboj.7601512", "@IdType": "doi"}, {"#text": "PMC1794378", "@IdType": "pmc"}, {"#text": "17255951", "@IdType": "pubmed"}]}, "Citation": "Kim YK, Kim VN. Processing of intronic microRNAs. EMBO J. (2007) 26:775\u201383. 10.1038/sj.emboj.7601512"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.jmb.2004.03.065", "@IdType": "doi"}, {"#text": "15136036", "@IdType": "pubmed"}]}, "Citation": "Tanzer A, Stadler PF. Molecular evolution of a microRNA cluster. J Mol Biol. (2004) 339:327\u201335. 10.1016/j.jmb.2004.03.065"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1530/REP-17-0603", "@IdType": "doi"}, {"#text": "29615475", "@IdType": "pubmed"}]}, "Citation": "Hayder H, O'Brien J, Nadeem U, Peng C. MicroRNAs: crucial regulators of placental development. Reproduction (2018) 155:R259\u201371. 10.1530/REP-17-0603"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature03049", "@IdType": "doi"}, {"#text": "15531879", "@IdType": "pubmed"}]}, "Citation": "Denli AM, Tops BB, Plasterk RH, Ketting RF, Hannon GJ. Processing of primary microRNAs by the Microprocessor complex. Nature (2004) 432:231\u20135. 10.1038/nature03049"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature14281", "@IdType": "doi"}, {"#text": "PMC4475635", "@IdType": "pmc"}, {"#text": "25799998", "@IdType": "pubmed"}]}, "Citation": "Alarcon CR, Lee H, Goodarzi H, Halberg N, Tavazoie SF. N6-methyladenosine marks primary microRNAs for processing. Nature (2015) 519:482\u20135. 10.1038/nature14281"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1101/gad.1262504", "@IdType": "doi"}, {"#text": "PMC535913", "@IdType": "pmc"}, {"#text": "15574589", "@IdType": "pubmed"}]}, "Citation": "Han J, Lee Y, Yeom KH, Kim YK, Jin H, Kim VN. The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev. (2004) 18:3016\u201327. 10.1101/gad.1262504"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1126/science.1178705", "@IdType": "doi"}, {"#text": "19965479", "@IdType": "pubmed"}]}, "Citation": "Okada C, Yamashita E, Lee SJ, Shibata S, Katahira J, Nakagawa A, et al. . A high-resolution structure of the pre-microRNA nuclear export machinery. Science (2009) 326:1275\u20139. 10.1126/science.1178705"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cell.2004.06.017", "@IdType": "doi"}, {"#text": "15242644", "@IdType": "pubmed"}]}, "Citation": "Zhang H, Kolb FA, Jaskiewicz L, Westhof E, Filipowicz W. Single processing center models for human Dicer and bacterial RNase III. Cell (2004) 118:57\u201368. 10.1016/j.cell.2004.06.017"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nsmb.1733", "@IdType": "doi"}, {"#text": "PMC2915567", "@IdType": "pmc"}, {"#text": "19966796", "@IdType": "pubmed"}]}, "Citation": "Yoda M, Kawamata T, Paroo Z, Ye X, Iwasaki S, Liu Q, et al. . ATP-dependent human RISC assembly pathways. Nat Struct Mol Biol. (2010) 17:17\u201323. 10.1038/nsmb.1733"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1042/BST20140142", "@IdType": "doi"}, {"#text": "25110015", "@IdType": "pubmed"}]}, "Citation": "Meijer HA, Smith EM, Bushell M. Regulation of miRNA strand selection: follow the leader? Biochem Soc Trans. (2014) 42:1135\u201340. 10.1042/BST20140142"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/S0092-8674(03)00801-8", "@IdType": "doi"}, {"#text": "14567918", "@IdType": "pubmed"}]}, "Citation": "Khvorova A, Reynolds A, Jayasena SD. Functional siRNAs and miRNAs exhibit strand bias. Cell (2003) 115:209\u201316. 10.1016/S0092-8674(03)00801-8"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature05983", "@IdType": "doi"}, {"#text": "PMC2475599", "@IdType": "pmc"}, {"#text": "17589500", "@IdType": "pubmed"}]}, "Citation": "Ruby JG, Jan CH, Bartel DP. Intronic microRNA precursors that bypass Drosha processing. Nature (2007) 448:83\u20136. 10.1038/nature05983"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1101/gad.1705308", "@IdType": "doi"}, {"#text": "PMC2569885", "@IdType": "pmc"}, {"#text": "18923076", "@IdType": "pubmed"}]}, "Citation": "Babiarz JE, Ruby JG, Wang Y, Bartel DP, Blelloch R. Mouse ES cells express endogenous shRNAs, siRNAs, and other Microprocessor-independent, Dicer-dependent small RNAs. Genes Dev. (2008) 22:2773\u201385. 10.1101/gad.1705308"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cell.2013.11.027", "@IdType": "doi"}, {"#text": "PMC3899828", "@IdType": "pmc"}, {"#text": "24360278", "@IdType": "pubmed"}]}, "Citation": "Xie M, Li M, Vilborg A, Lee N, Shu MD, Yartseva V, et al. . Mammalian 5\u2032-capped microRNA precursors that generate a single microRNA. Cell (2013) 155:1568\u201380. 10.1016/j.cell.2013.11.027"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.1006432107", "@IdType": "doi"}, {"#text": "PMC2930549", "@IdType": "pmc"}, {"#text": "20699384", "@IdType": "pubmed"}]}, "Citation": "Yang JS, Maurin T, Robine N, Rasmussen KD, Jeffrey KL, Chandwani R, et al. . Conserved vertebrate mir-451 provides a platform for Dicer-independent, Ago2-mediated microRNA biogenesis. Proc Natl Acad Sci USA. (2010) 107:15163\u20138. 10.1073/pnas.1006432107"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature09092", "@IdType": "doi"}, {"#text": "PMC2995450", "@IdType": "pmc"}, {"#text": "20424607", "@IdType": "pubmed"}]}, "Citation": "Cheloufi S, Dos Santos CO, Chong MMW, Hannon GJ. A dicer-independent miRNA biogenesis pathway that requires Ago catalysis. Nature (2010) 465:584\u20139. 10.1038/nature09092"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrg2936", "@IdType": "doi"}, {"#text": "21245828", "@IdType": "pubmed"}]}, "Citation": "Huntzinger E, Izaurralde E. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet. (2011) 12:99\u2013110. 10.1038/nrg2936"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nsmb.2931", "@IdType": "doi"}, {"#text": "PMC4450863", "@IdType": "pmc"}, {"#text": "25565029", "@IdType": "pubmed"}]}, "Citation": "Ipsaro JJ, Joshua-Tor L. From guide to target: molecular insights into eukaryotic RNA-interference machinery. Nat Struct Mol Biol. (2015) 22:20\u20138. 10.1038/nsmb.2931"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/1471-2105-15-S7-S4", "@IdType": "doi"}, {"#text": "PMC4110731", "@IdType": "pmc"}, {"#text": "25077573", "@IdType": "pubmed"}]}, "Citation": "Xu W, San Lucas A, Wang Z, Liu Y. Identifying microRNA targets in different gene regions. BMC Bioinformatics (2014) 15(Suppl. 7):S4. 10.1186/1471-2105-15-S7-S4"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.0803230105", "@IdType": "doi"}, {"#text": "PMC2567461", "@IdType": "pmc"}, {"#text": "18812516", "@IdType": "pubmed"}]}, "Citation": "Forman JJ, Legesse-Miller A, Coller HA. A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence. Proc Natl Acad Sci USA. (2008) 105:14879\u201384. 10.1073/pnas.0803230105"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/ol.2018.8217", "@IdType": "doi"}, {"#text": "PMC5962847", "@IdType": "pmc"}, {"#text": "29849790", "@IdType": "pubmed"}]}, "Citation": "Zhang J, Zhou W, Liu Y, Liu T, Li C, Wang L. Oncogenic role of microRNA-532-5p in human colorectal cancer via targeting of the 5\u2032 UTR of RUNX3. Oncol Lett. (2018) 15:7215\u201320. 10.3892/ol.2018.8217"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1371/journal.pone.0079467", "@IdType": "doi"}, {"#text": "PMC3827167", "@IdType": "pmc"}, {"#text": "24265774", "@IdType": "pubmed"}]}, "Citation": "Dharap A, Pokrzywa C, Murali S, Pandi G, Vemuganti R. MicroRNA miR-324-3p induces promoter-mediated expression of RelA gene. PLoS ONE (2013) 8:e79467. 10.1371/journal.pone.0079467"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.tibs.2010.03.009", "@IdType": "doi"}, {"#text": "20395147", "@IdType": "pubmed"}]}, "Citation": "Kawamata T, Tomari Y. Making RISC. Trends Biochem Sci. (2010) 35:368\u201376. 10.1016/j.tibs.2010.03.009"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.molcel.2015.04.027", "@IdType": "doi"}, {"#text": "26140367", "@IdType": "pubmed"}]}, "Citation": "Jo MH, Shin S, Jung SR, Kim E, Song JJ, Hohng S. Human Argonaute 2 Has diverse reaction pathways on Target RNAs. Mol Cell. (2015) 59:117\u201324. 10.1016/j.molcel.2015.04.027"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature04303", "@IdType": "doi"}, {"#text": "16258535", "@IdType": "pubmed"}]}, "Citation": "Kr\u00fctzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, et al. . Silencing of microRNAs in vivo with \u2018antagomirs\u2019. Nature (2005) 438:685\u20139. 10.1038/nature04303"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1126/science.1187058", "@IdType": "doi"}, {"#text": "PMC2902985", "@IdType": "pmc"}, {"#text": "20558712", "@IdType": "pubmed"}]}, "Citation": "Ameres SL, Horwich MD, Hung JH, Xu J, Ghildiyal M, Weng Z, et al. . Target RNA-directed trimming and tailing of small silencing RNAs. Science (2010) 328:1534\u20139. 10.1126/science.1187058"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrg3965", "@IdType": "doi"}, {"#text": "26077373", "@IdType": "pubmed"}]}, "Citation": "Jonas S, Izaurralde E. Towards a molecular understanding of microRNA-mediated gene silencing. Nat Rev Genet. (2015) 16:421\u201333. 10.1038/nrg3965"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/bioinformatics/btr149", "@IdType": "doi"}, {"#text": "PMC3087955", "@IdType": "pmc"}, {"#text": "21441577", "@IdType": "pubmed"}]}, "Citation": "Ellwanger DC, Buttner FA, Mewes HW, Stumpflen V. The sufficient minimal set of miRNA seed types. Bioinformatics (2011) 27:1346\u201350. 10.1093/bioinformatics/btr149"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1101/gad.1424106", "@IdType": "doi"}, {"#text": "PMC1522082", "@IdType": "pmc"}, {"#text": "16815998", "@IdType": "pubmed"}]}, "Citation": "Behm-Ansmant I, Rehwinkel J, Doerks T, Stark A, Bork P, Izaurralde E. mRNA degradation by miRNAs and GW182 requires both CCR4:NOT deadenylase and DCP1:DCP2 decapping complexes. Genes Dev. (2006) 20:1885\u201398. 10.1101/gad.1424106"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.molcel.2013.07.011", "@IdType": "doi"}, {"#text": "23932717", "@IdType": "pubmed"}]}, "Citation": "Christie M, Boland A, Huntzinger E, Weichenrieder O, Izaurralde E. Structure of the PAN3 pseudokinase reveals the basis for interactions with the PAN2 deadenylase and the GW182 proteins. Mol Cell. (2013) 51:360\u201373. 10.1016/j.molcel.2013.07.011"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nsmb.2413", "@IdType": "doi"}, {"#text": "23142987", "@IdType": "pubmed"}]}, "Citation": "Braun JE, Truffault V, Boland A, Huntzinger E, Chang CT, Haas G, et al. . A direct interaction between DCP1 and XRN1 couples mRNA decapping to 5\u2032 exonucleolytic degradation. Nat Struct Mol Biol. (2012) 19:1324\u201331. 10.1038/nsmb.2413"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cell.2007.01.038", "@IdType": "doi"}, {"#text": "PMC3430382", "@IdType": "pmc"}, {"#text": "17382880", "@IdType": "pubmed"}]}, "Citation": "Vasudevan S, Steitz JA. AU-rich-element-mediated upregulation of translation by FXR1 and Argonaute 2. Cell (2007) 128:1105\u201318. 10.1016/j.cell.2007.01.038"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/srep00842", "@IdType": "doi"}, {"#text": "PMC3496365", "@IdType": "pmc"}, {"#text": "23150790", "@IdType": "pubmed"}]}, "Citation": "Truesdell SS, Mortensen RD, Seo M, Schroeder JC, Lee JH, LeTonqueze O, et al. . MicroRNA-mediated mRNA translation activation in quiescent cells and oocytes involves recruitment of a nuclear microRNP. Sci Rep. (2012) 2:842. 10.1038/srep00842"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.molcel.2016.02.013", "@IdType": "doi"}, {"#text": "PMC4811377", "@IdType": "pmc"}, {"#text": "26942679", "@IdType": "pubmed"}]}, "Citation": "Bukhari SIA, Truesdell SS, Lee S, Kollu S, Classon A, Boukhali M, et al. . A specialized mechanism of translation mediated by FXR1a-associated microRNP in cellular quiescence. Mol Cell. (2016) 61:760\u201373. 10.1016/j.molcel.2016.02.013"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.molcel.2008.05.001", "@IdType": "doi"}, {"#text": "18498749", "@IdType": "pubmed"}]}, "Citation": "Orom UA, Nielsen FC, Lund AH. MicroRNA-10a binds the 5\u2032UTR of ribosomal protein mRNAs and enhances their translation. Mol Cell. (2008) 30:460\u201371. 10.1016/j.molcel.2008.05.001"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1261/rna.034769.112", "@IdType": "doi"}, {"#text": "PMC3527724", "@IdType": "pmc"}, {"#text": "23150874", "@IdType": "pubmed"}]}, "Citation": "Nishi K, Nishi A, Nagasawa T, Ui-Tei K. Human TNRC6A is an Argonaute-navigator protein for microRNA-mediated gene silencing in the nucleus. RNA (2013) 19:17\u201335. 10.1261/rna.034769.112"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/ncb2443", "@IdType": "doi"}, {"#text": "PMC5423543", "@IdType": "pmc"}, {"#text": "22366686", "@IdType": "pubmed"}]}, "Citation": "Benhamed M, Herbig U, Ye T, Dejean A, Bischof O. Senescence is an endogenous trigger for microRNA-directed transcriptional gene silencing in human cells. Nat Cell Biol. (2012) 14:266\u201375. 10.1038/ncb2443"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.celrep.2017.03.075", "@IdType": "doi"}, {"#text": "PMC5482240", "@IdType": "pmc"}, {"#text": "28423324", "@IdType": "pubmed"}]}, "Citation": "Pitchiaya S, Heinicke LA, Park JI, Cameron EL, Walter NG. Resolving subcellular miRNA trafficking and turnover at single-molecule resolution. Cell Rep. (2017) 19:630\u201342. 10.1016/j.celrep.2017.03.075"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature10492", "@IdType": "doi"}, {"#text": "PMC4082306", "@IdType": "pmc"}, {"#text": "22056986", "@IdType": "pubmed"}]}, "Citation": "Cernilogar FM, Onorati MC, Kothe GO, Burroughs AM, Parsi KM, Breiling A, et al. . Chromatin-associated RNA interference components contribute to transcriptional regulation in Drosophila. Nature (2011) 480:391\u20135. 10.1038/nature10492"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41467-017-01126-x", "@IdType": "doi"}, {"#text": "PMC5662751", "@IdType": "pmc"}, {"#text": "29084942", "@IdType": "pubmed"}]}, "Citation": "Bottini S, Hamouda-Tekaya N, Mategot R, Zaragosi LE, Audebert S, Pisano S, et al. . Post-transcriptional gene silencing mediated by microRNAs is controlled by nucleoplasmic Sfpq. Nat Commun. (2017) 8:1189. 10.1038/s41467-017-01126-x"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.1416858111", "@IdType": "doi"}, {"#text": "PMC4226100", "@IdType": "pmc"}, {"#text": "25313066", "@IdType": "pubmed"}]}, "Citation": "Allo M, Agirre E, Bessonov S, Bertucci P, Gomez Acuna L, Buggiano V, et al. . Argonaute-1 binds transcriptional enhancers and controls constitutive and alternative splicing in human cells. Proc Natl Acad Sci USA. (2014) 111:15622\u20139. 10.1073/pnas.1416858111"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1371/journal.pgen.1004312", "@IdType": "doi"}, {"#text": "PMC4006729", "@IdType": "pmc"}, {"#text": "24786770", "@IdType": "pubmed"}]}, "Citation": "Havens MA, Reich AA, Hastings ML. Drosha promotes splicing of a pre-microRNA-like alternative exon. PLoS Genet. (2014) 10:e1004312. 10.1371/journal.pgen.1004312"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bbagrm.2016.02.016", "@IdType": "doi"}, {"#text": "26926595", "@IdType": "pubmed"}]}, "Citation": "Miao L, Yao H, Li C, Pu M, Yao X, Yang H, et al. . A dual inhibition: microRNA-552 suppresses both transcription and translation of cytochrome P450 2E1. Biochim Biophys Acta (2016) 1859:650\u201362. 10.1016/j.bbagrm.2016.02.016"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1080/15476286.2015.1112487", "@IdType": "doi"}, {"#text": "PMC5711461", "@IdType": "pmc"}, {"#text": "26853707", "@IdType": "pubmed"}]}, "Citation": "Xiao M, Li J, Li W, Wang Y, Wu F, Xi Y, et al. . MicroRNAs activate gene transcription epigenetically as an enhancer trigger. RNA Biol. (2017) 14:1326\u201334. 10.1080/15476286.2015.1112487"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.molcel.2014.02.013", "@IdType": "doi"}, {"#text": "PMC4062300", "@IdType": "pmc"}, {"#text": "24631284", "@IdType": "pubmed"}]}, "Citation": "Nam JW, Rissland OS, Koppstein D, Abreu-Goodger C, Jan CH, Agarwal V, et al. . Global analyses of the effect of different cellular contexts on microRNA targeting. Mol Cell. (2014) 53:1031\u201343. 10.1016/j.molcel.2014.02.013"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1534/genetics.116.196774", "@IdType": "doi"}, {"#text": "PMC5499184", "@IdType": "pmc"}, {"#text": "28348061", "@IdType": "pubmed"}]}, "Citation": "Blazie SM, Geissel HC, Wilky H, Joshi R, Newbern J, Mangone M. Alternative polyadenylation directs tissue-specific miRNA targeting in Caenorhabditis elegans Somatic Tissues. Genetics (2017) 206:757\u201374. 10.1534/genetics.116.196774"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1074/jbc.C115.661868", "@IdType": "doi"}, {"#text": "PMC4598978", "@IdType": "pmc"}, {"#text": "26304123", "@IdType": "pubmed"}]}, "Citation": "Barman B, Bhattacharyya SN. mRNA targeting to endoplasmic reticulum precedes ago protein interaction and microRNA (miRNA)-mediated translation repression in mammalian cells. J Biol Chem. (2015) 290:24650\u20136. 10.1074/jbc.C115.661868"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/nar/gkv1026", "@IdType": "doi"}, {"#text": "PMC4787778", "@IdType": "pmc"}, {"#text": "26446993", "@IdType": "pubmed"}]}, "Citation": "Nishi K, Takahashi T, Suzawa M, Miyakawa T, Nagasawa T, Ming Y, et al. . Control of the localization and function of a miRNA silencing component TNRC6A by Argonaute protein. Nucleic Acids Res (2015) 43:9856\u201373. 10.1093/nar/gkv1026"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/nar/gkq1216", "@IdType": "doi"}, {"#text": "PMC3074141", "@IdType": "pmc"}, {"#text": "21148147", "@IdType": "pubmed"}]}, "Citation": "Detzer A, Engel C, Wunsche W, Sczakiel G. Cell stress is related to re-localization of Argonaute 2 and to decreased RNA interference in human cells. Nucleic Acids Res. (2011) 39:2727\u201341. 10.1093/nar/gkq1216"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1128/MCB.00464-16", "@IdType": "doi"}, {"#text": "PMC5288578", "@IdType": "pmc"}, {"#text": "27895152", "@IdType": "pubmed"}]}, "Citation": "Bose M, Barman B, Goswami A, Bhattacharyya SN. Spatiotemporal uncoupling of MicroRNA-mediated translational repression and target RNA degradation controls microRNP recycling in mammalian cells. Mol Cell Biol. (2017) 37:e00464\u201316. 10.1128/MCB.00464-16"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/ncb1929", "@IdType": "doi"}, {"#text": "19684575", "@IdType": "pubmed"}]}, "Citation": "Gibbings DJ, Ciaudo C, Erhardt M, Voinnet O. Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat Cell Biol. (2009) 11:1143\u20139. 10.1038/ncb1929"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1371/journal.pone.0020220", "@IdType": "doi"}, {"#text": "PMC3102686", "@IdType": "pmc"}, {"#text": "21637849", "@IdType": "pubmed"}]}, "Citation": "Barrey E, Saint-Auret G, Bonnamy B, Damas D, Boyer O, Gidrol X. Pre-microRNA and mature microRNA in human mitochondria. PLoS ONE (2011) 6:e20220. 10.1371/journal.pone.0020220"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cell.2014.05.047", "@IdType": "doi"}, {"#text": "PMC4119298", "@IdType": "pmc"}, {"#text": "25083871", "@IdType": "pubmed"}]}, "Citation": "Zhang X, Zuo X, Yang B, Li Z, Xue Y, Zhou Y, et al. . MicroRNA directly enhances mitochondrial translation during muscle differentiation. Cell (2014) 158:607\u201319. 10.1016/j.cell.2014.05.047"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.celrep.2013.12.013", "@IdType": "doi"}, {"#text": "PMC3916906", "@IdType": "pmc"}, {"#text": "24388755", "@IdType": "pubmed"}]}, "Citation": "Gagnon KT, Li L, Chu Y, Janowski BA, Corey DR. RNAi factors are present and active in human cell nuclei. Cell Rep. (2014) 6:211\u201321. 10.1016/j.celrep.2013.12.013"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/ncb1274", "@IdType": "doi"}, {"#text": "PMC1855297", "@IdType": "pmc"}, {"#text": "15937477", "@IdType": "pubmed"}]}, "Citation": "Liu J, Valencia-Sanchez MA, Hannon GJ, Parker R. MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat Cell Biol. (2005) 7:719\u201323. 10.1038/ncb1274"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.molcel.2007.02.011", "@IdType": "doi"}, {"#text": "17349952", "@IdType": "pubmed"}]}, "Citation": "Parker R, Sheth U. P bodies and the control of mRNA translation and degradation. Mol Cell. (2007) 25:635\u201346. 10.1016/j.molcel.2007.02.011"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1128/MCB.00128-07", "@IdType": "doi"}, {"#text": "PMC1900022", "@IdType": "pmc"}, {"#text": "17403906", "@IdType": "pubmed"}]}, "Citation": "Eulalio A, Behm-Ansmant I, Schweizer D, Izaurralde E. P-body formation is a consequence, not the cause, of RNA-mediated gene silencing. Mol Cell Biol. (2007) 27:3970\u201381. 10.1128/MCB.00128-07"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1083/jcb.201306076", "@IdType": "doi"}, {"#text": "PMC4033771", "@IdType": "pmc"}, {"#text": "24862572", "@IdType": "pubmed"}]}, "Citation": "Rajgor D, Mellad JA, Soong D, Rattner JB, Fritzler MJ, Shanahan CM. Mammalian microtubule P-body dynamics are mediated by nesprin-1. J Cell Biol. (2014) 205:457\u201375. 10.1083/jcb.201306076"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1083/jcb.201004145", "@IdType": "doi"}, {"#text": "PMC3019555", "@IdType": "pmc"}, {"#text": "21220510", "@IdType": "pubmed"}]}, "Citation": "Carbonaro M, O'Brate A, Giannakakou P. Microtubule disruption targets HIF-1alpha mRNA to cytoplasmic P-bodies for translational repression. J Cell Biol. (2011) 192:83\u201399. 10.1083/jcb.201004145"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1126/science.1115079", "@IdType": "doi"}, {"#text": "16081698", "@IdType": "pubmed"}]}, "Citation": "Pillai RS, Bhattacharyya SN, Artus CG, Zoller T, Cougot N, Basyuk E, et al. . Inhibition of translational initiation by Let-7 MicroRNA in human cells. Science (2005) 309:1573\u20136. 10.1126/science.1115079"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1261/rna.033142.112", "@IdType": "doi"}, {"#text": "PMC3425777", "@IdType": "pmc"}, {"#text": "22836355", "@IdType": "pubmed"}]}, "Citation": "Molotski N, Soen Y. Differential association of microRNAs with polysomes reflects distinct strengths of interactions with their mRNA targets. RNA (2012) 18:1612\u201323. 10.1261/rna.033142.112"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cell.2012.10.036", "@IdType": "doi"}, {"#text": "PMC3595543", "@IdType": "pmc"}, {"#text": "23178124", "@IdType": "pubmed"}]}, "Citation": "Wee LM, Flores-Jasso CF, Salomon WE, Zamore PD. Argonaute divides its RNA guide into domains with distinct functions and RNA-binding properties. Cell (2012) 151:1055\u201367. 10.1016/j.cell.2012.10.036"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/nar/gkw550", "@IdType": "doi"}, {"#text": "PMC5291278", "@IdType": "pmc"}, {"#text": "27317695", "@IdType": "pubmed"}]}, "Citation": "Lai X, Wolkenhauer O, Vera J. Understanding microRNA-mediated gene regulatory networks through mathematical modelling. Nucleic Acids Res. (2016) 44:6019\u201335. 10.1093/nar/gkw550"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.4161/rna.8.5.16043", "@IdType": "doi"}, {"#text": "21743293", "@IdType": "pubmed"}]}, "Citation": "Zhang JF, Fu WM, He ML, Xie WD, Lv Q, Wan G, et al. . MiRNA-20a promotes osteogenic differentiation of human mesenchymal stem cells by co-regulating BMP signaling. RNA Biol. (2011) 8:829\u201338. 10.4161/rna.8.5.16043"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41598-017-13470-5", "@IdType": "doi"}, {"#text": "PMC5645395", "@IdType": "pmc"}, {"#text": "29042600", "@IdType": "pubmed"}]}, "Citation": "Shu J, Silva B, Gao T, Xu Z, Cui J. Dynamic and modularized microRNA regulation and its implication in human cancers. Sci Rep. (2017) 7:13356. 10.1038/s41598-017-13470-5"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/ncomms3364", "@IdType": "doi"}, {"#text": "PMC3836244", "@IdType": "pmc"}, {"#text": "24077216", "@IdType": "pubmed"}]}, "Citation": "Siciliano V, Garzilli I, Fracassi C, Criscuolo S, Ventre S, di Bernardo D. MiRNAs confer phenotypic robustness to gene networks by suppressing biological noise. Nat Commun. (2013) 4:2364. 10.1038/ncomms3364"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1126/science.aaa1738", "@IdType": "doi"}, {"#text": "25838385", "@IdType": "pubmed"}]}, "Citation": "Schmiedel JM, Klemm SL, Zheng Y, Sahay A, Bl\u00fcthgen N, Marks DS, et al. . MicroRNA control of protein expression noise. Science (2015) 348:128\u201332. 10.1126/science.aaa1738"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cell.2012.04.005", "@IdType": "doi"}, {"#text": "PMC3351105", "@IdType": "pmc"}, {"#text": "22541426", "@IdType": "pubmed"}]}, "Citation": "Ebert MS, Sharp PA. Roles for microRNAs in conferring robustness to biological processes. Cell (2012) 149:515\u201324. 10.1016/j.cell.2012.04.005"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cell.2018.03.007", "@IdType": "doi"}, {"#text": "PMC5978003", "@IdType": "pmc"}, {"#text": "29606352", "@IdType": "pubmed"}]}, "Citation": "Lalanne JB, Taggart JC, Guo MS, Herzel L, Schieler A, Li GW. Evolutionary convergence of pathway-specific enzyme expression stoichiometry. Cell (2018) 173:749\u2013761. 10.1016/j.cell.2018.03.007"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature10098", "@IdType": "doi"}, {"#text": "21593866", "@IdType": "pubmed"}]}, "Citation": "Schwanh\u00e4usser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J, et al. . Global quantification of mammalian gene expression control. Nature (2011) 473:337\u201342. 10.1038/nature10098"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.molcel.2016.09.027", "@IdType": "doi"}, {"#text": "PMC5101187", "@IdType": "pmc"}, {"#text": "27871486", "@IdType": "pubmed"}]}, "Citation": "Denzler R, McGeary SE, Title AC, Agarwal V, Bartel DP, Stoffel M. Impact of MicroRNA levels, target-site complementarity, and cooperativity on competing endogenous RNA-regulated gene expression. Mol Cell (2016) 64:565\u201379. 10.1016/j.molcel.2016.09.027"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3389/fgene.2014.00008", "@IdType": "doi"}, {"#text": "PMC3906566", "@IdType": "pmc"}, {"#text": "24523727", "@IdType": "pubmed"}]}, "Citation": "Kartha RV, Subramanian S. Competing endogenous RNAs (ceRNAs): new entrants to the intricacies of gene regulation. Front Genet. (2014) 5:8. 10.3389/fgene.2014.00008"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1242/dev.128074", "@IdType": "doi"}, {"#text": "PMC4920157", "@IdType": "pmc"}, {"#text": "27246710", "@IdType": "pubmed"}]}, "Citation": "Barrett SP, Salzman J. Circular RNAs: analysis, expression and potential functions. Development (2016) 143:1838\u201347. 10.1242/dev.128074"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41467-017-01216-w", "@IdType": "doi"}, {"#text": "PMC5658440", "@IdType": "pmc"}, {"#text": "29074849", "@IdType": "pubmed"}]}, "Citation": "Yu CY, Li TC, Wu YY, Yeh CH, Chiang W, Chuang CY, et al. . The circular RNA circBIRC6 participates in the molecular circuitry controlling human pluripotency. Nat Commun. (2017) 8:1149. 10.1038/s41467-017-01216-w"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1126/science.aaf8995", "@IdType": "doi"}, {"#text": "28183980", "@IdType": "pubmed"}]}, "Citation": "Sambandan S, Akbalik G, Kochen L, Rinne J, Kahlstatt J, Glock C, et al. . Activity-dependent spatially localized miRNA maturation in neuronal dendrites. Science (2017) 355:634\u20137. 10.1126/science.aaf8995"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/nar/gkx1067", "@IdType": "doi"}, {"#text": "PMC5753222", "@IdType": "pmc"}, {"#text": "29126174", "@IdType": "pubmed"}]}, "Citation": "Chou CH, Shrestha S, Yang CD, Chang NW, Lin YL, Liao KW, et al. . miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions. Nucleic Acids Res. (2018) 46:D296\u2013D302. 10.1093/nar/gkx1067"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.molcel.2017.07.007", "@IdType": "doi"}, {"#text": "PMC5915679", "@IdType": "pmc"}, {"#text": "28781232", "@IdType": "pubmed"}]}, "Citation": "Elkayam E, Faehnle CR, Morales M, Sun J, Li H, Joshua-Tor L. Multivalent recruitment of human argonaute by GW182. Mol Cell. (2017) 67:646\u2013658.e3. 10.1016/j.molcel.2017.07.007"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/bioinformatics/btu373", "@IdType": "doi"}, {"#text": "24894504", "@IdType": "pubmed"}]}, "Citation": "Li Y, Liang C, Wong KC, Luo J, Zhang Z. Mirsynergy: detecting synergistic miRNA regulatory modules by overlapping neighbourhood expansion. Bioinformatics (2014) 30:2627\u201335. 10.1093/bioinformatics/btu373"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/srep45197", "@IdType": "doi"}, {"#text": "PMC5364550", "@IdType": "pmc"}, {"#text": "28338079", "@IdType": "pubmed"}]}, "Citation": "Lemus-Diaz N, Boker KO, Rodriguez-Polo I, Mitter M, Preis J, Arlt M, et al. . Dissecting miRNA gene repression on single cell level with an advanced fluorescent reporter system. Sci Rep. (2017) 7:45197. 10.1038/srep45197"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/ncomms12200", "@IdType": "doi"}, {"#text": "PMC4961841", "@IdType": "pmc"}, {"#text": "27448149", "@IdType": "pubmed"}]}, "Citation": "Bose M, Bhattacharyya SN. Target-dependent biogenesis of cognate microRNAs in human cells. Nat Commun. (2016) 7:12200. 10.1038/ncomms12200"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.stemcr.2017.02.012", "@IdType": "doi"}, {"#text": "PMC5390108", "@IdType": "pmc"}, {"#text": "28330621", "@IdType": "pubmed"}]}, "Citation": "Pons-Espinal M, de Luca E, Marzi MJ, Beckervordersandforth R, Armirotti A, Nicassio F, et al. . Synergic functions of miRNAs determine neuronal fate of adult neural stem cells. Stem Cell Rep. (2017) 8:1046\u201361. 10.1016/j.stemcr.2017.02.012"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ijbiomac.2018.03.061", "@IdType": "doi"}, {"#text": "29550426", "@IdType": "pubmed"}]}, "Citation": "Sahu M, Mallick B. Deciphering synergistic regulatory networks of microRNAs in hESCs and fibroblasts. Int J Biol Macromol. (2018) 113:1279\u201386. 10.1016/j.ijbiomac.2018.03.061"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrc2657", "@IdType": "doi"}, {"#text": "PMC2722839", "@IdType": "pmc"}, {"#text": "19440234", "@IdType": "pubmed"}]}, "Citation": "Abbas T, Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer (2009) 9:400\u201314. 10.1038/nrc2657"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/onc.2010.34", "@IdType": "doi"}, {"#text": "20190813", "@IdType": "pubmed"}]}, "Citation": "Wu S, Huang S, Ding J, Zhao Y, Liang L, Liu T, et al. . Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3\u2032 untranslated region. Oncogene (2010) 29:2302\u20138. 10.1038/onc.2010.34"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.virol.2014.04.007", "@IdType": "doi"}, {"#text": "24928040", "@IdType": "pubmed"}]}, "Citation": "Yao W, Guo G, Zhang Q, Fan L, Wu N, Bo Y. The application of multiple miRNA response elements enables oncolytic adenoviruses to possess specificity to glioma cells. Virology (2014). 458\u2013459, 69\u201382. 10.1016/j.virol.2014.04.007"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1242/jcs.202002", "@IdType": "doi"}, {"#text": "29444950", "@IdType": "pubmed"}]}, "Citation": "Kucherenko MM, Shcherbata HR. miRNA targeting and alternative splicing in the stress response - events hosted by membrane-less compartments. J Cell Sci. (2018) 131:jcs202002. 10.1242/jcs.202002"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/nar/gkq601", "@IdType": "doi"}, {"#text": "PMC2978372", "@IdType": "pmc"}, {"#text": "20615901", "@IdType": "pubmed"}]}, "Citation": "Wang K, Zhang S, Weber J, Baxter D, Galas DJ. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res. (2010) 38:7248\u201359. 10.1093/nar/gkq601"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.0608845103", "@IdType": "doi"}, {"#text": "PMC1838717", "@IdType": "pmc"}, {"#text": "17116888", "@IdType": "pubmed"}]}, "Citation": "Leung AK, Calabrese JM, Sharp PA. Quantitative analysis of Argonaute protein reveals microRNA-dependent localization to stress granules. Proc Natl Acad Sci USA. (2006) 103:18125\u201330. 10.1073/pnas.0608845103"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.tcb.2016.05.004", "@IdType": "doi"}, {"#text": "PMC4993645", "@IdType": "pmc"}, {"#text": "27289443", "@IdType": "pubmed"}]}, "Citation": "Protter DS, Parker R. Principles and Properties of Stress Granules. Trends Cell Biol. (2016) 26:668\u201379. 10.1016/j.tcb.2016.05.004"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.jhep.2014.07.017", "@IdType": "doi"}, {"#text": "25306489", "@IdType": "pubmed"}]}, "Citation": "Roderburg C, Luedde T. Circulating microRNAs as markers of liver inflammation, fibrosis and cancer. J Hepatol. (2014) 61:1434\u20137. 10.1016/j.jhep.2014.07.017"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/emm.2015.68", "@IdType": "doi"}, {"#text": "PMC4650928", "@IdType": "pmc"}, {"#text": "26380927", "@IdType": "pubmed"}]}, "Citation": "Sohn W, Kim J, Kang SH, Yang SR, Cho JY, Cho HC, et al. . Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma. Exp Mol Med. (2015) 47:e184. 10.1038/emm.2015.68"}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5840275", "@IdType": "pmc"}, {"#text": "29531852", "@IdType": "pubmed"}]}, "Citation": "Pereira-da-Silva T, Coutinho Cruz M, Carrusca C, Cruz Ferreira R, Napoleao P, Mota Carmo M. Circulating microRNA profiles in different arterial territories of stable atherosclerotic disease: a systematic review. Am J Cardiovasc Dis. (2018) 8:1\u201313."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/bies.201500130", "@IdType": "doi"}, {"#text": "26934338", "@IdType": "pubmed"}]}, "Citation": "Iftikhar H, Carney GE. Evidence and potential in vivo functions for biofluid miRNAs: from expression profiling to functional testing: potential roles of extracellular miRNAs as indicators of physiological change and as agents of intercellular information exchange. Bioessays (2016) 38:367\u201378. 10.1002/bies.201500130"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/cr.2008.282", "@IdType": "doi"}, {"#text": "18766170", "@IdType": "pubmed"}]}, "Citation": "Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al. . Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res (2008) 18:997\u20131006. 10.1038/cr.2008.282"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.1019055108", "@IdType": "doi"}, {"#text": "PMC3064324", "@IdType": "pmc"}, {"#text": "21383194", "@IdType": "pubmed"}]}, "Citation": "Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, et al. . Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA (2011) 108:5003\u20138. 10.1073/pnas.1019055108"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3233/JAD-2008-14103", "@IdType": "doi"}, {"#text": "18525125", "@IdType": "pubmed"}]}, "Citation": "Cogswell JP, Ward J, Taylor IA, Waters M, Shi Y, Cannon B, et al. . Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis. (2008) 14:27\u201341. 10.3233/JAD-2008-14103"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1371/journal.pone.0030679", "@IdType": "doi"}, {"#text": "PMC3302865", "@IdType": "pmc"}, {"#text": "22427800", "@IdType": "pubmed"}]}, "Citation": "Gallo A, Tandon M, Alevizos I, Illei GG. The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS ONE (2012) 7:e30679. 10.1371/journal.pone.0030679"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.7150/ijbs.8.118", "@IdType": "doi"}, {"#text": "PMC3248653", "@IdType": "pmc"}, {"#text": "22211110", "@IdType": "pubmed"}]}, "Citation": "Zhou Q, Li M, Wang X, Li Q, Wang T, Zhu Q, et al. . Immune-related microRNAs are abundant in breast milk exosomes. Int J Biol Sci (2012) 8:118\u201323. 10.7150/ijbs.8.118"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1373/clinchem.2010.147405", "@IdType": "doi"}, {"#text": "PMC4846276", "@IdType": "pmc"}, {"#text": "20847327", "@IdType": "pubmed"}]}, "Citation": "Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, et al. . The microRNA spectrum in 12 body fluids. Clin Chem. (2010) 56:1733\u201341. 10.1373/clinchem.2010.147405"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1095/biolreprod.111.093252", "@IdType": "doi"}, {"#text": "22116803", "@IdType": "pubmed"}]}, "Citation": "da Silveira JC, Veeramachaneni DN, Winger QA, Carnevale EM, Bouma GJ. Cell-secreted vesicles in equine ovarian follicular fluid contain miRNAs and proteins: a possible new form of cell communication within the ovarian follicle. Biol Reprod. (2012) 86:71. 10.1095/biolreprod.111.093252"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.0804549105", "@IdType": "doi"}, {"#text": "PMC2492472", "@IdType": "pmc"}, {"#text": "18663219", "@IdType": "pubmed"}]}, "Citation": "Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. . Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA. (2008) 105:10513\u20138. 10.1073/pnas.0804549105"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/nar/gkr254", "@IdType": "doi"}, {"#text": "PMC3167594", "@IdType": "pmc"}, {"#text": "21609964", "@IdType": "pubmed"}]}, "Citation": "Turchinovich A, Weiz L, Langheinz A, Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res. (2011) 39:7223\u201333. 10.1093/nar/gkr254"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/ncb2210", "@IdType": "doi"}, {"#text": "PMC3074610", "@IdType": "pmc"}, {"#text": "21423178", "@IdType": "pubmed"}]}, "Citation": "Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol. (2011) 13:423\u201333. 10.1038/ncb2210"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/ncomms4292", "@IdType": "doi"}, {"#text": "PMC4189962", "@IdType": "pmc"}, {"#text": "24576947", "@IdType": "pubmed"}]}, "Citation": "Tabet F, Vickers KC, Cuesta Torres LF, Wiese CB, Shoucri BM, Lambert G, et al. . HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells. Nat Commun. (2014) 5:3292. 10.1038/ncomms4292"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.tibs.2012.08.003", "@IdType": "doi"}, {"#text": "22944280", "@IdType": "pubmed"}]}, "Citation": "Turchinovich A, Weiz L, Burwinkel B. Extracellular miRNAs: the mystery of their origin and function. Trends Biochem Sci. (2012) 37:460\u20135. 10.1016/j.tibs.2012.08.003"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1074/jbc.M110.107821", "@IdType": "doi"}, {"#text": "PMC2878508", "@IdType": "pmc"}, {"#text": "20353945", "@IdType": "pubmed"}]}, "Citation": "Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y, Ochiya T. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem. (2010) 285:17442\u201352. 10.1074/jbc.M110.107821"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.1700561114", "@IdType": "doi"}, {"#text": "PMC5547597", "@IdType": "pmc"}, {"#text": "28716920", "@IdType": "pubmed"}]}, "Citation": "Zhu JJ, Liu YF, Zhang YP, Zhao CR, Yao WJ, Li YS, et al. . VAMP3 and SNAP23 mediate the disturbed flow-induced endothelial microRNA secretion and smooth muscle hyperplasia. Proc Natl Acad Sci USA. (2017) 114:8271\u20136. 10.1073/pnas.1700561114"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/srep45661", "@IdType": "doi"}, {"#text": "PMC5372467", "@IdType": "pmc"}, {"#text": "28358390", "@IdType": "pubmed"}]}, "Citation": "Gumurdu A, Yildiz R, Eren E, Karakulah G, Unver T, Genc S, et al. . MicroRNA exocytosis by large dense-core vesicle fusion. Sci Rep. (2017) 7:45661. 10.1038/srep45661"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/1476-4598-10-117", "@IdType": "doi"}, {"#text": "PMC3190352", "@IdType": "pmc"}, {"#text": "21939504", "@IdType": "pubmed"}]}, "Citation": "Yang M, Chen J, Su F, Yu B, Su F, Lin L, et al. . Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Mol Cancer (2011) 10:117. 10.1186/1476-4598-10-117"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12943-015-0400-7", "@IdType": "doi"}, {"#text": "PMC4504101", "@IdType": "pmc"}, {"#text": "26178901", "@IdType": "pubmed"}]}, "Citation": "Hannafon BN, Carpenter KJ, Berry WL, Janknecht R, Dooley WC, Ding WQ. Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA). Mol Cancer (2015) 14:133. 10.1186/s12943-015-0400-7"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ccr.2014.03.007", "@IdType": "doi"}, {"#text": "PMC4016197", "@IdType": "pmc"}, {"#text": "24735924", "@IdType": "pubmed"}]}, "Citation": "Zhou W, Fong MY, Min Y, Somlo G, Liu L, Palomares MR, et al. . Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell (2014) 25:501\u201315. 10.1016/j.ccr.2014.03.007"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.7150/thno.21234", "@IdType": "doi"}, {"#text": "PMC5743467", "@IdType": "pmc"}, {"#text": "29290800", "@IdType": "pubmed"}]}, "Citation": "Hu Y, Rao SS, Wang ZX, Cao J, Tan YJ, Luo J, et al. . Exosomes from human umbilical cord blood accelerate cutaneous wound healing through miR-21-3p-mediated promotion of angiogenesis and fibroblast function. Theranostics (2018) 8:169\u201384. 10.7150/thno.21234"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/srep38750", "@IdType": "doi"}, {"#text": "PMC5144099", "@IdType": "pmc"}, {"#text": "27929118", "@IdType": "pubmed"}]}, "Citation": "Sakha S, Muramatsu T, Ueda K, Inazawa J. Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma. Sci Rep. (2016) 6:38750. 10.1038/srep38750"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1098/rstb.2016.0486", "@IdType": "doi"}, {"#text": "PMC5717440", "@IdType": "pmc"}, {"#text": "29158315", "@IdType": "pubmed"}]}, "Citation": "Fabbri M. MicroRNAs and miRceptors: a new mechanism of action for intercellular communication. Philos Trans R Soc Lond B Biol Sci. (2018) 373:E2110\u20136. 10.1098/rstb.2016.0486"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.1209414109", "@IdType": "doi"}, {"#text": "PMC3412003", "@IdType": "pmc"}, {"#text": "22753494", "@IdType": "pubmed"}]}, "Citation": "Fabbri M, Paone A, Calore F, Galli R, Gaudio E, Santhanam R, et al. . MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci USA. (2012) 109:E2110\u2013E2116. 10.1073/pnas.1209414109"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nn.3113", "@IdType": "doi"}, {"#text": "22610069", "@IdType": "pubmed"}]}, "Citation": "Lehmann SM, Kruger C, Park B, Derkow K, Rosenberger K, Baumgart J, et al. . An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nat Neurosci. (2012) 15:827\u201335. 10.1038/nn.3113"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.tcb.2011.12.001", "@IdType": "doi"}, {"#text": "22260888", "@IdType": "pubmed"}]}, "Citation": "Chen X, Liang H, Zhang J, Zen K, Zhang CY. Secreted microRNAs: a new form of intercellular communication. Trends Cell Biol. (2012) 22:125\u201332. 10.1016/j.tcb.2011.12.001"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1111/jnc.12057", "@IdType": "doi"}, {"#text": "23083096", "@IdType": "pubmed"}]}, "Citation": "Xu J, Chen Q, Zen K, Zhang C, Zhang Q. Synaptosomes secrete and uptake functionally active microRNAs via exocytosis and endocytosis pathways. J Neurochem. (2013) 124:15\u201325. 10.1111/jnc.12057"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1074/jbc.M114.588046", "@IdType": "doi"}, {"#text": "PMC4139237", "@IdType": "pmc"}, {"#text": "24951588", "@IdType": "pubmed"}]}, "Citation": "Tian T, Zhu YL, Zhou YY, Liang GF, Wang YY, Hu FH, et al. . Exosome uptake through clathrin-mediated endocytosis and macropinocytosis and mediating miR-21 delivery. J Biol Chem. (2014) 289:22258\u201367. 10.1074/jbc.M114.588046"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12943-017-0694-8", "@IdType": "doi"}, {"#text": "PMC5526308", "@IdType": "pmc"}, {"#text": "28743280", "@IdType": "pubmed"}]}, "Citation": "Wei F, Ma C, Zhou T, Dong X, Luo Q, Geng L, et al. . Exosomes derived from gemcitabine-resistant cells transfer malignant phenotypic traits via delivery of miRNA-222-3p. Mol Cancer (2017) 16:132. 10.1186/s12943-017-0694-8"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.4049/jimmunol.1301728", "@IdType": "doi"}, {"#text": "PMC3858238", "@IdType": "pmc"}, {"#text": "24227773", "@IdType": "pubmed"}]}, "Citation": "Aucher A, Rudnicka D, Davis DM. MicroRNAs transfer from human macrophages to hepato-carcinoma cells and inhibit proliferation. J Immunol. (2013) 191:6250\u201360. 10.4049/jimmunol.1301728"}]}}}}}, "PMC": "PMC6085463", "PMID": "30123182", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "18": {"Abstract": "MicroRNAs (miRNAs) are a class of small, endogenous RNAs of 21-25 nucleotides (nts) in length. They play an important regulatory role in animals and plants by targeting specific mRNAs for degradation or translation repression. Recent scientific advances have revealed the synthesis pathways and the regulatory mechanisms of miRNAs in animals and plants. miRNA-based regulation is implicated in disease etiology and has been studied for treatment. Furthermore, several preclinical and clinical trials have been initiated for miRNA-based therapeutics. In this review, the existing knowledge about miRNAs synthesis, mechanisms for regulation of the genome, and their widespread functions in animals and plants is summarized. The current status of preclinical and clinical trials regarding miRNA therapeutics is also reviewed. The recent findings in miRNA studies, summarized in this review, may add new dimensions to small RNA biology and miRNA therapeutics.", "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "5478262921684549483", "Part1": "School of life Sciences and Biotechnology", "Part2": "College of Natural sciences", "Part3": "Kyungpook National University", "Part4": "Buk-ku", "Part5": "Taegu", "Part6": "Korea.", "Text": "School of life Sciences and Biotechnology, College of Natural sciences, Kyungpook National University, Buk-ku, Taegu, Korea."}], "ForeName": "Fazli", "FullName": "Fazli Wahid", "HashID": "-7799955716433794218", "LastName": "Wahid", "ORCID": null}, {"Affiliations": null, "ForeName": "Adeeb", "FullName": "Adeeb Shehzad", "HashID": "-8056920883352510361", "LastName": "Shehzad", "ORCID": null}, {"Affiliations": null, "ForeName": "Taous", "FullName": "Taous Khan", "HashID": "5727408224546516097", "LastName": "Khan", "ORCID": null}, {"Affiliations": null, "ForeName": "You Young", "FullName": "You Young Kim", "HashID": "7723080174907887290", "LastName": "Kim", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.1016/j.bbamcr.2010.06.013", "InsertType": null, "Journal": "Biochimica et biophysica acta", "Keywords": [{"IS_Major": false, "IS_Mesh": true, "Text": "Animals"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Clinical Trials as Topic"}, {"IS_Major": true, "IS_Mesh": true, "Text": "Gene Expression Regulation"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Humans"}, {"IS_Major": false, "IS_Mesh": true, "Text": "MicroRNAs"}, {"IS_Major": true, "IS_Mesh": true, "Text": "Models, Genetic"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Neoplasms"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Plants"}, {"IS_Major": false, "IS_Mesh": true, "Text": "RNA, Messenger"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "MEDLINE", "Article": {"@PubModel": "Print-Electronic", "Abstract": {"AbstractText": "MicroRNAs (miRNAs) are a class of small, endogenous RNAs of 21-25 nucleotides (nts) in length. They play an important regulatory role in animals and plants by targeting specific mRNAs for degradation or translation repression. Recent scientific advances have revealed the synthesis pathways and the regulatory mechanisms of miRNAs in animals and plants. miRNA-based regulation is implicated in disease etiology and has been studied for treatment. Furthermore, several preclinical and clinical trials have been initiated for miRNA-based therapeutics. In this review, the existing knowledge about miRNAs synthesis, mechanisms for regulation of the genome, and their widespread functions in animals and plants is summarized. The current status of preclinical and clinical trials regarding miRNA therapeutics is also reviewed. The recent findings in miRNA studies, summarized in this review, may add new dimensions to small RNA biology and miRNA therapeutics.", "CopyrightInformation": "Copyright \u00a9 2010 Elsevier B.V. All rights reserved."}, "ArticleDate": {"@DateType": "Electronic", "Day": "07", "Month": "07", "Year": "2010"}, "ArticleTitle": "MicroRNAs: synthesis, mechanism, function, and recent clinical trials.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "School of life Sciences and Biotechnology, College of Natural sciences, Kyungpook National University, Buk-ku, Taegu, Korea."}, "ForeName": "Fazli", "Initials": "F", "LastName": "Wahid"}, {"@ValidYN": "Y", "ForeName": "Adeeb", "Initials": "A", "LastName": "Shehzad"}, {"@ValidYN": "Y", "ForeName": "Taous", "Initials": "T", "LastName": "Khan"}, {"@ValidYN": "Y", "ForeName": "You Young", "Initials": "YY", "LastName": "Kim"}]}, "ELocationID": {"#text": "10.1016/j.bbamcr.2010.06.013", "@EIdType": "doi", "@ValidYN": "Y"}, "Journal": {"ISOAbbreviation": "Biochim Biophys Acta", "ISSN": {"#text": "0006-3002", "@IssnType": "Print"}, "JournalIssue": {"@CitedMedium": "Print", "Issue": "11", "PubDate": {"Month": "Nov", "Year": "2010"}, "Volume": "1803"}, "Title": "Biochimica et biophysica acta"}, "Language": "eng", "Pagination": {"EndPage": "1243", "MedlinePgn": "1231-43", "StartPage": "1231"}, "PublicationTypeList": {"PublicationType": [{"#text": "Journal Article", "@UI": "D016428"}, {"#text": "Review", "@UI": "D016454"}]}}, "ChemicalList": {"Chemical": [{"NameOfSubstance": {"#text": "MicroRNAs", "@UI": "D035683"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "RNA, Messenger", "@UI": "D012333"}, "RegistryNumber": "0"}]}, "CitationSubset": "IM", "DateCompleted": {"Day": "30", "Month": "11", "Year": "2010"}, "DateRevised": {"Day": "30", "Month": "03", "Year": "2022"}, "MedlineJournalInfo": {"Country": "Netherlands", "ISSNLinking": "0006-3002", "MedlineTA": "Biochim Biophys Acta", "NlmUniqueID": "0217513"}, "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"#text": "Animals", "@MajorTopicYN": "N", "@UI": "D000818"}}, {"DescriptorName": {"#text": "Clinical Trials as Topic", "@MajorTopicYN": "N", "@UI": "D002986"}}, {"DescriptorName": {"#text": "Gene Expression Regulation", "@MajorTopicYN": "Y", "@UI": "D005786"}}, {"DescriptorName": {"#text": "Humans", "@MajorTopicYN": "N", "@UI": "D006801"}}, {"DescriptorName": {"#text": "MicroRNAs", "@MajorTopicYN": "N", "@UI": "D035683"}, "QualifierName": [{"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}, {"#text": "metabolism", "@MajorTopicYN": "N", "@UI": "Q000378"}]}, {"DescriptorName": {"#text": "Models, Genetic", "@MajorTopicYN": "Y", "@UI": "D008957"}}, {"DescriptorName": {"#text": "Neoplasms", "@MajorTopicYN": "N", "@UI": "D009369"}, "QualifierName": [{"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}, {"#text": "pathology", "@MajorTopicYN": "N", "@UI": "Q000473"}, {"#text": "therapy", "@MajorTopicYN": "N", "@UI": "Q000628"}]}, {"DescriptorName": {"#text": "Plants", "@MajorTopicYN": "N", "@UI": "D010944"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "RNA, Messenger", "@MajorTopicYN": "N", "@UI": "D012333"}, "QualifierName": [{"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}, {"#text": "metabolism", "@MajorTopicYN": "N", "@UI": "Q000378"}]}]}, "PMID": {"#text": "20619301", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "20619301", "@IdType": "pubmed"}, {"#text": "10.1016/j.bbamcr.2010.06.013", "@IdType": "doi"}, {"#text": "S0167-4889(10)00183-7", "@IdType": "pii"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "received", "Day": "18", "Month": "5", "Year": "2010"}, {"@PubStatus": "revised", "Day": "30", "Month": "6", "Year": "2010"}, {"@PubStatus": "accepted", "Day": "30", "Month": "6", "Year": "2010"}, {"@PubStatus": "entrez", "Day": "13", "Hour": "6", "Minute": "0", "Month": "7", "Year": "2010"}, {"@PubStatus": "pubmed", "Day": "14", "Hour": "6", "Minute": "0", "Month": "7", "Year": "2010"}, {"@PubStatus": "medline", "Day": "14", "Hour": "6", "Minute": "0", "Month": "12", "Year": "2010"}]}, "PublicationStatus": "ppublish"}}}}, "PMC": null, "PMID": "20619301", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "MicroRNAs: synthesis, mechanism, function, and recent clinical trials.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "19": {"Abstract": "MicroRNAs (miRNAs) are noncoding RNAs that have been identified as important posttranscriptional regulators of gene expression. miRNAs production is controlled at multiple levels, including transcriptional and posttranscriptional regulation. Extensive profiling studies have shown that the regulation of mature miRNAs expression plays a causal role in cancer development and progression. miRNAs have been identified to act as tumor suppressors (TS) or as oncogenes based on their modulating effect on the expression of their target genes. Upregulation of oncogenic miRNAs blocks TS genes and leads to tumor formation. In contrast, downregulation of miRNAs with TS function increases the translation of oncogenes. Several miRNAs exhibiting TS properties have been studied. In this review we focus on recent studies on the role of TS miRNAs in cancer cells and the tumor microenvironment (TME). Furthermore, we discuss how TS miRNA impacts the aggressiveness of cancer cells, with focus of the mechanism that regulate its expression. The study of the mechanisms of miRNA regulation in cancer cells and the TME may paved the way to understand its critical role in the development and progression of cancer and is likely to have important clinical implications in a near future. Finally, the potential roles of miRNAs as specific biomarkers for the diagnosis and the prognosis of cancer and the replacement of tumor suppressive miRNAs using miRNA mimics could be promising approaches for cancer therapy.", "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "-3387613024324024092", "Part1": "Experimental Hematology Laboratory", "Part2": "Jules Bordet Institute", "Part3": "Universit\u00e9 libre de Bruxelles", "Part4": "Brussels", "Part5": "Belgium.", "Part6": null, "Text": "Experimental Hematology Laboratory, Jules Bordet Institute, Universit\u00e9 libre de Bruxelles, Brussels, Belgium."}], "ForeName": "Khalid", "FullName": "Khalid Otmani", "HashID": "168267126550327857", "LastName": "Otmani", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-3387613024324024092", "Part1": "Experimental Hematology Laboratory", "Part2": "Jules Bordet Institute", "Part3": "Universit\u00e9 libre de Bruxelles", "Part4": "Brussels", "Part5": "Belgium.", "Part6": null, "Text": "Experimental Hematology Laboratory, Jules Bordet Institute, Universit\u00e9 libre de Bruxelles, Brussels, Belgium."}], "ForeName": "Philippe", "FullName": "Philippe Lewalle", "HashID": "4277541126138578706", "LastName": "Lewalle", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.3389/fonc.2021.708765", "InsertType": null, "Journal": "Frontiers in oncology", "Keywords": [{"IS_Major": false, "IS_Mesh": false, "Text": "cancer"}, {"IS_Major": false, "IS_Mesh": false, "Text": "functional regulation"}, {"IS_Major": false, "IS_Mesh": false, "Text": "microRNA"}, {"IS_Major": false, "IS_Mesh": false, "Text": "tumor microenvironment"}, {"IS_Major": false, "IS_Mesh": false, "Text": "tumor suppressor miRNA"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "PubMed-not-MEDLINE", "Article": {"@PubModel": "Electronic-eCollection", "Abstract": {"AbstractText": "MicroRNAs (miRNAs) are noncoding RNAs that have been identified as important posttranscriptional regulators of gene expression. miRNAs production is controlled at multiple levels, including transcriptional and posttranscriptional regulation. Extensive profiling studies have shown that the regulation of mature miRNAs expression plays a causal role in cancer development and progression. miRNAs have been identified to act as tumor suppressors (TS) or as oncogenes based on their modulating effect on the expression of their target genes. Upregulation of oncogenic miRNAs blocks TS genes and leads to tumor formation. In contrast, downregulation of miRNAs with TS function increases the translation of oncogenes. Several miRNAs exhibiting TS properties have been studied. In this review we focus on recent studies on the role of TS miRNAs in cancer cells and the tumor microenvironment (TME). Furthermore, we discuss how TS miRNA impacts the aggressiveness of cancer cells, with focus of the mechanism that regulate its expression. The study of the mechanisms of miRNA regulation in cancer cells and the TME may paved the way to understand its critical role in the development and progression of cancer and is likely to have important clinical implications in a near future. Finally, the potential roles of miRNAs as specific biomarkers for the diagnosis and the prognosis of cancer and the replacement of tumor suppressive miRNAs using miRNA mimics could be promising approaches for cancer therapy.", "CopyrightInformation": "Copyright \u00a9 2021 Otmani and Lewalle."}, "ArticleDate": {"@DateType": "Electronic", "Day": "15", "Month": "10", "Year": "2021"}, "ArticleTitle": "Tumor Suppressor miRNA in Cancer Cells and the Tumor Microenvironment: Mechanism of Deregulation and Clinical Implications.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Experimental Hematology Laboratory, Jules Bordet Institute, Universit\u00e9 libre de Bruxelles, Brussels, Belgium."}, "ForeName": "Khalid", "Initials": "K", "LastName": "Otmani"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Experimental Hematology Laboratory, Jules Bordet Institute, Universit\u00e9 libre de Bruxelles, Brussels, Belgium."}, "ForeName": "Philippe", "Initials": "P", "LastName": "Lewalle"}]}, "ELocationID": [{"#text": "708765", "@EIdType": "pii", "@ValidYN": "Y"}, {"#text": "10.3389/fonc.2021.708765", "@EIdType": "doi", "@ValidYN": "Y"}], "Journal": {"ISOAbbreviation": "Front Oncol", "ISSN": {"#text": "2234-943X", "@IssnType": "Print"}, "JournalIssue": {"@CitedMedium": "Print", "PubDate": {"Year": "2021"}, "Volume": "11"}, "Title": "Frontiers in oncology"}, "Language": "eng", "Pagination": {"MedlinePgn": "708765", "StartPage": "708765"}, "PublicationTypeList": {"PublicationType": [{"#text": "Journal Article", "@UI": "D016428"}, {"#text": "Review", "@UI": "D016454"}]}}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.", "DateRevised": {"Day": "02", "Month": "11", "Year": "2021"}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"#text": "cancer", "@MajorTopicYN": "N"}, {"#text": "functional regulation", "@MajorTopicYN": "N"}, {"#text": "microRNA", "@MajorTopicYN": "N"}, {"#text": "tumor microenvironment", "@MajorTopicYN": "N"}, {"#text": "tumor suppressor miRNA", "@MajorTopicYN": "N"}]}, "MedlineJournalInfo": {"Country": "Switzerland", "ISSNLinking": "2234-943X", "MedlineTA": "Front Oncol", "NlmUniqueID": "101568867"}, "PMID": {"#text": "34722255", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "34722255", "@IdType": "pubmed"}, {"#text": "PMC8554338", "@IdType": "pmc"}, {"#text": "10.3389/fonc.2021.708765", "@IdType": "doi"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "received", "Day": "12", "Month": "5", "Year": "2021"}, {"@PubStatus": "accepted", "Day": "27", "Month": "9", "Year": "2021"}, {"@PubStatus": "entrez", "Day": "1", "Hour": "9", "Minute": "24", "Month": "11", "Year": "2021"}, {"@PubStatus": "pubmed", "Day": "2", "Hour": "6", "Minute": "0", "Month": "11", "Year": "2021"}, {"@PubStatus": "medline", "Day": "2", "Hour": "6", "Minute": "1", "Month": "11", "Year": "2021"}]}, "PublicationStatus": "epublish", "ReferenceList": {"Reference": [{"ArticleIdList": {"ArticleId": [{"#text": "10.1590/S1415-47572011000300001", "@IdType": "doi"}, {"#text": "PMC3168173", "@IdType": "pmc"}, {"#text": "21931505", "@IdType": "pubmed"}]}, "Citation": "Palmero EI, de Campos SG, Campos M, de Souza NC, Guerreiro ID, Carvalho AL, et al. . Mechanisms and Role of microRNA Deregulation in Cancer Onset and Progression. Genet Mol Biol (2011) 34(3):363\u201370. doi:\u00a010.1590/S1415-47572011000300001"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature03702", "@IdType": "doi"}, {"#text": "15944708", "@IdType": "pubmed"}]}, "Citation": "Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. . MicroRNA Expression Profiles Classify Human Cancers. Nature (2005) 435(7043):834\u20138. doi:\u00a010.1038/nature03702"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.0510565103", "@IdType": "doi"}, {"#text": "PMC1413718", "@IdType": "pmc"}, {"#text": "16461460", "@IdType": "pubmed"}]}, "Citation": "Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. . A microRNA Expression Signature of Human Solid Tumors Defines Cancer Gene Targets. Proc Natl Acad Sci U S A (2005) 103(7):2257\u201361. doi:\u00a010.1073/pnas.0510565103"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/onc.2011.140", "@IdType": "doi"}, {"#text": "21532615", "@IdType": "pubmed"}]}, "Citation": "Musumeci M, Coppola V, Addario A, Patrizii M, Maugeri-Sacc\u00e0 M, Memeo L, et al. . Control of Tumor and Microenvironment Cross-Talk by miR-15a and miR-16 in Prostate Cancer. Oncogene (2011) 30(41):4231\u201342. doi:\u00a010.1038/onc.2011.140"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41388-019-0804-8", "@IdType": "doi"}, {"#text": "PMC6755984", "@IdType": "pmc"}, {"#text": "30967628", "@IdType": "pubmed"}]}, "Citation": "Ram\u00edrez-Moya J, Wert-Lamas L, Riesco-Eizaguirre G, Santisteban P. Impaired microRNA Processing by DICER1 Downregulation Endows Thyroid Cancer With Increased Aggressiveness. Oncogene (2019) 38(27):5486\u201399. doi:\u00a010.1038/s41388-019-0804-8"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/ng2003", "@IdType": "doi"}, {"#text": "17401365", "@IdType": "pubmed"}]}, "Citation": "Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T. Impaired microRNA Processing Enhances Cellular Transformation and Tumorigenesis. Nat Genet (2007) 39(5):673\u20137. doi:\u00a010.1038/ng2003"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/s0092-8674(04)00045-5", "@IdType": "doi"}, {"#text": "14744438", "@IdType": "pubmed"}]}, "Citation": "Bartel DP, Lee R, Feinbaum R. MicroRNAs\u202f: Genomics, Biogenesis, Mechanism, and Function Genomics\u202f: The miRNA Genes. Cell (2004) 116:281\u201397. doi:\u00a010.1016/s0092-8674(04)00045-5"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.242606799", "@IdType": "doi"}, {"#text": "PMC137750", "@IdType": "pmc"}, {"#text": "12434020", "@IdType": "pubmed"}]}, "Citation": "Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, et al. . Frequent Deletions and Down-Regulation of Micro-RNA Genes Mir15 and Mir16 at 13q14 in Chronic Lymphocytic Leukemia. Proc Natl Acad Sci USA (2002) 99(24):15524\u20139. doi:\u00a010.1073/pnas.242606799"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/cdd.2014.87", "@IdType": "doi"}, {"#text": "PMC4262785", "@IdType": "pmc"}, {"#text": "24971479", "@IdType": "pubmed"}]}, "Citation": "Pekarsky Y, Croce CM. Role of miR-15/16 in CLL. Cell Death Differ (2015) 22(1):6\u201311. doi:\u00a010.1038/cdd.2014.87"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.0506654102", "@IdType": "doi"}, {"#text": "PMC1236577", "@IdType": "pmc"}, {"#text": "16166262", "@IdType": "pubmed"}]}, "Citation": "Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, et al. . miR-15 and miR-16 Induce Apoptosis by Targeting BCL2. Proc Natl Acad Sci USA (2005) 102(39):13944\u20139. doi:\u00a010.1073/pnas.0506654102"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.1708264114", "@IdType": "doi"}, {"#text": "PMC5635897", "@IdType": "pmc"}, {"#text": "28923920", "@IdType": "pubmed"}]}, "Citation": "Rassenti LZ, Balatti V, Ghia EM, Palamarchuk A, Tomasello L, Fadda P, et al. . MicroRNA Dysregulation to Identify Therapeutic Target Combinations for Chronic Lymphocytic Leukemia. Proc Natl Acad Sci USA (2017) 114(40):10731\u20136. doi:\u00a010.1073/pnas.1708264114"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/cam4.3840", "@IdType": "doi"}, {"#text": "PMC8124101", "@IdType": "pmc"}, {"#text": "33838016", "@IdType": "pubmed"}]}, "Citation": "Liu D, Chen C, Cui M, Zhang H. miR-140-3p Inhibits Colorectal Cancer Progression and its Liver Metastasis by Targeting BCL9 and BCL2. Cancer Med (2021) 10(10):3358\u201372. doi:\u00a010.1002/cam4.3840"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.31557/APJCP.2021.22.6.1949", "@IdType": "doi"}, {"#text": "PMC8418855", "@IdType": "pmc"}, {"#text": "34181356", "@IdType": "pubmed"}]}, "Citation": "Elnaggar GN, El-Hifnawi NM, Ismail A, Yahia M, Elshimy RAA. Micro RNA-148a Targets Bcl-2 in Patients With Non-Small Cell Lung Cancer. Asian Pacific J Cancer Prev (2021) 22(6):1949\u201355. doi:\u00a010.31557/APJCP.2021.22.6.1949"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.12659/MSM.898121", "@IdType": "doi"}, {"#text": "PMC4917329", "@IdType": "pmc"}, {"#text": "27153225", "@IdType": "pubmed"}]}, "Citation": "Xie W, Qin W, Kang Y, Zhou Z, Qin A. MicroRNA-340 Inhibits Tumor Cell Proliferation and Induces Apoptosis in Endometrial Carcinoma Cell Line RL 95-2. Med Sci Monit (2016) 22:1540\u20136. doi:\u00a010.12659/MSM.898121"}, {"ArticleIdList": {"ArticleId": {"#text": "28682430", "@IdType": "pubmed"}}, "Citation": "Zhang LL, Xie FJ, Tang CH, Xu WR, Ding XS, Liang J. miR-340 Suppresses Tumor Growth and Enhances Chemosensitivity of Colorectal Cancer by Targeting RLIP76. Eur Rev Med Pharmacol Sci (2017) 21(12):2875\u201386."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.23703", "@IdType": "doi"}, {"#text": "PMC5797040", "@IdType": "pmc"}, {"#text": "29435169", "@IdType": "pubmed"}]}, "Citation": "Arivazhagan R, Lee J, Bayarsaikhan D, Kwak P, Son M, Byun K, et al. . MicroRNA-340 Inhibits the Proliferation and Promotes the Apoptosis of Colon Cancer Cells by Modulating REV3L. Oncotarget (2018) 9(4):5155\u201368. doi:\u00a010.18632/oncotarget.23703"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.12659/MSM.898449", "@IdType": "doi"}, {"#text": "PMC5238948", "@IdType": "pmc"}, {"#text": "28057912", "@IdType": "pubmed"}]}, "Citation": "Yu J, Wang R, Chen J, Wu J, Dang Z, Zhang Q, et al. . miR-340 Inhibits Proliferation and Induces Apoptosis in Gastric Cancer Cell Line SGC-7901, Possibly via the AKT Pathway. Med Sci Monit (2017) 23:71\u20137. doi:\u00a010.12659/MSM.898449"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1159/000445553", "@IdType": "doi"}, {"#text": "27160777", "@IdType": "pubmed"}]}, "Citation": "Li P, Sun Y, Liu Q. MicroRNA-340 Induces Apoptosis and Inhibits Metastasis of Ovarian Cancer Cells by Inactivation of NF-\u03bab1. Cell Physiol Biochem (2016) 38(5):1915\u201327. doi:\u00a010.1159/000445553"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.scitotenv.2019.136171", "@IdType": "doi"}, {"#text": "PMC6949727", "@IdType": "pmc"}, {"#text": "31934125", "@IdType": "pubmed"}]}, "Citation": "Lu H, Hao L, Yang H, Chen J, Liu J. miRNA-34a Suppresses Colon Carcinoma Proliferation and Induces Cell Apoptosis by Targeting SYT1. Int J Clin Exp Pathol (2019) 12(8):2887\u201397. doi:\u00a010.1016/j.scitotenv.2019.136171"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrm3758", "@IdType": "doi"}, {"#text": "PMC4240281", "@IdType": "pmc"}, {"#text": "24556840", "@IdType": "pubmed"}]}, "Citation": "Lamouille S, Xu J, Derynck R. Molecular Mechanisms of Epithelial \u2013 Mesenchymal Transition. Nat Publ Gr (2014) 15(3):178\u201396. doi:\u00a010.1038/nrm3758"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/ncb3513", "@IdType": "doi"}, {"#text": "28414315", "@IdType": "pubmed"}]}, "Citation": "Krebs AM, Mitschke J, Lasierra Losada M, Schmalhofer O, Boerries M, Busch H, et al. . The EMT-Activator Zeb1 is a Key Factor for Cell Plasticity and Promotes Metastasis in Pancreatic Cancer. Nat Cell Biol (2017) 19(5):518\u201329. doi:\u00a010.1038/ncb3513"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/ncb1722", "@IdType": "doi"}, {"#text": "18376396", "@IdType": "pubmed"}]}, "Citation": "Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, et al. . The miR-200 Family and miR-205 Regulate Epithelial to Mesenchymal Transition by Targeting ZEB1 and SIP1. Nat Cell Biol (2008) 10(5):593\u2013601. doi:\u00a010.1038/ncb1722"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/embor.2008.74", "@IdType": "doi"}, {"#text": "PMC2396950", "@IdType": "pmc"}, {"#text": "18483486", "@IdType": "pubmed"}]}, "Citation": "Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S, et al. . A Reciprocal Repression Between ZEB1 and Members of the miR-200 Family Promotes EMT and Invasion in Cancer Cells. EMBO Rep (2008) 9(6):582\u20139. doi:\u00a010.1038/embor.2008.74"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41467-018-07130-z", "@IdType": "doi"}, {"#text": "PMC6220299", "@IdType": "pmc"}, {"#text": "30405106", "@IdType": "pubmed"}]}, "Citation": "Title AC, Hong SJ, Pires ND, Hasen\u00f6hrl L, Godbersen S, Stokar-Regenscheit N, et al. . Genetic Dissection of the miR-200\u2013Zeb1 Axis Reveals its Importance in Tumor Differentiation and Invasion. Nat Commun (2018) 9(1):4671. doi:\u00a010.1038/s41467-018-07130-z"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1091/mbc.E11-02-0103", "@IdType": "doi"}, {"#text": "PMC3093321", "@IdType": "pmc"}, {"#text": "21411626", "@IdType": "pubmed"}]}, "Citation": "Gregory PA, Bracken CP, Smith E, Bert AG, Wright JA, Roslan S, et al. . An Autocrine TGF-\u03b2/ZEB/miR-200 Signaling Network Regulates Establishment and Maintenance of Epithelial-Mesenchymal Transition. Mol Biol Cell (2011) 22(10):1686\u201398. doi:\u00a010.1091/mbc.E11-02-0103"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/onc.2012.573", "@IdType": "doi"}, {"#text": "23318420", "@IdType": "pubmed"}]}, "Citation": "Guo L, Chen C, Shi M, Wang F, Chen X, Diao F, et al. . Circuits Initiate and Maintain Oncostatin M-Driven Epithelial \u2013 Mesenchymal Transition. (2013) 32(45):5272\u201382. doi:\u00a010.1038/onc.2012.573"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/cancers13061469", "@IdType": "doi"}, {"#text": "PMC8004805", "@IdType": "pmc"}, {"#text": "33806868", "@IdType": "pubmed"}]}, "Citation": "Wang H, Chirshev E, Hojo N, Suzuki T, Bertucci A, Pierce M, et al. . The Epithelial\u2013Mesenchymal Transcription Factor Snai1 Represses Transcription of the Tumor Suppressor miRNA Let-7 in Cancer. Cancers (Basel) (2021) 13(6):1\u201318. doi:\u00a010.3390/cancers13061469"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s13277-015-4513-9", "@IdType": "doi"}, {"#text": "26758430", "@IdType": "pubmed"}]}, "Citation": "Mohammadi-Yeganeh S, Paryan M, Arefian E, Vasei M, Ghanbarian H, Mahdian R, et al. . MicroRNA-340 Inhibits the Migration, Invasion, and Metastasis of Breast Cancer Cells by Targeting Wnt Pathway. Tumor Biol (2016) 37(7):8993\u20139000. doi:\u00a010.1007/s13277-015-4513-9"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.12923", "@IdType": "doi"}, {"#text": "PMC5355165", "@IdType": "pmc"}, {"#text": "27793042", "@IdType": "pubmed"}]}, "Citation": "Peng Y, Zhang X, Feng X, Fan X, Jin Z. The Crosstalk Between microRNAs and the Wnt/\u03b2-Catenin Signaling Pathway in Cancer. Oncotarget (2017) 8(8):14089\u2013106. doi:\u00a010.18632/oncotarget.12923"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.6223", "@IdType": "doi"}, {"#text": "PMC4823036", "@IdType": "pmc"}, {"#text": "26506234", "@IdType": "pubmed"}]}, "Citation": "Pon JR, Marra MA. MEF2 Transcription Factors: Developmental Regulators and Emerging Cancer Genes. Oncotarget (2015) 7(3):2297\u2013312. doi: 10.18632/oncotarget.6223"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.21037/jgo-20-418", "@IdType": "doi"}, {"#text": "PMC8261329", "@IdType": "pmc"}, {"#text": "34295552", "@IdType": "pubmed"}]}, "Citation": "He MQ, Wan JF, Zeng HF, Tang YY, He MQ. miR-133a-5p Suppresses Gastric Cancer Through TCF4 Down-Regulation. J Gastrointest. Oncol (2021) 12(3):1007\u201319. doi:\u00a010.21037/jgo-20-418"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1111/jcmm.14404", "@IdType": "doi"}, {"#text": "PMC6652730", "@IdType": "pmc"}, {"#text": "31199581", "@IdType": "pubmed"}]}, "Citation": "Feng H, Ge F, Du L, Zhang Z, Liu D. MiR - 34b - 3p Represses Cell Proliferation, Cell Cycle Progression and Cell Apoptosis in Non - Small - Cell Lung Cancer (NSCLC) by Targeting CDK4. J Cell Mol Med (2019) 23(8):5282\u201391. doi:\u00a010.1111/jcmm.14404"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.molcel.2007.05.017", "@IdType": "doi"}, {"#text": "17540598", "@IdType": "pubmed"}]}, "Citation": "Raver-shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N, et al. . Article Transcriptional Activation of miR-34a Contributes to P53-Mediated Apoptosis. Mol Cell (2007) 26(5):731\u201343. doi:\u00a010.1016/j.molcel.2007.05.017"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nm.2284", "@IdType": "doi"}, {"#text": "PMC3076220", "@IdType": "pmc"}, {"#text": "21240262", "@IdType": "pubmed"}]}, "Citation": "Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H, et al. . Identification of miR-34a as a Potent Inhibitor of Prostate Cancer Progenitor Cells and Metastasis by Directly Repressing CD44 HHS Public Access. Nat Med (2011) 17(2):211\u20135. doi:\u00a010.1038/nm.2284"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1172/JCI73531DS1", "@IdType": "doi"}, {"#text": "PMC3973098", "@IdType": "pmc"}, {"#text": "24642471", "@IdType": "pubmed"}]}, "Citation": "Rokavec M, \u00d6ner MG, Li H, Jackstadt R, Jiang L, Lodygin D, et al. . Promotes EMT-Mediated Colorectal Cancer Invasion and Metastasis. J Clin Invest (2014) 124(4):1853\u201367. doi:\u00a010.1172/JCI73531DS1"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1101/gad.233585.113", "@IdType": "doi"}, {"#text": "PMC3950342", "@IdType": "pmc"}, {"#text": "24532687", "@IdType": "pubmed"}]}, "Citation": "Okada N, Lin CP, Ribeiro MC, Biton A, Lai G, He X, et al. . A Positive Feedback Between P53 and miR-34 miRNAs Mediates Tumor Suppression. Genes Dev (2014) 28(5):438\u201350. doi:\u00a010.1101/gad.233585.113"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrc3239.The", "@IdType": "doi"}, {"#text": "PMC4856023", "@IdType": "pmc"}, {"#text": "22437870", "@IdType": "pubmed"}]}, "Citation": "Pardoll DM. The Blockade of Immune Checkpoints in Cancer Immunotherapy. Nat Rev Cancer (2016) 12: (4):252\u201364. doi:\u00a010.1038/nrc3239.The"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/jnci/djv303", "@IdType": "doi"}, {"#text": "PMC4862407", "@IdType": "pmc"}, {"#text": "26577528", "@IdType": "pubmed"}]}, "Citation": "Cortez MA, Ivan C, Valdecanas D, Wang X, Peltier HJ, Ye Y, et al. . PDL1 Regulation by P53 via miR-34. J Natl Cancer Inst (2016) 108(1):djv303. doi:\u00a010.1093/jnci/djv303"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cellsig.2014.12.003", "@IdType": "doi"}, {"#text": "25499621", "@IdType": "pubmed"}]}, "Citation": "Wang X, Li J, Dong K, Lin F, Long M, Ouyang Y, et al. . Tumor Suppressor miR-34a Targets PD-L1 and Functions as a Potential Immunotherapeutic Target in Acute Myeloid Leukemia. Cell Signal (2015) 27(3):443\u201352. doi:\u00a010.1016/j.cellsig.2014.12.003"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.tcb.2008.07.007", "@IdType": "doi"}, {"#text": "18774294", "@IdType": "pubmed"}]}, "Citation": "Roush S, Slack FJ. The Let-7 Family of microRNAs. Trends Cell Biol (2008) 18(10):505\u201316. doi:\u00a010.1016/j.tcb.2008.07.007"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cell.2007.10.054", "@IdType": "doi"}, {"#text": "18083101", "@IdType": "pubmed"}]}, "Citation": "Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C, et al. . Let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells. Cell (2007) 131(6):1109\u201323. doi:\u00a010.1016/j.cell.2007.10.054"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12967-015-0462-8", "@IdType": "doi"}, {"#text": "PMC4391148", "@IdType": "pmc"}, {"#text": "25884389", "@IdType": "pubmed"}]}, "Citation": "Wu A, Wu K, Li J, Mo Y, Lin Y, Wang Y, et al. . Let-7a Inhibits Migration, Invasion and Epithelial-Mesenchymal Transition by Targeting HMGA2 in Nasopharyngeal Carcinoma. J Transl Med (2015) 13(1):1\u201313. doi:\u00a010.1186/s12967-015-0462-8"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.15999", "@IdType": "doi"}, {"#text": "PMC5438645", "@IdType": "pmc"}, {"#text": "28415668", "@IdType": "pubmed"}]}, "Citation": "Guo M, Zhao X, Yuan X, Jiang J, Li P. MiR-Let-7a Inhibits Cell Proliferation, Migration, and Invasion by Down-Regulating PKM2 in Cervical Cancer. Oncotarget (2017) 8(17):28226\u201336. doi:\u00a010.18632/oncotarget.15999"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/0008-5472.CAN-08-1954", "@IdType": "doi"}, {"#text": "PMC2762326", "@IdType": "pmc"}, {"#text": "19074899", "@IdType": "pubmed"}]}, "Citation": "Yang N, Kaur S, Volinia S, Greshock J, Lassus H, Hasegawa K, et al. . MicroRNA Microarray Identifies Let-7i as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian Cancer. Cancer Res (2008) 68(24):10307\u201314. doi:\u00a010.1158/0008-5472.CAN-08-1954"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/cddis.2016.438", "@IdType": "doi"}, {"#text": "PMC5386357", "@IdType": "pmc"}, {"#text": "28102845", "@IdType": "pubmed"}]}, "Citation": "Peng F, Li TT, Wang KL, Xiao GQ, Wang JH, Zhao HD, et al. . H19/let-7/LIN28 Reciprocal Negative Regulatory Circuit Promotes Breast Cancer Stem Cell Maintenance. Cell Death Dis (2017) 8(1):e2569. doi:\u00a010.1038/cddis.2016.438"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cell.2005.01.014", "@IdType": "doi"}, {"#text": "15766527", "@IdType": "pubmed"}]}, "Citation": "Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, et al. . RAS is Regulated by the Let-7 microRNA Family. Cell (2005) 120(5):635\u201347. doi:\u00a010.1016/j.cell.2005.01.014"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.stem.2013.11.001", "@IdType": "doi"}, {"#text": "PMC3982312", "@IdType": "pmc"}, {"#text": "24239284", "@IdType": "pubmed"}]}, "Citation": "Worringer KA, Rand TA, Hayashi Y, Sami S, Takahashi K, Tanabe K, et al. . The Let-7/LIN-41 Pathway Regulates Reprogramming to Human Induced Pluripotent Stem Cells by Controlling Expression of Prodifferentiation Genes. Cell Stem Cell (2014) 14(1):40\u201352. doi:\u00a010.1016/j.stem.2013.11.001"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/or.2011.1360", "@IdType": "doi"}, {"#text": "21725603", "@IdType": "pubmed"}]}, "Citation": "Chang C, Hsu CC, Chang CH, Tsai LL, Chang YC, Lu SW, et al. . Let-7d Functions as Novel Regulator of Epithelial-Mesenchymal Transition and Chemoresistant Property in Oral Cancer. Oncol Rep (2011) 110:1003\u201310. doi:\u00a010.3892/or.2011.1360"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/sj.emboj.7600385", "@IdType": "doi"}, {"#text": "PMC524334", "@IdType": "pmc"}, {"#text": "15372072", "@IdType": "pubmed"}]}, "Citation": "Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek SH, et al. . MicroRNA Genes are Transcribed by RNA Polymerase II. EMBO J (2004) 23(20):4051\u201360. doi:\u00a010.1038/sj.emboj.7600385"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrg2843", "@IdType": "doi"}, {"#text": "20661255", "@IdType": "pubmed"}]}, "Citation": "Krol J, Loedige I, Filipowicz W. The Widespread Regulation of microRNA Biogenesis, Function and Decay. Nat Rev Genet (2010) 11(9):597\u2013610. doi:\u00a010.1038/nrg2843"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/leu.2013.246", "@IdType": "doi"}, {"#text": "23974981", "@IdType": "pubmed"}]}, "Citation": "Allegra D, Bilan V, Garding A, D\u00f6hner H, Stilgenbauer S, Kuchenbauer F, et al. . Defective DROSHA Processing Contributes to Downregulation of MiR-15/-16 in Chronic Lymphocytic Leukemia. Leukemia (2014) 28(1):98\u2013107. doi:\u00a010.1038/leu.2013.246"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s13277-011-0179-0", "@IdType": "doi"}, {"#text": "PMC3131523", "@IdType": "pmc"}, {"#text": "21559780", "@IdType": "pubmed"}]}, "Citation": "Torres A, Torres K, Paszkowski T, Jod\u0142owska-J\u0119drych B, Radoma\u0144ski T, Ksi\u0105\u017cek A, et al. . Major Regulators of microRNAs Biogenesis Dicer and Drosha are Down-Regulated in Endometrial Cancer. Tumor Biol (2011) 32(4):769\u201376. doi:\u00a010.1007/s13277-011-0179-0"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature09459", "@IdType": "doi"}, {"#text": "PMC3055799", "@IdType": "pmc"}, {"#text": "20962848", "@IdType": "pubmed"}]}, "Citation": "Su X, Chakravarti D, Cho MS, Liu L, Gi YJ, Lin YL, et al. . TAp63 Suppresses Metastasis Through Coordinate Regulation of Dicer and miRNAs. Nature (2010) 467(7318):986\u201390. doi:\u00a010.1038/nature09459"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cell.2010.05.017", "@IdType": "doi"}, {"#text": "20603000", "@IdType": "pubmed"}]}, "Citation": "Martello G, Rosato A, Ferrari F, Manfrin A, Cordenonsi M, Dupont S, et al. . A microRNA Targeting Dicer for Metastasis Control. Cell (2010) 141(7):1195\u2013207. doi:\u00a010.1016/j.cell.2010.05.017"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/onc.2015.492", "@IdType": "doi"}, {"#text": "PMC4931989", "@IdType": "pmc"}, {"#text": "26725326", "@IdType": "pubmed"}]}, "Citation": "Rupaimoole R, Ivan C, Yang D, Gharpure KM, Wu SY, Pecot CV, et al. . Hypoxia-Upregulated microRNA-630 Targets Dicer, Leading to Increased Tumor Progression. Oncogene (2016) 35(33):4312\u201320. doi:\u00a010.1038/onc.2015.492"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2353/ajpath.2006.060480", "@IdType": "doi"}, {"#text": "PMC1780192", "@IdType": "pmc"}, {"#text": "17071602", "@IdType": "pubmed"}]}, "Citation": "Chiosea S, Jelezcova E, Chandran U, Acquafondata M, McHale T, Sobol RW, et al. . Up-Regulation of Dicer, a Component of the microRNA Machinery, in Prostate Adenocarcinoma. Am J Pathol (2006) 169(5):1812\u201320. doi:\u00a010.2353/ajpath.2006.060480"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.leukres.2009.02.003", "@IdType": "doi"}, {"#text": "19278725", "@IdType": "pubmed"}]}, "Citation": "Martin MG, Payton JE, Link DC. Dicer and Outcomes in Patients With Acute Myeloid Leukemia (AML). Leuk Res (2009) 33(8):63110. doi:\u00a010.1016/j.leukres.2009.02.003"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/0008-5472.CAN-06-3533", "@IdType": "doi"}, {"#text": "17332367", "@IdType": "pubmed"}]}, "Citation": "Chiosea S, Jelezcova E, Chandran U, Luo J, Mantha G, Sobol RW, et al. . Overexpression of Dicer in Precursor Lesions of Lung Adenocarcinoma. Cancer Res (2007) 67(5):2345\u201350. doi:\u00a010.1158/0008-5472.CAN-06-3533"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature12080", "@IdType": "doi"}, {"#text": "PMC3717558", "@IdType": "pmc"}, {"#text": "23636329", "@IdType": "pubmed"}]}, "Citation": "Shen J, Xia W, Khotskaya YB, Huo L, Nakanishi K, Lim SO, et al. . EGFR Modulates microRNA Maturation in Response to Hypoxia Through Phosphorylation of AGO2. Nature (2013) 497(7449):383\u20137. doi:\u00a010.1038/nature12080"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ccell.2016.10.001", "@IdType": "doi"}, {"#text": "PMC5127275", "@IdType": "pmc"}, {"#text": "27846390", "@IdType": "pubmed"}]}, "Citation": "Sun HL, Cui R, Zhou J, Teng KY, Hsiao YH, Nakanishi K, et al. . ERK Activation Globally Downregulates miRNAs Through Phosphorylating Exportin-5. Cancer Cell (2016) 30(5):723\u201336. doi:\u00a010.1016/j.ccell.2016.10.001"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41418-018-0065-z", "@IdType": "doi"}, {"#text": "PMC6143530", "@IdType": "pmc"}, {"#text": "29445125", "@IdType": "pubmed"}]}, "Citation": "Li J, Pu W, Sun HL, Zhou JK, Fan X, Zheng Y, et al. . Pin1 Impairs microRNA Biogenesis by Mediating Conformation Change of XPO5 in Hepatocellular Carcinoma. Cell Death Differ (2018) 25(9):1612\u201324. doi:\u00a010.1038/s41418-018-0065-z"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bbamcr.2014.06.001", "@IdType": "doi"}, {"#text": "24915000", "@IdType": "pubmed"}]}, "Citation": "Lee KH, Lin FC, Hsu TI, Lin JT, Guo JH, Tsai CH, et al. . MicroRNA-296-5p (miR-296-5p) Functions as a Tumor Suppressor in Prostate Cancer by Directly Targeting Pin1. Biochim Biophys Acta - Mol Cell Res (2014) 1843(9):2055\u201366. doi:\u00a010.1016/j.bbamcr.2014.06.001"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1111/cas.14085", "@IdType": "doi"}, {"#text": "PMC6676117", "@IdType": "pmc"}, {"#text": "31148345", "@IdType": "pubmed"}]}, "Citation": "Chen L, Xu X, Wen X, Xu S, Wang L, Lu W, et al. . Targeting PIN1 Exerts Potent Antitumor Activity in Pancreatic Ductal Carcinoma via inhibiting Tumor Metastasis. Cancer Sci (2019) 110(8):2442\u201355. doi:\u00a010.1111/cas.14085"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2147/CMAR.S233859", "@IdType": "doi"}, {"#text": "PMC7127878", "@IdType": "pmc"}, {"#text": "32280273", "@IdType": "pubmed"}]}, "Citation": "Tang X, Long Y, Xu L, Yan X. Lncrna Mort Inhibits Cancer Cell Proliferation and Promotes Apoptosis in Mantle Cell Lymphoma by Upregulating Mirna-16. Cancer Manage Res (2020) 12:2119\u201325. doi:\u00a010.2147/CMAR.S233859"}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6511647", "@IdType": "pmc"}, {"#text": "31105998", "@IdType": "pubmed"}]}, "Citation": "Li X, Chen N, Zhou L, Wang C, Wen X, Jia L, et al. . Genome-Wide Target Interactome Profiling Reveals a Novel EEF1A1 Epigenetic Pathway for Oncogenic lncRNA MALAT1 in Breast Cancer. Am J Cancer Res (2019) 9(4):714\u201329."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12943-020-01206-5", "@IdType": "doi"}, {"#text": "PMC7206728", "@IdType": "pmc"}, {"#text": "32384893", "@IdType": "pubmed"}]}, "Citation": "Liang Y, Song X, Li Y, Chen B, Zhao W, Wang L, et al. . LncRNA BCRT1 Promotes Breast Cancer Progression by Targeting miR-1303/PTBP3 Axis. Mol Cancer (2020) 19(1):1\u201320. doi:\u00a010.1186/s12943-020-01206-5"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3727/096504017X15031557924132", "@IdType": "doi"}, {"#text": "PMC7844685", "@IdType": "pmc"}, {"#text": "28835319", "@IdType": "pubmed"}]}, "Citation": "Song W, Mei JZ, Zhang M. Long Noncoding RNA PlncRNA-1 Promotes Colorectal Cancer Cell Progression by Regulating the PI3K/Akt Signaling Pathway. Oncol Res (2018) 26(2):261\u20138. doi:\u00a010.3727/096504017X15031557924132"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1159/000489651", "@IdType": "doi"}, {"#text": "29742512", "@IdType": "pubmed"}]}, "Citation": "Xu Y, Zhang G, Zou C, Zhang H, Gong Z, Wang W, et al. . LncRNA MT1JP Suppresses Gastric Cancer Cell Proliferation and Migration Through MT1JP/MiR-214-3p/RUNX3 Axis. Cell Physiol Biochem (2018) 46(6):2445\u201359. doi:\u00a010.1159/000489651"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2147/CMAR.S192452", "@IdType": "doi"}, {"#text": "PMC6391123", "@IdType": "pmc"}, {"#text": "30863183", "@IdType": "pubmed"}]}, "Citation": "Zhang Y, Liu X, Li Q, Zhang Y. IncRNA LINC00460 Promoted Colorectal Cancer Cells Metastasis via miR-939-5p Sponging. Cancer Manage Res (2019) 11:1779\u201389. doi:\u00a010.2147/CMAR.S192452"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3389/fonc.2021.649107", "@IdType": "doi"}, {"#text": "PMC8097102", "@IdType": "pmc"}, {"#text": "33968749", "@IdType": "pubmed"}]}, "Citation": "Ghafouri-Fard S, Gholipour M, Hussen BM, Taheri M. The Impact of Long Non-Coding RNAs in the Pathogenesis of Hepatocellular Carcinoma. Front Oncol (2021) 11:649107. doi:\u00a010.3389/fonc.2021.649107"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/ol.2021.12802", "@IdType": "doi"}, {"#text": "PMC8157334", "@IdType": "pmc"}, {"#text": "34079594", "@IdType": "pubmed"}]}, "Citation": "Zhou H, Shi P, Jia X, Xue Q. Long Non\u2212Coding RNA LINC01018 Inhibits the Progression of Acute Myeloid Leukemia by Targeting Mir\u2212499a\u22125p to Regulate PDCD4. Oncol Lett (2021) 22(1):1\u201311. doi:\u00a010.3892/ol.2021.12802"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1042/bsr20204177", "@IdType": "doi"}, {"#text": "PMC8319491", "@IdType": "pmc"}, {"#text": "33899079", "@IdType": "pubmed"}]}, "Citation": "Chen Z, Zhong T, Li T, Zhong J, Tang Y, Liu Z, et al. . LncRNA SNHG15 Modulates Gastric Cancer Tumorigenesis by Impairing miR-506-5p Expression. Biosci Rep (2021) 41(7):1\u201310. doi:\u00a010.1042/bsr20204177"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/jgm.3162", "@IdType": "doi"}, {"#text": "31951299", "@IdType": "pubmed"}]}, "Citation": "Jiang T, Wang C, Zhu Y, Han H. LINC01410 Promotes Cell Proliferation and Migration of Cholangiocarcinoma Through Modulating miR-124-3p/SMAD5 Axis. J Gene Med (2020) 22(6):1\u20139. doi:\u00a010.1002/jgm.3162"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1080/21655979.2021.1920325", "@IdType": "doi"}, {"#text": "33944676", "@IdType": "pubmed"}]}, "Citation": "Liu H, Chi Z, Jin H, Yang W. MicroRNA miR-188-5p as a Mediator of Long Non-Coding RNA MALAT1 Regulates Cell Proliferation and Apoptosis in Multiple Myeloma. Bioengineered (2021) 12(1):1611\u201326. doi:\u00a010.1080/21655979.2021.1920325"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrm2632", "@IdType": "doi"}, {"#text": "19165215", "@IdType": "pubmed"}]}, "Citation": "Kim VN, Han J, Siomi MC. Biogenesis of Small RNAs in Animals. Nat Rev Mol Cell Biol (2009) 10(2):126\u201339. doi:\u00a010.1038/nrm2632"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1371/journal.pone.0014742", "@IdType": "doi"}, {"#text": "PMC3048388", "@IdType": "pmc"}, {"#text": "21390222", "@IdType": "pubmed"}]}, "Citation": "Bosia C, Osella M, Caselle M, El Baroudi M, Cora D. A Curated Database of miRNA Mediated Feed-Forward Loops Involving MYC as Master Regulator. PLoS One (2011) 6(3):17\u20138. doi:\u00a010.1371/journal.pone.0014742"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.0808300106", "@IdType": "doi"}, {"#text": "PMC2651245", "@IdType": "pmc"}, {"#text": "19211792", "@IdType": "pubmed"}]}, "Citation": "Chang TC, Zeitels LR, Hwang HW, Chivukula R, Wentzel EA, Dews M, et al. . Lin-28B Transactivation is Necessary for Myc-Mediated Let-7 Repression and Proliferation. Proc Natl Acad Sci USA (2009) 106(9):3384\u20139. doi:\u00a010.1073/pnas.0808300106"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/bcr3059", "@IdType": "doi"}, {"#text": "PMC3326558", "@IdType": "pmc"}, {"#text": "22113133", "@IdType": "pubmed"}]}, "Citation": "Lee YM, Lee JY, Ho CC, Hong QS, Yu SL, Tzeng CR, et al. . miRNA-34b as a Tumor Suppressor in Estrogen-Dependent Growth of Breast Cancer Cells. Breast Cancer Res (2011) 13(6):R116. doi:\u00a010.1186/bcr3059"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2353/ajpath.2010.090837", "@IdType": "doi"}, {"#text": "PMC2861078", "@IdType": "pmc"}, {"#text": "20348243", "@IdType": "pubmed"}]}, "Citation": "Cicatiello L, et al. . Estrogen Receptor \u03b1 Controls a Gene Network in Luminal-Like Breast Cancer Cells Comprising Multiple Transcription Factors and microRNAs. Am J Pathol (2010) 176(5):2113\u201330. doi:\u00a010.2353/ajpath.2010.090837"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.7150/thno.44877", "@IdType": "doi"}, {"#text": "PMC7330864", "@IdType": "pmc"}, {"#text": "32641987", "@IdType": "pubmed"}]}, "Citation": "Chen Y, Zhou Y, Han F, Zhao Y, Tu M, Wang Y, et al. . A Novel miR-1291-Err\u03b1-CPT1C Axis Modulates Tumor Cell Proliferation, Metabolism and Tumorigenesis. Theranostics (2020) 10(16):7193\u2013210. doi:\u00a010.7150/thno.44877"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/bcr3644", "@IdType": "doi"}, {"#text": "PMC4053242", "@IdType": "pmc"}, {"#text": "24735615", "@IdType": "pubmed"}]}, "Citation": "Tan S, Ding K, Li R, Zhang W, Li G, Kong X, et al. . Identification of miR-26 as a Key Mediator of Estrogen Stimulated Cell Proliferation by Targeting CHD1, GREB1 and KPNA2. Breast Cancer Res (2014) 16(2):1\u201313. doi:\u00a010.1186/bcr3644"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cell.2013.12.043", "@IdType": "doi"}, {"#text": "PMC3982296", "@IdType": "pmc"}, {"#text": "24581491", "@IdType": "pubmed"}]}, "Citation": "Mori M, Triboulet R, Mohseni M, Schlegelmilch K, Shrestha K, Camargo FD, et al. . Hippo Signaling Regulates Microprocessor and Links Cell-Density-Dependent Mirna Biogenesis to Cancer. Cell (2014) 156(5):893\u2013906. doi:\u00a010.1016/j.cell.2013.12.043"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12935-019-0818-x", "@IdType": "doi"}, {"#text": "PMC6480894", "@IdType": "pmc"}, {"#text": "31049030", "@IdType": "pubmed"}]}, "Citation": "Huang X, Tang F, Weng Z, Zhou M, Zhang Q. MiR-591 Functions as Tumor Suppressor in Breast Cancer by Targeting TCF4 and Inhibits Hippo-YAP/TAZ Signaling Pathway. Cancer Cell Int (2019) 19(1):1\u20139. doi:\u00a010.1186/s12935-019-0818-x"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/1078-0432.CCR-12-1959", "@IdType": "doi"}, {"#text": "23340296", "@IdType": "pubmed"}]}, "Citation": "Yu SJ, Hu JY, Kuang XY, Luo JM, Hou YF, Di GH, et al. . MicroRNA-200a Promotes Anoikis Resistance and Metastasis by Targeting YAP1 in Human Breast Cancer. Clin Cancer Res (2013) 19(6):1389\u201399. doi:\u00a010.1158/1078-0432.CCR-12-1959"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/aps.2014.59", "@IdType": "doi"}, {"#text": "PMC4155531", "@IdType": "pmc"}, {"#text": "25087998", "@IdType": "pubmed"}]}, "Citation": "Wang Y, Cui M, Di Sun B, Liu FB, Zhang XD, Ye LH. MiR-506 Suppresses Proliferation of Hepatoma Cells Through Targeting YAP mRNA 3\u2032UTR. Acta Pharmacol Sin (2014) 35(9):1207\u201314. doi:\u00a010.1038/aps.2014.59"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.molcel.2007.05.010", "@IdType": "doi"}, {"#text": "PMC1939978", "@IdType": "pmc"}, {"#text": "17540599", "@IdType": "pubmed"}]}, "Citation": "Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, et al. . Transactivation of miR-34a by P53 Broadly Influences Gene Expression and Promotes Apoptosis. Mol Cell (2007) 26(5):745\u201352. doi:\u00a010.1016/j.molcel.2007.05.010"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature05939", "@IdType": "doi"}, {"#text": "PMC4590999", "@IdType": "pmc"}, {"#text": "17554337", "@IdType": "pubmed"}]}, "Citation": "He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, et al. . A microRNA Component of the P53 Tumour Suppressor Network. Nature (2007) 447(7148):1130\u20134. doi:\u00a010.1038/nature05939"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41418-018-0103-x", "@IdType": "doi"}, {"#text": "PMC6262018", "@IdType": "pmc"}, {"#text": "29666469", "@IdType": "pubmed"}]}, "Citation": "Di Gennaro A, Damiano N, Brisotto N, Armellin N, Perin N, Zucchetto N, et al. . A P53/miR-30a/ZEB2 Axis Controls Triple Negative Breast Cancer Aggressiveness. Cell Death Differ (2018) 25(12):2165\u201380. doi:\u00a010.1038/s41418-018-0103-x"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/onc.2013.286", "@IdType": "doi"}, {"#text": "23851509", "@IdType": "pubmed"}]}, "Citation": "Zhang N, Wang X, Huo Q, Sun M, Cai C, Liu Z, et al. . MicroRNA-30a Suppresses Breast Tumor Growth and Metastasis by Targeting Metadherin. Oncogene (2014) 33(24):3119\u201328. doi:\u00a010.1038/onc.2013.286"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature08199", "@IdType": "doi"}, {"#text": "19626115", "@IdType": "pubmed"}]}, "Citation": "Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S, Miyazono K. Modulation of microRNA Processing by P53. Nature (2009) 460(7254):529\u201333. doi:\u00a010.1038/nature08199"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1177/0300060520923522", "@IdType": "doi"}, {"#text": "PMC7287201", "@IdType": "pmc"}, {"#text": "32436415", "@IdType": "pubmed"}]}, "Citation": "Sai X, Qin C, Wu Y, Zhao Y, Bian T. Downregulation of PTEN Mediates Bleomycin-Induced Premature Senescence in Lung Cancer Cells by Suppressing Autophagy. J Int Med Res (2020) 48(5):1\u201312. doi:\u00a010.1177/0300060520923522"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.celrep.2019.07.001", "@IdType": "doi"}, {"#text": "PMC7546539", "@IdType": "pmc"}, {"#text": "31365877", "@IdType": "pubmed"}]}, "Citation": "Donehower LA, Soussi T, Korkut A, Liu Y, Schultz A, Cardenas M, et al. . Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas. Cell Rep (2019) 28(5):1370\u201384.e5. doi:\u00a010.1016/j.celrep.2019.07.001"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/sj.onc.1210302", "@IdType": "doi"}, {"#text": "17401424", "@IdType": "pubmed"}]}, "Citation": "Petitjean A, Achatz MIW, Borresen-Dale AL, Hainaut P, Olivier M. TP53 Mutations in Human Cancers: Functional Selection and Impact on Cancer Prognosis and Outcomes. Oncogene (2007) 26(15):2157\u201365. doi:\u00a010.1038/sj.onc.1210302"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ccr.2014.01.021", "@IdType": "doi"}, {"#text": "PMC3970583", "@IdType": "pmc"}, {"#text": "24651012", "@IdType": "pubmed"}]}, "Citation": "Muller PAJ, Vousden KH. Mutant P53 in Cancer: New Functions and Therapeutic Opportunities. Cancer Cell (2014) 25(3):304\u201317. doi:\u00a010.1016/j.ccr.2014.01.021"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrc2731", "@IdType": "doi"}, {"#text": "19776746", "@IdType": "pubmed"}]}, "Citation": "Donehower LA, Lozano G. 20 Years Studying P53 Functions in Genetically Engineered Mice. Nat Rev Cancer (2009) 11:831\u201341. doi:\u00a010.1038/nrc2731"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/humu.22507", "@IdType": "doi"}, {"#text": "24415648", "@IdType": "pubmed"}]}, "Citation": "Donehower LA. Insights Into Wild-Type and Mutant P53 Functions Provided by Genetically Engineered Mice. Hum Mutat (2014) 35(6):715\u201327. doi:\u00a010.1002/humu.22507"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1074/jbc.M109.094813", "@IdType": "doi"}, {"#text": "PMC2863202", "@IdType": "pmc"}, {"#text": "20223820", "@IdType": "pubmed"}]}, "Citation": "Gurtner A, Starace G, Norelli G, Piaggio G, Sacchi A, Bossi G. Mutant P53-Induced Up-Regulation of Mitogen-Activated Protein Kinase Kinase 3 Contributes to Gain of Function. J Biol Chem (2010) 285(19):14160\u20139. doi:\u00a010.1074/jbc.M109.094813"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s13046-016-0319-x", "@IdType": "doi"}, {"#text": "PMC4789259", "@IdType": "pmc"}, {"#text": "26971015", "@IdType": "pubmed"}]}, "Citation": "Gurtner A, Falcone E, Garibaldi F, Piaggio G. Dysregulation of microRNA Biogenesis in Cancer: The Impact of Mutant P53 on Drosha Complex Activity. J Exp Clin Cancer Res (2016) 35(1):1\u20139. doi:\u00a010.1186/s13046-016-0319-x"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.6350", "@IdType": "doi"}, {"#text": "PMC4792583", "@IdType": "pmc"}, {"#text": "26587974", "@IdType": "pubmed"}]}, "Citation": "Jiang FZ, He YY, Wang HH, Zhang HL, Zhang J, Yan XF, et al. . Mutant P53 Induces EZH2 Expression and Promotes Epithelial-Mesenchymal Transition by Disrupting P68-Drosha Complex Assembly and Attenuating miR-26a Processing. Oncotarget (2015) 6(42):44660\u201374. doi:\u00a010.18632/oncotarget.6350"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/onc.2016.51", "@IdType": "doi"}, {"#text": "26996669", "@IdType": "pubmed"}]}, "Citation": "Garibaldi F, Falcone E, Trisciuoglio D, Colombo T, Lisek K, Walerych D, et al. . Mutant P53 Inhibits miRNA Biogenesis by Interfering With the Microprocessor Complex. Oncogene (2016) 35(29):3760\u201370. doi:\u00a010.1038/onc.2016.51"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.omtn.2020.10.018", "@IdType": "doi"}, {"#text": "PMC7679243", "@IdType": "pmc"}, {"#text": "33251049", "@IdType": "pubmed"}]}, "Citation": "Meng X, Sun W, Yu J, Zhou Y, Gu Y, Han J, et al. . LINC00460-miR-149-5p/miR-150-5p-Mutant P53 Feedback Loop Promotes Oxaliplatin Resistance in Colorectal Cancer. Mol Ther - Nucleic Acids (2020) 22:1004\u201315. doi:\u00a010.1016/j.omtn.2020.10.018"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/ijc.25919", "@IdType": "doi"}, {"#text": "21960261", "@IdType": "pubmed"}]}, "Citation": "Tsai K, Wu CW, Hu LY, Li SC, Liao YL, Lai CH, et al. . Epigenetic Regulation of miR-34b and miR-129 Expression in Gastric Cancer. Int J Cancer (2011) 2610(11):2600\u201310. doi:\u00a010.1002/ijc.25919"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1111/j.1349-7006.2009.01434.x", "@IdType": "doi"}, {"#text": "19958364", "@IdType": "pubmed"}]}, "Citation": "Ushijima T, Asada K. Aberrant DNA Methylation in Contrast with Mutations. Cancer Sci (2009) 101(2):300\u20135. doi:\u00a010.1111/j.1349-7006.2009.01434.x"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.molonc.2012.07.007", "@IdType": "doi"}, {"#text": "PMC5528344", "@IdType": "pmc"}, {"#text": "22902148", "@IdType": "pubmed"}]}, "Citation": "Suzuki H, Maruyama R, Yamamoto E, Kai M. DNA Methylation and microRNA Dysregulation in Cancer. Mol Oncol (2012) 6(6):567\u201378. doi:\u00a010.1016/j.molonc.2012.07.007"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.0803055105", "@IdType": "doi"}, {"#text": "PMC2528872", "@IdType": "pmc"}, {"#text": "18768788", "@IdType": "pubmed"}]}, "Citation": "Lujambio A, Calin GA, Villanueva A, Ropero S, S\u00e1nchez-C\u00e9spedes M, Blanco D, et al. . A microRNA DNA Methylation Signature for Human Cancer Metastasis. Proc Natl Acad Sci USA (2008) 105(36):13556\u201361. doi:\u00a010.1073/pnas.0803055105"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1242/jcs.122275", "@IdType": "doi"}, {"#text": "23525011", "@IdType": "pubmed"}]}, "Citation": "Lim YY, Wright JA, Attema JL, Gregory PA, Bert AG, Smith E, et al. . Epigenetic Modulation of the miR-200 Family is Associated With Transition to a Breast Cancer Stem-Celllike State. J Cell Sci (2013) 126(10):2256\u201366. doi:\u00a010.1242/jcs.122275"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41389-020-00284-w", "@IdType": "doi"}, {"#text": "PMC7652937", "@IdType": "pmc"}, {"#text": "33168810", "@IdType": "pubmed"}]}, "Citation": "Xu L, Lin J, Deng W, Luo W, Huang Y, Liu CQ, et al. . EZH2 Facilitates BMI1-Dependent Hepatocarcinogenesis Through Epigenetically Silencing microRNA-200c. Oncogenesis (2020) 9(11):101. doi:\u00a010.1038/s41389-020-00284-w"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41389-020-00281-z", "@IdType": "doi"}, {"#text": "PMC7652948", "@IdType": "pmc"}, {"#text": "33168819", "@IdType": "pubmed"}]}, "Citation": "Tong D, Zhang J, Wang X, Li Q, Liu L, Lu A, et al. . MiR-22, Regulated by MeCP2, Suppresses Gastric Cancer Cell Proliferation by Inducing a Deficiency in Endogenous S-Adenosylmethionine. Oncogenesis (2020) 9(11):99. doi:\u00a010.1038/s41389-020-00281-z"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1182/blood-2011-06-361022", "@IdType": "doi"}, {"#text": "21976676", "@IdType": "pubmed"}]}, "Citation": "Wong KY, Yim RLH, So CC, Jin DY, Liang R, Chim CS. Epigenetic Inactivation of the MIR34B/C in Multiple Myeloma. Blood (2011) 118(22):5901\u20134. doi:\u00a010.1182/blood-2011-06-361022"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/hmg/ddab187", "@IdType": "doi"}, {"#text": "34240140", "@IdType": "pubmed"}]}, "Citation": "Peinado P, Andrades A, Martorell-Marug\u00e1n J, Haswell JR, Slack FJ, Carmona-S\u00e1ez P, et al. . The SWI/SNF Complex Regulates the Expression of miR-222, a Tumor Suppressor microRNA in Lung Adenocarcinoma. Hum Mol Genet (2021) 00(00):1\u20139. doi:\u00a010.1093/hmg/ddab187"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1146/annurev-pathol-012414-040445", "@IdType": "doi"}, {"#text": "25387058", "@IdType": "pubmed"}]}, "Citation": "Masliah-Planchon J, Bi\u00e8che I, Guinebreti\u00e8re JM, Bourdeaut F, Delattre O. SWI/SNF Chromatin Remodeling and Human Malignancies. Annu Rev Pathol Mech Dis (2015) 10:145\u201371. doi:\u00a010.1146/annurev-pathol-012414-040445"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/cancers11060793", "@IdType": "doi"}, {"#text": "PMC6627760", "@IdType": "pmc"}, {"#text": "31181801", "@IdType": "pubmed"}]}, "Citation": "Galka-Marciniak P, Urbanek-Trzeciak MO, Nawrocka PM, Dutkiewicz A, Giefing M, Lewandowska MA, et al. . Somatic Mutations in miRNA Genes in Lung Cancer\u2014Potential Functional Consequences of Non-Coding Sequence Variants. Cancers (Basel) (2019) 11(6):1\u201326. doi:\u00a010.3390/cancers11060793"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.0508889103", "@IdType": "doi"}, {"#text": "PMC1474008", "@IdType": "pmc"}, {"#text": "16754881", "@IdType": "pubmed"}]}, "Citation": "Zhang L, Huang J, Yang N, Greshock J, Megraw MS, Giannakakis A, et al. . MicroRNAs Exhibit High Frequency Genomic Alterations in Human Cancer. Proc Natl Acad Sci U S A (2006) 103(24):9136\u201341. doi:\u00a010.1073/pnas.0508889103."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/ng1215", "@IdType": "doi"}, {"#text": "12923544", "@IdType": "pubmed"}]}, "Citation": "Albertson DG, Collins C, McCormick F, Gray JW. Chromosome Aberrations in Solid Tumors. Nat Genet (2003) 34(4):369\u201376. doi:\u00a010.1038/ng1215"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.4351", "@IdType": "doi"}, {"#text": "PMC4695126", "@IdType": "pmc"}, {"#text": "26156018", "@IdType": "pubmed"}]}, "Citation": "Czubak K, Lewandowska MA, Klonowska K, Roszkowski K, Kowalewski J, Figlerowicz M, et al. . High Copy Number Variation of Cancer-Related microRNA Genes and Frequent Amplification of DICER1 and DROSHA in Lung Cancer. Oncotarget (2015) 6(27):23399\u2013416. doi:\u00a010.18632/oncotarget.4351"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1126/science.1235122", "@IdType": "doi"}, {"#text": "PMC3749880", "@IdType": "pmc"}, {"#text": "23539594", "@IdType": "pubmed"}]}, "Citation": "Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA, Kinzler KW. Cancer Genome Landscapes. Sci (80-) (2013) 340(6127):1546\u201358. doi:\u00a010.1126/science.1235122"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.neo.2015.08.003", "@IdType": "doi"}, {"#text": "PMC4674484", "@IdType": "pmc"}, {"#text": "26408257", "@IdType": "pubmed"}]}, "Citation": "Wang Y, Chen J, Yang W, Mo F, Senz J, Yap D, et al. . The Oncogenic Roles of DICER1 RNase IIIb Domain Mutations in Ovarian Sertoli-Leydig Cell Tumors. Neoplasia (2015) 17(8):650\u201360. doi:\u00a010.1016/j.neo.2015.08.003"}, {"ArticleIdList": {"ArticleId": {"#text": "10.1016/j.jsbmb.2011.07.002.Identification", "@IdType": "doi"}}, "Citation": "Dennis DA, Ivanovich J, Priest JR, Gurnett CA, Dehner LP, Desruisseau D, et al. . Germline DICER1 Mutations in Familial Pleuropulmonary Blastoma. Sci (80-) (2012) 127(5943):358\u201366. doi:\u00a010.1016/j.jsbmb.2011.07.002.Identification"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/path.4569", "@IdType": "doi"}, {"#text": "26033159", "@IdType": "pubmed"}]}, "Citation": "Chen J, Wang Y, McMonechy MK, Anglesio MS, Yang W, Senz J, et al. . Recurrent DICER1 Hotspot Mutations in Endometrial Tumours and Their Impact on microRNA Biogenesis. J Pathol (2015) 237(2):215\u201325. doi:\u00a010.1002/path.4569"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/modpathol.2017.100", "@IdType": "doi"}, {"#text": "28862265", "@IdType": "pubmed"}]}, "Citation": "Wu MK, Vujanic GM, Fahiminiya S, Watanabe N, Thorner PS, O'Sullivan MJ, et al. . Anaplastic Sarcomas of the Kidney are Characterized by DICER1 Mutations. Mod Pathol (2018) 31(1):169\u201378. doi:\u00a010.1038/modpathol.2017.100"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41379-018-0132-5", "@IdType": "doi"}, {"#text": "30266945", "@IdType": "pubmed"}]}, "Citation": "Bean GR, Anderson J, Sangoi AR, Krings G, Garg K. DICER1 Mutations are Frequent in M\u00fcllerian Adenosarcomas and Are Independent of Rhabdomyosarcomatous Differentiation. Mod Pathol (2019) 32(2):280\u20139. doi:\u00a010.1038/s41379-018-0132-5"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.humpath.2016.09.005", "@IdType": "doi"}, {"#text": "27664536", "@IdType": "pubmed"}]}, "Citation": "Kato N, Kusumi T, Kamataki A, Tsunoda R, Fukase M, Kurose A. DICER1 Hotspot Mutations in Ovarian Sertoli-Leydig Cell Tumors: A Potential Association With Androgenic Effects. Hum Pathol (2017) 59:41\u20137. doi:\u00a010.1016/j.humpath.2016.09.005"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1101/gad.1848209", "@IdType": "doi"}, {"#text": "PMC2788328", "@IdType": "pmc"}, {"#text": "19903759", "@IdType": "pubmed"}]}, "Citation": "Kumar MS, Pester RE, Chen CY, Lane K, Chin C, Lu J, et al. . Dicer1 Functions as a Haploinsufficient Tumor Suppressor. Genes Dev (2009) 23(23):2700\u20134. doi:\u00a010.1101/gad.1848209"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1101/gad.1248505", "@IdType": "doi"}, {"#text": "PMC548949", "@IdType": "pmc"}, {"#text": "15713842", "@IdType": "pubmed"}]}, "Citation": "Kanellopoulou C, Muljo SA, Kung AL, Ganesan S, Drapkin R, Jenuwein T, et al. . Dicer-Deficient Mouse Embryonic Stem Cells Are Defective in Differentiation and Centromeric Silencing. Genes Dev (2005) 19(4):489\u2013501. doi:\u00a010.1101/gad.1248505"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1056/NEJMoa0803785", "@IdType": "doi"}, {"#text": "PMC2710981", "@IdType": "pmc"}, {"#text": "19092150", "@IdType": "pubmed"}]}, "Citation": "Merritt WM, Lin YG, Han LY, Kamat AA, Spannuth WA, Schmandt R, et al. . Dicer, Drosha, and Outcomes in Patients With Ovarian Cancer. New Engl J (2008) 359(25):2641\u201350. doi:\u00a010.1056/NEJMoa0803785"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41467-019-11610-1", "@IdType": "doi"}, {"#text": "PMC6695490", "@IdType": "pmc"}, {"#text": "31417090", "@IdType": "pubmed"}]}, "Citation": "Vedanayagam J, Chatila WK, Aksoy BA, Majumdar S, Skanderup AJ, Demir E, et al. . Cancer-Associated Mutations in DICER1 RNase IIIa and IIIb Domains Exert Similar Effects on miRNA Biogenesis. Nat Commun (2019) 10(1):3682. doi:\u00a010.1038/s41467-019-11610-1"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/ncb2672", "@IdType": "doi"}, {"#text": "PMC3660859", "@IdType": "pmc"}, {"#text": "23354167", "@IdType": "pubmed"}]}, "Citation": "Chou J, Lin JH, Brenot A, Kim JW, Provot S, Werb Z. GATA3 Suppresses Metastasis and Modulates the Tumour Microenvironment by Regulating microRNA-29b Expression. Nat Cell Biol (2013) 15(2):201\u201313. doi:\u00a010.1038/ncb2672"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ccr.2010.09.007", "@IdType": "doi"}, {"#text": "20951941", "@IdType": "pubmed"}]}, "Citation": "Melo SA, Moutinho C, Ropero S, Calin GA, Rossi S, Spizzo R, et al. . A Genetic Defect in Exportin-5 Traps Precursor MicroRNAs in the Nucleus of Cancer Cells. Cancer Cell (2010) 18(4):303\u201315. doi:\u00a010.1016/j.ccr.2010.09.007"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3389/fimmu.2021.624725", "@IdType": "doi"}, {"#text": "PMC8167795", "@IdType": "pmc"}, {"#text": "34084160", "@IdType": "pubmed"}]}, "Citation": "Xing Y, Ruan G, Ni H, Qin H, Chen S, Gu X, et al. . Tumor Immune Microenvironment and Its Related miRNAs in Tumor Progression. Front Immunol (2021) 12:624725. doi:\u00a010.3389/fimmu.2021.624725"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/jcp.27111", "@IdType": "doi"}, {"#text": "30146796", "@IdType": "pubmed"}]}, "Citation": "Li BL, Lu W, Qu JJ, Ye L, Du GQ, Wan XP. Loss of Exosomal miR-148b From Cancer-Associated Fibroblasts Promotes Endometrial Cancer Cell Invasion and Cancer Metastasis. J Cell Physiol (2019) 234(3):2943\u201353. doi:\u00a010.1002/jcp.27111"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/jcm8081158", "@IdType": "doi"}, {"#text": "PMC6723910", "@IdType": "pmc"}, {"#text": "31382461", "@IdType": "pubmed"}]}, "Citation": "Purvis IJ, Avilala J, Guda MR, Venkataraman S, Vibhakar R, Tsung AJ, et al. . Role of MYC-miR-29-B7-H3 in Medulloblastoma Growth and Angiogenesis. J Clin Med (2019) 8(8):1158. doi:\u00a010.3390/jcm8081158"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1111/j.1365-2559.2008.03070.x", "@IdType": "doi"}, {"#text": "PMC2658025", "@IdType": "pmc"}, {"#text": "18613926", "@IdType": "pubmed"}]}, "Citation": "Gregorio A, Corrias MV, Castriconi R, Dondero A, Mosconi M, Gambini C, et al. . Small Round Blue Cell Tumours: Diagnostic and Prognostic Usefulness of the Expression of B7-H3 Surface Molecule. Histopathology (2008) 53(1):73\u201380. doi:\u00a010.1111/j.1365-2559.2008.03070.x"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1371/journal.pone.0078885", "@IdType": "doi"}, {"#text": "PMC3827283", "@IdType": "pmc"}, {"#text": "24236063", "@IdType": "pubmed"}]}, "Citation": "Mesri MJ, Gillette M, Carr SA, Paulovich AG, Smith RD, Rodland KK, et al. . Identification and Characterization of Angiogenesis Targets Through Proteomic Profiling of Endothelial Cells in Human Cancer Tissues. PloS One (2013) 8(11). doi:\u00a010.1371/journal.pone.0078885"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.8784", "@IdType": "doi"}, {"#text": "PMC5045411", "@IdType": "pmc"}, {"#text": "27121051", "@IdType": "pubmed"}]}, "Citation": "Ma J, Ma P, Zhao C, Xue X, Han H, Liu C, et al. . B7-H3 as a Promising Target for Cytotoxicity T Cell in Human Cancer Therapy. Oncotarget (2016) 7(20):29480\u201391. doi:\u00a010.18632/oncotarget.8784"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s00404-018-4999-7", "@IdType": "doi"}, {"#text": "PMC6435611", "@IdType": "pmc"}, {"#text": "30585294", "@IdType": "pubmed"}]}, "Citation": "Bieg D, Sypniewski D, Nowak E, Bednarek I. MiR \u2212 424 \u2212 3p Suppresses Galectin \u2212 3 Expression and Sensitizes Ovarian Cancer Cells to Cisplatin. Arch Gynecol Obstet (2019) 299(4):1077\u201387. doi:\u00a010.1007/s00404-018-4999-7"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.biocel.2012.12.008", "@IdType": "doi"}, {"#text": "23262291", "@IdType": "pubmed"}]}, "Citation": "Bhushan R, Gr\u00fcnhagen J, Becker J, Robinson PN, Ott CE, Knaus P. The International Journal of Biochemistry miR-181a Promotes Osteoblastic Differentiation Through Repression of TGF- \u03b2 Signaling Molecules. Int J Biochem Cell Biol (2013) 45(3):696\u2013705. doi:\u00a010.1016/j.biocel.2012.12.008"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/aps.2012.195", "@IdType": "doi"}, {"#text": "PMC3587916", "@IdType": "pmc"}, {"#text": "23377548", "@IdType": "pubmed"}]}, "Citation": "Shen G, Li X, Jia YF, Piazza GA, Xi Y. Hypoxia-Regulated microRNAs in Human Cancer. Acta Pharmacol Sin (2013) 34(3):336\u201341. doi:\u00a010.1038/aps.2012.195"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1074/jbc.M110.158790", "@IdType": "doi"}, {"#text": "PMC3023502", "@IdType": "pmc"}, {"#text": "21081489", "@IdType": "pubmed"}]}, "Citation": "Chan YC, Khanna S, Roy S, Sen CK. MiR-200b Targets Ets-1 and is Down-Regulated by Hypoxia to Induce Angiogenic Response of Endothelial Cells. J\u00a0Biol Chem (2011) 286(3):2047\u201356. doi:\u00a010.1074/jbc.M110.158790"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/emboj.2011.38", "@IdType": "doi"}, {"#text": "PMC3094116", "@IdType": "pmc"}, {"#text": "21343907", "@IdType": "pubmed"}]}, "Citation": "Jafarifar F, Yao P, Fox PL. Repression of VEGFA by CA-Rich Element-Binding microRNAs Is Modulated by hnRNP L. EMBO J (2011) 30(7):1324\u201334. doi:\u00a010.1038/emboj.2011.38"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1371/journal.pone.0000116", "@IdType": "doi"}, {"#text": "PMC1762435", "@IdType": "pmc"}, {"#text": "17205120", "@IdType": "pubmed"}]}, "Citation": "Hua Z, Lv Q, Ye W, Wong CK, Cai G, Gu D, et al. . MiRNA-Directed Regulation of VEGF and Other Angiogenic Factors Under Hypoxia. PLoS One (2006) 1(1):e116. doi:\u00a010.1371/journal.pone.0000116"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/ncomms6203.Hypoxia", "@IdType": "doi"}, {"#text": "PMC4255228", "@IdType": "pmc"}, {"#text": "25351418", "@IdType": "pubmed"}]}, "Citation": "Van Den Beucken T, Koch E, Chu K, Rupaimoole R, Prickaerts P, Adriaens M, et al. . Europe PMC Funders Group Hypoxia Promotes Stem Cell Phenotypes and Poor Prognosis Through Epigenetic Regulation of DICER. (2015) 5:5203. doi:\u00a010.1038/ncomms6203.Hypoxia"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.0804549105", "@IdType": "doi"}, {"#text": "PMC2492472", "@IdType": "pmc"}, {"#text": "18663219", "@IdType": "pubmed"}]}, "Citation": "Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. . Circulating microRNAs as Stable Blood-Based Markers for Cancer Detection. Proc Natl Acad Sci USA (2008) 105(30):10513\u20138. doi:\u00a010.1073/pnas.0804549105"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.0704372104", "@IdType": "doi"}, {"#text": "PMC2040910", "@IdType": "pmc"}, {"#text": "17600087", "@IdType": "pubmed"}]}, "Citation": "Shell S, Park SM, Radjabi AR, Schickel R, Kistner EO, Jewell DA, et al. . Let-7 Expression Defines Two Differentiation Stages of Cancer. Proc Natl Acad Sci USA (2007) 104(27):11400\u20135. doi:\u00a010.1073/pnas.0704372104"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/ijc.28371", "@IdType": "doi"}, {"#text": "23825028", "@IdType": "pubmed"}]}, "Citation": "Tang Z, Ow GS, Thiery JP, Ivshina AV, Kuznetsov VA. Prognostic Biomarker and Predicts Molecular and Clinical Subclasses in High-Grade Serous Ovarian Carcinoma. Int J Cancer (2014) 318:306\u201318. doi:\u00a010.1002/ijc.28371"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/jcm8101661", "@IdType": "doi"}, {"#text": "PMC6833074", "@IdType": "pmc"}, {"#text": "31614612", "@IdType": "pubmed"}]}, "Citation": "Bottani M, Banfi G, Lombardi G. Circulating miRNAs as Diagnostic and Prognostic Biomarkers in Common Solid Tumors: Focus on Lung, Breast, Prostate Cancers, and Osteosarcoma. J Clin Med (2019) 8(10):1661. doi:\u00a010.3390/jcm8101661"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.17305/BJBMS.2018.3399", "@IdType": "doi"}, {"#text": "PMC6387672", "@IdType": "pmc"}, {"#text": "29924958", "@IdType": "pubmed"}]}, "Citation": "Han J, Yu J, Dai Y, Li J, Guo M, Song J, et al. . Overexpression of miR-361-5p in Triple-Negative Breast Cancer (TNBC) Inhibits Migration and Invasion by Targeting RQCD1 and Inhibiting the EGFR/PI3K/Akt Pathway. Bosn. J\u00a0Basic Med Sci (2019) 19(1):52\u20139. doi:\u00a010.17305/BJBMS.2018.3399"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2147/OTT.S171539", "@IdType": "doi"}, {"#text": "PMC6118279", "@IdType": "pmc"}, {"#text": "30214229", "@IdType": "pubmed"}]}, "Citation": "Liu J, Yang J, Yu L, Rao C, Wang Q, Sun C, et al. . MiR-361-5p Inhibits Glioma Migration and Invasion by Targeting SND1. Onco. Targets. Ther (2018) 11:5239\u201352. doi:\u00a010.2147/OTT.S171539"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.3744", "@IdType": "doi"}, {"#text": "PMC4627317", "@IdType": "pmc"}, {"#text": "25965817", "@IdType": "pubmed"}]}, "Citation": "Ma F, Song H, Guo B, Zhang Y, Zheng Y, Lin C, et al. . MiR-361-5p Inhibits Colorectal and Gastric Cancer Growth and Metastasis by Targeting Staphylococcal Nuclease Domain Containing-1. Oncotarget (2015) 6(19):17404\u201316. doi:\u00a010.18632/oncotarget.3744"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/ijc.28371", "@IdType": "doi"}, {"#text": "23825028", "@IdType": "pubmed"}]}, "Citation": "Tang Z, Ow GS, Thiery JP, Ivshina AV, Kuznetsov VA. Meta-Analysis of Transcriptome Reveals Let-7b as an Unfavorable Prognostic Biomarker and Predicts Molecular and Clinical Subclasses in High-Grade Serous Ovarian Carcinoma. Int J Cancer (2014) 134(2):306\u201318. doi:\u00a010.1002/ijc.28371"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.urolonc.2019.08.008", "@IdType": "doi"}, {"#text": "31635993", "@IdType": "pubmed"}]}, "Citation": "Saleeb R, Kim SS, Ding Q, Scorilas A, Lin S, Khella HW, et al. . The miR-200 Family as Prognostic Markers in Clear Cell Renal Cell Carcinoma. Urol. Oncol Semin Orig Investig (2019) 37(12):955\u201363. doi:\u00a010.1016/j.urolonc.2019.08.008"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.7150/jca.27529", "@IdType": "doi"}, {"#text": "PMC6692621", "@IdType": "pmc"}, {"#text": "31417645", "@IdType": "pubmed"}]}, "Citation": "Yu C, Wan H, Shan R, Wen W, Li J, Luo D, et al. . The Prognostic Value of the MiR-200 Family in Colorectal Cancer: A Meta-Analysis With 1882 Patients. J Cancer (2019) 10(17):4009\u201316. doi:\u00a010.7150/jca.27529"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.gene.2019.144025", "@IdType": "doi"}, {"#text": "31394177", "@IdType": "pubmed"}]}, "Citation": "Yuan L, Bing Z, Yan P, Li R, Wang C. Integrative Data Mining and Meta-Analysis to Investigate the Prognostic Role of microRNA-200 Family in Various Human Malignant Neoplasms\u202f: A Consideration on Heterogeneity. Gene (2019) 716:144025. doi:\u00a010.1016/j.gene.2019.144025"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.mam.2019.09.005", "@IdType": "doi"}, {"#text": "31558294", "@IdType": "pubmed"}]}, "Citation": "Huang GL, Sun J, Lu Y, Liu Y, Cao H, Zhang H, et al. . MiR-200 Family and Cancer: From a Meta-Analysis View. Mol Aspects Med (2019) 70:57\u201371. doi:\u00a010.1016/j.mam.2019.09.005"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1126/science.1113329", "@IdType": "doi"}, {"#text": "16141076", "@IdType": "pubmed"}]}, "Citation": "Jopling CL, Yi MK, Lancaster AM, Lemon SM, Sarnow P. Molecular Biology: Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA. Sci (80-) (2005) 309(5740):1577\u201381. doi:\u00a010.1126/science.1113329"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1128/jvi.03631-14", "@IdType": "doi"}, {"#text": "PMC4474307", "@IdType": "pmc"}, {"#text": "25855736", "@IdType": "pubmed"}]}, "Citation": "Thibault PA, Huys A, Amador-Ca\u00f1izares Y, Gailius JE, Pinel DE, Wilson JA. Regulation of Hepatitis C Virus Genome Replication by Xrn1 and MicroRNA-122 Binding to Individual Sites in the 5\u2032 Untranslated Region. J Virol (2015) 89(12):6294\u2013311. doi:\u00a010.1128/jvi.03631-14"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrd.2016.246", "@IdType": "doi"}, {"#text": "28209991", "@IdType": "pubmed"}]}, "Citation": "Rupaimoole R, Slack FJ. MicroRNA Therapeutics: Towards a New Era for the Management of Cancer and Other Diseases. Nat Rev Drug Discov (2017) 16(3):203\u201321. doi:\u00a010.1038/nrd.2016.246"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/0008-5472.CAN-10-0655", "@IdType": "doi"}, {"#text": "PMC2913706", "@IdType": "pmc"}, {"#text": "20570894", "@IdType": "pubmed"}]}, "Citation": "Wiggins JF, Ruffino L, Kelnar K, Omotola M, Patrawala L, Brown D, et al. . Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor microRNA-34. Cancer Res (2010) 70(14):5923\u201330. doi:\u00a010.1158/0008-5472.CAN-10-0655"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1080/15384101.2014.1003008", "@IdType": "doi"}, {"#text": "PMC4615025", "@IdType": "pmc"}, {"#text": "25714397", "@IdType": "pubmed"}]}, "Citation": "Stahlhut C, Slack FJ. Combinatorial Action of MicroRNAs Let-7 and miR-34 Effectively Synergizes With Erlotinib to Suppress Non-Small Cell Lung Cancer Cell Proliferation. Cell Cycle (2015) 14(13):2171\u201380. doi:\u00a010.1080/15384101.2014.1003008"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/mt.2014.79", "@IdType": "doi"}, {"#text": "PMC4435581", "@IdType": "pmc"}, {"#text": "24791940", "@IdType": "pubmed"}]}, "Citation": "Cortez MA, Valdecanas D, Zhang X, Zhan Y, Bhardwaj V, Calin GA, et al. . Therapeutic Delivery of MiR-200c Enhances Radiosensitivity in Lung Cancer. Mol Ther (2014) 22(8):1494\u2013503. doi:\u00a010.1038/mt.2014.79"}]}}}}}, "PMC": "PMC8554338", "PMID": "34722255", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "Tumor Suppressor miRNA in Cancer Cells and the Tumor Microenvironment: Mechanism of Deregulation and Clinical Implications.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "20": {"Abstract": "Tumor metastasis is the main cause of treatment failure and death in patients with late stage of gastric cancer (GC). Studies showed that microRNAs (miRNAs) are important regulators in the process of tumor metastasis. In this study, we used miRNA array analysis to search for metastasis-associated miRNAs in primary and matched metastasis tissues of patients with GC and found that miR-345-5p (miR-345) was significantly higher in primary sites. Decreased expression of miR-345 was observed in GC tissues and cell lines, which was correlated with aggressive stage and grade. Patients with a higher level of miR-345 had a better prognosis. miR-345 could inhibit the migration and spheroid formation abilities in GC cell lines in transwell assay and spheroid formation assay. RNA sequencing and bioinformatics analysis revealed that miR-345 downregulated the epidermal growth factor receptor pathway substrate 8 (EPS8) and its downstream Rac1 signaling. Mechanistically, we confirmed that miR-345 could target EPS8 by directly binding to its 3' untranslated region by luciferase reporter assay. Further rescue assay showed that the ability of miR-345 in inhibiting the migration, stem-like cell phenotype, and epithelial-mesenchymal transition (EMT) in GC was partly dependent on targeting EPS8. In conclusion, miR-345 plays an inhibitory role in GC metastasis through inhibiting cell migration, EMT, and cancer stem cell phenotype via inactivation of Rac1 signaling by targeting EPS8, which provides the potential therapeutic and predictive value of miR-345 in GC.", "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "-141699806890284170", "Part1": "Department of Medical Oncology", "Part2": "Fudan University Shanghai Cancer Center", "Part3": "Shanghai 200032", "Part4": "China.", "Part5": null, "Part6": null, "Text": "Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China."}, {"Has_Extra": false, "HashID": "-6705189804931625827", "Part1": "Department of Oncology", "Part2": "Shanghai Medical College", "Part3": "Fudan University", "Part4": "Shanghai 200032", "Part5": "China.", "Part6": null, "Text": "Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China."}], "ForeName": "Jieyun", "FullName": "Jieyun Zhang", "HashID": "4003444127426182379", "LastName": "Zhang", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-141699806890284170", "Part1": "Department of Medical Oncology", "Part2": "Fudan University Shanghai Cancer Center", "Part3": "Shanghai 200032", "Part4": "China.", "Part5": null, "Part6": null, "Text": "Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China."}, {"Has_Extra": false, "HashID": "-6705189804931625827", "Part1": "Department of Oncology", "Part2": "Shanghai Medical College", "Part3": "Fudan University", "Part4": "Shanghai 200032", "Part5": "China.", "Part6": null, "Text": "Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China."}], "ForeName": "Chenchen", "FullName": "Chenchen Wang", "HashID": "8864870786570485502", "LastName": "Wang", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-7206484038108160289", "Part1": "Department of Surgery", "Part2": "Huashan Hospital", "Part3": "Fudan University", "Part4": "Shanghai 200040", "Part5": "China.", "Part6": null, "Text": "Department of Surgery, Huashan Hospital, Fudan University, Shanghai 200040, China."}], "ForeName": "Shican", "FullName": "Shican Yan", "HashID": "-3576108236728445719", "LastName": "Yan", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-141699806890284170", "Part1": "Department of Medical Oncology", "Part2": "Fudan University Shanghai Cancer Center", "Part3": "Shanghai 200032", "Part4": "China.", "Part5": null, "Part6": null, "Text": "Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China."}, {"Has_Extra": false, "HashID": "-6705189804931625827", "Part1": "Department of Oncology", "Part2": "Shanghai Medical College", "Part3": "Fudan University", "Part4": "Shanghai 200032", "Part5": "China.", "Part6": null, "Text": "Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China."}], "ForeName": "Yanan", "FullName": "Yanan Yang", "HashID": "4365376892537879790", "LastName": "Yang", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-141699806890284170", "Part1": "Department of Medical Oncology", "Part2": "Fudan University Shanghai Cancer Center", "Part3": "Shanghai 200032", "Part4": "China.", "Part5": null, "Part6": null, "Text": "Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China."}, {"Has_Extra": false, "HashID": "-6705189804931625827", "Part1": "Department of Oncology", "Part2": "Shanghai Medical College", "Part3": "Fudan University", "Part4": "Shanghai 200032", "Part5": "China.", "Part6": null, "Text": "Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China."}], "ForeName": "Xiaowei", "FullName": "Xiaowei Zhang", "HashID": "631873743125935899", "LastName": "Zhang", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-141699806890284170", "Part1": "Department of Medical Oncology", "Part2": "Fudan University Shanghai Cancer Center", "Part3": "Shanghai 200032", "Part4": "China.", "Part5": null, "Part6": null, "Text": "Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China."}, {"Has_Extra": false, "HashID": "-6705189804931625827", "Part1": "Department of Oncology", "Part2": "Shanghai Medical College", "Part3": "Fudan University", "Part4": "Shanghai 200032", "Part5": "China.", "Part6": null, "Text": "Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China."}], "ForeName": "Weijian", "FullName": "Weijian Guo", "HashID": "-2866734874591003181", "LastName": "Guo", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.1093/abbs/gmz166", "InsertType": null, "Journal": "Acta biochimica et biophysica Sinica", "Keywords": [{"IS_Major": false, "IS_Mesh": true, "Text": "3' Untranslated Regions"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Adaptor Proteins, Signal Transducing"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Adult"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Aged"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Aged, 80 and over"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Cell Line, Tumor"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Cell Movement"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Down-Regulation"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Epithelial-Mesenchymal Transition"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Female"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Humans"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Male"}, {"IS_Major": false, "IS_Mesh": true, "Text": "MicroRNAs"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Middle Aged"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Neoplasm Metastasis"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Neoplastic Stem Cells"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Prognosis"}, {"IS_Major": false, "IS_Mesh": true, "Text": "RNA Interference"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Signal Transduction"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Stomach Neoplasms"}, {"IS_Major": false, "IS_Mesh": true, "Text": "rac1 GTP-Binding Protein"}, {"IS_Major": false, "IS_Mesh": false, "Text": "EPS8"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Rac1"}, {"IS_Major": false, "IS_Mesh": false, "Text": "gastric cancer"}, {"IS_Major": false, "IS_Mesh": false, "Text": "metastasis"}, {"IS_Major": false, "IS_Mesh": false, "Text": "miR-345"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "MEDLINE", "Article": {"@PubModel": "Print", "Abstract": {"AbstractText": "Tumor metastasis is the main cause of treatment failure and death in patients with late stage of gastric cancer (GC). Studies showed that microRNAs (miRNAs) are important regulators in the process of tumor metastasis. In this study, we used miRNA array analysis to search for metastasis-associated miRNAs in primary and matched metastasis tissues of patients with GC and found that miR-345-5p (miR-345) was significantly higher in primary sites. Decreased expression of miR-345 was observed in GC tissues and cell lines, which was correlated with aggressive stage and grade. Patients with a higher level of miR-345 had a better prognosis. miR-345 could inhibit the migration and spheroid formation abilities in GC cell lines in transwell assay and spheroid formation assay. RNA sequencing and bioinformatics analysis revealed that miR-345 downregulated the epidermal growth factor receptor pathway substrate 8 (EPS8) and its downstream Rac1 signaling. Mechanistically, we confirmed that miR-345 could target EPS8 by directly binding to its 3' untranslated region by luciferase reporter assay. Further rescue assay showed that the ability of miR-345 in inhibiting the migration, stem-like cell phenotype, and epithelial-mesenchymal transition (EMT) in GC was partly dependent on targeting EPS8. In conclusion, miR-345 plays an inhibitory role in GC metastasis through inhibiting cell migration, EMT, and cancer stem cell phenotype via inactivation of Rac1 signaling by targeting EPS8, which provides the potential therapeutic and predictive value of miR-345 in GC.", "CopyrightInformation": "\u00a9 The Author(s) 2020. Published by Oxford University Press on behalf of the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. All rights reserved. For permissions, please email: journals.permissions@oup.com."}, "ArticleTitle": "miR-345 inhibits migration and stem-like cell phenotype in gastric cancer via inactivation of Rac1 by targeting EPS8.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China."}, {"Affiliation": "Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China."}], "ForeName": "Jieyun", "Initials": "J", "LastName": "Zhang"}, {"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China."}, {"Affiliation": "Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China."}], "ForeName": "Chenchen", "Initials": "C", "LastName": "Wang"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Surgery, Huashan Hospital, Fudan University, Shanghai 200040, China."}, "ForeName": "Shican", "Initials": "S", "LastName": "Yan"}, {"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China."}, {"Affiliation": "Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China."}], "ForeName": "Yanan", "Initials": "Y", "LastName": "Yang"}, {"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China."}, {"Affiliation": "Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China."}], "ForeName": "Xiaowei", "Initials": "X", "LastName": "Zhang"}, {"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China."}, {"Affiliation": "Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China."}], "ForeName": "Weijian", "Initials": "W", "LastName": "Guo"}]}, "ELocationID": {"#text": "10.1093/abbs/gmz166", "@EIdType": "doi", "@ValidYN": "Y"}, "Journal": {"ISOAbbreviation": "Acta Biochim Biophys Sin (Shanghai)", "ISSN": {"#text": "1745-7270", "@IssnType": "Electronic"}, "JournalIssue": {"@CitedMedium": "Internet", "Issue": "3", "PubDate": {"Day": "18", "Month": "Mar", "Year": "2020"}, "Volume": "52"}, "Title": "Acta biochimica et biophysica Sinica"}, "Language": "eng", "Pagination": {"EndPage": "267", "MedlinePgn": "259-267", "StartPage": "259"}, "PublicationTypeList": {"PublicationType": {"#text": "Journal Article", "@UI": "D016428"}}}, "ChemicalList": {"Chemical": [{"NameOfSubstance": {"#text": "3' Untranslated Regions", "@UI": "D020413"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "Adaptor Proteins, Signal Transducing", "@UI": "D048868"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "EPS8 protein, human", "@UI": "C489989"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "MIRN345 microRNA, human", "@UI": "C561417"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "MicroRNAs", "@UI": "D035683"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "RAC1 protein, human", "@UI": "C107953"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "rac1 GTP-Binding Protein", "@UI": "D020830"}, "RegistryNumber": "EC 3.6.5.2"}]}, "CitationSubset": "IM", "DateCompleted": {"Day": "17", "Month": "12", "Year": "2020"}, "DateRevised": {"Day": "17", "Month": "12", "Year": "2020"}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"#text": "EPS8", "@MajorTopicYN": "N"}, {"#text": "Rac1", "@MajorTopicYN": "N"}, {"#text": "gastric cancer", "@MajorTopicYN": "N"}, {"#text": "metastasis", "@MajorTopicYN": "N"}, {"#text": "miR-345", "@MajorTopicYN": "N"}]}, "MedlineJournalInfo": {"Country": "China", "ISSNLinking": "1672-9145", "MedlineTA": "Acta Biochim Biophys Sin (Shanghai)", "NlmUniqueID": "101206716"}, "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"#text": "3' Untranslated Regions", "@MajorTopicYN": "N", "@UI": "D020413"}}, {"DescriptorName": {"#text": "Adaptor Proteins, Signal Transducing", "@MajorTopicYN": "N", "@UI": "D048868"}, "QualifierName": [{"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}, {"#text": "metabolism", "@MajorTopicYN": "Y", "@UI": "Q000378"}]}, {"DescriptorName": {"#text": "Adult", "@MajorTopicYN": "N", "@UI": "D000328"}}, {"DescriptorName": {"#text": "Aged", "@MajorTopicYN": "N", "@UI": "D000368"}}, {"DescriptorName": {"#text": "Aged, 80 and over", "@MajorTopicYN": "N", "@UI": "D000369"}}, {"DescriptorName": {"#text": "Cell Line, Tumor", "@MajorTopicYN": "N", "@UI": "D045744"}}, {"DescriptorName": {"#text": "Cell Movement", "@MajorTopicYN": "N", "@UI": "D002465"}, "QualifierName": {"#text": "physiology", "@MajorTopicYN": "N", "@UI": "Q000502"}}, {"DescriptorName": {"#text": "Down-Regulation", "@MajorTopicYN": "N", "@UI": "D015536"}}, {"DescriptorName": {"#text": "Epithelial-Mesenchymal Transition", "@MajorTopicYN": "N", "@UI": "D058750"}}, {"DescriptorName": {"#text": "Female", "@MajorTopicYN": "N", "@UI": "D005260"}}, {"DescriptorName": {"#text": "Humans", "@MajorTopicYN": "N", "@UI": "D006801"}}, {"DescriptorName": {"#text": "Male", "@MajorTopicYN": "N", "@UI": "D008297"}}, {"DescriptorName": {"#text": "MicroRNAs", "@MajorTopicYN": "N", "@UI": "D035683"}, "QualifierName": [{"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}, {"#text": "metabolism", "@MajorTopicYN": "Y", "@UI": "Q000378"}]}, {"DescriptorName": {"#text": "Middle Aged", "@MajorTopicYN": "N", "@UI": "D008875"}}, {"DescriptorName": {"#text": "Neoplasm Metastasis", "@MajorTopicYN": "N", "@UI": "D009362"}}, {"DescriptorName": {"#text": "Neoplastic Stem Cells", "@MajorTopicYN": "N", "@UI": "D014411"}, "QualifierName": [{"#text": "metabolism", "@MajorTopicYN": "N", "@UI": "Q000378"}, {"#text": "pathology", "@MajorTopicYN": "N", "@UI": "Q000473"}]}, {"DescriptorName": {"#text": "Prognosis", "@MajorTopicYN": "N", "@UI": "D011379"}}, {"DescriptorName": {"#text": "RNA Interference", "@MajorTopicYN": "N", "@UI": "D034622"}}, {"DescriptorName": {"#text": "Signal Transduction", "@MajorTopicYN": "N", "@UI": "D015398"}}, {"DescriptorName": {"#text": "Stomach Neoplasms", "@MajorTopicYN": "N", "@UI": "D013274"}, "QualifierName": [{"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}, {"#text": "metabolism", "@MajorTopicYN": "Y", "@UI": "Q000378"}, {"#text": "pathology", "@MajorTopicYN": "N", "@UI": "Q000473"}]}, {"DescriptorName": {"#text": "rac1 GTP-Binding Protein", "@MajorTopicYN": "N", "@UI": "D020830"}, "QualifierName": [{"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}, {"#text": "metabolism", "@MajorTopicYN": "Y", "@UI": "Q000378"}]}]}, "PMID": {"#text": "32147678", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "32147678", "@IdType": "pubmed"}, {"#text": "10.1093/abbs/gmz166", "@IdType": "doi"}, {"#text": "5788694", "@IdType": "pii"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "received", "Day": "10", "Month": "8", "Year": "2019"}, {"@PubStatus": "revised", "Day": "18", "Month": "11", "Year": "2019"}, {"@PubStatus": "accepted", "Day": "27", "Month": "12", "Year": "2019"}, {"@PubStatus": "pubmed", "Day": "10", "Hour": "6", "Minute": "0", "Month": "3", "Year": "2020"}, {"@PubStatus": "medline", "Day": "18", "Hour": "6", "Minute": "0", "Month": "12", "Year": "2020"}, {"@PubStatus": "entrez", "Day": "10", "Hour": "6", "Minute": "0", "Month": "3", "Year": "2020"}]}, "PublicationStatus": "ppublish"}}}}, "PMC": null, "PMID": "32147678", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "miR-345 inhibits migration and stem-like cell phenotype in gastric cancer via inactivation of Rac1 by targeting EPS8.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "21": {"Abstract": " MiRNAs might function as oncogenes or tumor suppressor genes in the tumorigenesis process. Dysregulation of miR-345 is a frequent event in many types of human cancers. However, the tissue miR-345 expression level in non-small cell lung cancer (NSCLC) and its potential clinical significance remains unknown. Real-time PCR was conducted to evaluate the expression level of miR-345 in NSCLC tissues as well as cell lines. Then the association between tissue miR-345 expression level and clinical outcome was investigated. The expression level of miR-345 was significantly decreased in NSCLC tissues and cell lines compared with the controls (P<0.05; P<0.01). Tissue miR-345 expression level was associated with various clinicopathological parameters including LN metastasis (P=0.012), distant metastasis (P=0.007), TNM stage (P=0.008) and grade (P=0.030). In addition, the NSCLC patients in thelow tissue miR-345 expression group had significantly shorter 5-year overall survival time than those in the high tissue miR-345expression group (P=0.016). Multivariate analysis showed that tissue miR-345 was an independent risk factor for NSCLC (HR=3.921, 95% CI: 2.285-10.540; P=0.008). The expression level of miR-345 was reduced in NSCLC tissues and cell lines. Low tissue miR-345 expression was associated with progression and poor prognosis of NSCLC, indicating that tissue miR-345 may serve as a novel prognostic marker in NSCLC.", "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "-2307802816061400313", "Part1": "Department of Oncology", "Part2": "The First Affiliated Hospital of Shantou University Medical College Shantou", "Part3": "Guangdong", "Part4": "China.", "Part5": null, "Part6": null, "Text": "Department of Oncology, The First Affiliated Hospital of Shantou University Medical College Shantou, Guangdong, China."}], "ForeName": "Liming", "FullName": "Liming Chen", "HashID": "9172708975237854903", "LastName": "Chen", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-2307802816061400313", "Part1": "Department of Oncology", "Part2": "The First Affiliated Hospital of Shantou University Medical College Shantou", "Part3": "Guangdong", "Part4": "China.", "Part5": null, "Part6": null, "Text": "Department of Oncology, The First Affiliated Hospital of Shantou University Medical College Shantou, Guangdong, China."}], "ForeName": "Xiaojie", "FullName": "Xiaojie Li", "HashID": "8896226722272801203", "LastName": "Li", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-2307802816061400313", "Part1": "Department of Oncology", "Part2": "The First Affiliated Hospital of Shantou University Medical College Shantou", "Part3": "Guangdong", "Part4": "China.", "Part5": null, "Part6": null, "Text": "Department of Oncology, The First Affiliated Hospital of Shantou University Medical College Shantou, Guangdong, China."}], "ForeName": "Xiaojun", "FullName": "Xiaojun Chen", "HashID": "-2806840616922717120", "LastName": "Chen", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": null, "InsertType": null, "Journal": "International journal of clinical and experimental medicine", "Keywords": [{"IS_Major": false, "IS_Mesh": false, "Text": "Biomarker"}, {"IS_Major": false, "IS_Mesh": false, "Text": "MiR-345"}, {"IS_Major": false, "IS_Mesh": false, "Text": "non-small cell lung cancer"}, {"IS_Major": false, "IS_Mesh": false, "Text": "prognosis"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "PubMed-not-MEDLINE", "Article": {"@PubModel": "Electronic-eCollection", "Abstract": {"AbstractText": [{"#text": "MiRNAs might function as oncogenes or tumor suppressor genes in the tumorigenesis process. Dysregulation of miR-345 is a frequent event in many types of human cancers. However, the tissue miR-345 expression level in non-small cell lung cancer (NSCLC) and its potential clinical significance remains unknown.", "@Label": "BACKGROUND", "@NlmCategory": "BACKGROUND"}, {"#text": "Real-time PCR was conducted to evaluate the expression level of miR-345 in NSCLC tissues as well as cell lines. Then the association between tissue miR-345 expression level and clinical outcome was investigated.", "@Label": "MATERIALS AND METHODS", "@NlmCategory": "METHODS"}, {"#text": "The expression level of miR-345 was significantly decreased in NSCLC tissues and cell lines compared with the controls (P<0.05; P<0.01). Tissue miR-345 expression level was associated with various clinicopathological parameters including LN metastasis (P=0.012), distant metastasis (P=0.007), TNM stage (P=0.008) and grade (P=0.030). In addition, the NSCLC patients in thelow tissue miR-345 expression group had significantly shorter 5-year overall survival time than those in the high tissue miR-345expression group (P=0.016). Multivariate analysis showed that tissue miR-345 was an independent risk factor for NSCLC (HR=3.921, 95% CI: 2.285-10.540; P=0.008).", "@Label": "RESULTS", "@NlmCategory": "RESULTS"}, {"#text": "The expression level of miR-345 was reduced in NSCLC tissues and cell lines. Low tissue miR-345 expression was associated with progression and poor prognosis of NSCLC, indicating that tissue miR-345 may serve as a novel prognostic marker in NSCLC.", "@Label": "CONCLUSIONS", "@NlmCategory": "CONCLUSIONS"}]}, "ArticleDate": {"@DateType": "Electronic", "Day": "15", "Month": "11", "Year": "2015"}, "ArticleTitle": "Prognostic significance of tissue miR-345 downregulation in non-small cell lung cancer.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Oncology, The First Affiliated Hospital of Shantou University Medical College Shantou, Guangdong, China."}, "ForeName": "Liming", "Initials": "L", "LastName": "Chen"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Oncology, The First Affiliated Hospital of Shantou University Medical College Shantou, Guangdong, China."}, "ForeName": "Xiaojie", "Initials": "X", "LastName": "Li"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Oncology, The First Affiliated Hospital of Shantou University Medical College Shantou, Guangdong, China."}, "ForeName": "Xiaojun", "Initials": "X", "LastName": "Chen"}]}, "Journal": {"ISOAbbreviation": "Int J Clin Exp Med", "ISSN": {"#text": "1940-5901", "@IssnType": "Print"}, "JournalIssue": {"@CitedMedium": "Print", "Issue": "11", "PubDate": {"Year": "2015"}, "Volume": "8"}, "Title": "International journal of clinical and experimental medicine"}, "Language": "eng", "Pagination": {"EndPage": "20976", "MedlinePgn": "20971-6", "StartPage": "20971"}, "PublicationTypeList": {"PublicationType": {"#text": "Journal Article", "@UI": "D016428"}}}, "DateCompleted": {"Day": "17", "Month": "02", "Year": "2016"}, "DateRevised": {"Day": "30", "Month": "09", "Year": "2020"}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"#text": "Biomarker", "@MajorTopicYN": "N"}, {"#text": "MiR-345", "@MajorTopicYN": "N"}, {"#text": "non-small cell lung cancer", "@MajorTopicYN": "N"}, {"#text": "prognosis", "@MajorTopicYN": "N"}]}, "MedlineJournalInfo": {"Country": "United States", "ISSNLinking": "1940-5901", "MedlineTA": "Int J Clin Exp Med", "NlmUniqueID": "101471010"}, "PMID": {"#text": "26885027", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "26885027", "@IdType": "pubmed"}, {"#text": "PMC4723872", "@IdType": "pmc"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "received", "Day": "1", "Month": "9", "Year": "2015"}, {"@PubStatus": "accepted", "Day": "5", "Month": "11", "Year": "2015"}, {"@PubStatus": "entrez", "Day": "18", "Hour": "6", "Minute": "0", "Month": "2", "Year": "2016"}, {"@PubStatus": "pubmed", "Day": "18", "Hour": "6", "Minute": "0", "Month": "2", "Year": "2016"}, {"@PubStatus": "medline", "Day": "18", "Hour": "6", "Minute": "1", "Month": "2", "Year": "2016"}]}, "PublicationStatus": "epublish", "ReferenceList": {"Reference": [{"ArticleIdList": {"ArticleId": {"#text": "24399786", "@IdType": "pubmed"}}, "Citation": "Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9\u201329."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4212620", "@IdType": "pmc"}, {"#text": "25401087", "@IdType": "pubmed"}]}, "Citation": "Wink KC, Roelofs E, Solberg T, Lin L, Simone CB 2nd, Jakobi A, Richter C, Lambin P, Troost EG. Particle therapy for non-small cell lung tumors: where do we stand? A systematic review of the literature. Front Oncol. 2014;4:292."}, {"ArticleIdList": {"ArticleId": {"#text": "16885332", "@IdType": "pubmed"}}, "Citation": "Calin GA, Croce CM. MicroRNA-cancer connection: the beginning of a new tale. Cancer Res. 2006;66:7390\u20137394."}, {"ArticleIdList": {"ArticleId": {"#text": "18167339", "@IdType": "pubmed"}}, "Citation": "Yu SL, Chen HY, Chang GC, Chen CY, Chen HW, Singh S, Cheng CL, Yu CJ, Lee YC, Chen HS, Su TJ, Chiang CC, Li HN, Hong QS, Su HY, Chen CC, Chen WJ, Liu CC, Chan WK, Chen WJ, Li KC, Chen JJ, Yang PC. MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell. 2008;13:48\u201357."}, {"ArticleIdList": {"ArticleId": {"#text": "16530703", "@IdType": "pubmed"}}, "Citation": "Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM, Harris CC. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell. 2006;9:189\u2013198."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5378885", "@IdType": "pmc"}, {"#text": "26202143", "@IdType": "pubmed"}]}, "Citation": "Nadal E, Truini A, Nakata A, Lin J, Reddy RM, Chang AC, Ramnath N, Gotoh N, Beer DG, Chen G. A novel serum 4-microRNA signature for lung cancer detection. Sci Rep. 2015;5:12464."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4453672", "@IdType": "pmc"}, {"#text": "25867273", "@IdType": "pubmed"}]}, "Citation": "Mavridis K, Gueugnon F, Petit-Courty A, Courty Y, Barascu A, Guyetant S, Scorilas A. The oncomiR miR-197 is a novel prognostic indicator for non-small cell lung cancer patients. Br J Cancer. 2015;112:1527\u20131535."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4043973", "@IdType": "pmc"}, {"#text": "24893170", "@IdType": "pubmed"}]}, "Citation": "Wang SY, Shiboski S, Belair CD, Cooperberg MR, Simko JP, Stoppler H, Cowan J, Carroll PR, Blelloch R. miR-19, miR-345, miR-519c-5p serum levels predict adverse pathology in prostate cancer patients eligible for active surveillance. PLoS One. 2014;9:e98597."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4357086", "@IdType": "pmc"}, {"#text": "25767621", "@IdType": "pubmed"}]}, "Citation": "Kaur S, Lotsari JE, Al-Sohaily S, Warusavitarne J, Kohonen-Corish MR, Peltom\u00e4ki P. Identification of subgroup-specific miRNA patterns by epigenetic profiling of sporadic and Lynch syndrome-associated colorectal and endometrial carcinoma. Clin Epigenetics. 2015;7:20."}, {"ArticleIdList": {"ArticleId": {"#text": "23970374", "@IdType": "pubmed"}}, "Citation": "Li X, Li D, Zhuang Y, Shi Q, Wei W, Ju X. Overexpression of miR-708 and its targets in the childhood common precursor B-cell ALL. Pediatr Blood Cancer. 2013;60:2060\u20132067."}, {"ArticleIdList": {"ArticleId": {"#text": "20708002", "@IdType": "pubmed"}}, "Citation": "Melo SA, Esteller M. Dysregulation of microRNAs in cancer: playing with fire. FEBS Lett. 2011;585:2087\u20132099."}, {"ArticleIdList": {"ArticleId": {"#text": "19464788", "@IdType": "pubmed"}}, "Citation": "Ruan K, Fang X, Ouyang G. MicroRNAs: novel regulators in the hallmarks of human cancer. Cancer Lett. 2009;285:116\u2013126."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4647691", "@IdType": "pmc"}, {"#text": "26158421", "@IdType": "pubmed"}]}, "Citation": "Pichler M, Calin GA. MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients. Br J Cancer. 2015;113:569\u2013573."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4151750", "@IdType": "pmc"}, {"#text": "25114235", "@IdType": "pubmed"}]}, "Citation": "Xue W, Dahlman JE, Tammela T, Khan OF, Sood S, Dave A, Cai W, Chirino LM, Yang GR, Bronson R, Crowley DG, Sahay G, Schroeder A, Langer R, Anderson DG, Jacks T. Small RNA combination therapy for lung cancer. Proc Natl Acad Sci U S A. 2014;111:E3553\u20133561."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3808371", "@IdType": "pmc"}, {"#text": "24205215", "@IdType": "pubmed"}]}, "Citation": "Sun Z, Yu JT, Jiang T, Li MM, Tan L, Zhang Q, Tan L. Genome-wide microRNA profiling of rat hippocampus after status epilepticus induced by amygdala stimulation identifies modulators of neuronal apoptosis. PLoS One. 2013;8:e78375."}, {"ArticleIdList": {"ArticleId": {"#text": "24509687", "@IdType": "pubmed"}}, "Citation": "Mart\u00ednez-Ramos R, Garc\u00eda-Lozano JR, Lucena JM, Castillo-Palma MJ, Garc\u00eda-Hern\u00e1ndez F, Rodr\u00edguez MC, N\u00fa\u00f1ez-Rold\u00e1n A, Gonz\u00e1lez-Escribano MF. Differential expression pattern of microRNAs in CD4+ and CD19+ cells from asymptomatic patients with systemic lupus erythematosus. Lupus. 2014;23:353\u2013359."}, {"ArticleIdList": {"ArticleId": {"#text": "26227059", "@IdType": "pubmed"}}, "Citation": "Chen QG, Zhou W, Han T, Du SQ, Li ZH, Zhang Z, Shan GY, Kong CZ. MiR-345 suppresses proliferation, migration and invasion by targeting Smad1 in human prostate cancer. J Cancer Res Clin Oncol. 2015 [Epub ahead of print]"}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4647684", "@IdType": "pmc"}, {"#text": "26247574", "@IdType": "pubmed"}]}, "Citation": "Srivastava SK, Bhardwaj A, Arora S, Tyagi N, Singh S, Andrews J, McClellan S, Wang B, Singh AP. MicroRNA-345 induces apoptosis in pancreatic cancer cells through potentiation of caspase-dependent and -independent pathways. Br J Cancer. 2015;113:660\u2013668."}, {"ArticleIdList": {"ArticleId": {"#text": "21665895", "@IdType": "pubmed"}}, "Citation": "Tang JT, Wang JL, Du W, Hong J, Zhao SL, Wang YC, Xiong H, Chen HM, Fang JY. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer. Carcinogenesis. 2011;32:1207\u20131215."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4062472", "@IdType": "pmc"}, {"#text": "24940606", "@IdType": "pubmed"}]}, "Citation": "Schou JV, Rossi S, Jensen BV, Nielsen DL, Pfeiffer P, H\u00f8gdall E, Yilmaz M, Tejpar S, Delorenzi M, Kruh\u00f8ffer M, Johansen JS. miR-345 in metastatic colorectal cancer: a non-invasive biomarker for clinical outcome in non-KRAS mutant patients treated with 3rd line cetuximab and irinotecan. PLoS One. 2014;9:e99886."}, {"ArticleIdList": {"ArticleId": {"#text": "24020903", "@IdType": "pubmed"}}, "Citation": "Brito JA, Gomes CC, Guimar\u00e3es AL, Campos K, Gomez RS. Relationship between microRNA expression levels and histopathological features of dysplasia in oral leukoplakia. J Oral Pathol Med. 2014;43:211\u2013216."}, {"ArticleIdList": {"ArticleId": {"#text": "19396864", "@IdType": "pubmed"}}, "Citation": "Guled M, Lahti L, Lindholm PM, Salmenkivi K, Bagwan I, Nicholson AG, Knuutila S. CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma-A miRNA microarray analysis. Genes Chromosomes Cancer. 2009;48:615\u2013623."}]}}}}}, "PMC": "PMC4723872", "PMID": "26885027", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "Prognostic significance of tissue miR-345 downregulation in non-small cell lung cancer.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "22": {"Abstract": "Non-small cell lung cancer (NSCLC) accounts for about 85% of all lung cancer cases. The pathogenesis of NSCLC involves complex gene networks that include different types of non-coding RNAs, such as long non-coding RNAs (lncRNAs). The role of lncRNAs in NSCLC is gaining an increasing interest as their function is being explored in various human cancers. Recently, a new oncogenic lncRNA, LINC00152 (cytoskeleton regulator RNA (CYTOR)), has been identified in different tumor types. In NSCLC, the high expression of LINC00152 in tumor tissue and peripheral blood samples has been shown to be associated with worse prognoses of NSCLC patients. Overexpression of LINC00152 has been confirmed to promote the proliferation, invasion, and migration of NSCLC cells in vitro, as well as increase tumor growth in vivo. This review discusses the role of LINC00152 in NSCLC.", "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "-898762260767538288", "Part1": "Cell Biology Laboratory", "Part2": "Jilin Province Institute of Cancer Prevention and Treatment", "Part3": "Jilin Cancer Hospital", "Part4": "Changchun 130012", "Part5": "China.", "Part6": null, "Text": "Cell Biology Laboratory, Jilin Province Institute of Cancer Prevention and Treatment, Jilin Cancer Hospital, Changchun 130012, China."}], "ForeName": "Hong", "FullName": "Hong Yu", "HashID": "-3392617226330994628", "LastName": "Yu", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "8754991636222405997", "Part1": "Department of Internal Medicine", "Part2": "Southern Branch of Guang'anmen Hospital", "Part3": "China Academy of Chinese Medical Sciences", "Part4": "Beijing 102600", "Part5": "China.", "Part6": null, "Text": "Department of Internal Medicine, Southern Branch of Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 102600, China."}], "ForeName": "Shu-Bin", "FullName": "Shu-Bin Li", "HashID": "5874368185586881186", "LastName": "Li", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.1631/jzus.B1900312", "InsertType": null, "Journal": "Journal of Zhejiang University. Science. B", "Keywords": [{"IS_Major": false, "IS_Mesh": true, "Text": "Apoptosis"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Biomarkers, Tumor"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Carcinoma, Non-Small-Cell Lung"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Cell Cycle Checkpoints"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Computational Biology"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Epithelial-Mesenchymal Transition"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Humans"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Lung Neoplasms"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Prognosis"}, {"IS_Major": false, "IS_Mesh": true, "Text": "RNA, Long Noncoding"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Radiation Tolerance"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Long non-coding RNA; LINC00152; Non-small cell lung cancer; Proliferation; Prognosis"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "MEDLINE", "Article": {"@PubModel": "Print", "Abstract": {"AbstractText": "Non-small cell lung cancer (NSCLC) accounts for about 85% of all lung cancer cases. The pathogenesis of NSCLC involves complex gene networks that include different types of non-coding RNAs, such as long non-coding RNAs (lncRNAs). The role of lncRNAs in NSCLC is gaining an increasing interest as their function is being explored in various human cancers. Recently, a new oncogenic lncRNA, LINC00152 (cytoskeleton regulator RNA (CYTOR)), has been identified in different tumor types. In NSCLC, the high expression of LINC00152 in tumor tissue and peripheral blood samples has been shown to be associated with worse prognoses of NSCLC patients. Overexpression of LINC00152 has been confirmed to promote the proliferation, invasion, and migration of NSCLC cells in vitro, as well as increase tumor growth in vivo. This review discusses the role of LINC00152 in NSCLC."}, "ArticleTitle": "Role of LINC00152 in non-small cell lung cancer.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Cell Biology Laboratory, Jilin Province Institute of Cancer Prevention and Treatment, Jilin Cancer Hospital, Changchun 130012, China."}, "ForeName": "Hong", "Initials": "H", "LastName": "Yu"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Internal Medicine, Southern Branch of Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 102600, China."}, "ForeName": "Shu-Bin", "Initials": "SB", "LastName": "Li"}]}, "ELocationID": {"#text": "10.1631/jzus.B1900312", "@EIdType": "doi", "@ValidYN": "Y"}, "Journal": {"ISOAbbreviation": "J Zhejiang Univ Sci B", "ISSN": {"#text": "1862-1783", "@IssnType": "Electronic"}, "JournalIssue": {"@CitedMedium": "Internet", "Issue": "3", "PubDate": {"MedlineDate": "2020 Mar."}, "Volume": "21"}, "Title": "Journal of Zhejiang University. Science. B"}, "Language": "eng", "Pagination": {"EndPage": "191", "MedlinePgn": "179-191", "StartPage": "179"}, "PublicationTypeList": {"PublicationType": {"#text": "Journal Article", "@UI": "D016428"}}}, "ChemicalList": {"Chemical": [{"NameOfSubstance": {"#text": "Biomarkers, Tumor", "@UI": "D014408"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "RNA, Long Noncoding", "@UI": "D062085"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "long non-coding RNA Linc00152, human", "@UI": "C000608524"}, "RegistryNumber": "0"}]}, "CitationSubset": "IM", "CoiStatement": {"#text": "Hong YU and Shu-bin LI declare that they have no conflict of interest. This article does not contain any studies with human or animal subjects performed by either of the authors.", "b": "Compliance with ethics guidelines:"}, "DateCompleted": {"Day": "07", "Month": "01", "Year": "2021"}, "DateRevised": {"Day": "07", "Month": "01", "Year": "2021"}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": {"#text": "Long non-coding RNA; LINC00152; Non-small cell lung cancer; Proliferation; Prognosis", "@MajorTopicYN": "N"}}, "MedlineJournalInfo": {"Country": "China", "ISSNLinking": "1673-1581", "MedlineTA": "J Zhejiang Univ Sci B", "NlmUniqueID": "101236535"}, "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"#text": "Apoptosis", "@MajorTopicYN": "N", "@UI": "D017209"}}, {"DescriptorName": {"#text": "Biomarkers, Tumor", "@MajorTopicYN": "N", "@UI": "D014408"}, "QualifierName": {"#text": "blood", "@MajorTopicYN": "N", "@UI": "Q000097"}}, {"DescriptorName": {"#text": "Carcinoma, Non-Small-Cell Lung", "@MajorTopicYN": "N", "@UI": "D002289"}, "QualifierName": [{"#text": "etiology", "@MajorTopicYN": "Y", "@UI": "Q000209"}, {"#text": "mortality", "@MajorTopicYN": "N", "@UI": "Q000401"}, {"#text": "pathology", "@MajorTopicYN": "N", "@UI": "Q000473"}, {"#text": "radiotherapy", "@MajorTopicYN": "N", "@UI": "Q000532"}]}, {"DescriptorName": {"#text": "Cell Cycle Checkpoints", "@MajorTopicYN": "N", "@UI": "D059447"}}, {"DescriptorName": {"#text": "Computational Biology", "@MajorTopicYN": "N", "@UI": "D019295"}}, {"DescriptorName": {"#text": "Epithelial-Mesenchymal Transition", "@MajorTopicYN": "N", "@UI": "D058750"}}, {"DescriptorName": {"#text": "Humans", "@MajorTopicYN": "N", "@UI": "D006801"}}, {"DescriptorName": {"#text": "Lung Neoplasms", "@MajorTopicYN": "N", "@UI": "D008175"}, "QualifierName": [{"#text": "etiology", "@MajorTopicYN": "Y", "@UI": "Q000209"}, {"#text": "mortality", "@MajorTopicYN": "N", "@UI": "Q000401"}, {"#text": "pathology", "@MajorTopicYN": "N", "@UI": "Q000473"}, {"#text": "radiotherapy", "@MajorTopicYN": "N", "@UI": "Q000532"}]}, {"DescriptorName": {"#text": "Prognosis", "@MajorTopicYN": "N", "@UI": "D011379"}}, {"DescriptorName": {"#text": "RNA, Long Noncoding", "@MajorTopicYN": "N", "@UI": "D062085"}, "QualifierName": [{"#text": "blood", "@MajorTopicYN": "N", "@UI": "Q000097"}, {"#text": "physiology", "@MajorTopicYN": "Y", "@UI": "Q000502"}]}, {"DescriptorName": {"#text": "Radiation Tolerance", "@MajorTopicYN": "N", "@UI": "D011836"}}]}, "PMID": {"#text": "32133796", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "32133796", "@IdType": "pubmed"}, {"#text": "PMC7086013", "@IdType": "pmc"}, {"#text": "10.1631/jzus.B1900312", "@IdType": "doi"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "entrez", "Day": "6", "Hour": "6", "Minute": "0", "Month": "3", "Year": "2020"}, {"@PubStatus": "pubmed", "Day": "7", "Hour": "6", "Minute": "0", "Month": "3", "Year": "2020"}, {"@PubStatus": "medline", "Day": "8", "Hour": "6", "Minute": "0", "Month": "1", "Year": "2021"}]}, "PublicationStatus": "ppublish", "ReferenceList": {"Reference": [{"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature24049", "@IdType": "doi"}, {"#text": "PMC5706658", "@IdType": "pmc"}, {"#text": "28976959", "@IdType": "pubmed"}]}, "Citation": "Abudayyeh OO, Gootenberg JS, Essletzbichler P, et al. RNA targeting with CRISPR-Cas13. Nature. 2017;550(7675):280\u2013284. doi: 10.1038/nature24049."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.molmed.2018.01.001", "@IdType": "doi"}, {"#text": "PMC5840027", "@IdType": "pmc"}, {"#text": "29449148", "@IdType": "pubmed"}]}, "Citation": "Arun G, Diermeier SD, Spector DL. Therapeutic targeting of long non-coding RNAs in cancer. Trends Mol Med. 2018;24(3):257\u2013277. doi: 10.1016/j.molmed.2018.01.001."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/0008-5472.CAN-16-2634", "@IdType": "doi"}, {"#text": "28701486", "@IdType": "pubmed"}]}, "Citation": "Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: a new paradigm. Cancer Res. 2017;77(15):3965\u20133981. doi: 10.1158/0008-5472.CAN-16-2634."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41389-017-0008-4", "@IdType": "doi"}, {"#text": "PMC5868057", "@IdType": "pmc"}, {"#text": "29180678", "@IdType": "pubmed"}]}, "Citation": "Bian ZH, Zhang JW, Li M, et al. Long non-coding RNA LINC00152 promotes cell proliferation, metastasis, and confers 5-FU resistance in colorectal cancer by inhibiting miR-139-5p. Oncogenesis. 2017;6(11):395. doi: 10.1038/s41389-017-0008-4."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s11060-018-2951-0", "@IdType": "doi"}, {"#text": "30043319", "@IdType": "pubmed"}]}, "Citation": "Cai JQ, Zhang JW, Wu PF, et al. Blocking LINC00152 suppresses glioblastoma malignancy by impairing mesenchymal phenotype through the miR-612/AKT2/NF-\u03baB pathway. J Neuro-Oncol. 2018;140(2):225\u2013236. doi: 10.1007/s11060-018-2951-0."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5095302", "@IdType": "pmc"}, {"#text": "27829993", "@IdType": "pubmed"}]}, "Citation": "Cai Q, Wang ZQ, Wang SH, et al. Upregulation of long non-coding RNA LINC00152 by SP1 contributes to gallbladder cancer cell growth and tumor metastasis via PI3K/AKT pathway. Am J Transl Res. 2016;8(10):4068\u20134081."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1098/rsob.160247", "@IdType": "doi"}, {"#text": "PMC5303272", "@IdType": "pmc"}, {"#text": "28077595", "@IdType": "pubmed"}]}, "Citation": "Cai Q, Wang ZQ, Wang SH, et al. Long non-coding RNA LINC00152 promotes gallbladder cancer metastasis and epithelial-mesenchymal transition by regulating HIF-1\u03b1 via miR-138. Open Biol. 2017;7(1):160247. doi: 10.1098/rsob.160247."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5308740", "@IdType": "pmc"}, {"#text": "27566568", "@IdType": "pubmed"}]}, "Citation": "Chen J, Zhang K, Song HZ, et al. Long noncoding RNA CCAT1 acts as an oncogene and promotes chemoresistance in docetaxel-resistant lung adenocarcinoma cells. Oncotarget. 2016;7(38):62474\u201362489."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1097/cad.0000000000000725", "@IdType": "doi"}, {"#text": "30543527", "@IdType": "pubmed"}]}, "Citation": "Chen MW, Xu XN, Ma HQ. Identification of oncogenic long noncoding RNAs CASC9 and LINC00152 in oral carcinoma through genome-wide comprehensive analysis. Anti-Cancer Drugs. 2019;30(4):356\u2013362. doi: 10.1097/cad.0000000000000725."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/cam4.1547", "@IdType": "doi"}, {"#text": "PMC6144155", "@IdType": "pmc"}, {"#text": "30030896", "@IdType": "pubmed"}]}, "Citation": "Chen PX, Fang XL, Xia B, et al. Long noncoding RNA LINC00152 promotes cell proliferation through competitively binding endogenous miR-125b with MCL-1 by regulating mitochondrial apoptosis pathways in ovarian cancer. Cancer Med. 2018;7(9):4530\u20134541. doi: 10.1002/cam4.1547."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12943-017-0581-3", "@IdType": "doi"}, {"#text": "PMC5251237", "@IdType": "pmc"}, {"#text": "28109288", "@IdType": "pubmed"}]}, "Citation": "Chen QN, Chen X, Chen ZY, et al. Long intergenic non-coding RNA 00152 promotes lung adenocarcinoma proliferation via interacting with EZH2 and repressing IL24 expression. Mol Cancer. 2017;16(1):17. doi: 10.1186/s12943-017-0581-3."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4891083", "@IdType": "pmc"}, {"#text": "26799422", "@IdType": "pubmed"}]}, "Citation": "Chen WM, Huang MD, Sun DP, et al. Long intergenic non-coding RNA 00152 promotes tumor cell cycle progression by binding to EZH2 and repressing p15 and p21 in gastric cancer. Oncotarget. 2016;7(9):9773\u20139787."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1159/000488836", "@IdType": "doi"}, {"#text": "29669323", "@IdType": "pubmed"}]}, "Citation": "Chen X, Li DH, Gao Y, et al. Long intergenic noncoding RNA 00152 promotes glioma cell proliferation and invasion by interacting with miR-16. Cell Physiol Biochem. 2018;46(3):1055\u20131064. doi: 10.1159/000488836."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/bib/bby055", "@IdType": "doi"}, {"#text": "PMC6917221", "@IdType": "pmc"}, {"#text": "30010717", "@IdType": "pubmed"}]}, "Citation": "Choi SW, Kim HW, Nam JW. The small peptide world in long noncoding RNAs. Brief Bioinf. 2019;20(5):1853\u20131864. doi: 10.1093/bib/bby055."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature13385", "@IdType": "doi"}, {"#text": "PMC4231481", "@IdType": "pmc"}, {"#text": "25079552", "@IdType": "pubmed"}]}, "Citation": "Collisson EA, Campbell JD, Brooks AN, et al. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014;511(7511):543\u2013550. doi: 10.1038/nature13385."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1089/nat.2016.0656", "@IdType": "doi"}, {"#text": "PMC5372764", "@IdType": "pmc"}, {"#text": "28080221", "@IdType": "pubmed"}]}, "Citation": "Crooke ST. Molecular mechanisms of antisense oligonucleotides. Nucleic Acid Ther. 2017;27(2):70\u201377. doi: 10.1089/nat.2016.0656."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1042/bj20100323", "@IdType": "doi"}, {"#text": "20626350", "@IdType": "pubmed"}]}, "Citation": "Cuadrado A, Nebreda AR. Mechanisms and functions of p38 MAPK signalling. Biochem J. 2010;429(3):403\u2013417. doi: 10.1042/bj20100323."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/nar/gkx1081", "@IdType": "doi"}, {"#text": "PMC5753278", "@IdType": "pmc"}, {"#text": "29126249", "@IdType": "pubmed"}]}, "Citation": "Davis CA, Hitz BC, Sloan CA, et al. The encyclopedia of DNA elements (ENCODE): data portal update. Nucleic Acids Res. 2018;46(D1):D794\u2013D801. doi: 10.1093/nar/gkx1081."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.biopha.2017.03.031", "@IdType": "doi"}, {"#text": "28343069", "@IdType": "pubmed"}]}, "Citation": "Deng X, Zhao XF, Liang XQ, et al. Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma. Biomed Pharmacother. 2017;90:100\u2013108. doi: 10.1016/j.biopha.2017.03.031."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.4161/21541272.2014.944014", "@IdType": "doi"}, {"#text": "PMC4581346", "@IdType": "pmc"}, {"#text": "25483404", "@IdType": "pubmed"}]}, "Citation": "Dey BK, Mueller AC, Dutta A. Long non-coding RNAs as emerging regulators of differentiation, development, and disease. Transcription. 2014;5(4):e944014. doi: 10.4161/21541272.2014.944014."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/0008-5472.CAN-16-2055", "@IdType": "doi"}, {"#text": "PMC5028108", "@IdType": "pmc"}, {"#text": "27635040", "@IdType": "pubmed"}]}, "Citation": "El-Deiry WS. p21(WAF1) mediates cell-cycle inhibition, relevant to cancer suppression and therapy. Cancer Res. 2016;76(18):5189\u20135191. doi: 10.1158/0008-5472.CAN-16-2055."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12885-019-5435-5", "@IdType": "doi"}, {"#text": "PMC6417110", "@IdType": "pmc"}, {"#text": "30866866", "@IdType": "pubmed"}]}, "Citation": "Esfandi F, Taheri M, Omrani MD, et al. Expression of long non-coding RNAs (lncRNAs) has been dysregulated in non-small cell lung cancer tissues. BMC Cancer, 19: 222. 2019 doi: 10.1186/s12885-019-5435-5."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.6004/jnccn.2015.0071", "@IdType": "doi"}, {"#text": "25964637", "@IdType": "pubmed"}]}, "Citation": "Ettinger DS, Wood D, Akerley W, et al. Non-small cell lung cancer, version 6.2015. J Natl Compr Canc Netw. 2015;13(5):515\u2013524. doi: 10.6004/jnccn.2015.0071."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrg3606", "@IdType": "doi"}, {"#text": "24296535", "@IdType": "pubmed"}]}, "Citation": "Fatica A, Bozzoni I. Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet. 2014;15(1):7\u201321. doi: 10.1038/nrg3606."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41598-017-03043-x", "@IdType": "doi"}, {"#text": "PMC5462773", "@IdType": "pmc"}, {"#text": "28592840", "@IdType": "pubmed"}]}, "Citation": "Feng SM, Zhang J, Su WM, et al. Overexpression of LINC00152 correlates with poor patient survival and knockdown impairs cell proliferation in lung cancer. Sci Rep. 2017;7(1):2982. doi: 10.1038/s41598-017-03043-x."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3389/fonc.2018.00293", "@IdType": "doi"}, {"#text": "PMC6103267", "@IdType": "pmc"}, {"#text": "30155440", "@IdType": "pubmed"}]}, "Citation": "Fidler MM, Bray F. Global cancer inequalities. Front Oncol, 8:293. 2018 doi: 10.3389/fonc.2018.00293."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1021/acsami.8b18288", "@IdType": "doi"}, {"#text": "30548064", "@IdType": "pubmed"}]}, "Citation": "Gong NQ, Teng XC, Li JH, et al. Antisense oligonucleotide-conjugated nanostructure-targeting lncRNA MALAT1 inhibits cancer metastasis. ACS Appl Mater Interfaces. 2019;11(1):37\u201342. doi: 10.1021/acsami.8b18288."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1631/jzus.B1900162", "@IdType": "doi"}, {"#text": "PMC6568220", "@IdType": "pmc"}, {"#text": "31090273", "@IdType": "pubmed"}]}, "Citation": "Gudenas BL, Wang J, Kuang SZ, et al. Genomic data mining for functional annotation of human long noncoding RNAs. J Zhejiang Univ-Sci B (Biomed & Biotechnol) 2019;20(6):476\u2013487. doi: 10.1631/jzus.B1900162."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/0008-5472.CAN-12-2850", "@IdType": "doi"}, {"#text": "PMC3589741", "@IdType": "pmc"}, {"#text": "23243023", "@IdType": "pubmed"}]}, "Citation": "Gutschner T, H\u00e4mmerle M, Ei\u00dfmann M, et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res. 2013;73(3):1180\u20131189. doi: 10.1158/0008-5472.CAN-12-2850."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1159/000452529", "@IdType": "doi"}, {"#text": "27855375", "@IdType": "pubmed"}]}, "Citation": "Hu HB, Jie HY, Zheng XX. Three circulating lncRNA predict early progress of esophageal squamous cell carcinoma. Cell Physiol Biochem. 2016;40(1-2):117\u2013125. doi: 10.1159/000452529."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s13277-015-4023-9", "@IdType": "doi"}, {"#text": "26453113", "@IdType": "pubmed"}]}, "Citation": "Hu XD, Bao JT, Wang Z, et al. The plasma lncRNA acting as fingerprint in non-small-cell lung cancer. Tumour Biol. 2016;37(3):3497\u20133504. doi: 10.1007/s13277-015-4023-9."}, {"ArticleIdList": {"ArticleId": {"#text": "29863253", "@IdType": "pubmed"}}, "Citation": "Hu XL, Wang J, He W, et al. Down-regulation of lncRNA Linc00152 suppressed cell viability, invasion, migration, and epithelial to mesenchymal transition, and reversed chemo-resistance in breast cancer cells. Eur Rev Med Pharmacol Sci. 2018;22(10):3074\u20133084."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1042/bsr20171607", "@IdType": "doi"}, {"#text": "PMC5938421", "@IdType": "pmc"}, {"#text": "29339419", "@IdType": "pubmed"}]}, "Citation": "Huang Y, Luo H, Li F, et al. LINC00152 down-regulated miR-193a-3p to enhance MCL1 expression and promote gastric cancer cells proliferation. Biosci Rep. 2018;38(3):BSR20171607. doi: 10.1042/bsr20171607."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4767473", "@IdType": "pmc"}, {"#text": "26540343", "@IdType": "pubmed"}]}, "Citation": "Ji J, Tang JW, Deng L, et al. LINC00152 promotes proliferation in hepatocellular carcinoma by targeting EpCAM via the mTOR signaling pathway. Oncotarget. 2015;6(40):42813\u201342824."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1159/000430387", "@IdType": "doi"}, {"#text": "26356260", "@IdType": "pubmed"}]}, "Citation": "Li J, Wang X, Tang J, et al. HULC and Linc00152 act as novel biomarkers in predicting diagnosis of hepatocellular carcinoma. Cell Physiol Biochem. 2015;37(2):687\u2013696. doi: 10.1159/000430387."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2147/ott.s168807", "@IdType": "doi"}, {"#text": "PMC6166755", "@IdType": "pmc"}, {"#text": "30310293", "@IdType": "pubmed"}]}, "Citation": "Li MH, Ning J, Li ZH, et al. LINC00152 promotes the growth and invasion of oral squamous cell carcinoma by regulating miR-139-5p. OncoTargets Ther. 2018;11:6295\u20136304. doi: 10.2147/ott.s168807."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1155/2017/7439698", "@IdType": "doi"}, {"#text": "PMC5742528", "@IdType": "pmc"}, {"#text": "29375177", "@IdType": "pubmed"}]}, "Citation": "Li ND, Feng XB, Tan Q, et al. Identification of circulating long noncoding RNA Linc00152 as a novel biomarker for diagnosis and monitoring of non-small-cell lung cancer. Disease markers, 2017:7439698. 2017 doi: 10.1155/2017/7439698."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s13277-014-2807-y", "@IdType": "doi"}, {"#text": "25391424", "@IdType": "pubmed"}]}, "Citation": "Li QE, Shao YF, Zhang XJ, et al. Plasma long noncoding RNA protected by exosomes as a potential stable biomarker for gastric cancer. Tumor Biol. 2015;36(3):2007\u20132012. doi: 10.1007/s13277-014-2807-y."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2147/ott.s160428", "@IdType": "doi"}, {"#text": "PMC5995430", "@IdType": "pmc"}, {"#text": "29922070", "@IdType": "pubmed"}]}, "Citation": "Li SH, Wen DC, Che ST, et al. Knockdown of long noncoding RNA 00152 (LINC00152) inhibits human retinoblastoma progression. OncoTargets Ther. 2018;11:3215\u20133223. doi: 10.2147/ott.s160428."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.biopha.2019.108654", "@IdType": "doi"}, {"#text": "30784933", "@IdType": "pubmed"}]}, "Citation": "Liu DL, Gao M, Wu K, et al. LINC00152 facilitates tumorigenesis in esophageal squamous cell carcinoma via miR-153-3p/FYN axis. Biomed Pharmacother, 112:108654. 2019 doi: 10.1016/j.biopha.2019.108654."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1371/journal.pone.0114586", "@IdType": "doi"}, {"#text": "PMC4439130", "@IdType": "pmc"}, {"#text": "25992654", "@IdType": "pubmed"}]}, "Citation": "Liu J, Wan L, Lu KH, et al. The long noncoding RNA MEG3 contributes to cisplatin resistance of human lung adenocarcinoma. PLoS ONE. 2015;10(5):e0114586. doi: 10.1371/journal.pone.0114586."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s11356-018-1784-x", "@IdType": "doi"}, {"#text": "29671226", "@IdType": "pubmed"}]}, "Citation": "Liu XZ, Yidayitula Y, Zhao H, et al. LncRNA LINC00152 promoted glioblastoma progression through targeting the miR-107 expression. Environ Sci Pollut Res. 2018;25(18):17674\u201317681. doi: 10.1007/s11356-018-1784-x."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1371/journal.pone.0077293", "@IdType": "doi"}, {"#text": "PMC3796503", "@IdType": "pmc"}, {"#text": "24155936", "@IdType": "pubmed"}]}, "Citation": "Liu ZL, Sun M, Lu KH, et al. The long noncoding RNA HOTAIR contributes to cisplatin resistance of human lung adenocarcinoma cells via downregualtion of p21WAF1/CIP1 expression. PLoS ONE. 2013;8(10):e77293. doi: 10.1371/journal.pone.0077293."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/toxsci/kfy254", "@IdType": "doi"}, {"#text": "30289508", "@IdType": "pubmed"}]}, "Citation": "Liu ZZ, Liu AF, Nan A, et al. The linc00152 controls cell cycle progression by regulating CCND1 in 16HBE cells malignantly transformed by cigarette smoke extract. Toxicol Sci. 2019;167(2):496\u2013508. doi: 10.1093/toxsci/kfy254."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.biopha.2016.12.079", "@IdType": "doi"}, {"#text": "28040594", "@IdType": "pubmed"}]}, "Citation": "Ma P, Zhang ML, Nie FQ, et al. Transcriptome analysis of EGFR tyrosine kinase inhibitors resistance associated long noncoding RNA in non-small cell lung cancer. Biomed Pharmacother. 2017;87:20\u201326. doi: 10.1016/j.biopha.2016.12.079."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1080/15384101.2018.1464834", "@IdType": "doi"}, {"#text": "PMC6103663", "@IdType": "pmc"}, {"#text": "29895195", "@IdType": "pubmed"}]}, "Citation": "Ma P, Wang HT, Sun JY, et al. LINC00152 promotes cell cycle progression in hepatocellular carcinoma via miR-193a/b-3p/CCND1 axis. Cell Cycle. 2018;17(8):974\u2013984. doi: 10.1080/15384101.2018.1464834."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/jcb.27655", "@IdType": "doi"}, {"#text": "30304559", "@IdType": "pubmed"}]}, "Citation": "Mao Y, Tie Y, Du J, et al. LINC00152 promotes the proliferation of gastric cancer cells by regulating B-cell lymphoma-2. J Cell Biochem. 2019;120(3):3747\u20133756. doi: 10.1002/jcb.27655."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/ijo.2017.4218", "@IdType": "doi"}, {"#text": "29345294", "@IdType": "pubmed"}]}, "Citation": "Nishizawa Y, Konno M, Asai A, et al. Hypoxia stimulates the cytoplasmic localization of oncogenic long noncoding RNA LINC00152 in colorectal cancer. Int J Oncol. 2018;52(2):453\u2013460. doi: 10.3892/ijo.2017.4218."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41598-017-02357-0", "@IdType": "doi"}, {"#text": "PMC5442156", "@IdType": "pmc"}, {"#text": "28536419", "@IdType": "pubmed"}]}, "Citation": "N\u00f6tzold L, Frank L, Gandhi M, et al. The long non-coding RNA LINC00152 is essential for cell cycle progression through mitosis in HeLa cells. Sci Rep. 2017;7(1):2265. doi: 10.1038/s41598-017-02357-0."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cell.2010.09.001", "@IdType": "doi"}, {"#text": "PMC4108080", "@IdType": "pmc"}, {"#text": "20887892", "@IdType": "pubmed"}]}, "Citation": "Orom UA, Derrien T, Beringer M, et al. Long noncoding RNAs with enhancer-like function in human cells. Cell. 2010;143(1):46\u201358. doi: 10.1016/j.cell.2010.09.001."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/onc.2017.184", "@IdType": "doi"}, {"#text": "PMC6450570", "@IdType": "pmc"}, {"#text": "28604750", "@IdType": "pubmed"}]}, "Citation": "Peng WX, Koirala P, Mo YY. LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 2017;36(41):5661\u20135667. doi: 10.1038/onc.2017.184."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s13277-015-3448-5", "@IdType": "doi"}, {"#text": "25894381", "@IdType": "pubmed"}]}, "Citation": "Qiu JJ, Yan JB. Long non-coding RNA LINC01296 is a potential prognostic biomarker in patients with colorectal cancer. Tumor Biol. 2015;36(9):7175\u20137183. doi: 10.1007/s13277-015-3448-5."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.csbj.2016.05.004", "@IdType": "doi"}, {"#text": "PMC4913179", "@IdType": "pmc"}, {"#text": "27358717", "@IdType": "pubmed"}]}, "Citation": "Rapisuwon S, Vietsch EE, Wellstein A. Circulating biomarkers to monitor cancer progression and treatment. Comput Struct Biotechnol J. 2016;14:211\u2013222. doi: 10.1016/j.csbj.2016.05.004."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/1541-7786.mcr-18-0322", "@IdType": "doi"}, {"#text": "PMC6170721", "@IdType": "pmc"}, {"#text": "29991527", "@IdType": "pubmed"}]}, "Citation": "Reon BJ, Karia BTR, Kiran M, et al. LINC00152 promotes invasion through a 3'-hairpin structure and associates with prognosis in glioblastoma. Mol Cancer Res. 2018;16(10):1470\u20131482. doi: 10.1158/1541-7786.mcr-18-0322."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1101/gr.145144.112", "@IdType": "doi"}, {"#text": "PMC3483540", "@IdType": "pmc"}, {"#text": "22975805", "@IdType": "pubmed"}]}, "Citation": "Seo JS, Ju YS, Lee WC, et al. The transcriptional landscape and mutational profile of lung adenocarcinoma. Genome Res. 2012;22(11):2109\u20132119. doi: 10.1101/gr.145144.112."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bbrc.2018.12.074", "@IdType": "doi"}, {"#text": "30594392", "@IdType": "pubmed"}]}, "Citation": "Shen X, Zhong JX, Yu P, et al. YY1-regulated LINC00152 promotes triple negative breast cancer progression by affecting on stability of PTEN protein. Biochem Biophys Res Commun. 2019;509(2):448\u2013454. doi: 10.1016/j.bbrc.2018.12.074."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.7150/jca.27098", "@IdType": "doi"}, {"#text": "PMC6277609", "@IdType": "pmc"}, {"#text": "30519315", "@IdType": "pubmed"}]}, "Citation": "Su M, Xiao YH, Tang JM, et al. Role of lncRNA and EZH2 interaction/regulatory network in lung cancer. J Cancer. 2018;9(22):4156\u20134165. doi: 10.7150/jca.27098."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/jcp.26928", "@IdType": "doi"}, {"#text": "30146756", "@IdType": "pubmed"}]}, "Citation": "Sun ZH, Guo X, Zang MC, et al. Long non-coding RNA LINC00152 promotes cell growth and invasion of papillary thyroid carcinoma by regulating the miR-497/BDNF axis. J Cell Physiol. 2019;234(2):1336\u20131345. doi: 10.1002/jcp.26928."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5689590", "@IdType": "pmc"}, {"#text": "29156700", "@IdType": "pubmed"}]}, "Citation": "Teng W, Qiu CG, He ZH, et al. Linc00152 suppresses apoptosis and promotes migration by sponging miR-4767 in vascular endothelial cells. Oncotarget. 2017;8(49):85014\u201385023."}, {"ArticleIdList": {"ArticleId": {"#text": "10.1007/978-3-319-24223-1_1", "@IdType": "doi"}}, "Citation": "Torre LA, Siegel RL, Jemal A. Lung cancer statistics. In: Ahmad A Gadgeel S., editor. Lung Cancer and Personalized Medicine: Current Knowledge and Therapies. Springer, Cham; 2016. pp. 1\u201319."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1021/bi0485732", "@IdType": "doi"}, {"#text": "15491130", "@IdType": "pubmed"}]}, "Citation": "Vester B, Wengel J. LNA (locked nucleic acid):\u2009 high-affinity targeting of complementary RNA and DNA. Biochemistry. 2004;43(42):13233\u201313241. doi: 10.1021/bi0485732."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1080/15384047.2018.1529124", "@IdType": "doi"}, {"#text": "PMC6422511", "@IdType": "pmc"}, {"#text": "30404587", "@IdType": "pubmed"}]}, "Citation": "Wang HF, Chen WX, Yang P, et al. Knockdown of linc00152 inhibits the progression of gastric cancer by regulating microRNA-193b-3p/ETS1 axis. Cancer Biol Ther. 2019;20(4):461\u2013473. doi: 10.1080/15384047.2018.1529124."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1111/cns.12850", "@IdType": "doi"}, {"#text": "PMC6489806", "@IdType": "pmc"}, {"#text": "29577647", "@IdType": "pubmed"}]}, "Citation": "Wang W, Wu F, Zhao Z, et al. Long noncoding RNA LINC00152 is a potential prognostic biomarker in patients with high-grade glioma. CNS Neurosci Ther. 2018;24(10):957\u2013966. doi: 10.1111/cns.12850."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12943-018-0860-7", "@IdType": "doi"}, {"#text": "PMC6069835", "@IdType": "pmc"}, {"#text": "30064438", "@IdType": "pubmed"}]}, "Citation": "Wang X, Yu HF, Sun WJ, et al. The long non-coding RNA CYTOR drives colorectal cancer progression by interacting with NCL and Sam68. Mol Cancer. 2018;17(1):110. doi: 10.1186/s12943-018-0860-7."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/jcp.26186", "@IdType": "doi"}, {"#text": "28926089", "@IdType": "pubmed"}]}, "Citation": "Wang Y, Zhou J, Xu YJ, et al. Long non-coding RNA LINC00968 acts as oncogene in NSCLC by activating the Wnt signaling pathway. J Cell Physiol. 2018;233(4):3397\u20133406. doi: 10.1002/jcp.26186."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5336504", "@IdType": "pmc"}, {"#text": "28337379", "@IdType": "pubmed"}]}, "Citation": "Wang YJ, Liu JZ, Bai HZ, et al. Long intergenic non-coding RNA 00152 promotes renal cell carcinoma progression by epigenetically suppressing P16 and negatively regulates miR-205. Am J Cancer Res. 2017;7(2):312\u2013322."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.lfs.2019.03.006", "@IdType": "doi"}, {"#text": "30851338", "@IdType": "pubmed"}]}, "Citation": "Wang YL, Li MM, Dong CX, et al. Linc00152 knockdown inactivates the Akt/mTOR and Notch1 pathways to exert its anti-hemangioma effect. Life Sci. 2019;223:22\u201328. doi: 10.1016/j.lfs.2019.03.006."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.biopha.2017.11.055", "@IdType": "doi"}, {"#text": "29156515", "@IdType": "pubmed"}]}, "Citation": "Wu JL, Shuang ZY, Zhao JF, et al. Linc00152 promotes tumorigenesis by regulating DNMTs in triple-negative breast cancer. Biomed Pharmacother. 2018;97:1275\u20131281. doi: 10.1016/j.biopha.2017.11.055."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4859660", "@IdType": "pmc"}, {"#text": "27186403", "@IdType": "pubmed"}]}, "Citation": "Wu Y, Tan C, Weng WW, et al. Long non-coding RNA Linc00152 is a positive prognostic factor for and demonstrates malignant biological behavior in clear cell renal cell carcinoma. Am J Cancer Res. 2016;6(2):285\u2013299."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/1878-0261.12188", "@IdType": "doi"}, {"#text": "PMC5928376", "@IdType": "pmc"}, {"#text": "29504701", "@IdType": "pubmed"}]}, "Citation": "Xie YJ, Zhang Y, Du LT, et al. Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer. Mol Oncol. 2018;12(5):648\u2013658. doi: 10.1002/1878-0261.12188."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1159/000486170", "@IdType": "doi"}, {"#text": "29268251", "@IdType": "pubmed"}]}, "Citation": "Xu SP, Wan L, Yin HZ, et al. Long noncoding RNA Linc00152 functions as a tumor propellant in pan-cancer. Cell Physiol Biochem. 2017;44(6):2476\u20132490. doi: 10.1159/000486170."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.canep.2016.08.015", "@IdType": "doi"}, {"#text": "27592063", "@IdType": "pubmed"}]}, "Citation": "Yang T, Zeng HM, Chen WQ, et al. Helicobacter pylori infection, H19 and LINC00152 expression in serum and risk of gastric cancer in a Chinese population. Cancer Epidemiol. 2016;44:147\u2013153. doi: 10.1016/j.canep.2016.08.015."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.7150/jca.17510", "@IdType": "doi"}, {"#text": "PMC5370496", "@IdType": "pmc"}, {"#text": "28367232", "@IdType": "pubmed"}]}, "Citation": "Yu JJ, Liu Y, Guo C, et al. Upregulated long non-coding RNA LINC00152 expression is associated with progression and poor prognosis of tongue squamous cell carcinoma. J Cancer. 2017;8(4):523\u2013530. doi: 10.7150/jca.17510."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12943-017-0677-9", "@IdType": "doi"}, {"#text": "PMC5485714", "@IdType": "pmc"}, {"#text": "28651608", "@IdType": "pubmed"}]}, "Citation": "Yu MJ, Xue YX, Zheng J, et al. Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway. Mol Cancer. 2017;16(1):110. doi: 10.1186/s12943-017-0677-9."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/or.2018.6721", "@IdType": "doi"}, {"#text": "30272368", "@IdType": "pubmed"}]}, "Citation": "Yu TH, Xu ZH, Zhang XH, et al. Long intergenic non-protein coding RNA 152 promotes multiple myeloma progression by negatively regulating microRNA-497. Oncol Rep. 2018;40(6):3763\u20133771. doi: 10.3892/or.2018.6721."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1111/cpr.12349", "@IdType": "doi"}, {"#text": "PMC6529135", "@IdType": "pmc"}, {"#text": "28464433", "@IdType": "pubmed"}]}, "Citation": "Yu Y, Yang J, Li QP, et al. LINC00152: a pivotal oncogenic long non-coding RNA in human cancers. Cell Prolif. 2017;50(4):e12349. doi: 10.1111/cpr.12349."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/mt.2016.180", "@IdType": "doi"}, {"#text": "PMC5167786", "@IdType": "pmc"}, {"#text": "27633443", "@IdType": "pubmed"}]}, "Citation": "Yue B, Cai DL, Liu CC, et al. Linc00152 functions as a competing endogenous RNA to confer oxaliplatin resistance and holds prognostic values in colon cancer. Mol Ther. 2016;24(12):2064\u20132077. doi: 10.1038/mt.2016.180."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ymthe.2018.02.024", "@IdType": "doi"}, {"#text": "PMC5993983", "@IdType": "pmc"}, {"#text": "29606502", "@IdType": "pubmed"}]}, "Citation": "Yue B, Liu CC, Sun HM, et al. A positive feed-forward loop between lncRNA-CYTOR and Wnt/\u03b2-catenin signaling promotes metastasis of colon cancer. Mol Ther. 2018;26(5):1287\u20131298. doi: 10.1016/j.ymthe.2018.02.024."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1042/BSR20181599", "@IdType": "doi"}, {"#text": "PMC6435535", "@IdType": "pmc"}, {"#text": "30487160", "@IdType": "pubmed"}]}, "Citation": "Zhang J, Li WQ. Long noncoding RNA CYTOR sponges miR-195 to modulate proliferation, migration, invasion and radiosensitivity in nonsmall cell lung cancer cells. Biosci Rep. 2018;38(6):BSR20181599. doi: 10.1042/BSR20181599."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.7150/jca.18852", "@IdType": "doi"}, {"#text": "PMC5559966", "@IdType": "pmc"}, {"#text": "28819405", "@IdType": "pubmed"}]}, "Citation": "Zhang PP, Wang YQ, Weng WW, et al. Linc00152 promotes cancer cell proliferation and invasion and predicts poor prognosis in lung adenocarcinoma. J Cancer. 2017;8(11):2042\u20132050. doi: 10.7150/jca.18852."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1089/dna.2018.4482", "@IdType": "doi"}, {"#text": "30707636", "@IdType": "pubmed"}]}, "Citation": "Zhang XX, Tao WG. Long noncoding RNA LINC00152 facilitates the leukemogenesis of acute myeloid leukemia by promoting CDK9 through miR-193a. DNA Cell Biol. 2019;38(3):236\u2013242. doi: 10.1089/dna.2018.4482."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.biopha.2017.07.120", "@IdType": "doi"}, {"#text": "28787699", "@IdType": "pubmed"}]}, "Citation": "Zhang Y, Xiang C, Wang YL, et al. LncRNA LINC00152 knockdown had effects to suppress biological activity of lung cancer via EGFR/PI3K/AKT pathway. Biomed Pharmacother. 2017;94:644\u2013651. doi: 10.1016/j.biopha.2017.07.120."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5209482", "@IdType": "pmc"}, {"#text": "28078002", "@IdType": "pubmed"}]}, "Citation": "Zhang YH, Fu J, Zhang ZJ, et al. LncRNA-LINC00152 down-regulated by miR-376c-3p restricts viability and promotes apoptosis of colorectal cancer cells. Am J Transl Res. 2016;8(12):5286\u20135297."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2147/ott.s167633", "@IdType": "doi"}, {"#text": "PMC6134945", "@IdType": "pmc"}, {"#text": "30233202", "@IdType": "pubmed"}]}, "Citation": "Zhao B, Xu H, Ai X, et al. Expression profiles of long noncoding RNAs in lung adenocarcinoma. OncoTargets Ther. 2018;11:5383\u20135390. doi: 10.2147/ott.s167633."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1080/15384101.2015.1078034", "@IdType": "doi"}, {"#text": "PMC4825539", "@IdType": "pmc"}, {"#text": "26237576", "@IdType": "pubmed"}]}, "Citation": "Zhao J, Liu YC, Zhang WH, et al. Long non-coding RNA Linc00152 is involved in cell cycle arrest, apoptosis, epithelial to mesenchymal transition, cell migration and invasion in gastric cancer. Cell Cycle. 2015;14(19):3112\u20133123. doi: 10.1080/15384101.2015.1078034."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.prp.2018.12.031", "@IdType": "doi"}, {"#text": "30600185", "@IdType": "pubmed"}]}, "Citation": "Zheng LL, Hu N, Zhou XZ. TCF3-activated LINC00152 exerts oncogenic role in osteosarcoma through regulating miR-1182/CDK14 axis. Pathol Res Pract. 2019;215(2):373\u2013380. doi: 10.1016/j.prp.2018.12.031."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s13046-015-0250-6", "@IdType": "doi"}, {"#text": "PMC4632266", "@IdType": "pmc"}, {"#text": "26538117", "@IdType": "pubmed"}]}, "Citation": "Zhou JP, Zhi XF, Wang LJ, et al. Linc00152 promotes proliferation in gastric cancer through the EGFR-dependent pathway. J Exp Clin Cancer Res. 2015;34(1):135. doi: 10.1186/s13046-015-0250-6."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3727/096504017x15016337254597", "@IdType": "doi"}, {"#text": "PMC7844725", "@IdType": "pmc"}, {"#text": "28800786", "@IdType": "pubmed"}]}, "Citation": "Zhu ZK, Dai JH, Liao YF, et al. Knockdown of long noncoding RNA LINC00152 suppresses cellular proliferation and invasion in glioma cells by regulating miR-4775. Oncol Res. 2018;26(6):857\u2013867. doi: 10.3727/096504017x15016337254597."}]}}}}}, "PMC": "PMC7086013", "PMID": "32133796", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "Role of LINC00152 in non-small cell lung cancer.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "23": {"Abstract": "Large-scale transcriptome sequencing efforts have vastly expanded the catalog of long non-coding RNAs (lncRNAs) with varying evolutionary conservation, lineage expression, and cancer specificity. Here, we functionally characterize a novel ultraconserved lncRNA, THOR (ENSG00000226856), which\u00a0exhibits expression exclusively in testis and a broad range of human cancers. THOR knockdown and overexpression in multiple cell lines and animal models alters cell or tumor growth supporting an oncogenic role. We discovered a conserved interaction of THOR with IGF2BP1 and show that THOR contributes to the mRNA stabilization activities of IGF2BP1. Notably, transgenic THOR knockout produced fertilization defects in zebrafish and also conferred a resistance to melanoma onset. Likewise, ectopic expression of human THOR in zebrafish accelerated the onset of melanoma. THOR represents a novel class of functionally important cancer/testis lncRNAs whose structure and function have undergone positive evolutionary selection.", "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "7265346360791168702", "Part1": "Michigan Center for Translational Pathology", "Part2": "University of Michigan", "Part3": "Ann Arbor", "Part4": "MI", "Part5": "USA.", "Part6": null, "Text": "Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA."}], "ForeName": "Yasuyuki", "FullName": "Yasuyuki Hosono", "HashID": "7552434837906927132", "LastName": "Hosono", "ORCID": null}, {"Affiliations": [{"Has_Extra": true, "HashID": "7265346360791168702", "Part1": "Michigan Center for Translational Pathology", "Part2": "University of Michigan", "Part3": "Ann Arbor", "Part4": "MI", "Part5": "USA; Department of Cellular and Molecular Biology", "Part6": "University of Michigan", "Text": "Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA; Department of Cellular and Molecular Biology, University of Michigan, Ann Arbor, MI, USA."}], "ForeName": "Yashar S", "FullName": "Yashar S Niknafs", "HashID": "-4205473654068608410", "LastName": "Niknafs", "ORCID": null}, {"Affiliations": [{"Has_Extra": true, "HashID": "7265346360791168702", "Part1": "Michigan Center for Translational Pathology", "Part2": "University of Michigan", "Part3": "Ann Arbor", "Part4": "MI", "Part5": "USA; Department of Pediatrics", "Part6": "Boston Children's Hospital", "Text": "Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA; Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA."}], "ForeName": "John R", "FullName": "John R Prensner", "HashID": "-5833920883871877520", "LastName": "Prensner", "ORCID": null}, {"Affiliations": [{"Has_Extra": true, "HashID": "7265346360791168702", "Part1": "Michigan Center for Translational Pathology", "Part2": "University of Michigan", "Part3": "Ann Arbor", "Part4": "MI", "Part5": "USA; Department of Computational Medicine and Bioinformatics", "Part6": "University of Michigan", "Text": "Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA."}], "ForeName": "Matthew K", "FullName": "Matthew K Iyer", "HashID": "6340150999800829162", "LastName": "Iyer", "ORCID": null}, {"Affiliations": [{"Has_Extra": true, "HashID": "7265346360791168702", "Part1": "Michigan Center for Translational Pathology", "Part2": "University of Michigan", "Part3": "Ann Arbor", "Part4": "MI", "Part5": "USA; Department of Pathology", "Part6": "University of Michigan", "Text": "Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA; Department of Pathology, University of Michigan, Ann Arbor, MI, USA."}], "ForeName": "Saravana M", "FullName": "Saravana M Dhanasekaran", "HashID": "-5089758292804597925", "LastName": "Dhanasekaran", "ORCID": null}, {"Affiliations": [{"Has_Extra": true, "HashID": "7265346360791168702", "Part1": "Michigan Center for Translational Pathology", "Part2": "University of Michigan", "Part3": "Ann Arbor", "Part4": "MI", "Part5": "USA; Department of Pathology", "Part6": "University of Michigan", "Text": "Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA; Department of Pathology, University of Michigan, Ann Arbor, MI, USA."}], "ForeName": "Rohit", "FullName": "Rohit Mehra", "HashID": "4697371451007585464", "LastName": "Mehra", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "7265346360791168702", "Part1": "Michigan Center for Translational Pathology", "Part2": "University of Michigan", "Part3": "Ann Arbor", "Part4": "MI", "Part5": "USA.", "Part6": null, "Text": "Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA."}], "ForeName": "Sethuramasundaram", "FullName": "Sethuramasundaram Pitchiaya", "HashID": "-3210449076791627260", "LastName": "Pitchiaya", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "7265346360791168702", "Part1": "Michigan Center for Translational Pathology", "Part2": "University of Michigan", "Part3": "Ann Arbor", "Part4": "MI", "Part5": "USA.", "Part6": null, "Text": "Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA."}], "ForeName": "Jean", "FullName": "Jean Tien", "HashID": "-2118725636919655651", "LastName": "Tien", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "2364749452575388515", "Part1": "Department of Urology", "Part2": "University of Michigan", "Part3": "Ann Arbor", "Part4": "MI", "Part5": "USA.", "Part6": null, "Text": "Department of Urology, University of Michigan, Ann Arbor, MI, USA."}], "ForeName": "June", "FullName": "June Escara-Wilke", "HashID": "8067681179314378303", "LastName": "Escara-Wilke", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "7265346360791168702", "Part1": "Michigan Center for Translational Pathology", "Part2": "University of Michigan", "Part3": "Ann Arbor", "Part4": "MI", "Part5": "USA.", "Part6": null, "Text": "Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA."}], "ForeName": "Anton", "FullName": "Anton Poliakov", "HashID": "5465207916923197633", "LastName": "Poliakov", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "7265346360791168702", "Part1": "Michigan Center for Translational Pathology", "Part2": "University of Michigan", "Part3": "Ann Arbor", "Part4": "MI", "Part5": "USA.", "Part6": null, "Text": "Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA."}], "ForeName": "Shih-Chun", "FullName": "Shih-Chun Chu", "HashID": "-7317667280502574962", "LastName": "Chu", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "7265346360791168702", "Part1": "Michigan Center for Translational Pathology", "Part2": "University of Michigan", "Part3": "Ann Arbor", "Part4": "MI", "Part5": "USA.", "Part6": null, "Text": "Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA."}], "ForeName": "Sahal", "FullName": "Sahal Saleh", "HashID": "6797949020365416976", "LastName": "Saleh", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "7265346360791168702", "Part1": "Michigan Center for Translational Pathology", "Part2": "University of Michigan", "Part3": "Ann Arbor", "Part4": "MI", "Part5": "USA.", "Part6": null, "Text": "Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA."}], "ForeName": "Keerthana", "FullName": "Keerthana Sankar", "HashID": "9155103501692494719", "LastName": "Sankar", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "7265346360791168702", "Part1": "Michigan Center for Translational Pathology", "Part2": "University of Michigan", "Part3": "Ann Arbor", "Part4": "MI", "Part5": "USA.", "Part6": null, "Text": "Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA."}], "ForeName": "Fengyun", "FullName": "Fengyun Su", "HashID": "-3744742311716153926", "LastName": "Su", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-1638531074584525657", "Part1": "Ionis Pharmaceuticals", "Part2": "Carlsbad", "Part3": "CA", "Part4": "USA.", "Part5": null, "Part6": null, "Text": "Ionis Pharmaceuticals, Carlsbad, CA, USA."}], "ForeName": "Shuling", "FullName": "Shuling Guo", "HashID": "7039185247523144254", "LastName": "Guo", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "7265346360791168702", "Part1": "Michigan Center for Translational Pathology", "Part2": "University of Michigan", "Part3": "Ann Arbor", "Part4": "MI", "Part5": "USA.", "Part6": null, "Text": "Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA."}], "ForeName": "Yuanyuan", "FullName": "Yuanyuan Qiao", "HashID": "638563829519930133", "LastName": "Qiao", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-1638531074584525657", "Part1": "Ionis Pharmaceuticals", "Part2": "Carlsbad", "Part3": "CA", "Part4": "USA.", "Part5": null, "Part6": null, "Text": "Ionis Pharmaceuticals, Carlsbad, CA, USA."}], "ForeName": "Susan M", "FullName": "Susan M Freier", "HashID": "6211498335457597301", "LastName": "Freier", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-1638531074584525657", "Part1": "Ionis Pharmaceuticals", "Part2": "Carlsbad", "Part3": "CA", "Part4": "USA.", "Part5": null, "Part6": null, "Text": "Ionis Pharmaceuticals, Carlsbad, CA, USA."}], "ForeName": "Huynh-Hoa", "FullName": "Huynh-Hoa Bui", "HashID": "-4346578318815964043", "LastName": "Bui", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "7265346360791168702", "Part1": "Michigan Center for Translational Pathology", "Part2": "University of Michigan", "Part3": "Ann Arbor", "Part4": "MI", "Part5": "USA.", "Part6": null, "Text": "Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA."}], "ForeName": "Xuhong", "FullName": "Xuhong Cao", "HashID": "-221284954653069188", "LastName": "Cao", "ORCID": null}, {"Affiliations": [{"Has_Extra": true, "HashID": "7265346360791168702", "Part1": "Michigan Center for Translational Pathology", "Part2": "University of Michigan", "Part3": "Ann Arbor", "Part4": "MI", "Part5": "USA; Department of Pathology", "Part6": "University of Michigan", "Text": "Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA; Department of Pathology, University of Michigan, Ann Arbor, MI, USA."}], "ForeName": "Rohit", "FullName": "Rohit Malik", "HashID": "7163594773607530773", "LastName": "Malik", "ORCID": null}, {"Affiliations": [{"Has_Extra": true, "HashID": "3590091835013375293", "Part1": "Department of Dermatology", "Part2": "University of Michigan Medical School", "Part3": "Ann Arbor", "Part4": "MI", "Part5": "USA; Comprehensive Cancer Center", "Part6": "University of Michigan", "Text": "Department of Dermatology, University of Michigan Medical School, Ann Arbor, MI, USA; Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA."}], "ForeName": "Timothy M", "FullName": "Timothy M Johnson", "HashID": "679157349635105300", "LastName": "Johnson", "ORCID": null}, {"Affiliations": [{"Has_Extra": true, "HashID": "-580217478068278873", "Part1": "Comprehensive Cancer Center", "Part2": "University of Michigan", "Part3": "Ann Arbor", "Part4": "MI", "Part5": "USA; Section of Thoracic Surgery", "Part6": "Department of Surgery", "Text": "Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA; Section of Thoracic Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI, USA."}], "ForeName": "David G", "FullName": "David G Beer", "HashID": "-5657313194952131678", "LastName": "Beer", "ORCID": null}, {"Affiliations": [{"Has_Extra": true, "HashID": "7265346360791168702", "Part1": "Michigan Center for Translational Pathology", "Part2": "University of Michigan", "Part3": "Ann Arbor", "Part4": "MI", "Part5": "USA; Comprehensive Cancer Center", "Part6": "University of Michigan", "Text": "Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA; Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA."}], "ForeName": "Felix Y", "FullName": "Felix Y Feng", "HashID": "3391893511672089521", "LastName": "Feng", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "5816523248918234951", "Part1": "Department of Pediatrics and Communicable Diseases", "Part2": "University of Michigan", "Part3": "Ann Arbor", "Part4": "MI", "Part5": "USA.", "Part6": null, "Text": "Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, MI, USA."}], "ForeName": "Weibin", "FullName": "Weibin Zhou", "HashID": "-7848019446002133701", "LastName": "Zhou", "ORCID": null}, {"Affiliations": [{"Has_Extra": true, "HashID": "7265346360791168702", "Part1": "Michigan Center for Translational Pathology", "Part2": "University of Michigan", "Part3": "Ann Arbor", "Part4": "MI", "Part5": "USA; Department of Cellular and Molecular Biology", "Part6": "University of Michigan", "Text": "Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA; Department of Cellular and Molecular Biology, University of Michigan, Ann Arbor, MI, USA; Department of Pathology, University of Michigan, Ann Arbor, MI, USA; Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA; Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI, USA; Department of Urology, University of Michigan, Ann Arbor, MI, USA. Electronic address: arul@med.umich.edu."}], "ForeName": "Arul M", "FullName": "Arul M Chinnaiyan", "HashID": "-4032769192364799979", "LastName": "Chinnaiyan", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.1016/j.cell.2017.11.040", "InsertType": null, "Journal": "Cell", "Keywords": [{"IS_Major": false, "IS_Mesh": true, "Text": "Animals"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Cell Line, Tumor"}, {"IS_Major": true, "IS_Mesh": true, "Text": "Disease Models, Animal"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Gene Knockout Techniques"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Humans"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Male"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Melanoma"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Mice"}, {"IS_Major": false, "IS_Mesh": true, "Text": "RNA, Long Noncoding"}, {"IS_Major": false, "IS_Mesh": true, "Text": "RNA-Binding Proteins"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Testis"}, {"IS_Major": true, "IS_Mesh": true, "Text": "Zebrafish"}, {"IS_Major": false, "IS_Mesh": false, "Text": "IGF2BP1"}, {"IS_Major": false, "IS_Mesh": false, "Text": "RNA"}, {"IS_Major": false, "IS_Mesh": false, "Text": "RNA-seq"}, {"IS_Major": false, "IS_Mesh": false, "Text": "cancer"}, {"IS_Major": false, "IS_Mesh": false, "Text": "conservation"}, {"IS_Major": false, "IS_Mesh": false, "Text": "fertility"}, {"IS_Major": false, "IS_Mesh": false, "Text": "iCLIP"}, {"IS_Major": false, "IS_Mesh": false, "Text": "lncRNA"}, {"IS_Major": false, "IS_Mesh": false, "Text": "zebrafish"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "MEDLINE", "Article": {"@PubModel": "Print", "Abstract": {"AbstractText": "Large-scale transcriptome sequencing efforts have vastly expanded the catalog of long non-coding RNAs (lncRNAs) with varying evolutionary conservation, lineage expression, and cancer specificity. Here, we functionally characterize a novel ultraconserved lncRNA, THOR (ENSG00000226856), which\u00a0exhibits expression exclusively in testis and a broad range of human cancers. THOR knockdown and overexpression in multiple cell lines and animal models alters cell or tumor growth supporting an oncogenic role. We discovered a conserved interaction of THOR with IGF2BP1 and show that THOR contributes to the mRNA stabilization activities of IGF2BP1. Notably, transgenic THOR knockout produced fertilization defects in zebrafish and also conferred a resistance to melanoma onset. Likewise, ectopic expression of human THOR in zebrafish accelerated the onset of melanoma. THOR represents a novel class of functionally important cancer/testis lncRNAs whose structure and function have undergone positive evolutionary selection.", "CopyrightInformation": "Copyright \u00a9 2017 Elsevier Inc. All rights reserved."}, "ArticleTitle": "Oncogenic Role of THOR, a Conserved Cancer/Testis Long Non-coding RNA.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA."}, "ForeName": "Yasuyuki", "Initials": "Y", "LastName": "Hosono"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA; Department of Cellular and Molecular Biology, University of Michigan, Ann Arbor, MI, USA."}, "ForeName": "Yashar S", "Initials": "YS", "LastName": "Niknafs"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA; Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA."}, "ForeName": "John R", "Initials": "JR", "LastName": "Prensner"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA."}, "ForeName": "Matthew K", "Initials": "MK", "LastName": "Iyer"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA; Department of Pathology, University of Michigan, Ann Arbor, MI, USA."}, "ForeName": "Saravana M", "Initials": "SM", "LastName": "Dhanasekaran"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA; Department of Pathology, University of Michigan, Ann Arbor, MI, USA."}, "ForeName": "Rohit", "Initials": "R", "LastName": "Mehra"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA."}, "ForeName": "Sethuramasundaram", "Initials": "S", "LastName": "Pitchiaya"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA."}, "ForeName": "Jean", "Initials": "J", "LastName": "Tien"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Urology, University of Michigan, Ann Arbor, MI, USA."}, "ForeName": "June", "Initials": "J", "LastName": "Escara-Wilke"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA."}, "ForeName": "Anton", "Initials": "A", "LastName": "Poliakov"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA."}, "ForeName": "Shih-Chun", "Initials": "SC", "LastName": "Chu"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA."}, "ForeName": "Sahal", "Initials": "S", "LastName": "Saleh"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA."}, "ForeName": "Keerthana", "Initials": "K", "LastName": "Sankar"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA."}, "ForeName": "Fengyun", "Initials": "F", "LastName": "Su"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Ionis Pharmaceuticals, Carlsbad, CA, USA."}, "ForeName": "Shuling", "Initials": "S", "LastName": "Guo"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA."}, "ForeName": "Yuanyuan", "Initials": "Y", "LastName": "Qiao"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Ionis Pharmaceuticals, Carlsbad, CA, USA."}, "ForeName": "Susan M", "Initials": "SM", "LastName": "Freier"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Ionis Pharmaceuticals, Carlsbad, CA, USA."}, "ForeName": "Huynh-Hoa", "Initials": "HH", "LastName": "Bui"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA."}, "ForeName": "Xuhong", "Initials": "X", "LastName": "Cao"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA; Department of Pathology, University of Michigan, Ann Arbor, MI, USA."}, "ForeName": "Rohit", "Initials": "R", "LastName": "Malik"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Dermatology, University of Michigan Medical School, Ann Arbor, MI, USA; Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA."}, "ForeName": "Timothy M", "Initials": "TM", "LastName": "Johnson"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA; Section of Thoracic Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI, USA."}, "ForeName": "David G", "Initials": "DG", "LastName": "Beer"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA; Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA."}, "ForeName": "Felix Y", "Initials": "FY", "LastName": "Feng"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, MI, USA."}, "ForeName": "Weibin", "Initials": "W", "LastName": "Zhou"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA; Department of Cellular and Molecular Biology, University of Michigan, Ann Arbor, MI, USA; Department of Pathology, University of Michigan, Ann Arbor, MI, USA; Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA; Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI, USA; Department of Urology, University of Michigan, Ann Arbor, MI, USA. Electronic address: arul@med.umich.edu."}, "ForeName": "Arul M", "Initials": "AM", "LastName": "Chinnaiyan"}]}, "ELocationID": [{"#text": "10.1016/j.cell.2017.11.040", "@EIdType": "doi", "@ValidYN": "Y"}, {"#text": "S0092-8674(17)31430-7", "@EIdType": "pii", "@ValidYN": "Y"}], "GrantList": {"@CompleteYN": "Y", "Grant": [{"Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States", "GrantID": "P30 CA046592"}, {"Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States", "GrantID": "U01 CA214170"}, {"Acronym": "GM", "Agency": "NIGMS NIH HHS", "Country": "United States", "GrantID": "T32 GM007863"}, {"Acronym": "DK", "Agency": "NIDDK NIH HHS", "Country": "United States", "GrantID": "R00 DK091405"}, {"Acronym": "DK", "Agency": "NIDDK NIH HHS", "Country": "United States", "GrantID": "P30 DK081943"}, {"Acronym": "DK", "Agency": "NIDDK NIH HHS", "Country": "United States", "GrantID": "K99 DK091405"}, {"Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States", "GrantID": "F30 CA200328"}, {"Acronym": "GM", "Agency": "NIGMS NIH HHS", "Country": "United States", "GrantID": "T32 GM007315"}, {"Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States", "GrantID": "R01 CA154365"}, {"Acronym": "HHMI", "Agency": "Howard Hughes Medical Institute", "Country": "United States"}]}, "Journal": {"ISOAbbreviation": "Cell", "ISSN": {"#text": "1097-4172", "@IssnType": "Electronic"}, "JournalIssue": {"@CitedMedium": "Internet", "Issue": "7", "PubDate": {"Day": "14", "Month": "Dec", "Year": "2017"}, "Volume": "171"}, "Title": "Cell"}, "Language": "eng", "Pagination": {"EndPage": "1572.e20", "MedlinePgn": "1559-1572.e20", "StartPage": "1559"}, "PublicationTypeList": {"PublicationType": {"#text": "Journal Article", "@UI": "D016428"}}}, "ChemicalList": {"Chemical": [{"NameOfSubstance": {"#text": "IGF2BP1 protein, human", "@UI": "C406144"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "RNA, Long Noncoding", "@UI": "D062085"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "RNA-Binding Proteins", "@UI": "D016601"}, "RegistryNumber": "0"}]}, "CitationSubset": "IM", "DateCompleted": {"Day": "28", "Month": "12", "Year": "2017"}, "DateRevised": {"Day": "08", "Month": "04", "Year": "2022"}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"#text": "IGF2BP1", "@MajorTopicYN": "N"}, {"#text": "RNA", "@MajorTopicYN": "N"}, {"#text": "RNA-seq", "@MajorTopicYN": "N"}, {"#text": "cancer", "@MajorTopicYN": "N"}, {"#text": "conservation", "@MajorTopicYN": "N"}, {"#text": "fertility", "@MajorTopicYN": "N"}, {"#text": "iCLIP", "@MajorTopicYN": "N"}, {"#text": "lncRNA", "@MajorTopicYN": "N"}, {"#text": "zebrafish", "@MajorTopicYN": "N"}]}, "MedlineJournalInfo": {"Country": "United States", "ISSNLinking": "0092-8674", "MedlineTA": "Cell", "NlmUniqueID": "0413066"}, "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"#text": "Animals", "@MajorTopicYN": "N", "@UI": "D000818"}}, {"DescriptorName": {"#text": "Cell Line, Tumor", "@MajorTopicYN": "N", "@UI": "D045744"}}, {"DescriptorName": {"#text": "Disease Models, Animal", "@MajorTopicYN": "Y", "@UI": "D004195"}}, {"DescriptorName": {"#text": "Gene Knockout Techniques", "@MajorTopicYN": "N", "@UI": "D055786"}}, {"DescriptorName": {"#text": "Humans", "@MajorTopicYN": "N", "@UI": "D006801"}}, {"DescriptorName": {"#text": "Male", "@MajorTopicYN": "N", "@UI": "D008297"}}, {"DescriptorName": {"#text": "Melanoma", "@MajorTopicYN": "N", "@UI": "D008545"}, "QualifierName": {"#text": "metabolism", "@MajorTopicYN": "Y", "@UI": "Q000378"}}, {"DescriptorName": {"#text": "Mice", "@MajorTopicYN": "N", "@UI": "D051379"}}, {"DescriptorName": {"#text": "RNA, Long Noncoding", "@MajorTopicYN": "N", "@UI": "D062085"}, "QualifierName": {"#text": "metabolism", "@MajorTopicYN": "Y", "@UI": "Q000378"}}, {"DescriptorName": {"#text": "RNA-Binding Proteins", "@MajorTopicYN": "N", "@UI": "D016601"}, "QualifierName": {"#text": "metabolism", "@MajorTopicYN": "N", "@UI": "Q000378"}}, {"DescriptorName": {"#text": "Testis", "@MajorTopicYN": "N", "@UI": "D013737"}, "QualifierName": {"#text": "metabolism", "@MajorTopicYN": "N", "@UI": "Q000378"}}, {"DescriptorName": {"#text": "Zebrafish", "@MajorTopicYN": "Y", "@UI": "D015027"}}]}, "PMID": {"#text": "29245011", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "29245011", "@IdType": "pubmed"}, {"#text": "NIHMS922696", "@IdType": "mid"}, {"#text": "PMC5734106", "@IdType": "pmc"}, {"#text": "10.1016/j.cell.2017.11.040", "@IdType": "doi"}, {"#text": "S0092-8674(17)31430-7", "@IdType": "pii"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "received", "Day": "15", "Month": "2", "Year": "2017"}, {"@PubStatus": "revised", "Day": "29", "Month": "8", "Year": "2017"}, {"@PubStatus": "accepted", "Day": "20", "Month": "11", "Year": "2017"}, {"@PubStatus": "entrez", "Day": "16", "Hour": "6", "Minute": "0", "Month": "12", "Year": "2017"}, {"@PubStatus": "pubmed", "Day": "16", "Hour": "6", "Minute": "0", "Month": "12", "Year": "2017"}, {"@PubStatus": "medline", "Day": "29", "Hour": "6", "Minute": "0", "Month": "12", "Year": "2017"}]}, "PublicationStatus": "ppublish", "ReferenceList": {"Reference": [{"ArticleIdList": {"ArticleId": [{"#text": "PMC3218662", "@IdType": "pmc"}, {"#text": "20979621", "@IdType": "pubmed"}]}, "Citation": "Anders S, Huber W. Differential expression analysis for sequence count data. Genome Biol. 2010;11:R106."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3320027", "@IdType": "pmc"}, {"#text": "22460905", "@IdType": "pubmed"}]}, "Citation": "Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S, Wilson CJ, Leh\u00e1r J, Kryukov GV, Sonkin D, et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012;483:603\u2013307."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3708292", "@IdType": "pmc"}, {"#text": "23069990", "@IdType": "pubmed"}]}, "Citation": "Bell JL, W\u00e4chter K, M\u00fchleck B, Pazaitis N, K\u00f6hn M, Lederer M, H\u00fcttelmaier S. Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression? Cell Mol Life Sci CMLS. 2013;70:2657\u20132675."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC544293", "@IdType": "pmc"}, {"#text": "15630097", "@IdType": "pubmed"}]}, "Citation": "Berghmans S, Murphey RD, Wienholds E, Neuberg D, Kutok JL, Fletcher CDM, Morris JP, Liu TX, Schulte-Merker S, Kanki JP, et al. Tp53 Mutant Zebrafish Develop Malignant Peripheral Nerve Sheath Tumors. Proc Natl Acad Sci U S A. 2005;102:407\u2013412."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2212820", "@IdType": "pmc"}, {"#text": "17571346", "@IdType": "pubmed"}]}, "Citation": "Birney E, Stamatoyannopoulos JA, Dutta A, Guig\u00f3 R, Gingeras TR, Margulies EH, Weng Z, Snyder M, Dermitzakis ET, Thurman RE, et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature. 2007;447:799\u2013816."}, {"ArticleIdList": {"ArticleId": {"#text": "27043002", "@IdType": "pubmed"}}, "Citation": "Bray NL, Pimentel H, Melsted P, Pachter L. Near-optimal probabilistic RNA-seq quantification. Nat Biotech. 2016;34:525\u2013527."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3185964", "@IdType": "pmc"}, {"#text": "21890647", "@IdType": "pubmed"}]}, "Citation": "Cabili MN, Trapnell C, Goff L, Koziol M, Tazon-Vega B, Regev A, Rinn JL. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 2011;25:1915\u20131927."}, {"ArticleIdList": {"ArticleId": {"#text": "17785203", "@IdType": "pubmed"}}, "Citation": "Calin GA, Liu C, Ferracin M, Hyslop T, Spizzo R, Sevignani C, Fabbri M, Cimmino A, Lee EJ, Wojcik SE, et al. Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell. 2007;12:215\u2013229."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3795411", "@IdType": "pmc"}, {"#text": "23287718", "@IdType": "pubmed"}]}, "Citation": "Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA, et al. Multiplex Genome Engineering Using CRISPR/Cas Systems. Science. 2013;339:819\u2013823."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4010069", "@IdType": "pmc"}, {"#text": "23715323", "@IdType": "pubmed"}]}, "Citation": "Consortium TG. The Genotype-Tissue Expression (GTEx) project. Nat Genet. 2013;45:580\u2013585."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3428773", "@IdType": "pmc"}, {"#text": "22763747", "@IdType": "pubmed"}]}, "Citation": "Decker CJ, Parker R. P-bodies and stress granules: possible roles in the control of translation and mRNA degradation. Cold Spring Harb Perspect Biol. 2012;4:1\u201316."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3530905", "@IdType": "pmc"}, {"#text": "23104886", "@IdType": "pubmed"}]}, "Citation": "Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. STAR: Ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15\u201321."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2943216", "@IdType": "pmc"}, {"#text": "19954345", "@IdType": "pubmed"}]}, "Citation": "Dovey M, White RM, Zon LI. Oncogenic NRAS cooperates with p53 loss to generate melanoma in zebrafish. Zebrafish. 2009;6:397\u2013404."}, {"ArticleIdList": {"ArticleId": {"#text": "17620336", "@IdType": "pubmed"}}, "Citation": "El-Shewy HM, Lee MH, Obeid LM, Jaffa AA, Luttrell LM. The insulin-like growth factor type 1 and insulin-like growth factor type 2/mannose-6-phosphate receptors independently regulate ERK1/2 activity in HEK293 cells. J Biol Chem. 2007;282:26150\u201326157."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5528287", "@IdType": "pmc"}, {"#text": "21376678", "@IdType": "pubmed"}]}, "Citation": "Fratta E, Coral S, Covre A, Parisi G, Colizzi F, Danielli R, Marie Nicolay HJ, Sigalotti L, Maio M. The biology of cancer testis antigens: Putative function, regulation and therapeutic potential. Mol Oncol. 2011;5:164\u2013182."}, {"Citation": "Gaysinskaya V, Soh IY, van der Heijden GW, Bortvin A. Optimized flow cytometry isolation of murine spermatocytes. Cytom Part J Int Soc Anal Cytol. 2014;85:556\u2013565."}, {"ArticleIdList": {"ArticleId": {"#text": "15774722", "@IdType": "pubmed"}}, "Citation": "Giraldez AJ, Cinalli RM, Glasner ME, Enright AJ, Thomson JM, Baskerville S, Hammond SM, Bartel DP, Schier AF. MicroRNAs regulate brain morphogenesis in zebrafish. Science. 2005;308:833\u2013838."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2858862", "@IdType": "pmc"}, {"#text": "18342629", "@IdType": "pubmed"}]}, "Citation": "Glisovic T, Bachorik JL, Yong J, Dreyfuss G. RNA-binding proteins and post-transcriptional gene regulation. FEBS Lett. 2008;582:1977\u20131986."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3049919", "@IdType": "pmc"}, {"#text": "20393566", "@IdType": "pubmed"}]}, "Citation": "Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010;464:1071\u20131076."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2861495", "@IdType": "pmc"}, {"#text": "20371350", "@IdType": "pubmed"}]}, "Citation": "Hafner M, Landthaler M, Burger L, Khorshid M, Hausser J, Berninger P, Rothballer A, Ascano M, Jungkamp AC, Munschauer M, et al. Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell. 2010;141:129\u2013141."}, {"ArticleIdList": {"ArticleId": {"#text": "23728852", "@IdType": "pubmed"}}, "Citation": "H\u00e4mmerle M, Gutschner T, Uckelmann H, Ozgur S, Fiskin E, Gross M, Skawran B, Geffers R, Longerich T, Breuhahn K, et al. Posttranscriptional destabilization of the liver-specific long noncoding RNA HULC by the IGF2 mRNA-binding protein 1 (IGF2BP1) Hepatology. 2013;58:1703\u20131712."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3431492", "@IdType": "pmc"}, {"#text": "22955987", "@IdType": "pubmed"}]}, "Citation": "Harrow J, Frankish A, Gonzalez JM, Tapanari E, Diekhans M, Kokocinski F, Aken BL, Barrell D, Zadissa A, Searle S, et al. GENCODE: The reference human genome annotation for the ENCODE project. Genome Res. 2012;22:1760\u20131774."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3626580", "@IdType": "pmc"}, {"#text": "23409773", "@IdType": "pubmed"}]}, "Citation": "Hudson RS, Yi M, Volfovsky N, Prueitt RL, Esposito D, Volinia S, Liu CG, Schetter AJ, Van Roosbroeck K, Stephens RM, et al. Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer. Mol Cancer. 2013;12:13."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3686313", "@IdType": "pmc"}, {"#text": "23360964", "@IdType": "pubmed"}]}, "Citation": "Hwang WY, Fu Y, Reyon D, Maeder ML, Tsai SQ, Sander JD, Peterson RT, Yeh JRJ, Joung JK. Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat Biotechnol. 2013;31:227\u2013229."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4417758", "@IdType": "pmc"}, {"#text": "25599403", "@IdType": "pubmed"}]}, "Citation": "Iyer MK, Niknafs YS, Malik R, Singhal U, Sahu A, Hosono Y, Barrette TR, Prensner JR, Evans JR, Zhao S, et al. The landscape of long noncoding RNAs in the human transcriptome. Nat Genet. 2015 advance on."}, {"ArticleIdList": {"ArticleId": {"#text": "17891185", "@IdType": "pubmed"}}, "Citation": "Kauffmann A, Rosselli F, Lazar V, Winnepenninckx V, Mansuet-Lupo A, Dessen P, van den Oord JJ, Spatz A, Sarasin A. High expression of DNA repair pathways is associated with metastasis in melanoma patients. Oncogene. 2007;27:565\u2013573."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC187518", "@IdType": "pmc"}, {"#text": "11932250", "@IdType": "pubmed"}]}, "Citation": "Kent WJ. BLAT\u2013The BLAST-Like Alignment Tool. Genome Res. 2002;12:656\u2013664."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC231389", "@IdType": "pmc"}, {"#text": "8668210", "@IdType": "pubmed"}]}, "Citation": "Khosravi-Far R, White MA, Westwick JK, Solski PA, Chrzanowska-Wodnicka M, Van Aelst L, Wigler MH, Der CJ. Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation. Mol Cell Biol. 1996;16:3923\u20133933."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3020079", "@IdType": "pmc"}, {"#text": "20393465", "@IdType": "pubmed"}]}, "Citation": "Kim TK, Hemberg M, Gray JM, Costa AM, Bear DM, Wu J, Harmin DA, Laptewicz M, Barbara-Haley K, Kuersten S, et al. Widespread transcription at neuronal activity-regulated enhancers. Nature. 2010;465:182\u2013187."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3674581", "@IdType": "pmc"}, {"#text": "23201690", "@IdType": "pubmed"}]}, "Citation": "Kretz M, Siprashvili Z, Chu C, Webster DE, Zehnder A, Qu K, Lee CS, Flockhart RJ, Groff AF, Chow J, et al. Control of somatic tissue differentiation by the long non-coding RNA TINCR. Nature. 2013;493:231\u2013235."}, {"ArticleIdList": {"ArticleId": {"#text": "17937395", "@IdType": "pubmed"}}, "Citation": "Kwan KM, Fujimoto E, Grabher C, Mangum BD, Hardy ME, Campbell DS, Parant JM, Yost HJ, Kanki JP, Chien CB. The Tol2kit: a multisite gateway-based construction kit for Tol2 transposon transgenesis constructs. Dev Dyn Off Publ Am Assoc Anat. 2007;236:3088\u20133099."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2680704", "@IdType": "pmc"}, {"#text": "18345029", "@IdType": "pubmed"}]}, "Citation": "Langenau DM, Keefe MD, Storer NY, Jette CA, Smith ACH, Ceol CJ, Bourque C, Look AT, Zon LI. Co-injection strategies to modify radiation sensitivity and tumor initiation in transgenic Zebrafish. Oncogene. 2008;27:4242\u20134248."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4417002", "@IdType": "pmc"}, {"#text": "25869999", "@IdType": "pubmed"}]}, "Citation": "St Laurent G, Wahlestedt C, Kapranov P. The Landscape of long noncoding RNA classification. Trends Genet. 2015;31:239\u2013251."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4715682", "@IdType": "pmc"}, {"#text": "26724866", "@IdType": "pubmed"}]}, "Citation": "Lee S, Kopp F, Chang TC, Sataluri A, Chen B, Sivakumar S, Yu H, Xie Y, Mendell JT. Noncoding RNA NORAD Regulates Genomic Stability by Sequestering PUMILIO Proteins. Cell 2015"}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3163565", "@IdType": "pmc"}, {"#text": "21816040", "@IdType": "pubmed"}]}, "Citation": "Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 2011;12:323."}, {"ArticleIdList": {"ArticleId": {"#text": "24227677", "@IdType": "pubmed"}}, "Citation": "Liao Y, Smyth GK, Shi W. FeatureCounts: An efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30:923\u2013930."}, {"ArticleIdList": {"ArticleId": {"#text": "17440532", "@IdType": "pubmed"}}, "Citation": "Lieschke GJ, Currie PD. Animal models of human disease: zebrafish swim into view. Nat Rev Genet. 2007;8:353\u2013367."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3898314", "@IdType": "pmc"}, {"#text": "23831555", "@IdType": "pubmed"}]}, "Citation": "Lister JA, Capper A, Zeng Z, Mathers ME, Richardson J, Paranthaman K, Jackson IJ, Patton EE. A conditional zebrafish MITF mutation reveals MITF levels are critical for melanoma promotion vs. regression in vivo. J Invest Dermatol. 2014;134:133\u2013140."}, {"ArticleIdList": {"ArticleId": {"#text": "24080445", "@IdType": "pubmed"}}, "Citation": "Livingstone C. IGF2 and cancer. Endocr Relat Cancer. 2013;20:321\u2013339."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2722245", "@IdType": "pmc"}, {"#text": "19629047", "@IdType": "pubmed"}]}, "Citation": "Luke B, Lingner J. TERRA: telomeric repeat-containing RNA. EMBO J. 2009;28:2503\u20132510."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3712628", "@IdType": "pmc"}, {"#text": "23287722", "@IdType": "pubmed"}]}, "Citation": "Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church GM. RNA-guided human genome engineering via Cas9. Science. 2013;339:823\u2013826."}, {"ArticleIdList": {"ArticleId": {"#text": "16651366", "@IdType": "pubmed"}}, "Citation": "Mattick JS, Makunin IV. Non-coding RNA. Hum Mol Genet. 2006;15:17\u201329. Spec No."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4309259", "@IdType": "pmc"}, {"#text": "25499224", "@IdType": "pubmed"}]}, "Citation": "Mehra R, Shi Y, Udager AM, Prensner JR, Sahu A, Iyer MK, Siddiqui J, Cao X, Wei J, Jiang H, et al. A novel RNA in situ hybridization assay for the long noncoding RNA SChLAP1 predicts poor clinical outcome after radical prostatectomy in clinically localized prostate cancer. Neoplasia N Y N. 2014;16:1121\u20131127."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4547472", "@IdType": "pmc"}, {"#text": "25954002", "@IdType": "pubmed"}]}, "Citation": "Mel\u00e9 M, Ferreira PG, Reverter F, DeLuca DS, Monlong J, Sammeth M, Young TR, Goldmann JM, Pervouchine DD, Sullivan TJ, et al. The human transcriptome across tissues and individuals. Science. 2015;348:660\u2013665."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4314111", "@IdType": "pmc"}, {"#text": "24776770", "@IdType": "pubmed"}]}, "Citation": "Morris KV, Mattick JS. The rise of regulatory RNA. Nat Rev Genet. 2014;15:423\u2013437."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4892890", "@IdType": "pmc"}, {"#text": "26816378", "@IdType": "pubmed"}]}, "Citation": "Nelson BR, Makarewich CA, Anderson DM, Winders BR, Troupes CD, Wu F, Reese AL, McAnally JR, Chen X, Kavalali ET, et al. A peptide encoded by a transcript annotated as long noncoding RNA enhances SERCA activity in muscle. Science. 2016;351:271\u2013275."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC116055", "@IdType": "pmc"}, {"#text": "9891060", "@IdType": "pubmed"}]}, "Citation": "Nielsen J, Christiansen J, Lykke-Andersen J, Johnsen AH, Wewer UM, Nielsen FC. A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol Cell Biol. 1999;19:1262\u20131270."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC514376", "@IdType": "pmc"}, {"#text": "15314207", "@IdType": "pubmed"}]}, "Citation": "Nielsen J, Kristensen MA, Willemo\u00ebs M, Nielsen FC, Christiansen J. Sequential dimerization of human zipcode-binding protein IMP1 on RNA: A cooperative mechanism providing RNP stability. Nucleic Acids Res. 2004;32:4368\u20134376."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4107353", "@IdType": "pmc"}, {"#text": "24407481", "@IdType": "pubmed"}]}, "Citation": "Pauli A, Norris MLM, Valen E, Chew GL, Gagnon JA, Zimmerman S, Mitchell A, Ma J, Dubrulle J, Reyon D, et al. Toddler: an embryonic signal that promotes cell movement via Apelin receptors. Science. 2014;343:1248636."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3410386", "@IdType": "pmc"}, {"#text": "22688967", "@IdType": "pubmed"}]}, "Citation": "Pitchiaya S, Androsavich JR, Walter NG. Intracellular single molecule microscopy reveals two kinetically distinct pathways for microRNA assembly. EMBO Rep. 2012;13:709\u2013715."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3108839", "@IdType": "pmc"}, {"#text": "21421797", "@IdType": "pubmed"}]}, "Citation": "Poliakov A, Russell CW, Ponnala L, Hoops HJ, Sun Q, Douglas AE, van Wijk KJ. Large-scale label-free quantitative proteomics of the pea aphid-Buchnera symbiosis. Mol Cell Proteomics MCP. 2011;10 M110.007039."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3215093", "@IdType": "pmc"}, {"#text": "22096659", "@IdType": "pubmed"}]}, "Citation": "Prensner JR, Chinnaiyan AM. The emergence of lncRNAs in cancer biology. Cancer Discov. 2011;1:391\u2013407."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3812362", "@IdType": "pmc"}, {"#text": "24076601", "@IdType": "pubmed"}]}, "Citation": "Prensner JR, Iyer MK, Sahu A, Asangani IA, Cao Q, Patel L, Vergara IA, Davicioni E, Erho N, Ghadessi M, et al. The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex. Nat Genet. 2013;45:1392\u20131398."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3126653", "@IdType": "pmc"}, {"#text": "18806792", "@IdType": "pubmed"}]}, "Citation": "Raj A, van den Bogaard P, Rifkin SA, van Oudenaarden A, Tyagi S. Imaging individual mRNA molecules using multiple singly labeled probes. Nat Methods. 2008;5:877\u2013879."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4672369", "@IdType": "pmc"}, {"#text": "26693181", "@IdType": "pubmed"}]}, "Citation": "Sahu A, Singhal U, Chinnaiyan AM. Long Noncoding RNAs in Cancer: From Function to Translation. Trends Cancer. 2016;1:93\u2013109."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3235919", "@IdType": "pmc"}, {"#text": "21802130", "@IdType": "pubmed"}]}, "Citation": "Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell. 2011;146:353\u2013358."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4530801", "@IdType": "pmc"}, {"#text": "26040603", "@IdType": "pubmed"}]}, "Citation": "S\u00e1nchez-Rivera FJ, Jacks T. Applications of the CRISPR-Cas9 system in cancer biology. Nat Rev Cancer. 2015;15:387\u2013395."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3874104", "@IdType": "pmc"}, {"#text": "24381249", "@IdType": "pubmed"}]}, "Citation": "Sauvageau M, Goff LA, Lodato S, Bonev B, Groff AF, Gerhardinger C, Sanchez-Gomez DB, Hacisuleyman E, Li E, Spence M, et al. Multiple knockout mouse models reveal lincRNAs are required for life and brain development. eLife. 2013;2013:1\u201324."}, {"ArticleIdList": {"ArticleId": {"#text": "12445278", "@IdType": "pubmed"}}, "Citation": "Scanlan MJ, Gure AO, Jungbluth AA, Old LJ, Chen YT. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev. 2002;188:22\u201332."}, {"ArticleIdList": {"ArticleId": {"#text": "16034368", "@IdType": "pubmed"}}, "Citation": "Simpson AJG, Caballero OL, Jungbluth A, Chen YT, Old LJ. Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer. 2005;5:615\u2013625."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC1239896", "@IdType": "pmc"}, {"#text": "16199517", "@IdType": "pubmed"}]}, "Citation": "Subramanian A, Subramanian A, Tamayo P, Tamayo P, Mootha VK, Mootha VK, Mukherjee S, Mukherjee S, Ebert BL, Ebert BL, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545\u201350."}, {"ArticleIdList": {"ArticleId": {"#text": "14659893", "@IdType": "pubmed"}}, "Citation": "Tapparel C, Reymond A, Girardet C, Guillou L, Lyle R, Lamon C, Hutter P, Antonarakis SE. The TPTE gene family: Cellular expression, subcellular localization and alternative splicing. Gene. 2003;323:189\u2013199."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3924787", "@IdType": "pmc"}, {"#text": "23827673", "@IdType": "pubmed"}]}, "Citation": "Ulitsky I, Bartel DP. LincRNAs: Genomics, evolution, and mechanisms. Cell. 2013;154:26\u201346."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3376356", "@IdType": "pmc"}, {"#text": "22196729", "@IdType": "pubmed"}]}, "Citation": "Ulitsky I, Shkumatava A, Jan CH, Sive H, Bartel DP. Conserved function of lincRNAs in vertebrate embryonic development despite rapid sequence evolution. Cell. 2011;147:1537\u20131550."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3670758", "@IdType": "pmc"}, {"#text": "21423168", "@IdType": "pubmed"}]}, "Citation": "Wang KC, Yang YW, Liu B, Sanyal A, Corces-Zimmerman R, Chen Y, Lajoie BR, Protacio A, Flynn RA, Gupta RA, et al. A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature. 2011;472:120\u2013124."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3616698", "@IdType": "pmc"}, {"#text": "23335781", "@IdType": "pubmed"}]}, "Citation": "Wang L, Park HJ, Dasari S, Wang S, Kocher JP, Li W. CPAT: Coding-potential assessment tool using an alignment-free logistic regression model. Nucleic Acids Res. 2013;41:1\u20137."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2612774", "@IdType": "pmc"}, {"#text": "19029303", "@IdType": "pubmed"}]}, "Citation": "Weidensdorfer D, St\u00f6hr N, Baude A, Lederer M, K\u00f6hn M, Schierhorn A, Buchmeier S, Wahle E, H\u00fcttelmaier S. Control of c-myc mRNA stability by IGF2BP1-associated cytoplasmic RNPs. RNA N Y N. 2009;15:104\u2013115."}, {"Citation": "Westerfield M. The Zebrafish Book A Guide for the Laboratory Use of Zebrafish (Danio rerio) 5th. Univ Or Press Eugene Book; 2007."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6040891", "@IdType": "pmc"}, {"#text": "23969693", "@IdType": "pubmed"}]}, "Citation": "White R, Rose K, Zon L. Zebrafish cancer: the state of the art and the path forward 2013"}, {"ArticleIdList": {"ArticleId": {"#text": "16595783", "@IdType": "pubmed"}}, "Citation": "Winnepenninckx V, Lazar V, Michiels S, Dessen P, Stas M, Alonso SR, Avril MF, Romero O, L P, Robert T, et al. Gene Expression Profiling of Primary Cutaneous Melanoma and Clinical Outcome. JNCI J Natl Cancer Inst. 2006;98:472\u2013482."}]}}}}}, "PMC": "PMC5734106", "PMID": "29245011", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "Oncogenic Role of THOR, a Conserved Cancer/Testis Long Non-coding RNA.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "24": {"Abstract": " The zebrafish xenograft model has become a reliable  model for human cancer research. Compared to a mouse model, the zebrafish xenograft has many advantages, including optical transparency, intuitive  observation, and speed. Long noncoding RNAs (lncRNAs) have been identified as crucial regulatory factors in the progression of colorectal cancer (CRC). The biological function of lncRNA small nucleolar RNA host gene 4 () in CRC is still unclear. We analyzed the expression of  in CRC patient samples by the Gene Expression Profiling Interactive Analysis (GEPIA) software. The quantitative real time-polymerase chain reaction (qRT-PCR) was used to verify in CRC cell lines. The colony formation assay was used to study the cell proliferation, and we used the transwell assay to detect the migration ability. Then the zebrafish xenograft models were used to confirm these roles of  . Moreover, we detected epithelial mesenchymal transition (EMT) related genes by qRT-PCR. We found the expression of  was upregulated in CRC patient samples by analyzing GEPIA software, which was also verified in CRC cell lines. We also found that silencing  inhibited the proliferation and migration of CRC cells, and its roles were verified in zebrafish xenografts . Further, we found that the expression of  was significantly upregulated and  was downregulated when knocking-down  in CRC cells. Our findings demonstrated that  played oncogenic roles in CRC, which could be a potential target for treatment of CRC patients, and the results strongly revealed that zebrafish xenograft could be used for functional research of lncRNAs in human cancer.", "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "-6547506933755460377", "Part1": "Department of General Surgery", "Part2": "Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine", "Part3": "Nanjing", "Part4": "China.", "Part5": null, "Part6": null, "Text": "Department of General Surgery, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, China."}, {"Has_Extra": false, "HashID": "6585627280855423683", "Part1": "Department of General Surgery", "Part2": "The Affiliated Huai'an Hospital of Xuzhou Medical University", "Part3": "Xuzhou", "Part4": "China.", "Part5": null, "Part6": null, "Text": "Department of General Surgery, The Affiliated Huai'an Hospital of Xuzhou Medical University, Xuzhou, China."}], "ForeName": "Jian", "FullName": "Jian Wang", "HashID": "-2220239737699140507", "LastName": "Wang", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "6585627280855423683", "Part1": "Department of General Surgery", "Part2": "The Affiliated Huai'an Hospital of Xuzhou Medical University", "Part3": "Xuzhou", "Part4": "China.", "Part5": null, "Part6": null, "Text": "Department of General Surgery, The Affiliated Huai'an Hospital of Xuzhou Medical University, Xuzhou, China."}], "ForeName": "Xiao-Yu", "FullName": "Xiao-Yu Zhang", "HashID": "-2101930459040459967", "LastName": "Zhang", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "1728439948323435050", "Part1": "Department of Gastroenterology", "Part2": "The Affiliated Huai'an Hospital of Xuzhou Medical University", "Part3": "Xuzhou", "Part4": "China.", "Part5": null, "Part6": null, "Text": "Department of Gastroenterology, The Affiliated Huai'an Hospital of Xuzhou Medical University, Xuzhou, China."}], "ForeName": "Dong-Yan", "FullName": "Dong-Yan Xu", "HashID": "-8500441329183302230", "LastName": "Xu", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.21037/jgo-21-832", "InsertType": null, "Journal": "Journal of gastrointestinal oncology", "Keywords": [{"IS_Major": false, "IS_Mesh": false, "Text": "Zebrafish xenograft"}, {"IS_Major": false, "IS_Mesh": false, "Text": "cell migration"}, {"IS_Major": false, "IS_Mesh": false, "Text": "cell proliferation"}, {"IS_Major": false, "IS_Mesh": false, "Text": "colorectal cancer (CRC)"}, {"IS_Major": false, "IS_Mesh": false, "Text": "lncRNA SNHG4"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "PubMed-not-MEDLINE", "Article": {"@PubModel": "Print", "Abstract": {"AbstractText": [{"#text": "The zebrafish xenograft model has become a reliable  model for human cancer research. Compared to a mouse model, the zebrafish xenograft has many advantages, including optical transparency, intuitive  observation, and speed. Long noncoding RNAs (lncRNAs) have been identified as crucial regulatory factors in the progression of colorectal cancer (CRC). The biological function of lncRNA small nucleolar RNA host gene 4 () in CRC is still unclear.", "@Label": "BACKGROUND", "@NlmCategory": "UNASSIGNED", "i": ["in vivo", "in vivo", "SNHG4"]}, {"#text": "We analyzed the expression of  in CRC patient samples by the Gene Expression Profiling Interactive Analysis (GEPIA) software. The quantitative real time-polymerase chain reaction (qRT-PCR) was used to verify in CRC cell lines. The colony formation assay was used to study the cell proliferation, and we used the transwell assay to detect the migration ability. Then the zebrafish xenograft models were used to confirm these roles of  . Moreover, we detected epithelial mesenchymal transition (EMT) related genes by qRT-PCR.", "@Label": "METHODS", "@NlmCategory": "UNASSIGNED", "i": ["SNHG4", "SNHG4", "in vivo"]}, {"#text": "We found the expression of  was upregulated in CRC patient samples by analyzing GEPIA software, which was also verified in CRC cell lines. We also found that silencing  inhibited the proliferation and migration of CRC cells, and its roles were verified in zebrafish xenografts . Further, we found that the expression of  was significantly upregulated and  was downregulated when knocking-down  in CRC cells.", "@Label": "RESULTS", "@NlmCategory": "UNASSIGNED", "i": ["SNHG4", "SNHG4", "in vivo", "E-cadherin", "N-cadherin", "SNHG4"]}, {"#text": "Our findings demonstrated that  played oncogenic roles in CRC, which could be a potential target for treatment of CRC patients, and the results strongly revealed that zebrafish xenograft could be used for functional research of lncRNAs in human cancer.", "@Label": "CONCLUSIONS", "@NlmCategory": "UNASSIGNED", "i": "SNHG4"}], "CopyrightInformation": "2022 Journal of Gastrointestinal Oncology. All rights reserved."}, "ArticleTitle": "Zebrafish xenograft model for studying the function of lncRNA SNHG4 in the proliferation and migration of colorectal cancer.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of General Surgery, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, China."}, {"Affiliation": "Department of General Surgery, The Affiliated Huai'an Hospital of Xuzhou Medical University, Xuzhou, China."}], "ForeName": "Jian", "Initials": "J", "LastName": "Wang"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of General Surgery, The Affiliated Huai'an Hospital of Xuzhou Medical University, Xuzhou, China."}, "ForeName": "Xiao-Yu", "Initials": "XY", "LastName": "Zhang"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Gastroenterology, The Affiliated Huai'an Hospital of Xuzhou Medical University, Xuzhou, China."}, "ForeName": "Dong-Yan", "Initials": "DY", "LastName": "Xu"}]}, "ELocationID": {"#text": "10.21037/jgo-21-832", "@EIdType": "doi", "@ValidYN": "Y"}, "Journal": {"ISOAbbreviation": "J Gastrointest Oncol", "ISSN": {"#text": "2078-6891", "@IssnType": "Print"}, "JournalIssue": {"@CitedMedium": "Print", "Issue": "1", "PubDate": {"Month": "Feb", "Year": "2022"}, "Volume": "13"}, "Title": "Journal of gastrointestinal oncology"}, "Language": "eng", "Pagination": {"EndPage": "220", "MedlinePgn": "210-220", "StartPage": "210"}, "PublicationTypeList": {"PublicationType": {"#text": "Journal Article", "@UI": "D016428"}}}, "CoiStatement": "Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jgo.amegroups.com/article/view/10.21037/jgo-21-832/coif). The authors have no conflicts of interest to declare.", "DateRevised": {"Day": "15", "Month": "03", "Year": "2022"}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"#text": "Zebrafish xenograft", "@MajorTopicYN": "N"}, {"#text": "cell migration", "@MajorTopicYN": "N"}, {"#text": "cell proliferation", "@MajorTopicYN": "N"}, {"#text": "colorectal cancer (CRC)", "@MajorTopicYN": "N"}, {"#text": "lncRNA SNHG4", "@MajorTopicYN": "N"}]}, "MedlineJournalInfo": {"Country": "China", "ISSNLinking": "2078-6891", "MedlineTA": "J Gastrointest Oncol", "NlmUniqueID": "101557751"}, "PMID": {"#text": "35284103", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "35284103", "@IdType": "pubmed"}, {"#text": "PMC8899727", "@IdType": "pmc"}, {"#text": "10.21037/jgo-21-832", "@IdType": "doi"}, {"#text": "jgo-13-01-210", "@IdType": "pii"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "received", "Day": "2", "Month": "11", "Year": "2021"}, {"@PubStatus": "accepted", "Day": "30", "Month": "1", "Year": "2022"}, {"@PubStatus": "entrez", "Day": "14", "Hour": "5", "Minute": "58", "Month": "3", "Year": "2022"}, {"@PubStatus": "pubmed", "Day": "15", "Hour": "6", "Minute": "0", "Month": "3", "Year": "2022"}, {"@PubStatus": "medline", "Day": "15", "Hour": "6", "Minute": "1", "Month": "3", "Year": "2022"}]}, "PublicationStatus": "ppublish", "ReferenceList": {"Reference": [{"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrg2091", "@IdType": "doi"}, {"#text": "17440532", "@IdType": "pubmed"}]}, "Citation": "Lieschke GJ, Currie PD. Animal models of human disease: zebrafish swim into view. Nat Rev Genet 2007;8:353-67. 10.1038/nrg2091"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1089/zeb.2009.0614", "@IdType": "doi"}, {"#text": "19954326", "@IdType": "pubmed"}]}, "Citation": "Snaar-Jagalska BE. ZF-CANCER: developing high-throughput bioassays for human cancers in zebrafish. Zebrafish 2009;6:441-3. 10.1089/zeb.2009.0614"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/genes10110935", "@IdType": "doi"}, {"#text": "PMC6896156", "@IdType": "pmc"}, {"#text": "31731811", "@IdType": "pubmed"}]}, "Citation": "Hason M, Bart\u016fn\u011bk P. Zebrafish Models of Cancer-New Insights on Modeling Human Cancer in a Non-Mammalian Vertebrate. Genes (Basel) 2019;10:935. 10.3390/genes10110935"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/1471-2407-13-453", "@IdType": "doi"}, {"#text": "PMC3852235", "@IdType": "pmc"}, {"#text": "24089705", "@IdType": "pubmed"}]}, "Citation": "Teng Y, Xie X, Walker S, et al. Evaluating human cancer cell metastasis in zebrafish. BMC Cancer 2013;13:453. 10.1186/1471-2407-13-453"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.1618389114", "@IdType": "doi"}, {"#text": "PMC5625889", "@IdType": "pmc"}, {"#text": "28835536", "@IdType": "pubmed"}]}, "Citation": "Fior R, P\u00f3voa V, Mendes RV, et al. Single-cell functional and chemosensitive profiling of combinatorial colorectal therapy in zebrafish xenografts. Proc Natl Acad Sci U S A 2017;114:E8234-43. 10.1073/pnas.1618389114"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/1078-0432.CCR-17-0101", "@IdType": "doi"}, {"#text": "28420724", "@IdType": "pubmed"}]}, "Citation": "Liu C, Zhang Y, Lim S, et al. A Zebrafish Model Discovers a Novel Mechanism of Stromal Fibroblast-Mediated Cancer Metastasis. Clin Cancer Res 2017;23:4769-79. 10.1158/1078-0432.CCR-17-0101"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/biomedicines5040058", "@IdType": "doi"}, {"#text": "PMC5744082", "@IdType": "pmc"}, {"#text": "28961226", "@IdType": "pubmed"}]}, "Citation": "Lu JW, Ho YJ, Ciou SC, et al. Innovative Disease Model: Zebrafish as an In Vivo Platform for Intestinal Disorder and Tumors. Biomedicines 2017;5:58. 10.3390/biomedicines5040058"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s13046-017-0631-0", "@IdType": "doi"}, {"#text": "PMC5688753", "@IdType": "pmc"}, {"#text": "29141689", "@IdType": "pubmed"}]}, "Citation": "Wu JQ, Zhai J, Li CY, et al. Patient-derived xenograft in zebrafish embryos: a new platform for translational research in gastric cancer. J Exp Clin Cancer Res 2017;36:160. 10.1186/s13046-017-0631-0"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41598-018-28515-6", "@IdType": "doi"}, {"#text": "PMC6041265", "@IdType": "pmc"}, {"#text": "29992995", "@IdType": "pubmed"}]}, "Citation": "Fornabaio G, Barnhill RL, Lugassy C, et al. Angiotropism and extravascular migratory metastasis in cutaneous and uveal melanoma progression in a zebrafish model. Sci Rep 2018;8:10448. 10.1038/s41598-018-28515-6"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/dvdy.20471", "@IdType": "doi"}, {"#text": "15968639", "@IdType": "pubmed"}]}, "Citation": "Lee LM, Seftor EA, Bonde G, et al. The fate of human malignant melanoma cells transplanted into zebrafish embryos: assessment of migration and cell division in the absence of tumor formation. Dev Dyn 2005;233:1560-70. 10.1002/dvdy.20471"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/1471-2407-9-128", "@IdType": "doi"}, {"#text": "PMC2697170", "@IdType": "pmc"}, {"#text": "19400945", "@IdType": "pubmed"}]}, "Citation": "Marques IJ, Weiss FU, Vlecken DH, et al. Metastatic behaviour of primary human tumours in a zebrafish xenotransplantation model. BMC Cancer 2009;9:128. 10.1186/1471-2407-9-128"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/978-3-319-30654-4_13", "@IdType": "doi"}, {"#text": "27165359", "@IdType": "pubmed"}]}, "Citation": "Wertman J, Veinotte CJ, Dellaire G, et al. The Zebrafish Xenograft Platform: Evolution of a Novel Cancer Model and Preclinical Screening Tool. Adv Exp Med Biol 2016;916:289-314. 10.1007/978-3-319-30654-4_13"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s10456-006-9040-2", "@IdType": "doi"}, {"#text": "17051341", "@IdType": "pubmed"}]}, "Citation": "Haldi M, Ton C, Seng WL, et al. Human melanoma cells transplanted into zebrafish proliferate, migrate, produce melanin, form masses and stimulate angiogenesis in zebrafish. Angiogenesis 2006;9:139-51. 10.1007/s10456-006-9040-2"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.0703446104", "@IdType": "doi"}, {"#text": "PMC2077269", "@IdType": "pmc"}, {"#text": "17954920", "@IdType": "pubmed"}]}, "Citation": "Stoletov K, Montel V, Lester RD, et al. High-resolution imaging of the dynamic tumor cell vascular interface in transparent zebrafish. Proc Natl Acad Sci U S A 2007;104:17406-11. 10.1073/pnas.0703446104"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3322/caac.21551", "@IdType": "doi"}, {"#text": "30620402", "@IdType": "pubmed"}]}, "Citation": "Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019;69:7-34. 10.3322/caac.21551"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1055/s-0029-1242463", "@IdType": "doi"}, {"#text": "PMC2796099", "@IdType": "pmc"}, {"#text": "21037814", "@IdType": "pubmed"}]}, "Citation": "Villeneuve PJ, Sundaresan RS. Surgical management of colorectal lung metastasis. Clin Colon Rectal Surg 2009;22:233-41. 10.1055/s-0029-1242463"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cell.2017.07.008", "@IdType": "doi"}, {"#text": "PMC5767127", "@IdType": "pmc"}, {"#text": "28753429", "@IdType": "pubmed"}]}, "Citation": "Yu T, Guo F, Yu Y, et al. Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy. Cell 2017;170:548-563.e16. 10.1016/j.cell.2017.07.008"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.jconrel.2018.02.008", "@IdType": "doi"}, {"#text": "PMC5908241", "@IdType": "pmc"}, {"#text": "29421609", "@IdType": "pubmed"}]}, "Citation": "Rychahou P, Bae Y, Reichel D, et al. Colorectal cancer lung metastasis treatment with polymer-drug nanoparticles. J Control Release 2018;275:85-91. 10.1016/j.jconrel.2018.02.008"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1126/science.1112014", "@IdType": "doi"}, {"#text": "16141072", "@IdType": "pubmed"}]}, "Citation": "Carninci P, Kasukawa T, Katayama S, et al. The transcriptional landscape of the mammalian genome. Science 2005;309:1559-63. 10.1126/science.1112014"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cell.2011.03.014", "@IdType": "doi"}, {"#text": "21496640", "@IdType": "pubmed"}]}, "Citation": "Nagano T, Fraser P. No-nonsense functions for long noncoding RNAs. Cell 2011;145:178-81. 10.1016/j.cell.2011.03.014"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12943-017-0583-1", "@IdType": "doi"}, {"#text": "PMC5237133", "@IdType": "pmc"}, {"#text": "28086904", "@IdType": "pubmed"}]}, "Citation": "Han P, Li JW, Zhang BM, et al. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/\u03b2-catenin signaling. Mol Cancer 2017;16:9. 10.1186/s12943-017-0583-1"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41419-018-0759-7", "@IdType": "doi"}, {"#text": "PMC6006356", "@IdType": "pmc"}, {"#text": "29915311", "@IdType": "pubmed"}]}, "Citation": "Shan Y, Ma J, Pan Y, et al. LncRNA SNHG7 sponges miR-216b to promote proliferation and liver metastasis of colorectal cancer through upregulating GALNT1. Cell Death Dis 2018;9:722. 10.1038/s41419-018-0759-7"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s13046-018-0771-x", "@IdType": "doi"}, {"#text": "PMC5960095", "@IdType": "pmc"}, {"#text": "29776371", "@IdType": "pubmed"}]}, "Citation": "Sun J, Hu J, Wang G, et al. LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancer. J Exp Clin Cancer Res 2018;37:106. 10.1186/s13046-018-0771-x"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41419-019-2077-0", "@IdType": "doi"}, {"#text": "PMC6828701", "@IdType": "pmc"}, {"#text": "31685807", "@IdType": "pubmed"}]}, "Citation": "Liang ZX, Liu HS, Wang FW, et al. LncRNA RPPH1 promotes colorectal cancer metastasis by interacting with TUBB3 and by promoting exosomes-mediated macrophage M2 polarization. Cell Death Dis 2019;10:829. 10.1038/s41419-019-2077-0"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12943-019-1063-6", "@IdType": "doi"}, {"#text": "PMC6729021", "@IdType": "pmc"}, {"#text": "31492160", "@IdType": "pubmed"}]}, "Citation": "Xu M, Xu X, Pan B, et al. LncRNA SATB2-AS1 inhibits tumor metastasis and affects the tumor immune cell microenvironment in colorectal cancer by regulating SATB2. Mol Cancer 2019;18:135. 10.1186/s12943-019-1063-6"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cell.2017.11.040", "@IdType": "doi"}, {"#text": "PMC5734106", "@IdType": "pmc"}, {"#text": "29245011", "@IdType": "pubmed"}]}, "Citation": "Hosono Y, Niknafs YS, Prensner JR, et al. Oncogenic Role of THOR, a Conserved Cancer/Testis Long Non-coding RNA. Cell 2017;171:1559-1572.e20. 10.1016/j.cell.2017.11.040"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1111/cpr.12515", "@IdType": "doi"}, {"#text": "PMC6528889", "@IdType": "pmc"}, {"#text": "30152090", "@IdType": "pubmed"}]}, "Citation": "Xu R, Feng F, Yu X, et al. LncRNA SNHG4 promotes tumour growth by sponging miR-224-3p and predicts poor survival and recurrence in human osteosarcoma. Cell Prolif 2018;51:e12515. 10.1111/cpr.12515"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.biochi.2019.05.006", "@IdType": "doi"}, {"#text": "31078583", "@IdType": "pubmed"}]}, "Citation": "Abel Y, Rederstorff M. SnoRNAs and the emerging class of sdRNAs: Multifaceted players in oncogenesis. Biochimie 2019;164:17-21. 10.1016/j.biochi.2019.05.006"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/cam4.2622", "@IdType": "doi"}, {"#text": "PMC6912041", "@IdType": "pmc"}, {"#text": "31691514", "@IdType": "pubmed"}]}, "Citation": "Yang H, Jiang Z, Wang S, et al. Long non-coding small nucleolar RNA host genes in digestive cancers. Cancer Med 2019;8:7693-704. 10.1002/cam4.2622"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.23255", "@IdType": "doi"}, {"#text": "PMC5788627", "@IdType": "pmc"}, {"#text": "29416759", "@IdType": "pubmed"}]}, "Citation": "Tian T, Qiu R, Qiu X. SNHG1 promotes cell proliferation by acting as a sponge of miR-145 in colorectal cancer. Oncotarget 2017;9:2128-39. 10.18632/oncotarget.23255"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/or.2017.5837", "@IdType": "doi"}, {"#text": "PMC5549033", "@IdType": "pmc"}, {"#text": "28731158", "@IdType": "pubmed"}]}, "Citation": "Huang W, Tian Y, Dong S, et al. The long non-coding RNA SNHG3 functions as a competing endogenous RNA to promote malignant development of colorectal cancer. Oncol Rep 2017;38:1402-10. 10.3892/or.2017.5837"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1139/bcb-2019-0065", "@IdType": "doi"}, {"#text": "31220419", "@IdType": "pubmed"}]}, "Citation": "Tang Y, Wu L, Zhao M, et al. LncRNA SNHG4 promotes the proliferation, migration, invasiveness, and epithelial-mesenchymal transition of lung cancer cells by regulating miR-98-5p. Biochem Cell Biol 2019;97:767-76. 10.1139/bcb-2019-0065"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1097/WNR.0000000000001469", "@IdType": "doi"}, {"#text": "32427712", "@IdType": "pubmed"}]}, "Citation": "Wang X, Tian W, Wu L, et al. LncRNA SNHG4 regulates miR-138/c-Met axis to promote the proliferation of glioblastoma cells. Neuroreport 2020;31:657-62. 10.1097/WNR.0000000000001469"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/jcp.29285", "@IdType": "doi"}, {"#text": "31608997", "@IdType": "pubmed"}]}, "Citation": "Wang ZY, Duan Y, Wang P. SP1-mediated upregulation of lncRNA SNHG4 functions as a ceRNA for miR-377 to facilitate prostate cancer progression through regulation of ZIC5. J Cell Physiol 2020;235:3916-27. 10.1002/jcp.29285"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.4149/neo_2020_191023N1081", "@IdType": "doi"}, {"#text": "32614236", "@IdType": "pubmed"}]}, "Citation": "Yang H, Guo JF, Zhang ML, et al. LncRNA SNHG4 promotes neuroblastoma proliferation, migration, and invasion by sponging miR-377-3p. Neoplasma 2020;67:1054-62. 10.4149/neo_2020_191023N1081"}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC8581836", "@IdType": "pmc"}, {"#text": "34786048", "@IdType": "pubmed"}]}, "Citation": "Zhou N, Chen Y, Yang L, et al. LncRNA SNHG4 promotes malignant biological behaviors and immune escape of colorectal cancer cells by regulating the miR-144-3p/MET axis. Am J Transl Res 2021;13:11144-61."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/aging.202737", "@IdType": "doi"}, {"#text": "PMC8064176", "@IdType": "pmc"}, {"#text": "33744866", "@IdType": "pubmed"}]}, "Citation": "Zhou Z, Tan F, Pei Q, et al. lncRNA SNHG4 modulates colorectal cancer cell cycle and cell proliferation through regulating miR-590-3p/CDK1 axis. Aging (Albany NY) 2021;13:9838-58. 10.18632/aging.202737"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1006/dbio.2002.0711", "@IdType": "doi"}, {"#text": "12167406", "@IdType": "pubmed"}]}, "Citation": "Lawson ND, Weinstein BM. In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev Biol 2002;248:307-18. 10.1006/dbio.2002.0711"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12935-020-01460-z", "@IdType": "doi"}, {"#text": "PMC7409423", "@IdType": "pmc"}, {"#text": "32774169", "@IdType": "pubmed"}]}, "Citation": "Shen W, Pu J, Sun J, et al. Zebrafish xenograft model of human lung cancer for studying the function of LINC00152 in cell proliferation and invasion. Cancer Cell Int 2020;20:376. 10.1186/s12935-020-01460-z"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s13045-018-0656-7", "@IdType": "doi"}, {"#text": "PMC6125951", "@IdType": "pmc"}, {"#text": "30185232", "@IdType": "pubmed"}]}, "Citation": "Zhang M, Weng W, Zhang Q, et al. The lncRNA NEAT1 activates Wnt/\u03b2-catenin signaling and promotes colorectal cancer progression via interacting with DDX5. J Hematol Oncol 2018;11:113. 10.1186/s13045-018-0656-7"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12943-019-1079-y", "@IdType": "doi"}, {"#text": "PMC6794841", "@IdType": "pmc"}, {"#text": "31619268", "@IdType": "pubmed"}]}, "Citation": "Ni W, Yao S, Zhou Y, et al. Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m6A reader YTHDF3. Mol Cancer 2019;18:143. 10.1186/s12943-019-1079-y"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41467-019-11447-8", "@IdType": "doi"}, {"#text": "PMC6677832", "@IdType": "pmc"}, {"#text": "31375671", "@IdType": "pubmed"}]}, "Citation": "Tang J, Yan T, Bao Y, et al. LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc. Nat Commun 2019;10:3499. 10.1038/s41467-019-11447-8"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12943-019-1105-0", "@IdType": "doi"}, {"#text": "PMC6886219", "@IdType": "pmc"}, {"#text": "31791342", "@IdType": "pubmed"}]}, "Citation": "Wang Y, Lu JH, Wu QN, et al. LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer. Mol Cancer 2019;18:174. 10.1186/s12943-019-1105-0"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1080/15384101.2019.1674071", "@IdType": "doi"}, {"#text": "PMC6927695", "@IdType": "pmc"}, {"#text": "31590627", "@IdType": "pubmed"}]}, "Citation": "Li H, Hong J, Wijayakulathilaka WSMA. Long non-coding RNA SNHG4 promotes cervical cancer progression through regulating c-Met via targeting miR-148a-3p. Cell Cycle 2019;18:3313-24. 10.1080/15384101.2019.1674071"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1080/15384047.2020.1794239", "@IdType": "doi"}, {"#text": "PMC7515495", "@IdType": "pmc"}, {"#text": "32730165", "@IdType": "pubmed"}]}, "Citation": "O'Brien SJ, Bishop C, Hallion J, et al. Long non-coding RNA (lncRNA) and epithelial-mesenchymal transition (EMT) in colorectal cancer: a systematic review. Cancer Biol Ther 2020;21:769-81. 10.1080/15384047.2020.1794239"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1371/journal.pone.0021768", "@IdType": "doi"}, {"#text": "PMC3135597", "@IdType": "pmc"}, {"#text": "21765912", "@IdType": "pubmed"}]}, "Citation": "Zhao C, Wang X, Zhao Y, et al. A novel xenograft model in zebrafish for high-resolution investigating dynamics of neovascularization in tumors. PLoS One 2011;6:e21768. 10.1371/journal.pone.0021768"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/laban0108-26", "@IdType": "doi"}, {"#text": "18094699", "@IdType": "pubmed"}]}, "Citation": "Steel CD, Stephens AL, Hahto SM, et al. Comparison of the lateral tail vein and the retro-orbital venous sinus as routes of intravenous drug delivery in a transgenic mouse model. Lab Anim (NY) 2008;37:26-32. 10.1038/laban0108-26"}]}}}}}, "PMC": "PMC8899727", "PMID": "35284103", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "Zebrafish xenograft model for studying the function of lncRNA SNHG4 in the proliferation and migration of colorectal cancer.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "25": {"Abstract": "Our current understanding of the molecular events that functionally characterize cellular biology continues to be revised. Recent observations find that the vast majority of the human genome is transcribed and may be functionally relevant. Many of these previously unrecognized transcripts, both short and long non-coding RNAs, have been found to be active modulators of protein coding gene function. While such observations were in the past relegated to imprinted genes, it is now becoming apparent that several different genes in differentiated cells may be under some form of non-coding RNA based regulatory control. Emerging evidence suggests that some of these long non-coding RNAs are functional in controlling gene transcription by the targeted recruitment of epigenetic silencing complexes to homology-containing loci in the genome. Most notably when these repressor non-coding RNAs are targeted using small RNA-based inhibitors (such as with RNA interference), a de-repression of the targeted gene can occur resulting in activation of gene expression. Knowledge of this emerging RNA based epigenetic regulatory network has implications not only in cellular evolution but also for the development of an entirely new area of pharmacology.", "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "-3824494855829330870", "Part1": "Department of Molecular and Experimental Medicine", "Part2": "The Scripps Research Institute", "Part3": "La Jolla", "Part4": "California 92037", "Part5": "USA.", "Part6": null, "Text": "Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California 92037, USA."}], "ForeName": "Marc S", "FullName": "Marc S Weinberg", "HashID": "-2668195250660964076", "LastName": "Weinberg", "ORCID": null}, {"Affiliations": null, "ForeName": "Kevin V", "FullName": "Kevin V Morris", "HashID": "-5961021227450775058", "LastName": "Morris", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.1089/nat.2012.0412", "InsertType": null, "Journal": "Nucleic acid therapeutics", "Keywords": [{"IS_Major": false, "IS_Mesh": true, "Text": "Epigenesis, Genetic"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Gene Silencing"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Humans"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Models, Genetic"}, {"IS_Major": false, "IS_Mesh": true, "Text": "RNA Interference"}, {"IS_Major": false, "IS_Mesh": true, "Text": "RNA, Antisense"}, {"IS_Major": false, "IS_Mesh": true, "Text": "RNA, Long Noncoding"}, {"IS_Major": true, "IS_Mesh": true, "Text": "Transcription, Genetic"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Transcriptional Activation"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "MEDLINE", "Article": {"@PubModel": "Print", "Abstract": {"AbstractText": "Our current understanding of the molecular events that functionally characterize cellular biology continues to be revised. Recent observations find that the vast majority of the human genome is transcribed and may be functionally relevant. Many of these previously unrecognized transcripts, both short and long non-coding RNAs, have been found to be active modulators of protein coding gene function. While such observations were in the past relegated to imprinted genes, it is now becoming apparent that several different genes in differentiated cells may be under some form of non-coding RNA based regulatory control. Emerging evidence suggests that some of these long non-coding RNAs are functional in controlling gene transcription by the targeted recruitment of epigenetic silencing complexes to homology-containing loci in the genome. Most notably when these repressor non-coding RNAs are targeted using small RNA-based inhibitors (such as with RNA interference), a de-repression of the targeted gene can occur resulting in activation of gene expression. Knowledge of this emerging RNA based epigenetic regulatory network has implications not only in cellular evolution but also for the development of an entirely new area of pharmacology."}, "ArticleTitle": "Long non-coding RNA targeting and transcriptional de-repression.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California 92037, USA."}, "ForeName": "Marc S", "Initials": "MS", "LastName": "Weinberg"}, {"@ValidYN": "Y", "ForeName": "Kevin V", "Initials": "KV", "LastName": "Morris"}]}, "ELocationID": {"#text": "10.1089/nat.2012.0412", "@EIdType": "doi", "@ValidYN": "Y"}, "GrantList": {"@CompleteYN": "Y", "Grant": [{"Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States", "GrantID": "R01 CA151574"}, {"Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States", "GrantID": "R01 CA153124"}, {"Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States", "GrantID": "P01 AI099783-01"}, {"Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States", "GrantID": "R56 AI096861-01"}]}, "Journal": {"ISOAbbreviation": "Nucleic Acid Ther", "ISSN": {"#text": "2159-3345", "@IssnType": "Electronic"}, "JournalIssue": {"@CitedMedium": "Internet", "Issue": "1", "PubDate": {"Month": "Feb", "Year": "2013"}, "Volume": "23"}, "Title": "Nucleic acid therapeutics"}, "Language": "eng", "Pagination": {"EndPage": "14", "MedlinePgn": "9-14", "StartPage": "9"}, "PublicationTypeList": {"PublicationType": [{"#text": "Journal Article", "@UI": "D016428"}, {"#text": "Research Support, N.I.H., Extramural", "@UI": "D052061"}, {"#text": "Review", "@UI": "D016454"}]}}, "ChemicalList": {"Chemical": [{"NameOfSubstance": {"#text": "RNA, Antisense", "@UI": "D016372"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "RNA, Long Noncoding", "@UI": "D062085"}, "RegistryNumber": "0"}]}, "CitationSubset": "IM", "DateCompleted": {"Day": "06", "Month": "09", "Year": "2013"}, "DateRevised": {"Day": "01", "Month": "11", "Year": "2021"}, "MedlineJournalInfo": {"Country": "United States", "ISSNLinking": "2159-3337", "MedlineTA": "Nucleic Acid Ther", "NlmUniqueID": "101562758"}, "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"#text": "Epigenesis, Genetic", "@MajorTopicYN": "N", "@UI": "D044127"}}, {"DescriptorName": {"#text": "Gene Silencing", "@MajorTopicYN": "N", "@UI": "D020868"}}, {"DescriptorName": {"#text": "Humans", "@MajorTopicYN": "N", "@UI": "D006801"}}, {"DescriptorName": {"#text": "Models, Genetic", "@MajorTopicYN": "N", "@UI": "D008957"}}, {"DescriptorName": {"#text": "RNA Interference", "@MajorTopicYN": "N", "@UI": "D034622"}}, {"DescriptorName": {"#text": "RNA, Antisense", "@MajorTopicYN": "N", "@UI": "D016372"}, "QualifierName": [{"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}, {"#text": "metabolism", "@MajorTopicYN": "N", "@UI": "Q000378"}]}, {"DescriptorName": {"#text": "RNA, Long Noncoding", "@MajorTopicYN": "N", "@UI": "D062085"}, "QualifierName": [{"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}, {"#text": "metabolism", "@MajorTopicYN": "Y", "@UI": "Q000378"}]}, {"DescriptorName": {"#text": "Transcription, Genetic", "@MajorTopicYN": "Y", "@UI": "D014158"}}, {"DescriptorName": {"#text": "Transcriptional Activation", "@MajorTopicYN": "N", "@UI": "D015533"}}]}, "PMID": {"#text": "23391414", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "23391414", "@IdType": "pubmed"}, {"#text": "PMC3569965", "@IdType": "pmc"}, {"#text": "10.1089/nat.2012.0412", "@IdType": "doi"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "entrez", "Day": "9", "Hour": "6", "Minute": "0", "Month": "2", "Year": "2013"}, {"@PubStatus": "pubmed", "Day": "9", "Hour": "6", "Minute": "0", "Month": "2", "Year": "2013"}, {"@PubStatus": "medline", "Day": "7", "Hour": "6", "Minute": "0", "Month": "9", "Year": "2013"}]}, "PublicationStatus": "ppublish", "ReferenceList": {"Reference": [{"Citation": "ALBERTS B. BRAY D. LEWIS J. RAFF M. ROBERTS K. WATSON J.D. Molecular Biology of the Cell. 3rd. Garland Science; New York: 1994."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3431482", "@IdType": "pmc"}, {"#text": "22955977", "@IdType": "pubmed"}]}, "Citation": "BANFAI B. JIA H. KHATUN J. WOOD E. RISK B. GUNDLING W.E., JR. KUNDAJE A. GUNAWARDENA H.P. YU Y. XIE L., et al. Long noncoding RNAs are rarely translated in two human cell lines. Genome Res. 2012;22:1646\u20131657."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3439153", "@IdType": "pmc"}, {"#text": "22955616", "@IdType": "pubmed"}]}, "Citation": "BERNSTEIN B.E. BIRNEY E. DUNHAM I. GREEN E.D. GUNTER C. SNYDER M. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489:57\u201374."}, {"ArticleIdList": {"ArticleId": {"#text": "21846568", "@IdType": "pubmed"}}, "Citation": "GREEN V.A. WEINBERG M.S. Small RNA-induced transcriptional gene regulation in mammals mechanisms, therapeutic applications, and scope within the genome. Prog. Mol. Biol. Transl. Sci. 2011;102:11\u201346."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC1924466", "@IdType": "pmc"}, {"#text": "17640892", "@IdType": "pubmed"}]}, "Citation": "HAN J. KIM D. MORRIS K.V. Promoter-associated RNA is required for RNA-directed transcriptional gene silencing in human cells. Proc. Natl. Acad. Sci. U. S. A. 2007;104:12422\u201312427."}, {"ArticleIdList": {"ArticleId": {"#text": "15372045", "@IdType": "pubmed"}}, "Citation": "HANNON G.J. ROSSI J.J. Unlocking the potential of the human genome with RNA interference. Nature. 2004;431:371\u2013378."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2999937", "@IdType": "pmc"}, {"#text": "21151833", "@IdType": "pubmed"}]}, "Citation": "HAWKINS P.G. MORRIS K.V. Transcriptional regulation of Oct4 by a long non-coding RNA antisense to Oct4-pseudogene 5. Transcription. 2010;1:165\u2013175."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2685082", "@IdType": "pmc"}, {"#text": "19304753", "@IdType": "pubmed"}]}, "Citation": "HAWKINS P.G. SANTOSO S. ADAMS C. ANEST V. MORRIS K.V. Promoter targeted small RNAs induce long-term transcriptional gene silencing in human cells. Nucleic Acids Res. 2009;37:2984\u20132995."}, {"ArticleIdList": {"ArticleId": {"#text": "16936728", "@IdType": "pubmed"}}, "Citation": "JANOWSKI B.A. HUFFMAN K.E. SCHWARTZ J.C. RAM R. NORDSELL R. SHAMES D.S. MINNA J.D. COREY D.R. Involvement of AGO1 and AGO2 in mammalian transcriptional silencing. Nat. Struct. Mol. Biol. 2006;13:787\u2013792."}, {"ArticleIdList": {"ArticleId": {"#text": "22491950", "@IdType": "pubmed"}}, "Citation": "KERIN T. RAMANATHAN A. RIVAS K. GREPO N. COETZEE G.A. CAMPBELL D.B. A noncoding RNA antisense to moesin at 5p14.1 in autism. Sci. Transl. Med. 2012;4:128ra40."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2571020", "@IdType": "pmc"}, {"#text": "18852463", "@IdType": "pubmed"}]}, "Citation": "KIM D.H. SAETROM P. SNOVE O., JR. ROSSI J.J. MicroRNA-directed transcriptional gene silencing in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 2008;105:16230\u201316235."}, {"ArticleIdList": {"ArticleId": {"#text": "16936726", "@IdType": "pubmed"}}, "Citation": "KIM D.H. VILLENEUVE L.M. MORRIS K.V. ROSSI J.J. Argonaute-1 directs siRNA-mediated transcriptional gene silencing in human cells. Nat. Struct. Mol. Biol. 2006;13:793\u2013797."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC1955452", "@IdType": "pmc"}, {"#text": "17663774", "@IdType": "pubmed"}]}, "Citation": "KLASE Z. KALE P. WINOGRAD R. GUPTA M.V. HEYDARIAN M. BERRO R. MCCAFFREY T. KASHANCHI F. HIV-1 TAR element is processed by Dicer to yield a viral micro-RNA involved in chromatin remodeling of the viral LTR. BMC Mol. Biol. 2007;8:63."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2847177", "@IdType": "pmc"}, {"#text": "19229135", "@IdType": "pubmed"}]}, "Citation": "LATOS P.A. BARLOW D.P. Regulation of imprinted expression by macro non-coding RNAs. RNA Biol. 2009;6:100\u2013106."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2725936", "@IdType": "pmc"}, {"#text": "19684108", "@IdType": "pubmed"}]}, "Citation": "LEE J.T. Lessons from X-chromosome inactivation: long ncRNA as guides and tethers to the epigenome. Genes Dev. 2009;23:1831\u20131842."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC1859931", "@IdType": "pmc"}, {"#text": "17085592", "@IdType": "pubmed"}]}, "Citation": "LI L.C. OKINO S.T. ZHAO H. POOKOT D. PLACE R.F. URAKAMI S. ENOKIDA H. DAHIYA R. Small dsRNAs induce transcriptional activation in human cells. Proc. Natl. Acad. Sci. U. S. A. 2006;103:17337\u201317342."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3522156", "@IdType": "pmc"}, {"#text": "22960213", "@IdType": "pubmed"}]}, "Citation": "LIPOVICH L. DACHET F. CAI J. BAGLA S. BALAN K. JAI H. LOEB J.A. Activity-dependent human brain coding/non-coding gene regulatory networks. Genetics. 2012;192:1133\u20131148."}, {"ArticleIdList": {"ArticleId": {"#text": "16651366", "@IdType": "pubmed"}}, "Citation": "MATTICK J.S. MAKUNIN I.V. Non-coding RNA. Hum. Mol. Genet. 2006;15(1):R17\u201329."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4144683", "@IdType": "pmc"}, {"#text": "22446693", "@IdType": "pubmed"}]}, "Citation": "MODARRESI F. FAGHIHI M.A. LOPEZ-TOLEDANO M.A. FATEMI R.P. MAGISTRI M. BROTHERS S.P. VAN DER BRUG M.P. WAHLESTEDT C. Inhibition of natural antisense transcripts in vivo results in gene-specific transcriptional upregulation. Nat. Biotechnol. 2012;30:453\u2013459."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2757163", "@IdType": "pmc"}, {"#text": "19633414", "@IdType": "pubmed"}]}, "Citation": "MORRIS K.V. Long antisense non-coding RNAs function to direct epigenetic complexes that regulate transcription in human cells. Epigenetics. 2009a;4:296\u2013301."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2754389", "@IdType": "pmc"}, {"#text": "19305164", "@IdType": "pubmed"}]}, "Citation": "MORRIS K.V. Non-coding RNAs, epigenetic memory, and the passage of information to progeny. RNA Biol. 2009b;6:242\u2013247."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3130838", "@IdType": "pmc"}, {"#text": "21333746", "@IdType": "pubmed"}]}, "Citation": "MORRIS K.V. The emerging role of RNA in the regulation of gene transcription in human cells. Semin. Cell Dev. Biol. 2011;22:351\u2013358."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2576438", "@IdType": "pmc"}, {"#text": "19008947", "@IdType": "pubmed"}]}, "Citation": "MORRIS K.V. SANTOSO S. TURNER A.M. PASTORI C. HAWKINS P.G. Bidirectional transcription directs both transcriptional gene activation and suppression in human cells. PLoS Genet. 2008;4:e1000258."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3040850", "@IdType": "pmc"}, {"#text": "20581457", "@IdType": "pubmed"}]}, "Citation": "MORRIS K.V. VOGT P.K. Long antisense non-coding RNAs and their role in transcription and oncogenesis. Cell Cycle. 2010;9:2544\u20132547."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2699364", "@IdType": "pmc"}, {"#text": "19461583", "@IdType": "pubmed"}]}, "Citation": "NAPOLI S. PASTORI C. MAGISTRI M. CARBONE G.M. CATAPANO C.V. Promoter-specific transcriptional interference and c-myc gene silencing by siRNAs in human cells. EMBO J. 2009;28:1708\u20131719."}, {"ArticleIdList": {"ArticleId": {"#text": "15722536", "@IdType": "pubmed"}}, "Citation": "OMOTO S. FUJII Y.R. Regulation of human immunodeficiency virus 1 transcription by nef microRNA. J. Gen. Virol. 2005;86:751\u2013755."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC544868", "@IdType": "pmc"}, {"#text": "15601474", "@IdType": "pubmed"}]}, "Citation": "OMOTO S. ITO M. TSUTSUMI Y. ICHIKAWA Y. OKUYAMA H. BRISIBE E.A. SAKSENA N.K. FUJII Y.R. HIV-1 nef suppression by virally encoded microRNA. Retrovirology. 2004;1:44."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2234192", "@IdType": "pmc"}, {"#text": "18227514", "@IdType": "pubmed"}]}, "Citation": "PLACE R.F. LI L.C. POOKOT D. NOONAN E.J. DAHIYA R. MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc. Natl. Acad. Sci. U. S. A. 2008;105:1608\u20131613."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2516975", "@IdType": "pmc"}, {"#text": "18519571", "@IdType": "pubmed"}]}, "Citation": "SUZUKI K. JUELICH T. LIM H. ISHIDA T. WATANEBE T. COOPER D.A. RAO S. KELLEHER A.D. Closed chromatin architecture is induced by an RNA duplex targeting the HIV-1 promoter region. J. Biol. Chem. 2008;283:23353\u201323363."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2737205", "@IdType": "pmc"}, {"#text": "19771207", "@IdType": "pubmed"}]}, "Citation": "SUZUKI K. SHIJUUKU T. FUKAMACHI T. ZAUNDERS J. GUILLEMIN G. COOPER D. KELLEHER A. Prolonged transcriptional silencing and CpG methylation induced by siRNAs targeted to the HIV-1 promoter region. J. RNAi Gene Silencing. 2005;1:66\u201378."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3225313", "@IdType": "pmc"}, {"#text": "22078386", "@IdType": "pubmed"}]}, "Citation": "TAHIRA A.C. KUBRUSLY M.S. FARIA M.F. DAZZANI B. FONSECA R.S. MARACAJA-COUTINHO V. VERJOVSKI-ALMEIDA S. MACHADO M.C. REIS E.M. Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer. Mol. Cancer. 2011;10:141."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2680403", "@IdType": "pmc"}, {"#text": "19232136", "@IdType": "pubmed"}]}, "Citation": "TAN Y. ZHANG B. WU T. SKOGERBO G. ZHU X. GUO X. HE S. CHEN R. Transcriptional inhibition of Hoxd4 expression by noncoding RNAs in human breast cancer cells. BMC Mol. Biol. 2009;10:12."}, {"ArticleIdList": {"ArticleId": {"#text": "15741316", "@IdType": "pubmed"}}, "Citation": "TOMARI Y. ZAMORE P.D. Perspective: machines for RNAi. Genes Dev. 2005;19:517\u2013529."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2835059", "@IdType": "pmc"}, {"#text": "19066594", "@IdType": "pubmed"}]}, "Citation": "TURNER A.M. DE LA CRUZ J. MORRIS K.V. Mobilization-competent lentiviral vector-mediated sustained transcriptional modulation of HIV-1 expression. Mol. Ther. 2009;17:360\u2013368."}, {"ArticleIdList": {"ArticleId": {"#text": "20569216", "@IdType": "pubmed"}}, "Citation": "TURNER A.M. MORRIS K.V. Controlling transcription with noncoding RNAs in mammalian cells. Biotechniques. 2010;48:ix\u2013xvi."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2671169", "@IdType": "pmc"}, {"#text": "19401777", "@IdType": "pubmed"}]}, "Citation": "WEI J.X. YANG J. SUN J.F. JIA L.T. ZHANG Y. ZHANG H.Z. LI X. MENG Y.L. YAO L.B. YANG A.G. Both strands of siRNA have potential to guide posttranscriptional gene silencing in mammalian cells. PLoS One. 2009;4:e5382."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC1370905", "@IdType": "pmc"}, {"#text": "16373483", "@IdType": "pubmed"}]}, "Citation": "WEINBERG M.S. VILLENEUVE L.M. EHSANI A. AMARZGUIOUI M. AAGAARD L. CHEN Z.X. RIGGS A.D. ROSSI J.J. MORRIS K.V. The antisense strand of small interfering RNAs directs histone methylation and transcriptional gene silencing in human cells. RNA. 2006;12:256\u2013262."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2743558", "@IdType": "pmc"}, {"#text": "18185590", "@IdType": "pubmed"}]}, "Citation": "YU W. GIUS D. ONYANGO P. MULDOON-JACOBS K. KARP J. FEINBERG A.P. CUI H. Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature. 2008;451:202\u2013206."}, {"ArticleIdList": {"ArticleId": {"#text": "22327224", "@IdType": "pubmed"}}, "Citation": "ZARDO G. CIOLFI A. VIAN L. STARNES L.M. BILLI M. RACANICCHI S. MARESCA C. FAZI F. TRAVAGLINI L. NOGUERA N., et al. Polycombs and microRNA-223 regulate human granulopoiesis by transcriptional control of target gene expression. Blood. 2012;119:4034\u20134046."}]}}}}}, "PMC": "PMC3569965", "PMID": "23391414", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "Long non-coding RNA targeting and transcriptional de-repression.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "26": {"Abstract": "During development, functional structures must form with the correct three-dimensional geometry composed of the correct cell types. In many cases cell types are specified at locations distant to where they will ultimately reside for normal biological function. Although cell migration is crucial for normal development and morphogenesis of animal body plans and organ systems, abnormal cell migration during adult life underlies pathological states such as invasion and metastasis of cancer. In both contexts cells migrate either individually, as loosely associated sheets or as clusters of cells. In this review, we summarize, compare and integrate knowledge gained from several in vivo model systems that have yielded insights into the regulation of morphogenic cell migration, such as the zebrafish lateral line primordium and primordial germ cells, Drosophila border cell clusters, vertebrate neural crest migration and angiogenic sprouts in the post-natal mouse retina. Because of its broad multicontextual and multiphylletic distribution, understanding cell migration in its various manifestations in vivo is likely to provide new insights into both the function and malfunction of key embryonic and postembryonic events. In this review, we will provide a succinct phenotypic description of the many model systems utilized to study cell migration in vivo. More importantly, we will highlight, compare and integrate recent advances in our understanding of how cell migration is regulated in these varied model systems with special emphasis on individual and collective cell movements.", "Authors": [{"Affiliations": [{"Has_Extra": true, "HashID": "-5912159683733336272", "Part1": "University of Utah", "Part2": "Department Neurobiology and Anatomy", "Part3": "20N Medical Drive", "Part4": "MREB 401", "Part5": "Salt Lake City", "Part6": "UT 84132", "Text": "University of Utah, Department Neurobiology and Anatomy, 20N Medical Drive, MREB 401, Salt Lake City, UT 84132, USA."}], "ForeName": "Andy", "FullName": "Andy Aman", "HashID": "-3917166814513632265", "LastName": "Aman", "ORCID": null}, {"Affiliations": null, "ForeName": "Tatjana", "FullName": "Tatjana Piotrowski", "HashID": "3324131799936239205", "LastName": "Piotrowski", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.1016/j.ydbio.2009.11.014", "InsertType": null, "Journal": "Developmental biology", "Keywords": [{"IS_Major": false, "IS_Mesh": true, "Text": "Animals"}, {"IS_Major": true, "IS_Mesh": true, "Text": "Cell Movement"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Cell Shape"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Germ Cells"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Lateral Line System"}, {"IS_Major": true, "IS_Mesh": true, "Text": "Morphogenesis"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Neovascularization, Physiologic"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "MEDLINE", "Article": {"@PubModel": "Print-Electronic", "Abstract": {"AbstractText": "During development, functional structures must form with the correct three-dimensional geometry composed of the correct cell types. In many cases cell types are specified at locations distant to where they will ultimately reside for normal biological function. Although cell migration is crucial for normal development and morphogenesis of animal body plans and organ systems, abnormal cell migration during adult life underlies pathological states such as invasion and metastasis of cancer. In both contexts cells migrate either individually, as loosely associated sheets or as clusters of cells. In this review, we summarize, compare and integrate knowledge gained from several in vivo model systems that have yielded insights into the regulation of morphogenic cell migration, such as the zebrafish lateral line primordium and primordial germ cells, Drosophila border cell clusters, vertebrate neural crest migration and angiogenic sprouts in the post-natal mouse retina. Because of its broad multicontextual and multiphylletic distribution, understanding cell migration in its various manifestations in vivo is likely to provide new insights into both the function and malfunction of key embryonic and postembryonic events. In this review, we will provide a succinct phenotypic description of the many model systems utilized to study cell migration in vivo. More importantly, we will highlight, compare and integrate recent advances in our understanding of how cell migration is regulated in these varied model systems with special emphasis on individual and collective cell movements.", "CopyrightInformation": "Copyright 2009 Elsevier Inc. All rights reserved."}, "ArticleDate": {"@DateType": "Electronic", "Day": "13", "Month": "11", "Year": "2009"}, "ArticleTitle": "Cell migration during morphogenesis.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "University of Utah, Department Neurobiology and Anatomy, 20N Medical Drive, MREB 401, Salt Lake City, UT 84132, USA."}, "ForeName": "Andy", "Initials": "A", "LastName": "Aman"}, {"@ValidYN": "Y", "ForeName": "Tatjana", "Initials": "T", "LastName": "Piotrowski"}]}, "ELocationID": {"#text": "10.1016/j.ydbio.2009.11.014", "@EIdType": "doi", "@ValidYN": "Y"}, "Journal": {"ISOAbbreviation": "Dev Biol", "ISSN": {"#text": "1095-564X", "@IssnType": "Electronic"}, "JournalIssue": {"@CitedMedium": "Internet", "Issue": "1", "PubDate": {"Day": "01", "Month": "May", "Year": "2010"}, "Volume": "341"}, "Title": "Developmental biology"}, "Language": "eng", "Pagination": {"EndPage": "33", "MedlinePgn": "20-33", "StartPage": "20"}, "PublicationTypeList": {"PublicationType": [{"#text": "Journal Article", "@UI": "D016428"}, {"#text": "Review", "@UI": "D016454"}]}}, "CitationSubset": "IM", "DateCompleted": {"Day": "26", "Month": "04", "Year": "2010"}, "DateRevised": {"Day": "04", "Month": "04", "Year": "2018"}, "MedlineJournalInfo": {"Country": "United States", "ISSNLinking": "0012-1606", "MedlineTA": "Dev Biol", "NlmUniqueID": "0372762"}, "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"#text": "Animals", "@MajorTopicYN": "N", "@UI": "D000818"}}, {"DescriptorName": {"#text": "Cell Movement", "@MajorTopicYN": "Y", "@UI": "D002465"}}, {"DescriptorName": {"#text": "Cell Shape", "@MajorTopicYN": "N", "@UI": "D048430"}}, {"DescriptorName": {"#text": "Germ Cells", "@MajorTopicYN": "N", "@UI": "D005854"}, "QualifierName": {"#text": "cytology", "@MajorTopicYN": "N", "@UI": "Q000166"}}, {"DescriptorName": {"#text": "Lateral Line System", "@MajorTopicYN": "N", "@UI": "D053403"}, "QualifierName": {"#text": "cytology", "@MajorTopicYN": "N", "@UI": "Q000166"}}, {"DescriptorName": {"#text": "Morphogenesis", "@MajorTopicYN": "Y", "@UI": "D009024"}}, {"DescriptorName": {"#text": "Neovascularization, Physiologic", "@MajorTopicYN": "N", "@UI": "D018919"}}]}, "NumberOfReferences": "138", "PMID": {"#text": "19914236", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "19914236", "@IdType": "pubmed"}, {"#text": "10.1016/j.ydbio.2009.11.014", "@IdType": "doi"}, {"#text": "S0012-1606(09)01360-8", "@IdType": "pii"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "received", "Day": "19", "Month": "7", "Year": "2009"}, {"@PubStatus": "revised", "Day": "4", "Month": "11", "Year": "2009"}, {"@PubStatus": "accepted", "Day": "8", "Month": "11", "Year": "2009"}, {"@PubStatus": "entrez", "Day": "17", "Hour": "6", "Minute": "0", "Month": "11", "Year": "2009"}, {"@PubStatus": "pubmed", "Day": "17", "Hour": "6", "Minute": "0", "Month": "11", "Year": "2009"}, {"@PubStatus": "medline", "Day": "27", "Hour": "6", "Minute": "0", "Month": "4", "Year": "2010"}]}, "PublicationStatus": "ppublish"}}}}, "PMC": null, "PMID": "19914236", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "Cell migration during morphogenesis.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "27": {"Abstract": " Aberrant regulation of cell migration drives progression of many diseases, including cancer cell invasion and metastasis formation. Analysis of tumour invasion and metastasis in living organisms to date is cumbersome and involves difficult and time consuming investigative techniques. For primary human tumours we establish here a simple, fast, sensitive and cost-effective in vivo model to analyse tumour invasion and metastatic behaviour. We fluorescently labelled small explants from gastrointestinal human tumours and investigated their metastatic behaviour after transplantation into zebrafish embryos and larvae. The transparency of the zebrafish embryos allows to follow invasion, migration and micrometastasis formation in real-time. High resolution imaging was achieved through laser scanning confocal microscopy of live zebrafish. In the transparent zebrafish embryos invasion, circulation of tumour cells in blood vessels, migration and micrometastasis formation can be followed in real-time. Xenografts of primary human tumours showed invasiveness and micrometastasis formation within 24 hours after transplantation, which was absent when non-tumour tissue was implanted. Furthermore, primary human tumour cells, when organotopically implanted in the zebrafish liver, demonstrated invasiveness and metastatic behaviour, whereas primary control cells remained in the liver. Pancreatic tumour cells showed no metastatic behaviour when injected into cloche mutant embryos, which lack a functional vasculature. Our results show that the zebrafish is a useful in vivo animal model for rapid analysis of invasion and metastatic behaviour of primary human tumour specimen.", "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "-8638426900046524733", "Part1": "Institute of Biology", "Part2": "Department of Integrative Zoology", "Part3": "University of Leiden", "Part4": "2333 AL", "Part5": "Leiden", "Part6": "The Netherlands. i.j.marques@biology.leidenuniv.nl", "Text": "Institute of Biology, Department of Integrative Zoology, University of Leiden, 2333 AL, Leiden, The Netherlands. i.j.marques@biology.leidenuniv.nl"}], "ForeName": "Ines J", "FullName": "Ines J Marques", "HashID": "5488712234517864305", "LastName": "Marques", "ORCID": null}, {"Affiliations": null, "ForeName": "Frank Ulrich", "FullName": "Frank Ulrich Weiss", "HashID": "-4817481294257000184", "LastName": "Weiss", "ORCID": null}, {"Affiliations": null, "ForeName": "Danielle H", "FullName": "Danielle H Vlecken", "HashID": "-7504319731324691908", "LastName": "Vlecken", "ORCID": null}, {"Affiliations": null, "ForeName": "Claudia", "FullName": "Claudia Nitsche", "HashID": "5698223500590038049", "LastName": "Nitsche", "ORCID": null}, {"Affiliations": null, "ForeName": "Jeroen", "FullName": "Jeroen Bakkers", "HashID": "-3799892611206759999", "LastName": "Bakkers", "ORCID": null}, {"Affiliations": null, "ForeName": "Anne K", "FullName": "Anne K Lagendijk", "HashID": "-2881591082570782305", "LastName": "Lagendijk", "ORCID": null}, {"Affiliations": null, "ForeName": "Lars Ivo", "FullName": "Lars Ivo Partecke", "HashID": "-8748326590241545351", "LastName": "Partecke", "ORCID": null}, {"Affiliations": null, "ForeName": "Claus-Dieter", "FullName": "Claus-Dieter Heidecke", "HashID": "-3619798854857734069", "LastName": "Heidecke", "ORCID": null}, {"Affiliations": null, "ForeName": "Markus M", "FullName": "Markus M Lerch", "HashID": "-2793314044875420442", "LastName": "Lerch", "ORCID": null}, {"Affiliations": null, "ForeName": "Christoph P", "FullName": "Christoph P Bagowski", "HashID": "5143073724888641990", "LastName": "Bagowski", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.1186/1471-2407-9-128", "InsertType": null, "Journal": "BMC cancer", "Keywords": [{"IS_Major": false, "IS_Mesh": true, "Text": "Animals"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Cell Movement"}, {"IS_Major": true, "IS_Mesh": true, "Text": "Disease Models, Animal"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Gastrointestinal Neoplasms"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Humans"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Mice"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Neoplasm Metastasis"}, {"IS_Major": true, "IS_Mesh": true, "Text": "Neoplasm Transplantation"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Neoplasms"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Pancreatic Neoplasms"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Transplantation, Heterologous"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Zebrafish"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "MEDLINE", "Article": {"@PubModel": "Electronic", "Abstract": {"AbstractText": [{"#text": "Aberrant regulation of cell migration drives progression of many diseases, including cancer cell invasion and metastasis formation. Analysis of tumour invasion and metastasis in living organisms to date is cumbersome and involves difficult and time consuming investigative techniques. For primary human tumours we establish here a simple, fast, sensitive and cost-effective in vivo model to analyse tumour invasion and metastatic behaviour.", "@Label": "BACKGROUND", "@NlmCategory": "BACKGROUND"}, {"#text": "We fluorescently labelled small explants from gastrointestinal human tumours and investigated their metastatic behaviour after transplantation into zebrafish embryos and larvae. The transparency of the zebrafish embryos allows to follow invasion, migration and micrometastasis formation in real-time. High resolution imaging was achieved through laser scanning confocal microscopy of live zebrafish.", "@Label": "METHODS", "@NlmCategory": "METHODS"}, {"#text": "In the transparent zebrafish embryos invasion, circulation of tumour cells in blood vessels, migration and micrometastasis formation can be followed in real-time. Xenografts of primary human tumours showed invasiveness and micrometastasis formation within 24 hours after transplantation, which was absent when non-tumour tissue was implanted. Furthermore, primary human tumour cells, when organotopically implanted in the zebrafish liver, demonstrated invasiveness and metastatic behaviour, whereas primary control cells remained in the liver. Pancreatic tumour cells showed no metastatic behaviour when injected into cloche mutant embryos, which lack a functional vasculature.", "@Label": "RESULTS", "@NlmCategory": "RESULTS"}, {"#text": "Our results show that the zebrafish is a useful in vivo animal model for rapid analysis of invasion and metastatic behaviour of primary human tumour specimen.", "@Label": "CONCLUSION", "@NlmCategory": "CONCLUSIONS"}]}, "ArticleDate": {"@DateType": "Electronic", "Day": "28", "Month": "04", "Year": "2009"}, "ArticleTitle": "Metastatic behaviour of primary human tumours in a zebrafish xenotransplantation model.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Institute of Biology, Department of Integrative Zoology, University of Leiden, 2333 AL, Leiden, The Netherlands. i.j.marques@biology.leidenuniv.nl"}, "ForeName": "Ines J", "Initials": "IJ", "LastName": "Marques"}, {"@ValidYN": "Y", "ForeName": "Frank Ulrich", "Initials": "FU", "LastName": "Weiss"}, {"@ValidYN": "Y", "ForeName": "Danielle H", "Initials": "DH", "LastName": "Vlecken"}, {"@ValidYN": "Y", "ForeName": "Claudia", "Initials": "C", "LastName": "Nitsche"}, {"@ValidYN": "Y", "ForeName": "Jeroen", "Initials": "J", "LastName": "Bakkers"}, {"@ValidYN": "Y", "ForeName": "Anne K", "Initials": "AK", "LastName": "Lagendijk"}, {"@ValidYN": "Y", "ForeName": "Lars Ivo", "Initials": "LI", "LastName": "Partecke"}, {"@ValidYN": "Y", "ForeName": "Claus-Dieter", "Initials": "CD", "LastName": "Heidecke"}, {"@ValidYN": "Y", "ForeName": "Markus M", "Initials": "MM", "LastName": "Lerch"}, {"@ValidYN": "Y", "ForeName": "Christoph P", "Initials": "CP", "LastName": "Bagowski"}]}, "ELocationID": {"#text": "10.1186/1471-2407-9-128", "@EIdType": "doi", "@ValidYN": "Y"}, "Journal": {"ISOAbbreviation": "BMC Cancer", "ISSN": {"#text": "1471-2407", "@IssnType": "Electronic"}, "JournalIssue": {"@CitedMedium": "Internet", "PubDate": {"Day": "28", "Month": "Apr", "Year": "2009"}, "Volume": "9"}, "Title": "BMC cancer"}, "Language": "eng", "Pagination": {"MedlinePgn": "128", "StartPage": "128"}, "PublicationTypeList": {"PublicationType": [{"#text": "Journal Article", "@UI": "D016428"}, {"#text": "Research Support, Non-U.S. Gov't", "@UI": "D013485"}]}}, "CitationSubset": "IM", "DateCompleted": {"Day": "27", "Month": "07", "Year": "2009"}, "DateRevised": {"Day": "18", "Month": "03", "Year": "2022"}, "MedlineJournalInfo": {"Country": "England", "ISSNLinking": "1471-2407", "MedlineTA": "BMC Cancer", "NlmUniqueID": "100967800"}, "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"#text": "Animals", "@MajorTopicYN": "N", "@UI": "D000818"}}, {"DescriptorName": {"#text": "Cell Movement", "@MajorTopicYN": "N", "@UI": "D002465"}, "QualifierName": {"#text": "physiology", "@MajorTopicYN": "N", "@UI": "Q000502"}}, {"DescriptorName": {"#text": "Disease Models, Animal", "@MajorTopicYN": "Y", "@UI": "D004195"}}, {"DescriptorName": {"#text": "Gastrointestinal Neoplasms", "@MajorTopicYN": "N", "@UI": "D005770"}, "QualifierName": {"#text": "pathology", "@MajorTopicYN": "N", "@UI": "Q000473"}}, {"DescriptorName": {"#text": "Humans", "@MajorTopicYN": "N", "@UI": "D006801"}}, {"DescriptorName": {"#text": "Mice", "@MajorTopicYN": "N", "@UI": "D051379"}}, {"DescriptorName": {"#text": "Neoplasm Metastasis", "@MajorTopicYN": "N", "@UI": "D009362"}}, {"DescriptorName": {"#text": "Neoplasm Transplantation", "@MajorTopicYN": "Y", "@UI": "D009368"}}, {"DescriptorName": {"#text": "Neoplasms", "@MajorTopicYN": "N", "@UI": "D009369"}, "QualifierName": {"#text": "pathology", "@MajorTopicYN": "Y", "@UI": "Q000473"}}, {"DescriptorName": {"#text": "Pancreatic Neoplasms", "@MajorTopicYN": "N", "@UI": "D010190"}, "QualifierName": {"#text": "pathology", "@MajorTopicYN": "N", "@UI": "Q000473"}}, {"DescriptorName": {"#text": "Transplantation, Heterologous", "@MajorTopicYN": "N", "@UI": "D014183"}}, {"DescriptorName": {"#text": "Zebrafish", "@MajorTopicYN": "N", "@UI": "D015027"}, "QualifierName": {"#text": "embryology", "@MajorTopicYN": "Y", "@UI": "Q000196"}}]}, "PMID": {"#text": "19400945", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "19400945", "@IdType": "pubmed"}, {"#text": "PMC2697170", "@IdType": "pmc"}, {"#text": "10.1186/1471-2407-9-128", "@IdType": "doi"}, {"#text": "1471-2407-9-128", "@IdType": "pii"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "received", "Day": "20", "Month": "6", "Year": "2008"}, {"@PubStatus": "accepted", "Day": "28", "Month": "4", "Year": "2009"}, {"@PubStatus": "entrez", "Day": "30", "Hour": "9", "Minute": "0", "Month": "4", "Year": "2009"}, {"@PubStatus": "pubmed", "Day": "30", "Hour": "9", "Minute": "0", "Month": "4", "Year": "2009"}, {"@PubStatus": "medline", "Day": "28", "Hour": "9", "Minute": "0", "Month": "7", "Year": "2009"}]}, "PublicationStatus": "epublish", "ReferenceList": {"Reference": [{"ArticleIdList": {"ArticleId": {"#text": "17237035", "@IdType": "pubmed"}}, "Citation": "Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer Statistics, 2007. CA Cancer J Clin. 2007;57(1):43\u201366."}, {"ArticleIdList": {"ArticleId": {"#text": "12778135", "@IdType": "pubmed"}}, "Citation": "Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer. 2003;3(6):453\u2013458."}, {"ArticleIdList": {"ArticleId": {"#text": "15688071", "@IdType": "pubmed"}}, "Citation": "Zon LI, Peterson RT. In vivo drug discovery in the zebrafish. Nat Rev Drug Discov. 2005;4(1):35\u201344."}, {"ArticleIdList": {"ArticleId": {"#text": "17495877", "@IdType": "pubmed"}}, "Citation": "Kari G, Rodeck U, Dicker AP. Zebrafish: An Emerging Model System for Human Disease and Drug Discovery. Clin Pharmacol Ther. 2007;82(1):70\u201380."}, {"ArticleIdList": {"ArticleId": {"#text": "16307377", "@IdType": "pubmed"}}, "Citation": "den Hertog J. Chemical Genetics: Drug Screens in Zebrafish. Bioscience Reports. 2005;25(5):289\u2013297."}, {"ArticleIdList": {"ArticleId": {"#text": "15090155", "@IdType": "pubmed"}}, "Citation": "Parng C, Seng WL, Semino C, McGrath P. Zebrafish: A Preclinical Model for Drug Screening. ASSAY and Drug Development Technologies. 2002;1(1):41\u201348."}, {"ArticleIdList": {"ArticleId": {"#text": "17557959", "@IdType": "pubmed"}}, "Citation": "Goessling W, North TE, Zon LI. New Waves of Discovery: Modeling Cancer in Zebrafish. J Clin Oncol. 2007;25(17):2473\u20132479."}, {"ArticleIdList": {"ArticleId": {"#text": "17384580", "@IdType": "pubmed"}}, "Citation": "Hendrix MJC, Seftor EA, Seftor REB, Kasemeier-Kulesa J, Kulesa PM, Postovit L-M. Reprogramming metastatic tumour cells with embryonic microenvironments. Nat Rev Cancer. 2007;7(4):246\u2013255."}, {"ArticleIdList": {"ArticleId": {"#text": "12209146", "@IdType": "pubmed"}}, "Citation": "Grunwald DJ, Eisen JS. Headwaters of the zebrafish [mdash] emergence of a new model vertebrate. Nat Rev Genet. 2002;3(9):717\u2013724."}, {"ArticleIdList": {"ArticleId": {"#text": "12574629", "@IdType": "pubmed"}}, "Citation": "Langenau DM, Traver D, Ferrando AA, Kutok JL, Aster JC, Kanki JP, Lin S, Prochownik E, Trede NS, Zon LI. Myc-Induced T Cell Leukemia in Transgenic Zebrafish. Science. 2003;299(5608):887\u2013890."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2077269", "@IdType": "pmc"}, {"#text": "17954920", "@IdType": "pubmed"}]}, "Citation": "Stoletov K, Montel V, Lester RD, Gonias SL, Klemke R. High-resolution imaging of the dynamic tumor cell vascular interface in transparent zebrafish. Proc Natl Acad Sci U S A. 2007;104(44):17406\u201317411."}, {"ArticleIdList": {"ArticleId": {"#text": "15968639", "@IdType": "pubmed"}}, "Citation": "Lee Lisa MJ, Seftor EA, Bonde G, Cornell RA, Hendrix MJC. The fate of human malignant melanoma cells transplanted into zebrafish embryos: Assessment of migration and cell division in the absence of tumor formation. Developmental Dynamics. 2005;233(4):1560\u20131570."}, {"ArticleIdList": {"ArticleId": {"#text": "16892036", "@IdType": "pubmed"}}, "Citation": "Topczewska JM, Postovit L-M, Margaryan NV, Sam A, Hess AR, Wheaton WW, Nickoloff BJ, Topczewski J, Hendrix MJC. Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness. Nat Med. 2006;12(8):925\u2013932."}, {"ArticleIdList": {"ArticleId": {"#text": "17051341", "@IdType": "pubmed"}}, "Citation": "Haldi M, Ton C, Seng W, McGrath P. Human melanoma cells transplanted into zebrafish proliferate, migrate, produce melanin, form masses and stimulate angiogenesis in zebrafish. Angiogenesis. 2006;9(3):139\u2013151."}, {"ArticleIdList": {"ArticleId": {"#text": "17409396", "@IdType": "pubmed"}}, "Citation": "Nicoli S, Ribatti D, Cotelli F, Presta M. Mammalian Tumor Xenografts Induce Neovascularization in Zebrafish Embryos. Cancer Res. 2007;67(7):2927\u20132931."}, {"ArticleIdList": {"ArticleId": {"#text": "18007628", "@IdType": "pubmed"}}, "Citation": "Nicoli S, Presta M. The zebrafish/tumor xenograft angiogenesis assay. Nat Protoc. 2007;2(11):2918\u20132923."}, {"ArticleIdList": {"ArticleId": {"#text": "18032732", "@IdType": "pubmed"}}, "Citation": "Herpers R, Kamp E van de, Duckers HJ, Schulte-Merker S. Redundant Roles for Sox7 and Sox18 in Arteriovenous Specification in Zebrafish. Circ Res. 2008;102(1):12\u201315."}, {"ArticleIdList": {"ArticleId": {"#text": "17406593", "@IdType": "pubmed"}}, "Citation": "Liang C-C, Park AY, Guan J-L. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc. 2007;2(2):329\u2013333."}, {"ArticleIdList": {"ArticleId": {"#text": "17045553", "@IdType": "pubmed"}}, "Citation": "te Velthuis AJW, Ott EB, Marques IJ, Bagowski CP. Gene expression patterns of the ALP family during zebrafish development. Gene Expression Patterns. 2007;7(3):297\u2013305."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2200676", "@IdType": "pmc"}, {"#text": "17828398", "@IdType": "pubmed"}]}, "Citation": "Marques I, Leito J, Spaink H, Testerink J, Jaspers R, Witte F, Berg S van den, Bagowski C. Transcriptome analysis of the response to chronic constant hypoxia in zebrafish hearts. Journal of Comparative Physiology B: Biochemical, Systemic, and Environmental Physiology. 2008;178(1):77\u201392."}, {"ArticleIdList": {"ArticleId": {"#text": "8843198", "@IdType": "pubmed"}}, "Citation": "Oft M, Peli J, Rudaz C, Schwarz H, Beug H, Reichmann E. TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev. 1996;10(19):2462\u20132477."}, {"ArticleIdList": {"ArticleId": {"#text": "9822576", "@IdType": "pubmed"}}, "Citation": "Oft M, Heider K-H, Beug H. TGF[beta] signaling is necessary for carcinoma cell invasiveness and metastasis. Current Biology. 1998;8(23):1243\u20131252."}, {"ArticleIdList": {"ArticleId": {"#text": "16959614", "@IdType": "pubmed"}}, "Citation": "Waerner T, Alacakaptan M, Tamir I, Oberauer R, Gal A, Brabletz T, Schreiber M, Jechlinger M, Beug H. ILEI: A cytokine essential for EMT, tumor formation, and late events in metastasis in epithelial cells. Cancer Cell. 2006;10(3):227\u2013239."}, {"ArticleIdList": {"ArticleId": {"#text": "12167406", "@IdType": "pubmed"}}, "Citation": "Lawson ND, Weinstein BM. In Vivo Imaging of Embryonic Vascular Development Using Transgenic Zebrafish. Developmental Biology. 2002;248(2):307\u2013318."}, {"ArticleIdList": {"ArticleId": {"#text": "1348891", "@IdType": "pubmed"}}, "Citation": "Els\u00e4sser H, PL U, Agricola B, Kern HF. Establishment and characterisation of two cell lines with different grade of differentiation derived from one primary human pancreatic adenocarcinoma. Virchows Arch B Cell Pathol Incl Mol Pathol. 1992;61(5):295\u2013306."}, {"ArticleIdList": {"ArticleId": {"#text": "11309315", "@IdType": "pubmed"}}, "Citation": "Menke A, Philippi C, Vogelmann R, Seidel B, Lutz MP, Adler G, Wedlich D. Down-Regulation of E-Cadherin Gene Expression by Collagen Type I and Type III in Pancreatic Cancer Cell Lines. Cancer Res. 2001;61(8):3508\u20133517."}, {"ArticleIdList": {"ArticleId": {"#text": "16230078", "@IdType": "pubmed"}}, "Citation": "Mayerle J, Schnekenburger J, Kruger B, Kellermann J, Ruthenburger M, Weiss FU, Nalli A, Domschke W, Lerch MM. Extracellular Cleavage of E-Cadherin by Leukocyte Elastase During Acute Experimental Pancreatitis in Rats. Gastroenterology. 2005;129(4):1251\u20131267."}, {"ArticleIdList": {"ArticleId": {"#text": "8617990", "@IdType": "pubmed"}}, "Citation": "Cha D, OB P, O'Toole EA, Woodley DT, Hudson LG. Enhanced modulation of keratinocyte motility by transforming growth factor-alpha (TGF-alpha) relative to epidermal growth factor (EGF) J Invest Dermatol. pp. 590\u2013597."}, {"ArticleIdList": {"ArticleId": {"#text": "16915232", "@IdType": "pubmed"}}, "Citation": "Sharpless NE, DePinho RA. The mighty mouse: genetically engineered mouse models in cancer drug development. Nat Rev Drug Discov. 2006;5(9):741\u2013754."}, {"ArticleIdList": {"ArticleId": {"#text": "17687385", "@IdType": "pubmed"}}, "Citation": "Frese KK, Tuveson DA. Maximizing mouse cancer models. Nat Rev Cancer. 2007;7(9):654\u2013658."}, {"ArticleIdList": {"ArticleId": {"#text": "15911987", "@IdType": "pubmed"}}, "Citation": "Hoffman R. Orthotopic metastatic (MetaMouse) models for discovery and development of novel chemotherapy. Methods Mol Med. 2005;111:297\u2013322."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2363645", "@IdType": "pmc"}, {"#text": "11355958", "@IdType": "pubmed"}]}, "Citation": "Johnson JI, S D, Zaharevitz D, Rubinstein LV, Venditti JM, Schepartz S, Kalyandrug S, Christian M, Arbuck S, Hollingshead M, Sausville EA. Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials. British Journal of Cancer. 2001;84:1424\u20131431."}, {"ArticleIdList": {"ArticleId": {"#text": "12962979", "@IdType": "pubmed"}}, "Citation": "Lam SH, Chua HL, Gong Z, Lam TJ, Sin YM. Development and maturation of the immune system in zebrafish, Danio rerio: a gene expression profiling, in situ hybridization and immunological study. Developmental & Comparative Immunology. 2004;28(1):9\u201328."}, {"ArticleIdList": {"ArticleId": {"#text": "1688681", "@IdType": "pubmed"}}, "Citation": "Weiss L. Metastatic inefficiency. Adv Cancer Res. 1990;54:159\u2013211."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2292119", "@IdType": "pmc"}, {"#text": "18371439", "@IdType": "pubmed"}]}, "Citation": "White RM, Sessa A, Burke C, Bowman T, LeBlanc J, Ceol C, Bourque C, Dovey M, Goessling W, Burns CE. Transparent Adult Zebrafish as a Tool for In Vivo Transplantation Analysis. Cell Stem Cell. 2008;2(2):183\u2013189."}]}}}}}, "PMC": "PMC2697170", "PMID": "19400945", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "Metastatic behaviour of primary human tumours in a zebrafish xenotransplantation model.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "28": {"Abstract": " YAP activation is crucial for cancer development including colorectal cancer (CRC). Nevertheless, it remains unclear whether N6-Methyladenosine (mA) modified transcripts of long noncoding RNAs (lncRNAs) can regulate YAP activation in cancer progression. We investigated the functional link between lncRNAs and the mA modification in YAP signaling and CRC progression. YAP interacting lncRNAs were screened by RIP-sequencing, RNA FISH and immunofluorescence co-staining assays. Interaction between YAP and lncRNA GAS5 was studied by biochemical methods. MeRIP-sequencing combined with lncRNA-sequencing were used to identify the mA modified targets of YTHDF3 in CRC. Gain-of-function and Loss-of-function analysis were performed to measure the function of GAS5-YAP-YTHDF3 axis in CRC progression in vitro and in vivo. GAS5 directly interacts with WW domain of YAP to facilitate translocation of endogenous YAP from the nucleus to the cytoplasm and promotes phosphorylation and subsequently ubiquitin-mediated degradation of YAP to inhibit CRC progression in vitro and in vivo. Notably, we demonstrate the mA reader YTHDF3 not only a novel target of YAP but also a key player in YAP signaling by facilitating mA-modified lncRNA GAS5 degradation, which profile a new insight into CRC progression. Clinically, lncRNA GAS5 expressions is negatively correlated with YAP and YTHDF3 protein levels in tumors from CRC patients. Our study uncovers a negative functional loop of lncRNA GAS5-YAP-YTHDF3 axis, and identifies a new mechanism for mA-induced decay of GAS5 on YAP signaling in progression of CRC which may offer a promising approach for CRC treatment.", "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "-396451621870803958", "Part1": "Department of Pathology", "Part2": "Sun Yat-sen Memorial Hospital", "Part3": "Sun Yat-sen University", "Part4": "Guangzhou", "Part5": "510120", "Part6": "China.", "Text": "Department of Pathology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}, {"Has_Extra": false, "HashID": "-3430635002995754660", "Part1": "Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation", "Part2": "Sun Yat-sen Memorial Hospital", "Part3": "Sun Yat-sen University", "Part4": "Guangzhou", "Part5": "510120", "Part6": "China.", "Text": "Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}, {"Has_Extra": false, "HashID": "8429048519019900385", "Part1": "RNA Biomedical Institute", "Part2": "Sun Yat-sen Memorial Hospital", "Part3": "Sun Yat-sen University", "Part4": "Guangzhou", "Part5": "510120", "Part6": "China.", "Text": "RNA Biomedical Institute, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}], "ForeName": "Wen", "FullName": "Wen Ni", "HashID": "-665452214375694861", "LastName": "Ni", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-396451621870803958", "Part1": "Department of Pathology", "Part2": "Sun Yat-sen Memorial Hospital", "Part3": "Sun Yat-sen University", "Part4": "Guangzhou", "Part5": "510120", "Part6": "China.", "Text": "Department of Pathology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}], "ForeName": "Su", "FullName": "Su Yao", "HashID": "7004149490626965711", "LastName": "Yao", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-396451621870803958", "Part1": "Department of Pathology", "Part2": "Sun Yat-sen Memorial Hospital", "Part3": "Sun Yat-sen University", "Part4": "Guangzhou", "Part5": "510120", "Part6": "China.", "Text": "Department of Pathology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}, {"Has_Extra": false, "HashID": "-3430635002995754660", "Part1": "Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation", "Part2": "Sun Yat-sen Memorial Hospital", "Part3": "Sun Yat-sen University", "Part4": "Guangzhou", "Part5": "510120", "Part6": "China.", "Text": "Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}, {"Has_Extra": false, "HashID": "8429048519019900385", "Part1": "RNA Biomedical Institute", "Part2": "Sun Yat-sen Memorial Hospital", "Part3": "Sun Yat-sen University", "Part4": "Guangzhou", "Part5": "510120", "Part6": "China.", "Text": "RNA Biomedical Institute, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}], "ForeName": "Yunxia", "FullName": "Yunxia Zhou", "HashID": "8113280894506259233", "LastName": "Zhou", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-396451621870803958", "Part1": "Department of Pathology", "Part2": "Sun Yat-sen Memorial Hospital", "Part3": "Sun Yat-sen University", "Part4": "Guangzhou", "Part5": "510120", "Part6": "China.", "Text": "Department of Pathology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}, {"Has_Extra": false, "HashID": "-3430635002995754660", "Part1": "Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation", "Part2": "Sun Yat-sen Memorial Hospital", "Part3": "Sun Yat-sen University", "Part4": "Guangzhou", "Part5": "510120", "Part6": "China.", "Text": "Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}, {"Has_Extra": false, "HashID": "8429048519019900385", "Part1": "RNA Biomedical Institute", "Part2": "Sun Yat-sen Memorial Hospital", "Part3": "Sun Yat-sen University", "Part4": "Guangzhou", "Part5": "510120", "Part6": "China.", "Text": "RNA Biomedical Institute, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}], "ForeName": "Yuanyuan", "FullName": "Yuanyuan Liu", "HashID": "-7878413320880972683", "LastName": "Liu", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-396451621870803958", "Part1": "Department of Pathology", "Part2": "Sun Yat-sen Memorial Hospital", "Part3": "Sun Yat-sen University", "Part4": "Guangzhou", "Part5": "510120", "Part6": "China.", "Text": "Department of Pathology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}, {"Has_Extra": false, "HashID": "-3430635002995754660", "Part1": "Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation", "Part2": "Sun Yat-sen Memorial Hospital", "Part3": "Sun Yat-sen University", "Part4": "Guangzhou", "Part5": "510120", "Part6": "China.", "Text": "Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}, {"Has_Extra": false, "HashID": "8429048519019900385", "Part1": "RNA Biomedical Institute", "Part2": "Sun Yat-sen Memorial Hospital", "Part3": "Sun Yat-sen University", "Part4": "Guangzhou", "Part5": "510120", "Part6": "China.", "Text": "RNA Biomedical Institute, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}], "ForeName": "Piao", "FullName": "Piao Huang", "HashID": "7696041385862930258", "LastName": "Huang", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-396451621870803958", "Part1": "Department of Pathology", "Part2": "Sun Yat-sen Memorial Hospital", "Part3": "Sun Yat-sen University", "Part4": "Guangzhou", "Part5": "510120", "Part6": "China.", "Text": "Department of Pathology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}, {"Has_Extra": false, "HashID": "-3430635002995754660", "Part1": "Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation", "Part2": "Sun Yat-sen Memorial Hospital", "Part3": "Sun Yat-sen University", "Part4": "Guangzhou", "Part5": "510120", "Part6": "China.", "Text": "Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}, {"Has_Extra": false, "HashID": "8429048519019900385", "Part1": "RNA Biomedical Institute", "Part2": "Sun Yat-sen Memorial Hospital", "Part3": "Sun Yat-sen University", "Part4": "Guangzhou", "Part5": "510120", "Part6": "China.", "Text": "RNA Biomedical Institute, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}], "ForeName": "Aijun", "FullName": "Aijun Zhou", "HashID": "292463713167272926", "LastName": "Zhou", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-396451621870803958", "Part1": "Department of Pathology", "Part2": "Sun Yat-sen Memorial Hospital", "Part3": "Sun Yat-sen University", "Part4": "Guangzhou", "Part5": "510120", "Part6": "China.", "Text": "Department of Pathology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}, {"Has_Extra": false, "HashID": "-3430635002995754660", "Part1": "Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation", "Part2": "Sun Yat-sen Memorial Hospital", "Part3": "Sun Yat-sen University", "Part4": "Guangzhou", "Part5": "510120", "Part6": "China.", "Text": "Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}, {"Has_Extra": false, "HashID": "8429048519019900385", "Part1": "RNA Biomedical Institute", "Part2": "Sun Yat-sen Memorial Hospital", "Part3": "Sun Yat-sen University", "Part4": "Guangzhou", "Part5": "510120", "Part6": "China.", "Text": "RNA Biomedical Institute, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}], "ForeName": "Jingwen", "FullName": "Jingwen Liu", "HashID": "939232156660430989", "LastName": "Liu", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-396451621870803958", "Part1": "Department of Pathology", "Part2": "Sun Yat-sen Memorial Hospital", "Part3": "Sun Yat-sen University", "Part4": "Guangzhou", "Part5": "510120", "Part6": "China.", "Text": "Department of Pathology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}, {"Has_Extra": false, "HashID": "-3430635002995754660", "Part1": "Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation", "Part2": "Sun Yat-sen Memorial Hospital", "Part3": "Sun Yat-sen University", "Part4": "Guangzhou", "Part5": "510120", "Part6": "China.", "Text": "Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}, {"Has_Extra": false, "HashID": "8429048519019900385", "Part1": "RNA Biomedical Institute", "Part2": "Sun Yat-sen Memorial Hospital", "Part3": "Sun Yat-sen University", "Part4": "Guangzhou", "Part5": "510120", "Part6": "China.", "Text": "RNA Biomedical Institute, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}], "ForeName": "Liheng", "FullName": "Liheng Che", "HashID": "-442953080502732715", "LastName": "Che", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-396451621870803958", "Part1": "Department of Pathology", "Part2": "Sun Yat-sen Memorial Hospital", "Part3": "Sun Yat-sen University", "Part4": "Guangzhou", "Part5": "510120", "Part6": "China. lijming3@mail.sysu.edu.cn.", "Text": "Department of Pathology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China. lijming3@mail.sysu.edu.cn."}, {"Has_Extra": false, "HashID": "-3430635002995754660", "Part1": "Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation", "Part2": "Sun Yat-sen Memorial Hospital", "Part3": "Sun Yat-sen University", "Part4": "Guangzhou", "Part5": "510120", "Part6": "China. lijming3@mail.sysu.edu.cn.", "Text": "Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China. lijming3@mail.sysu.edu.cn."}, {"Has_Extra": false, "HashID": "8429048519019900385", "Part1": "RNA Biomedical Institute", "Part2": "Sun Yat-sen Memorial Hospital", "Part3": "Sun Yat-sen University", "Part4": "Guangzhou", "Part5": "510120", "Part6": "China. lijming3@mail.sysu.edu.cn.", "Text": "RNA Biomedical Institute, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China. lijming3@mail.sysu.edu.cn."}], "ForeName": "Jianming", "FullName": "Jianming Li", "HashID": "5451311940925037253", "LastName": "Li", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.1186/s12943-019-1079-y", "InsertType": null, "Journal": "Molecular cancer", "Keywords": [{"IS_Major": false, "IS_Mesh": true, "Text": "Animals"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Cell Cycle Proteins"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Cell Line, Tumor"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Cell Proliferation"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Colorectal Neoplasms"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Disease Progression"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Female"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Gene Expression Profiling"}, {"IS_Major": true, "IS_Mesh": true, "Text": "Gene Expression Regulation, Neoplastic"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Humans"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Male"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Mice"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Models, Biological"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Nucleic Acid Conformation"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Phosphorylation"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Prognosis"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Protein Binding"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Proteolysis"}, {"IS_Major": false, "IS_Mesh": true, "Text": "RNA, Long Noncoding"}, {"IS_Major": false, "IS_Mesh": true, "Text": "RNA-Binding Proteins"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Signal Transduction"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Transcription Factors"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Ubiquitination"}, {"IS_Major": false, "IS_Mesh": false, "Text": "LncRNA GAS5"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Ubiquitination and degradation"}, {"IS_Major": false, "IS_Mesh": false, "Text": "YAP signaling"}, {"IS_Major": false, "IS_Mesh": false, "Text": "YTHDF3"}, {"IS_Major": false, "IS_Mesh": false, "Text": "m6A modification"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "MEDLINE", "Article": {"@PubModel": "Electronic", "Abstract": {"AbstractText": [{"#text": "YAP activation is crucial for cancer development including colorectal cancer (CRC). Nevertheless, it remains unclear whether N6-Methyladenosine (mA) modified transcripts of long noncoding RNAs (lncRNAs) can regulate YAP activation in cancer progression. We investigated the functional link between lncRNAs and the mA modification in YAP signaling and CRC progression.", "@Label": "BACKGROUND", "sup": ["6", "6"]}, {"#text": "YAP interacting lncRNAs were screened by RIP-sequencing, RNA FISH and immunofluorescence co-staining assays. Interaction between YAP and lncRNA GAS5 was studied by biochemical methods. MeRIP-sequencing combined with lncRNA-sequencing were used to identify the mA modified targets of YTHDF3 in CRC. Gain-of-function and Loss-of-function analysis were performed to measure the function of GAS5-YAP-YTHDF3 axis in CRC progression in vitro and in vivo.", "@Label": "METHODS", "sup": "6"}, {"#text": "GAS5 directly interacts with WW domain of YAP to facilitate translocation of endogenous YAP from the nucleus to the cytoplasm and promotes phosphorylation and subsequently ubiquitin-mediated degradation of YAP to inhibit CRC progression in vitro and in vivo. Notably, we demonstrate the mA reader YTHDF3 not only a novel target of YAP but also a key player in YAP signaling by facilitating mA-modified lncRNA GAS5 degradation, which profile a new insight into CRC progression. Clinically, lncRNA GAS5 expressions is negatively correlated with YAP and YTHDF3 protein levels in tumors from CRC patients.", "@Label": "RESULTS", "sup": ["6", "6"]}, {"#text": "Our study uncovers a negative functional loop of lncRNA GAS5-YAP-YTHDF3 axis, and identifies a new mechanism for mA-induced decay of GAS5 on YAP signaling in progression of CRC which may offer a promising approach for CRC treatment.", "@Label": "CONCLUSIONS", "sup": "6"}]}, "ArticleDate": {"@DateType": "Electronic", "Day": "16", "Month": "10", "Year": "2019"}, "ArticleTitle": {"#text": "Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the mA reader YTHDF3.", "sup": "6"}, "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of Pathology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}, {"Affiliation": "Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}, {"Affiliation": "RNA Biomedical Institute, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}], "ForeName": "Wen", "Initials": "W", "LastName": "Ni"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Pathology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}, "ForeName": "Su", "Initials": "S", "LastName": "Yao"}, {"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of Pathology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}, {"Affiliation": "Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}, {"Affiliation": "RNA Biomedical Institute, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}], "ForeName": "Yunxia", "Initials": "Y", "LastName": "Zhou"}, {"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of Pathology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}, {"Affiliation": "Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}, {"Affiliation": "RNA Biomedical Institute, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}], "ForeName": "Yuanyuan", "Initials": "Y", "LastName": "Liu"}, {"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of Pathology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}, {"Affiliation": "Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}, {"Affiliation": "RNA Biomedical Institute, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}], "ForeName": "Piao", "Initials": "P", "LastName": "Huang"}, {"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of Pathology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}, {"Affiliation": "Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}, {"Affiliation": "RNA Biomedical Institute, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}], "ForeName": "Aijun", "Initials": "A", "LastName": "Zhou"}, {"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of Pathology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}, {"Affiliation": "Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}, {"Affiliation": "RNA Biomedical Institute, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}], "ForeName": "Jingwen", "Initials": "J", "LastName": "Liu"}, {"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of Pathology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}, {"Affiliation": "Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}, {"Affiliation": "RNA Biomedical Institute, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China."}], "ForeName": "Liheng", "Initials": "L", "LastName": "Che"}, {"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of Pathology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China. lijming3@mail.sysu.edu.cn."}, {"Affiliation": "Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China. lijming3@mail.sysu.edu.cn."}, {"Affiliation": "RNA Biomedical Institute, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China. lijming3@mail.sysu.edu.cn."}], "ForeName": "Jianming", "Initials": "J", "LastName": "Li"}]}, "ELocationID": [{"#text": "143", "@EIdType": "pii", "@ValidYN": "Y"}, {"#text": "10.1186/s12943-019-1079-y", "@EIdType": "doi", "@ValidYN": "Y"}], "Journal": {"ISOAbbreviation": "Mol Cancer", "ISSN": {"#text": "1476-4598", "@IssnType": "Electronic"}, "JournalIssue": {"@CitedMedium": "Internet", "Issue": "1", "PubDate": {"Day": "16", "Month": "Oct", "Year": "2019"}, "Volume": "18"}, "Title": "Molecular cancer"}, "Language": "eng", "Pagination": {"MedlinePgn": "143", "StartPage": "143"}, "PublicationTypeList": {"PublicationType": [{"#text": "Journal Article", "@UI": "D016428"}, {"#text": "Research Support, Non-U.S. Gov't", "@UI": "D013485"}]}}, "ChemicalList": {"Chemical": [{"NameOfSubstance": {"#text": "Cell Cycle Proteins", "@UI": "D018797"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "GAS5 long non-coding RNA, human", "@UI": "C561567"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "RNA, Long Noncoding", "@UI": "D062085"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "RNA-Binding Proteins", "@UI": "D016601"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "Transcription Factors", "@UI": "D014157"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "YTHDF3 protein, human", "@UI": "C000625021"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "YY1AP1 protein, human", "@UI": "C456659"}, "RegistryNumber": "0"}]}, "CitationSubset": "IM", "CoiStatement": "The authors declare that they have no competing interests.", "DateCompleted": {"Day": "15", "Month": "04", "Year": "2020"}, "DateRevised": {"Day": "15", "Month": "04", "Year": "2020"}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"#text": "LncRNA GAS5", "@MajorTopicYN": "N"}, {"#text": "Ubiquitination and degradation", "@MajorTopicYN": "N"}, {"#text": "YAP signaling", "@MajorTopicYN": "N"}, {"#text": "YTHDF3", "@MajorTopicYN": "N"}, {"#text": "m6A modification", "@MajorTopicYN": "N"}]}, "MedlineJournalInfo": {"Country": "England", "ISSNLinking": "1476-4598", "MedlineTA": "Mol Cancer", "NlmUniqueID": "101147698"}, "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"#text": "Animals", "@MajorTopicYN": "N", "@UI": "D000818"}}, {"DescriptorName": {"#text": "Cell Cycle Proteins", "@MajorTopicYN": "N", "@UI": "D018797"}, "QualifierName": {"#text": "metabolism", "@MajorTopicYN": "Y", "@UI": "Q000378"}}, {"DescriptorName": {"#text": "Cell Line, Tumor", "@MajorTopicYN": "N", "@UI": "D045744"}}, {"DescriptorName": {"#text": "Cell Proliferation", "@MajorTopicYN": "N", "@UI": "D049109"}}, {"DescriptorName": {"#text": "Colorectal Neoplasms", "@MajorTopicYN": "N", "@UI": "D015179"}, "QualifierName": [{"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}, {"#text": "metabolism", "@MajorTopicYN": "Y", "@UI": "Q000378"}, {"#text": "mortality", "@MajorTopicYN": "N", "@UI": "Q000401"}, {"#text": "pathology", "@MajorTopicYN": "N", "@UI": "Q000473"}]}, {"DescriptorName": {"#text": "Disease Progression", "@MajorTopicYN": "N", "@UI": "D018450"}}, {"DescriptorName": {"#text": "Female", "@MajorTopicYN": "N", "@UI": "D005260"}}, {"DescriptorName": {"#text": "Gene Expression Profiling", "@MajorTopicYN": "N", "@UI": "D020869"}}, {"DescriptorName": {"#text": "Gene Expression Regulation, Neoplastic", "@MajorTopicYN": "Y", "@UI": "D015972"}}, {"DescriptorName": {"#text": "Humans", "@MajorTopicYN": "N", "@UI": "D006801"}}, {"DescriptorName": {"#text": "Male", "@MajorTopicYN": "N", "@UI": "D008297"}}, {"DescriptorName": {"#text": "Mice", "@MajorTopicYN": "N", "@UI": "D051379"}}, {"DescriptorName": {"#text": "Models, Biological", "@MajorTopicYN": "N", "@UI": "D008954"}}, {"DescriptorName": {"#text": "Nucleic Acid Conformation", "@MajorTopicYN": "N", "@UI": "D009690"}}, {"DescriptorName": {"#text": "Phosphorylation", "@MajorTopicYN": "N", "@UI": "D010766"}}, {"DescriptorName": {"#text": "Prognosis", "@MajorTopicYN": "N", "@UI": "D011379"}}, {"DescriptorName": {"#text": "Protein Binding", "@MajorTopicYN": "N", "@UI": "D011485"}}, {"DescriptorName": {"#text": "Proteolysis", "@MajorTopicYN": "N", "@UI": "D059748"}}, {"DescriptorName": {"#text": "RNA, Long Noncoding", "@MajorTopicYN": "N", "@UI": "D062085"}, "QualifierName": [{"#text": "chemistry", "@MajorTopicYN": "N", "@UI": "Q000737"}, {"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}]}, {"DescriptorName": {"#text": "RNA-Binding Proteins", "@MajorTopicYN": "N", "@UI": "D016601"}, "QualifierName": {"#text": "metabolism", "@MajorTopicYN": "Y", "@UI": "Q000378"}}, {"DescriptorName": {"#text": "Signal Transduction", "@MajorTopicYN": "N", "@UI": "D015398"}}, {"DescriptorName": {"#text": "Transcription Factors", "@MajorTopicYN": "N", "@UI": "D014157"}, "QualifierName": {"#text": "metabolism", "@MajorTopicYN": "Y", "@UI": "Q000378"}}, {"DescriptorName": {"#text": "Ubiquitination", "@MajorTopicYN": "N", "@UI": "D054875"}}]}, "PMID": {"#text": "31619268", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "31619268", "@IdType": "pubmed"}, {"#text": "PMC6794841", "@IdType": "pmc"}, {"#text": "10.1186/s12943-019-1079-y", "@IdType": "doi"}, {"#text": "10.1186/s12943-019-1079-y", "@IdType": "pii"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "received", "Day": "24", "Month": "6", "Year": "2019"}, {"@PubStatus": "accepted", "Day": "23", "Month": "9", "Year": "2019"}, {"@PubStatus": "entrez", "Day": "18", "Hour": "6", "Minute": "0", "Month": "10", "Year": "2019"}, {"@PubStatus": "pubmed", "Day": "18", "Hour": "6", "Minute": "0", "Month": "10", "Year": "2019"}, {"@PubStatus": "medline", "Day": "16", "Hour": "6", "Minute": "0", "Month": "4", "Year": "2020"}]}, "PublicationStatus": "epublish", "ReferenceList": {"Reference": [{"ArticleIdList": {"ArticleId": [{"#text": "10.3322/caac.21442", "@IdType": "doi"}, {"#text": "29313949", "@IdType": "pubmed"}]}, "Citation": "Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7\u201330. doi: 10.3322/caac.21442."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1101/gad.1909210", "@IdType": "doi"}, {"#text": "PMC2861185", "@IdType": "pmc"}, {"#text": "20439427", "@IdType": "pubmed"}]}, "Citation": "Zhao B, Li L, Lei Q, Guan KL. The hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev. 2010;24(9):862\u2013874. doi: 10.1101/gad.1909210."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/0008-5472.CAN-15-2882", "@IdType": "doi"}, {"#text": "27325643", "@IdType": "pubmed"}]}, "Citation": "Guo PD, Lu XX, Gan WJ, Li XM, He XS, Zhang S, et al. RARgamma downregulation contributes to colorectal tumorigenesis and metastasis by derepressing the hippo-yaP <pathway. Cancer Res. 2016;76(13):3813\u20133825. doi: 10.1158/0008-5472.CAN-15-2882."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrd4161", "@IdType": "doi"}, {"#text": "PMC4167640", "@IdType": "pmc"}, {"#text": "24336504", "@IdType": "pubmed"}]}, "Citation": "Johnson R, Halder G. The two faces of hippo: targeting the hippo pathway for regenerative medicine and cancer treatment. Nat Rev Drug Discov. 2014;13(1):63\u201379. doi: 10.1038/nrd4161."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cell.2005.06.007", "@IdType": "doi"}, {"#text": "16096061", "@IdType": "pubmed"}]}, "Citation": "Huang J, Wu S, Barrera J, Matthews K, Pan D. The hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the drosophila homolog of YAP. Cell. 2005;122(3):421\u2013434. doi: 10.1016/j.cell.2005.06.007."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.15252/embr.201642683", "@IdType": "doi"}, {"#text": "PMC5210122", "@IdType": "pmc"}, {"#text": "27979972", "@IdType": "pubmed"}]}, "Citation": "Moon S, Kim W, Kim S, Kim Y, Song Y, Bilousov O, et al. Phosphorylation by NLK inhibits YAP-14-3-3-interactions and induces its nuclear localization. EMBO Rep. 2017;18(1):61\u201371. doi: 10.15252/embr.201642683."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.15252/embr.201642681", "@IdType": "doi"}, {"#text": "PMC5210094", "@IdType": "pmc"}, {"#text": "27979971", "@IdType": "pubmed"}]}, "Citation": "Hong AW, Meng Z, Yuan HX, Plouffe SW, Moon S. Osmotic stress-induced phosphorylation by NLK at Ser128 activates YAP. EMBO Rep. 2017;18(1):72\u201386. doi: 10.15252/embr.201642681."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ccell.2018.06.002", "@IdType": "doi"}, {"#text": "30008322", "@IdType": "pubmed"}]}, "Citation": "Fang L, Teng H, Wang Y, Liao G, Weng L, Li Y, et al. SET1A-mediated mono-methylation at K342 regulates YAP activation by blocking its nuclear export and promotes tumorigenesis. Cancer Cell. 2018;34(1):103\u2013118. doi: 10.1016/j.ccell.2018.06.002."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.molcel.2011.08.018", "@IdType": "doi"}, {"#text": "PMC3199020", "@IdType": "pmc"}, {"#text": "21925379", "@IdType": "pubmed"}]}, "Citation": "Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011;43(6):904\u2013914. doi: 10.1016/j.molcel.2011.08.018."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cell.2013.02.016", "@IdType": "doi"}, {"#text": "23498939", "@IdType": "pubmed"}]}, "Citation": "Lee JT, Bartolomei MS. X-inactivation, imprinting, and long noncoding RNAs in health and disease. Cell. 2013;152(6):1308\u20131323. doi: 10.1016/j.cell.2013.02.016."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/nar/gkw802", "@IdType": "doi"}, {"#text": "PMC5159544", "@IdType": "pmc"}, {"#text": "27634931", "@IdType": "pubmed"}]}, "Citation": "Kalwa M, Hanzelmann S, Otto S, Kuo CC, Franzen J, Joussen S, et al. The lncRNA HOTAIR impacts on mesenchymal stem cells via triple helix formation. Nucleic Acids Res. 2016;44(22):10631\u201310643. doi: 10.1093/nar/gkw802."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41556-018-0204-2", "@IdType": "doi"}, {"#text": "30250064", "@IdType": "pubmed"}]}, "Citation": "Wang Y, Hu SB, Wang MR, Yao RW, Wu D, Yang L, et al. Genome-wide screening of NEAT1 regulators reveals cross-regulation between paraspeckles and mitochondria. Nat Cell Biol. 2018;20(10):1145\u20131158. doi: 10.1038/s41556-018-0204-2."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2819218", "@IdType": "pmc"}, {"#text": "20124551", "@IdType": "pubmed"}]}, "Citation": "Kino T, Hurt DE, Ichijo T, Nader N, Chrousos GP. Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci Signal. 2010;3(107):ra8."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s13045-017-0449-4", "@IdType": "doi"}, {"#text": "PMC5395742", "@IdType": "pmc"}, {"#text": "28420424", "@IdType": "pubmed"}]}, "Citation": "Ni W, Zhang Y, Zhan Z, Ye F, Liang Y, Huang J, et al. A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1. J Hematol Oncol. 2017;10(1):91. doi: 10.1186/s13045-017-0449-4."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41422-018-0034-6", "@IdType": "doi"}, {"#text": "PMC5951805", "@IdType": "pmc"}, {"#text": "29686311", "@IdType": "pubmed"}]}, "Citation": "Deng X, Su R, Weng H, Huang H, Li Z, Chen J. RNA N(6)-methyladenosine modification in cancers: current status and perspectives. Cell Res. 2018;28(5):507\u2013517. doi: 10.1038/s41422-018-0034-6."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ccell.2016.11.017", "@IdType": "doi"}, {"#text": "PMC5234852", "@IdType": "pmc"}, {"#text": "28017614", "@IdType": "pubmed"}]}, "Citation": "Li Z, Weng H, Su R, Weng X, Zuo Z, Li C, et al. FTO plays an oncogenic role in acute myeloid leukemia as a N(6)-Methyladenosine RNA demethylase. Cancer Cell. 2017;31(1):127\u2013141. doi: 10.1016/j.ccell.2016.11.017."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/cr.2017.15", "@IdType": "doi"}, {"#text": "PMC5339834", "@IdType": "pmc"}, {"#text": "28106072", "@IdType": "pubmed"}]}, "Citation": "Shi H, Wang X, Lu Z, Zhao BS, Ma H, Hsu PJ, et al. YTHDF3 facilitates translation and decay of N(6)-methyladenosine-modified RNA. Cell Res. 2017;27(3):315\u2013328. doi: 10.1038/cr.2017.15."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/0008-5472.CAN-14-3595", "@IdType": "doi"}, {"#text": "26669864", "@IdType": "pubmed"}]}, "Citation": "Xing C, Lu XX, Guo PD, Shen T, Zhang S, He XS, et al. Ubiquitin-specific protease 4-mediated Deubiquitination and stabilization of PRL-3 is required for potentiating colorectal oncogenesis. Cancer Res. 2016;76(1):83\u201395. doi: 10.1158/0008-5472.CAN-14-3595."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/nar/30.1.207", "@IdType": "doi"}, {"#text": "PMC99122", "@IdType": "pmc"}, {"#text": "11752295", "@IdType": "pubmed"}]}, "Citation": "Edgar R, Domrachev M, Lash AE. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30(1):207\u2013210. doi: 10.1093/nar/30.1.207."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/emboj/19.24.6778", "@IdType": "doi"}, {"#text": "PMC305881", "@IdType": "pmc"}, {"#text": "11118213", "@IdType": "pubmed"}]}, "Citation": "Kanai F, Marignani PA, Sarbassova D, Yagi R, Hall RA, Donowitz M, et al. TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J. 2000;19(24):6778\u20136791. doi: 10.1093/emboj/19.24.6778."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1101/gad.1664408", "@IdType": "doi"}, {"#text": "PMC2492741", "@IdType": "pmc"}, {"#text": "18579750", "@IdType": "pubmed"}]}, "Citation": "Zhao B, Ye X, Yu J, Li L, Li W, Li S, et al. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev. 2008;22(14):1962\u20131971. doi: 10.1101/gad.1664408."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/abbs/gmu110", "@IdType": "doi"}, {"#text": "25487920", "@IdType": "pubmed"}]}, "Citation": "Zhu C, Li L, Zhao B. The regulation and function of YAP transcription co-activator. Acta Biochim Biophys Sin Shanghai. 2015;47(1):16\u201328. doi: 10.1093/abbs/gmu110."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ccell.2018.11.006", "@IdType": "doi"}, {"#text": "PMC6294301", "@IdType": "pmc"}, {"#text": "30537512", "@IdType": "pubmed"}]}, "Citation": "Li Z, Razavi P, Li Q, Toy W, Liu B, Ping C, et al. Loss of the FAT1 tumor suppressor promotes resistance to CDK4/6 inhibitors via the hippo pathway. Cancer Cell. 2018;34(6):893\u2013905. doi: 10.1016/j.ccell.2018.11.006."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/2159-8290.CD-17-1124", "@IdType": "doi"}, {"#text": "PMC6481611", "@IdType": "pmc"}, {"#text": "29907586", "@IdType": "pubmed"}]}, "Citation": "Ni X, Tao J, Barbi J, Chen Q, Park BV, Li Z, et al. YAP is essential for Treg-mediated suppression of antitumor immunity. Cancer Discov. 2018;8(8):1026\u20131043. doi: 10.1158/2159-8290.CD-17-1124."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.molcel.2007.12.022", "@IdType": "doi"}, {"#text": "18280240", "@IdType": "pubmed"}]}, "Citation": "Levy D, Adamovich Y, Reuven N, Shaul Y. Yap1 phosphorylation by c-Abl is a critical steP <in selective activation of proapoptotic genes in response to DNA damage. Mol Cell. 2008;29(3):350\u2013361. doi: 10.1016/j.molcel.2007.12.022."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cell.2012.11.026", "@IdType": "doi"}, {"#text": "PMC3530160", "@IdType": "pmc"}, {"#text": "23245941", "@IdType": "pubmed"}]}, "Citation": "Rosenbluh J, Nijhawan D, Cox AG, Li X, Neal JT, Schafer EJ, et al. Schinzel AC et al: beta-catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis. Cell. 2012;151(7):1457\u20131473. doi: 10.1016/j.cell.2012.11.026."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.molcel.2017.10.010", "@IdType": "doi"}, {"#text": "29100056", "@IdType": "pubmed"}]}, "Citation": "Peng C, Zhu Y, Zhang W, Liao Q, Chen Y, Zhao X, et al. Regulation of the hippo-YAP pathway by glucose sensor O-GlcNAcylation. Mol Cell. 2017;68(3):591\u2013604. doi: 10.1016/j.molcel.2017.10.010."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41586-018-0658-1", "@IdType": "doi"}, {"#text": "30401838", "@IdType": "pubmed"}]}, "Citation": "Chang L, Azzolin L, Di Biagio D, Zanconato F, Battilana G, Lucon Xiccato R, et al. The SWI/SNF complex is a mechanoregulated inhibitor of YAP and TAZ. Nature. 2018;563(7730):265\u2013269. doi: 10.1038/s41586-018-0658-1."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12943-015-0323-3", "@IdType": "doi"}, {"#text": "PMC4342823", "@IdType": "pmc"}, {"#text": "25743273", "@IdType": "pubmed"}]}, "Citation": "Kang W, Tong JH, Lung RW, Dong Y, Zhao J, Liang Q, et al. Targeting of YAP1 by microRNA-15a and microRNA-16-1 exerts tumor suppressor function in gastric adenocarcinoma. Mol Cancer. 2015;14:52. doi: 10.1186/s12943-015-0323-3."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12943-018-0917-7", "@IdType": "doi"}, {"#text": "PMC6280518", "@IdType": "pmc"}, {"#text": "30514309", "@IdType": "pubmed"}]}, "Citation": "Liu G, Huang K, Jie Z, Wu Y, Chen J, Chen Z, et al. CircFAT1 sponges miR-375 to promote the expression of yes-associated protein 1 in osteosarcoma cells. Mol Cancer. 2018;17(1):170. doi: 10.1186/s12943-018-0917-7."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/ncb3464", "@IdType": "doi"}, {"#text": "PMC5336186", "@IdType": "pmc"}, {"#text": "28114269", "@IdType": "pubmed"}]}, "Citation": "Li C, Wang S, Xing Z, Lin A, Liang K, Song J, et al. A ROR1-HER3-lncRNA signalling axis modulates the hippo-YAP pathway to regulate bone metastasis. Nat Cell Biol. 2017;19(2):106\u2013119. doi: 10.1038/ncb3464."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/ncomms12692", "@IdType": "doi"}, {"#text": "PMC5133634", "@IdType": "pmc"}, {"#text": "27886176", "@IdType": "pubmed"}]}, "Citation": "Qu L, Wu Z, Li Y, Xu Z, Liu B, Liu F, et al. A feed-forward looP <between lncARSR and YAP activity promotes expansion of renal tumour-initiating cells. Nat Commun. 2016;7:12692. doi: 10.1038/ncomms12692."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nchembio.1309", "@IdType": "doi"}, {"#text": "23892894", "@IdType": "pubmed"}]}, "Citation": "Wang S, Yin J, Chen D, Nie F, Song X, Fei C, et al. Small-molecule modulation of Wnt signaling via modulating the Axin-LRP5/6 interaction. Nat Chem Biol. 2013;9(9):579\u2013585. doi: 10.1038/nchembio.1309."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s12032-014-0253-8", "@IdType": "doi"}, {"#text": "25326054", "@IdType": "pubmed"}]}, "Citation": "Yin D, He X, Zhang E, Kong R, De W, Zhang Z. Long noncoding RNA GAS5 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer. Med Oncol. 2014;31(11):253. doi: 10.1007/s12032-014-0253-8."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/mc.22120", "@IdType": "doi"}, {"#text": "24357161", "@IdType": "pubmed"}]}, "Citation": "Shi X, Sun M, Liu H, Yao Y, Kong R, Chen F, et al. A critical role for the long non-coding RNA GAS5 in proliferation and apoptosis in non-small-cell lung cancer. Mol Carcinog. 2015;54(Suppl 1):E1\u2013E12. doi: 10.1002/mc.22120."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/ng1429", "@IdType": "doi"}, {"#text": "15448691", "@IdType": "pubmed"}]}, "Citation": "Mendell JT, Sharifi NA, Meyers JL, Martinez-Murillo F, Dietz HC. Nonsense surveillance regulates expression of diverse classes of mammalian transcripts and mutes genomic noise. Nat Genet. 2004;36(10):1073\u20131078. doi: 10.1038/ng1429."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature19342", "@IdType": "doi"}, {"#text": "PMC5509218", "@IdType": "pmc"}, {"#text": "27602518", "@IdType": "pubmed"}]}, "Citation": "Patil DP, Chen CK, Pickering BF, Chow A, Jackson C, Guttman M. Jaffrey SR: m(6)a RNA methylation promotes XIST-mediated transcriptional repression. Nature. 2016;537(7620):369\u2013373. doi: 10.1038/nature19342."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/nar/gky130", "@IdType": "doi"}, {"#text": "PMC5934679", "@IdType": "pmc"}, {"#text": "29529255", "@IdType": "pubmed"}]}, "Citation": "Yang D, Qiao J, Wang G, Lan Y, Li G, Guo X, et al. N6-Methyladenosine modification of lincRNA 1281 is critically required for mESC differentiation potential. Nucleic Acids Res. 2018;46(8):3906\u20133920. doi: 10.1093/nar/gky130."}]}}}}}, "PMC": "PMC6794841", "PMID": "31619268", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the mA reader YTHDF3.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "29": {"Abstract": "Cisplatin is a chemotherapy drug commonly used in cancer treatment. Tumour cells are more sensitive to cisplatin than normal cells. Cisplatin exerts an antitumour effect by interfering with DNA replication and transcription processes. However, the drug-resistance properties of tumour cells often cause loss of cisplatin efficacy and failure of chemotherapy, leading to tumour progression. Owing to the large amounts of energy and compounds required by tumour cells, metabolic reprogramming plays an important part in the occurrence and development of tumours. The interplay between DNA damage repair and metabolism also has an effect on cisplatin resistance; the molecular changes to glucose metabolism, amino acid metabolism, lipid metabolism, and other metabolic pathways affect the cisplatin resistance of tumour cells. Here, we review the mechanism of action of cisplatin, the mechanism of resistance to cisplatin, the role of metabolic remodelling in tumorigenesis and development, and the effects of common metabolic pathways on cisplatin resistance.", "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "-7762777614718504092", "Part1": "Central Laboratory", "Part2": "Affiliated Jinhua Hospital", "Part3": "Zhejiang University School of Medicine", "Part4": "Jinhua", "Part5": "China.", "Part6": null, "Text": "Central Laboratory, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China."}], "ForeName": "Lude", "FullName": "Lude Wang", "HashID": "43257159156539117", "LastName": "Wang", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-7762777614718504092", "Part1": "Central Laboratory", "Part2": "Affiliated Jinhua Hospital", "Part3": "Zhejiang University School of Medicine", "Part4": "Jinhua", "Part5": "China.", "Part6": null, "Text": "Central Laboratory, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China."}], "ForeName": "Xiaoya", "FullName": "Xiaoya Zhao", "HashID": "244916089282157311", "LastName": "Zhao", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-8204489944241611314", "Part1": "Department of Medical Oncology", "Part2": "Affiliated Jinhua Hospital", "Part3": "Zhejiang University School of Medicine", "Part4": "Jinhua", "Part5": "China.", "Part6": null, "Text": "Department of Medical Oncology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China."}], "ForeName": "Jianfei", "FullName": "Jianfei Fu", "HashID": "-1324205208493458637", "LastName": "Fu", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-7762777614718504092", "Part1": "Central Laboratory", "Part2": "Affiliated Jinhua Hospital", "Part3": "Zhejiang University School of Medicine", "Part4": "Jinhua", "Part5": "China.", "Part6": null, "Text": "Central Laboratory, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China."}], "ForeName": "Wenxia", "FullName": "Wenxia Xu", "HashID": "1832013832009025110", "LastName": "Xu", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-5544476098737289018", "Part1": "Department of Neurosurgery", "Part2": "Affiliated Jinhua Hospital", "Part3": "Zhejiang University School of Medicine", "Part4": "Jinhua", "Part5": "China.", "Part6": null, "Text": "Department of Neurosurgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China."}], "ForeName": "Jianlie", "FullName": "Jianlie Yuan", "HashID": "-7427473191881477415", "LastName": "Yuan", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.3389/fmolb.2021.691795", "InsertType": null, "Journal": "Frontiers in molecular biosciences", "Keywords": [{"IS_Major": false, "IS_Mesh": false, "Text": "DNA damage repair"}, {"IS_Major": false, "IS_Mesh": false, "Text": "ROS"}, {"IS_Major": false, "IS_Mesh": false, "Text": "cisplatin"}, {"IS_Major": false, "IS_Mesh": false, "Text": "resistance"}, {"IS_Major": false, "IS_Mesh": false, "Text": "tumour metabolism"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "PubMed-not-MEDLINE", "Article": {"@PubModel": "Electronic-eCollection", "Abstract": {"AbstractText": "Cisplatin is a chemotherapy drug commonly used in cancer treatment. Tumour cells are more sensitive to cisplatin than normal cells. Cisplatin exerts an antitumour effect by interfering with DNA replication and transcription processes. However, the drug-resistance properties of tumour cells often cause loss of cisplatin efficacy and failure of chemotherapy, leading to tumour progression. Owing to the large amounts of energy and compounds required by tumour cells, metabolic reprogramming plays an important part in the occurrence and development of tumours. The interplay between DNA damage repair and metabolism also has an effect on cisplatin resistance; the molecular changes to glucose metabolism, amino acid metabolism, lipid metabolism, and other metabolic pathways affect the cisplatin resistance of tumour cells. Here, we review the mechanism of action of cisplatin, the mechanism of resistance to cisplatin, the role of metabolic remodelling in tumorigenesis and development, and the effects of common metabolic pathways on cisplatin resistance.", "CopyrightInformation": "Copyright \u00a9 2021 Wang, Zhao, Fu, Xu and Yuan."}, "ArticleDate": {"@DateType": "Electronic", "Day": "23", "Month": "06", "Year": "2021"}, "ArticleTitle": "The Role of Tumour Metabolism in Cisplatin Resistance.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Central Laboratory, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China."}, "ForeName": "Lude", "Initials": "L", "LastName": "Wang"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Central Laboratory, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China."}, "ForeName": "Xiaoya", "Initials": "X", "LastName": "Zhao"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Medical Oncology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China."}, "ForeName": "Jianfei", "Initials": "J", "LastName": "Fu"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Central Laboratory, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China."}, "ForeName": "Wenxia", "Initials": "W", "LastName": "Xu"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Neurosurgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China."}, "ForeName": "Jianlie", "Initials": "J", "LastName": "Yuan"}]}, "ELocationID": [{"#text": "691795", "@EIdType": "pii", "@ValidYN": "Y"}, {"#text": "10.3389/fmolb.2021.691795", "@EIdType": "doi", "@ValidYN": "Y"}], "Journal": {"ISOAbbreviation": "Front Mol Biosci", "ISSN": {"#text": "2296-889X", "@IssnType": "Print"}, "JournalIssue": {"@CitedMedium": "Print", "PubDate": {"Year": "2021"}, "Volume": "8"}, "Title": "Frontiers in molecular biosciences"}, "Language": "eng", "Pagination": {"MedlinePgn": "691795", "StartPage": "691795"}, "PublicationTypeList": {"PublicationType": [{"#text": "Journal Article", "@UI": "D016428"}, {"#text": "Review", "@UI": "D016454"}]}}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.", "DateRevised": {"Day": "13", "Month": "07", "Year": "2021"}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"#text": "DNA damage repair", "@MajorTopicYN": "N"}, {"#text": "ROS", "@MajorTopicYN": "N"}, {"#text": "cisplatin", "@MajorTopicYN": "N"}, {"#text": "resistance", "@MajorTopicYN": "N"}, {"#text": "tumour metabolism", "@MajorTopicYN": "N"}]}, "MedlineJournalInfo": {"Country": "Switzerland", "ISSNLinking": "2296-889X", "MedlineTA": "Front Mol Biosci", "NlmUniqueID": "101653173"}, "PMID": {"#text": "34250022", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "34250022", "@IdType": "pubmed"}, {"#text": "PMC8261055", "@IdType": "pmc"}, {"#text": "10.3389/fmolb.2021.691795", "@IdType": "doi"}, {"#text": "691795", "@IdType": "pii"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "received", "Day": "7", "Month": "4", "Year": "2021"}, {"@PubStatus": "accepted", "Day": "10", "Month": "6", "Year": "2021"}, {"@PubStatus": "entrez", "Day": "12", "Hour": "5", "Minute": "57", "Month": "7", "Year": "2021"}, {"@PubStatus": "pubmed", "Day": "13", "Hour": "6", "Minute": "0", "Month": "7", "Year": "2021"}, {"@PubStatus": "medline", "Day": "13", "Hour": "6", "Minute": "1", "Month": "7", "Year": "2021"}]}, "PublicationStatus": "epublish", "ReferenceList": {"Reference": [{"ArticleIdList": {"ArticleId": {"#text": "28591093", "@IdType": "pubmed"}}, "Citation": "Adra N., Einhorn L. H. (2017). Testicular Cancer Update. Clin. Adv. Hematol. Oncol. 15 (5), 386\u2013396."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3389/fphys.2014.00358", "@IdType": "doi"}, {"#text": "PMC4166897", "@IdType": "pmc"}, {"#text": "25278906", "@IdType": "pubmed"}]}, "Citation": "Alleman R. J., Katunga L. A., Nelson M. A. M., Brown D. A., Anderson E. J. (2014). The \u201cGoldilocks Zone\u201d from a Redox perspective\u2014Adaptive vs. Deleterious Responses to Oxidative Stress in Striated Muscle. Front. Physiol. 5, 358. 10.3389/fphys.2014.00358"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.metabol.2014.04.003", "@IdType": "doi"}, {"#text": "24814684", "@IdType": "pubmed"}]}, "Citation": "Ameer F., Scandiuzzi L., Hasnain S., Kalbacher H., Zaidi N. (2014). De Novo lipogenesis in Health and Disease. Metabolism 63 (7), 895\u2013902. 10.1016/j.metabol.2014.04.003"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1056/nejmoa052985", "@IdType": "doi"}, {"#text": "16394300", "@IdType": "pubmed"}]}, "Citation": "Armstrong D. K., Bundy B., Wenzel L., Huang H. Q., Baergen R., Lele S., et al. Gynecologic Oncology Group (2006). Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer. N. Engl. J. Med. 354 (1), 34\u201343. 10.1056/nejmoa052985"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12967-015-0511-3", "@IdType": "doi"}, {"#text": "PMC4504229", "@IdType": "pmc"}, {"#text": "25947066", "@IdType": "pubmed"}]}, "Citation": "Bauerschlag D. O., Maass N., Leonhardt P., Verburg F. A., Pecks U., Zeppernick F., et al. (2015). Fatty Acid Synthase Overexpression: Target for Therapy and Reversal of Chemoresistance in Ovarian Cancer. J. Transl Med., 13, 146.10.1186/s12967-015-0511-3"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/ijc.22132", "@IdType": "doi"}, {"#text": "17044026", "@IdType": "pubmed"}]}, "Citation": "Berndtsson M., Hagg M., Panaretakis T., Havelka A. M., Shoshan M. C., Linder S. (2007). Acute Apoptosis by Cisplatin Requires Induction of Reactive Oxygen Species but Is Not Associated with Damage to Nuclear DNA. Int. J. Cancer 120 (1), 175\u2013180. 10.1002/ijc.22132"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.immuni.2015.09.001", "@IdType": "doi"}, {"#text": "26377897", "@IdType": "pubmed"}]}, "Citation": "Biswas S. K., (2015). Metabolic Reprogramming of Immune Cells in Cancer Progression[Journal Article; Research Support, Non-U.S. Gov't; Review], Immunity. 43 (3), 435\u2013449. 10.1016/j.immuni.2015.09.001"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/jnci/92.16.1295", "@IdType": "doi"}, {"#text": "10944550", "@IdType": "pubmed"}]}, "Citation": "Borst P., Evers R., Kool M., Wijnholds J. (2000). A Family of Drug Transporters: the Multidrug Resistance-Associated proteinsResearch Support, Non-U.S. Gov't; Review]. J Natl Cancer Inst. 92 (16), 1295\u20131302. 10.1093/jnci/92.16.1295"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1200/jco.2004.11.019", "@IdType": "doi"}, {"#text": "15117981", "@IdType": "pubmed"}]}, "Citation": "Brandes A. A., Basso U., Reni M., Vastola F., Tosoni A., Cavallo G., et al. (2004). First-line chemotherapy with cisplatin plus fractionated temozolomide in recurrent glioblastoma multiforme: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia. J. Clin. Oncol. 22 (9), 1598\u20131604. 10.1200/jco.2004.11.019"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1056/nejmoa1613493", "@IdType": "doi"}, {"#text": "PMC6487310", "@IdType": "pmc"}, {"#text": "28636851", "@IdType": "pubmed"}]}, "Citation": "Carbone D. P., Reck M., Paz-Ares L., Creelan B., Horn L., Steins M., et al. (2017). First-Line Nivolumab in Stage IV or Recurrent Non-small-cell Lung Cancer. [Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Comment]. N. Engl. J. Med. 376, 2415\u20132426. 10.1056/nejmoa1613493"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s13402-016-0291-7", "@IdType": "doi"}, {"#text": "27473273", "@IdType": "pubmed"}]}, "Citation": "Chen P., Li J., Chen Y. C., Qian H., Chen Y. J., Su J. Y., et al. (2016). The Functional Status of DNA Repair Pathways Determines the Sensitization Effect to Cisplatin in Non-small Cell Lung Cancer Cells. [Journal Article]. Cel Oncol (Dordr) 39 (6), 511\u2013522. 10.1007/s13402-016-0291-7"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.7150/thno.37556", "@IdType": "doi"}, {"#text": "PMC6735381", "@IdType": "pmc"}, {"#text": "31534516", "@IdType": "pubmed"}]}, "Citation": "Chen W., Wang P., Lu Y., Jin T., Lei X., Liu M., et al. (2019). Decreased Expression of Mitochondrial miR-5787 Contributes to Chemoresistance by Reprogramming Glucose Metabolism and Inhibiting MT-CO3 translation. [Journal Article; Research Support, Non-U.S. Gov't]. Theranostics 9 (20), 5739\u20135754. 10.7150/thno.37556"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s40880-018-0301-4", "@IdType": "doi"}, {"#text": "PMC5993136", "@IdType": "pmc"}, {"#text": "29784041", "@IdType": "pubmed"}]}, "Citation": "Cheng C., Geng F., Cheng X., Guo D. (2018). Lipid Metabolism Reprogramming and its Potential Targets in Cancer. Cancer Commun. (Lond) 38 (1), 27. 10.1186/s40880-018-0301-4"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/path.4218", "@IdType": "doi"}, {"#text": "PMC3757307", "@IdType": "pmc"}, {"#text": "23729358", "@IdType": "pubmed"}]}, "Citation": "Choi S. Y., Collins C. C., Gout P. W., Wang Y. (2013). Cancer-generated Lactic Acid: a Regulatory, Immunosuppressive Metabolite? [Journal Article; Research Support, Non-U.S. Gov't; Review]. J. Pathol. 230 (4), 350\u2013355. 10.1002/path.4218"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrm3841", "@IdType": "doi"}, {"#text": "25053359", "@IdType": "pubmed"}]}, "Citation": "Choudhary C., Weinert B. T., Nishida Y., Verdin E., Mann M. (2014). The Growing Landscape of Lysine Acetylation Links Metabolism and Cell signalling. [Journal Article; Research Support, Non-U.S. Gov't; Review]. Nat Rev. Mol. Cel Biol 15 (8), 536\u2013550. 10.1038/nrm3841"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/s0021-9258(17)42175-2", "@IdType": "doi"}, {"#text": "8288625", "@IdType": "pubmed"}]}, "Citation": "Chu G. (1994). Cellular Responses to Cisplatin. The Roles of DNA-Binding Proteins and DNA Repair. Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review]. J. Biol. Chem. 269, 787\u2013790. 10.1016/s0021-9258(17)42175-2"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.trecan.2017.01.005", "@IdType": "doi"}, {"#text": "PMC5383348", "@IdType": "pmc"}, {"#text": "28393116", "@IdType": "pubmed"}]}, "Citation": "Cluntun A. A., Lukey M. J., Cerione R. A., Locasale J. W. (2017). Glutamine Metabolism in Cancer: Understanding the Heterogeneity. [Journal Article; Review; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't]. Trends Cancer 3, 169\u2013180. 10.1016/j.trecan.2017.01.005"}, {"ArticleIdList": {"ArticleId": {"#text": "17091764", "@IdType": "pubmed"}}, "Citation": "Cory J. G., Cory A. H. (2006). Critical Roles of Glutamine as Nitrogen Donors in Purine and Pyrimidine Nucleotide Synthesis: Asparaginase Treatment in Childhood Acute Lymphoblastic Leukemia. [Journal Article; Review]. In. Vivo 20 (5), 587\u2013589."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12885-016-2999-1", "@IdType": "doi"}, {"#text": "PMC5214767", "@IdType": "pmc"}, {"#text": "28056859", "@IdType": "pubmed"}]}, "Citation": "Cree I. A., Charlton P. (2017). Molecular Chess? Hallmarks of Anti-cancer Drug Resistance. [Journal Article; Review]. BMC Cancer 17 (1), 10. 10.1186/s12885-016-2999-1"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ejphar.2014.07.025", "@IdType": "doi"}, {"#text": "PMC4146684", "@IdType": "pmc"}, {"#text": "25058905", "@IdType": "pubmed"}]}, "Citation": "Dasari S., Tchounwou P. B. (2014). Cisplatin in Cancer Therapy: Molecular Mechanisms of Action. [Journal Article; Research Support, N.I.H., Extramural; Review]. Eur J. Pharmacol. 740, 364\u2013378. 10.1016/j.ejphar.2014.07.025"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ctrv.2020.102054", "@IdType": "doi"}, {"#text": "32593915", "@IdType": "pubmed"}]}, "Citation": "de Vries G., Rosas-Plaza X., van Vugt M. A. T. M., Gietema J. A., de Jong S. (2020). Testicular Cancer: Determinants of Cisplatin Sensitivity and Novel Therapeutic Opportunities. [Journal Article; Review]. Cancer Treat Rev 88, 102054. 10.1016/j.ctrv.2020.102054"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/ng.3421", "@IdType": "doi"}, {"#text": "PMC4721512", "@IdType": "pmc"}, {"#text": "26482881", "@IdType": "pubmed"}]}, "Citation": "DeNicola G. M., Chen P. H., Mullarky E., Sudderth J. A., Hu Z., Wu D., et al. (2015). NRF2 Regulates Serine Biosynthesis in Non-small Cell Lung Cancer. [Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't]. Nat. Genet. 47, 1475\u20131481. 10.1038/ng.3421"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/nar/gki528", "@IdType": "doi"}, {"#text": "PMC1088968", "@IdType": "pmc"}, {"#text": "15872216", "@IdType": "pubmed"}]}, "Citation": "Diggle C. P., Bentley J., Knowles M. A., Kiltie A. E. (2005). Inhibition of Double-Strand Break Non-homologous End-Joining by Cisplatin Adducts in Human Cell extracts. [Journal ArticleResearch Support, Non-U.S. Gov't]. Nucleic Acids Res. 33 (8), 2531\u20132539. 10.1093/nar/gki528"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41598-018-21831-x", "@IdType": "doi"}, {"#text": "PMC5840399", "@IdType": "pmc"}, {"#text": "29511244", "@IdType": "pubmed"}]}, "Citation": "Duan G., Shi M., Xie L., Xu M., Wang Y., Yan H., et al. (2018a). Increased Glutamine Consumption in Cisplatin-Resistant Cells Has a Negative Impact on Cell Growth. [Journal Article; Research Support, Non-U.S. Gov't]. Sci. Rep. 8 (1), 4067. 10.1038/s41598-018-21831-x"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1155/2018/1736738", "@IdType": "doi"}, {"#text": "PMC6260253", "@IdType": "pmc"}, {"#text": "30539004", "@IdType": "pubmed"}]}, "Citation": "Duan G., Song Z., Qi M., Bai X., Wang J., Zhang Y., et al. (2018b). Increased Autophagy Levels Mediate Cisplatin Resistance in Cisplatin-Resistant Cells while Also Rendering Them Vulnerable to Autophagy Induction. [Journal Article]. Biomed. Res. Int. 2018, 1736738. 10.1155/2018/1736738"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1021/acs.chemrev.8b00396", "@IdType": "doi"}, {"#text": "30489072", "@IdType": "pubmed"}]}, "Citation": "Englinger B., Pirker C., Heffeter P., Terenzi A., Kowol C. R., Keppler B. K., et al. (2019). Metal Drugs and the Anticancer Immune Response. [Journal Article; Research Support, Non-U.S. Gov't; Review]. Chem. Rev. 119 (2), 1519\u20131624. 10.1021/acs.chemrev.8b00396"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/s1470-2045(17)30318-2", "@IdType": "doi"}, {"#text": "PMC5555437", "@IdType": "pmc"}, {"#text": "28642008", "@IdType": "pubmed"}]}, "Citation": "Faivre-Finn C., Snee M., Ashcroft L., Appel W., Barlesi F., Bhatnagar A., et al. (2017). Concurrent Once-Daily versus Twice-Daily Chemoradiotherapy in Patients with Limited-Stage Small-Cell Lung Cancer (CONVERT): an Open-Label, Phase 3, Randomised, Superiority Trial. Lancet Oncol. 18 (8), 1116\u20131125. 10.1016/s1470-2045(17)30318-2"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/msb.2013.65", "@IdType": "doi"}, {"#text": "PMC3882799", "@IdType": "pmc"}, {"#text": "24301801", "@IdType": "pubmed"}]}, "Citation": "Fan J., Kamphorst J. J., Mathew R., Chung M. K., White E., Shlomi T., et al. (2013). Glutamine-driven Oxidative Phosphorylation Is a Major ATP Source in Transformed Mammalian Cells in Both Normoxia and Hypoxia. Mol. Syst. Biol. 9, 712. 10.1038/msb.2013.65"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/annonc/mdu099", "@IdType": "doi"}, {"#text": "24595454", "@IdType": "pubmed"}]}, "Citation": "Fizazi K., Gravis G., Flechon A., Geoffrois L., Chevreau C., Laguerre B., et al. (2014). Combining Gemcitabine, Cisplatin, and Ifosfamide (GIP) Is Active in Patients with Relapsed Metastatic Germ-Cell Tumors (GCT): a Prospective Multicenter GETUG Phase II Trial. Ann. Oncol. 25 (5), 987\u2013991. 10.1093/annonc/mdu099"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1056/nejmoa031317", "@IdType": "doi"}, {"#text": "14645636", "@IdType": "pubmed"}]}, "Citation": "Forastiere A. A., Goepfert H., Maor M., Pajak T. F., Weber R., Morrison W., et al. (2003). Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer. N. Engl. J. Med. 349 (22), 2091\u20132098. 10.1056/nejmoa031317"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/onc.2011.384", "@IdType": "doi"}, {"#text": "21892204", "@IdType": "pubmed"}]}, "Citation": "Galluzzi L., Senovilla L., Vitale I., Michels J., Martins I., Kepp O., et al. (2012). Molecular Mechanisms of Cisplatin Resistance. Oncogene 31 (15), 1869\u20131883. 10.1038/onc.2011.384"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/cddis.2013.428", "@IdType": "doi"}, {"#text": "PMC4047912", "@IdType": "pmc"}, {"#text": "24874729", "@IdType": "pubmed"}]}, "Citation": "Galluzzi L., Vitale I., Michels J., Brenner C., Szabadkai G., Harel-Bellan A., et al. (2014). Systems Biology of Cisplatin Resistance: Past, Present and Future. Cell Death Dis 5, e1257. 10.1038/cddis.2013.428"}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4211756", "@IdType": "pmc"}, {"#text": "25356106", "@IdType": "pubmed"}]}, "Citation": "Gan X., Chen B., Shen Z., Liu Y., Li H., Xie X., et al. (2014). High GPX1 Expression Promotes Esophageal Squamous Cell Carcinoma Invasion, Migration, Proliferation and Cisplatin-Resistance but Can Be Reduced by Vitamin D. [Journal Article]. Int. J. Clin. Exp. Med. 7 (9), 2530\u20132540."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/ijms21030937", "@IdType": "doi"}, {"#text": "PMC7036764", "@IdType": "pmc"}, {"#text": "32023830", "@IdType": "pubmed"}]}, "Citation": "Giacomini I., Ragazzi E., Pasut G., Montopoli M. (2020). The Pentose Phosphate Pathway and its Involvement in Cisplatin Resistance. Int. J. Mol. Sci. 21 (3). 937. 10.3390/ijms21030937"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1124/mol.59.4.657", "@IdType": "doi"}, {"#text": "11259608", "@IdType": "pubmed"}]}, "Citation": "Gonzalez V. M., Fuertes M. A., Alonso C., Perez J. M. (2001). Is Cisplatin-Induced Cell Death Always Produced by Apoptosis?. Mol. Pharmacol. 59 (4), 657\u2013663. 10.1124/mol.59.4.657"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cell.2011.02.013", "@IdType": "doi"}, {"#text": "21376230", "@IdType": "pubmed"}]}, "Citation": "Hanahan D., Weinberg R. A. (2011). Hallmarks of Cancer: the Next Generation. Cell 144 (5), 646\u2013674. 10.1016/j.cell.2011.02.013"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrc.2016.77", "@IdType": "doi"}, {"#text": "PMC5516800", "@IdType": "pmc"}, {"#text": "27634447", "@IdType": "pubmed"}]}, "Citation": "Hay N. (2016). Reprogramming Glucose Metabolism in Cancer: Can it Be Exploited for Cancer Therapy? Nat. Rev. Cancer 16 (10), 635\u2013649. 10.1038/nrc.2016.77"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1124/mol.106.022624", "@IdType": "doi"}, {"#text": "16847145", "@IdType": "pubmed"}]}, "Citation": "Holzer A. K., Manorek G. H., Howell S. B., (2006). Contribution of the Major Copper Influx Transporter CTR1 to the Cellular Accumulation of Cisplatin, Carboplatin, and Oxaliplatin. [Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.]. Mol. Pharmacol. 70, 1390\u20131394. 10.1124/mol.106.022624"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3389/fphar.2018.00043", "@IdType": "doi"}, {"#text": "PMC5797786", "@IdType": "pmc"}, {"#text": "29445340", "@IdType": "pubmed"}]}, "Citation": "Hong W., Cai P., Xu C., Cao D., Yu W., Zhao Z., et al. (2018). Inhibition of Glucose-6-Phosphate Dehydrogenase Reverses Cisplatin Resistance in Lung Cancer Cells via the Redox System. [Journal Article]. Front. Pharmacol. 9, 43. 10.3389/fphar.2018.00043"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1200/jco.1993.11.11.2150", "@IdType": "doi"}, {"#text": "8229129", "@IdType": "pubmed"}]}, "Citation": "Housset M., Maulard C., Chretien Y., Dufour B., Delanian S., Huart J., et al. (1993). Combined Radiation and Chemotherapy for Invasive Transitional-Cell Carcinoma of the Bladder: a Prospective Study. J. Clin. Oncol. 11 (11), 2150\u20132157. 10.1200/jco.1993.11.11.2150"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/s1470-2045(15)70064-1", "@IdType": "doi"}, {"#text": "25795409", "@IdType": "pubmed"}]}, "Citation": "Hu X. C., Zhang J., Xu B. H., Cai L., Wang Z. H., Ragaz J., et al. (2015). Cisplatin Plus Gemcitabine versus Paclitaxel Plus Gemcitabine as First-Line Therapy for Metastatic Triple-Negative Breast Cancer (CBCSG006): a Randomised, Open-Label, Multicentre, Phase 3 Trial. Lancet Oncol. 16 (4), 436\u2013446. 10.1016/s1470-2045(15)70064-1"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41419-019-2177-x", "@IdType": "doi"}, {"#text": "PMC6901542", "@IdType": "pmc"}, {"#text": "31819048", "@IdType": "pubmed"}]}, "Citation": "Huang Z., Zhang Y., Li H., Zhou Y., Zhang Q., Chen R., et al. (2019). Vitamin D Promotes the Cisplatin Sensitivity of Oral Squamous Cell Carcinoma by Inhibiting LCN2-Modulated NF-kappaB Pathway Activation through RPS3. [Journal Article; Research Support, Non-U.S. Gov't]. Cel Death Dis 10 (12), 936. 10.1038/s41419-019-2177-x"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.9317", "@IdType": "doi"}, {"#text": "PMC5173084", "@IdType": "pmc"}, {"#text": "27191653", "@IdType": "pubmed"}]}, "Citation": "Hudson C. D., Savadelis A., Nagaraj A. B., Joseph P., Avril S., DiFeo A., et al. (2016). Altered Glutamine Metabolism in Platinum Resistant Ovarian Cancer. [Journal Article]. Oncotarget 7 (27), 41637\u201341649. 10.18632/oncotarget.9317"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.yexcr.2014.09.023", "@IdType": "doi"}, {"#text": "25278484", "@IdType": "pubmed"}]}, "Citation": "Jeggo P. A., Downs J. A. (2014). Roles of Chromatin Remodellers in DNA Double Strand Break Repair. [Journal Article; Research Support, Non-U.S. Gov't; Review]. Exp. Cel Res 329 (1), 69\u201377. 10.1016/j.yexcr.2014.09.023"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/cancers11060804", "@IdType": "doi"}, {"#text": "PMC6627209", "@IdType": "pmc"}, {"#text": "31212591", "@IdType": "pubmed"}]}, "Citation": "Jiang J., Srivastava S., Zhang J. (2019). Starve Cancer Cells of Glutamine: Break the Spell or Make a Hungry Monster?. Cancers (Basel) 11 (6). 10.3390/cancers11060804"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ccell.2018.06.012", "@IdType": "doi"}, {"#text": "PMC6092215", "@IdType": "pmc"}, {"#text": "30033091", "@IdType": "pubmed"}]}, "Citation": "Jin L., Chun J., Pan C., Li D., Lin R., Alesi G. N., et al. (2018). MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-independent MEK Activation. [Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.]. Cancer Cell 34, 315\u2013330. 10.1016/j.ccell.2018.06.012"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1200/jco.1996.14.3.806", "@IdType": "doi"}, {"#text": "8622028", "@IdType": "pubmed"}]}, "Citation": "Johnson B. E., Bridges J. D., Sobczeck M., Gray J., Linnoila R. I., Gazdar A. F., et al. (1996). Mar). Patients with Limited-Stage Small-Cell Lung Cancer Treated with Concurrent Twice-Daily Chest Radiotherapy and Etoposide/cisplatin Followed by Cyclophosphamide, Doxorubicin, and Vincristine. J. Clin. Oncol. 14 (3), 806\u2013813. 10.1200/jco.1996.14.3.806"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/annonc/mdn717", "@IdType": "doi"}, {"#text": "19153121", "@IdType": "pubmed"}]}, "Citation": "Kang Y. K., Kang W. K., Shin D. B., Chen J., Xiong J., Wang J., et al. (2009). Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as First-Line Therapy in Patients with Advanced Gastric Cancer: a Randomised Phase III Noninferiority Trial. Ann. Oncol. 20 (4), 666\u2013673. 10.1093/annonc/mdn717"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1634/theoncologist.5-6-471", "@IdType": "doi"}, {"#text": "11110598", "@IdType": "pubmed"}]}, "Citation": "Kaufman D. S., Winter K. A., Wu S., Heney N. M., Chetner M. P., Souhami L., et al. (2000). The Initial Results in Muscle-Invading Bladder Cancer of RTOG 95-06: Phase I/II Trial of Transurethral Surgery Plus Radiation Therapy with Concurrent Cisplatin and 5-fluorouracil Followed by Selective Bladder Preservation or Cystectomy Depending on the Initial Response. Oncologist 5 (6), 471\u2013476. 10.1634/theoncologist.5-6-471"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/0140-6736(92)91404-v", "@IdType": "doi"}, {"#text": "1353804", "@IdType": "pubmed"}]}, "Citation": "Kaye S. B., Lewis C. R., Paul J., Duncan I. D., Gordon H. K., Kitchener H. C., et al. (1992). Randomised Study of Two Doses of Cisplatin with Cyclophosphamide in Epithelial Ovarian Cancer. [Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't]. Lancet 340 (8815), 329\u2013333. 10.1016/0140-6736(92)91404-v"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrc2167", "@IdType": "doi"}, {"#text": "17625587", "@IdType": "pubmed"}]}, "Citation": "Kelland L. (2007). The Resurgence of Platinum-Based Cancer Chemotherapy. Nat. Rev. Cancer 7 (8), 573\u2013584. 10.1038/nrc2167"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.5306/wjco.v7.i1.106", "@IdType": "doi"}, {"#text": "PMC4734932", "@IdType": "pmc"}, {"#text": "26862494", "@IdType": "pubmed"}]}, "Citation": "Kilari D., Guancial E., Kim E. S. (2016). Role of Copper Transporters in Platinum Resistance. World J. Clin. Oncol. 7 (1), 106\u2013113. 10.5306/wjco.v7.i1.106"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/j.1460-2075.1995.tb00245.x", "@IdType": "doi"}, {"#text": "PMC394672", "@IdType": "pmc"}, {"#text": "8521815", "@IdType": "pubmed"}]}, "Citation": "Kischkel F. C., Hellbardt S., Behrmann I., Germer M., Pawlita M., Krammer P. H., et al. (1995). Cytotoxicity-dependent APO-1 (Fas/CD95)-Associated Proteins Form a Death-Inducing Signaling Complex (DISC) with the Receptor. EMBO J. 14 (22), 5579\u20135588. 10.1002/j.1460-2075.1995.tb00245.x"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1200/jco.2014.58.4391", "@IdType": "doi"}, {"#text": "25732161", "@IdType": "pubmed"}]}, "Citation": "Kitagawa R., Katsumata N., Shibata T., Kamura T., Kasamatsu T., Nakanishi T., et al. (2015). Paclitaxel Plus Carboplatin versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505. J. Clin. Oncol. 33 (19), 2129\u20132135. 10.1200/jco.2014.58.4391"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1200/jco.1990.8.9.1556", "@IdType": "doi"}, {"#text": "2167953", "@IdType": "pubmed"}]}, "Citation": "Klastersky J., Sculier J. P., Lacroix H., Dabouis G., Bureau G., Libert P., et al. (1990). A Randomized Study Comparing Cisplatin or Carboplatin with Etoposide in Patients with Advanced Non-small-cell Lung Cancer: European Organization for Research and Treatment of Cancer Protocol 07861. J. Clin. Oncol. 8 (9), 1556\u20131562. 10.1200/jco.1990.8.9.1556"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1200/jco.2005.19.638", "@IdType": "doi"}, {"#text": "16170162", "@IdType": "pubmed"}]}, "Citation": "Kondagunta G. V., Bacik J., Donadio A., Bajorin D., Marion S., Sheinfeld J., et al. (2005). Combination of Paclitaxel, Ifosfamide, and Cisplatin Is an Effective Second-Line Therapy for Patients with Relapsed Testicular Germ Cell Tumors. J. Clin. Oncol. 23 (27), 6549\u20136555. 10.1200/jco.2005.19.638"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.celrep.2014.04.045", "@IdType": "doi"}, {"#text": "24813884", "@IdType": "pubmed"}]}, "Citation": "Labuschagne C. F., van den Broek N. J., Mackay G. M., Vousden K. H., Maddocks O. D. (2014). Serine, but Not glycine, Supports One-Carbon Metabolism and Proliferation of Cancer cells. [Journal Article; Research Support, Non-U.S. Gov't]. Cell Rep. 7 (4), 1248\u20131258. 10.1016/j.celrep.2014.04.045"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/nar/gkv047", "@IdType": "doi"}, {"#text": "PMC4344498", "@IdType": "pmc"}, {"#text": "25628363", "@IdType": "pubmed"}]}, "Citation": "Lane A. N., Fan T. W. (2015). Regulation of Mammalian Nucleotide Metabolism and Biosynthesis. [Journal Article; Research Support, N.I.H., Extramural; Review]. Nucleic Acids Res. 43 (4), 2466\u20132485. 10.1093/nar/gkv047"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1200/jco.2011.39.1953", "@IdType": "doi"}, {"#text": "22184384", "@IdType": "pubmed"}]}, "Citation": "Lee J., Lim D. H., Kim S., Park S. H., Park J. O., Park Y. S., et al. (2012). Phase III Trial Comparing Capecitabine Plus Cisplatin versus Capecitabine Plus Cisplatin with Concurrent Capecitabine Radiotherapy in Completely Resected Gastric Cancer with D2 Lymph Node Dissection: the ARTIST Trial. J. Clin. Oncol. 30 (3), 268\u2013273. 10.1200/jco.2011.39.1953"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.lfs.2019.116679", "@IdType": "doi"}, {"#text": "31340168", "@IdType": "pubmed"}]}, "Citation": "Li F., Zhang Z., Wang P., Wen P., Xu Q., Wang Y., et al. (2019). ALC1 Knockdown Enhances Cisplatin Cytotoxicity of Esophageal Squamous Cell Carcinoma Cells by Inhibition of Glycolysis through PI3K/Akt Pathway. [Journal Article]. Life Sci. 232, 116679. 10.1016/j.lfs.2019.116679"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s00018-015-2070-4", "@IdType": "doi"}, {"#text": "26499846", "@IdType": "pubmed"}]}, "Citation": "Li Z., Zhang H. (2016). Reprogramming of Glucose, Fatty Acid and Amino Acid Metabolism for Cancer progression. [Journal Article; Research Support, Non-U.S. Gov't; Review]. Cell Mol. Life Sci. 73 (2), 377\u2013392. 10.1007/s00018-015-2070-4"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1046/j.1523-1747.2003.12313.x", "@IdType": "doi"}, {"#text": "12839578", "@IdType": "pubmed"}]}, "Citation": "Liedert B., Materna V., Schadendorf D., Thomale J., Lage H. (2003). Overexpression of cMOAT (MRP2/ABCC2) Is Associated with Decreased Formation of Platinum-DNA Adducts and Decreased G2-Arrest in Melanoma Cells Resistant to cisplatin. [Journal Article; Research Support, Non-U.S. Gov't]. J Invest. Dermatol. 121 (1), 172\u2013176. 10.1046/j.1523-1747.2003.12313.x"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2147/ott.s163266", "@IdType": "doi"}, {"#text": "PMC5975610", "@IdType": "pmc"}, {"#text": "29872321", "@IdType": "pubmed"}]}, "Citation": "Lin M., Lv D., Zheng Y., Wu M., Xu C., Zhang Q., et al. (2018). Downregulation of CPT2 Promotes Tumorigenesis and Chemoresistance to Cisplatin in Hepatocellular Carcinoma. [Journal Article]. Onco Targets Ther. 11, 3101\u20133110. 10.2147/ott.s163266"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.5483/bmbrep.2018.51.9.114", "@IdType": "doi"}, {"#text": "PMC6177506", "@IdType": "pmc"}, {"#text": "30103844", "@IdType": "pubmed"}]}, "Citation": "Liu Z., Peng Q., Li Y., Gao Y. (2018). Resveratrol Enhances Cisplatin-Induced Apoptosis in Human Hepatoma Cells via Glutamine Metabolism Inhibition. BMB Rep. 51 (9), 474\u2013479. 10.5483/bmbrep.2018.51.9.114"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1200/jco.1998.16.7.2500", "@IdType": "doi"}, {"#text": "9667270", "@IdType": "pubmed"}]}, "Citation": "Loehrer P. J., Sr, Gonin R., Nichols C. R., Weathers T., Einhorn L. H. (1998). Vinblastine Plus Ifosfamide Plus Cisplatin as Initial Salvage Therapy in Recurrent Germ Cell Tumor. J. Clin. Oncol. 16 (7), 2500\u20132504. 10.1200/jco.1998.16.7.2500"}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5992506", "@IdType": "pmc"}, {"#text": "29888102", "@IdType": "pubmed"}]}, "Citation": "Long J., Zhang C. J., Zhu N., Du K., Yin Y. F., Tan X., et al. (2018). Lipid Metabolism and Carcinogenesis, Cancer Development. Am. J. Cancer Res. 8 (5), 778\u2013791."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1074/jbc.m210284200", "@IdType": "doi"}, {"#text": "12509415", "@IdType": "pubmed"}]}, "Citation": "Mandic A., Hansson J., Linder S., Shoshan M. C. (2003). Cisplatin Induces Endoplasmic Reticulum Stress and Nucleus-independent Apoptotic signaling. [Journal Article; Research Support, Non-U.S. Gov't]. J Biol. Chem. 278 (11), 9100\u20139106. 10.1074/jbc.m210284200"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ejps.2015.04.022", "@IdType": "doi"}, {"#text": "25930121", "@IdType": "pubmed"}]}, "Citation": "Manerba M., Di Ianni L., Fiume L., Roberti M., Recanatini M., Di Stefano G. (2015). Lactate Dehydrogenase Inhibitors Sensitize Lymphoma Cells to Cisplatin without Enhancing the Drug Effects on Immortalized normal Lymphocytes. Eur. J. Pharm. Sci. 74, 95\u2013102. 10.1016/j.ejps.2015.04.022"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/jcb.26814", "@IdType": "doi"}, {"#text": "29633308", "@IdType": "pubmed"}]}, "Citation": "Masamha C. P., LaFontaine P. (2018). Molecular Targeting of Glutaminase Sensitizes Ovarian Cancer Cells to Chemotherapy. [Journal Article; Research Support, Non-U.S. Gov't]. J. Cel Biochem 119 (7), 6136\u20136145. 10.1002/jcb.26814"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1242/dev.128389", "@IdType": "doi"}, {"#text": "PMC5312031", "@IdType": "pmc"}, {"#text": "28196802", "@IdType": "pubmed"}]}, "Citation": "Mathieu J., Ruohola-Baker H. (2017). Metabolic Remodeling during the Loss and Acquisition of Pluripotency. Journal Article; Review; Research Support, N.I.H., Extramural]. Development 144, 541\u2013551. 10.1242/dev.128389"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1083/jcb.201604085", "@IdType": "doi"}, {"#text": "PMC4970329", "@IdType": "pmc"}, {"#text": "27458133", "@IdType": "pubmed"}]}, "Citation": "Mattaini K. R., Sullivan M. R., Vander H. M. G. (2016). The Importance of Serine Metabolism in Cancer. [Journal Article; Review; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural]. J. Cel Biol 214, 249\u2013257. 10.1083/jcb.201604085"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1200/jco.1997.15.7.2559", "@IdType": "doi"}, {"#text": "9215825", "@IdType": "pubmed"}]}, "Citation": "McCaffrey J. A., Mazumdar M., Bajorin D. F., Bosl G. J., Vlamis V., Motzer R. J. (1997). Ifosfamide- and Cisplatin-Containing Chemotherapy as First-Line Salvage Therapy in Germ Cell Tumors: Response and Survival. J. Clin. Oncol. 15 (7), 2559\u20132563. 10.1200/jco.1997.15.7.2559"}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC1888599", "@IdType": "pmc"}, {"#text": "16789469", "@IdType": "pubmed"}]}, "Citation": "McCarthy E. F. (2006). The Toxins of William B. Coley and the Treatment of Bone and Soft-Tissue Sarcomas. [Biography; Historical Article; Journal Article; Portrait]. Iowa Orthop J 26, 154\u2013158."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1056/nejm199601043340101", "@IdType": "doi"}, {"#text": "7494563", "@IdType": "pubmed"}]}, "Citation": "McGuire W. P., Hoskins W. J., Brady M. F., Kucera P. R., Partridge E. E., Look K. Y., et al. (1996). Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer. N. Engl. J. Med. 334 (1), 1\u20136. 10.1056/nejm199601043340101"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/ncomms13666", "@IdType": "doi"}, {"#text": "PMC5171841", "@IdType": "pmc"}, {"#text": "27966532", "@IdType": "pubmed"}]}, "Citation": "Mehrmohamadi M., Mentch L. K., Clark A. G., Locasale J. W. (2016). Integrative Modelling of Tumour DNA Methylation Quantifies the Contribution of Metabolism. [Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't]. Nat. Commun. 7, 13666. 10.1038/ncomms13666"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1200/jco.1997.15.4.1427", "@IdType": "doi"}, {"#text": "9193335", "@IdType": "pubmed"}]}, "Citation": "Miller K. D., Loehrer P. J., Gonin R., Einhorn L. H. (1997). Salvage Chemotherapy with Vinblastine, Ifosfamide, and Cisplatin in Recurrent Seminoma. J. Clin. Oncol. 15 (4), 1427\u20131431. 10.1200/jco.1997.15.4.1427"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1021/acs.chemrestox.6b00389", "@IdType": "doi"}, {"#text": "PMC5567688", "@IdType": "pmc"}, {"#text": "28282121", "@IdType": "pubmed"}]}, "Citation": "Ming X., Groehler A. Th., Michaelson-Richie E. D., Villalta P. W., Campbell C., Tretyakova N. Y. (2017). Mass Spectrometry Based Proteomics Study of Cisplatin-Induced DNA-Protein Cross-Linking in Human Fibrosarcoma (HT1080) Cells. [Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't]. Chem. Res. Toxicol. 30 (4), 980\u2013995. 10.1021/acs.chemrestox.6b00389"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ijrobp.2006.08.064", "@IdType": "doi"}, {"#text": "17126209", "@IdType": "pubmed"}]}, "Citation": "Mirzayans R., Severin D., Murray D. (2006). Relationship between DNA Double-Strand Break Rejoining and Cell Survival after Exposure to Ionizing Radiation in Human Fibroblast Strains with Differing ATM/p53 Status: Implications for Evaluation of Clinical Radiosensitivity. [Journal Article; Research Support, Non-U.S. Gov't]. Int. J. Radiat. Oncol. Biol. Phys. 66 (5), 1498\u20131505. 10.1016/j.ijrobp.2006.08.064"}, {"ArticleIdList": {"ArticleId": {"#text": "11034077", "@IdType": "pubmed"}}, "Citation": "Mitsuuchi Y., Johnson S. W., Selvakumaran M., Williams S. J., Hamilton T. C., Testa J. R., et al. (2000). The Phosphatidylinositol 3-kinase/AKT Signal Transduction Pathway Plays a Critical Role in the Expression of p21WAF1/CIP1/SDI1 Induced by Cisplatin and Paclitaxel. [Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.]. Cancer Res. 60, 5390\u20135394."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1200/jco.2015.60.7481", "@IdType": "doi"}, {"#text": "26503202", "@IdType": "pubmed"}]}, "Citation": "Muggia F. M., Bonetti A., Hoeschele J. D., Rozencweig M., Howell S. B. (2015). Platinum Antitumor Complexes: 50 Years since Barnett Rosenberg's Discovery. [Biography; Historical Article; Journal Article]. J. Clin. Oncol. 33 (35), 4219\u20134226. 10.1200/jco.2015.60.7481"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/1541-7786.mcr-19-0239", "@IdType": "doi"}, {"#text": "PMC7262740", "@IdType": "pmc"}, {"#text": "31628200", "@IdType": "pubmed"}]}, "Citation": "Nguyen D. J. M., Theodoropoulos G., Li Y. Y., Wu C., Sha W., Feun L. G., et al. (2020). Targeting the Kynurenine Pathway for the Treatment of Cisplatin-Resistant Lung Cancer. Mol. Cancer Res. 18 (1), 105\u2013117. 10.1158/1541-7786.mcr-19-0239"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrc3184", "@IdType": "doi"}, {"#text": "22237392", "@IdType": "pubmed"}]}, "Citation": "Nguyen L. V., Vanner R., Dirks P., Eaves C. J. (2012). Cancer Stem Cells: an Evolving Concept. [Research Support, Non-U.S. Gov't; Review]. Nat. Rev. Cancer 12 (2), 133\u2013143. 10.1038/nrc3184"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/jn/132.8.2333s", "@IdType": "doi"}, {"#text": "12163687", "@IdType": "pubmed"}]}, "Citation": "Niculescu M. D., Zeisel S. H. (2002). Diet, Methyl Donors and DNA Methylation: Interactions between Dietary Folate, Methionine and Choline. [Journal Article; Research Support, U.S. Gov't, P.H.S.]. J. Nutr. 132, 2333S\u20132335S. 10.1093/jn/132.8.2333s"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1128/mcb.22.16.5793-5800.2002", "@IdType": "doi"}, {"#text": "PMC133987", "@IdType": "pmc"}, {"#text": "12138190", "@IdType": "pubmed"}]}, "Citation": "Nikiforov M. A., Chandriani S., O'Connell B., Petrenko O., Kotenko I., Beavis A., et al. (2002). A Functional Screen for Myc-Responsive Genes Reveals Serine Hydroxymethyltransferase, a Major Source of the One-Carbon Unit for Cell Metabolism. [Journal Article; Research Support, U.S. Gov't, P.H.S.]. Mol. Cel Biol 22, 5793\u20135800. 10.1128/mcb.22.16.5793-5800.2002"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/1078-0432.ccr-13-0895", "@IdType": "doi"}, {"#text": "PMC3740724", "@IdType": "pmc"}, {"#text": "23743568", "@IdType": "pubmed"}]}, "Citation": "Nishino M., Giobbie-Hurder A., Gargano M., Suda M., Ramaiya N. H., Hodi F. S., et al. (2013). Developing a Common Language for Tumor Response to Immunotherapy: Immune-Related Response Criteria Using Unidimensional Measurements. [Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't], Clin. Cancer Res. 19, 3936\u20133943. 10.1158/1078-0432.ccr-13-0895"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/sj.onc.1202581", "@IdType": "doi"}, {"#text": "9916986", "@IdType": "pubmed"}]}, "Citation": "Nunez G., Benedict M. A., Hu Y., Inohara N. (1998). Caspases: the Proteases of the Apoptotic Pathway. Oncogene 17 (25), 3237\u20133245. 10.1038/sj.onc.1202581"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.15252/embj.201798597", "@IdType": "doi"}, {"#text": "PMC6043854", "@IdType": "pmc"}, {"#text": "29875130", "@IdType": "pubmed"}]}, "Citation": "Obrist F., Michels J., Durand S., Chery A., Pol J., Levesque S., et al. (2018). Metabolic Vulnerability of Cisplatin-Resistant Cancers. EMBO J. 37 (14). 10.15252/embj.201798597"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1200/jco.2003.02.153", "@IdType": "doi"}, {"#text": "12860964", "@IdType": "pubmed"}]}, "Citation": "Ozols R. F., Bundy B. N., Greer B. E., Fowler J. M., Clarke-Pearson D., Burger R. A., et al. (2003). Phase III Trial of Carboplatin and Paclitaxel Compared with Cisplatin and Paclitaxel in Patients with Optimally Resected Stage III Ovarian Cancer: a Gynecologic Oncology Group Study. J. Clin. Oncol. 21 (17), 3194\u20133200. 10.1200/jco.2003.02.153"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1080/14728222.2019.1615883", "@IdType": "doi"}, {"#text": "PMC6594827", "@IdType": "pmc"}, {"#text": "31076001", "@IdType": "pubmed"}]}, "Citation": "Pope E. D. Rd., Kimbrough E. O., Vemireddy L. P., Surapaneni P. K., Copland J. A. Rd., Mody K., et al. (2019). Aberrant Lipid Metabolism as a Therapeutic Target in Liver cancer. Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review]. Expert Opin. Ther. Targets 23, 473\u2013483. 10.1080/14728222.2019.1615883"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1056/nejmoa070956", "@IdType": "doi"}, {"#text": "17960013", "@IdType": "pubmed"}]}, "Citation": "Posner M. R., Hershock D. M., Blajman C. R., Mickiewicz E., Winquist E., Gorbounova V., et al. (2007). Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer. N. Engl. J. Med. 357 (17), 1705\u20131715. 10.1056/nejmoa070956"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/s0305-7372(79)80057-2", "@IdType": "doi"}, {"#text": "378370", "@IdType": "pubmed"}]}, "Citation": "Prestayko A. W., D'Aoust J. C., Issell B. F., Crooke S. T. (1979). Cisplatin (Cis-diamminedichloroplatinum II). [Clinical Trial; Comparative Study; Journal Article; Review]. Cancer Treat Rev 6. 17\u201339. 10.1016/s0305-7372(79)80057-2"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.17868", "@IdType": "doi"}, {"#text": "PMC5564598", "@IdType": "pmc"}, {"#text": "28548950", "@IdType": "pubmed"}]}, "Citation": "Qian X., Xu W., Xu J., Shi Q., Li J., Weng Y., et al. (2017). Enolase 1 Stimulates Glycolysis to Promote Chemoresistance in Gastric Cancer. [Journal Article]. Oncotarget 8 (29), 47691\u201347708. 10.18632/oncotarget.17868"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/jcb.29179", "@IdType": "doi"}, {"#text": "31218757", "@IdType": "pubmed"}]}, "Citation": "Qiao H., Wang Y., Zhu B., Jiang L., Yuan W., Zhou Y., et al. (2019). Enolase1 Overexpression Regulates the Growth of Gastric Cancer Cells and Predicts Poor survival. [Journal Article; Research Support, Non-U.S. Gov't]. J Cel Biochem 120 (11), 18714\u201318723. 10.1002/jcb.29179"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/2159-8290.cd-14-1507", "@IdType": "doi"}, {"#text": "PMC4456212", "@IdType": "pmc"}, {"#text": "25829424", "@IdType": "pubmed"}]}, "Citation": "Qiu B., Ackerman D., Sanchez D. J., Li B., Ochocki J. D., Grazioli A., et al. (2015). HIF2alpha-Dependent Lipid Storage Promotes Endoplasmic Reticulum Homeostasis in Clear-Cell Renal Cell Carcinoma. Cancer Discov. 5 (6), 652\u2013667. 10.1158/2159-8290.cd-14-1507"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bulcan.2016.11.011", "@IdType": "doi"}, {"#text": "27989629", "@IdType": "pubmed"}]}, "Citation": "Rancoule C., Guy J. B., Vallard A., Ben Mrad. M., Rehailia A., Magne N. (2017). [50th Anniversary of Cisplatin]. [Historical Article; Journal Article; Review]. Bull. Cancer 104 (2), 167\u2013176. 10.1016/j.bulcan.2016.11.011"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/ncomms9468", "@IdType": "doi"}, {"#text": "PMC4598839", "@IdType": "pmc"}, {"#text": "26399441", "@IdType": "pubmed"}]}, "Citation": "Rao X., Duan X., Mao W., Li X., Li Z., Li Q., et al. (2015). O-GlcNAcylation of G6PD Promotes the Pentose Phosphate Pathway and Tumor growth. [Journal Article; Research Support, Non-U.S. Gov't]. Nat Commun. 6, 8468. 10.1038/ncomms9468"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.canlet.2015.11.023", "@IdType": "doi"}, {"#text": "26607904", "@IdType": "pubmed"}]}, "Citation": "Roh J. L., Park J. Y., Kim E. H., Jang H. J., Kwon M. (2016). Activation of Mitochondrial Oxidation by PDK2 Inhibition Reverses Cisplatin Resistance in Head and Neck Cancer. [Journal Article; Research Support, Non-U.S. Gov't]. cancer Lett. 371, 20\u201329. 10.1016/j.canlet.2015.11.023"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/s0021-9258(18)96186-7", "@IdType": "doi"}, {"#text": "5337590", "@IdType": "pubmed"}]}, "Citation": "Rosenberg B., Van Camp L., Grimley E. B., Thomson A. J. (1967). The Inhibition of Growth or Cell Division in Escherichia coli by Different Ionic Species of Platinum(IV) Complexes. [Journal Article]. J. Biol. Chem. 242 (6), 1347\u20131352. 10.1016/s0021-9258(18)96186-7"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/205698a0", "@IdType": "doi"}, {"#text": "14287410", "@IdType": "pubmed"}]}, "Citation": "Rosenberg B., Vancamp L., Krigas T. (1965). inhibition of cell division in escherichia coli by electrolysis products from a platinum electrode. [journal article]. Nature 205, 698\u2013699. 10.1038/205698a0"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1080/10428194.2017.1386305", "@IdType": "doi"}, {"#text": "29045165", "@IdType": "pubmed"}]}, "Citation": "Salzer W., Bostrom B., Messinger Y., Perissinotti A. J., Marini B., Gov't Non-U. S. (2018). \u201cAsparaginase Activity Levels and Monitoring in Patients with Acute Lymphoblastic Leukemia. [Journal Article; Research Support, Non-U.S. Gov't; Review]. Leuk. Lymphoma, 59, 1797\u20131806. 10.1080/10428194.2017.1386305"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.pharmthera.2012.07.003", "@IdType": "doi"}, {"#text": "22796517", "@IdType": "pubmed"}]}, "Citation": "Sancho-Martinez S. M., Prieto-Garcia L., Prieto M., Lopez-Novoa J. M., Lopez-Hernandez F. J. (2012). Subcellular Targets of Cisplatin Cytotoxicity: an Integrated View. Pharmacol. Ther. 136 (1), 35\u201355. 10.1016/j.pharmthera.2012.07.003"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1111/cas.13995", "@IdType": "doi"}, {"#text": "PMC6500964", "@IdType": "pmc"}, {"#text": "30861255", "@IdType": "pubmed"}]}, "Citation": "Sawayama H., Ogata Y., Ishimoto T., Mima K., Hiyoshi Y., Iwatsuki M., et al. (2019). Glucose Transporter 1 Regulates the Proliferation and Cisplatin Sensitivity of Esophageal Cancer. Cancer Sci. 110 (5), 1705\u20131714. 10.1111/cas.13995"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1074/jbc.m112.344911", "@IdType": "doi"}, {"#text": "PMC3397852", "@IdType": "pmc"}, {"#text": "22621925", "@IdType": "pubmed"}]}, "Citation": "Sears C. R., Turchi J. J. (2012). Complex Cisplatin-Double Strand Break (DSB) Lesions Directly Impair Cellular Non-homologous End-Joining (NHEJ) Independent of Downstream Damage Response (DDR) Pathways. [Journal Article; Research Support, N.I.H., Extramural]. J. Biol. Chem. 287 (29), 24263\u201324272. 10.1074/jbc.m112.344911"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/ijo.2017.3950", "@IdType": "doi"}, {"#text": "28393220", "@IdType": "pubmed"}]}, "Citation": "Shang D., Wu J., Guo L., Xu Y., Liu L., Lu J. (2017). Metformin Increases Sensitivity of Osteosarcoma Stem Cells to Cisplatin by Inhibiting Expression of PKM2. [Journal Article]. Int. J. Oncol. 50 (5), 1848\u20131856. 10.3892/ijo.2017.3950"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s00109-011-0731-9", "@IdType": "doi"}, {"#text": "21301794", "@IdType": "pubmed"}]}, "Citation": "Shanware N. P., Mullen A. R., DeBerardinis R. J., Abraham R. T. (2011). Glutamine: Pleiotropic Roles in Tumor Growth and Stress Resistance. [Journal Article; Review]. J. Mol. Med. (Berl) 89 (3), 229\u2013236. 10.1007/s00109-011-0731-9"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cell.2017.01.017", "@IdType": "doi"}, {"#text": "PMC5391692", "@IdType": "pmc"}, {"#text": "28187290", "@IdType": "pubmed"}]}, "Citation": "Sharma P., Hu-Lieskovan S., Wargo J. A., Ribas A., Extramural N. I. H. (2017), Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy. [Journal Article; Review; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't]. Cell 168, 707\u2013723. 10.1016/j.cell.2017.01.017"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2174/1871520616666160330104413", "@IdType": "doi"}, {"#text": "27025656", "@IdType": "pubmed"}]}, "Citation": "Sheng H., Chen X., Liu B., Li P., Cao W. (2016). Omega-3 Polyunsaturated Fatty Acids Enhance Cisplatin Efficacy in Gastric Cancer Cells by Inducing Apoptosis via ADORA1. [Journal Article]. Anticancer Agents Med. Chem. 16 (9), 1085\u20131092. 10.2174/1871520616666160330104413"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/cr.2008.2", "@IdType": "doi"}, {"#text": "PMC2432112", "@IdType": "pmc"}, {"#text": "18166981", "@IdType": "pubmed"}]}, "Citation": "Shuck S. C., Short E. A., Turchi J. J. (2008). Eukaryotic Nucleotide Excision Repair: from Understanding Mechanisms to Influencing Biology. [Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review]. Cell Res 18, 64\u201372. 10.1038/cr.2008.2"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/0008-5472.can-06-3717", "@IdType": "doi"}, {"#text": "PMC3852417", "@IdType": "pmc"}, {"#text": "17409446", "@IdType": "pubmed"}]}, "Citation": "Simons A. L., Ahmad I. M., Mattson D. M., Dornfeld K. J., Spitz D. R. (2007). 2-Deoxy-D-glucose Combined with Cisplatin Enhances Cytotoxicity via Metabolic Oxidative Stress in Human Head and Neck Cancer Cells. [Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't]. Cancer Res. 67, 3364\u20133370. 10.1158/0008-5472.can-06-3717"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.molcel.2017.06.008", "@IdType": "doi"}, {"#text": "PMC5580398", "@IdType": "pmc"}, {"#text": "28689661", "@IdType": "pubmed"}]}, "Citation": "Sivanand S., Rhoades S., Jiang Q., Lee J. V., Benci J., Zhang J., et al. (2017). Nuclear Acetyl-CoA Production by ACLY Promotes Homologous Recombination. [Journal Article]. Mol. Cel 67 (2), 252\u2013265. 10.1016/j.molcel.2017.06.008"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1039/c6mt00183a", "@IdType": "doi"}, {"#text": "PMC5123636", "@IdType": "pmc"}, {"#text": "27722429", "@IdType": "pubmed"}]}, "Citation": "Sooriyaarachchi M., George G. N., Pickering I. J., Narendran A., Gailer J. (2016). Tuning the Metabolism of the Anticancer Drug Cisplatin with Chemoprotective Agents to Improve its Safety and Efficacy. Journal Article; Review; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't]. Metallomics 8, 1170\u20131176. 10.1039/c6mt00183a"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/sj.cdd.4401248", "@IdType": "doi"}, {"#text": "12815464", "@IdType": "pubmed"}]}, "Citation": "Spierings D. C., de Vries E. G., Vellenga E., de Jong S. (2003). Loss of Drug-Induced Activation of the CD95 Apoptotic Pathway in a Cisplatin-Resistant Testicular Germ Cell Tumor Cell Line. [Journal Article; Research Support, Non-U.S. Gov't]. Cell Death Differ 10 (7), 808\u2013822. 10.1038/sj.cdd.4401248"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/bs.irn.2019.05.003", "@IdType": "doi"}, {"#text": "31208525", "@IdType": "pubmed"}]}, "Citation": "Stacpoole P. W., Martyniuk C. J., James M. O., Calcutt N. A. (2019). Dichloroacetate-induced Peripheral Neuropathy. [Journal Article; Review]. Int. Rev. Neurobiol. 145, 211\u2013238. 10.1016/bs.irn.2019.05.003"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bbcan.2018.06.005", "@IdType": "doi"}, {"#text": "29959989", "@IdType": "pubmed"}]}, "Citation": "Sun L., Suo C., Li S. T., Zhang H., Gao P. (2018). Metabolic Reprogramming for Cancer Cells and Their Microenvironment: Beyond the Warburg Effect. Biochim. Biophys. Acta Rev. Cancer 1870 (1), 51\u201366. 10.1016/j.bbcan.2018.06.005"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/ol.2019.10639", "@IdType": "doi"}, {"#text": "PMC6676455", "@IdType": "pmc"}, {"#text": "31452760", "@IdType": "pubmed"}]}, "Citation": "Sun Z., Xu L. (2019). Expression of PDK-1 and DMBT1 in the Thyroid Carcinoma and its Clinicopathological Significance. [Journal Article]. Oncol. Lett. 18 (3), 2819\u20132824. 10.3892/ol.2019.10639"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.oraloncology.2018.10.018", "@IdType": "doi"}, {"#text": "PMC6294331", "@IdType": "pmc"}, {"#text": "30527243", "@IdType": "pubmed"}]}, "Citation": "Tanaka N., Osman A. A., Takahashi Y., Lindemann A., Patel A. A., Zhao M., et al. (2018). Head and Neck Cancer Organoids Established by Modification of the CTOS Method Can Be Used to Predict In Vivo Drug Sensitivity. [Evaluation Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't]. Oral Oncol. 87, 49\u201357. 10.1016/j.oraloncology.2018.10.018"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1155/2019/8201079", "@IdType": "doi"}, {"#text": "PMC6885244", "@IdType": "pmc"}, {"#text": "31827705", "@IdType": "pubmed"}]}, "Citation": "Tataranni T., Piccoli C. (2019).Dichloroacetate (DCA) and Cancer: An Overview towards Clinical Applications. [Journal Article; Review]. Oxid Med Cell Longev 2019, 8201079. 10.1155/2019/8201079"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/1078-0432.ccr-15-2477", "@IdType": "doi"}, {"#text": "PMC6773427", "@IdType": "pmc"}, {"#text": "26957554", "@IdType": "pubmed"}]}, "Citation": "Telli M. L., Timms K. M., Reid J., Hennessy B., Mills G. B., Jensen K. C., et al. (2016). Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer. [Clinical Trial, Phase II; Journal Article]. Clin. Cancer Res. 22 (15), 3764\u20133773. 10.1158/1078-0432.ccr-15-2477"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/cancers12082252", "@IdType": "doi"}, {"#text": "PMC7464784", "@IdType": "pmc"}, {"#text": "32806533", "@IdType": "pubmed"}]}, "Citation": "Varghese E., Samuel S. M., Liskova A., Samec M., Kubatka P., Busselberg D. (2020). Targeting Glucose Metabolism to Overcome Resistance to Anticancer Chemotherapy in Breast Cancer. Cancers (Basel) 12 (8). 10.3390/cancers12082252"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1056/nejmoa071028", "@IdType": "doi"}, {"#text": "17960012", "@IdType": "pubmed"}]}, "Citation": "Vermorken J. B., Remenar E., van Herpen C., Gorlia T., Mesia R., Degardin M., et al. (2007). Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer. N. Engl. J. Med. 357 (17), 1695\u20131704. 10.1056/nejmoa071028"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrm2147", "@IdType": "doi"}, {"#text": "17380161", "@IdType": "pubmed"}]}, "Citation": "Vousden K. H., Lane D. P. (2007). p53 in Health and Disease. [Journal Article; Review]. Nat. Rev. Mol. Cel Biol 8 (4), 275\u2013283. 10.1038/nrm2147"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.biomaterials.2018.08.035", "@IdType": "doi"}, {"#text": "30149232", "@IdType": "pubmed"}]}, "Citation": "Wang C., Wu J., Wang Z., Yang Z., Li Z., Deng H., et al. (2018a). Glutamine Addiction Activates Polyglutamine-Based Nanocarriers Delivering Therapeutic siRNAs to Orthotopic Lung Tumor Mediated by Glutamine Transporter SLC1A5. [Journal Article; Research Support, Non-U.S. Gov't]. Biomaterials 183, 77\u201392. 10.1016/j.biomaterials.2018.08.035"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1042/BSR20182099", "@IdType": "doi"}, {"#text": "PMC6522739", "@IdType": "pmc"}, {"#text": "30988063", "@IdType": "pubmed"}]}, "Citation": "Wang G., Liu X., Xie J., Meng J., Ni X. (2019). PDK-1 Mediated Hippo-YAP-IRS2 Signaling Pathway and Involved in the Apoptosis of Non-small Cell Lung Cancer Cells. [Journal Article]. Biosci. Rep. 39 (5). BSR20182099. 10.1042/BSR20182099"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/srep45983", "@IdType": "doi"}, {"#text": "PMC5380992", "@IdType": "pmc"}, {"#text": "28378811", "@IdType": "pubmed"}]}, "Citation": "Wang X., Zhang F., Wu X. R. (2017). Inhibition of Pyruvate Kinase M2 Markedly Reduces Chemoresistance of Advanced Bladder Cancer to Cisplatin. Sci. Rep. 7, 45983. 10.1038/srep45983"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.4103/0973-1482.187292", "@IdType": "doi"}, {"#text": "30249876", "@IdType": "pubmed"}]}, "Citation": "Wang Y., Liu L., Ji F., Jiang J., Yu Y., Sheng S., et al. (2018b). Soybean (Glycine max) Prevents the Progression of Breast Cancer Cells by Downregulating the Level of Histone Demethylase JMJD5. [Journal Article]. J. Cancer Res. Ther. 14 (Suppl. ment), S609\u2013S615. 10.4103/0973-1482.187292"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1085/jgp.8.6.519", "@IdType": "doi"}, {"#text": "PMC2140820", "@IdType": "pmc"}, {"#text": "19872213", "@IdType": "pubmed"}]}, "Citation": "Warburg O., Wind F., Negelein E. (1927). THE METABOLISM of TUMORS IN the BODY. [Journal Article]. J. Gen. Physiol. 8 (6), 519\u2013530. 10.1085/jgp.8.6.519"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3389/fcell.2020.603837", "@IdType": "doi"}, {"#text": "PMC7835483", "@IdType": "pmc"}, {"#text": "33511116", "@IdType": "pubmed"}]}, "Citation": "Wei Z., Liu X., Cheng C., Yu W., Yi P. (2020). Metabolism of Amino Acids in Cancer. Front Cel Dev Biol 8, 603837. 10.3389/fcell.2020.603837"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bbalip.2018.06.005", "@IdType": "doi"}, {"#text": "29883801", "@IdType": "pubmed"}]}, "Citation": "Wen H., Lee S., Zhu W. G., Lee O. J., Yun S. J., Kim J., et al. (2019). \u201cGlucose-derived Acetate and ACSS2 as Key Players in Cisplatin Resistance in Bladder Cancer. [Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.]. Biochim. Biophys. Acta Mol. Cel Biol Lipids, 1864, 413\u2013421. 10.1016/j.bbalip.2018.06.005"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrneph.2017.59", "@IdType": "doi"}, {"#text": "28480903", "@IdType": "pubmed"}]}, "Citation": "Wettersten H. I., Aboud O. A., Lara P. N., Jr, Weiss R. H. (2017). Metabolic Reprogramming in clear Cell Renal Cell Carcinoma. [Journal Article; Review]. Nat. Rev. Nephrol. 13 (7), 410\u2013419. 10.1038/nrneph.2017.59"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/s0021-9258(19)42329-6", "@IdType": "doi"}, {"#text": "4605420", "@IdType": "pubmed"}]}, "Citation": "Windmueller H. G., Spaeth A. E. (1974). Uptake and Metabolism of Plasma Glutamine by the Small Intestine. J. Biol. Chem. 249 (16), 5070\u20135079. 10.1016/s0021-9258(19)42329-6"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ebiom.2015.05.022", "@IdType": "doi"}, {"#text": "PMC4535307", "@IdType": "pmc"}, {"#text": "26288805", "@IdType": "pubmed"}]}, "Citation": "Wishart D. S. (2015). Is Cancer a Genetic Disease or a Metabolic Disease? [Journal Article]. EBioMedicine 2 (6), 478\u2013479. 10.1016/j.ebiom.2015.05.022"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s00726-009-0269-0", "@IdType": "doi"}, {"#text": "19301095", "@IdType": "pubmed"}]}, "Citation": "Wu G. (2009). Amino Acids: Metabolism, Functions, and Nutrition. Amino Acids 37 (1), 1\u201317. 10.1007/s00726-009-0269-0"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1021/acs.molpharmaceut.8b00076", "@IdType": "doi"}, {"#text": "29939755", "@IdType": "pubmed"}]}, "Citation": "Wu J., Li Z., Yang Z., Guo L., Zhang Y., Deng H., et al. (2018). A Glutamine-Rich Carrier Efficiently Delivers Anti-CD47 siRNA Driven by a \"Glutamine Trap\" to Inhibit Lung Cancer Cell Growth. [Journal Article; Research Support, Non-U.S. Gov't]. Mol. Pharm. 15 (8), 3032\u20133045. 10.1021/acs.molpharmaceut.8b00076"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.canlet.2014.03.013", "@IdType": "doi"}, {"#text": "24657660", "@IdType": "pubmed"}]}, "Citation": "Wu Q., Yang Z., Nie Y., Shi Y., Fan D., (2014), Multi-drug Resistance in Cancer Chemotherapeutics: Mechanisms and Lab Approaches. [Journal Article; Research Support, Non-U.S. Gov't; Review]. Cancer Lett 347, 159\u2013166. 10.1016/j.canlet.2014.03.013"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12885-018-4521-4", "@IdType": "doi"}, {"#text": "PMC5987622", "@IdType": "pmc"}, {"#text": "29866066", "@IdType": "pubmed"}]}, "Citation": "Xintaropoulou C., Ward C., Wise A., Queckborner S., Turnbull A., Michie C. O., et al. (2018). Expression of Glycolytic Enzymes in Ovarian Cancers and Evaluation of the Glycolytic Pathway as a Strategy for Ovarian Cancer Treatment. [Journal Article]. BMC Cancer 18 (1), 636. 10.1186/s12885-018-4521-4"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.7150/thno.31301", "@IdType": "doi"}, {"#text": "PMC6568185", "@IdType": "pmc"}, {"#text": "31244938", "@IdType": "pubmed"}]}, "Citation": "Xu J., Shi Q., Xu W., Zhou Q., Shi R., Ma Y., et al. (2019). Metabolic Enzyme PDK3 Forms a Positive Feedback Loop with Transcription Factor HSF1 to Drive chemoresistance. [Journal Article; Research Support, Non-U.S. Gov't]. Theranostics 9 (10), 2999\u20133013. 10.7150/thno.31301"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/ijo.2018.4476", "@IdType": "doi"}, {"#text": "PMC6065457", "@IdType": "pmc"}, {"#text": "30015875", "@IdType": "pubmed"}]}, "Citation": "Xu Y., Gao W., Zhang Y., Wu S., Liu Y., Deng X., et al. (2018). ABT737 Reverses Cisplatin Resistance by Targeting Glucose Metabolism of Human Ovarian Cancer Cells. [Journal Article]. Int. J. Oncol. 53 (3), 1055\u20131068. 10.3892/ijo.2018.4476"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s13046-015-0221-y", "@IdType": "doi"}, {"#text": "PMC4595070", "@IdType": "pmc"}, {"#text": "26445347", "@IdType": "pubmed"}]}, "Citation": "Yoshida G. J. (2015). Metabolic Reprogramming: the Emerging Concept and Associated Therapeutic Strategies. [Journal Article; Review]. J. Exp. Clin. Cancer Res. 34, 111. 10.1186/s13046-015-0221-y"}, {"ArticleIdList": {"ArticleId": {"#text": "25745780", "@IdType": "pubmed"}}, "Citation": "Zajdel A., Wilczok A., Latocha M., Tarkowski M., Kokocinska M., Dzierzewicz Z. (2014). Polyunsaturated Fatty Acids Potentiate Cytotoxicity of Cisplatin in A549 Cells. [Journal Article; Research Support, Non-U.S. Gov't]. Acta Pol. Pharm. 71 (6), 1060\u20131065."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/annonc/mdy209", "@IdType": "doi"}, {"#text": "29905759", "@IdType": "pubmed"}]}, "Citation": "Zhang J., Lin Y., Sun X. J., Wang B. Y., Wang Z. H., Luo J. F., et al. (2018a). Biomarker Assessment of the CBCSG006 Trial: a Randomized Phase III Trial of Cisplatin Plus Gemcitabine Compared with Paclitaxel Plus Gemcitabine as First-Line Therapy for Patients with Metastatic Triple-Negative Breast Cancer. Ann. Oncol. 29 (8), 1741\u20131747. 10.1093/annonc/mdy209"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/jcp.27369", "@IdType": "doi"}, {"#text": "30229902", "@IdType": "pubmed"}]}, "Citation": "Zhang M., Cong Q., Zhang X. Y., Zhang M. X., Lu Y. Y., Xu C. J. (2019). Pyruvate Dehydrogenase Kinase 1 Contributes to Cisplatin Resistance of Ovarian Cancer through EGFR activation. [Journal Article; Research Support, Non-U.S. Gov't]. J Cel Physiol 234 (5), 6361\u20136370. 10.1002/jcp.27369"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.biocel.2017.12.010", "@IdType": "doi"}, {"#text": "29247711", "@IdType": "pubmed"}]}, "Citation": "Zhang X. Y., Zhang M., Cong Q., Zhang M. X., Zhang M. Y., Lu Y. Y., et al. (2018b). Hexokinase 2 Confers Resistance to Cisplatin in Ovarian Cancer Cells by Enhancing Cisplatin-Induced Autophagy. Int. J. Biochem. Cel Biol 95, 9\u201316. 10.1016/j.biocel.2017.12.010"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2147/ott.s246430", "@IdType": "doi"}, {"#text": "PMC7269635", "@IdType": "pmc"}, {"#text": "32581546", "@IdType": "pubmed"}]}, "Citation": "Zhao X., Fu J., Tang W., Yu L., Xu W. (2020). Inhibition of Serine Metabolism Promotes Resistance to Cisplatin in Gastric Cancer. Onco Targets Ther. 13, 4833\u20134842. 10.2147/ott.s246430"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.7314/apjcp.2014.15.7.3219", "@IdType": "doi"}, {"#text": "24815474", "@IdType": "pubmed"}]}, "Citation": "Zhu Y., Liu X. J., Yang P., Zhao M., Lv L. X., Zhang G. D., et al. (2014). Alkylglyceronephosphate Synthase (AGPS) Alters Lipid Signaling Pathways and Supports Chemotherapy Resistance of Glioma and Hepatic Carcinoma Cell lines. [Journal Article; Research Support, Non-U.S. Gov't]. Asian Pac. J. Cancer Prev. 15 (7), 3219\u20133226. 10.7314/apjcp.2014.15.7.3219"}]}}}}}, "PMC": "PMC8261055", "PMID": "34250022", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "The Role of Tumour Metabolism in Cisplatin Resistance.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "30": {"Abstract": "Now days, breast cancer is the most frequently diagnosed life-threatening cancer in women and the leading cause of cancer death among women. Since last two decades, researches related to the breast cancer has lead to extraordinary progress in our understanding of the disease, resulting in more efficient and less toxic treatments. Increased public awareness and improved screening have led to earlier diagnosis at stages amenable to complete surgical resection and curative therapies. Consequently, survival rates for breast cancer have improved significantly, particularly in younger women. This article addresses the types, causes, clinical symptoms and various approach both non- drug (such as surgery and radiation) and drug treatment (including chemotherapy, gene therapy etc.) of breast cancer.", "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "3935362063572665781", "Part1": "School of Pharmaceutical Sciences", "Part2": "Jaipur National University", "Part3": "Jaipur", "Part4": "Rajasthan", "Part5": "India.", "Part6": null, "Text": "School of Pharmaceutical Sciences, Jaipur National University, Jaipur, Rajasthan, India."}], "ForeName": "Ganesh N", "FullName": "Ganesh N Sharma", "HashID": "-8313581722610441109", "LastName": "Sharma", "ORCID": null}, {"Affiliations": null, "ForeName": "Rahul", "FullName": "Rahul Dave", "HashID": "-4024501618946362886", "LastName": "Dave", "ORCID": null}, {"Affiliations": null, "ForeName": "Jyotsana", "FullName": "Jyotsana Sanadya", "HashID": "2456534563394512038", "LastName": "Sanadya", "ORCID": null}, {"Affiliations": null, "ForeName": "Piush", "FullName": "Piush Sharma", "HashID": "7659093212861298405", "LastName": "Sharma", "ORCID": null}, {"Affiliations": null, "ForeName": "K K", "FullName": "K K Sharma", "HashID": "-7501814370139997783", "LastName": "Sharma", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": null, "InsertType": null, "Journal": "Journal of advanced pharmaceutical technology & research", "Keywords": [{"IS_Major": false, "IS_Mesh": false, "Text": "Breast Cancer"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Chemotherapy"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Gene Therapy"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Tumor"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "PubMed-not-MEDLINE", "Article": {"@PubModel": "Print", "Abstract": {"AbstractText": "Now days, breast cancer is the most frequently diagnosed life-threatening cancer in women and the leading cause of cancer death among women. Since last two decades, researches related to the breast cancer has lead to extraordinary progress in our understanding of the disease, resulting in more efficient and less toxic treatments. Increased public awareness and improved screening have led to earlier diagnosis at stages amenable to complete surgical resection and curative therapies. Consequently, survival rates for breast cancer have improved significantly, particularly in younger women. This article addresses the types, causes, clinical symptoms and various approach both non- drug (such as surgery and radiation) and drug treatment (including chemotherapy, gene therapy etc.) of breast cancer."}, "ArticleTitle": "Various types and management of breast cancer: an overview.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "School of Pharmaceutical Sciences, Jaipur National University, Jaipur, Rajasthan, India."}, "ForeName": "Ganesh N", "Initials": "GN", "LastName": "Sharma"}, {"@ValidYN": "Y", "ForeName": "Rahul", "Initials": "R", "LastName": "Dave"}, {"@ValidYN": "Y", "ForeName": "Jyotsana", "Initials": "J", "LastName": "Sanadya"}, {"@ValidYN": "Y", "ForeName": "Piush", "Initials": "P", "LastName": "Sharma"}, {"@ValidYN": "Y", "ForeName": "K K", "Initials": "KK", "LastName": "Sharma"}]}, "Journal": {"ISOAbbreviation": "J Adv Pharm Technol Res", "ISSN": {"#text": "0976-2094", "@IssnType": "Electronic"}, "JournalIssue": {"@CitedMedium": "Internet", "Issue": "2", "PubDate": {"Month": "Apr", "Year": "2010"}, "Volume": "1"}, "Title": "Journal of advanced pharmaceutical technology & research"}, "Language": "eng", "Pagination": {"EndPage": "126", "MedlinePgn": "109-26", "StartPage": "109"}, "PublicationTypeList": {"PublicationType": {"#text": "Journal Article", "@UI": "D016428"}}}, "DateCompleted": {"Day": "02", "Month": "10", "Year": "2012"}, "DateRevised": {"Day": "21", "Month": "10", "Year": "2021"}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"#text": "Breast Cancer", "@MajorTopicYN": "N"}, {"#text": "Chemotherapy", "@MajorTopicYN": "N"}, {"#text": "Gene Therapy", "@MajorTopicYN": "N"}, {"#text": "Tumor", "@MajorTopicYN": "N"}]}, "MedlineJournalInfo": {"Country": "India", "ISSNLinking": "0976-2094", "MedlineTA": "J Adv Pharm Technol Res", "NlmUniqueID": "101537797"}, "PMID": {"#text": "22247839", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "22247839", "@IdType": "pubmed"}, {"#text": "PMC3255438", "@IdType": "pmc"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "received", "Day": "29", "Month": "3", "Year": "2010"}, {"@PubStatus": "revised", "Day": "19", "Month": "5", "Year": "2010"}, {"@PubStatus": "accepted", "Day": "5", "Month": "6", "Year": "2010"}, {"@PubStatus": "entrez", "Day": "17", "Hour": "6", "Minute": "0", "Month": "1", "Year": "2012"}, {"@PubStatus": "pubmed", "Day": "1", "Hour": "0", "Minute": "0", "Month": "4", "Year": "2010"}, {"@PubStatus": "medline", "Day": "1", "Hour": "0", "Minute": "1", "Month": "4", "Year": "2010"}]}, "PublicationStatus": "ppublish", "ReferenceList": {"Reference": [{"Citation": "Cancer-Its various types along with causes, symptoms, treatments and stages, in: cancer info guide. 2009.  [15 Mar. 2010].  http://www.cancer-info-guide.com/"}, {"Citation": "Mieszkowski M. R. Cancer \u2013 A biophysicist's point of view. In: Digital Recordings. 2006. Sep 04,  [15 Mar 2010].  http://www.digital-recordings.com/publ/cancer.html ."}, {"Citation": "Immune system. In: Kids Health. 2010.  [16 Mar. 2010].  http://kidshealth.org/parent/general/body_basics/immune.html# ."}, {"Citation": "Helmberg A. 2010.  [17 Mar. 2010].  http://helmberg.at/carcinogenesis.htm ."}, {"Citation": "Diet and Physical Activity: What's the Cancer Connection? In: Prevention & Early Detection. 2009. Oct 09,  [17 Mar. 2010].  http://www.cancer.org/docroot/PED/content/PED_3_1x_Link_Between_Lifestyle_and_CancerMarch03.asp ."}, {"Citation": "Margot New SEER Report Documents High Risk of Second Cancers in Cancer Survivors. Oncology Times. 2007;29(5):8."}, {"Citation": "Ershler W.B. The Influence of Advanced Age on Cancer Occurrence and Growth. In: Balducci L., Extermann M, editors. Biological Basis of Geriatric Oncology. Vol. 124. Springer US: 2005. pp. 75\u201387."}, {"Citation": "[17 Mar. 2010].  http://www.breastcancersource.com/?itemId=2784236 ."}, {"Citation": "Khuwaja G. A., Abu-Rezq A. N. Bimodal breast cancer classification system. Pattern Analysis and application. 2004;7:235\u2013242."}, {"Citation": "Breast cancer process india, Breast cancer cost india, Breast cancer, delhi India. Breast cancer information and resources. 2010. Apr 13,  [14 April 2010].  http://www.digforthecure.org/breast-cancer-process-india-breast-cancer-cost-india-breast-cancer-delhi-india. html ."}, {"Citation": "What is breast cancer? Imaginis. 2008. Jun 11,  [17 Mar 2010].  http://www.imaginis.com/breast-health/what-is-breast-cancer-2 ."}, {"Citation": "What is breast cancer? American cancer society. 2009. Sep 18,  [18 Mar 2010].  http://www.cancer.org/docroot/CRI/content/CRI_2_4_1X_What_is_breast_cancer_5.asp ."}, {"Citation": "Breast cancer. merck. 2008.  [18 Mar. 2010].  http://www.merck.com/mmhe/sec22/ch251/ch251f.html ."}, {"Citation": "Types of breast cancer. Rethink breast cancer. 2003.  [18 Mar. 2010].  http://www.rethinkbreastcancer.com/types_of_breast_cancer.html ."}, {"Citation": "Types of breast cancer. Abviva. 2009.  [18 Mar. 2010].  http://abviva.com/1.html ."}, {"Citation": "Ductal breast cancer. Cancer studies. Mar.  [28 Mar. 2010].  http://cancer-studies.com/ductal-breast-cancer ."}, {"Citation": "Fayed L. Types of breast cancer. About.com: Cancer. 2009. Jul 09,  [20 Mar. 2010].  http://cancer.about.com/od/breastcancer/a/cancertypes.htm ."}, {"Citation": "Stephan P. Mucinous (Colloid) Carcinoma of the breast. About.com: Cancer. 2008. Aug 05,  [20 Mar. 2010].  http://breastcancer.about.com/od/types/p/mucinous_ca.htm ."}, {"ArticleIdList": {"ArticleId": {"#text": "16034008", "@IdType": "pubmed"}}, "Citation": "Hartmann L. C., Sellers T. A., Frost M. H., Frost M. H., Lingle W. L., Degnim A. C., Ghosh K., Vierkant R. A., Maloney S. D., Pankratz V. S., Hillman D. W., Suman V. J., Blake C., Tlsty T., Vachon C. M. Benign breast disease and the risk of breast cancer. N Engl J Med. 2005;353:229\u2013237."}, {"ArticleIdList": {"ArticleId": {"#text": "15879569", "@IdType": "pubmed"}}, "Citation": "Eberl M. M., Sunga A. Y., Farrell C. D., Mahoney M. C. Patients with a Family History of Cancer: Identification and Management. JABFM. 2005;18:211\u2013217."}, {"Citation": "Breast cancer. emedicinehealth. 2010.  [20 Mar 2010].  http://www.emedicinehealth.com/breast_cancer/page2_em.htm ."}, {"Citation": "Fletcher S. W. Patient information: Risk factor for breast cancer. Up-To-Date. 2008. Jan 29,  [20 Mar 2010].  http://www.utdol.com/patients/content/topic.do?topicKey=~_rZvVFHbEjbw ."}, {"ArticleIdList": {"ArticleId": {"#text": "12897329", "@IdType": "pubmed"}}, "Citation": "Tiernan A. M. Behavioral risk factor in breast cancer: Can risk be modified? The Oncologist. 2003;8:326\u2013334."}, {"Citation": "Definite breast cancer risks. CancerHelp UK. 2008. Sep 26,  [20 Mar 2010].  http://www.cancerhelp.org.uk/type/breast-cancer/about/risks/definite-breast-cancer-risks ."}, {"Citation": "Stephan P. What you need to know about breast cancer symptoms. About.com: Breast cancer. 2007. Dec 06,  [20 Mar 2010].  http://breastcancer.about.com/od/whatisbreastcancer/a/bc_symptoms.htm ."}, {"ArticleIdList": {"ArticleId": {"#text": "18443206", "@IdType": "pubmed"}}, "Citation": "Smith R. A., Cokkinides V., Brawley O. W. Cancer screening in the United States, 2008. CA Cancer J Clin. 2008;58:161\u2013179."}, {"Citation": "Lippman M. E. Breast cancer. In: Fauci A. S., editor. Harrison's Principles of Internal Medicine. 17th ed. Library of Congress Cataloging in Publication Data; 2008."}, {"Citation": "Stages of breast cancer, Breast cancer.org. 2010. Jan 21,  [20 Mar 2010].  http://www.breastcancer.org/symptoms/diagnosis/staging.jsp ."}, {"Citation": "Breast cancer treatment, the breast cancerInfo.com.  [21 Mar 2010].  http://thebreastcancerinfo.com/breast_cancer_treatment.htm ."}, {"Citation": "Surgical oncology. UT health science center. 2009. Sep 24,  [21 Mar 2010].  http://www.surgery.uthscsa.edu/surgicaloncology/breast.asp ."}, {"Citation": "Rath G. K. Radiation Therapy in the Management of Cancer. 50 Years of Cancer Control in India.  [21 Mar 2010].  http://mohfw.nic.in/pg96to104.pdf ."}, {"Citation": "Detailed guide: Breast cancer radiation therapy. American cancer society. 2009. Sep 18,  [21 Mar 2010].  http://www.cancer.org/docroot/CRI/content/CRI_2_4_4X_Radiation_Therapy_5.asp?sitearea ."}, {"Citation": "Breast health chemotherapy for breast cancer treatment.  [21 Mar 2010];University Virginia Health System. 2006 Aug 29; http://www.healthsystem.virginia.edu/uvahealth/adult_breast/chemo.cfm ."}, {"Citation": "Cancer. Wellness.com. 2006-2010.  [21 Mar 2010].  http://www.wellness.com/reference/conditions/cancer/prevention-and-treatment ."}, {"Citation": "Wells B G. 5th ed. New Delhi: Tata McGraw hill publishing company limited; 2004. Breast Cancer, Pharmacotherapy hand book."}, {"ArticleIdList": {"ArticleId": {"#text": "18663578", "@IdType": "pubmed"}}, "Citation": "Tanaka T., Decuzzi P., Cristofanilli M., Sakamoto J. M., Tasciotti V., Robertson F. M., Ferrari M. Nanotechnology for breast cancer therapy. Biomed Microdevices. 2009;11:49\u201363."}, {"ArticleIdList": {"ArticleId": {"#text": "698967", "@IdType": "pubmed"}}, "Citation": "McGu ire W. L. Steroid receptors in human breast cancer. Cancer research. 1978;38:4289\u20134291."}, {"ArticleIdList": {"ArticleId": {"#text": "6351950", "@IdType": "pubmed"}}, "Citation": "Clark G. M., McGuire W. L. Progesterone receptors and human breast cancer. Breast cancer research and treatment. 1983;3:157\u2013163."}, {"ArticleIdList": {"ArticleId": {"#text": "15266090", "@IdType": "pubmed"}}, "Citation": "Osborne C., Wilson P., Tripathy D. Oncogenes and tumor suppressor genes in breast cancer. Potential diagnostic and therapeutic applications. The oncologist. 2004;4:361\u2013377."}, {"ArticleIdList": {"ArticleId": {"#text": "12673383", "@IdType": "pubmed"}}, "Citation": "Jin-Hui W., Xin-Yuan L. Targeting Strategies in Cancer Gene Therapy. ACTH Biochimica and biophysics sinica. 2003;35:311\u2013316."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2757664", "@IdType": "pmc"}, {"#text": "19809560", "@IdType": "pubmed"}]}, "Citation": "Disis M. L., Park K. H. Immunomodulation of breast cancer via tumor antigen specific Th1. Cancer res treat. 2009;41:117\u2013121."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2687709", "@IdType": "pmc"}, {"#text": "19183447", "@IdType": "pubmed"}]}, "Citation": "Weber G., Chamorro C. I., Granath F., Liljegren A., Zreika S., Saidak Z., Sandstedt B., Rotstein S., Mentaverri R., Sanchez F., Pivarcsi A., Stahle M. Human antimicrobial protein hCAP18/LL-37 promotes a metastatic phenotype in breast cancer. Breast cancer research. 2011;11:R6."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2656894", "@IdType": "pmc"}, {"#text": "19036156", "@IdType": "pubmed"}]}, "Citation": "Kelemen L. E., Couch F. J., Ahmed S., Dunning A. M., Pharoah P. D., Easton D. F., Fredericksen Z. S., Vierkant R. A., Pankratz V. S., Goode E. L., Scott C. G., Rider D. N., Vachon C. M. Genetic variation in stromal proteins decorin and lumican with breast cancer: investigations in two case-control studies. Breast cancer research. 2008;10:R98."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2614512", "@IdType": "pmc"}, {"#text": "18808688", "@IdType": "pubmed"}]}, "Citation": "Borggist S., Jogi A., Ponten F., Ryden L., Brennan D. J., Jirstrom K. Prognostic impact of tumor-specific HMG-CoA reductase expression in primary breast cancer. Breast cancer research. 2008;10:R79."}, {"ArticleIdList": {"ArticleId": {"#text": "14988743", "@IdType": "pubmed"}}, "Citation": "Mellstedt H. Monoclonal antibody in human cancer. Medicamentos de actualidad. 2003;39:1\u201316."}]}}}}}, "PMC": "PMC3255438", "PMID": "22247839", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "Various types and management of breast cancer: an overview.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "31": {"Abstract": null, "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "3496608104705698424", "Part1": "Department of Clinical Oncology", "Part2": "Kyoto University Hospital", "Part3": "Japan.", "Part4": null, "Part5": null, "Part6": null, "Text": "Department of Clinical Oncology, Kyoto University Hospital, Japan."}, {"Has_Extra": false, "HashID": "2359202025383168230", "Part1": "Department of Respiratory Medicine", "Part2": "Kyoto University Hospital", "Part3": "Japan.", "Part4": null, "Part5": null, "Part6": null, "Text": "Department of Respiratory Medicine, Kyoto University Hospital, Japan."}], "ForeName": "Hiroki", "FullName": "Hiroki Nagai", "HashID": "2234754420120631128", "LastName": "Nagai", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "2359202025383168230", "Part1": "Department of Respiratory Medicine", "Part2": "Kyoto University Hospital", "Part3": "Japan.", "Part4": null, "Part5": null, "Part6": null, "Text": "Department of Respiratory Medicine, Kyoto University Hospital, Japan."}], "ForeName": "Young Hak", "FullName": "Young Hak Kim", "HashID": "-9015056807264466115", "LastName": "Kim", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.21037/jtd.2017.02.75", "InsertType": null, "Journal": "Journal of thoracic disease", "Keywords": [], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "PubMed-not-MEDLINE", "Article": {"@PubModel": "Print", "ArticleTitle": "Cancer prevention from the perspective of global cancer burden patterns.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of Clinical Oncology, Kyoto University Hospital, Japan."}, {"Affiliation": "Department of Respiratory Medicine, Kyoto University Hospital, Japan."}], "ForeName": "Hiroki", "Initials": "H", "LastName": "Nagai"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Respiratory Medicine, Kyoto University Hospital, Japan."}, "ForeName": "Young Hak", "Initials": "YH", "LastName": "Kim"}]}, "ELocationID": {"#text": "10.21037/jtd.2017.02.75", "@EIdType": "doi", "@ValidYN": "Y"}, "Journal": {"ISOAbbreviation": "J Thorac Dis", "ISSN": {"#text": "2072-1439", "@IssnType": "Print"}, "JournalIssue": {"@CitedMedium": "Print", "Issue": "3", "PubDate": {"Month": "Mar", "Year": "2017"}, "Volume": "9"}, "Title": "Journal of thoracic disease"}, "Language": "eng", "Pagination": {"EndPage": "451", "MedlinePgn": "448-451", "StartPage": "448"}, "PublicationTypeList": {"PublicationType": [{"#text": "Editorial", "@UI": "D016421"}, {"#text": "Comment", "@UI": "D016420"}]}}, "CoiStatement": "Conflicts of Interest: The authors have no conflicts of interest to declare.", "CommentsCorrectionsList": {"CommentsCorrections": {"@RefType": "CommentOn", "PMID": {"#text": "27918777", "@Version": "1"}, "RefSource": "JAMA Oncol. 2017 Apr 1;3(4):524-548"}}, "DateRevised": {"Day": "10", "Month": "04", "Year": "2022"}, "MedlineJournalInfo": {"Country": "China", "ISSNLinking": "2072-1439", "MedlineTA": "J Thorac Dis", "NlmUniqueID": "101533916"}, "PMID": {"#text": "28449441", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "28449441", "@IdType": "pubmed"}, {"#text": "PMC5394024", "@IdType": "pmc"}, {"#text": "10.21037/jtd.2017.02.75", "@IdType": "doi"}, {"#text": "jtd-09-03-448", "@IdType": "pii"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "entrez", "Day": "29", "Hour": "6", "Minute": "0", "Month": "4", "Year": "2017"}, {"@PubStatus": "pubmed", "Day": "30", "Hour": "6", "Minute": "0", "Month": "4", "Year": "2017"}, {"@PubStatus": "medline", "Day": "30", "Hour": "6", "Minute": "1", "Month": "4", "Year": "2017"}]}, "PublicationStatus": "ppublish", "ReferenceList": {"Reference": [{"ArticleIdList": {"ArticleId": [{"#text": "10.1016/S0140-6736(16)31012-1", "@IdType": "doi"}, {"#text": "PMC5388903", "@IdType": "pmc"}, {"#text": "27733281", "@IdType": "pubmed"}]}, "Citation": "GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016;388:1459-544. 10.1016/S0140-6736(16)31012-1"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1056/NEJMp1600894", "@IdType": "doi"}, {"#text": "PMC5101951", "@IdType": "pmc"}, {"#text": "27043262", "@IdType": "pubmed"}]}, "Citation": "Lowy DR, Collins FS. Aiming High--Changing the Trajectory for Cancer. N Engl J Med 2016;374:1901-4. 10.1056/NEJMp1600894"}, {"Citation": "Horton S, Gauvreau CL. Cancer in Low- and Middle-Income Countries: An Economic Overview. In: Gelband H, Jha P, Sankaranarayanan R, et al. editors. SourceCancer: Disease Control Priorities, Third Edition (Volume 3). Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2015 Nov. Chapter 16."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/S0140-6736(13)62224-2", "@IdType": "doi"}, {"#text": "24351322", "@IdType": "pubmed"}]}, "Citation": "Vineis P, Wild CP. Global cancer patterns: causes and prevention. Lancet 2014;383:549-57. 10.1016/S0140-6736(13)62224-2"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1371/journal.pmed.1001774", "@IdType": "doi"}, {"#text": "PMC4280122", "@IdType": "pmc"}, {"#text": "25549238", "@IdType": "pubmed"}]}, "Citation": "Qu C, Chen T, Fan C, et al. Efficacy of neonatal HBV vaccination on liver cancer and other liver diseases over 30-year follow-up of the Qidong hepatitis B intervention study: a cluster randomized controlled trial. PLoS Med 2014;11:e1001774. 10.1371/journal.pmed.1001774"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/hep.21826", "@IdType": "doi"}, {"#text": "17680653", "@IdType": "pubmed"}]}, "Citation": "Bruno S, Crosignani A, Maisonneuve P, et al. Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study. Hepatology 2007;46:1350-6. 10.1002/hep.21826"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/ijc.25797", "@IdType": "doi"}, {"#text": "21128245", "@IdType": "pubmed"}]}, "Citation": "Ertle J, Dech\u00eane A, Sowa JP, et al. Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis. Int J Cancer 2011;128:2436-43. 10.1002/ijc.25797"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1056/NEJM199911253412201", "@IdType": "doi"}, {"#text": "10572150", "@IdType": "pubmed"}]}, "Citation": "Wallin KL, Wiklund F, Angstr\u00f6m T, et al. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 1999;341:1633-8. 10.1056/NEJM199911253412201"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1200/JCO.2012.47.2738", "@IdType": "doi"}, {"#text": "PMC3709056", "@IdType": "pmc"}, {"#text": "23775966", "@IdType": "pubmed"}]}, "Citation": "Kreimer AR, Johansson M, Waterboer T, et al. Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer. J Clin Oncol 2013;31:2708-15. 10.1200/JCO.2012.47.2738"}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4781057", "@IdType": "pmc"}, {"#text": "18354839", "@IdType": "pubmed"}]}, "Citation": "IARC Working Group on the Evaluation of Carcinogenic Risks to Humans Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum 2007;90:1-636."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1097/01.AOG.0000192397.41191.fb", "@IdType": "doi"}, {"#text": "16394035", "@IdType": "pubmed"}]}, "Citation": "Mao C, Koutsky LA, Ault KA, et al. Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial. Obstet Gynecol 2006;107:18-27. 10.1097/01.AOG.0000192397.41191.fb"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1056/NEJMoa1010971", "@IdType": "doi"}, {"#text": "22029979", "@IdType": "pubmed"}]}, "Citation": "Palefsky JM, Giuliano AR, Goldstone S, et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med 2011;365:1576-85. 10.1056/NEJMoa1010971"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3748/wjg.v12.i2.181", "@IdType": "doi"}, {"#text": "PMC4066024", "@IdType": "pmc"}, {"#text": "16482615", "@IdType": "pubmed"}]}, "Citation": "Ando T, Goto Y, Maeda O, et al. Causal role of Helicobacter pylori infection in gastric cancer. World J Gastroenterol 2006;12:181-6. 10.3748/wjg.v12.i2.181"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1056/NEJM199405053301803", "@IdType": "doi"}, {"#text": "8145781", "@IdType": "pubmed"}]}, "Citation": "Parsonnet J, Hansen S, Rodriguez L, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994;330:1267-71. 10.1056/NEJM199405053301803"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.7326/0003-4819-151-2-200907210-00009", "@IdType": "doi"}, {"#text": "19620164", "@IdType": "pubmed"}]}, "Citation": "Fuccio L, Zagari RM, Eusebi LH, et al. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med 2009;151:121-8. 10.7326/0003-4819-151-2-200907210-00009"}, {"Citation": "The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta, Ga: U.S. Department of Health and Human Services, CDC, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. 2004. Available online: https://www.cdc.gov/tobacco/data_statistics/sgr/2004/index.htm"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/jnci/89.24.1852", "@IdType": "doi"}, {"#text": "9414173", "@IdType": "pubmed"}]}, "Citation": "Cinciripini PM, Hecht SS, Henningfield JE, et al. Tobacco addiction: implications for treatment and cancer prevention. J Natl Cancer Inst 1997;89:1852-67. 10.1093/jnci/89.24.1852"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/ije/dyp291", "@IdType": "doi"}, {"#text": "PMC2817090", "@IdType": "pmc"}, {"#text": "19805488", "@IdType": "pubmed"}]}, "Citation": "Marron M, Boffetta P, Zhang ZF, et al. Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk. Int J Epidemiol 2010;39:182-96. 10.1093/ije/dyp291"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1056/NEJMoa021423", "@IdType": "doi"}, {"#text": "12711737", "@IdType": "pubmed"}]}, "Citation": "Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-38. 10.1056/NEJMoa021423"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1023/A:1020239211145", "@IdType": "doi"}, {"#text": "12420953", "@IdType": "pubmed"}]}, "Citation": "Morimoto LM, White E, Chen Z, et al. Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States). Cancer Causes Control 2002;13:741-51. 10.1023/A:1020239211145"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/jnci/djg010", "@IdType": "doi"}, {"#text": "12928351", "@IdType": "pubmed"}]}, "Citation": "Engeland A, Tretli S, Bj\u00f8rge T. Height, body mass index, and ovarian cancer: a follow-up of 1.1 million Norwegian women. J Natl Cancer Inst 2003;95:1244-8. 10.1093/jnci/djg010"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/sj.bjc.6604917", "@IdType": "doi"}, {"#text": "PMC2653744", "@IdType": "pmc"}, {"#text": "19209175", "@IdType": "pubmed"}]}, "Citation": "Wolin KY, Yan Y, Colditz GA, et al. Physical activity and colon cancer prevention: a meta-analysis. Br J Cancer 2009;100:611-6. 10.1038/sj.bjc.6604917"}, {"ArticleIdList": {"ArticleId": {"#text": "11319168", "@IdType": "pubmed"}}, "Citation": "Friedenreich CM. Physical activity and cancer prevention: from observational to intervention research. Cancer Epidemiol Biomarkers Prev 2001;10:287-301."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1056/NEJMoa1102873", "@IdType": "doi"}, {"#text": "PMC4356534", "@IdType": "pmc"}, {"#text": "21714641", "@IdType": "pubmed"}]}, "Citation": "National Lung Screening Trial Research Team , Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409. 10.1056/NEJMoa1102873"}]}}}}}, "PMC": "PMC5394024", "PMID": "28449441", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "Cancer prevention from the perspective of global cancer burden patterns.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "32": {"Abstract": "Long noncoding RNAs (lncRNAs) are composed of >\u2009200 nucleotides; they lack the ability to encode proteins but play important roles in a variety of human tumors. A large number of studies have shown that dysregulated expression of lncRNAs is related to tumor oncogenesis and progression. Emerging evidence shows that SNHG3 is a novel oncogenic lncRNA that is abnormally expressed in various tumors, including osteosarcoma, liver cancer, lung cancer, etc. SNHG3 primarily competes as a competitive endogenous RNA (ceRNA) that targets tumor suppressor microRNAs (miRNAs) and ceRNA mechanisms that regulate biological processes of tumors. In addition, abnormal expression of SNHG3 is significantly correlated with patient clinical features. Upregulation of SNHG3 contributes to biological functions, including tumor cell proliferation, migration, invasion and EMT. Therefore, SNHG3 may represent a potential diagnostic and prognostic biomarker, as well as a novel therapeutic target.", "Authors": [{"Affiliations": [{"Has_Extra": true, "HashID": "-2131433129856417962", "Part1": "Department of Neurosurgery", "Part2": "Wuxi People's Hospital Affiliated to Nanjing Medical University", "Part3": "No. 299 Qing Yang Road", "Part4": "Wuxi", "Part5": "214023", "Part6": "Jiangsu", "Text": "Department of Neurosurgery, Wuxi People's Hospital Affiliated to Nanjing Medical University, No. 299 Qing Yang Road, Wuxi, 214023, Jiangsu, China."}], "ForeName": "Bin", "FullName": "Bin Xu", "HashID": "8327748808597000203", "LastName": "Xu", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "4998685689853045995", "Part1": "Department of Oncology", "Part2": "Wuxi People's Hospital Affiliated to Nanjing Medical University", "Part3": "Wuxi", "Part4": "P. R. China.", "Part5": null, "Part6": null, "Text": "Department of Oncology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, P. R. China."}], "ForeName": "Jie", "FullName": "Jie Mei", "HashID": "-3383181897279367638", "LastName": "Mei", "ORCID": null}, {"Affiliations": [{"Has_Extra": true, "HashID": "-2131433129856417962", "Part1": "Department of Neurosurgery", "Part2": "Wuxi People's Hospital Affiliated to Nanjing Medical University", "Part3": "No. 299 Qing Yang Road", "Part4": "Wuxi", "Part5": "214023", "Part6": "Jiangsu", "Text": "Department of Neurosurgery, Wuxi People's Hospital Affiliated to Nanjing Medical University, No. 299 Qing Yang Road, Wuxi, 214023, Jiangsu, China."}], "ForeName": "Wei", "FullName": "Wei Ji", "HashID": "-5031520665544409986", "LastName": "Ji", "ORCID": null}, {"Affiliations": [{"Has_Extra": true, "HashID": "-2131433129856417962", "Part1": "Department of Neurosurgery", "Part2": "Wuxi People's Hospital Affiliated to Nanjing Medical University", "Part3": "No. 299 Qing Yang Road", "Part4": "Wuxi", "Part5": "214023", "Part6": "Jiangsu", "Text": "Department of Neurosurgery, Wuxi People's Hospital Affiliated to Nanjing Medical University, No. 299 Qing Yang Road, Wuxi, 214023, Jiangsu, China."}], "ForeName": "Zheng", "FullName": "Zheng Bian", "HashID": "-162329160490242078", "LastName": "Bian", "ORCID": null}, {"Affiliations": [{"Has_Extra": true, "HashID": "-2131433129856417962", "Part1": "Department of Neurosurgery", "Part2": "Wuxi People's Hospital Affiliated to Nanjing Medical University", "Part3": "No. 299 Qing Yang Road", "Part4": "Wuxi", "Part5": "214023", "Part6": "Jiangsu", "Text": "Department of Neurosurgery, Wuxi People's Hospital Affiliated to Nanjing Medical University, No. 299 Qing Yang Road, Wuxi, 214023, Jiangsu, China."}], "ForeName": "Jiantong", "FullName": "Jiantong Jiao", "HashID": "-4347240132107664366", "LastName": "Jiao", "ORCID": null}, {"Affiliations": [{"Has_Extra": true, "HashID": "-2131433129856417962", "Part1": "Department of Neurosurgery", "Part2": "Wuxi People's Hospital Affiliated to Nanjing Medical University", "Part3": "No. 299 Qing Yang Road", "Part4": "Wuxi", "Part5": "214023", "Part6": "Jiangsu", "Text": "Department of Neurosurgery, Wuxi People's Hospital Affiliated to Nanjing Medical University, No. 299 Qing Yang Road, Wuxi, 214023, Jiangsu, China. wxrmsj@163.com."}], "ForeName": "Jun", "FullName": "Jun Sun", "HashID": "4726183288650804087", "LastName": "Sun", "ORCID": "0000-0002-1018-3723"}, {"Affiliations": [{"Has_Extra": true, "HashID": "-2131433129856417962", "Part1": "Department of Neurosurgery", "Part2": "Wuxi People's Hospital Affiliated to Nanjing Medical University", "Part3": "No. 299 Qing Yang Road", "Part4": "Wuxi", "Part5": "214023", "Part6": "Jiangsu", "Text": "Department of Neurosurgery, Wuxi People's Hospital Affiliated to Nanjing Medical University, No. 299 Qing Yang Road, Wuxi, 214023, Jiangsu, China. wxrmyysjf@163.com."}], "ForeName": "Junfei", "FullName": "Junfei Shao", "HashID": "2387548041405786356", "LastName": "Shao", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.1186/s12935-020-01608-x", "InsertType": null, "Journal": "Cancer cell international", "Keywords": [{"IS_Major": false, "IS_Mesh": false, "Text": "Biomarker"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Cancer"}, {"IS_Major": false, "IS_Mesh": false, "Text": "LncRNA"}, {"IS_Major": false, "IS_Mesh": false, "Text": "SNHG3"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "PubMed-not-MEDLINE", "Article": {"@PubModel": "Electronic", "Abstract": {"AbstractText": "Long noncoding RNAs (lncRNAs) are composed of >\u2009200 nucleotides; they lack the ability to encode proteins but play important roles in a variety of human tumors. A large number of studies have shown that dysregulated expression of lncRNAs is related to tumor oncogenesis and progression. Emerging evidence shows that SNHG3 is a novel oncogenic lncRNA that is abnormally expressed in various tumors, including osteosarcoma, liver cancer, lung cancer, etc. SNHG3 primarily competes as a competitive endogenous RNA (ceRNA) that targets tumor suppressor microRNAs (miRNAs) and ceRNA mechanisms that regulate biological processes of tumors. In addition, abnormal expression of SNHG3 is significantly correlated with patient clinical features. Upregulation of SNHG3 contributes to biological functions, including tumor cell proliferation, migration, invasion and EMT. Therefore, SNHG3 may represent a potential diagnostic and prognostic biomarker, as well as a novel therapeutic target."}, "ArticleDate": {"@DateType": "Electronic", "Day": "04", "Month": "11", "Year": "2020"}, "ArticleTitle": "LncRNA SNHG3, a potential oncogene in human cancers.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Neurosurgery, Wuxi People's Hospital Affiliated to Nanjing Medical University, No. 299 Qing Yang Road, Wuxi, 214023, Jiangsu, China."}, "ForeName": "Bin", "Initials": "B", "LastName": "Xu"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Oncology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, P. R. China."}, "ForeName": "Jie", "Initials": "J", "LastName": "Mei"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Neurosurgery, Wuxi People's Hospital Affiliated to Nanjing Medical University, No. 299 Qing Yang Road, Wuxi, 214023, Jiangsu, China."}, "ForeName": "Wei", "Initials": "W", "LastName": "Ji"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Neurosurgery, Wuxi People's Hospital Affiliated to Nanjing Medical University, No. 299 Qing Yang Road, Wuxi, 214023, Jiangsu, China."}, "ForeName": "Zheng", "Initials": "Z", "LastName": "Bian"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Neurosurgery, Wuxi People's Hospital Affiliated to Nanjing Medical University, No. 299 Qing Yang Road, Wuxi, 214023, Jiangsu, China."}, "ForeName": "Jiantong", "Initials": "J", "LastName": "Jiao"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Neurosurgery, Wuxi People's Hospital Affiliated to Nanjing Medical University, No. 299 Qing Yang Road, Wuxi, 214023, Jiangsu, China. wxrmsj@163.com."}, "ForeName": "Jun", "Identifier": {"#text": "0000-0002-1018-3723", "@Source": "ORCID"}, "Initials": "J", "LastName": "Sun"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Neurosurgery, Wuxi People's Hospital Affiliated to Nanjing Medical University, No. 299 Qing Yang Road, Wuxi, 214023, Jiangsu, China. wxrmyysjf@163.com."}, "ForeName": "Junfei", "Initials": "J", "LastName": "Shao"}]}, "ELocationID": [{"#text": "536", "@EIdType": "pii", "@ValidYN": "Y"}, {"#text": "10.1186/s12935-020-01608-x", "@EIdType": "doi", "@ValidYN": "Y"}], "Journal": {"ISOAbbreviation": "Cancer Cell Int", "ISSN": {"#text": "1475-2867", "@IssnType": "Print"}, "JournalIssue": {"@CitedMedium": "Print", "Issue": "1", "PubDate": {"Day": "04", "Month": "Nov", "Year": "2020"}, "Volume": "20"}, "Title": "Cancer cell international"}, "Language": "eng", "Pagination": {"MedlinePgn": "536", "StartPage": "536"}, "PublicationTypeList": {"PublicationType": [{"#text": "Journal Article", "@UI": "D016428"}, {"#text": "Review", "@UI": "D016454"}]}}, "CoiStatement": "The authors declare that they have no competing interests.", "DateRevised": {"Day": "12", "Month": "12", "Year": "2020"}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"#text": "Biomarker", "@MajorTopicYN": "N"}, {"#text": "Cancer", "@MajorTopicYN": "N"}, {"#text": "LncRNA", "@MajorTopicYN": "N"}, {"#text": "SNHG3", "@MajorTopicYN": "N"}]}, "MedlineJournalInfo": {"Country": "England", "ISSNLinking": "1475-2867", "MedlineTA": "Cancer Cell Int", "NlmUniqueID": "101139795"}, "PMID": {"#text": "33292213", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "33292213", "@IdType": "pubmed"}, {"#text": "PMC7640707", "@IdType": "pmc"}, {"#text": "10.1186/s12935-020-01608-x", "@IdType": "doi"}, {"#text": "10.1186/s12935-020-01608-x", "@IdType": "pii"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "received", "Day": "31", "Month": "7", "Year": "2020"}, {"@PubStatus": "accepted", "Day": "15", "Month": "10", "Year": "2020"}, {"@PubStatus": "entrez", "Day": "9", "Hour": "5", "Minute": "42", "Month": "12", "Year": "2020"}, {"@PubStatus": "pubmed", "Day": "10", "Hour": "6", "Minute": "0", "Month": "12", "Year": "2020"}, {"@PubStatus": "medline", "Day": "10", "Hour": "6", "Minute": "1", "Month": "12", "Year": "2020"}]}, "PublicationStatus": "epublish", "ReferenceList": {"Reference": [{"ArticleIdList": {"ArticleId": [{"#text": "10.3322/caac.21492", "@IdType": "doi"}, {"#text": "30207593", "@IdType": "pubmed"}]}, "Citation": "Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424. doi: 10.3322/caac.21492."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3322/caac.21262", "@IdType": "doi"}, {"#text": "25651787", "@IdType": "pubmed"}]}, "Citation": "Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87\u2013108. doi: 10.3322/caac.21262."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/S0140-6736(17)33326-3", "@IdType": "doi"}, {"#text": "PMC5879496", "@IdType": "pmc"}, {"#text": "29395269", "@IdType": "pubmed"}]}, "Citation": "Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Niksic M, Bonaventure A, Valkov M, Johnson CJ, Esteve J, et al. Global surveillance of trends in cancer survival 2000\u201314 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023\u20131075. doi: 10.1016/S0140-6736(17)33326-3."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cell.2018.01.011", "@IdType": "doi"}, {"#text": "PMC5978744", "@IdType": "pmc"}, {"#text": "29373828", "@IdType": "pubmed"}]}, "Citation": "Kopp F, Mendell JT. Functional classification and experimental dissection of long noncoding RNAs. Cell. 2018;172(3):393\u2013407. doi: 10.1016/j.cell.2018.01.011."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1126/science.aad8709", "@IdType": "doi"}, {"#text": "PMC6035743", "@IdType": "pmc"}, {"#text": "27313039", "@IdType": "pubmed"}]}, "Citation": "Sullenger BA, Nair S. From the RNA world to the clinic. Science. 2016;352(6292):1417\u20131420. doi: 10.1126/science.aad8709."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41556-019-0311-8", "@IdType": "doi"}, {"#text": "31048766", "@IdType": "pubmed"}]}, "Citation": "Yao RW, Wang Y, Chen LL. Cellular functions of long noncoding RNAs. Nat Cell Biol. 2019;21(5):542\u2013551. doi: 10.1038/s41556-019-0311-8."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.tig.2015.03.007", "@IdType": "doi"}, {"#text": "PMC4417002", "@IdType": "pmc"}, {"#text": "25869999", "@IdType": "pubmed"}]}, "Citation": "St Laurent G, Wahlestedt C, Kapranov P. The landscape of long noncoding RNA classification. Trends Genet. 2015;31(5):239\u2013251. doi: 10.1016/j.tig.2015.03.007."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrg3074", "@IdType": "doi"}, {"#text": "22094949", "@IdType": "pubmed"}]}, "Citation": "Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011;12(12):861\u2013874. doi: 10.1038/nrg3074."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1152/physrev.00041.2015", "@IdType": "doi"}, {"#text": "27535639", "@IdType": "pubmed"}]}, "Citation": "Beermann J, Piccoli MT, Viereck J, Thum T. Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches. Physiol Rev. 2016;96(4):1297\u20131325. doi: 10.1152/physrev.00041.2015."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.gpb.2015.09.006", "@IdType": "doi"}, {"#text": "PMC4792843", "@IdType": "pmc"}, {"#text": "26883671", "@IdType": "pubmed"}]}, "Citation": "Fang Y, Fullwood MJ. Roles, functions, and mechanisms of long non-coding RNAs in cancer. Genom Proteom Bioinform. 2016;14(1):42\u201354. doi: 10.1016/j.gpb.2015.09.006."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrm.2017.104", "@IdType": "doi"}, {"#text": "PMC5889127", "@IdType": "pmc"}, {"#text": "29138516", "@IdType": "pubmed"}]}, "Citation": "Ransohoff JD, Wei Y, Khavari PA. The functions and unique features of long intergenic non-coding RNA. Nat Rev Mol Cell Biol. 2018;19(3):143\u2013157. doi: 10.1038/nrm.2017.104."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41571-018-0035-x", "@IdType": "doi"}, {"#text": "29784926", "@IdType": "pubmed"}]}, "Citation": "Anfossi S, Babayan A, Pantel K, Calin GA. Clinical utility of circulating non-coding RNAs\u2014an update. Nat Rev Clin Oncol. 2018;15(9):541\u2013563. doi: 10.1038/s41571-018-0035-x."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/eurheartj/ehx165", "@IdType": "doi"}, {"#text": "PMC6454570", "@IdType": "pmc"}, {"#text": "28430919", "@IdType": "pubmed"}]}, "Citation": "Poller W, Dimmeler S, Heymans S, Zeller T, Haas J, Karakas M, Leistner DM, Jakob P, Nakagawa S, Blankenberg S, et al. Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives. Eur Heart J. 2018;39(29):2704\u20132716. doi: 10.1093/eurheartj/ehx165."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrm.2017.12", "@IdType": "doi"}, {"#text": "28270684", "@IdType": "pubmed"}]}, "Citation": "Skalska L, Beltran-Nebot M, Ule J, Jenner RG. Regulatory feedback from nascent RNA to chromatin and transcription. Nat Rev Mol Cell Biol. 2017;18(5):331\u2013337. doi: 10.1038/nrm.2017.12."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/2159-8290.CD-16-1292", "@IdType": "doi"}, {"#text": "PMC5997407", "@IdType": "pmc"}, {"#text": "28320778", "@IdType": "pubmed"}]}, "Citation": "Esteller M, Pandolfi PP. The epitranscriptome of noncoding RNAs in cancer. Cancer Discov. 2017;7(4):359\u2013368. doi: 10.1158/2159-8290.CD-16-1292."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrc.2017.99", "@IdType": "doi"}, {"#text": "PMC6337726", "@IdType": "pmc"}, {"#text": "29170536", "@IdType": "pubmed"}]}, "Citation": "Anastasiadou E, Jacob LS, Slack FJ. Non-coding RNA networks in cancer. Nat Rev Cancer. 2018;18(1):5\u201318. doi: 10.1038/nrc.2017.99."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ccell.2016.03.010", "@IdType": "doi"}, {"#text": "PMC4831138", "@IdType": "pmc"}, {"#text": "27070700", "@IdType": "pubmed"}]}, "Citation": "Schmitt AM, Chang HY. Long noncoding RNAs in cancer pathways. Cancer Cell. 2016;29(4):452\u2013463. doi: 10.1016/j.ccell.2016.03.010."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrd.2016.117", "@IdType": "doi"}, {"#text": "PMC5831170", "@IdType": "pmc"}, {"#text": "27444227", "@IdType": "pubmed"}]}, "Citation": "Matsui M, Corey DR. Non-coding RNAs as drug targets. Nat Rev Drug Discov. 2017;16(3):167\u2013179. doi: 10.1038/nrd.2016.117."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.1120791109", "@IdType": "doi"}, {"#text": "PMC3289292", "@IdType": "pmc"}, {"#text": "22308462", "@IdType": "pubmed"}]}, "Citation": "Kato L, Begum NA, Burroughs AM, Doi T, Kawai J, Daub CO, Kawaguchi T, Matsuda F, Hayashizaki Y, Honjo T. Nonimmunoglobulin target loci of activation-induced cytidine deaminase (AID) share unique features with immunoglobulin genes. Proc Natl Acad Sci USA. 2012;109(7):2479\u20132484. doi: 10.1073/pnas.1120791109."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s13287-019-1270-5", "@IdType": "doi"}, {"#text": "PMC6545032", "@IdType": "pmc"}, {"#text": "31151411", "@IdType": "pubmed"}]}, "Citation": "Lu W, Yu J, Shi F, Zhang J, Huang R, Yin S, Songyang Z, Huang J. The long non-coding RNA Snhg3 is essential for mouse embryonic stem cell self-renewal and pluripotency. Stem Cell Res Ther. 2019;10(1):157. doi: 10.1186/s13287-019-1270-5."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3389/fonc.2019.00587", "@IdType": "doi"}, {"#text": "PMC6629867", "@IdType": "pmc"}, {"#text": "31338327", "@IdType": "pubmed"}]}, "Citation": "Liang J, Wen J, Huang Z, Chen XP, Zhang BX, Chu L. Small nucleolar RNAs: insight into their function in cancer. Front Oncol. 2019;9:587. doi: 10.3389/fonc.2019.00587."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.celrep.2017.10.070", "@IdType": "doi"}, {"#text": "29141226", "@IdType": "pubmed"}]}, "Citation": "Gong J, Li Y, Liu CJ, Xiang Y, Li C, Ye Y, Zhang Z, Hawke DH, Park PK, Diao L, et al. A pan-cancer analysis of the expression and clinical relevance of small nucleolar RNAs in human cancer. Cell Rep. 2017;21(7):1968\u20131981. doi: 10.1016/j.celrep.2017.10.070."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41419-019-1940-3", "@IdType": "doi"}, {"#text": "PMC6751301", "@IdType": "pmc"}, {"#text": "31534128", "@IdType": "pubmed"}]}, "Citation": "Xuan Y, Wang Y. Long non-coding RNA SNHG3 promotes progression of gastric cancer by regulating neighboring MED18 gene methylation. Cell Death Dis. 2019;10(10):694. doi: 10.1038/s41419-019-1940-3."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1042/BSR20180420", "@IdType": "doi"}, {"#text": "PMC6127675", "@IdType": "pmc"}, {"#text": "30042166", "@IdType": "pubmed"}]}, "Citation": "Fei F, He Y, He S, He Z, Wang Y, Wu G, Li M. LncRNA SNHG3 enhances the malignant progress of glioma through silencing KLF2 and p21. Biosci Rep. 2018 doi: 10.1042/BSR20180420."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.biopha.2019.108695", "@IdType": "doi"}, {"#text": "30797154", "@IdType": "pubmed"}]}, "Citation": "Zheng S, Jiang F, Ge D, Tang J, Chen H, Yang J, Yao Y, Yan J, Qiu J, Yin Z, et al. LncRNA SNHG3/miRNA-151a-3p/RAB22A axis regulates invasion and migration of osteosarcoma. Biomed Pharmacother. 2019;112:108695. doi: 10.1016/j.biopha.2019.108695."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s13167-020-00209-y", "@IdType": "doi"}, {"#text": "PMC7272521", "@IdType": "pmc"}, {"#text": "32549918", "@IdType": "pubmed"}]}, "Citation": "Li N, Zhan X. Anti-parasite drug ivermectin can suppress ovarian cancer by regulating lncRNA-EIF4A3-mRNA axes. EPMA J. 2020;11(2):289\u2013309. doi: 10.1007/s13167-020-00209-y."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3322/caac.21412", "@IdType": "doi"}, {"#text": "28972651", "@IdType": "pubmed"}]}, "Citation": "DeSantis CE, Ma J, Goding Sauer A, Newman LA, Jemal A. Breast cancer statistics, 2017, racial disparity in mortality by state. CA Cancer J Clin. 2017;67(6):439\u2013448. doi: 10.3322/caac.21412."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1001/jama.2014.17322", "@IdType": "doi"}, {"#text": "25585328", "@IdType": "pubmed"}]}, "Citation": "Iqbal J, Ginsburg O, Rochon PA, Sun P, Narod SA. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States. JAMA. 2015;313(2):165\u2013173. doi: 10.1001/jama.2014.17322."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cell.2011.02.013", "@IdType": "doi"}, {"#text": "21376230", "@IdType": "pubmed"}]}, "Citation": "Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u2013674. doi: 10.1016/j.cell.2011.02.013."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3322/caac.21321", "@IdType": "doi"}, {"#text": "26431342", "@IdType": "pubmed"}]}, "Citation": "Ward EM, DeSantis CE, Lin CC, Kramer JL, Jemal A, Kohler B, Brawley OW, Gansler T. Cancer statistics: breast cancer in situ. CA Cancer J Clin. 2015;65(6):481\u2013495. doi: 10.3322/caac.21321."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s13577-019-00287-9", "@IdType": "doi"}, {"#text": "31586299", "@IdType": "pubmed"}]}, "Citation": "Ma Q, Qi X, Lin X, Li L, Chen L, Hu W. LncRNA SNHG3 promotes cell proliferation and invasion through the miR-384/hepatoma-derived growth factor axis in breast cancer. Hum Cell. 2020;33(1):232\u2013242. doi: 10.1007/s13577-019-00287-9."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s12010-020-03244-7", "@IdType": "doi"}, {"#text": "PMC7320061", "@IdType": "pmc"}, {"#text": "31956955", "@IdType": "pubmed"}]}, "Citation": "Li Y, Zhao Z, Liu W, Li X. SNHG3 functions as miRNA sponge to promote breast cancer cells growth through the metabolic reprogramming. Appl Biochem Biotechnol. 2020;191(3):1084\u20131099. doi: 10.1007/s12010-020-03244-7."}, {"ArticleIdList": {"ArticleId": {"#text": "32495883", "@IdType": "pubmed"}}, "Citation": "Wang P, Liu GZ, Wang JF, Du YY. SNHG3 silencing suppresses the malignant development of triple-negative breast cancer cells by regulating miRNA-326/integrin alpha5 axis and inactivating Vav2/Rac1 signaling pathway. Eur Rev Med Pharmacol Sci. 2020;24(10):5481\u20135492."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/jcp.28767", "@IdType": "doi"}, {"#text": "31062358", "@IdType": "pubmed"}]}, "Citation": "Taherian-Esfahani Z, Taheri M, Dashti S, Kholghi-Oskooei V, Geranpayeh L, Ghafouri-Fard S. Assessment of the expression pattern of mTOR-associated lncRNAs and their genomic variants in the patients with breast cancer. J Cell Physiol. 2019;234(12):22044\u201322056. doi: 10.1002/jcp.28767."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrendo.2017.16", "@IdType": "doi"}, {"#text": "28338660", "@IdType": "pubmed"}]}, "Citation": "Gianferante DM, Mirabello L, Savage SA. Germline and somatic genetics of osteosarcoma\u2014connecting aetiology, biology and therapy. Nat Rev Endocrinol. 2017;13(8):480\u2013491. doi: 10.1038/nrendo.2017.16."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1080/14737140.2018.1413939", "@IdType": "doi"}, {"#text": "29210294", "@IdType": "pubmed"}]}, "Citation": "Harrison DJ, Geller DS, Gill JD, Lewis VO, Gorlick R. Current and future therapeutic approaches for osteosarcoma. Expert Rev Anticancer Ther. 2018;18(1):39\u201350. doi: 10.1080/14737140.2018.1413939."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1159/000479205", "@IdType": "doi"}, {"#text": "28715796", "@IdType": "pubmed"}]}, "Citation": "Li Z, Dou P, Liu T, He S. Application of long noncoding RNAs in osteosarcoma: biomarkers and therapeutic targets. Cell Physiol Biochem. 2017;42(4):1407\u20131419. doi: 10.1159/000479205."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6329016", "@IdType": "pmc"}, {"#text": "30791797", "@IdType": "pubmed"}]}, "Citation": "Chen J, Wu Z, Zhang Y. LncRNA SNHG3 promotes cell growth by sponging miR-196a-5p and indicates the poor survival in osteosarcoma. Int J Immunopathol Pharmacol. 2019;33:2058738418820743."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s13311-017-0519-x", "@IdType": "doi"}, {"#text": "PMC5398991", "@IdType": "pmc"}, {"#text": "28281173", "@IdType": "pubmed"}]}, "Citation": "Chen R, Smith-Cohn M, Cohen AL, Colman H. Glioma subclassifications and their clinical significance. Neurotherapeutics. 2017;14(2):284\u2013297. doi: 10.1007/s13311-017-0519-x."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12943-018-0812-2", "@IdType": "doi"}, {"#text": "PMC5817731", "@IdType": "pmc"}, {"#text": "29458374", "@IdType": "pubmed"}]}, "Citation": "Peng Z, Liu C, Wu M. New insights into long noncoding RNAs and their roles in glioma. Mol Cancer. 2018;17(1):61. doi: 10.1186/s12943-018-0812-2."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3322/caac.21343", "@IdType": "doi"}, {"#text": "27002678", "@IdType": "pubmed"}]}, "Citation": "Cohen EE, LaMonte SJ, Erb NL, Beckman KL, Sadeghi N, Hutcheson KA, Stubblefield MD, Abbott DM, Fisher PS, Stein KD, et al. American cancer society head and neck cancer survivorship care guideline. CA Cancer J Clin. 2016;66(3):203\u2013239. doi: 10.3322/caac.21343."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1056/NEJMoa031317", "@IdType": "doi"}, {"#text": "14645636", "@IdType": "pubmed"}]}, "Citation": "Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, Glisson B, Trotti A, Ridge JA, Chao C, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349(22):2091\u20132098. doi: 10.1056/NEJMoa031317."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrc.2018.11", "@IdType": "doi"}, {"#text": "29497144", "@IdType": "pubmed"}]}, "Citation": "Leemans CR, Snijders PJF, Brakenhoff RH. The molecular landscape of head and neck cancer. Nat Rev Cancer. 2018;18(5):269\u2013282. doi: 10.1038/nrc.2018.11."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.lfs.2019.116597", "@IdType": "doi"}, {"#text": "31238052", "@IdType": "pubmed"}]}, "Citation": "Wang L, Su K, Wu H, Li J, Song D. LncRNA SNHG3 regulates laryngeal carcinoma proliferation and migration by modulating the miR-384/WEE1 axis. Life Sci. 2019;232:116597. doi: 10.1016/j.lfs.2019.116597."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.4149/neo_2020_191022N1073", "@IdType": "doi"}, {"#text": "32538668", "@IdType": "pubmed"}]}, "Citation": "Kang R, Yao DF, Xu GZ, Zhou YH. The knockdown of SNHG3 inhibits the progression of laryngeal squamous cell carcinoma by miR-340-5p/YAP1 axis and Wnt/beta-catenin pathway. Neoplasma. 2020;67(5):1094\u20131105. doi: 10.4149/neo_2020_191022N1073."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3322/caac.21551", "@IdType": "doi"}, {"#text": "30620402", "@IdType": "pubmed"}]}, "Citation": "Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7\u201334. doi: 10.3322/caac.21551."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1056/NEJMoa1708423", "@IdType": "doi"}, {"#text": "29562147", "@IdType": "pubmed"}]}, "Citation": "Choi IJ, Kook MC, Kim YI, Cho SJ, Lee JY, Kim CG, Park B, Nam BH. Helicobacter pylori therapy for the prevention of metachronous gastric cancer. N Engl J Med. 2018;378(12):1085\u20131095. doi: 10.1056/NEJMoa1708423."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1053/j.gastro.2016.01.028", "@IdType": "doi"}, {"#text": "26836587", "@IdType": "pubmed"}]}, "Citation": "Lee YC, Chiang TH, Chou CK, Tu YK, Liao WC, Wu MS, Graham DY. Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis. Gastroenterology. 2016;150(5):1113.e1115\u20131124.e1115. doi: 10.1053/j.gastro.2016.01.028."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.4251/wjgo.v11.i10.804", "@IdType": "doi"}, {"#text": "PMC6815928", "@IdType": "pmc"}, {"#text": "31662821", "@IdType": "pubmed"}]}, "Citation": "Bonelli P, Borrelli A, Tuccillo FM, Silvestro L, Palaia R, Buonaguro FM. Precision medicine in gastric cancer. World J Gastrointest Oncol. 2019;11(10):804\u2013829. doi: 10.4251/wjgo.v11.i10.804."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrg.2015.10", "@IdType": "doi"}, {"#text": "26666209", "@IdType": "pubmed"}]}, "Citation": "Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet. 2016;17(1):47\u201362. doi: 10.1038/nrg.2015.10."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3322/caac.21349", "@IdType": "doi"}, {"#text": "27253694", "@IdType": "pubmed"}]}, "Citation": "Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R, Jemal A. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66(4):271\u2013289. doi: 10.3322/caac.21349."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/1078-0432.CCR-17-0023", "@IdType": "doi"}, {"#text": "28533224", "@IdType": "pubmed"}]}, "Citation": "Stiegelbauer V, Vychytilova-Faltejskova P, Karbiener M, Pehserl AM, Reicher A, Resel M, Heitzer E, Ivan C, Bullock M, Ling H, et al. miR-196b-5p regulates colorectal cancer cell migration and metastases through interaction with HOXB7 and GALNT5. Clin Cancer Res. 2017;23(17):5255\u20135266. doi: 10.1158/1078-0432.CCR-17-0023."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/or.2017.5837", "@IdType": "doi"}, {"#text": "PMC5549033", "@IdType": "pmc"}, {"#text": "28731158", "@IdType": "pubmed"}]}, "Citation": "Huang W, Tian Y, Dong S, Cha Y, Li J, Guo X, Yuan X. The long non-coding RNA SNHG3 functions as a competing endogenous RNA to promote malignant development of colorectal cancer. Oncol Rep. 2017;38(3):1402\u20131410. doi: 10.3892/or.2017.5837."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.biopha.2020.110039", "@IdType": "doi"}, {"#text": "32187965", "@IdType": "pubmed"}]}, "Citation": "Dacheng W, Songhe L, Weidong J, Shutao Z, Jingjing L, Jiaming Z. LncRNA SNHG3 promotes the growth and metastasis of colorectal cancer by regulating miR-539/RUNX2 axis. Biomed Pharmacother. 2020;125:110039. doi: 10.1016/j.biopha.2020.110039."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12943-017-0681-0", "@IdType": "doi"}, {"#text": "PMC5490088", "@IdType": "pmc"}, {"#text": "28659173", "@IdType": "pubmed"}]}, "Citation": "Li JK, Chen C, Liu JY, Shi JZ, Liu SP, Liu B, Wu DS, Fang ZY, Bao Y, Jiang MM, et al. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling. Mol Cancer. 2017;16(1):111. doi: 10.1186/s12943-017-0681-0."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1056/NEJMoa1712126", "@IdType": "doi"}, {"#text": "PMC5972549", "@IdType": "pmc"}, {"#text": "29562145", "@IdType": "pubmed"}]}, "Citation": "Motzer RJ, Tannir NM, McDermott DF, Aren Frontera O, Melichar B, Choueiri TK, Plimack ER, Barthelemy P, Porta C, George S, et al. Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma. N Engl J Med. 2018;378(14):1277\u20131290. doi: 10.1056/NEJMoa1712126."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.yexcr.2019.111595", "@IdType": "doi"}, {"#text": "31505165", "@IdType": "pubmed"}]}, "Citation": "Zhang C, Qu Y, Xiao H, Xiao W, Liu J, Gao Y, Li M, Liu J. LncRNA SNHG3 promotes clear cell renal cell carcinoma proliferation and migration by upregulating TOP2A. Exp Cell Res. 2019;384(1):111595. doi: 10.1016/j.yexcr.2019.111595."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1053/j.gastro.2018.08.065", "@IdType": "doi"}, {"#text": "PMC6340716", "@IdType": "pmc"}, {"#text": "30367835", "@IdType": "pubmed"}]}, "Citation": "Kulik L, El-Serag HB. Epidemiology and management of hepatocellular carcinoma. Gastroenterology. 2019;156(2):477.e471\u2013491.e471. doi: 10.1053/j.gastro.2018.08.065."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.lfs.2017.10.007", "@IdType": "doi"}, {"#text": "28987633", "@IdType": "pubmed"}]}, "Citation": "Qiu L, Tang Q, Li G, Chen K. Long non-coding RNAs as biomarkers and therapeutic targets: recent insights into hepatocellular carcinoma. Life Sci. 2017;191:273\u2013282. doi: 10.1016/j.lfs.2017.10.007."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2147/OTT.S196630", "@IdType": "doi"}, {"#text": "PMC6708045", "@IdType": "pmc"}, {"#text": "31692508", "@IdType": "pubmed"}]}, "Citation": "Wu J, Liu L, Jin H, Li Q, Wang S, Peng B. LncSNHG3/miR-139-5p/BMI1 axis regulates proliferation, migration, and invasion in hepatocellular carcinoma. Onco Targets Ther. 2019;12:6623\u20136638. doi: 10.2147/OTT.S196630."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1620/tjem.249.43", "@IdType": "doi"}, {"#text": "31548493", "@IdType": "pubmed"}]}, "Citation": "Zhao Q, Wu C, Wang J, Li X, Fan Y, Gao S, Wang K. LncRNA SNHG3 promotes hepatocellular tumorigenesis by targeting miR-326. Tohoku J Exp Med. 2019;249(1):43\u201356. doi: 10.1620/tjem.249.43."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/jcp.27095", "@IdType": "doi"}, {"#text": "30132868", "@IdType": "pubmed"}]}, "Citation": "Zhang PF, Wang F, Wu J, Wu Y, Huang W, Liu D, Huang XY, Zhang XM, Ke AW. LncRNA SNHG3 induces EMT and sorafenib resistance by modulating the miR-128/CD151 pathway in hepatocellular carcinoma. J Cell Physiol. 2019;234(3):2788\u20132794. doi: 10.1002/jcp.27095."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s13277-015-4052-4", "@IdType": "doi"}, {"#text": "26373735", "@IdType": "pubmed"}]}, "Citation": "Zhang T, Cao C, Wu D, Liu L. SNHG3 correlates with malignant status and poor prognosis in hepatocellular carcinoma. Tumour Biol. 2016;37(2):2379\u20132385. doi: 10.1007/s13277-015-4052-4."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.7717/peerj.8021", "@IdType": "doi"}, {"#text": "PMC6827457", "@IdType": "pmc"}, {"#text": "31695969", "@IdType": "pubmed"}]}, "Citation": "Liu J, Li W, Zhang J, Ma Z, Wu X, Tang L. Identification of key genes and long non-coding RNA associated ceRNA networks in hepatocellular carcinoma. PeerJ. 2019;7:e8021. doi: 10.7717/peerj.8021."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bbrc.2017.06.055", "@IdType": "doi"}, {"#text": "28623135", "@IdType": "pubmed"}]}, "Citation": "Zhang R, Xia Y, Wang Z, Zheng J, Chen Y, Li X, Wang Y, Ming H. Serum long non coding RNA MALAT-1 protected by exosomes is up-regulated and promotes cell proliferation and migration in non-small cell lung cancer. Biochem Biophys Res Commun. 2017;490(2):406\u2013414. doi: 10.1016/j.bbrc.2017.06.055."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/jcp.29194", "@IdType": "doi"}, {"#text": "31602642", "@IdType": "pubmed"}]}, "Citation": "Shi J, Li J, Yang S, Hu X, Chen J, Feng J, Shi T, He Y, Mei Z, He W, et al. LncRNA SNHG3 is activated by E2F1 and promotes proliferation and migration of non-small-cell lung cancer cells through activating TGF-beta pathway and IL-6/JAK2/STAT3 pathway. J Cell Physiol. 2020;235(3):2891\u20132900. doi: 10.1002/jcp.29194."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6081568", "@IdType": "pmc"}, {"#text": "30154938", "@IdType": "pubmed"}]}, "Citation": "Liu L, Ni J, He X. Upregulation of the long noncoding RNA SNHG3 promotes lung adenocarcinoma proliferation. Dis Mark. 2018;2018:5736716."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1182/blood-2016-03-643544", "@IdType": "doi"}, {"#text": "27069254", "@IdType": "pubmed"}]}, "Citation": "Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391\u20132405. doi: 10.1182/blood-2016-03-643544."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1200/JCO.2010.30.2554", "@IdType": "doi"}, {"#text": "21220609", "@IdType": "pubmed"}]}, "Citation": "Marcucci G, Haferlach T, Dohner H. Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications. J Clin Oncol. 2011;29(5):475\u2013486. doi: 10.1200/JCO.2010.30.2554."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/jcb.29336", "@IdType": "doi"}, {"#text": "31452272", "@IdType": "pubmed"}]}, "Citation": "Peng L, Zhang Y, Xin H. lncRNA SNHG3 facilitates acute myeloid leukemia cell growth via the regulation of miR-758-3p/SRGN axis. J Cell Biochem. 2020;121(2):1023\u20131031. doi: 10.1002/jcb.29336."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC7049421", "@IdType": "pmc"}, {"#text": "32149112", "@IdType": "pubmed"}]}, "Citation": "Xu J, Wu M, Sun Y, Zhao H, Wang Y, Gao J. Identifying dysregulated lncRNA-associated ceRNA Network biomarkers in CML based on dynamical network biomarkers. Biomed Res Int. 2020;2020:5189549."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/S0140-6736(18)32552-2", "@IdType": "doi"}, {"#text": "30910306", "@IdType": "pubmed"}]}, "Citation": "Lheureux S, Gourley C, Vergote I, Oza AM. Epithelial ovarian cancer. Lancet. 2019;393(10177):1240\u20131253. doi: 10.1016/S0140-6736(18)32552-2."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ygyno.2018.06.013", "@IdType": "doi"}, {"#text": "29921511", "@IdType": "pubmed"}]}, "Citation": "Li N, Zhan X, Zhan X. The lncRNA SNHG3 regulates energy metabolism of ovarian cancer by an analysis of mitochondrial proteomes. Gynecol Oncol. 2018;150(2):343\u2013354. doi: 10.1016/j.ygyno.2018.06.013."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3233/CBM-170710", "@IdType": "doi"}, {"#text": "29758922", "@IdType": "pubmed"}]}, "Citation": "Hong L, Chen W, Wu D, Wang Y. Upregulation of SNHG3 expression associated with poor prognosis and enhances malignant progression of ovarian cancer. Cancer Biomark. 2018;22(3):367\u2013374. doi: 10.3233/CBM-170710."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1056/NEJMc1613118", "@IdType": "doi"}, {"#text": "27959678", "@IdType": "pubmed"}]}, "Citation": "Fahiminiya S, de Kock L, Foulkes WD. Biologic and clinical perspectives on thyroid cancer. N Engl J Med. 2016;375(23):2306\u20132307. doi: 10.1056/NEJMc1613118."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/jcp.29557", "@IdType": "doi"}, {"#text": "32048306", "@IdType": "pubmed"}]}, "Citation": "Sui G, Zhang B, Fei D, Wang H, Guo F, Luo Q. The lncRNA SNHG3 accelerates papillary thyroid carcinoma progression via the miR-214-3p/PSMD10 axis. J Cell Physiol. 2020;235(10):6615\u20136624. doi: 10.1002/jcp.29557."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.7150/jca.42070", "@IdType": "doi"}, {"#text": "PMC7150443", "@IdType": "pmc"}, {"#text": "32284745", "@IdType": "pubmed"}]}, "Citation": "Duan Y, Wang Z, Xu L, Sun L, Song H, Yin H, He F. lncRNA SNHG3 acts as a novel tumor suppressor and regulates tumor proliferation and metastasis via AKT/mTOR/ERK pathway in papillary thyroid carcinoma. J Cancer. 2020;11(12):3492\u20133501. doi: 10.7150/jca.42070."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/cam4.2992", "@IdType": "doi"}, {"#text": "PMC7286463", "@IdType": "pmc"}, {"#text": "32248648", "@IdType": "pubmed"}]}, "Citation": "Li T, Xing Y, Yang F, Sun Y, Zhang S, Wang Q, Zhang W. LncRNA SNHG3 sponges miR-577 to up-regulate SMURF1 expression in prostate cancer. Cancer Med. 2020;9(11):3852\u20133862. doi: 10.1002/cam4.2992."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1111/jcmm.15564", "@IdType": "doi"}, {"#text": "PMC7417716", "@IdType": "pmc"}, {"#text": "32596993", "@IdType": "pubmed"}]}, "Citation": "Dai G, Huang C, Yang J, Jin L, Fu K, Yuan F, Zhu J, Xue B. LncRNA SNHG3 promotes bladder cancer proliferation and metastasis through miR-515\u20135p/GINS2 axis. J Cell Mol Med. 2020;24(16):9231\u20139243. doi: 10.1111/jcmm.15564."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/jcb.29421", "@IdType": "doi"}, {"#text": "31762107", "@IdType": "pubmed"}]}, "Citation": "Liu Z, Tao H. Small nucleolar RNA host gene 3 facilitates cell proliferation and migration in oral squamous cell carcinoma via targeting nuclear transcription factor Y subunit gamma. J Cell Biochem. 2020;121(3):2150\u20132158. doi: 10.1002/jcb.29421."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1080/15476286.2019.1679585", "@IdType": "doi"}, {"#text": "PMC7567505", "@IdType": "pmc"}, {"#text": "31607216", "@IdType": "pubmed"}]}, "Citation": "Ye B, Shi J, Kang H, Oyebamiji O, Hill D, Yu H, Ness S, Ye F, Ping J, He J, et al. Advancing pan-cancer gene expression survial analysis by inclusion of non-coding RNA. RNA Biol. 2020;17(11):1666\u20131673. doi: 10.1080/15476286.2019.1679585."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/gcc.22709", "@IdType": "doi"}, {"#text": "30461116", "@IdType": "pubmed"}]}, "Citation": "Lorenzi L, Avila Cobos F, Decock A, Everaert C, Helsmoortel H, Lefever S, Verboom K, Volders PJ, Speleman F, Vandesompele J, et al. Long noncoding RNA expression profiling in cancer: challenges and opportunities. Genes Chromosomes Cancer. 2019;58(4):191\u2013199. doi: 10.1002/gcc.22709."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5784569", "@IdType": "pmc"}, {"#text": "29343207", "@IdType": "pubmed"}]}, "Citation": "Hao S, Yao L, Huang J, He H, Yang F, Di Y, Jin C, Fu D. Genome-wide analysis identified a number of dysregulated long noncoding RNA (lncRNA) in human pancreatic ductal adenocarcinoma. Technol Cancer Res Treat. 2018;17:1533034617748429."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/aging.102894", "@IdType": "doi"}, {"#text": "PMC7093172", "@IdType": "pmc"}, {"#text": "32126023", "@IdType": "pubmed"}]}, "Citation": "Yang W, Zhang K, Li L, Ma K, Hong B, Gong Y, Gong K. Discovery and validation of the prognostic value of the lncRNAs encoding snoRNAs in patients with clear cell renal cell carcinoma. Aging. 2020;12(5):4424\u20134444. doi: 10.18632/aging.102894."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3748/wjg.v24.i27.2949", "@IdType": "doi"}, {"#text": "PMC6054943", "@IdType": "pmc"}, {"#text": "30038463", "@IdType": "pubmed"}]}, "Citation": "To KK, Tong CW, Wu M, Cho WC. MicroRNAs in the prognosis and therapy of colorectal cancer: from bench to bedside. World J Gastroenterol. 2018;24(27):2949\u20132973. doi: 10.3748/wjg.v24.i27.2949."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/wrna.14", "@IdType": "doi"}, {"#text": "21956909", "@IdType": "pubmed"}]}, "Citation": "Snead NM, Rossi JJ. Biogenesis and function of endogenous and exogenous siRNAs. Wiley Interdiscip Rev RNA. 2010;1(1):117\u2013131. doi: 10.1002/wrna.14."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s00253-019-09934-5", "@IdType": "doi"}, {"#text": "PMC7068804", "@IdType": "pmc"}, {"#text": "31187211", "@IdType": "pubmed"}]}, "Citation": "Petrek H, Batra N, Ho PY, Tu MJ, Yu AM. Bioengineering of a single long noncoding RNA molecule that carries multiple small RNAs. Appl Microbiol Biotechnol. 2019;103(15):6107\u20136117. doi: 10.1007/s00253-019-09934-5."}, {"ArticleIdList": {"ArticleId": {"#text": "32233021", "@IdType": "pubmed"}}, "Citation": "Quemener AM, Bachelot L, Forestier A, Donnou-Fournet E, Gilot D, Galibert MD. The powerful world of antisense oligonucleotides: from bench to bedside. Wiley Interdiscip Rev RNA. 2020;11(5):e1594."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12943-020-01185-7", "@IdType": "doi"}, {"#text": "PMC7081551", "@IdType": "pmc"}, {"#text": "32192494", "@IdType": "pubmed"}]}, "Citation": "Wei L, Sun J, Zhang N, Zheng Y, Wang X, Lv L, Liu J, Xu Y, Shen Y, Yang M. Noncoding RNAs in gastric cancer: implications for drug resistance. Mol Cancer. 2020;19(1):62. doi: 10.1186/s12943-020-01185-7."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3389/fonc.2020.00389", "@IdType": "doi"}, {"#text": "PMC7154078", "@IdType": "pmc"}, {"#text": "32318335", "@IdType": "pubmed"}]}, "Citation": "Zimta AA, Tigu AB, Braicu C, Stefan C, Ionescu C, Berindan-Neagoe I. An Emerging class of long non-coding RNA with oncogenic role arises from the snoRNA host genes. Front Oncol. 2020;10:389. doi: 10.3389/fonc.2020.00389."}]}}}}}, "PMC": "PMC7640707", "PMID": "33292213", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "LncRNA SNHG3, a potential oncogene in human cancers.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "33": {"Abstract": "In addition to mutations or aberrant expression in the protein-coding genes, mutations and misregulation of noncoding RNAs, in particular long noncoding RNAs (lncRNA), appear to play major roles in cancer. Genome-wide association studies of tumor samples have identified a large number of lncRNAs associated with various types of cancer. Alterations in lncRNA expression and their mutations promote tumorigenesis and metastasis. LncRNAs may exhibit tumor-suppressive and -promoting (oncogenic) functions. Because of their genome-wide expression patterns in a variety of tissues and their tissue-specific expression characteristics, lncRNAs hold strong promise as novel biomarkers and therapeutic targets for cancer. In this article, we have reviewed the emerging functions and association of lncRNAs in different types of cancer and discussed their potential implications in cancer diagnosis and therapy. .", "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "3663358436608533972", "Part1": "Gene Regulation and Epigenetics Research Lab", "Part2": "Department of Chemistry and Biochemistry", "Part3": "The University of Texas at Arlington", "Part4": "Arlington", "Part5": "Texas.", "Part6": null, "Text": "Gene Regulation and Epigenetics Research Lab, Department of Chemistry and Biochemistry, The University of Texas at Arlington, Arlington, Texas."}], "ForeName": "Arunoday", "FullName": "Arunoday Bhan", "HashID": "2833614013328404566", "LastName": "Bhan", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "3663358436608533972", "Part1": "Gene Regulation and Epigenetics Research Lab", "Part2": "Department of Chemistry and Biochemistry", "Part3": "The University of Texas at Arlington", "Part4": "Arlington", "Part5": "Texas.", "Part6": null, "Text": "Gene Regulation and Epigenetics Research Lab, Department of Chemistry and Biochemistry, The University of Texas at Arlington, Arlington, Texas."}], "ForeName": "Milad", "FullName": "Milad Soleimani", "HashID": "1316831608661371121", "LastName": "Soleimani", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "3663358436608533972", "Part1": "Gene Regulation and Epigenetics Research Lab", "Part2": "Department of Chemistry and Biochemistry", "Part3": "The University of Texas at Arlington", "Part4": "Arlington", "Part5": "Texas. smandal@uta.edu.", "Part6": null, "Text": "Gene Regulation and Epigenetics Research Lab, Department of Chemistry and Biochemistry, The University of Texas at Arlington, Arlington, Texas. smandal@uta.edu."}], "ForeName": "Subhrangsu S", "FullName": "Subhrangsu S Mandal", "HashID": "-5040936352200162438", "LastName": "Mandal", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.1158/0008-5472.CAN-16-2634", "InsertType": null, "Journal": "Cancer research", "Keywords": [{"IS_Major": false, "IS_Mesh": true, "Text": "Humans"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Neoplasms"}, {"IS_Major": false, "IS_Mesh": true, "Text": "RNA, Long Noncoding"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "MEDLINE", "Article": {"@PubModel": "Print-Electronic", "Abstract": {"AbstractText": {"#text": "In addition to mutations or aberrant expression in the protein-coding genes, mutations and misregulation of noncoding RNAs, in particular long noncoding RNAs (lncRNA), appear to play major roles in cancer. Genome-wide association studies of tumor samples have identified a large number of lncRNAs associated with various types of cancer. Alterations in lncRNA expression and their mutations promote tumorigenesis and metastasis. LncRNAs may exhibit tumor-suppressive and -promoting (oncogenic) functions. Because of their genome-wide expression patterns in a variety of tissues and their tissue-specific expression characteristics, lncRNAs hold strong promise as novel biomarkers and therapeutic targets for cancer. In this article, we have reviewed the emerging functions and association of lncRNAs in different types of cancer and discussed their potential implications in cancer diagnosis and therapy. .", "i": "Cancer Res; 77(15); 3965-81. \u00a92017 AACR"}, "CopyrightInformation": "\u00a92017 American Association for Cancer Research."}, "ArticleDate": {"@DateType": "Electronic", "Day": "12", "Month": "07", "Year": "2017"}, "ArticleTitle": "Long Noncoding RNA and Cancer: A New Paradigm.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Gene Regulation and Epigenetics Research Lab, Department of Chemistry and Biochemistry, The University of Texas at Arlington, Arlington, Texas."}, "ForeName": "Arunoday", "Initials": "A", "LastName": "Bhan"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Gene Regulation and Epigenetics Research Lab, Department of Chemistry and Biochemistry, The University of Texas at Arlington, Arlington, Texas."}, "ForeName": "Milad", "Initials": "M", "LastName": "Soleimani"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Gene Regulation and Epigenetics Research Lab, Department of Chemistry and Biochemistry, The University of Texas at Arlington, Arlington, Texas. smandal@uta.edu."}, "ForeName": "Subhrangsu S", "Initials": "SS", "LastName": "Mandal"}]}, "ELocationID": {"#text": "10.1158/0008-5472.CAN-16-2634", "@EIdType": "doi", "@ValidYN": "Y"}, "GrantList": {"@CompleteYN": "Y", "Grant": {"Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States", "GrantID": "R15 ES019129"}}, "Journal": {"ISOAbbreviation": "Cancer Res", "ISSN": {"#text": "1538-7445", "@IssnType": "Electronic"}, "JournalIssue": {"@CitedMedium": "Internet", "Issue": "15", "PubDate": {"Day": "01", "Month": "Aug", "Year": "2017"}, "Volume": "77"}, "Title": "Cancer research"}, "Language": "eng", "Pagination": {"EndPage": "3981", "MedlinePgn": "3965-3981", "StartPage": "3965"}, "PublicationTypeList": {"PublicationType": [{"#text": "Journal Article", "@UI": "D016428"}, {"#text": "Review", "@UI": "D016454"}, {"#text": "Research Support, N.I.H., Extramural", "@UI": "D052061"}]}}, "ChemicalList": {"Chemical": {"NameOfSubstance": {"#text": "RNA, Long Noncoding", "@UI": "D062085"}, "RegistryNumber": "0"}}, "CitationSubset": "IM", "DateCompleted": {"Day": "26", "Month": "09", "Year": "2017"}, "DateRevised": {"Day": "10", "Month": "04", "Year": "2022"}, "MedlineJournalInfo": {"Country": "United States", "ISSNLinking": "0008-5472", "MedlineTA": "Cancer Res", "NlmUniqueID": "2984705R"}, "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"#text": "Humans", "@MajorTopicYN": "N", "@UI": "D006801"}}, {"DescriptorName": {"#text": "Neoplasms", "@MajorTopicYN": "N", "@UI": "D009369"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "RNA, Long Noncoding", "@MajorTopicYN": "N", "@UI": "D062085"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}}]}, "PMID": {"#text": "28701486", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "28701486", "@IdType": "pubmed"}, {"#text": "NIHMS876077", "@IdType": "mid"}, {"#text": "PMC8330958", "@IdType": "pmc"}, {"#text": "10.1158/0008-5472.CAN-16-2634", "@IdType": "doi"}, {"#text": "0008-5472.CAN-16-2634", "@IdType": "pii"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "received", "Day": "26", "Month": "9", "Year": "2016"}, {"@PubStatus": "revised", "Day": "5", "Month": "4", "Year": "2017"}, {"@PubStatus": "accepted", "Day": "4", "Month": "5", "Year": "2017"}, {"@PubStatus": "pubmed", "Day": "14", "Hour": "6", "Minute": "0", "Month": "7", "Year": "2017"}, {"@PubStatus": "medline", "Day": "28", "Hour": "6", "Minute": "0", "Month": "9", "Year": "2017"}, {"@PubStatus": "entrez", "Day": "14", "Hour": "6", "Minute": "0", "Month": "7", "Year": "2017"}]}, "PublicationStatus": "ppublish", "ReferenceList": {"Reference": [{"ArticleIdList": {"ArticleId": {"#text": "8689615", "@IdType": "pubmed"}}, "Citation": "Glassman ML, de Groot N, Hochberg A. Relaxation of imprinting in carcinogenesis. Cancer Genet Cytogenet. 1996;89:69\u201373."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2704857", "@IdType": "pmc"}, {"#text": "19571010", "@IdType": "pubmed"}]}, "Citation": "Khalil AM, Guttman M, Huarte M, Garber M, Raj A, Rivea Morales D, et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proceedings of the National Academy of Sciences. 2009;106:11667\u201372."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2754849", "@IdType": "pmc"}, {"#text": "19182780", "@IdType": "pubmed"}]}, "Citation": "Guttman M, Amit I, Garber M, French C, Lin MF, Feldser D, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature. 2009;458:223\u20137."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4544839", "@IdType": "pmc"}, {"#text": "26208723", "@IdType": "pubmed"}]}, "Citation": "Bhan A, Mandal SS. LncRNA HOTAIR: A master regulator of chromatin dynamics and cancer. Biochim Biophys Acta. 2015;1856:151\u201364."}, {"ArticleIdList": {"ArticleId": {"#text": "24433357", "@IdType": "pubmed"}}, "Citation": "Sanfilippo PG, Hewitt AW. Translating the ENCyclopedia Of DNA Elements Project findings to the clinic: ENCODE's implications for eye disease. Clin Exp Ophthalmol. 2014;42:78\u201383."}, {"ArticleIdList": {"ArticleId": {"#text": "24723339", "@IdType": "pubmed"}}, "Citation": "Tragante V, Moore JH, Asselbergs FW. The ENCODE project and perspectives on pathways. Genet Epidemiol. 2014;38:275\u201380."}, {"ArticleIdList": {"ArticleId": {"#text": "24677606", "@IdType": "pubmed"}}, "Citation": "Bhan A, Mandal SS. Long noncoding RNAs: emerging stars in gene regulation, epigenetics and human disease. ChemMedChem. 2014;9:1932\u201356."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4111732", "@IdType": "pmc"}, {"#text": "23696037", "@IdType": "pubmed"}]}, "Citation": "Ma L, Bajic VB, Zhang Z. On the classification of long non-coding RNAs. RNA Biol. 2013;10:925\u201333."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3199020", "@IdType": "pmc"}, {"#text": "21925379", "@IdType": "pubmed"}]}, "Citation": "Wang Kevin C, Chang Howard Y. Molecular Mechanisms of Long Noncoding RNAs. Molecular cell. 2011;43:904\u201314."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3132428", "@IdType": "pmc"}, {"#text": "21626138", "@IdType": "pubmed"}]}, "Citation": "Pontier DB, Gribnau J. Xist regulation and function explored. Hum Genet. 2011;130:223\u201336."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5210264", "@IdType": "pmc"}, {"#text": "28049499", "@IdType": "pubmed"}]}, "Citation": "Dong Y, He D, Peng Z, Peng W, Shi W, Wang J, et al. Circular RNAs in cancer: an emerging key player. J Hematol Oncol. 2017;10:2."}, {"ArticleIdList": {"ArticleId": {"#text": "23446346", "@IdType": "pubmed"}}, "Citation": "Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495:384\u20138."}, {"ArticleIdList": {"ArticleId": {"#text": "25259915", "@IdType": "pubmed"}}, "Citation": "Vicens Q, Westhof E. Biogenesis of Circular RNAs. Cell. 2014;159:13\u20134."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5052039", "@IdType": "pmc"}, {"#text": "27365365", "@IdType": "pubmed"}]}, "Citation": "Zhang XO, Dong R, Zhang Y, Zhang JL, Luo Z, Zhang J, et al. Diverse alternative back-splicing and alternative splicing landscape of circular RNAs. Genome Res. 2016;26:1277\u201387."}, {"ArticleIdList": {"ArticleId": {"#text": "24014594", "@IdType": "pubmed"}}, "Citation": "Hansen TB, Kjems J, Damgaard CK. Circular RNA and miR-7 in cancer. Cancer Res. 2013;73:5609\u201312."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5282898", "@IdType": "pmc"}, {"#text": "28143578", "@IdType": "pubmed"}]}, "Citation": "Wang Y, Mo Y, Gong Z, Yang X, Yang M, Zhang S, et al. Circular RNAs in human cancer. Mol Cancer. 2017;16:25."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4121655", "@IdType": "pmc"}, {"#text": "24811520", "@IdType": "pubmed"}]}, "Citation": "Jeck WR, Sharpless NE. Detecting and characterizing circular RNAs. Nat Biotechnol. 2014;32:453\u201361."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4948998", "@IdType": "pmc"}, {"#text": "27050930", "@IdType": "pubmed"}]}, "Citation": "Salzman J. Circular RNA Expression: Its Potential Regulation and Function. Trends Genet. 2016;32:309\u201316."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2996334", "@IdType": "pmc"}, {"#text": "21151960", "@IdType": "pubmed"}]}, "Citation": "Burd CE, Jeck WR, Liu Y, Sanoff HK, Wang Z, Sharpless NE. Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk. PLoS Genet. 2010;6:e1001233."}, {"ArticleIdList": {"ArticleId": {"#text": "24035497", "@IdType": "pubmed"}}, "Citation": "Zhang Y, Zhang XO, Chen T, Xiang JF, Yin QF, Xing YH, et al. Circular intronic long noncoding RNAs. Mol Cell. 2013;51:792\u2013806."}, {"ArticleIdList": {"ArticleId": {"#text": "25113790", "@IdType": "pubmed"}}, "Citation": "Vitiello M, Tuccoli A, Poliseno L. Long non-coding RNAs in cancer: implications for personalized therapy. Cell Oncol (Dordr) 2015;38:17\u201328."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4884374", "@IdType": "pmc"}, {"#text": "27233618", "@IdType": "pubmed"}]}, "Citation": "Bartonicek N, Maag JL, Dinger ME. Long noncoding RNAs in cancer: mechanisms of action and technological advancements. Mol Cancer. 2016;15:43."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3971185", "@IdType": "pmc"}, {"#text": "24723937", "@IdType": "pubmed"}]}, "Citation": "Kornfeld JW, Bruning JC. Regulation of metabolism by long, non-coding RNAs. Front Genet. 2014;5:57."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4842029", "@IdType": "pmc"}, {"#text": "27143813", "@IdType": "pubmed"}]}, "Citation": "Shi T, Gao G, Cao Y. Long Noncoding RNAs as Novel Biomarkers Have a Promising Future in Cancer Diagnostics. Dis Markers. 2016;2016:9085195."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4053743", "@IdType": "pmc"}, {"#text": "22929540", "@IdType": "pubmed"}]}, "Citation": "Brunner AL, Beck AH, Edris B, Sweeney RT, Zhu SX, Li R, et al. Transcriptional profiling of long non-coding RNAs and novel transcribed regions across a diverse panel of archived human cancers. Genome Biol. 2012;13:R75."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4777353", "@IdType": "pmc"}, {"#text": "26461095", "@IdType": "pubmed"}]}, "Citation": "Yan X, Hu Z, Feng Y, Hu X, Yuan J, Zhao SD, et al. Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers. Cancer Cell. 2015;28:529\u201340."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3152676", "@IdType": "pmc"}, {"#text": "21804560", "@IdType": "pubmed"}]}, "Citation": "Prensner JR, Iyer MK, Balbin OA, Dhanasekaran SM, Cao Q, Brenner JC, et al. Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nat Biotechnol. 2011;29:742\u20139."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3996663", "@IdType": "pmc"}, {"#text": "24519926", "@IdType": "pubmed"}]}, "Citation": "Crea F, Watahiki A, Quagliata L, Xue H, Pikor L, Parolia A, et al. Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer. Oncotarget. 2014;5:764\u201374."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3968238", "@IdType": "pmc"}, {"#text": "24072184", "@IdType": "pubmed"}]}, "Citation": "Warrick JI, Tomlins SA, Carskadon SL, Young AM, Siddiqui J, Wei JT, et al. Evaluation of tissue PCA3 expression in prostate cancer by RNA in situ hybridization--a correlative study with urine PCA3 and TMPRSS2-ERG. Mod Pathol. 2014;27:609\u201320."}, {"ArticleIdList": {"ArticleId": {"#text": "24333241", "@IdType": "pubmed"}}, "Citation": "Chevli KK, Duff M, Walter P, Yu C, Capuder B, Elshafei A, et al. Urinary PCA3 as a predictor of prostate cancer in a cohort of 3,073 men undergoing initial prostate biopsy. J Urol. 2014;191:1743\u20138."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4407822", "@IdType": "pmc"}, {"#text": "25168616", "@IdType": "pubmed"}]}, "Citation": "Vedder MM, de Bekker-Grob EW, Lilja HG, Vickers AJ, van Leenders GJ, Steyerberg EW, et al. The added value of percentage of free to total prostate-specific antigen, PCA3, and a kallikrein panel to the ERSPC risk calculator for prostate cancer in prescreened men. Eur Urol. 2014;66:1109\u201315."}, {"ArticleIdList": {"ArticleId": {"#text": "25641459", "@IdType": "pubmed"}}, "Citation": "Albino G, Capoluongo E, Rocchetti S, Palumbo S, Zuppi C, Cirillo-Marucco E. Evaluation of the diagnostic and predictive power of PCA3 in the prostate cancer. A different best cut-off in each different scenario. Preliminary results. Arch Ital Urol Androl. 2014;86:306\u201310."}, {"ArticleIdList": {"ArticleId": {"#text": "25043536", "@IdType": "pubmed"}}, "Citation": "Dijkstra S, Leyten GH, Jannink SA, de Jong H, Mulders PF, van Oort IM, et al. KLK3, PCA3, and TMPRSS2-ERG expression in the peripheral blood mononuclear cell fraction from castration-resistant prostate cancer patients and response to docetaxel treatment. Prostate. 2014;74:1222\u201330."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4500257", "@IdType": "pmc"}, {"#text": "26080435", "@IdType": "pubmed"}]}, "Citation": "Salameh A, Lee AK, Cardo-Vila M, Nunes DN, Efstathiou E, Staquicini FI, et al. PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3. Proc Natl Acad Sci U S A. 2015;112:8403\u20138."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4034386", "@IdType": "pmc"}, {"#text": "23945587", "@IdType": "pubmed"}]}, "Citation": "Yang L, Lin C, Jin C, Yang JC, Tanasa B, Li W, et al. lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs. Nature. 2013;500:598\u2013602."}, {"ArticleIdList": {"ArticleId": {"#text": "16569192", "@IdType": "pubmed"}}, "Citation": "Fu X, Ravindranath L, Tran N, Petrovics G, Srivastava S. Regulation of apoptosis by a prostate-specific and prostate cancer-associated noncoding gene, PCGEM1. DNA Cell Biol. 2006;25:135\u201341."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4284533", "@IdType": "pmc"}, {"#text": "25512540", "@IdType": "pubmed"}]}, "Citation": "Hung CL, Wang LY, Yu YL, Chen HW, Srivastava S, Petrovics G, et al. A long noncoding RNA connects c-Myc to tumor metabolism. Proc Natl Acad Sci U S A. 2014;111:18697\u2013702."}, {"ArticleIdList": {"ArticleId": {"#text": "24836411", "@IdType": "pubmed"}}, "Citation": "Walsh AL, Tuzova AV, Bolton EM, Lynch TH, Perry AS. Long noncoding RNAs and prostate carcinogenesis: the missing 'linc'? Trends Mol Med. 2014;20:428\u201336."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4240923", "@IdType": "pmc"}, {"#text": "25425964", "@IdType": "pubmed"}]}, "Citation": "Prensner JR, Chen W, Han S, Iyer MK, Cao Q, Kothari V, et al. The long non-coding RNA PCAT-1 promotes prostate cancer cell proliferation through cMyc. Neoplasia. 2014;16:900\u20138."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3479836", "@IdType": "pmc"}, {"#text": "23097625", "@IdType": "pubmed"}]}, "Citation": "Wang R, Asangani IA, Chakravarthi BV, Ateeq B, Lonigro RJ, Cao Q, et al. Role of transcriptional corepressor CtBP1 in prostate cancer progression. Neoplasia. 2012;14:905\u201314."}, {"ArticleIdList": {"ArticleId": {"#text": "23900077", "@IdType": "pubmed"}}, "Citation": "Weichenhan D, Plass C. The evolving epigenome. Hum Mol Genet. 2013;22:R1\u20136."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6944435", "@IdType": "pmc"}, {"#text": "24842953", "@IdType": "pubmed"}]}, "Citation": "Moiola CP, De Luca P, Zalazar F, Cotignola J, Rodriguez-Segui SA, Gardner K, et al. Prostate tumor growth is impaired by CtBP1 depletion in high-fat diet-fed mice. Clin Cancer Res. 2014;20:4086\u201395."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4259443", "@IdType": "pmc"}, {"#text": "25296969", "@IdType": "pubmed"}]}, "Citation": "Su X, Malouf GG, Chen Y, Zhang J, Yao H, Valero V, et al. Comprehensive analysis of long non-coding RNAs in human breast cancer clinical subtypes. Oncotarget. 2014;5:9864\u201376."}, {"ArticleIdList": {"ArticleId": {"#text": "26708950", "@IdType": "pubmed"}}, "Citation": "Li Y, Wang X. Role of long noncoding RNAs in malignant disease (Review) Mol Med Rep. 2016;13:1463\u20139."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3679254", "@IdType": "pmc"}, {"#text": "23375982", "@IdType": "pubmed"}]}, "Citation": "Bhan A, Hussain I, Ansari KI, Kasiri S, Bashyal A, Mandal SS. Antisense Transcript Long Noncoding RNA (lncRNA) HOTAIR is Transcriptionally Induced by Estradiol. J Mol Biol. 2013;425:3707\u201322."}, {"ArticleIdList": {"ArticleId": {"#text": "23600210", "@IdType": "pubmed"}}, "Citation": "Cui L, Xie XY, Wang H, Chen XL, Liu SL, Hu LN. [Expression of long non-coding RNA HOTAIR mRNA in ovarian cancer] Sichuan Da Xue Xue Bao Yi Xue Ban. 2013;44:57\u20139."}, {"ArticleIdList": {"ArticleId": {"#text": "22289527", "@IdType": "pubmed"}}, "Citation": "Geng Y, Xie S, Li Q, Ma J, Wang G. Large Intervening Non-Coding RNA HOTAIR is Associated with Hepatocellular Carcinoma Progression. J Int Med Res. 2011;39:2119\u201328."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3484248", "@IdType": "pmc"}, {"#text": "22614017", "@IdType": "pubmed"}]}, "Citation": "Kim K, Jutooru I, Chadalapaka G, Johnson G, Frank J, Burghardt R, et al. HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene. 2013;32:1616\u201325."}, {"ArticleIdList": {"ArticleId": {"#text": "23141928", "@IdType": "pubmed"}}, "Citation": "Li D, Feng J, Wu T, Wang Y, Sun Y, Ren J, et al. Long Intergenic Noncoding RNA HOTAIR Is Overexpressed and Regulates PTEN Methylation in Laryngeal Squamous Cell Carcinoma. The American journal of pathology. 2013;182:64\u201370."}, {"ArticleIdList": {"ArticleId": {"#text": "23743197", "@IdType": "pubmed"}}, "Citation": "Nakagawa T, Endo H, Yokoyama M, Abe J, Tamai K, Tanaka N, et al. Large noncoding RNA HOTAIR enhances aggressive biological behavior and is associated with short disease-free survival in human non-small cell lung cancer. Biochem Biophys Res Commun. 2013;436:319\u201324."}, {"ArticleIdList": {"ArticleId": {"#text": "21327457", "@IdType": "pubmed"}}, "Citation": "Yang Z, Zhou L, Wu L-M, Lai M-C, Xie H-Y, Zhang F, et al. Overexpression of Long Non-coding RNA HOTAIR Predicts Tumor Recurrence in Hepatocellular Carcinoma Patients Following Liver Transplantation. Ann Surg Oncol. 2011;18:1243\u201350."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3049919", "@IdType": "pmc"}, {"#text": "20393566", "@IdType": "pubmed"}]}, "Citation": "Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010;464:1071\u20136."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2084369", "@IdType": "pmc"}, {"#text": "17604720", "@IdType": "pubmed"}]}, "Citation": "Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, et al. Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs. Cell. 2007;129:1311\u201323."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2967777", "@IdType": "pmc"}, {"#text": "20616235", "@IdType": "pubmed"}]}, "Citation": "Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F, et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science. 2010;329:689\u201393."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4038295", "@IdType": "pmc"}, {"#text": "24075995", "@IdType": "pubmed"}]}, "Citation": "Li L, Liu B, Wapinski OL, Tsai MC, Qu K, Zhang J, et al. Targeted disruption of Hotair leads to homeotic transformation and gene derepression. Cell Rep. 2013;5:3\u201312."}, {"ArticleIdList": {"ArticleId": {"#text": "23313959", "@IdType": "pubmed"}}, "Citation": "Xhemalce B. From histones to RNA: role of methylation in cancer. Brief Funct Genomics. 2013;12:244\u201353."}, {"ArticleIdList": {"ArticleId": {"#text": "21862635", "@IdType": "pubmed"}}, "Citation": "Kogo R, Shimamura T, Mimori K, Kawahara K, Imoto S, Sudo T, et al. Long Noncoding RNA HOTAIR Regulates Polycomb-Dependent Chromatin Modification and Is Associated with Poor Prognosis in Colorectal Cancers. Cancer Res. 2011;71:6320\u20136."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3612017", "@IdType": "pmc"}, {"#text": "23543869", "@IdType": "pubmed"}]}, "Citation": "Milhem MM, Knutson T, Yang S, Zhu D, Wang X, Leslie KK, et al. Correlation of MTDH/AEG-1 and HOTAIR Expression with Metastasis and Response to Treatment in Sarcoma Patients. J Cancer Sci Ther. 2011:S5."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3858397", "@IdType": "pmc"}, {"#text": "22663078", "@IdType": "pubmed"}]}, "Citation": "Rinn JL, Chang HY. Genome regulation by long noncoding RNAs. Annu Rev Biochem. 2012;81:145\u201366."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4556280", "@IdType": "pmc"}, {"#text": "24326307", "@IdType": "pubmed"}]}, "Citation": "Yoon JH, Abdelmohsen K, Kim J, Yang X, Martindale JL, Tominaga-Yamanaka K, et al. Scaffold function of long non-coding RNA HOTAIR in protein ubiquitination. Nat Commun. 2013;4:2939."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4025971", "@IdType": "pmc"}, {"#text": "24533973", "@IdType": "pubmed"}]}, "Citation": "Bhan A, Hussain I, Ansari KI, Bobzean SA, Perrotti LI, Mandal SS. Bisphenol-A and diethylstilbestrol exposure induces the expression of breast cancer associated long noncoding RNA HOTAIR in vitro and in vivo. J Steroid Biochem Mol Biol. 2014;141:160\u201370."}, {"ArticleIdList": {"ArticleId": {"#text": "26585152", "@IdType": "pubmed"}}, "Citation": "Bhan A, Mandal SS. Estradiol-Induced Transcriptional Regulation of Long Non-Coding RNA, HOTAIR. Methods Mol Biol. 2016;1366:395\u2013412."}, {"ArticleIdList": {"ArticleId": {"#text": "19438726", "@IdType": "pubmed"}}, "Citation": "Ansari KI, Hussain I, Das HK, Mandal SS. Overexpression of human histone methylase MLL1 upon exposure to a food contaminant mycotoxin, deoxynivalenol. FEBS J. 2009;276:3299\u2013307."}, {"ArticleIdList": {"ArticleId": {"#text": "22143955", "@IdType": "pubmed"}}, "Citation": "Ansari KI, Hussain I, Kasiri S, Mandal SS. HOXC10 is overexpressed in breast cancer and transcriptionally regulated by estrogen via involvement of histone methylases MLL3 and MLL4. J Mol Endocrinol. 2012;48:61\u201375."}, {"ArticleIdList": {"ArticleId": {"#text": "25088689", "@IdType": "pubmed"}}, "Citation": "Bhan A, Hussain I, Ansari KI, Bobzean SA, Perrotti LI, Mandal SS. Histone methyltransferase EZH2 is transcriptionally induced by estradiol as well as estrogenic endocrine disruptors bisphenol-A and diethylstilbestrol. J Mol Biol. 2014;426:3426\u201341."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3339196", "@IdType": "pmc"}, {"#text": "21828241", "@IdType": "pubmed"}]}, "Citation": "Aguilo F, Zhou MM, Walsh MJ. Long noncoding RNA, polycomb, and the ghosts haunting INK4b-ARF-INK4a expression. Cancer Res. 2011;71:5365\u20139."}, {"ArticleIdList": {"ArticleId": {"#text": "21414664", "@IdType": "pubmed"}}, "Citation": "Iacobucci I, Sazzini M, Garagnani P, Ferrari A, Boattini A, Lonetti A, et al. A polymorphism in the chromosome 9p21 ANRIL locus is associated to Philadelphia positive acute lymphoblastic leukemia. Leuk Res. 2011;35:1052\u20139."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3230933", "@IdType": "pmc"}, {"#text": "21151178", "@IdType": "pubmed"}]}, "Citation": "Kotake Y, Nakagawa T, Kitagawa K, Suzuki S, Liu N, Kitagawa M, et al. Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene. 2011;30:1956\u201362."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2886305", "@IdType": "pmc"}, {"#text": "20541999", "@IdType": "pubmed"}]}, "Citation": "Yap KL, Li S, Mu\u00f1oz-Cabello AM, Raguz S, Zeng L, Mujtaba S, et al. Molecular Interplay of the Noncoding RNA ANRIL and Methylated Histone H3 Lysine 27 by Polycomb CBX7 in Transcriptional Silencing of INK4a. Mol Cell. 2010;38:662\u201374."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2743558", "@IdType": "pmc"}, {"#text": "18185590", "@IdType": "pubmed"}]}, "Citation": "Yu W, Gius D, Onyango P, Muldoon-Jacobs K, Karp J, Feinberg AP, et al. Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature. 2008;451:202\u20136."}, {"ArticleIdList": {"ArticleId": {"#text": "17008550", "@IdType": "pubmed"}}, "Citation": "Healy J, B\u00e9langer H, Beaulieu P, Larivi\u00e8re M, Labuda D, Sinnett D. Promoter SNPs in G1/S checkpoint regulators and their impact on the susceptibility to childhood leukemia. Blood. 2007;109:683\u201392."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2851566", "@IdType": "pmc"}, {"#text": "20386740", "@IdType": "pubmed"}]}, "Citation": "Cunnington MS, Santibanez Koref M, Mayosi BM, Burn J, Keavney B. Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression. PLoS Genet. 2010;6:e1000899."}, {"ArticleIdList": {"ArticleId": {"#text": "20056914", "@IdType": "pubmed"}}, "Citation": "Holdt LM, Beutner F, Scholz M, Gielen S, G\u00e4bel G, Bergert H, et al. ANRIL Expression Is Associated With Atherosclerosis Risk at Chromosome 9p21. Arterioscler Thromb Vasc Biol. 2010;30:620\u20137."}, {"ArticleIdList": {"ArticleId": {"#text": "20956613", "@IdType": "pubmed"}}, "Citation": "Pasmant E, Sabbagh A, Vidaud M, Bieche I. ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB J. 2011;25:444\u20138."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2632758", "@IdType": "pmc"}, {"#text": "19214202", "@IdType": "pubmed"}]}, "Citation": "Schaefer AS, Richter GM, Groessner-Schreiber B, Noack B, Nothnagel M, El Mokhtari NE, et al. Identification of a shared genetic susceptibility locus for coronary heart disease and periodontitis. PLoS Genet. 2009;5:e1000378."}, {"ArticleIdList": {"ArticleId": {"#text": "27121324", "@IdType": "pubmed"}}, "Citation": "Lan WG, Xu DH, Xu C, Ding CL, Ning FL, Zhou YL, et al. Silencing of long non-coding RNA ANRIL inhibits the development of multidrug resistance in gastric cancer cells. Oncol Rep. 2016;36:263\u201370."}, {"ArticleIdList": {"ArticleId": {"#text": "27314206", "@IdType": "pubmed"}}, "Citation": "Sun Y, Zheng ZP, Li H, Zhang HQ, Ma FQ. ANRIL is associated with the survival rate of patients with colorectal cancer, and affects cell migration and invasion in vitro. Mol Med Rep. 2016;14:1714\u201320."}, {"ArticleIdList": {"ArticleId": {"#text": "17440112", "@IdType": "pubmed"}}, "Citation": "Pasmant E, Laurendeau I, Heron D, Vidaud M, Vidaud D, Bieche I. Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer Res. 2007;67:3963\u20139."}, {"ArticleIdList": {"ArticleId": {"#text": "26540387", "@IdType": "pubmed"}}, "Citation": "Huarte M. The emerging role of lncRNAs in cancer. Nat Med. 2015;21:1253\u201361."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4959596", "@IdType": "pmc"}, {"#text": "27499635", "@IdType": "pubmed"}]}, "Citation": "Peng Z, Zhang C, Duan C. Functions and mechanisms of long noncoding RNAs in lung cancer. Onco Targets Ther. 2016;9:4411\u201324."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5081511", "@IdType": "pmc"}, {"#text": "27786280", "@IdType": "pubmed"}]}, "Citation": "Wu CH, Hsu CL, Lu PC, Lin WC, Juan HF, Huang HC. Identification of lncRNA functions in lung cancer based on associated protein-protein interaction modules. Sci Rep. 2016;6:35939."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5093404", "@IdType": "pmc"}, {"#text": "27397102", "@IdType": "pubmed"}]}, "Citation": "Wei MM, Zhou GB. Long Non-coding RNAs and Their Roles in Non-small-cell Lung Cancer. Genomics Proteomics Bioinformatics. 2016;14:280\u20138."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2944070", "@IdType": "pmc"}, {"#text": "20729808", "@IdType": "pubmed"}]}, "Citation": "Bernard D, Prasanth KV, Tripathi V, Colasse S, Nakamura T, Xuan Z, et al. A long nuclear-retained non-coding RNA regulates synaptogenesis by modulating gene expression. EMBO J. 2010;29:3082\u201393."}, {"ArticleIdList": {"ArticleId": {"#text": "20213048", "@IdType": "pubmed"}}, "Citation": "Guo F, Li Y, Liu Y, Wang J, Li G. Inhibition of metastasis-associated lung adenocarcinoma transcript 1 in CaSki human cervical cancer cells suppresses cell proliferation and invasion. Acta Biochim Biophys Sin (Shanghai) 2010;42:224\u20139."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3589741", "@IdType": "pmc"}, {"#text": "23243023", "@IdType": "pubmed"}]}, "Citation": "Gutschner T, H\u00e4mmerle M, Ei\u00dfmann M, Hsu J, Kim Y, Hung G, et al. The Noncoding RNA MALAT1 Is a Critical Regulator of the Metastasis Phenotype of Lung Cancer Cells. Cancer Res. 2013;73:1180\u20139."}, {"ArticleIdList": {"ArticleId": {"#text": "23153939", "@IdType": "pubmed"}}, "Citation": "Han Y, Liu Y, Nie L, Gui Y, Cai Z. Inducing Cell Proliferation Inhibition, Apoptosis, and Motility Reduction by Silencing Long Noncoding Ribonucleic Acid Metastasis-associated Lung Adenocarcinoma Transcript 1 in Urothelial Carcinoma of the Bladder. Urology. 2013;81 209.e1-.e7."}, {"ArticleIdList": {"ArticleId": {"#text": "12970751", "@IdType": "pubmed"}}, "Citation": "Ji P, Diederichs S, Wang W, Boing S, Metzger R, Schneider PM, et al. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene. 2003;22:8031\u201341."}, {"ArticleIdList": {"ArticleId": {"#text": "21678027", "@IdType": "pubmed"}}, "Citation": "Lai M-c, Yang Z, Zhou L, Zhu Q-q, Xie H-y, Zhang F, et al. Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol. 2012;29:1810\u20136."}, {"ArticleIdList": {"ArticleId": {"#text": "23748105", "@IdType": "pubmed"}}, "Citation": "Li CH, Chen Y. Targeting long non-coding RNAs in cancers: Progress and prospects. The International Journal of Biochemistry & Cell Biology. 2013;45:1895\u2013910."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3708039", "@IdType": "pmc"}, {"#text": "23847441", "@IdType": "pubmed"}]}, "Citation": "Xu ZY, Yu QM, Du YA, Yang LT, Dong RZ, Huang L, et al. Knockdown of long non-coding RNA HOTAIR suppresses tumor invasion and reverses epithelial-mesenchymal transition in gastric cancer. Int J Biol Sci. 2013;9:587\u201397."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4701977", "@IdType": "pmc"}, {"#text": "26701265", "@IdType": "pubmed"}]}, "Citation": "Arun G, Diermeier S, Akerman M, Chang KC, Wilkinson JE, Hearn S, et al. Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss. Genes Dev. 2016;30:34\u201351."}, {"ArticleIdList": {"ArticleId": {"#text": "26453113", "@IdType": "pubmed"}}, "Citation": "Hu X, Bao J, Wang Z, Zhang Z, Gu P, Tao F, et al. The plasma lncRNA acting as fingerprint in non-small-cell lung cancer. Tumour Biol. 2016;37:3497\u2013504."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5190027", "@IdType": "pmc"}, {"#text": "27270317", "@IdType": "pubmed"}]}, "Citation": "Jiang P, Wu X, Wang X, Huang W, Feng Q. NEAT1 upregulates EGCG-induced CTR1 to enhance cisplatin sensitivity in lung cancer cells. Oncotarget. 2016"}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5239515", "@IdType": "pmc"}, {"#text": "27351135", "@IdType": "pubmed"}]}, "Citation": "Sun C, Li S, Zhang F, Xi Y, Wang L, Bi Y, et al. Long non-coding RNA NEAT1 promotes non-small cell lung cancer progression through regulation of miR-377-3p-E2F3 pathway. Oncotarget. 2016"}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3873887", "@IdType": "pmc"}, {"#text": "24173718", "@IdType": "pubmed"}]}, "Citation": "Hirose T, Virnicchi G, Tanigawa A, Naganuma T, Li R, Kimura H, et al. NEAT1 long noncoding RNA regulates transcription via protein sequestration within subnuclear bodies. Mol Biol Cell. 2014;25:169\u201383."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4849421", "@IdType": "pmc"}, {"#text": "27147820", "@IdType": "pubmed"}]}, "Citation": "Ke H, Zhao L, Feng X, Xu H, Zou L, Yang Q, et al. NEAT1 is Required for Survival of Breast Cancer Cells Through FUS and miR-548. Gene Regul Syst Bio. 2016;10:11\u20137."}, {"ArticleIdList": {"ArticleId": {"#text": "25971364", "@IdType": "pubmed"}}, "Citation": "Blume CJ, Hotz-Wagenblatt A, Hullein J, Sellner L, Jethwa A, Stolz T, et al. p53-dependent non-coding RNA networks in chronic lymphocytic leukemia. Leukemia. 2015;29:2015\u201323."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4868682", "@IdType": "pmc"}, {"#text": "26637808", "@IdType": "pubmed"}]}, "Citation": "Xie X, Tang B, Xiao YF, Xie R, Li BS, Dong H, et al. Long non-coding RNAs in colorectal cancer. Oncotarget. 2016;7:5226\u201339."}, {"ArticleIdList": {"ArticleId": {"#text": "24603586", "@IdType": "pubmed"}}, "Citation": "Xu MD, Qi P, Du X. Long non-coding RNAs in colorectal cancer: implications for pathogenesis and clinical application. Mod Pathol. 2014;27:1310\u201320."}, {"ArticleIdList": {"ArticleId": {"#text": "23748105", "@IdType": "pubmed"}}, "Citation": "Li CH, Chen Y. Targeting long non-coding RNAs in cancers: progress and prospects. Int J Biochem Cell Biol. 2013;45:1895\u2013910."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC1186987", "@IdType": "pmc"}, {"#text": "11193051", "@IdType": "pubmed"}]}, "Citation": "Ariel I, Sughayer M, Fellig Y, Pizov G, Ayesh S, Podeh D, et al. The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma. Mol Pathol. 2000;53:320\u20133."}, {"ArticleIdList": {"ArticleId": {"#text": "16707459", "@IdType": "pubmed"}}, "Citation": "Barsyte-Lovejoy D, Lau SK, Boutros PC, Khosravi F, Jurisica I, Andrulis IL, et al. The c-Myc Oncogene Directly Induces the H19 Noncoding RNA by Allele-Specific Binding to Potentiate Tumorigenesis. Cancer Res. 2006;66:5330\u20137."}, {"ArticleIdList": {"ArticleId": {"#text": "15985428", "@IdType": "pubmed"}}, "Citation": "Berteaux N, Lottin S, Mont\u00e9 D, Pinte S, Quatannens B, Coll J, et al. H19 mRNA-like Noncoding RNA Promotes Breast Cancer Cell Proliferation through Positive Control by E2F1. J Biol Chem. 2005;280:29625\u201336."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC1800509", "@IdType": "pmc"}, {"#text": "17237358", "@IdType": "pubmed"}]}, "Citation": "Cai X, Cullen BR. The imprinted H19 noncoding RNA is a primary microRNA precursor. RNA. 2007;13:313\u20136."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2909899", "@IdType": "pmc"}, {"#text": "20668672", "@IdType": "pubmed"}]}, "Citation": "Castle JC, Armour CD, Lower M, Haynor D, Biery M, Bouzek H, et al. Digital genome-wide ncRNA expression, including SnoRNAs, across 11 human tissues using polyA-neutral amplification. PLoS One. 2010;5:e11779."}, {"ArticleIdList": {"ArticleId": {"#text": "9224757", "@IdType": "pubmed"}}, "Citation": "Hashimoto K, Azuma C, Tokugawa Y, Nobunaga T, Aki TA, Matsui Y, et al. Loss of H19 imprinting and up-regulation of H19 and SNRPN in a case with malignant mixed Mullerian tumor of the uterus. Hum Pathol. 1997;28:862\u20135."}, {"ArticleIdList": {"ArticleId": {"#text": "8564957", "@IdType": "pubmed"}}, "Citation": "Hibi K, Nakamura H, Hirai A, Fujikake Y, Kasai Y, Akiyama S, et al. Loss of H19 imprinting in esophageal cancer. Cancer Res. 1996;56:480\u20132."}, {"ArticleIdList": {"ArticleId": {"#text": "7700644", "@IdType": "pubmed"}}, "Citation": "Kondo M, Suzuki H, Ueda R, Osada H, Takagi K, Takahashi T. Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers. Oncogene. 1995;10:1193\u20138."}, {"ArticleIdList": {"ArticleId": {"#text": "12419837", "@IdType": "pubmed"}}, "Citation": "Lottin S, Adriaenssens E, Dupressoir T, Berteaux N, Montpellier C, Coll J, et al. Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells. Carcinogenesis. 2002;23:1885\u201395."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC1959184", "@IdType": "pmc"}, {"#text": "17786216", "@IdType": "pubmed"}]}, "Citation": "Matouk IJ, DeGroot N, Mezan S, Ayesh S, Abu-lail R, Hochberg A, et al. The H19 non-coding RNA is essential for human tumor growth. PLoS One. 2007;2:e845."}, {"ArticleIdList": {"ArticleId": {"#text": "20117150", "@IdType": "pubmed"}}, "Citation": "Matouk IJ, Mezan S, Mizrahi A, Ohana P, Abu-lail R, Fellig Y, et al. The oncofetal H19 RNA connection: Hypoxia, p53 and cancer. Biochim Biophys Acta. 2010;1803:443\u201351."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC391738", "@IdType": "pmc"}, {"#text": "6206499", "@IdType": "pubmed"}]}, "Citation": "Pachnis V, Belayew A, Tilghman SM. Locus unlinked to alpha-fetoprotein under the control of the murine raf and Rif genes. Proceedings of the National Academy of Sciences. 1984;81:5523\u20137."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC454372", "@IdType": "pmc"}, {"#text": "3396539", "@IdType": "pubmed"}]}, "Citation": "Pachnis V, Brannan CI, Tilghman SM. The structure and expression of a novel gene activated in early mouse embryogenesis. EMBO J. 1988;7:673\u201381."}, {"ArticleIdList": {"ArticleId": {"#text": "1811930", "@IdType": "pubmed"}}, "Citation": "Poirier F, Chan CT, Timmons PM, Robertson EJ, Evans MJ, Rigby PW. The murine H19 gene is activated during embryonic stem cell differentiation in vitro and at the time of implantation in the developing embryo. Development. 1991;113:1105\u201314."}, {"ArticleIdList": {"ArticleId": {"#text": "17408396", "@IdType": "pubmed"}}, "Citation": "Takeuchi S, Hofmann W-K, Tsukasaki K, Takeuchi N, Ikezoe T, Matsushita M, et al. Loss of H19 imprinting in adult T-cell leukaemia/lymphoma. Br J Haematol. 2007;137:380\u20131."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2527926", "@IdType": "pmc"}, {"#text": "18719115", "@IdType": "pubmed"}]}, "Citation": "Yoshimizu T, Miroglio A, Ripoche M-A, Gabory A, Vernucci M, Riccio A, et al. The H19 locus acts in vivo as a tumor suppressor. Proceedings of the National Academy of Sciences. 2008;105:12417\u201322."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC360709", "@IdType": "pmc"}, {"#text": "1688465", "@IdType": "pubmed"}]}, "Citation": "Brannan CI, Dees EC, Ingram RS, Tilghman SM. The product of the H19 gene may function as an RNA. Mol Cell Biol. 1990;10:28\u201336."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3443897", "@IdType": "pmc"}, {"#text": "22993648", "@IdType": "pubmed"}]}, "Citation": "Amit D, Hochberg A. Development of targeted therapy for a broad spectrum of cancers (pancreatic cancer, ovarian cancer, glioblastoma and HCC) mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequences. Int J Clin Exp Med. 2012;5:296\u2013305."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3371723", "@IdType": "pmc"}, {"#text": "22701803", "@IdType": "pubmed"}]}, "Citation": "Sorin V, Ohana P, Gallula J, Birman T, Matouk I, Hubert A, et al. H19-promoter-targeted therapy combined with gemcitabine in the treatment of pancreatic cancer. ISRN Oncol. 2012;2012:351750."}, {"ArticleIdList": {"ArticleId": {"#text": "10369866", "@IdType": "pubmed"}}, "Citation": "Mitsuya K, Meguro M, Lee MP, Katoh M, Schulz TC, Kugoh H, et al. LIT1, an Imprinted Antisense RNA in the Human KvLQT1 Locus Identified by Screening for Differentially Expressed Transcripts Using Monochromosomal Hybrids. Hum Mol Genet. 1999;8:1209\u201317."}, {"ArticleIdList": {"ArticleId": {"#text": "16965397", "@IdType": "pubmed"}}, "Citation": "Nakano S, Murakami K, Meguro M, Soejima H, Higashimoto K, Urano T, et al. Expression profile of LIT1/KCNQ1OT1 and epigenetic status at the KvDMR1 in colorectal cancers. Cancer Sci. 2006;97:1147\u201354."}, {"ArticleIdList": {"ArticleId": {"#text": "15459184", "@IdType": "pubmed"}}, "Citation": "Pandey RR, Ceribelli M, Singh PB, Ericsson J, Mantovani R, Kanduri C. NF-Y Regulates the Antisense Promoter, Bidirectional Silencing, and Differential Epigenetic Marks of the Kcnq1 Imprinting Control Region. J Biol Chem. 2004;279:52685\u201393."}, {"ArticleIdList": {"ArticleId": {"#text": "18951091", "@IdType": "pubmed"}}, "Citation": "Pandey RR, Mondal T, Mohammad F, Enroth S, Redrup L, Komorowski J, et al. Kcnq1ot1 Antisense Noncoding RNA Mediates Lineage-Specific Transcriptional Silencing through Chromatin-Level Regulation. Mol Cell. 2008;32:232\u201346."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3882787", "@IdType": "pmc"}, {"#text": "24395636", "@IdType": "pubmed"}]}, "Citation": "Zhang H, Zeitz MJ, Wang H, Niu B, Ge S, Li W, et al. Long noncoding RNA-mediated intrachromosomal interactions promote imprinting at the Kcnq1 locus. J Cell Biol. 2014;204:61\u201375."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3533950", "@IdType": "pmc"}, {"#text": "23153226", "@IdType": "pubmed"}]}, "Citation": "Robbins KM, Chen Z, Wells KD, Rivera RM. Expression of KCNQ1OT1, CDKN1C, H19, and PLAGL1 and the methylation patterns at the KvDMR1 and H19/IGF2 imprinting control regions is conserved between human and bovine. J Biomed Sci. 2012;19:95."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC384940", "@IdType": "pmc"}, {"#text": "11813134", "@IdType": "pubmed"}]}, "Citation": "DeBaun MR, Niemitz EL, McNeil DE, Brandenburg SA, Lee MP, Feinberg AP. Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects. Am J Hum Genet. 2002;70:604\u201311."}, {"ArticleIdList": {"ArticleId": {"#text": "22094949", "@IdType": "pubmed"}}, "Citation": "Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011;12:861\u201374."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3917980", "@IdType": "pmc"}, {"#text": "24384562", "@IdType": "pubmed"}]}, "Citation": "Peng JC, Shen J, Ran ZH. Transcribed ultraconserved region in human cancers. RNA Biol. 2013;10:1771\u20137."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5192503", "@IdType": "pmc"}, {"#text": "27983635", "@IdType": "pubmed"}]}, "Citation": "Terreri S, Durso M, Colonna V, Romanelli A, Terracciano D, Ferro M, et al. New Cross-Talk Layer between Ultraconserved Non-Coding RNAs, MicroRNAs and Polycomb Protein YY1 in Bladder Cancer. Genes (Basel) 2016;7"}, {"ArticleIdList": {"ArticleId": {"#text": "27914101", "@IdType": "pubmed"}}, "Citation": "Wang C, Wang Z, Zhou J, Liu S, Wu C, Huang C, et al. TUC.338 promotes invasion and metastasis in colorectal cancer. Int J Cancer. 2017;140:1457\u201364."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4971523", "@IdType": "pmc"}, {"#text": "27500182", "@IdType": "pubmed"}]}, "Citation": "Jiang BC, Yang T, He LN, Tao YX, Gao YJ. Altered T-UCRs expression profile in the spinal cord of mice with neuropathic pain. Transl Perioper Pain Med. 2016;1:1\u201310."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3021052", "@IdType": "pmc"}, {"#text": "21187392", "@IdType": "pubmed"}]}, "Citation": "Braconi C, Valeri N, Kogure T, Gasparini P, Huang N, Nuovo GJ, et al. Expression and functional role of a transcribed noncoding RNA with an ultraconserved element in hepatocellular carcinoma. Proc Natl Acad Sci U S A. 2011;108:786\u201391."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3007676", "@IdType": "pmc"}, {"#text": "20802525", "@IdType": "pubmed"}]}, "Citation": "Lujambio A, Portela A, Liz J, Melo SA, Rossi S, Spizzo R, et al. CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer. Oncogene. 2010;29:6390\u2013401."}, {"ArticleIdList": {"ArticleId": {"#text": "24910097", "@IdType": "pubmed"}}, "Citation": "Liz J, Portela A, Soler M, Gomez A, Ling H, Michlewski G, et al. Regulation of pri-miRNA processing by a long noncoding RNA transcribed from an ultraconserved region. Mol Cell. 2014;55:138\u201347."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4426458", "@IdType": "pmc"}, {"#text": "25902512", "@IdType": "pubmed"}]}, "Citation": "Boque-Sastre R, Soler M, Oliveira-Mateos C, Portela A, Moutinho C, Sayols S, et al. Head-to-head antisense transcription and R-loop formation promotes transcriptional activation. Proc Natl Acad Sci U S A. 2015;112:5785\u201390."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5389582", "@IdType": "pmc"}, {"#text": "27956498", "@IdType": "pubmed"}]}, "Citation": "Zhang E, Han L, Yin D, He X, Hong L, Si X, et al. H3K27 acetylation activated-long non-coding RNA CCAT1 affects cell proliferation and migration by regulating SPRY4 and HOXB13 expression in esophageal squamous cell carcinoma. Nucleic Acids Res. 2016"}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5308740", "@IdType": "pmc"}, {"#text": "27566568", "@IdType": "pubmed"}]}, "Citation": "Chen J, Zhang K, Song H, Wang R, Chu X, Chen L. Long noncoding RNA CCAT1 acts as an oncogene and promotes chemoresistance in docetaxel-resistant lung adenocarcinoma cells. Oncotarget. 2016;7:62474\u201389."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4339002", "@IdType": "pmc"}, {"#text": "25884472", "@IdType": "pubmed"}]}, "Citation": "Deng L, Yang SB, Xu FF, Zhang JH. Long noncoding RNA CCAT1 promotes hepatocellular carcinoma progression by functioning as let-7 sponge. J Exp Clin Cancer Res. 2015;34:18."}, {"ArticleIdList": {"ArticleId": {"#text": "27638771", "@IdType": "pubmed"}}, "Citation": "Guo X, Hua Y. CCAT1: an oncogenic long noncoding RNA in human cancers. J Cancer Res Clin Oncol. 2017;143:555\u201362."}, {"ArticleIdList": {"ArticleId": {"#text": "22289527", "@IdType": "pubmed"}}, "Citation": "Geng YJ, Xie SL, Li Q, Ma J, Wang GY. Large intervening non-coding RNA HOTAIR is associated with hepatocellular carcinoma progression. J Int Med Res. 2011;39:2119\u201328."}, {"ArticleIdList": {"ArticleId": {"#text": "24183851", "@IdType": "pubmed"}}, "Citation": "He Y, Meng XM, Huang C, Wu BM, Zhang L, Lv XW, et al. Long noncoding RNAs: Novel insights into hepatocelluar carcinoma. Cancer Lett. 2014;344:20\u20137."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4851900", "@IdType": "pmc"}, {"#text": "27013343", "@IdType": "pubmed"}]}, "Citation": "Parasramka MA, Maji S, Matsuda A, Yan IK, Patel T. Long non-coding RNAs as novel targets for therapy in hepatocellular carcinoma. Pharmacol Ther. 2016;161:67\u201378."}, {"ArticleIdList": {"ArticleId": {"#text": "17241883", "@IdType": "pubmed"}}, "Citation": "Panzitt K, Tschernatsch MMO, Guelly C, Moustafa T, Stradner M, Strohmaier HM, et al. Characterization of HULC, a Novel Gene With Striking Up-Regulation in Hepatocellular Carcinoma, as Noncoding RNA. Gastroenterology. 2007;132:330\u201342."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3406714", "@IdType": "pmc"}, {"#text": "22685290", "@IdType": "pubmed"}]}, "Citation": "Du Y, Kong G, You X, Zhang S, Zhang T, Gao Y, et al. Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18. J Biol Chem. 2012;287:26302\u201311."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4684503", "@IdType": "pmc"}, {"#text": "26674525", "@IdType": "pubmed"}]}, "Citation": "Wang K, Guo WX, Li N, Gao CF, Shi J, Tang YF, et al. Serum LncRNAs Profiles Serve as Novel Potential Biomarkers for the Diagnosis of HBV-Positive Hepatocellular Carcinoma. PLoS One. 2015;10:e0144934."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2938198", "@IdType": "pmc"}, {"#text": "20423907", "@IdType": "pubmed"}]}, "Citation": "Wang J, Liu X, Wu H, Ni P, Gu Z, Qiao Y, et al. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res. 2010;38:5366\u201383."}, {"ArticleIdList": {"ArticleId": {"#text": "21769904", "@IdType": "pubmed"}}, "Citation": "Yang F, Zhang L, Huo XS, Yuan JH, Xu D, Yuan SX, et al. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology. 2011;54:1679\u201389."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4612899", "@IdType": "pmc"}, {"#text": "26550214", "@IdType": "pubmed"}]}, "Citation": "Zhang Y, Li Z, Zhang Y, Zhong Q, Chen Q, Zhang L. Molecular mechanism of HEIH and HULC in the proliferation and invasion of hepatoma cells. Int J Clin Exp Med. 2015;8:12956\u201362."}, {"ArticleIdList": {"ArticleId": {"#text": "23791884", "@IdType": "pubmed"}}, "Citation": "Shi X, Sun M, Liu H, Yao Y, Song Y. Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett. 2013;339:159\u201366."}, {"ArticleIdList": {"ArticleId": {"#text": "26812074", "@IdType": "pubmed"}}, "Citation": "Wang X, Sun W, Shen W, Xia M, Chen C, Xiang D, et al. Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axis. J Hepatol. 2016;64:1283\u201394."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4672369", "@IdType": "pmc"}, {"#text": "26693181", "@IdType": "pubmed"}]}, "Citation": "Sahu A, Singhal U, Chinnaiyan AM. Long noncoding RNAs in cancer: from function to translation. Trends Cancer. 2015;1:93\u2013109."}, {"ArticleIdList": {"ArticleId": {"#text": "27064878", "@IdType": "pubmed"}}, "Citation": "Zhang SR, Yang JK, Xie JK, Zhao LC. Long noncoding RNA HOTTIP contributes to the progression of prostate cancer by regulating HOXA13. Cell Mol Biol (Noisy-le-grand) 2016;62:84\u20138."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4372045", "@IdType": "pmc"}, {"#text": "25889214", "@IdType": "pubmed"}]}, "Citation": "Li Z, Zhao X, Zhou Y, Liu Y, Zhou Q, Ye H, et al. The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cancer. J Transl Med. 2015;13:84."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3943759", "@IdType": "pmc"}, {"#text": "24114970", "@IdType": "pubmed"}]}, "Citation": "Quagliata L, Matter MS, Piscuoglio S, Arabi L, Ruiz C, Procino A, et al. Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients. Hepatology. 2014;59:911\u201323."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5216934", "@IdType": "pmc"}, {"#text": "27363013", "@IdType": "pubmed"}]}, "Citation": "Huang M, Zhong Z, Lv M, Shu J, Tian Q, Chen J. Comprehensive analysis of differentially expressed profiles of lncRNAs and circRNAs with associated co-expression and ceRNA networks in bladder carcinoma. Oncotarget. 2016"}, {"ArticleIdList": {"ArticleId": {"#text": "27562722", "@IdType": "pubmed"}}, "Citation": "Chen P, Wan D, Zheng D, Zheng Q, Wu F, Zhi Q. Long non-coding RNA UCA1 promotes the tumorigenesis in pancreatic cancer. Biomed Pharmacother. 2016;83:1220\u20136."}, {"ArticleIdList": {"ArticleId": {"#text": "24495014", "@IdType": "pubmed"}}, "Citation": "Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F, et al. Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling. FEBS J. 2014;281:1750\u20138."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5158064", "@IdType": "pmc"}, {"#text": "27977766", "@IdType": "pubmed"}]}, "Citation": "Liu H, Wang G, Yang L, Qu J, Yang Z, Zhou X. Knockdown of Long Non-Coding RNA UCA1 Increases the Tamoxifen Sensitivity of Breast Cancer Cells through Inhibition of Wnt/beta-Catenin Pathway. PLoS One. 2016;11:e0168406."}, {"ArticleIdList": {"ArticleId": {"#text": "25842979", "@IdType": "pubmed"}}, "Citation": "Wang Y, He L, Du Y, Zhu P, Huang G, Luo J, et al. The long noncoding RNA lncTCF7 promotes self-renewal of human liver cancer stem cells through activation of Wnt signaling. Cell Stem Cell. 2015;16:413\u201325."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4736767", "@IdType": "pmc"}, {"#text": "26880946", "@IdType": "pubmed"}]}, "Citation": "Hu S, Shan G. LncRNAs in Stem Cells. Stem Cells Int. 2016;2016:2681925."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4024349", "@IdType": "pmc"}, {"#text": "24609766", "@IdType": "pubmed"}]}, "Citation": "Alvarez-Dominguez JR, Hu W, Gromatzky AA, Lodish HF. Long noncoding RNAs during normal and malignant hematopoiesis. Int J Hematol. 2014;99:531\u201341."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3248679", "@IdType": "pmc"}, {"#text": "22155924", "@IdType": "pubmed"}]}, "Citation": "Hu W, Yuan B, Flygare J, Lodish HF. Long noncoding RNA-mediated anti-apoptotic activity in murine erythroid terminal differentiation. Genes Dev. 2011;25:2573\u20138."}, {"ArticleIdList": {"ArticleId": {"#text": "19347735", "@IdType": "pubmed"}}, "Citation": "Mertens D, Philippen A, Ruppel M, Allegra D, Bhattacharya N, Tschuch C, et al. Chronic lymphocytic leukemia and 13q14: miRs and more. Leuk Lymphoma. 2009;50:502\u20135."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3616974", "@IdType": "pmc"}, {"#text": "23593011", "@IdType": "pubmed"}]}, "Citation": "Garding A, Bhattacharya N, Claus R, Ruppel M, Tschuch C, Filarsky K, et al. Epigenetic upregulation of lncRNAs at 13q14.3 in leukemia is linked to the In Cis downregulation of a gene cluster that targets NF-kB. PLoS Genet. 2013;9:e1003373."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4131209", "@IdType": "pmc"}, {"#text": "25083870", "@IdType": "pubmed"}]}, "Citation": "Trimarchi T, Bilal E, Ntziachristos P, Fabbri G, Dalla-Favera R, Tsirigos A, et al. Genome-wide mapping and characterization of Notch-regulated long noncoding RNAs in acute leukemia. Cell. 2014;158:593\u2013606."}, {"ArticleIdList": {"ArticleId": {"#text": "26796267", "@IdType": "pubmed"}}, "Citation": "Peng W, Feng J. Long noncoding RNA LUNAR1 associates with cell proliferation and predicts a poor prognosis in diffuse large B-cell lymphoma. Biomed Pharmacother. 2016;77:65\u201371."}, {"ArticleIdList": {"ArticleId": {"#text": "24837367", "@IdType": "pubmed"}}, "Citation": "Guo G, Kang Q, Zhu X, Chen Q, Wang X, Chen Y, et al. A long noncoding RNA critically regulates Bcr-Abl-mediated cellular transformation by acting as a competitive endogenous RNA. Oncogene. 2015;34:1768\u201379."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4549704", "@IdType": "pmc"}, {"#text": "26306906", "@IdType": "pubmed"}]}, "Citation": "Xia T, Chen S, Jiang Z, Shao Y, Jiang X, Li P, et al. Long noncoding RNA FER1L4 suppresses cancer cell growth by acting as a competing endogenous RNA and regulating PTEN expression. Sci Rep. 2015;5:13445."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5082402", "@IdType": "pmc"}, {"#text": "27307307", "@IdType": "pubmed"}]}, "Citation": "Wan L, Kong J, Tang J, Wu Y, Xu E, Lai M, et al. HOTAIRM1 as a potential biomarker for diagnosis of colorectal cancer functions the role in the tumour suppressor. J Cell Mol Med. 2016;20:2036\u201344."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5388432", "@IdType": "pmc"}, {"#text": "28180285", "@IdType": "pubmed"}]}, "Citation": "Wang XQ, Dostie J. Reciprocal regulation of chromatin state and architecture by HOTAIRM1 contributes to temporal collinear HOXA gene activation. Nucleic Acids Res. 2016"}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4156508", "@IdType": "pmc"}, {"#text": "24824789", "@IdType": "pubmed"}]}, "Citation": "Zhang X, Weissman SM, Newburger PE. Long intergenic non-coding RNA HOTAIRM1 regulates cell cycle progression during myeloid maturation in NB4 human promyelocytic leukemia cells. RNA Biol. 2014;11:777\u201387."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4857283", "@IdType": "pmc"}, {"#text": "27146823", "@IdType": "pubmed"}]}, "Citation": "Wei S, Zhao M, Wang X, Li Y, Wang K. PU.1 controls the expression of long noncoding RNA HOTAIRM1 during granulocytic differentiation. J Hematol Oncol. 2016;9:44."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4539689", "@IdType": "pmc"}, {"#text": "26282267", "@IdType": "pubmed"}]}, "Citation": "Cerase A, Pintacuda G, Tattermusch A, Avner P. Xist localization and function: new insights from multiple levels. Genome Biol. 2015;16:166."}, {"ArticleIdList": {"ArticleId": {"#text": "12492109", "@IdType": "pubmed"}}, "Citation": "Huang KC, Rao PH, Lau CC, Heard E, Ng SK, Brown C, et al. Relationship of XIST expression and responses of ovarian cancer to chemotherapy. Mol Cancer Ther. 2002;1:769\u201376."}, {"ArticleIdList": {"ArticleId": {"#text": "18501714", "@IdType": "pubmed"}}, "Citation": "Wang F, Li X, Xie X, Zhao L, Chen W. UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion. FEBS Lett. 2008;582:1919\u201327."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4429197", "@IdType": "pmc"}, {"#text": "26064090", "@IdType": "pubmed"}]}, "Citation": "Kladi-Skandali A, Michaelidou K, Scorilas A, Mavridis K. Long Noncoding RNAs in Digestive System Malignancies: A Novel Class of Cancer Biomarkers and Therapeutic Targets? Gastroenterol Res Pract. 2015;2015:319861."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3225313", "@IdType": "pmc"}, {"#text": "22078386", "@IdType": "pubmed"}]}, "Citation": "Tahira AC, Kubrusly MS, Faria MF, Dazzani B, Fonseca RS, Maracaja-Coutinho V, et al. Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer. Mol Cancer. 2011;10:141."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3040650", "@IdType": "pmc"}, {"#text": "21057500", "@IdType": "pubmed"}]}, "Citation": "Loewer S, Cabili MN, Guttman M, Loh YH, Thomas K, Park IH, et al. Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells. Nat Genet. 2010;42:1113\u20137."}, {"ArticleIdList": {"ArticleId": {"#text": "25756403", "@IdType": "pubmed"}}, "Citation": "Ren C, Li X, Wang T, Wang G, Zhao C, Liang T, et al. Functions and Mechanisms of Long Noncoding RNAs in Ovarian Cancer. Int J Gynecol Cancer. 2015;25:566\u20139."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5084630", "@IdType": "pmc"}, {"#text": "27603915", "@IdType": "pubmed"}]}, "Citation": "Zhong Y, Gao D, He S, Shuai C, Peng S. Dysregulated Expression of Long Noncoding RNAs in Ovarian Cancer. Int J Gynecol Cancer. 2016;26:1564\u201370."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4326488", "@IdType": "pmc"}, {"#text": "25685243", "@IdType": "pubmed"}]}, "Citation": "Blondeau JJ, Deng M, Syring I, Schrodter S, Schmidt D, Perner S, et al. Identification of novel long non-coding RNAs in clear cell renal cell carcinoma. Clin Epigenetics. 2015;7:10."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4849029", "@IdType": "pmc"}, {"#text": "27092491", "@IdType": "pubmed"}]}, "Citation": "Seles M, Hutterer GC, Kiesslich T, Pummer K, Berindan-Neagoe I, Perakis S, et al. Current Insights into Long Non-Coding RNAs in Renal Cell Carcinoma. Int J Mol Sci. 2016;17:573."}, {"ArticleIdList": {"ArticleId": {"#text": "25769450", "@IdType": "pubmed"}}, "Citation": "Gu W, Gao T, Sun Y, Zheng X, Wang J, Ma J, et al. LncRNA expression profile reveals the potential role of lncRNAs in gastric carcinogenesis. Cancer Biomark. 2015;15:249\u201358."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4342515", "@IdType": "pmc"}, {"#text": "25636450", "@IdType": "pubmed"}]}, "Citation": "Wan X, Ding X, Chen S, Song H, Jiang H, Fang Y, et al. The functional sites of miRNAs and lncRNAs in gastric carcinogenesis. Tumour Biol. 2015;36:521\u201332."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4849144", "@IdType": "pmc"}, {"#text": "26913601", "@IdType": "pubmed"}]}, "Citation": "Zhang E, He X, Yin D, Han L, Qiu M, Xu T, et al. Increased expression of long noncoding RNA TUG1 predicts a poor prognosis of gastric cancer and regulates cell proliferation by epigenetically silencing of p57. Cell Death Dis. 2016;7:e2109."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4280393", "@IdType": "pmc"}, {"#text": "25561975", "@IdType": "pubmed"}]}, "Citation": "Kraus TF, Greiner A, Guibourt V, Lisec K, Kretzschmar HA. Identification of Stably Expressed lncRNAs as Valid Endogenous Controls for Profiling of Human Glioma. J Cancer. 2015;6:111\u20139."}, {"ArticleIdList": {"ArticleId": {"#text": "22234798", "@IdType": "pubmed"}}, "Citation": "Wang P, Ren Z, Sun P. Overexpression of the long non-coding RNA MEG3 impairs in vitro glioma cell proliferation. J Cell Biochem. 2012;113:1868\u201374."}, {"ArticleIdList": {"ArticleId": {"#text": "27381864", "@IdType": "pubmed"}}, "Citation": "Qiao Q, Li H. LncRNA FER1L4 suppresses cancer cell proliferation and cycle by regulating PTEN expression in endometrial carcinoma. Biochem Biophys Res Commun. 2016;478:507\u201312."}, {"ArticleIdList": {"ArticleId": {"#text": "25517750", "@IdType": "pubmed"}}, "Citation": "Pandey GK, Mitra S, Subhash S, Hertwig F, Kanduri M, Mishra K, et al. The risk-associated long noncoding RNA NBAT-1 controls neuroblastoma progression by regulating cell proliferation and neuronal differentiation. Cancer Cell. 2014;26:722\u201337."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4466945", "@IdType": "pmc"}, {"#text": "26097558", "@IdType": "pubmed"}]}, "Citation": "Xue S, Li QW, Che JP, Guo Y, Yang FQ, Zheng JH. Decreased expression of long non-coding RNA NBAT-1 is associated with poor prognosis in patients with clear cell renal cell carcinoma. Int J Clin Exp Pathol. 2015;8:3765\u201374."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4625733", "@IdType": "pmc"}, {"#text": "26511107", "@IdType": "pubmed"}]}, "Citation": "Guo C, Song WQ, Sun P, Jin L, Dai HY. LncRNA-GAS5 induces PTEN expression through inhibiting miR-103 in endometrial cancer cells. J Biomed Sci. 2015;22:100."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4422020", "@IdType": "pmc"}, {"#text": "25999983", "@IdType": "pubmed"}]}, "Citation": "Isin M, Uysaler E, Ozgur E, Koseoglu H, Sanli O, Yucel OB, et al. Exosomal lncRNA-p21 levels may help to distinguish prostate cancer from benign disease. Front Genet. 2015;6:168."}, {"ArticleIdList": {"ArticleId": {"#text": "18836484", "@IdType": "pubmed"}}, "Citation": "Mourtada-Maarabouni M, Pickard MR, Hedge VL, Farzaneh F, Williams GT. GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene. 2009;28:195\u2013208."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4221572", "@IdType": "pmc"}, {"#text": "22859208", "@IdType": "pubmed"}]}, "Citation": "Wheeler TM, Leger AJ, Pandey SK, MacLeod AR, Nakamori M, Cheng SH, et al. Targeting nuclear RNA for in vivo correction of myotonic dystrophy. Nature. 2012;488:111\u20135."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5053687", "@IdType": "pmc"}, {"#text": "27034004", "@IdType": "pubmed"}]}, "Citation": "Li W, Zhai L, Wang H, Liu C, Zhang J, Chen W, et al. Downregulation of LncRNA GAS5 causes trastuzumab resistance in breast cancer. Oncotarget. 2016;7:27778\u201386."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4584312", "@IdType": "pmc"}, {"#text": "26198250", "@IdType": "pubmed"}]}, "Citation": "Pickard MR, Williams GT. Molecular and Cellular Mechanisms of Action of Tumour Suppressor GAS5 LncRNA. Genes (Basel) 2015;6:484\u201399."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5008375", "@IdType": "pmc"}, {"#text": "26967566", "@IdType": "pubmed"}]}, "Citation": "Yan R, Wang K, Peng R, Wang S, Cao J, Wang P, et al. Genetic variants in lncRNA SRA and risk of breast cancer. Oncotarget. 2016;7:22486\u201396."}, {"ArticleIdList": {"ArticleId": {"#text": "17916692", "@IdType": "pubmed"}}, "Citation": "Azzalin CM, Reichenbach P, Khoriauli L, Giulotto E, Lingner J. Telomeric Repeat\u2013Containing RNA and RNA Surveillance Factors at Mammalian Chromosome Ends. Science. 2007;318:798\u2013801."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2749977", "@IdType": "pmc"}, {"#text": "19716786", "@IdType": "pubmed"}]}, "Citation": "Deng Z, Norseen J, Wiedmer A, Riethman H, Lieberman PM. TERRA RNA Binding to TRF2 Facilitates Heterochromatin Formation and ORC Recruitment at Telomeres. Mol Cell. 2009;35:403\u201313."}, {"ArticleIdList": {"ArticleId": {"#text": "22617877", "@IdType": "pubmed"}}, "Citation": "Maicher A, Kastner L, Luke B. Telomeres and disease: enter TERRA. RNA Biol. 2012;9:843\u20139."}, {"ArticleIdList": {"ArticleId": {"#text": "21287134", "@IdType": "pubmed"}}, "Citation": "Arora R, Brun CM, Azzalin CM. TERRA: Long Noncoding RNA at Eukaryotic Telomeres. Prog Mol Subcell Biol. 2011;51:65\u201394."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4808022", "@IdType": "pmc"}, {"#text": "26506418", "@IdType": "pubmed"}]}, "Citation": "Thorenoor N, Faltejskova-Vychytilova P, Hombach S, Mlcochova J, Kretz M, Svoboda M, et al. Long non-coding RNA ZFAS1 interacts with CDK1 and is involved in p53-dependent cell cycle control and apoptosis in colorectal cancer. Oncotarget. 2016;7:622\u201337."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5503528", "@IdType": "pmc"}, {"#text": "27246976", "@IdType": "pubmed"}]}, "Citation": "Nie F, Yu X, Huang M, Wang Y, Xie M, Ma H, et al. Long noncoding RNA ZFAS1 promotes gastric cancer cells proliferation by epigenetically repressing KLF2 and NKD2 expression. Oncotarget. 2016"}, {"ArticleIdList": {"ArticleId": {"#text": "26069248", "@IdType": "pubmed"}}, "Citation": "Li T, Xie J, Shen C, Cheng D, Shi Y, Wu Z, et al. Amplification of Long Noncoding RNA ZFAS1 Promotes Metastasis in Hepatocellular Carcinoma. Cancer Res. 2015;75:3181\u201391."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3078737", "@IdType": "pmc"}, {"#text": "21460236", "@IdType": "pubmed"}]}, "Citation": "Askarian-Amiri ME, Crawford J, French JD, Smart CE, Smith MA, Clark MB, et al. SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer. RNA. 2011;17:878\u201391."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4391155", "@IdType": "pmc"}, {"#text": "25883951", "@IdType": "pubmed"}]}, "Citation": "Colombo T, Farina L, Macino G, Paci P. PVT1: a rising star among oncogenic long noncoding RNAs. Biomed Res Int. 2015;2015:304208."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4399399", "@IdType": "pmc"}, {"#text": "25890171", "@IdType": "pubmed"}]}, "Citation": "Kong R, Zhang EB, Yin DD, You LH, Xu TP, Chen WM, et al. Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16. Mol Cancer. 2015;14:82."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4723819", "@IdType": "pmc"}, {"#text": "26884974", "@IdType": "pubmed"}]}, "Citation": "Liu E, Liu Z, Zhou Y, Mi R, Wang D. Overexpression of long non-coding RNA PVT1 in ovarian cancer cells promotes cisplatin resistance by regulating apoptotic pathways. Int J Clin Exp Med. 2015;8:20565\u201372."}, {"ArticleIdList": {"ArticleId": {"#text": "21316338", "@IdType": "pubmed"}}, "Citation": "You L, Chang D, Du HZ, Zhao YP. Genome-wide screen identifies PVT1 as a regulator of Gemcitabine sensitivity in human pancreatic cancer cells. Biochem Biophys Res Commun. 2011;407:1\u20136."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4883781", "@IdType": "pmc"}, {"#text": "27232880", "@IdType": "pubmed"}]}, "Citation": "Iden M, Fye S, Li K, Chowdhury T, Ramchandran R, Rader JS. The lncRNA PVT1 Contributes to the Cervical Cancer Phenotype and Associates with Poor Patient Prognosis. PLoS One. 2016;11:e0156274."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2579639", "@IdType": "pmc"}, {"#text": "18628527", "@IdType": "pubmed"}]}, "Citation": "Gejman R, Batista DL, Zhong Y, Zhou Y, Zhang X, Swearingen B, et al. Selective Loss of MEG3 Expression and Intergenic Differentially Methylated Region Hypermethylation in the MEG3/DLK1 Locus in Human Clinically Nonfunctioning Pituitary Adenomas. J Clin Endocrinol Metab. 2008;93:4119\u201325."}, {"ArticleIdList": {"ArticleId": {"#text": "10759892", "@IdType": "pubmed"}}, "Citation": "Miyoshi N, Wagatsuma H, Wakana S, Shiroishi T, Nomura M, Aisaka K, et al. Identification of an imprinted gene, Meg3/Gtl2 and its human homologue MEG3, first mapped on mouse distal chromosome 12 and human chromosome 14q. Genes Cells. 2000;5:211\u201320."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2987571", "@IdType": "pmc"}, {"#text": "20179190", "@IdType": "pubmed"}]}, "Citation": "Zhang X, Gejman R, Mahta A, Zhong Y, Rice KA, Zhou Y, et al. Maternally Expressed Gene 3, an Imprinted Noncoding RNA Gene, Is Associated with Meningioma Pathogenesis and Progression. Cancer Res. 2010;70:2350\u20138."}, {"ArticleIdList": {"ArticleId": {"#text": "17569660", "@IdType": "pubmed"}}, "Citation": "Zhou Y, Zhong Y, Wang Y, Zhang X, Batista DL, Gejman R, et al. Activation of p53 by MEG3 Non-coding RNA. J Biol Chem. 2007;282:24731\u201342."}, {"ArticleIdList": {"ArticleId": {"#text": "23295831", "@IdType": "pubmed"}}, "Citation": "Ying L, Huang Y, Chen H, Wang Y, Xia L, Chen Y, et al. Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer. Mol Biosyst. 2013;9:407\u201311."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4525211", "@IdType": "pmc"}, {"#text": "26205790", "@IdType": "pubmed"}]}, "Citation": "Mondal T, Subhash S, Vaid R, Enroth S, Uday S, Reinius B, et al. MEG3 long noncoding RNA regulates the TGF-beta pathway genes through formation of RNA-DNA triplex structures. Nat Commun. 2015;6:7743."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4250419", "@IdType": "pmc"}, {"#text": "25128828", "@IdType": "pubmed"}]}, "Citation": "Toiyama Y, Okugawa Y, Goel A. DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer. Biochem Biophys Res Commun. 2014;455:43\u201357."}, {"ArticleIdList": {"ArticleId": {"#text": "11980670", "@IdType": "pubmed"}}, "Citation": "de Kok JB, Verhaegh GW, Roelofs RW, Hessels D, Kiemeney LA, Aalders TW, et al. DD3(PCA3), a very sensitive and specific marker to detect prostate tumors. Cancer Res. 2002;62:2695\u20138."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4730403", "@IdType": "pmc"}, {"#text": "26703666", "@IdType": "pubmed"}]}, "Citation": "Ilboudo A, Chouhan J, McNeil BK, Osborne JR, Ogunwobi OO. PVT1 Exon 9: A Potential Biomarker of Aggressive Prostate Cancer? Int J Environ Res Public Health. 2015;13 ijerph13010012."}, {"ArticleIdList": {"ArticleId": {"#text": "24931166", "@IdType": "pubmed"}}, "Citation": "Orfanelli U, Jachetti E, Chiacchiera F, Grioni M, Brambilla P, Briganti A, et al. Antisense transcription at the TRPM2 locus as a novel prognostic marker and therapeutic target in prostate cancer. Oncogene. 2015;34:2094\u2013102."}, {"ArticleIdList": {"ArticleId": {"#text": "26033707", "@IdType": "pubmed"}}, "Citation": "Zhang L, Song X, Wang X, Xie Y, Wang Z, Xu Y, et al. Circulating DNA of HOTAIR in serum is a novel biomarker for breast cancer. Breast Cancer Res Treat. 2015;152:199\u2013208."}, {"ArticleIdList": {"ArticleId": {"#text": "26921339", "@IdType": "pubmed"}}, "Citation": "Jiang YZ, Liu YR, Xu XE, Jin X, Hu X, Yu KD, et al. Transcriptome Analysis of Triple-Negative Breast Cancer Reveals an Integrated mRNA-lncRNA Signature with Predictive and Prognostic Value. Cancer Res. 2016;76:2105\u201314."}, {"Citation": "TA(E)C-GP Versus A(E)C-T for the High Risk TNBC Patients and Validation of the mRNA-lncRNA Signature.   https://ClinicalTrials.gov/show/NCT02641847."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4029199", "@IdType": "pmc"}, {"#text": "24313945", "@IdType": "pubmed"}]}, "Citation": "Weber DG, Johnen G, Casjens S, Bryk O, Pesch B, Jockel KH, et al. Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancer. BMC Res Notes. 2013;6:518."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4467267", "@IdType": "pmc"}, {"#text": "26137228", "@IdType": "pubmed"}]}, "Citation": "Guo F, Yu F, Wang J, Li Y, Li Y, Li Z, et al. Expression of MALAT1 in the peripheral whole blood of patients with lung cancer. Biomed Rep. 2015;3:309\u201312."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4565407", "@IdType": "pmc"}, {"#text": "26380024", "@IdType": "pubmed"}]}, "Citation": "Wang HM, Lu JH, Chen WY, Gu AQ. Upregulated lncRNA-UCA1 contributes to progression of lung cancer and is closely related to clinical diagnosis as a predictive biomarker in plasma. Int J Clin Exp Med. 2015;8:11824\u201330."}, {"ArticleIdList": {"ArticleId": {"#text": "25432874", "@IdType": "pubmed"}}, "Citation": "Xue Y, Gu D, Ma G, Zhu L, Hua Q, Chu H, et al. Genetic variants in lncRNA HOTAIR are associated with risk of colorectal cancer. Mutagenesis. 2015;30:303\u201310."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4713512", "@IdType": "pmc"}, {"#text": "26823726", "@IdType": "pubmed"}]}, "Citation": "Zhao W, Song M, Zhang J, Kuerban M, Wang H. Combined identification of long non-coding RNA CCAT1 and HOTAIR in serum as an effective screening for colorectal carcinoma. Int J Clin Exp Pathol. 2015;8:14131\u201340."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4638023", "@IdType": "pmc"}, {"#text": "26224446", "@IdType": "pubmed"}]}, "Citation": "Yue B, Sun B, Liu C, Zhao S, Zhang D, Yu F, et al. Long non-coding RNA Fer-1-like protein 4 suppresses oncogenesis and exhibits prognostic value by associating with miR-106a-5p in colon cancer. Cancer Sci. 2015;106:1323\u201332."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4548337", "@IdType": "pmc"}, {"#text": "26328256", "@IdType": "pubmed"}]}, "Citation": "Shi J, Li X, Zhang F, Zhang C, Guan Q, Cao X, et al. Circulating lncRNAs associated with occurrence of colorectal cancer progression. Am J Cancer Res. 2015;5:2258\u201365."}, {"ArticleIdList": {"ArticleId": {"#text": "26356260", "@IdType": "pubmed"}}, "Citation": "Li J, Wang X, Tang J, Jiang R, Zhang W, Ji J, et al. HULC and Linc00152 Act as Novel Biomarkers in Predicting Diagnosis of Hepatocellular Carcinoma. Cell Physiol Biochem. 2015;37:687\u201396."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4414207", "@IdType": "pmc"}, {"#text": "25714016", "@IdType": "pubmed"}]}, "Citation": "Tang J, Jiang R, Deng L, Zhang X, Wang K, Sun B. Circulation long non-coding RNAs act as biomarkers for predicting tumorigenesis and metastasis in hepatocellular carcinoma. Oncotarget. 2015;6:4505\u201315."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4294360", "@IdType": "pmc"}, {"#text": "25526029", "@IdType": "pubmed"}]}, "Citation": "Wang F, Ren S, Chen R, Lu J, Shi X, Zhu Y, et al. Development and prospective multicenter evaluation of the long noncoding RNA MALAT-1 as a diagnostic urinary biomarker for prostate cancer. Oncotarget. 2014;5:11091\u2013102."}, {"ArticleIdList": {"ArticleId": {"#text": "23726266", "@IdType": "pubmed"}}, "Citation": "Ren S, Wang F, Shen J, Sun Y, Xu W, Lu J, et al. Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer. Eur J Cancer. 2013;49:2949\u201359."}, {"ArticleIdList": {"ArticleId": {"#text": "25929808", "@IdType": "pubmed"}}, "Citation": "Xu N, Chen F, Wang F, Lu X, Wang X, Lv M, et al. Clinical significance of high expression of circulating serum lncRNA RP11-445H22.4 in breast cancer patients: a Chinese population-based study. Tumour Biol. 2015;36:7659\u201365."}, {"ArticleIdList": {"ArticleId": {"#text": "16914571", "@IdType": "pubmed"}}, "Citation": "Wang XS, Zhang Z, Wang HC, Cai JL, Xu QW, Li MQ, et al. Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma. Clin Cancer Res. 2006;12:4851\u20138."}, {"ArticleIdList": {"ArticleId": {"#text": "26781446", "@IdType": "pubmed"}}, "Citation": "Shang C, Guo Y, Zhang H, Xue YX. Long noncoding RNA HOTAIR is a prognostic biomarker and inhibits chemosensitivity to doxorubicin in bladder transitional cell carcinoma. Cancer Chemother Pharmacol. 2016;77:507\u201313."}, {"ArticleIdList": {"ArticleId": {"#text": "26204929", "@IdType": "pubmed"}}, "Citation": "Melo CP, Campos CB, Rodrigues Jde O, Aguirre-Neto JC, Atalla A, Pianovski MA, et al. Long non-coding RNAs: biomarkers for acute leukaemia subtypes. Br J Haematol. 2016;173:318\u201320."}, {"ArticleIdList": {"ArticleId": {"#text": "27608895", "@IdType": "pubmed"}}, "Citation": "Chen ZJ, Zhang Z, Xie BB, Zhang HY. Clinical significance of up-regulated lncRNA NEAT1 in prognosis of ovarian cancer. Eur Rev Med Pharmacol Sci. 2016;20:3373\u20137."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5154346", "@IdType": "pmc"}, {"#text": "26878386", "@IdType": "pubmed"}]}, "Citation": "Wu Y, Wang YQ, Weng WW, Zhang QY, Yang XQ, Gan HL, et al. A serum-circulating long noncoding RNA signature can discriminate between patients with clear cell renal cell carcinoma and healthy controls. Oncogenesis. 2016;5:e192."}, {"ArticleIdList": {"ArticleId": {"#text": "25366139", "@IdType": "pubmed"}}, "Citation": "Li J, Wang Y, Yu J, Dong R, Qiu H. A high level of circulating HOTAIR is associated with progression and poor prognosis of cervical cancer. Tumour Biol. 2015;36:1661\u20135."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4631113", "@IdType": "pmc"}, {"#text": "25608466", "@IdType": "pubmed"}]}, "Citation": "Tong YS, Wang XW, Zhou XL, Liu ZH, Yang TX, Shi WH, et al. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma. Mol Cancer. 2015;14:3."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4476094", "@IdType": "pmc"}, {"#text": "26096073", "@IdType": "pubmed"}]}, "Citation": "Zhou X, Yin C, Dang Y, Ye F, Zhang G. Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer. Sci Rep. 2015;5:11516."}, {"ArticleIdList": {"ArticleId": {"#text": "24523021", "@IdType": "pubmed"}}, "Citation": "Pang Q, Ge J, Shao Y, Sun W, Song H, Xia T, et al. Increased expression of long intergenic non-coding RNA LINC00152 in gastric cancer and its clinical significance. Tumour Biol. 2014;35:5441\u20137."}, {"ArticleIdList": {"ArticleId": {"#text": "25903045", "@IdType": "pubmed"}}, "Citation": "Zheng Q, Wu F, Dai WY, Zheng DC, Zheng C, Ye H, et al. Aberrant expression of UCA1 in gastric cancer and its clinical significance. Clin Transl Oncol. 2015;17:640\u20136."}, {"ArticleIdList": {"ArticleId": {"#text": "25694351", "@IdType": "pubmed"}}, "Citation": "Dong L, Qi P, Xu MD, Ni SJ, Huang D, Xu QH, et al. Circulating CUDR, LSINCT-5 and PTENP1 long noncoding RNAs in sera distinguish patients with gastric cancer from healthy controls. Int J Cancer. 2015;137:1128\u201335."}, {"ArticleIdList": {"ArticleId": {"#text": "24986041", "@IdType": "pubmed"}}, "Citation": "Shao Y, Ye M, Jiang X, Sun W, Ding X, Liu Z, et al. Gastric juice long noncoding RNA used as a tumor marker for screening gastric cancer. Cancer. 2014;120:3320\u20138."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4548803", "@IdType": "pmc"}, {"#text": "24172333", "@IdType": "pubmed"}]}, "Citation": "Ling H, Fabbri M, Calin GA. MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov. 2013;12:847\u201365."}, {"ArticleIdList": {"ArticleId": {"#text": "23463315", "@IdType": "pubmed"}}, "Citation": "Mercer TR, Mattick JS. Structure and function of long noncoding RNAs in epigenetic regulation. Nat Struct Mol Biol. 2013;20:300\u20137."}, {"Citation": "A Study on the Gastrointestinal Disease and Helicobacter Pylori Controlled Long Non-coding RNA.   https://ClinicalTrials.gov/show/NCT03057171."}, {"ArticleIdList": {"ArticleId": {"#text": "21176272", "@IdType": "pubmed"}}, "Citation": "Bourdoumis A, Papatsoris AG, Chrisofos M, Efstathiou E, Skolarikos A, Deliveliotis C. The novel prostate cancer antigen 3 (PCA3) biomarker. Int Braz J Urol. 2010;36:665\u20138. discussion 9."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4904991", "@IdType": "pmc"}, {"#text": "27308347", "@IdType": "pubmed"}]}, "Citation": "Li C, Yang L, Lin C. Long noncoding RNAs in prostate cancer: mechanisms and applications. Mol Cell Oncol. 2014;1:e963469."}, {"ArticleIdList": {"ArticleId": {"#text": "27374059", "@IdType": "pubmed"}}, "Citation": "Shi L, Peng F, Tao Y, Fan X, Li N. Roles of long noncoding RNAs in hepatocellular carcinoma. Virus Res. 2016;223:131\u20139."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3320879", "@IdType": "pmc"}, {"#text": "22493738", "@IdType": "pubmed"}]}, "Citation": "Liu Y, Pan S, Liu L, Zhai X, Liu J, Wen J, et al. A genetic variant in long non-coding RNA HULC contributes to risk of HBV-related hepatocellular carcinoma in a Chinese population. PLoS One. 2012;7:e35145."}, {"ArticleIdList": {"ArticleId": {"#text": "23292722", "@IdType": "pubmed"}}, "Citation": "Ishibashi M, Kogo R, Shibata K, Sawada G, Takahashi Y, Kurashige J, et al. Clinical significance of the expression of long non-coding RNA HOTAIR in primary hepatocellular carcinoma. Oncol Rep. 2013;29:946\u201350."}, {"ArticleIdList": {"ArticleId": {"#text": "27210721", "@IdType": "pubmed"}}, "Citation": "Lavorgna G, Vago R, Sarmini M, Montorsi F, Salonia A, Bellone M. Long non-coding RNAs as novel therapeutic targets in cancer. Pharmacol Res. 2016;110:131\u20138."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5831170", "@IdType": "pmc"}, {"#text": "27444227", "@IdType": "pubmed"}]}, "Citation": "Matsui M, Corey DR. Non-coding RNAs as drug targets. Nat Rev Drug Discov. 2017;16:167\u201379."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4590572", "@IdType": "pmc"}, {"#text": "26442763", "@IdType": "pubmed"}]}, "Citation": "Cai Y, He J, Zhang D. Long noncoding RNA CCAT2 promotes breast tumor growth by regulating the Wnt signaling pathway. Onco Targets Ther. 2015;8:2657\u201364."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4982398", "@IdType": "pmc"}, {"#text": "26853146", "@IdType": "pubmed"}]}, "Citation": "Redis RS, Vela LE, Lu W, Ferreira de Oliveira J, Ivan C, Rodriguez-Aguayo C, et al. Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2. Mol Cell. 2016;61:520\u201334."}, {"ArticleIdList": {"ArticleId": {"#text": "27558961", "@IdType": "pubmed"}}, "Citation": "Zheng J, Zhao S, He X, Zheng Z, Bai W, Duan Y, et al. The up-regulation of long non-coding RNA CCAT2 indicates a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition. Biochem Biophys Res Commun. 2016"}, {"ArticleIdList": {"ArticleId": {"#text": "16368707", "@IdType": "pubmed"}}, "Citation": "Johnstone KA, DuBose AJ, Futtner CR, Elmore MD, Brannan CI, Resnick JL. A human imprinting centre demonstrates conserved acquisition but diverged maintenance of imprinting in a mouse model for Angelman syndrome imprinting defects. Hum Mol Genet. 2006;15:393\u2013404."}, {"ArticleIdList": {"ArticleId": {"#text": "26758979", "@IdType": "pubmed"}}, "Citation": "Tan WH, Bird LM. Pharmacological therapies for Angelman syndrome. Wien Med Wochenschr. 2016"}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2967839", "@IdType": "pmc"}, {"#text": "21052499", "@IdType": "pubmed"}]}, "Citation": "Scaiewicz V, Sorin V, Fellig Y, Birman T, Mizrahi A, Galula J, et al. Use of H19 Gene Regulatory Sequences in DNA-Based Therapy for Pancreatic Cancer. J Oncol. 2010;2010:178174."}, {"ArticleIdList": {"ArticleId": {"#text": "25257554", "@IdType": "pubmed"}}, "Citation": "Chen H, Xin Y, Zhou L, Huang JM, Tao L, Cheng L, et al. Cisplatin and paclitaxel target significant long noncoding RNAs in laryngeal squamous cell carcinoma. Med Oncol. 2014;31:246."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4791209", "@IdType": "pmc"}, {"#text": "26364613", "@IdType": "pubmed"}]}, "Citation": "Xue X, Yang YA, Zhang A, Fong KW, Kim J, Song B, et al. LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer. Oncogene. 2016;35:2746\u201355."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4548321", "@IdType": "pmc"}, {"#text": "26328013", "@IdType": "pubmed"}]}, "Citation": "Zhao W, Dong S, Duan B, Chen P, Shi L, Gao H, et al. HOTAIR is a predictive and prognostic biomarker for patients with advanced gastric adenocarcinoma receiving fluorouracil and platinum combination chemotherapy. Am J Transl Res. 2015;7:1295\u2013302."}, {"ArticleIdList": {"ArticleId": {"#text": "26707824", "@IdType": "pubmed"}}, "Citation": "Fang S, Gao H, Tong Y, Yang J, Tang R, Niu Y, et al. Long noncoding RNA-HOTAIR affects chemoresistance by regulating HOXA1 methylation in small cell lung cancer cells. Lab Invest. 2016;96:60\u20138."}, {"ArticleIdList": {"ArticleId": {"#text": "22961206", "@IdType": "pubmed"}}, "Citation": "Han Y, Liu Y, Gui Y, Cai Z. Long intergenic non-coding RNA TUG1 is overexpressed in urothelial carcinoma of the bladder. J Surg Oncol. 2013;107:555\u20139."}, {"ArticleIdList": {"ArticleId": {"#text": "15797018", "@IdType": "pubmed"}}, "Citation": "Young TL, Matsuda T, Cepko CL. The Noncoding RNA Taurine Upregulated Gene 1 Is Required for Differentiation of the Murine Retina. Curr Biol. 2005;15:501\u201312."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6496395", "@IdType": "pmc"}, {"#text": "27339553", "@IdType": "pubmed"}]}, "Citation": "Li Z, Shen J, Chan MT, Wu WK. TUG1: a pivotal oncogenic long non-coding RNA of human cancers. Cell Prolif. 2016;49:471\u20135."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5223434", "@IdType": "pmc"}, {"#text": "28069000", "@IdType": "pubmed"}]}, "Citation": "Niu Y, Ma F, Huang W, Fang S, Li M, Wei T, et al. Long non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2. Mol Cancer. 2017;16:5."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5237133", "@IdType": "pmc"}, {"#text": "28086904", "@IdType": "pubmed"}]}, "Citation": "Han P, Li JW, Zhang BM, Lv JC, Li YM, Gu XY, et al. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/beta-catenin signaling. Mol Cancer. 2017;16:9."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4891451", "@IdType": "pmc"}, {"#text": "27347346", "@IdType": "pubmed"}]}, "Citation": "Li Z, Zhao L, Wang Q. Overexpression of long non-coding RNA HOTTIP increases chemoresistance of osteosarcoma cell by activating the Wnt/beta-catenin pathway. Am J Transl Res. 2016;8:2385\u201393."}, {"ArticleIdList": {"ArticleId": {"#text": "27827524", "@IdType": "pubmed"}}, "Citation": "Liu X, Jiao T, Wang Y, Su W, Tang Z, Han C. Long non-coding RNA GAS5 acts as a molecular sponge to regulate miR-23a in gastric cancer. Minerva Med. 2016"}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5410262", "@IdType": "pmc"}, {"#text": "28187000", "@IdType": "pubmed"}]}, "Citation": "Chen W, Xu XK, Li JL, Kong KK, Li H, Chen C, et al. MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression. Oncotarget. 2017"}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4583851", "@IdType": "pmc"}, {"#text": "26464619", "@IdType": "pubmed"}]}, "Citation": "Zhu KP, Zhang CL, Shen GQ, Zhu ZS. Long noncoding RNA expression profiles of the doxorubicin-resistant human osteosarcoma cell line MG63/DXR and its parental cell line MG63 as ascertained by microarray analysis. Int J Clin Exp Pathol. 2015;8:8754\u201373."}, {"ArticleIdList": {"ArticleId": {"#text": "26408180", "@IdType": "pubmed"}}, "Citation": "Zhang CL, Zhu KP, Shen GQ, Zhu ZS. A long non-coding RNA contributes to doxorubicin resistance of osteosarcoma. Tumour Biol. 2016;37:2737\u201348."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5348405", "@IdType": "pmc"}, {"#text": "27845892", "@IdType": "pubmed"}]}, "Citation": "Si X, Zang R, Zhang E, Liu Y, Shi X, Zhang E, et al. LncRNA H19 confers chemoresistance in ERalpha-positive breast cancer through epigenetic silencing of the pro-apoptotic gene BIK. Oncotarget. 2016;7:81452\u201362."}, {"ArticleIdList": {"ArticleId": {"#text": "23722346", "@IdType": "pubmed"}}, "Citation": "Wahlestedt C. Targeting long non-coding RNA to therapeutically upregulate gene expression. Nat Rev Drug Discov. 2013;12:433\u201346."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4429916", "@IdType": "pmc"}, {"#text": "25921091", "@IdType": "pubmed"}]}, "Citation": "Alvarez-Dominguez JR, Bai Z, Xu D, Yuan B, Lo KA, Yoon MJ, et al. De Novo Reconstruction of Adipose Tissue Transcriptomes Reveals Long Non-coding RNA Regulators of Brown Adipocyte Development. Cell Metab. 2015;21:764\u201376."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4376378", "@IdType": "pmc"}, {"#text": "25560704", "@IdType": "pubmed"}]}, "Citation": "Knoll M, Lodish HF, Sun L. Long non-coding RNAs as regulators of the endocrine system. Nat Rev Endocrinol. 2015;11:151\u201360."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3587215", "@IdType": "pmc"}, {"#text": "23401553", "@IdType": "pubmed"}]}, "Citation": "Sun L, Goff LA, Trapnell C, Alexander R, Lo KA, Hacisuleyman E, et al. Long noncoding RNAs regulate adipogenesis. Proc Natl Acad Sci U S A. 2013;110:3387\u201392."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3901070", "@IdType": "pmc"}, {"#text": "24200680", "@IdType": "pubmed"}]}, "Citation": "Alvarez-Dominguez JR, Hu W, Yuan B, Shi J, Park SS, Gromatzky AA, et al. Global discovery of erythroid long noncoding RNAs reveals novel regulators of red cell maturation. Blood. 2014;123:570\u201381."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3546715", "@IdType": "pmc"}, {"#text": "23222637", "@IdType": "pubmed"}]}, "Citation": "Baldassarre A, Masotti A. Long non-coding RNAs and p53 regulation. Int J Mol Sci. 2012;13:16708\u201317."}, {"ArticleIdList": {"ArticleId": {"#text": "26666209", "@IdType": "pubmed"}}, "Citation": "Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet. 2016;17:47\u201362."}]}}}}}, "PMC": "PMC8330958", "PMID": "28701486", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "Long Noncoding RNA and Cancer: A New Paradigm.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "34": {"Abstract": "Therapeutic targeting of noncoding RNAs (ncRNAs), such as microRNAs (miRNAs) and long noncoding RNAs (lncRNAs), represents an attractive approach for the treatment of cancers, as well as many other diseases. Over the past decade, substantial effort has been made towards the clinical application of RNA-based therapeutics, employing mostly antisense oligonucleotides and small interfering RNAs, with several gaining FDA approval. However, trial results have so far been ambivalent, with some studies reporting potent effects whereas others demonstrated limited efficacy or toxicity. Alternative entities such as antimiRNAs are undergoing clinical testing, and lncRNA-based therapeutics are gaining interest. In this Perspective, we discuss key challenges facing ncRNA therapeutics - including issues associated with specificity, delivery and tolerability - and focus on promising emerging approaches that aim to boost their success.", "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "-7264447848327722003", "Part1": "Translational Molecular Pathology", "Part2": "MD Anderson Cancer Center", "Part3": "Texas State University", "Part4": "Houston", "Part5": "TX", "Part6": "USA.", "Text": "Translational Molecular Pathology, MD Anderson Cancer Center, Texas State University, Houston, TX, USA."}], "ForeName": "Melanie", "FullName": "Melanie Winkle", "HashID": "-4813400644598118984", "LastName": "Winkle", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "1004627979977757040", "Part1": "Medical Biochemistry Department", "Part2": "Medical Research Division - Cancer Biology and Genetics Laboratory", "Part3": "Centre of Excellence for Advanced Sciences - National Research Centre", "Part4": "Cairo", "Part5": "Egypt.", "Part6": null, "Text": "Medical Biochemistry Department, Medical Research Division - Cancer Biology and Genetics Laboratory, Centre of Excellence for Advanced Sciences - National Research Centre, Cairo, Egypt."}], "ForeName": "Sherien M", "FullName": "Sherien M El-Daly", "HashID": "4678999493308733925", "LastName": "El-Daly", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "4634189526176275670", "Part1": "Cancer Biology Program", "Part2": "University of Hawaii Cancer Center", "Part3": "Honolulu", "Part4": "HI", "Part5": "USA.", "Part6": null, "Text": "Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, HI, USA."}], "ForeName": "Muller", "FullName": "Muller Fabbri", "HashID": "-310657193525935771", "LastName": "Fabbri", "ORCID": "0000-0002-8797-4793"}, {"Affiliations": [{"Has_Extra": false, "HashID": "-7264447848327722003", "Part1": "Translational Molecular Pathology", "Part2": "MD Anderson Cancer Center", "Part3": "Texas State University", "Part4": "Houston", "Part5": "TX", "Part6": "USA. gcalin@mdanderson.org.", "Text": "Translational Molecular Pathology, MD Anderson Cancer Center, Texas State University, Houston, TX, USA. gcalin@mdanderson.org."}, {"Has_Extra": false, "HashID": "8092379651234285748", "Part1": "The RNA Interference and Non-codingRNA Center", "Part2": "MD Anderson Cancer Center", "Part3": "Texas State University", "Part4": "Houston", "Part5": "TX", "Part6": "USA. gcalin@mdanderson.org.", "Text": "The RNA Interference and Non-codingRNA Center, MD Anderson Cancer Center, Texas State University, Houston, TX, USA. gcalin@mdanderson.org."}], "ForeName": "George A", "FullName": "George A Calin", "HashID": "-4510640675344345573", "LastName": "Calin", "ORCID": "0000-0002-7427-0578"}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.1038/s41573-021-00219-z", "InsertType": null, "Journal": "Nature reviews. Drug discovery", "Keywords": [{"IS_Major": false, "IS_Mesh": true, "Text": "Animals"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Genetic Therapy"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Humans"}, {"IS_Major": true, "IS_Mesh": true, "Text": "Molecular Targeted Therapy"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Neoplasms"}, {"IS_Major": false, "IS_Mesh": true, "Text": "RNA, Long Noncoding"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "MEDLINE", "Article": {"@PubModel": "Print-Electronic", "Abstract": {"AbstractText": "Therapeutic targeting of noncoding RNAs (ncRNAs), such as microRNAs (miRNAs) and long noncoding RNAs (lncRNAs), represents an attractive approach for the treatment of cancers, as well as many other diseases. Over the past decade, substantial effort has been made towards the clinical application of RNA-based therapeutics, employing mostly antisense oligonucleotides and small interfering RNAs, with several gaining FDA approval. However, trial results have so far been ambivalent, with some studies reporting potent effects whereas others demonstrated limited efficacy or toxicity. Alternative entities such as antimiRNAs are undergoing clinical testing, and lncRNA-based therapeutics are gaining interest. In this Perspective, we discuss key challenges facing ncRNA therapeutics - including issues associated with specificity, delivery and tolerability - and focus on promising emerging approaches that aim to boost their success.", "CopyrightInformation": "\u00a9 2021. Springer Nature Limited."}, "ArticleDate": {"@DateType": "Electronic", "Day": "18", "Month": "06", "Year": "2021"}, "ArticleTitle": "Noncoding RNA therapeutics - challenges and potential solutions.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Translational Molecular Pathology, MD Anderson Cancer Center, Texas State University, Houston, TX, USA."}, "ForeName": "Melanie", "Initials": "M", "LastName": "Winkle"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Medical Biochemistry Department, Medical Research Division - Cancer Biology and Genetics Laboratory, Centre of Excellence for Advanced Sciences - National Research Centre, Cairo, Egypt."}, "ForeName": "Sherien M", "Initials": "SM", "LastName": "El-Daly"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, HI, USA."}, "ForeName": "Muller", "Identifier": {"#text": "0000-0002-8797-4793", "@Source": "ORCID"}, "Initials": "M", "LastName": "Fabbri"}, {"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Translational Molecular Pathology, MD Anderson Cancer Center, Texas State University, Houston, TX, USA. gcalin@mdanderson.org."}, {"Affiliation": "The RNA Interference and Non-codingRNA Center, MD Anderson Cancer Center, Texas State University, Houston, TX, USA. gcalin@mdanderson.org."}], "ForeName": "George A", "Identifier": {"#text": "0000-0002-7427-0578", "@Source": "ORCID"}, "Initials": "GA", "LastName": "Calin"}]}, "ELocationID": {"#text": "10.1038/s41573-021-00219-z", "@EIdType": "doi", "@ValidYN": "Y"}, "GrantList": {"@CompleteYN": "Y", "Grant": [{"Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States", "GrantID": "R01 CA222007"}, {"Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States", "GrantID": "R01 CA219024"}, {"Acronym": "TR", "Agency": "NCATS NIH HHS", "Country": "United States", "GrantID": "UH3 TR000943"}, {"Acronym": "GM", "Agency": "NIGMS NIH HHS", "Country": "United States", "GrantID": "R01 GM122775"}, {"Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States", "GrantID": "R01 CA182905"}, {"Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States", "GrantID": "R01 CA215753"}, {"Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States", "GrantID": "P30 CA071789"}]}, "Journal": {"ISOAbbreviation": "Nat Rev Drug Discov", "ISSN": {"#text": "1474-1784", "@IssnType": "Electronic"}, "JournalIssue": {"@CitedMedium": "Internet", "Issue": "8", "PubDate": {"Month": "Aug", "Year": "2021"}, "Volume": "20"}, "Title": "Nature reviews. Drug discovery"}, "Language": "eng", "Pagination": {"EndPage": "651", "MedlinePgn": "629-651", "StartPage": "629"}, "PublicationTypeList": {"PublicationType": [{"#text": "Journal Article", "@UI": "D016428"}, {"#text": "Review", "@UI": "D016454"}]}}, "ChemicalList": {"Chemical": {"NameOfSubstance": {"#text": "RNA, Long Noncoding", "@UI": "D062085"}, "RegistryNumber": "0"}}, "CitationSubset": "IM", "CoiStatement": "G.A.C. is one of the scientific founders of Ithax Pharmaceuticals. The other authors declare no competing interests.", "DateCompleted": {"Day": "06", "Month": "09", "Year": "2021"}, "DateRevised": {"Day": "12", "Month": "02", "Year": "2023"}, "MedlineJournalInfo": {"Country": "England", "ISSNLinking": "1474-1776", "MedlineTA": "Nat Rev Drug Discov", "NlmUniqueID": "101124171"}, "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"#text": "Animals", "@MajorTopicYN": "N", "@UI": "D000818"}}, {"DescriptorName": {"#text": "Genetic Therapy", "@MajorTopicYN": "N", "@UI": "D015316"}, "QualifierName": {"#text": "methods", "@MajorTopicYN": "Y", "@UI": "Q000379"}}, {"DescriptorName": {"#text": "Humans", "@MajorTopicYN": "N", "@UI": "D006801"}}, {"DescriptorName": {"#text": "Molecular Targeted Therapy", "@MajorTopicYN": "Y", "@UI": "D058990"}}, {"DescriptorName": {"#text": "Neoplasms", "@MajorTopicYN": "N", "@UI": "D009369"}, "QualifierName": [{"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}, {"#text": "therapy", "@MajorTopicYN": "Y", "@UI": "Q000628"}]}, {"DescriptorName": {"#text": "RNA, Long Noncoding", "@MajorTopicYN": "N", "@UI": "D062085"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}}]}, "PMID": {"#text": "34145432", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "34145432", "@IdType": "pubmed"}, {"#text": "PMC8212082", "@IdType": "pmc"}, {"#text": "10.1038/s41573-021-00219-z", "@IdType": "doi"}, {"#text": "10.1038/s41573-021-00219-z", "@IdType": "pii"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "accepted", "Day": "27", "Month": "4", "Year": "2021"}, {"@PubStatus": "pubmed", "Day": "20", "Hour": "6", "Minute": "0", "Month": "6", "Year": "2021"}, {"@PubStatus": "medline", "Day": "7", "Hour": "6", "Minute": "0", "Month": "9", "Year": "2021"}, {"@PubStatus": "entrez", "Day": "19", "Hour": "6", "Minute": "17", "Month": "6", "Year": "2021"}]}, "PublicationStatus": "ppublish", "ReferenceList": {"Reference": [{"ArticleIdList": {"ArticleId": [{"#text": "10.1158/0008-5472.CAN-06-0800", "@IdType": "doi"}, {"#text": "16885332", "@IdType": "pubmed"}]}, "Citation": "Calin GA, Croce CM. MicroRNA-cancer connection: the beginning of a new tale. Cancer Res. 2006;66:7390\u20137394. doi: 10.1158/0008-5472.CAN-06-0800."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s00439-014-1434-4", "@IdType": "doi"}, {"#text": "PMC4677487", "@IdType": "pmc"}, {"#text": "24609542", "@IdType": "pubmed"}]}, "Citation": "Lenkala D, et al. The impact of microRNA expression on cellular proliferation. Hum. Genet. 2014;133:931\u2013938. doi: 10.1007/s00439-014-1434-4."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1101/cshperspect.a008144", "@IdType": "doi"}, {"#text": "PMC4484971", "@IdType": "pmc"}, {"#text": "26134312", "@IdType": "pubmed"}]}, "Citation": "Ivey KN, Srivastava D. microRNAs as developmental regulators. Cold Spring Harb. Perspect. Biol. 2015;7:a008144. doi: 10.1101/cshperspect.a008144."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.4161/rna.20481", "@IdType": "doi"}, {"#text": "PMC3495743", "@IdType": "pmc"}, {"#text": "22664915", "@IdType": "pubmed"}]}, "Citation": "Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 2012;9:703\u2013719. doi: 10.4161/rna.20481."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ccell.2016.03.010", "@IdType": "doi"}, {"#text": "PMC4831138", "@IdType": "pmc"}, {"#text": "27070700", "@IdType": "pubmed"}]}, "Citation": "Schmitt AM, Chang HY. Long noncoding RNAs in cancer pathways. Cancer Cell. 2016;29:452\u2013463. doi: 10.1016/j.ccell.2016.03.010."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nri.2016.40", "@IdType": "doi"}, {"#text": "27121651", "@IdType": "pubmed"}]}, "Citation": "Mehta A, Baltimore D. MicroRNAs as regulatory elements in immune system logic. Nat. Rev. Immunol. 2016;16:279\u2013294. doi: 10.1038/nri.2016.40."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41586-020-1996-3", "@IdType": "doi"}, {"#text": "PMC9723538", "@IdType": "pmc"}, {"#text": "32051587", "@IdType": "pubmed"}]}, "Citation": "Amit M, et al. Loss of p53 drives neuron reprogramming in head and neck cancer. Nature. 2020;578:449\u2013454. doi: 10.1038/s41586-020-1996-3."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s00441-017-2711-z", "@IdType": "doi"}, {"#text": "29079882", "@IdType": "pubmed"}]}, "Citation": "Andersen RE, Lim DA. Forging our understanding of lncRNAs in the brain. Cell Tissue Res. 2018;371:55\u201371. doi: 10.1007/s00441-017-2711-z."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/978-981-13-1426-1_16", "@IdType": "doi"}, {"#text": "30259368", "@IdType": "pubmed"}]}, "Citation": "Constantin L. Circular RNAs and neuronal development. Adv. Exp. Med. Biol. 2018;1087:205\u2013213. doi: 10.1007/978-981-13-1426-1_16."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrd4140", "@IdType": "doi"}, {"#text": "PMC4548803", "@IdType": "pmc"}, {"#text": "24172333", "@IdType": "pubmed"}]}, "Citation": "Ling H, Fabbri M, Calin GA. MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat. Rev. Drug Discov. 2013;12:847\u2013865. doi: 10.1038/nrd4140."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrd.2016.246", "@IdType": "doi"}, {"#text": "28209991", "@IdType": "pubmed"}]}, "Citation": "Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat. Rev. Drug Discov. 2017;16:203\u2013222. doi: 10.1038/nrd.2016.246."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrd3864", "@IdType": "doi"}, {"#text": "PMC6813819", "@IdType": "pmc"}, {"#text": "23080337", "@IdType": "pubmed"}]}, "Citation": "van Rooij E, Olson EN. MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles. Nat. Rev. Drug Discov. 2012;11:860\u2013872. doi: 10.1038/nrd3864."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cell.2019.10.017", "@IdType": "doi"}, {"#text": "PMC7347159", "@IdType": "pmc"}, {"#text": "31730848", "@IdType": "pubmed"}]}, "Citation": "Slack FJ, Chinnaiyan AM. The role of non-coding RNAs in oncology. Cell. 2019;179:1033\u20131055. doi: 10.1016/j.cell.2019.10.017."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ebiom.2016.09.017", "@IdType": "doi"}, {"#text": "PMC5078622", "@IdType": "pmc"}, {"#text": "27720213", "@IdType": "pubmed"}]}, "Citation": "Shah MY, Ferrajoli A, Sood AK, Lopez-Berestein G, Calin GA. MicroRNA therapeutics in cancer - an emerging concept. EBioMedicine. 2016;12:34\u201342. doi: 10.1016/j.ebiom.2016.09.017."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.0800121105", "@IdType": "doi"}, {"#text": "PMC2278188", "@IdType": "pmc"}, {"#text": "18362358", "@IdType": "pubmed"}]}, "Citation": "Calin GA, et al. MiR-15a and miR-16-1 cluster functions in human leukemia. Proc. Natl Acad. Sci. USA. 2008;105:5166\u20135171. doi: 10.1073/pnas.0800121105."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.0506654102", "@IdType": "doi"}, {"#text": "PMC1236577", "@IdType": "pmc"}, {"#text": "16166262", "@IdType": "pubmed"}]}, "Citation": "Cimmino A, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl Acad. Sci. USA. 2005;102:13944\u201313949. doi: 10.1073/pnas.0506654102."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.molmed.2018.01.001", "@IdType": "doi"}, {"#text": "PMC5840027", "@IdType": "pmc"}, {"#text": "29449148", "@IdType": "pubmed"}]}, "Citation": "Arun G, Diermeier SD, Spector DL. Therapeutic targeting of long non-coding RNAs in cancer. Trends Mol. Med. 2018;24:257\u2013277. doi: 10.1016/j.molmed.2018.01.001."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nbt.2158", "@IdType": "doi"}, {"#text": "PMC4144683", "@IdType": "pmc"}, {"#text": "22446693", "@IdType": "pubmed"}]}, "Citation": "Modarresi F, et al. Inhibition of natural antisense transcripts in vivo results in gene-specific transcriptional upregulation. Nat. Biotechnol. 2012;30:453\u2013459. doi: 10.1038/nbt.2158."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ebiom.2016.05.011", "@IdType": "doi"}, {"#text": "PMC4972487", "@IdType": "pmc"}, {"#text": "27333023", "@IdType": "pubmed"}]}, "Citation": "Hsiao J, et al. Upregulation of haploinsufficient gene expression in the brain by targeting a long non-coding RNA improves seizure phenotype in a model of dravet syndrome. EBioMedicine. 2016;9:257\u2013277. doi: 10.1016/j.ebiom.2016.05.011."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.jconrel.2021.01.027", "@IdType": "doi"}, {"#text": "PMC7946770", "@IdType": "pmc"}, {"#text": "33484777", "@IdType": "pubmed"}]}, "Citation": "Padmakumar S, et al. Minimally invasive nasal depot (MIND) technique for direct BDNF AntagoNAT delivery to the brain. J. Control. Rel. 2021;331:176\u2013186. doi: 10.1016/j.jconrel.2021.01.027."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/1078-0432.CCR-08-1104", "@IdType": "doi"}, {"#text": "PMC4375958", "@IdType": "pmc"}, {"#text": "19047121", "@IdType": "pubmed"}]}, "Citation": "Moulder SL, et al. Phase I/II study of G3139 (Bcl-2 antisense oligonucleotide) in combination with doxorubicin and docetaxel in breast cancer. Clin. Cancer Res. 2008;14:7909\u20137916. doi: 10.1158/1078-0432.CCR-08-1104."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/0008-5472.CAN-16-1248", "@IdType": "doi"}, {"#text": "PMC5117672", "@IdType": "pmc"}, {"#text": "27694602", "@IdType": "pubmed"}]}, "Citation": "Croce CM, Reed JC. Finally, an apoptosis-targeting therapeutic for cancer. Cancer Res. 2016;76:5914\u20135920. doi: 10.1158/0008-5472.CAN-16-1248."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s10637-016-0407-y", "@IdType": "doi"}, {"#text": "PMC5893501", "@IdType": "pmc"}, {"#text": "27917453", "@IdType": "pubmed"}]}, "Citation": "Beg MS, et al. Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors. Invest. New Drugs. 2017;35:180\u2013188. doi: 10.1007/s10637-016-0407-y."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41416-020-0802-1", "@IdType": "doi"}, {"#text": "PMC7251107", "@IdType": "pmc"}, {"#text": "32238921", "@IdType": "pubmed"}]}, "Citation": "Hong DS, et al. Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours. Br. J. Cancer. 2020;122:1630\u20131637. doi: 10.1038/s41416-020-0802-1."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/S1470-2045(17)30621-6", "@IdType": "doi"}, {"#text": "28870611", "@IdType": "pubmed"}]}, "Citation": "van Zandwijk N, et al. Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study. Lancet Oncol. 2017;18:1386\u20131396. doi: 10.1016/S1470-2045(17)30621-6."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.jid.2018.11.007", "@IdType": "doi"}, {"#text": "30472058", "@IdType": "pubmed"}]}, "Citation": "Gallant-Behm CL, et al. A microRNA-29 mimic (Remlarsen) represses extracellular matrix expression and fibroplasia in the skin. J. Invest. Dermatol. 2019;139:1073\u20131081. doi: 10.1016/j.jid.2018.11.007."}, {"ArticleIdList": {"ArticleId": {"#text": "32329877", "@IdType": "pubmed"}}, "Citation": "Chakraborty C, Sharma AR, Sharma G, Bhattacharya M, Lee SS. SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options. Eur. Rev. Med. Pharmacol. Sci. 2020;24:4016\u20134026."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3109/08830185.2010.529976", "@IdType": "doi"}, {"#text": "21235323", "@IdType": "pubmed"}]}, "Citation": "Kumar H, Kawai T, Akira S. Pathogen recognition by the innate immune system. Int. Rev. Immunol. 2011;30:16\u201334. doi: 10.3109/08830185.2010.529976."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/ncb1038", "@IdType": "doi"}, {"#text": "12942087", "@IdType": "pubmed"}]}, "Citation": "Sledz CA, Holko M, de Veer MJ, Silverman RH, Williams BR. Activation of the interferon system by short-interfering RNAs. Nat. Cell Biol. 2003;5:834\u2013839. doi: 10.1038/ncb1038."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nbt1038", "@IdType": "doi"}, {"#text": "15558046", "@IdType": "pubmed"}]}, "Citation": "Heidel JD, Hu S, Liu XF, Triche TJ, Davis ME. Lack of interferon response in animalsto naked siRNAs. Nat. Biotechnol. 2004;22:1579\u20131582. doi: 10.1038/nbt1038."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature06765", "@IdType": "doi"}, {"#text": "PMC2642938", "@IdType": "pmc"}, {"#text": "18368052", "@IdType": "pubmed"}]}, "Citation": "Kleinman ME, et al. Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature. 2008;452:591\u2013597. doi: 10.1038/nature06765."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1126/science.1085536", "@IdType": "doi"}, {"#text": "12791976", "@IdType": "pubmed"}]}, "Citation": "Barton GM, Medzhitov R. Toll-like receptor signaling pathways. Science. 2003;300:1524\u20131525. doi: 10.1126/science.1085536."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1126/science.1093620", "@IdType": "doi"}, {"#text": "14976262", "@IdType": "pubmed"}]}, "Citation": "Heil F, et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science. 2004;303:1526\u20131529. doi: 10.1126/science.1093620."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.jmb.2005.03.013", "@IdType": "doi"}, {"#text": "15854645", "@IdType": "pubmed"}]}, "Citation": "Sioud M. Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization. J. Mol. Biol. 2005;348:1079\u20131090. doi: 10.1016/j.jmb.2005.03.013."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nm1191", "@IdType": "doi"}, {"#text": "15723075", "@IdType": "pubmed"}]}, "Citation": "Hornung V, et al. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat. Med. 2005;11:263\u2013270. doi: 10.1038/nm1191."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nbt1081", "@IdType": "doi"}, {"#text": "15778705", "@IdType": "pubmed"}]}, "Citation": "Judge AD, et al. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat. Biotechnol. 2005;23:457\u2013462. doi: 10.1038/nbt1081."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.4049/jimmunol.180.6.3729", "@IdType": "doi"}, {"#text": "18322178", "@IdType": "pubmed"}]}, "Citation": "Forsbach A, et al. Identification of RNA sequence motifs stimulating sequence-specific TLR8-dependent immune responses. J. Immunol. 2008;180:3729\u20133738. doi: 10.4049/jimmunol.180.6.3729."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/eji.200535708", "@IdType": "doi"}, {"#text": "16609928", "@IdType": "pubmed"}]}, "Citation": "Sioud M. Single-stranded small interfering RNA are more immunostimulatory than their double-stranded counterparts: a central role for 2\u2032-hydroxyl uridines in immune responses. Eur. J. Immunol. 2006;36:1222\u20131230. doi: 10.1002/eji.200535708."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.1209414109", "@IdType": "doi"}, {"#text": "PMC3412003", "@IdType": "pmc"}, {"#text": "22753494", "@IdType": "pubmed"}]}, "Citation": "Fabbri M, et al. MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc. Natl Acad. Sci. USA. 2012;109:E2110\u2013E2116. doi: 10.1073/pnas.1209414109."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/jnci/djv135", "@IdType": "doi"}, {"#text": "PMC4651042", "@IdType": "pmc"}, {"#text": "25972604", "@IdType": "pubmed"}]}, "Citation": "Challagundla KB, et al. Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy. J. Natl Cancer Inst. 2015;107:djv135. doi: 10.1093/jnci/djv135."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nn.3113", "@IdType": "doi"}, {"#text": "22610069", "@IdType": "pubmed"}]}, "Citation": "Lehmann SM, et al. An unconventional role for miRNA: let-7 activates toll-like receptor 7 and causes neurodegeneration. Nat. Neurosci. 2012;15:827\u2013835. doi: 10.1038/nn.3113."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cell.2018.07.040", "@IdType": "doi"}, {"#text": "30096304", "@IdType": "pubmed"}]}, "Citation": "Dragomir MP, Knutsen E, Calin GA. SnapShot: unconventional miRNA functions. Cell. 2018;174:1038\u20131038.e1. doi: 10.1016/j.cell.2018.07.040."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/cddis.2014.515", "@IdType": "doi"}, {"#text": "PMC4649832", "@IdType": "pmc"}, {"#text": "25476907", "@IdType": "pubmed"}]}, "Citation": "Tudor S, et al. Cellular and Kaposi\u2019s sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma. Cell. Death Dis. 2014;5:e1559. doi: 10.1038/cddis.2014.515."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.micinf.2012.10.008", "@IdType": "doi"}, {"#text": "PMC7110875", "@IdType": "pmc"}, {"#text": "23123977", "@IdType": "pubmed"}]}, "Citation": "Li Y, et al. Extraordinary GU-rich single-strand RNA identified from SARS coronavirus contributes an excessive innate immune response. Microbes Infect. 2013;15:88\u201395. doi: 10.1016/j.micinf.2012.10.008."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nbt1122", "@IdType": "doi"}, {"#text": "16041363", "@IdType": "pubmed"}]}, "Citation": "Morrissey DV, et al. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat. Biotechnol. 2005;23:1002\u20131007. doi: 10.1038/nbt1122."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ymthe.2005.11.002", "@IdType": "doi"}, {"#text": "16343994", "@IdType": "pubmed"}]}, "Citation": "Judge AD, Bola G, Lee AC, MacLachlan I. Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo. Mol. Ther. 2006;13:494\u2013505. doi: 10.1016/j.ymthe.2005.11.002."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nbt1205", "@IdType": "doi"}, {"#text": "16648842", "@IdType": "pubmed"}]}, "Citation": "Marques JT, et al. A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells. Nat. Biotechnol. 2006;24:559\u2013565. doi: 10.1038/nbt1205."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ejphar.2013.09.050", "@IdType": "doi"}, {"#text": "24099962", "@IdType": "pubmed"}]}, "Citation": "Chen X, et al. 5\u2032-triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells. Eur. J. Pharmacol. 2013;721:86\u201395. doi: 10.1016/j.ejphar.2013.09.050."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nm.2284", "@IdType": "doi"}, {"#text": "PMC3076220", "@IdType": "pmc"}, {"#text": "21240262", "@IdType": "pubmed"}]}, "Citation": "Liu C, et al. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat. Med. 2011;17:211\u2013215. doi: 10.1038/nm.2284."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3389/fgene.2012.00120", "@IdType": "doi"}, {"#text": "PMC3387671", "@IdType": "pmc"}, {"#text": "22783274", "@IdType": "pubmed"}]}, "Citation": "Bader AG. miR-34 - a microRNA replacement therapy is headed to the clinic. Front. Genet. 2012;3:120. doi: 10.3389/fgene.2012.00120."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/1535-7163.MCT-14-0209", "@IdType": "doi"}, {"#text": "25053820", "@IdType": "pubmed"}]}, "Citation": "Daige CL, et al. Systemic delivery of a miR34a mimic as a potential therapeutic for liver cancer. Mol. Cancer Ther. 2014;13:2352\u20132360. doi: 10.1158/1535-7163.MCT-14-0209."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s00280-013-2361-0", "@IdType": "doi"}, {"#text": "PMC3909249", "@IdType": "pmc"}, {"#text": "24297683", "@IdType": "pubmed"}]}, "Citation": "Tolcher AW, et al. A phase 1 study of the BCL2-targeted deoxyribonucleic acid inhibitor (DNAi) PNT2258 in patients with advanced solid tumors. Cancer Chemother. Pharmacol. 2014;73:363\u2013371. doi: 10.1007/s00280-013-2361-0."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/978-1-4939-2727-2_8", "@IdType": "doi"}, {"#text": "26072405", "@IdType": "pubmed"}]}, "Citation": "Kelnar K, Bader AG. A qRT-PCR method for determining the biodistribution profile of a miR-34a mimic. Methods Mol. Biol. 2015;1317:125\u2013133. doi: 10.1007/978-1-4939-2727-2_8."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cellsig.2014.12.003", "@IdType": "doi"}, {"#text": "25499621", "@IdType": "pubmed"}]}, "Citation": "Wang X, et al. Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia. Cell. Signal. 2015;27:443\u2013452. doi: 10.1016/j.cellsig.2014.12.003."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/S0140-6736(11)60756-3", "@IdType": "doi"}, {"#text": "PMC3156980", "@IdType": "pmc"}, {"#text": "21784508", "@IdType": "pubmed"}]}, "Citation": "Cirak S, et al. Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study. Lancet. 2011;378:595\u2013605. doi: 10.1016/S0140-6736(11)60756-3."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/ana.23982", "@IdType": "doi"}, {"#text": "23907995", "@IdType": "pubmed"}]}, "Citation": "Mendell JR, et al. Eteplirsen for the treatment of Duchenne muscular dystrophy. Ann. Neurol. 2013;74:637\u2013647. doi: 10.1002/ana.23982."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1212/WNL.0000000000005680", "@IdType": "doi"}, {"#text": "29752304", "@IdType": "pubmed"}]}, "Citation": "Charleston JS, et al. Eteplirsen treatment for Duchenne muscular dystrophy: exon skipping and dystrophin production. Neurology. 2018;90:e2146\u2013e2154. doi: 10.1212/WNL.0000000000005680."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/hmg/ddy187", "@IdType": "doi"}, {"#text": "29796608", "@IdType": "pubmed"}]}, "Citation": "Artegiani B, Clevers H. Use and application of 3D-organoid technology. Hum. Mol. Genet. 2018;27:R99\u2013R107. doi: 10.1093/hmg/ddy187."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrc3944", "@IdType": "doi"}, {"#text": "25907221", "@IdType": "pubmed"}]}, "Citation": "Aparicio S, Hidalgo M, Kung AL. Examining the utility of patient-derived xenograft mouse models. Nat. Rev. Cancer. 2015;15:311\u2013316. doi: 10.1038/nrc3944."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bcp.2019.113640", "@IdType": "doi"}, {"#text": "31536726", "@IdType": "pubmed"}]}, "Citation": "He J, et al. FRET biosensor-based kinase inhibitor screen for ERK and AKT activity reveals differential kinase dependencies for proliferation in TNBC cells. Biochem. Pharmacol. 2019;169:113640. doi: 10.1016/j.bcp.2019.113640."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/nar/gkt1181", "@IdType": "doi"}, {"#text": "PMC3965103", "@IdType": "pmc"}, {"#text": "24275495", "@IdType": "pubmed"}]}, "Citation": "Kozomara A, Griffiths-Jones S. miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 2013;42:D68\u2013D73. doi: 10.1093/nar/gkt1181."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.4161/rna.20206", "@IdType": "doi"}, {"#text": "PMC3495747", "@IdType": "pmc"}, {"#text": "22617878", "@IdType": "pubmed"}]}, "Citation": "Dalpke A, Helm M. RNA mediated Toll-like receptor stimulation in health and disease. RNA Biol. 2012;9:828\u2013842. doi: 10.4161/rna.20206."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/ng.786", "@IdType": "doi"}, {"#text": "PMC3541685", "@IdType": "pmc"}, {"#text": "21423181", "@IdType": "pubmed"}]}, "Citation": "Obad S, et al. Silencing of microRNA families by seed-targeting tiny LNAs. Nat. Genet. 2011;43:371\u2013378. doi: 10.1038/ng.786."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/0008-5472.CAN-13-0927", "@IdType": "doi"}, {"#text": "PMC3857104", "@IdType": "pmc"}, {"#text": "24145352", "@IdType": "pubmed"}]}, "Citation": "Murphy BL, et al. Silencing of the miR-17~92 cluster family inhibits medulloblastoma progression. Cancer Res. 2013;73:7068\u20137078. doi: 10.1158/0008-5472.CAN-13-0927."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.1206432109", "@IdType": "doi"}, {"#text": "PMC3491509", "@IdType": "pmc"}, {"#text": "23047694", "@IdType": "pubmed"}]}, "Citation": "Bernardo BC, et al. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function. Proc. Natl Acad. Sci. USA. 2012;109:17615\u201317620. doi: 10.1073/pnas.1206432109."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1155/2019/5483791", "@IdType": "doi"}, {"#text": "PMC6446118", "@IdType": "pmc"}, {"#text": "31015835", "@IdType": "pubmed"}]}, "Citation": "Simsek C, Esin E, Yalcin S. Metronomic chemotherapy: a systematic review of the literature and clinical experience. J. Oncol. 2019;2019:5483791. doi: 10.1155/2019/5483791."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/S1470-2045(18)30083-4", "@IdType": "doi"}, {"#text": "29433963", "@IdType": "pubmed"}]}, "Citation": "Wildiers H, et al. Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group. Lancet Oncol. 2018;19:323\u2013336. doi: 10.1016/S1470-2045(18)30083-4."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrclinonc.2018.33", "@IdType": "doi"}, {"#text": "29485134", "@IdType": "pubmed"}]}, "Citation": "Romero D. Breast cancer: metronomic chemotherapy for elderly and/or frail patients. Nat. Rev. Clin. Oncol. 2018;15:266. doi: 10.1038/nrclinonc.2018.33."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.4183", "@IdType": "doi"}, {"#text": "PMC4695206", "@IdType": "pmc"}, {"#text": "26009994", "@IdType": "pubmed"}]}, "Citation": "Golan T, et al. RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients. Oncotarget. 2015;6:24560\u201324570. doi: 10.18632/oncotarget.4183."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/gcc.22725", "@IdType": "doi"}, {"#text": "PMC6368474", "@IdType": "pmc"}, {"#text": "30578699", "@IdType": "pubmed"}]}, "Citation": "Cortez MA, et al. Role of miRNAs in immune responses and immunotherapy in cancer. Genes Chromosomes Cancer. 2019;58:244\u2013253. doi: 10.1002/gcc.22725."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1111/febs.14030", "@IdType": "doi"}, {"#text": "28132417", "@IdType": "pubmed"}]}, "Citation": "Smolle MA, Calin HN, Pichler M, Calin GA. Noncoding RNAs and immune checkpoints-clinical implications as cancer therapeutics. FEBS J. 2017;284:1952\u20131966. doi: 10.1111/febs.14030."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6924635", "@IdType": "pmc"}, {"#text": "31867576", "@IdType": "pubmed"}]}, "Citation": "De Los Santos MC, Dragomir MP, Calin GA. The role of exosomal long non-coding RNAs in cancer drug resistance. Cancer Drug Resist. 2019;2:1178\u20131192."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature05697", "@IdType": "doi"}, {"#text": "17429401", "@IdType": "pubmed"}]}, "Citation": "Whitehurst AW, et al. Synthetic lethal screen identification of chemosensitizer loci in cancer cells. Nature. 2007;446:815\u2013819. doi: 10.1038/nature05697."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/1078-0432.CCR-16-1025", "@IdType": "doi"}, {"#text": "PMC5449263", "@IdType": "pmc"}, {"#text": "27903673", "@IdType": "pubmed"}]}, "Citation": "Van Roosbroeck K, et al. Combining anti-Mir-155 with chemotherapy for the treatment of lung cancers. Clin. Cancer Res. 2017;23:2891\u20132904. doi: 10.1158/1078-0432.CCR-16-1025."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1371/journal.pone.0089105", "@IdType": "doi"}, {"#text": "PMC3925231", "@IdType": "pmc"}, {"#text": "24551227", "@IdType": "pubmed"}]}, "Citation": "Zhao J, Kelnar K, Bader AG. In-depth analysis shows synergy between erlotinib and miR-34a. PLoS ONE. 2014;9:e89105. doi: 10.1371/journal.pone.0089105."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/mtna.2015.47", "@IdType": "doi"}, {"#text": "PMC5014539", "@IdType": "pmc"}, {"#text": "26670277", "@IdType": "pubmed"}]}, "Citation": "Cortez MA, et al. In vivo delivery of miR-34a sensitizes lung tumors to radiation through RAD51 regulation. Mol. Ther. Nucleic Acids. 2015;4:e270. doi: 10.1038/mtna.2015.47."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.pharmthera.2018.04.001", "@IdType": "doi"}, {"#text": "29649500", "@IdType": "pubmed"}]}, "Citation": "Leucci E. Cancer development and therapy resistance: spotlights on the dark side of the genome. Pharmacol. Ther. 2018;189:22\u201330. doi: 10.1016/j.pharmthera.2018.04.001."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.drup.2020.100683", "@IdType": "doi"}, {"#text": "32146422", "@IdType": "pubmed"}]}, "Citation": "Jiang W, et al. Long non-coding RNAs as a determinant of cancer drug resistance: towards the overcoming of chemoresistance via modulation of lncRNAs. Drug Resist. Updat. 2020;50:100683. doi: 10.1016/j.drup.2020.100683."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1111/jvh.13282", "@IdType": "doi"}, {"#text": "32096313", "@IdType": "pubmed"}]}, "Citation": "Deng Y, et al. Randomized clinical trials towards a single-visit cure for chronic hepatitis C: oral GSK2878175 and injectable RG-101 in chronic hepatitis C patients and long-acting injectable GSK2878175 in healthy participants. J. Viral Hepat. 2020;27:699\u2013708. doi: 10.1111/jvh.13282."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/S0140-6736(16)31715-9", "@IdType": "doi"}, {"#text": "28087069", "@IdType": "pubmed"}]}, "Citation": "van der Ree MH, et al. Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial. Lancet. 2017;389:709\u2013717. doi: 10.1016/S0140-6736(16)31715-9."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s11095-018-2401-x", "@IdType": "doi"}, {"#text": "29679159", "@IdType": "pubmed"}]}, "Citation": "Zhao G, Zhang H. Notch-1 siRNA and methotrexate towards a multifunctional approach in rhematoid arthritis management: a nanomedicine approach. Pharm. Res. 2018;35:123. doi: 10.1007/s11095-018-2401-x."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1021/acsami.9b21214", "@IdType": "doi"}, {"#text": "PMC7011569", "@IdType": "pmc"}, {"#text": "31939276", "@IdType": "pubmed"}]}, "Citation": "Wang Y, et al. Endosomolytic and tumor-penetrating mesoporous silica nanoparticles for siRNA/miRNA combination cancer therapy. ACS Appl. Mater. Interfaces. 2020;12:4308\u20134322. doi: 10.1021/acsami.9b21214."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.4161/cbt.7.7.6168", "@IdType": "doi"}, {"#text": "PMC2705979", "@IdType": "pmc"}, {"#text": "18443431", "@IdType": "pubmed"}]}, "Citation": "Lu C, et al. EphA2 overexpression promotes ovarian cancer growth. Cancer Biol. Ther. 2008;7:1098\u20131103. doi: 10.4161/cbt.7.7.6168."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/2159-8290.CD-13-0159", "@IdType": "doi"}, {"#text": "PMC3855315", "@IdType": "pmc"}, {"#text": "24002999", "@IdType": "pubmed"}]}, "Citation": "Nishimura M, et al. Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment. Cancer Discov. 2013;3:1302\u20131315. doi: 10.1158/2159-8290.CD-13-0159."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.biomaterials.2018.09.017", "@IdType": "doi"}, {"#text": "30241030", "@IdType": "pubmed"}]}, "Citation": "Song Y, Tang C, Yin C. Combination antitumor immunotherapy with VEGF and PIGF siRNA via systemic delivery of multi-functionalized nanoparticles to tumor-associated macrophages and breast cancer cells. Biomaterials. 2018;185:117\u2013132. doi: 10.1016/j.biomaterials.2018.09.017."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s00253-019-09934-5", "@IdType": "doi"}, {"#text": "PMC7068804", "@IdType": "pmc"}, {"#text": "31187211", "@IdType": "pubmed"}]}, "Citation": "Petrek H, Batra N, Ho PY, Tu MJ, Yu AM. Bioengineering of a single long noncoding RNA molecule that carries multiple small RNAs. Appl. Microbiol. Biotechnol. 2019;103:6107\u20136117. doi: 10.1007/s00253-019-09934-5."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/nar/gkv228", "@IdType": "doi"}, {"#text": "PMC4402540", "@IdType": "pmc"}, {"#text": "25800741", "@IdType": "pubmed"}]}, "Citation": "Chen QX, Wang WP, Zeng S, Urayama S, Yu AM. A general approach to high-yield biosynthesis of chimeric RNAs bearing various types of functional small RNAs for broad applications. Nucleic Acids Res. 2015;43:3857\u20133869. doi: 10.1093/nar/gkv228."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1124/jpet.118.247775", "@IdType": "doi"}, {"#text": "PMC5931433", "@IdType": "pmc"}, {"#text": "29602831", "@IdType": "pubmed"}]}, "Citation": "Ho PY, et al. Bioengineered noncoding RNAs selectively change cellular miRNome profiles for cancer therapy. J. Pharmacol. Exp. Ther. 2018;365:494\u2013506. doi: 10.1124/jpet.118.247775."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/clpt.2010.46", "@IdType": "doi"}, {"#text": "PMC3902962", "@IdType": "pmc"}, {"#text": "20428111", "@IdType": "pubmed"}]}, "Citation": "Zhang S, Chen L, Jung EJ, Calin GA. Targeting microRNAs with small molecules: from dream to reality. Clin. Pharmacol. Ther. 2010;87:754\u2013758. doi: 10.1038/clpt.2010.46."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1021/cb400668h", "@IdType": "doi"}, {"#text": "24359019", "@IdType": "pubmed"}]}, "Citation": "Vo DD, et al. Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules. ACS Chem. Biol. 2014;9:711\u2013721. doi: 10.1021/cb400668h."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/978-1-4939-6563-2_11", "@IdType": "doi"}, {"#text": "27924481", "@IdType": "pubmed"}]}, "Citation": "Periwal V, Scaria V. Machine learning approaches toward building predictive models for small molecule modulators of miRNA and its utility in virtual screening of molecular databases. Methods Mol. Biol. 2017;1517:155\u2013168. doi: 10.1007/978-1-4939-6563-2_11."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.celrep.2018.04.116", "@IdType": "doi"}, {"#text": "PMC6511231", "@IdType": "pmc"}, {"#text": "29874593", "@IdType": "pubmed"}]}, "Citation": "Wang L, et al. Small-molecule inhibitors disrupt let-7 oligouridylation and release the selective blockade of let-7 processing by LIN28. Cell. Rep. 2018;23:3091\u20133101. doi: 10.1016/j.celrep.2018.04.116."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/chem.201502913", "@IdType": "doi"}, {"#text": "26440562", "@IdType": "pubmed"}]}, "Citation": "Fukuzumi T, Murata A, Aikawa H, Harada Y, Nakatani K. Exploratory study on the RNA-binding structural motifs by library screening targeting pre-miRNA-29a. Chemistry. 2015;21:16859\u201316867. doi: 10.1002/chem.201502913."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1021/cb300650y", "@IdType": "doi"}, {"#text": "23402670", "@IdType": "pubmed"}]}, "Citation": "Bose D, Jayaraj GG, Kumar S, Maiti S. A molecular-beacon-based screen for small molecule inhibitors of miRNA maturation. ACS Chem. Biol. 2013;8:930\u2013938. doi: 10.1021/cb300650y."}, {"ArticleIdList": {"ArticleId": {"#text": "30325405", "@IdType": "pubmed"}}, "Citation": "Chen X, Guan NN, Sun YZ, Li JQ, Qu J. MicroRNA-small molecule association identification: from experimental results to computational models. Brief. Bioinform. 2020;21:47\u201361."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/srep00282", "@IdType": "doi"}, {"#text": "PMC3282946", "@IdType": "pmc"}, {"#text": "22355792", "@IdType": "pubmed"}]}, "Citation": "Jiang W, et al. Identification of links between small molecules and miRNAs in human cancers based on transcriptional responses. Sci. Rep. 2012;2:282. doi: 10.1038/srep00282."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.10052", "@IdType": "doi"}, {"#text": "PMC5216744", "@IdType": "pmc"}, {"#text": "27329603", "@IdType": "pubmed"}]}, "Citation": "Li J, et al. Network-based identification of microRNAs as potential pharmacogenomic biomarkers for anticancer drugs. Oncotarget. 2016;7:45584\u201345596. doi: 10.18632/oncotarget.10052."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/bioinformatics/bts698", "@IdType": "doi"}, {"#text": "23220571", "@IdType": "pubmed"}]}, "Citation": "Liu X, et al. SM2miR: a database of the experimentally validated small molecules\u2019 effects on microRNA expression. Bioinformatics. 2013;29:409\u2013411. doi: 10.1093/bioinformatics/bts698."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1021/acschembio.6b00001", "@IdType": "doi"}, {"#text": "PMC4912454", "@IdType": "pmc"}, {"#text": "27097021", "@IdType": "pubmed"}]}, "Citation": "Disney MD, et al. Inforna 2.0: a platform for the sequence-based design of small molecules targeting structured RNAs. ACS Chem. Biol. 2016;11:1720\u20131728. doi: 10.1021/acschembio.6b00001."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.jgg.2017.04.003", "@IdType": "doi"}, {"#text": "28529075", "@IdType": "pubmed"}]}, "Citation": "Chen X, Xie WB, Xiao PP, Zhao XM, Yan H. mTD: a database of microRNAs affecting therapeutic effects of drugs. J. Genet. Genomics. 2017;44:269\u2013271. doi: 10.1016/j.jgg.2017.04.003."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/database/bax057", "@IdType": "doi"}, {"#text": "PMC5527270", "@IdType": "pmc"}, {"#text": "29220444", "@IdType": "pubmed"}]}, "Citation": "Chen X, et al. NRDTD: a database for clinically or experimentally supported non-coding RNAs and drug targets associations. Database. 2017 doi: 10.1093/database/bax057."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12859-016-1002-0", "@IdType": "doi"}, {"#text": "PMC4836156", "@IdType": "pmc"}, {"#text": "27091357", "@IdType": "pubmed"}]}, "Citation": "Su EC, et al. ChemiRs: a web application for microRNAs and chemicals. BMC Bioinform. 2016;17:167. doi: 10.1186/s12859-016-1002-0."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41598-018-20053-5", "@IdType": "doi"}, {"#text": "PMC5786041", "@IdType": "pmc"}, {"#text": "29374231", "@IdType": "pubmed"}]}, "Citation": "Staedel C, et al. Modulation of oncogenic miRNA biogenesis using functionalized polyamines. Sci. Rep. 2018;8:1667. doi: 10.1038/s41598-018-20053-5."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/anie.200801555", "@IdType": "doi"}, {"#text": "PMC3428715", "@IdType": "pmc"}, {"#text": "18712719", "@IdType": "pubmed"}]}, "Citation": "Gumireddy K, et al. Small-molecule inhibitors of microrna miR-21 function. Angew. Chem. Int. Ed. Engl. 2008;47:7482\u20137484. doi: 10.1002/anie.200801555."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1021/ja910275u", "@IdType": "doi"}, {"#text": "20527935", "@IdType": "pubmed"}]}, "Citation": "Young DD, Connelly CM, Grohmann C, Deiters A. Small molecule modifiers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinoma. J. Am. Chem. Soc. 2010;132:7976\u20137981. doi: 10.1021/ja910275u."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bmcl.2011.10.061", "@IdType": "doi"}, {"#text": "22100313", "@IdType": "pubmed"}]}, "Citation": "Chandrasekhar S, et al. za-flavanones as potent cross-species microRNA inhibitors that arrest cell cycle. Bioorg. Med. Chem. Lett. 2012;22:645\u2013648. doi: 10.1016/j.bmcl.2011.10.061."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.1523975113", "@IdType": "doi"}, {"#text": "PMC4889373", "@IdType": "pmc"}, {"#text": "27170187", "@IdType": "pubmed"}]}, "Citation": "Velagapudi SP, et al. Design of a small molecule against an oncogenic noncoding RNA. Proc. Natl Acad. Sci. USA. 2016;113:5898\u20135903. doi: 10.1073/pnas.1523975113."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.omtn.2020.03.003", "@IdType": "doi"}, {"#text": "PMC7118281", "@IdType": "pmc"}, {"#text": "32244168", "@IdType": "pubmed"}]}, "Citation": "Bautista-S\u00e1nchez D, et al. The promising role of miR-21 as a cancer biomarker and its importance in RNA-based therapeutics. Mol. Ther. Nucleic Acids. 2020;20:409\u2013420. doi: 10.1016/j.omtn.2020.03.003."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/anie.201106455", "@IdType": "doi"}, {"#text": "22173871", "@IdType": "pubmed"}]}, "Citation": "Bose D, et al. The tuberculosis drug streptomycin as a potential cancer therapeutic: inhibition of miR-21 function by directly targeting its precursor. Angew. Chem. Int. Ed. Engl. 2012;51:1019\u20131023. doi: 10.1002/anie.201106455."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/nar/gkv185", "@IdType": "doi"}, {"#text": "PMC4417150", "@IdType": "pmc"}, {"#text": "25824952", "@IdType": "pubmed"}]}, "Citation": "Bose D, et al. Selective inhibition of miR-21 by phage display screened peptide. Nucleic Acids Res. 2015;43:4342\u20134352. doi: 10.1093/nar/gkv185."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/0008-5472.CAN-13-0280", "@IdType": "doi"}, {"#text": "23811941", "@IdType": "pubmed"}]}, "Citation": "Shi Z, et al. AC1MMYR2, an inhibitor of dicer-mediated biogenesis of Oncomir miR-21, reverses epithelial-mesenchymal transition and suppresses tumor growth and progression. Cancer Res. 2013;73:5519\u20135531. doi: 10.1158/0008-5472.CAN-13-0280."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1021/acschembio.6b00214", "@IdType": "doi"}, {"#text": "27536863", "@IdType": "pubmed"}]}, "Citation": "Murata A, Otabe T, Zhang J, Nakatani K. BzDANP, a small-molecule modulator of pre-miR-29a maturation by dicer. ACS Chem. Biol. 2016;11:2790\u20132796. doi: 10.1021/acschembio.6b00214."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bmc.2019.03.031", "@IdType": "doi"}, {"#text": "30952388", "@IdType": "pubmed"}]}, "Citation": "Otabe T, Nagano K, Kawai G, Murata A, Nakatani K. Inhibition of pre-miRNA-136 processing by Dicer with small molecule BzDANP suggested the formation of ternary complex of pre-miR-136-BzDANP-Dicer. Bioorg. Med. Chem. 2019;27:2140\u20132148. doi: 10.1016/j.bmc.2019.03.031."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1128/MCB.01242-10", "@IdType": "doi"}, {"#text": "PMC3133367", "@IdType": "pmc"}, {"#text": "21555452", "@IdType": "pubmed"}]}, "Citation": "Kelly TJ, Souza AL, Clish CB, Puigserver PA. Hypoxia-Induced Positive Feedback Loop Promotes Hypoxia-Inducible Factor 1\u03b1 Stability through miR-210 Suppression of Glycerol-3-Phosphate Dehydrogenase 1-Like. Mol. Cell. Biol. 2011;31:2696\u20132706. doi: 10.1128/MCB.01242-10."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1128/MCB.01395-06", "@IdType": "doi"}, {"#text": "PMC1820461", "@IdType": "pmc"}, {"#text": "17194750", "@IdType": "pubmed"}]}, "Citation": "Kulshreshtha R, et al. A MicroRNA Signature of Hypoxia. Mol. Cell. Biol. 2007;27:1859\u20131867. doi: 10.1128/MCB.01395-06."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1021/jacs.6b11273", "@IdType": "doi"}, {"#text": "PMC5810126", "@IdType": "pmc"}, {"#text": "28240549", "@IdType": "pubmed"}]}, "Citation": "Costales MG, et al. Small molecule inhibition of microRNA-210 reprograms an oncogenic hypoxic circuit. J. Am. Chem. Soc. 2017;139:3446\u20133455. doi: 10.1021/jacs.6b11273."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41598-018-30989-3", "@IdType": "doi"}, {"#text": "PMC6117344", "@IdType": "pmc"}, {"#text": "30166612", "@IdType": "pubmed"}]}, "Citation": "Monroig-Bosque PDC, et al. OncomiR-10b hijacks the small molecule inhibitor linifanib in human cancers. Sci. Rep. 2018;8:13106. doi: 10.1038/s41598-018-30989-3."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1021/jacs.8b01233", "@IdType": "doi"}, {"#text": "PMC6100793", "@IdType": "pmc"}, {"#text": "29792692", "@IdType": "pubmed"}]}, "Citation": "Costales MG, Matsumoto Y, Velagapudi SP, Disney MD. Small molecule targeted recruitment of a nuclease to RNA. J. Am. Chem. Soc. 2018;140:6741\u20136744. doi: 10.1021/jacs.8b01233."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.1914286117", "@IdType": "doi"}, {"#text": "PMC7007575", "@IdType": "pmc"}, {"#text": "31964809", "@IdType": "pubmed"}]}, "Citation": "Costales MG, et al. Small-molecule targeted recruitment of a nuclease to cleave an oncogenic RNA in a mouse model of metastatic cancer. Proc. Natl Acad. Sci. USA. 2020;117:2406\u20132411. doi: 10.1073/pnas.1914286117."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ymeth.2019.05.004", "@IdType": "doi"}, {"#text": "PMC6756959", "@IdType": "pmc"}, {"#text": "31077820", "@IdType": "pubmed"}]}, "Citation": "Yan H, Liang F. S. miRNA inhibition by proximity-enabled Dicer inactivation. Methods. 2019;167:117\u2013123. doi: 10.1016/j.ymeth.2019.05.004."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bioorg.2018.07.003", "@IdType": "doi"}, {"#text": "PMC6098719", "@IdType": "pmc"}, {"#text": "29990897", "@IdType": "pubmed"}]}, "Citation": "Yan H, Bhattarai U, Song Y, Liang FS. Design, synthesis and activity of light deactivatable microRNA inhibitor. Bioorg. Chem. 2018;80:492\u2013497. doi: 10.1016/j.bioorg.2018.07.003."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/ijo.2012.1542", "@IdType": "doi"}, {"#text": "22766763", "@IdType": "pubmed"}]}, "Citation": "Dong CG, et al. Co-inhibition of microRNA-10b and microRNA-21 exerts synergistic inhibition on the proliferation and invasion of human glioma cells. Int. J. Oncol. 2012;41:1005\u20131012. doi: 10.3892/ijo.2012.1542."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.chembiol.2019.04.009", "@IdType": "doi"}, {"#text": "PMC6713458", "@IdType": "pmc"}, {"#text": "31155510", "@IdType": "pubmed"}]}, "Citation": "Song JH, et al. Small-molecule-targeting hairpin loop of hTERT promoter G-quadruplex induces cancer cell death. Cell. Chem. Biol. 2019;26:1110\u20131121.e4. doi: 10.1016/j.chembiol.2019.04.009."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.chembiol.2018.11.012", "@IdType": "doi"}, {"#text": "30661991", "@IdType": "pubmed"}]}, "Citation": "Shi Y, et al. Stabilization of lncRNA GAS5 by a small molecule and its implications in diabetic adipocytes. Cell. Chem. Biol. 2019;26:319\u2013330.e6. doi: 10.1016/j.chembiol.2018.11.012."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/anie.201808823", "@IdType": "doi"}, {"#text": "PMC6589350", "@IdType": "pmc"}, {"#text": "30134013", "@IdType": "pubmed"}]}, "Citation": "Donlic A, et al. Discovery of small molecule ligands for MALAT1 by tuning an RNA-binding scaffold. Angew. Chem. Int. Ed. Engl. 2018;57:13242\u201313247. doi: 10.1002/anie.201808823."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1021/acschembio.8b00807", "@IdType": "doi"}, {"#text": "PMC6709583", "@IdType": "pmc"}, {"#text": "30620551", "@IdType": "pubmed"}]}, "Citation": "Abulwerdi FA, et al. Selective small-molecule targeting of a triple helix encoded by the long noncoding RNA, MALAT1. ACS Chem. Biol. 2019;14:223\u2013235. doi: 10.1021/acschembio.8b00807."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3389/fgene.2020.00093", "@IdType": "doi"}, {"#text": "PMC7056701", "@IdType": "pmc"}, {"#text": "32174966", "@IdType": "pubmed"}]}, "Citation": "Chen Q, Zhu C, Jin Y. The oncogenic and tumor suppressive functions of the long noncoding RNA MALAT1: an emerging controversy. Front. Genet. 2020;11:93. doi: 10.3389/fgene.2020.00093."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1021/acs.accounts.8b00650", "@IdType": "doi"}, {"#text": "30912917", "@IdType": "pubmed"}]}, "Citation": "Egli M, Manoharan M. Re-engineering RNA molecules into therapeutic agents. Acc. Chem. Res. 2019;52:1036\u20131047. doi: 10.1021/acs.accounts.8b00650."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1021/jacs.0c04928", "@IdType": "doi"}, {"#text": "32786803", "@IdType": "pubmed"}]}, "Citation": "Crooke ST, Seth PP, Vickers TA, Liang XH. The interaction of phosphorothioate-containing RNA targeted drugs with proteins is a critical determinant of the therapeutic effects of these agents. J. Am. Chem. Soc. 2020;142:14754\u201314771. doi: 10.1021/jacs.0c04928."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1074/jbc.M307089200", "@IdType": "doi"}, {"#text": "12952966", "@IdType": "pubmed"}]}, "Citation": "Saxena S, J\u00f3nsson ZO, Dutta A. Small RNAs with imperfect match to endogenous mRNA repress translation. Implications for off-target activity of small inhibitory RNA in mammalian cells. J. Biol. Chem. 2003;278:44312\u201344319. doi: 10.1074/jbc.M307089200."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1261/rna.25706", "@IdType": "doi"}, {"#text": "PMC1484447", "@IdType": "pmc"}, {"#text": "16682560", "@IdType": "pubmed"}]}, "Citation": "Jackson AL, et al. Widespread siRNA \u201coff-target\u201d transcript silencing mediated by seed region sequence complementarity. RNA. 2006;12:1179\u20131187. doi: 10.1261/rna.25706."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/nar/gkn902", "@IdType": "doi"}, {"#text": "PMC2602766", "@IdType": "pmc"}, {"#text": "18988625", "@IdType": "pubmed"}]}, "Citation": "Ui-Tei K, Naito Y, Nishi K, Juni A, Saigo K. Thermodynamic stability and Watson-Crick base pairing in the seed duplex are major determinants of the efficiency of the siRNA-based off-target effect. Nucleic Acids Res. 2008;36:7100\u20137109. doi: 10.1093/nar/gkn902."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/nar/gki193", "@IdType": "doi"}, {"#text": "PMC546170", "@IdType": "pmc"}, {"#text": "15653644", "@IdType": "pubmed"}]}, "Citation": "Elm\u00e9n J, et al. Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality. Nucleic Acids Res. 2005;33:439\u2013447. doi: 10.1093/nar/gki193."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/1535-7163.MCT-06-0195", "@IdType": "doi"}, {"#text": "17363479", "@IdType": "pubmed"}]}, "Citation": "Mook OR, Baas F, de Wissel MB, Fluiter K. Evaluation of locked nucleic acid-modified small interfering RNA in vitro and in vivo. Mol. Cancer Ther. 2007;6:833\u2013843. doi: 10.1158/1535-7163.MCT-06-0195."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/ncomms4459", "@IdType": "doi"}, {"#text": "PMC4112501", "@IdType": "pmc"}, {"#text": "24619206", "@IdType": "pubmed"}]}, "Citation": "Wu SY, et al. 2\u2019-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity. Nat. Commun. 2014;5:3459. doi: 10.1038/ncomms4459."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/mt.2008.298", "@IdType": "doi"}, {"#text": "PMC2835116", "@IdType": "pmc"}, {"#text": "19156133", "@IdType": "pubmed"}]}, "Citation": "Chang CI, et al. Asymmetric shorter-duplex siRNA structures trigger efficient gene silencing with reduced nonspecific effects. Mol. Ther. 2009;17:725\u2013732. doi: 10.1038/mt.2008.298."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/nar/gkm548", "@IdType": "doi"}, {"#text": "PMC2034465", "@IdType": "pmc"}, {"#text": "17726057", "@IdType": "pubmed"}]}, "Citation": "Bramsen JB, et al. Improved silencing properties using small internally segmented interfering RNAs. Nucleic Acids Res. 2007;35:5886\u20135897. doi: 10.1093/nar/gkm548."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/978-1-0716-0290-4_9", "@IdType": "doi"}, {"#text": "32006400", "@IdType": "pubmed"}]}, "Citation": "Mobergslien A, Sioud M. Exploring 5\u2032-biotinylation of the sense strand to improve siRNA specificity and potency. Methods Mol. Biol. 2020;2115:163\u2013170. doi: 10.1007/978-1-0716-0290-4_9."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/nar/gkt200", "@IdType": "doi"}, {"#text": "PMC3695504", "@IdType": "pmc"}, {"#text": "23620279", "@IdType": "pubmed"}]}, "Citation": "Snead NM, et al. Molecular basis for improved gene silencing by Dicer substrate interfering RNA compared with other siRNA variants. Nucleic Acids Res. 2013;41:6209\u20136221. doi: 10.1093/nar/gkt200."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1200/JCO.2007.14.3461", "@IdType": "doi"}, {"#text": "PMC3715075", "@IdType": "pmc"}, {"#text": "18281659", "@IdType": "pubmed"}]}, "Citation": "Rudin CM, et al. Randomized phase II study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer: CALGB 30103. J. Clin. Oncol. 2008;26:870\u2013876. doi: 10.1200/JCO.2007.14.3461."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/annonc/mdn784", "@IdType": "doi"}, {"#text": "19297314", "@IdType": "pubmed"}]}, "Citation": "Sternberg CN, et al. Docetaxel plus oblimersen sodium (Bcl-2 antisense oligonucleotide): an EORTC multicenter, randomized phase II study in patients with castration-resistant prostate cancer. Ann. Oncol. 2009;20:1264\u20131269. doi: 10.1093/annonc/mdn784."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/sj.cgt.7700901", "@IdType": "doi"}, {"#text": "16195754", "@IdType": "pubmed"}]}, "Citation": "Anderson EM, et al. Gene profiling study of G3139- and Bcl-2-targeting siRNAs identifies a unique G3139 molecular signature. Cancer Gene Ther. 2006;13:406\u2013414. doi: 10.1038/sj.cgt.7700901."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/cmdc.201000156", "@IdType": "doi"}, {"#text": "20544786", "@IdType": "pubmed"}]}, "Citation": "Winkler J, Stessl M, Amartey J, Noe CR. Off-target effects related to the phosphorothioate modification of nucleic acids. ChemMedChem. 2010;5:1344\u20131352. doi: 10.1002/cmdc.201000156."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.0602217103", "@IdType": "doi"}, {"#text": "PMC1464367", "@IdType": "pmc"}, {"#text": "16648253", "@IdType": "pubmed"}]}, "Citation": "Lai JC, et al. A pharmacologic target of G3139 in melanoma cells may be the mitochondrial VDAC. Proc. Natl Acad. Sci. USA. 2006;103:7494\u20137499. doi: 10.1073/pnas.0602217103."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1529/biophysj.107.105379", "@IdType": "doi"}, {"#text": "PMC1929033", "@IdType": "pmc"}, {"#text": "17483171", "@IdType": "pubmed"}]}, "Citation": "Tan W, Loke YH, Stein CA, Miller P, Colombini M. Phosphorothioate oligonucleotides block the VDAC channel. Biophys. J. 2007;93:1184\u20131191. doi: 10.1529/biophysj.107.105379."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/annonc/mdn672", "@IdType": "doi"}, {"#text": "PMC2733126", "@IdType": "pmc"}, {"#text": "18977852", "@IdType": "pubmed"}]}, "Citation": "Pisano M, et al. Targeting Bcl-2 protein in treatment of melanoma still requires further clarifications. Ann. Oncol. 2008;19:2092\u20132093. doi: 10.1093/annonc/mdn672."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1172/JCI63966", "@IdType": "doi"}, {"#text": "PMC3408753", "@IdType": "pmc"}, {"#text": "22820284", "@IdType": "pubmed"}]}, "Citation": "Wen J, Friedman J. R. miR-122 regulates hepatic lipid metabolism and tumor suppression. J. Clin. Invest. 2012;122:2773\u20132776. doi: 10.1172/JCI63966."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/hep.22656", "@IdType": "doi"}, {"#text": "PMC2635423", "@IdType": "pmc"}, {"#text": "19127519", "@IdType": "pubmed"}]}, "Citation": "Hand NJ, Master ZR, Le Lay J, Friedman JR. Hepatic function is preserved in the absence of mature microRNAs. Hepatology. 2009;49:618\u2013626. doi: 10.1002/hep.22656."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.antiviral.2014.08.015", "@IdType": "doi"}, {"#text": "25218783", "@IdType": "pubmed"}]}, "Citation": "van der Ree MH, et al. Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients. Antivir. Res. 2014;111:53\u201359. doi: 10.1016/j.antiviral.2014.08.015."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41419-018-1295-1", "@IdType": "doi"}, {"#text": "PMC6362007", "@IdType": "pmc"}, {"#text": "30718475", "@IdType": "pubmed"}]}, "Citation": "Hart M, et al. miR-34a: a new player in the regulation of T cell function by modulation of NF-\u03baB signaling. Cell Death Dis. 2019;10:46. doi: 10.1038/s41419-018-1295-1."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ymthe.2019.09.008", "@IdType": "doi"}, {"#text": "PMC6952168", "@IdType": "pmc"}, {"#text": "31604677", "@IdType": "pubmed"}]}, "Citation": "Xu Y, et al. Macrophage miR-34a is a key regulator of cholesterol efflux and atherosclerosis. Mol. Ther. 2020;28:202\u2013216. doi: 10.1016/j.ymthe.2019.09.008."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1136/jitc-2020-001617", "@IdType": "doi"}, {"#text": "PMC7684812", "@IdType": "pmc"}, {"#text": "33229509", "@IdType": "pubmed"}]}, "Citation": "Hart M, et al. Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4(+), CD8(+) T cells, and M1 macrophages. J. Immunother. Cancer. 2020;8:e001617. doi: 10.1136/jitc-2020-001617."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.canlet.2012.06.015", "@IdType": "doi"}, {"#text": "22776562", "@IdType": "pubmed"}]}, "Citation": "LaCasse EC. Pulling the plug on a cancer cell by eliminating XIAP with AEG35156. Cancer Lett. 2013;332:215\u2013224. doi: 10.1016/j.canlet.2012.06.015."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature04791", "@IdType": "doi"}, {"#text": "16724069", "@IdType": "pubmed"}]}, "Citation": "Grimm D, et al. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature. 2006;441:537\u2013541. doi: 10.1038/nature04791."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nbt.1543", "@IdType": "doi"}, {"#text": "PMC2782465", "@IdType": "pmc"}, {"#text": "19465925", "@IdType": "pubmed"}]}, "Citation": "Khan AA, et al. Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs. Nat. Biotechnol. 2009;27:549\u2013555. doi: 10.1038/nbt.1543."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1371/journal.pbio.0030085", "@IdType": "doi"}, {"#text": "PMC1043860", "@IdType": "pmc"}, {"#text": "15723116", "@IdType": "pubmed"}]}, "Citation": "Brennecke J, Stark A, Russell RB, Cohen SM. Principles of microRNA-target recognition. PLoS Biol. 2005;3:e85. doi: 10.1371/journal.pbio.0030085."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/ng1536", "@IdType": "doi"}, {"#text": "15806104", "@IdType": "pubmed"}]}, "Citation": "Krek A, et al. Combinatorial microRNA target predictions. Nat. Genet. 2005;37:495\u2013500. doi: 10.1038/ng1536."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3389/fgene.2015.00340", "@IdType": "doi"}, {"#text": "PMC4667072", "@IdType": "pmc"}, {"#text": "26697058", "@IdType": "pubmed"}]}, "Citation": "Jin HY, et al. Transfection of microRNA mimics should be used with caution. Front. Genet. 2015;6:340. doi: 10.3389/fgene.2015.00340."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1261/rna.046862.114", "@IdType": "doi"}, {"#text": "PMC4338329", "@IdType": "pmc"}, {"#text": "25576498", "@IdType": "pubmed"}]}, "Citation": "Nyayanit D, Gadgil CJ. Mathematical modeling of combinatorial regulation suggests that apparent positive regulation of targets by miRNA could be an artifact resulting from competition for mRNA. RNA. 2015;21:307\u2013319. doi: 10.1261/rna.046862.114."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrdp.2016.78", "@IdType": "doi"}, {"#text": "27830764", "@IdType": "pubmed"}]}, "Citation": "Matthay KK, et al. Neuroblastoma. Nat. Rev. Dis. Prim. 2016;2:16078. doi: 10.1038/nrdp.2016.78."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.0801775105", "@IdType": "doi"}, {"#text": "PMC2311380", "@IdType": "pmc"}, {"#text": "18398004", "@IdType": "pubmed"}]}, "Citation": "McBride JL, et al. Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proc. Natl Acad. Sci. USA. 2008;105:5868\u20135873. doi: 10.1073/pnas.0801775105."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/gt.2011.10", "@IdType": "doi"}, {"#text": "PMC3131434", "@IdType": "pmc"}, {"#text": "21368900", "@IdType": "pubmed"}]}, "Citation": "Martin JN, et al. Lethal toxicity caused by expression of shRNA in the mouse striatum: implications for therapeutic design. Gene Ther. 2011;18:666\u2013673. doi: 10.1038/gt.2011.10."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s13059-017-1224-0", "@IdType": "doi"}, {"#text": "PMC5442648", "@IdType": "pmc"}, {"#text": "28535802", "@IdType": "pubmed"}]}, "Citation": "Rigoutsos I, et al. N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration. Genome Biol. 2017;18:98. doi: 10.1186/s13059-017-1224-0."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1136/gutjnl-2019-318903", "@IdType": "doi"}, {"#text": "PMC7382985", "@IdType": "pmc"}, {"#text": "31988194", "@IdType": "pubmed"}]}, "Citation": "Pichler M, et al. Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer. Gut. 2020;69:1818\u20131831. doi: 10.1136/gutjnl-2019-318903."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1136/gutjnl-2019-318279", "@IdType": "doi"}, {"#text": "32034004", "@IdType": "pubmed"}]}, "Citation": "Dragomir MP, Kopetz S, Ajani JA, Calin GA. Non-coding RNAs in GI cancers: from cancer hallmarks to clinical utility. Gut. 2020;69:748\u2013763. doi: 10.1136/gutjnl-2019-318279."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.gpb.2017.04.002", "@IdType": "doi"}, {"#text": "PMC5487532", "@IdType": "pmc"}, {"#text": "28602844", "@IdType": "pubmed"}]}, "Citation": "Awan HM, Shah A, Rashid F, Shan G. Primate-specific long non-coding RNAs and microRNAs. Genomics Proteom. Bioinform. 2017;15:187\u2013195. doi: 10.1016/j.gpb.2017.04.002."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1021/bi9627525", "@IdType": "doi"}, {"#text": "9125529", "@IdType": "pubmed"}]}, "Citation": "Jensen KK, Orum H, Nielsen PE, Nord\u00e9n B. Kinetics for hybridization of peptide nucleic acids (PNA) with DNA and RNA studied with the BIAcore technique. Biochemistry. 1997;36:5072\u20135077. doi: 10.1021/bi9627525."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.4161/adna.20911", "@IdType": "doi"}, {"#text": "PMC3429535", "@IdType": "pmc"}, {"#text": "22699795", "@IdType": "pubmed"}]}, "Citation": "Avitabile C, et al. Targeting pre-miRNA by peptide nucleic acids: a new strategy to interfere in the miRNA maturation. Artif. DNA PNA XNA. 2012;3:88\u201396. doi: 10.4161/adna.20911."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/cbic.201100745", "@IdType": "doi"}, {"#text": "PMC3401907", "@IdType": "pmc"}, {"#text": "22639449", "@IdType": "pubmed"}]}, "Citation": "Manicardi A, et al. Cellular uptakes, biostabilities and anti-miR-210 activities of chiral arginine-PNAs in leukaemic K562 cells. Chembiochem. 2012;13:1327\u20131337. doi: 10.1002/cbic.201100745."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/978-1-62703-703-7_13", "@IdType": "doi"}, {"#text": "24166311", "@IdType": "pubmed"}]}, "Citation": "Avitabile C, Fabbri E, Bianchi N, Gambari R, Romanelli A. Inhibition of miRNA maturation by peptide nucleic acids. Methods Mol. Biol. 2014;1095:157\u2013164. doi: 10.1007/978-1-62703-703-7_13."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41556-019-0345-y", "@IdType": "doi"}, {"#text": "PMC6697424", "@IdType": "pmc"}, {"#text": "31235936", "@IdType": "pubmed"}]}, "Citation": "Clancy JW, Zhang Y, Sheehan C, D\u2019Souza-Schorey C. An ARF6-Exportin-5 axis delivers pre-miRNA cargo to tumour microvesicles. Nat. Cell Biol. 2019;21:856\u2013866. doi: 10.1038/s41556-019-0345-y."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1021/ja0754453", "@IdType": "doi"}, {"#text": "18001025", "@IdType": "pubmed"}]}, "Citation": "Abe N, Abe H, Ito Y. Dumbbell-shaped nanocircular RNAs for RNA interference. J. Am. Chem. Soc. 2007;129:15108\u201315109. doi: 10.1021/ja0754453."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1021/bc2003154", "@IdType": "doi"}, {"#text": "21899349", "@IdType": "pubmed"}]}, "Citation": "Abe N, et al. Synthesis, structure, and biological activity of dumbbell-shaped nanocircular RNAs for RNA interference. Bioconjug. Chem. 2011;22:2082\u20132092. doi: 10.1021/bc2003154."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/ol.2020.12336", "@IdType": "doi"}, {"#text": "PMC7716711", "@IdType": "pmc"}, {"#text": "33365086", "@IdType": "pubmed"}]}, "Citation": "Gnanamony M, et al. Circular dumbbell miR-34a-3p and -5p suppresses pancreatic tumor cell-induced angiogenesis and activates macrophages. Oncol. Lett. 2021;21:75. doi: 10.3892/ol.2020.12336."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.omtn.2017.12.007", "@IdType": "doi"}, {"#text": "PMC5768153", "@IdType": "pmc"}, {"#text": "29499936", "@IdType": "pubmed"}]}, "Citation": "Zhang L, et al. Circular siRNAs for reducing off-target effects and enhancing long-term gene silencing in cells and mice. Mol. Ther. Nucleic Acids. 2018;10:237\u2013244. doi: 10.1016/j.omtn.2017.12.007."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1089/nat.2020.0894", "@IdType": "doi"}, {"#text": "33016851", "@IdType": "pubmed"}]}, "Citation": "Hagiwara K, et al. Development of prodrug type circular siRNA for in vivo knockdown by systemic administration. Nucleic Acid. Ther. 2020;30:346\u2013364. doi: 10.1089/nat.2020.0894."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bmc.2013.04.082", "@IdType": "doi"}, {"#text": "PMC3789856", "@IdType": "pmc"}, {"#text": "23721917", "@IdType": "pubmed"}]}, "Citation": "Griepenburg JC, Ruble BK, Dmochowski IJ. Caged oligonucleotides for bidirectional photomodulation of let-7 miRNA in zebrafish embryos. Bioorg. Med. Chem. 2013;21:6198\u20136204. doi: 10.1016/j.bmc.2013.04.082."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1039/C9CC04872C", "@IdType": "doi"}, {"#text": "31828267", "@IdType": "pubmed"}]}, "Citation": "Kimura Y, et al. Intracellular build-up RNAi with single-strand circular RNAs as siRNA precursors. Chem. Commun. 2020;56:466\u2013469. doi: 10.1039/C9CC04872C."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature11993", "@IdType": "doi"}, {"#text": "23446346", "@IdType": "pubmed"}]}, "Citation": "Hansen TB, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495:384\u2013388. doi: 10.1038/nature11993."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.molcel.2015.03.027", "@IdType": "doi"}, {"#text": "25921068", "@IdType": "pubmed"}]}, "Citation": "Rybak-Wolf A, et al. Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed. Mol. Cell. 2015;58:870\u2013885. doi: 10.1016/j.molcel.2015.03.027."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41576-019-0158-7", "@IdType": "doi"}, {"#text": "31395983", "@IdType": "pubmed"}]}, "Citation": "Kristensen LS, et al. The biogenesis, biology and characterization of circular RNAs. Nat. Rev. Genet. 2019;20:675\u2013691. doi: 10.1038/s41576-019-0158-7."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/srep08057", "@IdType": "doi"}, {"#text": "PMC4306919", "@IdType": "pmc"}, {"#text": "25624062", "@IdType": "pubmed"}]}, "Citation": "Bachmayr-Heyda A, et al. Correlation of circular RNA abundance with proliferation\u2013exemplified with colorectal and ovarian cancer, idiopathic lung fibrosis, and normal human tissues. Sci. Rep. 2015;5:8057. doi: 10.1038/srep08057."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.molcel.2017.05.022", "@IdType": "doi"}, {"#text": "PMC5610545", "@IdType": "pmc"}, {"#text": "28625551", "@IdType": "pubmed"}]}, "Citation": "Chen YG, et al. Sensing self and foreign circular RNAs by intron identity. Mol. Cell. 2017;67:228\u2013238.e5. doi: 10.1016/j.molcel.2017.05.022."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.molcel.2019.07.016", "@IdType": "doi"}, {"#text": "PMC6778039", "@IdType": "pmc"}, {"#text": "31474572", "@IdType": "pubmed"}]}, "Citation": "Chen YG, et al. N6-methyladenosine modification controls circular RNA immunity. Mol. Cell. 2019;76:96\u2013109.e9. doi: 10.1016/j.molcel.2019.07.016."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.molcel.2019.02.015", "@IdType": "doi"}, {"#text": "PMC6724735", "@IdType": "pmc"}, {"#text": "30902547", "@IdType": "pubmed"}]}, "Citation": "Wesselhoeft RA, et al. RNA circularization diminishes immunogenicity and can extend translation duration in vivo. Mol. Cell. 2019;74:508\u2013520.e4. doi: 10.1016/j.molcel.2019.02.015."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1097/CJI.0b013e318194a6e8", "@IdType": "doi"}, {"#text": "PMC2683970", "@IdType": "pmc"}, {"#text": "19238016", "@IdType": "pubmed"}]}, "Citation": "Hollyman D, et al. Manufacturing validation of biologically functional T cells targeted to CD19 antigen for autologous adoptive cell therapy. J. Immunother. 2009;32:169\u2013180. doi: 10.1097/CJI.0b013e318194a6e8."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1126/science.1231143", "@IdType": "doi"}, {"#text": "PMC3795411", "@IdType": "pmc"}, {"#text": "23287718", "@IdType": "pubmed"}]}, "Citation": "Cong L, et al. Multiplex genome engineering using CRISPR/Cas systems. Science. 2013;339:819\u2013823. doi: 10.1126/science.1231143."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1126/science.1232033", "@IdType": "doi"}, {"#text": "PMC3712628", "@IdType": "pmc"}, {"#text": "23287722", "@IdType": "pubmed"}]}, "Citation": "Mali P, et al. RNA-guided human genome engineering via Cas9. Science. 2013;339:823\u2013826. doi: 10.1126/science.1232033."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/mt.2011.269", "@IdType": "doi"}, {"#text": "PMC3293620", "@IdType": "pmc"}, {"#text": "22186789", "@IdType": "pubmed"}]}, "Citation": "Senzer N, et al. Phase I trial of \u201cbi-shRNAi(furin)/GMCSF DNA/autologous tumor cell\u201d vaccine (FANG) in advanced cancer. Mol. Ther. 2012;20:679\u2013686. doi: 10.1038/mt.2011.269."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ygyno.2016.09.018", "@IdType": "doi"}, {"#text": "27678295", "@IdType": "pubmed"}]}, "Citation": "Oh J, et al. Phase II study of Vigil\u00ae DNA engineered immunotherapy as maintenance in advanced stage ovarian cancer. Gynecol. Oncol. 2016;143:504\u2013510. doi: 10.1016/j.ygyno.2016.09.018."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/978-1-62703-119-6_14", "@IdType": "doi"}, {"#text": "23027056", "@IdType": "pubmed"}]}, "Citation": "Rao DD, et al. Bifunctional short hairpin RNA (bi-shRNA): design and pathway to clinical application. Methods Mol. Biol. 2013;942:259\u2013278. doi: 10.1007/978-1-62703-119-6_14."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/mt.2016.86", "@IdType": "doi"}, {"#text": "PMC5023386", "@IdType": "pmc"}, {"#text": "27109631", "@IdType": "pubmed"}]}, "Citation": "Ghisoli M, et al. Three-year follow up of GMCSF/bi-shRNA(furin) DNA-transfected autologous tumor immunotherapy (Vigil) in metastatic advanced Ewing\u2019s sarcoma. Mol. Ther. 2016;24:1478\u20131483. doi: 10.1038/mt.2016.86."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/wrna.1481", "@IdType": "doi"}, {"#text": "29790280", "@IdType": "pubmed"}]}, "Citation": "Swarts DC, Jinek M. Cas9 versus Cas12a/Cpf1: Structure-function comparisons and implications for genome editing. Wiley Interdiscip. Rev. RNA. 2018 doi: 10.1002/wrna.1481."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/srep16277", "@IdType": "doi"}, {"#text": "PMC4633726", "@IdType": "pmc"}, {"#text": "26538064", "@IdType": "pubmed"}]}, "Citation": "Zhang Y, et al. CRISPR/gRNA-directed synergistic activation mediator (SAM) induces specific, persistent and robust reactivation of the HIV-1 latent reservoirs. Sci. Rep. 2015;5:16277. doi: 10.1038/srep16277."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1126/science.aaq0180", "@IdType": "doi"}, {"#text": "PMC5793859", "@IdType": "pmc"}, {"#text": "29070703", "@IdType": "pubmed"}]}, "Citation": "Cox DBT, et al. RNA editing with CRISPR-Cas13. Science. 2017;358:1019\u20131027. doi: 10.1126/science.aaq0180."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12920-018-0394-2", "@IdType": "doi"}, {"#text": "PMC6131778", "@IdType": "pmc"}, {"#text": "30200981", "@IdType": "pubmed"}]}, "Citation": "Zhang Y, et al. Comprehensive off-target analysis of dCas9-SAM-mediated HIV reactivation via long noncoding RNA and mRNA profiling. BMC Med. Genomics. 2018;11:78. doi: 10.1186/s12920-018-0394-2."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ijid.2020.01.006", "@IdType": "doi"}, {"#text": "31945493", "@IdType": "pubmed"}]}, "Citation": "Shen L, et al. Roles and potential applications of lncRNAs in HIV infection. Int. J. Infect. Dis. 2020;92:97\u2013104. doi: 10.1016/j.ijid.2020.01.006."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ejphar.2019.04.042", "@IdType": "doi"}, {"#text": "31039344", "@IdType": "pubmed"}]}, "Citation": "Khosravi MA, et al. Targeted deletion of BCL11A gene by CRISPR-Cas9 system for fetal hemoglobin reactivation: a promising approach for gene therapy of beta thalassemia disease. Eur. J. Pharmacol. 2019;854:398\u2013405. doi: 10.1016/j.ejphar.2019.04.042."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41467-018-06883-x", "@IdType": "doi"}, {"#text": "PMC6197277", "@IdType": "pmc"}, {"#text": "30349036", "@IdType": "pubmed"}]}, "Citation": "Liu J, et al. Long non-coding RNA-dependent mechanism to regulate heme biosynthesis and erythrocyte development. Nat. Commun. 2018;9:4386. doi: 10.1038/s41467-018-06883-x."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/wsbm.1408.", "@IdType": "doi"}, {"#text": "29083112", "@IdType": "pubmed"}]}, "Citation": "Chew WL. Immunity to CRISPR Cas9 and Cas12a therapeutics. Wiley Interdiscip. Rev. Syst. Biol. Med. 2018 doi: 10.1002/wsbm.1408.."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.4155/fmc.14.116", "@IdType": "doi"}, {"#text": "PMC4417715", "@IdType": "pmc"}, {"#text": "25495987", "@IdType": "pubmed"}]}, "Citation": "Baumann V, Winkler J. miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents. Future Med. Chem. 2014;6:1967\u20131984. doi: 10.4155/fmc.14.116."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41434-020-0156-6", "@IdType": "doi"}, {"#text": "32483212", "@IdType": "pubmed"}]}, "Citation": "Dzierlega K, Yokota T. Optimization of antisense-mediated exon skipping for Duchenne muscular dystrophy. Gene Ther. 2020;27:407\u2013416. doi: 10.1038/s41434-020-0156-6."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1089/nat.2017.0716", "@IdType": "doi"}, {"#text": "PMC6000866", "@IdType": "pmc"}, {"#text": "29883296", "@IdType": "pubmed"}]}, "Citation": "Johannes L, Lucchino M. Current challenges in delivery and cytosolic translocation of therapeutic RNAs. Nucleic Acid. Ther. 2018;28:178\u2013193. doi: 10.1089/nat.2017.0716."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nbt.3802", "@IdType": "doi"}, {"#text": "28244992", "@IdType": "pubmed"}]}, "Citation": "Dowdy SF. Overcoming cellular barriers for RNA therapeutics. Nat. Biotechnol. 2017;35:222\u2013229. doi: 10.1038/nbt.3802."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.93.21.11493", "@IdType": "doi"}, {"#text": "PMC38085", "@IdType": "pmc"}, {"#text": "8876163", "@IdType": "pubmed"}]}, "Citation": "Zelphati O, Szoka FC., Jr. Mechanism of oligonucleotide release from cationic liposomes. Proc. Natl Acad. Sci. USA. 1996;93:11493\u201311498. doi: 10.1073/pnas.93.21.11493."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s13023-015-0326-6", "@IdType": "doi"}, {"#text": "PMC4559363", "@IdType": "pmc"}, {"#text": "26338094", "@IdType": "pubmed"}]}, "Citation": "Suhr OB, et al. Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study. Orphanet J. Rare Dis. 2015;10:109. doi: 10.1186/s13023-015-0326-6."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.nano.2016.07.016", "@IdType": "doi"}, {"#text": "27520723", "@IdType": "pubmed"}]}, "Citation": "Zhou Z, Kennell C, Lee JY, Leung YK, Tarapore P. Calcium phosphate-polymer hybrid nanoparticles for enhanced triple negative breast cancer treatment via co-delivery of paclitaxel and miR-221/222 inhibitors. Nanomedicine. 2017;13:403\u2013410. doi: 10.1016/j.nano.2016.07.016."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.actbio.2015.07.020", "@IdType": "doi"}, {"#text": "26169933", "@IdType": "pubmed"}]}, "Citation": "Gao S, et al. miRNA oligonucleotide and sponge for miRNA-21 inhibition mediated by PEI-PLL in breast cancer therapy. Acta Biomater. 2015;25:184\u2013193. doi: 10.1016/j.actbio.2015.07.020."}, {"ArticleIdList": {"ArticleId": {"#text": "10.1515/chem-2018-0138", "@IdType": "doi"}}, "Citation": "Chen CY, et al. MicroRNA delivery mediated by PEGylated polyethylenimine for prostate cancer therapy. Open Chem. 2018;16:1257\u20131267. doi: 10.1515/chem-2018-0138."}, {"ArticleIdList": {"ArticleId": {"#text": "23881828", "@IdType": "pubmed"}}, "Citation": "Biray Avc\u0131 \u00c7, \u00d6zcan \u0130, Balc\u0131 T, \u00d6zer \u00d6, G\u00fcnd\u00fcz C. Design of polyethylene glycol-polyethylenimine nanocomplexes as non-viral carriers: mir-150 delivery to chronic myeloid leukemia cells. Cell Biol. Int. 2013;37:1205\u20131214."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4069140", "@IdType": "pmc"}, {"#text": "24971005", "@IdType": "pubmed"}]}, "Citation": "Arora S, et al. Synthesis, characterization, and evaluation of poly (D,L-lactide-co-glycolide)-based nanoformulation of miRNA-150: potential implications for pancreatic cancer therapy. Int. J. Nanomed. 2014;9:2933\u20132942."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/srep17579", "@IdType": "doi"}, {"#text": "PMC4665167", "@IdType": "pmc"}, {"#text": "26620594", "@IdType": "pubmed"}]}, "Citation": "Cosco D, et al. Delivery of miR-34a by chitosan/PLGA nanoplexes for the anticancer treatment of multiple myeloma. Sci. Rep. 2015;5:17579. doi: 10.1038/srep17579."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/0008-5472.CAN-10-4645", "@IdType": "doi"}, {"#text": "21690566", "@IdType": "pubmed"}]}, "Citation": "Ibrahim AF, et al. MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma. Cancer Res. 2011;71:5214\u20135224. doi: 10.1158/0008-5472.CAN-10-4645."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/gt.2016.60", "@IdType": "doi"}, {"#text": "27482839", "@IdType": "pubmed"}]}, "Citation": "Liang G, et al. Cationic microRNA-delivering nanocarriers for efficient treatment of colon carcinoma in xenograft model. Gene Ther. 2016;23:829\u2013838. doi: 10.1038/gt.2016.60."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.nano.2015.09.014", "@IdType": "doi"}, {"#text": "26711968", "@IdType": "pubmed"}]}, "Citation": "Wang S, Zhang J, Wang Y, Chen M. Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy. Nanomedicine. 2016;12:411\u2013420. doi: 10.1016/j.nano.2015.09.014."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1177/0192623316645860", "@IdType": "doi"}, {"#text": "27147553", "@IdType": "pubmed"}]}, "Citation": "Ramot Y, et al. Preclinical safety evaluation in rats of a polymeric matrix containing an siRNA drug used as a local and prolonged delivery system for pancreatic cancer therapy. Toxicol. Pathol. 2016;44:856\u2013865. doi: 10.1177/0192623316645860."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.1314307110", "@IdType": "doi"}, {"#text": "PMC3870687", "@IdType": "pmc"}, {"#text": "24297898", "@IdType": "pubmed"}]}, "Citation": "Zorde Khvalevsky E, et al. Mutant KRAS is a druggable target for pancreatic cancer. Proc. Natl Acad. Sci. USA. 2013;110:20723\u201320728. doi: 10.1073/pnas.1314307110."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1021/acs.bioconjchem.5b00265", "@IdType": "doi"}, {"#text": "26011654", "@IdType": "pubmed"}]}, "Citation": "\u00d8stergaard ME, et al. Efficient synthesis and biological evaluation of 5\u2019-GalNAc conjugated antisense oligonucleotides. Bioconjug. Chem. 2015;26:1451\u20131455. doi: 10.1021/acs.bioconjchem.5b00265."}, {"ArticleIdList": {"ArticleId": {"#text": "26264060", "@IdType": "pubmed"}}, "Citation": "Sundqvist M, et al. Preclinical pharmacokinetics-pharmacodynamics modelling to guide first-time-in-human studies with the anti-miR-103/107, RG-125 (AZD4076). 51st EASD Annual Meeting. Diabetologia. 2015;58:1\u2013607."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/jcm10040838", "@IdType": "doi"}, {"#text": "PMC7922418", "@IdType": "pmc"}, {"#text": "33670689", "@IdType": "pubmed"}]}, "Citation": "Dugal-Tessier J, Thirumalairajan S, Jain N. Antibody-oligonucleotide conjugates: a twist to antibody-drug conjugates. J. Clin. Med. 2021;10:838. doi: 10.3390/jcm10040838."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/molecules24183287", "@IdType": "doi"}, {"#text": "PMC6767100", "@IdType": "pmc"}, {"#text": "31509944", "@IdType": "pubmed"}]}, "Citation": "Huggins IJ, et al. Site selective antibody-oligonucleotide conjugation via microbial transglutaminase. Molecules. 2019;24:3287. doi: 10.3390/molecules24183287."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/nar/gkaa286", "@IdType": "doi"}, {"#text": "PMC7261152", "@IdType": "pmc"}, {"#text": "32347936", "@IdType": "pubmed"}]}, "Citation": "Nanna AR, et al. Generation and validation of structurally defined antibody-siRNA conjugates. Nucleic Acids Res. 2020;48:5281\u20135293. doi: 10.1093/nar/gkaa286."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.jconrel.2016.06.036", "@IdType": "doi"}, {"#text": "27369865", "@IdType": "pubmed"}]}, "Citation": "Sugo T, et al. Development of antibody-siRNA conjugate targeted to cardiac and skeletal muscles. J. Control. Rel. 2016;237:1\u201313. doi: 10.1016/j.jconrel.2016.06.036."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/nar/gku1362", "@IdType": "doi"}, {"#text": "PMC4333408", "@IdType": "pmc"}, {"#text": "25550431", "@IdType": "pubmed"}]}, "Citation": "Cuellar TL, et al. Systematic evaluation of antibody-mediated siRNA delivery using an industrial platform of THIOMAB-siRNA conjugates. Nucleic Acids Res. 2015;43:1189\u20131203. doi: 10.1093/nar/gku1362."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ebiom.2019.06.036", "@IdType": "doi"}, {"#text": "PMC6642283", "@IdType": "pmc"}, {"#text": "31257147", "@IdType": "pubmed"}]}, "Citation": "Tsoumpra MK, et al. Peptide-conjugate antisense based splice-correction for Duchenne muscular dystrophy and other neuromuscular diseases. EBioMedicine. 2019;45:630\u2013645. doi: 10.1016/j.ebiom.2019.06.036."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1089/nat.2020.0907", "@IdType": "doi"}, {"#text": "PMC7997716", "@IdType": "pmc"}, {"#text": "33567244", "@IdType": "pubmed"}]}, "Citation": "Tone Y, et al. Immortalized canine dystrophic myoblast cell lines for development of peptide-conjugated splice-switching oligonucleotides. Nucleic Acid Ther. 2021;31:172\u2013181. doi: 10.1089/nat.2020.0907."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ijpharm.2021.120398", "@IdType": "doi"}, {"#text": "33640427", "@IdType": "pubmed"}]}, "Citation": "Dastpeyman M, et al. Endosomal escape cell-penetrating peptides significantly enhance pharmacological effectiveness and CNS activity of systemically administered antisense oligonucleotides. Int. J. Pharm. 2021;599:120398. doi: 10.1016/j.ijpharm.2021.120398."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1080/1061186X.2017.1387790", "@IdType": "doi"}, {"#text": "28972797", "@IdType": "pubmed"}]}, "Citation": "Khoshnevisan K, et al. The promising potentials of capped gold nanoparticles for drug delivery systems. J. Drug Target. 2018;26:525\u2013532. doi: 10.1080/1061186X.2017.1387790."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/anie.201104514", "@IdType": "doi"}, {"#text": "PMC3786135", "@IdType": "pmc"}, {"#text": "22028047", "@IdType": "pubmed"}]}, "Citation": "Jewell CM, et al. Oligonucleotide delivery by cell-penetrating \u201cstriped\u201d nanoparticles. Angew. Chem. Int. Ed. Engl. 2011;50:12312\u201312315. doi: 10.1002/anie.201104514."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1126/scitranslmed.3006839", "@IdType": "doi"}, {"#text": "PMC4017940", "@IdType": "pmc"}, {"#text": "24174328", "@IdType": "pubmed"}]}, "Citation": "Jensen SA, et al. Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma. Sci. Transl. Med. 2013;5:209ra152. doi: 10.1126/scitranslmed.3006839."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1101/gad.257394.114", "@IdType": "doi"}, {"#text": "PMC4387715", "@IdType": "pmc"}, {"#text": "25838542", "@IdType": "pubmed"}]}, "Citation": "Kouri FM, et al. miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma. Genes Dev. 2015;29:732\u2013745. doi: 10.1101/gad.257394.114."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2147/IJN.S241055", "@IdType": "doi"}, {"#text": "PMC7185647", "@IdType": "pmc"}, {"#text": "32368056", "@IdType": "pubmed"}]}, "Citation": "Grafals-Ruiz N, et al. Brain targeted gold liposomes improve RNAi delivery for Glioblastoma. Int. J. Nanomed. 2020;15:2809\u20132828. doi: 10.2147/IJN.S241055."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1126/scitranslmed.abb3945", "@IdType": "doi"}, {"#text": "PMC8272521", "@IdType": "pmc"}, {"#text": "33692132", "@IdType": "pubmed"}]}, "Citation": "Kumthekar P, et al. A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma. Sci. Transl. Med. 2021;13:eabb3945. doi: 10.1126/scitranslmed.abb3945."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/gt.2017.14", "@IdType": "doi"}, {"#text": "PMC5404203", "@IdType": "pmc"}, {"#text": "28300083", "@IdType": "pubmed"}]}, "Citation": "Samaranch L, et al. MR-guided parenchymal delivery of adeno-associated viral vector serotype 5 in non-human primate brain. Gene Ther. 2017;24:253\u2013261. doi: 10.1038/gt.2017.14."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.omtm.2019.09.010", "@IdType": "doi"}, {"#text": "PMC6849441", "@IdType": "pmc"}, {"#text": "31737741", "@IdType": "pubmed"}]}, "Citation": "Keskin S, et al. AAV5-miHTT lowers huntingtin mRNA and protein without off-target effects in patient-derived neuronal cultures and astrocytes. Mol. Ther. Methods Clin. Dev. 2019;15:275\u2013284. doi: 10.1016/j.omtm.2019.09.010."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/molecules21091249", "@IdType": "doi"}, {"#text": "PMC6272875", "@IdType": "pmc"}, {"#text": "27657028", "@IdType": "pubmed"}]}, "Citation": "Qiu Y, Lam JK, Leung SW, Liang W. Delivery of RNAi therapeutics to the airways-from bench to bedside. Molecules. 2016;21:1249. doi: 10.3390/molecules21091249."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.pharmthera.2016.10.009", "@IdType": "doi"}, {"#text": "27771436", "@IdType": "pubmed"}]}, "Citation": "Moschos SA, Usher L, Lindsay MA. Clinical potential of oligonucleotide-based therapeutics in the respiratory system. Pharmacol. Ther. 2017;169:83\u2013103. doi: 10.1016/j.pharmthera.2016.10.009."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/1878-0261.12144", "@IdType": "doi"}, {"#text": "PMC5709614", "@IdType": "pmc"}, {"#text": "29024380", "@IdType": "pubmed"}]}, "Citation": "Bayraktar R, Van Roosbroeck K, Calin GA. Cell-to-cell communication: microRNAs as hormones. Mol. Oncol. 2017;11:1673\u20131686. doi: 10.1002/1878-0261.12144."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/ijms21093387", "@IdType": "doi"}, {"#text": "PMC7246984", "@IdType": "pmc"}, {"#text": "32403283", "@IdType": "pubmed"}]}, "Citation": "El-Daly SM, Bayraktar R, Anfossi S, Calin GA. The interplay between microRNAs and the components of the tumor microenvironment in B-cell malignancies. Int. J. Mol. Sci. 2020;21:3387. doi: 10.3390/ijms21093387."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/wrna.1363", "@IdType": "doi"}, {"#text": "27196002", "@IdType": "pubmed"}]}, "Citation": "Zhou Y, et al. Exosome-mediated small RNA delivery for gene therapy. Wiley Interdiscip. Rev. RNA. 2016;7:758\u2013771. doi: 10.1002/wrna.1363."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.5772/61186", "@IdType": "doi"}, {"#text": "PMC5572985", "@IdType": "pmc"}, {"#text": "28936243", "@IdType": "pubmed"}]}, "Citation": "McKelvey KJ, Powell KL, Ashton AW, Morris JM, McCracken SA. Exosomes: mechanisms of uptake. J. Circ. Biomark. 2015;4:7. doi: 10.5772/61186."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature22341", "@IdType": "doi"}, {"#text": "PMC5538883", "@IdType": "pmc"}, {"#text": "28607485", "@IdType": "pubmed"}]}, "Citation": "Kamerkar S, et al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature. 2017;546:498\u2013503. doi: 10.1038/nature22341."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/ijms21217850", "@IdType": "doi"}, {"#text": "PMC7660226", "@IdType": "pmc"}, {"#text": "33105908", "@IdType": "pubmed"}]}, "Citation": "Jung KO, et al. Identification of lymphatic and hematogenous routes of rapidly labeled radioactive and fluorescent exosomes through highly sensitive multimodal imaging. Int. J. Mol. Sci. 2020;21:7850. doi: 10.3390/ijms21217850."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/advs.202001467", "@IdType": "doi"}, {"#text": "PMC7539214", "@IdType": "pmc"}, {"#text": "33042758", "@IdType": "pubmed"}]}, "Citation": "Wu AY, et al. Multiresolution imaging using bioluminescence resonance energy transfer identifies distinct biodistribution profiles of extracellular vesicles and exomeres with redirected tropism. Adv. Sci. 2020;7:2001467. doi: 10.1002/advs.202001467."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1080/20013078.2020.1800222", "@IdType": "doi"}, {"#text": "PMC7481830", "@IdType": "pmc"}, {"#text": "32944187", "@IdType": "pubmed"}]}, "Citation": "Gupta D, et al. Quantification of extracellular vesicles in vitro and in vivo using sensitive bioluminescence imaging. J. Extracell. Vesicles. 2020;9:1800222. doi: 10.1080/20013078.2020.1800222."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1080/20013078.2020.1779458", "@IdType": "doi"}, {"#text": "PMC7480572", "@IdType": "pmc"}, {"#text": "32944169", "@IdType": "pubmed"}]}, "Citation": "Xu L, et al. Design of experiment (DoE)-driven in vitro and in vivo uptake studies of exosomes for pancreatic cancer delivery enabled by copper-free click chemistry-based labelling. J. Extracell. Vesicles. 2020;9:1779458. doi: 10.1080/20013078.2020.1779458."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nbt.1807", "@IdType": "doi"}, {"#text": "21423189", "@IdType": "pubmed"}]}, "Citation": "Alvarez-Erviti L, et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol. 2011;29:341\u2013345. doi: 10.1038/nbt.1807."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s12015-019-09944-w", "@IdType": "doi"}, {"#text": "31898802", "@IdType": "pubmed"}]}, "Citation": "Naseri Z, Oskuee RK, Forouzandeh-Moghadam M, Jaafari MR. Delivery of LNA-antimiR-142-3p by mesenchymal stem cells-derived exosomes to breast cancer stem cells reduces tumorigenicity. Stem Cell. Rev. Rep. 2020;16:541\u2013556. doi: 10.1007/s12015-019-09944-w."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12951-019-0563-2", "@IdType": "doi"}, {"#text": "PMC6950820", "@IdType": "pmc"}, {"#text": "31918721", "@IdType": "pubmed"}]}, "Citation": "Liang G, et al. Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer. J. Nanobiotechnol. 2020;18:10. doi: 10.1186/s12951-019-0563-2."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ymeth.2019.11.007", "@IdType": "doi"}, {"#text": "31734187", "@IdType": "pubmed"}]}, "Citation": "Thone MN, Kwon YJ. Extracellular blebs: artificially-induced extracellular vesicles for facile production and clinical translation. Methods. 2020;177:135\u2013145. doi: 10.1016/j.ymeth.2019.11.007."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.canlet.2015.10.020", "@IdType": "doi"}, {"#text": "PMC4706492", "@IdType": "pmc"}, {"#text": "26604130", "@IdType": "pubmed"}]}, "Citation": "Munagala R, Aqil F, Jeyabalan J, Gupta RC. Bovine milk-derived exosomes for drug delivery. Cancer Lett. 2016;371:48\u201361. doi: 10.1016/j.canlet.2015.10.020."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/mt.2013.64", "@IdType": "doi"}, {"#text": "PMC3702113", "@IdType": "pmc"}, {"#text": "23752315", "@IdType": "pubmed"}]}, "Citation": "Ju S, et al. Grape exosome-like nanoparticles induce intestinal stem cells and protect mice from DSS-induced colitis. Mol. Ther. 2013;21:1345\u20131357. doi: 10.1038/mt.2013.64."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/0008-5472.CAN-14-3095", "@IdType": "doi"}, {"#text": "PMC4470740", "@IdType": "pmc"}, {"#text": "25883092", "@IdType": "pubmed"}]}, "Citation": "Wang Q, et al. Grapefruit-derived nanovectors use an activated leukocyte trafficking pathway to deliver therapeutic agents to inflammatory tumor sites. Cancer Res. 2015;75:2520\u20132529. doi: 10.1158/0008-5472.CAN-14-3095."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1080/20013078.2018.1522236", "@IdType": "doi"}, {"#text": "PMC6161586", "@IdType": "pmc"}, {"#text": "30275938", "@IdType": "pubmed"}]}, "Citation": "Phan J, et al. Engineering mesenchymal stem cells to improve their exosome efficacy and yield for cell-free therapy. J. Extracell. Vesicles. 2018;7:1522236. doi: 10.1080/20013078.2018.1522236."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1111/j.1742-4658.2012.08512.x", "@IdType": "doi"}, {"#text": "22309233", "@IdType": "pubmed"}]}, "Citation": "Pan Y, et al. Development of a microRNA delivery system based on bacteriophage MS2 virus-like particles. FEBS J. 2012;279:1198\u20131208. doi: 10.1111/j.1742-4658.2012.08512.x."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.jbiosc.2017.03.012", "@IdType": "doi"}, {"#text": "28442387", "@IdType": "pubmed"}]}, "Citation": "Sun Y, Sun Y, Zhao R. Establishment of microRNA delivery system by PP7 bacteriophage-like particles carrying cell-penetrating peptide. J. Biosci. Bioeng. 2017;124:242\u2013249. doi: 10.1016/j.jbiosc.2017.03.012."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1021/mp3003754", "@IdType": "doi"}, {"#text": "23214968", "@IdType": "pubmed"}]}, "Citation": "Farkas ME, et al. PET Imaging and biodistribution of chemically modified bacteriophage MS2. Mol. Pharm. 2013;10:69\u201376. doi: 10.1021/mp3003754."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cmi.2020.04.039", "@IdType": "doi"}, {"#text": "32387436", "@IdType": "pubmed"}]}, "Citation": "Lin YW, et al. Pharmacokinetics/pharmacodynamics of antipseudomonal bacteriophage therapy in rats: a proof-of-concept study. Clin. Microbiol. Infect. 2020;26:1229\u20131235. doi: 10.1016/j.cmi.2020.04.039."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3389/fmicb.2019.00689", "@IdType": "doi"}, {"#text": "PMC6458305", "@IdType": "pmc"}, {"#text": "31019499", "@IdType": "pubmed"}]}, "Citation": "Otero J, et al. Biodistribution of liposome-encapsulated bacteriophages and their transcytosis during oral phage therapy. Front. Microbiol. 2019;10:689. doi: 10.3389/fmicb.2019.00689."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1111/j.1462-5822.2006.00737.x", "@IdType": "doi"}, {"#text": "16984417", "@IdType": "pubmed"}]}, "Citation": "Giacalone MJ, et al. The use of bacterial minicells to transfer plasmid DNA to eukaryotic cells. Cell. Microbiol. 2006;8:1624\u20131633. doi: 10.1111/j.1462-5822.2006.00737.x."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/annonc/mdt412", "@IdType": "doi"}, {"#text": "24148817", "@IdType": "pubmed"}]}, "Citation": "Reid G, et al. Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma. Ann. Oncol. 2013;24:3128\u20133135. doi: 10.1093/annonc/mdt412."}, {"ArticleIdList": {"ArticleId": {"#text": "10.1093/annonc/mdv090.2", "@IdType": "doi"}}, "Citation": "van Zandwijk N, et al. P1.02 - MesomiR 1: a phase I study of TargomiRs in patients with refractory malignant pleural mesothelioma (MPM) and lung cancer (NSCLC) Ann. Oncol. 2015;26:ii16. doi: 10.1093/annonc/mdv090.2."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.jconrel.2010.11.004", "@IdType": "doi"}, {"#text": "21078351", "@IdType": "pubmed"}]}, "Citation": "Varkouhi AK, Scholte M, Storm G, Haisma HJ. Endosomal escape pathways for delivery of biologicals. J. Control. Rel. 2011;151:220\u2013228. doi: 10.1016/j.jconrel.2010.11.004."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1371/journal.pone.0151832", "@IdType": "doi"}, {"#text": "PMC4822833", "@IdType": "pmc"}, {"#text": "27050167", "@IdType": "pubmed"}]}, "Citation": "MacDiarmid JA, et al. Targeted doxorubicin delivery to brain tumors via minicells: proof of principle using dogs with spontaneously occurring tumors as a model. PLoS ONE. 2016;11:e0151832. doi: 10.1371/journal.pone.0151832."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.nano.2016.06.004", "@IdType": "doi"}, {"#text": "27378204", "@IdType": "pubmed"}]}, "Citation": "Jivrajani M, Nivsarkar M. Ligand-targeted bacterial minicells: Futuristic nano-sized drug delivery system for the efficient and cost effective delivery of shRNA to cancer cells. Nanomedicine. 2016;12:2485\u20132498. doi: 10.1016/j.nano.2016.06.004."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.7150/thno.34895", "@IdType": "doi"}, {"#text": "PMC6815962", "@IdType": "pmc"}, {"#text": "31660088", "@IdType": "pubmed"}]}, "Citation": "Kopechek JA, et al. Ultrasound and microbubble-targeted delivery of a microRNA inhibitor to the heart suppresses cardiac hypertrophy and preserves cardiac function. Theranostics. 2019;9:7088\u20137098. doi: 10.7150/thno.34895."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.chembiol.2011.12.008", "@IdType": "doi"}, {"#text": "PMC3269031", "@IdType": "pmc"}, {"#text": "22284355", "@IdType": "pubmed"}]}, "Citation": "Burnett JC, Rossi JJ. RNA-based therapeutics: current progress and future prospects. Chem. Biol. 2012;19:60\u201371. doi: 10.1016/j.chembiol.2011.12.008."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/annonc/mdw435.20", "@IdType": "doi"}, {"#text": "0", "@IdType": "pubmed"}]}, "Citation": "Fizazi K, et al. Final overall survival (OS) from the AFFINITY phase 3 trial of custirsen and cabazitaxel/prednisone in men with previously treated metastatic castration-resistant prostate cancer (mCRPC) Ann. Oncol. 2016;27:1\u201336. doi: 10.1093/annonc/mdw435.20."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s13075-015-0578-5", "@IdType": "doi"}, {"#text": "PMC4415222", "@IdType": "pmc"}, {"#text": "25885521", "@IdType": "pubmed"}]}, "Citation": "Warren MS, Hughes SG, Singleton W, Yamashita M, Genovese MC. Results of a proof of concept, double-blind, randomized trial of a second generation antisense oligonucleotide targeting high-sensitivity C-reactive protein (hs-CRP) in rheumatoid arthritis. Arthritis Res. Ther. 2015;17:80. doi: 10.1186/s13075-015-0578-5."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1167/iovs.12-9961", "@IdType": "doi"}, {"#text": "23074206", "@IdType": "pubmed"}]}, "Citation": "Nguyen QD, et al. Dose-ranging evaluation of intravitreal siRNA PF-04523655 for diabetic macular edema (the DEGAS study) Invest. Ophthalmol. Vis. Sci. 2012;53:7666\u20137674. doi: 10.1167/iovs.12-9961."}, {"Citation": "ISIS Pharmaceuticals. ISIS 104838 discontinuation. 10-K (2005)."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/S0090-8258(02)00144-0", "@IdType": "doi"}, {"#text": "12694666", "@IdType": "pubmed"}]}, "Citation": "Oza AM, et al. Phase II study of CGP 69846A (ISIS 5132) in recurrent epithelial ovarian cancer: an NCIC clinical trials group study (NCIC IND.116) Gynecol. Oncol. 2003;89:129\u2013133. doi: 10.1016/S0090-8258(02)00144-0."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1200/JCO.2005.04.3299", "@IdType": "doi"}, {"#text": "16549837", "@IdType": "pubmed"}]}, "Citation": "Paz-Ares L, et al. Phase III study of gemcitabine and cisplatin with or without aprinocarsen, a protein kinase C-alpha antisense oligonucleotide, in patients with advanced-stage non-small-cell lung cancer. J. Clin. Oncol. 2006;24:1428\u20131434. doi: 10.1200/JCO.2005.04.3299."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1126/science.1062961", "@IdType": "doi"}, {"#text": "11452083", "@IdType": "pubmed"}]}, "Citation": "Hutv\u00c3\u00a1gner G, et al. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science. 2001;293:834\u2013838. doi: 10.1126/science.1062961."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature01957", "@IdType": "doi"}, {"#text": "14508493", "@IdType": "pubmed"}]}, "Citation": "Lee Y, et al. The nuclear RNase III Drosha initiates microRNA processing. Nature. 2003;425:415\u2013419. doi: 10.1038/nature01957."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1101/gad.1158803", "@IdType": "doi"}, {"#text": "PMC305252", "@IdType": "pmc"}, {"#text": "14681208", "@IdType": "pubmed"}]}, "Citation": "Yi R, Qin Y, Macara IG, Cullen BR. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 2003;17:3011\u20133016. doi: 10.1101/gad.1158803."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature03120", "@IdType": "doi"}, {"#text": "15531877", "@IdType": "pubmed"}]}, "Citation": "Gregory RI, et al. The microprocessor complex mediates the genesis of microRNAs. Nature. 2004;432:235\u2013240. doi: 10.1038/nature03120."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.0803230105", "@IdType": "doi"}, {"#text": "PMC2567461", "@IdType": "pmc"}, {"#text": "18812516", "@IdType": "pubmed"}]}, "Citation": "Forman JJ, Legesse-Miller A, Coller HA. A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence. Proc. Natl Acad. Sci. USA. 2008;105:14879\u201314884. doi: 10.1073/pnas.0803230105."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature07299", "@IdType": "doi"}, {"#text": "18806776", "@IdType": "pubmed"}]}, "Citation": "Tay Y, Zhang J, Thomson AM, Lim B, Rigoutsos I. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature. 2008;455:1124\u20131128. doi: 10.1038/nature07299."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1101/gad.17446611", "@IdType": "doi"}, {"#text": "PMC3185964", "@IdType": "pmc"}, {"#text": "21890647", "@IdType": "pubmed"}]}, "Citation": "Cabili MN, et al. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 2011;25:1915\u20131927. doi: 10.1101/gad.17446611."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1101/gr.247239.118", "@IdType": "doi"}, {"#text": "PMC6724670", "@IdType": "pmc"}, {"#text": "31434680", "@IdType": "pubmed"}]}, "Citation": "Fabbri M, Girnita L, Varani G, Calin GA. Decrypting noncoding RNA interactions, structures, and functional networks. Genome Res. 2019;29:1377\u20131388. doi: 10.1101/gr.247239.118."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1146/annurev-biochem-051410-092902", "@IdType": "doi"}, {"#text": "PMC3858397", "@IdType": "pmc"}, {"#text": "22663078", "@IdType": "pubmed"}]}, "Citation": "Rinn JL, Chang HY. Genome regulation by long noncoding RNAs. Annu. Rev. Biochem. 2012;81:145\u2013166. doi: 10.1146/annurev-biochem-051410-092902."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature10887", "@IdType": "doi"}, {"#text": "PMC4197003", "@IdType": "pmc"}, {"#text": "22337053", "@IdType": "pubmed"}]}, "Citation": "Guttman M, Rinn JL. Modular regulatory principles of large non-coding RNAs. Nature. 2012;482:339\u2013346. doi: 10.1038/nature10887."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3389/fonc.2018.00179", "@IdType": "doi"}, {"#text": "PMC5992376", "@IdType": "pmc"}, {"#text": "29911069", "@IdType": "pubmed"}]}, "Citation": "Dragomir M, Calin GA. Circular RNAs in cancer- lessons learned from microRNAs. Front. Oncol. 2018;8:179. doi: 10.3389/fonc.2018.00179."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nbt.3765", "@IdType": "doi"}, {"#text": "PMC5517098", "@IdType": "pmc"}, {"#text": "28244990", "@IdType": "pubmed"}]}, "Citation": "Khvorova A, Watts JK. The chemical evolution of oligonucleotide therapies of clinical utility. Nat. Biotechnol. 2017;35:238\u2013248. doi: 10.1038/nbt.3765."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/molecules25204659", "@IdType": "doi"}, {"#text": "PMC7587394", "@IdType": "pmc"}, {"#text": "33066073", "@IdType": "pubmed"}]}, "Citation": "Ochoa S, Milam VT. Modified nucleic acids: expanding the capabilities of functional oligonucleotides. Molecules. 2020;25:4659. doi: 10.3390/molecules25204659."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1089/nat.2016.0656", "@IdType": "doi"}, {"#text": "PMC5372764", "@IdType": "pmc"}, {"#text": "28080221", "@IdType": "pubmed"}]}, "Citation": "Crooke ST. Molecular mechanisms of antisense oligonucleotides. Nucleic Acid. Ther. 2017;27:70\u201377. doi: 10.1089/nat.2016.0656."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/978-1-4939-8651-4_26", "@IdType": "doi"}, {"#text": "PMC6195309", "@IdType": "pmc"}, {"#text": "30171557", "@IdType": "pubmed"}]}, "Citation": "Singh NN, Luo D, Singh RN. Pre-mRNA splicing modulation by antisense oligonucleotides. Methods Mol. Biol. 2018;1828:415\u2013437. doi: 10.1007/978-1-4939-8651-4_26."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/35078107", "@IdType": "doi"}, {"#text": "11373684", "@IdType": "pubmed"}]}, "Citation": "Elbashir SM, et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 2001;411:494\u2013498. doi: 10.1038/35078107."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/mt.2016.93", "@IdType": "doi"}, {"#text": "PMC5023384", "@IdType": "pmc"}, {"#text": "27166877", "@IdType": "pubmed"}]}, "Citation": "Rao DD, et al. Preclinical justification of pbi-shRNA EWS/FLI1 Lipoplex (LPX) treatment for Ewing\u2019s sarcoma. Mol. Ther. 2016;24:1412\u20131422. doi: 10.1038/mt.2016.93."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/toxsci/kfw223", "@IdType": "doi"}, {"#text": "27815492", "@IdType": "pubmed"}]}, "Citation": "Wang Z, et al. Preclinical biodistribution and safety evaluation of a pbi-shRNA STMN1 Lipoplex after subcutaneous delivery. Toxicol. Sci. 2017;155:400\u2013408. doi: 10.1093/toxsci/kfw223."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.15252/emmm.201100899", "@IdType": "doi"}, {"#text": "PMC4119351", "@IdType": "pmc"}, {"#text": "24935956", "@IdType": "pubmed"}]}, "Citation": "van Rooij E, Kauppinen S. Development of microRNA therapeutics is coming of age. EMBO Mol. Med. 2014;6:851\u2013864. doi: 10.15252/emmm.201100899."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature04303", "@IdType": "doi"}, {"#text": "16258535", "@IdType": "pubmed"}]}, "Citation": "Kr\u00c3\u00bctzfeldt J, et al. Silencing of microRNAs in vivo with \u2018antagomirs\u2019. Nature. 2005;438:685\u2013689. doi: 10.1038/nature04303."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/nar/gkt852", "@IdType": "doi"}, {"#text": "PMC3874169", "@IdType": "pmc"}, {"#text": "24068553", "@IdType": "pubmed"}]}, "Citation": "Gebert LF, et al. Miravirsen (SPC3649) can inhibit the biogenesis of miR-122. Nucleic Acids Res. 2014;42:609\u2013621. doi: 10.1093/nar/gkt852."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nmeth1079", "@IdType": "doi"}, {"#text": "PMC3857099", "@IdType": "pmc"}, {"#text": "17694064", "@IdType": "pubmed"}]}, "Citation": "Ebert MS, Neilson JR, Sharp PA. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat. Methods. 2007;4:721\u2013726. doi: 10.1038/nmeth1079."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1080/15476286.2018.1445959", "@IdType": "doi"}, {"#text": "PMC5927725", "@IdType": "pmc"}, {"#text": "29570036", "@IdType": "pubmed"}]}, "Citation": "Lima JF, Cerqueira L, Figueiredo C, Oliveira C, Azevedo NF. Anti-miRNA oligonucleotides: A comprehensive guide for design. RNA Biol. 2018;15:338\u2013352. doi: 10.1080/15476286.2018.1445959."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ymeth.2012.07.019", "@IdType": "doi"}, {"#text": "22836127", "@IdType": "pubmed"}]}, "Citation": "Kluiver J, et al. Generation of miRNA sponge constructs. Methods. 2012;58:113\u2013117. doi: 10.1016/j.ymeth.2012.07.019."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/978-1-4939-7435-1_15", "@IdType": "doi"}, {"#text": "29086379", "@IdType": "pubmed"}]}, "Citation": "Chang S. Construction of multi-potent microRNA sponge and its functional evaluation. Methods Mol. Biol. 2018;1699:201\u2013209. doi: 10.1007/978-1-4939-7435-1_15."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.4827", "@IdType": "doi"}, {"#text": "PMC4653011", "@IdType": "pmc"}, {"#text": "26284487", "@IdType": "pubmed"}]}, "Citation": "Jung J, et al. Simultaneous inhibition of multiple oncogenic miRNAs by a multi-potent microRNA sponge. Oncotarget. 2015;6:20370\u201320387. doi: 10.18632/oncotarget.4827."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1161/JAHA.116.004694", "@IdType": "doi"}, {"#text": "PMC5524005", "@IdType": "pmc"}, {"#text": "28242633", "@IdType": "pubmed"}]}, "Citation": "Das S, et al. Divergent effects of miR-181 family members on myocardial function through protective cytosolic and detrimental mitochondrial microRNA targets. J. Am. Heart Assoc. 2017;6:e004694. doi: 10.1161/JAHA.116.004694."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3389/fphar.2018.01090", "@IdType": "doi"}, {"#text": "PMC6160554", "@IdType": "pmc"}, {"#text": "30298011", "@IdType": "pubmed"}]}, "Citation": "Bernardo BC, Gregorevic P, Ritchie RH, McMullen JR. Generation of microRNA-34 sponges and tough decoys for the heart: developments and challenges. Front. Pharmacol. 2018;9:1090. doi: 10.3389/fphar.2018.01090."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/978-1-60761-863-8_3", "@IdType": "doi"}, {"#text": "20931388", "@IdType": "pubmed"}]}, "Citation": "Wang Z. The principles of MiRNA-masking antisense oligonucleotides technology. Methods Mol. Biol. 2011;676:43\u201349. doi: 10.1007/978-1-60761-863-8_3."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/br.2014.260", "@IdType": "doi"}, {"#text": "PMC4051476", "@IdType": "pmc"}, {"#text": "24944797", "@IdType": "pubmed"}]}, "Citation": "Murakami K, Miyagishi M. Tiny masking locked nucleic acids effectively bind to mRNA and inhibit binding of microRNAs in relation to thermodynamic stability. Biomed. Rep. 2014;2:509\u2013512. doi: 10.3892/br.2014.260."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/ncb3623", "@IdType": "doi"}, {"#text": "28991221", "@IdType": "pubmed"}]}, "Citation": "Gilot D, et al. A non-coding function of TYRP1 mRNA promotes melanoma growth. Nat. Cell Biol. 2017;19:1348\u20131357. doi: 10.1038/ncb3623."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3389/fgene.2018.00439", "@IdType": "doi"}, {"#text": "PMC6176045", "@IdType": "pmc"}, {"#text": "30333857", "@IdType": "pubmed"}]}, "Citation": "Girardi E, L\u00f3pez P, Pfeffer S. On the importance of host microRNAs during viral infection. Front. Genet. 2018;9:439. doi: 10.3389/fgene.2018.00439."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.molmed.2016.11.003", "@IdType": "doi"}, {"#text": "PMC5836316", "@IdType": "pmc"}, {"#text": "27989642", "@IdType": "pubmed"}]}, "Citation": "Trobaugh DW, Klimstra WB. MicroRNA regulation of RNA virus replication and pathogenesis. Trends Mol. Med. 2017;23:80\u201393. doi: 10.1016/j.molmed.2016.11.003."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cmet.2006.01.005", "@IdType": "doi"}, {"#text": "16459310", "@IdType": "pubmed"}]}, "Citation": "Esau C, et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell. Metab. 2006;3:87\u201398. doi: 10.1016/j.cmet.2006.01.005."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/nar/gkr426", "@IdType": "doi"}, {"#text": "PMC3177192", "@IdType": "pmc"}, {"#text": "21653556", "@IdType": "pubmed"}]}, "Citation": "Roberts AP, Lewis AP, Jopling CL. miR-122 activates hepatitis C virus translation by a specialized mechanism requiring particular RNA components. Nucleic Acids Res. 2011;39:7716\u20137729. doi: 10.1093/nar/gkr426."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.chom.2014.07.006", "@IdType": "doi"}, {"#text": "PMC4227615", "@IdType": "pmc"}, {"#text": "25121753", "@IdType": "pubmed"}]}, "Citation": "Sedano CD, Sarnow P. Hepatitis C virus subverts liver-specific miR-122 to protect the viral genome from exoribonuclease Xrn2. Cell. Host Microbe. 2014;16:257\u2013264. doi: 10.1016/j.chom.2014.07.006."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/nar/gkz194", "@IdType": "doi"}, {"#text": "PMC6547439", "@IdType": "pmc"}, {"#text": "30941417", "@IdType": "pubmed"}]}, "Citation": "Chahal J, et al. miR-122 and Ago interactions with the HCV genome alter the structure of the viral 5\u2019 terminus. Nucleic Acids Res. 2019;47:5307\u20135324. doi: 10.1093/nar/gkz194."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/nar/gky273", "@IdType": "doi"}, {"#text": "PMC6007490", "@IdType": "pmc"}, {"#text": "29672716", "@IdType": "pubmed"}]}, "Citation": "Amador-Ca\u00f1izares Y, Bernier A, Wilson JA, Sagan SM. miR-122 does not impact recognition of the HCV genome by innate sensors of RNA but rather protects the 5\u2032 end from the cellular pyrophosphatases, DOM3Z and DUSP11. Nucleic Acids Res. 2018;46:5139\u20135158. doi: 10.1093/nar/gky273."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.chom.2016.02.007", "@IdType": "doi"}, {"#text": "PMC4826034", "@IdType": "pmc"}, {"#text": "26962949", "@IdType": "pubmed"}]}, "Citation": "Scheel TK, et al. A broad RNA virus survey reveals both miRNA dependence and functional sequestration. Cell. Host Microbe. 2016;19:409\u2013423. doi: 10.1016/j.chom.2016.02.007."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1371/journal.ppat.1007867", "@IdType": "doi"}, {"#text": "PMC6936876", "@IdType": "pmc"}, {"#text": "31658290", "@IdType": "pubmed"}]}, "Citation": "Trobaugh DW, et al. Cooperativity between the 3\u2019 untranslated region microRNA binding sites is critical for the virulence of eastern equine encephalitis virus. PLoS Pathog. 2019;15:e1007867. doi: 10.1371/journal.ppat.1007867."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/ijms19113381", "@IdType": "doi"}, {"#text": "PMC6274926", "@IdType": "pmc"}, {"#text": "30380612", "@IdType": "pubmed"}]}, "Citation": "Zheng H, et al. MicroRNA-221-5p inhibits porcine epidemic diarrhea virus replication by targeting genomic viral RNA and activating the NF-\u03baB pathway. Int. J. Mol. Sci. 2018;19:3381. doi: 10.3390/ijms19113381."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/v13020308", "@IdType": "doi"}, {"#text": "PMC7920029", "@IdType": "pmc"}, {"#text": "33669264", "@IdType": "pubmed"}]}, "Citation": "Lee YR, et al. Honeysuckle aqueous extracts induced let-7a suppress EV71 replication and pathogenesis in vitro and in vivo and is predicted to inhibit SARS-CoV-2. Viruses. 2021;13:308. doi: 10.3390/v13020308."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1128/JVI.02678-13", "@IdType": "doi"}, {"#text": "PMC3911702", "@IdType": "pmc"}, {"#text": "24109243", "@IdType": "pubmed"}]}, "Citation": "Lai FW, Stephenson KB, Mahony J, Lichty BD. Human coronavirus OC43 nucleocapsid protein binds microRNA 9 and potentiates NF-\u03baB activation. J. Virol. 2014;88:54\u201365. doi: 10.1128/JVI.02678-13."}, {"ArticleIdList": {"ArticleId": {"#text": "11931780", "@IdType": "pubmed"}}, "Citation": "Vitravene Study Group. A randomized controlled clinical trial of intravitreous fomivirsen for treatment of newly diagnosed peripheral cytomegalovirus retinitis in patients with AIDS. Am. J. Ophthalmol. 2002;133:467\u2013474."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ymthe.2017.03.023", "@IdType": "doi"}, {"#text": "PMC5417833", "@IdType": "pmc"}, {"#text": "28366767", "@IdType": "pubmed"}]}, "Citation": "Stein CA, Castanotto D. FDA-approved oligonucleotide therapies in 2017. Mol. Ther. 2017;25:1069\u20131075. doi: 10.1016/j.ymthe.2017.03.023."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/hep.29148", "@IdType": "doi"}, {"#text": "PMC5850982", "@IdType": "pmc"}, {"#text": "28295463", "@IdType": "pubmed"}]}, "Citation": "Stelma F, et al. Immune phenotype and function of natural killer and T cells in chronic hepatitis C patients who received a single dose of anti-MicroRNA-122, RG-101. Hepatology. 2017;66:57\u201368. doi: 10.1002/hep.29148."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1056/NEJMoa1209026", "@IdType": "doi"}, {"#text": "23534542", "@IdType": "pubmed"}]}, "Citation": "Janssen HL, et al. Treatment of HCV infection by targeting microRNA. N. Engl. J. Med. 2013;368:1685\u20131694. doi: 10.1056/NEJMoa1209026."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.1016606108", "@IdType": "doi"}, {"#text": "PMC3064388", "@IdType": "pmc"}, {"#text": "21383155", "@IdType": "pubmed"}]}, "Citation": "Li YP, Gottwein JM, Scheel TK, Jensen TB, Bukh J. MicroRNA-122 antagonism against hepatitis C virus genotypes 1-6 and reduced efficacy by host RNA insertion or mutations in the HCV 5\u2019 UTR. Proc. Natl Acad. Sci. USA. 2011;108:4991\u20134996. doi: 10.1073/pnas.1016606108."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1099/jgv.0.000445", "@IdType": "doi"}, {"#text": "26935756", "@IdType": "pubmed"}]}, "Citation": "Li YP, Van Pham L, Uzcategui N, Bukh J. Functional analysis of microRNA-122 binding sequences of hepatitis C virus and identification of variants with high resistance against a specific antagomir. J. Gen. Virol. 2016;97:1381\u20131394. doi: 10.1099/jgv.0.000445."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1128/AAC.04220-14", "@IdType": "doi"}, {"#text": "PMC4291405", "@IdType": "pmc"}, {"#text": "25385103", "@IdType": "pubmed"}]}, "Citation": "Ottosen S, et al. In vitro antiviral activity and preclinical and clinical resistance profile of miravirsen, a novel anti-hepatitis C virus therapeutic targeting the human factor miR-122. Antimicrob. Agents Chemother. 2015;59:599\u2013608. doi: 10.1128/AAC.04220-14."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s40265-021-01474-5", "@IdType": "doi"}, {"#text": "PMC7910799", "@IdType": "pmc"}, {"#text": "33638807", "@IdType": "pubmed"}]}, "Citation": "Hum C, et al. MicroRNA mimics or inhibitors as antiviral therapeutic approaches against COVID-19. Drugs. 2021;81:517\u2013531. doi: 10.1007/s40265-021-01474-5."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2174/0929866528666210222150347", "@IdType": "doi"}, {"#text": "33618635", "@IdType": "pubmed"}]}, "Citation": "Kheirkhah AH, et al. Mesenchymal stem cell derived-exosomes as effective factors in reducing cytokine storm symptoms of COVID-19. Protein Pept. Lett. 2021 doi: 10.2174/0929866528666210222150347."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s12015-021-10122-0", "@IdType": "doi"}, {"#text": "PMC7842178", "@IdType": "pmc"}, {"#text": "33511519", "@IdType": "pubmed"}]}, "Citation": "Schultz IC, Bertoni APS, Wink MR. Mesenchymal stem cell-derived extracellular vesicles carrying miRNA as a potential multi target therapy to COVID-19: an in silico analysis. Stem Cell. Rev. Rep. 2021;17:341\u2013356. doi: 10.1007/s12015-021-10122-0."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.meegid.2020.104417", "@IdType": "doi"}, {"#text": "PMC7833518", "@IdType": "pmc"}, {"#text": "32526370", "@IdType": "pubmed"}]}, "Citation": "Guterres A, de Azeredo Lima CH, Miranda RL, Gadelha MR. What is the potential function of microRNAs as biomarkers and therapeutic targets in COVID-19? Infect. Genet. Evol. 2020;85:104417. doi: 10.1016/j.meegid.2020.104417."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.7717/peerj.9369", "@IdType": "doi"}, {"#text": "PMC7278893", "@IdType": "pmc"}, {"#text": "32547891", "@IdType": "pubmed"}]}, "Citation": "Sa\u00e7ar Demirci MD, Adan A. Computational analysis of microRNA-mediated interactions in SARS-CoV-2 infection. PeerJ. 2020;8:e9369. doi: 10.7717/peerj.9369."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3389/fgene.2020.00765", "@IdType": "doi"}, {"#text": "PMC7381279", "@IdType": "pmc"}, {"#text": "32765592", "@IdType": "pubmed"}]}, "Citation": "Khan MA, Sany MRU, Islam MS, Islam ABMMK. Epigenetic regulator miRNA pattern differences among SARS-CoV, SARS-CoV-2, and SARS-CoV-2 world-wide isolates delineated the mystery behind the epic pathogenicity and distinct clinical characteristics of pandemic COVID-19. Front. Genet. 2020;11:765. doi: 10.3389/fgene.2020.00765."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.7717/peerj.10505", "@IdType": "doi"}, {"#text": "PMC7919535", "@IdType": "pmc"}, {"#text": "33680575", "@IdType": "pubmed"}]}, "Citation": "Rohani N, Ahmadi Moughari F, Eslahchi C. DisCoVering potential candidates of RNAi-based therapy for COVID-19 using computational methods. PeerJ. 2021;9:e10505. doi: 10.7717/peerj.10505."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/ncrna7010014", "@IdType": "doi"}, {"#text": "PMC7931055", "@IdType": "pmc"}, {"#text": "33670580", "@IdType": "pubmed"}]}, "Citation": "Natarelli L, et al. MicroRNAs and long non-coding RNAs as potential candidates to target specific motifs of SARS-CoV-2. Noncoding RNA. 2021;7:14. doi: 10.3390/ncrna7010014."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1152/ajplung.00252.2020", "@IdType": "doi"}, {"#text": "PMC7473886", "@IdType": "pmc"}, {"#text": "32755307", "@IdType": "pubmed"}]}, "Citation": "Bartoszewski R, et al. SARS-CoV-2 may regulate cellular responses through depletion of specific host miRNAs. Am. J. Physiol. Lung Cell. Mol. Physiol. 2020;319:L444\u2013L455. doi: 10.1152/ajplung.00252.2020."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/cells10020319", "@IdType": "doi"}, {"#text": "PMC7913991", "@IdType": "pmc"}, {"#text": "33557205", "@IdType": "pubmed"}]}, "Citation": "Mohammadi-Dehcheshmeh M, et al. A transcription regulatory sequence in the 5\u2019 untranslated region of SARS-CoV-2 is vital for virus replication with an altered evolutionary pattern against human inhibitory microRNAs. Cells. 2021;10:319. doi: 10.3390/cells10020319."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2174/1381612826999201001200529", "@IdType": "doi"}, {"#text": "33023438", "@IdType": "pubmed"}]}, "Citation": "Satyam R, et al. miRNAs in SARS-CoV 2: a spoke in the wheel of pathogenesis. Curr. Pharm. Des. 2020 doi: 10.2174/1381612826999201001200529."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/bioinformatics/btaa1002", "@IdType": "doi"}, {"#text": "PMC7717134", "@IdType": "pmc"}, {"#text": "33244583", "@IdType": "pubmed"}]}, "Citation": "Merino GA, et al. Novel SARS-CoV-2 encoded small RNAs in the passage to humans. Bioinformatics. 2020;36:5571\u20135581. doi: 10.1093/bioinformatics/btaa1002."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2174/1567201818666210301102", "@IdType": "doi"}, {"#text": "33645482", "@IdType": "pubmed"}]}, "Citation": "\u00c7etin Z, Bayrak T, O\u011ful H, Sayg\u0131l\u0131 E\u0130, Akkol EK. Predicted SARS-CoV-2 miRNAs associated with epigenetic viral pathogenesis and the detection of new possible drugs for Covid-19. Curr. Drug Deliv. 2021 doi: 10.2174/1567201818666210301102."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.yjmcc.2020.08.017", "@IdType": "doi"}, {"#text": "PMC7470794", "@IdType": "pmc"}, {"#text": "32891636", "@IdType": "pubmed"}]}, "Citation": "Lu D, et al. MicroRNAs targeting the SARS-CoV-2 entry receptor ACE2 in cardiomyocytes. J. Mol. Cell. Cardiol. 2020;148:46\u201349. doi: 10.1016/j.yjmcc.2020.08.017."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.21203/rs.3.rs-192099/v1", "@IdType": "doi"}, {"#text": "0", "@IdType": "pubmed"}]}, "Citation": "Mone P, et al. miR-24 targets SARS-CoV-2 co-factor Neuropilin-1 in human brain microvascular endothelial cells: insights for COVID-19 neurological manifestations. Res. Sq. 2021 doi: 10.21203/rs.3.rs-192099/v1."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1152/ajplung.00457.2020", "@IdType": "doi"}, {"#text": "PMC7938642", "@IdType": "pmc"}, {"#text": "33651636", "@IdType": "pubmed"}]}, "Citation": "Centa A, et al. Deregulated miRNA expression is associated with endothelial dysfunction in post-mortem lung biopsies of COVID-19 patients. Am. J. Physiol. Lung Cell. Mol. Physiol. 2020;320:L405\u2013L412. doi: 10.1152/ajplung.00457.2020."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/genes11070760", "@IdType": "doi"}, {"#text": "PMC7397219", "@IdType": "pmc"}, {"#text": "32646047", "@IdType": "pubmed"}]}, "Citation": "Vishnubalaji R, Shaath H, Alajez NM. Protein coding and long noncoding RNA (lncRNA) transcriptional landscape in SARS-CoV-2 infected bronchial epithelial cells highlight a role for interferon and inflammatory response. Genes. 2020;11:760. doi: 10.3390/genes11070760."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.heliyon.2021.e06395", "@IdType": "doi"}, {"#text": "PMC7914022", "@IdType": "pmc"}, {"#text": "33688586", "@IdType": "pubmed"}]}, "Citation": "Laha S, et al. In silico analysis of altered expression of long non-coding RNA in SARS-CoV-2 infected cells and their possible regulation by STAT1, STAT3 and interferon regulatory factors. Heliyon. 2021;7:e06395. doi: 10.1016/j.heliyon.2021.e06395."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1371/journal.pone.0007837", "@IdType": "doi"}, {"#text": "PMC2773932", "@IdType": "pmc"}, {"#text": "19915717", "@IdType": "pubmed"}]}, "Citation": "Mallick B, Ghosh Z, Chakrabarti J. MicroRNome analysis unravels the molecular basis of SARS infection in bronchoalveolar stem cells. PLoS ONE. 2009;4:e7837. doi: 10.1371/journal.pone.0007837."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.omtn.2019.05.009", "@IdType": "doi"}, {"#text": "PMC6796730", "@IdType": "pmc"}, {"#text": "31604167", "@IdType": "pubmed"}]}, "Citation": "Wei L, Li J, Han Z, Chen Z, Zhang Q. Silencing of lncRNA MALAT1 prevents inflammatory injury after lung transplant ischemia-reperfusion by downregulation of IL-8 via p300. Mol. Ther. Nucleic Acids. 2019;18:285\u2013297. doi: 10.1016/j.omtn.2019.05.009."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.gene.2020.145057", "@IdType": "doi"}, {"#text": "PMC7428439", "@IdType": "pmc"}, {"#text": "32805314", "@IdType": "pubmed"}]}, "Citation": "Arora S, Singh P, Dohare R, Jha R, Ali Syed M. Unravelling host-pathogen interactions: ceRNA network in SARS-CoV-2 infection (COVID-19) Gene. 2020;762:145057. doi: 10.1016/j.gene.2020.145057."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2217/fvl-2020-0188", "@IdType": "doi"}, {"#text": "PMC7664154", "@IdType": "pmc"}, {"#text": "33224264", "@IdType": "pubmed"}]}, "Citation": "Turjya RR, Khan MA, Islam ABMMK. Perversely expressed long noncoding RNAs can alter host response and viral proliferation in SARS-CoV-2 infection. Future Virol. 2020;15:577\u2013593. doi: 10.2217/fvl-2020-0188."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3389/fimmu.2018.02906", "@IdType": "doi"}, {"#text": "PMC6299252", "@IdType": "pmc"}, {"#text": "30619270", "@IdType": "pubmed"}]}, "Citation": "Hadjicharalambous MR, et al. Long non-coding RNAs are central regulators of the IL-1\u03b2-induced inflammatory response in normal and idiopathic pulmonary lung fibroblasts. Front. Immunol. 2018;9:2906. doi: 10.3389/fimmu.2018.02906."}]}}}}}, "PMC": "PMC8212082", "PMID": "34145432", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "Noncoding RNA therapeutics - challenges and potential solutions.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "35": {"Abstract": "Connective tissue growth factor (CTGF or CCN2) is a secreted protein that belongs to the CCN [cysteine-rich CYR61/CTGF/nephroblastoma-overexpressed gene] family. These proteins have been implicated in various biological processes, including stimulation of cell proliferation, migration, angiogenesis and tumorigenesis. In a previous study, we found that CTGF mRNA was elevated in primary gliomas, and a significant correlation existed between CTGF mRNA levels versus tumor grade, histology and patient survival. In this study, the role of CTGF in glioma tumorigenesis was explored. Forced expression of CTGF in glioblastoma multiforme (GBM) cells accelerated their growth in liquid culture and soft agar, stimulated cells migration in Boyden chamber assays and significantly increased their ability to form large, vascularized tumors in nude mice. CTGF induced the expression of the antiapoptotic proteins, Bcl-xl, Survivin and Flip. Overexpression of CTGF caused the U343 GBM cells to survive for longer than 40 days in serum-free medium and resist antitumor drugs including tumor necrosis factor (TNF), TNF-related apoptosis-inducing ligand, VELCADE (bortezomib, proteasome inhibitor) and temozolomide. Our data suggest that CTGF plays an important role in glioma progression, by supporting tumor cells survival and drug resistance.", "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "-2920164347362663867", "Part1": "Department of Pathology", "Part2": "Shantou University Medical College", "Part3": "Guangdong", "Part4": "China.", "Part5": null, "Part6": null, "Text": "Department of Pathology, Shantou University Medical College, Guangdong, China."}], "ForeName": "Dong", "FullName": "Dong Yin", "HashID": "1285560911849145430", "LastName": "Yin", "ORCID": null}, {"Affiliations": null, "ForeName": "Weikai", "FullName": "Weikai Chen", "HashID": "-6855265167051974701", "LastName": "Chen", "ORCID": null}, {"Affiliations": null, "ForeName": "James", "FullName": "James O'Kelly", "HashID": "8307599626812807063", "LastName": "O'Kelly", "ORCID": null}, {"Affiliations": null, "ForeName": "Daning", "FullName": "Daning Lu", "HashID": "-3838871892804074913", "LastName": "Lu", "ORCID": null}, {"Affiliations": null, "ForeName": "Michelle", "FullName": "Michelle Ham", "HashID": "6830220726007393169", "LastName": "Ham", "ORCID": null}, {"Affiliations": null, "ForeName": "Ngan B", "FullName": "Ngan B Doan", "HashID": "-8969378759191352538", "LastName": "Doan", "ORCID": null}, {"Affiliations": null, "ForeName": "Dong", "FullName": "Dong Xie", "HashID": "5614614848796924760", "LastName": "Xie", "ORCID": null}, {"Affiliations": null, "ForeName": "Charles", "FullName": "Charles Wang", "HashID": "-3726040506549759796", "LastName": "Wang", "ORCID": null}, {"Affiliations": null, "ForeName": "Jay", "FullName": "Jay Vadgama", "HashID": "3002825457915378853", "LastName": "Vadgama", "ORCID": null}, {"Affiliations": null, "ForeName": "Jonathan W", "FullName": "Jonathan W Said", "HashID": "3002178023413467109", "LastName": "Said", "ORCID": null}, {"Affiliations": null, "ForeName": "Keith L", "FullName": "Keith L Black", "HashID": "-5659527670936192922", "LastName": "Black", "ORCID": null}, {"Affiliations": null, "ForeName": "H Phillip", "FullName": "H Phillip Koeffler", "HashID": "-8224809500775580722", "LastName": "Koeffler", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.1002/ijc.25257", "InsertType": null, "Journal": "International journal of cancer", "Keywords": [{"IS_Major": false, "IS_Mesh": true, "Text": "Animals"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Brain Neoplasms"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Cell Growth Processes"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Cell Line, Tumor"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Cell Movement"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Cell Transformation, Neoplastic"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Connective Tissue Growth Factor"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Culture Media, Serum-Free"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Drug Resistance, Neoplasm"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Glioblastoma"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Humans"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Mice"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Mice, Nude"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Neovascularization, Pathologic"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Transfection"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "MEDLINE", "Article": {"@PubModel": "Print", "Abstract": {"AbstractText": "Connective tissue growth factor (CTGF or CCN2) is a secreted protein that belongs to the CCN [cysteine-rich CYR61/CTGF/nephroblastoma-overexpressed gene] family. These proteins have been implicated in various biological processes, including stimulation of cell proliferation, migration, angiogenesis and tumorigenesis. In a previous study, we found that CTGF mRNA was elevated in primary gliomas, and a significant correlation existed between CTGF mRNA levels versus tumor grade, histology and patient survival. In this study, the role of CTGF in glioma tumorigenesis was explored. Forced expression of CTGF in glioblastoma multiforme (GBM) cells accelerated their growth in liquid culture and soft agar, stimulated cells migration in Boyden chamber assays and significantly increased their ability to form large, vascularized tumors in nude mice. CTGF induced the expression of the antiapoptotic proteins, Bcl-xl, Survivin and Flip. Overexpression of CTGF caused the U343 GBM cells to survive for longer than 40 days in serum-free medium and resist antitumor drugs including tumor necrosis factor (TNF), TNF-related apoptosis-inducing ligand, VELCADE (bortezomib, proteasome inhibitor) and temozolomide. Our data suggest that CTGF plays an important role in glioma progression, by supporting tumor cells survival and drug resistance."}, "ArticleTitle": "Connective tissue growth factor associated with oncogenic activities and drug resistance in glioblastoma multiforme.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Pathology, Shantou University Medical College, Guangdong, China."}, "ForeName": "Dong", "Initials": "D", "LastName": "Yin"}, {"@ValidYN": "Y", "ForeName": "Weikai", "Initials": "W", "LastName": "Chen"}, {"@ValidYN": "Y", "ForeName": "James", "Initials": "J", "LastName": "O'Kelly"}, {"@ValidYN": "Y", "ForeName": "Daning", "Initials": "D", "LastName": "Lu"}, {"@ValidYN": "Y", "ForeName": "Michelle", "Initials": "M", "LastName": "Ham"}, {"@ValidYN": "Y", "ForeName": "Ngan B", "Initials": "NB", "LastName": "Doan"}, {"@ValidYN": "Y", "ForeName": "Dong", "Initials": "D", "LastName": "Xie"}, {"@ValidYN": "Y", "ForeName": "Charles", "Initials": "C", "LastName": "Wang"}, {"@ValidYN": "Y", "ForeName": "Jay", "Initials": "J", "LastName": "Vadgama"}, {"@ValidYN": "Y", "ForeName": "Jonathan W", "Initials": "JW", "LastName": "Said"}, {"@ValidYN": "Y", "ForeName": "Keith L", "Initials": "KL", "LastName": "Black"}, {"@ValidYN": "Y", "ForeName": "H Phillip", "Initials": "HP", "LastName": "Koeffler"}]}, "ELocationID": {"#text": "10.1002/ijc.25257", "@EIdType": "doi", "@ValidYN": "Y"}, "GrantList": {"@CompleteYN": "Y", "Grant": [{"Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States", "GrantID": "U54 CA143931-01"}, {"Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States", "GrantID": "1U54 CA143930-01"}, {"Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States", "GrantID": "U56 CA101599"}, {"Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States", "GrantID": "U54 CA143930"}, {"Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States", "GrantID": "R01 CA026038-32"}, {"Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States", "GrantID": "U56 CA101599-01"}, {"Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States", "GrantID": "R01 CA026038"}, {"Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States", "GrantID": "U56 CA101599-02S1"}, {"Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States", "GrantID": "U54 CA143931"}]}, "Journal": {"ISOAbbreviation": "Int J Cancer", "ISSN": {"#text": "1097-0215", "@IssnType": "Electronic"}, "JournalIssue": {"@CitedMedium": "Internet", "Issue": "10", "PubDate": {"Day": "15", "Month": "Nov", "Year": "2010"}, "Volume": "127"}, "Title": "International journal of cancer"}, "Language": "eng", "Pagination": {"EndPage": "2267", "MedlinePgn": "2257-67", "StartPage": "2257"}, "PublicationTypeList": {"PublicationType": [{"#text": "Journal Article", "@UI": "D016428"}, {"#text": "Research Support, N.I.H., Extramural", "@UI": "D052061"}, {"#text": "Research Support, Non-U.S. Gov't", "@UI": "D013485"}]}}, "ChemicalList": {"Chemical": [{"NameOfSubstance": {"#text": "CCN2 protein, human", "@UI": "C526317"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "Culture Media, Serum-Free", "@UI": "D016895"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "Connective Tissue Growth Factor", "@UI": "D055513"}, "RegistryNumber": "139568-91-5"}]}, "CitationSubset": "IM", "DateCompleted": {"Day": "04", "Month": "11", "Year": "2010"}, "DateRevised": {"Day": "20", "Month": "10", "Year": "2021"}, "MedlineJournalInfo": {"Country": "United States", "ISSNLinking": "0020-7136", "MedlineTA": "Int J Cancer", "NlmUniqueID": "0042124"}, "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"#text": "Animals", "@MajorTopicYN": "N", "@UI": "D000818"}}, {"DescriptorName": {"#text": "Brain Neoplasms", "@MajorTopicYN": "N", "@UI": "D001932"}, "QualifierName": [{"#text": "blood supply", "@MajorTopicYN": "N", "@UI": "Q000098"}, {"#text": "drug therapy", "@MajorTopicYN": "N", "@UI": "Q000188"}, {"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}, {"#text": "pathology", "@MajorTopicYN": "N", "@UI": "Q000473"}]}, {"DescriptorName": {"#text": "Cell Growth Processes", "@MajorTopicYN": "N", "@UI": "D048708"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Cell Line, Tumor", "@MajorTopicYN": "N", "@UI": "D045744"}}, {"DescriptorName": {"#text": "Cell Movement", "@MajorTopicYN": "N", "@UI": "D002465"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Cell Transformation, Neoplastic", "@MajorTopicYN": "N", "@UI": "D002471"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Connective Tissue Growth Factor", "@MajorTopicYN": "N", "@UI": "D055513"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Culture Media, Serum-Free", "@MajorTopicYN": "N", "@UI": "D016895"}}, {"DescriptorName": {"#text": "Drug Resistance, Neoplasm", "@MajorTopicYN": "N", "@UI": "D019008"}}, {"DescriptorName": {"#text": "Glioblastoma", "@MajorTopicYN": "N", "@UI": "D005909"}, "QualifierName": [{"#text": "blood supply", "@MajorTopicYN": "N", "@UI": "Q000098"}, {"#text": "drug therapy", "@MajorTopicYN": "N", "@UI": "Q000188"}, {"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}, {"#text": "pathology", "@MajorTopicYN": "N", "@UI": "Q000473"}]}, {"DescriptorName": {"#text": "Humans", "@MajorTopicYN": "N", "@UI": "D006801"}}, {"DescriptorName": {"#text": "Mice", "@MajorTopicYN": "N", "@UI": "D051379"}}, {"DescriptorName": {"#text": "Mice, Nude", "@MajorTopicYN": "N", "@UI": "D008819"}}, {"DescriptorName": {"#text": "Neovascularization, Pathologic", "@MajorTopicYN": "N", "@UI": "D009389"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Transfection", "@MajorTopicYN": "N", "@UI": "D014162"}}]}, "PMID": {"#text": "20162579", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "20162579", "@IdType": "pubmed"}, {"#text": "NIHMS216495", "@IdType": "mid"}, {"#text": "PMC2946420", "@IdType": "pmc"}, {"#text": "10.1002/ijc.25257", "@IdType": "doi"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "entrez", "Day": "18", "Hour": "6", "Minute": "0", "Month": "2", "Year": "2010"}, {"@PubStatus": "pubmed", "Day": "18", "Hour": "6", "Minute": "0", "Month": "2", "Year": "2010"}, {"@PubStatus": "medline", "Day": "5", "Hour": "6", "Minute": "0", "Month": "11", "Year": "2010"}]}, "PublicationStatus": "ppublish", "ReferenceList": {"Reference": [{"ArticleIdList": {"ArticleId": {"#text": "11150363", "@IdType": "pubmed"}}, "Citation": "DeAngelis LM. Brain tumors. N Engl J Med. 2001;344:114\u201323."}, {"ArticleIdList": {"ArticleId": {"#text": "9619835", "@IdType": "pubmed"}}, "Citation": "Duerr EM, Rollbrocker B, Hayashi Y, Peters N, Meyer-Puttlitz B, Louis DN, Schramm J, Wiestler OD, Parsons R, Eng C, von Deimling A. PTEN mutations in gliomas and glioneuronal tumors. Oncogene. 1998;16:2259\u201364."}, {"ArticleIdList": {"ArticleId": {"#text": "9072974", "@IdType": "pubmed"}}, "Citation": "Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 1997;275:1943\u20137."}, {"ArticleIdList": {"ArticleId": {"#text": "9090379", "@IdType": "pubmed"}}, "Citation": "Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet. 1997;15:356\u201362."}, {"ArticleIdList": {"ArticleId": {"#text": "7987821", "@IdType": "pubmed"}}, "Citation": "Schmidt EE, Ichimura K, Reifenberger G, Collins VP. CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res. 1994;54:6321\u20134."}, {"ArticleIdList": {"ArticleId": {"#text": "8548755", "@IdType": "pubmed"}}, "Citation": "Ueki K, Ono Y, Henson JW, Efird JT, von Deimling A, Louis DN. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated. Cancer Res. 1996;56:150\u20133."}, {"ArticleIdList": {"ArticleId": {"#text": "12622447", "@IdType": "pubmed"}}, "Citation": "Ghimenti C, Fiano V, Chiado-Piat L, Chio A, Cavalla P, Schiffer D. Deregulation of the p14ARF/Mdm2/p53 pathway and G1/S transition in two glioblastoma sets. J Neurooncol. 2003;61:95\u2013102."}, {"ArticleIdList": {"ArticleId": {"#text": "11172594", "@IdType": "pubmed"}}, "Citation": "Ljubimova JY, Khazenzon NM, Chen Z, Neyman YI, Turner L, Riedinger MS, Black KL. Gene expression abnormalities in human glial tumors identified by gene array. Int J Oncol. 2001;18:287\u201395."}, {"ArticleIdList": {"ArticleId": {"#text": "7687569", "@IdType": "pubmed"}}, "Citation": "Bork P. The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett. 1993;327:125\u201330."}, {"ArticleIdList": {"ArticleId": {"#text": "15105373", "@IdType": "pubmed"}}, "Citation": "Mercurio S, Latinkic B, Itasaki N, Krumlauf R, Smith JC. Connective-tissue growth factor modulates WNT signalling and interacts with the WNT receptor complex. Development. 2004;131:2137\u201347."}, {"ArticleIdList": {"ArticleId": {"#text": "12904165", "@IdType": "pubmed"}}, "Citation": "Brigstock DR. The CCN family: a new stimulus package. J Endocrinol. 2003;178:169\u201375."}, {"ArticleIdList": {"ArticleId": {"#text": "14723997", "@IdType": "pubmed"}}, "Citation": "Perbal B. CCN proteins: multifunctional signalling regulators. Lancet. 2004;363:62\u20134."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC194616", "@IdType": "pmc"}, {"#text": "12969515", "@IdType": "pubmed"}]}, "Citation": "Planque N, Perbal B. A structural approach to the role of CCN (CYR61/CTGF/NOV) proteins in tumourigenesis. Cancer Cell Int. 2003;3:15."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC1852221", "@IdType": "pmc"}, {"#text": "17170128", "@IdType": "pubmed"}]}, "Citation": "Sala-Torra O, Gundacker HM, Stirewalt DL, Ladne PA, Pogosova-Agadjanyan EL, Slovak ML, Willman CL, Heimfeld S, Boldt DH, Radich JP. Connective tissue growth factor (CTGF) expression and outcome in adult patients with acute lymphoblastic leukemia. Blood. 2007;109:3080\u20133."}, {"ArticleIdList": {"ArticleId": {"#text": "17951630", "@IdType": "pubmed"}}, "Citation": "Deng YZ, Chen PP, Wang Y, Yin D, Koeffler HP, Li B, Tong XJ, Xie D. Connective tissue growth factor is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenicity through beta-catenin-T-cell factor/Lef signaling. J Biol Chem. 2007;282:36571\u201381."}, {"ArticleIdList": {"ArticleId": {"#text": "17786299", "@IdType": "pubmed"}}, "Citation": "Kwon S, Munroe X, Crawley SC, Lee HY, Spong S, Bradham D, Gum JR, Jr, Sleisenger MH, Kim YS. Expression of connective tissue growth factor in pancreatic cancer cell lines. Int J Oncol. 2007;31:693\u2013703."}, {"ArticleIdList": {"ArticleId": {"#text": "16204060", "@IdType": "pubmed"}}, "Citation": "Yang F, Tuxhorn JA, Ressler SJ, McAlhany SJ, Dang TD, Rowley DR. Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. Cancer Res. 2005;65:8887\u201395."}, {"ArticleIdList": {"ArticleId": {"#text": "12392205", "@IdType": "pubmed"}}, "Citation": "Pan LH, Beppu T, Kurose A, Yamauchi K, Sugawara A, Suzuki M, Ogawa A, Sawai T. Neoplastic cells and proliferating endothelial cells express connective tissue growth factor (CTGF) in glioblastoma. Neurol Res. 2002;24:677\u201383."}, {"ArticleIdList": {"ArticleId": {"#text": "15041728", "@IdType": "pubmed"}}, "Citation": "Xie D, Yin D, Wang HJ, Liu GT, Elashoff R, Black K, Koeffler HP. Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas. Clin Cancer Res. 2004;10:2072\u201381."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2701536", "@IdType": "pmc"}, {"#text": "18395916", "@IdType": "pubmed"}]}, "Citation": "Liu LY, Han YC, Wu SH, Lv ZH. Expression of connective tissue growth factor in tumor tissues is an independent predictor of poor prognosis in patients with gastric cancer. World J Gastroenterol. 2008;14:2110\u20134."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC1888724", "@IdType": "pmc"}, {"#text": "17579708", "@IdType": "pubmed"}]}, "Citation": "Chen PP, Li WJ, Wang Y, Zhao S, Li DY, Feng LY, Shi XL, Koeffler HP, Tong XJ, Xie D. Expression of Cyr61, CTGF, and WISP-1 correlates with clinical features of lung cancer. PLoS ONE. 2007;2:e534."}, {"ArticleIdList": {"ArticleId": {"#text": "15613452", "@IdType": "pubmed"}}, "Citation": "Jiang WG, Watkins G, Fodstad O, Douglas-Jones A, Mokbel K, Mansel RE. Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer. Endocr Relat Cancer. 2004;11:781\u201391."}, {"ArticleIdList": {"ArticleId": {"#text": "18451226", "@IdType": "pubmed"}}, "Citation": "Alvarez H, Corvalan A, Roa JC, Argani P, Murillo F, Edwards J, Beaty R, Feldmann G, Hong SM, Mullendore M, Roa I, Ibanez L, et al. Serial analysis of gene expression identifies connective tissue growth factor expression as a prognostic biomarker in gallbladder cancer. Clin Cancer Res. 2008;14:2631\u20138."}, {"ArticleIdList": {"ArticleId": {"#text": "11013359", "@IdType": "pubmed"}}, "Citation": "Shakunaga T, Ozaki T, Ohara N, Asaumi K, Doi T, Nishida K, Kawai A, Nakanishi T, Takigawa M, Inoue H. Expression of connective tissue growth factor in cartilaginous tumors. Cancer. 2000;89:1466\u201373."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2275271", "@IdType": "pmc"}, {"#text": "18230158", "@IdType": "pubmed"}]}, "Citation": "Demuth T, Rennert JL, Hoelzinger DB, Reavie LB, Nakada M, Beaudry C, Nakada S, Anderson EM, Henrichs AN, McDonough WS, Holz D, Joy A, et al. Glioma cells on the run - the migratory transcriptome of 10 human glioma cell lines. BMC Genomics. 2008;9:54."}, {"ArticleIdList": {"ArticleId": {"#text": "15026334", "@IdType": "pubmed"}}, "Citation": "Xie D, Yin D, Tong X, O\u2019Kelly J, Mori A, Miller C, Black K, Gui D, Said JW, Koeffler HP. Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways. Cancer Res. 2004;64:1987\u201396."}, {"ArticleIdList": {"ArticleId": {"#text": "19351859", "@IdType": "pubmed"}}, "Citation": "Wang MY, Chen PS, Prakash E, Hsu HC, Huang HY, Lin MT, Chang KJ, Kuo ML. Connective tissue growth factor confers drug resistance in breast cancer through concomitant up-regulation of Bcl-xL and cIAP1. Cancer Res. 2009;69:3482\u201391."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2259449", "@IdType": "pmc"}, {"#text": "18323016", "@IdType": "pubmed"}]}, "Citation": "Lefranc F, Kiss R. The sodium pump alpha1 subunit as a potential target to combat apoptosis-resistant glioblastomas. Neoplasia. 2008;10:198\u2013206."}, {"ArticleIdList": {"ArticleId": {"#text": "17596214", "@IdType": "pubmed"}}, "Citation": "Dhandapani KM, Mahesh VB, Brann DW. Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors. J Neurochem. 2007;102:522\u201338."}, {"ArticleIdList": {"ArticleId": {"#text": "15531918", "@IdType": "pubmed"}}, "Citation": "Yin D, Zhou H, Kumagai T, Liu G, Ong JM, Black KL, Koeffler HP. Proteasome inhibitor PS-341 causes cell growth arrest and apoptosis in human glioblastoma multiforme (GBM) Oncogene. 2005;24:344\u201354."}, {"ArticleIdList": {"ArticleId": {"#text": "15504253", "@IdType": "pubmed"}}, "Citation": "Kasuga C, Ebata T, Kayagaki N, Yagita H, Hishii M, Arai H, Sato K, Okumura K. Sensitization of human glioblastomas to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by NF-kappaB inhibitors. Cancer Sci. 2004;95:840\u20134."}]}}}}}, "PMC": "PMC2946420", "PMID": "20162579", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "Connective tissue growth factor associated with oncogenic activities and drug resistance in glioblastoma multiforme.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "36": {"Abstract": " Thousands of long noncoding RNAs (lncRNAs) are aberrantly expressed in various types of cancers, however our understanding of their role in the disease is still very limited. We applied RNAseq analysis from patient-derived data with validation in independent cohort of patients. We followed these studies with gene regulation analysis as well as experimental dissection of the role of the identified lncRNA by multiple in vitro and in vivo methods. We analyzed RNA-seq data from tumors of 456 CRC patients compared to normal samples, and identified SNHG15 as a potentially oncogenic lncRNA that encodes a snoRNA in one of its introns. The processed SNHG15 is overexpressed in CRC tumors and its expression is highly correlated with poor survival of patients. Interestingly, SNHG15 is more highly expressed in tumors with high levels of MYC expression, while MYC protein binds to two E-box motifs on SNHG15 sequence, indicating that SNHG15 transcription is directly regulated by the oncogene MYC. The depletion of SNHG15 by siRNA or CRISPR-Cas9 inhibits cell proliferation and invasion, decreases colony formation as well as the tumorigenic capacity of CRC cells, whereas its overexpression leads to opposite effects. Gene expression analysis performed upon SNHG15 inhibition showed changes in multiple relevant genes implicated in cancer progression, including MYC, NRAS, BAG3 or ERBB3. Several of these genes are functionally related to AIF, a protein that we found to specifically interact with SNHG15, suggesting that the SNHG15 acts, at least in part, by regulating the activity of AIF. Interestingly, ROS levels, which are directly regulated by AIF, show a significant reduction in SNHG15-depleted cells. Moreover, knockdown of SNHG15 increases the sensitiveness of the cells to 5-FU, while its overexpression renders them more resistant to the chemotherapeutic drug. Altogether, these results describe an important role of SNHG15 in promoting colon cancer and mediating drug resistance, suggesting its potential as prognostic marker and target for RNA-based therapies.", "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "-7164283497818568506", "Part1": "Department of Biology", "Part2": "Faculty of Science", "Part3": "Ferdowsi University of Mashhad", "Part4": "Mashhad", "Part5": "Iran.", "Part6": null, "Text": "Department of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran."}, {"Has_Extra": false, "HashID": "4035558079198157288", "Part1": "Industrial Biotechnology Reasearch Group", "Part2": "Institute of Biotechnology", "Part3": "Ferdowsi University of Mashhad", "Part4": "Mashhad", "Part5": "Iran.", "Part6": null, "Text": "Industrial Biotechnology Reasearch Group, Institute of Biotechnology, Ferdowsi University of Mashhad, Mashhad, Iran."}], "ForeName": "Morvarid", "FullName": "Morvarid Saeinasab", "HashID": "-7864440816195653020", "LastName": "Saeinasab", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-7164283497818568506", "Part1": "Department of Biology", "Part2": "Faculty of Science", "Part3": "Ferdowsi University of Mashhad", "Part4": "Mashhad", "Part5": "Iran.", "Part6": null, "Text": "Department of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran."}, {"Has_Extra": false, "HashID": "4035558079198157288", "Part1": "Industrial Biotechnology Reasearch Group", "Part2": "Institute of Biotechnology", "Part3": "Ferdowsi University of Mashhad", "Part4": "Mashhad", "Part5": "Iran.", "Part6": null, "Text": "Industrial Biotechnology Reasearch Group, Institute of Biotechnology, Ferdowsi University of Mashhad, Mashhad, Iran."}], "ForeName": "Ahmad Reza", "FullName": "Ahmad Reza Bahrami", "HashID": "533186465852928119", "LastName": "Bahrami", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "1581143852348603113", "Part1": "Department of Gene Therapy and Regulation of Gene Expression", "Part2": "Center for Applied Medical Research", "Part3": "University of Navarra", "Part4": "Pamplona", "Part5": "Spain.", "Part6": null, "Text": "Department of Gene Therapy and Regulation of Gene Expression, Center for Applied Medical Research, University of Navarra, Pamplona, Spain."}, {"Has_Extra": false, "HashID": "8276472214121381465", "Part1": "Institute of Health Research of Navarra (IdiSNA)", "Part2": "Pamplona", "Part3": "Spain.", "Part4": null, "Part5": null, "Part6": null, "Text": "Institute of Health Research of Navarra (IdiSNA), Pamplona, Spain."}], "ForeName": "Jovanna", "FullName": "Jovanna Gonz\u00e1lez", "HashID": "7052637354023440508", "LastName": "Gonz\u00e1lez", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "1581143852348603113", "Part1": "Department of Gene Therapy and Regulation of Gene Expression", "Part2": "Center for Applied Medical Research", "Part3": "University of Navarra", "Part4": "Pamplona", "Part5": "Spain.", "Part6": null, "Text": "Department of Gene Therapy and Regulation of Gene Expression, Center for Applied Medical Research, University of Navarra, Pamplona, Spain."}, {"Has_Extra": false, "HashID": "8276472214121381465", "Part1": "Institute of Health Research of Navarra (IdiSNA)", "Part2": "Pamplona", "Part3": "Spain.", "Part4": null, "Part5": null, "Part6": null, "Text": "Institute of Health Research of Navarra (IdiSNA), Pamplona, Spain."}], "ForeName": "Francesco P", "FullName": "Francesco P Marchese", "HashID": "-2391496389816429764", "LastName": "Marchese", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "1581143852348603113", "Part1": "Department of Gene Therapy and Regulation of Gene Expression", "Part2": "Center for Applied Medical Research", "Part3": "University of Navarra", "Part4": "Pamplona", "Part5": "Spain.", "Part6": null, "Text": "Department of Gene Therapy and Regulation of Gene Expression, Center for Applied Medical Research, University of Navarra, Pamplona, Spain."}, {"Has_Extra": false, "HashID": "8276472214121381465", "Part1": "Institute of Health Research of Navarra (IdiSNA)", "Part2": "Pamplona", "Part3": "Spain.", "Part4": null, "Part5": null, "Part6": null, "Text": "Institute of Health Research of Navarra (IdiSNA), Pamplona, Spain."}], "ForeName": "Dannys", "FullName": "Dannys Martinez", "HashID": "-1553296635467359330", "LastName": "Martinez", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-92971076365073866", "Part1": "Department of Molecular Genetics", "Part2": "Faculty of Biological Sciences", "Part3": "Tarbiat Modares University", "Part4": "Tehran", "Part5": "Iran.", "Part6": null, "Text": "Department of Molecular Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran."}], "ForeName": "Seyed Javad", "FullName": "Seyed Javad Mowla", "HashID": "-721589820938885482", "LastName": "Mowla", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-7164283497818568506", "Part1": "Department of Biology", "Part2": "Faculty of Science", "Part3": "Ferdowsi University of Mashhad", "Part4": "Mashhad", "Part5": "Iran. matin@um.ac.ir.", "Part6": null, "Text": "Department of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran. matin@um.ac.ir."}, {"Has_Extra": false, "HashID": "4035558079198157288", "Part1": "Industrial Biotechnology Reasearch Group", "Part2": "Institute of Biotechnology", "Part3": "Ferdowsi University of Mashhad", "Part4": "Mashhad", "Part5": "Iran. matin@um.ac.ir.", "Part6": null, "Text": "Industrial Biotechnology Reasearch Group, Institute of Biotechnology, Ferdowsi University of Mashhad, Mashhad, Iran. matin@um.ac.ir."}], "ForeName": "Maryam M", "FullName": "Maryam M Matin", "HashID": "6516544483955156884", "LastName": "Matin", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "1581143852348603113", "Part1": "Department of Gene Therapy and Regulation of Gene Expression", "Part2": "Center for Applied Medical Research", "Part3": "University of Navarra", "Part4": "Pamplona", "Part5": "Spain. maitehuarte@unav.es.", "Part6": null, "Text": "Department of Gene Therapy and Regulation of Gene Expression, Center for Applied Medical Research, University of Navarra, Pamplona, Spain. maitehuarte@unav.es."}, {"Has_Extra": false, "HashID": "637856386381006673", "Part1": "Institute of Health Research of Navarra (IdiSNA)", "Part2": "Pamplona", "Part3": "Spain. maitehuarte@unav.es.", "Part4": null, "Part5": null, "Part6": null, "Text": "Institute of Health Research of Navarra (IdiSNA), Pamplona, Spain. maitehuarte@unav.es."}], "ForeName": "Maite", "FullName": "Maite Huarte", "HashID": "7980929947042119537", "LastName": "Huarte", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.1186/s13046-019-1169-0", "InsertType": null, "Journal": "Journal of experimental & clinical cancer research : CR", "Keywords": [{"IS_Major": false, "IS_Mesh": true, "Text": "Animals"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Apoptosis Inducing Factor"}, {"IS_Major": false, "IS_Mesh": true, "Text": "CRISPR-Cas Systems"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Cell Line, Tumor"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Cell Proliferation"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Colorectal Neoplasms"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Drug Resistance, Neoplasm"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Female"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Fluorouracil"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Gene Expression Regulation, Neoplastic"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Humans"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Kaplan-Meier Estimate"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Male"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Mice"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Middle Aged"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Neoplasm Invasiveness"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Proto-Oncogene Proteins c-myc"}, {"IS_Major": false, "IS_Mesh": true, "Text": "RNA, Long Noncoding"}, {"IS_Major": false, "IS_Mesh": true, "Text": "RNA, Small Nucleolar"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Sequence Analysis, RNA"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Xenograft Model Antitumor Assays"}, {"IS_Major": false, "IS_Mesh": false, "Text": "AIF"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Colorectal cancer"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Drug resistance"}, {"IS_Major": false, "IS_Mesh": false, "Text": "SNHG15"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Survival"}, {"IS_Major": false, "IS_Mesh": false, "Text": "lncRNA"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "MEDLINE", "Article": {"@PubModel": "Electronic", "Abstract": {"AbstractText": [{"#text": "Thousands of long noncoding RNAs (lncRNAs) are aberrantly expressed in various types of cancers, however our understanding of their role in the disease is still very limited.", "@Label": "BACKGROUND"}, {"#text": "We applied RNAseq analysis from patient-derived data with validation in independent cohort of patients. We followed these studies with gene regulation analysis as well as experimental dissection of the role of the identified lncRNA by multiple in vitro and in vivo methods.", "@Label": "METHODS"}, {"#text": "We analyzed RNA-seq data from tumors of 456 CRC patients compared to normal samples, and identified SNHG15 as a potentially oncogenic lncRNA that encodes a snoRNA in one of its introns. The processed SNHG15 is overexpressed in CRC tumors and its expression is highly correlated with poor survival of patients. Interestingly, SNHG15 is more highly expressed in tumors with high levels of MYC expression, while MYC protein binds to two E-box motifs on SNHG15 sequence, indicating that SNHG15 transcription is directly regulated by the oncogene MYC. The depletion of SNHG15 by siRNA or CRISPR-Cas9 inhibits cell proliferation and invasion, decreases colony formation as well as the tumorigenic capacity of CRC cells, whereas its overexpression leads to opposite effects. Gene expression analysis performed upon SNHG15 inhibition showed changes in multiple relevant genes implicated in cancer progression, including MYC, NRAS, BAG3 or ERBB3. Several of these genes are functionally related to AIF, a protein that we found to specifically interact with SNHG15, suggesting that the SNHG15 acts, at least in part, by regulating the activity of AIF. Interestingly, ROS levels, which are directly regulated by AIF, show a significant reduction in SNHG15-depleted cells. Moreover, knockdown of SNHG15 increases the sensitiveness of the cells to 5-FU, while its overexpression renders them more resistant to the chemotherapeutic drug.", "@Label": "RESULTS"}, {"#text": "Altogether, these results describe an important role of SNHG15 in promoting colon cancer and mediating drug resistance, suggesting its potential as prognostic marker and target for RNA-based therapies.", "@Label": "CONCLUSION"}]}, "ArticleDate": {"@DateType": "Electronic", "Day": "24", "Month": "04", "Year": "2019"}, "ArticleTitle": "SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran."}, {"Affiliation": "Industrial Biotechnology Reasearch Group, Institute of Biotechnology, Ferdowsi University of Mashhad, Mashhad, Iran."}], "ForeName": "Morvarid", "Initials": "M", "LastName": "Saeinasab"}, {"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran."}, {"Affiliation": "Industrial Biotechnology Reasearch Group, Institute of Biotechnology, Ferdowsi University of Mashhad, Mashhad, Iran."}], "ForeName": "Ahmad Reza", "Initials": "AR", "LastName": "Bahrami"}, {"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of Gene Therapy and Regulation of Gene Expression, Center for Applied Medical Research, University of Navarra, Pamplona, Spain."}, {"Affiliation": "Institute of Health Research of Navarra (IdiSNA), Pamplona, Spain."}], "ForeName": "Jovanna", "Initials": "J", "LastName": "Gonz\u00e1lez"}, {"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of Gene Therapy and Regulation of Gene Expression, Center for Applied Medical Research, University of Navarra, Pamplona, Spain."}, {"Affiliation": "Institute of Health Research of Navarra (IdiSNA), Pamplona, Spain."}], "ForeName": "Francesco P", "Initials": "FP", "LastName": "Marchese"}, {"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of Gene Therapy and Regulation of Gene Expression, Center for Applied Medical Research, University of Navarra, Pamplona, Spain."}, {"Affiliation": "Institute of Health Research of Navarra (IdiSNA), Pamplona, Spain."}], "ForeName": "Dannys", "Initials": "D", "LastName": "Martinez"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Molecular Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran."}, "ForeName": "Seyed Javad", "Initials": "SJ", "LastName": "Mowla"}, {"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran. matin@um.ac.ir."}, {"Affiliation": "Industrial Biotechnology Reasearch Group, Institute of Biotechnology, Ferdowsi University of Mashhad, Mashhad, Iran. matin@um.ac.ir."}], "ForeName": "Maryam M", "Initials": "MM", "LastName": "Matin"}, {"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of Gene Therapy and Regulation of Gene Expression, Center for Applied Medical Research, University of Navarra, Pamplona, Spain. maitehuarte@unav.es."}, {"Affiliation": "Institute of Health Research of Navarra (IdiSNA), Pamplona, Spain. maitehuarte@unav.es."}], "ForeName": "Maite", "Initials": "M", "LastName": "Huarte"}]}, "ELocationID": [{"#text": "172", "@EIdType": "pii", "@ValidYN": "Y"}, {"#text": "10.1186/s13046-019-1169-0", "@EIdType": "doi", "@ValidYN": "Y"}], "GrantList": {"@CompleteYN": "Y", "Grant": {"Agency": "Ministerio de Econom\u00eda, Industria y Competitividad, Gobierno de Espa\u00f1a", "Country": "International", "GrantID": "BFU2014-58027-R"}}, "Journal": {"ISOAbbreviation": "J Exp Clin Cancer Res", "ISSN": {"#text": "1756-9966", "@IssnType": "Electronic"}, "JournalIssue": {"@CitedMedium": "Internet", "Issue": "1", "PubDate": {"Day": "24", "Month": "Apr", "Year": "2019"}, "Volume": "38"}, "Title": "Journal of experimental & clinical cancer research : CR"}, "Language": "eng", "Pagination": {"MedlinePgn": "172", "StartPage": "172"}, "PublicationTypeList": {"PublicationType": [{"#text": "Journal Article", "@UI": "D016428"}, {"#text": "Research Support, Non-U.S. Gov't", "@UI": "D013485"}]}}, "ChemicalList": {"Chemical": [{"NameOfSubstance": {"#text": "AIFM1 protein, human", "@UI": "C494829"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "Apoptosis Inducing Factor", "@UI": "D051033"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "MYC protein, human", "@UI": "C489427"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "Proto-Oncogene Proteins c-myc", "@UI": "D016271"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "RNA, Long Noncoding", "@UI": "D062085"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "RNA, Small Nucleolar", "@UI": "D020537"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "SNHG16 lncRNA, human", "@UI": "C000624322"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "Fluorouracil", "@UI": "D005472"}, "RegistryNumber": "U3P01618RT"}]}, "CoiStatement": "ETHICS APPROVAL AND CONSENT TO PARTICIPATE: This study was authorized by the Ethics Committee of Ferdowsi University of Mashhad and all CRC patients signed informed consent forms. All the animal studies were performed according to the Research Ethics Committee (CEI) of Navarra University. CONSENT FOR PUBLICATION: Not applicable. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER\u2019S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.", "CommentsCorrectionsList": {"CommentsCorrections": {"@RefType": "ErratumIn", "PMID": {"#text": "31666117", "@Version": "1"}, "RefSource": "J Exp Clin Cancer Res. 2019 Oct 31;38(1):441"}}, "DateCompleted": {"Day": "16", "Month": "08", "Year": "2019"}, "DateRevised": {"Day": "09", "Month": "03", "Year": "2020"}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"#text": "AIF", "@MajorTopicYN": "N"}, {"#text": "Colorectal cancer", "@MajorTopicYN": "N"}, {"#text": "Drug resistance", "@MajorTopicYN": "N"}, {"#text": "SNHG15", "@MajorTopicYN": "N"}, {"#text": "Survival", "@MajorTopicYN": "N"}, {"#text": "lncRNA", "@MajorTopicYN": "N"}]}, "MedlineJournalInfo": {"Country": "England", "ISSNLinking": "0392-9078", "MedlineTA": "J Exp Clin Cancer Res", "NlmUniqueID": "8308647"}, "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"#text": "Animals", "@MajorTopicYN": "N", "@UI": "D000818"}}, {"DescriptorName": {"#text": "Apoptosis Inducing Factor", "@MajorTopicYN": "N", "@UI": "D051033"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "CRISPR-Cas Systems", "@MajorTopicYN": "N", "@UI": "D064113"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Cell Line, Tumor", "@MajorTopicYN": "N", "@UI": "D045744"}}, {"DescriptorName": {"#text": "Cell Proliferation", "@MajorTopicYN": "N", "@UI": "D049109"}, "QualifierName": {"#text": "drug effects", "@MajorTopicYN": "N", "@UI": "Q000187"}}, {"DescriptorName": {"#text": "Colorectal Neoplasms", "@MajorTopicYN": "N", "@UI": "D015179"}, "QualifierName": [{"#text": "drug therapy", "@MajorTopicYN": "N", "@UI": "Q000188"}, {"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}, {"#text": "pathology", "@MajorTopicYN": "N", "@UI": "Q000473"}]}, {"DescriptorName": {"#text": "Drug Resistance, Neoplasm", "@MajorTopicYN": "N", "@UI": "D019008"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Female", "@MajorTopicYN": "N", "@UI": "D005260"}}, {"DescriptorName": {"#text": "Fluorouracil", "@MajorTopicYN": "N", "@UI": "D005472"}, "QualifierName": {"#text": "administration & dosage", "@MajorTopicYN": "N", "@UI": "Q000008"}}, {"DescriptorName": {"#text": "Gene Expression Regulation, Neoplastic", "@MajorTopicYN": "N", "@UI": "D015972"}, "QualifierName": {"#text": "drug effects", "@MajorTopicYN": "N", "@UI": "Q000187"}}, {"DescriptorName": {"#text": "Humans", "@MajorTopicYN": "N", "@UI": "D006801"}}, {"DescriptorName": {"#text": "Kaplan-Meier Estimate", "@MajorTopicYN": "N", "@UI": "D053208"}}, {"DescriptorName": {"#text": "Male", "@MajorTopicYN": "N", "@UI": "D008297"}}, {"DescriptorName": {"#text": "Mice", "@MajorTopicYN": "N", "@UI": "D051379"}}, {"DescriptorName": {"#text": "Middle Aged", "@MajorTopicYN": "N", "@UI": "D008875"}}, {"DescriptorName": {"#text": "Neoplasm Invasiveness", "@MajorTopicYN": "N", "@UI": "D009361"}, "QualifierName": [{"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}, {"#text": "pathology", "@MajorTopicYN": "N", "@UI": "Q000473"}]}, {"DescriptorName": {"#text": "Proto-Oncogene Proteins c-myc", "@MajorTopicYN": "N", "@UI": "D016271"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "RNA, Long Noncoding", "@MajorTopicYN": "N", "@UI": "D062085"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "RNA, Small Nucleolar", "@MajorTopicYN": "N", "@UI": "D020537"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Sequence Analysis, RNA", "@MajorTopicYN": "N", "@UI": "D017423"}}, {"DescriptorName": {"#text": "Xenograft Model Antitumor Assays", "@MajorTopicYN": "N", "@UI": "D023041"}}]}, "PMID": {"#text": "31014355", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "31014355", "@IdType": "pubmed"}, {"#text": "PMC6480895", "@IdType": "pmc"}, {"#text": "10.1186/s13046-019-1169-0", "@IdType": "doi"}, {"#text": "10.1186/s13046-019-1169-0", "@IdType": "pii"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "received", "Day": "29", "Month": "12", "Year": "2018"}, {"@PubStatus": "accepted", "Day": "7", "Month": "4", "Year": "2019"}, {"@PubStatus": "entrez", "Day": "25", "Hour": "6", "Minute": "0", "Month": "4", "Year": "2019"}, {"@PubStatus": "pubmed", "Day": "25", "Hour": "6", "Minute": "0", "Month": "4", "Year": "2019"}, {"@PubStatus": "medline", "Day": "17", "Hour": "6", "Minute": "0", "Month": "8", "Year": "2019"}]}, "PublicationStatus": "epublish", "ReferenceList": {"Reference": [{"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature11233", "@IdType": "doi"}, {"#text": "PMC3684276", "@IdType": "pmc"}, {"#text": "22955620", "@IdType": "pubmed"}]}, "Citation": "Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, et al. Landscape of transcription in human cells. Nature. 2012;489:101\u2013108. doi: 10.1038/nature11233."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/hmg/ddl046", "@IdType": "doi"}, {"#text": "16651366", "@IdType": "pubmed"}]}, "Citation": "Mattick JS, Makunin IV. Non-coding RNA. Hum Mol Genet. 2006;15:17\u201329. doi: 10.1093/hmg/ddl046."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1261/rna.1951310", "@IdType": "doi"}, {"#text": "PMC2905748", "@IdType": "pmc"}, {"#text": "20587619", "@IdType": "pubmed"}]}, "Citation": "Jia H, Osak M, Bogu GK, Stanton LW, Johnson R, et al. Genome-wide computational identification and manual annotation of human long noncoding RNA genes. RNA. 2010;16:1478\u20131487. doi: 10.1261/rna.1951310."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1101/gad.17446611", "@IdType": "doi"}, {"#text": "PMC3185964", "@IdType": "pmc"}, {"#text": "21890647", "@IdType": "pubmed"}]}, "Citation": "Cabili MN, Trapnell C, Goff L, Koziol M, Tazon-Vega B, et al. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 2011;25:1915\u20131927. doi: 10.1101/gad.17446611."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1101/gr.135350.111", "@IdType": "doi"}, {"#text": "PMC3431492", "@IdType": "pmc"}, {"#text": "22955987", "@IdType": "pubmed"}]}, "Citation": "Harrow J, Frankish A, Gonzalez JM, Tapanari E, Diekhans M, et al. GENCODE: the reference human genome annotation for the ENCODE project. Genome Res. 2012;22:1760\u20131774. doi: 10.1101/gr.135350.111."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrg2521", "@IdType": "doi"}, {"#text": "19188922", "@IdType": "pubmed"}]}, "Citation": "Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10:155\u2013159. doi: 10.1038/nrg2521."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/978-3-319-42059-2_1", "@IdType": "doi"}, {"#text": "27573892", "@IdType": "pubmed"}]}, "Citation": "Hombach S, Kretz M. Non-coding RNAs: classification, biology and functioning. Adv Exp Med Biol. 2016;937:3\u201317. doi: 10.1007/978-3-319-42059-2_1."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/cmdc.201300534", "@IdType": "doi"}, {"#text": "24677606", "@IdType": "pubmed"}]}, "Citation": "Bhan A, Mandal SS. Long noncoding RNAs: emerging stars in gene regulation, epigenetics and human disease. Chem Med Chem. 2014;9:1932\u20131956. doi: 10.1002/cmdc.201300534."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s13402-014-0180-x", "@IdType": "doi"}, {"#text": "25113790", "@IdType": "pubmed"}]}, "Citation": "Vitiello M, Tuccoli A, Poliseno L. Long non-coding RNAs in cancer: implications for personalized therapy. Cell Oncol. 2015;38:17\u201328. doi: 10.1007/s13402-014-0180-x."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12943-016-0530-6", "@IdType": "doi"}, {"#text": "PMC4884374", "@IdType": "pmc"}, {"#text": "27233618", "@IdType": "pubmed"}]}, "Citation": "Bartonicek N, Maag JL, Dinger ME. Long noncoding RNAs in cancer: mechanisms of action and technological advancements. Mol Cancer. 2016;15:43\u201352. doi: 10.1186/s12943-016-0530-6."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3389/fgene.2014.00057", "@IdType": "doi"}, {"#text": "PMC3971185", "@IdType": "pmc"}, {"#text": "24723937", "@IdType": "pubmed"}]}, "Citation": "Kornfeld JW, Bruning JC. Regulation of metabolism by long, non-coding RNAs. Front Genet. 2014;5:57\u201364. doi: 10.3389/fgene.2014.00057."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/S0140-6736(13)61649-9", "@IdType": "doi"}, {"#text": "24225001", "@IdType": "pubmed"}]}, "Citation": "Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet. 2014;383:1490\u20131502. doi: 10.1016/S0140-6736(13)61649-9."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3322/caac.21262", "@IdType": "doi"}, {"#text": "25651787", "@IdType": "pubmed"}]}, "Citation": "Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87\u2013108. doi: 10.3322/caac.21262."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4868682", "@IdType": "pmc"}, {"#text": "26637808", "@IdType": "pubmed"}]}, "Citation": "Xie X, Tang B, Xiao YF, Xie R, Li BS, et al. Long non-coding RNAs in colorectal cancer. Oncotarget. 2016;7:5226\u20135239."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5400657", "@IdType": "pmc"}, {"#text": "28108736", "@IdType": "pubmed"}]}, "Citation": "Luo J, Qu J, Wu D-K, Lu ZL, Sun YS, et al. Long non-coding RNAs: a rising biotarget in colorectal cancer. Oncotarget. 2017;8:22187\u201322202."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1126/science.1231143", "@IdType": "doi"}, {"#text": "PMC3795411", "@IdType": "pmc"}, {"#text": "23287718", "@IdType": "pubmed"}]}, "Citation": "Cong L, Ran FA, Cox D, Lin S, Barretto R, et al. Multiplex genome engineering using CRISPR/Cas systems. Science. 2013;339:819\u2013823. doi: 10.1126/science.1231143."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/978-1-4939-1369-5_8", "@IdType": "doi"}, {"#text": "25240889", "@IdType": "pubmed"}]}, "Citation": "Mari\u2019n-Be\u2019jar O, Huarte M. RNA pulldown protocol for in vitro detection and identification of RNA-associated proteins. Methods Mol Biol. 2015;1206:87\u201395. doi: 10.1007/978-1-4939-1369-5_8."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.canlet.2018.03.038", "@IdType": "doi"}, {"#text": "29604394", "@IdType": "pubmed"}]}, "Citation": "Jiang H, Li T, Qu Y, Wang X, Li B, et al. Long non-coding RNA SNHG15 interacts with and stabilizes transcription factor slug and promotes colon cancer progression. Cancer Lett. 2018;425:78\u201387. doi: 10.1016/j.canlet.2018.03.038."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1128/MCB.24.13.5797-5807.2004", "@IdType": "doi"}, {"#text": "PMC480876", "@IdType": "pmc"}, {"#text": "15199136", "@IdType": "pubmed"}]}, "Citation": "Kiss AM, J\u00e1dy BE, Bertrand E, Kiss T. Human box H/ACA pseudouridylation guide RNA machinery. Mol Cell Biol. 2004;24:5797\u20135807. doi: 10.1128/MCB.24.13.5797-5807.2004."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.molcel.2015.02.028", "@IdType": "doi"}, {"#text": "PMC4427524", "@IdType": "pmc"}, {"#text": "25818646", "@IdType": "pubmed"}]}, "Citation": "Thomas LR, Wang Q, Grieb BC, Phan J, Foshage AM, et al. Interaction with WDR5 promotes target gene recognition and tumorigenesis by MYC. Mol Cell. 2015;58:440\u2013452. doi: 10.1016/j.molcel.2015.02.028."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1074/jbc.M010498200", "@IdType": "doi"}, {"#text": "11278689", "@IdType": "pubmed"}]}, "Citation": "Miramar MD, Costantini P, Ravagnan L, Saraiva LM, Haouzi D, et al. NADH oxidase activity of mitochondrial apoptosis-inducing factor. J Biol Chem. 2001;276:16391\u201316398. doi: 10.1074/jbc.M010498200."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/sj.emboj.7600746", "@IdType": "doi"}, {"#text": "PMC1182241", "@IdType": "pmc"}, {"#text": "16001080", "@IdType": "pubmed"}]}, "Citation": "Urbano A, Lakshmanan U, Choo PH, Kwan JC, Ng PY, et al. AIF suppresses chemical stress-induced apoptosis and maintains the transformed state of tumor cells. EMBO J. 2005;24:2815\u20132826. doi: 10.1038/sj.emboj.7600746."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3109/10715761003667554", "@IdType": "doi"}, {"#text": "PMC3880197", "@IdType": "pmc"}, {"#text": "20370557", "@IdType": "pubmed"}]}, "Citation": "Liou G-Y, Storz P. Reactive oxygen species in cancer. Free Radic Res. 2010;44:479\u2013496. doi: 10.3109/10715761003667554."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/sj.onc.1209206", "@IdType": "doi"}, {"#text": "16278674", "@IdType": "pubmed"}]}, "Citation": "Vahsen N, Cande C, Dupaigne P, Giordanetto F, Kroemer RT, et al. Physical interaction of apoptosis-inducing factor with DNA and RNA. Oncogene. 2006;25:1763\u20131774. doi: 10.1038/sj.onc.1209206."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.7150/jca.19794", "@IdType": "doi"}, {"#text": "PMC5665037", "@IdType": "pmc"}, {"#text": "29158793", "@IdType": "pubmed"}]}, "Citation": "Yang Y, Junjie P, Sanjun C, Ma Y. Long non-coding RNAs in colorectal cancer: progression and future directions. J Cancer. 2017;8:3212\u20133225. doi: 10.7150/jca.19794."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/S0014-5793(00)01731-2", "@IdType": "doi"}, {"#text": "10913597", "@IdType": "pubmed"}]}, "Citation": "Daugas E, Nochy D, Ravagnan L, Loeffler M, Susin SA, et al. Apoptosis inducing factor (AIF): a ubiquitous mitochondrial oxidoreductase involved in apoptosis. FEBS Lett. 2000;476:118\u2013123. doi: 10.1016/S0014-5793(00)01731-2."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/sj.emboj.7600614", "@IdType": "doi"}, {"#text": "PMC1142539", "@IdType": "pmc"}, {"#text": "15775970", "@IdType": "pubmed"}]}, "Citation": "Otera H, Ohsakaya S, Nagaura Z, Ishihara N, Mihara K. Export of mitochondrial AIF in response to pro-apoptotic stimuli depends on processing at the intermembrane space. EMBO J. 2005;24:1375\u20131386. doi: 10.1038/sj.emboj.7600614."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/sj.cdd.4401687", "@IdType": "doi"}, {"#text": "15933737", "@IdType": "pubmed"}]}, "Citation": "Yuste VJ, Moubarak RS, Delettre C, Bras M, Sancho P, et al. Cysteine protease inhibition prevents mitochondrial apoptosis-inducing factor (AIF) release. Cell Death Differ. 2005;12:1445\u20131448. doi: 10.1038/sj.cdd.4401687."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1074/jbc.M413269200", "@IdType": "doi"}, {"#text": "15590628", "@IdType": "pubmed"}]}, "Citation": "Polster BM, Basa\u00f1ez G, Etxebarria A, Hardwick JM, Nicholls DG. Calpain I induces cleavage and release of apoptosis-inducing factor from isolated mitochondria. J Biol Chem. 2005;280:6447\u20136454. doi: 10.1074/jbc.M413269200."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/ncb0901-839", "@IdType": "doi"}, {"#text": "11533664", "@IdType": "pubmed"}]}, "Citation": "Ravagnan L, Gurbuxani S, Susin SA, Maisse C, Daugas E, et al. Heat- shock protein 70 antagonizes apoptosis-inducing factor. Nat Cell Biol. 2001;3:839\u2013843. doi: 10.1038/ncb0901-839."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/sj.onc.1206794", "@IdType": "doi"}, {"#text": "14555980", "@IdType": "pubmed"}]}, "Citation": "Gurbuxani S, Schmitt E, Cande C, Parcellier A, Hammann A, et al. Heat shock protein 70 binding inhibits the nuclear import of apoptosis-inducing factor. Oncogene. 2003;22:6669\u20136678. doi: 10.1038/sj.onc.1206794."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bbrc.2013.09.006", "@IdType": "doi"}, {"#text": "24036268", "@IdType": "pubmed"}]}, "Citation": "Tani H, Torimura M. Identification of short-lived long non-coding RNAs as surrogate indicators for chemical stress response. Biochem Biophys Res Commun. 2013;439:547\u2013551. doi: 10.1016/j.bbrc.2013.09.006."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2147/OTT.S108929", "@IdType": "doi"}, {"#text": "PMC5138041", "@IdType": "pmc"}, {"#text": "27942222", "@IdType": "pubmed"}]}, "Citation": "Yang K, Gao K, Hu G, Wen Y, Lin C, et al. CTGF enhances resistance to 5-FU-mediating cell apoptosis through FAK/MEK/ERK signal pathway in colorectal cancer. Onco Targets Ther. 2016;9:7285\u20137295. doi: 10.2147/OTT.S108929."}, {"ArticleIdList": {"ArticleId": {"#text": "8950993", "@IdType": "pubmed"}}, "Citation": "Smith ML, Kontny HU, Zhan Q, Sreenath A, Pm O\u2019C, et al. Antisense GADD45 expression results in decreased DNA repair and sensitizes cells to UV-irradiation or cisplatin. Oncogene. 1996;13:2255\u20132263."}, {"Citation": "Moreira MP, Silva LM, Martins WK. The role of GADD45A in resistance to oxidative stress-mediated cell death in human Colon tumor cell lines. Applied Cancer Research. 2009;29:179\u2013184."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/1479-5876-10-215", "@IdType": "doi"}, {"#text": "PMC3495754", "@IdType": "pmc"}, {"#text": "23110778", "@IdType": "pubmed"}]}, "Citation": "Wang L, Xiao X, Li D, Chi Y, Wei P, et al. Abnormal expression of GADD45B in human colorectal carcinoma. J Transl Med. 2012;10:215. doi: 10.1186/1479-5876-10-215."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/0008-5472.CAN-04-0202", "@IdType": "doi"}, {"#text": "15231668", "@IdType": "pubmed"}]}, "Citation": "Kim HR, Wheeler MA, Wilson CM, Iida J, Eng D, et al. Hyaluronan facilitates invasion of colon carcinoma cells in vitro via interaction with CD44. Cancer Res. 2004;64:4569\u20134576. doi: 10.1158/0008-5472.CAN-04-0202."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2386915", "@IdType": "pmc"}, {"#text": "18326857", "@IdType": "pubmed"}]}, "Citation": "Misra S, Obeid LM, Hannun YA, Minamisawa S, Berger FG, et al. Hyaluronan constitutively regulates activation of COX-2-mediated cell survival activity in intestinal epithelial and colon carcinoma cells. J Biol Chem. 2008:28314335\u201344."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1177/1947601911411084", "@IdType": "doi"}, {"#text": "PMC3128640", "@IdType": "pmc"}, {"#text": "21779504", "@IdType": "pubmed"}]}, "Citation": "Fernandez-Medarde A, Santos E. Ras in cancer and developmental diseases. Genes & cancer. 2011;2:344\u2013358. doi: 10.1177/1947601911411084."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/ng.115", "@IdType": "doi"}, {"#text": "PMC2410301", "@IdType": "pmc"}, {"#text": "18372904", "@IdType": "pubmed"}]}, "Citation": "Haigis KM, Kendall KR, Wang Y, Cheung A, Haigis MC, et al. Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon. Nat Genet. 2008;40:600\u2013608. doi: 10.1038/ng.115."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s13277-015-4403-1", "@IdType": "doi"}, {"#text": "26577854", "@IdType": "pubmed"}]}, "Citation": "Shi H, Xu H, Li Z, Zhen Y, Wang B, et al. BAG3 regulates cell proliferation, migration, and invasion in human colorectal cancer. Tumour Biol. 2016;37:5591\u20135597. doi: 10.1007/s13277-015-4403-1."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12885-018-4657-2", "@IdType": "doi"}, {"#text": "PMC6080525", "@IdType": "pmc"}, {"#text": "30081850", "@IdType": "pubmed"}]}, "Citation": "Li N, Chen M, Cao Y, Li H, Zhao J, et al. Bcl-2- associated athanogene 3 (BAG3) is associated with tumor cell proliferation, migration, invasion and chemoresistance in colorectal cancer. BMC Cancer. 2018;18:793. doi: 10.1186/s12885-018-4657-2."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.biocel.2007.03.007", "@IdType": "doi"}, {"#text": "17493862", "@IdType": "pubmed"}]}, "Citation": "Rosati A, Ammirante M, Gentilella A, Basile A, Festa M, et al. Apoptosis inhibition in cancer cells: a novel molecular pathway that involves BAG3 protein. Int J Biochem Cell Biol. 2007;39:1337\u20131342. doi: 10.1016/j.biocel.2007.03.007."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12929-017-0353-9", "@IdType": "doi"}, {"#text": "PMC5516387", "@IdType": "pmc"}, {"#text": "28720111", "@IdType": "pubmed"}]}, "Citation": "Liu K, Hou Y, Liu Y, Zheng J. LncRNA SNHG15 contributes to proliferation, invasion and autophagy in osteosarcoma cells by sponging miR-141. J Biomed Sci. 2017;24:46\u201356. doi: 10.1186/s12929-017-0353-9."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/or.2017.5985", "@IdType": "doi"}, {"#text": "29048682", "@IdType": "pubmed"}]}, "Citation": "Ma Y, Xue Y, Liu X, Qu C, Cia H, et al. SNHG15 affects the growth of glioma microvascular endothelial cells by negatively regulating miR-153. Oncol Rep. 2017;38:3265\u20133277. doi: 10.3892/or.2017.5985."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bbrc.2017.12.013", "@IdType": "doi"}, {"#text": "29217194", "@IdType": "pubmed"}]}, "Citation": "Kong Q, Qiu M. Long noncoding RNA SNHG15 promotes human breast cancer proliferation, migration and invasion by sponging miR-211-3p. Biochem Biophys Res Commun. 2018;495:1594\u20131600. doi: 10.1016/j.bbrc.2017.12.013."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s13277-015-4404-0", "@IdType": "doi"}, {"#text": "26662309", "@IdType": "pubmed"}]}, "Citation": "Chen SX, Yin JF, Lin BC, Su HF, Zheng Z, et al. Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC. Tumour Biol. 2016;37:6801\u20136812. doi: 10.1007/s13277-015-4404-0."}, {"ArticleIdList": {"ArticleId": {"#text": "27212162", "@IdType": "pubmed"}}, "Citation": "Zhang JH, Wei HW, Yang HG. Long noncoding RNA SNHG15, a potential prognostic biomarker for hepatocellular carcinoma. Eur Rev Med Pharmacol Sci. 2016;20:1720\u20131724."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5663584", "@IdType": "pmc"}, {"#text": "29137412", "@IdType": "pubmed"}]}, "Citation": "Ma Z, Huang H, Wang J, Zhou Y, Pu F, et al. Long non-coding RNA SNHG15 inhibits P15 and KLF2 expression to promote pancreatic cancer proliferation through EZH2-mediated H3K27me3. Oncotarget. 2017;8:84153\u201384167."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/jcp.27456", "@IdType": "doi"}, {"#text": "30317592", "@IdType": "pubmed"}]}, "Citation": "Huang Liang, Lin Hongcheng, Kang Liang, Huang Pinzhu, Huang Jun, Cai Jinlin, Xian Zhenyu, Zhu Peixuan, Huang Meijin, Wang Liping, Xian Cory J., Wang Jianping, Dong Jianghui. Aberrant expression of long noncoding RNA SNHG15 correlates with liver metastasis and poor survival in colorectal cancer. Journal of Cellular Physiology. 2018;234(5):7032\u20137039. doi: 10.1002/jcp.27456."}]}}}}}, "PMC": "PMC6480895", "PMID": "31014355", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "37": {"Abstract": "The first identified Gadd45 gene, Gadd45a, encodes a ubiquitously expressed protein that is often induced by DNA damage and other stress signals associated with growth arrest and apoptosis. This protein and the other two members of this small gene family, Gadd45b and Gadd45g, have been implicated in a variety of the responses to cell injury including cell cycle checkpoints, apoptosis, and DNA repair. In vivo, many of the prominent roles for the Gadd45 proteins are associated with signaling mediated by p38 mitogen-activated protein kinases (MAPK). Gadd45 proteins can contribute to p38 activation either by activation of upstream kinase(s) or by direct interaction. In vivo, there are important tissue and cell-type-specific differences in the roles for Gadd45 in MAPK signaling. In addition to being p53-regulated, Gadd45a has been found to contribute to p53 activation via p38. Like other stress and signaling proteins, Gadd45 proteins show complex regulation and numerous effectors.", "Authors": [{"Affiliations": [{"Has_Extra": true, "HashID": "-5402920886155139850", "Part1": "Department of Immunology and Oncology", "Part2": "Centro Nacional de Biotecnolog\u00eda", "Part3": "(CNB-CSIC) Lab 417", "Part4": "c/Darwin n 3", "Part5": "Campus Cantoblanco", "Part6": "28049", "Text": "Department of Immunology and Oncology, Centro Nacional de Biotecnolog\u00eda, (CNB-CSIC) Lab 417, c/Darwin n 3, Campus Cantoblanco, 28049, Madrid, Spain."}], "ForeName": "Jes\u00fas M", "FullName": "Jes\u00fas M Salvador", "HashID": "-2122361347696170159", "LastName": "Salvador", "ORCID": null}, {"Affiliations": null, "ForeName": "Joshua D", "FullName": "Joshua D Brown-Clay", "HashID": "-5230903152659566923", "LastName": "Brown-Clay", "ORCID": null}, {"Affiliations": null, "ForeName": "Albert J", "FullName": "Albert J Fornace", "HashID": "4450275200488004224", "LastName": "Fornace", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.1007/978-1-4614-8289-5_1", "InsertType": null, "Journal": "Advances in experimental medicine and biology", "Keywords": [{"IS_Major": false, "IS_Mesh": true, "Text": "Apoptosis"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Carcinogenesis"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Cell Cycle Checkpoints"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Cell Cycle Proteins"}, {"IS_Major": false, "IS_Mesh": true, "Text": "DNA"}, {"IS_Major": false, "IS_Mesh": true, "Text": "DNA Damage"}, {"IS_Major": true, "IS_Mesh": true, "Text": "DNA Repair"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Gene Expression Regulation"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Humans"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Nuclear Proteins"}, {"IS_Major": true, "IS_Mesh": true, "Text": "Signal Transduction"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Stress, Physiological"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Tumor Suppressor Protein p53"}, {"IS_Major": false, "IS_Mesh": true, "Text": "p38 Mitogen-Activated Protein Kinases"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "MEDLINE", "Article": {"@PubModel": "Print", "Abstract": {"AbstractText": "The first identified Gadd45 gene, Gadd45a, encodes a ubiquitously expressed protein that is often induced by DNA damage and other stress signals associated with growth arrest and apoptosis. This protein and the other two members of this small gene family, Gadd45b and Gadd45g, have been implicated in a variety of the responses to cell injury including cell cycle checkpoints, apoptosis, and DNA repair. In vivo, many of the prominent roles for the Gadd45 proteins are associated with signaling mediated by p38 mitogen-activated protein kinases (MAPK). Gadd45 proteins can contribute to p38 activation either by activation of upstream kinase(s) or by direct interaction. In vivo, there are important tissue and cell-type-specific differences in the roles for Gadd45 in MAPK signaling. In addition to being p53-regulated, Gadd45a has been found to contribute to p53 activation via p38. Like other stress and signaling proteins, Gadd45 proteins show complex regulation and numerous effectors."}, "ArticleTitle": "Gadd45 in stress signaling, cell cycle control, and apoptosis.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Immunology and Oncology, Centro Nacional de Biotecnolog\u00eda, (CNB-CSIC) Lab 417, c/Darwin n 3, Campus Cantoblanco, 28049, Madrid, Spain."}, "ForeName": "Jes\u00fas M", "Initials": "JM", "LastName": "Salvador"}, {"@ValidYN": "Y", "ForeName": "Joshua D", "Initials": "JD", "LastName": "Brown-Clay"}, {"@ValidYN": "Y", "ForeName": "Albert J", "Initials": "AJ", "LastName": "Fornace", "Suffix": "Jr"}]}, "ELocationID": {"#text": "10.1007/978-1-4614-8289-5_1", "@EIdType": "doi", "@ValidYN": "Y"}, "Journal": {"ISOAbbreviation": "Adv Exp Med Biol", "ISSN": {"#text": "0065-2598", "@IssnType": "Print"}, "JournalIssue": {"@CitedMedium": "Print", "PubDate": {"Year": "2013"}, "Volume": "793"}, "Title": "Advances in experimental medicine and biology"}, "Language": "eng", "Pagination": {"EndPage": "19", "MedlinePgn": "1-19", "StartPage": "1"}, "PublicationTypeList": {"PublicationType": [{"#text": "Journal Article", "@UI": "D016428"}, {"#text": "Review", "@UI": "D016454"}]}}, "ChemicalList": {"Chemical": [{"NameOfSubstance": {"#text": "Cell Cycle Proteins", "@UI": "D018797"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "GADD45A protein, human", "@UI": "C439070"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "Nuclear Proteins", "@UI": "D009687"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "Tumor Suppressor Protein p53", "@UI": "D016159"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "DNA", "@UI": "D004247"}, "RegistryNumber": "9007-49-2"}, {"NameOfSubstance": {"#text": "p38 Mitogen-Activated Protein Kinases", "@UI": "D048051"}, "RegistryNumber": "EC 2.7.11.24"}]}, "CitationSubset": "IM", "DateCompleted": {"Day": "18", "Month": "02", "Year": "2014"}, "DateRevised": {"Day": "18", "Month": "03", "Year": "2022"}, "MedlineJournalInfo": {"Country": "United States", "ISSNLinking": "0065-2598", "MedlineTA": "Adv Exp Med Biol", "NlmUniqueID": "0121103"}, "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"#text": "Apoptosis", "@MajorTopicYN": "N", "@UI": "D017209"}}, {"DescriptorName": {"#text": "Carcinogenesis", "@MajorTopicYN": "N", "@UI": "D063646"}}, {"DescriptorName": {"#text": "Cell Cycle Checkpoints", "@MajorTopicYN": "N", "@UI": "D059447"}}, {"DescriptorName": {"#text": "Cell Cycle Proteins", "@MajorTopicYN": "N", "@UI": "D018797"}, "QualifierName": [{"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}, {"#text": "metabolism", "@MajorTopicYN": "N", "@UI": "Q000378"}]}, {"DescriptorName": {"#text": "DNA", "@MajorTopicYN": "N", "@UI": "D004247"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "DNA Damage", "@MajorTopicYN": "N", "@UI": "D004249"}}, {"DescriptorName": {"#text": "DNA Repair", "@MajorTopicYN": "Y", "@UI": "D004260"}}, {"DescriptorName": {"#text": "Gene Expression Regulation", "@MajorTopicYN": "N", "@UI": "D005786"}}, {"DescriptorName": {"#text": "Humans", "@MajorTopicYN": "N", "@UI": "D006801"}}, {"DescriptorName": {"#text": "Nuclear Proteins", "@MajorTopicYN": "N", "@UI": "D009687"}, "QualifierName": [{"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}, {"#text": "metabolism", "@MajorTopicYN": "N", "@UI": "Q000378"}]}, {"DescriptorName": {"#text": "Signal Transduction", "@MajorTopicYN": "Y", "@UI": "D015398"}}, {"DescriptorName": {"#text": "Stress, Physiological", "@MajorTopicYN": "N", "@UI": "D013312"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Tumor Suppressor Protein p53", "@MajorTopicYN": "N", "@UI": "D016159"}, "QualifierName": [{"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}, {"#text": "metabolism", "@MajorTopicYN": "N", "@UI": "Q000378"}]}, {"DescriptorName": {"#text": "p38 Mitogen-Activated Protein Kinases", "@MajorTopicYN": "N", "@UI": "D048051"}, "QualifierName": [{"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}, {"#text": "metabolism", "@MajorTopicYN": "N", "@UI": "Q000378"}]}]}, "PMID": {"#text": "24104470", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "24104470", "@IdType": "pubmed"}, {"#text": "10.1007/978-1-4614-8289-5_1", "@IdType": "doi"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "entrez", "Day": "10", "Hour": "6", "Minute": "0", "Month": "10", "Year": "2013"}, {"@PubStatus": "pubmed", "Day": "10", "Hour": "6", "Minute": "0", "Month": "10", "Year": "2013"}, {"@PubStatus": "medline", "Day": "19", "Hour": "6", "Minute": "0", "Month": "2", "Year": "2014"}]}, "PublicationStatus": "ppublish"}}}}, "PMC": null, "PMID": "24104470", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "Gadd45 in stress signaling, cell cycle control, and apoptosis.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "38": {"Abstract": "Caspase-3 is a member of the cysteine protease family, which plays a crucial role in apoptotic pathways by cleaving a variety of key cellular proteins. Caspase-3 can be activated by diverse death-inducing signals, including the chemotherapeutic agents. The purpose of this study was to determine the levels of caspase-3 expression in breast tumor samples and to determine whether alterations in its expression can affect their ability to undergo apoptosis. Primary breast tumor and normal breast parenchyma samples were obtained from patients undergoing breast surgery and the expression of caspases-3 was studied. Similarly, normal mammary epithelial cells and several established mammary cancer cell lines were studied for caspases-3 expression by reverse transcriptase-polymerase chain reaction, Northern blot analysis, and Western blot analysis. Approximately 75% of the tumor as well as morphologically normal peritumoral tissue samples lacked the caspase-3 transcript and caspase-3 protein expression. In addition, the caspases-3 mRNA levels in commercially available total RNA samples from breast, ovarian, and cervical tumors were either undetectable (breast and cervical) or substantially decreased (ovarian). Despite the complete loss of caspase-3, the expression levels of other caspases, such as caspase-8 and caspase-9, were normal in all of the tumor samples studied. The sensitivity of caspase-3-deficient breast cancer (MCF-7) cells to undergo apoptosis in response to doxorubicin and other apoptotic stimuli could be augmented by reconstituting caspase-3 expression. These results suggest that the loss of caspases-3 expression may represent an important cell survival mechanism in breast cancer patients.", "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "-8103555498469619328", "Part1": "Department of Bioimmunotherapy", "Part2": "The University of Texas MD Anderson Cancer Center", "Part3": "Houston", "Part4": "Texas", "Part5": "TX 77030", "Part6": "USA.", "Text": "Department of Bioimmunotherapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, TX 77030, USA."}], "ForeName": "Eswaran", "FullName": "Eswaran Devarajan", "HashID": "-4604206269522845816", "LastName": "Devarajan", "ORCID": null}, {"Affiliations": null, "ForeName": "Aysegul A", "FullName": "Aysegul A Sahin", "HashID": "-656435544825471862", "LastName": "Sahin", "ORCID": null}, {"Affiliations": null, "ForeName": "Jack S", "FullName": "Jack S Chen", "HashID": "4413563733682715508", "LastName": "Chen", "ORCID": null}, {"Affiliations": null, "ForeName": "Raghu R", "FullName": "Raghu R Krishnamurthy", "HashID": "7299887712209127448", "LastName": "Krishnamurthy", "ORCID": null}, {"Affiliations": null, "ForeName": "Neeraj", "FullName": "Neeraj Aggarwal", "HashID": "3354836902286594087", "LastName": "Aggarwal", "ORCID": null}, {"Affiliations": null, "ForeName": "Anne-Marie", "FullName": "Anne-Marie Brun", "HashID": "1697881213538837548", "LastName": "Brun", "ORCID": null}, {"Affiliations": null, "ForeName": "Anna", "FullName": "Anna Sapino", "HashID": "8189811202038383901", "LastName": "Sapino", "ORCID": null}, {"Affiliations": null, "ForeName": "Fan", "FullName": "Fan Zhang", "HashID": "-6600484150145061382", "LastName": "Zhang", "ORCID": null}, {"Affiliations": null, "ForeName": "Dhawal", "FullName": "Dhawal Sharma", "HashID": "3567690538876082675", "LastName": "Sharma", "ORCID": null}, {"Affiliations": null, "ForeName": "Xiao-He", "FullName": "Xiao-He Yang", "HashID": "-8254362183144567448", "LastName": "Yang", "ORCID": null}, {"Affiliations": null, "ForeName": "Ann D", "FullName": "Ann D Tora", "HashID": "-7378287229959135512", "LastName": "Tora", "ORCID": null}, {"Affiliations": null, "ForeName": "Kapil", "FullName": "Kapil Mehta", "HashID": "8191629279598390117", "LastName": "Mehta", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.1038/sj.onc.1206044", "InsertType": null, "Journal": "Oncogene", "Keywords": [{"IS_Major": false, "IS_Mesh": true, "Text": "Base Sequence"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Blotting, Northern"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Blotting, Western"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Breast Neoplasms"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Caspase 3"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Caspases"}, {"IS_Major": false, "IS_Mesh": true, "Text": "DNA Primers"}, {"IS_Major": true, "IS_Mesh": true, "Text": "Down-Regulation"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Drug Resistance, Neoplasm"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Flow Cytometry"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Humans"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Tumor Cells, Cultured"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "MEDLINE", "Article": {"@PubModel": "Print", "Abstract": {"AbstractText": "Caspase-3 is a member of the cysteine protease family, which plays a crucial role in apoptotic pathways by cleaving a variety of key cellular proteins. Caspase-3 can be activated by diverse death-inducing signals, including the chemotherapeutic agents. The purpose of this study was to determine the levels of caspase-3 expression in breast tumor samples and to determine whether alterations in its expression can affect their ability to undergo apoptosis. Primary breast tumor and normal breast parenchyma samples were obtained from patients undergoing breast surgery and the expression of caspases-3 was studied. Similarly, normal mammary epithelial cells and several established mammary cancer cell lines were studied for caspases-3 expression by reverse transcriptase-polymerase chain reaction, Northern blot analysis, and Western blot analysis. Approximately 75% of the tumor as well as morphologically normal peritumoral tissue samples lacked the caspase-3 transcript and caspase-3 protein expression. In addition, the caspases-3 mRNA levels in commercially available total RNA samples from breast, ovarian, and cervical tumors were either undetectable (breast and cervical) or substantially decreased (ovarian). Despite the complete loss of caspase-3, the expression levels of other caspases, such as caspase-8 and caspase-9, were normal in all of the tumor samples studied. The sensitivity of caspase-3-deficient breast cancer (MCF-7) cells to undergo apoptosis in response to doxorubicin and other apoptotic stimuli could be augmented by reconstituting caspase-3 expression. These results suggest that the loss of caspases-3 expression may represent an important cell survival mechanism in breast cancer patients."}, "ArticleTitle": "Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Bioimmunotherapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, TX 77030, USA."}, "ForeName": "Eswaran", "Initials": "E", "LastName": "Devarajan"}, {"@ValidYN": "Y", "ForeName": "Aysegul A", "Initials": "AA", "LastName": "Sahin"}, {"@ValidYN": "Y", "ForeName": "Jack S", "Initials": "JS", "LastName": "Chen"}, {"@ValidYN": "Y", "ForeName": "Raghu R", "Initials": "RR", "LastName": "Krishnamurthy"}, {"@ValidYN": "Y", "ForeName": "Neeraj", "Initials": "N", "LastName": "Aggarwal"}, {"@ValidYN": "Y", "ForeName": "Anne-Marie", "Initials": "AM", "LastName": "Brun"}, {"@ValidYN": "Y", "ForeName": "Anna", "Initials": "A", "LastName": "Sapino"}, {"@ValidYN": "Y", "ForeName": "Fan", "Initials": "F", "LastName": "Zhang"}, {"@ValidYN": "Y", "ForeName": "Dhawal", "Initials": "D", "LastName": "Sharma"}, {"@ValidYN": "Y", "ForeName": "Xiao-He", "Initials": "XH", "LastName": "Yang"}, {"@ValidYN": "Y", "ForeName": "Ann D", "Initials": "AD", "LastName": "Tora"}, {"@ValidYN": "Y", "ForeName": "Kapil", "Initials": "K", "LastName": "Mehta"}]}, "Journal": {"ISOAbbreviation": "Oncogene", "ISSN": {"#text": "0950-9232", "@IssnType": "Print"}, "JournalIssue": {"@CitedMedium": "Print", "Issue": "57", "PubDate": {"Day": "12", "Month": "Dec", "Year": "2002"}, "Volume": "21"}, "Title": "Oncogene"}, "Language": "eng", "Pagination": {"EndPage": "8851", "MedlinePgn": "8843-51", "StartPage": "8843"}, "PublicationTypeList": {"PublicationType": [{"#text": "Journal Article", "@UI": "D016428"}, {"#text": "Research Support, Non-U.S. Gov't", "@UI": "D013485"}, {"#text": "Research Support, U.S. Gov't, Non-P.H.S.", "@UI": "D013486"}]}}, "ChemicalList": {"Chemical": [{"NameOfSubstance": {"#text": "DNA Primers", "@UI": "D017931"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "CASP3 protein, human", "@UI": "C505407"}, "RegistryNumber": "EC 3.4.22.-"}, {"NameOfSubstance": {"#text": "Caspase 3", "@UI": "D053148"}, "RegistryNumber": "EC 3.4.22.-"}, {"NameOfSubstance": {"#text": "Caspases", "@UI": "D020169"}, "RegistryNumber": "EC 3.4.22.-"}]}, "CitationSubset": "IM", "DateCompleted": {"Day": "23", "Month": "01", "Year": "2003"}, "DateRevised": {"Day": "18", "Month": "03", "Year": "2022"}, "MedlineJournalInfo": {"Country": "England", "ISSNLinking": "0950-9232", "MedlineTA": "Oncogene", "NlmUniqueID": "8711562"}, "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"#text": "Base Sequence", "@MajorTopicYN": "N", "@UI": "D001483"}}, {"DescriptorName": {"#text": "Blotting, Northern", "@MajorTopicYN": "N", "@UI": "D015152"}}, {"DescriptorName": {"#text": "Blotting, Western", "@MajorTopicYN": "N", "@UI": "D015153"}}, {"DescriptorName": {"#text": "Breast Neoplasms", "@MajorTopicYN": "N", "@UI": "D001943"}, "QualifierName": [{"#text": "enzymology", "@MajorTopicYN": "Y", "@UI": "Q000201"}, {"#text": "pathology", "@MajorTopicYN": "N", "@UI": "Q000473"}]}, {"DescriptorName": {"#text": "Caspase 3", "@MajorTopicYN": "N", "@UI": "D053148"}}, {"DescriptorName": {"#text": "Caspases", "@MajorTopicYN": "N", "@UI": "D020169"}, "QualifierName": [{"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}, {"#text": "metabolism", "@MajorTopicYN": "N", "@UI": "Q000378"}]}, {"DescriptorName": {"#text": "DNA Primers", "@MajorTopicYN": "N", "@UI": "D017931"}}, {"DescriptorName": {"#text": "Down-Regulation", "@MajorTopicYN": "Y", "@UI": "D015536"}}, {"DescriptorName": {"#text": "Drug Resistance, Neoplasm", "@MajorTopicYN": "N", "@UI": "D019008"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Flow Cytometry", "@MajorTopicYN": "N", "@UI": "D005434"}}, {"DescriptorName": {"#text": "Humans", "@MajorTopicYN": "N", "@UI": "D006801"}}, {"DescriptorName": {"#text": "Tumor Cells, Cultured", "@MajorTopicYN": "N", "@UI": "D014407"}}]}, "PMID": {"#text": "12483536", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "12483536", "@IdType": "pubmed"}, {"#text": "10.1038/sj.onc.1206044", "@IdType": "doi"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "received", "Day": "19", "Month": "7", "Year": "2002"}, {"@PubStatus": "revised", "Day": "10", "Month": "9", "Year": "2002"}, {"@PubStatus": "accepted", "Day": "16", "Month": "9", "Year": "2002"}, {"@PubStatus": "pubmed", "Day": "17", "Hour": "4", "Minute": "0", "Month": "12", "Year": "2002"}, {"@PubStatus": "medline", "Day": "24", "Hour": "4", "Minute": "0", "Month": "1", "Year": "2003"}, {"@PubStatus": "entrez", "Day": "17", "Hour": "4", "Minute": "0", "Month": "12", "Year": "2002"}]}, "PublicationStatus": "ppublish"}}}}, "PMC": null, "PMID": "12483536", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "39": {"Abstract": "Colorectal cancer (CRC) is one of the most commonly diagnosed cancers among both males and females; the chemotherapy drug 5-fluorouracil (5-FU) is one of a doctors' first lines of defense against CRC. However, therapeutic failures are common because of the emergence of drug resistance. Connective tissue growth factor (CTGF) is a secreted protein that binds to integrins, and regulates the invasiveness and metastasis of certain carcinoma cells. Here, we found that CTGF was upregulated in drug-resistant phenotype of human CRC cells. Overexpression of CTGF enhanced the resistance to 5-FU-induced cell apoptosis. Moreover, downregulating the expression of CTGF promoted the curative effect of chemotherapy and blocked the cell cycle in the G1 phase. We also found that CTGF facilitated resistance to 5-FU-induced apoptosis by increasing the expression of B-cell lymphoma-extra large (Bcl-xL) and survivin. Then we pharmacologically blocked MEK/ERK signal pathway and assessed 5-FU response by MTT assays. Our current results indicate that the expression of phosphorylated forms of MEK/ERK increased in high CTGF expression cells and MEK inhibited increases in 5-FU-mediated apoptosis of resistant CRC cells. Therefore, our data suggest that MEK/ERK signaling contributes to 5-FU resistance through upstream of CTGF, and supports CRC cell growth. Comprehending the molecular mechanism underlying 5-FU resistance may ultimately aid the fight against CRC.", "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "-8207853030117860234", "Part1": "Department of General Surgery", "Part2": "The Third Affiliated Hospital of Central South University", "Part3": "Central South University", "Part4": "Changsha", "Part5": "Hunan", "Part6": "People's Republic of China.", "Text": "Department of General Surgery, The Third Affiliated Hospital of Central South University, Central South University, Changsha, Hunan, People's Republic of China."}], "ForeName": "Kai", "FullName": "Kai Yang", "HashID": "-6649758013226054315", "LastName": "Yang", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-8207853030117860234", "Part1": "Department of General Surgery", "Part2": "The Third Affiliated Hospital of Central South University", "Part3": "Central South University", "Part4": "Changsha", "Part5": "Hunan", "Part6": "People's Republic of China.", "Text": "Department of General Surgery, The Third Affiliated Hospital of Central South University, Central South University, Changsha, Hunan, People's Republic of China."}], "ForeName": "Kai", "FullName": "Kai Gao", "HashID": "6070129072081772765", "LastName": "Gao", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-8207853030117860234", "Part1": "Department of General Surgery", "Part2": "The Third Affiliated Hospital of Central South University", "Part3": "Central South University", "Part4": "Changsha", "Part5": "Hunan", "Part6": "People's Republic of China.", "Text": "Department of General Surgery, The Third Affiliated Hospital of Central South University, Central South University, Changsha, Hunan, People's Republic of China."}], "ForeName": "Gui", "FullName": "Gui Hu", "HashID": "-4321570392056703141", "LastName": "Hu", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-8207853030117860234", "Part1": "Department of General Surgery", "Part2": "The Third Affiliated Hospital of Central South University", "Part3": "Central South University", "Part4": "Changsha", "Part5": "Hunan", "Part6": "People's Republic of China.", "Text": "Department of General Surgery, The Third Affiliated Hospital of Central South University, Central South University, Changsha, Hunan, People's Republic of China."}], "ForeName": "Yanguang", "FullName": "Yanguang Wen", "HashID": "-1252708267239778901", "LastName": "Wen", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-8207853030117860234", "Part1": "Department of General Surgery", "Part2": "The Third Affiliated Hospital of Central South University", "Part3": "Central South University", "Part4": "Changsha", "Part5": "Hunan", "Part6": "People's Republic of China.", "Text": "Department of General Surgery, The Third Affiliated Hospital of Central South University, Central South University, Changsha, Hunan, People's Republic of China."}], "ForeName": "Changwei", "FullName": "Changwei Lin", "HashID": "-2923477094263703299", "LastName": "Lin", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-8207853030117860234", "Part1": "Department of General Surgery", "Part2": "The Third Affiliated Hospital of Central South University", "Part3": "Central South University", "Part4": "Changsha", "Part5": "Hunan", "Part6": "People's Republic of China.", "Text": "Department of General Surgery, The Third Affiliated Hospital of Central South University, Central South University, Changsha, Hunan, People's Republic of China."}], "ForeName": "Xiaorong", "FullName": "Xiaorong Li", "HashID": "-6943090872551144280", "LastName": "Li", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.2147/OTT.S108929", "InsertType": null, "Journal": "OncoTargets and therapy", "Keywords": [{"IS_Major": false, "IS_Mesh": false, "Text": "5-fluorouracil"}, {"IS_Major": false, "IS_Mesh": false, "Text": "colorectal cancer"}, {"IS_Major": false, "IS_Mesh": false, "Text": "connective tissue growth factor"}, {"IS_Major": false, "IS_Mesh": false, "Text": "mitogen-activated protein kinase/extracellular regulated protein kinases"}, {"IS_Major": false, "IS_Mesh": false, "Text": "phosphatidyl inositol 3-kinase/serine/threonine kinase Akt"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "PubMed-not-MEDLINE", "Article": {"@PubModel": "Electronic-eCollection", "Abstract": {"AbstractText": "Colorectal cancer (CRC) is one of the most commonly diagnosed cancers among both males and females; the chemotherapy drug 5-fluorouracil (5-FU) is one of a doctors' first lines of defense against CRC. However, therapeutic failures are common because of the emergence of drug resistance. Connective tissue growth factor (CTGF) is a secreted protein that binds to integrins, and regulates the invasiveness and metastasis of certain carcinoma cells. Here, we found that CTGF was upregulated in drug-resistant phenotype of human CRC cells. Overexpression of CTGF enhanced the resistance to 5-FU-induced cell apoptosis. Moreover, downregulating the expression of CTGF promoted the curative effect of chemotherapy and blocked the cell cycle in the G1 phase. We also found that CTGF facilitated resistance to 5-FU-induced apoptosis by increasing the expression of B-cell lymphoma-extra large (Bcl-xL) and survivin. Then we pharmacologically blocked MEK/ERK signal pathway and assessed 5-FU response by MTT assays. Our current results indicate that the expression of phosphorylated forms of MEK/ERK increased in high CTGF expression cells and MEK inhibited increases in 5-FU-mediated apoptosis of resistant CRC cells. Therefore, our data suggest that MEK/ERK signaling contributes to 5-FU resistance through upstream of CTGF, and supports CRC cell growth. Comprehending the molecular mechanism underlying 5-FU resistance may ultimately aid the fight against CRC."}, "ArticleDate": {"@DateType": "Electronic", "Day": "30", "Month": "11", "Year": "2016"}, "ArticleTitle": "CTGF enhances resistance to 5-FU-mediating cell apoptosis through FAK/MEK/ERK signal pathway in colorectal cancer.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of General Surgery, The Third Affiliated Hospital of Central South University, Central South University, Changsha, Hunan, People's Republic of China."}, "ForeName": "Kai", "Initials": "K", "LastName": "Yang"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of General Surgery, The Third Affiliated Hospital of Central South University, Central South University, Changsha, Hunan, People's Republic of China."}, "ForeName": "Kai", "Initials": "K", "LastName": "Gao"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of General Surgery, The Third Affiliated Hospital of Central South University, Central South University, Changsha, Hunan, People's Republic of China."}, "ForeName": "Gui", "Initials": "G", "LastName": "Hu"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of General Surgery, The Third Affiliated Hospital of Central South University, Central South University, Changsha, Hunan, People's Republic of China."}, "ForeName": "Yanguang", "Initials": "Y", "LastName": "Wen"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of General Surgery, The Third Affiliated Hospital of Central South University, Central South University, Changsha, Hunan, People's Republic of China."}, "ForeName": "Changwei", "Initials": "C", "LastName": "Lin"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of General Surgery, The Third Affiliated Hospital of Central South University, Central South University, Changsha, Hunan, People's Republic of China."}, "ForeName": "Xiaorong", "Initials": "X", "LastName": "Li"}]}, "Journal": {"ISOAbbreviation": "Onco Targets Ther", "ISSN": {"#text": "1178-6930", "@IssnType": "Print"}, "JournalIssue": {"@CitedMedium": "Print", "PubDate": {"Year": "2016"}, "Volume": "9"}, "Title": "OncoTargets and therapy"}, "Language": "eng", "Pagination": {"EndPage": "7295", "MedlinePgn": "7285-7295", "StartPage": "7285"}, "PublicationTypeList": {"PublicationType": {"#text": "Journal Article", "@UI": "D016428"}}}, "CoiStatement": "The authors report no conflicts of interest in this work.", "DateRevised": {"Day": "29", "Month": "09", "Year": "2020"}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"#text": "5-fluorouracil", "@MajorTopicYN": "N"}, {"#text": "colorectal cancer", "@MajorTopicYN": "N"}, {"#text": "connective tissue growth factor", "@MajorTopicYN": "N"}, {"#text": "mitogen-activated protein kinase/extracellular regulated protein kinases", "@MajorTopicYN": "N"}, {"#text": "phosphatidyl inositol 3-kinase/serine/threonine kinase Akt", "@MajorTopicYN": "N"}]}, "MedlineJournalInfo": {"Country": "New Zealand", "ISSNLinking": "1178-6930", "MedlineTA": "Onco Targets Ther", "NlmUniqueID": "101514322"}, "PMID": {"#text": "27942222", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "27942222", "@IdType": "pubmed"}, {"#text": "PMC5138041", "@IdType": "pmc"}, {"#text": "10.2147/OTT.S108929", "@IdType": "doi"}, {"#text": "ott-9-7285", "@IdType": "pii"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "entrez", "Day": "13", "Hour": "6", "Minute": "0", "Month": "12", "Year": "2016"}, {"@PubStatus": "pubmed", "Day": "13", "Hour": "6", "Minute": "0", "Month": "12", "Year": "2016"}, {"@PubStatus": "medline", "Day": "13", "Hour": "6", "Minute": "1", "Month": "12", "Year": "2016"}]}, "PublicationStatus": "epublish", "ReferenceList": {"Reference": [{"ArticleIdList": {"ArticleId": [{"#text": "PMC5216764", "@IdType": "pmc"}, {"#text": "27323852", "@IdType": "pubmed"}]}, "Citation": "Xie X, Liu H, Wang Y, et al. Nicotinamide N-methyltransferase enhances resistance to 5-fluorouracil in colorectal cancer cells through inhibition of the ASK1-p38 MAPK pathway. Oncotarget. 2016 Jun 13; Epub."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4081407", "@IdType": "pmc"}, {"#text": "25013487", "@IdType": "pubmed"}]}, "Citation": "Mhaidat NM, Bouklihacene M, Thorne RF. 5-Fluorouracil-induced apoptosis in colorectal cancer cells is caspase-9-dependent and mediated by activation of protein kinase C-delta. Oncol Lett. 2014;8(2):699\u2013704."}, {"ArticleIdList": {"ArticleId": {"#text": "27173050", "@IdType": "pubmed"}}, "Citation": "Liu H, Yin Y, Hu Y, et al. miR-139-5p sensitizes colorectal cancer cells to 5-fluorouracil by targeting NOTCH-1. Pathol Res Pract. 2016;212(7):643\u2013649."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2946420", "@IdType": "pmc"}, {"#text": "20162579", "@IdType": "pubmed"}]}, "Citation": "Yin D, Chen W, O\u2019Kelly J, et al. Connective tissue growth factor associated with oncogenic activities and drug resistance in glioblastoma multiforme. Int J Cancer. 2010;127(10):2257\u20132267."}, {"ArticleIdList": {"ArticleId": {"#text": "21558398", "@IdType": "pubmed"}}, "Citation": "Lin BR, Chang CC, Chen RJ, et al. Connective tissue growth factor acts as a therapeutic agent and predictor for peritoneal carcinomatosis of colorectal cancer. Clin Cancer Res. 2011;17(10):3077\u20133088."}, {"ArticleIdList": {"ArticleId": {"#text": "19351859", "@IdType": "pubmed"}}, "Citation": "Wang MY, Chen PS, Prakash E, et al. Connective tissue growth factor confers drug resistance in breast cancer through concomitant up-regulation of Bcl-xL and cIAP1. Cancer Res. 2009;69(8):3482\u20133491."}, {"ArticleIdList": {"ArticleId": {"#text": "21503841", "@IdType": "pubmed"}}, "Citation": "Cui L, Zhang Q, Mao Z, et al. CTGF is overexpressed in papillary thyroid carcinoma and promotes the growth of papillary thyroid cancer cells. Tumour Biol. 2011;32(4):721\u2013728."}, {"ArticleIdList": {"ArticleId": {"#text": "21081514", "@IdType": "pubmed"}}, "Citation": "Ladwa R, Pringle H, Kumar R, West K. Expression of CTGF and Cyr61 in colorectal cancer. J Clin Pathol. 2011;64(1):58\u201364."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3650616", "@IdType": "pmc"}, {"#text": "23531216", "@IdType": "pubmed"}]}, "Citation": "Gayle SS, Castellino RC, Buss MC, Nahta R. MEK inhibition increases lapatinib sensitivity via modulation of FOXM1. Curr Med Chem. 2013;20(19):2486\u20132499."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC539194", "@IdType": "pmc"}, {"#text": "15630443", "@IdType": "pubmed"}]}, "Citation": "Minn AJ, Kang Y, Serganova I, et al. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest. 2005;115(1):44\u201355."}, {"ArticleIdList": {"ArticleId": {"#text": "17266502", "@IdType": "pubmed"}}, "Citation": "Cepeda V, Fuertes MA, Castilla J, Alonso C, Quevedo C, P\u00e9rez JM. Biochemical mechanisms of cisplatin cytotoxicity. Anticancer Agents Med Chem. 2007;7(1):3\u201318."}, {"ArticleIdList": {"ArticleId": {"#text": "16705726", "@IdType": "pubmed"}}, "Citation": "Wang W, Luo H, Wang A. Expression of survivin and correlation with PCNA in osteosarcoma. J Surg Oncol. 2006;93(7):578\u2013584."}, {"ArticleIdList": {"ArticleId": {"#text": "18996209", "@IdType": "pubmed"}}, "Citation": "Liang X, Da M, Zhuang Z, et al. Effects of Survivin on cell proliferation and apoptosis in MG-63 cells in vitro. Cell Biol Int. 2009;33(1):119\u2013124."}, {"ArticleIdList": {"ArticleId": {"#text": "19442052", "@IdType": "pubmed"}}, "Citation": "Gimenez-Bonafe P, Tortosa A, Perez-Tomas R. Overcoming drug resistance by enhancing apoptosis of tumor cells. Curr Cancer Drug Targets. 2009;9(3):320\u2013340."}, {"ArticleIdList": {"ArticleId": {"#text": "8358726", "@IdType": "pubmed"}}, "Citation": "Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res. 1993;53(17):3976\u20133985."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4699262", "@IdType": "pmc"}, {"#text": "26753006", "@IdType": "pubmed"}]}, "Citation": "Hammond WA, Swaika A, Mody K. Pharmacologic resistance in colorectal cancer: a review. Ther Adv Med Oncol. 2016;8(1):57\u201384."}, {"ArticleIdList": {"ArticleId": {"#text": "15633118", "@IdType": "pubmed"}}, "Citation": "Lin BR, Chang CC, Che TF, et al. Connective tissue growth factor inhibits metastasis and acts as an independent prognostic marker in colorectal cancer. Gastroenterology. 2005;128(1):9\u201323."}, {"ArticleIdList": {"ArticleId": {"#text": "25501363", "@IdType": "pubmed"}}, "Citation": "Guo Y, Li X, Lin C, et al. MicroRNA133b inhibits connective tissue growth factor in colorectal cancer and correlates with the clinical stage of the disease. Mol Med Rep. 2015;11(4):2805\u20132812."}, {"ArticleIdList": {"ArticleId": {"#text": "11013359", "@IdType": "pubmed"}}, "Citation": "Shakunaga T, Ozaki T, Ohara N, et al. Expression of connective tissue growth factor in cartilaginous tumors. Cancer. 2000;89(7):1466\u20131473."}, {"ArticleIdList": {"ArticleId": {"#text": "19132753", "@IdType": "pubmed"}}, "Citation": "Sodek KL, Ringuette MJ, Brown TJ. Compact spheroid formation by ovarian cancer cells is associated with contractile behavior and an invasive phenotype. Int J Cancer. 2009;124(9):2060\u20132070."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3822297", "@IdType": "pmc"}, {"#text": "24273517", "@IdType": "pubmed"}]}, "Citation": "Hamada S, Masamune A, Shimosegawa T. Novel therapeutic strategies targeting tumor-stromal interactions in pancreatic cancer. Front Physiol. 2013;4:331."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3956456", "@IdType": "pmc"}, {"#text": "24637722", "@IdType": "pubmed"}]}, "Citation": "Tsai HC, Huang CY, Su HL, Tang CH. CCN2 enhances resistance to cisplatin-mediating cell apoptosis in human osteosarcoma. PloS One. 2014;9(3):e90159."}, {"ArticleIdList": {"ArticleId": {"#text": "24462773", "@IdType": "pubmed"}}, "Citation": "Tsai HC, Huang CY, Su HL, Tang CH. CTGF increases drug resistance to paclitaxel by upregulating survivin expression in human osteosarcoma cells. Biochim Biophys Acta. 2014;1843(5):846\u2013854."}, {"ArticleIdList": {"ArticleId": {"#text": "16382892", "@IdType": "pubmed"}}, "Citation": "Karczmarek-Borowska B, Filip A, Wojcierowski J, Smole\u0144 A, Pilecka I, Jab\u0142onka A. Survivin antiapoptotic gene expression as a prognostic factor in non-small cell lung cancer: in situ hybridization study. Folia Histochem Cytobiol. 2005;43(4):237\u2013242."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4917988", "@IdType": "pmc"}, {"#text": "27340370", "@IdType": "pubmed"}]}, "Citation": "Garg H, Suri P, Gupta JC, Talwar GP, Dubey S. Survivin: a unique target for tumor therapy. Cancer Cell Int. 2016;16:49."}, {"ArticleIdList": {"ArticleId": {"#text": "9256286", "@IdType": "pubmed"}}, "Citation": "Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nature Med. 1997;3(8):917\u2013921."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4116521", "@IdType": "pmc"}, {"#text": "25003330", "@IdType": "pubmed"}]}, "Citation": "Tsai HC, Su HL, Huang CY, Fong YC, Hsu CJ, Tang CH. CTGF increases matrix metalloproteinases expression and subsequently promotes tumor metastasis in human osteosarcoma through down-regulating miR-519d. Oncotarget. 2014;5(11):3800\u20133812."}, {"ArticleIdList": {"ArticleId": {"#text": "22674530", "@IdType": "pubmed"}}, "Citation": "Spina A, Sorvillo L, Di Maiolo F. Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway. J Cell Physiol. 2013;228(1):198\u2013206."}]}}}}}, "PMC": "PMC5138041", "PMID": "27942222", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "CTGF enhances resistance to 5-FU-mediating cell apoptosis through FAK/MEK/ERK signal pathway in colorectal cancer.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "40": {"Abstract": "Loss of p53 function in cancer cells commonly results in a condition of genomic instability. This is believed to emanate from a loss of the G1 checkpoint response to DNA damage. While the role of p53 in the induction of a G1 arrest is well-accepted, additional p53 functions are being discovered. Cell cycle checkpoints presumably function to allow additional time for DNA repair after damage is incurred, however, genetic studies in yeast suggest that components of the checkpoint pathway may also be involved in DNA lesion processing (Lydall and Weinert, 1995). Recent evidence suggests that this may also be the case for p53, as suggested by numerous reports linking p53 function to DNA repair. Thus, loss of p53 function might contribute to genomic instability independent of G1-arrest. In the present study, we explored the effect of p53 disruption and consequences of antisense GADD45 expression on the DNA repair capacity of human colon carcinoma RKO cells. DNA repair was assayed using host-cell reactivation of u.v.-damaged reporter plasmids and unscheduled DNA synthesis experiments in transiently-transfected cells. We show that a number of transfected genes that suppress p53 function reduce the ability of cells to repair u.v.-induced DNA damage. Moreover, cells in which expression of the p53-regulated gene GADD45 was blocked by antisense vectors, also showed altered levels of DNA repair. Blocking Gadd45 expression by constitutive antisense expression sensitized cells to killing by u.v.-radiation or by cis-platinum (II) diamine-dichloride (CDDP, or cisplatin), a cancer chemotherapy drug which produces DNA cross-links. These findings suggest the involvement of downstream effectors of the p53 pathway in the coordination of cell cycle arrest and DNA repair.", "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "8177081861053347208", "Part1": "Division of Cancer Treatment", "Part2": "National Cancer Institute", "Part3": "National Institutes of Health", "Part4": "Bethesda", "Part5": "Maryland 20892", "Part6": "USA.", "Text": "Division of Cancer Treatment, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA."}], "ForeName": "M L", "FullName": "M L Smith", "HashID": "2679650708815063445", "LastName": "Smith", "ORCID": null}, {"Affiliations": null, "ForeName": "H U", "FullName": "H U Kontny", "HashID": "-3418907774276069459", "LastName": "Kontny", "ORCID": null}, {"Affiliations": null, "ForeName": "Q", "FullName": "Q Zhan", "HashID": "3439087813279993556", "LastName": "Zhan", "ORCID": null}, {"Affiliations": null, "ForeName": "A", "FullName": "A Sreenath", "HashID": "3170184059603075323", "LastName": "Sreenath", "ORCID": null}, {"Affiliations": null, "ForeName": "P M", "FullName": "P M O'Connor", "HashID": "9098317090961106242", "LastName": "O'Connor", "ORCID": null}, {"Affiliations": null, "ForeName": "A J", "FullName": "A J Fornace", "HashID": "-4643664296980519972", "LastName": "Fornace", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": null, "InsertType": null, "Journal": "Oncogene", "Keywords": [{"IS_Major": false, "IS_Mesh": true, "Text": "Antineoplastic Agents"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Chloramphenicol O-Acetyltransferase"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Cisplatin"}, {"IS_Major": false, "IS_Mesh": true, "Text": "DNA"}, {"IS_Major": false, "IS_Mesh": true, "Text": "DNA Repair"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Genes, Reporter"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Genes, p53"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Genetic Vectors"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Humans"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Intracellular Signaling Peptides and Proteins"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Oncogene Proteins, Viral"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Proteins"}, {"IS_Major": false, "IS_Mesh": true, "Text": "RNA, Antisense"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Radiation-Sensitizing Agents"}, {"IS_Major": true, "IS_Mesh": true, "Text": "Repressor Proteins"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Transfection"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Tumor Cells, Cultured"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "MEDLINE", "Article": {"@PubModel": "Print", "Abstract": {"AbstractText": "Loss of p53 function in cancer cells commonly results in a condition of genomic instability. This is believed to emanate from a loss of the G1 checkpoint response to DNA damage. While the role of p53 in the induction of a G1 arrest is well-accepted, additional p53 functions are being discovered. Cell cycle checkpoints presumably function to allow additional time for DNA repair after damage is incurred, however, genetic studies in yeast suggest that components of the checkpoint pathway may also be involved in DNA lesion processing (Lydall and Weinert, 1995). Recent evidence suggests that this may also be the case for p53, as suggested by numerous reports linking p53 function to DNA repair. Thus, loss of p53 function might contribute to genomic instability independent of G1-arrest. In the present study, we explored the effect of p53 disruption and consequences of antisense GADD45 expression on the DNA repair capacity of human colon carcinoma RKO cells. DNA repair was assayed using host-cell reactivation of u.v.-damaged reporter plasmids and unscheduled DNA synthesis experiments in transiently-transfected cells. We show that a number of transfected genes that suppress p53 function reduce the ability of cells to repair u.v.-induced DNA damage. Moreover, cells in which expression of the p53-regulated gene GADD45 was blocked by antisense vectors, also showed altered levels of DNA repair. Blocking Gadd45 expression by constitutive antisense expression sensitized cells to killing by u.v.-radiation or by cis-platinum (II) diamine-dichloride (CDDP, or cisplatin), a cancer chemotherapy drug which produces DNA cross-links. These findings suggest the involvement of downstream effectors of the p53 pathway in the coordination of cell cycle arrest and DNA repair."}, "ArticleTitle": "Antisense GADD45 expression results in decreased DNA repair and sensitizes cells to u.v.-irradiation or cisplatin.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Division of Cancer Treatment, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA."}, "ForeName": "M L", "Initials": "ML", "LastName": "Smith"}, {"@ValidYN": "Y", "ForeName": "H U", "Initials": "HU", "LastName": "Kontny"}, {"@ValidYN": "Y", "ForeName": "Q", "Initials": "Q", "LastName": "Zhan"}, {"@ValidYN": "Y", "ForeName": "A", "Initials": "A", "LastName": "Sreenath"}, {"@ValidYN": "Y", "ForeName": "P M", "Initials": "PM", "LastName": "O'Connor"}, {"@ValidYN": "Y", "ForeName": "A J", "Initials": "AJ", "LastName": "Fornace", "Suffix": "Jr"}]}, "Journal": {"ISOAbbreviation": "Oncogene", "ISSN": {"#text": "0950-9232", "@IssnType": "Print"}, "JournalIssue": {"@CitedMedium": "Print", "Issue": "10", "PubDate": {"Day": "21", "Month": "Nov", "Year": "1996"}, "Volume": "13"}, "Title": "Oncogene"}, "Language": "eng", "Pagination": {"EndPage": "2263", "MedlinePgn": "2255-63", "StartPage": "2255"}, "PublicationTypeList": {"PublicationType": {"#text": "Journal Article", "@UI": "D016428"}}}, "ChemicalList": {"Chemical": [{"NameOfSubstance": {"#text": "Antineoplastic Agents", "@UI": "D000970"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "E6 protein, Human papillomavirus type 16", "@UI": "C068651"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "GADD45 protein", "@UI": "C086050"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "Intracellular Signaling Peptides and Proteins", "@UI": "D047908"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "Oncogene Proteins, Viral", "@UI": "D009856"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "Proteins", "@UI": "D011506"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "RNA, Antisense", "@UI": "D016372"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "Radiation-Sensitizing Agents", "@UI": "D011838"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "Repressor Proteins", "@UI": "D012097"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "DNA", "@UI": "D004247"}, "RegistryNumber": "9007-49-2"}, {"NameOfSubstance": {"#text": "Chloramphenicol O-Acetyltransferase", "@UI": "D015500"}, "RegistryNumber": "EC 2.3.1.28"}, {"NameOfSubstance": {"#text": "Cisplatin", "@UI": "D002945"}, "RegistryNumber": "Q20Q21Q62J"}]}, "CitationSubset": "IM", "DateCompleted": {"Day": "09", "Month": "01", "Year": "1997"}, "DateRevised": {"Day": "21", "Month": "11", "Year": "2013"}, "MedlineJournalInfo": {"Country": "England", "ISSNLinking": "0950-9232", "MedlineTA": "Oncogene", "NlmUniqueID": "8711562"}, "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"#text": "Antineoplastic Agents", "@MajorTopicYN": "N", "@UI": "D000970"}, "QualifierName": {"#text": "pharmacology", "@MajorTopicYN": "N", "@UI": "Q000494"}}, {"DescriptorName": {"#text": "Chloramphenicol O-Acetyltransferase", "@MajorTopicYN": "N", "@UI": "D015500"}, "QualifierName": [{"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}, {"#text": "metabolism", "@MajorTopicYN": "N", "@UI": "Q000378"}]}, {"DescriptorName": {"#text": "Cisplatin", "@MajorTopicYN": "N", "@UI": "D002945"}, "QualifierName": {"#text": "pharmacology", "@MajorTopicYN": "N", "@UI": "Q000494"}}, {"DescriptorName": {"#text": "DNA", "@MajorTopicYN": "N", "@UI": "D004247"}, "QualifierName": [{"#text": "biosynthesis", "@MajorTopicYN": "N", "@UI": "Q000096"}, {"#text": "radiation effects", "@MajorTopicYN": "Y", "@UI": "Q000528"}]}, {"DescriptorName": {"#text": "DNA Repair", "@MajorTopicYN": "N", "@UI": "D004260"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Genes, Reporter", "@MajorTopicYN": "N", "@UI": "D017930"}, "QualifierName": [{"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}, {"#text": "radiation effects", "@MajorTopicYN": "N", "@UI": "Q000528"}]}, {"DescriptorName": {"#text": "Genes, p53", "@MajorTopicYN": "N", "@UI": "D016158"}, "QualifierName": [{"#text": "drug effects", "@MajorTopicYN": "N", "@UI": "Q000187"}, {"#text": "physiology", "@MajorTopicYN": "Y", "@UI": "Q000502"}]}, {"DescriptorName": {"#text": "Genetic Vectors", "@MajorTopicYN": "N", "@UI": "D005822"}}, {"DescriptorName": {"#text": "Humans", "@MajorTopicYN": "N", "@UI": "D006801"}}, {"DescriptorName": {"#text": "Intracellular Signaling Peptides and Proteins", "@MajorTopicYN": "N", "@UI": "D047908"}}, {"DescriptorName": {"#text": "Oncogene Proteins, Viral", "@MajorTopicYN": "N", "@UI": "D009856"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Proteins", "@MajorTopicYN": "N", "@UI": "D011506"}, "QualifierName": [{"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}, {"#text": "metabolism", "@MajorTopicYN": "Y", "@UI": "Q000378"}]}, {"DescriptorName": {"#text": "RNA, Antisense", "@MajorTopicYN": "N", "@UI": "D016372"}, "QualifierName": [{"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}, {"#text": "metabolism", "@MajorTopicYN": "Y", "@UI": "Q000378"}]}, {"DescriptorName": {"#text": "Radiation-Sensitizing Agents", "@MajorTopicYN": "N", "@UI": "D011838"}, "QualifierName": {"#text": "pharmacology", "@MajorTopicYN": "N", "@UI": "Q000494"}}, {"DescriptorName": {"#text": "Repressor Proteins", "@MajorTopicYN": "Y", "@UI": "D012097"}}, {"DescriptorName": {"#text": "Transfection", "@MajorTopicYN": "N", "@UI": "D014162"}}, {"DescriptorName": {"#text": "Tumor Cells, Cultured", "@MajorTopicYN": "N", "@UI": "D014407"}, "QualifierName": {"#text": "drug effects", "@MajorTopicYN": "N", "@UI": "Q000187"}}]}, "PMID": {"#text": "8950993", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": {"#text": "8950993", "@IdType": "pubmed"}}, "History": {"PubMedPubDate": [{"@PubStatus": "pubmed", "Day": "21", "Month": "11", "Year": "1996"}, {"@PubStatus": "medline", "Day": "28", "Hour": "10", "Minute": "1", "Month": "3", "Year": "2001"}, {"@PubStatus": "entrez", "Day": "21", "Hour": "0", "Minute": "0", "Month": "11", "Year": "1996"}]}, "PublicationStatus": "ppublish"}}}}, "PMC": null, "PMID": "8950993", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "Antisense GADD45 expression results in decreased DNA repair and sensitizes cells to u.v.-irradiation or cisplatin.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "41": {"Abstract": "Accumulation of data indicates that misregulated long noncoding RNAs (lncRNAs) are implicated in cancer tumorigenesis and progression and might be served as diagnosis and prognosis biomarker or potential therapeutic targets. Identification of cancer-associated lncRNAs and investigation of their biological functions and molecular mechanisms are significant for understanding the development and progression of cancer. In this study, we identified a novel lncRNA SNHG15, whose expression was upregulated in tumor tissues in 106 patients with gastric cancer (GC) compared with those in the adjacent normal tissues (P\u2009<\u20090.001). Furthermore, increased SNHG15 expression was positively correlated with invasion depth (P\u2009<\u20090.001), advanced tumor node metastasis (TNM) stage (P\u2009=\u20090.001), and lymph node metastasis (P\u2009=\u20090.019). SNHG15 levels were robust in differentiating GC tissues from controls (area under the curve (AUC)\u2009=\u20090.722; 95\u00a0% confidence interval (CI)\u2009=\u20090.657-0.782, P\u2009<\u20090.01). Kaplan-Meier analysis demonstrated that elevated SNHG15 expression contributed to poor overall survival (P\u2009<\u20090.01) and disease-free survival (P\u2009<\u20090.01) of patients. A multivariate survival analysis also indicated that SNHG15 could be an independent prognostic marker. Furthermore, knockdown of SNHG15 expression by siRNA could inhibit cell proliferation and invasion and induce apoptosis, while ectopic expression of SNHG15 promoted cell proliferation and invasion in GC cells partly via regulating MMP2 and MMP9 protein expression. Our findings present that elevated lncRNA SNHG15 could be identified as a poor prognostic biomarker in GC and regulate cell invasion.", "Authors": [{"Affiliations": [{"Has_Extra": true, "HashID": "8074767927853697341", "Part1": "Department of Tumor Rehabilitation", "Part2": "The 1st Affiliated Hospital of Wenzhou Medical University", "Part3": "No.2 Fuxue Lane", "Part4": "Wenzhou", "Part5": "Zhejiang Province", "Part6": "325000", "Text": "Department of Tumor Rehabilitation, The 1st Affiliated Hospital of Wenzhou Medical University, No.2 Fuxue Lane, Wenzhou, Zhejiang Province, 325000, China."}], "ForeName": "Su-Xiu", "FullName": "Su-Xiu Chen", "HashID": "265609514873240218", "LastName": "Chen", "ORCID": null}, {"Affiliations": [{"Has_Extra": true, "HashID": "2630168617246390601", "Part1": "Department of General Surgery", "Part2": "Yangzhou No 1 People's Hospital", "Part3": "The Second Clinical School of Yangzhou University", "Part4": "Yangzhou", "Part5": "225000", "Part6": "Jiangsu Province", "Text": "Department of General Surgery, Yangzhou No 1 People's Hospital, The Second Clinical School of Yangzhou University, Yangzhou, 225000, Jiangsu Province, People's Republic of China."}], "ForeName": "Jun-Feng", "FullName": "Jun-Feng Yin", "HashID": "-1194476713255396986", "LastName": "Yin", "ORCID": null}, {"Affiliations": [{"Has_Extra": true, "HashID": "7223579831420653884", "Part1": "Radiotherapy and Chemotherapy Department", "Part2": "The 1st Affiliated Hospital of Wenzhou Medical University", "Part3": "No.2 Fuxue Lane", "Part4": "Wenzhou", "Part5": "Zhejiang Province", "Part6": "325000", "Text": "Radiotherapy and Chemotherapy Department, The 1st Affiliated Hospital of Wenzhou Medical University, No.2 Fuxue Lane, Wenzhou, Zhejiang Province, 325000, China."}], "ForeName": "Bao-Chai", "FullName": "Bao-Chai Lin", "HashID": "1938276776687735677", "LastName": "Lin", "ORCID": null}, {"Affiliations": [{"Has_Extra": true, "HashID": "7223579831420653884", "Part1": "Radiotherapy and Chemotherapy Department", "Part2": "The 1st Affiliated Hospital of Wenzhou Medical University", "Part3": "No.2 Fuxue Lane", "Part4": "Wenzhou", "Part5": "Zhejiang Province", "Part6": "325000", "Text": "Radiotherapy and Chemotherapy Department, The 1st Affiliated Hospital of Wenzhou Medical University, No.2 Fuxue Lane, Wenzhou, Zhejiang Province, 325000, China."}], "ForeName": "Hua-Fang", "FullName": "Hua-Fang Su", "HashID": "7682809577254288614", "LastName": "Su", "ORCID": null}, {"Affiliations": [{"Has_Extra": true, "HashID": "7223579831420653884", "Part1": "Radiotherapy and Chemotherapy Department", "Part2": "The 1st Affiliated Hospital of Wenzhou Medical University", "Part3": "No.2 Fuxue Lane", "Part4": "Wenzhou", "Part5": "Zhejiang Province", "Part6": "325000", "Text": "Radiotherapy and Chemotherapy Department, The 1st Affiliated Hospital of Wenzhou Medical University, No.2 Fuxue Lane, Wenzhou, Zhejiang Province, 325000, China."}], "ForeName": "Zhen", "FullName": "Zhen Zheng", "HashID": "6520592347717140602", "LastName": "Zheng", "ORCID": null}, {"Affiliations": [{"Has_Extra": true, "HashID": "7223579831420653884", "Part1": "Radiotherapy and Chemotherapy Department", "Part2": "The 1st Affiliated Hospital of Wenzhou Medical University", "Part3": "No.2 Fuxue Lane", "Part4": "Wenzhou", "Part5": "Zhejiang Province", "Part6": "325000", "Text": "Radiotherapy and Chemotherapy Department, The 1st Affiliated Hospital of Wenzhou Medical University, No.2 Fuxue Lane, Wenzhou, Zhejiang Province, 325000, China. xiecongyingwz@sina.com."}], "ForeName": "Cong-Ying", "FullName": "Cong-Ying Xie", "HashID": "8571704937842711650", "LastName": "Xie", "ORCID": null}, {"Affiliations": [{"Has_Extra": true, "HashID": "7223579831420653884", "Part1": "Radiotherapy and Chemotherapy Department", "Part2": "The 1st Affiliated Hospital of Wenzhou Medical University", "Part3": "No.2 Fuxue Lane", "Part4": "Wenzhou", "Part5": "Zhejiang Province", "Part6": "325000", "Text": "Radiotherapy and Chemotherapy Department, The 1st Affiliated Hospital of Wenzhou Medical University, No.2 Fuxue Lane, Wenzhou, Zhejiang Province, 325000, China. hui-y@163.com."}], "ForeName": "Zheng-Hua", "FullName": "Zheng-Hua Fei", "HashID": "4218951974651136185", "LastName": "Fei", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.1007/s13277-015-4404-0", "InsertType": null, "Journal": "Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine", "Keywords": [{"IS_Major": false, "IS_Mesh": true, "Text": "Adult"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Aged"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Animals"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Apoptosis"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Biomarkers, Tumor"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Cell Line, Tumor"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Cell Movement"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Cell Proliferation"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Cell Transformation, Neoplastic"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Disease Models, Animal"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Female"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Follow-Up Studies"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Gene Expression Profiling"}, {"IS_Major": true, "IS_Mesh": true, "Text": "Gene Expression Regulation, Neoplastic"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Humans"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Kaplan-Meier Estimate"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Male"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Matrix Metalloproteinase 2"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Matrix Metalloproteinase 9"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Mice"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Middle Aged"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Neoplasm Grading"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Neoplasm Metastasis"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Neoplasm Staging"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Prognosis"}, {"IS_Major": false, "IS_Mesh": true, "Text": "RNA, Long Noncoding"}, {"IS_Major": false, "IS_Mesh": true, "Text": "ROC Curve"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Stomach Neoplasms"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Tumor Burden"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Up-Regulation"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Xenograft Model Antitumor Assays"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Clinical relevance"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Gastric cancer"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Long noncoding RNA"}, {"IS_Major": false, "IS_Mesh": false, "Text": "SNHG15"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "MEDLINE", "Article": {"@PubModel": "Print-Electronic", "Abstract": {"AbstractText": "Accumulation of data indicates that misregulated long noncoding RNAs (lncRNAs) are implicated in cancer tumorigenesis and progression and might be served as diagnosis and prognosis biomarker or potential therapeutic targets. Identification of cancer-associated lncRNAs and investigation of their biological functions and molecular mechanisms are significant for understanding the development and progression of cancer. In this study, we identified a novel lncRNA SNHG15, whose expression was upregulated in tumor tissues in 106 patients with gastric cancer (GC) compared with those in the adjacent normal tissues (P\u2009<\u20090.001). Furthermore, increased SNHG15 expression was positively correlated with invasion depth (P\u2009<\u20090.001), advanced tumor node metastasis (TNM) stage (P\u2009=\u20090.001), and lymph node metastasis (P\u2009=\u20090.019). SNHG15 levels were robust in differentiating GC tissues from controls (area under the curve (AUC)\u2009=\u20090.722; 95\u00a0% confidence interval (CI)\u2009=\u20090.657-0.782, P\u2009<\u20090.01). Kaplan-Meier analysis demonstrated that elevated SNHG15 expression contributed to poor overall survival (P\u2009<\u20090.01) and disease-free survival (P\u2009<\u20090.01) of patients. A multivariate survival analysis also indicated that SNHG15 could be an independent prognostic marker. Furthermore, knockdown of SNHG15 expression by siRNA could inhibit cell proliferation and invasion and induce apoptosis, while ectopic expression of SNHG15 promoted cell proliferation and invasion in GC cells partly via regulating MMP2 and MMP9 protein expression. Our findings present that elevated lncRNA SNHG15 could be identified as a poor prognostic biomarker in GC and regulate cell invasion."}, "ArticleDate": {"@DateType": "Electronic", "Day": "10", "Month": "12", "Year": "2015"}, "ArticleTitle": "Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Tumor Rehabilitation, The 1st Affiliated Hospital of Wenzhou Medical University, No.2 Fuxue Lane, Wenzhou, Zhejiang Province, 325000, China."}, "ForeName": "Su-Xiu", "Initials": "SX", "LastName": "Chen"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of General Surgery, Yangzhou No 1 People's Hospital, The Second Clinical School of Yangzhou University, Yangzhou, 225000, Jiangsu Province, People's Republic of China."}, "ForeName": "Jun-Feng", "Initials": "JF", "LastName": "Yin"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Radiotherapy and Chemotherapy Department, The 1st Affiliated Hospital of Wenzhou Medical University, No.2 Fuxue Lane, Wenzhou, Zhejiang Province, 325000, China."}, "ForeName": "Bao-Chai", "Initials": "BC", "LastName": "Lin"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Radiotherapy and Chemotherapy Department, The 1st Affiliated Hospital of Wenzhou Medical University, No.2 Fuxue Lane, Wenzhou, Zhejiang Province, 325000, China."}, "ForeName": "Hua-Fang", "Initials": "HF", "LastName": "Su"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Radiotherapy and Chemotherapy Department, The 1st Affiliated Hospital of Wenzhou Medical University, No.2 Fuxue Lane, Wenzhou, Zhejiang Province, 325000, China."}, "ForeName": "Zhen", "Initials": "Z", "LastName": "Zheng"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Radiotherapy and Chemotherapy Department, The 1st Affiliated Hospital of Wenzhou Medical University, No.2 Fuxue Lane, Wenzhou, Zhejiang Province, 325000, China. xiecongyingwz@sina.com."}, "ForeName": "Cong-Ying", "Initials": "CY", "LastName": "Xie"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Radiotherapy and Chemotherapy Department, The 1st Affiliated Hospital of Wenzhou Medical University, No.2 Fuxue Lane, Wenzhou, Zhejiang Province, 325000, China. hui-y@163.com."}, "ForeName": "Zheng-Hua", "Initials": "ZH", "LastName": "Fei"}]}, "ELocationID": {"#text": "10.1007/s13277-015-4404-0", "@EIdType": "doi", "@ValidYN": "Y"}, "Journal": {"ISOAbbreviation": "Tumour Biol", "ISSN": {"#text": "1423-0380", "@IssnType": "Electronic"}, "JournalIssue": {"@CitedMedium": "Internet", "Issue": "5", "PubDate": {"Month": "May", "Year": "2016"}, "Volume": "37"}, "Title": "Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine"}, "Language": "eng", "Pagination": {"EndPage": "6812", "MedlinePgn": "6801-12", "StartPage": "6801"}, "PublicationTypeList": {"PublicationType": {"#text": "Journal Article", "@UI": "D016428"}}}, "ChemicalList": {"Chemical": [{"NameOfSubstance": {"#text": "Biomarkers, Tumor", "@UI": "D014408"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "RNA, Long Noncoding", "@UI": "D062085"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "Matrix Metalloproteinase 2", "@UI": "D020778"}, "RegistryNumber": "EC 3.4.24.24"}, {"NameOfSubstance": {"#text": "Matrix Metalloproteinase 9", "@UI": "D020780"}, "RegistryNumber": "EC 3.4.24.35"}]}, "CitationSubset": "IM", "DateCompleted": {"Day": "06", "Month": "02", "Year": "2017"}, "DateRevised": {"Day": "30", "Month": "03", "Year": "2022"}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"#text": "Clinical relevance", "@MajorTopicYN": "N"}, {"#text": "Gastric cancer", "@MajorTopicYN": "N"}, {"#text": "Long noncoding RNA", "@MajorTopicYN": "N"}, {"#text": "SNHG15", "@MajorTopicYN": "N"}]}, "MedlineJournalInfo": {"Country": "Netherlands", "ISSNLinking": "1010-4283", "MedlineTA": "Tumour Biol", "NlmUniqueID": "8409922"}, "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"#text": "Adult", "@MajorTopicYN": "N", "@UI": "D000328"}}, {"DescriptorName": {"#text": "Aged", "@MajorTopicYN": "N", "@UI": "D000368"}}, {"DescriptorName": {"#text": "Animals", "@MajorTopicYN": "N", "@UI": "D000818"}}, {"DescriptorName": {"#text": "Apoptosis", "@MajorTopicYN": "N", "@UI": "D017209"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Biomarkers, Tumor", "@MajorTopicYN": "N", "@UI": "D014408"}}, {"DescriptorName": {"#text": "Cell Line, Tumor", "@MajorTopicYN": "N", "@UI": "D045744"}}, {"DescriptorName": {"#text": "Cell Movement", "@MajorTopicYN": "N", "@UI": "D002465"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Cell Proliferation", "@MajorTopicYN": "N", "@UI": "D049109"}}, {"DescriptorName": {"#text": "Cell Transformation, Neoplastic", "@MajorTopicYN": "N", "@UI": "D002471"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Disease Models, Animal", "@MajorTopicYN": "N", "@UI": "D004195"}}, {"DescriptorName": {"#text": "Female", "@MajorTopicYN": "N", "@UI": "D005260"}}, {"DescriptorName": {"#text": "Follow-Up Studies", "@MajorTopicYN": "N", "@UI": "D005500"}}, {"DescriptorName": {"#text": "Gene Expression Profiling", "@MajorTopicYN": "N", "@UI": "D020869"}}, {"DescriptorName": {"#text": "Gene Expression Regulation, Neoplastic", "@MajorTopicYN": "Y", "@UI": "D015972"}}, {"DescriptorName": {"#text": "Humans", "@MajorTopicYN": "N", "@UI": "D006801"}}, {"DescriptorName": {"#text": "Kaplan-Meier Estimate", "@MajorTopicYN": "N", "@UI": "D053208"}}, {"DescriptorName": {"#text": "Male", "@MajorTopicYN": "N", "@UI": "D008297"}}, {"DescriptorName": {"#text": "Matrix Metalloproteinase 2", "@MajorTopicYN": "N", "@UI": "D020778"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Matrix Metalloproteinase 9", "@MajorTopicYN": "N", "@UI": "D020780"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Mice", "@MajorTopicYN": "N", "@UI": "D051379"}}, {"DescriptorName": {"#text": "Middle Aged", "@MajorTopicYN": "N", "@UI": "D008875"}}, {"DescriptorName": {"#text": "Neoplasm Grading", "@MajorTopicYN": "N", "@UI": "D060787"}}, {"DescriptorName": {"#text": "Neoplasm Metastasis", "@MajorTopicYN": "N", "@UI": "D009362"}}, {"DescriptorName": {"#text": "Neoplasm Staging", "@MajorTopicYN": "N", "@UI": "D009367"}}, {"DescriptorName": {"#text": "Prognosis", "@MajorTopicYN": "N", "@UI": "D011379"}}, {"DescriptorName": {"#text": "RNA, Long Noncoding", "@MajorTopicYN": "N", "@UI": "D062085"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "ROC Curve", "@MajorTopicYN": "N", "@UI": "D012372"}}, {"DescriptorName": {"#text": "Stomach Neoplasms", "@MajorTopicYN": "N", "@UI": "D013274"}, "QualifierName": [{"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}, {"#text": "mortality", "@MajorTopicYN": "N", "@UI": "Q000401"}, {"#text": "pathology", "@MajorTopicYN": "Y", "@UI": "Q000473"}]}, {"DescriptorName": {"#text": "Tumor Burden", "@MajorTopicYN": "N", "@UI": "D047368"}}, {"DescriptorName": {"#text": "Up-Regulation", "@MajorTopicYN": "N", "@UI": "D015854"}}, {"DescriptorName": {"#text": "Xenograft Model Antitumor Assays", "@MajorTopicYN": "N", "@UI": "D023041"}}]}, "PMID": {"#text": "26662309", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "26662309", "@IdType": "pubmed"}, {"#text": "10.1007/s13277-015-4404-0", "@IdType": "doi"}, {"#text": "10.1007/s13277-015-4404-0", "@IdType": "pii"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "received", "Day": "24", "Month": "8", "Year": "2015"}, {"@PubStatus": "accepted", "Day": "6", "Month": "11", "Year": "2015"}, {"@PubStatus": "entrez", "Day": "15", "Hour": "6", "Minute": "0", "Month": "12", "Year": "2015"}, {"@PubStatus": "pubmed", "Day": "15", "Hour": "6", "Minute": "0", "Month": "12", "Year": "2015"}, {"@PubStatus": "medline", "Day": "7", "Hour": "6", "Minute": "0", "Month": "2", "Year": "2017"}]}, "PublicationStatus": "ppublish", "ReferenceList": {"Reference": [{"ArticleIdList": {"ArticleId": {"#text": "20553069", "@IdType": "pubmed"}}, "Citation": "Asian Pac J Cancer Prev. 2010;11 Suppl 2:67-80"}, {"ArticleIdList": {"ArticleId": {"#text": "20601294", "@IdType": "pubmed"}}, "Citation": "Bone. 2011 Jan;48(1):44-53"}, {"ArticleIdList": {"ArticleId": {"#text": "23681802", "@IdType": "pubmed"}}, "Citation": "Tumour Biol. 2013 Aug;34(4):2041-51"}, {"ArticleIdList": {"ArticleId": {"#text": "21151178", "@IdType": "pubmed"}}, "Citation": "Oncogene. 2011 Apr 21;30(16):1956-62"}, {"ArticleIdList": {"ArticleId": {"#text": "25600645", "@IdType": "pubmed"}}, "Citation": "Cancer Res. 2015 Apr 1;75(7):1322-31"}, {"ArticleIdList": {"ArticleId": {"#text": "25280565", "@IdType": "pubmed"}}, "Citation": "Carcinogenesis. 2014 Dec;35(12):2731-9"}, {"ArticleIdList": {"ArticleId": {"#text": "20610543", "@IdType": "pubmed"}}, "Citation": "CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300"}, {"ArticleIdList": {"ArticleId": {"#text": "20371345", "@IdType": "pubmed"}}, "Citation": "Cell. 2010 Apr 2;141(1):52-67"}, {"ArticleIdList": {"ArticleId": {"#text": "24036268", "@IdType": "pubmed"}}, "Citation": "Biochem Biophys Res Commun. 2013 Oct 4;439(4):547-51"}, {"ArticleIdList": {"ArticleId": {"#text": "19657673", "@IdType": "pubmed"}}, "Citation": "Hum Genet. 2009 Nov;126(5):615-28"}, {"ArticleIdList": {"ArticleId": {"#text": "22996375", "@IdType": "pubmed"}}, "Citation": "Mod Pathol. 2013 Feb;26(2):155-65"}, {"ArticleIdList": {"ArticleId": {"#text": "24473064", "@IdType": "pubmed"}}, "Citation": "Cancer Res. 2014 Mar 15;74(6):1651-60"}, {"ArticleIdList": {"ArticleId": {"#text": "20429936", "@IdType": "pubmed"}}, "Citation": "BMC Bioinformatics. 2010 Apr 29;11:221"}, {"ArticleIdList": {"ArticleId": {"#text": "24884417", "@IdType": "pubmed"}}, "Citation": "BMC Cancer. 2014 May 06;14:319"}, {"ArticleIdList": {"ArticleId": {"#text": "24449823", "@IdType": "pubmed"}}, "Citation": "Clin Cancer Res. 2014 Mar 15;20(6):1531-41"}, {"ArticleIdList": {"ArticleId": {"#text": "24006224", "@IdType": "pubmed"}}, "Citation": "Tumour Biol. 2014 Feb;35(2):1065-73"}, {"ArticleIdList": {"ArticleId": {"#text": "25890171", "@IdType": "pubmed"}}, "Citation": "Mol Cancer. 2015 Apr 12;14 :82"}, {"ArticleIdList": {"ArticleId": {"#text": "21989130", "@IdType": "pubmed"}}, "Citation": "Nat Rev Genet. 2011 Oct 12;12(11):742"}, {"ArticleIdList": {"ArticleId": {"#text": "17145715", "@IdType": "pubmed"}}, "Citation": "Nucleic Acids Res. 2007 Jan;35(Database issue):D178-82"}, {"ArticleIdList": {"ArticleId": {"#text": "22558417", "@IdType": "pubmed"}}, "Citation": "PLoS One. 2012;7(4):e36275"}, {"ArticleIdList": {"ArticleId": {"#text": "25468426", "@IdType": "pubmed"}}, "Citation": "J Biosci Bioeng. 2015 May;119(5):604-8"}, {"ArticleIdList": {"ArticleId": {"#text": "19239885", "@IdType": "pubmed"}}, "Citation": "Cell. 2009 Feb 20;136(4):629-41"}, {"ArticleIdList": {"ArticleId": {"#text": "25167886", "@IdType": "pubmed"}}, "Citation": "J Hematol Oncol. 2014 Aug 29;7:63"}, {"ArticleIdList": {"ArticleId": {"#text": "17604720", "@IdType": "pubmed"}}, "Citation": "Cell. 2007 Jun 29;129(7):1311-23"}, {"ArticleIdList": {"ArticleId": {"#text": "20393566", "@IdType": "pubmed"}}, "Citation": "Nature. 2010 Apr 15;464(7291):1071-6"}]}}}}}, "PMC": null, "PMID": "26662309", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "42": {"Abstract": "During angiogenesis, new vessels emerge from existing endothelial lined vessels to promote the degradation of the vascular basement membrane and remodel the extracellular matrix (ECM), followed by endothelial cell migration, and proliferation and the new generation of matrix components. Matrix metalloproteinases (MMPs) participate in the disruption, tumor neovascularization, and subsequent metastasis while tissue inhibitors of metalloproteinases (TIMPs) downregulate the activity of these MMPs. Then, the angiogenic response can be directly or indirectly mediated by MMPs through the modulation of the balance between pro- and anti-angiogenic factors. This review analyzes recent knowledge on MMPs and their participation in angiogenesis.", "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "7042426980223351030", "Part1": "Multidisciplinary Research Laboratory", "Part2": "Military School of Graduate of Health", "Part3": "Mexico City", "Part4": "Mexico.", "Part5": null, "Part6": null, "Text": "Multidisciplinary Research Laboratory, Military School of Graduate of Health, Mexico City, Mexico."}], "ForeName": "Saray", "FullName": "Saray Quintero-Fabi\u00e1n", "HashID": "2650638846788519739", "LastName": "Quintero-Fabi\u00e1n", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "6819440881232618679", "Part1": "Psychiatric Genetics Department", "Part2": "National Institute of Psychiatry \"Ram\u00f3n de la Fuente\"", "Part3": "Clinical Research Branch", "Part4": "Mexico City", "Part5": "Mexico.", "Part6": null, "Text": "Psychiatric Genetics Department, National Institute of Psychiatry \"Ram\u00f3n de la Fuente\", Clinical Research Branch, Mexico City, Mexico."}], "ForeName": "Rodrigo", "FullName": "Rodrigo Arreola", "HashID": "5724174179102541447", "LastName": "Arreola", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "986662533110191779", "Part1": "Psychoimmunology Laboratory", "Part2": "National Institute of Psychiatry \"Ram\u00f3n de la Fuente\"", "Part3": "Mexico City", "Part4": "Mexico.", "Part5": null, "Part6": null, "Text": "Psychoimmunology Laboratory, National Institute of Psychiatry \"Ram\u00f3n de la Fuente\", Mexico City, Mexico."}], "ForeName": "Enrique", "FullName": "Enrique Becerril-Villanueva", "HashID": "1123794152985851487", "LastName": "Becerril-Villanueva", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-7250459027256792591", "Part1": "Biochemistry and Molecular Genetics Laboratory", "Part2": "Facultad de Qu\u00edmica de la Universidad Aut\u00f3noma de Yucat\u00e1n", "Part3": "Merida", "Part4": "Mexico.", "Part5": null, "Part6": null, "Text": "Biochemistry and Molecular Genetics Laboratory, Facultad de Qu\u00edmica de la Universidad Aut\u00f3noma de Yucat\u00e1n, Merida, Mexico."}], "ForeName": "Julio C\u00e9sar", "FullName": "Julio C\u00e9sar Torres-Romero", "HashID": "7801169171987593737", "LastName": "Torres-Romero", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-4819378300875742822", "Part1": "Pharmacology Laboratory", "Part2": "Facultad de Qu\u00edmica de la Universidad Aut\u00f3noma de Yucat\u00e1n", "Part3": "M\u00e9rida", "Part4": "Mexico.", "Part5": null, "Part6": null, "Text": "Pharmacology Laboratory, Facultad de Qu\u00edmica de la Universidad Aut\u00f3noma de Yucat\u00e1n, M\u00e9rida, Mexico."}], "ForeName": "Victor", "FullName": "Victor Arana-Arg\u00e1ez", "HashID": "1582578499268926169", "LastName": "Arana-Arg\u00e1ez", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-7250459027256792591", "Part1": "Biochemistry and Molecular Genetics Laboratory", "Part2": "Facultad de Qu\u00edmica de la Universidad Aut\u00f3noma de Yucat\u00e1n", "Part3": "Merida", "Part4": "Mexico.", "Part5": null, "Part6": null, "Text": "Biochemistry and Molecular Genetics Laboratory, Facultad de Qu\u00edmica de la Universidad Aut\u00f3noma de Yucat\u00e1n, Merida, Mexico."}], "ForeName": "Julio", "FullName": "Julio Lara-Riegos", "HashID": "-6197335611058325106", "LastName": "Lara-Riegos", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "2964338292118027751", "Part1": "Centro de Informaci\u00f3n de Medicamentos", "Part2": "Facultad de Qu\u00edmica de la Universidad Aut\u00f3noma de Yucat\u00e1n", "Part3": "M\u00e9rida", "Part4": "Mexico.", "Part5": null, "Part6": null, "Text": "Centro de Informaci\u00f3n de Medicamentos, Facultad de Qu\u00edmica de la Universidad Aut\u00f3noma de Yucat\u00e1n, M\u00e9rida, Mexico."}], "ForeName": "Mario Alberto", "FullName": "Mario Alberto Ram\u00edrez-Camacho", "HashID": "6249215193113414346", "LastName": "Ram\u00edrez-Camacho", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "3648487055728414754", "Part1": "Genomic Sciences Graduate Program", "Part2": "Universidad Aut\u00f3noma de la Ciudad de Mexico", "Part3": "Mexico City", "Part4": "Mexico.", "Part5": null, "Part6": null, "Text": "Genomic Sciences Graduate Program, Universidad Aut\u00f3noma de la Ciudad de Mexico, Mexico City, Mexico."}], "ForeName": "Mar\u00eda Elizbeth", "FullName": "Mar\u00eda Elizbeth Alvarez-S\u00e1nchez", "HashID": "-8434856673461642009", "LastName": "Alvarez-S\u00e1nchez", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.3389/fonc.2019.01370", "InsertType": null, "Journal": "Frontiers in oncology", "Keywords": [{"IS_Major": false, "IS_Mesh": false, "Text": "MMP"}, {"IS_Major": false, "IS_Mesh": false, "Text": "MT-MMP"}, {"IS_Major": false, "IS_Mesh": false, "Text": "angiogenesis and cancer"}, {"IS_Major": false, "IS_Mesh": false, "Text": "immune system"}, {"IS_Major": false, "IS_Mesh": false, "Text": "metalloproteinases"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "PubMed-not-MEDLINE", "Article": {"@PubModel": "Electronic-eCollection", "Abstract": {"AbstractText": "During angiogenesis, new vessels emerge from existing endothelial lined vessels to promote the degradation of the vascular basement membrane and remodel the extracellular matrix (ECM), followed by endothelial cell migration, and proliferation and the new generation of matrix components. Matrix metalloproteinases (MMPs) participate in the disruption, tumor neovascularization, and subsequent metastasis while tissue inhibitors of metalloproteinases (TIMPs) downregulate the activity of these MMPs. Then, the angiogenic response can be directly or indirectly mediated by MMPs through the modulation of the balance between pro- and anti-angiogenic factors. This review analyzes recent knowledge on MMPs and their participation in angiogenesis.", "CopyrightInformation": "Copyright \u00a9 2019 Quintero-Fabi\u00e1n, Arreola, Becerril-Villanueva, Torres-Romero, Arana-Arg\u00e1ez, Lara-Riegos, Ram\u00edrez-Camacho and Alvarez-S\u00e1nchez."}, "ArticleDate": {"@DateType": "Electronic", "Day": "06", "Month": "12", "Year": "2019"}, "ArticleTitle": "Role of Matrix Metalloproteinases in Angiogenesis and Cancer.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Multidisciplinary Research Laboratory, Military School of Graduate of Health, Mexico City, Mexico."}, "ForeName": "Saray", "Initials": "S", "LastName": "Quintero-Fabi\u00e1n"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Psychiatric Genetics Department, National Institute of Psychiatry \"Ram\u00f3n de la Fuente\", Clinical Research Branch, Mexico City, Mexico."}, "ForeName": "Rodrigo", "Initials": "R", "LastName": "Arreola"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Psychoimmunology Laboratory, National Institute of Psychiatry \"Ram\u00f3n de la Fuente\", Mexico City, Mexico."}, "ForeName": "Enrique", "Initials": "E", "LastName": "Becerril-Villanueva"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Biochemistry and Molecular Genetics Laboratory, Facultad de Qu\u00edmica de la Universidad Aut\u00f3noma de Yucat\u00e1n, Merida, Mexico."}, "ForeName": "Julio C\u00e9sar", "Initials": "JC", "LastName": "Torres-Romero"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Pharmacology Laboratory, Facultad de Qu\u00edmica de la Universidad Aut\u00f3noma de Yucat\u00e1n, M\u00e9rida, Mexico."}, "ForeName": "Victor", "Initials": "V", "LastName": "Arana-Arg\u00e1ez"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Biochemistry and Molecular Genetics Laboratory, Facultad de Qu\u00edmica de la Universidad Aut\u00f3noma de Yucat\u00e1n, Merida, Mexico."}, "ForeName": "Julio", "Initials": "J", "LastName": "Lara-Riegos"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Centro de Informaci\u00f3n de Medicamentos, Facultad de Qu\u00edmica de la Universidad Aut\u00f3noma de Yucat\u00e1n, M\u00e9rida, Mexico."}, "ForeName": "Mario Alberto", "Initials": "MA", "LastName": "Ram\u00edrez-Camacho"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Genomic Sciences Graduate Program, Universidad Aut\u00f3noma de la Ciudad de Mexico, Mexico City, Mexico."}, "ForeName": "Mar\u00eda Elizbeth", "Initials": "ME", "LastName": "Alvarez-S\u00e1nchez"}]}, "ELocationID": [{"#text": "1370", "@EIdType": "pii", "@ValidYN": "Y"}, {"#text": "10.3389/fonc.2019.01370", "@EIdType": "doi", "@ValidYN": "Y"}], "Journal": {"ISOAbbreviation": "Front Oncol", "ISSN": {"#text": "2234-943X", "@IssnType": "Print"}, "JournalIssue": {"@CitedMedium": "Print", "PubDate": {"Year": "2019"}, "Volume": "9"}, "Title": "Frontiers in oncology"}, "Language": "eng", "Pagination": {"MedlinePgn": "1370", "StartPage": "1370"}, "PublicationTypeList": {"PublicationType": [{"#text": "Journal Article", "@UI": "D016428"}, {"#text": "Review", "@UI": "D016454"}]}}, "DateRevised": {"Day": "01", "Month": "10", "Year": "2020"}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"#text": "MMP", "@MajorTopicYN": "N"}, {"#text": "MT-MMP", "@MajorTopicYN": "N"}, {"#text": "angiogenesis and cancer", "@MajorTopicYN": "N"}, {"#text": "immune system", "@MajorTopicYN": "N"}, {"#text": "metalloproteinases", "@MajorTopicYN": "N"}]}, "MedlineJournalInfo": {"Country": "Switzerland", "ISSNLinking": "2234-943X", "MedlineTA": "Front Oncol", "NlmUniqueID": "101568867"}, "PMID": {"#text": "31921634", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "31921634", "@IdType": "pubmed"}, {"#text": "PMC6915110", "@IdType": "pmc"}, {"#text": "10.3389/fonc.2019.01370", "@IdType": "doi"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "received", "Day": "24", "Month": "6", "Year": "2019"}, {"@PubStatus": "accepted", "Day": "20", "Month": "11", "Year": "2019"}, {"@PubStatus": "entrez", "Day": "11", "Hour": "6", "Minute": "0", "Month": "1", "Year": "2020"}, {"@PubStatus": "pubmed", "Day": "11", "Hour": "6", "Minute": "0", "Month": "1", "Year": "2020"}, {"@PubStatus": "medline", "Day": "11", "Hour": "6", "Minute": "1", "Month": "1", "Year": "2020"}]}, "PublicationStatus": "epublish", "ReferenceList": {"Reference": [{"ArticleIdList": {"ArticleId": [{"#text": "10.3390/cells7080089", "@IdType": "doi"}, {"#text": "PMC6115737", "@IdType": "pmc"}, {"#text": "30060564", "@IdType": "pubmed"}]}, "Citation": "Di Cara G, Marabeti M, Musso R, Riili I, Cancemi P, Pucci Minafra I. New insights into the occurrence of matrix metalloproteases\u22122 and\u22129 in a Cohort of Breast Cancer Patients and Proteomic Correlations. Cells. (2018) 7:89. 10.3390/cells7080089"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cell.2011.09.024", "@IdType": "doi"}, {"#text": "PMC3261217", "@IdType": "pmc"}, {"#text": "22000009", "@IdType": "pubmed"}]}, "Citation": "Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell. (2011) 147:275\u201392. 10.1016/j.cell.2011.09.024"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1615/CritRevOncog.v18.i1-2.40", "@IdType": "doi"}, {"#text": "PMC3597235", "@IdType": "pmc"}, {"#text": "23237552", "@IdType": "pubmed"}]}, "Citation": "Seyfried TN, Huysentruyt LC. On the origin of cancer metastasis. Crit Rev Oncog. (2013) 18:43\u201373. 10.1615/CritRevOncog.v18.i1-2.40"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrc822", "@IdType": "doi"}, {"#text": "12189386", "@IdType": "pubmed"}]}, "Citation": "Thiery JP. Epithelial\u2013mesenchymal transitions in tumour progression. Nat Rev Cancer. (2002) 2:442\u201354. 10.1038/nrc822"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2147/OTT.S136840", "@IdType": "doi"}, {"#text": "PMC5626388", "@IdType": "pmc"}, {"#text": "29026320", "@IdType": "pubmed"}]}, "Citation": "Yu D, Ye T, Xiang Y, Shi Z, Zhang J, Lou B, et al. . Quercetin inhibits epithelial-mesenchymal transition, decreases invasiveness and metastasis, and reverses IL-6 induced epithelial-mesenchymal transition, expression of MMP by inhibiting STAT3 signaling in pancreatic cancer cells. Onco Targets Ther. (2017) 10:4719\u201329. 10.2147/OTT.S136840"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ejcb.2016.06.002", "@IdType": "doi"}, {"#text": "27397693", "@IdType": "pubmed"}]}, "Citation": "Horejs CM. Basement membrane fragments in the context of the epithelial-to-mesenchymal transition. Eur J Cell Biol. (2016) 95:427\u201340. 10.1016/j.ejcb.2016.06.002"}, {"ArticleIdList": {"ArticleId": {"#text": "5750121", "@IdType": "pubmed"}}, "Citation": "Ehrmann RL, Knoth M. Choriocarcinoma: transfilter stimulation of vasoproliferation in the hamster cheek pouch\u2014studied by light and electron microscopy. J Natl Cancer Inst. (1968) 41:1329\u201341."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1097/PPO.0000000000000138", "@IdType": "doi"}, {"#text": "PMC4670555", "@IdType": "pmc"}, {"#text": "26222078", "@IdType": "pubmed"}]}, "Citation": "Bielenberg DR, Zetter BR. The Contribution of Angiogenesis to the Process of Metastasis. Cancer J. (2015) 21:267\u201373. 10.1097/PPO.0000000000000138"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.7150/jca.25666", "@IdType": "doi"}, {"#text": "PMC6160669", "@IdType": "pmc"}, {"#text": "30271493", "@IdType": "pubmed"}]}, "Citation": "Fukushima R, Kasamatsu A, Nakashima D, Higo M, Fushimi K, Kasama H, et al. . Overexpression of translocation associated membrane protein 2 leading to cancer-associated matrix metalloproteinase activation as a putative metastatic factor for human oral cancer. J Cancer. (2018) 9:3326\u201333. 10.7150/jca.25666"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/onc.2014.2", "@IdType": "doi"}, {"#text": "PMC4317372", "@IdType": "pmc"}, {"#text": "24561529", "@IdType": "pubmed"}]}, "Citation": "Miyake M, Goodison S, Lawton A, Gomes-Giacoia E, Rosser CJ. Angiogenin promotes tumoral growth and angiogenesis by regulating matrix metallopeptidase-2 expression via the ERK1/2 pathway. Oncogene. (2015) 34:890\u2013901. 10.1038/onc.2014.2"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1371/journal.pone.0137923", "@IdType": "doi"}, {"#text": "PMC4574527", "@IdType": "pmc"}, {"#text": "26378920", "@IdType": "pubmed"}]}, "Citation": "Saito T, Kasamatsu A, Ogawara K, Miyamoto I, Saito K, Iyoda M, et al. . Semaphorin7A promotion of tumoral growth and metastasis in human oral cancer by regulation of G1 cell cycle and matrix metalloproteases: possible contribution to tumoral angiogenesis. PLoS ONE. (2015) 10:e0137923. 10.1371/journal.pone.0137923"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s00432-012-1356-2", "@IdType": "doi"}, {"#text": "23207790", "@IdType": "pubmed"}]}, "Citation": "Yamamoto A, Kasamatsu A, Ishige S, Koike K, Saito K, Kouzu Y, et al. . Exocyst complex component Sec8: a presumed component in the progression of human oral squamous-cell carcinoma by secretion of matrix metalloproteinases. J Cancer Res Clin Oncol. (2013) 139:533\u201342. 10.1007/s00432-012-1356-2"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bbcan.2004.09.006", "@IdType": "doi"}, {"#text": "15588763", "@IdType": "pubmed"}]}, "Citation": "Mook ORF, Frederiks WM, Van Noorden CJF. The role of gelatinases in colorectal cancer progression and metastasis. Biochim Biophys Acta Rev Cancer. (2004) 1705:69\u201389. 10.1016/j.bbcan.2004.09.006"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cardiores.2005.12.002", "@IdType": "doi"}, {"#text": "16405877", "@IdType": "pubmed"}]}, "Citation": "Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. (2006) 69:562\u201373. 10.1016/j.cardiores.2005.12.002"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bbamcr.2010.01.003", "@IdType": "doi"}, {"#text": "PMC2853873", "@IdType": "pmc"}, {"#text": "20080133", "@IdType": "pubmed"}]}, "Citation": "Brew K, Nagase H. The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim Biophys Acta. (2010) 1803:55\u201371. 10.1016/j.bbamcr.2010.01.003"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s13059-015-0676-3", "@IdType": "doi"}, {"#text": "PMC4448532", "@IdType": "pmc"}, {"#text": "26025392", "@IdType": "pubmed"}]}, "Citation": "Kelwick R, Desanlis I, Wheeler GN, Edwards DR. The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) family. Genome Biol. (2015) 16:113. 10.1186/s13059-015-0676-3"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.48.6.1014", "@IdType": "doi"}, {"#text": "PMC220898", "@IdType": "pmc"}, {"#text": "13902219", "@IdType": "pubmed"}]}, "Citation": "Gross, Jerome, Lapiere C. Collagenolytic activity in amphibian tissues: a tissue culture assay. Pnas. (1962) 48:1014\u201322. 10.1073/pnas.48.6.1014"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1155/2013/928315", "@IdType": "doi"}, {"#text": "PMC3694547", "@IdType": "pmc"}, {"#text": "23840100", "@IdType": "pubmed"}]}, "Citation": "Chen Q, Jin M, Yang F, Zhu J, Xiao Q, Zhang L. Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling. Mediators Inflamm. (2013) 2013:928315. 10.1155/2013/928315"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/bs.apha.2017.08.002", "@IdType": "doi"}, {"#text": "PMC5765875", "@IdType": "pmc"}, {"#text": "29310800", "@IdType": "pubmed"}]}, "Citation": "Wang X, Khalil RA. Chapter 8: Matrix metalloproteinases, vascular remodeling, and vascular disease. In: Khalil RA. editor. Advances in Pharmacology. San Diego, CA: Academic Press; (2018). p. 241\u2013330. 10.1016/bs.apha.2017.08.002"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/0263-7855(96)00018-5", "@IdType": "doi"}, {"#text": "8744570", "@IdType": "pubmed"}]}, "Citation": "Humphrey W, Dalke A, Schulten K. VMD: Visual molecular dynamics. J Mol Graph. (1996) 14: 33\u20138. 10.1016/0263-7855(96)00018-5"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.mam.2008.05.002", "@IdType": "doi"}, {"#text": "PMC2810947", "@IdType": "pmc"}, {"#text": "18619669", "@IdType": "pubmed"}]}, "Citation": "Murphy G, Nagase H. Progress in matrix metalloproteinase research. Mol Aspects Med. (2008) 29:290\u2013308. 10.1016/j.mam.2008.05.002"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3109/14756366.2016.1161620", "@IdType": "doi"}, {"#text": "27028474", "@IdType": "pubmed"}]}, "Citation": "Jab\u0142onska-Trypu\u0107 A, Matejczyk M, Rosochacki S. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs. J Enzyme Inhib Med Chem. (2016) 31:177\u201383. 10.3109/14756366.2016.1161620"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1172/JCI35213", "@IdType": "doi"}, {"#text": "PMC2528912", "@IdType": "pmc"}, {"#text": "18776941", "@IdType": "pubmed"}]}, "Citation": "Kujawski M, Kay H, Yu H, Kujawski M, Kortylewski M, Lee H, et al. angiogenesis in mice Find the latest version : Stat3 mediates myeloid cell \u2013 dependent tumor angiogenesis in mice. (2008) 118:3367\u201377. 10.1172/JCI35213"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/or.2012.1857", "@IdType": "doi"}, {"#text": "22710862", "@IdType": "pubmed"}]}, "Citation": "Lee EJ, Park SS, Kim WJ, Moon SK. IL-5-induced migration via ERK1/2-mediated MMP-9 expression by inducing activation of NF-\u03baB in HT1376 cells. Oncol Rep. (2012) 28:1084\u201390. 10.3892/or.2012.1857"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cellsig.2013.06.004", "@IdType": "doi"}, {"#text": "23770289", "@IdType": "pubmed"}]}, "Citation": "Lee EJ, Lee SJ, Kim S, Cho SC, Choi YH, Kim WJ, et al. . Interleukin-5 enhances the migration and invasion of bladder cancer cells via ERK1/2-mediated MMP-9/NF-\u03baB/AP-1 pathway: Involvement of the p21WAF1 expression. Cell Signal. (2013) 25:2025\u201338. 10.1016/j.cellsig.2013.06.004"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.matbio.2015.09.003", "@IdType": "doi"}, {"#text": "26407638", "@IdType": "pubmed"}]}, "Citation": "Eckhard U, Huesgen PF, Schilling O, Bellac CL, Butler GS, Cox JH, et al. . Active site specificity profiling of the matrix metalloproteinase family: proteomic identification of 4300 cleavage sites by nine MMPs explored with structural and synthetic peptide cleavage analyses. Matrix Biol. (2016) 49:37\u201360. 10.1016/j.matbio.2015.09.003"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1074/jbc.M100900200", "@IdType": "doi"}, {"#text": "11279151", "@IdType": "pubmed"}]}, "Citation": "Kridel SJ, Chen E, Kotra LP, Howard EW, Mobashery S, Smith JW. Substrate hydrolysis by matrix metalloproteinase-9. J Biol Chem. (2001) 276:20572\u20138. 10.1074/jbc.M100900200"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1074/jbc.R800069200", "@IdType": "doi"}, {"#text": "PMC2708831", "@IdType": "pmc"}, {"#text": "19201757", "@IdType": "pubmed"}]}, "Citation": "Gomiz-R\u00fcth FX. Catalytic domain architecture of metzincin metalloproteases. J Biol Chem. (2009) 284:15353\u20137. 10.1074/jbc.R800069200"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bbamcr.2009.04.003", "@IdType": "doi"}, {"#text": "19374923", "@IdType": "pubmed"}]}, "Citation": "Tallant C, Marrero A, Gomis-R\u00fcth FX. Matrix metalloproteinases: Fold and function of their catalytic domains. Biochim Biophys Acta Mol Cell Res. (2010) 1803:20\u20138. 10.1016/j.bbamcr.2009.04.003"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1161/01.RES.0000070112.80711.3D", "@IdType": "doi"}, {"#text": "12730128", "@IdType": "pubmed"}]}, "Citation": "Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases. Circ Res. (2003) 92:827\u201339. 10.1161/01.RES.0000070112.80711.3D"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/biomedicines5020034", "@IdType": "doi"}, {"#text": "PMC5489820", "@IdType": "pmc"}, {"#text": "28635679", "@IdType": "pubmed"}]}, "Citation": "Rajabi M, Mousa S. The role of angiogenesis in cancer treatment. Biomedicines. (2017) 5:34. 10.3390/biomedicines5020034"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1111/j.1582-4934.2005.tb00355.x", "@IdType": "doi"}, {"#text": "PMC6740080", "@IdType": "pmc"}, {"#text": "15963249", "@IdType": "pubmed"}]}, "Citation": "Rundhaug JE. Matrix metalloproteinases and angiogenesis Angiogenesis Review Series. J Cell Mol Med. (2005) 9:267\u201385. 10.1111/j.1582-4934.2005.tb00355.x"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature10144", "@IdType": "doi"}, {"#text": "PMC4049445", "@IdType": "pmc"}, {"#text": "21593862", "@IdType": "pubmed"}]}, "Citation": "Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature. (2011) 473:298\u2013307. 10.1038/nature10144"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/cr.1998.17", "@IdType": "doi"}, {"#text": "9791730", "@IdType": "pubmed"}]}, "Citation": "Sang QX. MINIREVIEW Complex role of matrix metalloproteinases in angiogen- esis. Cell Res. (1998) 8:171\u20137. 10.1038/cr.1998.17"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1172/JCI6870", "@IdType": "doi"}, {"#text": "PMC408361", "@IdType": "pmc"}, {"#text": "10225966", "@IdType": "pubmed"}]}, "Citation": "Stetler-Stevenson WG. Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J Clin Invest. (1999) 103:1237\u201341. 10.1172/JCI6870"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1055/s-2008-1068751", "@IdType": "doi"}, {"#text": "9383830", "@IdType": "pubmed"}]}, "Citation": "Smith SK. Angiogenesis. Semin Reprod Med. (1997) 15:221\u20137. 10.1055/s-2008-1068751"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.yexcr.2013.01.010", "@IdType": "doi"}, {"#text": "23328307", "@IdType": "pubmed"}]}, "Citation": "Benedito R, Hellstr\u00f6m M. Notch as a hub for signaling in angiogenesis. Exp Cell Res. (2013) 319:1281\u20138. 10.1016/j.yexcr.2013.01.010"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrc865", "@IdType": "doi"}, {"#text": "12154349", "@IdType": "pubmed"}]}, "Citation": "Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer. (2002) 2:563\u201372. 10.1038/nrc865"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s13402-016-0281-9", "@IdType": "doi"}, {"#text": "PMC5052283", "@IdType": "pmc"}, {"#text": "27126599", "@IdType": "pubmed"}]}, "Citation": "Paduch R. The role of lymphangiogenesis and angiogenesis in tumor metastasis. Cell Oncol. (2016) 39:397\u2013410. 10.1007/s13402-016-0281-9"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/onc.2011.602", "@IdType": "doi"}, {"#text": "22179834", "@IdType": "pubmed"}]}, "Citation": "Alitalo A, Detmar M. Interaction of tumor cells and lymphatic vessels in cancer progression. Oncogene. (2012) 31:4499\u2013508. 10.1038/onc.2011.602"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/ijc.24702", "@IdType": "doi"}, {"#text": "19569051", "@IdType": "pubmed"}]}, "Citation": "Sleeman JP, Thiele W. Tumor metastasis and the lymphatic vasculature. Int J Cancer. (2009) 125:2747\u201356. 10.1002/ijc.24702"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/0008-5472.CAN-08-1488", "@IdType": "doi"}, {"#text": "PMC2800077", "@IdType": "pmc"}, {"#text": "18829538", "@IdType": "pubmed"}]}, "Citation": "Burton JB, Priceman SJ, Sung JL, Brakenhielm E, Dong SA, Pytowski B, et al. . Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis. Cancer Res. (2008) 68:7828\u201337. 10.1158/0008-5472.CAN-08-1488"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1074/jbc.M116.736801", "@IdType": "doi"}, {"#text": "PMC5207153", "@IdType": "pmc"}, {"#text": "27852824", "@IdType": "pubmed"}]}, "Citation": "Davydova N, Harris NC, Roufail S, Paquet-Fifield S, Ishaq M, Streltsov VA, et al. . Differential receptor binding and regulatory mechanisms for the lymphangiogenic growth factors vascular endothelial growth factor (VEGF)-C and -D. J Biol Chem. (2016) 291:27265\u201378. 10.1074/jbc.M116.736801"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/0008-5472.CAN-05-1843", "@IdType": "doi"}, {"#text": "16510584", "@IdType": "pubmed"}]}, "Citation": "Roberts N, Kloos B, Cassella M, Podgrabinska S, Persaud K, Wu Y, et al. . Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2. Cancer Res. (2006) 66:2650\u201357. 10.1158/0008-5472.CAN-05-1843"}, {"ArticleIdList": {"ArticleId": {"#text": "10.4199/C00017ED1V01Y201009ISP010", "@IdType": "doi"}}, "Citation": "Aldair T, Montani J. Chapter 1: Overview of angiogenesis. In: Granger N, Granger J. editors. Angiogenesis. San Rafael, CA: Morgan & Claypool Life Sciences; (2010). p. 1\u201384. 10.4199/C00017ED1V01Y201009ISP010"}, {"ArticleIdList": {"ArticleId": {"#text": "10.1017/9781107360044.013", "@IdType": "doi"}}, "Citation": "Jadvar H. Chapter 12: Angiogenesis. In: Jadvar H, Jacene H, Graham M. editors. Molecular Imaging: An Introduction. Los Angeles, CA: Cambridge University Press; (2017). p. 52\u20134. 10.1017/9781107360044.013"}, {"ArticleIdList": {"ArticleId": {"#text": "10.1007/978-1-4614-5857-9_18", "@IdType": "doi"}}, "Citation": "Prager GW, Zielinski CC. Angiogenesis in cancer. In: Jawahar LM, Dhalla NS. editors. Biochemical Basis and Therapeutic Implications of Angiogenesis. New York, NY: Springer; (2017). p. 335\u201356. 10.1007/978-1-4614-5857-9_18"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrc1187", "@IdType": "doi"}, {"#text": "13130303", "@IdType": "pubmed"}]}, "Citation": "Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer. (2003) 3:721\u201332. 10.1038/nrc1187"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrm2183", "@IdType": "doi"}, {"#text": "17522591", "@IdType": "pubmed"}]}, "Citation": "Adams RH, Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol. (2007) 8:464\u201378. 10.1038/nrm2183"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.yexcr.2005.11.012", "@IdType": "doi"}, {"#text": "16336962", "@IdType": "pubmed"}]}, "Citation": "Shibuya M, Claesson-Welsh L. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp Cell Res. (2006) 312:549\u201360. 10.1016/j.yexcr.2005.11.012"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.devcel.2010.05.012", "@IdType": "doi"}, {"#text": "PMC2905377", "@IdType": "pmc"}, {"#text": "20627072", "@IdType": "pubmed"}]}, "Citation": "Egeblad M, Nakasone ES, Werb Z. Tumors as organs: complex tissues that interface with the entire organism. Dev Cell. (2010) 18:884\u2013901. 10.1016/j.devcel.2010.05.012"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/bioengineering5040076", "@IdType": "doi"}, {"#text": "PMC6315429", "@IdType": "pmc"}, {"#text": "30241287", "@IdType": "pubmed"}]}, "Citation": "Majumder P. Integrin-mediated delivery of drugs and nucleic acids for anti-angiogenic cancer therapy: current landscape and remaining challenges. Bioengineering. (2018) 5:76. 10.3390/bioengineering5040076"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1074/mcp.M900381-MCP200", "@IdType": "doi"}, {"#text": "PMC2877972", "@IdType": "pmc"}, {"#text": "20124223", "@IdType": "pubmed"}]}, "Citation": "Park JE, Tan H, Sen Datta A, Lai RC, Zhang H, Meng W, et al. . Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes. Mol Cell Proteomics. (2010) 9:1085\u201399. 10.1074/mcp.M900381-MCP200"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/or.2017.5391", "@IdType": "doi"}, {"#text": "28112361", "@IdType": "pubmed"}]}, "Citation": "Roomi MW, Kalinovsky T, Rath M, Niedzwiecki A. Modulation of MMP-2 and MMP-9 secretion by cytokines, inducers and inhibitors in human glioblastoma T-98G cells. Oncol Rep. (2017) 37:1907\u201313. 10.3892/or.2017.5391"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/1476-4598-13-18", "@IdType": "doi"}, {"#text": "PMC3937117", "@IdType": "pmc"}, {"#text": "24479681", "@IdType": "pubmed"}]}, "Citation": "Huang Q, Lan F, Wang X, Yu Y, Ouyang X, Zheng F, et al. . IL-1\u03b2-induced activation of p38 promotes metastasis in gastric adenocarcinoma via upregulation of AP-1/c-fos, MMP2 and MMP9. Mol Cancer. (2014) 13:1\u201315. 10.1186/1476-4598-13-18"}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4128980", "@IdType": "pmc"}, {"#text": "25120745", "@IdType": "pubmed"}]}, "Citation": "Ji Y, Yang X, Li J, Lu Z, Li X, Yu J, et al. . IL-22 promotes the migration and invasion of gastric cancer cells via IL-22R1/AKT/MMP-9 signaling. Int J Clin Exp Pathol. (2014) 7:3694\u2013703. Available online at: http://www.ijcep.com/files/ijcep0000514.pdf"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/bjc.2014.336", "@IdType": "doi"}, {"#text": "PMC4134496", "@IdType": "pmc"}, {"#text": "24937671", "@IdType": "pubmed"}]}, "Citation": "Fukui H, Zhang X, Sun C, Hara K, Kikuchi S, Yamasaki T, et al. . IL-22 produced by cancer-associated fibroblasts promotes gastric cancer cell invasion via STAT3 and ERK signaling. Br J Cancer. (2014) 111:763\u201371. 10.1038/bjc.2014.336"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12885-015-1466-8", "@IdType": "doi"}, {"#text": "PMC4456051", "@IdType": "pmc"}, {"#text": "26043921", "@IdType": "pubmed"}]}, "Citation": "Cardoso AP, Pinto ML, Pinto AT, Pinto MT, Monteiro C, Oliveira MI, et al. . Matrix metalloproteases as maestros for the dual role of LPS- and IL-10-stimulated macrophages in cancer cell behaviour. BMC Cancer. (2015) 15:1\u201314. 10.1186/s12885-015-1466-8"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3389/fimmu.2017.00205", "@IdType": "doi"}, {"#text": "PMC5340783", "@IdType": "pmc"}, {"#text": "28337194", "@IdType": "pubmed"}]}, "Citation": "Espinoza-S\u00e1nchez NA, Chimal-Ram\u00edrez GK, Mantilla A, Fuentes-Panan\u00e1 EM. IL-1\u03b2, IL-8, and matrix metalloproteinases-1,\u22122, and\u221210 are enriched upon monocyte-breast cancer cell cocultivation in a matrigel-based three-dimensional system. Front Immunol. (2017) 8:205 10.3389/fimmu.2017.00205"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.biopha.2018.04.022", "@IdType": "doi"}, {"#text": "29656182", "@IdType": "pubmed"}]}, "Citation": "Ning Y, Cui Y, Li X, Cao X, Chen A, Xu C, et al. . Co-culture of ovarian cancer stem-like cells with macrophages induced SKOV3 cells stemness via IL-8/STAT3 signaling. Biomed Pharmacother. (2018) 103:262\u201371. 10.1016/j.biopha.2018.04.022"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.4569", "@IdType": "doi"}, {"#text": "PMC4694886", "@IdType": "pmc"}, {"#text": "26305549", "@IdType": "pubmed"}]}, "Citation": "Ou Z, Wang Y, Liu L, Li L, Yeh S, Qi L, et al. . Tumor microenvironment B cells increase bladder cancer metastasis via modulation of the IL-8/androgen receptor (AR)/MMPs signals. Oncotarget. (2015) 6:26065\u201378. 10.18632/oncotarget.4569"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cyto.2016.07.013", "@IdType": "doi"}, {"#text": "27468958", "@IdType": "pubmed"}]}, "Citation": "Ha NH, Park DG, Woo BH, Kim DJ, Choi J, II, Park BS, et al. . Porphyromonas gingivalis increases the invasiveness of oral cancer cells by upregulating IL-8 and MMPs. Cytokine. (2016) 86:64\u201372. 10.1016/j.cyto.2016.07.013"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.4049/jimmunol.170.6.3369", "@IdType": "doi"}, {"#text": "12626597", "@IdType": "pubmed"}]}, "Citation": "Li A, Dubey S, Varney ML, Dave BJ, Singh RK. IL-8 Directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol. (2003) 170:3369\u201376. 10.4049/jimmunol.170.6.3369"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/mc.22240", "@IdType": "doi"}, {"#text": "25358651", "@IdType": "pubmed"}]}, "Citation": "Epanchintsev A, Shyamsunder P, Verma RS, Lyakhovich A. IL-6, IL-8, MMP-2, MMP-9 are overexpressed in Fanconi anemia cells through a NF-\u03baB/TNF-\u03b1 dependent mechanism. Mol Carcinog. (2015) 54:1686\u201399. 10.1002/mc.22240"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cellsig.2013.05.025", "@IdType": "doi"}, {"#text": "23714383", "@IdType": "pubmed"}]}, "Citation": "Desai S, Laskar S, Pandey BN. Autocrine IL-8 and VEGF mediate epithelial-mesenchymal transition and invasiveness via p38/JNK-ATF-2 signalling in A549 lung cancer cells. Cell Signal. (2013) 25:1780\u201391. 10.1016/j.cellsig.2013.05.025"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1096/fj.201701103R", "@IdType": "doi"}, {"#text": "29763380", "@IdType": "pubmed"}]}, "Citation": "Bruno A, Bassani B, D'Urso DG, Pitaku I, Cassinotti E, Pelosi G, et al. . Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer. FASEB J. (2018) 32:5365\u201377. 10.1096/fj.201701103R"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.21037/tcr.2018.05.09", "@IdType": "doi"}, {"#text": "PMC6135085", "@IdType": "pmc"}, {"#text": "30221145", "@IdType": "pubmed"}]}, "Citation": "Bates AM, Gomez Hernandez MP, Lanzel EA, Qian F, Brogden KA. Matrix metalloproteinase (MMP) and immunosuppressive biomarker profiles of seven head and neck squamous cell carcinoma (HNSCC) cell lines. Transl Cancer Res. (2018) 7:533\u201342. 10.21037/tcr.2018.05.09"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.phymed.2018.09.172", "@IdType": "doi"}, {"#text": "30466990", "@IdType": "pubmed"}]}, "Citation": "Kim SJ, Pham TH, Bak Y, Ryu HW, Oh SR, Yoon DY. Orientin inhibits invasion by suppressing MMP-9 and IL-8 expression via the PKC\u03b1/ ERK/AP-1/STAT3-mediated signaling pathways in TPA-treated MCF-7 breast cancer cells. Phytomedicine. (2018) 50:35\u201342. 10.1016/j.phymed.2018.09.172"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.25863", "@IdType": "doi"}, {"#text": "PMC6135685", "@IdType": "pmc"}, {"#text": "30220965", "@IdType": "pubmed"}]}, "Citation": "Jayatilaka H, Umanzor FG, Shah V, Meirson T, Russo G, Starich B, et al. . Tumor cell density regulates matrix metalloproteinases for enhanced migration. Oncotarget. (2018) 9:32556\u201369. 10.18632/oncotarget.25863"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1111/jcmm.14342", "@IdType": "doi"}, {"#text": "PMC6584525", "@IdType": "pmc"}, {"#text": "31044528", "@IdType": "pubmed"}]}, "Citation": "Zhang Y, Wang S, Liu Z, Yang L, Liu J, Xiu M. Increased Six1 expression in macrophages promotes hepatocellular carcinoma growth and invasion by regulating MMP-9. J Cell Mol Med. (2019)23:4523\u201333. 10.1111/jcmm.14342"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41598-017-08581-y", "@IdType": "doi"}, {"#text": "PMC5561029", "@IdType": "pmc"}, {"#text": "28819304", "@IdType": "pubmed"}]}, "Citation": "Cutler SJ, Doecke JD, Ghazawi I, Yang J, Griffiths LR, Spring KJ, et al. . Novel STAT binding elements mediate IL-6 regulation of MMP-1 and MMP-3. Sci Rep. (2017) 7:1\u201312. 10.1038/s41598-017-08581-y"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s13277-015-4186-4", "@IdType": "doi"}, {"#text": "PMC5461876", "@IdType": "pmc"}, {"#text": "26453114", "@IdType": "pubmed"}]}, "Citation": "Zergoun AA, Zebboudj A, Sellam SL, Kariche N, Djennaoui D, Ouraghi S, et al. . IL-6/NOS2 inflammatory signals regulate MMP-9 and MMP-2 activity and disease outcome in nasopharyngeal carcinoma patients. Tumor Biol. (2016) 37:3505\u201314. 10.1007/s13277-015-4186-4"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.11515", "@IdType": "doi"}, {"#text": "PMC5308737", "@IdType": "pmc"}, {"#text": "27613828", "@IdType": "pubmed"}]}, "Citation": "Chen W, Xia T, Wang D, Huang B, Zhao P, Wang J, et al. . Human astrocytes secrete IL-6 to promote glioma migration and invasion through upregulation of cytomembrane MMP14. Oncotarget. (2016) 7:62425\u201338. 10.18632/oncotarget.11515"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1172/JCI34944", "@IdType": "doi"}, {"#text": "PMC2323192", "@IdType": "pmc"}, {"#text": "18431520", "@IdType": "pubmed"}]}, "Citation": "Ernst M, Najdovska M, Grail D, Lundgren-May T, Buchert M, Tye H, et al. . STAT3 and STAT1 mediate IL-11\u2013dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. J Clin Invest. (2008) 118:1727\u201338. 10.1172/JCI34944"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.4196/kjpp.2014.18.5.391", "@IdType": "doi"}, {"#text": "PMC4211122", "@IdType": "pmc"}, {"#text": "25352758", "@IdType": "pubmed"}]}, "Citation": "Lim JH. Inhibition of the interleukin-11-STAT3 axis attenuates hypoxia-induced migration and invasion in MDA-MB-231 breast cancer cells. Korean J Physiol Pharmacol. (2014) 18:391\u20136. 10.4196/kjpp.2014.18.5.391"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12885-016-2701-7", "@IdType": "doi"}, {"#text": "PMC4994391", "@IdType": "pmc"}, {"#text": "27549240", "@IdType": "pubmed"}]}, "Citation": "Yue T, Zheng X, Dou Y, Zheng X, Sun R, Tian Z, et al. . Interleukin 12 shows a better curative effect on lung cancer than paclitaxel and cisplatin doublet chemotherapy. BMC Cancer. (2016) 16:1\u201313. 10.1186/s12885-016-2701-7"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1054/bjoc.2000.1487", "@IdType": "doi"}, {"#text": "PMC2363423", "@IdType": "pmc"}, {"#text": "11076665", "@IdType": "pubmed"}]}, "Citation": "Scott KA, Holdsworth H, Balkwill FR, Dias S. Exploiting changes in the tumour microenvironment with sequential cytokine and matrix metalloprotease inhibitor treatment in a murine breast cancer model. Br J Cancer. (2000) 83:1538\u201343. 10.1054/bjoc.2000.1487"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/ijms19123880", "@IdType": "doi"}, {"#text": "PMC6321268", "@IdType": "pmc"}, {"#text": "30518157", "@IdType": "pubmed"}]}, "Citation": "Fabre JAS, Giustinniani J, Garbar C, Merrouche Y, Antonicelli F, Bensussan A. The interleukin-17 family of cytokines in breast cancer. Int J Mol Sci. (2018) 19:3880. 10.3390/ijms19123880"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/bcr2195", "@IdType": "doi"}, {"#text": "PMC2656888", "@IdType": "pmc"}, {"#text": "19014637", "@IdType": "pubmed"}]}, "Citation": "Zhu XW, Mulcahy LA, Mohammed RAA, Lee AHS, Franks HA, Kilpatrick L, et al. . IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines. Breast Cancer Res. (2008) 10:1\u201311. 10.1186/bcr2195"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1371/journal.pone.0180097", "@IdType": "doi"}, {"#text": "PMC5489190", "@IdType": "pmc"}, {"#text": "28658303", "@IdType": "pubmed"}]}, "Citation": "Amara S, Majors C, Roy B, Hill S, Rose KL, Myles EL, et al. . Critical role of SIK3 in mediating high salt and IL-17 synergy leading to breast cancer cell proliferation. PLoS ONE. (2017) 12:e180097. 10.1371/journal.pone.0180097"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/onc.2016.240", "@IdType": "doi"}, {"#text": "PMC5213194", "@IdType": "pmc"}, {"#text": "27375020", "@IdType": "pubmed"}]}, "Citation": "Zhang Q, Liu S, Parajuli KR, Zhang W, Zhang K, Mo Z, et al. . Interleukin-17 promotes prostate cancer via MMP7-induced epithelial-to-mesenchymal transition. Oncogene. (2017) 36:687\u201399. 10.1038/onc.2016.240"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.molimm.2017.06.034", "@IdType": "doi"}, {"#text": "28715683", "@IdType": "pubmed"}]}, "Citation": "Ren L, Xu Y, Liu C, Wang S, Qin G. IL-17RB enhances thyroid cancer cell invasion and metastasis via ERK1/2 pathway-mediated MMP-9 expression. Mol Immunol. (2017) 90:126\u201335. 10.1016/j.molimm.2017.06.034"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/or.2017.5426", "@IdType": "doi"}, {"#text": "28184939", "@IdType": "pubmed"}]}, "Citation": "Liu D, Zhang R, Wu J, Pu Y, Yin X, Cheng Y, et al. . Interleukin-17A promotes esophageal adenocarcinoma cell invasiveness through ROS-dependent, NF-\u03baB-mediated MMP-2/9 activation. Oncol Rep. (2017) 37:1779\u201385. 10.3892/or.2017.5426"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3389/fimmu.2018.00334", "@IdType": "doi"}, {"#text": "PMC5845536", "@IdType": "pmc"}, {"#text": "29559970", "@IdType": "pubmed"}]}, "Citation": "Kobori T, Hamasaki S, Kitaura A, Yamazaki Y, Nishinaka T, Niwa A, et al. . Interleukin-18 amplifies macrophage polarization and morphological alteration, leading to excessive angiogenesis. Front Immunol. (2018) 9:334. 10.3389/fimmu.2018.00334"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/ijmm.2015.2159", "@IdType": "doi"}, {"#text": "25846944", "@IdType": "pubmed"}]}, "Citation": "Zhou Y, Hu Z, Li N, Jiang R. Interleukin-32 stimulates osteosarcoma cell invasionand motility via AKT pathway-mediated MMP-13 expression. Int J Mol Med. (2015) 35:1729\u201333. 10.3892/ijmm.2015.2159"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1159/000498857", "@IdType": "doi"}, {"#text": "30928981", "@IdType": "pubmed"}]}, "Citation": "Yang F, Wen M, Pan D, Lin X, Mo J, Dong X, et al. . IL-33/ST2 axis regulates vasculogenic mimicry via ERK1/2-MMP-2/9 pathway in melanoma. Dermatology. (2019) 235:225\u201333. 10.1159/000498857"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2147/OTT.S155905", "@IdType": "doi"}, {"#text": "PMC5820469", "@IdType": "pmc"}, {"#text": "29497316", "@IdType": "pubmed"}]}, "Citation": "Yang Z, Gao X, Wang J, Xu L, Zheng Y, Xu Y. Interleukin-33 enhanced the migration and invasiveness of human lung cancer cells. Onco Targets Ther. (2018) 11:843\u20139. 10.2147/OTT.S155905"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.1422445112", "@IdType": "doi"}, {"#text": "PMC4434739", "@IdType": "pmc"}, {"#text": "25918379", "@IdType": "pubmed"}]}, "Citation": "Maywald RL, Doerner SK, Pastorelli L, De Salvo C, Benton SM, Dawson EP, et al. . IL-33 activates tumor stroma to promote intestinal polyposis. Proc Natl Acad Sci USA. (2015) 112:E2487\u201396. 10.1073/pnas.1422445112"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1023/A:1025867130437", "@IdType": "doi"}, {"#text": "15000152", "@IdType": "pubmed"}]}, "Citation": "Zucker S, Vacirca J. Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev. (2004) 23:101\u201317. 10.1023/A:1025867130437"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.16819", "@IdType": "doi"}, {"#text": "PMC5464885", "@IdType": "pmc"}, {"#text": "28432279", "@IdType": "pubmed"}]}, "Citation": "Zou J-M, Qin J, Li Y-C, Wang Y, Li D, Shu Y, et al. . IL-35 induces N2 phenotype of neutrophils to promote tumor growth. Oncotarget. (2017) 8:33501\u201314. 10.18632/oncotarget.16819"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.10141", "@IdType": "doi"}, {"#text": "PMC5216752", "@IdType": "pmc"}, {"#text": "27329841", "@IdType": "pubmed"}]}, "Citation": "Long J, Guo H, Cui S, Zhang H, Liu X, Li D, et al. . IL-35 expression in hepatocellular carcinoma cells is associated with tumor progression. Oncotarget. (2016) 7: 45678\u201386. 10.18632/oncotarget.10141"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3233/CBM-170732", "@IdType": "doi"}, {"#text": "29278881", "@IdType": "pubmed"}]}, "Citation": "Chen YH, Zhou BY, Wu GC, Liao DQ, Li J, Liang SS, et al. . Effects of exogenous IL-37 on the biological characteristics of human lung adenocarcinoma A549 cells and the chemotaxis of regulatory T cells. Cancer Biomarkers. (2018) 21:661\u201373. 10.3233/CBM-170732"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.gene.2018.07.018", "@IdType": "doi"}, {"#text": "30010038", "@IdType": "pubmed"}]}, "Citation": "Li M, Lu Y, Xu Y, Wang J, Zhang C, Du Y, et al. . Horizontal transfer of exosomal CXCR4 promotes murine hepatocarcinoma cell migration, invasion and lymphangiogenesis. Gene. (2018) 676:101\u20139. 10.1016/j.gene.2018.07.018"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/or.19.4.1007", "@IdType": "doi"}, {"#text": "18357389", "@IdType": "pubmed"}]}, "Citation": "Lee S, Park S, Cho Y, Park K, Kim E, Jung K, et al. . Activation of matrix metalloproteinase-9 by TNF-\u03b1 in human urinary bladder cancer HT1376 cells.pdf. Oncol Rep. (2008) 19:1007\u201313. 10.3892/or.19.4.1007"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/ijo.2016.3653", "@IdType": "doi"}, {"#text": "27511626", "@IdType": "pubmed"}]}, "Citation": "Tanaka T, Imamura T, Yoneda M, Irie A, Ogi H, Nagata M, et al. . Enhancement of active MMP release and invasive activity of lymph node metastatic tongue cancer cells by elevated signaling via the TNF-\u03b1-TNFR1-NF-B pathway and a possible involvement of angiopoietin-like 4 in lung metastasis. Int J Oncol. (2016) 49:1377\u201384. 10.3892/ijo.2016.3653"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/jcb.25219", "@IdType": "doi"}, {"#text": "25959126", "@IdType": "pubmed"}]}, "Citation": "Xia P, Zhang R, Ge G. C/EBP\u03b2 mediates TNF-\u03b1-induced cancer cell migration by inducing MMP expression dependent on p38 MAPK. J Cell Biochem. (2015) 116:2766\u201377. 10.1002/jcb.25219"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1111/odi.12594", "@IdType": "doi"}, {"#text": "27868311", "@IdType": "pubmed"}]}, "Citation": "Ohta K, Naruse T, Ishida Y, Shigeishi H, Nakagawa T, Fukui A, et al. . TNF-\u03b1-induced IL-6 and MMP-9 expression in immortalized ameloblastoma cell line established by hTERT. Oral Dis. (2017) 23:199\u2013209. 10.1111/odi.12594"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/1078-0432.CCR-04-1688", "@IdType": "doi"}, {"#text": "15814625", "@IdType": "pubmed"}]}, "Citation": "Gutwein P, Stoeck A, Riedle S, Gast D, Runz S, Condon TP, et al. . Cleavage of L1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cells. Clin Cancer Res. (2005) 11:2492\u2013501. 10.1158/1078-0432.CCR-04-1688"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/jcb.25762", "@IdType": "doi"}, {"#text": "27735991", "@IdType": "pubmed"}]}, "Citation": "Mahmoodi F, Akrami H. PlGF knockdown decreases tumorigenicity and stemness properties of spheroid body cells derived from gastric cancer cells. J Cell Biochem. (2017) 118:851\u20139. 10.1002/jcb.25762"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ccr.2004.10.011", "@IdType": "doi"}, {"#text": "15607960", "@IdType": "pubmed"}]}, "Citation": "Winkler F, Kozin S V, Tong RT, Chae S-S, Booth MF, Garkavtsev I, et al. . Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation. Cancer Cell. (2004) 6:553\u201363. 10.1016/j.ccr.2004.10.011"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/bjc.2013.745", "@IdType": "doi"}, {"#text": "PMC3899771", "@IdType": "pmc"}, {"#text": "24292449", "@IdType": "pubmed"}]}, "Citation": "Kahlert C, Pecqueux M, Halama N, Dienemann H, Muley T, Pfannschmidt J, et al. . Tumour-site-dependent expression profile of angiogenic factors in tumour-associated stroma of primary colorectal cancer and metastases. Br J Cancer. (2014) 110:441\u20139. 10.1038/bjc.2013.745"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1136/gutjnl-2011-301179", "@IdType": "doi"}, {"#text": "22213796", "@IdType": "pubmed"}]}, "Citation": "\u00c5gesen TH, Sveen A, Merok MA, Lind GE, Nesbakken A, Skotheim RI, et al. . ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis. Gut. (2012) 61:1560\u20137. 10.1136/gutjnl-2011-301179"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.7150/ijms.5185", "@IdType": "doi"}, {"#text": "PMC3558716", "@IdType": "pmc"}, {"#text": "23372434", "@IdType": "pubmed"}]}, "Citation": "Huang Q, Zhao SL, Tian XY, Li B, Li Z. Increased co-expression of macrophage migration in-hibitory factor and matrix metalloproteinase 9 is as-sociated with tumor recurrence of meningioma. Int J Med Sci. (2013) 10:276\u201385. 10.7150/ijms.5185"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/cam4.1758", "@IdType": "doi"}, {"#text": "PMC6198203", "@IdType": "pmc"}, {"#text": "30256540", "@IdType": "pubmed"}]}, "Citation": "Wu D-M, Deng S-H, Liu T, Han R, Zhang T, Xu Y. TGF-\u03b2-mediated exosomal lnc-MMP2-2 regulates migration and invasion of lung cancer cells to the vasculature by promoting MMP2 expression. Cancer Med. (2018) 7:5118\u201329. 10.1002/cam4.1758"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.neo.2016.06.003", "@IdType": "doi"}, {"#text": "PMC4954934", "@IdType": "pmc"}, {"#text": "27435927", "@IdType": "pubmed"}]}, "Citation": "Tjomsland V, Pomianowska E, Aasrum M, Sandnes D, Verbeke CS, Gladhaug IP. Profile of MMP and TIMP expression in human pancreatic stellate cells: regulation by IL-1\u03b1 and TGF\u03b2 and implications for migration of pancreatic cancer cells. Neoplasia. (2016) 18:447\u201356. 10.1016/j.neo.2016.06.003"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12935-019-0819-9", "@IdType": "doi"}, {"#text": "PMC6492435", "@IdType": "pmc"}, {"#text": "31068761", "@IdType": "pubmed"}]}, "Citation": "Yu S, Zhou R, Yang T, Liu S, Cui Z, Qiao Q, et al. . Hypoxia promotes colorectal cancer cell migration and invasion in a SIRT1-dependent manner. Cancer Cell Int. (2019) 19:1\u201312. 10.1186/s12935-019-0819-9"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s13045-017-0408-0", "@IdType": "doi"}, {"#text": "PMC5286803", "@IdType": "pmc"}, {"#text": "28143526", "@IdType": "pubmed"}]}, "Citation": "Chen Y, Zhang S, Wang Q, Zhang X. Tumor-recruited M2 macrophages promote gastric and breast cancer metastasis via M2 macrophage-secreted CHI3L1 protein. J Hematol Oncol. (2017) 10:36. 10.1186/s13045-017-0408-0"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ceb.2004.07.010", "@IdType": "doi"}, {"#text": "PMC2775446", "@IdType": "pmc"}, {"#text": "15363807", "@IdType": "pubmed"}]}, "Citation": "Mott JD, Werb Z. Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol. (2004) 16:558\u201364. 10.1016/j.ceb.2004.07.010"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/S0962-8924(03)00129-6", "@IdType": "doi"}, {"#text": "12837607", "@IdType": "pubmed"}]}, "Citation": "Schenk S, Quaranta V. Tales from the crypt[ic] sites of the extracellular matrix. Trends Cell Biol. (2003) 13:366\u201375. 10.1016/S0962-8924(03)00129-6"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1074/jbc.M112.417451", "@IdType": "doi"}, {"#text": "PMC3537058", "@IdType": "pmc"}, {"#text": "23155052", "@IdType": "pubmed"}]}, "Citation": "Mazor R, Alsaigh T, Shaked H, Altshuler AE, Pocock ES, Kistler EB, et al. . Matrix metalloproteinase-1-mediated up-regulation of vascular endothelial growth factor-2 in endothelial cells. J Biol Chem. (2013) 288:598\u2013607. 10.1074/jbc.M112.417451"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1182/blood-2008-08-172742", "@IdType": "doi"}, {"#text": "18974372", "@IdType": "pubmed"}]}, "Citation": "Ito TK, Ishii G, Saito S, Yano K, Hoshino A, Suzuki T, et al. . Degradation of soluble VEGF receptor-1 by MMP-7 allows VEGF access to endothelial cells. Blood. (2009) 113:2363\u20139. 10.1182/blood-2008-08-172742"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1074/jbc.272.50.31504", "@IdType": "doi"}, {"#text": "9395486", "@IdType": "pubmed"}]}, "Citation": "Hanemaaijer R, Sorsa T, Konttinen YT, Ding Y, Sutinen M, Visser H, et al. . Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. J Biol Chem. (2002) 272:31504\u20139. 10.1074/jbc.272.50.31504"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1161/01.RES.0000260801.12916.b5", "@IdType": "doi"}, {"#text": "17322177", "@IdType": "pubmed"}]}, "Citation": "Cheng XW, Kuzuya M, Nakamura K, Maeda K, Tsuzuki M, Kim W, et al. . Mechanisms underlying the impairment of ischemia-induced neovascularization in matrix metalloproteinase 2-deficient mice. Circ Res. (2007) 100:904\u201313. 10.1161/01.RES.0000260801.12916.b5"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/cvr/cvt060", "@IdType": "doi"}, {"#text": "23512982", "@IdType": "pubmed"}]}, "Citation": "Fang C, Wen G, Zhang L, Lin L, Moore A, Wu S, et al. . An important role of matrix metalloproteinase-8 in angiogenesis in vitro and in vivo. Cardiovasc Res. (2013) 99:146\u201355. 10.1093/cvr/cvt060"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/S0002-9440(10)64887-0", "@IdType": "doi"}, {"#text": "PMC1850663", "@IdType": "pmc"}, {"#text": "11839588", "@IdType": "pubmed"}]}, "Citation": "Taraboletti G, D'Ascenzo S, Borsotti P, Giavazzi R, Pavan A, Dolo V. Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. Am J Pathol. (2002) 160:673\u201380. 10.1016/S0002-9440(10)64887-0"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/S1535-6108(03)00133-8", "@IdType": "doi"}, {"#text": "PMC2775452", "@IdType": "pmc"}, {"#text": "12842087", "@IdType": "pubmed"}]}, "Citation": "Hamano Y, Zeisberg M, Sugimoto H, Lively JC, Maeshima Y, Yang C, et al. . Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin. Cancer Cell. (2003) 3:589\u2013601. 10.1016/S1535-6108(03)00133-8"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3389/fphar.2011.00111", "@IdType": "doi"}, {"#text": "PMC3108474", "@IdType": "pmc"}, {"#text": "21687519", "@IdType": "pubmed"}]}, "Citation": "Sounni NE, Paye A, Host L, No\u00ebl A. MT-MMPS as regulators of vessel stability associated with angiogenesis. Front Pharmacol. (2011) 2:111. 10.3389/fphar.2011.00111"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bbrc.2013.06.046", "@IdType": "doi"}, {"#text": "23796708", "@IdType": "pubmed"}]}, "Citation": "Lee H, Chang KW, Yang HY, Lin PW, Chen SU, Huang YL. MT1-MMP regulates MMP-2 expression and angiogenesis-related functions in human umbilical vein endothelial cells. Biochem Biophys Res Commun. (2013) 437:232\u20138. 10.1016/j.bbrc.2013.06.046"}, {"ArticleIdList": {"ArticleId": {"#text": "20495735", "@IdType": "pubmed"}}, "Citation": "Am\u0103linei C, C\u0103runtu ID, Giu\u015fc\u0103 SE, B\u0103lan RA. Matrix metalloproteinases involvement in pathologic conditions. Rom J Morphol Embryol. (2010) 51:215\u201328. Available online at: http://www.rjme.ro/RJME/resources/files/510210215228.pdf"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/cancers6010396", "@IdType": "doi"}, {"#text": "PMC3980592", "@IdType": "pmc"}, {"#text": "24531055", "@IdType": "pubmed"}]}, "Citation": "Iizuka S, Ishimaru N, Kudo Y. Matrix metalloproteinases: the gene expression signatures of head and neck cancer progression. Cancers. (2014) 6:396\u2013415. 10.3390/cancers6010396"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/cancers6010366", "@IdType": "doi"}, {"#text": "PMC3980606", "@IdType": "pmc"}, {"#text": "24518611", "@IdType": "pubmed"}]}, "Citation": "Said A, Raufman J-P, Xie G. The role of matrix metalloproteinases in colorectal cancer. Cancers. (2014) 6:366\u201375. 10.3390/cancers6010366"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/0008-5472.CAN-12-4495", "@IdType": "doi"}, {"#text": "PMC3754905", "@IdType": "pmc"}, {"#text": "23687338", "@IdType": "pubmed"}]}, "Citation": "Juncker-Jensen A, Deryugina EI, Rimann I, Zajac E, Kupriyanova TA, Engelholm LH, et al. . Tumor MMP-1 activates endothelial PAR1 to facilitate vascular intravasation and metastatic dissemination. Cancer Res. (2013) 73:4196\u2013211. 10.1158/0008-5472.CAN-12-4495"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bbadis.2015.09.001", "@IdType": "doi"}, {"#text": "PMC4615546", "@IdType": "pmc"}, {"#text": "26343184", "@IdType": "pubmed"}]}, "Citation": "Shin DH, Dier U, Melendez JA, Hempel N. Regulation of MMP-1 expression in response to hypoxia is dependent on the intracellular redox status of metastatic bladder cancer cells. Biochim Biophys Acta - Mol Basis Dis. (2015) 1852:2593\u2013602. 10.1016/j.bbadis.2015.09.001"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1371/journal.pone.0014250", "@IdType": "doi"}, {"#text": "PMC2999525", "@IdType": "pmc"}, {"#text": "21170377", "@IdType": "pubmed"}]}, "Citation": "Jawad MU, Garamszegi N, Garamszegi SP, Correa-Medina M, Diez JA, Wen R, et al. . Matrix metalloproteinase 1: role in sarcoma biology. PLoS ONE. (2010) 5:e14250. 10.1371/journal.pone.0014250"}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC1858026", "@IdType": "pmc"}, {"#text": "9327744", "@IdType": "pubmed"}]}, "Citation": "Luca M, Huang S, Gershenwald JE, Singh RK, Reich R, Bar-Eli M. Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis. Am J Pathol. (1997) 151:1105\u201313."}, {"ArticleIdList": {"ArticleId": {"#text": "10463616", "@IdType": "pubmed"}}, "Citation": "Elkin M, Ariel I, Miao HQ, Nagler A, Pines M, De-Groot N, et al. . Inhibition of bladder carcinoma angiogenesis, stromal support, and tumor growth by halofuginone. Cancer Res. (1999) 59:4111\u20138."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.12659/MSM.882614", "@IdType": "doi"}, {"#text": "PMC3560834", "@IdType": "pmc"}, {"#text": "22460086", "@IdType": "pubmed"}]}, "Citation": "Partyka R, Gonciarz M, Ja\u0142owiecki P, Kokocinska D, Byrczek T. VEGF and metalloproteinase 2 (MMP 2) expression in gastric cancer tissue. Med Sci Monit. (2012) 18:BR130\u20134. 10.12659/MSM.882614"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/35036374", "@IdType": "doi"}, {"#text": "PMC2852586", "@IdType": "pmc"}, {"#text": "11025665", "@IdType": "pubmed"}]}, "Citation": "Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, et al. . Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol. (2000) 2:737\u201344. 10.1038/35036374"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/sj.bjc.6605538", "@IdType": "doi"}, {"#text": "PMC2822952", "@IdType": "pmc"}, {"#text": "20087345", "@IdType": "pubmed"}]}, "Citation": "Bhoopathi P, Chetty C, Gujrati M, Dinh DH, Rao JS, Lakka SS. The role of MMP-9 in the anti-angiogenic effect of secreted protein acidic and rich in cysteine. Br J Cancer. (2010) 102:530\u201340. 10.1038/sj.bjc.6605538"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/sj.onc.1210463", "@IdType": "doi"}, {"#text": "17452979", "@IdType": "pubmed"}]}, "Citation": "Takafuji V, Forgues M, Unsworth E, Goldsmith P, Wang XW. An osteopontin fragment is essential for tumor cell invasion in hepatocellular carcinoma. Oncogene. (2007) 26:6361\u201371. 10.1038/sj.onc.1210463"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/cancers5020617", "@IdType": "doi"}, {"#text": "PMC3730333", "@IdType": "pmc"}, {"#text": "24216994", "@IdType": "pubmed"}]}, "Citation": "Gupta A, Zhou C, Chellaiah M. Osteopontin and MMP9: associations with VEGF expression/secretion and angiogenesis in PC3 prostate cancer cells. Cancers. (2013) 5:617\u201338. 10.3390/cancers5020617"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1096/fj.04-2140fje", "@IdType": "doi"}, {"#text": "PMC2771171", "@IdType": "pmc"}, {"#text": "15550552", "@IdType": "pubmed"}]}, "Citation": "Masson V, de la Ballina LR, Munaut C, Wielockx B, Jost M, Maillard C, et al. Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytes. FASEB J. (2005) 19:234\u20136. 10.1096/fj.04-2140fje"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1101/gad.14.2.163", "@IdType": "doi"}, {"#text": "PMC316345", "@IdType": "pmc"}, {"#text": "10652271", "@IdType": "pubmed"}]}, "Citation": "Yu Q, Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-\u03b2 and promotes tumor invasion and angiogenesis. Genes Dev. (2000) 14:163\u201376. 10.1101/gad.14.2.163"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12885-017-3418-y", "@IdType": "doi"}, {"#text": "PMC5477686", "@IdType": "pmc"}, {"#text": "28633655", "@IdType": "pubmed"}]}, "Citation": "Webb AH, Gao BT, Goldsmith ZK, Irvine AS, Saleh N, Lee RP, et al. . Inhibition of MMP-2 and MMP-9 decreases cellular migration, and angiogenesis in in vitro models of retinoblastoma. BMC Cancer. (2017) 17:434. 10.1186/s12885-017-3418-y"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1074/jbc.M103608200", "@IdType": "doi"}, {"#text": "11375993", "@IdType": "pubmed"}]}, "Citation": "Agnihotri R, Crawford HC, Haro H, Matrisian LM, Havrda MC, Liaw L. Osteopontin, a novel substrate for matrix metalloproteinase-3 (Stromelysin-1) and matrix metalloproteinase-7 (Matrilysin). J Biol Chem. (2001) 276:28261\u201367. 10.1074/jbc.M103608200"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1111/j.1349-7006.2006.00328.x", "@IdType": "doi"}, {"#text": "16999819", "@IdType": "pubmed"}]}, "Citation": "Jin X, Yagi M, Akiyama N, Hirosaki T, Higashi S, Lin C-Y, et al. . Matriptase activates stromelysin (MMP-3) and promotes tumor growth and angiogenesis. Cancer Sci. (2006) 97:1327\u201334. 10.1111/j.1349-7006.2006.00328.x"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1074/jbc.M112.373159", "@IdType": "doi"}, {"#text": "PMC3493915", "@IdType": "pmc"}, {"#text": "22992737", "@IdType": "pubmed"}]}, "Citation": "Kudo Y, Iizuka S, Yoshida M, Tsunematsu T, Kondo T, Subarnbhesaj A, et al. . Matrix Metalloproteinase-13 (MMP-13) directly and indirectly promotes tumor angiogenesis. J Biol Chem. (2012) 287:38716\u201328. 10.1074/jbc.M112.373159"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1074/jbc.272.46.28823", "@IdType": "doi"}, {"#text": "9360944", "@IdType": "pubmed"}]}, "Citation": "Patterson BC, Sang QA. Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/Type IV collagenase (MMP-9). J Biol Chem. (1997) 272:28823\u20135. 10.1074/jbc.272.46.28823"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/glia.20719", "@IdType": "doi"}, {"#text": "18563800", "@IdType": "pubmed"}]}, "Citation": "Rorive S, Berton A, D'haene N, Takacs CN, Debeir O, Decaestecker C, et al. . Matrix metalloproteinase-9 interplays with the IGFBP2-IGFII complex to promote cell growth and motility in astrocytomas. Glia. (2008) 56:1679\u201390. 10.1002/glia.20719"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1210/en.2011-1121", "@IdType": "doi"}, {"#text": "21750048", "@IdType": "pubmed"}]}, "Citation": "Azar WJ, Azar SHX, Higgins S, Hu J-F, Hoffman AR, Newgreen DF, et al. . IGFBP-2 enhances VEGF gene promoter activity and consequent promotion of angiogenesis by neuroblastoma cells. Endocrinology. (2011) 152:3332\u201342. 10.1210/en.2011-1121"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/ijc.25855", "@IdType": "doi"}, {"#text": "21165953", "@IdType": "pubmed"}]}, "Citation": "Chan KC, Ko JMY, Lung HL, Sedlacek R, Zhang Z-F, Luo D-Z, et al. . Catalytic activity of matrix metalloproteinase-19 is essential for tumor suppressor and anti-angiogenic activities in nasopharyngeal carcinoma. Int J Cancer. (2011) 129:1826\u201337. 10.1002/ijc.25855"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1096/fj.01-0790com", "@IdType": "doi"}, {"#text": "11919158", "@IdType": "pubmed"}]}, "Citation": "Sounni NE, Devy L, Hajitou A, Frankenne F, Munaut C, Gilles C, et al. . MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression. FASEB J. (2002) 16:555\u201364. 10.1096/fj.01-0790com"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1242/jcs.062711", "@IdType": "doi"}, {"#text": "21062896", "@IdType": "pubmed"}]}, "Citation": "Eisenach PA, Roghi C, Fogarasi M, Murphy G, English WR. MT1-MMP regulates VEGF-A expression through a complex with VEGFR-2 and Src. J Cell Sci. (2010) 123:4182\u201393. 10.1242/jcs.062711"}, {"ArticleIdList": {"ArticleId": {"#text": "11809713", "@IdType": "pubmed"}}, "Citation": "Deryugina EI, Soroceanu L, Strongin AY. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis. Cancer Res. (2002) 62:580\u20138. Available online at: https://cancerres.aacrjournals.org/content/62/2/580.full-text.pdf"}, {"ArticleIdList": {"ArticleId": {"#text": "10.4103/glioma.glioma_10_17", "@IdType": "doi"}}, "Citation": "Xu Y, Yuan F-E, Chen Q-X, Liu B-H. Molecular mechanisms involved in angiogenesis and potential target of antiangiogenesis in human glioblastomas. Glioma. (2018) 1:35 10.4103/glioma.glioma_10_17"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1074/jbc.M609570200", "@IdType": "doi"}, {"#text": "17204469", "@IdType": "pubmed"}]}, "Citation": "Basile JR, Holmbeck K, Bugge TH, Gutkind JS. MT1-MMP controls tumor-induced angiogenesis through the release of semaphorin 4D. J Biol Chem. (2007) 282:6899\u2013905. 10.1074/jbc.M609570200"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrc1092", "@IdType": "doi"}, {"#text": "12778131", "@IdType": "pubmed"}]}, "Citation": "Hendrix MJC, Seftor EA, Hess AR, Seftor REB. Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nat Rev Cancer. (2003) 3:411\u201321. 10.1038/nrc1092"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/0008-5472.CAN-09-4466", "@IdType": "doi"}, {"#text": "20424116", "@IdType": "pubmed"}]}, "Citation": "Hawinkels LJAC, Kuiper P, Wiercinska E, Verspaget HW, Liu Z, Pardali E, et al. . Matrix Metalloproteinase-14 (MT1-MMP)-mediated endoglin shedding inhibits tumor angiogenesis. Cancer Res. (2010) 70:4141\u201350. 10.1158/0008-5472.CAN-09-4466"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.0910962106", "@IdType": "doi"}, {"#text": "PMC2787166", "@IdType": "pmc"}, {"#text": "19915148", "@IdType": "pubmed"}]}, "Citation": "Ota I, Li X-Y, Hu Y, Weiss SJ. Induction of a MT1-MMP and MT2-MMP-dependent basement membrane transmigration program in cancer cells by Snail1. Proc Natl Acad Sci USA. (2009) 106:20318\u201323. 10.1073/pnas.0910962106"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.10194", "@IdType": "doi"}, {"#text": "PMC5217011", "@IdType": "pmc"}, {"#text": "27374080", "@IdType": "pubmed"}]}, "Citation": "Liu Y, Sun X, Feng J, Deng L-L, Liu Y, Li B, et al. . MT2-MMP induces proteolysis and leads to EMT in carcinomas. Oncotarget. (2016) 7:48193\u2013205. 10.18632/oncotarget.10194"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1074/jbc.M308708200", "@IdType": "doi"}, {"#text": "14681236", "@IdType": "pubmed"}]}, "Citation": "Zhao H, Bernardo MM, Osenkowski P, Sohail A, Pei D, Nagase H, et al. Differential Inhibition of Membrane Type 3 (MT3)-Matrix Metalloproteinase (MMP) and MT1-MMP by Tissue Inhibitor of Metalloproteinase (TIMP)-2 and TIMP-3 Regulates Pro-MMP-2 activation. J Biol Chem. (2004) 279:8592\u2013601. 10.1074/jbc.M308708200"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1111/j.1582-4934.2009.00764.x", "@IdType": "doi"}, {"#text": "PMC4516547", "@IdType": "pmc"}, {"#text": "19426156", "@IdType": "pubmed"}]}, "Citation": "Chabottaux V, Ricaud S, Host L, Blacher S, Paye A, Thiry M, et al. . Membrane-type 4 matrix metalloproteinase (MT4-MMP) induces lung metastasis by alteration of primary breast tumour vascular architecture. J Cell Mol Med. (2009) 13:4002\u201313. 10.1111/j.1582-4934.2009.00764.x"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/ijc.27436", "@IdType": "doi"}, {"#text": "22262494", "@IdType": "pubmed"}]}, "Citation": "Host L, Paye A, Detry B, Blacher S, Munaut C, Foidart JM, et al. . The proteolytic activity of MT4-MMP is required for its pro-angiogenic and pro-metastatic promoting effects. Int J Cancer. (2012) 131:1537\u201348. 10.1002/ijc.27436"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/0008-5472.CAN-13-2994", "@IdType": "doi"}, {"#text": "25320013", "@IdType": "pubmed"}]}, "Citation": "Paye A, Truong A, Yip C, Cimino J, Blacher S, Munaut C, et al. . EGFR Activation and signaling in cancer cells are enhanced by the membrane-bound metalloprotease MT4-MMP. Cancer Res. (2014) 74:6758\u201370. 10.1158/0008-5472.CAN-13-2994"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1074/jbc.M701737200", "@IdType": "doi"}, {"#text": "PMC1978545", "@IdType": "pmc"}, {"#text": "17513868", "@IdType": "pubmed"}]}, "Citation": "Sun Q, Weber CR, Sohail A, Bernardo MM, Toth M, Zhao H, et al. . MMP25 (MT6-MMP) is highly expressed in human colon cancer, promotes tumor growth, and exhibits unique biochemical properties. J Biol Chem. (2007) 282:21998\u20132010. 10.1074/jbc.M701737200"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrc2868", "@IdType": "doi"}, {"#text": "20574450", "@IdType": "pubmed"}]}, "Citation": "Chung AS, Lee J, Ferrara N. Targeting the tumour vasculature: Insights from physiological angiogenesis. Nat Rev Cancer. (2010) 10:505\u201314. 10.1038/nrc2868"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12943-019-0982-6", "@IdType": "doi"}, {"#text": "PMC6441221", "@IdType": "pmc"}, {"#text": "30925935", "@IdType": "pubmed"}]}, "Citation": "Meng W, Hao Y, He C, Li L, Zhu G. Exosome-orchestrated hypoxic tumor microenvironment. Mol Cancer. (2019) 18:1\u201314. 10.1186/s12943-019-0982-6"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.7150/jca.17648", "@IdType": "doi"}, {"#text": "PMC5381164", "@IdType": "pmc"}, {"#text": "28382138", "@IdType": "pubmed"}]}, "Citation": "Wang M, Zhao J, Zhang L, Wei F, Lian Y, Wu Y, et al. . Role of tumor microenvironment in tumorigenesis. J Cancer. (2017) 8:761\u201373. 10.7150/jca.17648"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.17671", "@IdType": "doi"}, {"#text": "PMC5564583", "@IdType": "pmc"}, {"#text": "28537901", "@IdType": "pubmed"}]}, "Citation": "Blank S, Nienh\u00fcser H, Dreikhausen L, Sisic L, Heger U, Ott K, et al. . Inflammatory cytokines are associated with response and prognosis in patients with esophageal cancer. Oncotarget. (2017) 8:47518\u201332. 10.18632/oncotarget.17671"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.15119", "@IdType": "doi"}, {"#text": "PMC5400541", "@IdType": "pmc"}, {"#text": "28186964", "@IdType": "pubmed"}]}, "Citation": "Wu X, Tao P, Zhou Q, Li J, Yu Z, Wang X, et al. . IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway. Oncotarget. (2017) 8:20741\u201350. 10.18632/oncotarget.15119"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.jss.2008.04.040", "@IdType": "doi"}, {"#text": "18952231", "@IdType": "pubmed"}]}, "Citation": "Matsuo Y, Sawai H, Ochi N, Yasuda A, Takahashi H, Funahashi H, et al. . Interleukin-1\u03b1 secreted by pancreatic cancer cells promotes angiogenesis and its therapeutic implications. J Surg Res. (2009) 153:274\u201381. 10.1016/j.jss.2008.04.040"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1053/j.gastro.2017.09.039", "@IdType": "doi"}, {"#text": "28989066", "@IdType": "pubmed"}]}, "Citation": "Huang C, Li Z, Li N, Li Y, Chang A, Zhao T, et al. . Interleukin 35 expression correlates with microvessel density in pancreatic ductal adenocarcinoma, recruits monocytes, and promotes growth and angiogenesis of xenograft tumors in mice. Gastroenterology. (2018) 154:675\u201388. 10.1053/j.gastro.2017.09.039"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.22526", "@IdType": "doi"}, {"#text": "PMC5739702", "@IdType": "pmc"}, {"#text": "29285315", "@IdType": "pubmed"}]}, "Citation": "Hosono M, Koma Y-I, Takase N, Urakawa N, Higashino N, Suemune K, et al. . CXCL8 derived from tumor-associated macrophages and esophageal squamous cell carcinomas contributes to tumor progression by promoting migration and invasion of cancer cells. Oncotarget. (2017) 8:106071\u201388. 10.18632/oncotarget.22526"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1177/1535370216685435", "@IdType": "doi"}, {"#text": "PMC5685257", "@IdType": "pmc"}, {"#text": "28058861", "@IdType": "pubmed"}]}, "Citation": "Aikins AR, Kim MJ, Raymundo B, Kim CW. Downregulation of transgelin blocks interleukin-8 utilization and suppresses vasculogenic mimicry in breast cancer cells. Exp Biol Med. (2017) 242:573\u201383. 10.1177/1535370216685435"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.4317/jced.52712", "@IdType": "doi"}, {"#text": "PMC4808306", "@IdType": "pmc"}, {"#text": "27034751", "@IdType": "pubmed"}]}, "Citation": "Andisheh-Tadbir A, Mardani M, Pourshahidi S, Nezarati K, Bahadori P. Prognostic value of matrix metalloproteinase-9 expression in oral squamous cell carcinoma and its association with angiogenesis. J Clin Exp Dent. (2016) 8:e130\u20135. 10.4317/jced.52712"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.4161/onci.24010", "@IdType": "doi"}, {"#text": "PMC3667897", "@IdType": "pmc"}, {"#text": "23762791", "@IdType": "pubmed"}]}, "Citation": "Eir\u00f3 N, Fernandez-Garcia B, Gonz\u00e1lez LO, Vizoso FJ. Cytokines related to MMP-11 expression by inflammatory cells and breast cancer metastasis. Oncoimmunology. (2013) 2:e24010. 10.4161/onci.24010"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/path.4868", "@IdType": "doi"}, {"#text": "28026024", "@IdType": "pubmed"}]}, "Citation": "Lin SC, Hsiao KY, Chang N, Hou PC, Tsai SJ. Loss of dual-specificity phosphatase-2 promotes angiogenesis and metastasis via up-regulation of interleukin-8 in colon cancer. J Pathol. (2017) 241:638\u201348. 10.1002/path.4868"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s13046-016-0301-7", "@IdType": "doi"}, {"#text": "PMC4743194", "@IdType": "pmc"}, {"#text": "26847351", "@IdType": "pubmed"}]}, "Citation": "Huang L, Hu B, Ni J, Wu J, Jiang W, Chen C, et al. . Transcriptional repression of SOCS3 mediated by IL-6/STAT3 signaling via DNMT1 promotes pancreatic cancer growth and metastasis. J Exp Clin Cancer Res. (2016) 35:1\u201315. 10.1186/s13046-016-0301-7"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/ol.2015.4035", "@IdType": "doi"}, {"#text": "PMC4734231", "@IdType": "pmc"}, {"#text": "26893688", "@IdType": "pubmed"}]}, "Citation": "Shi J, Wei PK. Interleukin-8: a potent promoter of angiogenesis in gastric cancer. Oncol Lett. (2016) 11:1043\u201350. 10.3892/ol.2015.4035"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/0008-5472.CAN-17-0994", "@IdType": "doi"}, {"#text": "29162616", "@IdType": "pubmed"}]}, "Citation": "Ruivo CF, Adem B, Silva M, Melo SA. The biology of cancer exosomes: insights and new perspectives. Cancer Res. (2017) 77:6480\u20138. 10.1158/0008-5472.CAN-17-0994"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.pharmthera.2016.09.011", "@IdType": "doi"}, {"#text": "27613100", "@IdType": "pubmed"}]}, "Citation": "Atretkhany KSN, Drutskaya MS, Nedospasov SA, Grivennikov SI, Kuprash D V. Chemokines, cytokines and exosomes help tumors to shape inflammatory microenvironment. Pharmacol Ther. (2016) 168:98\u2013112. 10.1016/j.pharmthera.2016.09.011"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/ijc.24479", "@IdType": "doi"}, {"#text": "PMC2769262", "@IdType": "pmc"}, {"#text": "19462451", "@IdType": "pubmed"}]}, "Citation": "Wysoczynski M, Ratajczak MZ. Lung cancer secreted microvesicles: Underappreciated modulators of microenvironment in expanding tumors. Int J Cancer. (2009) 125:1595\u2013603. 10.1002/ijc.24479"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/ol.2018.9239", "@IdType": "doi"}, {"#text": "PMC6126183", "@IdType": "pmc"}, {"#text": "30214613", "@IdType": "pubmed"}]}, "Citation": "Sun K, Liao Q, Chen Z, Chen T, Zhang J. Expression of Livin and PlGF in human osteosarcoma is associated with tumor progression and clinical outcome. Oncol Lett. (2018) 16:4953\u201360. 10.3892/ol.2018.9239"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.14670/HH-11-708", "@IdType": "doi"}, {"#text": "26662176", "@IdType": "pubmed"}]}, "Citation": "Gai C, Carpanetto A, Deregibus MC, Camussi G. Extracellular vesicle-mediated modulation of angiogenesis. Histol Histopathol. (2016) 31:379\u201391. 10.14670/HH-11-708"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/1078-0432.CCR-08-2276", "@IdType": "doi"}, {"#text": "19470735", "@IdType": "pubmed"}]}, "Citation": "Loges S, Schmidt T, Carmeliet P. \u201cAntimyeloangiogenic\u201d therapy for cancer by inhibiting PlGF. Clin Cancer Res. (2009) 15:3648\u201353. 10.1158/1078-0432.CCR-08-2276"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/ncb1800", "@IdType": "doi"}, {"#text": "PMC3423894", "@IdType": "pmc"}, {"#text": "19011622", "@IdType": "pubmed"}]}, "Citation": "Skog J, W\u00fcrdinger T, van Rijn S, Meijer DH, Gainche L, Curry WT, et al. . Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. (2008) 10:1470\u201376. 10.1038/ncb1800"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3389/fimmu.2014.00144", "@IdType": "doi"}, {"#text": "PMC3980107", "@IdType": "pmc"}, {"#text": "24765093", "@IdType": "pubmed"}]}, "Citation": "Klinker MW, Lizzio V, Reed TJ, Fox DA, Lundy SK. Human B cell-derived lymphoblastoid cell lines constitutively produce fas ligand and secrete MHCII(+)FasL(+) killer exosomes. Front Immunol. (2014) 5:144. 10.3389/fimmu.2014.00144"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cytogfr.2005.01.004", "@IdType": "doi"}, {"#text": "15863032", "@IdType": "pubmed"}]}, "Citation": "Presta M, Dell'Era P, Mitola S, Moroni E, Ronca R, Rusnati M. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev. (2005) 16:159\u201378. 10.1016/j.cytogfr.2005.01.004"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3389/fphar.2019.00462", "@IdType": "doi"}, {"#text": "PMC6509437", "@IdType": "pmc"}, {"#text": "31130862", "@IdType": "pubmed"}]}, "Citation": "Saby C, Collin G, Sinane M, Buache E, Van Gulick L, Saltel F, et al. . DDR1 and MT1-MMP expression levels are determinant for triggering BIK-mediated apoptosis by 3D Type I collagen matrix in invasive basal-like breast carcinoma cells. Front Pharmacol. (2019) 10:462. 10.3389/fphar.2019.00462"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1371/journal.pone.0116006", "@IdType": "doi"}, {"#text": "PMC4638154", "@IdType": "pmc"}, {"#text": "25774665", "@IdType": "pubmed"}]}, "Citation": "Assent D, Bourgot I, Hennuy B, Geurts P, No\u00ebl A, Foidart JM, et al. . A Membrane-type-1 matrix metalloproteinase (MT1-MMP) - Discoidin domain receptor 1 axis regulates collagen-induced apoptosis in breast cancer cells. PLoS ONE. (2015) 10:e116006. 10.1371/journal.pone.0116006"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1136/thoraxjnl-2016-209389", "@IdType": "doi"}, {"#text": "PMC5738540", "@IdType": "pmc"}, {"#text": "28202627", "@IdType": "pubmed"}]}, "Citation": "Vannitamby A, Seow HJ, Anderson G, Vlahos R, Thompson M, Steinfort D, et al. . Tumour-associated neutrophils and loss of epithelial PTEN can promote corticosteroid-insensitive MMP-9 expression in the chronically inflamed lung microenvironment. Thorax. (2017) 72:1140\u20133. 10.1136/thoraxjnl-2016-209389"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/jcp.25808", "@IdType": "doi"}, {"#text": "28098359", "@IdType": "pubmed"}]}, "Citation": "Vinnakota K, Zhang Y, Selvanesan BC, Topi G, Salim T, Sand-Dejmek J, et al. . M2-like macrophages induce colon cancer cell invasion via matrix metalloproteinases. J Cell Physiol. (2017) 232:3468\u201380. 10.1002/jcp.25808"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ajpath.2011.05.031", "@IdType": "doi"}, {"#text": "PMC3157227", "@IdType": "pmc"}, {"#text": "21741942", "@IdType": "pubmed"}]}, "Citation": "Bekes EM, Schweighofer B, Kupriyanova TA, Zajac E, Ardi VC, Quigley JP, et al. . Tumor-recruited neutrophils and neutrophil TIMP-free MMP-9 regulate coordinately the levels of tumor angiogenesis and efficiency of malignant cell intravasation. Am J Pathol. (2011) 179:1455\u201370. 10.1016/j.ajpath.2011.05.031"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrc.2017.51", "@IdType": "doi"}, {"#text": "28706266", "@IdType": "pubmed"}]}, "Citation": "De Palma M, Biziato D, Petrova TV. Microenvironmental regulation of tumour angiogenesis. Nat Rev Cancer. (2017) 17:457\u201374. 10.1038/nrc.2017.51"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/1479-5876-9-216", "@IdType": "doi"}, {"#text": "PMC3286485", "@IdType": "pmc"}, {"#text": "22176642", "@IdType": "pubmed"}]}, "Citation": "Heusinkveld M, van der Burg SH. Identification and manipulation of tumor associated macrophages in human cancers. J Transl Med. (2011) 9:216. 10.1186/1479-5876-9-216"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrc2444", "@IdType": "doi"}, {"#text": "18633355", "@IdType": "pubmed"}]}, "Citation": "Murdoch C, Muthana M, Coffelt SB, Lewis CE. The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer. (2008) 8:618\u201331. 10.1038/nrc2444"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.amjsurg.2017.08.003", "@IdType": "doi"}, {"#text": "28830617", "@IdType": "pubmed"}]}, "Citation": "Hurt B, Schulick R, Edil B, El Kasmi KC, Barnett C. Cancer-promoting mechanisms of tumor-associated neutrophils. Am J Surg. (2017) 214:938\u201344. 10.1016/j.amjsurg.2017.08.003"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12865-018-0241-4", "@IdType": "doi"}, {"#text": "PMC5781310", "@IdType": "pmc"}, {"#text": "29361917", "@IdType": "pubmed"}]}, "Citation": "Jackute J, Zemaitis M, Pranys D, Sitkauskiene B, Miliauskas S, Vaitkiene S, et al. . Distribution of M1 and M2 macrophages in tumor islets and stroma in relation to prognosis of non-small cell lung cancer. BMC Immunol. (2018) 19:3. 10.1186/s12865-018-0241-4"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1111/j.1440-1827.2010.02514.x", "@IdType": "doi"}, {"#text": "20403029", "@IdType": "pubmed"}]}, "Citation": "Niino D, Komohara Y, Murayama T, Aoki R, Kimura Y, Hashikawa K, et al. . Ratio of M2 macrophage expression is closely associated with poor prognosis for Angioimmunoblastic T-cell lymphoma (AITL). Pathol Int. (2010) 60:278\u201383. 10.1111/j.1440-1827.2010.02514.x"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/jcm6010007", "@IdType": "doi"}, {"#text": "PMC5294960", "@IdType": "pmc"}, {"#text": "28067804", "@IdType": "pubmed"}]}, "Citation": "Costanza B, Umelo I, Bellier J, Castronovo V, Turtoi A. Stromal modulators of TGF-\u03b2 in cancer. J Clin Med. (2017) 6:7. 10.3390/jcm6010007"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1155/2014/521754", "@IdType": "doi"}, {"#text": "PMC3918721", "@IdType": "pmc"}, {"#text": "24578639", "@IdType": "pubmed"}]}, "Citation": "Krstic J, Santibanez JF. Transforming growth factor-beta and matrix metalloproteinases: functional interactions in tumor stroma-infiltrating myeloid cells. Sci World J. (2014) 2014:521754. 10.1155/2014/521754"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1074/jbc.M111663200", "@IdType": "doi"}, {"#text": "11929865", "@IdType": "pubmed"}]}, "Citation": "Dallas SL, Rosser JL, Mundy GR, Bonewald LF. Proteolysis of latent Transforming Growth Factor-\u03b2 (TGF-\u03b2)-binding Protein-1 by osteoclasts. J Biol Chem. (2002) 277:21352\u201360. 10.1074/jbc.M111663200"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1161/CIRCRESAHA.112.268268", "@IdType": "doi"}, {"#text": "PMC4162309", "@IdType": "pmc"}, {"#text": "22550139", "@IdType": "pubmed"}]}, "Citation": "Xiong W, Meisinger T, Knispel R, Worth JM, Baxter BT. MMP-2 Regulates Erk1/2 phosphorylation and aortic dilatation in marfan syndrome. Circ Res. (2012) 110:e92\u2013101.10.1161/CIRCRESAHA.112.268268"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1083/jcb.106.5.1659", "@IdType": "doi"}, {"#text": "PMC2115066", "@IdType": "pmc"}, {"#text": "2967299", "@IdType": "pubmed"}]}, "Citation": "Lyons RM, Keski-Oja J, Moses HL. Proteolytic activation of latent transforming growth factor-\u03b2 from fibroblast-conditioned medium. J Cell Biol. (1988) 106:1659\u201365. 10.1083/jcb.106.5.1659"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1182/blood.V96.8.2673", "@IdType": "doi"}, {"#text": "11023497", "@IdType": "pubmed"}]}, "Citation": "Van den Steen PE, Proost P, Wuyts A, Van Damme J, Opdenakker G. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. Blood. (2000) 96:2673\u201381. 10.1182/blood.V96.8.2673"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41598-018-25490-w", "@IdType": "doi"}, {"#text": "PMC5940908", "@IdType": "pmc"}, {"#text": "29740050", "@IdType": "pubmed"}]}, "Citation": "Xu S, Webb SE, Lau TCK, Cheng SH. Matrix metalloproteinases (MMPs) mediate leukocyte recruitment during the inflammatory phase of zebrafish heart regeneration. Sci Rep. (2018) 8:1\u201314. 10.1038/s41598-018-25490-w"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1073/pnas.1903330116", "@IdType": "doi"}, {"#text": "PMC6697876", "@IdType": "pmc"}, {"#text": "31363054", "@IdType": "pubmed"}]}, "Citation": "Lopez T, Mustafa Z, Chen C, Lee KB, Ramirez A, Benitez C, et al. . Functional selection of protease inhibitory antibodies. Proc Natl Acad Sci USA. (2019) 116:16314\u20139. 10.1073/pnas.1903330116"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/ijc.32607", "@IdType": "doi"}, {"#text": "PMC7004098", "@IdType": "pmc"}, {"#text": "31381135", "@IdType": "pubmed"}]}, "Citation": "Larsson P, Syed Khaja AS, Semenas J, Wang T, Sarwar M, Dizeyi N, et al. . The functional interlink between AR and MMP9/VEGF signaling axis is mediated through PIP5K1\u03b1/pAKT in prostate cancer. Int J cancer. (2019). 10.1002/ijc.32607. [Epub ahead of print]."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.7314/APJCP.2012.13.7.3259", "@IdType": "doi"}, {"#text": "22994744", "@IdType": "pubmed"}]}, "Citation": "Hassan ZK, Daghestani MH. Curcumin effect on MMPs and TIMPs genes in a breast cancer cell line. Asian Pac J Cancer Prev. (2012) 13:3259\u201364. 10.7314/APJCP.2012.13.7.3259"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1177/1758835919864247", "@IdType": "doi"}, {"#text": "PMC6637839", "@IdType": "pmc"}, {"#text": "31360238", "@IdType": "pubmed"}]}, "Citation": "Su C-W, Lin C-W, Yang W-E, Yang S-F. TIMP-3 as a therapeutic target for cancer. Ther Adv Med Oncol. (2019) 11:175883591986424. 10.1177/1758835919864247"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s41021-019-0131-x", "@IdType": "doi"}, {"#text": "PMC6647068", "@IdType": "pmc"}, {"#text": "31367263", "@IdType": "pubmed"}]}, "Citation": "Shailender G, Kumari S, Kiranmayi P, Malla RR. Effect of MMP-2 gene silencing on radiation-induced DNA damage in human normal dermal fibroblasts and breast cancer cells. Genes Environ Off J Japanese Environ Mutagen Soc. (2019) 41:16. 10.1186/s41021-019-0131-x"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.26355/eurrev_201906_18175", "@IdType": "doi"}, {"#text": "31298364", "@IdType": "pubmed"}]}, "Citation": "Sun X-Y, Han X-M, Zhao X-L, Cheng X-M, Zhang Y. MiR-93-5p promotes cervical cancer progression by targeting THBS2/MMPS signal pathway. Eur Rev Med Pharmacol Sci. (2019) 23:5113\u201321. 10.26355/eurrev_201906_18175"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.neuroscience.2010.03.064", "@IdType": "doi"}, {"#text": "20382206", "@IdType": "pubmed"}]}, "Citation": "Gabelloni P, Da Pozzo E, Bendinelli S, Costa B, Nuti E, Casalini F, et al. . Inhibition of metalloproteinases derived from tumours: new insights in the treatment of human glioblastoma. Neuroscience. (2010) 168:514\u201322. 10.1016/j.neuroscience.2010.03.064"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1242/jcs.023820", "@IdType": "doi"}, {"#text": "PMC2995612", "@IdType": "pmc"}, {"#text": "21123617", "@IdType": "pubmed"}]}, "Citation": "Frantz C, Stewart KM, Weaver VM. The extracellular matrix at a glance. J Cell Sci. (2010) 123:4195\u2013200. 10.1242/jcs.023820"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1172/JCI39104", "@IdType": "doi"}, {"#text": "PMC2689101", "@IdType": "pmc"}, {"#text": "19487818", "@IdType": "pubmed"}]}, "Citation": "Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. (2009) 119:1420\u20138. 10.1172/JCI39104"}]}}}}}, "PMC": "PMC6915110", "PMID": "31921634", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "Role of Matrix Metalloproteinases in Angiogenesis and Cancer.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "43": {"Abstract": "Long non-coding RNAs (lncRNA) have been demonstrated to act as essential regulators in the development and progression of breast cancer. In our study, we found that long noncoding RNA SNHG15 was highly expressed in breast cancer tissues and cell lines. And the expression of SNHG15 was correlated with TNM stage, lymphnode metastasis and survival in breast cancer patients. SNHG15 knockdown significantly inhibited the proliferation and induced apoptosis in breast cancer cells in\u00a0vitro and in\u00a0vivo. Besides, SNHG15 downregulation suppressed cell migration and invasion in MCF-7 and BT-20\u00a0cells, and inhibited epithelial-mesenchymal transition (EMT). In mechanism, we found that SNHG15 acted as a competing endogenous RNA to sponge miR-211-3p, which was downregulated in breast cancers and inhibited cell proliferation and migration. Our results showed that there was a negative correlation between SNHG15 and miR-211-3p expression in breast cancer patients. Collectively, we, for the first time, revealed the functions of SNHG15 and miR-211-3p in breast cancer.", "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "6026151938244108896", "Part1": "Department of Oncology", "Part2": "Affiliated Hospital of Jining Medical College", "Part3": "Jining", "Part4": "272029", "Part5": "Shangdong province", "Part6": "China.", "Text": "Department of Oncology, Affiliated Hospital of Jining Medical College, Jining, 272029, Shangdong province, China."}], "ForeName": "Qingli", "FullName": "Qingli Kong", "HashID": "1581306899033866470", "LastName": "Kong", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "5498431509383503384", "Part1": "Department of Breast and Thyroid Surgery", "Part2": "Affiliated Hospital of Jining Medical College", "Part3": "Jining", "Part4": "272029", "Part5": "Shangdong province", "Part6": "China. Electronic address: qiumin1116@163.com.", "Text": "Department of Breast and Thyroid Surgery, Affiliated Hospital of Jining Medical College, Jining, 272029, Shangdong province, China. Electronic address: qiumin1116@163.com."}], "ForeName": "Min", "FullName": "Min Qiu", "HashID": "-2110751515755450645", "LastName": "Qiu", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.1016/j.bbrc.2017.12.013", "InsertType": null, "Journal": "Biochemical and biophysical research communications", "Keywords": [{"IS_Major": false, "IS_Mesh": true, "Text": "Animals"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Apoptosis"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Breast Neoplasms"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Cell Line, Tumor"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Cell Movement"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Cell Proliferation"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Disease Progression"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Epithelial-Mesenchymal Transition"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Female"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Gene Expression Regulation, Neoplastic"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Gene Knockdown Techniques"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Heterografts"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Humans"}, {"IS_Major": false, "IS_Mesh": true, "Text": "MCF-7 Cells"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Mice"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Mice, Inbred BALB C"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Mice, Nude"}, {"IS_Major": false, "IS_Mesh": true, "Text": "MicroRNAs"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Neoplasm Invasiveness"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Neoplasm Transplantation"}, {"IS_Major": false, "IS_Mesh": true, "Text": "RNA, Long Noncoding"}, {"IS_Major": false, "IS_Mesh": true, "Text": "RNA, Neoplasm"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Breast cancer"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Proliferation"}, {"IS_Major": false, "IS_Mesh": false, "Text": "SNHG15"}, {"IS_Major": false, "IS_Mesh": false, "Text": "miR-211-3p"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "MEDLINE", "Article": {"@PubModel": "Print-Electronic", "Abstract": {"AbstractText": "Long non-coding RNAs (lncRNA) have been demonstrated to act as essential regulators in the development and progression of breast cancer. In our study, we found that long noncoding RNA SNHG15 was highly expressed in breast cancer tissues and cell lines. And the expression of SNHG15 was correlated with TNM stage, lymphnode metastasis and survival in breast cancer patients. SNHG15 knockdown significantly inhibited the proliferation and induced apoptosis in breast cancer cells in\u00a0vitro and in\u00a0vivo. Besides, SNHG15 downregulation suppressed cell migration and invasion in MCF-7 and BT-20\u00a0cells, and inhibited epithelial-mesenchymal transition (EMT). In mechanism, we found that SNHG15 acted as a competing endogenous RNA to sponge miR-211-3p, which was downregulated in breast cancers and inhibited cell proliferation and migration. Our results showed that there was a negative correlation between SNHG15 and miR-211-3p expression in breast cancer patients. Collectively, we, for the first time, revealed the functions of SNHG15 and miR-211-3p in breast cancer.", "CopyrightInformation": "Copyright \u00a9 2017 Elsevier Inc. All rights reserved."}, "ArticleDate": {"@DateType": "Electronic", "Day": "05", "Month": "12", "Year": "2017"}, "ArticleTitle": "Long noncoding RNA SNHG15 promotes human breast cancer proliferation, migration and invasion by sponging miR-211-3p.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Oncology, Affiliated Hospital of Jining Medical College, Jining, 272029, Shangdong province, China."}, "ForeName": "Qingli", "Initials": "Q", "LastName": "Kong"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Breast and Thyroid Surgery, Affiliated Hospital of Jining Medical College, Jining, 272029, Shangdong province, China. Electronic address: qiumin1116@163.com."}, "ForeName": "Min", "Initials": "M", "LastName": "Qiu"}]}, "ELocationID": [{"#text": "10.1016/j.bbrc.2017.12.013", "@EIdType": "doi", "@ValidYN": "Y"}, {"#text": "S0006-291X(17)32397-5", "@EIdType": "pii", "@ValidYN": "Y"}], "Journal": {"ISOAbbreviation": "Biochem Biophys Res Commun", "ISSN": {"#text": "1090-2104", "@IssnType": "Electronic"}, "JournalIssue": {"@CitedMedium": "Internet", "Issue": "2", "PubDate": {"Day": "08", "Month": "Jan", "Year": "2018"}, "Volume": "495"}, "Title": "Biochemical and biophysical research communications"}, "Language": "eng", "Pagination": {"EndPage": "1600", "MedlinePgn": "1594-1600", "StartPage": "1594"}, "PublicationTypeList": {"PublicationType": {"#text": "Journal Article", "@UI": "D016428"}}}, "ChemicalList": {"Chemical": [{"NameOfSubstance": {"#text": "MIRN211 microRNA, human", "@UI": "C549405"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "MicroRNAs", "@UI": "D035683"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "RNA, Long Noncoding", "@UI": "D062085"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "RNA, Neoplasm", "@UI": "D012334"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "SNHG16 lncRNA, human", "@UI": "C000624322"}, "RegistryNumber": "0"}]}, "CitationSubset": "IM", "DateCompleted": {"Day": "20", "Month": "02", "Year": "2018"}, "DateRevised": {"Day": "30", "Month": "03", "Year": "2022"}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"#text": "Breast cancer", "@MajorTopicYN": "N"}, {"#text": "Proliferation", "@MajorTopicYN": "N"}, {"#text": "SNHG15", "@MajorTopicYN": "N"}, {"#text": "miR-211-3p", "@MajorTopicYN": "N"}]}, "MedlineJournalInfo": {"Country": "United States", "ISSNLinking": "0006-291X", "MedlineTA": "Biochem Biophys Res Commun", "NlmUniqueID": "0372516"}, "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"#text": "Animals", "@MajorTopicYN": "N", "@UI": "D000818"}}, {"DescriptorName": {"#text": "Apoptosis", "@MajorTopicYN": "N", "@UI": "D017209"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Breast Neoplasms", "@MajorTopicYN": "N", "@UI": "D001943"}, "QualifierName": [{"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}, {"#text": "metabolism", "@MajorTopicYN": "N", "@UI": "Q000378"}, {"#text": "pathology", "@MajorTopicYN": "Y", "@UI": "Q000473"}]}, {"DescriptorName": {"#text": "Cell Line, Tumor", "@MajorTopicYN": "N", "@UI": "D045744"}}, {"DescriptorName": {"#text": "Cell Movement", "@MajorTopicYN": "N", "@UI": "D002465"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Cell Proliferation", "@MajorTopicYN": "N", "@UI": "D049109"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Disease Progression", "@MajorTopicYN": "N", "@UI": "D018450"}}, {"DescriptorName": {"#text": "Epithelial-Mesenchymal Transition", "@MajorTopicYN": "N", "@UI": "D058750"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Female", "@MajorTopicYN": "N", "@UI": "D005260"}}, {"DescriptorName": {"#text": "Gene Expression Regulation, Neoplastic", "@MajorTopicYN": "N", "@UI": "D015972"}}, {"DescriptorName": {"#text": "Gene Knockdown Techniques", "@MajorTopicYN": "N", "@UI": "D055785"}}, {"DescriptorName": {"#text": "Heterografts", "@MajorTopicYN": "N", "@UI": "D064593"}}, {"DescriptorName": {"#text": "Humans", "@MajorTopicYN": "N", "@UI": "D006801"}}, {"DescriptorName": {"#text": "MCF-7 Cells", "@MajorTopicYN": "N", "@UI": "D061986"}}, {"DescriptorName": {"#text": "Mice", "@MajorTopicYN": "N", "@UI": "D051379"}}, {"DescriptorName": {"#text": "Mice, Inbred BALB C", "@MajorTopicYN": "N", "@UI": "D008807"}}, {"DescriptorName": {"#text": "Mice, Nude", "@MajorTopicYN": "N", "@UI": "D008819"}}, {"DescriptorName": {"#text": "MicroRNAs", "@MajorTopicYN": "N", "@UI": "D035683"}, "QualifierName": [{"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}, {"#text": "metabolism", "@MajorTopicYN": "N", "@UI": "Q000378"}]}, {"DescriptorName": {"#text": "Neoplasm Invasiveness", "@MajorTopicYN": "N", "@UI": "D009361"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Neoplasm Transplantation", "@MajorTopicYN": "N", "@UI": "D009368"}}, {"DescriptorName": {"#text": "RNA, Long Noncoding", "@MajorTopicYN": "N", "@UI": "D062085"}, "QualifierName": [{"#text": "antagonists & inhibitors", "@MajorTopicYN": "N", "@UI": "Q000037"}, {"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}, {"#text": "metabolism", "@MajorTopicYN": "N", "@UI": "Q000378"}]}, {"DescriptorName": {"#text": "RNA, Neoplasm", "@MajorTopicYN": "N", "@UI": "D012334"}, "QualifierName": [{"#text": "antagonists & inhibitors", "@MajorTopicYN": "N", "@UI": "Q000037"}, {"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}, {"#text": "metabolism", "@MajorTopicYN": "N", "@UI": "Q000378"}]}]}, "PMID": {"#text": "29217194", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "29217194", "@IdType": "pubmed"}, {"#text": "10.1016/j.bbrc.2017.12.013", "@IdType": "doi"}, {"#text": "S0006-291X(17)32397-5", "@IdType": "pii"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "received", "Day": "25", "Month": "11", "Year": "2017"}, {"@PubStatus": "accepted", "Day": "3", "Month": "12", "Year": "2017"}, {"@PubStatus": "pubmed", "Day": "9", "Hour": "6", "Minute": "0", "Month": "12", "Year": "2017"}, {"@PubStatus": "medline", "Day": "21", "Hour": "6", "Minute": "0", "Month": "2", "Year": "2018"}, {"@PubStatus": "entrez", "Day": "9", "Hour": "6", "Minute": "0", "Month": "12", "Year": "2017"}]}, "PublicationStatus": "ppublish"}}}}, "PMC": null, "PMID": "29217194", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "Long noncoding RNA SNHG15 promotes human breast cancer proliferation, migration and invasion by sponging miR-211-3p.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "44": {"Abstract": "Cisplatin, cisplatinum, or cis-diamminedichloroplatinum (II), is a well-known chemotherapeutic drug. It has been used for treatment of numerous human cancers including bladder, head and neck, lung, ovarian, and testicular cancers. It is effective against various types of cancers, including carcinomas, germ cell tumors, lymphomas, and sarcomas. Its mode of action has been linked to its ability to crosslink with the purine bases on the DNA; interfering with DNA repair mechanisms, causing DNA damage, and subsequently inducing apoptosis in cancer cells. However, because of drug resistance and numerous undesirable side effects such as severe kidney problems, allergic reactions, decrease immunity to infections, gastrointestinal disorders, hemorrhage, and hearing loss especially in younger patients, other platinum-containing anti-cancer drugs such as carboplatin, oxaliplatin and others, have also been used. Furthermore, combination therapies of cisplatin with other drugs have been highly considered to overcome drug-resistance and reduce toxicity. This comprehensive review highlights the physicochemical properties of cisplatin and related platinum-based drugs, and discusses its uses (either alone or in combination with other drugs) for the treatment of various human cancers. A special attention is paid to its molecular mechanisms of action, and its undesirable side effects.", "Authors": [{"Affiliations": [{"Has_Extra": true, "HashID": "195374880375151750", "Part1": "Cellomics and Toxicogenomics Research Laboratory", "Part2": "NIH/NIMHD RCMI-Center for Environmental Health", "Part3": "College of Science", "Part4": "Engineering and Technology", "Part5": "Jackson State University", "Part6": "1400 Lynch Street", "Text": "Cellomics and Toxicogenomics Research Laboratory, NIH/NIMHD RCMI-Center for Environmental Health, College of Science, Engineering and Technology, Jackson State University, 1400 Lynch Street, Box 18750, Jackson, MS 39217, USA."}], "ForeName": "Shaloam", "FullName": "Shaloam Dasari", "HashID": "215185631067477701", "LastName": "Dasari", "ORCID": null}, {"Affiliations": [{"Has_Extra": true, "HashID": "195374880375151750", "Part1": "Cellomics and Toxicogenomics Research Laboratory", "Part2": "NIH/NIMHD RCMI-Center for Environmental Health", "Part3": "College of Science", "Part4": "Engineering and Technology", "Part5": "Jackson State University", "Part6": "1400 Lynch Street", "Text": "Cellomics and Toxicogenomics Research Laboratory, NIH/NIMHD RCMI-Center for Environmental Health, College of Science, Engineering and Technology, Jackson State University, 1400 Lynch Street, Box 18750, Jackson, MS 39217, USA. Electronic address: paul.b.tchounwou@jsums.edu."}], "ForeName": "Paul Bernard", "FullName": "Paul Bernard Tchounwou", "HashID": "5040236985610414013", "LastName": "Tchounwou", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.1016/j.ejphar.2014.07.025", "InsertType": null, "Journal": "European journal of pharmacology", "Keywords": [{"IS_Major": false, "IS_Mesh": true, "Text": "Animals"}, {"IS_Major": true, "IS_Mesh": true, "Text": "Antineoplastic Agents"}, {"IS_Major": true, "IS_Mesh": true, "Text": "Cisplatin"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Drug Therapy, Combination"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Humans"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Neoplasms"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Cancer treatment"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Cisplatin"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Mechanisms of action"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Platinum-based drugs"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "MEDLINE", "Article": {"@PubModel": "Print-Electronic", "Abstract": {"AbstractText": "Cisplatin, cisplatinum, or cis-diamminedichloroplatinum (II), is a well-known chemotherapeutic drug. It has been used for treatment of numerous human cancers including bladder, head and neck, lung, ovarian, and testicular cancers. It is effective against various types of cancers, including carcinomas, germ cell tumors, lymphomas, and sarcomas. Its mode of action has been linked to its ability to crosslink with the purine bases on the DNA; interfering with DNA repair mechanisms, causing DNA damage, and subsequently inducing apoptosis in cancer cells. However, because of drug resistance and numerous undesirable side effects such as severe kidney problems, allergic reactions, decrease immunity to infections, gastrointestinal disorders, hemorrhage, and hearing loss especially in younger patients, other platinum-containing anti-cancer drugs such as carboplatin, oxaliplatin and others, have also been used. Furthermore, combination therapies of cisplatin with other drugs have been highly considered to overcome drug-resistance and reduce toxicity. This comprehensive review highlights the physicochemical properties of cisplatin and related platinum-based drugs, and discusses its uses (either alone or in combination with other drugs) for the treatment of various human cancers. A special attention is paid to its molecular mechanisms of action, and its undesirable side effects.", "CopyrightInformation": "Copyright \u00a9 2014 Elsevier B.V. All rights reserved."}, "ArticleDate": {"@DateType": "Electronic", "Day": "21", "Month": "07", "Year": "2014"}, "ArticleTitle": "Cisplatin in cancer therapy: molecular mechanisms of action.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Cellomics and Toxicogenomics Research Laboratory, NIH/NIMHD RCMI-Center for Environmental Health, College of Science, Engineering and Technology, Jackson State University, 1400 Lynch Street, Box 18750, Jackson, MS 39217, USA."}, "ForeName": "Shaloam", "Initials": "S", "LastName": "Dasari"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Cellomics and Toxicogenomics Research Laboratory, NIH/NIMHD RCMI-Center for Environmental Health, College of Science, Engineering and Technology, Jackson State University, 1400 Lynch Street, Box 18750, Jackson, MS 39217, USA. Electronic address: paul.b.tchounwou@jsums.edu."}, "ForeName": "Paul Bernard", "Initials": "PB", "LastName": "Tchounwou"}]}, "ELocationID": [{"#text": "10.1016/j.ejphar.2014.07.025", "@EIdType": "doi", "@ValidYN": "Y"}, {"#text": "S0014-2999(14)00562-7", "@EIdType": "pii", "@ValidYN": "Y"}], "GrantList": {"@CompleteYN": "Y", "Grant": [{"Acronym": "MD", "Agency": "NIMHD NIH HHS", "Country": "United States", "GrantID": "G12 MD007581"}, {"Acronym": "MD", "Agency": "NIMHD NIH HHS", "Country": "United States", "GrantID": "G12MD007581"}]}, "Journal": {"ISOAbbreviation": "Eur J Pharmacol", "ISSN": {"#text": "1879-0712", "@IssnType": "Electronic"}, "JournalIssue": {"@CitedMedium": "Internet", "PubDate": {"Day": "05", "Month": "Oct", "Year": "2014"}, "Volume": "740"}, "Title": "European journal of pharmacology"}, "Language": "eng", "Pagination": {"EndPage": "378", "MedlinePgn": "364-78", "StartPage": "364"}, "PublicationTypeList": {"PublicationType": [{"#text": "Journal Article", "@UI": "D016428"}, {"#text": "Research Support, N.I.H., Extramural", "@UI": "D052061"}, {"#text": "Review", "@UI": "D016454"}]}}, "ChemicalList": {"Chemical": [{"NameOfSubstance": {"#text": "Antineoplastic Agents", "@UI": "D000970"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "Cisplatin", "@UI": "D002945"}, "RegistryNumber": "Q20Q21Q62J"}]}, "CitationSubset": "IM", "DateCompleted": {"Day": "30", "Month": "10", "Year": "2015"}, "DateRevised": {"Day": "09", "Month": "11", "Year": "2022"}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"#text": "Cancer treatment", "@MajorTopicYN": "N"}, {"#text": "Cisplatin", "@MajorTopicYN": "N"}, {"#text": "Mechanisms of action", "@MajorTopicYN": "N"}, {"#text": "Platinum-based drugs", "@MajorTopicYN": "N"}]}, "MedlineJournalInfo": {"Country": "Netherlands", "ISSNLinking": "0014-2999", "MedlineTA": "Eur J Pharmacol", "NlmUniqueID": "1254354"}, "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"#text": "Animals", "@MajorTopicYN": "N", "@UI": "D000818"}}, {"DescriptorName": {"#text": "Antineoplastic Agents", "@MajorTopicYN": "Y", "@UI": "D000970"}, "QualifierName": [{"#text": "adverse effects", "@MajorTopicYN": "N", "@UI": "Q000009"}, {"#text": "pharmacology", "@MajorTopicYN": "N", "@UI": "Q000494"}, {"#text": "therapeutic use", "@MajorTopicYN": "N", "@UI": "Q000627"}]}, {"DescriptorName": {"#text": "Cisplatin", "@MajorTopicYN": "Y", "@UI": "D002945"}, "QualifierName": [{"#text": "adverse effects", "@MajorTopicYN": "N", "@UI": "Q000009"}, {"#text": "pharmacology", "@MajorTopicYN": "N", "@UI": "Q000494"}, {"#text": "therapeutic use", "@MajorTopicYN": "N", "@UI": "Q000627"}]}, {"DescriptorName": {"#text": "Drug Therapy, Combination", "@MajorTopicYN": "N", "@UI": "D004359"}}, {"DescriptorName": {"#text": "Humans", "@MajorTopicYN": "N", "@UI": "D006801"}}, {"DescriptorName": {"#text": "Neoplasms", "@MajorTopicYN": "N", "@UI": "D009369"}, "QualifierName": [{"#text": "drug therapy", "@MajorTopicYN": "Y", "@UI": "Q000188"}, {"#text": "metabolism", "@MajorTopicYN": "N", "@UI": "Q000378"}]}]}, "PMID": {"#text": "25058905", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "25058905", "@IdType": "pubmed"}, {"#text": "NIHMS615599", "@IdType": "mid"}, {"#text": "PMC4146684", "@IdType": "pmc"}, {"#text": "10.1016/j.ejphar.2014.07.025", "@IdType": "doi"}, {"#text": "S0014-2999(14)00562-7", "@IdType": "pii"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "received", "Day": "27", "Month": "3", "Year": "2014"}, {"@PubStatus": "revised", "Day": "13", "Month": "7", "Year": "2014"}, {"@PubStatus": "accepted", "Day": "14", "Month": "7", "Year": "2014"}, {"@PubStatus": "entrez", "Day": "25", "Hour": "6", "Minute": "0", "Month": "7", "Year": "2014"}, {"@PubStatus": "pubmed", "Day": "25", "Hour": "6", "Minute": "0", "Month": "7", "Year": "2014"}, {"@PubStatus": "medline", "Day": "31", "Hour": "6", "Minute": "0", "Month": "10", "Year": "2015"}]}, "PublicationStatus": "ppublish", "ReferenceList": {"Reference": [{"ArticleIdList": {"ArticleId": {"#text": "12748309", "@IdType": "pubmed"}}, "Citation": "Abrams TJ, Lee LB, Murray LJ, Pryer NK, Cherrington JM. SU11248 inhibits KIT and platelet-derived growth factor receptor beta in preclinical models of human small cell lung cancer. Mol.Cancer Ther. 2003;2:471\u2013478."}, {"ArticleIdList": {"ArticleId": {"#text": "12835670", "@IdType": "pubmed"}}, "Citation": "Agarwal R, Kaye SB. Ovarian cancer: strategies for overcoming resistance to chemotherapy. Nat.Rev.Cancer. 2003;3:502\u2013516."}, {"ArticleIdList": {"ArticleId": {"#text": "8515048", "@IdType": "pubmed"}}, "Citation": "Aggarwal SK. A histochemical approach to the mechanism of action of cisplatin and its analogues. J.Histochem.Cytochem. 1993;41:1053\u20131073."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2365104", "@IdType": "pmc"}, {"#text": "18475826", "@IdType": "pubmed"}]}, "Citation": "Aggarwal SK. Calcium modulation of toxicities due to Cisplatin. Met.Based.Drugs. 1998;5:77\u201381."}, {"ArticleIdList": {"ArticleId": {"#text": "7438327", "@IdType": "pubmed"}}, "Citation": "Aggarwal SK, Broomhead JA, Fairlie DP, Whitehouse MW. Platinum drugs: combined anti-lymphoproliferative and nephrotoxicity assay in rats. Cancer Chemother.Pharmacol. 1980;4:249\u2013258."}, {"ArticleIdList": {"ArticleId": {"#text": "18430910", "@IdType": "pubmed"}}, "Citation": "Ajani JA, Winter KA, Gunderson LL, Pedersen J, Benson AB, III, Thomas CR, Jr., Mayer RJ, Haddock MG, Rich TA, Willett C. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA. 2008;299:1914\u20131921."}, {"Citation": "Akron  The Chemical Database.  [3/25/14];The Department of Chemistry at the University of Akron. 2009   http://ull.chemistry.uakron.edu/erd and search on CAS number."}, {"ArticleIdList": {"ArticleId": {"#text": "7194729", "@IdType": "pubmed"}}, "Citation": "Alberts DS, Manning MR, Coulthard SW, Koopmann CF, Jr., Herman TS. Adriamycin/cis-platinum/cyclophosphamide combination chemotherapy for advanced carcinoma of the parotid gland. Cancer. 1981;47:645\u2013648."}, {"ArticleIdList": {"ArticleId": {"#text": "17309516", "@IdType": "pubmed"}}, "Citation": "Al-Majed AA. Carnitine deficiency provokes cisplatin-induced hepatotoxicity in rats. Basic Clin.Pharmacol.Toxicol. 2007;100:145\u2013150."}, {"ArticleIdList": {"ArticleId": {"#text": "16436331", "@IdType": "pubmed"}}, "Citation": "Al-Majed AA, Sayed-Ahmed MM, Al-Yahya AA, Aleisa AM, Al-Rejaie SS, Al-Shabanah OA. Propionyl-L-carnitine prevents the progression of cisplatin-induced cardiomyopathy in a carnitine-depleted rat model. Pharmacol.Res. 2006;53:278\u2013286."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3522379", "@IdType": "pmc"}, {"#text": "23301148", "@IdType": "pubmed"}]}, "Citation": "Alizadehnohi M, Nabiuni M, Nazari Z, Safaeinejad Z, Irian S. The synergistic cytotoxic effect of cisplatin and honey bee venom on human ovarian cancer cell line A2780cp. J.Venom.Res. 2012;3:22\u201327."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3637172", "@IdType": "pmc"}, {"#text": "23521834", "@IdType": "pubmed"}]}, "Citation": "Apostolou P, Toloudi M, Chatziioannou M, Ioannou E, Knocke DR, Nester J, Komiotis D, Papasotiriou I. AnvirzelTM in combination with cisplatin in breast, colon, lung, prostate, melanoma and pancreatic cancer cell lines. BMC.Pharmacol.Toxicol. 2013;14:18."}, {"ArticleIdList": {"ArticleId": {"#text": "13680535", "@IdType": "pubmed"}}, "Citation": "Arany I, Safirstein RL. Cisplatin nephrotoxicity. Semin.Nephrol. 2003;23:460\u2013464."}, {"ArticleIdList": {"ArticleId": {"#text": "2044044", "@IdType": "pubmed"}}, "Citation": "Ardizzoni A, Rosso R, Salvati F, Fusco V, Cinquegrana A, De PM, Serrano J, Pennucci MC, Soresi E, Crippa M. Activity of doxorubicin and cisplatin combination chemotherapy in patients with diffuse malignant pleural mesothelioma. An Italian Lung Cancer Task Force (FONICAP) Phase II study. Cancer. 1991;67:2984\u20132987."}, {"ArticleIdList": {"ArticleId": {"#text": "10371339", "@IdType": "pubmed"}}, "Citation": "Arts HJ, Hollema H, Lemstra W, Willemse PH, De Vries EG, Kampinga HH, Van der Zee AG. Heat-shock-protein-27 (hsp27) expression in ovarian carcinoma: relation in response to chemotherapy and prognosis. Int.J.Cancer. 1999;84:234\u2013238."}, {"ArticleIdList": {"ArticleId": {"#text": "8440749", "@IdType": "pubmed"}}, "Citation": "Baniahmad A, Tsai MJ. Mechanisms of transcriptional activation by steroid hormone receptors. J.Cell Biochem. 1993;51:151\u2013156."}, {"Citation": "Basch H, Krauss M, Stevens WJ, Cohen D. Binding of Pt(NH3)32+ to nucleic acid bases. Inorg.Chem. 1986;25:684\u2013688."}, {"ArticleIdList": {"ArticleId": {"#text": "8309991", "@IdType": "pubmed"}}, "Citation": "Basu A. The potential of protein kinase C as a target for anticancer treatment. Pharmacol.Ther. 1993;59:257\u2013280."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2929606", "@IdType": "pmc"}, {"#text": "20811617", "@IdType": "pubmed"}]}, "Citation": "Basu A, Krishnamurthy S. Cellular responses to Cisplatin-induced DNA damage. J.Nucleic Acids 2010. 2010"}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC1986651", "@IdType": "pmc"}, {"#text": "17537614", "@IdType": "pubmed"}]}, "Citation": "Basu A, Sivaprasad U. Protein kinase Cepsilon makes the life and death decision. Cell Signal. 2007;19:1633\u20131642."}, {"ArticleIdList": {"ArticleId": {"#text": "16039614", "@IdType": "pubmed"}}, "Citation": "Basu A, Tu H. Activation of ERK during DNA damage-induced apoptosis involves protein kinase Cdelta. Biochem.Biophys.Res.Commun. 2005;334:1068\u20131073."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC246480", "@IdType": "pmc"}, {"#text": "4584807", "@IdType": "pubmed"}]}, "Citation": "Beck DJ, Brubaker RR. Effect of cis-platinum(II)diamminodichloride on wild type and deoxyribonucleic acid repair deficient mutants of Escherichia coli. J.Bacteriol. 1973;116:1247\u20131252."}, {"ArticleIdList": {"ArticleId": {"#text": "10198218", "@IdType": "pubmed"}}, "Citation": "Belfi CA, Chatterjee S, Gosky DM, Berger SJ, Berger NA. Increased sensitivity of human colon cancer cells to DNA cross-linking agents after GRP78 up-regulation. Biochem.Biophys.Res.Commun. 1999;257:361\u2013368."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2741477", "@IdType": "pmc"}, {"#text": "19805294", "@IdType": "pubmed"}]}, "Citation": "Bertolini G, Roz L, Perego P, Tortoreto M, Fontanella E, Gatti L, Pratesi G, Fabbri A, Andriani F, Tinelli S, Roz E, Caserini R, Lo VS, Camerini T, Mariani L, Delia D, Calabro E, Pastorino U, Sozzi G. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc.Natl.Acad.Sci.U.S.A. 2009;106:16281\u201316286."}, {"ArticleIdList": {"ArticleId": {"#text": "11701324", "@IdType": "pubmed"}}, "Citation": "Brazil DP, Hemmings BA. Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem.Sci. 2001;26:657\u2013664."}, {"ArticleIdList": {"ArticleId": {"#text": "20163198", "@IdType": "pubmed"}}, "Citation": "Brozovic A, Ambriovic-Ristov A, Osmak M. The relationship between cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatin. Crit Rev.Toxicol. 2010;40:347\u2013359."}, {"ArticleIdList": {"ArticleId": {"#text": "11478701", "@IdType": "pubmed"}}, "Citation": "Brozovic A, Simaga S, Osmak M. Induction of heat shock protein 70 in drug-resistant cells by anticancer drugs and hyperthermia. Neoplasma. 2001;48:99\u2013103."}, {"ArticleIdList": {"ArticleId": {"#text": "23338680", "@IdType": "pubmed"}}, "Citation": "Byun JM, Jeong DH, Lee DS, Kim JR, Park SG, Kang MS, Kim YN, Lee KB, Sung MS, Kim KT. Tetraarsenic oxide and cisplatin induce apoptotic synergism in cervical cancer. Oncol.Rep. 2013;29:1540\u20131546."}, {"ArticleIdList": {"ArticleId": {"#text": "3002623", "@IdType": "pubmed"}}, "Citation": "Canetta R, Rozencweig M, Carter SK. Carboplatin: the clinical spectrum to date. Cancer Treat.Rev. 1985;12(Suppl A):125\u2013136."}, {"Citation": "Carloni P, Andreoni W. Platinum-Modified Nucleobase Pairs in the Solid State:G\u00c7\u00eb A Theoretical Study. J.Phys.Chem. 1996;100:17797\u201317800."}, {"Citation": "Carloni P, Sprik M, Andreoni W. Key Steps of the cis-Platin-DNA Interaction:G\u00c7\u00eb Density Functional Theory-Based Molecular Dynamics Simulations. J.Phys.Chem.B. 2000;104:823\u2013835."}, {"ArticleIdList": {"ArticleId": {"#text": "14744237", "@IdType": "pubmed"}}, "Citation": "Caro AA, Cederbaum AI. Oxidative stress, toxicology, and pharmacology of CYP2E1. Annu.Rev.Pharmacol.Toxicol. 2004;44:27\u201342."}, {"ArticleIdList": {"ArticleId": {"#text": "16158393", "@IdType": "pubmed"}}, "Citation": "Cetin R, Devrim E, Kilicoglu B, Avci A, Candir O, Durak I. Cisplatin impairs antioxidant system and causes oxidation in rat kidney tissues: possible protective roles of natural antioxidant foods. J.Appl.Toxicol. 2006;26:42\u201346."}, {"ArticleIdList": {"ArticleId": {"#text": "24761924", "@IdType": "pubmed"}}, "Citation": "Chian S, Li YY, Wang XJ, Tang XW. Luteolin sensitizes two oxaliplatin-resistant colorectal cancer cell lines to chemotherapeutic drugs via inhibition of the nrf2 pathway. Asian Pac.J.Cancer Prev. 2014;15:2911\u20132916."}, {"ArticleIdList": {"ArticleId": {"#text": "11242034", "@IdType": "pubmed"}}, "Citation": "Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature. 2001;410:37\u201340."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2668551", "@IdType": "pmc"}, {"#text": "19204194", "@IdType": "pubmed"}]}, "Citation": "Chen G, Huynh M, Fehrenbacher L, West H, Lara PN, Jr., Yavorkovsky LL, Russin M, Goldstein D, Gandara D, Lau D. Phase II trial of irinotecan and carboplatin for extensive or relapsed small-cell lung cancer. J.Clin.Oncol. 2009;27:1401\u20131404."}, {"ArticleIdList": {"ArticleId": {"#text": "18036733", "@IdType": "pubmed"}}, "Citation": "Cho JM, Manandhar S, Lee HR, Park HM, Kwak MK. Role of the Nrf2-antioxidant system in cytotoxicity mediated by anticancer cisplatin: implication to cancer cell resistance. Cancer Lett. 2008;260:96\u2013108."}, {"ArticleIdList": {"ArticleId": {"#text": "2418394", "@IdType": "pubmed"}}, "Citation": "Colombo N, Sessa C, Landoni F, Sartori E, Pecorelli S, Mangioni C. Cisplatin, vinblastine, and bleomycin combination chemotherapy in metastatic granulosa cell tumor of the ovary. Obstet.Gynecol. 1986;67:265\u2013268."}, {"ArticleIdList": {"ArticleId": {"#text": "6684986", "@IdType": "pubmed"}}, "Citation": "Creagan ET, Woods JE, Schutt AJ, O'Fallon JR. Cyclophosphamide, adriamycin, and cis-diamminedichloroplatinum (II) in the treatment of advanced nonsquamous cell head and neck cancer. Cancer. 1983;52:2007\u20132010."}, {"ArticleIdList": {"ArticleId": {"#text": "8996156", "@IdType": "pubmed"}}, "Citation": "Crino L, Scagliotti G, Marangolo M, Figoli F, Clerici M, De MF, Salvati F, Cruciani G, Dogliotti L, Pucci F, Paccagnella A, Adamo V, Altavilla G, Incoronato P, Trippetti M, Mosconi AM, Santucci A, Sorbolini S, Oliva C, Tonato M. Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study. J.Clin.Oncol. 1997;15:297\u2013303."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC1852783", "@IdType": "pmc"}, {"#text": "17380123", "@IdType": "pubmed"}]}, "Citation": "Cuadrado A, Lafarga V, Cheung PC, Dolado I, Llanos S, Cohen P, Nebreda AR. A new p38 MAP kinase-regulated transcriptional coactivator that stimulates p53-dependent apoptosis. EMBO J. 2007;26:2115\u20132126."}, {"ArticleIdList": {"ArticleId": {"#text": "10773044", "@IdType": "pubmed"}}, "Citation": "Cummings BS, Lasker JM, Lash LH. Expression of glutathione-dependent enzymes and cytochrome P450s in freshly isolated and primary cultures of proximal tubular cells from human kidney. J.Pharmacol.Exp.Ther. 2000;293:677\u2013685."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2747572", "@IdType": "pmc"}, {"#text": "12698184", "@IdType": "pubmed"}]}, "Citation": "de Jongh FE, van Veen RN, Veltman SJ, de WR, van der Burg ME, van den Bent MJ, Planting AS, Graveland WJ, Stoter G, Verweij J. Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients. Br.J.Cancer. 2003;88:1199\u20131206."}, {"ArticleIdList": {"ArticleId": {"#text": "14766126", "@IdType": "pubmed"}}, "Citation": "Decatris MP, Sundar S, O'Byrne KJ. Platinum-based chemotherapy in metastatic breast cancer: current status. Cancer Treat.Rev. 2004;30:53\u201381."}, {"ArticleIdList": {"ArticleId": {"#text": "11761456", "@IdType": "pubmed"}}, "Citation": "DeHaan RD, Yazlovitskaya EM, Persons DL. Regulation of p53 target gene expression by cisplatin-induced extracellular signal-regulated kinase. Cancer Chemother.Pharmacol. 2001;48:383\u2013388."}, {"ArticleIdList": {"ArticleId": {"#text": "23494564", "@IdType": "pubmed"}}, "Citation": "Deng L, Zhang E, Chen C. Synergistic interaction of beta-galactosyl-pyrrolidinyl diazeniumdiolate with cisplatin against three tumor cells. Arch.Pharm.Res. 2013;36:619\u2013625."}, {"ArticleIdList": {"ArticleId": {"#text": "11923064", "@IdType": "pubmed"}}, "Citation": "Desoize B. Cancer and metals and metal compounds: part I--carcinogenesis. Crit Rev.Oncol.Hematol. 2002;42:1\u20133."}, {"ArticleIdList": {"ArticleId": {"#text": "12050023", "@IdType": "pubmed"}}, "Citation": "Desoize B, Madoulet C. Particular aspects of platinum compounds used at present in cancer treatment. Crit Rev.Oncol.Hematol. 2002;42:317\u2013325."}, {"ArticleIdList": {"ArticleId": {"#text": "12010058", "@IdType": "pubmed"}}, "Citation": "Deubel DV. On the Competition of the Purine Bases, Functionalities of Peptide Side Chains, and Protecting Agents for the Coordination Sites of Dicationic Cisplatin DerivativesG\u00c7\u00e1. J.Am.Chem.Soc. 2002;124:5834\u20135842."}, {"ArticleIdList": {"ArticleId": {"#text": "15137764", "@IdType": "pubmed"}}, "Citation": "Deubel DV. Factors Governing the Kinetic Competition of Nitrogen and Sulfur Ligands in Cisplatin Binding to Biological TargetsG\u00c7\u00e1. J.Am.Chem.Soc. 2004;126:5999\u20136004."}, {"ArticleIdList": {"ArticleId": {"#text": "1719241", "@IdType": "pubmed"}}, "Citation": "Dexeus FH, Logothetis CJ, Sella A, Amato R, Kilbourn R, Fitz K, Striegel A. Combination chemotherapy with methotrexate, bleomycin and cisplatin for advanced squamous cell carcinoma of the male genital tract. J.Urol. 1991;146:1284\u20131287."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3033286", "@IdType": "pmc"}, {"#text": "21233423", "@IdType": "pubmed"}]}, "Citation": "Dhar S, Kolishetti N, Lippard SJ, Farokhzad OC. Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo. Proc.Natl.Acad.Sci.U.S.A. 2011;108:1850\u20131855."}, {"ArticleIdList": {"ArticleId": {"#text": "2112183", "@IdType": "pubmed"}}, "Citation": "Dimery IW, Legha SS, Shirinian M, Hong WK. Fluorouracil, doxorubicin, cyclophosphamide, and cisplatin combination chemotherapy in advanced or recurrent salivary gland carcinoma. J.Clin.Oncol. 1990;8:1056\u20131062."}, {"ArticleIdList": {"ArticleId": {"#text": "17850778", "@IdType": "pubmed"}}, "Citation": "dos Santos NA, Martins NM, Curti C, Pires Bianchi ML, dos Santos AC. Dimethylthiourea protects against mitochondrial oxidative damage induced by cisplatin in liver of rats. Chem.Biol.Interact. 2007;170:177\u2013186."}, {"ArticleIdList": {"ArticleId": {"#text": "2824016", "@IdType": "pubmed"}}, "Citation": "Dreyfuss AI, Clark JR, Fallon BG, Posner MR, Norris CM, Jr., Miller D. Cyclophosphamide, doxorubicin, and cisplatin combination chemotherapy for advanced carcinomas of salivary gland origin. Cancer. 1987;60:2869\u20132872."}, {"ArticleIdList": {"ArticleId": {"#text": "23525453", "@IdType": "pubmed"}}, "Citation": "Du N, Li X, Li F, Zhao H, Fan Z, Ma J, Fu Y, Kang H. Intrapleural combination therapy with bevacizumab and cisplatin for non-small cell lung cancermediated malignant pleural effusion. Oncol.Rep. 2013;29:2332\u20132340."}, {"ArticleIdList": {"ArticleId": {"#text": "1673965", "@IdType": "pubmed"}}, "Citation": "Einzig AI, Hochster H, Wiernik PH, Trump DL, Dutcher JP, Garowski E, Sasloff J, Smith TJ. A phase II study of taxol in patients with malignant melanoma. Invest New Drugs. 1991;9:59\u201364."}, {"ArticleIdList": {"ArticleId": {"#text": "1357110", "@IdType": "pubmed"}}, "Citation": "Einzig AI, Wiernik PH, Sasloff J, Runowicz CD, Goldberg GL. Phase II study and long-term follow-up of patients treated with taxol for advanced ovarian adenocarcinoma. J.Clin.Oncol. 1992;10:1748\u20131753."}, {"ArticleIdList": {"ArticleId": {"#text": "3884153", "@IdType": "pubmed"}}, "Citation": "Eisenberger MA. Supporting evidence for an active treatment program for advanced salivary gland carcinomas. Cancer Treat.Rep. 1985;69:319\u2013321."}, {"ArticleIdList": {"ArticleId": {"#text": "7939763", "@IdType": "pubmed"}}, "Citation": "Forastiere AA. Paclitaxel (Taxol) for the treatment of head and neck cancer. Semin.Oncol. 1994;21:49\u201352."}, {"ArticleIdList": {"ArticleId": {"#text": "672924", "@IdType": "pubmed"}}, "Citation": "Fraval HN, Rawlings CJ, Roberts JJ. Increased sensitivity of UV-repair-deficient human cells to DNA bound platinum products which unlike thymine dimers are not recognized by an endonuclease extracted from Micrococcus luteus. Mutat.Res. 1978;51:121\u2013132."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3759287", "@IdType": "pmc"}, {"#text": "20337575", "@IdType": "pubmed"}]}, "Citation": "Frezza M, Hindo S, Chen D, Davenport A, Schmitt S, Tomco D, Dou QP. Novel metals and metal complexes as platforms for cancer therapy. Curr.Pharm.Des. 2010;16:1813\u20131825."}, {"ArticleIdList": {"ArticleId": {"#text": "381088", "@IdType": "pubmed"}}, "Citation": "Fujii S, Kitano S, Ikenaka K, Shirasaka T. Effect of coadministration of uracil or cytosine on the anti-tumor activity of clinical doses of 1-(2-tetrahydrofuryl)-5-fluorouracil and level of 5-fluorouracil in rodents. Gann. 1979;70:209\u2013214."}, {"ArticleIdList": {"ArticleId": {"#text": "10458260", "@IdType": "pubmed"}}, "Citation": "Go RS, Adjei AA. Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin. J.Clin.Oncol. 1999;17:409\u2013422."}, {"ArticleIdList": {"ArticleId": {"#text": "10391249", "@IdType": "pubmed"}}, "Citation": "Gong JG, Costanzo A, Yang HQ, Melino G, Kaelin WG, Jr., Levrero M, Wang JY. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature. 1999;399:806\u2013809."}, {"ArticleIdList": {"ArticleId": {"#text": "11902585", "@IdType": "pubmed"}}, "Citation": "Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat.Rev.Cancer. 2002;2:48\u201358."}, {"ArticleIdList": {"ArticleId": {"#text": "16582013", "@IdType": "pubmed"}}, "Citation": "Goodsell DS. The molecular perspective: Cisplatin. Stem Cells. 2006;24:514\u2013515."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3324815", "@IdType": "pmc"}, {"#text": "22117137", "@IdType": "pubmed"}]}, "Citation": "Gupta SC, Hevia D, Patchva S, Park B, Koh W, Aggarwal BB. Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy. Antioxid.Redox.Signal. 2012;16:1295\u20131322."}, {"ArticleIdList": {"ArticleId": {"#text": "9323034", "@IdType": "pubmed"}}, "Citation": "Hampton MB, Orrenius S. Dual regulation of caspase activity by hydrogen peroxide: implications for apoptosis. FEBS Lett. 1997;414:552\u2013556."}, {"ArticleIdList": {"ArticleId": {"#text": "10958599", "@IdType": "pubmed"}}, "Citation": "Hartmann JT, Fels LM, Knop S, Stolt H, Kanz L, Bokemeyer C. A randomized trial comparing the nephrotoxicity of cisplatin/ifosfamide-based combination chemotherapy with or without amifostine in patients with solid tumors. Invest New Drugs. 2000;18:281\u2013289."}, {"ArticleIdList": {"ArticleId": {"#text": "12783586", "@IdType": "pubmed"}}, "Citation": "Hartmann JT, Lipp HP. Toxicity of platinum compounds. Expert.Opin.Pharmacother. 2003;4:889\u2013901."}, {"ArticleIdList": {"ArticleId": {"#text": "15546613", "@IdType": "pubmed"}}, "Citation": "Hayakawa J, Mittal S, Wang Y, Korkmaz KS, Adamson E, English C, Ohmichi M, McClelland M, Mercola D. Identification of promoters bound by c-Jun/ATF2 during rapid large-scale gene activation following genotoxic stress. Mol.Cell. 2004;16:521\u2013535."}, {"ArticleIdList": {"ArticleId": {"#text": "10531373", "@IdType": "pubmed"}}, "Citation": "Hayakawa J, Ohmichi M, Kurachi H, Ikegami H, Kimura A, Matsuoka T, Jikihara H, Mercola D, Murata Y. Inhibition of extracellular signal-regulated protein kinase or c-Jun N-terminal protein kinase cascade, differentially activated by cisplatin, sensitizes human ovarian cancer cell line. J.Biol.Chem. 1999;274:31648\u201331654."}, {"ArticleIdList": {"ArticleId": {"#text": "11085518", "@IdType": "pubmed"}}, "Citation": "Hayakawa J, Ohmichi M, Kurachi H, Kanda Y, Hisamoto K, Nishio Y, Adachi K, Tasaka K, Kanzaki T, Murata Y. Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin. Cancer Res. 2000;60:5988\u20135994."}, {"Citation": "Hazardous Substances Data Bank. National Library of Medicine   [3/19/14];  http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?HSDB and search on CAS number."}, {"ArticleIdList": {"ArticleId": {"#text": "8375936", "@IdType": "pubmed"}}, "Citation": "Hirata J, Kikuchi Y, Kita T, Imaizumi E, Tode T, Ishii K, Kudoh K, Nagata I. Modulation of sensitivity of human ovarian cancer cells to cis-diamminedichloroplatinum(II) by 12-O-tetradecanoylphorbol-13-acetate and D,L-buthionine-S,R-sulphoximine. Int.J.Cancer. 1993;55:521\u2013527."}, {"ArticleIdList": {"ArticleId": {"#text": "9932167", "@IdType": "pubmed"}}, "Citation": "Hitt R, Castellano D, Hidalgo M, Garcia-Carbonero R, Pena M, Brandariz A, Millan JM, Alvarez Vincent JJ, Cortes-Funes H. Phase II trial of cisplatin and gemcitabine in advanced squamous-cell carcinoma of the head and neck. Ann.Oncol. 1998;9:1347\u20131349."}, {"ArticleIdList": {"ArticleId": {"#text": "1683908", "@IdType": "pubmed"}}, "Citation": "Holmes FA, Walters RS, Theriault RL, Forman AD, Newton LK, Raber MN, Buzdar AU, Frye DK, Hortobagyi GN. Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer. J.Natl.Cancer Inst. 1991;83:1797\u20131805."}, {"ArticleIdList": {"ArticleId": {"#text": "16847145", "@IdType": "pubmed"}}, "Citation": "Holzer AK, Manorek GH, Howell SB. Contribution of the major copper influx transporter CTR1 to the cellular accumulation of cisplatin, carboplatin, and oxaliplatin. Mol.Pharmacol. 2006;70:1390\u20131394."}, {"ArticleIdList": {"ArticleId": {"#text": "10741285", "@IdType": "pubmed"}}, "Citation": "Huang TG, Ip SM, Yeung WS, Ngan HY. Changes in p21WAF1, pRb, Mdm-2, Bax and Bcl-2 expression in cervical cancer cell lines transfected with a p53 expressing adenovirus. Eur.J.Cancer. 2000;36:249\u2013256."}, {"Citation": "IARC . IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans. Vol. 26. International Agency for Research on Cancer; Lyon, France: 1981. Cisplatin. In Some Antineoplastic and Immunosuppressive Agents. pp. 151\u2013164."}, {"ArticleIdList": {"ArticleId": {"#text": "10640963", "@IdType": "pubmed"}}, "Citation": "Ichinose Y, Yosimori K, Yoneda S, Kuba M, Kudoh S, Niitani H. UFT plus cisplatin combination chemotherapy in the treatment of patients with advanced nonsmall cell lung carcinoma: a multiinstitutional phase II trial. For the Japan UFT Lung Cancer Study Group. Cancer. 2000;88:318\u2013323."}, {"ArticleIdList": {"ArticleId": {"#text": "16081592", "@IdType": "pubmed"}}, "Citation": "Iraz M, Kalcioglu MT, Kizilay A, Karatas E. Aminoguanidine prevents ototoxicity induced by cisplatin in rats. Ann.Clin.Lab Sci. 2005;35:329\u2013335."}, {"ArticleIdList": {"ArticleId": {"#text": "17196726", "@IdType": "pubmed"}}, "Citation": "Iseri S, Ercan F, Gedik N, Yuksel M, Alican I. Simvastatin attenuates cisplatin-induced kidney and liver damage in rats. Toxicology. 2007;230:256\u2013264."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC137878", "@IdType": "pmc"}, {"#text": "12370430", "@IdType": "pubmed"}]}, "Citation": "Ishida S, Lee J, Thiele DJ, Herskowitz I. Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals. Proc.Natl.Acad.Sci.U.S.A. 2002;99:14298\u201314302."}, {"ArticleIdList": {"ArticleId": {"#text": "2303468", "@IdType": "pubmed"}}, "Citation": "Isonishi S, Andrews PA, Howell SB. Increased sensitivity to cis-diamminedichloroplatinum(II) in human ovarian carcinoma cells in response to treatment with 12-O-tetradecanoylphorbol 13-acetate. J.Biol.Chem. 1990;265:3623\u20133627."}, {"ArticleIdList": {"ArticleId": {"#text": "16236883", "@IdType": "pubmed"}}, "Citation": "Iwasaki Y, Nagata K, Nakanishi M, Natuhara A, Kubota Y, Ueda M, Arimoto T, Hara H. Double-cycle, high-dose ifosfamide, carboplatin, and etoposide followed by peripheral blood stem-cell transplantation for small cell lung cancer. Chest. 2005;128:2268\u20132273."}, {"ArticleIdList": {"ArticleId": {"#text": "7736908", "@IdType": "pubmed"}}, "Citation": "Jennerwein M, Andrews PA. Effect of intracellular chloride on the cellular pharmacodynamics of cis-diamminedichloroplatinum(II). Drug Metab Dispos. 1995;23:178\u2013184."}, {"ArticleIdList": {"ArticleId": {"#text": "12471242", "@IdType": "pubmed"}}, "Citation": "Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. 2002;298:1911\u20131912."}, {"ArticleIdList": {"ArticleId": {"#text": "8660948", "@IdType": "pubmed"}}, "Citation": "Johnson SW, Shen D, Pastan I, Gottesman MM, Hamilton TC. Cross-resistance, cisplatin accumulation, and platinum-DNA adduct formation and removal in cisplatin-sensitive and -resistant human hepatoma cell lines. Exp.Cell Res. 1996;226:133\u2013139."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2267308", "@IdType": "pmc"}, {"#text": "17521288", "@IdType": "pubmed"}]}, "Citation": "Jones EV, Dickman MJ, Whitmarsh AJ. Regulation of p73-mediated apoptosis by c-Jun N-terminal kinase. Biochem.J. 2007;405:617\u2013623."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3402232", "@IdType": "pmc"}, {"#text": "22713472", "@IdType": "pubmed"}]}, "Citation": "Kakar SS, Jala VR, Fong MY. Synergistic cytotoxic action of cisplatin and withaferin A on ovarian cancer cell lines. Biochem.Biophys.Res.Commun. 2012;423:819\u2013825."}, {"ArticleIdList": {"ArticleId": {"#text": "19268559", "@IdType": "pubmed"}}, "Citation": "Kart A, Cigremis Y, Karaman M, Ozen H. Caffeic acid phenethyl ester (CAPE) ameliorates cisplatin-induced hepatotoxicity in rabbit. Exp.Toxicol.Pathol. 2010;62:45\u201352."}, {"ArticleIdList": {"ArticleId": {"#text": "17625587", "@IdType": "pubmed"}}, "Citation": "Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat.Rev.Cancer. 2007;7:573\u2013584."}, {"ArticleIdList": {"ArticleId": {"#text": "6890409", "@IdType": "pubmed"}}, "Citation": "Khan AB, D'Souza BJ, Wharam MD, Champion LA, Sinks LF, Woo SY, McCullough DC, Leventhal BG. Cisplatin therapy in recurrent childhood brain tumors. Cancer Treat.Rep. 1982;66:2013\u20132020."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC85948", "@IdType": "pmc"}, {"#text": "10866655", "@IdType": "pubmed"}]}, "Citation": "Kharbanda S, Pandey P, Yamauchi T, Kumar S, Kaneki M, Kumar V, Bharti A, Yuan ZM, Ghanem L, Rana A, Weichselbaum R, Johnson G, Kufe D. Activation of MEK kinase 1 by the c-Abl protein tyrosine kinase in response to DNA damage. Mol.Cell Biol. 2000;20:4979\u20134989."}, {"ArticleIdList": {"ArticleId": {"#text": "10023695", "@IdType": "pubmed"}}, "Citation": "Kim YH, Shin SW, Kim BS, Kim JH, Kim JG, Mok YJ, Kim CS, Rhyu HS, Hyun JH, Kim JS. Paclitaxel, 5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma. Cancer. 1999;85:295\u2013301."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC394672", "@IdType": "pmc"}, {"#text": "8521815", "@IdType": "pubmed"}]}, "Citation": "Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH, Peter ME. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 1995;14:5579\u20135588."}, {"ArticleIdList": {"ArticleId": {"#text": "23396090", "@IdType": "pubmed"}}, "Citation": "Koch M, Krieger ML, Stolting D, Brenner N, Beier M, Jaehde U, Wiese M, Royer HD, Bendas G. Overcoming chemotherapy resistance of ovarian cancer cells by liposomal cisplatin: molecular mechanisms unveiled by gene expression profiling. Biochem.Pharmacol. 2013;85:1077\u20131090."}, {"ArticleIdList": {"ArticleId": {"#text": "18282805", "@IdType": "pubmed"}}, "Citation": "Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, Miyashita K, Nishizaki T, Kobayashi O, Takiyama W, Toh Y, Nagaie T, Takagi S, Yamamura Y, Yanaoka K, Orita H, Takeuchi M. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol. 2008;9:215\u2013221."}, {"ArticleIdList": {"ArticleId": {"#text": "11134204", "@IdType": "pubmed"}}, "Citation": "Kosmas C, Tsavaris NB, Malamos NA, Vadiaka M, Koufos C. Phase II study of paclitaxel, ifosfamide, and cisplatin as second-line treatment in relapsed small-cell lung cancer. J.Clin.Oncol. 2001;19:119\u2013126."}, {"ArticleIdList": {"ArticleId": {"#text": "9430835", "@IdType": "pubmed"}}, "Citation": "Kuhlmann MK, Burkhardt G, Kohler H. Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application. Nephrol.Dial.Transplant. 1997;12:2478\u20132480."}, {"ArticleIdList": {"ArticleId": {"#text": "26626384", "@IdType": "pubmed"}}, "Citation": "Lau JK-C, Deubel DV. Hydrolysis of the Anticancer Drug Cisplatin:G\u00c7\u00eb Pitfalls in the Interpretation of Quantum Chemical Calculations. J.Chem.Theory Comput. 2005;2:103\u2013106."}, {"ArticleIdList": {"ArticleId": {"#text": "8113844", "@IdType": "pubmed"}}, "Citation": "Le CT, Brisgand D, Douillard JY, Pujol JL, Alberola V, Monnier A, Riviere A, Lianes P, Chomy P, Cigolari S. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients. J.Clin.Oncol. 1994;12:360\u2013367."}, {"ArticleIdList": {"ArticleId": {"#text": "1970948", "@IdType": "pubmed"}}, "Citation": "Legha SS, Ring S, Papadopoulos N, Raber M, Benjamin RS. A phase II trial of taxol in metastatic melanoma. Cancer. 1990;65:2478\u20132481."}, {"ArticleIdList": {"ArticleId": {"#text": "18280240", "@IdType": "pubmed"}}, "Citation": "Levy D, Adamovich Y, Reuven N, Shaul Y. Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage. Mol.Cell. 2008;29:350\u2013361."}, {"ArticleIdList": {"ArticleId": {"#text": "18282716", "@IdType": "pubmed"}}, "Citation": "Liao Y, Lu X, Lu C, Li G, Jin Y, Tang H. Selection of agents for prevention of cisplatin-induced hepatotoxicity. Pharmacol.Res. 2008;57:125\u2013131."}, {"ArticleIdList": {"ArticleId": {"#text": "9288784", "@IdType": "pubmed"}}, "Citation": "Light BW, Yu WD, McElwain MC, Russell DM, Trump DL, Johnson CS. Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system. Cancer Res. 1997;57:3759\u20133764."}, {"ArticleIdList": {"ArticleId": {"#text": "23526220", "@IdType": "pubmed"}}, "Citation": "Lin CC, Yeh HH, Huang WL, Yan JJ, Lai WW, Su WP, Chen HH, Su WC. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway. Am.J.Respir.Cell Mol.Biol. 2013;49:241\u2013250."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4028303", "@IdType": "pmc"}, {"#text": "24846322", "@IdType": "pubmed"}]}, "Citation": "Lin J, Zhang Q, Lu Y, Xue W, Xu Y, Zhu Y, Hu X. Downregulation of HIPK2 Increases Resistance of Bladder Cancer Cell to Cisplatin by Regulating Wip1. PLoS.One. 2014;9:e98418."}, {"ArticleIdList": {"ArticleId": {"#text": "12391279", "@IdType": "pubmed"}}, "Citation": "Lin X, Okuda T, Holzer A, Howell SB. The copper transporter CTR1 regulates cisplatin uptake in Saccharomyces cerevisiae. Mol.Pharmacol. 2002;62:1154\u20131159."}, {"ArticleIdList": {"ArticleId": {"#text": "11830553", "@IdType": "pubmed"}}, "Citation": "Liu JR, Opipari AW, Tan L, Jiang Y, Zhang Y, Tang H, Nunez G. Dysfunctional apoptosome activation in ovarian cancer: implications for chemoresistance. Cancer Res. 2002;62:924\u2013931."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3615335", "@IdType": "pmc"}, {"#text": "20935493", "@IdType": "pubmed"}]}, "Citation": "Llanos S, Serrano M. Depletion of ribosomal protein L37 occurs in response to DNA damage and activates p53 through the L11/MDM2 pathway. Cell Cycle. 2010;9:4005\u20134012."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2778287", "@IdType": "pmc"}, {"#text": "19383374", "@IdType": "pubmed"}]}, "Citation": "Lynch HT, Casey MJ, Snyder CL, Bewtra C, Lynch JF, Butts M, Godwin AK. Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management. Mol.Oncol. 2009;3:97\u2013137."}, {"ArticleIdList": {"ArticleId": {"#text": "14657961", "@IdType": "pubmed"}}, "Citation": "Machuy N, Rajalingam K, Rudel T. Requirement of caspase-mediated cleavage of c-Abl during stress-induced apoptosis. Cell Death.Differ. 2004;11:290\u2013300."}, {"ArticleIdList": {"ArticleId": {"#text": "12509415", "@IdType": "pubmed"}}, "Citation": "Mandic A, Hansson J, Linder S, Shoshan MC. Cisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signaling. J.Biol.Chem. 2003;278:9100\u20139106."}, {"ArticleIdList": {"ArticleId": {"#text": "17129399", "@IdType": "pubmed"}}, "Citation": "Mansour HH, Hafez HF, Fahmy NM. Silymarin modulates Cisplatin-induced oxidative stress and hepatotoxicity in rats. J.Biochem.Mol.Biol. 2006;39:656\u2013661."}, {"Citation": "Mantri Y, Baik MH. Encyclopedia of Inorganic Chemistry. John Wiley & Sons, Ltd.; 2006. Computational Studies: Cisplatin."}, {"ArticleIdList": {"ArticleId": {"#text": "7834738", "@IdType": "pubmed"}}, "Citation": "Marshall CJ. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell. 1995;80:179\u2013185."}, {"ArticleIdList": {"ArticleId": {"#text": "12115731", "@IdType": "pubmed"}}, "Citation": "Martindale JL, Holbrook NJ. Cellular response to oxidative stress: signaling for suicide and survival. J.Cell Physiol. 2002;192:1\u201315."}, {"ArticleIdList": {"ArticleId": {"#text": "23457933", "@IdType": "pubmed"}}, "Citation": "Matsuki M, Takahashi A, Katou S, Takayanagi A, Takagi Y, Kamata K. [Pathological complete response to gemcitabine and cisplatin chemotherapy for advanced upper tract urothelial carcinoma: a case report]. Nihon Hinyokika Gakkai Zasshi. 2013;104:33\u201337."}, {"ArticleIdList": {"ArticleId": {"#text": "2569287", "@IdType": "pubmed"}}, "Citation": "McGuire WP, Rowinsky EK, Rosenshein NB, Grumbine FC, Ettinger DS, Armstrong DK, Donehower RC. Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. Ann.Intern.Med. 1989;111:273\u2013279."}, {"ArticleIdList": {"ArticleId": {"#text": "7494563", "@IdType": "pubmed"}}, "Citation": "McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY, Clarke-Pearson DL, Davidson M. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N.Engl.J.Med. 1996;334:1\u20136."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3593556", "@IdType": "pmc"}, {"#text": "23370212", "@IdType": "pubmed"}]}, "Citation": "Meng F, Sun G, Zhong M, Yu Y, Brewer MA. Anticancer efficacy of cisplatin and trichostatin A or 5-aza-2'-deoxycytidine on ovarian cancer. Br.J.Cancer. 2013;108:579\u2013586."}, {"ArticleIdList": {"ArticleId": {"#text": "23393334", "@IdType": "pubmed"}}, "Citation": "Milczarek M, Rosinska S, Psurski M, Maciejewska M, Kutner A, Wietrzyk J. Combined colonic cancer treatment with vitamin D analogs and irinotecan or oxaliplatin. Anticancer Res. 2013;33:433\u2013444."}, {"ArticleIdList": {"ArticleId": {"#text": "23239809", "@IdType": "pubmed"}}, "Citation": "Minami D, Takigawa N, Takeda H, Takata M, Ochi N, Ichihara E, Hisamoto A, Hotta K, Tanimoto M, Kiura K. Synergistic effect of olaparib with combination of cisplatin on PTEN-deficient lung cancer cells. Mol.Cancer Res. 2013;11:140\u2013148."}, {"ArticleIdList": {"ArticleId": {"#text": "8094466", "@IdType": "pubmed"}}, "Citation": "Murphy WK, Fossella FV, Winn RJ, Shin DM, Hynes HE, Gross HM, Davilla E, Leimert J, Dhingra H, Raber MN. Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer. J.Natl.Cancer Inst. 1993;85:384\u2013388."}, {"ArticleIdList": {"ArticleId": {"#text": "15798098", "@IdType": "pubmed"}}, "Citation": "Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr.Rev. 2005;26:662\u2013687."}, {"ArticleIdList": {"ArticleId": {"#text": "10535754", "@IdType": "pubmed"}}, "Citation": "Natarajan G, Malathi R, Holler E. Increased DNA-binding activity of cis-1,1-cyclobutanedicarboxylatodiammineplatinum(II) (carboplatin) in the presence of nucleophiles and human breast cancer MCF-7 cell cytoplasmic extracts: activation theory revisited. Biochem.Pharmacol. 1999;58:1625\u20131629."}, {"ArticleIdList": {"ArticleId": {"#text": "14751677", "@IdType": "pubmed"}}, "Citation": "Naziroglu M, Karaoglu A, Aksoy AO. Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats. Toxicology. 2004;195:221\u2013230."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2362240", "@IdType": "pmc"}, {"#text": "10098743", "@IdType": "pubmed"}]}, "Citation": "Nehme A, Baskaran R, Nebel S, Fink D, Howell SB, Wang JY, Christen RD. Induction of JNK and c-Abl signalling by cisplatin and oxaliplatin in mismatch repair-proficient and -deficient cells. Br.J.Cancer. 1999;79:1104\u20131110."}, {"ArticleIdList": {"ArticleId": {"#text": "22110201", "@IdType": "pubmed"}}, "Citation": "Nessa MU, Beale P, Chan C, Yu JQ, Huq F. Synergism from combinations of cisplatin and oxaliplatin with quercetin and thymoquinone in human ovarian tumour models. Anticancer Res. 2011;31:3789\u20133797."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC1223206", "@IdType": "pmc"}, {"#text": "12495431", "@IdType": "pubmed"}]}, "Citation": "Newton AC. Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm. Biochem.J. 2003;370:361\u2013371."}, {"Citation": "Nikolov GS, Trendafilova N, Sch+\u00a6nenberger H, Gust R, Kritzenberger J, Yersin H. Molecular mechanical and quantum chemical study on the species involved in the hydrolysis of cis-diamminedichloroplatinum(II) and substituted bis(ethylenediamine)dichloroplatinum(II) complexes Part I. Reactants and products. Inorganica Chimica Acta. 1994;217:159\u2013170."}, {"ArticleIdList": {"ArticleId": {"#text": "1411571", "@IdType": "pubmed"}}, "Citation": "Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science. 1992;258:607\u2013614."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC1948818", "@IdType": "pmc"}, {"#text": "12218054", "@IdType": "pubmed"}]}, "Citation": "Nowak G. Protein kinase C-alpha and ERK1/2 mediate mitochondrial dysfunction, decreases in active Na+ transport, and cisplatin-induced apoptosis in renal cells. J.Biol.Chem. 2002;277:43377\u201343388."}, {"ArticleIdList": {"ArticleId": {"#text": "9916986", "@IdType": "pubmed"}}, "Citation": "Nunez G, Benedict MA, Hu Y, Inohara N. Caspases: the proteases of the apoptotic pathway. Oncogene. 1998;17:3237\u20133245."}, {"ArticleIdList": {"ArticleId": {"#text": "16396982", "@IdType": "pubmed"}}, "Citation": "Ohta T, Ohmichi M, Hayasaka T, Mabuchi S, Saitoh M, Kawagoe J, Takahashi K, Igarashi H, Du B, Doshida M, Mirei IG, Motoyama T, Tasaka K, Kurachi H. Inhibition of phosphatidylinositol 3-kinase increases efficacy of cisplatin in in vivo ovarian cancer models. Endocrinology. 2006;147:1761\u20131769."}, {"ArticleIdList": {"ArticleId": {"#text": "17593552", "@IdType": "pubmed"}}, "Citation": "Ozben T. Oxidative stress and apoptosis: impact on cancer therapy. J.Pharm.Sci. 2007;96:2181\u20132196."}, {"Citation": "Pavankumar PNV, Seetharamulu P, Yao S, Saxe JD, Reddy DG, Hausheer FH. Comprehensive ab initio quantum mechanical and molecular orbital (MO) analysis of cisplatin: Structure, bonding, charge density, and vibrational frequencies. J.Comput.Chem. 1999;20:365\u2013382."}, {"ArticleIdList": {"ArticleId": {"#text": "15761078", "@IdType": "pubmed"}}, "Citation": "Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J.Clin. 2005;55:74\u2013108."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2111958", "@IdType": "pmc"}, {"#text": "6118377", "@IdType": "pubmed"}]}, "Citation": "Parness J, Horwitz SB. Taxol binds to polymerized tubulin in vitro. J.Cell Biol. 1981;91:479\u2013487."}, {"ArticleIdList": {"ArticleId": {"#text": "10353733", "@IdType": "pubmed"}}, "Citation": "Persons DL, Yazlovitskaya EM, Cui W, Pelling JC. Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin. Clin.Cancer Res. 1999;5:1007\u20131014."}, {"ArticleIdList": {"ArticleId": {"#text": "18506026", "@IdType": "pubmed"}}, "Citation": "Pignon JP, Tribodet H, Scagliotti GV, Douillard JY, Shepherd FA, Stephens RJ, Dunant A, Torri V, Rosell R, Seymour L, Spiro SG, Rolland E, Fossati R, Aubert D, Ding K, Waller D, Le CT. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J.Clin.Oncol. 2008;26:3552\u20133559."}, {"ArticleIdList": {"ArticleId": {"#text": "23433853", "@IdType": "pubmed"}}, "Citation": "Pinto-Leite R, Arantes-Rodrigues R, Palmeira C, Colaco B, Lopes C, Colaco A, Costa C, da Silva VM, Oliveira P, Santos L. Everolimus combined with cisplatin has a potential role in treatment of urothelial bladder cancer. Biomed.Pharmacother. 2013;67:116\u2013121."}, {"ArticleIdList": {"ArticleId": {"#text": "16865238", "@IdType": "pubmed"}}, "Citation": "Previati M, Lanzoni I, Corbacella E, Magosso S, Guaran V, Martini A, Capitani S. Cisplatin-induced apoptosis in human promyelocytic leukemia cells. Int.J.Mol.Med. 2006;18:511\u2013516."}, {"ArticleIdList": {"ArticleId": {"#text": "19754416", "@IdType": "pubmed"}}, "Citation": "Rodriguez-Fernandez E, Manzano JL, Alonso A, Almendral MJ, Perez-Andres M, Orfao A, Criado JJ. Fluorescent cisplatin analogues and cytotoxic activity. Curr.Med.Chem. 2009;16:4314\u20134327."}, {"ArticleIdList": {"ArticleId": {"#text": "14287410", "@IdType": "pubmed"}}, "Citation": "Rosenberg b., vancamp l., krigas t. Inhibition of cell division in escherichia coli by electrolysis products from a platinum electrode. Nature. 1965;205:698\u2013699."}, {"ArticleIdList": {"ArticleId": {"#text": "15659050", "@IdType": "pubmed"}}, "Citation": "Saad SY, Najjar TA, Alashari M. Role of non-selective adenosine receptor blockade and phosphodiesterase inhibition in cisplatin-induced nephrogonadal toxicity in rats. Clin.Exp.Pharmacol.Physiol. 2004;31:862\u2013867."}, {"ArticleIdList": {"ArticleId": {"#text": "15077141", "@IdType": "pubmed"}}, "Citation": "Salvesen GS, Abrams JM. Caspase activation - stepping on the gas or releasing the brakes? Lessons from humans and flies. Oncogene. 2004;23:2774\u20132784."}, {"ArticleIdList": {"ArticleId": {"#text": "9390553", "@IdType": "pubmed"}}, "Citation": "Salvesen GS, Dixit VM. Caspases: intracellular signaling by proteolysis. Cell. 1997;91:443\u2013446."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC1351372", "@IdType": "pmc"}, {"#text": "16434701", "@IdType": "pubmed"}]}, "Citation": "Saramaki A, Banwell CM, Campbell MJ, Carlberg C. Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor. Nucleic Acids Res. 2006;34:543\u2013554."}, {"ArticleIdList": {"ArticleId": {"#text": "1376773", "@IdType": "pubmed"}}, "Citation": "Sarosy G, Kohn E, Stone DA, Rothenberg M, Jacob J, Adamo DO, Ognibene FP, Cunnion RE, Reed E. Phase I study of taxol and granulocyte colony-stimulating factor in patients with refractory ovarian cancer. J.Clin.Oncol. 1992;10:1165\u20131170."}, {"ArticleIdList": {"ArticleId": {"#text": "1433578", "@IdType": "pubmed"}}, "Citation": "Scher HI. A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. J.Urol. 1992;148:1625\u20131626."}, {"ArticleIdList": {"ArticleId": {"#text": "24800467", "@IdType": "pubmed"}}, "Citation": "Shaili E. Platinum anticancer drugs and photochemotherapeutic agents: recent advances and future developments. Sci.Prog. 2014;97:20\u201340."}, {"ArticleIdList": {"ArticleId": {"#text": "15385639", "@IdType": "pubmed"}}, "Citation": "Shen DW, Liang XJ, Gawinowicz MA, Gottesman MM. Identification of cytoskeletal [14C]carboplatin-binding proteins reveals reduced expression and disorganization of actin and filamin in cisplatin-resistant cell lines. Mol.Pharmacol. 2004;66:789\u2013793."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC1409811", "@IdType": "pmc"}, {"#text": "16394183", "@IdType": "pubmed"}]}, "Citation": "Shen DW, Liang XJ, Suzuki T, Gottesman MM. Identification by functional cloning from a retroviral cDNA library of cDNAs for ribosomal protein L36 and the 10-kDa heat shock protein that confer cisplatin resistance. Mol.Pharmacol. 2006;69:1383\u20131388."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3400836", "@IdType": "pmc"}, {"#text": "22659329", "@IdType": "pubmed"}]}, "Citation": "Shen DW, Pouliot LM, Hall MD, Gottesman MM. Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes. Pharmacol.Rev. 2012;64:706\u2013721."}, {"ArticleIdList": {"ArticleId": {"#text": "24752576", "@IdType": "pubmed"}}, "Citation": "Shi X, Wu S, Yang Y, Tang L, Wang Y, Dong J, Lu B, Jiang G, Zhao W. AQP5 silencing suppresses p38 MAPK signaling and improves drug resistance in colon cancer cells. Tumour.Biol. 2014 [Epub ahead of print]"}, {"ArticleIdList": {"ArticleId": {"#text": "21566064", "@IdType": "pubmed"}}, "Citation": "Shrivastava A, Kuzontkoski PM, Groopman JE, Prasad A. Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy. Mol.Cancer Ther. 2011;10:1161\u20131172."}, {"ArticleIdList": {"ArticleId": {"#text": "14576837", "@IdType": "pubmed"}}, "Citation": "Siddik ZH. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene. 2003;22:7265\u20137279."}, {"ArticleIdList": {"ArticleId": {"#text": "11497279", "@IdType": "pubmed"}}, "Citation": "Siwinska A, Opolski A, Chrobak A, Wietrzyk J, Wojdat E, Kutner A, Szelejewski W, Radzikowski C. Potentiation of the antiproliferative effect in vitro of doxorubicin, cisplatin and genistein by new analogues of vitamin D. Anticancer Res. 2001;21:1925\u20131929."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4037830", "@IdType": "pmc"}, {"#text": "24786604", "@IdType": "pubmed"}]}, "Citation": "Skvortsov S, Dudas J, Eichberger P, Witsch-Baumgartner M, Loeffler-Ragg J, Pritz C, Schartinger VH, Maier H, Hall J, Debbage P, Riechelmann H, Lukas P, Skvortsova I. Rac1 as a potential therapeutic target for chemo-radioresistant head and neck squamous cell carcinomas (HNSCC). Br.J.Cancer. 2014;110(11):2677\u20132687."}, {"ArticleIdList": {"ArticleId": {"#text": "18306929", "@IdType": "pubmed"}}, "Citation": "Smith L, Welham KJ, Watson MB, Drew PJ, Lind MJ, Cawkwell L. The proteomic analysis of cisplatin resistance in breast cancer cells. Oncol.Res. 2007;16:497\u2013506."}, {"ArticleIdList": {"ArticleId": {"#text": "24748236", "@IdType": "pubmed"}}, "Citation": "Song YD, Zhang KF, Liu D, Guo YQ, Wang DY, Cui MY, Li G, Sun YX, Shen JH, Li XG, Zhang L, Shi FJ. Inhibition of EGFR-induced glucose metabolism sensitizes chondrosarcoma cells to cisplatin. Tumour.Biol. 2014 [Epub ahead of print]"}, {"ArticleIdList": {"ArticleId": {"#text": "19269895", "@IdType": "pubmed"}}, "Citation": "Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10:459\u2013466."}, {"ArticleIdList": {"ArticleId": {"#text": "15758009", "@IdType": "pubmed"}}, "Citation": "Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N.Engl.J.Med. 2005;352:987\u2013996."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2814351", "@IdType": "pmc"}, {"#text": "20126471", "@IdType": "pubmed"}]}, "Citation": "Tang MK, Zhou HY, Yam JW, Wong AS. c-Met overexpression contributes to the acquired apoptotic resistance of nonadherent ovarian cancer cells through a cross talk mediated by phosphatidylinositol 3-kinase and extracellular signal-regulated kinase 1/2. Neoplasia. 2010;12:128\u2013138."}, {"Citation": "[3/21/14]; The chemical book data base  http://www.chemicalbook.com/ProductIndex_EN.aspxand search on product details."}, {"ArticleIdList": {"ArticleId": {"#text": "19826112", "@IdType": "pubmed"}}, "Citation": "Tsimberidou AM, Braiteh F, Stewart DJ, Kurzrock R. Ultimate fate of oncology drugs approved by the us food and drug administration without a randomized Trial. J.Clin.Oncol. 2009;27:6243\u20136250."}, {"ArticleIdList": {"ArticleId": {"#text": "20375404", "@IdType": "pubmed"}}, "Citation": "Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, Madhusudan S, Iveson T, Hughes S, Pereira SP, Roughton M, Bridgewater J. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N.Engl.J.Med. 2010;362:1273\u20131281."}, {"ArticleIdList": {"ArticleId": {"#text": "9761114", "@IdType": "pubmed"}}, "Citation": "Vargas-Roig LM, Gago FE, Tello O, Aznar JC, Ciocca DR. Heat shock protein expression and drug resistance in breast cancer patients treated with induction chemotherapy. Int.J.Cancer. 1998;79:468\u2013475."}, {"ArticleIdList": {"ArticleId": {"#text": "16034041", "@IdType": "pubmed"}}, "Citation": "von der MH, Sengelov L, Roberts JT, Ricci S, Dogliotti L, Oliver T, Moore MJ, Zimmermann A, Arning M. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer. J.Clin.Oncol. 2005;23:4602\u20134608."}, {"ArticleIdList": {"ArticleId": {"#text": "15789122", "@IdType": "pubmed"}}, "Citation": "Wang D, Lippard SJ. Cellular processing of platinum anticancer drugs. Nat.Rev.Drug Discov. 2005;4:307\u2013320."}, {"ArticleIdList": {"ArticleId": {"#text": "24333218", "@IdType": "pubmed"}}, "Citation": "Wang H, Zhang G, Zhang H, Zhang F, Zhou B, Ning F, Wang HS, Cai SH, Du J. Acquisition of epithelial-mesenchymal transition phenotype and cancer stem cell-like properties in cisplatin-resistant lung cancer cells through AKT/beta-catenin/Snail signaling pathway. Eur.J.Pharmacol. 2014;723:156\u2013166."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4059157", "@IdType": "pmc"}, {"#text": "24794870", "@IdType": "pubmed"}]}, "Citation": "Wang J, Wu GS. Role of autophagy in cisplatin resistance in ovarian cancer cells. J.Biol.Chem. 2014 [Epub ahead of print]"}, {"ArticleIdList": {"ArticleId": {"#text": "10993883", "@IdType": "pubmed"}}, "Citation": "Wang X, Martindale JL, Holbrook NJ. Requirement for ERK activation in cisplatin-induced apoptosis. J.Biol.Chem. 2000;275:39435\u201339443."}, {"ArticleIdList": {"ArticleId": {"#text": "7693428", "@IdType": "pubmed"}}, "Citation": "Weiss RB, Christian MC. New cisplatin analogues in development. A review. Drugs. 1993;46:360\u2013377."}, {"ArticleIdList": {"ArticleId": {"#text": "16785992", "@IdType": "pubmed"}}, "Citation": "Winograd-Katz SE, Levitzki A. Cisplatin induces PKB/Akt activation and p38(MAPK) phosphorylation of the EGF receptor. Oncogene. 2006;25:7381\u20137390."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3570148", "@IdType": "pmc"}, {"#text": "23404433", "@IdType": "pubmed"}]}, "Citation": "Xu XM, Zhang Y, Qu D, Liu HB, Gu X, Jiao GY, Zhao L. Combined anticancer activity of osthole and cisplatin in NCI-H460 lung cancer cells in vitro. Exp.Ther.Med. 2013;5:707\u2013710."}, {"ArticleIdList": {"ArticleId": {"#text": "17700201", "@IdType": "pubmed"}}, "Citation": "Yao X, Panichpisal K, Kurtzman N, Nugent K. Cisplatin nephrotoxicity: a review. Am.J.Med.Sci. 2007;334:115\u2013124."}, {"ArticleIdList": {"ArticleId": {"#text": "11996883", "@IdType": "pubmed"}}, "Citation": "Yeh PY, Chuang SE, Yeh KH, Song YC, Ea CK, Cheng AL. Increase of the resistance of human cervical carcinoma cells to cisplatin by inhibition of the MEK to ERK signaling pathway partly via enhancement of anticancer drug-induced NF kappa B activation. Biochem.Pharmacol. 2002;63:1423\u20131430."}, {"ArticleIdList": {"ArticleId": {"#text": "15225672", "@IdType": "pubmed"}}, "Citation": "Yilmaz HR, Iraz M, Sogut S, Ozyurt H, Yildirim Z, Akyol O, Gergerlioglu S. The effects of erdosteine on the activities of some metabolic enzymes during cisplatin-induced nephrotoxicity in rats. Pharmacol.Res. 2004;50:287\u2013290."}, {"ArticleIdList": {"ArticleId": {"#text": "15986578", "@IdType": "pubmed"}}, "Citation": "Yilmaz HR, Sogut S, Ozyurt B, Ozugurlu F, Sahin S, Isik B, Uz E, Ozyurt H. The activities of liver adenosine deaminase, xanthine oxidase, catalase, superoxide dismutase enzymes and the levels of malondialdehyde and nitric oxide after cisplatin toxicity in rats: protective effect of caffeic acid phenethyl ester. Toxicol.Ind.Health. 2005;21:67\u201373."}, {"ArticleIdList": {"ArticleId": {"#text": "18670299", "@IdType": "pubmed"}}, "Citation": "Youlden DR, Cramb SM, Baade PD. The International Epidemiology of Lung Cancer: geographical distribution and secular trends. J.Thorac.Oncol. 2008;3:819\u2013831."}, {"ArticleIdList": {"ArticleId": {"#text": "19425235", "@IdType": "pubmed"}}, "Citation": "Yousef MI, Saad AA, El-Shennawy LK. Protective effect of grape seed proanthocyanidin extract against oxidative stress induced by cisplatin in rats. Food Chem.Toxicol. 2009;47:1176\u20131183."}, {"ArticleIdList": {"ArticleId": {"#text": "11562220", "@IdType": "pubmed"}}, "Citation": "Zhang Y, Guo Z, You XZ. Hydrolysis Theory for Cisplatin and Its Analogues Based on Density Functional Studies. J.Am.Chem.Soc. 2001;123:9378\u20139387."}]}}}}}, "PMC": "PMC4146684", "PMID": "25058905", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "Cisplatin in cancer therapy: molecular mechanisms of action.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "45": {"Abstract": "Tumor-associated macrophages (TAMs) are major components of the tumor microenvironment (TME) which are closely associated with the tumor malignant progression. However, the regulatory mechanisms by which TAMs influence the progression of triple-negative breast cancer (TNBC) remain unclear. Here, we report that hepatic leukemia factor (HLF) acts as a novel oncoprotein in TNBC. We found that HLF was regulated by transforming growth factor-beta1 (TGF-\u03b21) that is secreted by TAMs. Then, HLF transactivated gamma-glutamyltransferase 1 (GGT1) to promote the ferroptosis resistance, thus driving TNBC cell proliferation, metastasis and cisplatin resistance. Reciprocally, IL-6 produced by TNBC cells activated the JAK2/STAT3 axis to induce TGF-\u03b21 secretion by TAMs, thus constituted a feed-forward circuit. The accuracy of TNBC patient prognosis could be improved by employing a combination of HLF and GGT1 values. Thus, our findings document that the interactive dialogue between TNBC cells and TAMs promotes sustained activation of HLF in tumor cells through the IL-6-TGF-\u03b21 axis. Subsequently, HLF promotes the ferroptosis resistance in TNBC cells via GGT1 and ultimately facilitates the malignant tumor progression. Our study provides a potential target for the treatment of TNBC.", "Authors": [{"Affiliations": [{"Has_Extra": true, "HashID": "-8677154081965349607", "Part1": "Department of Breast and Thyroid Surgery", "Part2": "Changhai Hospital", "Part3": "Naval Military Medical University", "Part4": "230 Changhai Road", "Part5": "Shanghai", "Part6": "200433", "Text": "Department of Breast and Thyroid Surgery, Changhai Hospital, Naval Military Medical University, 230 Changhai Road, Shanghai, 200433, China. lhy@smmu.edu.cn."}], "ForeName": "Hengyu", "FullName": "Hengyu Li", "HashID": "739784102271441891", "LastName": "Li", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-5563456444480565075", "Part1": "Department of Hepatic Surgery", "Part2": "Third Affiliated Hospital of Naval Military Medical University", "Part3": "Shanghai", "Part4": "200438", "Part5": "China.", "Part6": null, "Text": "Department of Hepatic Surgery, Third Affiliated Hospital of Naval Military Medical University, Shanghai, 200438, China."}], "ForeName": "Pinghua", "FullName": "Pinghua Yang", "HashID": "9005990699643048652", "LastName": "Yang", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-5563456444480565075", "Part1": "Department of Hepatic Surgery", "Part2": "Third Affiliated Hospital of Naval Military Medical University", "Part3": "Shanghai", "Part4": "200438", "Part5": "China.", "Part6": null, "Text": "Department of Hepatic Surgery, Third Affiliated Hospital of Naval Military Medical University, Shanghai, 200438, China."}, {"Has_Extra": true, "HashID": "2012408743878427401", "Part1": "Department of Hepatobiliary Surgery", "Part2": "East Hospital", "Part3": "School of Medicine", "Part4": "Tongji University", "Part5": "Shanghai", "Part6": "200120", "Text": "Department of Hepatobiliary Surgery, East Hospital, School of Medicine, Tongji University, Shanghai, 200120, China."}], "ForeName": "JingHan", "FullName": "JingHan Wang", "HashID": "-9033268822215554939", "LastName": "Wang", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-5563456444480565075", "Part1": "Department of Hepatic Surgery", "Part2": "Third Affiliated Hospital of Naval Military Medical University", "Part3": "Shanghai", "Part4": "200438", "Part5": "China.", "Part6": null, "Text": "Department of Hepatic Surgery, Third Affiliated Hospital of Naval Military Medical University, Shanghai, 200438, China."}], "ForeName": "Jin", "FullName": "Jin Zhang", "HashID": "9178443459990680361", "LastName": "Zhang", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-1762838310904395328", "Part1": "Department of Urology Surgery", "Part2": "Changhai Hospital", "Part3": "Naval Military Medical University", "Part4": "Shanghai", "Part5": "200433", "Part6": "China.", "Text": "Department of Urology Surgery, Changhai Hospital, Naval Military Medical University, Shanghai, 200433, China."}], "ForeName": "Qianyun", "FullName": "Qianyun Ma", "HashID": "7004664880017712752", "LastName": "Ma", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-7844830128562478644", "Part1": "Department of Pathology", "Part2": "Changhai Hospital", "Part3": "Naval Military Medical University", "Part4": "Shanghai", "Part5": "200433", "Part6": "China.", "Text": "Department of Pathology, Changhai Hospital, Naval Military Medical University, Shanghai, 200433, China."}], "ForeName": "Yingjie", "FullName": "Yingjie Jiang", "HashID": "-2031986457805063860", "LastName": "Jiang", "ORCID": null}, {"Affiliations": [{"Has_Extra": true, "HashID": "-8677154081965349607", "Part1": "Department of Breast and Thyroid Surgery", "Part2": "Changhai Hospital", "Part3": "Naval Military Medical University", "Part4": "230 Changhai Road", "Part5": "Shanghai", "Part6": "200433", "Text": "Department of Breast and Thyroid Surgery, Changhai Hospital, Naval Military Medical University, 230 Changhai Road, Shanghai, 200433, China."}], "ForeName": "Yani", "FullName": "Yani Wu", "HashID": "8511702322751692708", "LastName": "Wu", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-2140567556634133332", "Part1": "Department of Oncology", "Part2": "The First Affiliated Hospital of China Medical University", "Part3": "155 Nanjing North Street", "Part4": "Shenyang", "Part5": "110001", "Part6": "China. than1984@sina.com.", "Text": "Department of Oncology, The First Affiliated Hospital of China Medical University, 155 Nanjing North Street, Shenyang, 110001, China. than1984@sina.com."}], "ForeName": "Tao", "FullName": "Tao Han", "HashID": "49425662595573797", "LastName": "Han", "ORCID": null}, {"Affiliations": [{"Has_Extra": true, "HashID": "5080959469781541945", "Part1": "State Key Laboratory of Oncogenes and Related Genes", "Part2": "Shanghai Cancer Institute", "Part3": "Renji Hospital", "Part4": "Shanghai Jiao Tong University School of Medicine", "Part5": "No. 25", "Part6": "Lane 2200", "Text": "State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, No. 25, Lane 2200, Xietu Road, Shanghai, 200127, China. xdm20079@126.com."}], "ForeName": "Daimin", "FullName": "Daimin Xiang", "HashID": "875002683265508773", "LastName": "Xiang", "ORCID": "0000-0002-1386-8082"}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.1186/s13045-021-01223-x", "InsertType": null, "Journal": "Journal of hematology & oncology", "Keywords": [{"IS_Major": false, "IS_Mesh": true, "Text": "Antineoplastic Agents"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Basic-Leucine Zipper Transcription Factors"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Drug Resistance, Neoplasm"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Female"}, {"IS_Major": true, "IS_Mesh": true, "Text": "Ferroptosis"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Humans"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Triple Negative Breast Neoplasms"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Tumor Microenvironment"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Tumor-Associated Macrophages"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Ferroptosis"}, {"IS_Major": false, "IS_Mesh": false, "Text": "GGT1"}, {"IS_Major": false, "IS_Mesh": false, "Text": "TGF-\u03b21/SMAD3/HLF/IL-6/JAK2/STAT3 pathway"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Triple-negative breast cancer"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Tumor-associated macrophages"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "MEDLINE", "Article": {"@PubModel": "Electronic", "Abstract": {"AbstractText": "Tumor-associated macrophages (TAMs) are major components of the tumor microenvironment (TME) which are closely associated with the tumor malignant progression. However, the regulatory mechanisms by which TAMs influence the progression of triple-negative breast cancer (TNBC) remain unclear. Here, we report that hepatic leukemia factor (HLF) acts as a novel oncoprotein in TNBC. We found that HLF was regulated by transforming growth factor-beta1 (TGF-\u03b21) that is secreted by TAMs. Then, HLF transactivated gamma-glutamyltransferase 1 (GGT1) to promote the ferroptosis resistance, thus driving TNBC cell proliferation, metastasis and cisplatin resistance. Reciprocally, IL-6 produced by TNBC cells activated the JAK2/STAT3 axis to induce TGF-\u03b21 secretion by TAMs, thus constituted a feed-forward circuit. The accuracy of TNBC patient prognosis could be improved by employing a combination of HLF and GGT1 values. Thus, our findings document that the interactive dialogue between TNBC cells and TAMs promotes sustained activation of HLF in tumor cells through the IL-6-TGF-\u03b21 axis. Subsequently, HLF promotes the ferroptosis resistance in TNBC cells via GGT1 and ultimately facilitates the malignant tumor progression. Our study provides a potential target for the treatment of TNBC.", "CopyrightInformation": "\u00a9 2022. The Author(s)."}, "ArticleDate": {"@DateType": "Electronic", "Day": "06", "Month": "01", "Year": "2022"}, "ArticleTitle": "HLF regulates ferroptosis, development and chemoresistance of triple-negative breast cancer by activating tumor cell-macrophage crosstalk.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@EqualContrib": "Y", "@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Breast and Thyroid Surgery, Changhai Hospital, Naval Military Medical University, 230 Changhai Road, Shanghai, 200433, China. lhy@smmu.edu.cn."}, "ForeName": "Hengyu", "Initials": "H", "LastName": "Li"}, {"@EqualContrib": "Y", "@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Hepatic Surgery, Third Affiliated Hospital of Naval Military Medical University, Shanghai, 200438, China."}, "ForeName": "Pinghua", "Initials": "P", "LastName": "Yang"}, {"@EqualContrib": "Y", "@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of Hepatic Surgery, Third Affiliated Hospital of Naval Military Medical University, Shanghai, 200438, China."}, {"Affiliation": "Department of Hepatobiliary Surgery, East Hospital, School of Medicine, Tongji University, Shanghai, 200120, China."}], "ForeName": "JingHan", "Initials": "J", "LastName": "Wang"}, {"@EqualContrib": "Y", "@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Hepatic Surgery, Third Affiliated Hospital of Naval Military Medical University, Shanghai, 200438, China."}, "ForeName": "Jin", "Initials": "J", "LastName": "Zhang"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Urology Surgery, Changhai Hospital, Naval Military Medical University, Shanghai, 200433, China."}, "ForeName": "Qianyun", "Initials": "Q", "LastName": "Ma"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Pathology, Changhai Hospital, Naval Military Medical University, Shanghai, 200433, China."}, "ForeName": "Yingjie", "Initials": "Y", "LastName": "Jiang"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Breast and Thyroid Surgery, Changhai Hospital, Naval Military Medical University, 230 Changhai Road, Shanghai, 200433, China."}, "ForeName": "Yani", "Initials": "Y", "LastName": "Wu"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Oncology, The First Affiliated Hospital of China Medical University, 155 Nanjing North Street, Shenyang, 110001, China. than1984@sina.com."}, "ForeName": "Tao", "Initials": "T", "LastName": "Han"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, No. 25, Lane 2200, Xietu Road, Shanghai, 200127, China. xdm20079@126.com."}, "ForeName": "Daimin", "Identifier": {"#text": "0000-0002-1386-8082", "@Source": "ORCID"}, "Initials": "D", "LastName": "Xiang"}]}, "ELocationID": [{"#text": "2", "@EIdType": "pii", "@ValidYN": "Y"}, {"#text": "10.1186/s13045-021-01223-x", "@EIdType": "doi", "@ValidYN": "Y"}], "Journal": {"ISOAbbreviation": "J Hematol Oncol", "ISSN": {"#text": "1756-8722", "@IssnType": "Electronic"}, "JournalIssue": {"@CitedMedium": "Internet", "Issue": "1", "PubDate": {"Day": "06", "Month": "Jan", "Year": "2022"}, "Volume": "15"}, "Title": "Journal of hematology & oncology"}, "Language": "eng", "Pagination": {"MedlinePgn": "2", "StartPage": "2"}, "PublicationTypeList": {"PublicationType": [{"#text": "Letter", "@UI": "D016422"}, {"#text": "Research Support, Non-U.S. Gov't", "@UI": "D013485"}]}}, "ChemicalList": {"Chemical": [{"NameOfSubstance": {"#text": "Antineoplastic Agents", "@UI": "D000970"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "Basic-Leucine Zipper Transcription Factors", "@UI": "D050976"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "HLF protein, human", "@UI": "C490671"}, "RegistryNumber": "0"}]}, "CitationSubset": "IM", "CoiStatement": "No potential competing interest was disclosed.", "DateCompleted": {"Day": "15", "Month": "02", "Year": "2022"}, "DateRevised": {"Day": "15", "Month": "02", "Year": "2022"}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"#text": "Ferroptosis", "@MajorTopicYN": "N"}, {"#text": "GGT1", "@MajorTopicYN": "N"}, {"#text": "TGF-\u03b21/SMAD3/HLF/IL-6/JAK2/STAT3 pathway", "@MajorTopicYN": "N"}, {"#text": "Triple-negative breast cancer", "@MajorTopicYN": "N"}, {"#text": "Tumor-associated macrophages", "@MajorTopicYN": "N"}]}, "MedlineJournalInfo": {"Country": "England", "ISSNLinking": "1756-8722", "MedlineTA": "J Hematol Oncol", "NlmUniqueID": "101468937"}, "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"#text": "Antineoplastic Agents", "@MajorTopicYN": "N", "@UI": "D000970"}, "QualifierName": [{"#text": "pharmacology", "@MajorTopicYN": "N", "@UI": "Q000494"}, {"#text": "therapeutic use", "@MajorTopicYN": "N", "@UI": "Q000627"}]}, {"DescriptorName": {"#text": "Basic-Leucine Zipper Transcription Factors", "@MajorTopicYN": "N", "@UI": "D050976"}, "QualifierName": [{"#text": "analysis", "@MajorTopicYN": "N", "@UI": "Q000032"}, {"#text": "metabolism", "@MajorTopicYN": "Y", "@UI": "Q000378"}]}, {"DescriptorName": {"#text": "Drug Resistance, Neoplasm", "@MajorTopicYN": "N", "@UI": "D019008"}}, {"DescriptorName": {"#text": "Female", "@MajorTopicYN": "N", "@UI": "D005260"}}, {"DescriptorName": {"#text": "Ferroptosis", "@MajorTopicYN": "Y", "@UI": "D000079403"}, "QualifierName": {"#text": "drug effects", "@MajorTopicYN": "N", "@UI": "Q000187"}}, {"DescriptorName": {"#text": "Humans", "@MajorTopicYN": "N", "@UI": "D006801"}}, {"DescriptorName": {"#text": "Triple Negative Breast Neoplasms", "@MajorTopicYN": "N", "@UI": "D064726"}, "QualifierName": [{"#text": "drug therapy", "@MajorTopicYN": "N", "@UI": "Q000188"}, {"#text": "metabolism", "@MajorTopicYN": "N", "@UI": "Q000378"}, {"#text": "pathology", "@MajorTopicYN": "Y", "@UI": "Q000473"}]}, {"DescriptorName": {"#text": "Tumor Microenvironment", "@MajorTopicYN": "N", "@UI": "D059016"}, "QualifierName": {"#text": "drug effects", "@MajorTopicYN": "N", "@UI": "Q000187"}}, {"DescriptorName": {"#text": "Tumor-Associated Macrophages", "@MajorTopicYN": "N", "@UI": "D000084582"}, "QualifierName": [{"#text": "drug effects", "@MajorTopicYN": "N", "@UI": "Q000187"}, {"#text": "metabolism", "@MajorTopicYN": "N", "@UI": "Q000378"}, {"#text": "pathology", "@MajorTopicYN": "Y", "@UI": "Q000473"}]}]}, "PMID": {"#text": "34991659", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "34991659", "@IdType": "pubmed"}, {"#text": "PMC8740349", "@IdType": "pmc"}, {"#text": "10.1186/s13045-021-01223-x", "@IdType": "doi"}, {"#text": "10.1186/s13045-021-01223-x", "@IdType": "pii"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "received", "Day": "10", "Month": "9", "Year": "2021"}, {"@PubStatus": "accepted", "Day": "28", "Month": "12", "Year": "2021"}, {"@PubStatus": "entrez", "Day": "7", "Hour": "5", "Minute": "47", "Month": "1", "Year": "2022"}, {"@PubStatus": "pubmed", "Day": "8", "Hour": "6", "Minute": "0", "Month": "1", "Year": "2022"}, {"@PubStatus": "medline", "Day": "16", "Hour": "6", "Minute": "0", "Month": "2", "Year": "2022"}]}, "PublicationStatus": "epublish", "ReferenceList": {"Reference": [{"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ccr.2014.03.021", "@IdType": "doi"}, {"#text": "24823638", "@IdType": "pubmed"}]}, "Citation": "Su S, Liu Q, Chen J, Chen J, Chen F, He C, Huang D, Wu W, Lin L, Huang W, et al. A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis. Cancer Cell. 2014;25:605\u2013620. doi: 10.1016/j.ccr.2014.03.021."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12943-019-0976-4", "@IdType": "doi"}, {"#text": "PMC6441214", "@IdType": "pmc"}, {"#text": "30927925", "@IdType": "pubmed"}]}, "Citation": "Wei C, Yang C, Wang S, Shi D, Zhang C, Lin X, Liu Q, Dou R, Xiong B. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis. Mol Cancer. 2019;18:64. doi: 10.1186/s12943-019-0976-4."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/1078-0432.CCR-17-1283", "@IdType": "doi"}, {"#text": "28928161", "@IdType": "pubmed"}]}, "Citation": "Yin Y, Yao S, Hu Y, Feng Y, Li M, Bian Z, Zhang J, Qin Y, Qi X, Zhou L, et al. The immune-microenvironment confers chemoresistance of colorectal cancer through macrophage-derived IL6. Clin Cancer Res. 2017;23:7375\u20137387. doi: 10.1158/1078-0432.CCR-17-1283."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/0008-5472.CAN-17-3841", "@IdType": "doi"}, {"#text": "29880482", "@IdType": "pubmed"}]}, "Citation": "Wang X, Luo G, Zhang K, Cao J, Huang C, Jiang T, Liu B, Su L, Qiu Z. Hypoxic tumor-derived exosomal miR-301a mediates M2 macrophage polarization via PTEN/PI3Kgamma to promote pancreatic cancer metastasis. Cancer Res. 2018;78:4586\u20134598. doi: 10.1158/0008-5472.CAN-17-3841."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1136/gutjnl-2016-313392", "@IdType": "doi"}, {"#text": "28754776", "@IdType": "pubmed"}]}, "Citation": "Xiang D, Sun W, Ning B, Zhou T, Li X, Zhong W, Cheng Z, Xia M, Wang X, Deng X, et al. The HLF/IL-6/STAT3 feedforward circuit drives hepatic stellate cell activation to promote liver fibrosis. Gut. 2018;67:1704\u20131715. doi: 10.1136/gutjnl-2016-313392."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1136/gutjnl-2018-317440", "@IdType": "doi"}, {"#text": "31118247", "@IdType": "pubmed"}]}, "Citation": "Xiang D, Sun W, Zhou T, Zhang C, Cheng Z, Li S, Jiang W, Wang R, Fu G, Cui X, et al. Oncofetal HLF transactivates c-Jun to promote hepatocellular carcinoma development and sorafenib resistance. Gut. 2019;68:1858\u20131871. doi: 10.1136/gutjnl-2018-317440."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/1541-7786.MCR-18-1204", "@IdType": "doi"}, {"#text": "PMC6726546", "@IdType": "pmc"}, {"#text": "31151999", "@IdType": "pubmed"}]}, "Citation": "Bansal A, Sanchez DJ, Nimgaonkar V, Sanchez D, Riscal R, Skuli N, Simon MC. Gamma-glutamyltransferase 1 promotes clear cell renal cell carcinoma initiation and progression. Mol Cancer Res. 2019;17:1881\u20131892. doi: 10.1158/1541-7786.MCR-18-1204."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41467-021-21841-w", "@IdType": "doi"}, {"#text": "PMC7952727", "@IdType": "pmc"}, {"#text": "33707434", "@IdType": "pubmed"}]}, "Citation": "Zhang Y, Swanda RV, Nie L, Liu X, Wang C, Lee H, Lei G, Mao C, Koppula P, Cheng W, et al. mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation. Nat Commun. 2021;12:1589. doi: 10.1038/s41467-021-21841-w."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12885-017-3301-x", "@IdType": "doi"}, {"#text": "PMC5420129", "@IdType": "pmc"}, {"#text": "28476099", "@IdType": "pubmed"}]}, "Citation": "Kawakami K, Fujita Y, Matsuda Y, Arai T, Horie K, Kameyama K, Kato T, Masunaga K, Kasuya Y, Tanaka M, et al. Gamma-glutamyltransferase activity in exosomes as a potential marker for prostate cancer. BMC Cancer. 2017;17:316. doi: 10.1186/s12885-017-3301-x."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12943-019-0988-0", "@IdType": "doi"}, {"#text": "PMC6421700", "@IdType": "pmc"}, {"#text": "30885232", "@IdType": "pubmed"}]}, "Citation": "Weng YS, Tseng HY, Chen YA, Shen PC, Al Haq AT, Chen LM, Tung YC, Hsu HL. MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer. Mol Cancer. 2019;18:42. doi: 10.1186/s12943-019-0988-0."}]}}}}}, "PMC": "PMC8740349", "PMID": "34991659", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "HLF regulates ferroptosis, development and chemoresistance of triple-negative breast cancer by activating tumor cell-macrophage crosstalk.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "46": {"Abstract": " Increasing evidence implies the participation of long non-coding RNAs (lncRNAs) in chemoresistance to cancer treatment. Their role and molecular mechanisms in breast cancer chemoresistance, nevertheless, are yet not considerably elucidated. In this work, we research the function of small nucleolar RNA host gene 15 (SNHG15) in cisplatin (DDP) resistance of breast cancer and uncover the underlying molecular mechanism. SNHG15 and miR-381 expression levels were detected using Quantitative real-time PCR (qRT-PCR) analysis. The functional roles of SNHG15 and miR-381 in breast cancer were determined using MTT assay and flow cytometry analysis. The effect of SNHG15 on miR-381 expression was determined using Luciferase reporter assay, RNA immunoprecipitation (RIP) assay and qRT-PCR analysis. SNHG15 was found to be up-regulated in cisplatin resistant breast cancer tissues and cell lines. Breast cancer patients with high SNHG15 expression had a poor prognosis. SNHG15 silencing enhanced cisplatin sensitivity of MCF-7/DDP and MDA-MB-231/DDP cells. Additionally, SNHG15 could function as a miR-381 sponge. miR-381 overexpression could overcome cisplatin resistance. miR-381 knockdown countered SNHG15 knockdown-mediated enhancement of cisplatin sensitivity in MCF-7/DDP and MDA-MB-231/DDP cells. Besides, SNHG15 knockdown facilitated cisplatin sensitivity of cisplatin resistant breast cancer cells in vivo. In summary, SNHG15 knockdown overcame cisplatin resistance of breast cancer by sponging miR-381, providing a novel therapeutic target for breast cancer.", "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "-8937986724278213575", "Part1": "Department of Breast Surgery", "Part2": "The First Affiliated Hospital of Zhengzhou University", "Part3": "Zhengzhou 475000", "Part4": "People's Republic of China.", "Part5": null, "Part6": null, "Text": "Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 475000, People's Republic of China."}], "ForeName": "Hailong", "FullName": "Hailong Mi", "HashID": "2678550651523501331", "LastName": "Mi", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-8937986724278213575", "Part1": "Department of Breast Surgery", "Part2": "The First Affiliated Hospital of Zhengzhou University", "Part3": "Zhengzhou 475000", "Part4": "People's Republic of China.", "Part5": null, "Part6": null, "Text": "Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 475000, People's Republic of China."}], "ForeName": "Xiaochun", "FullName": "Xiaochun Wang", "HashID": "3785661634893303119", "LastName": "Wang", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-8937986724278213575", "Part1": "Department of Breast Surgery", "Part2": "The First Affiliated Hospital of Zhengzhou University", "Part3": "Zhengzhou 475000", "Part4": "People's Republic of China.", "Part5": null, "Part6": null, "Text": "Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 475000, People's Republic of China."}], "ForeName": "Fang", "FullName": "Fang Wang", "HashID": "-4577477781586970446", "LastName": "Wang", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-8937986724278213575", "Part1": "Department of Breast Surgery", "Part2": "The First Affiliated Hospital of Zhengzhou University", "Part3": "Zhengzhou 475000", "Part4": "People's Republic of China.", "Part5": null, "Part6": null, "Text": "Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 475000, People's Republic of China."}], "ForeName": "Lin", "FullName": "Lin Li", "HashID": "-7464910386757730154", "LastName": "Li", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-8937986724278213575", "Part1": "Department of Breast Surgery", "Part2": "The First Affiliated Hospital of Zhengzhou University", "Part3": "Zhengzhou 475000", "Part4": "People's Republic of China.", "Part5": null, "Part6": null, "Text": "Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 475000, People's Republic of China."}], "ForeName": "Mingzhi", "FullName": "Mingzhi Zhu", "HashID": "-8290385569778675313", "LastName": "Zhu", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-8937986724278213575", "Part1": "Department of Breast Surgery", "Part2": "The First Affiliated Hospital of Zhengzhou University", "Part3": "Zhengzhou 475000", "Part4": "People's Republic of China.", "Part5": null, "Part6": null, "Text": "Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 475000, People's Republic of China."}], "ForeName": "Nan", "FullName": "Nan Wang", "HashID": "-3258482972926119730", "LastName": "Wang", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-8937986724278213575", "Part1": "Department of Breast Surgery", "Part2": "The First Affiliated Hospital of Zhengzhou University", "Part3": "Zhengzhou 475000", "Part4": "People's Republic of China.", "Part5": null, "Part6": null, "Text": "Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 475000, People's Republic of China."}], "ForeName": "Youyi", "FullName": "Youyi Xiong", "HashID": "2198686531489939489", "LastName": "Xiong", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-8937986724278213575", "Part1": "Department of Breast Surgery", "Part2": "The First Affiliated Hospital of Zhengzhou University", "Part3": "Zhengzhou 475000", "Part4": "People's Republic of China.", "Part5": null, "Part6": null, "Text": "Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 475000, People's Republic of China."}], "ForeName": "Yuanting", "FullName": "Yuanting Gu", "HashID": "967480482145773197", "LastName": "Gu", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.2147/OTT.S223321", "InsertType": null, "Journal": "OncoTargets and therapy", "Keywords": [{"IS_Major": false, "IS_Mesh": false, "Text": "breast cancer"}, {"IS_Major": false, "IS_Mesh": false, "Text": "cisplatin"}, {"IS_Major": false, "IS_Mesh": false, "Text": "miR-381"}, {"IS_Major": false, "IS_Mesh": false, "Text": "small nucleolar RNA host gene 15"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "PubMed-not-MEDLINE", "Article": {"@PubModel": "Electronic-eCollection", "Abstract": {"AbstractText": [{"#text": "Increasing evidence implies the participation of long non-coding RNAs (lncRNAs) in chemoresistance to cancer treatment. Their role and molecular mechanisms in breast cancer chemoresistance, nevertheless, are yet not considerably elucidated. In this work, we research the function of small nucleolar RNA host gene 15 (SNHG15) in cisplatin (DDP) resistance of breast cancer and uncover the underlying molecular mechanism.", "@Label": "BACKGROUND", "@NlmCategory": "BACKGROUND"}, {"#text": "SNHG15 and miR-381 expression levels were detected using Quantitative real-time PCR (qRT-PCR) analysis. The functional roles of SNHG15 and miR-381 in breast cancer were determined using MTT assay and flow cytometry analysis. The effect of SNHG15 on miR-381 expression was determined using Luciferase reporter assay, RNA immunoprecipitation (RIP) assay and qRT-PCR analysis.", "@Label": "METHODS", "@NlmCategory": "METHODS"}, {"#text": "SNHG15 was found to be up-regulated in cisplatin resistant breast cancer tissues and cell lines. Breast cancer patients with high SNHG15 expression had a poor prognosis. SNHG15 silencing enhanced cisplatin sensitivity of MCF-7/DDP and MDA-MB-231/DDP cells. Additionally, SNHG15 could function as a miR-381 sponge. miR-381 overexpression could overcome cisplatin resistance. miR-381 knockdown countered SNHG15 knockdown-mediated enhancement of cisplatin sensitivity in MCF-7/DDP and MDA-MB-231/DDP cells. Besides, SNHG15 knockdown facilitated cisplatin sensitivity of cisplatin resistant breast cancer cells in vivo.", "@Label": "RESULTS", "@NlmCategory": "RESULTS"}, {"#text": "In summary, SNHG15 knockdown overcame cisplatin resistance of breast cancer by sponging miR-381, providing a novel therapeutic target for breast cancer.", "@Label": "CONCLUSION", "@NlmCategory": "CONCLUSIONS"}], "CopyrightInformation": "\u00a9 2020 Mi et al."}, "ArticleDate": {"@DateType": "Electronic", "Day": "21", "Month": "01", "Year": "2020"}, "ArticleTitle": "SNHG15 Contributes To Cisplatin Resistance In Breast Cancer Through Sponging miR-381.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@EqualContrib": "Y", "@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 475000, People's Republic of China."}, "ForeName": "Hailong", "Initials": "H", "LastName": "Mi"}, {"@EqualContrib": "Y", "@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 475000, People's Republic of China."}, "ForeName": "Xiaochun", "Initials": "X", "LastName": "Wang"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 475000, People's Republic of China."}, "ForeName": "Fang", "Initials": "F", "LastName": "Wang"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 475000, People's Republic of China."}, "ForeName": "Lin", "Initials": "L", "LastName": "Li"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 475000, People's Republic of China."}, "ForeName": "Mingzhi", "Initials": "M", "LastName": "Zhu"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 475000, People's Republic of China."}, "ForeName": "Nan", "Initials": "N", "LastName": "Wang"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 475000, People's Republic of China."}, "ForeName": "Youyi", "Initials": "Y", "LastName": "Xiong"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 475000, People's Republic of China."}, "ForeName": "Yuanting", "Initials": "Y", "LastName": "Gu"}]}, "ELocationID": {"#text": "10.2147/OTT.S223321", "@EIdType": "doi", "@ValidYN": "Y"}, "Journal": {"ISOAbbreviation": "Onco Targets Ther", "ISSN": {"#text": "1178-6930", "@IssnType": "Print"}, "JournalIssue": {"@CitedMedium": "Print", "PubDate": {"Year": "2020"}, "Volume": "13"}, "Title": "OncoTargets and therapy"}, "Language": "eng", "Pagination": {"EndPage": "666", "MedlinePgn": "657-666", "StartPage": "657"}, "PublicationTypeList": {"PublicationType": {"#text": "Journal Article", "@UI": "D016428"}}}, "CoiStatement": "The authors have no conflicts of interest to declare regarding this work.", "DateRevised": {"Day": "12", "Month": "04", "Year": "2022"}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"#text": "breast cancer", "@MajorTopicYN": "N"}, {"#text": "cisplatin", "@MajorTopicYN": "N"}, {"#text": "miR-381", "@MajorTopicYN": "N"}, {"#text": "small nucleolar RNA host gene 15", "@MajorTopicYN": "N"}]}, "MedlineJournalInfo": {"Country": "New Zealand", "ISSNLinking": "1178-6930", "MedlineTA": "Onco Targets Ther", "NlmUniqueID": "101514322"}, "PMID": {"#text": "32021307", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "32021307", "@IdType": "pubmed"}, {"#text": "PMC6983676", "@IdType": "pmc"}, {"#text": "10.2147/OTT.S223321", "@IdType": "doi"}, {"#text": "223321", "@IdType": "pii"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "received", "Day": "15", "Month": "7", "Year": "2019"}, {"@PubStatus": "accepted", "Day": "22", "Month": "10", "Year": "2019"}, {"@PubStatus": "entrez", "Day": "6", "Hour": "6", "Minute": "0", "Month": "2", "Year": "2020"}, {"@PubStatus": "pubmed", "Day": "6", "Hour": "6", "Minute": "0", "Month": "2", "Year": "2020"}, {"@PubStatus": "medline", "Day": "6", "Hour": "6", "Minute": "1", "Month": "2", "Year": "2020"}]}, "PublicationStatus": "epublish", "ReferenceList": {"Reference": [{"ArticleIdList": {"ArticleId": [{"#text": "10.3322/caac.21332", "@IdType": "doi"}, {"#text": "26742998", "@IdType": "pubmed"}]}, "Citation": "Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. Ca A Cancer J Clinicians. 2016;66:1. doi:10.3322/caac.21332"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1200/JGO.2016.003095", "@IdType": "doi"}, {"#text": "PMC5493273", "@IdType": "pmc"}, {"#text": "28717754", "@IdType": "pubmed"}]}, "Citation": "Sutter SA, Slinker A, Balumuka DD, Mitchell KB. Surgical management of breast cancer in Africa: a continent-wide review of intervention practices, barriers to care, and adjuvant therapy. J Glob Oncol. 2017;3(2):162\u2013168. doi:10.1200/JGO.2016.003095"}, {"Citation": "Villarreal-Garza C, Khalaf D, Bouganim N, et al. Platinum-based chemotherapy in triple-negative advanced breast cancer. Dtsch Med Wochenschr. 2015;26(8):894\u2013901."}, {"ArticleIdList": {"ArticleId": {"#text": "16518375", "@IdType": "pubmed"}}, "Citation": "Szak\u00e1cs G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM. Targeting multidrug resistance in cancer. Nat Rev Drug Discovery. 2006;5(3):219\u2013234."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ctrv.2008.01.007", "@IdType": "doi"}, {"#text": "18367336", "@IdType": "pubmed"}]}, "Citation": "Coley HM. Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer. Cancer Treat Rev. 2008;34(4):378. doi:10.1016/j.ctrv.2008.01.007"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/ol.2015.3553", "@IdType": "doi"}, {"#text": "PMC4579800", "@IdType": "pmc"}, {"#text": "26622780", "@IdType": "pubmed"}]}, "Citation": "Yu X, Li Z. Long non-coding RNA growth arrest-specific transcript 5 in tumor biology (Review). Oncol Lett. 2015;10(4):1953\u20131958. doi:10.3892/ol.2015.3553"}, {"ArticleIdList": {"ArticleId": {"#text": "26586396", "@IdType": "pubmed"}}, "Citation": "Zhang F, Zhang L, Zhang C. Long noncoding RNAs and tumorigenesis: genetic associations, molecular mechanisms, and therapeutic strategies. Tumour Biol J Int Soc Oncodevelopmental Biol Med. 2015;37(1):163\u2013175."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nature12548", "@IdType": "doi"}, {"#text": "PMC5332550", "@IdType": "pmc"}, {"#text": "23945584", "@IdType": "pubmed"}]}, "Citation": "Schmitt AM, Chang HY. Gene regulation: long RNAs wire up cancer growth. Nature. 2013;500(7464):536\u2013537. doi:10.1038/nature12548"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1111/his.12616", "@IdType": "doi"}, {"#text": "25406670", "@IdType": "pubmed"}]}, "Citation": "Yang QQ, Deng YF. Genome\u2010wide analysis of long non\u2010coding RNA in primary nasopharyngeal carcinoma by microarray. Histopathology. 2015;66(7):1022\u20131030. doi:10.1111/his.12616"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1111/cas.2013.104.issue-4", "@IdType": "doi"}, {"#text": "PMC7657223", "@IdType": "pmc"}, {"#text": "23281836", "@IdType": "pubmed"}]}, "Citation": "Nie Y, Liu X, Qu S, Song E, Zou H, Gong C. Long non\u2010coding RNA HOTAIR is an independent prognostic marker for nasopharyngeal carcinoma progression and survival. Cancer Sci. 2013;104(4):458\u2013464. doi:10.1111/cas.2013.104.issue-4"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2217/fon-2018-0303", "@IdType": "doi"}, {"#text": "30468082", "@IdType": "pubmed"}]}, "Citation": "Abu N, Hon KW, Jeyaraman S, et al. Long noncoding RNAs as biotargets in cisplatin-based drug resistance. Future Oncol. 2018;14(29):3085\u20133095. doi:10.2217/fon-2018-0303"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.15252/embr.201643139", "@IdType": "doi"}, {"#text": "PMC5376760", "@IdType": "pmc"}, {"#text": "28264987", "@IdType": "pubmed"}]}, "Citation": "Shen Y, Liu S, Fan J, et al. Nuclear retention of the lncRNA SNHG1 by doxorubicin attenuates hnRNPC-p53 protein interactions. EMBO Rep. 2017;18(4):536\u2013548. doi:10.15252/embr.201643139"}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6480895", "@IdType": "pmc"}, {"#text": "31014355", "@IdType": "pubmed"}]}, "Citation": "Saeinasab M, Bahrami AR, Gonz\u00e1lez J, et al. SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF. J Exp Clin Cancer Res. 2019;38(1):172."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrg.2016.20", "@IdType": "doi"}, {"#text": "27040487", "@IdType": "pubmed"}]}, "Citation": "Thomson DW, Dinger ME. Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet. 2016;17(5):272\u2013283. doi:10.1038/nrg.2016.20"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.tibs.2010.03.009", "@IdType": "doi"}, {"#text": "20395147", "@IdType": "pubmed"}]}, "Citation": "Kawamata T, Tomari Y. Making RISC. Trends Biochem Sci. 2010;35(7):368\u2013376. doi:10.1016/j.tibs.2010.03.009"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1146/annurev-pathol-012513-104715", "@IdType": "doi"}, {"#text": "PMC4009396", "@IdType": "pmc"}, {"#text": "24079833", "@IdType": "pubmed"}]}, "Citation": "Di Leva G, Garofalo M, Croce CM. MicroRNAs in cancer. Annu Rev Pathol. 2014;9:287\u2013314. doi:10.1146/annurev-pathol-012513-104715"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1159/000494004", "@IdType": "doi"}, {"#text": "30282072", "@IdType": "pubmed"}]}, "Citation": "Liu X, Luo X, Wu Y, et al. MicroRNA-34a attenuates paclitaxel resistance in prostate cancer cells via direct suppression of JAG1/Notch1 axis. Cell Physiol Biochem. 2018;50(1):261\u2013276. doi:10.1159/000494004"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.biopha.2017.12.092", "@IdType": "doi"}, {"#text": "29287202", "@IdType": "pubmed"}]}, "Citation": "Huang R-S, Zheng Y-L, Zhao J, Chun X. microRNA-381 suppresses the growth and increases cisplatin sensitivity in non-small cell lung cancer cells through inhibition of nuclear factor-\u03baB signaling. Biomed Pharmacother. 2018;98:538\u2013544. doi:10.1016/j.biopha.2017.12.092"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/cbin.v43.1", "@IdType": "doi"}, {"#text": "30444043", "@IdType": "pubmed"}]}, "Citation": "Yi D, Xu L, Wang R, Lu X, Sang J. miR\u2010381 overcomes cisplatin resistance in breast cancer by targeting MDR1. Cell Biol Int. 2019;43(1):12\u201321. doi:10.1002/cbin.v43.1"}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3788715", "@IdType": "pmc"}, {"#text": "24098538", "@IdType": "pubmed"}]}, "Citation": "Wang WJ, Yao Y, Jiang LL, et al. Knockdown of lymphoid enhancer factor 1 inhibits colon cancer progression in vitro and in vivo. PLoS One. 2013;8(10):e76596."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2147/OTT.S182657", "@IdType": "doi"}, {"#text": "PMC6304080", "@IdType": "pmc"}, {"#text": "30588034", "@IdType": "pubmed"}]}, "Citation": "Qu C, Dai C, Guo Y, Qin R, Liu J. Long noncoding RNA SNHG15 serves as an oncogene and predicts poor prognosis in epithelial ovarian cancer. Onco Targets Ther. 2019;12:101. doi:10.2147/OTT.S182657"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.bbrc.2017.12.013", "@IdType": "doi"}, {"#text": "29217194", "@IdType": "pubmed"}]}, "Citation": "Kong Q, Qiu M. Long noncoding RNA SNHG15 promotes human breast cancer proliferation, migration and invasion by sponging miR-211-3p. Biochem Biophys Res Commun. 2018;495(2):1594\u20131600. doi:10.1016/j.bbrc.2017.12.013"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/jcp.26543", "@IdType": "doi"}, {"#text": "PMC6001572", "@IdType": "pmc"}, {"#text": "29630731", "@IdType": "pubmed"}]}, "Citation": "Jin B, Jin H, Wu HB, Xu JJ, Li B. Long non\u2010coding RNA SNHG15 promotes CDK14 expression via miR\u2010486 to accelerate non\u2010small cell lung cancer cells progression and metastasis. J Cell Physiol. 2018;233(9):7164\u20137172. doi:10.1002/jcp.26543"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41419-018-0975-1", "@IdType": "doi"}, {"#text": "PMC6148237", "@IdType": "pmc"}, {"#text": "30237435", "@IdType": "pubmed"}]}, "Citation": "Wu D-M, Wang S, Wen X, et al. LncRNA SNHG15 acts as a ceRNA to regulate YAP1-Hippo signaling pathway by sponging miR-200a-3p in papillary thyroid carcinoma. Cell Death Dis. 2018;9(10):947. doi:10.1038/s41419-018-0975-1"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/or.2017.5956", "@IdType": "doi"}, {"#text": "29048619", "@IdType": "pubmed"}]}, "Citation": "Tian C, Li J, Ren L, Peng R, Chen B, Lin Y. MicroRNA-381 serves as a prognostic factor and inhibits migration and invasion in non-small cell lung cancer by targeting LRH-1. Oncol Rep. 2017;38(5):3071\u20133077. doi:10.3892/or.2017.5956"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s13046-017-0499-z", "@IdType": "doi"}, {"#text": "PMC5307754", "@IdType": "pmc"}, {"#text": "28193228", "@IdType": "pubmed"}]}, "Citation": "Cao Q, Liu F, Ji K, et al. MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expression. J Exp Clin Cancer Res. 2017;36(1):29. doi:10.1186/s13046-017-0499-z"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.biopha.2016.12.051", "@IdType": "doi"}, {"#text": "28012397", "@IdType": "pubmed"}]}, "Citation": "Xue Y, Xu W, Zhao W, Wang W, Zhang D, Wu P. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4. Biomed Pharmacother. 2017;86:426\u2013433. doi:10.1016/j.biopha.2016.12.051"}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4789845", "@IdType": "pmc"}, {"#text": "27094913", "@IdType": "pubmed"}]}, "Citation": "He X, Wei Y, Wang Y, Liu L, Wang W, Li N. MiR-381 functions as a tumor suppressor in colorectal cancer by targeting Twist1. Onco Targets Ther. 2016;9:1231."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.3061", "@IdType": "doi"}, {"#text": "PMC4413644", "@IdType": "pmc"}, {"#text": "25605243", "@IdType": "pubmed"}]}, "Citation": "Wang Z, Yang J, Xu G, et al. Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors. Oncotarget. 2015;6(5):3147\u20133164. doi:10.18632/oncotarget.3061"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1179/1973947813Y.0000000092", "@IdType": "doi"}, {"#text": "23816136", "@IdType": "pubmed"}]}, "Citation": "Chen B, Duan L, Yin G, Jing T, Jiang X. miR-381, a novel intrinsic WEE1 inhibitor, sensitizes renal cancer cells to 5-FU by up-regulation of Cdc2 activities in 786-O. J Chemother. 2013;25(4):229\u2013238. doi:10.1179/1973947813Y.0000000092"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.11861", "@IdType": "doi"}, {"#text": "PMC5356575", "@IdType": "pmc"}, {"#text": "27612424", "@IdType": "pubmed"}]}, "Citation": "Li Y, Zhao C, Yu Z, et al. Low expression of miR-381 is a favorite prognosis factor and enhances the chemosensitivity of osteosarcoma. Oncotarget. 2016;7(42):68585\u201368596. doi:10.18632/oncotarget.11861"}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1371/journal.pone.0082062", "@IdType": "doi"}, {"#text": "PMC3841137", "@IdType": "pmc"}, {"#text": "24303078", "@IdType": "pubmed"}]}, "Citation": "Xu Y, Ohms S, Li Z, et al. Changes in the expression of miR-381 and miR-495 are inversely associated with the expression of the MDR1 gene and development of multi-drug resistance. PLoS One. 2013;8(11):e82062. doi:10.1371/journal.pone.0082062"}]}}}}}, "PMC": "PMC6983676", "PMID": "32021307", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "SNHG15 Contributes To Cisplatin Resistance In Breast Cancer Through Sponging miR-381.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "47": {"Abstract": "Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with high mortality, poor prognosis, and palliative treatments, due to the rapid upregulation of alternative compensatory pathways and desmoplastic reaction. miRNAs, small non-coding RNAs, have been recently identified as key players regulating cancer pathogenesis. Dysregulated miRNAs are associated with molecular pathways involved in tumor development, metastasis, and chemoresistance in PDAC, as well as other cancers. Targeted treatment strategies that alter miRNA levels in cancers have promising potential as therapeutic interventions. miRNA-345 (miR-345) plays a critical role in tumor suppression and is differentially expressed in various cancers, including pancreatic cancer (PC). The underlying mechanism(s) and delivery strategies of miR-345 have been investigated by us previously. Here, we summarize the potential therapeutic roles of miR-345 in different cancers, with emphasis on PDAC, for miRNA drug discovery, development, status, and implications. Further, we focus on miRNA nanodelivery system(s), based on different materials and nanoformulations, specifically for the delivery of miR-345.", "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "-6688469407156065940", "Part1": "Department of Biochemistry and Molecular Biology", "Part2": "University of Nebraska Medical Center", "Part3": "Omaha", "Part4": "NE 68198-5870", "Part5": "USA.", "Part6": null, "Text": "Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198-5870, USA."}], "ForeName": "Nagabhishek Sirpu", "FullName": "Nagabhishek Sirpu Natesh", "HashID": "8615562542838219420", "LastName": "Natesh", "ORCID": "0000-0003-3826-1591"}, {"Affiliations": [{"Has_Extra": false, "HashID": "3757204296777374050", "Part1": "Department of Chemical and Biological Engineering", "Part2": "Iowa State University", "Part3": "Ames", "Part4": "IA 50011", "Part5": "USA.", "Part6": null, "Text": "Department of Chemical and Biological Engineering, Iowa State University, Ames, IA 50011, USA."}], "ForeName": "Brianna M", "FullName": "Brianna M White", "HashID": "-8540538552507417468", "LastName": "White", "ORCID": "0000-0001-6814-8341"}, {"Affiliations": [{"Has_Extra": false, "HashID": "-6688469407156065940", "Part1": "Department of Biochemistry and Molecular Biology", "Part2": "University of Nebraska Medical Center", "Part3": "Omaha", "Part4": "NE 68198-5870", "Part5": "USA.", "Part6": null, "Text": "Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198-5870, USA."}], "ForeName": "Maia M C", "FullName": "Maia M C Bennett", "HashID": "5115045499718812759", "LastName": "Bennett", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "5475884358939232392", "Part1": "Department of Chemical and Biomedical Engineering", "Part2": "Cleveland State University", "Part3": "Cleveland", "Part4": "OH 44115-2214", "Part5": "USA.", "Part6": null, "Text": "Department of Chemical and Biomedical Engineering, Cleveland State University, Cleveland, OH 44115-2214, USA."}], "ForeName": "Metin", "FullName": "Metin Uz", "HashID": "-3893885564603164365", "LastName": "Uz", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-6688469407156065940", "Part1": "Department of Biochemistry and Molecular Biology", "Part2": "University of Nebraska Medical Center", "Part3": "Omaha", "Part4": "NE 68198-5870", "Part5": "USA.", "Part6": null, "Text": "Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198-5870, USA."}], "ForeName": "Rakhee Rathnam", "FullName": "Rakhee Rathnam Kalari Kandy", "HashID": "-6316437499740285847", "LastName": "Kalari Kandy", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-6688469407156065940", "Part1": "Department of Biochemistry and Molecular Biology", "Part2": "University of Nebraska Medical Center", "Part3": "Omaha", "Part4": "NE 68198-5870", "Part5": "USA.", "Part6": null, "Text": "Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198-5870, USA."}, {"Has_Extra": false, "HashID": "-6693940772351161792", "Part1": "Fred & Pamela Buffet Cancer Center", "Part2": "Eppley Institute for Research in Cancer and Allied Diseases", "Part3": "University of Nebraska Medical Center", "Part4": "Omaha", "Part5": "NE 68198-5950", "Part6": "USA.", "Text": "Fred & Pamela Buffet Cancer Center, Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198-5950, USA."}], "ForeName": "Surinder K", "FullName": "Surinder K Batra", "HashID": "3778948518617974686", "LastName": "Batra", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "3757204296777374050", "Part1": "Department of Chemical and Biological Engineering", "Part2": "Iowa State University", "Part3": "Ames", "Part4": "IA 50011", "Part5": "USA.", "Part6": null, "Text": "Department of Chemical and Biological Engineering, Iowa State University, Ames, IA 50011, USA."}], "ForeName": "Surya K", "FullName": "Surya K Mallapragada", "HashID": "-2115948875395261678", "LastName": "Mallapragada", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-6688469407156065940", "Part1": "Department of Biochemistry and Molecular Biology", "Part2": "University of Nebraska Medical Center", "Part3": "Omaha", "Part4": "NE 68198-5870", "Part5": "USA.", "Part6": null, "Text": "Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198-5870, USA."}], "ForeName": "Satyanarayana", "FullName": "Satyanarayana Rachagani", "HashID": "-2864765535943635259", "LastName": "Rachagani", "ORCID": "0000-0003-3949-8566"}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.3390/pharmaceutics13121987", "InsertType": null, "Journal": "Pharmaceutics", "Keywords": [{"IS_Major": false, "IS_Mesh": false, "Text": "PDAC"}, {"IS_Major": false, "IS_Mesh": false, "Text": "miR-345"}, {"IS_Major": false, "IS_Mesh": false, "Text": "miRNA nanodelivery"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "PubMed-not-MEDLINE", "Article": {"@PubModel": "Electronic", "Abstract": {"AbstractText": "Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with high mortality, poor prognosis, and palliative treatments, due to the rapid upregulation of alternative compensatory pathways and desmoplastic reaction. miRNAs, small non-coding RNAs, have been recently identified as key players regulating cancer pathogenesis. Dysregulated miRNAs are associated with molecular pathways involved in tumor development, metastasis, and chemoresistance in PDAC, as well as other cancers. Targeted treatment strategies that alter miRNA levels in cancers have promising potential as therapeutic interventions. miRNA-345 (miR-345) plays a critical role in tumor suppression and is differentially expressed in various cancers, including pancreatic cancer (PC). The underlying mechanism(s) and delivery strategies of miR-345 have been investigated by us previously. Here, we summarize the potential therapeutic roles of miR-345 in different cancers, with emphasis on PDAC, for miRNA drug discovery, development, status, and implications. Further, we focus on miRNA nanodelivery system(s), based on different materials and nanoformulations, specifically for the delivery of miR-345."}, "ArticleDate": {"@DateType": "Electronic", "Day": "23", "Month": "11", "Year": "2021"}, "ArticleTitle": "Emerging Role of miR-345 and Its Effective Delivery as a Potential Therapeutic Candidate in Pancreatic Cancer and Other Cancers.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198-5870, USA."}, "ForeName": "Nagabhishek Sirpu", "Identifier": {"#text": "0000-0003-3826-1591", "@Source": "ORCID"}, "Initials": "NS", "LastName": "Natesh"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Chemical and Biological Engineering, Iowa State University, Ames, IA 50011, USA."}, "ForeName": "Brianna M", "Identifier": {"#text": "0000-0001-6814-8341", "@Source": "ORCID"}, "Initials": "BM", "LastName": "White"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198-5870, USA."}, "ForeName": "Maia M C", "Initials": "MMC", "LastName": "Bennett"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Chemical and Biomedical Engineering, Cleveland State University, Cleveland, OH 44115-2214, USA."}, "ForeName": "Metin", "Initials": "M", "LastName": "Uz"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198-5870, USA."}, "ForeName": "Rakhee Rathnam", "Initials": "RR", "LastName": "Kalari Kandy"}, {"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198-5870, USA."}, {"Affiliation": "Fred & Pamela Buffet Cancer Center, Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198-5950, USA."}], "ForeName": "Surinder K", "Initials": "SK", "LastName": "Batra"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Chemical and Biological Engineering, Iowa State University, Ames, IA 50011, USA."}, "ForeName": "Surya K", "Initials": "SK", "LastName": "Mallapragada"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198-5870, USA."}, "ForeName": "Satyanarayana", "Identifier": {"#text": "0000-0003-3949-8566", "@Source": "ORCID"}, "Initials": "S", "LastName": "Rachagani"}]}, "ELocationID": [{"#text": "1987", "@EIdType": "pii", "@ValidYN": "Y"}, {"#text": "10.3390/pharmaceutics13121987", "@EIdType": "doi", "@ValidYN": "Y"}], "GrantList": {"@CompleteYN": "Y", "Grant": [{"Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States", "GrantID": "P01 CA217798"}, {"Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States", "GrantID": "R01 CA247763"}, {"Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States", "GrantID": "R01 CA247763, R21 CA238953, P01 CA21779"}]}, "Journal": {"ISOAbbreviation": "Pharmaceutics", "ISSN": {"#text": "1999-4923", "@IssnType": "Print"}, "JournalIssue": {"@CitedMedium": "Print", "Issue": "12", "PubDate": {"Day": "23", "Month": "Nov", "Year": "2021"}, "Volume": "13"}, "Title": "Pharmaceutics"}, "Language": "eng", "PublicationTypeList": {"PublicationType": [{"#text": "Journal Article", "@UI": "D016428"}, {"#text": "Review", "@UI": "D016454"}]}}, "CoiStatement": "Surinder Batra is one of the co-founders of Sanguine Diagnostics and Therapeutics, Inc., which is located in Omaha, NE, USA. Surya Mallapragada is a co-founder and has equity interests in Degimflex LLC. and ImmunoNanoMed Inc., both located in Ames, IA, USA. The terms of these arrangements have been reviewed and approved by Iowa State University, in accordance with its conflict of interest policies. The other authors declare that they have no conflict of interests.", "DateRevised": {"Day": "16", "Month": "07", "Year": "2022"}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"#text": "PDAC", "@MajorTopicYN": "N"}, {"#text": "miR-345", "@MajorTopicYN": "N"}, {"#text": "miRNA nanodelivery", "@MajorTopicYN": "N"}]}, "MedlineJournalInfo": {"Country": "Switzerland", "ISSNLinking": "1999-4923", "MedlineTA": "Pharmaceutics", "NlmUniqueID": "101534003"}, "PMID": {"#text": "34959269", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "34959269", "@IdType": "pubmed"}, {"#text": "PMC8707074", "@IdType": "pmc"}, {"#text": "10.3390/pharmaceutics13121987", "@IdType": "doi"}, {"#text": "pharmaceutics13121987", "@IdType": "pii"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "received", "Day": "18", "Month": "10", "Year": "2021"}, {"@PubStatus": "revised", "Day": "16", "Month": "11", "Year": "2021"}, {"@PubStatus": "accepted", "Day": "18", "Month": "11", "Year": "2021"}, {"@PubStatus": "entrez", "Day": "28", "Hour": "1", "Minute": "3", "Month": "12", "Year": "2021"}, {"@PubStatus": "pubmed", "Day": "29", "Hour": "6", "Minute": "0", "Month": "12", "Year": "2021"}, {"@PubStatus": "medline", "Day": "29", "Hour": "6", "Minute": "1", "Month": "12", "Year": "2021"}]}, "PublicationStatus": "epublish", "ReferenceList": {"Reference": [{"ArticleIdList": {"ArticleId": [{"#text": "10.3322/caac.21660", "@IdType": "doi"}, {"#text": "33538338", "@IdType": "pubmed"}]}, "Citation": "Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71:209\u2013249. doi: 10.3322/caac.21660."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12885-019-6284-y", "@IdType": "doi"}, {"#text": "PMC6868851", "@IdType": "pmc"}, {"#text": "31752758", "@IdType": "pubmed"}]}, "Citation": "Daoud A.Z., Mulholland E.J., Cole G., McCarthy H.O. MicroRNAs in Pancreatic Cancer: Biomarkers, prognostic, and therapeutic modulators. BMC Cancer. 2019;19:1130. doi: 10.1186/s12885-019-6284-y."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.14740/wjon1166", "@IdType": "doi"}, {"#text": "PMC6396775", "@IdType": "pmc"}, {"#text": "30834048", "@IdType": "pubmed"}]}, "Citation": "Rawla P., Sunkara T., Gaduputi V. Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors. World J. Oncol. 2019;10:10\u201327. doi: 10.14740/wjon1166."}, {"Citation": "Key Statistics for Pancreatic Cancer.  [(accessed on 5 May 2021)].  Available online:  https://www.cancer.org/cancer/pancreatic-cancer/about/key-statistics.html."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1080/0284186X.2016.1197419", "@IdType": "doi"}, {"#text": "27551890", "@IdType": "pubmed"}]}, "Citation": "Ferlay J., Partensky C., Bray F. More deaths from pancreatic cancer than breast cancer in the EU by 2017. Acta Oncol. 2016;55:1158\u20131160. doi: 10.1080/0284186X.2016.1197419."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.pan.2014.10.001", "@IdType": "doi"}, {"#text": "25547205", "@IdType": "pubmed"}]}, "Citation": "Hidalgo M., Cascinu S., Kleeff J., Labianca R., Lohr J.M., Neoptolemos J., Real F.X., Van Laethem J.L., Heinemann V. Addressing the challenges of pancreatic cancer: Future directions for improving outcomes. Pancreatology. 2015;15:8\u201318. doi: 10.1016/j.pan.2014.10.001."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/biomedicines9040389", "@IdType": "doi"}, {"#text": "PMC8067364", "@IdType": "pmc"}, {"#text": "33917380", "@IdType": "pubmed"}]}, "Citation": "Elsayed M., Abdelrahim M. The Latest Advancement in Pancreatic Ductal Adenocarcinoma Therapy: A Review Article for the Latest Guidelines and Novel Therapies. Biomedicines. 2021;9:389. doi: 10.3390/biomedicines9040389."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/cancers12113096", "@IdType": "doi"}, {"#text": "PMC7690843", "@IdType": "pmc"}, {"#text": "33114159", "@IdType": "pubmed"}]}, "Citation": "Jentzsch V., Davis J.A.A., Djamgoz M.B.A. Pancreatic Cancer (PDAC): Introduction of Evidence-Based Complementary Measures into Integrative Clinical Management. Cancers. 2020;12:3096. doi: 10.3390/cancers12113096."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/1535-7163.MCT-06-0686", "@IdType": "doi"}, {"#text": "17406031", "@IdType": "pubmed"}]}, "Citation": "Mahadevan D., Von Hoff D.D. Tumor-stroma interactions in pancreatic ductal adenocarcinoma. Mol. Cancer Ther. 2007;6:1186\u20131197. doi: 10.1158/1535-7163.MCT-06-0686."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/1476-4598-2-14", "@IdType": "doi"}, {"#text": "PMC149416", "@IdType": "pmc"}, {"#text": "12605717", "@IdType": "pubmed"}]}, "Citation": "Keleg S., Buchler P., Ludwig R., Buchler M.W., Friess H. Invasion and metastasis in pancreatic cancer. Mol. Cancer. 2003;2:14. doi: 10.1186/1476-4598-2-14."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3748/wjg.v24.i43.4846", "@IdType": "doi"}, {"#text": "PMC6250924", "@IdType": "pmc"}, {"#text": "30487695", "@IdType": "pubmed"}]}, "Citation": "McGuigan A., Kelly P., Turkington R.C., Jones C., Coleman H.G., McCain R.S. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes. World J. Gastroenterol. 2018;24:4846\u20134861. doi: 10.3748/wjg.v24.i43.4846."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1136/bmjgast-2019-000274", "@IdType": "doi"}, {"#text": "PMC6577306", "@IdType": "pmc"}, {"#text": "31275582", "@IdType": "pubmed"}]}, "Citation": "Hendifar A.E., Larson B.K., Rojansky R., Guan M., Gong J., Placencio V., Tuli R., Hitchins M. Pancreatic cancer \u2018mismatch\u2019 in Lynch syndrome. BMJ Open Gastroenterol. 2019;6:e000274. doi: 10.1136/bmjgast-2019-000274."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s13053-018-0088-y", "@IdType": "doi"}, {"#text": "PMC5842519", "@IdType": "pmc"}, {"#text": "29541281", "@IdType": "pubmed"}]}, "Citation": "Cremin C., Howard S., Le L., Karsan A., Schaeffer D.F., Renouf D., Schrader K.A. CDKN2A founder mutation in pancreatic ductal adenocarcinoma patients without cutaneous features of Familial Atypical Multiple Mole Melanoma (FAMMM) syndrome. Hered. Cancer Clin. Pract. 2018;16:7. doi: 10.1186/s13053-018-0088-y."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3748/wjg.v20.i33.11788", "@IdType": "doi"}, {"#text": "PMC4155369", "@IdType": "pmc"}, {"#text": "25206283", "@IdType": "pubmed"}]}, "Citation": "Pelaez-Luna M., Robles-Diaz G., Canizales-Quinteros S., Tusie-Luna M.T. PRSS1 and SPINK1 mutations in idiopathic chronic and recurrent acute pancreatitis. World J. Gastroenterol. 2014;20:11788\u201311792. doi: 10.3748/wjg.v20.i33.11788."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2147/CMAR.S211151", "@IdType": "doi"}, {"#text": "PMC7185320", "@IdType": "pmc"}, {"#text": "32368150", "@IdType": "pubmed"}]}, "Citation": "Wong W., Raufi A.G., Safyan R.A., Bates S.E., Manji G.A. BRCA Mutations in Pancreas Cancer: Spectrum, Current Management, Challenges and Future Prospects. Cancer Manag. Res. 2020;12:2731\u20132742. doi: 10.2147/CMAR.S211151."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.4251/wjgo.v12.i2.173", "@IdType": "doi"}, {"#text": "PMC7031151", "@IdType": "pmc"}, {"#text": "32104548", "@IdType": "pubmed"}]}, "Citation": "Sarantis P., Koustas E., Papadimitropoulou A., Papavassiliou A.G., Karamouzis M.V. Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy. World J. Gastrointest. Oncol. 2020;12:173\u2013181. doi: 10.4251/wjgo.v12.i2.173."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1200/JCO.2017.72.4948", "@IdType": "doi"}, {"#text": "28398845", "@IdType": "pubmed"}]}, "Citation": "Khorana A.A., Mangu P.B., Berlin J., Engebretson A., Hong T.S., Maitra A., Mohile S.G., Mumber M., Schulick R., Shapiro M., et al. Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J. Clin. Oncol. 2017;35:2324\u20132328. doi: 10.1200/JCO.2017.72.4948."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/ijms18071338", "@IdType": "doi"}, {"#text": "PMC5535831", "@IdType": "pmc"}, {"#text": "28640192", "@IdType": "pubmed"}]}, "Citation": "Adamska A., Domenichini A., Falasca M. Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies. Int. J. Mol. Sci. 2017;18:1338. doi: 10.3390/ijms18071338."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.9533", "@IdType": "doi"}, {"#text": "PMC5122409", "@IdType": "pmc"}, {"#text": "27413117", "@IdType": "pubmed"}]}, "Citation": "Wang L., Bai Y.Y., Yang Y., Hu F., Wang Y., Yu Z., Cheng Z., Zhou J. Diabetes mellitus stimulates pancreatic cancer growth and epithelial-mesenchymal transition-mediated metastasis via a p38 MAPK pathway. Oncotarget. 2016;7:38539\u201338550. doi: 10.18632/oncotarget.9533."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3932318", "@IdType": "pmc"}, {"#text": "23207610", "@IdType": "pubmed"}]}, "Citation": "Muniraj T., Chari S.T. Diabetes and pancreatic cancer. Minerva Gastroenterol. Dietol. 2012;58:331\u2013345."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.4061/2011/620601", "@IdType": "doi"}, {"#text": "PMC3068308", "@IdType": "pmc"}, {"#text": "21512581", "@IdType": "pubmed"}]}, "Citation": "Ottenhof N.A., de Wilde R.F., Maitra A., Hruban R.H., Offerhaus G.J. Molecular characteristics of pancreatic ductal adenocarcinoma. Patholog. Res. Int. 2011;2011:620601. doi: 10.4061/2011/620601."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.jconrel.2018.12.031", "@IdType": "doi"}, {"#text": "PMC6379902", "@IdType": "pmc"}, {"#text": "30576747", "@IdType": "pubmed"}]}, "Citation": "Uz M., Kalaga M., Pothuraju R., Ju J., Junker W.M., Batra S.K., Mallapragada S., Rachagani S. Dual delivery nanoscale device for miR-345 and gemcitabine co-delivery to treat pancreatic cancer. J. Control. Release. 2019;294:237\u2013246. doi: 10.1016/j.jconrel.2018.12.031."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1021/mp500847s", "@IdType": "doi"}, {"#text": "PMC4829351", "@IdType": "pmc"}, {"#text": "25679326", "@IdType": "pubmed"}]}, "Citation": "Kumar V., Mondal G., Slavik P., Rachagani S., Batra S.K., Mahato R.I. Codelivery of small molecule hedgehog inhibitor and miRNA for treating pancreatic cancer. Mol. Pharm. 2015;12:1289\u20131298. doi: 10.1021/mp500847s."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ajpath.2018.10.005", "@IdType": "doi"}, {"#text": "PMC6854437", "@IdType": "pmc"}, {"#text": "30558723", "@IdType": "pubmed"}]}, "Citation": "Tesfaye A.A., Azmi A.S., Philip P.A. miRNA and Gene Expression in Pancreatic Ductal Adenocarcinoma. Am. J. Pathol. 2019;189:58\u201370. doi: 10.1016/j.ajpath.2018.10.005."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.canlet.2009.11.010", "@IdType": "doi"}, {"#text": "PMC3229224", "@IdType": "pmc"}, {"#text": "20004512", "@IdType": "pubmed"}]}, "Citation": "Rachagani S., Kumar S., Batra S.K. MicroRNA in pancreatic cancer: Pathological, diagnostic and therapeutic implications. Cancer Lett. 2010;292:8\u201316. doi: 10.1016/j.canlet.2009.11.010."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.4161/cbt.23296", "@IdType": "doi"}, {"#text": "PMC3595302", "@IdType": "pmc"}, {"#text": "23291983", "@IdType": "pubmed"}]}, "Citation": "Singh R., Mo Y.Y. Role of microRNAs in breast cancer. Cancer Biol. Ther. 2013;14:201\u2013212. doi: 10.4161/cbt.23296."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrg3198", "@IdType": "doi"}, {"#text": "PMC4517822", "@IdType": "pmc"}, {"#text": "22510765", "@IdType": "pubmed"}]}, "Citation": "Pritchard C.C., Cheng H.H., Tewari M. MicroRNA profiling: Approaches and considerations. Nat. Rev. Genet. 2012;13:358\u2013369. doi: 10.1038/nrg3198."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s13148-018-0492-1", "@IdType": "doi"}, {"#text": "PMC5913875", "@IdType": "pmc"}, {"#text": "29713393", "@IdType": "pubmed"}]}, "Citation": "Wang H., Peng R., Wang J., Qin Z., Xue L. Circulating microRNAs as potential cancer biomarkers: The advantage and disadvantage. Clin. Epigenet. 2018;10:59. doi: 10.1186/s13148-018-0492-1."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/ijo.2014.2743", "@IdType": "doi"}, {"#text": "PMC4277249", "@IdType": "pmc"}, {"#text": "25384963", "@IdType": "pubmed"}]}, "Citation": "Abue M., Yokoyama M., Shibuya R., Tamai K., Yamaguchi K., Sato I., Tanaka N., Hamada S., Shimosegawa T., Sugamura K., et al. Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer. Int. J. Oncol. 2015;46:539\u2013547. doi: 10.3892/ijo.2014.2743."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/ijc.22394", "@IdType": "doi"}, {"#text": "PMC2680248", "@IdType": "pmc"}, {"#text": "17149698", "@IdType": "pubmed"}]}, "Citation": "Lee E.J., Gusev Y., Jiang J., Nuovo G.J., Lerner M.R., Frankel W.L., Morgan D.L., Postier R.G., Brackett D.J., Schmittgen T.D. Expression profiling identifies microRNA signature in pancreatic cancer. Int. J. Cancer. 2007;120:1046\u20131054. doi: 10.1002/ijc.22394."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/sj.onc.1210228", "@IdType": "doi"}, {"#text": "17237814", "@IdType": "pubmed"}]}, "Citation": "Szafranska A.E., Davison T.S., John J., Cannon T., Sipos B., Maghnouj A., Labourier E., Hahn S.A. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene. 2007;26:4442\u20134452. doi: 10.1038/sj.onc.1210228."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.surg.2011.06.017", "@IdType": "doi"}, {"#text": "22018284", "@IdType": "pubmed"}]}, "Citation": "Nakata K., Ohuchida K., Mizumoto K., Kayashima T., Ikenaga N., Sakai H., Lin C., Fujita H., Otsuka T., Aishima S., et al. MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis. Surgery. 2011;150:916\u2013922. doi: 10.1016/j.surg.2011.06.017."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/ijc.24687", "@IdType": "doi"}, {"#text": "19551852", "@IdType": "pubmed"}]}, "Citation": "Greither T., Grochola L.F., Udelnow A., Lautenschlager C., Wurl P., Taubert H. Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Int. J. Cancer. 2010;126:73\u201380. doi: 10.1002/ijc.24687."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1097/CM9.0000000000001804", "@IdType": "doi"}, {"#text": "PMC8577671", "@IdType": "pmc"}, {"#text": "34748526", "@IdType": "pubmed"}]}, "Citation": "Zhou Q.Y., Gui S.Y., Zhang P., Wang M. Upregulation of miR-345-5p suppresses cell growth of lung adenocarcinoma by regulating ras homolog family member A (RhoA) and Rho/Rho associated protein kinase (Rho/ROCK) pathway. Chin. Med. J. 2021;134:2619\u20132628. doi: 10.1097/CM9.0000000000001804."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.tranon.2020.100773", "@IdType": "doi"}, {"#text": "PMC7182759", "@IdType": "pmc"}, {"#text": "32334405", "@IdType": "pubmed"}]}, "Citation": "Ribatti D., Tamma R., Annese T. Epithelial-Mesenchymal Transition in Cancer: A Historical Overview. Transl. Oncol. 2020;13:100773. doi: 10.1016/j.tranon.2020.100773."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3389/fonc.2014.00358", "@IdType": "doi"}, {"#text": "PMC4263086", "@IdType": "pmc"}, {"#text": "25566498", "@IdType": "pubmed"}]}, "Citation": "Lindsey S., Langhans S.A. Crosstalk of Oncogenic Signaling Pathways during Epithelial-Mesenchymal Transition. Front. Oncol. 2014;4:358. doi: 10.3389/fonc.2014.00358."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/carcin/bgr114", "@IdType": "doi"}, {"#text": "21665895", "@IdType": "pubmed"}]}, "Citation": "Tang J.T., Wang J.L., Du W., Hong J., Zhao S.L., Wang Y.C., Xiong H., Chen H.M., Fang J.Y. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer. Carcinogenesis. 2011;32:1207\u20131215. doi: 10.1093/carcin/bgr114."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.7150/jca.22119", "@IdType": "doi"}, {"#text": "PMC5858488", "@IdType": "pmc"}, {"#text": "29556324", "@IdType": "pubmed"}]}, "Citation": "Wang P., Liu X.M., Ding L., Zhang X.J., Ma Z.L. mTOR signaling-related MicroRNAs and Cancer involvement. J. Cancer. 2018;9:667\u2013673. doi: 10.7150/jca.22119."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1111/jcmm.14086", "@IdType": "doi"}, {"#text": "PMC6433677", "@IdType": "pmc"}, {"#text": "30701693", "@IdType": "pubmed"}]}, "Citation": "Lu M., Liu B., Xiong H., Wu F., Hu C., Liu P. Trans-3,5,4 -trimethoxystilbene reduced gefitinib resistance in NSCLCs via suppressing MAPK/Akt/Bcl-2 pathway by upregulation of miR-345 and miR-498. J. Cell Mol. Med. 2019;23:2431\u20132441. doi: 10.1111/jcmm.14086."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/ijo.2017.3852", "@IdType": "doi"}, {"#text": "28098858", "@IdType": "pubmed"}]}, "Citation": "Yu M., Xue H., Wang Y., Shen Q., Jiang Q., Zhang X., Li K., Jia M., Jia J., Xu J., et al. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma. Int. J. Oncol. 2017;50:975\u2013983. doi: 10.3892/ijo.2017.3852."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1001/jama.297.17.1901", "@IdType": "doi"}, {"#text": "17473300", "@IdType": "pubmed"}]}, "Citation": "Bloomston M., Frankel W.L., Petrocca F., Volinia S., Alder H., Hagan J.P., Liu C.G., Bhatt D., Taccioli C., Croce C.M. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA. 2007;297:1901\u20131908. doi: 10.1001/jama.297.17.1901."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/bjc.2015.252", "@IdType": "doi"}, {"#text": "PMC4647684", "@IdType": "pmc"}, {"#text": "26247574", "@IdType": "pubmed"}]}, "Citation": "Srivastava S.K., Bhardwaj A., Arora S., Tyagi N., Singh S., Andrews J., McClellan S., Wang B., Singh A.P. MicroRNA-345 induces apoptosis in pancreatic cancer cells through potentiation of caspase-dependent and -independent pathways. Br. J. Cancer. 2015;113:660\u2013668. doi: 10.1038/bjc.2015.252."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1080/01926230701320337", "@IdType": "doi"}, {"#text": "PMC2117903", "@IdType": "pmc"}, {"#text": "17562483", "@IdType": "pubmed"}]}, "Citation": "Elmore S. Apoptosis: A review of programmed cell death. Toxicol. Pathol. 2007;35:495\u2013516. doi: 10.1080/01926230701320337."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1146/annurev-genet-102108-134850", "@IdType": "doi"}, {"#text": "PMC4762029", "@IdType": "pmc"}, {"#text": "19659442", "@IdType": "pubmed"}]}, "Citation": "Wang C., Youle R.J. The role of mitochondria in apoptosis*. Annu. Rev. Genet. 2009;43:95\u2013118. doi: 10.1146/annurev-genet-102108-134850."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/sj.cdd.4401950", "@IdType": "doi"}, {"#text": "16676004", "@IdType": "pubmed"}]}, "Citation": "Garrido C., Galluzzi L., Brunet M., Puig P.E., Didelot C., Kroemer G. Mechanisms of cytochrome c release from mitochondria. Cell Death Differ. 2006;13:1423\u20131433. doi: 10.1038/sj.cdd.4401950."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/sj.onc.1207517", "@IdType": "doi"}, {"#text": "15077142", "@IdType": "pubmed"}]}, "Citation": "Cregan S.P., Dawson V.L., Slack R.S. Role of AIF in caspase-dependent and caspase-independent cell death. Oncogene. 2004;23:2785\u20132796. doi: 10.1038/sj.onc.1207517."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/1756-9966-30-87", "@IdType": "doi"}, {"#text": "PMC3197541", "@IdType": "pmc"}, {"#text": "21943236", "@IdType": "pubmed"}]}, "Citation": "Wong R.S. Apoptosis in cancer: From pathogenesis to treatment. J. Exp. Clin. Cancer Res. 2011;30:87. doi: 10.1186/1756-9966-30-87."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1155/2012/524308", "@IdType": "doi"}, {"#text": "PMC3173728", "@IdType": "pmc"}, {"#text": "21941553", "@IdType": "pubmed"}]}, "Citation": "Tzifi F., Economopoulou C., Gourgiotis D., Ardavanis A., Papageorgiou S., Scorilas A. The Role of BCL2 Family of Apoptosis Regulator Proteins in Acute and Chronic Leukemias. Adv. Hematol. 2012;2012:524308. doi: 10.1155/2012/524308."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.biopha.2018.12.121", "@IdType": "doi"}, {"#text": "30841468", "@IdType": "pubmed"}]}, "Citation": "Mou T., Xie F., Zhong P., Hua H., Lai L., Yang Q., Wang J. MiR-345-5p functions as a tumor suppressor in pancreatic cancer by directly targeting CCL8. Biomed. Pharmacother. 2019;111:891\u2013900. doi: 10.1016/j.biopha.2018.12.121."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/1078-0432.CCR-16-1121", "@IdType": "doi"}, {"#text": "PMC5378683", "@IdType": "pmc"}, {"#text": "27702822", "@IdType": "pubmed"}]}, "Citation": "Zhang D., Li L., Jiang H., Knolhoff B.L., Lockhart A.C., Wang-Gillam A., DeNardo D.G., Ruzinova M.B., Lim K.H. Constitutive IRAK4 Activation Underlies Poor Prognosis and Chemoresistance in Pancreatic Ductal Adenocarcinoma. Clin. Cancer Res. 2017;23:1748\u20131759. doi: 10.1158/1078-0432.CCR-16-1121."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/cancers12092675", "@IdType": "doi"}, {"#text": "PMC7564842", "@IdType": "pmc"}, {"#text": "32961746", "@IdType": "pubmed"}]}, "Citation": "Khurana N., Dodhiawala P.B., Bulle A., Lim K.H. Deciphering the Role of Innate Immune NF-kB Pathway in Pancreatic Cancer. Cancers. 2020;12:2675. doi: 10.3390/cancers12092675."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1101/cshperspect.a000034", "@IdType": "doi"}, {"#text": "PMC2773619", "@IdType": "pmc"}, {"#text": "20066092", "@IdType": "pubmed"}]}, "Citation": "Oeckinghaus A., Ghosh S. The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb. Perspect. Biol. 2009;1:a000034. doi: 10.1101/cshperspect.a000034."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1111/j.1600-065X.2012.01099.x", "@IdType": "doi"}, {"#text": "22435567", "@IdType": "pubmed"}]}, "Citation": "DiDonato J.A., Mercurio F., Karin M. NF-kappaB and the link between inflammation and cancer. Immunol. Rev. 2012;246:379\u2013400. doi: 10.1111/j.1600-065X.2012.01099.x."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12865-017-0237-5", "@IdType": "doi"}, {"#text": "PMC5745793", "@IdType": "pmc"}, {"#text": "29281969", "@IdType": "pubmed"}]}, "Citation": "Ge B., Li J., Wei Z., Sun T., Song Y., Khan N.U. Functional expression of CCL8 and its interaction with chemokine receptor CCR3. BMC Immunol. 2017;18:54. doi: 10.1186/s12865-017-0237-5."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/ncb0407-361", "@IdType": "doi"}, {"#text": "17401385", "@IdType": "pubmed"}]}, "Citation": "Radisky D.C., Bissell M.J. NF-kappaB links oestrogen receptor signalling and EMT. Nat. Cell Biol. 2007;9:361\u2013363. doi: 10.1038/ncb0407-361."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1593/tlo.08013", "@IdType": "doi"}, {"#text": "PMC2510763", "@IdType": "pmc"}, {"#text": "18607507", "@IdType": "pubmed"}]}, "Citation": "Lee C.J., Li C., Simeone D.M. Human pancreatic cancer stem cells: Implications for how we treat pancreatic cancer. Transl. Oncol. 2008;1:14\u201318. doi: 10.1593/tlo.08013."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/onc.2009.220", "@IdType": "doi"}, {"#text": "PMC2910592", "@IdType": "pmc"}, {"#text": "19633682", "@IdType": "pubmed"}]}, "Citation": "Bailey J.M., Mohr A.M., Hollingsworth M.A. Sonic hedgehog paracrine signaling regulates metastasis and lymphangiogenesis in pancreatic cancer. Oncogene. 2009;28:3513\u20133525. doi: 10.1038/onc.2009.220."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/1078-0432.CCR-08-0291", "@IdType": "doi"}, {"#text": "PMC2782957", "@IdType": "pmc"}, {"#text": "18829478", "@IdType": "pubmed"}]}, "Citation": "Bailey J.M., Swanson B.J., Hamada T., Eggers J.P., Singh P.K., Caffery T., Ouellette M.M., Hollingsworth M.A. Sonic hedgehog promotes desmoplasia in pancreatic cancer. Clin. Cancer Res. 2008;14:5995\u20136004. doi: 10.1158/1078-0432.CCR-08-0291."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1371/journal.pone.0099886", "@IdType": "doi"}, {"#text": "PMC4062472", "@IdType": "pmc"}, {"#text": "24940606", "@IdType": "pubmed"}]}, "Citation": "Schou J.V., Rossi S., Jensen B.V., Nielsen D.L., Pfeiffer P., Hogdall E., Yilmaz M., Tejpar S., Delorenzi M., Kruhoffer M., et al. miR-345 in metastatic colorectal cancer: A non-invasive biomarker for clinical outcome in non-KRAS mutant patients treated with 3rd line cetuximab and irinotecan. PLoS ONE. 2014;9:e99886. doi: 10.1371/journal.pone.0099886."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.11649", "@IdType": "doi"}, {"#text": "PMC5325438", "@IdType": "pmc"}, {"#text": "27572313", "@IdType": "pubmed"}]}, "Citation": "Yu J., Li N., Wang X., Ren H., Wang W., Wang S., Song Y., Liu Y., Li Y., Zhou X., et al. Circulating serum microRNA-345 correlates with unfavorable pathological response to preoperative chemoradiotherapy in locally advanced rectal cancer. Oncotarget. 2016;7:64233\u201364243. doi: 10.18632/oncotarget.11649."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/ijo.2016.3517", "@IdType": "doi"}, {"#text": "27176124", "@IdType": "pubmed"}]}, "Citation": "Li Y., Zhang Y., Yao Z., Li S., Yin Z., Xu M. Forkhead box Q1: A key player in the pathogenesis of tumors (Review) Int. J. Oncol. 2016;49:51\u201358. doi: 10.3892/ijo.2016.3517."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/0008-5472.CAN-10-2825", "@IdType": "doi"}, {"#text": "PMC3906209", "@IdType": "pmc"}, {"#text": "21285253", "@IdType": "pubmed"}]}, "Citation": "Zhang H., Meng F., Liu G., Zhang B., Zhu J., Wu F., Ethier S.P., Miller F., Wu G. Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis. Cancer Res. 2011;71:1292\u20131301. doi: 10.1158/0008-5472.CAN-10-2825."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/or.2017.6001", "@IdType": "doi"}, {"#text": "PMC5780028", "@IdType": "pmc"}, {"#text": "29048674", "@IdType": "pubmed"}]}, "Citation": "Feng A., Yuan X., Li X. MicroRNA-345 inhibits metastasis and epithelial-mesenchymal transition of gastric cancer by targeting FOXQ1. Oncol. Rep. 2017;38:2752\u20132760. doi: 10.3892/or.2017.6001."}, {"ArticleIdList": {"ArticleId": {"#text": "12234996", "@IdType": "pubmed"}}, "Citation": "Lin L., Miller C.T., Contreras J.I., Prescott M.S., Dagenais S.L., Wu R., Yee J., Orringer M.B., Misek D.E., Hanash S.M., et al. The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas. Cancer Res. 2002;62:5273\u20135279."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/sj.onc.1207392", "@IdType": "doi"}, {"#text": "14767473", "@IdType": "pubmed"}]}, "Citation": "Nakamura T., Furukawa Y., Nakagawa H., Tsunoda T., Ohigashi H., Murata K., Ishikawa O., Ohgaki K., Kashimura N., Miyamoto M., et al. Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection. Oncogene. 2004;23:2385\u20132400. doi: 10.1038/sj.onc.1207392."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.4161/cbt.3.11.1175", "@IdType": "doi"}, {"#text": "15467436", "@IdType": "pubmed"}]}, "Citation": "Cao D., Hustinx S.R., Sui G., Bala P., Sato N., Martin S., Maitra A., Murphy K.M., Cameron J.L., Yeo C.J., et al. Identification of novel highly expressed genes in pancreatic ductal adenocarcinomas through a bioinformatics analysis of expressed sequence tags. Cancer Biol. Ther. 2004;3:1081\u20131090. doi: 10.4161/cbt.3.11.1175."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nrc2223", "@IdType": "doi"}, {"#text": "17943136", "@IdType": "pubmed"}]}, "Citation": "Myatt S.S., Lam E.W. The emerging roles of forkhead box (Fox) proteins in cancer. Nat. Rev. Cancer. 2007;7:847\u2013859. doi: 10.1038/nrc2223."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/pros.23650", "@IdType": "doi"}, {"#text": "29748958", "@IdType": "pubmed"}]}, "Citation": "Tinay I., Tan M., Gui B., Werner L., Kibel A.S., Jia L. Functional roles and potential clinical application of miRNA-345-5p in prostate cancer. Prostate. 2018;78:927\u2013937. doi: 10.1002/pros.23650."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s00432-015-2016-0", "@IdType": "doi"}, {"#text": "26227059", "@IdType": "pubmed"}]}, "Citation": "Chen Q.G., Zhou W., Han T., Du S.Q., Li Z.H., Zhang Z., Shan G.Y., Kong C.Z. MiR-345 suppresses proliferation, migration and invasion by targeting Smad1 in human prostate cancer. J. Cancer Res. Clin. Oncol. 2016;142:213\u2013224. doi: 10.1007/s00432-015-2016-0."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.26355/eurrev_201903_17390", "@IdType": "doi"}, {"#text": "30964169", "@IdType": "pubmed"}]}, "Citation": "Zhang M.Y., Lin J., Kui Y.C. MicroRNA-345 suppresses cell invasion and migration in non-small cell lung cancer by directly targeting YAP1. Eur. Rev. Med. Pharmacol. Sci. 2019;23:2436\u20132443. doi: 10.26355/eurrev_201903_17390."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1371/journal.pone.0043268", "@IdType": "doi"}, {"#text": "PMC3427341", "@IdType": "pmc"}, {"#text": "22937028", "@IdType": "pubmed"}]}, "Citation": "Wang T., Lv M., Shen S., Zhou S., Wang P., Chen Y., Liu B., Yu L., Hou Y. Cell-free microRNA expression profiles in malignant effusion associated with patient survival in non-small cell lung cancer. PLoS ONE. 2012;7:e43268. doi: 10.1371/journal.pone.0043268."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4723872", "@IdType": "pmc"}, {"#text": "26885027", "@IdType": "pubmed"}]}, "Citation": "Chen L., Li X., Chen X. Prognostic significance of tissue miR-345 downregulation in non-small cell lung cancer. Int. J. Clin. Exp. Med. 2015;8:20971\u201320976."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1158/1078-0432.CCR-07-0523", "@IdType": "doi"}, {"#text": "PMC2755230", "@IdType": "pmc"}, {"#text": "18223217", "@IdType": "pubmed"}]}, "Citation": "Jiang J., Gusev Y., Aderca I., Mettler T.A., Nagorney D.M., Brackett D.J., Roberts L.R., Schmittgen T.D. Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin. Cancer Res. 2008;14:419\u2013427. doi: 10.1158/1078-0432.CCR-07-0523."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1371/journal.pone.0061089", "@IdType": "doi"}, {"#text": "PMC3620056", "@IdType": "pmc"}, {"#text": "23577194", "@IdType": "pubmed"}]}, "Citation": "Shiu T.Y., Huang S.M., Shih Y.L., Chu H.C., Chang W.K., Hsieh T.Y. Hepatitis C virus core protein down-regulates p21(Waf1/Cip1) and inhibits curcumin-induced apoptosis through microRNA-345 targeting in human hepatoma cells. PLoS ONE. 2013;8:e61089. doi: 10.1371/journal.pone.0061089."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/ol.2018.9669", "@IdType": "doi"}, {"#text": "PMC6312945", "@IdType": "pmc"}, {"#text": "30655879", "@IdType": "pubmed"}]}, "Citation": "Ding A., Wang C., Zhang L. Effects of miR-101, miR-345 on HBV replication regulation and on the growth of liver cancer cells. Oncol. Lett. 2019;17:1167\u20131171. doi: 10.3892/ol.2018.9669."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1159/000347209", "@IdType": "doi"}, {"#text": "23797136", "@IdType": "pubmed"}]}, "Citation": "Ringelhan M., Heikenwalder M., Protzer U. Direct effects of hepatitis B virus-encoded proteins and chronic infection in liver cancer development. Dig. Dis. 2013;31:138\u2013151. doi: 10.1159/000347209."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.vaccine.2013.08.012", "@IdType": "doi"}, {"#text": "23948229", "@IdType": "pubmed"}]}, "Citation": "Liang X., Bi S., Yang W., Wang L., Cui G., Cui F., Zhang Y., Liu J., Gong X., Chen Y., et al. Reprint of: Epidemiological serosurvey of Hepatitis B in China\u2014Declining HBV prevalence due to Hepatitis B vaccination. Vaccine. 2013;31((Suppl. S9)):J21\u2013J28. doi: 10.1016/j.vaccine.2013.08.012."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/or.2017.5772", "@IdType": "doi"}, {"#text": "PMC5562085", "@IdType": "pmc"}, {"#text": "28677785", "@IdType": "pubmed"}]}, "Citation": "Zhang H., Liu H., Bi H. MicroRNA-345 inhibits hepatocellular carcinoma metastasis by inhibiting YAP1. Oncol. Rep. 2017;38:843\u2013849. doi: 10.3892/or.2017.5772."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/s41556-018-0142-z", "@IdType": "doi"}, {"#text": "PMC6186418", "@IdType": "pmc"}, {"#text": "30050119", "@IdType": "pubmed"}]}, "Citation": "Totaro A., Panciera T., Piccolo S. YAP/TAZ upstream signals and downstream responses. Nat. Cell Biol. 2018;20:888\u2013899. doi: 10.1038/s41556-018-0142-z."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.cell.2014.06.003", "@IdType": "doi"}, {"#text": "PMC4109295", "@IdType": "pmc"}, {"#text": "24954535", "@IdType": "pubmed"}]}, "Citation": "Kapoor A., Yao W., Ying H., Hua S., Liewen A., Wang Q., Zhong Y., Wu C.J., Sadanandam A., Hu B., et al. Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer. Cell. 2014;158:185\u2013197. doi: 10.1016/j.cell.2014.06.003."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.ccell.2016.05.005", "@IdType": "doi"}, {"#text": "PMC6186419", "@IdType": "pmc"}, {"#text": "27300434", "@IdType": "pubmed"}]}, "Citation": "Zanconato F., Cordenonsi M., Piccolo S. YAP/TAZ at the Roots of Cancer. Cancer Cell. 2016;29:783\u2013803. doi: 10.1016/j.ccell.2016.05.005."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.4161/cc.21278", "@IdType": "doi"}, {"#text": "22801550", "@IdType": "pubmed"}]}, "Citation": "Cheung T.H., Man K.N., Yu M.Y., Yim S.F., Siu N.S., Lo K.W., Doran G., Wong R.R., Wang V.W., Smith D.I., et al. Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm. Cell Cycle. 2012;11:2876\u20132884. doi: 10.4161/cc.21278."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/ijc.25191", "@IdType": "doi"}, {"#text": "20099276", "@IdType": "pubmed"}]}, "Citation": "Pogribny I.P., Filkowski J.N., Tryndyak V.P., Golubov A., Shpyleva S.I., Kovalchuk O. Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin. Int. J. Cancer. 2010;127:1785\u20131794. doi: 10.1002/ijc.25191."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2147/OTT.S152462", "@IdType": "doi"}, {"#text": "PMC5865556", "@IdType": "pmc"}, {"#text": "29593419", "@IdType": "pubmed"}]}, "Citation": "Hu W., Tan C., He Y., Zhang G., Xu Y., Tang J. Functional miRNAs in breast cancer drug resistance. OncoTargets Ther. 2018;11:1529\u20131541. doi: 10.2147/OTT.S152462."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.canlet.2020.03.025", "@IdType": "doi"}, {"#text": "32246957", "@IdType": "pubmed"}]}, "Citation": "Ulasov I., Borovjagin A., Fares J., Yakushov S., Malin D., Timashev P., Lesniak M.S. MicroRNA 345 (miR345) regulates KISS1-E-cadherin functional interaction in breast cancer brain metastases. Cancer Lett. 2020;481:24\u201331. doi: 10.1016/j.canlet.2020.03.025."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1093/hmg/ddp446", "@IdType": "doi"}, {"#text": "19776030", "@IdType": "pubmed"}]}, "Citation": "Cervigne N.K., Reis P.P., Machado J., Sadikovic B., Bradley G., Galloni N.N., Pintilie M., Jurisica I., Perez-Ordonez B., Gilbert R., et al. Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma. Hum. Mol. Genet. 2009;18:4818\u20134829. doi: 10.1093/hmg/ddp446."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/ijms19061789", "@IdType": "doi"}, {"#text": "PMC6032413", "@IdType": "pmc"}, {"#text": "29914173", "@IdType": "pubmed"}]}, "Citation": "Gissi D.B., Morandi L., Gabusi A., Tarsitano A., Marchetti C., Cura F., Palmieri A., Montebugnoli L., Asioli S., Foschini M.P., et al. A Noninvasive Test for MicroRNA Expression in Oral Squamous Cell Carcinoma. Int. J. Mol. Sci. 2018;19:1789. doi: 10.3390/ijms19061789."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.archoralbio.2020.104732", "@IdType": "doi"}, {"#text": "32445972", "@IdType": "pubmed"}]}, "Citation": "Wu J., Cao J., Li X., Wu B., Zhang S. MicroRNA-345 functions as a tumor suppressor via targeting ZEB2 in oral squamous cell carcinoma. Arch. Oral Biol. 2020;116:104732. doi: 10.1016/j.archoralbio.2020.104732."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5489885", "@IdType": "pmc"}, {"#text": "28670373", "@IdType": "pubmed"}]}, "Citation": "Li M.Z., Wang J.J., Yang S.B., Li W.F., Xiao L.B., He Y.L., Song X.M. ZEB2 promotes tumor metastasis and correlates with poor prognosis of human colorectal cancer. Am. J. Transl. Res. 2017;9:2838\u20132851."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s10620-012-2042-6", "@IdType": "doi"}, {"#text": "22350782", "@IdType": "pubmed"}]}, "Citation": "Dai Y.H., Tang Y.P., Zhu H.Y., Lv L., Chu Y., Zhou Y.Q., Huo J.R. ZEB2 promotes the metastasis of gastric cancer and modulates epithelial mesenchymal transition of gastric cancer cells. Dig. Dis. Sci. 2012;57:1253\u20131260. doi: 10.1007/s10620-012-2042-6."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/or.2013.2267", "@IdType": "doi"}, {"#text": "23381389", "@IdType": "pubmed"}]}, "Citation": "Cong N., Du P., Zhang A., Shen F., Su J., Pu P., Wang T., Zjang J., Kang C., Zhang Q. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/beta-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma. Oncol. Rep. 2013;29:1579\u20131587. doi: 10.3892/or.2013.2267."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1111/j.1349-7006.2009.01204.x", "@IdType": "doi"}, {"#text": "19486012", "@IdType": "pubmed"}]}, "Citation": "Yoshihara K., Tajima A., Komata D., Yamamoto T., Kodama S., Fujiwara H., Suzuki M., Onishi Y., Hatae M., Sueyoshi K., et al. Gene expression profiling of advanced-stage serous ovarian cancers distinguishes novel subclasses and implicates ZEB2 in tumor progression and prognosis. Cancer Sci. 2009;100:1421\u20131428. doi: 10.1111/j.1349-7006.2009.01204.x."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1371/journal.pone.0134045", "@IdType": "doi"}, {"#text": "PMC4516250", "@IdType": "pmc"}, {"#text": "26214683", "@IdType": "pubmed"}]}, "Citation": "Kong Y.H., Syed Zanaruddin S.N., Lau S.H., Ramanathan A., Kallarakkal T.G., Vincent-Chong V.K., Wan Mustafa W.M., Abraham M.T., Abdul Rahman Z.A., Zain R.B., et al. Co-Expression of TWIST1 and ZEB2 in Oral Squamous Cell Carcinoma Is Associated with Poor Survival. PLoS ONE. 2015;10:e0134045. doi: 10.1371/journal.pone.0134045."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/gcc.20669", "@IdType": "doi"}, {"#text": "19396864", "@IdType": "pubmed"}]}, "Citation": "Guled M., Lahti L., Lindholm P.M., Salmenkivi K., Bagwan I., Nicholson A.G., Knuutila S. CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis. Genes Chromosomes Cancer. 2009;48:615\u2013623. doi: 10.1002/gcc.20669."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1002/jcb.27461", "@IdType": "doi"}, {"#text": "30278103", "@IdType": "pubmed"}]}, "Citation": "Ying X., Zhang W., Fang M., Zhang W., Wang C., Han L. miR-345-5p regulates proliferation, cell cycle, and apoptosis of acute myeloid leukemia cells by targeting AKT2. J. Cell Biochem. 2018;120:1620\u20131629. doi: 10.1002/jcb.27461."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.blre.2017.11.006", "@IdType": "doi"}, {"#text": "29276026", "@IdType": "pubmed"}]}, "Citation": "Herschbein L., Liesveld J.L. Dueling for dual inhibition: Means to enhance effectiveness of PI3K/Akt/mTOR inhibitors in AML. Blood Rev. 2018;32:235\u2013248. doi: 10.1016/j.blre.2017.11.006."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1200/JCO.2010.31.0904", "@IdType": "doi"}, {"#text": "PMC4874213", "@IdType": "pmc"}, {"#text": "21220598", "@IdType": "pubmed"}]}, "Citation": "Konopleva M.Y., Jordan C.T. Leukemia stem cells and microenvironment: Biology and therapeutic targeting. J. Clin. Oncol. 2011;29:591\u2013599. doi: 10.1200/JCO.2010.31.0904."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1080/14728222.2017.1333600", "@IdType": "doi"}, {"#text": "28537457", "@IdType": "pubmed"}]}, "Citation": "Tabe Y., Tafuri A., Sekihara K., Yang H., Konopleva M. Inhibition of mTOR kinase as a therapeutic target for acute myeloid leukemia. Expert Opin. Ther. Targets. 2017;21:705\u2013714. doi: 10.1080/14728222.2017.1333600."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.4061/2011/407123", "@IdType": "doi"}, {"#text": "PMC3112511", "@IdType": "pmc"}, {"#text": "21687652", "@IdType": "pubmed"}]}, "Citation": "Marini F., Luzi E., Brandi M.L. MicroRNA Role in Thyroid Cancer Development. J. Thyroid Res. 2011;2011:407123. doi: 10.4061/2011/407123."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1007/s00784-020-03773-9", "@IdType": "doi"}, {"#text": "33439343", "@IdType": "pubmed"}]}, "Citation": "Assao A., Domingues M.A.C., Minicucci E.M., Marchi F.A., Coutinho-Camillo C.M., Oliveira D.T. The relevance of miRNAs as promising biomarkers in lip cancer. Clin. Oral Investig. 2021;25:4591\u20134598. doi: 10.1007/s00784-020-03773-9."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1186/s12935-020-01416-3", "@IdType": "doi"}, {"#text": "PMC7372762", "@IdType": "pmc"}, {"#text": "32699526", "@IdType": "pubmed"}]}, "Citation": "Cao J., Tang Z., Su Z. Long non-coding RNA LINC01426 facilitates glioblastoma progression via sponging miR-345-3p and upregulation of VAMP8. Cancer Cell Int. 2020;20:327. doi: 10.1186/s12935-020-01416-3."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.18632/oncotarget.7266", "@IdType": "doi"}, {"#text": "PMC4924655", "@IdType": "pmc"}, {"#text": "26872371", "@IdType": "pubmed"}]}, "Citation": "Yang C., Wu D., Gao L., Liu X., Jin Y., Wang D., Wang T., Li X. Competing endogenous RNA networks in human cancer: Hypothesis, validation, and perspectives. Oncotarget. 2016;7:13479\u201313490. doi: 10.18632/oncotarget.7266."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3892/ol.2015.3698", "@IdType": "doi"}, {"#text": "PMC4665929", "@IdType": "pmc"}, {"#text": "26722227", "@IdType": "pubmed"}]}, "Citation": "Dai Q., Li J., Zhou K., Liang T. Competing endogenous RNA: A novel posttranscriptional regulatory dimension associated with the progression of cancer. Oncol. Lett. 2015;10:2683\u20132690. doi: 10.3892/ol.2015.3698."}, {"Citation": "First-in-Human Study of INT-1B3 in Patients with Advanced Solid Tumors.  [(accessed on 31 May 2021)]; Available online:  https://clinicaltrials.gov/ct2/show/NCT04675996."}, {"Citation": "Safety and Proof-of-Concept (POC) Study with AMT-130 in Adults with Early Manifest Huntington Disease.  [(accessed on 31 May 2021)]; Available online:  https://clinicaltrials.gov/ct2/show/NCT04120493."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.jconrel.2014.09.001", "@IdType": "doi"}, {"#text": "PMC4254052", "@IdType": "pmc"}, {"#text": "25204288", "@IdType": "pubmed"}]}, "Citation": "Gandhi N.S., Tekade R.K., Chougule M.B. Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: Current progress and advances. J. Control. Release Off. J. Control. Release Soc. 2014;194:238\u2013256. doi: 10.1016/j.jconrel.2014.09.001."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1172/JCI33494", "@IdType": "doi"}, {"#text": "PMC2096447", "@IdType": "pmc"}, {"#text": "18060020", "@IdType": "pubmed"}]}, "Citation": "Akhtar S., Benter I.F. Nonviral delivery of synthetic siRNAs in vivo. J. Clin. Investig. 2007;117:3623\u20133632. doi: 10.1172/JCI33494."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2174/1389557515666150324123208", "@IdType": "doi"}, {"#text": "PMC4410078", "@IdType": "pmc"}, {"#text": "25807941", "@IdType": "pubmed"}]}, "Citation": "Simonson B., Das S. MicroRNA Therapeutics: The Next Magic Bullet? Mini Rev. Med. Chem. 2015;15:467\u2013474. doi: 10.2174/1389557515666150324123208."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.jconrel.2019.10.007", "@IdType": "doi"}, {"#text": "PMC6900258", "@IdType": "pmc"}, {"#text": "31622695", "@IdType": "pubmed"}]}, "Citation": "Lee S.W.L., Paoletti C., Campisi M., Osaki T., Adriani G., Kamm R.D., Mattu C., Chiono V. MicroRNA delivery through nanoparticles. J. Control. Release Off. J. Control. Release Soc. 2019;313:80\u201395. doi: 10.1016/j.jconrel.2019.10.007."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2147/IJN.S207837", "@IdType": "doi"}, {"#text": "PMC6529035", "@IdType": "pmc"}, {"#text": "31190817", "@IdType": "pubmed"}]}, "Citation": "Yan Y., Li X.-Q., Duan J.-L., Bao C.-J., Cui Y.-N., Su Z.-B., Xu J.-R., Luo Q., Chen M., Xie Y., et al. Nanosized functional miRNA liposomes and application in the treatment of TNBC by silencing Slug gene. Int. J. Nanomed. 2019;14:3645\u20133667. doi: 10.2147/IJN.S207837."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.omtn.2019.10.045", "@IdType": "doi"}, {"#text": "PMC6938807", "@IdType": "pmc"}, {"#text": "31877409", "@IdType": "pubmed"}]}, "Citation": "Gokita K., Inoue J., Ishihara H., Kojima K., Inazawa J. Therapeutic Potential of LNP-Mediated Delivery of miR-634 for Cancer Therapy. Mol. Ther. Nucleic Acids. 2020;19:330\u2013338. doi: 10.1016/j.omtn.2019.10.045."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.biomaterials.2011.10.071", "@IdType": "doi"}, {"#text": "22098779", "@IdType": "pubmed"}]}, "Citation": "Yang Y.P., Chien Y., Chiou G.Y., Cherng J.Y., Wang M.L., Lo W.L., Chang Y.L., Huang P.I., Chen Y.W., Shih Y.H., et al. Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI. Biomaterials. 2012;33:1462\u20131476. doi: 10.1016/j.biomaterials.2011.10.071."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.biomaterials.2014.04.053", "@IdType": "doi"}, {"#text": "24836307", "@IdType": "pubmed"}]}, "Citation": "Mittal A., Chitkara D., Behrman S.W., Mahato R.I. Efficacy of gemcitabine conjugated and miRNA-205 complexed micelles for treatment of advanced pancreatic cancer. Biomaterials. 2014;35:7077\u20137087. doi: 10.1016/j.biomaterials.2014.04.053."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1111/cas.13267", "@IdType": "doi"}, {"#text": "PMC5497927", "@IdType": "pmc"}, {"#text": "28444967", "@IdType": "pubmed"}]}, "Citation": "Li Y., Chen Y., Li J., Zhang Z., Huang C., Lian G., Yang K., Chen S., Lin Y., Wang L., et al. Co-delivery of microRNA-21 antisense oligonucleotides and gemcitabine using nanomedicine for pancreatic cancer therapy. Cancer Sci. 2017;108:1493\u20131503. doi: 10.1111/cas.13267."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/cancers11050640", "@IdType": "doi"}, {"#text": "PMC6562917", "@IdType": "pmc"}, {"#text": "31072061", "@IdType": "pubmed"}]}, "Citation": "Yoo J., Park C., Yi G., Lee D., Koo H. Active Targeting Strategies Using Biological Ligands for Nanoparticle Drug Delivery Systems. Cancers. 2019;11:640. doi: 10.3390/cancers11050640."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1021/acsami.8b06642", "@IdType": "doi"}, {"#text": "29978708", "@IdType": "pubmed"}]}, "Citation": "Gupta B., Ruttala H.B., Poudel B.K., Pathak S., Regmi S., Gautam M., Poudel K., Sung M.H., Ou W., Jin S.G., et al. Polyamino Acid Layer-by-Layer (LbL) Constructed Silica-Supported Mesoporous Titania Nanocarriers for Stimuli-Responsive Delivery of microRNA 708 and Paclitaxel for Combined Chemotherapy. ACS Appl. Mater. Interfaces. 2018;10:24392\u201324405. doi: 10.1021/acsami.8b06642."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.2147/IJN.S61949", "@IdType": "doi"}, {"#text": "PMC4069140", "@IdType": "pmc"}, {"#text": "24971005", "@IdType": "pubmed"}]}, "Citation": "Arora S., Swaminathan S.K., Kirtane A., Srivastava S.K., Bhardwaj A., Singh S., Panyam J., Singh A.P. Synthesis, characterization, and evaluation of poly (D,L-lactide-co-glycolide)-based nanoformulation of miRNA-150: Potential implications for pancreatic cancer therapy. Int. J. Nanomed. 2014;9:2933\u20132942. doi: 10.2147/IJN.S61949."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.3390/polym3031377", "@IdType": "doi"}, {"#text": "PMC3347861", "@IdType": "pmc"}, {"#text": "22577513", "@IdType": "pubmed"}]}, "Citation": "Makadia H.K., Siegel S.J. Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier. Polymers. 2011;3:1377\u20131397. doi: 10.3390/polym3031377."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nbt.3330", "@IdType": "doi"}, {"#text": "PMC4978509", "@IdType": "pmc"}, {"#text": "26348965", "@IdType": "pubmed"}]}, "Citation": "Blanco E., Shen H., Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat. Biotechnol. 2015;33:941\u2013951. doi: 10.1038/nbt.3330."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1371/journal.pone.0024374", "@IdType": "doi"}, {"#text": "PMC3172229", "@IdType": "pmc"}, {"#text": "21931696", "@IdType": "pubmed"}]}, "Citation": "Arvizo R.R., Miranda O.R., Moyano D.F., Walden C.A., Giri K., Bhattacharya R., Robertson J.D., Rotello V.M., Reid J.M., Mukherjee P. Modulating pharmacokinetics, tumor uptake and biodistribution by engineered nanoparticles. PLoS ONE. 2011;6:e24374. doi: 10.1371/journal.pone.0024374."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.addr.2018.07.007", "@IdType": "doi"}, {"#text": "PMC6130746", "@IdType": "pmc"}, {"#text": "30009886", "@IdType": "pubmed"}]}, "Citation": "Golombek S.K., May J.N., Theek B., Appold L., Drude N., Kiessling F., Lammers T. Tumor targeting via EPR: Strategies to enhance patient responses. Adv. Drug Deliv. Rev. 2018;130:17\u201338. doi: 10.1016/j.addr.2018.07.007."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1038/nbt1340", "@IdType": "doi"}, {"#text": "PMC2702539", "@IdType": "pmc"}, {"#text": "17891134", "@IdType": "pubmed"}]}, "Citation": "Choi H.S., Liu W., Misra P., Tanaka E., Zimmer J.P., Itty Ipe B., Bawendi M.G., Frangioni J.V. Renal clearance of quantum dots. Nat. Biotechnol. 2007;25:1165\u20131170. doi: 10.1038/nbt1340."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.7150/thno.24945", "@IdType": "doi"}, {"#text": "PMC6096395", "@IdType": "pmc"}, {"#text": "30128034", "@IdType": "pubmed"}]}, "Citation": "Kumar V., Mundra V., Peng Y., Wang Y., Tan C., Mahato R.I. Pharmacokinetics and biodistribution of polymeric micelles containing miRNA and small-molecule drug in orthotopic pancreatic tumor-bearing mice. Theranostics. 2018;8:4033\u20134049. doi: 10.7150/thno.24945."}, {"ArticleIdList": {"ArticleId": [{"#text": "10.1016/j.actbio.2010.11.033", "@IdType": "doi"}, {"#text": "21115139", "@IdType": "pubmed"}]}, "Citation": "Zhang B., Mallapragada S. The mechanism of selective transfection mediated by pentablock copolymers; part II: Nuclear entry and endosomal escape. Acta Biomater. 2011;7:1580\u20131587. doi: 10.1016/j.actbio.2010.11.033."}]}}}}}, "PMC": "PMC8707074", "PMID": "34959269", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "Emerging Role of miR-345 and Its Effective Delivery as a Potential Therapeutic Candidate in Pancreatic Cancer and Other Cancers.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "48": {"Abstract": "Cancer cells that develop resistance to chemotherapeutic agents are a major clinical obstacle in the successful treatment of breast cancer. Acquired cancer chemoresistance is a multifactorial phenomenon, involving various mechanisms and processes. Recent studies suggest that chemoresistance may be linked to drug-induced dysregulation of microRNA function. Furthermore, mounting evidence indicates the existence of similarities between drug-resistant and metastatic cancer cells in terms of resistance to apoptosis and enhanced invasiveness. We studied the role of miRNA alterations in the acquisition of cisplatin-resistant phenotype in MCF-7 human breast adenocarcinoma cells. We identified a total of 103 miRNAs that were overexpressed or underexpressed (46 upregulated and 57 downregulated) in MCF-7 cells resistant to cisplatin. These differentially expressed miRNAs are involved in the control of cell signaling, cell survival, DNA methylation and invasiveness. The most significantly dysregulated miRNAs were miR-146a, miR-10a, miR-221/222, miR-345, miR-200b and miR-200c. Furthermore, we demonstrated that miR-345 and miR-7 target the human multidrug resistance-associated protein 1. These results suggest that dysregulated miRNA expression may underlie the abnormal functioning of critical cellular processes associated with the cisplatin-resistant phenotype.", "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "865003654886981765", "Part1": "Division of Biochemical Toxicology", "Part2": "National Center for Toxicological Research", "Part3": "Jefferson", "Part4": "AR 72079", "Part5": "USA. igor.pogribny@fda.hhs.gov", "Part6": null, "Text": "Division of Biochemical Toxicology, National Center for Toxicological Research, Jefferson, AR 72079, USA. igor.pogribny@fda.hhs.gov"}], "ForeName": "Igor P", "FullName": "Igor P Pogribny", "HashID": "8320865782440690217", "LastName": "Pogribny", "ORCID": null}, {"Affiliations": null, "ForeName": "Jody N", "FullName": "Jody N Filkowski", "HashID": "590882526204680382", "LastName": "Filkowski", "ORCID": null}, {"Affiliations": null, "ForeName": "Volodymyr P", "FullName": "Volodymyr P Tryndyak", "HashID": "-3800104315581714563", "LastName": "Tryndyak", "ORCID": null}, {"Affiliations": null, "ForeName": "Andrey", "FullName": "Andrey Golubov", "HashID": "-1477574974200933040", "LastName": "Golubov", "ORCID": null}, {"Affiliations": null, "ForeName": "Svitlana I", "FullName": "Svitlana I Shpyleva", "HashID": "674008623431150093", "LastName": "Shpyleva", "ORCID": null}, {"Affiliations": null, "ForeName": "Olga", "FullName": "Olga Kovalchuk", "HashID": "2990559432700696104", "LastName": "Kovalchuk", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.1002/ijc.25191", "InsertType": null, "Journal": "International journal of cancer", "Keywords": [{"IS_Major": false, "IS_Mesh": true, "Text": "Antineoplastic Agents"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Biomarkers, Tumor"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Blotting, Western"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Breast Neoplasms"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Cisplatin"}, {"IS_Major": true, "IS_Mesh": true, "Text": "Drug Resistance, Neoplasm"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Female"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Gene Expression Profiling"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Humans"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Luciferases"}, {"IS_Major": false, "IS_Mesh": true, "Text": "MicroRNAs"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Multidrug Resistance-Associated Proteins"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Oligonucleotide Array Sequence Analysis"}, {"IS_Major": false, "IS_Mesh": true, "Text": "RNA, Messenger"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Reverse Transcriptase Polymerase Chain Reaction"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Tumor Cells, Cultured"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "MEDLINE", "Article": {"@PubModel": "Print", "Abstract": {"AbstractText": "Cancer cells that develop resistance to chemotherapeutic agents are a major clinical obstacle in the successful treatment of breast cancer. Acquired cancer chemoresistance is a multifactorial phenomenon, involving various mechanisms and processes. Recent studies suggest that chemoresistance may be linked to drug-induced dysregulation of microRNA function. Furthermore, mounting evidence indicates the existence of similarities between drug-resistant and metastatic cancer cells in terms of resistance to apoptosis and enhanced invasiveness. We studied the role of miRNA alterations in the acquisition of cisplatin-resistant phenotype in MCF-7 human breast adenocarcinoma cells. We identified a total of 103 miRNAs that were overexpressed or underexpressed (46 upregulated and 57 downregulated) in MCF-7 cells resistant to cisplatin. These differentially expressed miRNAs are involved in the control of cell signaling, cell survival, DNA methylation and invasiveness. The most significantly dysregulated miRNAs were miR-146a, miR-10a, miR-221/222, miR-345, miR-200b and miR-200c. Furthermore, we demonstrated that miR-345 and miR-7 target the human multidrug resistance-associated protein 1. These results suggest that dysregulated miRNA expression may underlie the abnormal functioning of critical cellular processes associated with the cisplatin-resistant phenotype."}, "ArticleTitle": "Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Division of Biochemical Toxicology, National Center for Toxicological Research, Jefferson, AR 72079, USA. igor.pogribny@fda.hhs.gov"}, "ForeName": "Igor P", "Initials": "IP", "LastName": "Pogribny"}, {"@ValidYN": "Y", "ForeName": "Jody N", "Initials": "JN", "LastName": "Filkowski"}, {"@ValidYN": "Y", "ForeName": "Volodymyr P", "Initials": "VP", "LastName": "Tryndyak"}, {"@ValidYN": "Y", "ForeName": "Andrey", "Initials": "A", "LastName": "Golubov"}, {"@ValidYN": "Y", "ForeName": "Svitlana I", "Initials": "SI", "LastName": "Shpyleva"}, {"@ValidYN": "Y", "ForeName": "Olga", "Initials": "O", "LastName": "Kovalchuk"}]}, "ELocationID": {"#text": "10.1002/ijc.25191", "@EIdType": "doi", "@ValidYN": "Y"}, "Journal": {"ISOAbbreviation": "Int J Cancer", "ISSN": {"#text": "1097-0215", "@IssnType": "Electronic"}, "JournalIssue": {"@CitedMedium": "Internet", "Issue": "8", "PubDate": {"Day": "15", "Month": "Oct", "Year": "2010"}, "Volume": "127"}, "Title": "International journal of cancer"}, "Language": "eng", "Pagination": {"EndPage": "1794", "MedlinePgn": "1785-94", "StartPage": "1785"}, "PublicationTypeList": {"PublicationType": [{"#text": "Journal Article", "@UI": "D016428"}, {"#text": "Research Support, Non-U.S. Gov't", "@UI": "D013485"}]}}, "ChemicalList": {"Chemical": [{"NameOfSubstance": {"#text": "Antineoplastic Agents", "@UI": "D000970"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "Biomarkers, Tumor", "@UI": "D014408"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "MicroRNAs", "@UI": "D035683"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "Multidrug Resistance-Associated Proteins", "@UI": "D027425"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "RNA, Messenger", "@UI": "D012333"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "Luciferases", "@UI": "D008156"}, "RegistryNumber": "EC 1.13.12.-"}, {"NameOfSubstance": {"#text": "Cisplatin", "@UI": "D002945"}, "RegistryNumber": "Q20Q21Q62J"}, {"NameOfSubstance": {"#text": "multidrug resistance-associated protein 1", "@UI": "C421109"}, "RegistryNumber": "Y49M64GZ4Q"}]}, "CitationSubset": "IM", "DateCompleted": {"Day": "23", "Month": "09", "Year": "2010"}, "DateRevised": {"Day": "21", "Month": "03", "Year": "2022"}, "MedlineJournalInfo": {"Country": "United States", "ISSNLinking": "0020-7136", "MedlineTA": "Int J Cancer", "NlmUniqueID": "0042124"}, "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"#text": "Antineoplastic Agents", "@MajorTopicYN": "N", "@UI": "D000970"}, "QualifierName": {"#text": "pharmacology", "@MajorTopicYN": "Y", "@UI": "Q000494"}}, {"DescriptorName": {"#text": "Biomarkers, Tumor", "@MajorTopicYN": "N", "@UI": "D014408"}, "QualifierName": [{"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}, {"#text": "metabolism", "@MajorTopicYN": "N", "@UI": "Q000378"}]}, {"DescriptorName": {"#text": "Blotting, Western", "@MajorTopicYN": "N", "@UI": "D015153"}}, {"DescriptorName": {"#text": "Breast Neoplasms", "@MajorTopicYN": "N", "@UI": "D001943"}, "QualifierName": [{"#text": "drug therapy", "@MajorTopicYN": "Y", "@UI": "Q000188"}, {"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}, {"#text": "pathology", "@MajorTopicYN": "N", "@UI": "Q000473"}]}, {"DescriptorName": {"#text": "Cisplatin", "@MajorTopicYN": "N", "@UI": "D002945"}, "QualifierName": {"#text": "pharmacology", "@MajorTopicYN": "Y", "@UI": "Q000494"}}, {"DescriptorName": {"#text": "Drug Resistance, Neoplasm", "@MajorTopicYN": "Y", "@UI": "D019008"}}, {"DescriptorName": {"#text": "Female", "@MajorTopicYN": "N", "@UI": "D005260"}}, {"DescriptorName": {"#text": "Gene Expression Profiling", "@MajorTopicYN": "N", "@UI": "D020869"}}, {"DescriptorName": {"#text": "Humans", "@MajorTopicYN": "N", "@UI": "D006801"}}, {"DescriptorName": {"#text": "Luciferases", "@MajorTopicYN": "N", "@UI": "D008156"}, "QualifierName": {"#text": "metabolism", "@MajorTopicYN": "N", "@UI": "Q000378"}}, {"DescriptorName": {"#text": "MicroRNAs", "@MajorTopicYN": "N", "@UI": "D035683"}, "QualifierName": {"#text": "physiology", "@MajorTopicYN": "Y", "@UI": "Q000502"}}, {"DescriptorName": {"#text": "Multidrug Resistance-Associated Proteins", "@MajorTopicYN": "N", "@UI": "D027425"}, "QualifierName": [{"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}, {"#text": "metabolism", "@MajorTopicYN": "N", "@UI": "Q000378"}]}, {"DescriptorName": {"#text": "Oligonucleotide Array Sequence Analysis", "@MajorTopicYN": "N", "@UI": "D020411"}}, {"DescriptorName": {"#text": "RNA, Messenger", "@MajorTopicYN": "N", "@UI": "D012333"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Reverse Transcriptase Polymerase Chain Reaction", "@MajorTopicYN": "N", "@UI": "D020133"}}, {"DescriptorName": {"#text": "Tumor Cells, Cultured", "@MajorTopicYN": "N", "@UI": "D014407"}}]}, "PMID": {"#text": "20099276", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "20099276", "@IdType": "pubmed"}, {"#text": "10.1002/ijc.25191", "@IdType": "doi"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "entrez", "Day": "26", "Hour": "6", "Minute": "0", "Month": "1", "Year": "2010"}, {"@PubStatus": "pubmed", "Day": "26", "Hour": "6", "Minute": "0", "Month": "1", "Year": "2010"}, {"@PubStatus": "medline", "Day": "24", "Hour": "6", "Minute": "0", "Month": "9", "Year": "2010"}]}, "PublicationStatus": "ppublish"}}}}, "PMC": null, "PMID": "20099276", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "49": {"Abstract": "Owing to improved early surveillance and advanced therapy strategies, the current death rate due to breast cancer has decreased; nevertheless, drug resistance and relapse remain obstacles on the path to successful systematic treatment. Multiple mechanisms responsible for drug resistance have been elucidated, and miRNAs seem to play a major part in almost every aspect of cancer progression, including tumorigenesis, metastasis, and drug resistance. In recent years, exosomes have emerged as novel modes of intercellular signaling vehicles, initiating cell-cell communication through their fusion with target cell membranes, delivering functional molecules including miRNAs and proteins. This review particularly focuses on enumerating functional miRNAs involved in breast cancer drug resistance as well as their targets and related mechanisms. Subsequently, we discuss the prospects and challenges of miRNA function in drug resistance and highlight valuable approaches for the investigation of the role of exosomal miRNAs in breast cancer progression and drug resistance.", "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "2173353413225266316", "Part1": "Department of General Surgery", "Part2": "The First Affiliated Hospital of Nanjing Medical University.", "Part3": null, "Part4": null, "Part5": null, "Part6": null, "Text": "Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University."}, {"Has_Extra": false, "HashID": "-9167175248047506402", "Part1": "School of Basic Medicine and Clinical Pharmacy", "Part2": "China Pharmaceutical University.", "Part3": null, "Part4": null, "Part5": null, "Part6": null, "Text": "School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University."}, {"Has_Extra": false, "HashID": "-4844007995677716728", "Part1": "Nanjing Medical University Affiliated Cancer Hospital.", "Part2": null, "Part3": null, "Part4": null, "Part5": null, "Part6": null, "Text": "Nanjing Medical University Affiliated Cancer Hospital."}], "ForeName": "Weizi", "FullName": "Weizi Hu", "HashID": "-9206405804502894680", "LastName": "Hu", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "2173353413225266316", "Part1": "Department of General Surgery", "Part2": "The First Affiliated Hospital of Nanjing Medical University.", "Part3": null, "Part4": null, "Part5": null, "Part6": null, "Text": "Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University."}, {"Has_Extra": false, "HashID": "-9167175248047506402", "Part1": "School of Basic Medicine and Clinical Pharmacy", "Part2": "China Pharmaceutical University.", "Part3": null, "Part4": null, "Part5": null, "Part6": null, "Text": "School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University."}, {"Has_Extra": false, "HashID": "-4844007995677716728", "Part1": "Nanjing Medical University Affiliated Cancer Hospital.", "Part2": null, "Part3": null, "Part4": null, "Part5": null, "Part6": null, "Text": "Nanjing Medical University Affiliated Cancer Hospital."}], "ForeName": "Chunli", "FullName": "Chunli Tan", "HashID": "2146465672323047069", "LastName": "Tan", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-1414461464225445509", "Part1": "The First Clinical School of Nanjing Medical University.", "Part2": null, "Part3": null, "Part4": null, "Part5": null, "Part6": null, "Text": "The First Clinical School of Nanjing Medical University."}], "ForeName": "Yunjie", "FullName": "Yunjie He", "HashID": "-4933553641934221490", "LastName": "He", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-9167175248047506402", "Part1": "School of Basic Medicine and Clinical Pharmacy", "Part2": "China Pharmaceutical University.", "Part3": null, "Part4": null, "Part5": null, "Part6": null, "Text": "School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University."}], "ForeName": "Guangqin", "FullName": "Guangqin Zhang", "HashID": "7167357844870315478", "LastName": "Zhang", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-4844007995677716728", "Part1": "Nanjing Medical University Affiliated Cancer Hospital.", "Part2": null, "Part3": null, "Part4": null, "Part5": null, "Part6": null, "Text": "Nanjing Medical University Affiliated Cancer Hospital."}, {"Has_Extra": false, "HashID": "-5468287689190107968", "Part1": "Jiangsu Key Lab of Cancer Biomarkers", "Part2": "Prevention and Treatment", "Part3": "Nanjing Medical University", "Part4": "Nanjing", "Part5": "People's Republic of China.", "Part6": null, "Text": "Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Nanjing Medical University, Nanjing, People's Republic of China."}], "ForeName": "Yong", "FullName": "Yong Xu", "HashID": "-6410193317697127517", "LastName": "Xu", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "2173353413225266316", "Part1": "Department of General Surgery", "Part2": "The First Affiliated Hospital of Nanjing Medical University.", "Part3": null, "Part4": null, "Part5": null, "Part6": null, "Text": "Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University."}], "ForeName": "Jinhai", "FullName": "Jinhai Tang", "HashID": "-4139322161833742100", "LastName": "Tang", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.2147/OTT.S152462", "InsertType": null, "Journal": "OncoTargets and therapy", "Keywords": [{"IS_Major": false, "IS_Mesh": false, "Text": "breast cancer"}, {"IS_Major": false, "IS_Mesh": false, "Text": "drug resistance"}, {"IS_Major": false, "IS_Mesh": false, "Text": "exosome"}, {"IS_Major": false, "IS_Mesh": false, "Text": "microRNA"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "PubMed-not-MEDLINE", "Article": {"@PubModel": "Electronic-eCollection", "Abstract": {"AbstractText": "Owing to improved early surveillance and advanced therapy strategies, the current death rate due to breast cancer has decreased; nevertheless, drug resistance and relapse remain obstacles on the path to successful systematic treatment. Multiple mechanisms responsible for drug resistance have been elucidated, and miRNAs seem to play a major part in almost every aspect of cancer progression, including tumorigenesis, metastasis, and drug resistance. In recent years, exosomes have emerged as novel modes of intercellular signaling vehicles, initiating cell-cell communication through their fusion with target cell membranes, delivering functional molecules including miRNAs and proteins. This review particularly focuses on enumerating functional miRNAs involved in breast cancer drug resistance as well as their targets and related mechanisms. Subsequently, we discuss the prospects and challenges of miRNA function in drug resistance and highlight valuable approaches for the investigation of the role of exosomal miRNAs in breast cancer progression and drug resistance."}, "ArticleDate": {"@DateType": "Electronic", "Day": "19", "Month": "03", "Year": "2018"}, "ArticleTitle": "Functional miRNAs in breast cancer drug resistance.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@EqualContrib": "Y", "@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University."}, {"Affiliation": "School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University."}, {"Affiliation": "Nanjing Medical University Affiliated Cancer Hospital."}], "ForeName": "Weizi", "Initials": "W", "LastName": "Hu"}, {"@EqualContrib": "Y", "@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University."}, {"Affiliation": "School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University."}, {"Affiliation": "Nanjing Medical University Affiliated Cancer Hospital."}], "ForeName": "Chunli", "Initials": "C", "LastName": "Tan"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "The First Clinical School of Nanjing Medical University."}, "ForeName": "Yunjie", "Initials": "Y", "LastName": "He"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University."}, "ForeName": "Guangqin", "Initials": "G", "LastName": "Zhang"}, {"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Nanjing Medical University Affiliated Cancer Hospital."}, {"Affiliation": "Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Nanjing Medical University, Nanjing, People's Republic of China."}], "ForeName": "Yong", "Initials": "Y", "LastName": "Xu"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University."}, "ForeName": "Jinhai", "Initials": "J", "LastName": "Tang"}]}, "ELocationID": {"#text": "10.2147/OTT.S152462", "@EIdType": "doi", "@ValidYN": "Y"}, "Journal": {"ISOAbbreviation": "Onco Targets Ther", "ISSN": {"#text": "1178-6930", "@IssnType": "Print"}, "JournalIssue": {"@CitedMedium": "Print", "PubDate": {"Year": "2018"}, "Volume": "11"}, "Title": "OncoTargets and therapy"}, "Language": "eng", "Pagination": {"EndPage": "1541", "MedlinePgn": "1529-1541", "StartPage": "1529"}, "PublicationTypeList": {"PublicationType": [{"#text": "Journal Article", "@UI": "D016428"}, {"#text": "Review", "@UI": "D016454"}]}}, "CoiStatement": "Disclosure The authors report no conflicts of interest in this work.", "DateRevised": {"Day": "18", "Month": "03", "Year": "2022"}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"#text": "breast cancer", "@MajorTopicYN": "N"}, {"#text": "drug resistance", "@MajorTopicYN": "N"}, {"#text": "exosome", "@MajorTopicYN": "N"}, {"#text": "microRNA", "@MajorTopicYN": "N"}]}, "MedlineJournalInfo": {"Country": "New Zealand", "ISSNLinking": "1178-6930", "MedlineTA": "Onco Targets Ther", "NlmUniqueID": "101514322"}, "PMID": {"#text": "29593419", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "29593419", "@IdType": "pubmed"}, {"#text": "PMC5865556", "@IdType": "pmc"}, {"#text": "10.2147/OTT.S152462", "@IdType": "doi"}, {"#text": "ott-11-1529", "@IdType": "pii"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "entrez", "Day": "30", "Hour": "6", "Minute": "0", "Month": "3", "Year": "2018"}, {"@PubStatus": "pubmed", "Day": "30", "Hour": "6", "Minute": "0", "Month": "3", "Year": "2018"}, {"@PubStatus": "medline", "Day": "30", "Hour": "6", "Minute": "1", "Month": "3", "Year": "2018"}]}, "PublicationStatus": "epublish", "ReferenceList": {"Reference": [{"ArticleIdList": {"ArticleId": {"#text": "20228384", "@IdType": "pubmed"}}, "Citation": "Smith RA, Cokkinides V, Brooks D, Saslow D, Brawley OW. Cancer screening in the United States. A review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2010;60(2):99\u2013119."}, {"ArticleIdList": {"ArticleId": {"#text": "24114568", "@IdType": "pubmed"}}, "Citation": "DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA Cancer J Clin. 2014;64(1):52\u201362."}, {"ArticleIdList": {"ArticleId": {"#text": "16918307", "@IdType": "pubmed"}}, "Citation": "O\u2019Driscoll L, Clynes M. Biomarkers and multiple drug resistance in breast cancer. Curr Cancer Drug Targets. 2006;6(5):365\u2013384."}, {"ArticleIdList": {"ArticleId": {"#text": "20008847", "@IdType": "pubmed"}}, "Citation": "Ellis LM, Hicklin D. Resistance to targeted therapies: refining anticancer therapy in the era of molecular oncology. Clin Cancer Res. 2009;15(24):7471\u20137478."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3156306", "@IdType": "pmc"}, {"#text": "21949547", "@IdType": "pubmed"}]}, "Citation": "Kutanzi KR, Yurchenko OV, Beland FA, et al. MicroRNA-mediated drug resistance in breast cancer. Clin Epigenetics. 2011;2(2):171."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4196180", "@IdType": "pmc"}, {"#text": "25026296", "@IdType": "pubmed"}]}, "Citation": "Wang Z, Wang N, Liu P, et al. MicroRNA-25 regulates chemoresistance-associated autophagy in breast cancer cells, a process modulated by the natural autophagy inducer isoliquiritigenin. Oncotarget. 2014;5(16):7013\u20137026."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3630848", "@IdType": "pmc"}, {"#text": "23436656", "@IdType": "pubmed"}]}, "Citation": "Haiyan H, Shuqin L, Xiuying C, et al. The overexpression of hypom-ethylated miR-663 induces chemotherapy resistance in human breast cancer cells by targeting heparin sulfate proteoglycan 2 (HSPG2) J Biol Chem. 2013;288(16):10973\u201310985."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5312343", "@IdType": "pmc"}, {"#text": "27487127", "@IdType": "pubmed"}]}, "Citation": "Gao M, Miao L, Liu M, et al. miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1. Oncotarget. 2016;7(37):59714\u201359726."}, {"ArticleIdList": {"ArticleId": {"#text": "24204025", "@IdType": "pubmed"}}, "Citation": "Mulrane L, Mcgee SF, Gallagher WM, et al. miRNA dysregulation in breast cancer. Cancer Res. 2013;73(22):6554\u20136562."}, {"ArticleIdList": {"ArticleId": {"#text": "25501033", "@IdType": "pubmed"}}, "Citation": "Penna E, Orso F, Taverna D. miR-214 as a key hub that controls cancer networks: small player, multiple functions. J Invest Dermatol. 2015;135(4):960\u2013969."}, {"ArticleIdList": {"ArticleId": {"#text": "26143224", "@IdType": "pubmed"}}, "Citation": "Milane L, Singh A, Mattheolabakis G, et al. Exosome mediated communication within the tumor microenvironment. J Control Release. 2015;219:278\u2013294."}, {"ArticleIdList": {"ArticleId": {"#text": "27054974", "@IdType": "pubmed"}}, "Citation": "Sheridan C. Exosome cancer diagnostic reaches market. Nat Biotechnol. 2016;34(4):359\u2013360."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4820618", "@IdType": "pmc"}, {"#text": "27021436", "@IdType": "pubmed"}]}, "Citation": "Chi LAY, Co NN, Tsuruga T, et al. Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1. Nat Commun. 2016;7:11150."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4496882", "@IdType": "pmc"}, {"#text": "26156517", "@IdType": "pubmed"}]}, "Citation": "Zhang X, Yuan X, Shi H, et al. Exosomes in cancer: small particle, big player. J Hematol Oncol. 2015;8:83."}, {"ArticleIdList": {"ArticleId": {"#text": "26061842", "@IdType": "pubmed"}}, "Citation": "O\u2019Driscoll L. Expanding on exosomes and ectosomes in cancer. N Engl J Med. 2015;372(24):2359\u20132362."}, {"ArticleIdList": {"ArticleId": {"#text": "26432333", "@IdType": "pubmed"}}, "Citation": "Yu DD, Wu Y, Zhang XH, et al. Exosomes from adriamycin-resistant breast cancer cells transmit drug resistance partly by delivering miR-222. Tumour Biol. 2016;37(3):3227\u20133235."}, {"ArticleIdList": {"ArticleId": {"#text": "21605702", "@IdType": "pubmed"}}, "Citation": "Dweep H, Sticht C, Pandey P, et al. miRWalk \u2013 database: prediction of possible miRNA binding sites by \u201cwalking\u201d the genes of three genomes. J Biomed Inform. 2011;44(5):839\u2013847."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4879690", "@IdType": "pmc"}, {"#text": "24888802", "@IdType": "pubmed"}]}, "Citation": "Sledge GW, Mamounas EP, Hortobagyi GN, et al. Past, present, and future challenges in breast cancer treatment. J Clin Oncol. 2014;32(19):1979\u20131986."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3247093", "@IdType": "pmc"}, {"#text": "22051041", "@IdType": "pubmed"}]}, "Citation": "Yamamoto Y, Yoshioka Y, Minoura K, et al. An integrative genomic analysis revealed the relevance of microRNA and gene expression for drug-resistance in human breast cancer cells. Mol Cancer. 2011;10(1):135."}, {"ArticleIdList": {"ArticleId": {"#text": "12094235", "@IdType": "pubmed"}}, "Citation": "Vivanco I, Sawyers CL. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer. 2002;2(7):489\u2013501."}, {"ArticleIdList": {"ArticleId": {"#text": "11803475", "@IdType": "pubmed"}}, "Citation": "Yuan XJ, Whang YE. PTEN sensitizes prostate cancer cells to death receptor-mediated and drug-induced apoptosis through a FADD-dependent pathway. Oncogene. 2002;21(2):319\u2013327."}, {"ArticleIdList": {"ArticleId": {"#text": "11965494", "@IdType": "pubmed"}}, "Citation": "Wan X, Yokoyama Y, Shinohara A, Takahashi Y, Tamaya T. PTEN augments staurosporine-induced apoptosis in PTEN-null Ishikawa cells by downregulating PI3K/Akt signaling pathway. Cell Death Differ. 2002;9(4):414\u2013420."}, {"ArticleIdList": {"ArticleId": {"#text": "21953503", "@IdType": "pubmed"}}, "Citation": "Zhu Y, Yu F, Jiao Y, et al. Reduced miR-128 in breast tumor-initiating cells induces chemotherapeutic resistance via Bmi-1 and ABCC5. Clin Cancer Res. 2011;17(22):7105\u20137115."}, {"ArticleIdList": {"ArticleId": {"#text": "24335172", "@IdType": "pubmed"}}, "Citation": "Zhu Y, Wu J, Li S, et al. The function role of miR-181a in chemosensitivity to adriamycin by targeting Bcl-2 in low-invasive breast cancer cells. Cell Physiol Biochem. 2013;32(5):1225\u20131237."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3921594", "@IdType": "pmc"}, {"#text": "24270410", "@IdType": "pubmed"}]}, "Citation": "Zhou Y, Hu Y, Yang M, et al. The miR-106b~25 cluster promotes bypass of doxorubicin-induced senescence and increase in motility and invasion by targeting the E-cadherin transcriptional activator EP300. Cell Death Differ. 2013;21(3):462\u2013474."}, {"ArticleIdList": {"ArticleId": {"#text": "15735033", "@IdType": "pubmed"}}, "Citation": "Cheung HW, Jin DY, Ling MT, et al. Mitotic arrest deficient 2 expression induces chemosensitization to a DNA-damaging agent, cisplatin, in nasopharyngeal carcinoma cells. Cancer Res. 2005;65(4):1450\u20131458."}, {"ArticleIdList": {"ArticleId": {"#text": "20099276", "@IdType": "pubmed"}}, "Citation": "Pogribny IP, Filkowski JN, Tryndyak VP, et al. Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin. Int J Cancer. 2010;127(8):1785\u20131794."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4808033", "@IdType": "pmc"}, {"#text": "26623722", "@IdType": "pubmed"}]}, "Citation": "Cataldo A, Cheung DG, Balsari A, et al. miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage response. Oncotarget. 2016;7(1):786\u2013797."}, {"Citation": "Sprowl JA, Parissenti A. Abstract 3550: Role of TNF\u03b1 in the cytotoxicity of docetaxel and in docetaxel resistance in MCF-7 cells. Cancer Res. 2011;70(8 Suppl):3550."}, {"ArticleIdList": {"ArticleId": {"#text": "25173798", "@IdType": "pubmed"}}, "Citation": "Wu MY, Fu J, Xiao X, et al. MiR-34a regulates therapy resistance by targeting HDAC1 and HDAC7 in breast cancer. Cancer Lett. 2014;354(2):311\u2013319."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4868715", "@IdType": "pmc"}, {"#text": "26744318", "@IdType": "pubmed"}]}, "Citation": "Zhang B, Zhao R, He Y, et al. Micro RNA 100 sensitizes luminal A breast cancer cells to paclitaxel treatment in part by targeting mTOR. Oncotarget. 2016;7(5):5702."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3723106", "@IdType": "pmc"}, {"#text": "23340433", "@IdType": "pubmed"}]}, "Citation": "Bockhorn J, Dalton R, Nwachukwu C, et al. MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11. Nat Commun. 2013;4(1):1393."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4614026", "@IdType": "pmc"}, {"#text": "26487539", "@IdType": "pubmed"}]}, "Citation": "Zhang Y, Wang Y, Wei Y, et al. MiR-129-3p promotes docetaxel resistance of breast cancer cells via CP110 inhibition. Sci Rep. 2015;5:15424."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2898411", "@IdType": "pmc"}, {"#text": "20460378", "@IdType": "pubmed"}]}, "Citation": "Zhou M, Liu ZY, Ding Y, et al. MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression. J Biol Chem. 2010;285(28):21496\u201321507."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4413652", "@IdType": "pmc"}, {"#text": "25605244", "@IdType": "pubmed"}]}, "Citation": "Yang Q, Wang Y, Lu X, et al. MiR-125b regulates epithelial-mesenchymal transition via targeting Sema4C in paclitaxel-resistant breast cancer cells. Oncotarget. 2015;6(5):3268\u20133279."}, {"ArticleIdList": {"ArticleId": {"#text": "19883630", "@IdType": "pubmed"}}, "Citation": "Liang Z, Wu H. Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1. Biochem Pharmacol. 2010;79(6):817\u2013824."}, {"ArticleIdList": {"ArticleId": {"#text": "25643696", "@IdType": "pubmed"}}, "Citation": "Ye FG, Song C, Cao ZG, et al. Cytidine deaminase axis modulated by miR-484 differentially regulates cell proliferation and chemoresistance in breast cancer. Cancer Res. 2015;75(7):1504\u20131515."}, {"ArticleIdList": {"ArticleId": {"#text": "25900794", "@IdType": "pubmed"}}, "Citation": "Hu Y, Xu K. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer. Breast Cancer Res Treat. 2015;151(2):269\u2013280."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5108343", "@IdType": "pmc"}, {"#text": "27362808", "@IdType": "pubmed"}]}, "Citation": "Hu Y, Qiu Y, Yag\u00fce E, et al. miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer. Cell Death Dis. 2016;7(6):e2291."}, {"ArticleIdList": {"ArticleId": {"#text": "17721431", "@IdType": "pubmed"}}, "Citation": "Vargo-Gogola T, Rosen JM. Modelling breast cancer: one size does not fit all. Nat Rev Cancer. 2007;7(9):659\u2013672."}, {"ArticleIdList": {"ArticleId": {"#text": "16247594", "@IdType": "pubmed"}}, "Citation": "Nicholson RI, Johnston SR. Endocrine therapy \u2013 current benefits and limitations. Breast Cancer Res Treat. 2005;93(Suppl 1):S3\u2013S10."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2573063", "@IdType": "pmc"}, {"#text": "18708351", "@IdType": "pubmed"}]}, "Citation": "Miller TE, Ghoshal K, Ramaswamy B, et al. MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1. J Biol Chem. 2008;283(44):29897."}, {"ArticleIdList": {"ArticleId": {"#text": "25531331", "@IdType": "pubmed"}}, "Citation": "Cui J, Yang Y, Li H, et al. MiR-873 regulates ER\u03b1 transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells. Oncogene. 2015;34(30):3895."}, {"ArticleIdList": {"ArticleId": {"#text": "15613444", "@IdType": "pubmed"}}, "Citation": "Ring A, Dowsett M. Mechanisms of tamoxifen resistance. Endocr Relat Cancer. 2004;11(4):643."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2994280", "@IdType": "pmc"}, {"#text": "20876285", "@IdType": "pubmed"}]}, "Citation": "Cittelly DM, Das PM, Salvo VA, et al. Oncogenic HER2{Delta}16 suppresses miR-15a/16 and deregulates BCL-2 to promote endocrine resistance of breast tumors. Carcinogenesis. 2010;31(12):2049\u20132057."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4348640", "@IdType": "pmc"}, {"#text": "25736597", "@IdType": "pubmed"}]}, "Citation": "L\u00fc M, Ding K, Zhang G, et al. MicroRNA-320a sensitizes tamoxifen-resistant breast cancer cells to tamoxifen by targeting ARPP-19 and ERR\u03b3*. Sci Rep. 2015;5:8735."}, {"ArticleIdList": {"ArticleId": {"#text": "26896688", "@IdType": "pubmed"}}, "Citation": "Liu ZR, Song Y, Wan LH, et al. Over-expression of miR-451a can enhance the sensitivity of breast cancer cells to tamoxifen by regulating 14-3-3\u03b6, estrogen receptor \u03b1, and autophagy. Life Sci. 2016;149:104\u2013113."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4678692", "@IdType": "pmc"}, {"#text": "26666173", "@IdType": "pubmed"}]}, "Citation": "Yu X, Luo A, Liu Y, et al. MiR-214 increases the sensitivity of breast cancer cells to tamoxifen and fulvestrant through inhibition of autophagy. Mol Cancer. 2015;14:208."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3024251", "@IdType": "pmc"}, {"#text": "21172025", "@IdType": "pubmed"}]}, "Citation": "Cittelly DM, Das PM, Spoelstra NS, et al. Downregulation of miR-342 is associated with tamoxifen resistant breast tumors. Mol Cancer. 2010;9(1):317."}, {"ArticleIdList": {"ArticleId": {"#text": "22508479", "@IdType": "pubmed"}}, "Citation": "Ward A, Balwierz A, Zhang JD, et al. Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer. Oncogene. 2012;32(9):1173."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4530347", "@IdType": "pmc"}, {"#text": "26255816", "@IdType": "pubmed"}]}, "Citation": "Ikeda K, Horieinoue K, Ueno T, et al. miR-378a-3p modulates tamoxifen sensitivity in breast cancer MCF-7 cells through targeting GOLT1A. Sci Rep. 2015;5:13170."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4284514", "@IdType": "pmc"}, {"#text": "25560734", "@IdType": "pubmed"}]}, "Citation": "Ujihira T, Ikeda K, Suzuki T, et al. MicroRNA-574-3p, identified by microRNA library-based functional screening, modulates tamoxifen response in breast cancer. Sci Rep. 2015;5:7641."}, {"ArticleIdList": {"ArticleId": {"#text": "20956939", "@IdType": "pubmed"}}, "Citation": "Sachdeva M, Wu H, Ru P, et al. MicroRNA-101-mediated Akt activation and estrogen-independent growth. Oncogene. 2011;30(7):822."}, {"ArticleIdList": {"ArticleId": {"#text": "2808542", "@IdType": "pubmed"}}, "Citation": "Zugmaier G, Ennis BW, Deschauer B, et al. Transforming growth factors type beta 1 and beta 2 are equipotent growth inhibitors of human breast cancer cell lines. J Cell Physiol. 1989;141(2):353\u2013361."}, {"ArticleIdList": {"ArticleId": {"#text": "11149423", "@IdType": "pubmed"}}, "Citation": "McEarchern JA, Kobie JJ, Mack V, et al. Invasion and metastasis of a mammary tumor involves TGF-beta signaling. Int J Cancer. 2001;91(1):76\u201382."}, {"ArticleIdList": {"ArticleId": {"#text": "21393507", "@IdType": "pubmed"}}, "Citation": "Shi W, Gerster K, Alajez NM, et al. MicroRNA-301 mediates proliferation and invasion in human breast cancer. Cancer Res. 2011;71(8):2926\u20132637."}, {"ArticleIdList": {"ArticleId": {"#text": "19208461", "@IdType": "pubmed"}}, "Citation": "Hynes NE, MacDonald G. ErbB receptors and signaling pathways in cancer. Curr Opin Cell Biol. 2009;21(2):177\u2013184."}, {"ArticleIdList": {"ArticleId": {"#text": "19536107", "@IdType": "pubmed"}}, "Citation": "Baselga J, Swain SM. Novel anticancer targets: revisiting ERBB2 and discovering ERBB3. Nat Rev Cancer. 2009;9:463\u2013475."}, {"ArticleIdList": {"ArticleId": {"#text": "10561337", "@IdType": "pubmed"}}, "Citation": "Cobleigh MA, Vogel CL, Tripathy D, et al. Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J Clin Oncol. 1999;17:2639\u20132648."}, {"ArticleIdList": {"ArticleId": {"#text": "12467226", "@IdType": "pubmed"}}, "Citation": "Rusnak DW, Lackey K, Affleck K, et al. The effects of the novel, reversible epidermal growth factor receptor/ErbB-2 tyrosine kinase inhibitor, GW2016, on the growth of human normal and tumor-derived cell lines in vitro and in vivo. Mol Cancer Ther. 2001;1:85\u201394."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3288043", "@IdType": "pmc"}, {"#text": "22384020", "@IdType": "pubmed"}]}, "Citation": "Ichikawa T, Sato F, Terasawa K, et al. Trastuzumab produces therapeutic actions by upregulating miR-26a and miR-30b in breast cancer cells. PLoS One. 2012;7(2):e31422."}, {"ArticleIdList": {"ArticleId": {"#text": "25712681", "@IdType": "pubmed"}}, "Citation": "Ock CY, Lee KW, Jin WK, et al. Optimal patient selection for trastuzumab treatment in HER2-positive advanced gastric cancer. Clin Cancer Res. 2015;21(11):2520."}, {"ArticleIdList": {"ArticleId": {"#text": "26456898", "@IdType": "pubmed"}}, "Citation": "Yeo B, Kotsori K, Mohammed K, et al. Long-term outcome of HER2 positive metastatic breast cancer patients treated with first-line trastuzumab. Breast. 2015;24(6):751\u2013757."}, {"ArticleIdList": {"ArticleId": {"#text": "11248153", "@IdType": "pubmed"}}, "Citation": "Lamon DJ, Leyland-Jones B, Shak S, et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med. 2001;344(11):783\u2013792."}, {"ArticleIdList": {"ArticleId": {"#text": "15911866", "@IdType": "pubmed"}}, "Citation": "Marty M, Cognetti F, Maraninchi D, et al. Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group. J Clin Oncol. 2005;23(19):4265\u20134274."}, {"ArticleIdList": {"ArticleId": {"#text": "11919237", "@IdType": "pubmed"}}, "Citation": "Esteva FJ, Valero V, Booser D, et al. Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer. J Clin Oncol. 2002;20(7):1800\u20131808."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3141770", "@IdType": "pmc"}, {"#text": "21676217", "@IdType": "pubmed"}]}, "Citation": "Wang L, Zhang Q, Zhang J, et al. PI3K pathway activation results in low efficacy of both trastuzumab and lapatinib. BMC Cancer. 2011;11:248."}, {"ArticleIdList": {"ArticleId": {"#text": "19671800", "@IdType": "pubmed"}}, "Citation": "Liu L, Greger J, Shi H, et al. Novel mechanism of lapatinib resistance in HER2-positive breast tumor cells: activation of AXL. Cancer Res. 2009;69:6871\u20136878."}, {"ArticleIdList": {"ArticleId": {"#text": "19442060", "@IdType": "pubmed"}}, "Citation": "Browne BC, O\u2019Brien N, Duffy MJ, et al. HER-2 signaling and inhibition in breast cancer. Curr Cancer Drug Targets. 2009;9:419\u2013438."}, {"ArticleIdList": {"ArticleId": {"#text": "17530017", "@IdType": "pubmed"}}, "Citation": "Nahta R, Esteva FJ. Trastuzumab: triumphs and tribulations. Oncogene. 2007;26:3637\u20133643."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3099726", "@IdType": "pmc"}, {"#text": "21471222", "@IdType": "pubmed"}]}, "Citation": "Gong C, Yao Y, Wang Y, et al. Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer. J Biol Chem. 2011;286(21):19127\u201319137."}, {"ArticleIdList": {"ArticleId": {"#text": "15324695", "@IdType": "pubmed"}}, "Citation": "Nagata Y, Lan KH, Zhou X, et al. PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients. Cancer Cell. 2004;6(2):117\u2013127."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4741929", "@IdType": "pmc"}, {"#text": "26452030", "@IdType": "pubmed"}]}, "Citation": "De ML, Bottai G, Nuciforo PG, et al. MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients. Oncotarget. 2015;6(35):37269\u201337280."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4133651", "@IdType": "pmc"}, {"#text": "25177545", "@IdType": "pubmed"}]}, "Citation": "Nielsen BS, Balslev E, Poulsen TS, et al. miR-21 expression in cancer cells may not predict resistance to adjuvant trastuzumab in primary breast cancer. Front Oncol. 2014;4:207."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4163864", "@IdType": "pmc"}, {"#text": "24286315", "@IdType": "pubmed"}]}, "Citation": "Ye X, Bai W, Zhu H, et al. MiR-221 promotes trastuzumab-resistance and metastasis in HER2-positive breast cancers by targeting PTEN. BMB Rep. 2014;47(5):268\u2013273."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3864019", "@IdType": "pmc"}, {"#text": "22370716", "@IdType": "pubmed"}]}, "Citation": "Jung EJ, Santarpia L, Kim J, et al. Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients. Cancer. 2012;118(10):2603\u20132614."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2664859", "@IdType": "pmc"}, {"#text": "19238171", "@IdType": "pubmed"}]}, "Citation": "Wu H, Zhu S, Mo Y-Y. Suppression of cell growth and invasion by miR-205 in breast cancer. Cell Res. 2009;19(4):439\u2013448."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4650737", "@IdType": "pmc"}, {"#text": "26181203", "@IdType": "pubmed"}]}, "Citation": "De CA, Volpe S, Budani MC, et al. miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance. Cell Death Dis. 2015;6:e1823."}, {"ArticleIdList": {"ArticleId": {"#text": "24615544", "@IdType": "pubmed"}}, "Citation": "Bai WD, Ye XM, Zhang MY, et al. MiR-200c suppresses TGF-\u03b2 signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer. Int J Cancer. 2014;135(6):1356\u20131368."}, {"ArticleIdList": {"ArticleId": {"#text": "25586125", "@IdType": "pubmed"}}, "Citation": "Ma T, Yang L, Zhang J. miRNA-542-3p downregulation promotes trastuzumab resistance in breast cancer cells via AKT activation. Oncol Rep. 2015;33(3):1215\u20131220."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3974046", "@IdType": "pmc"}, {"#text": "24571711", "@IdType": "pubmed"}]}, "Citation": "Ye XM, Zhu HY, Bai WD, et al. Epigenetic silencing of miR-375 induces trastuzumab resistance in HER2-positive breast cancer by targeting IGF1R. BMC Cancer. 2014;14:134."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4234346", "@IdType": "pmc"}, {"#text": "24655723", "@IdType": "pubmed"}]}, "Citation": "Corcoran C, Rani S, Breslin S, et al. miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer. Mol Cancer. 2014;13:71."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5832962", "@IdType": "pmc"}, {"#text": "27157613", "@IdType": "pubmed"}]}, "Citation": "Venturutti L, Russo RIC, Rivas MA, et al. MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1. Oncogene. 2016;35(48):6189\u20136202."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4273950", "@IdType": "pmc"}, {"#text": "25532106", "@IdType": "pubmed"}]}, "Citation": "Huynh FC, Jones FE. MicroRNA-7 inhibits multiple oncogenic pathways to suppress HER2\u039416 mediated breast tumorigenesis and reverse trastuzumab resistance. PLoS One. 2014;9(12):e114419."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4127598", "@IdType": "pmc"}, {"#text": "25114842", "@IdType": "pubmed"}]}, "Citation": "Zhao M, Ramaswamy B. Mechanisms and therapeutic advances in the management of endocrine-resistant breast cancer. World J Clin Oncol. 2014;5(3):248\u2013262."}, {"ArticleIdList": {"ArticleId": {"#text": "11384865", "@IdType": "pubmed"}}, "Citation": "Clarke R, Skaar TC, Bouker KB, et al. Molecular and pharmacological aspects of antiestrogen resistance. J Steroid Biochem Mol Biol. 2001;76(1\u20135):71\u201384."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3175015", "@IdType": "pmc"}, {"#text": "21666713", "@IdType": "pubmed"}]}, "Citation": "Bergamaschi A, Katzenellenbogen BS. Tamoxifen down-regulation of miR-451 increases 14-3-3\u03b6 and promotes breast cancer cell survival and endocrine resistance. Oncogene. 2012;31(1):39\u201347."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3342929", "@IdType": "pmc"}, {"#text": "21057537", "@IdType": "pubmed"}]}, "Citation": "Rao X, Leva GD, Li M, et al. MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways. Oncogene. 2010;30(9):1082\u20131097."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5386701", "@IdType": "pmc"}, {"#text": "28061479", "@IdType": "pubmed"}]}, "Citation": "Roscigno G, Puoti I, Giordano I, et al. MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer. Oncotarget. 2017;8(12):19507\u201319521."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4564359", "@IdType": "pmc"}, {"#text": "25746005", "@IdType": "pubmed"}]}, "Citation": "Knezevic J, Pfefferle AD, Petrovic I, et al. Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential. Oncogene. 2015;34(49):5997\u20136006."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3616322", "@IdType": "pmc"}, {"#text": "20811353", "@IdType": "pubmed"}]}, "Citation": "Yang Z, Klionsky DJ. Eaten alive: a history of macroautophagy. Nat Cell Biol. 2010;12(9):814."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3170456", "@IdType": "pmc"}, {"#text": "21878654", "@IdType": "pubmed"}]}, "Citation": "Yang ZJ, Chee CE, Huang S, et al. The role of autophagy in cancer: therapeutic implications. Mol Cancer Ther. 2011;10(9):1533\u20131541."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC1896119", "@IdType": "pmc"}, {"#text": "17363733", "@IdType": "pubmed"}]}, "Citation": "Carew JS, Nawrocki ST, Kahue CN, et al. Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance. Blood. 2007;110(1):313\u2013322."}, {"ArticleIdList": {"ArticleId": {"#text": "11048727", "@IdType": "pubmed"}}, "Citation": "Hengartner MO. The biochemistry of apoptosis. Nature. 2000;407(6805):770."}, {"ArticleIdList": {"ArticleId": {"#text": "9916985", "@IdType": "pubmed"}}, "Citation": "Reed JC. Bcl-2 family proteins. Oncogene. 1998;17(25):3225\u20133236."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4666837", "@IdType": "pmc"}, {"#text": "26028030", "@IdType": "pubmed"}]}, "Citation": "Niu J, Xue A, Chi Y, et al. Induction of miRNA-181a by genotoxic treatments promotes chemotherapeutic resistance and metastasis in breast cancer. Oncogene. 2016;35(10):1302\u20131313."}, {"ArticleIdList": {"ArticleId": {"#text": "21399894", "@IdType": "pubmed"}}, "Citation": "Kastl L, Brown I, Schofield AC. miRNA-34a is associated with docetaxel resistance in human breast cancer cells. Breast Cancer Res Treat. 2012;31(2):445\u2013454."}, {"ArticleIdList": {"ArticleId": {"#text": "11099028", "@IdType": "pubmed"}}, "Citation": "Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature. 2000;408(6810):307\u2013310."}, {"ArticleIdList": {"ArticleId": {"#text": "12324993", "@IdType": "pubmed"}}, "Citation": "Nurse P. Cyclin dependent kinases and cell cycle control (nobel lecture) Chembiochem. 2002;3(7):596\u2013603."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3830198", "@IdType": "pmc"}, {"#text": "23880895", "@IdType": "pubmed"}]}, "Citation": "Kitagawa M, Kitagawa K, Kotake Y, Niida H, Ohhata T. Cell cycle regulation by long non-coding RNAs. Cell Mol Life Sci. 2013;70(24):4785\u20134794."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4741652", "@IdType": "pmc"}, {"#text": "26397135", "@IdType": "pubmed"}]}, "Citation": "Chu J, Zhu Y, Liu Y, et al. E2F7 overexpression leads to tamoxifen resistance in breast cancer cells by competing with E2F1 at miR-15a/16 promoter. Oncotarget. 2015;6(31):31944\u201331957."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3203907", "@IdType": "pmc"}, {"#text": "22053213", "@IdType": "pubmed"}]}, "Citation": "Danilov AV, Neupane D, Nagaraja AS, et al. DeltaNp63alpha-mediated induction of epidermal growth factor receptor promotes pancreatic cancer cell growth and chemoresistance. PLoS One. 2011;6(10):e26815."}, {"ArticleIdList": {"ArticleId": {"#text": "25971596", "@IdType": "pubmed"}}, "Citation": "Boulbes DR, Chauhan GB, Jin Q, et al. CD44 expression contributes to trastuzumab resistance in HER2-positive breast cancer cells. Breast Cancer Res Treat. 2015;151(3):501\u2013513."}, {"ArticleIdList": {"ArticleId": {"#text": "24168191", "@IdType": "pubmed"}}, "Citation": "Shang Y, Cai X, Fan D. Roles of epithelial-mesenchymal transition in cancer drug resistance. Curr Cancer Drug Targets. 2013;13(9):915\u2013929."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5226553", "@IdType": "pmc"}, {"#text": "27409664", "@IdType": "pubmed"}]}, "Citation": "Raza U, Saatci \u00d6, Uhlmann S, et al. The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer. Oncotarget. 2016;7(31):49859\u201349877."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2728032", "@IdType": "pmc"}, {"#text": "18485877", "@IdType": "pubmed"}]}, "Citation": "Mani SA, Guo W, Liao MJ, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133(4):704\u2013715."}, {"ArticleIdList": {"ArticleId": {"#text": "23012306", "@IdType": "pubmed"}}, "Citation": "Boyle P. Triple-negative breast cancer: epidemiological coniderations and recommendations. Ann Oncol. 2012;23(Suppl 6):vi7\u2013vi12."}, {"ArticleIdList": {"ArticleId": {"#text": "21067385", "@IdType": "pubmed"}}, "Citation": "Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med. 2010;363(20):1938\u20131948."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2933868", "@IdType": "pmc"}, {"#text": "20706219", "@IdType": "pubmed"}]}, "Citation": "Brabletz S, Brabletz T. The ZEB/miR-200 feedback loop \u2013 a motor of cellular plasticity in development and cancer? EMBO Rep. 2010;11(9):670\u2013677."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3093321", "@IdType": "pmc"}, {"#text": "21411626", "@IdType": "pubmed"}]}, "Citation": "Gregory PA, Bracken CP, Smith E, et al. An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition. Mol Biol Cell. 2011;22(10):1686\u20131698."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2731699", "@IdType": "pmc"}, {"#text": "19665978", "@IdType": "pubmed"}]}, "Citation": "Shimono Y, Zabala M, Cho RW, et al. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell. 2009;138(3):592\u2013603."}, {"ArticleIdList": {"ArticleId": {"#text": "23525011", "@IdType": "pubmed"}}, "Citation": "Lim Y-Y, Wright JA, Attema JL, et al. Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like state. J Cell Sci. 2013;126(Pt 10):2256\u20132266."}, {"ArticleIdList": {"ArticleId": {"#text": "27726101", "@IdType": "pubmed"}}, "Citation": "Shi H, Zhang W, Zhi Q, et al. Lapatinib resistance in HER2+ cancers: latest findings and new concepts on molecular mechanisms. Tumour Biol. 2016 Oct 10; Epub."}, {"ArticleIdList": {"ArticleId": {"#text": "12654254", "@IdType": "pubmed"}}, "Citation": "Lin A, Karin M. NF-kappaB in cancer: a marked target. Semin Cancer Biol. 2003;13(2):107\u2013114."}, {"ArticleIdList": {"ArticleId": {"#text": "12001991", "@IdType": "pubmed"}}, "Citation": "Karin M, Cao Y, Greten FR, Li ZW. NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer. 2002;2(4):301\u2013310."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC199203", "@IdType": "pmc"}, {"#text": "11160144", "@IdType": "pubmed"}]}, "Citation": "Baldwin AS. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J Clin Invest. 2001;107(3):241\u2013246."}, {"ArticleIdList": {"ArticleId": {"#text": "15641020", "@IdType": "pubmed"}}, "Citation": "Longley DB, Johnston PG. Molecular mechanisms of drug resistance. J Pathol. 2005;205(2):275\u2013292."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3750319", "@IdType": "pmc"}, {"#text": "23915189", "@IdType": "pubmed"}]}, "Citation": "Hoesel B, Schmid JA. The complexity of NF-\u03baB signaling in inflammation and cancer. Mol Cancer. 2013;12(1):86."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3605692", "@IdType": "pmc"}, {"#text": "23364795", "@IdType": "pubmed"}]}, "Citation": "K\u00f6rner C, Keklikoglou I, Bender C, et al. MicroRNA-31 sensitizes human breast cells to apoptosis by direct targeting of protein kinase C epsilon (PKCepsilon) J Biol Chem. 2013;288(12):8750\u20138761."}, {"ArticleIdList": {"ArticleId": {"#text": "12648464", "@IdType": "pubmed"}}, "Citation": "Jorissen RN, Walker F, Pouliot N, Garrett TP, Ward CW, Burgess AW. Epidermal growth factor receptor: mechanisms of activation and signalling. Exp Cell Res. 2003;284(1):31\u201353."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC313958", "@IdType": "pmc"}, {"#text": "10880430", "@IdType": "pubmed"}]}, "Citation": "Olayioye MA, Neve RM, Lane HA, Hynes NE. The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J. 2000;19(13):3159\u20133167."}, {"ArticleIdList": {"ArticleId": {"#text": "9247307", "@IdType": "pubmed"}}, "Citation": "Pegram MD, Finn RS, Arzoo K, Beryt M, Pietras RJ, Slamon DJ. The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells. Oncogene. 1997;15(5):537\u2013547."}, {"ArticleIdList": {"ArticleId": {"#text": "11062025", "@IdType": "pubmed"}}, "Citation": "Chen X, Yeung TK, Wang Z. Enhanced drug resistance in cells coexpressing ErbB2 with EGF receptor or ErbB3. Biochem Biophys Res Commun. 2000;277(3):757\u2013763."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC20446", "@IdType": "pmc"}, {"#text": "9576951", "@IdType": "pubmed"}]}, "Citation": "Nagane M, Levitzki A, Gazit A, Cavenee WK, Huang HJ. Drug resistance of human glioblastoma cells conferred by a tumorspecific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases. Proc Natl Acad Sci U S A. 1998;95(10):5724\u20135729."}, {"ArticleIdList": {"ArticleId": {"#text": "11357143", "@IdType": "pubmed"}}, "Citation": "Blume-Jensen P, Hunter T. Oncogenic kinase signalling. Nature. 2001;411(6835):355\u2013365."}, {"ArticleIdList": {"ArticleId": {"#text": "20530697", "@IdType": "pubmed"}}, "Citation": "Takahashi-Yanaga F, Kahn M. Targeting Wnt signaling: can we safely eradicate cancer stem cells? Clin Cancer Res. 2010;16(12):3153\u20133162."}, {"ArticleIdList": {"ArticleId": {"#text": "25077924", "@IdType": "pubmed"}}, "Citation": "Lv MM, Zhu XY, Chen WX, et al. Exosomes mediate drug resistance transfer in MCF-7 breast cancer cells and a probable mechanism is delivery of P-glycoprotein. Tumour Biol. 2014;35(11):10773\u201310779."}, {"ArticleIdList": {"ArticleId": {"#text": "26499806", "@IdType": "pubmed"}}, "Citation": "Chen Z, Shi T, Zhang L, et al. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: a review of the past decade. Cancer Lett. 2016;370(1):153\u2013164."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC289151", "@IdType": "pmc"}, {"#text": "14633975", "@IdType": "pubmed"}]}, "Citation": "Cuconati A, Mukherjee C, Perez D, White E. DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells. Genes Dev. 2003;17(23):2922\u20132932."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4556383", "@IdType": "pmc"}, {"#text": "26052865", "@IdType": "pubmed"}]}, "Citation": "Yu DD, Wu Y, Shen HY, et al. Exosomes in development, metastasis and drug resistance of breast cancer. Cancer Sci. 2015;106(8):959\u2013964."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4991404", "@IdType": "pmc"}, {"#text": "26910922", "@IdType": "pubmed"}]}, "Citation": "Zhong S, Xiu C, Wang D, et al. MicroRNA expression profiles of drug-resistance breast cancer cells and their exosomes. Oncotarget. 2016;7(15):19601\u201319609."}, {"ArticleIdList": {"ArticleId": {"#text": "26555545", "@IdType": "pubmed"}}, "Citation": "Mao L, Li J, Chen WX, et al. Exosomes decrease sensitivity of breast cancer cells to adriamycin by delivering microRNAs. Tumour Biol. 2016;37(4):5247\u20135256."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3989268", "@IdType": "pmc"}, {"#text": "24740415", "@IdType": "pubmed"}]}, "Citation": "Chen WX, Liu XM, Lv MM, et al. Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs. PLoS One. 2014;9(4):e95240."}, {"ArticleIdList": {"ArticleId": {"#text": "24969560", "@IdType": "pubmed"}}, "Citation": "Chen WX, Cai YQ, Lv MM, et al. Exosomes from docetaxel-resistant breast cancer cells alter chemosensitivity by delivering microRNAs. Tumour Biol. 2014;35(10):9649."}, {"ArticleIdList": {"ArticleId": {"#text": "24272085", "@IdType": "pubmed"}}, "Citation": "Chen WX, Zhong SL, Ji MH, et al. MicroRNAs delivered by extracellular vesicles: an emerging resistance mechanism for breast cancer. Tumour Biol. 2014;35(4):2883\u20132892."}, {"ArticleIdList": {"ArticleId": {"#text": "25007959", "@IdType": "pubmed"}}, "Citation": "Wei Y, Lai X, Yu S, et al. Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells. Breast Cancer Res Treat. 2014;147(2):423\u2013431."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4741729", "@IdType": "pmc"}, {"#text": "26416415", "@IdType": "pubmed"}]}, "Citation": "O\u2019Brien K, Lowry MC, Corcoran C, et al. miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity. Oncotarget. 2015;6(32):32774."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4651042", "@IdType": "pmc"}, {"#text": "25972604", "@IdType": "pubmed"}]}, "Citation": "Challagundla KB, Wise PM, Neviani P, et al. Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy. J Natl Cancer Inst. 2015;107(7) pii:djv135."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5309735", "@IdType": "pmc"}, {"#text": "28198398", "@IdType": "pubmed"}]}, "Citation": "Mikamori M, Yamada D, Eguchi H, et al. MicroRNA-155 controls exosome synthesis and promotes gemcitabine resistance in pancreatic ductal adenocarcinoma. Sci Rep. 2017;7:42339."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3931805", "@IdType": "pmc"}, {"#text": "24586853", "@IdType": "pubmed"}]}, "Citation": "Xia X, Yu S, Li S, et al. Exosomes: decreased sensitivity of lung cancer A549 cells to cisplatin. PLoS One. 2014;9(2):e89534."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5526308", "@IdType": "pmc"}, {"#text": "28743280", "@IdType": "pubmed"}]}, "Citation": "Feng W, Ma C, Tong Z, et al. Exosomes derived from gemcitabine-resistant cells transfer malignant phenotypic traits via delivery of miRNA-222-3p. Mol Cancer. 2017;16(1):132."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5439933", "@IdType": "pmc"}, {"#text": "28553110", "@IdType": "pubmed"}]}, "Citation": "Qin X, Yu S, Zhou L, et al. Cisplatin-resistant lung cancer cell\u2013derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100\u20135p-dependent manner. Int J Nanomedicine. 2017;12:3721\u20133733."}, {"ArticleIdList": {"ArticleId": {"#text": "25053345", "@IdType": "pubmed"}}, "Citation": "Corcoran C, Rani S, O\u2019Driscoll L. miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression. Prostate. 2014;74(13):1320\u20131334."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5390430", "@IdType": "pmc"}, {"#text": "28407783", "@IdType": "pubmed"}]}, "Citation": "Zheng P, Lei C, Yuan X, et al. Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells. J Exp Clin Cancer Res. 2017;36(1):53."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4627430", "@IdType": "pmc"}, {"#text": "26514126", "@IdType": "pubmed"}]}, "Citation": "Lou G, Song X, Yang F, et al. Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma. J Hematol Oncol. 2015;8:122."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4027430", "@IdType": "pmc"}, {"#text": "24084846", "@IdType": "pubmed"}]}, "Citation": "Munoz JL, Bliss SA, Greco SJ, et al. Delivery of functional anti-miR-9 by mesenchymal stem cell-derived exosomes to glioblastoma multiforme cells conferred chemosensitivity. Mol Ther Nucleic Acids. 2013;2:e126."}, {"ArticleIdList": {"ArticleId": {"#text": "28678319", "@IdType": "pubmed"}}, "Citation": "Yuwen DL, Sheng BB, Liu J, et al. MiR-146a-5p level in serum exosomes predicts therapeutic effect of cisplatin in non-small cell lung cancer. Eur Rev Med Pharmacol Sci. 2017;21(11):2650\u20132658."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4035923", "@IdType": "pmc"}, {"#text": "24733904", "@IdType": "pubmed"}]}, "Citation": "Ma X, Chen Z, Hua D, et al. Essential role for TrpC5-containing extracellular vesicles in breast cancer with chemotherapeutic resistance. Proc Natl Acad Sci U S A. 2014;111(17):6389."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4283810", "@IdType": "pmc"}, {"#text": "25417103", "@IdType": "pubmed"}]}, "Citation": "Boelens MC, Wu TJ, Nabet BY, et al. Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways. Cell. 2014;159(3):499\u2013513."}, {"ArticleIdList": {"ArticleId": {"#text": "24928860", "@IdType": "pubmed"}}, "Citation": "Wang J, Hendrix A, Hernot S, et al. Bone marrow stromal cell-derived exosomes as communicators in drug resistance in multiple myeloma cells. Blood. 2014;124(4):555\u2013566."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4510410", "@IdType": "pmc"}, {"#text": "26258125", "@IdType": "pubmed"}]}, "Citation": "Neviani P, Fabbri M. Exosomic microRNAs in the tumor microenvironment. Front Med (Lausanne) 2015;2:47."}, {"ArticleIdList": {"ArticleId": {"#text": "12907600", "@IdType": "pubmed"}}, "Citation": "Shedden K, Xie XT, Chandaroy P, Chang YT, Rosania GR. Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles. Cancer Res. 2003;63(15):4331\u20134337."}, {"ArticleIdList": {"ArticleId": {"#text": "16227410", "@IdType": "pubmed"}}, "Citation": "Safaei R, Larson BJ, Cheng TC, et al. Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells. Mol Cancer Ther. 2005;4(10):1595\u20131604."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3916404", "@IdType": "pmc"}, {"#text": "24516610", "@IdType": "pubmed"}]}, "Citation": "Federici C, Petrucci F, Caimi S, et al. Exosome release and low pH belong to a framework of resistance of human melanoma cells to cisplatin. PLoS One. 2014;9(2):e88193."}]}}}}}, "PMC": "PMC5865556", "PMID": "29593419", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "Functional miRNAs in breast cancer drug resistance.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "50": {"Abstract": "Brain metastases manifest the advanced stage of breast cancer disease with poor prognosis for patient survival. Recent reports demonstrate that some therapeutic agents can activate the expression of several breast cancer-associated genes, whose products are involved in the onset and development of brain metastases. In this study, we discovered a functional link between KISS1 and E-cadherin that could be observed in both primary brain metastatic lesions and paired cell lines, such as parental CN34TGL and MDA-MB-231 and their respective brain metastatic subclones CN34Brm2Ctgl and MDA-MB-231Br. Remarkably, expression of KISS1 and E-cadherin genes consistently showed an inverse correlation in all of the above cell/tissue types. While E-cadherin expression was strongly upregulated in metastatic clones isolated from blood and brain, the levels of this protein in parental MDA-MB-231\u00a0cell line was low. Furthermore, E-cadherin upregulation can be artificially induced in MDA-MB-231Br and CN34Brm2Ctgl cell populations by knocking down KISS1 expression directly or through overexpressing the miR345 mimic. In the aggregate, our data suggest that the tumor microenvironment, which controls breast cancer spreading via miR345-regulated KISS1 expression, might modulate metastatic spreading by a mechanism(s) involving upregulation of E-cadherin production.", "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "3909726435885587558", "Part1": "Group of Experimental Biotherapy and Diagnostic", "Part2": "Institute for Regenerative Medicine", "Part3": "Sechenov First Moscow State Medical University", "Part4": "Moscow", "Part5": "119991", "Part6": "Russia. Electronic address: ulasov.iv@1msmu.ru.", "Text": "Group of Experimental Biotherapy and Diagnostic, Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, Moscow, 119991, Russia. Electronic address: ulasov.iv@1msmu.ru."}], "ForeName": "Ilya", "FullName": "Ilya Ulasov", "HashID": "-4850901137487067540", "LastName": "Ulasov", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-943335916247715194", "Part1": "University of Alabama at Birmingham", "Part2": "UAB", "Part3": "Birmingham", "Part4": "AL", "Part5": "35205", "Part6": "USA.", "Text": "University of Alabama at Birmingham, UAB, Birmingham, AL, 35205, USA."}], "ForeName": "Anton", "FullName": "Anton Borovjagin", "HashID": "-7447823029496095539", "LastName": "Borovjagin", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "9094346707992117466", "Part1": "Department of Neurological Surgery", "Part2": "Feinberg School of Medicine", "Part3": "Northwestern University", "Part4": "Chicago", "Part5": "60611", "Part6": "USA.", "Text": "Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, 60611, USA."}], "ForeName": "Jawad", "FullName": "Jawad Fares", "HashID": "239345248107404953", "LastName": "Fares", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "3909726435885587558", "Part1": "Group of Experimental Biotherapy and Diagnostic", "Part2": "Institute for Regenerative Medicine", "Part3": "Sechenov First Moscow State Medical University", "Part4": "Moscow", "Part5": "119991", "Part6": "Russia.", "Text": "Group of Experimental Biotherapy and Diagnostic, Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, Moscow, 119991, Russia."}], "ForeName": "Semyon", "FullName": "Semyon Yakushov", "HashID": "2150659673574193455", "LastName": "Yakushov", "ORCID": null}, {"Affiliations": [{"Has_Extra": true, "HashID": "-4586076988048082184", "Part1": "Department of Medicine", "Part2": "University of Wisconsin Carbone Cancer Center", "Part3": "University of Wisconsin School of Medicine and Public Health", "Part4": "Madison", "Part5": "WI", "Part6": "37115", "Text": "Department of Medicine, University of Wisconsin Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, 37115, USA."}], "ForeName": "Dmitry", "FullName": "Dmitry Malin", "HashID": "266203040300783393", "LastName": "Malin", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "689347817893460967", "Part1": "Institute for Regenerative Medicine", "Part2": "Sechenov First Moscow State Medical University", "Part3": "Moscow", "Part4": "119991", "Part5": "Russia.", "Part6": null, "Text": "Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, Moscow, 119991, Russia."}], "ForeName": "Peter", "FullName": "Peter Timashev", "HashID": "9163048313813290349", "LastName": "Timashev", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "9094346707992117466", "Part1": "Department of Neurological Surgery", "Part2": "Feinberg School of Medicine", "Part3": "Northwestern University", "Part4": "Chicago", "Part5": "60611", "Part6": "USA.", "Text": "Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, 60611, USA."}], "ForeName": "Maciej S", "FullName": "Maciej S Lesniak", "HashID": "5828681591219741980", "LastName": "Lesniak", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.1016/j.canlet.2020.03.025", "InsertType": null, "Journal": "Cancer letters", "Keywords": [{"IS_Major": false, "IS_Mesh": true, "Text": "Adult"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Antigens, CD"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Brain Neoplasms"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Breast Neoplasms"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Cadherins"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Carcinoma, Ductal, Breast"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Cell Line, Tumor"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Female"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Gene Expression Regulation, Neoplastic"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Genes, Tumor Suppressor"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Humans"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Kisspeptins"}, {"IS_Major": false, "IS_Mesh": true, "Text": "MicroRNAs"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Middle Aged"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Transcriptional Activation"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Tumor Microenvironment"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Up-Regulation"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Breast cancer"}, {"IS_Major": false, "IS_Mesh": false, "Text": "E-cadherin"}, {"IS_Major": false, "IS_Mesh": false, "Text": "KISS1 metastatic tumor suppressor"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Metastases"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "MEDLINE", "Article": {"@PubModel": "Print-Electronic", "Abstract": {"AbstractText": "Brain metastases manifest the advanced stage of breast cancer disease with poor prognosis for patient survival. Recent reports demonstrate that some therapeutic agents can activate the expression of several breast cancer-associated genes, whose products are involved in the onset and development of brain metastases. In this study, we discovered a functional link between KISS1 and E-cadherin that could be observed in both primary brain metastatic lesions and paired cell lines, such as parental CN34TGL and MDA-MB-231 and their respective brain metastatic subclones CN34Brm2Ctgl and MDA-MB-231Br. Remarkably, expression of KISS1 and E-cadherin genes consistently showed an inverse correlation in all of the above cell/tissue types. While E-cadherin expression was strongly upregulated in metastatic clones isolated from blood and brain, the levels of this protein in parental MDA-MB-231\u00a0cell line was low. Furthermore, E-cadherin upregulation can be artificially induced in MDA-MB-231Br and CN34Brm2Ctgl cell populations by knocking down KISS1 expression directly or through overexpressing the miR345 mimic. In the aggregate, our data suggest that the tumor microenvironment, which controls breast cancer spreading via miR345-regulated KISS1 expression, might modulate metastatic spreading by a mechanism(s) involving upregulation of E-cadherin production.", "CopyrightInformation": "Copyright \u00a9 2020 Elsevier B.V. All rights reserved."}, "ArticleDate": {"@DateType": "Electronic", "Day": "01", "Month": "04", "Year": "2020"}, "ArticleTitle": "MicroRNA 345 (miR345) regulates KISS1-E-cadherin functional interaction in breast cancer brain metastases.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Group of Experimental Biotherapy and Diagnostic, Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, Moscow, 119991, Russia. Electronic address: ulasov.iv@1msmu.ru."}, "ForeName": "Ilya", "Initials": "I", "LastName": "Ulasov"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "University of Alabama at Birmingham, UAB, Birmingham, AL, 35205, USA."}, "ForeName": "Anton", "Initials": "A", "LastName": "Borovjagin"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, 60611, USA."}, "ForeName": "Jawad", "Initials": "J", "LastName": "Fares"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Group of Experimental Biotherapy and Diagnostic, Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, Moscow, 119991, Russia."}, "ForeName": "Semyon", "Initials": "S", "LastName": "Yakushov"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Medicine, University of Wisconsin Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, 37115, USA."}, "ForeName": "Dmitry", "Initials": "D", "LastName": "Malin"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, Moscow, 119991, Russia."}, "ForeName": "Peter", "Initials": "P", "LastName": "Timashev"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, 60611, USA."}, "ForeName": "Maciej S", "Initials": "MS", "LastName": "Lesniak"}]}, "ELocationID": [{"#text": "10.1016/j.canlet.2020.03.025", "@EIdType": "doi", "@ValidYN": "Y"}, {"#text": "S0304-3835(20)30158-0", "@EIdType": "pii", "@ValidYN": "Y"}], "Journal": {"ISOAbbreviation": "Cancer Lett", "ISSN": {"#text": "1872-7980", "@IssnType": "Electronic"}, "JournalIssue": {"@CitedMedium": "Internet", "PubDate": {"Day": "01", "Month": "Jul", "Year": "2020"}, "Volume": "481"}, "Title": "Cancer letters"}, "Language": "eng", "Pagination": {"EndPage": "31", "MedlinePgn": "24-31", "StartPage": "24"}, "PublicationTypeList": {"PublicationType": [{"#text": "Journal Article", "@UI": "D016428"}, {"#text": "Research Support, Non-U.S. Gov't", "@UI": "D013485"}]}}, "ChemicalList": {"Chemical": [{"NameOfSubstance": {"#text": "Antigens, CD", "@UI": "D015703"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "CDH1 protein, human", "@UI": "C513384"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "Cadherins", "@UI": "D015820"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "KISS1 protein, human", "@UI": "C106628"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "Kisspeptins", "@UI": "D059648"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "MIRN345 microRNA, human", "@UI": "C561417"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "MicroRNAs", "@UI": "D035683"}, "RegistryNumber": "0"}]}, "CitationSubset": "IM", "CoiStatement": "Declaration of competing interest Authors declare no conflict of interest.", "DateCompleted": {"Day": "15", "Month": "12", "Year": "2020"}, "DateRevised": {"Day": "15", "Month": "12", "Year": "2020"}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"#text": "Breast cancer", "@MajorTopicYN": "N"}, {"#text": "E-cadherin", "@MajorTopicYN": "N"}, {"#text": "KISS1 metastatic tumor suppressor", "@MajorTopicYN": "N"}, {"#text": "Metastases", "@MajorTopicYN": "N"}]}, "MedlineJournalInfo": {"Country": "Ireland", "ISSNLinking": "0304-3835", "MedlineTA": "Cancer Lett", "NlmUniqueID": "7600053"}, "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"#text": "Adult", "@MajorTopicYN": "N", "@UI": "D000328"}}, {"DescriptorName": {"#text": "Antigens, CD", "@MajorTopicYN": "N", "@UI": "D015703"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Brain Neoplasms", "@MajorTopicYN": "N", "@UI": "D001932"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Breast Neoplasms", "@MajorTopicYN": "N", "@UI": "D001943"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Cadherins", "@MajorTopicYN": "N", "@UI": "D015820"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Carcinoma, Ductal, Breast", "@MajorTopicYN": "N", "@UI": "D018270"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Cell Line, Tumor", "@MajorTopicYN": "N", "@UI": "D045744"}}, {"DescriptorName": {"#text": "Female", "@MajorTopicYN": "N", "@UI": "D005260"}}, {"DescriptorName": {"#text": "Gene Expression Regulation, Neoplastic", "@MajorTopicYN": "N", "@UI": "D015972"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Genes, Tumor Suppressor", "@MajorTopicYN": "N", "@UI": "D016147"}, "QualifierName": {"#text": "physiology", "@MajorTopicYN": "N", "@UI": "Q000502"}}, {"DescriptorName": {"#text": "Humans", "@MajorTopicYN": "N", "@UI": "D006801"}}, {"DescriptorName": {"#text": "Kisspeptins", "@MajorTopicYN": "N", "@UI": "D059648"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "MicroRNAs", "@MajorTopicYN": "N", "@UI": "D035683"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Middle Aged", "@MajorTopicYN": "N", "@UI": "D008875"}}, {"DescriptorName": {"#text": "Transcriptional Activation", "@MajorTopicYN": "N", "@UI": "D015533"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Tumor Microenvironment", "@MajorTopicYN": "N", "@UI": "D059016"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Up-Regulation", "@MajorTopicYN": "N", "@UI": "D015854"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}}]}, "PMID": {"#text": "32246957", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "32246957", "@IdType": "pubmed"}, {"#text": "10.1016/j.canlet.2020.03.025", "@IdType": "doi"}, {"#text": "S0304-3835(20)30158-0", "@IdType": "pii"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "received", "Day": "3", "Month": "9", "Year": "2019"}, {"@PubStatus": "revised", "Day": "25", "Month": "3", "Year": "2020"}, {"@PubStatus": "accepted", "Day": "26", "Month": "3", "Year": "2020"}, {"@PubStatus": "pubmed", "Day": "5", "Hour": "6", "Minute": "0", "Month": "4", "Year": "2020"}, {"@PubStatus": "medline", "Day": "16", "Hour": "6", "Minute": "0", "Month": "12", "Year": "2020"}, {"@PubStatus": "entrez", "Day": "5", "Hour": "6", "Minute": "0", "Month": "4", "Year": "2020"}]}, "PublicationStatus": "ppublish"}}}}, "PMC": null, "PMID": "32246957", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "MicroRNA 345 (miR345) regulates KISS1-E-cadherin functional interaction in breast cancer brain metastases.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "51": {"Abstract": "E-cadherin is a tumor suppressor protein, and the loss of its expression in association with the epithelial mesenchymal transition (EMT) occurs frequently during tumor metastasis. However, many metastases continue to express E-cadherin, and a full EMT is not always necessary for metastasis; also, positive roles for E-cadherin expression in metastasis have been reported. We hypothesize instead that changes in the functional activity of E-cadherin expressed on tumor cells in response to environmental factors is an important determinant of the ability of the tumor cells to metastasize. We find that E-cadherin expression persists in metastatic lung nodules and circulating tumor cells (CTCs) in two mouse models of mammary cancer: genetically modified MMTV-PyMT mice and orthotopically grafted 4T1 tumor cells. Importantly, monoclonal antibodies that bind to and activate E-cadherin at the cell surface reduce lung metastasis from endogenous genetically driven tumors and from tumor cell grafts. E-cadherin activation inhibits metastasis at multiple stages, including the accumulation of CTCs from the primary tumor and the extravasation of tumor cells from the vasculature. These activating mAbs increase cell adhesion and reduce cell invasion and migration in both cell culture and three-dimensional spheroids grown from primary tumors. Moreover, activating mAbs increased the frequency of apoptotic cells without affecting proliferation. Although the growth of the primary tumors was unaffected by activating mAbs, CTCs and tumor cells in metastatic nodules exhibited increased apoptosis. Thus, the functional state of E-cadherin is an important determinant of metastatic potential beyond whether the gene is expressed.", "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "2377963821837307550", "Part1": "Center for Developmental Biology and Regenerative Medicine", "Part2": "Seattle Children's Research Institute", "Part3": "Seattle", "Part4": "WA 98101.", "Part5": null, "Part6": null, "Text": "Center for Developmental Biology and Regenerative Medicine, Seattle Children's Research Institute, Seattle, WA 98101."}], "ForeName": "Tae-Young", "FullName": "Tae-Young Na", "HashID": "8910363629691160266", "LastName": "Na", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "2377963821837307550", "Part1": "Center for Developmental Biology and Regenerative Medicine", "Part2": "Seattle Children's Research Institute", "Part3": "Seattle", "Part4": "WA 98101.", "Part5": null, "Part6": null, "Text": "Center for Developmental Biology and Regenerative Medicine, Seattle Children's Research Institute, Seattle, WA 98101."}], "ForeName": "Leslayann", "FullName": "Leslayann Schecterson", "HashID": "4835384747165237377", "LastName": "Schecterson", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "2377963821837307550", "Part1": "Center for Developmental Biology and Regenerative Medicine", "Part2": "Seattle Children's Research Institute", "Part3": "Seattle", "Part4": "WA 98101.", "Part5": null, "Part6": null, "Text": "Center for Developmental Biology and Regenerative Medicine, Seattle Children's Research Institute, Seattle, WA 98101."}], "ForeName": "Alisha M", "FullName": "Alisha M Mendonsa", "HashID": "3709700552637487230", "LastName": "Mendonsa", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-697439589525454474", "Part1": "Center for Developmental Biology and Regenerative Medicine", "Part2": "Seattle Children's Research Institute", "Part3": "Seattle", "Part4": "WA 98101; gumbiner@uw.edu.", "Part5": null, "Part6": null, "Text": "Center for Developmental Biology and Regenerative Medicine, Seattle Children's Research Institute, Seattle, WA 98101; gumbiner@uw.edu."}, {"Has_Extra": false, "HashID": "-5934607838578577146", "Part1": "Department of Pediatrics", "Part2": "University of Washington School of Medicine", "Part3": "Seattle", "Part4": "WA 98195.", "Part5": null, "Part6": null, "Text": "Department of Pediatrics, University of Washington School of Medicine, Seattle, WA 98195."}, {"Has_Extra": false, "HashID": "-5282821290128057548", "Part1": "Department of Biochemistry", "Part2": "University of Washington School of Medicine", "Part3": "Seattle", "Part4": "WA 98195.", "Part5": null, "Part6": null, "Text": "Department of Biochemistry, University of Washington School of Medicine, Seattle, WA 98195."}], "ForeName": "Barry M", "FullName": "Barry M Gumbiner", "HashID": "-1927992040749996081", "LastName": "Gumbiner", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.1073/pnas.1918167117", "InsertType": null, "Journal": "Proceedings of the National Academy of Sciences of the United States of America", "Keywords": [{"IS_Major": false, "IS_Mesh": true, "Text": "Animals"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Apoptosis"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Breast Neoplasms"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Cadherins"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Cell Adhesion"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Cell Line, Tumor"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Cell Movement"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Disease Models, Animal"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Epithelial-Mesenchymal Transition"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Female"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Gene Expression Regulation, Neoplastic"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Lung"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Lung Neoplasms"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Mice"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Mice, Inbred BALB C"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Neoplasm Invasiveness"}, {"IS_Major": true, "IS_Mesh": true, "Text": "Neoplasm Metastasis"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Neoplastic Cells, Circulating"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Neoplastic Processes"}, {"IS_Major": false, "IS_Mesh": false, "Text": "E-cadherin"}, {"IS_Major": false, "IS_Mesh": false, "Text": "E-cadherin-positive tumors"}, {"IS_Major": false, "IS_Mesh": false, "Text": "MMTV-PyMT breast cancer model"}, {"IS_Major": false, "IS_Mesh": false, "Text": "breast cancer metastasis"}, {"IS_Major": false, "IS_Mesh": false, "Text": "circulating tumor cells"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "MEDLINE", "Article": {"@PubModel": "Print-Electronic", "Abstract": {"AbstractText": "E-cadherin is a tumor suppressor protein, and the loss of its expression in association with the epithelial mesenchymal transition (EMT) occurs frequently during tumor metastasis. However, many metastases continue to express E-cadherin, and a full EMT is not always necessary for metastasis; also, positive roles for E-cadherin expression in metastasis have been reported. We hypothesize instead that changes in the functional activity of E-cadherin expressed on tumor cells in response to environmental factors is an important determinant of the ability of the tumor cells to metastasize. We find that E-cadherin expression persists in metastatic lung nodules and circulating tumor cells (CTCs) in two mouse models of mammary cancer: genetically modified MMTV-PyMT mice and orthotopically grafted 4T1 tumor cells. Importantly, monoclonal antibodies that bind to and activate E-cadherin at the cell surface reduce lung metastasis from endogenous genetically driven tumors and from tumor cell grafts. E-cadherin activation inhibits metastasis at multiple stages, including the accumulation of CTCs from the primary tumor and the extravasation of tumor cells from the vasculature. These activating mAbs increase cell adhesion and reduce cell invasion and migration in both cell culture and three-dimensional spheroids grown from primary tumors. Moreover, activating mAbs increased the frequency of apoptotic cells without affecting proliferation. Although the growth of the primary tumors was unaffected by activating mAbs, CTCs and tumor cells in metastatic nodules exhibited increased apoptosis. Thus, the functional state of E-cadherin is an important determinant of metastatic potential beyond whether the gene is expressed."}, "ArticleDate": {"@DateType": "Electronic", "Day": "03", "Month": "03", "Year": "2020"}, "ArticleTitle": "The functional activity of E-cadherin controls tumor cell metastasis at multiple steps.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Center for Developmental Biology and Regenerative Medicine, Seattle Children's Research Institute, Seattle, WA 98101."}, "ForeName": "Tae-Young", "Initials": "TY", "LastName": "Na"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Center for Developmental Biology and Regenerative Medicine, Seattle Children's Research Institute, Seattle, WA 98101."}, "ForeName": "Leslayann", "Initials": "L", "LastName": "Schecterson"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Center for Developmental Biology and Regenerative Medicine, Seattle Children's Research Institute, Seattle, WA 98101."}, "ForeName": "Alisha M", "Initials": "AM", "LastName": "Mendonsa"}, {"@ValidYN": "Y", "AffiliationInfo": [{"Affiliation": "Center for Developmental Biology and Regenerative Medicine, Seattle Children's Research Institute, Seattle, WA 98101; gumbiner@uw.edu."}, {"Affiliation": "Department of Pediatrics, University of Washington School of Medicine, Seattle, WA 98195."}, {"Affiliation": "Department of Biochemistry, University of Washington School of Medicine, Seattle, WA 98195."}], "ForeName": "Barry M", "Initials": "BM", "LastName": "Gumbiner"}]}, "ELocationID": {"#text": "10.1073/pnas.1918167117", "@EIdType": "doi", "@ValidYN": "Y"}, "GrantList": {"@CompleteYN": "Y", "Grant": {"Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States", "GrantID": "R01 CA207115"}}, "Journal": {"ISOAbbreviation": "Proc Natl Acad Sci U S A", "ISSN": {"#text": "1091-6490", "@IssnType": "Electronic"}, "JournalIssue": {"@CitedMedium": "Internet", "Issue": "11", "PubDate": {"Day": "17", "Month": "Mar", "Year": "2020"}, "Volume": "117"}, "Title": "Proceedings of the National Academy of Sciences of the United States of America"}, "Language": "eng", "Pagination": {"EndPage": "5937", "MedlinePgn": "5931-5937", "StartPage": "5931"}, "PublicationTypeList": {"PublicationType": [{"#text": "Journal Article", "@UI": "D016428"}, {"#text": "Research Support, N.I.H., Extramural", "@UI": "D052061"}]}}, "ChemicalList": {"Chemical": {"NameOfSubstance": {"#text": "Cadherins", "@UI": "D015820"}, "RegistryNumber": "0"}}, "CitationSubset": "IM", "CoiStatement": "The authors declare no competing interest.", "DateCompleted": {"Day": "06", "Month": "07", "Year": "2020"}, "DateRevised": {"Day": "03", "Month": "09", "Year": "2020"}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"#text": "E-cadherin", "@MajorTopicYN": "N"}, {"#text": "E-cadherin-positive tumors", "@MajorTopicYN": "N"}, {"#text": "MMTV-PyMT breast cancer model", "@MajorTopicYN": "N"}, {"#text": "breast cancer metastasis", "@MajorTopicYN": "N"}, {"#text": "circulating tumor cells", "@MajorTopicYN": "N"}]}, "MedlineJournalInfo": {"Country": "United States", "ISSNLinking": "0027-8424", "MedlineTA": "Proc Natl Acad Sci U S A", "NlmUniqueID": "7505876"}, "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"#text": "Animals", "@MajorTopicYN": "N", "@UI": "D000818"}}, {"DescriptorName": {"#text": "Apoptosis", "@MajorTopicYN": "N", "@UI": "D017209"}, "QualifierName": {"#text": "drug effects", "@MajorTopicYN": "N", "@UI": "Q000187"}}, {"DescriptorName": {"#text": "Breast Neoplasms", "@MajorTopicYN": "N", "@UI": "D001943"}, "QualifierName": [{"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}, {"#text": "metabolism", "@MajorTopicYN": "Y", "@UI": "Q000378"}, {"#text": "pathology", "@MajorTopicYN": "N", "@UI": "Q000473"}]}, {"DescriptorName": {"#text": "Cadherins", "@MajorTopicYN": "N", "@UI": "D015820"}, "QualifierName": [{"#text": "antagonists & inhibitors", "@MajorTopicYN": "Y", "@UI": "Q000037"}, {"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}, {"#text": "metabolism", "@MajorTopicYN": "Y", "@UI": "Q000378"}]}, {"DescriptorName": {"#text": "Cell Adhesion", "@MajorTopicYN": "N", "@UI": "D002448"}, "QualifierName": {"#text": "drug effects", "@MajorTopicYN": "N", "@UI": "Q000187"}}, {"DescriptorName": {"#text": "Cell Line, Tumor", "@MajorTopicYN": "N", "@UI": "D045744"}}, {"DescriptorName": {"#text": "Cell Movement", "@MajorTopicYN": "N", "@UI": "D002465"}, "QualifierName": {"#text": "drug effects", "@MajorTopicYN": "N", "@UI": "Q000187"}}, {"DescriptorName": {"#text": "Disease Models, Animal", "@MajorTopicYN": "N", "@UI": "D004195"}}, {"DescriptorName": {"#text": "Epithelial-Mesenchymal Transition", "@MajorTopicYN": "N", "@UI": "D058750"}}, {"DescriptorName": {"#text": "Female", "@MajorTopicYN": "N", "@UI": "D005260"}}, {"DescriptorName": {"#text": "Gene Expression Regulation, Neoplastic", "@MajorTopicYN": "N", "@UI": "D015972"}}, {"DescriptorName": {"#text": "Lung", "@MajorTopicYN": "N", "@UI": "D008168"}, "QualifierName": {"#text": "pathology", "@MajorTopicYN": "N", "@UI": "Q000473"}}, {"DescriptorName": {"#text": "Lung Neoplasms", "@MajorTopicYN": "N", "@UI": "D008175"}, "QualifierName": [{"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}, {"#text": "metabolism", "@MajorTopicYN": "Y", "@UI": "Q000378"}, {"#text": "pathology", "@MajorTopicYN": "N", "@UI": "Q000473"}]}, {"DescriptorName": {"#text": "Mice", "@MajorTopicYN": "N", "@UI": "D051379"}}, {"DescriptorName": {"#text": "Mice, Inbred BALB C", "@MajorTopicYN": "N", "@UI": "D008807"}}, {"DescriptorName": {"#text": "Neoplasm Invasiveness", "@MajorTopicYN": "N", "@UI": "D009361"}}, {"DescriptorName": {"#text": "Neoplasm Metastasis", "@MajorTopicYN": "Y", "@UI": "D009362"}, "QualifierName": {"#text": "drug therapy", "@MajorTopicYN": "N", "@UI": "Q000188"}}, {"DescriptorName": {"#text": "Neoplastic Cells, Circulating", "@MajorTopicYN": "N", "@UI": "D009360"}, "QualifierName": [{"#text": "metabolism", "@MajorTopicYN": "N", "@UI": "Q000378"}, {"#text": "pathology", "@MajorTopicYN": "N", "@UI": "Q000473"}]}, {"DescriptorName": {"#text": "Neoplastic Processes", "@MajorTopicYN": "N", "@UI": "D009385"}}]}, "PMID": {"#text": "32127478", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "32127478", "@IdType": "pubmed"}, {"#text": "PMC7084067", "@IdType": "pmc"}, {"#text": "10.1073/pnas.1918167117", "@IdType": "doi"}, {"#text": "1918167117", "@IdType": "pii"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "pubmed", "Day": "5", "Hour": "6", "Minute": "0", "Month": "3", "Year": "2020"}, {"@PubStatus": "medline", "Day": "7", "Hour": "6", "Minute": "0", "Month": "7", "Year": "2020"}, {"@PubStatus": "entrez", "Day": "5", "Hour": "6", "Minute": "0", "Month": "3", "Year": "2020"}]}, "PublicationStatus": "ppublish", "ReferenceList": {"Reference": [{"ArticleIdList": {"ArticleId": {"#text": "8814984", "@IdType": "pubmed"}}, "Citation": "Bracke M. E., Van Roy F. M., Mareel M. M., The E-cadherin/catenin complex in invasion and metastasis. Curr. Top. Microbiol. Immunol. 213, 123\u2013161 (1996)."}, {"ArticleIdList": {"ArticleId": {"#text": "21376230", "@IdType": "pubmed"}}, "Citation": "Hanahan D., Weinberg R. A., Hallmarks of cancer: The next generation. Cell 144, 646\u2013674 (2011)."}, {"ArticleIdList": {"ArticleId": {"#text": "15294153", "@IdType": "pubmed"}}, "Citation": "Kang Y., Massagu\u00e9 J., Epithelial-mesenchymal transitions: Twist in development and metastasis. Cell 118, 277\u2013279 (2004)."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3261217", "@IdType": "pmc"}, {"#text": "22000009", "@IdType": "pubmed"}]}, "Citation": "Valastyan S., Weinberg R. A., Tumor metastasis: Molecular insights and evolving paradigms. Cell 147, 275\u2013292 (2011)."}, {"ArticleIdList": {"ArticleId": {"#text": "10640987", "@IdType": "pubmed"}}, "Citation": "Bukholm I. K., Nesland J. M., B\u00f8rresen-Dale A. L., Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients [seecomments]. J. Pathol. 190, 15\u201319 (2000)."}, {"ArticleIdList": {"ArticleId": {"#text": "18773493", "@IdType": "pubmed"}}, "Citation": "Lou Y., et al. , Epithelial-mesenchymal transition (EMT) is not sufficient for spontaneous murine breast cancer metastasis. Dev. Dyn. 237, 2755\u20132768 (2008)."}, {"ArticleIdList": {"ArticleId": {"#text": "23338761", "@IdType": "pubmed"}}, "Citation": "Hollestelle A., et al. , Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer. Breast Cancer Res. Treat. 138, 47\u201357 (2013)."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3008612", "@IdType": "pmc"}, {"#text": "21063415", "@IdType": "pubmed"}]}, "Citation": "Querzoli P., et al. , An immunohistochemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancer. Br. J. Cancer 103, 1835\u20131839 (2010)."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3941206", "@IdType": "pmc"}, {"#text": "24332913", "@IdType": "pubmed"}]}, "Citation": "Cheung K. J., Gabrielson E., Werb Z., Ewald A. J., Collective invasion in breast cancer requires a conserved basal epithelial program. Cell 155, 1639\u20131651 (2013)."}, {"ArticleIdList": {"ArticleId": {"#text": "27124449", "@IdType": "pubmed"}}, "Citation": "Cheung K. J., Ewald A. J., A collective route to metastasis: Seeding by tumor cell clusters. Science 352, 167\u2013169 (2016)."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC7365572", "@IdType": "pmc"}, {"#text": "31485072", "@IdType": "pubmed"}]}, "Citation": "Padmanaban V., et al. , E-cadherin is required for metastasis in multiple models of breast cancer. Nature 573, 439\u2013444 (2019)."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2200019", "@IdType": "pmc"}, {"#text": "8034750", "@IdType": "pubmed"}]}, "Citation": "Brieher W. M., Gumbiner B. M., Regulation of C-cadherin function during activin induced morphogenesis of Xenopus animal caps. J. Cell Biol. 126, 519\u2013527 (1994)."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2132887", "@IdType": "pmc"}, {"#text": "9922460", "@IdType": "pubmed"}]}, "Citation": "Zhong Y., Brieher W. M., Gumbiner B. M., Analysis of C-cadherin regulation during tissue morphogenesis with an activating antibody. J. Cell Biol. 144, 351\u2013359 (1999)."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3364174", "@IdType": "pmc"}, {"#text": "22513089", "@IdType": "pubmed"}]}, "Citation": "Petrova Y. I., Spano M. M., Gumbiner B. M., Conformational epitopes at cadherin calcium-binding sites and p120-catenin phosphorylation regulate cell adhesion. Mol. Biol. Cell 23, 2092\u20132108 (2012)."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4571897", "@IdType": "pmc"}, {"#text": "26175155", "@IdType": "pubmed"}]}, "Citation": "Shashikanth N., et al. , Allosteric regulation of E-cadherin adhesion. J. Biol. Chem. 290, 21749\u201321761 (2015)."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4742228", "@IdType": "pmc"}, {"#text": "26845024", "@IdType": "pubmed"}]}, "Citation": "Maiden S. L., Petrova Y. I., Gumbiner B. M., Microtubules inhibit E-cadherin adhesive activity by maintaining phosphorylated p120-catenin in a colon carcinoma cell model. PLoS One 11, e0148574 (2016)."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5170857", "@IdType": "pmc"}, {"#text": "27582386", "@IdType": "pubmed"}]}, "Citation": "Petrova Y. I., Schecterson L., Gumbiner B. M., Roles for E-cadherin cell surface regulation in cancer. Mol. Biol. Cell 27, 3233\u20133244 (2016)."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC1779475", "@IdType": "pmc"}, {"#text": "16887003", "@IdType": "pubmed"}]}, "Citation": "Fantozzi A., Christofori G., Mouse models of breast cancer metastasis. Breast Cancer Res. 8, 212 (2006)."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3941052", "@IdType": "pmc"}, {"#text": "24590176", "@IdType": "pubmed"}]}, "Citation": "Shamir E. R., et al. , Twist1-induced dissemination preserves epithelial identity and requires E-cadherin. J. Cell Biol. 204, 839\u2013856 (2014)."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC4118667", "@IdType": "pmc"}, {"#text": "24855950", "@IdType": "pubmed"}]}, "Citation": "Cai D., et al. , Mechanical feedback through E-cadherin promotes direction sensing during collective cell migration. Cell 157, 1146\u20131159 (2014)."}, {"ArticleIdList": {"ArticleId": {"#text": "8954717", "@IdType": "pubmed"}}, "Citation": "Fagotto F., Gumbiner B. M., Cell contact-dependent signaling. Dev. Biol. 180, 445\u2013454 (1996)."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3141988", "@IdType": "pmc"}, {"#text": "21730131", "@IdType": "pubmed"}]}, "Citation": "Kim N. G., Koh E., Chen X., Gumbiner B. M., E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components. Proc. Natl. Acad. Sci. U.S.A. 108, 11930\u201311935 (2011)."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC1877107", "@IdType": "pmc"}, {"#text": "17392517", "@IdType": "pubmed"}]}, "Citation": "Perrais M., Chen X., Perez-Moreno M., Gumbiner B. M., E-cadherin homophilic ligation inhibits cell growth and epidermal growth factor receptor signaling independently of other cell interactions. Mol. Biol. Cell 18, 2013\u20132025 (2007)."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC6119098", "@IdType": "pmc"}, {"#text": "29780167", "@IdType": "pubmed"}]}, "Citation": "Mendonsa A. M., Na T. Y., Gumbiner B. M., E-cadherin in contact inhibition and cancer. Oncogene 37, 4769\u20134780 (2018)."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3492491", "@IdType": "pmc"}, {"#text": "23144919", "@IdType": "pubmed"}]}, "Citation": "Waldmeier L., Meyer-Schaller N., Diepenbruck M., Christofori G., Py2T murine breast cancer cells, a versatile model of TGF\u03b2-induced EMT in vitro and in vivo. PLoS One 7, e48651 (2012)."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC369527", "@IdType": "pmc"}, {"#text": "1312220", "@IdType": "pubmed"}]}, "Citation": "Guy C. T., Cardiff R. D., Muller W. J., Induction of mammary tumors by expression of polyomavirus middle T oncogene: A transgenic mouse model for metastatic disease. Mol. Cell Biol. 12, 954\u2013961 (1992)."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC5695084", "@IdType": "pmc"}, {"#text": "29051388", "@IdType": "pubmed"}]}, "Citation": "Micalizzi D. S., Maheswaran S., Haber D. A., A conduit to metastasis: Circulating tumor cell biology. Genes Dev. 31, 1827\u20131840 (2017)."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3296207", "@IdType": "pmc"}, {"#text": "22505926", "@IdType": "pubmed"}]}, "Citation": "Kim Y. N., Koo K. H., Sung J. Y., Yun U. J., Kim H., Anoikis resistance: An essential prerequisite for tumor metastasis. Int. J. Cell Biol. 2012, 306879 (2012)."}, {"ArticleIdList": {"ArticleId": {"#text": "16424029", "@IdType": "pubmed"}}, "Citation": "Witta S. E., et al. , Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines. Cancer Res. 66, 944\u2013950 (2006)."}, {"ArticleIdList": {"ArticleId": {"#text": "24882208", "@IdType": "pubmed"}}, "Citation": "Lu M., et al. , E-cadherin couples death receptors to the cytoskeleton to regulate apoptosis. Mol. Cell 54, 987\u2013998 (2014)."}, {"ArticleIdList": {"ArticleId": {"#text": "10797287", "@IdType": "pubmed"}}, "Citation": "Sasaki C. Y., Lin Hc., Passaniti A., Expression of E-cadherin reduces bcl-2 expression and increases sensitivity to etoposide-induced apoptosis. Int. J. Cancer 86, 660\u2013666 (2000)."}, {"ArticleIdList": {"ArticleId": {"#text": "15880654", "@IdType": "pubmed"}}, "Citation": "Galaz S., et al. , Loss of E-cadherin mediated cell-cell adhesion as an early trigger of apoptosis induced by photodynamic treatment. J. Cell. Physiol. 205, 86\u201396 (2005)."}, {"ArticleIdList": {"ArticleId": {"#text": "15292248", "@IdType": "pubmed"}}, "Citation": "Fouquet S., et al. , Early loss of E-cadherin from cell-cell contacts is involved in the onset of Anoikis in enterocytes. J. Biol. Chem. 279, 43061\u201343069 (2004)."}, {"ArticleIdList": {"ArticleId": {"#text": "11259266", "@IdType": "pubmed"}}, "Citation": "Peluso J. J., Pappalardo A., Fernandez G., E-cadherin-mediated cell contact prevents apoptosis of spontaneously immortalized granulosa cells by regulating Akt kinase activity. Biol. Reprod. 64, 1183\u20131190 (2001)."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3696683", "@IdType": "pmc"}, {"#text": "23677993", "@IdType": "pubmed"}]}, "Citation": "Hu X., et al. , Deregulation of apoptotic factors Bcl-xL and Bax confers apoptotic resistance to myeloid-derived suppressor cells and contributes to their persistence in cancer. J. Biol. Chem. 288, 19103\u201319115 (2013)."}, {"ArticleIdList": {"ArticleId": {"#text": "8608588", "@IdType": "pubmed"}}, "Citation": "Gumbiner B. M., Cell adhesion: The molecular basis of tissue architecture and morphogenesis. Cell 84, 345\u2013357 (1996)."}, {"ArticleIdList": {"ArticleId": {"#text": "10098402", "@IdType": "pubmed"}}, "Citation": "Christofori G., Semb H., The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem. Sci. 24, 73\u201376 (1999)."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3924201", "@IdType": "pmc"}, {"#text": "24532814", "@IdType": "pubmed"}]}, "Citation": "Gumbiner B. M., Kim N. G., The Hippo-YAP signaling pathway and contact inhibition of growth. J. Cell Sci. 127, 709\u2013717 (2014)."}, {"ArticleIdList": {"ArticleId": {"#text": "9729719", "@IdType": "pubmed"}}, "Citation": "Gumbiner B. M., Propagation and localization of Wnt signaling. Curr. Opin. Genet. Dev. 8, 430\u2013435 (1998)."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC3372896", "@IdType": "pmc"}, {"#text": "15001769", "@IdType": "pubmed"}]}, "Citation": "Nelson W. J., Nusse R., Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303, 1483\u20131487 (2004)."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2828280", "@IdType": "pmc"}, {"#text": "20182623", "@IdType": "pubmed"}]}, "Citation": "Heuberger J., Birchmeier W., Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling. Cold Spring Harb. Perspect. Biol. 2, a002915 (2010)."}, {"ArticleIdList": {"ArticleId": [{"#text": "PMC2172751", "@IdType": "pmc"}, {"#text": "12507993", "@IdType": "pubmed"}]}, "Citation": "Yap A. S., Kovacs E. M., Direct cadherin-activated cell signaling: A view from the plasma membrane. J. Cell Biol. 160, 11\u201316 (2003)."}]}}}}}, "PMC": "PMC7084067", "PMID": "32127478", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "The functional activity of E-cadherin controls tumor cell metastasis at multiple steps.", "FlagAffiliationMining": 0, "FlagExtractKG": null}, "52": {"Abstract": " Increasing evidence has demonstrated that microRNAs (miRNAs) are key regulators of human diseases and can serve as prognostic markers for several cancers, such as pancreatic ductal adenocarcinoma (PDAC). Previous studies have revealed various functions for miR-345-5p in several cancers. However, the role and potential mechanism of miR-345-5p in PDAC have not been resolved. Quantitative RT-PCR was performed to investigate the expression levels of miR-345-5p in pancreatic cancer tissues and cell lines, and the effect of miR-345-5p on the proliferation and invasiveness of pancreatic cancer was examined in Transwell assays with miR-345-5p overexpression. We used Western blot assay to explore the underlying mechanisms. Immunofluorescence staining was performed to examine changes in the cytoskeleton of PANC-1 cells in response to miR-345-5p. Luciferase assays were used to clarify the target and regulation mechanism of miR-345-5p. miR-345-5p expression was downregulated in PDAC cells and tissues. Upregulated miR-345-5p expression inhibited the proliferation and metastasis of PDAC cells. We identified CCL8 as a direct target of miR-345-5p and found CCL8 expression was inversely correlated with miR-345-5p expression in PDAC samples. CCL8 could activate the NF-\u03baB signaling pathway to promote the proliferation and invasiveness of PDAC cells. These results suggested that miR-345-5p inhibited PDAC progression by inactivating NF-\u03baB signaling. Here we demonstrated that miR-345-5p was a tumor-suppressive miRNA in pancreatic cancer progression by targeting CCL8. Our results suggest miR-345-5p may be a potential therapeutic biomarker for pancreatic cancer treatment.", "Authors": [{"Affiliations": [{"Has_Extra": false, "HashID": "-6985210685957177296", "Part1": "Department of Hepatic-Biliary-Pancreatic Surgery", "Part2": "the First people's Hospital of Neijiang", "Part3": "Neijiang", "Part4": "Sichuan", "Part5": "China.", "Part6": null, "Text": "Department of Hepatic-Biliary-Pancreatic Surgery, the First people's Hospital of Neijiang, Neijiang, Sichuan, China."}], "ForeName": "Tinggang", "FullName": "Tinggang Mou", "HashID": "581666052039730457", "LastName": "Mou", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-6985210685957177296", "Part1": "Department of Hepatic-Biliary-Pancreatic Surgery", "Part2": "the First people's Hospital of Neijiang", "Part3": "Neijiang", "Part4": "Sichuan", "Part5": "China.", "Part6": null, "Text": "Department of Hepatic-Biliary-Pancreatic Surgery, the First people's Hospital of Neijiang, Neijiang, Sichuan, China."}], "ForeName": "Fei", "FullName": "Fei Xie", "HashID": "7120070037436064615", "LastName": "Xie", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-6985210685957177296", "Part1": "Department of Hepatic-Biliary-Pancreatic Surgery", "Part2": "the First people's Hospital of Neijiang", "Part3": "Neijiang", "Part4": "Sichuan", "Part5": "China.", "Part6": null, "Text": "Department of Hepatic-Biliary-Pancreatic Surgery, the First people's Hospital of Neijiang, Neijiang, Sichuan, China."}], "ForeName": "Pingyong", "FullName": "Pingyong Zhong", "HashID": "-7590052766067664923", "LastName": "Zhong", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-6985210685957177296", "Part1": "Department of Hepatic-Biliary-Pancreatic Surgery", "Part2": "the First people's Hospital of Neijiang", "Part3": "Neijiang", "Part4": "Sichuan", "Part5": "China.", "Part6": null, "Text": "Department of Hepatic-Biliary-Pancreatic Surgery, the First people's Hospital of Neijiang, Neijiang, Sichuan, China."}], "ForeName": "Hao", "FullName": "Hao Hua", "HashID": "-7361392969450529624", "LastName": "Hua", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-6985210685957177296", "Part1": "Department of Hepatic-Biliary-Pancreatic Surgery", "Part2": "the First people's Hospital of Neijiang", "Part3": "Neijiang", "Part4": "Sichuan", "Part5": "China.", "Part6": null, "Text": "Department of Hepatic-Biliary-Pancreatic Surgery, the First people's Hospital of Neijiang, Neijiang, Sichuan, China."}], "ForeName": "Liang", "FullName": "Liang Lai", "HashID": "5626182891316248544", "LastName": "Lai", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "6683522047507893305", "Part1": "Department of Gastroenterology", "Part2": "the First people's Hospital of Neijiang", "Part3": "Neijiang", "Part4": "Sichuan", "Part5": "China.", "Part6": null, "Text": "Department of Gastroenterology, the First people's Hospital of Neijiang, Neijiang, Sichuan, China."}], "ForeName": "Qin", "FullName": "Qin Yang", "HashID": "-2826887278195777126", "LastName": "Yang", "ORCID": null}, {"Affiliations": [{"Has_Extra": false, "HashID": "-6985210685957177296", "Part1": "Department of Hepatic-Biliary-Pancreatic Surgery", "Part2": "the First people's Hospital of Neijiang", "Part3": "Neijiang", "Part4": "Sichuan", "Part5": "China. Electronic address: 348688347@qq.com.", "Part6": null, "Text": "Department of Hepatic-Biliary-Pancreatic Surgery, the First people's Hospital of Neijiang, Neijiang, Sichuan, China. Electronic address: 348688347@qq.com."}], "ForeName": "Jie", "FullName": "Jie Wang", "HashID": "8813770050406768901", "LastName": "Wang", "ORCID": null}], "CiteCrawlerDeep": 0, "CitedBy": null, "DOI": "10.1016/j.biopha.2018.12.121", "InsertType": null, "Journal": "Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie", "Keywords": [{"IS_Major": false, "IS_Mesh": true, "Text": "Adult"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Aged"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Cell Line"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Cell Line, Tumor"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Cell Proliferation"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Chemokine CCL8"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Down-Regulation"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Female"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Genes, Tumor Suppressor"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Humans"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Male"}, {"IS_Major": false, "IS_Mesh": true, "Text": "MicroRNAs"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Middle Aged"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Neoplasm Invasiveness"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Neoplasm Metastasis"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Pancreatic Neoplasms"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Signal Transduction"}, {"IS_Major": false, "IS_Mesh": true, "Text": "Up-Regulation"}, {"IS_Major": false, "IS_Mesh": false, "Text": "CCL8"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Invasion"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Migration"}, {"IS_Major": false, "IS_Mesh": false, "Text": "PDAC"}, {"IS_Major": false, "IS_Mesh": false, "Text": "Proliferation"}, {"IS_Major": false, "IS_Mesh": false, "Text": "miR-345-5p"}], "NamedEntities": null, "OreginalArticle": {"PubmedArticleSet": {"PubmedArticle": {"MedlineCitation": {"@Owner": "NLM", "@Status": "MEDLINE", "Article": {"@PubModel": "Print-Electronic", "Abstract": {"AbstractText": [{"#text": "Increasing evidence has demonstrated that microRNAs (miRNAs) are key regulators of human diseases and can serve as prognostic markers for several cancers, such as pancreatic ductal adenocarcinoma (PDAC). Previous studies have revealed various functions for miR-345-5p in several cancers. However, the role and potential mechanism of miR-345-5p in PDAC have not been resolved.", "@Label": "BACKGROUND", "@NlmCategory": "BACKGROUND"}, {"#text": "Quantitative RT-PCR was performed to investigate the expression levels of miR-345-5p in pancreatic cancer tissues and cell lines, and the effect of miR-345-5p on the proliferation and invasiveness of pancreatic cancer was examined in Transwell assays with miR-345-5p overexpression. We used Western blot assay to explore the underlying mechanisms. Immunofluorescence staining was performed to examine changes in the cytoskeleton of PANC-1 cells in response to miR-345-5p. Luciferase assays were used to clarify the target and regulation mechanism of miR-345-5p.", "@Label": "METHODS", "@NlmCategory": "METHODS"}, {"#text": "miR-345-5p expression was downregulated in PDAC cells and tissues. Upregulated miR-345-5p expression inhibited the proliferation and metastasis of PDAC cells. We identified CCL8 as a direct target of miR-345-5p and found CCL8 expression was inversely correlated with miR-345-5p expression in PDAC samples. CCL8 could activate the NF-\u03baB signaling pathway to promote the proliferation and invasiveness of PDAC cells. These results suggested that miR-345-5p inhibited PDAC progression by inactivating NF-\u03baB signaling.", "@Label": "RESULTS", "@NlmCategory": "RESULTS"}, {"#text": "Here we demonstrated that miR-345-5p was a tumor-suppressive miRNA in pancreatic cancer progression by targeting CCL8. Our results suggest miR-345-5p may be a potential therapeutic biomarker for pancreatic cancer treatment.", "@Label": "CONCLUSIONS", "@NlmCategory": "CONCLUSIONS"}], "CopyrightInformation": "Copyright \u00a9 2019 Elsevier Masson SAS. All rights reserved."}, "ArticleDate": {"@DateType": "Electronic", "Day": "07", "Month": "01", "Year": "2019"}, "ArticleTitle": "MiR-345-5p functions as a tumor suppressor in pancreatic cancer by directly targeting CCL8.", "AuthorList": {"@CompleteYN": "Y", "Author": [{"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Hepatic-Biliary-Pancreatic Surgery, the First people's Hospital of Neijiang, Neijiang, Sichuan, China."}, "ForeName": "Tinggang", "Initials": "T", "LastName": "Mou"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Hepatic-Biliary-Pancreatic Surgery, the First people's Hospital of Neijiang, Neijiang, Sichuan, China."}, "ForeName": "Fei", "Initials": "F", "LastName": "Xie"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Hepatic-Biliary-Pancreatic Surgery, the First people's Hospital of Neijiang, Neijiang, Sichuan, China."}, "ForeName": "Pingyong", "Initials": "P", "LastName": "Zhong"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Hepatic-Biliary-Pancreatic Surgery, the First people's Hospital of Neijiang, Neijiang, Sichuan, China."}, "ForeName": "Hao", "Initials": "H", "LastName": "Hua"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Hepatic-Biliary-Pancreatic Surgery, the First people's Hospital of Neijiang, Neijiang, Sichuan, China."}, "ForeName": "Liang", "Initials": "L", "LastName": "Lai"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Gastroenterology, the First people's Hospital of Neijiang, Neijiang, Sichuan, China."}, "ForeName": "Qin", "Initials": "Q", "LastName": "Yang"}, {"@ValidYN": "Y", "AffiliationInfo": {"Affiliation": "Department of Hepatic-Biliary-Pancreatic Surgery, the First people's Hospital of Neijiang, Neijiang, Sichuan, China. Electronic address: 348688347@qq.com."}, "ForeName": "Jie", "Initials": "J", "LastName": "Wang"}]}, "ELocationID": [{"#text": "10.1016/j.biopha.2018.12.121", "@EIdType": "doi", "@ValidYN": "Y"}, {"#text": "S0753-3322(18)37198-1", "@EIdType": "pii", "@ValidYN": "Y"}], "Journal": {"ISOAbbreviation": "Biomed Pharmacother", "ISSN": {"#text": "1950-6007", "@IssnType": "Electronic"}, "JournalIssue": {"@CitedMedium": "Internet", "PubDate": {"Month": "Mar", "Year": "2019"}, "Volume": "111"}, "Title": "Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"}, "Language": "eng", "Pagination": {"EndPage": "900", "MedlinePgn": "891-900", "StartPage": "891"}, "PublicationTypeList": {"PublicationType": {"#text": "Journal Article", "@UI": "D016428"}}}, "ChemicalList": {"Chemical": [{"NameOfSubstance": {"#text": "CCL8 protein, human", "@UI": "C515453"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "Chemokine CCL8", "@UI": "D054412"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "MIRN345 microRNA, human", "@UI": "C561417"}, "RegistryNumber": "0"}, {"NameOfSubstance": {"#text": "MicroRNAs", "@UI": "D035683"}, "RegistryNumber": "0"}]}, "CitationSubset": "IM", "DateCompleted": {"Day": "21", "Month": "06", "Year": "2019"}, "DateRevised": {"Day": "21", "Month": "06", "Year": "2019"}, "KeywordList": {"@Owner": "NOTNLM", "Keyword": [{"#text": "CCL8", "@MajorTopicYN": "N"}, {"#text": "Invasion", "@MajorTopicYN": "N"}, {"#text": "Migration", "@MajorTopicYN": "N"}, {"#text": "PDAC", "@MajorTopicYN": "N"}, {"#text": "Proliferation", "@MajorTopicYN": "N"}, {"#text": "miR-345-5p", "@MajorTopicYN": "N"}]}, "MedlineJournalInfo": {"Country": "France", "ISSNLinking": "0753-3322", "MedlineTA": "Biomed Pharmacother", "NlmUniqueID": "8213295"}, "MeshHeadingList": {"MeshHeading": [{"DescriptorName": {"#text": "Adult", "@MajorTopicYN": "N", "@UI": "D000328"}}, {"DescriptorName": {"#text": "Aged", "@MajorTopicYN": "N", "@UI": "D000368"}}, {"DescriptorName": {"#text": "Cell Line", "@MajorTopicYN": "N", "@UI": "D002460"}}, {"DescriptorName": {"#text": "Cell Line, Tumor", "@MajorTopicYN": "N", "@UI": "D045744"}}, {"DescriptorName": {"#text": "Cell Proliferation", "@MajorTopicYN": "N", "@UI": "D049109"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Chemokine CCL8", "@MajorTopicYN": "N", "@UI": "D054412"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Down-Regulation", "@MajorTopicYN": "N", "@UI": "D015536"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Female", "@MajorTopicYN": "N", "@UI": "D005260"}}, {"DescriptorName": {"#text": "Genes, Tumor Suppressor", "@MajorTopicYN": "N", "@UI": "D016147"}, "QualifierName": {"#text": "physiology", "@MajorTopicYN": "Y", "@UI": "Q000502"}}, {"DescriptorName": {"#text": "Humans", "@MajorTopicYN": "N", "@UI": "D006801"}}, {"DescriptorName": {"#text": "Male", "@MajorTopicYN": "N", "@UI": "D008297"}}, {"DescriptorName": {"#text": "MicroRNAs", "@MajorTopicYN": "N", "@UI": "D035683"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Middle Aged", "@MajorTopicYN": "N", "@UI": "D008875"}}, {"DescriptorName": {"#text": "Neoplasm Invasiveness", "@MajorTopicYN": "N", "@UI": "D009361"}, "QualifierName": [{"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}, {"#text": "pathology", "@MajorTopicYN": "N", "@UI": "Q000473"}]}, {"DescriptorName": {"#text": "Neoplasm Metastasis", "@MajorTopicYN": "N", "@UI": "D009362"}, "QualifierName": [{"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}, {"#text": "pathology", "@MajorTopicYN": "N", "@UI": "Q000473"}]}, {"DescriptorName": {"#text": "Pancreatic Neoplasms", "@MajorTopicYN": "N", "@UI": "D010190"}, "QualifierName": [{"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}, {"#text": "pathology", "@MajorTopicYN": "N", "@UI": "Q000473"}]}, {"DescriptorName": {"#text": "Signal Transduction", "@MajorTopicYN": "N", "@UI": "D015398"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "Y", "@UI": "Q000235"}}, {"DescriptorName": {"#text": "Up-Regulation", "@MajorTopicYN": "N", "@UI": "D015854"}, "QualifierName": {"#text": "genetics", "@MajorTopicYN": "N", "@UI": "Q000235"}}]}, "PMID": {"#text": "30841468", "@Version": "1"}}, "PubmedData": {"ArticleIdList": {"ArticleId": [{"#text": "30841468", "@IdType": "pubmed"}, {"#text": "10.1016/j.biopha.2018.12.121", "@IdType": "doi"}, {"#text": "S0753-3322(18)37198-1", "@IdType": "pii"}]}, "History": {"PubMedPubDate": [{"@PubStatus": "received", "Day": "10", "Month": "10", "Year": "2018"}, {"@PubStatus": "revised", "Day": "29", "Month": "12", "Year": "2018"}, {"@PubStatus": "accepted", "Day": "30", "Month": "12", "Year": "2018"}, {"@PubStatus": "entrez", "Day": "8", "Hour": "6", "Minute": "0", "Month": "3", "Year": "2019"}, {"@PubStatus": "pubmed", "Day": "8", "Hour": "6", "Minute": "0", "Month": "3", "Year": "2019"}, {"@PubStatus": "medline", "Day": "22", "Hour": "6", "Minute": "0", "Month": "6", "Year": "2019"}]}, "PublicationStatus": "ppublish"}}}}, "PMC": null, "PMID": "30841468", "QueryTranslation": null, "ReferenceCrawlerDeep": 0, "References": null, "State": -1, "Title": "MiR-345-5p functions as a tumor suppressor in pancreatic cancer by directly targeting CCL8.", "FlagAffiliationMining": 0, "FlagExtractKG": null}}}